Citrus Sinensis ID: 039516

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-----
Protein Sequence
MDFENNTGCQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLLMLPPKNQKLPKTSQKFVPYIKNRLQRLKQDKSNTGSEIIFCIDEAKRHRDA
Secondary Structure (PSIPRED)
cccccccccccccccHHHHHHHHcccccccccccccccccEEEccccccEEEEEEcccccccHHHHHHHHHHHHHHHcccccccEEcccccccEEEEEEEcccccccHHHHHHHHHHHHHHccccccEEEEccccccccccccccccccccccccccccccccccccccEEEEcccccHHHHccccccccccccccEEEEEEEEEcccccccccccccccHHHHHHHHccccccccccccccccccccccEEEEEEEEEccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHccccc
Secondary Structure Prediction (SSPRO)
cccccccccEEEHccHHHHHHHHccccHHccccccccccEEccccccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHHHEcccccEEEEEEEcccccHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEcccccEEccccEEEEEcccccHHHHHcccEcEcccHEHHEEEEEEEEccccccccccccccHHHHHHHHHHHHccccHHHccHHHcccccHHHHHHHHHHHHHHcccccHcccccHHHHHHHHccccccccccccccccccccccccccccccEEEEcccccccccccccccccEEEEHHHHHHcccc
Coil and Loop (DISEMBL)
mdfenntgcqtwsegakfvensSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWtsgqgrveFQNEAKLIAKLQYTNLVKLLGcsihgeerllvyefmpnksldssfsgtfkDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIfgvnesgantnrivgTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCgkknnksyhterplNLVGIAWQLWnegkdlelidltldgscppnedAFLLVSCVCkskqqidvqcpmlfpcllmnllpglylknlhfllmlppknqklpktsqkfVPYIKNRLQRLKqdksntgseiIFCIDEAKRHRDA
Flexible Loop (DISEMBL)
mdfenntgcqtwsegAKFVENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKasnillddqLNTKISDFGMARIfgvnesgantnrIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLLMLPPKNQKLPKTSQKFVPYIKNRLQrlkqdksntgseiifcideakrhrda
Low Complexity Region (SEG)
MDFENNTGCQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLLMLPPKNQKLPKTSQKFVPYIKNRLQRLKQDKSNTGSEIIFCIDEAKRHRDA
Disordered region (IsUnstruct)
********CQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLLMLPP**********KFVPYIKNRL************EIIFCI*********
Disordered Region (DISOPRED)
******TGCQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNL*******************************************FCI**AK*****
Disordered Region (DISEMBL)
*********QTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLLMLPPKNQKLPKTSQKFVPYIKNRLQRLKQDKSNTGSEIIFCIDEAKRHRDA
Disordered Region (DISPRO)
*****NTGCQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM*FPCLLMNLLPGLYLKNLHFLLMLPPKNQKLPKTSQKFVPYIKN***************II***DEAK*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDFENNTGCQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLLMLPPKNQKLPKTSQKFVPYIKNRLQRLKQDKSNTGSEIIFCIDEAKRHRDA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	345	2.2.26 [Sep-21-2011]
Q9LW83	850	G-type lectin S-receptor-	yes	no	0.646	0.262	0.528	1e-62
Q8GYA4	669	Cysteine-rich receptor-li	no	no	0.808	0.417	0.438	1e-62
O64793	818	G-type lectin S-receptor-	no	no	0.591	0.249	0.560	7e-62
Q9ZR08	852	G-type lectin S-receptor-	no	no	0.591	0.239	0.531	6e-61
Q9SXB8	842	G-type lectin S-receptor-	no	no	0.591	0.242	0.536	3e-60
Q8W4G6	627	Cysteine-rich receptor-li	no	no	0.617	0.339	0.502	4e-60
Q9LDQ3	669	Putative cysteine-rich re	no	no	0.684	0.352	0.494	6e-60
Q8L7G3	659	Cysteine-rich receptor-li	no	no	0.802	0.420	0.414	1e-58
O81906	849	G-type lectin S-receptor-	no	no	0.681	0.276	0.486	2e-58
O81905	850	Receptor-like serine/thre	no	no	0.582	0.236	0.520	4e-58

>sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2

 Score =  240 bits (612), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 128/242 (52%), Positives = 159/242 (65%), Gaps = 19/242 (7%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G+  + +EVAIKRL+  SGQG VEF+NEA LIAKLQ+TNLVKLLGC +  +E++L+YE+M
Sbjct: 544 GRLIDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYM 603

Query: 103 PNKSLD------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
           PNKSLD                      G  + LL LHKYSRL+VIHRD+KA NILLD+ 
Sbjct: 604 PNKSLDYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDED 663

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +N KISDFGMARIFG  ES ANT R+ GT+GYMS EY   G  S K+DVF FGVL+L+I+
Sbjct: 664 MNPKISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEII 723

Query: 205 CGKKNNKSYH-TERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSK 263
           CG+KNN  +H +E PLNL+   W L+ E +  E+ID +L  S   N      V       
Sbjct: 724 CGRKNNSFHHDSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCV 783

Query: 264 QQ 265
           QQ
Sbjct: 784 QQ 785

Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  240 bits (612), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 138/315 (43%), Positives = 187/315 (59%), Gaps = 36/315 (11%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G   +  EVA+KRL+ +SGQG VEF+NE  L+AKLQ+ NLV+LLG  + GEER+LVYE++
Sbjct: 365 GTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYV 424

Query: 103 PNKSLD------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
           PNKSLD                      G  + +L LH+ SRL +IHRDLKASNILLD  
Sbjct: 425 PNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDAD 484

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +N KI+DFGMARIFG++++  NT+RIVGTYGYMS EY M G  S+K+DV+ FGVLVL+I+
Sbjct: 485 MNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEII 544

Query: 205 CGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQ 264
            GKKN+  Y T+   +LV  AW LW+ G+ LEL+D  +  +C  NE    +V CV     
Sbjct: 545 SGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNE----VVRCV----- 595

Query: 265 QIDVQCPMLFPCLLMNLLPGLYLKNLHFLLMLPPKNQKLPKTSQKFVPYIKNRLQRLKQD 324
            I + C    P     L           +LML      LP   Q  + + ++R+ +   D
Sbjct: 596 HIGLLCVQEDPAERPTLST--------IVLMLTSNTVTLPVPRQPGL-FFQSRIGKDPLD 646

Query: 325 KSNTGSEIIFCIDEA 339
              T   ++  +D+A
Sbjct: 647 TDTTSKSLLGSVDDA 661

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3

 Score =  238 bits (606), Expect = 7e-62,   Method: Compositional matrix adjust.
 Identities = 125/223 (56%), Positives = 155/223 (69%), Gaps = 19/223 (8%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           GK  N +EVAIKRL+  SGQG VEF+NEA LIAKLQ+TNLV++LGC I  +E++L+YE+M
Sbjct: 513 GKLLNGEEVAIKRLSLASGQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYM 572

Query: 103 PNKSLD------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
            NKSLD                      G  + LL LHKYSRL+VIHRD+KASNILLD+ 
Sbjct: 573 QNKSLDYFLFDPLRKNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDED 632

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +N KISDFG+ARIFG  E+ ANT R+ GT+GYMS EY   G  S K+DVF FGVL+L+I+
Sbjct: 633 MNPKISDFGLARIFGAEETRANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEII 692

Query: 205 CGKKNNKSYHT-ERPLNLVGIAWQLWNEGKDLELIDLTLDGSC 246
           CG+KNN  +H  E PLNL+   W L+ E K  E+IDL+L  S 
Sbjct: 693 CGRKNNSFHHDLEGPLNLIVHVWNLFKENKIREVIDLSLRDSA 735

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3

 Score =  234 bits (598), Expect = 6e-61,   Method: Compositional matrix adjust.
 Identities = 118/222 (53%), Positives = 155/222 (69%), Gaps = 18/222 (8%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G FP +QE+A+KRL+  SGQG  EF+NE  LIAKLQ+ NLV+LLG  + GEE+LL+YE+M
Sbjct: 549 GMFPGDQEIAVKRLSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYM 608

Query: 103 PNKSLD------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
           P+KSLD                  +   G  + LL LH+ SRLR+IHRDLK SNILLD++
Sbjct: 609 PHKSLDFFIFDRKLCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEE 668

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +N KISDFG+ARIFG +E+ ANTNR+VGTYGYMS EY + G  S K+DVF FGV+V++ +
Sbjct: 669 MNPKISDFGLARIFGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETI 728

Query: 205 CGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC 246
            GK+N   +  E+ L+L+G AW LW   + +EL+D  L  SC
Sbjct: 729 SGKRNTGFHEPEKSLSLLGHAWDLWKAERGIELLDQALQESC 770

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  232 bits (592), Expect = 3e-60,   Method: Compositional matrix adjust.
 Identities = 119/222 (53%), Positives = 148/222 (66%), Gaps = 18/222 (8%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           GK P  QE+A+KRL+  SGQG  E  NE  +I+KLQ+ NLVKLLGC I GEER+LVYE+M
Sbjct: 541 GKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYM 600

Query: 103 PNKSLDSSF------------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
           P KSLD+                     G  + LL LH+ SRL++IHRDLKASNILLD+ 
Sbjct: 601 PKKSLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDEN 660

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           LN KISDFG+ARIF  NE  ANT R+VGTYGYMS EY M G  S K+DVF  GV+ L+I+
Sbjct: 661 LNPKISDFGLARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEII 720

Query: 205 CGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC 246
            G++N+ S+  E  LNL+  AW+LWN+G+   L D  +   C
Sbjct: 721 SGRRNSSSHKEENNLNLLAYAWKLWNDGEAASLADPAVFDKC 762

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2

 Score =  231 bits (590), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 118/235 (50%), Positives = 160/235 (68%), Gaps = 22/235 (9%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G F N  EVA+KRL+ +SGQG  EF+NE  ++AKLQ+ NLV+LLG SI G ER+LVYE+M
Sbjct: 354 GTFSNGTEVAVKRLSKSSGQGDTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYM 413

Query: 103 PNKSLD------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
           PNKSLD                      G  + +L LH+ SRL +IHRDLKASNILLD  
Sbjct: 414 PNKSLDYFLFDPAKQNQLDWTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDAD 473

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +N K++DFG+ARIFG++++  NT+RIVGT+GYM+ EY + G  S+K+DV+ FGVLVL+I+
Sbjct: 474 MNPKLADFGLARIFGMDQTQENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEII 533

Query: 205 CGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCV 259
            GKKNN  Y T+   +LV  AW+LW+ G  L+L+D  +  +C  +E    +V C+
Sbjct: 534 SGKKNNSFYETDGAHDLVTHAWRLWSNGTALDLVDPIIIDNCQKSE----VVRCI 584

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3

 Score =  231 bits (589), Expect = 6e-60,   Method: Compositional matrix adjust.
 Identities = 128/259 (49%), Positives = 169/259 (65%), Gaps = 23/259 (8%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           GK  +  EVA+KRL+ TSGQG  EF+NEA L++KLQ+ NLV+LLG  + GEE++LVYEF+
Sbjct: 362 GKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFV 421

Query: 103 PNKSLD------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
           PNKSLD                  +   G  + +L LH+ SRL +IHRDLKASNILLD  
Sbjct: 422 PNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDAD 481

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +N KI+DFGMARIFGV++S ANT RI GT+GYMS EY M G  S+K+DV+ FGVLVL+I+
Sbjct: 482 MNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEII 541

Query: 205 CGKKNNKSYHTERP-LNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLL-VSCVCKS 262
            GKKN+  Y+ +    NLV  AW+LW  G  LEL+D T+  S   +E    + ++ +C  
Sbjct: 542 SGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQ 601

Query: 263 KQQIDVQCPMLFPCLLMNL 281
           +   D     L P ++M L
Sbjct: 602 EDPADRP---LLPAIIMML 617

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1

 Score =  227 bits (578), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 134/323 (41%), Positives = 184/323 (56%), Gaps = 46/323 (14%)

Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           +  G F N  EVA+KRL+ TS QG  EF+NE  ++A L++ NLV++LG SI  EER+LVY
Sbjct: 350 VYKGTFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVY 409

Query: 100 EFMPNKSLDSSF------------------SGTFKDLLCLHKYSRLRVIHRDLKASNILL 141
           E++ NKSLD+                     G  + +L LH+ SRL +IHRDLKASNILL
Sbjct: 410 EYVENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILL 469

Query: 142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVL 201
           D  +N KI+DFGMARIFG++++  NT+RIVGTYGYMS EY M G  S+K+DV+ FGVLVL
Sbjct: 470 DADMNPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVL 529

Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCK 261
           +I+ G+KNN    T+   +LV  AW+LW  G  L+L+D  +  SC  +E    +V C   
Sbjct: 530 EIISGRKNNSFIETDDAQDLVTHAWRLWRNGTALDLVDPFIADSCRKSE----VVRCT-- 583

Query: 262 SKQQIDVQC----PMLFPCLLMNLLPGLYLKNLHFLLMLPPKNQKLPKTSQKFVPYIKNR 317
               I + C    P+  P +                +ML      LP   Q    ++++R
Sbjct: 584 ---HIGLLCVQEDPVKRPAMST------------ISVMLTSNTMALPAPQQPGF-FVRSR 627

Query: 318 --LQRLKQDKSNTGSEIIFCIDE 338
               RL  D+S T   +   ID+
Sbjct: 628 PGTNRLDSDQSTTNKSVTVSIDD 650

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  226 bits (577), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 124/255 (48%), Positives = 161/255 (63%), Gaps = 20/255 (7%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G   + +E+A+KRL+  SGQG  EF+NE  LIAKLQ+ NLV+LLGC   GEE++LVYE+M
Sbjct: 546 GVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYM 605

Query: 103 PNKSLD------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
           PNKSLD                  S   G  + LL LH+ SRLR+IHRDLK SN+LLD +
Sbjct: 606 PNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAE 665

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +N KISDFGMARIFG N++ ANT R+VGTYGYMS EY M G  S+K+DV+ FGVL+L+IV
Sbjct: 666 MNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIV 725

Query: 205 CGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQ 264
            GK+N     +E   +L+G AW L+  G+  EL+D  +  +C   E A   +       Q
Sbjct: 726 SGKRNTSLRSSEHG-SLIGYAWYLYTHGRSEELVDPKIRVTCSKRE-ALRCIHVAMLCVQ 783

Query: 265 QIDVQCPMLFPCLLM 279
               + P +   LLM
Sbjct: 784 DSAAERPNMASVLLM 798

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  225 bits (573), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 114/219 (52%), Positives = 151/219 (68%), Gaps = 18/219 (8%)

Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           ++  GK  + QE+A+KRL+ TS QG  EF+NE KLIA+LQ+ NLV+LL C +   E++L+
Sbjct: 539 IVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLI 598

Query: 99  YEFMPNKSLDSSF------------------SGTFKDLLCLHKYSRLRVIHRDLKASNIL 140
           YE++ N SLDS                    +G  + LL LH+ SR R+IHRDLKASNIL
Sbjct: 599 YEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNIL 658

Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           LD  +  KISDFGMARIFG +E+ ANT ++VGTYGYMS EY M G  S+K+DVF FGVL+
Sbjct: 659 LDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLL 718

Query: 201 LKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID 239
           L+I+  K+N   Y+++R LNL+G  W+ W EGK LE+ID
Sbjct: 719 LEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIID 757

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	345
255550026	795	Serine/threonine-protein kinase PBS1, pu	0.602	0.261	0.615	4e-69
356556159	480	PREDICTED: G-type lectin S-receptor-like	0.594	0.427	0.615	8e-69
357515969	796	Serine/threonine protein kinase [Medicag	0.602	0.261	0.584	2e-68
359482600	789	PREDICTED: G-type lectin S-receptor-like	0.6	0.262	0.610	3e-68
56561617	637	S-receptor kinase-like protein 1 [Seneci	0.6	0.324	0.591	5e-68
357516099	384	S-receptor kinase-like protein [Medicago	0.602	0.541	0.584	2e-67
224056633	756	predicted protein [Populus trichocarpa]	0.611	0.279	0.589	5e-67
357516031	806	S-receptor kinase-like protein [Medicago	0.611	0.261	0.576	8e-67
357516025	805	S-receptor kinase-like protein [Medicago	0.611	0.262	0.576	8e-67
357516049	798	Serine/threonine protein kinase [Medicag	0.602	0.260	0.579	1e-66

>gi|255550026|ref|XP_002516064.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223544969|gb|EEF46484.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis]

 Score =  268 bits (684), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 139/226 (61%), Positives = 166/226 (73%), Gaps = 18/226 (7%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           GK  + QE+AIKRL+ +SGQG VEF+NEA LIAKLQ+TNLVKLLG  + GEER+LVYE+M
Sbjct: 494 GKLLDGQEIAIKRLSRSSGQGLVEFKNEAILIAKLQHTNLVKLLGFCVDGEERILVYEYM 553

Query: 103 PNKSLD------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
           P KSLD                      G  + LL LHKYSRL+VIHRDLKASNILLDD+
Sbjct: 554 PKKSLDIYLFDSHKKSELDWKKRFKIIDGITQGLLYLHKYSRLKVIHRDLKASNILLDDE 613

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +N KISDFGMARIFG+ ES ANTNRIVGTYGYMS EY M+G VS KTDVF FGVL+L+I+
Sbjct: 614 MNPKISDFGMARIFGLKESEANTNRIVGTYGYMSPEYAMNGVVSTKTDVFSFGVLLLEII 673

Query: 205 CGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE 250
            G+KN   +++E P+NL+G AW LW + + LELID  LD   P N+
Sbjct: 674 SGRKNTSFHYSECPINLIGYAWLLWKDNRGLELIDPKLDEFLPQNQ 719

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356556159|ref|XP_003546394.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase CES101-like [Glycine max]

 Score =  266 bits (681), Expect = 8e-69,   Method: Compositional matrix adjust.
 Identities = 139/226 (61%), Positives = 164/226 (72%), Gaps = 21/226 (9%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G   ++QEVAIKRL+ +SGQG +EF NEAKL+AKLQ+TNLVKLLG  I  +ER+LVYE+M
Sbjct: 182 GNLSDQQEVAIKRLSKSSGQGLIEFTNEAKLMAKLQHTNLVKLLGFCIQRDERILVYEYM 241

Query: 103 PNKSLD------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
            NKSLD                  +   G  + LL LHKYSRL+VIHRDLKASNILLD +
Sbjct: 242 SNKSLDFYLFDSARKDLLDWEKRLNIIGGIAQGLLYLHKYSRLKVIHRDLKASNILLDHE 301

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +N KISDFGMARIFGV  S  NTNR+VGTYGYM+ EY M G VSIKTDVF FGVL+L+I+
Sbjct: 302 MNAKISDFGMARIFGVRVSEENTNRVVGTYGYMAPEYAMKGVVSIKTDVFSFGVLLLEIL 361

Query: 205 CGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE 250
             KKNN  YH++ PLNL+G    LWN G+ LELID TL+G C  NE
Sbjct: 362 SSKKNNSRYHSDHPLNLIG---YLWNAGRALELIDSTLNGLCSQNE 404

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357515969|ref|XP_003628273.1| Serine/threonine protein kinase [Medicago truncatula] gi|355522295|gb|AET02749.1| Serine/threonine protein kinase [Medicago truncatula]

 Score =  265 bits (678), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 132/226 (58%), Positives = 166/226 (73%), Gaps = 18/226 (7%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G  P  QE+A+KRL+ TSGQG VEF+NE  LI +LQ+TNLV+LLGC IH EER+L+YE+M
Sbjct: 491 GILPTGQEIAVKRLSKTSGQGIVEFKNEFVLICELQHTNLVQLLGCCIHQEERILIYEYM 550

Query: 103 PNKSLD------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
           PNKSLD                  +   G  + LL LHKYSRL++IHRDLKASNILLD+ 
Sbjct: 551 PNKSLDFYLFDSTRRKCLDWKKRLNIIEGISQGLLYLHKYSRLKIIHRDLKASNILLDEN 610

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +N KISDFGMAR+F   ES  NTNRIVGTYGYMS EY M G  S K+DV+ FGVL+L+I+
Sbjct: 611 MNPKISDFGMARMFTQQESVVNTNRIVGTYGYMSPEYAMEGICSTKSDVYSFGVLLLEII 670

Query: 205 CGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE 250
           CG++NN  Y  +RPLNL+G AW+LWN+G+ L+L+D TL+ +  P+E
Sbjct: 671 CGRRNNSFYDVDRPLNLIGHAWELWNDGEYLQLMDPTLNDTFVPDE 716

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482600|ref|XP_003632790.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase CES101-like [Vitis vinifera]

 Score =  265 bits (676), Expect = 3e-68,   Method: Compositional matrix adjust.
 Identities = 138/226 (61%), Positives = 166/226 (73%), Gaps = 19/226 (8%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           GK  + QE+AIKRL+ +S QG VEF+NE  LIAKLQ+ NLVKLLGC I  EE++L+YE++
Sbjct: 487 GKLLDGQEIAIKRLSKSSRQGLVEFKNEIALIAKLQHDNLVKLLGCCIKEEEKILIYEYL 546

Query: 103 PNKSLD------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
           PNKSLD                  +   G  + LL LHK+SRLRVIHRDLKASNILLD++
Sbjct: 547 PNKSLDFFIFDPSKKNLLNWKKRYNIIEGITQGLLYLHKFSRLRVIHRDLKASNILLDNE 606

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +N KISDFGMARIFG +E  ANTNR+VGTYGYMS EY M G  S K+DVF FGVL+L+IV
Sbjct: 607 MNPKISDFGMARIFGQDECEANTNRVVGTYGYMSPEYVMQGIFSTKSDVFSFGVLLLEIV 666

Query: 205 CGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL-DGSCPPN 249
             KKN+ +YH ERPLNL+G AW+LW EGK+LEL+D TL DG    N
Sbjct: 667 SSKKNHSNYHYERPLNLIGYAWELWKEGKELELMDQTLCDGPSSNN 712

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|56561617|emb|CAG28412.1| S-receptor kinase-like protein 1 [Senecio squalidus]

 Score =  264 bits (674), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 133/225 (59%), Positives = 163/225 (72%), Gaps = 18/225 (8%)

Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           +  GK  + +E+AIKRL+ TSGQG VEF+NE  LIAKLQ+TNLV++LGC IHGEE++L+Y
Sbjct: 334 VYKGKLSDGREIAIKRLSRTSGQGLVEFKNELILIAKLQHTNLVRVLGCCIHGEEKMLIY 393

Query: 100 EFMPNKSLD------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILL 141
           E+MPNKSLD                  +   G  + LL LHKYSR+RVIHRDLKA+NILL
Sbjct: 394 EYMPNKSLDFFLFDENRKAELDWPKRFNIIEGIAQGLLYLHKYSRMRVIHRDLKANNILL 453

Query: 142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVL 201
           D+ LN KISDFGMARIF  NE+ A TNR+VGTYGYMS EY M GT SIK+D+F FGVL+L
Sbjct: 454 DENLNPKISDFGMARIFKENETEAMTNRVVGTYGYMSPEYAMEGTFSIKSDIFSFGVLML 513

Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC 246
           +IV G+KN    H +R  NL+G AW+LW +G  LEL D TL  +C
Sbjct: 514 EIVTGRKNTSFVHLDRTFNLIGYAWELWQQGDTLELKDPTLGETC 558

Source: Senecio squalidus

Species: Senecio squalidus

Genus: Senecio

Family: Asteraceae

Order: Asterales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357516099|ref|XP_003628338.1| S-receptor kinase-like protein [Medicago truncatula] gi|355522360|gb|AET02814.1| S-receptor kinase-like protein [Medicago truncatula]

 Score =  262 bits (670), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 132/226 (58%), Positives = 164/226 (72%), Gaps = 18/226 (7%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G     QEVA+KRL+ TSGQG VEF+NE  LI +LQ+ NLV+LLGC IH EER+L+YE+M
Sbjct: 80  GILATGQEVAVKRLSKTSGQGIVEFKNELVLICELQHKNLVQLLGCCIHEEERILIYEYM 139

Query: 103 PNKSLD------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
           PNKSLD                  +   G  + LL LHKYSRL++IHRDLKASNILLD+ 
Sbjct: 140 PNKSLDFYLFDCTKKKFLDWKKRFNIIEGISQGLLYLHKYSRLKIIHRDLKASNILLDEN 199

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +N KI+DFGMAR+F   ES  NTNRIVGTYGYMS EY M G  S K+DV+ FGVL+L+IV
Sbjct: 200 MNPKIADFGMARMFTQQESVVNTNRIVGTYGYMSPEYAMEGVCSTKSDVYSFGVLLLEIV 259

Query: 205 CGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE 250
           CG+KNN  Y  +RPLNL+G AW+LWN+G+ L+L+D TL+ +  P+E
Sbjct: 260 CGRKNNSFYDGDRPLNLIGHAWELWNDGEYLKLMDPTLNDTFVPDE 305

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224056633|ref|XP_002298946.1| predicted protein [Populus trichocarpa] gi|222846204|gb|EEE83751.1| predicted protein [Populus trichocarpa]

 Score =  261 bits (666), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 135/229 (58%), Positives = 163/229 (71%), Gaps = 18/229 (7%)

Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           +  GK P+ +EVA+KRL+ TS QG VEF+NE  LIA LQ++NLVKLLGC + GEE++LVY
Sbjct: 441 VYKGKLPDGREVAVKRLSRTSRQGLVEFKNELILIANLQHSNLVKLLGCCVEGEEKMLVY 500

Query: 100 EFMPNKSLDS-----------SFSGTFK-------DLLCLHKYSRLRVIHRDLKASNILL 141
           E+MPNKSLDS            +   FK        LL LHKYSRLR+IHRDLKASNILL
Sbjct: 501 EYMPNKSLDSFIFDQSRRELLDWKKRFKIIEEIAQGLLYLHKYSRLRIIHRDLKASNILL 560

Query: 142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVL 201
           ++ L+ KISDFGMARIF +NE  ANTNRIVGTYGYMS EY M G  S+K+D + FGVLVL
Sbjct: 561 NEDLSPKISDFGMARIFKINELEANTNRIVGTYGYMSPEYAMEGVFSVKSDAYSFGVLVL 620

Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE 250
           +IV G+KN      + PLNLVG AW+LW EG   EL+D TL  SC  ++
Sbjct: 621 EIVSGRKNRGLLQMDPPLNLVGYAWELWKEGNQFELVDSTLRDSCSEDQ 669

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357516031|ref|XP_003628304.1| S-receptor kinase-like protein [Medicago truncatula] gi|355522326|gb|AET02780.1| S-receptor kinase-like protein [Medicago truncatula]

 Score =  260 bits (664), Expect = 8e-67,   Method: Compositional matrix adjust.
 Identities = 132/229 (57%), Positives = 165/229 (72%), Gaps = 18/229 (7%)

Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           +  G     QEVA+KRL+ TSGQG VEF+NE  LI +LQ+TNLV+LLGC IH EER+L+Y
Sbjct: 497 VYKGILATGQEVAVKRLSKTSGQGIVEFRNELALICELQHTNLVQLLGCCIHEEERILIY 556

Query: 100 EFMPNKSLD------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILL 141
           E+MPNKSLD                  +   G  + LL LHKYSRL++IHRDLKASNILL
Sbjct: 557 EYMPNKSLDFYLFDCTRKKLLDWKKRLNIIEGISQGLLYLHKYSRLKIIHRDLKASNILL 616

Query: 142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVL 201
           D+ +N KISDFGMAR+F   ES  NTNRIVGTYGYMS EY M G  S K+DV+ FGVL+L
Sbjct: 617 DENMNPKISDFGMARMFTQQESTVNTNRIVGTYGYMSPEYAMEGICSTKSDVYSFGVLLL 676

Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE 250
           +IVCG+KNN  +  +RPLNL+G AW+LWN+G+ L+L+D +L  +  P+E
Sbjct: 677 EIVCGRKNNSFHDVDRPLNLIGHAWELWNDGEYLQLLDPSLCDTFVPDE 725

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357516025|ref|XP_003628301.1| S-receptor kinase-like protein [Medicago truncatula] gi|355522323|gb|AET02777.1| S-receptor kinase-like protein [Medicago truncatula]

 Score =  260 bits (664), Expect = 8e-67,   Method: Compositional matrix adjust.
 Identities = 132/229 (57%), Positives = 165/229 (72%), Gaps = 18/229 (7%)

Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           +  G     QEVA+KRL+ TSGQG VEF+NE  LI +LQ+TNLV+LLGC IH EER+L+Y
Sbjct: 496 VYKGILATGQEVAVKRLSKTSGQGIVEFRNELALICELQHTNLVQLLGCCIHEEERILIY 555

Query: 100 EFMPNKSLD------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILL 141
           E+MPNKSLD                  +   G  + LL LHKYSRL++IHRDLKASNILL
Sbjct: 556 EYMPNKSLDFYLFDCTRKKLLDWKKRLNIIEGISQGLLYLHKYSRLKIIHRDLKASNILL 615

Query: 142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVL 201
           D+ LN KISDFGMAR+F   ES  NTNRIVGTYGYMS EY M G  S K+DV+ FGVL+L
Sbjct: 616 DENLNPKISDFGMARMFTQQESIVNTNRIVGTYGYMSPEYAMEGICSTKSDVYSFGVLLL 675

Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE 250
           +I+CG+KNN  +  +RPLNL+G AW+LWN+G+ L+L+D +L  +  P+E
Sbjct: 676 EIICGRKNNSFHDVDRPLNLIGHAWELWNDGEYLQLLDPSLCDTFVPDE 724

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357516049|ref|XP_003628313.1| Serine/threonine protein kinase [Medicago truncatula] gi|355522335|gb|AET02789.1| Serine/threonine protein kinase [Medicago truncatula]

 Score =  259 bits (663), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 131/226 (57%), Positives = 164/226 (72%), Gaps = 18/226 (7%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G     QEVAIKRL+ TSGQG +EF+NE  LI +LQ+ NLV+LLGC IH EER+L+Y++M
Sbjct: 494 GILATGQEVAIKRLSKTSGQGIMEFKNELVLICELQHINLVQLLGCCIHEEERILIYKYM 553

Query: 103 PNKSLD------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
           PNKSLD                  +   G  + LL LHKYSRL++IHRDLKASNILLD+ 
Sbjct: 554 PNKSLDFYLFDCTKKKLLDWKKRFNVIEGISQGLLYLHKYSRLKIIHRDLKASNILLDEN 613

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +N KI+DFGMAR+F   ES  NTNRIVGTYGYMS EY M G  S K+DV+ FGVL+L+IV
Sbjct: 614 MNPKIADFGMARMFTQQESVVNTNRIVGTYGYMSPEYAMEGVCSTKSDVYSFGVLLLEIV 673

Query: 205 CGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE 250
           CG+KNN  Y  +RPLNL+G AW+LWN+G+ L+L+D TL+ +  P+E
Sbjct: 674 CGRKNNSFYDVDRPLNLIGHAWELWNDGEYLKLMDPTLNDTFVPDE 719

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	345
TAIR|locus:2093397	850	CES101 "CALLUS EXPRESSION OF R	0.463	0.188	0.530	1.5e-59
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.414	0.213	0.557	7.2e-58
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.481	0.248	0.508	1.4e-57
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.382	0.155	0.586	3.8e-56
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.385	0.156	0.577	5.2e-56
TAIR|locus:2077147	676	CRK4 "cysteine-rich RLK (RECEP	0.449	0.229	0.5	9.7e-55
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.365	0.154	0.531	1.5e-54
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.388	0.157	0.585	2.3e-54
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.382	0.156	0.578	3.5e-54
TAIR|locus:2123056	656	CRK32 "cysteine-rich RLK (RECE	0.576	0.303	0.415	3.5e-54

TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)]

 Score = 416 (151.5 bits), Expect = 1.5e-59, Sum P(2) = 1.5e-59
 Identities = 87/164 (53%), Positives = 111/164 (67%)

Query:   113 GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG 172
             G  + LL LHKYSRL+VIHRD+KA NILLD+ +N KISDFGMARIFG  ES ANT R+ G
Sbjct:   632 GIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVAG 691

Query:   173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH-TERPLNLVGIAWQLWNE 231
             T+GYMS EY   G  S K+DVF FGVL+L+I+CG+KNN  +H +E PLNL+   W L+ E
Sbjct:   692 TFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLFKE 751

Query:   232 GKDLELIDLTLDGSCPPNEDAF--LLVSCVCKSKQQIDVQCPML 273
              +  E+ID +L  S   N      + V+ +C  +Q  D +  ML
Sbjct:   752 NRVREVIDPSLGDSAVENPQVLRCVQVALLCV-QQNADDRPSML 794

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 413 (150.4 bits), Expect = 7.2e-58, Sum P(2) = 7.2e-58
 Identities = 82/147 (55%), Positives = 107/147 (72%)

Query:   113 GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG 172
             G  + +L LH+ SRL +IHRDLKASNILLD  +N KI+DFGMARIFG++++  NT+RIVG
Sbjct:   453 GVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVG 512

Query:   173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEG 232
             TYGYMS EY M G  S+K+DV+ FGVLVL+I+ GKKN+  Y T+   +LV  AW LW+ G
Sbjct:   513 TYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNG 572

Query:   233 KDLELIDLTLDGSCPPNEDAFLLVSCV 259
             + LEL+D  +  +C  NE    +V CV
Sbjct:   573 RPLELVDPAIVENCQRNE----VVRCV 595

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 405 (147.6 bits), Expect = 1.4e-57, Sum P(2) = 1.4e-57
 Identities = 87/171 (50%), Positives = 116/171 (67%)

Query:   113 GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG 172
             G  + +L LH+ SRL +IHRDLKASNILLD  +N KI+DFGMARIFGV++S ANT RI G
Sbjct:   450 GIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAG 509

Query:   173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERP-LNLVGIAWQLWNE 231
             T+GYMS EY M G  S+K+DV+ FGVLVL+I+ GKKN+  Y+ +    NLV  AW+LW  
Sbjct:   510 TFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTHAWRLWRN 569

Query:   232 GKDLELIDLTLDGSCPPNEDAFLL-VSCVCKSKQQIDVQCPMLFPCLLMNL 281
             G  LEL+D T+  S   +E    + ++ +C  +   D   P+L P ++M L
Sbjct:   570 GSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADR--PLL-PAIIMML 617

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 414 (150.8 bits), Expect = 3.8e-56, Sum P(3) = 3.8e-56
 Identities = 78/133 (58%), Positives = 101/133 (75%)

Query:   112 SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
             +G  + LL LH+ SR R+IHRDLKASN+LLD  +  KISDFGMARIFG  E+ ANT R+V
Sbjct:   627 NGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVV 686

Query:   172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
             GTYGYMS EY M G  S+K+DVF FGVL+L+I+ GK+N   Y++ R LNL+G  W+ W E
Sbjct:   687 GTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKE 746

Query:   232 GKDLELID-LTLD 243
             GK+LE++D + +D
Sbjct:   747 GKELEIVDPINID 759

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 394 (143.8 bits), Expect = 5.2e-56, Sum P(2) = 5.2e-56
 Identities = 78/135 (57%), Positives = 99/135 (73%)

Query:   113 GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG 172
             G  + LL LH+ SRLRV+HRDLKASNILLD  +  KISDFGMAR+FG +++  NTNR+VG
Sbjct:   635 GIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVG 694

Query:   173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHT-ERPLNLVGIAWQLWNE 231
             T+GYMS EY M G  S+K+DV+GFGVL+L+I+ GK+   S+H  E  LN+ G AW+ WNE
Sbjct:   695 TFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRA-VSFHCHEDSLNIAGYAWRQWNE 753

Query:   232 GKDLELIDLTLDGSC 246
                 ELID  +  SC
Sbjct:   754 DNAAELIDPVIRASC 768

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 386 (140.9 bits), Expect = 9.7e-55, Sum P(2) = 9.7e-55
 Identities = 79/158 (50%), Positives = 108/158 (68%)

Query:   113 GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG 172
             G  + +L LH+ SRL +IHRDLKA NILL D +N KI+DFGMARIFG++++ ANT RIVG
Sbjct:   456 GIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVG 515

Query:   173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPL--NLVGIAWQLWN 230
             TYGYMS EY M G  S+K+DV+ FGVLVL+I+ GKKN+  Y  +     NLV   W+LW+
Sbjct:   516 TYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQMDGTSAGNLVTYTWRLWS 575

Query:   231 EGKDLELIDLTLDGSCPPNEDAFLL-VSCVCKSKQQID 267
              G  LEL+D +   +   NE +  + ++ +C  ++  D
Sbjct:   576 NGSPLELVDPSFRDNYRINEVSRCIHIALLCVQEEAED 613

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0012501 "programmed cell death" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 371 (135.7 bits), Expect = 1.5e-54, Sum P(2) = 1.5e-54
 Identities = 67/126 (53%), Positives = 95/126 (75%)

Query:   112 SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
             +G  + +L LH+ SRLR+IHRDLKA N+LLD+ +N KISDFG+A+ FG ++S ++TNR+V
Sbjct:   604 NGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVV 663

Query:   172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
             GTYGYM  EY + G  S+K+DVF FGVLVL+I+ GK N    H +  LNL+G  W++W E
Sbjct:   664 GTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVE 723

Query:   232 GKDLEL 237
              +++E+
Sbjct:   724 DREIEV 729

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 406 (148.0 bits), Expect = 2.3e-54, Sum P(2) = 2.3e-54
 Identities = 79/135 (58%), Positives = 101/135 (74%)

Query:   112 SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
             +G  + LL LH+ SR R+IHRDLKASNILLD  +  KISDFGMARIFG +E+ ANT ++V
Sbjct:   630 NGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVV 689

Query:   172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
             GTYGYMS EY M G  S+K+DVF FGVL+L+I+  K+N   Y+++R LNL+G  W+ W E
Sbjct:   690 GTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKE 749

Query:   232 GKDLELID-LTLDGS 245
             GK LE+ID +  D S
Sbjct:   750 GKGLEIIDPIITDSS 764

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 409 (149.0 bits), Expect = 3.5e-54, Sum P(2) = 3.5e-54
 Identities = 77/133 (57%), Positives = 100/133 (75%)

Query:   112 SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
             +G  + LL LH+ SR R+IHRDLKASN+LLD  +  KISDFGMARIFG  E+ ANT R+V
Sbjct:   623 NGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVV 682

Query:   172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
             GTYGYMS EY M G  S+K+DVF FGVL+L+I+ GK+N   Y++ R LNL+G  W+ W E
Sbjct:   683 GTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKE 742

Query:   232 GKDLELID-LTLD 243
             G +LE++D + +D
Sbjct:   743 GNELEIVDPINID 755

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2123056 CRK32 "cysteine-rich RLK (RECEPTOR-like protein kinase) 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 380 (138.8 bits), Expect = 3.5e-54, Sum P(2) = 3.5e-54
 Identities = 88/212 (41%), Positives = 125/212 (58%)

Query:   113 GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG 172
             G  + LL LH+ SRL +IHRD+KASNILLD  +N KI+DFGMAR F V+++  NT R+VG
Sbjct:   434 GITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRVDQTEDNTRRVVG 493

Query:   173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPL-NLVGIAWQLWNE 231
             T+GYM  EY   G  S K+DV+ FGVL+L+IVCGKKN+  Y  +    NLV   W+LWN 
Sbjct:   494 TFGYMPPEYVTHGQFSTKSDVYSFGVLILEIVCGKKNSSFYKIDDSGGNLVTHVWRLWNN 553

Query:   232 GKDLELIDLTLDGSCPPNEDAF--LLVSCVCKSKQQID-VQCPMLFPCLLMNLL------ 282
                L+LID  ++ SC  N+     + +  +C  +  +D  +   +F  L  + +      
Sbjct:   554 DSPLDLIDPAIEESCD-NDKVIRCIHIGLLCVQETPVDRPEMSTIFQMLTNSSITLPVPR 612

Query:   283 -PGLYLKNLHFLLMLPPKNQKLPKTSQKFVPY 313
              PG + +N   L  L     +L ++S K +PY
Sbjct:   613 PPGFFFRNRSNLDPLT-YGSELGQSSSKSIPY 643

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	345
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-29
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-28
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-27
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-26
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-24
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-22
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-20
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-15
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-15
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-15
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-15
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-15
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-14
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-14
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-14
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-12
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-12
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-12
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-12
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-11
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-11
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-11
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-10
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-10
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-10
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-10
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-10
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-08
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-08
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-08
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-08
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-07
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-07
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-07
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-07
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-07
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-07
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-07
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-07
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-07
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-07
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-06
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-06
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-06
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-06
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-06
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-06
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-06
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-06
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-06
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-05
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-05
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-05
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-05
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-05
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-05
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-05
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-04
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-04
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-04
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-04
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-04
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-04
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	0.001
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.001
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	0.001
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	0.001
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	0.002
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.002
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	0.002
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	0.003
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.003
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	0.003
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	0.003
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	0.004
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.004
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	0.004

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  114 bits (287), Expect = 8e-30
 Identities = 55/176 (31%), Positives = 79/176 (44%), Gaps = 22/176 (12%)

Query: 43  GKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF 101
                E EVA+K L    S Q   EF  EA+++ KL + N+VKLLG     E  ++V E+
Sbjct: 23  KGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82

Query: 102 MPNKSLDS---SFSGTFKDLLCLHKY-----------SRLRVIHRDLKASNILLDDQLNT 147
           MP   L             L  L  +                IHRDL A N L+ + L  
Sbjct: 83  MPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVV 142

Query: 148 KISDFGMARIFGVNESGANTNRIVGT---YGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           KISDFG++R    +    +  ++ G      +M+ E    G  + K+DV+ FGVL+
Sbjct: 143 KISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLL 194

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  113 bits (285), Expect = 1e-29
 Identities = 53/173 (30%), Positives = 78/173 (45%), Gaps = 17/173 (9%)

Query: 43  GKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF 101
                + EVA+K L    S Q   EF  EA+++ KL + N+VKLLG     E   +V E+
Sbjct: 23  KGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEY 82

Query: 102 MPNKSLDSSFSGTFKDLLC---LHKY-----------SRLRVIHRDLKASNILLDDQLNT 147
           M    L S +    +  L    L  +                IHRDL A N L+ + L  
Sbjct: 83  MEGGDLLS-YLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVV 141

Query: 148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           KISDFG++R    ++        +    +M+ E    G  + K+DV+ FGVL+
Sbjct: 142 KISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESLKEGKFTSKSDVWSFGVLL 193

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  109 bits (275), Expect = 1e-28
 Identities = 53/184 (28%), Positives = 79/184 (42%), Gaps = 24/184 (13%)

Query: 39  VILVGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL 97
           V L       ++VAIK +    S     E   E +++ KL + N+VKL G         L
Sbjct: 9   VYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYL 68

Query: 98  VYEFMPNKSLDS---SFSGT---------FKDLL----CLHKYSRLRVIHRDLKASNILL 141
           V E+    SL        G             +L     LH      +IHRDLK  NILL
Sbjct: 69  VMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILL 125

Query: 142 DDQLNT-KISDFGMARIFGVNESGANTNRIVGTYGYMSLE-YTMSGTVSIKTDVFGFGVL 199
           D      K++DFG++++       +    IVGT  YM+ E     G  S K+D++  GV+
Sbjct: 126 DSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVI 183

Query: 200 VLKI 203
           + ++
Sbjct: 184 LYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  109 bits (274), Expect = 8e-28
 Identities = 59/175 (33%), Positives = 80/175 (45%), Gaps = 30/175 (17%)

Query: 47  NEQEVAIKRLAW-TSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK 105
            E +VA+K L    S + R EF  EA ++ KL + N+V+LLG    GE   +V E+MP  
Sbjct: 27  TETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGG 86

Query: 106 SLDS-------SFSGTFKDLLC-----------LHKYSRLRVIHRDLKASNILLDDQLNT 147
            L             T KDLL            L        +HRDL A N L+ + L  
Sbjct: 87  DLLDFLRKHGEKL--TLKDLLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVV 141

Query: 148 KISDFGMARIFGVNESGANTNRIVGTYG---YMSLEYTMSGTVSIKTDVFGFGVL 199
           KISDFG++R   + E      R  G      +M+ E    G  + K+DV+ FGVL
Sbjct: 142 KISDFGLSRD--IYEDDYYRKR-GGGKLPIKWMAPESLKDGKFTSKSDVWSFGVL 193

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  106 bits (268), Expect = 5e-27
 Identities = 56/183 (30%), Positives = 83/183 (45%), Gaps = 24/183 (13%)

Query: 40  ILVGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
            L GK     EVA+K L    S + R +F  EA+++ KL + N+V+LLG     E   LV
Sbjct: 15  KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74

Query: 99  YEFMPNKSLDS-------SFSGTFKDLLC---LHKY-----------SRLRVIHRDLKAS 137
            E+M    L          F    K  L    L  +           +  + +HRDL A 
Sbjct: 75  LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAAR 134

Query: 138 NILLDDQLNTKISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGF 196
           N L+ + L  KISDFG++R ++  +     T   +    +M+ E    G  + K+DV+ F
Sbjct: 135 NCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPESLKDGIFTSKSDVWSF 193

Query: 197 GVL 199
           GVL
Sbjct: 194 GVL 196

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  105 bits (263), Expect = 2e-26
 Identities = 51/180 (28%), Positives = 80/180 (44%), Gaps = 25/180 (13%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQ---NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP 103
             + VA+K L     +   + Q    E +++ +L + N+V+L+      +   LV E+  
Sbjct: 23  TGKIVAVKIL-KKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCE 81

Query: 104 NKSLDS--SFSGTFKDLLC-------------LHKYSRLRVIHRDLKASNILLDDQLNTK 148
              L    S  G   +                LH      +IHRDLK  NILLD+    K
Sbjct: 82  GGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH---SNGIIHRDLKPENILLDENGVVK 138

Query: 149 ISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGT-VSIKTDVFGFGVLVLKIVCGK 207
           I+DFG+A+    + S   T   VGT  YM+ E  + G     K DV+  GV++ +++ GK
Sbjct: 139 IADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 99.5 bits (249), Expect = 2e-24
 Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 22/175 (12%)

Query: 49  QEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           + VAIK +     +   E    E K++ KL++ N+V+L       ++  LV E+     L
Sbjct: 25  KLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDL 84

Query: 108 DS------SFSGT-----FKDLLC----LHKYSRLRVIHRDLKASNILLDDQLNTKISDF 152
                     S        + +L     LH      ++HRDLK  NILLD+  + K++DF
Sbjct: 85  FDLLKKRGRLSEDEARFYLRQILSALEYLHS---KGIVHRDLKPENILLDEDGHVKLADF 141

Query: 153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           G+AR     + G      VGT  YM+ E  +        D++  GV++ +++ GK
Sbjct: 142 GLARQL---DPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 93.0 bits (232), Expect = 5e-22
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 22/178 (12%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK 105
              +EVAIK +   S + + +  NE +++ K ++ N+VK  G  +  +E  +V EF    
Sbjct: 23  RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82

Query: 106 SLD---SSFSGTF---------KDLL----CLHKYSRLRVIHRDLKASNILLDDQLNTKI 149
           SL     S + T          K+LL     LH      +IHRD+KA+NILL      K+
Sbjct: 83  SLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKL 139

Query: 150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
            DFG++            N +VGT  +M+ E         K D++  G+  +++  GK
Sbjct: 140 IDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 88.8 bits (221), Expect = 2e-20
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 24/179 (13%)

Query: 49  QEVAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER-LLVY-EFMPN 104
           + +A+K   L+  S +     + E ++++ LQ+ N+V+  G     E+  L ++ E++  
Sbjct: 26  ELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG 85

Query: 105 KSLDSSFSGTF------------KDLL----CLHKYSRLRVIHRDLKASNILLDDQLNTK 148
            SL SS    F            + +L     LH      ++HRD+K +NIL+D     K
Sbjct: 86  GSL-SSLLKKFGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVK 141

Query: 149 ISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           ++DFG A+  G  E+G  T  + GT  +M+ E           D++  G  V+++  GK
Sbjct: 142 LADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 84.7 bits (210), Expect = 7e-19
 Identities = 58/180 (32%), Positives = 84/180 (46%), Gaps = 24/180 (13%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF 101
           G +    +VA+K L    G    E F  EA+++ KL++  LV+L       E   +V E+
Sbjct: 25  GTWNGTTKVAVKTL--KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82

Query: 102 MPNKSL-DSSFSGTFKDLL--CLHKYS-----------RLRVIHRDLKASNILLDDQLNT 147
           M   SL D   SG  K L    L   +               IHRDL A NIL+ + L  
Sbjct: 83  MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVC 142

Query: 148 KISDFGMARIFGVNESGANTNRIVGT---YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           KI+DFG+AR+   +E  A      G      + + E    G  +IK+DV+ FG+L+ +IV
Sbjct: 143 KIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 81.8 bits (202), Expect = 7e-18
 Identities = 58/182 (31%), Positives = 88/182 (48%), Gaps = 23/182 (12%)

Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           + +G +    +VAIK L     QG +    F  EA L+ +LQ+  LV+L    +  E   
Sbjct: 22  VWMGYYNGHTKVAIKSLK----QGSMSPEAFLAEANLMKQLQHPRLVRLYAV-VTQEPIY 76

Query: 97  LVYEFMPNKSLDSSFSGTFKDLLCLHKY--------------SRLRVIHRDLKASNILLD 142
           ++ E+M N SL           L ++K                R   IHRDL+A+NIL+ 
Sbjct: 77  IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS 136

Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           + L  KI+DFG+AR+   NE  A          + + E    GT +IK+DV+ FG+L+ +
Sbjct: 137 ETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTE 195

Query: 203 IV 204
           IV
Sbjct: 196 IV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 79.9 bits (198), Expect = 3e-17
 Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 20/178 (11%)

Query: 46  PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN 104
           P  +  A+K++      + R +   E K +   +   +VK  G      E  +V E+M  
Sbjct: 24  PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83

Query: 105 KSLDS--SFSGTFKD-------------LLCLHKYSRLRVIHRDLKASNILLDDQLNTKI 149
            SL       G   +             L  LH   +  +IHRD+K SN+L++ +   KI
Sbjct: 84  GSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKI 141

Query: 150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           +DFG++++  +  +    N  VGT  YMS E     + S   D++  G+ +L+   GK
Sbjct: 142 ADFGISKV--LENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 79.4 bits (196), Expect = 6e-17
 Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 33/195 (16%)

Query: 41  LVGKFPNE--QEVAIKRLA-WTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL 97
           L G         VAIK L      + + EF+ EA+L++ LQ+ N+V LLG     +   +
Sbjct: 26  LTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85

Query: 98  VYEFMPNKSLD--------------SSFSGTFKDLL----CLH---------KY-SRLRV 129
           ++E++ +  L                S   T K  L     LH         +Y S    
Sbjct: 86  LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHF 145

Query: 130 IHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +HRDL A N L+ + L  KISDFG++R I+  +     +  ++    +M  E  + G  +
Sbjct: 146 VHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR-WMPPEAILYGKFT 204

Query: 189 IKTDVFGFGVLVLKI 203
            ++D++ FGV++ +I
Sbjct: 205 TESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 36/196 (18%)

Query: 35  TRDRVILVGKF----------PNEQE--VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTN 81
           T ++VI  G+F          P ++E  VAIK L A +S + R++F  EA ++ +  + N
Sbjct: 7   TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66

Query: 82  LVKLLGCSIHGEERLLVYEFMPNKSLDSSF---SGTFKDLLCLH---------KY-SRLR 128
           +++L G        +++ E+M N SLD       G F     +          KY S + 
Sbjct: 67  IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
            +HRDL A NIL++  L  K+SDFG++R    +E+   T       G + + +T    ++
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG-----GKIPIRWTAPEAIA 181

Query: 189 IK-----TDVFGFGVL 199
            +     +DV+ FG++
Sbjct: 182 YRKFTSASDVWSFGIV 197

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 61/186 (32%), Positives = 84/186 (45%), Gaps = 33/186 (17%)

Query: 46  PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN 104
             E +VA+K L  + S Q   +F  EA +++K  + N+V+L+G S     R ++ E M  
Sbjct: 34  AVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAG 93

Query: 105 KSLDS-----------SFSGTFKDLL-------CLHKY-SRLRVIHRDLKASNILLDD-- 143
             L S             S T KDLL          KY      IHRD+ A N LL    
Sbjct: 94  GDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG 153

Query: 144 -QLNTKISDFGMAR-IFGVNESGANTNRIVGT----YGYMSLEYTMSGTVSIKTDVFGFG 197
                KI+DFGMAR I+      A+  R  G       +M  E  + G  + KTDV+ FG
Sbjct: 154 PGRVAKIADFGMARDIY-----RASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFG 208

Query: 198 VLVLKI 203
           VL+ +I
Sbjct: 209 VLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 44/172 (25%), Positives = 81/172 (47%), Gaps = 15/172 (8%)

Query: 46  PNEQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN 104
             +  VAIK L   +  +   E  +EA ++A + + ++V+LLG  +   +  L+ + MP 
Sbjct: 34  KVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPL 92

Query: 105 KSLDS---SFSGTFKDLLCLH---------KY-SRLRVIHRDLKASNILLDDQLNTKISD 151
             L     +          L+          Y    R++HRDL A N+L+    + KI+D
Sbjct: 93  GCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITD 152

Query: 152 FGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           FG+A++  V+E   +         +M+LE  +    + K+DV+ +GV V ++
Sbjct: 153 FGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 75.5 bits (184), Expect = 3e-15
 Identities = 48/188 (25%), Positives = 80/188 (42%), Gaps = 27/188 (14%)

Query: 47  NEQEVAIKRLA---WTSGQGRVEFQNEAKLIAKLQYT-NLVKLLGCSIHGEERLLVYEFM 102
           + + VA+K LA    +  +    F  E +++A L +  N+VKL           LV E++
Sbjct: 21  DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80

Query: 103 PNKSLDSSFS--------------GTFKDLLC-LHKYSRLRVIHRDLKASNILLDDQLN- 146
              SL+                       +L  L       +IHRD+K  NILLD     
Sbjct: 81  DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRV 140

Query: 147 TKISDFGMARIFGVNES----GANTNRIVGTYGYMSLEYTMSGT---VSIKTDVFGFGVL 199
            K+ DFG+A++     S     A  +  VGT GYM+ E  +  +    S  +D++  G+ 
Sbjct: 141 VKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGIT 200

Query: 200 VLKIVCGK 207
           + +++ G 
Sbjct: 201 LYELLTGL 208

Length = 384

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 73.9 bits (181), Expect = 5e-15
 Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 37/202 (18%)

Query: 35  TRDRVILVGKF----------PNEQE--VAIKRL--AWTSGQGRVEFQNEAKLIAKLQYT 80
           T+ +VI  G+F          P  +E  VAIK L   +T  Q R +F +EA ++ +  + 
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQFSHH 66

Query: 81  NLVKLLGCSIHGEERLLVYEFMPNKSLD----------SSFS--GTFKDLLCLHKY-SRL 127
           N+++L G     +  +++ E+M N +LD          SS+   G  + +    KY S +
Sbjct: 67  NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM 126

Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
             +HRDL A NIL++  L  K+SDFG++R+   +  G  T     + G + + +T    +
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT----SGGKIPIRWTAPEAI 182

Query: 188 SIK-----TDVFGFGVLVLKIV 204
           + +     +DV+ FG+++ +++
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 73.6 bits (181), Expect = 5e-15
 Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 24/171 (14%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           Q+VA+K L   S   +  F  EA ++  L++ NLV+LLG  + G    +V E+M   SL 
Sbjct: 30  QKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88

Query: 109 SSFSGTFKDLL---CLHKYSR-----------LRVIHRDLKASNILLDDQLNTKISDFGM 154
                  + ++       ++               +HRDL A N+L+ + L  K+SDFG+
Sbjct: 89  DYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGL 148

Query: 155 ARIFGVNESGANTNRIVGTY--GYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           A+        A+  +  G     + + E       S K+DV+ FG+L+ +I
Sbjct: 149 AK-------EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 73.4 bits (181), Expect = 5e-15
 Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 27/188 (14%)

Query: 51  VAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           VAIK+++      +       E  L+  L++ N+VK +G     +   ++ E+  N SL 
Sbjct: 28  VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLR 87

Query: 109 S--SFSGTFKDLLC-------------LHKYSRLRVIHRDLKASNILLDDQLNTKISDFG 153
                 G F + L              LH+     VIHRD+KA+NIL       K++DFG
Sbjct: 88  QIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFG 144

Query: 154 MARIFGVNESGANTNRIVGTYGYMSLE-YTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKS 212
           +A    +N+   +   +VGT  +M+ E   MSG  S  +D++  G  V++++ G   N  
Sbjct: 145 VATK--LNDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTG---NPP 198

Query: 213 YHTERPLN 220
           Y+   P+ 
Sbjct: 199 YYDLNPMA 206

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 73.3 bits (181), Expect = 6e-15
 Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 22/155 (14%)

Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSLDS--SFSGTFKD-------- 117
            E  +++++ +  +VKL   +   EE+L LV E+ P   L S  S  G F +        
Sbjct: 42  TERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA 100

Query: 118 -----LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG 172
                L  LH    L +I+RDLK  NILLD   + K++DFG+A+      S  NT    G
Sbjct: 101 EIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCG 155

Query: 173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           T  Y++ E  +        D +  GVL+ +++ GK
Sbjct: 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 73.2 bits (180), Expect = 6e-15
 Identities = 54/170 (31%), Positives = 77/170 (45%), Gaps = 21/170 (12%)

Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP--- 103
           E EVA+K L       G+ EF  EA ++A+L +  +V+L+G    GE  +LV E  P   
Sbjct: 23  EVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGP 81

Query: 104 -NKSLDSSFSGTFKDLLCL-HKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGM 154
             K L         DL  L H+ +           +HRDL A N+LL ++   KISDFGM
Sbjct: 82  LLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGM 141

Query: 155 ARIFGVNESGANTNRI----VGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +R  G               +  Y    + Y   G  S K+DV+ +GV +
Sbjct: 142 SRALGAGSDYYRATTAGRWPLKWYAPECINY---GKFSSKSDVWSYGVTL 188

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 73.6 bits (181), Expect = 6e-15
 Identities = 48/170 (28%), Positives = 76/170 (44%), Gaps = 23/170 (13%)

Query: 49  QEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCS--IHGEERLLVYEFMPNK 105
           ++VA+K L      Q R +F+ E +++  L + N+VK  G      G    L+ E++P+ 
Sbjct: 34  EQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSG 93

Query: 106 SLDSSFSGTFK--DLLCLHKYS-----------RLRVIHRDLKASNILLDDQLNTKISDF 152
           SL           +L  L  +S             R IHRDL A NIL++ +   KISDF
Sbjct: 94  SLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDF 153

Query: 153 GMARIFGVNESG----ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGV 198
           G+A++  + E               + Y + E   +   S  +DV+ FGV
Sbjct: 154 GLAKV--LPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGV 200

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 72.6 bits (178), Expect = 1e-14
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 51/227 (22%)

Query: 37  DRVILVGKF----------PNEQE--VAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNL 82
           ++VI  G+F          P ++E  VAIK L   +T  Q R +F +EA ++ +  + N+
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRR-DFLSEASIMGQFDHPNI 67

Query: 83  VKLLGCSIHGEERLLVYEFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRV 129
           + L G     +  ++V E+M N SLD+               G  + +    KY S +  
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY 127

Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI 189
           +HRDL A NIL++  L  K+SDFG++R+   +   A T R     G + + +T    ++ 
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTAPEAIAY 183

Query: 190 K-----TDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
           +     +DV+ +G+++ +++       SY  ERP       W++ N+
Sbjct: 184 RKFTSASDVWSYGIVMWEVM-------SY-GERPY------WEMSNQ 216

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 55/180 (30%), Positives = 85/180 (47%), Gaps = 18/180 (10%)

Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           + +G + N  +VA+K L    G   V+ F  EA L+  LQ+  LV+L       E   ++
Sbjct: 22  VWMGYYNNSTKVAVKTL--KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79

Query: 99  YEFMPNKSLDSSFSGTFKDLLCLHKY--------------SRLRVIHRDLKASNILLDDQ 144
            E+M   SL           + L K                R   IHRDL+A+N+L+ + 
Sbjct: 80  TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES 139

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           L  KI+DFG+AR+   NE  A          + + E    G+ +IK+DV+ FG+L+ +IV
Sbjct: 140 LMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 16/158 (10%)

Query: 64  RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD------ 117
           R E  +EA+++AKL  + +++     +   +  +V E+  N  L                
Sbjct: 43  REEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQ 102

Query: 118 --------LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNR 169
                   LL L      +++HRD+K+ N+ LD   N KI D G+A++   N + ANT  
Sbjct: 103 VWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-- 160

Query: 170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           IVGT  Y+S E       + K+DV+  GV++ +   GK
Sbjct: 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 21/149 (14%)

Query: 49  QEVAIKRLAWTSGQGRVEFQ--NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN-- 104
           + VA+K++A    +G +  Q   E K +   Q+  +VKLL    HG   +LV E+MP+  
Sbjct: 26  ETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDL 85

Query: 105 ----KSLDSSFS-----GTFKDLL----CLHKYSRLRVIHRDLKASNILLDDQLNTKISD 151
               +  +            + LL     +H      ++HRDLK +N+L+      KI+D
Sbjct: 86  SEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIAD 142

Query: 152 FGMARIFGVNESGANTNRIVGTYGYMSLE 180
           FG+AR+F   E    +++ V T  Y + E
Sbjct: 143 FGLARLFSEEEPRLYSHQ-VATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 71.7 bits (176), Expect = 2e-14
 Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 22/179 (12%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G + N   VA+K L   +   + +F  EA+++ KL++  L++L       E   +V E M
Sbjct: 25  GLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83

Query: 103 PNKSLDSSFSGTFKDLLCLHK-------------YSRLR-VIHRDLKASNILLDDQLNTK 148
              SL     G     L L +             Y   +  IHRDL A N+L+ +    K
Sbjct: 84  KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICK 143

Query: 149 ISDFGMARIFGVNESGANTNRIVGT---YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++DFG+AR+   +   A      G      + + E  +    SIK+DV+ FG+L+ +IV
Sbjct: 144 VADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 71.4 bits (175), Expect = 3e-14
 Identities = 55/192 (28%), Positives = 96/192 (50%), Gaps = 25/192 (13%)

Query: 33  EQTRDRVILVGKFPNEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSI 90
           E  R R+ L GK   E  VAIK L   +T  Q R +F +EA ++ +  + N++ L G   
Sbjct: 19  EVCRGRLKLPGK--REIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNIIHLEGVVT 75

Query: 91  HGEERLLVYEFMPNKSLDS-------SFS-----GTFKDLLCLHKY-SRLRVIHRDLKAS 137
                +++ EFM N +LDS        F+     G  + +    KY S +  +HRDL A 
Sbjct: 76  KSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAAR 135

Query: 138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TD 192
           NIL++  L  K+SDFG++R    + S       +G  G + + +T    ++ +     +D
Sbjct: 136 NILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIPIRWTAPEAIAYRKFTSASD 193

Query: 193 VFGFGVLVLKIV 204
           V+ +G+++ +++
Sbjct: 194 VWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 71.0 bits (175), Expect = 4e-14
 Identities = 45/192 (23%), Positives = 83/192 (43%), Gaps = 26/192 (13%)

Query: 38  RVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER 95
           +V LV +  + +   +K +  +  S + R +  NE K++ KL + N++K         + 
Sbjct: 15  KVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL 74

Query: 96  LLVYEFMPNKSLDS------SFSGTFKD-------------LLCLHKYSRLRVIHRDLKA 136
            +V E+     L             F +             L  LH  SR +++HRD+K 
Sbjct: 75  CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--SR-KILHRDIKP 131

Query: 137 SNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGF 196
            NI L      K+ DFG++++       A T  +VGT  Y+S E   +   + K+D++  
Sbjct: 132 QNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQNKPYNYKSDIWSL 189

Query: 197 GVLVLKIVCGKK 208
           G ++ ++   K 
Sbjct: 190 GCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 71.0 bits (174), Expect = 5e-14
 Identities = 52/182 (28%), Positives = 83/182 (45%), Gaps = 25/182 (13%)

Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
              VA+K L    + Q + EF  EA L++   + N+VKLLG  +  E + ++ E M    
Sbjct: 26  PIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGD 85

Query: 107 LDSSFSG-----------TFKDLL--CL------HKYSRLRVIHRDLKASNILLDDQLNT 147
           L S               T K+LL  CL          ++  IHRDL A N L+ ++   
Sbjct: 86  LLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYD 145

Query: 148 -----KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
                KI DFG+AR    ++        +    +M+ E  + G  + ++DV+ FGVL+ +
Sbjct: 146 ADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWE 205

Query: 203 IV 204
           I+
Sbjct: 206 IL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 70.9 bits (174), Expect = 5e-14
 Identities = 50/184 (27%), Positives = 80/184 (43%), Gaps = 35/184 (19%)

Query: 51  VAIKRLA-WTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL-- 107
           VA+K L    S   R +F+ EA+L+   Q+ N+VK  G    G+  ++V+E+M +  L  
Sbjct: 38  VAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNK 97

Query: 108 -------DSSFSG---------TFKDLL--------CLHKYSRLRVIHRDLKASNILLDD 143
                  D++F           T   LL         +   +    +HRDL   N L+  
Sbjct: 98  FLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGT----YGYMSLEYTMSGTVSIKTDVFGFGVL 199
            L  KI DFGM+R     +      R+ G       +M  E  M    + ++DV+ FGV+
Sbjct: 158 DLVVKIGDFGMSRDVYTTD----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVV 213

Query: 200 VLKI 203
           + +I
Sbjct: 214 LWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 70.2 bits (172), Expect = 8e-14
 Identities = 56/188 (29%), Positives = 88/188 (46%), Gaps = 26/188 (13%)

Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLL 97
           V+ +GK+  + +VAIK +   +     +F  EAK++ KL + NLV+L G C+      + 
Sbjct: 19  VVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI- 76

Query: 98  VYEFMPNKSLDSSFSGTFKDLL--------CLH-----KY-SRLRVIHRDLKASNILLDD 143
           V E+M N  L  ++    K  L        C       +Y      IHRDL A N L+ +
Sbjct: 77  VTEYMANGCL-LNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE 135

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGT---YGYMSLEYTMSGTVSIKTDVFGFGVLV 200
               K+SDFG+AR    ++  ++     GT     +   E       S K+DV+ FGVL+
Sbjct: 136 DNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLM 191

Query: 201 LKI-VCGK 207
            ++   GK
Sbjct: 192 WEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 70.1 bits (171), Expect = 9e-14
 Identities = 53/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)

Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           + +G +     VAIK L    G    E F  EA+++ KL++  LV+L    +  E   +V
Sbjct: 22  VWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIV 78

Query: 99  YEFMPNKSLDSSFSGTFKDLLCLHKY--------------SRLRVIHRDLKASNILLDDQ 144
            E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + 
Sbjct: 79  TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 138

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           L  K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++
Sbjct: 139 LVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 36/120 (30%), Positives = 62/120 (51%), Gaps = 22/120 (18%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEER---LLVYEFMPN------KSLDSSFS-----GTF 115
           E KL+ KL++ N+V+L    +  + +    +V+E+M +       S +  F+        
Sbjct: 48  EIKLLQKLRHPNIVRLK-EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM 106

Query: 116 KDLLC----LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           K LL     LH      ++HRD+K SNIL+++    K++DFG+AR +    S   TNR++
Sbjct: 107 KQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 45/156 (28%), Positives = 83/156 (53%), Gaps = 16/156 (10%)

Query: 68  QNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKDLLCLH--- 122
             E  L+ +LQ+ N+V+ LG S+  +   +  E++P  S+ +  +  G F++ L  +   
Sbjct: 54  AREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR 113

Query: 123 ------KYSRLR-VIHRDLKASNILLDDQLNTKISDFGMARIFGVN--ESGANTNR--IV 171
                  Y   R +IHRD+K +NIL+D++   KISDFG+++    N   +  N  R  + 
Sbjct: 114 QILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173

Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           G+  +M+ E     + + K D++  G LV++++ GK
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 34/199 (17%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEF-QNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-- 102
           PN ++VAIKR+     Q  V+  + E + +++  + N+VK     + G+E  LV  ++  
Sbjct: 24  PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83

Query: 103 -----------PNKSLDSSFSGTF-----KDLLCLHKYSRLRVIHRDLKASNILLDDQLN 146
                      P   LD +   T      K L  LH   +   IHRD+KA NILL +  +
Sbjct: 84  GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGS 140

Query: 147 TKISDFGM-ARIFGVNESGANTNR----IVGTYGYMSLEYTMSGT-VSIKTDVFGFGVLV 200
            KI+DFG+ A +    + G  T +     VGT  +M+ E          K D++ FG+  
Sbjct: 141 VKIADFGVSASLA---DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITA 197

Query: 201 LKIVCGKKNNKSYHTERPL 219
           +++  G      Y    P+
Sbjct: 198 IELATGA---APYSKYPPM 213

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 32/186 (17%)

Query: 49  QEVAIKRLA-WTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           Q VAIK L    + Q   EFQ EA L+A+L + N+V LLG     +   +++E++    L
Sbjct: 35  QLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94

Query: 108 ---------------DSSFSGTFKDLLCLHKYSRLRV--------------IHRDLKASN 138
                           S   GT K  L    +  + +              +H+DL A N
Sbjct: 95  HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN 154

Query: 139 ILLDDQLNTKISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFG 197
           IL+ +QL+ KISD G++R I+  +        ++    +M  E  M G  S  +D++ FG
Sbjct: 155 ILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFG 213

Query: 198 VLVLKI 203
           V++ +I
Sbjct: 214 VVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 67.7 bits (165), Expect = 7e-13
 Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 30/193 (15%)

Query: 41  LVGKFPNEQE-----VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE 94
            +G+   E +     VA+K L A  +   R +F  E K++++L+  N+++LLG  +  + 
Sbjct: 32  FLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP 91

Query: 95  RLLVYEFMPNKSLD---------SSF-------SGTFKDLLCLH-------KY-SRLRVI 130
             ++ E+M N  L+         S+F       S +  +LL +        KY + L  +
Sbjct: 92  LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFV 151

Query: 131 HRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK 190
           HRDL   N L+ +    KI+DFGM+R     +      R V    +M+ E  + G  +  
Sbjct: 152 HRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA 211

Query: 191 TDVFGFGVLVLKI 203
           +DV+ FGV + ++
Sbjct: 212 SDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 40/208 (19%)

Query: 41  LVGKFPNE--QEVAIKRLA-WTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL 97
           L G  P E  Q VAIK L     G  R EF++EA + ++LQ+ N+V LLG     +   +
Sbjct: 26  LFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85

Query: 98  VYEFMPNKSL------------------DSSFSGTFKDLLCLHKYSRL----------RV 129
           ++ +  +  L                  D +   T +    +H  +++           V
Sbjct: 86  IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHV 145

Query: 130 IHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +H+DL   N+L+ D+LN KISD G+ R ++  +      N ++    +MS E  M G  S
Sbjct: 146 VHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR-WMSPEAIMYGKFS 204

Query: 189 IKTDVFGFGVLVLKIV-------CGKKN 209
           I +D++ +GV++ ++        CG  N
Sbjct: 205 IDSDIWSYGVVLWEVFSYGLQPYCGYSN 232

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 67.3 bits (164), Expect = 8e-13
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 21/181 (11%)

Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           ++ +G +  +++VAIK +         +F  EA+++ KL +  LV+L G         LV
Sbjct: 19  LVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77

Query: 99  YEFMPNKSLDS---SFSGTF--KDLL--CLHKYSRL------RVIHRDLKASNILLDDQL 145
           +EFM +  L     +  G F  + LL  CL     +       VIHRDL A N L+ +  
Sbjct: 78  FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ 137

Query: 146 NTKISDFGMARIFGVNESGANTNRIVGT---YGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
             K+SDFGM R    ++  ++T    GT     + S E       S K+DV+ FGVL+ +
Sbjct: 138 VVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWE 193

Query: 203 I 203
           +
Sbjct: 194 V 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 67.1 bits (164), Expect = 9e-13
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 20/178 (11%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G + N   VAIK L       + +FQ E + + +L++ +L+ L      GE   ++ E M
Sbjct: 25  GLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84

Query: 103 PN------------KSLDSS----FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN 146
                         + L  +     +    + +   +      IHRDL A NIL+ + L 
Sbjct: 85  EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLV 142

Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
            K++DFG+AR+   +   ++  +I   Y + + E    GT S K+DV+ FG+L+ ++ 
Sbjct: 143 CKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEMF 198

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 67.3 bits (164), Expect = 9e-13
 Identities = 61/249 (24%), Positives = 99/249 (39%), Gaps = 53/249 (21%)

Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL--- 107
           VA+K L   S   R +FQ EA+L+  LQ+ ++V+  G    G   L+V+E+M +  L   
Sbjct: 38  VAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRF 97

Query: 108 ------DSSFSGTFKDLLC--------LHKYSR----------LRVIHRDLKASNILLDD 143
                 D+      +D+          L   S+          L  +HRDL   N L+  
Sbjct: 98  LRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
            L  KI DFGM+R     +      R +    +M  E  +    + ++D++ FGV++ +I
Sbjct: 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217

Query: 204 VCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG-------SCPPNEDAFLLV 256
               K                  Q W +  + E I+    G       +CPP E   ++ 
Sbjct: 218 FTYGK------------------QPWYQLSNTEAIECITQGRELERPRTCPP-EVYAIMQ 258

Query: 257 SCVCKSKQQ 265
            C  +  QQ
Sbjct: 259 GCWQREPQQ 267

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 66.3 bits (162), Expect = 1e-12
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 32/213 (15%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           +EV + RL   S + R +  NE  +++ LQ+ N++      +     L+  E+    +L 
Sbjct: 31  KEVNLTRL---SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLY 87

Query: 109 SSFSGTFKDLL-----------------CLHKYSRLRVIHRDLKASNILLDDQLNTKISD 151
                    L                   +HK     ++HRD+K  NI L      K+ D
Sbjct: 88  DKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGD 144

Query: 152 FGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNK 211
           FG+++I G   S A T  +VGT  YMS E       + K+D++  G ++ +++  K   +
Sbjct: 145 FGISKILGSEYSMAET--VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK---R 199

Query: 212 SYHTERPLNLV-GI---AWQLWNEGKDLELIDL 240
           ++    PLNLV  I    +         ELI L
Sbjct: 200 TFDATNPLNLVVKIVQGNYTPVVSVYSSELISL 232

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 17/106 (16%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFM-----------PNKSLDSSFSGTFKD 117
           E  L+ +L + N+V+LL   +H E +L LV+EF+           P   LD     ++  
Sbjct: 48  EISLLKELNHPNIVRLLDV-VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY 106

Query: 118 LLC---LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
            L     + +S  RV+HRDLK  N+L+D +   K++DFG+AR FGV
Sbjct: 107 QLLQGIAYCHSH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGV 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 44/156 (28%), Positives = 68/156 (43%), Gaps = 27/156 (17%)

Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-----------------PNKSLDSSF 111
           +E  ++ +L++ N+V+     I       +Y  M                   K ++  F
Sbjct: 48  SEVNILRELKHPNIVRYYD-RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF 106

Query: 112 --SGTFKDLLCLH-----KYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG 164
                 + LL L+           V+HRDLK +NI LD   N K+ DFG+A+I G + S 
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166

Query: 165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           A T   VGT  YMS E     +   K+D++  G L+
Sbjct: 167 AKT--YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLI 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 59/180 (32%), Positives = 88/180 (48%), Gaps = 19/180 (10%)

Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           + +G +    +VAIK L    G    E F  EA+++ KL++  LV L    +  E   +V
Sbjct: 22  VWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV-VSEEPIYIV 78

Query: 99  YEFMPNKSL-DSSFSGTFKDLLC-------------LHKYSRLRVIHRDLKASNILLDDQ 144
            EFM   SL D    G  K L               +    R+  IHRDL+A+NIL+ D 
Sbjct: 79  TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN 138

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           L  KI+DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++V
Sbjct: 139 LVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 22/174 (12%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           +EVAIK++     Q +    NE  ++   ++ N+V      + G+E  +V E+M   SL 
Sbjct: 45  KEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103

Query: 109 SSFSGTFKD----------------LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF 152
              +  F                  L  LH      VIHRD+K+ NILL    + K++DF
Sbjct: 104 DIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADF 160

Query: 153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           G A    + +  +  N +VGT  +M+ E         K D++  G++ +++  G
Sbjct: 161 GFAAQ--LTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 29/86 (33%), Positives = 52/86 (60%), Gaps = 4/86 (4%)

Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           + + + ++IHRD+K SNIL++ +   K+ DFG++    VN S A T   VGT  YM+ E 
Sbjct: 115 YLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VN-SLAKTF--VGTSSYMAPER 170

Query: 182 TMSGTVSIKTDVFGFGVLVLKIVCGK 207
                 S+K+D++  G+ ++++  G+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 3e-12
 Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 24/175 (13%)

Query: 51  VAIKRLAWTSGQGRV-EFQNEAKLIAKLQYT---NLVKLLGCSIHGEERLLVYEF----- 101
           VA+K +   +    V + Q E  L+++L+ +   N+ K  G  + G    ++ E+     
Sbjct: 29  VALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGS 88

Query: 102 ----MPNKSLDSSFSG-----TFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF 152
               M    +   +           L  +HK     VIHRD+KA+NIL+ +  N K+ DF
Sbjct: 89  VRTLMKAGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDF 145

Query: 153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCG 206
           G+A +   N S  +T   VGT  +M+ E    G     K D++  G+ + ++  G
Sbjct: 146 GVAALLNQNSSKRST--FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 65.5 bits (159), Expect = 4e-12
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 16/182 (8%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           QEVAIK++       +    NE  ++ +L+  N+V  L   + G+E  +V E++   SL 
Sbjct: 45  QEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT 104

Query: 109 SSFSGTFKDLL--------CLHKYSRL---RVIHRDLKASNILLDDQLNTKISDFGMARI 157
              + T  D          CL     L   +VIHRD+K+ N+LL    + K++DFG    
Sbjct: 105 DVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164

Query: 158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER 217
               +S  +T  +VGT  +M+ E         K D++  G++ +++V G+     Y  E 
Sbjct: 165 ITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE---PPYLNEN 219

Query: 218 PL 219
           PL
Sbjct: 220 PL 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 65.2 bits (160), Expect = 4e-12
 Identities = 39/118 (33%), Positives = 57/118 (48%), Gaps = 21/118 (17%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN------KSLDSSFSGTF-----KD 117
           E  L+ +L++ N+VKLL   IH E +L LV+E+                S          
Sbjct: 48  EISLLKELKHPNIVKLL-DVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQ 106

Query: 118 LLC----LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           LL      H  S  R++HRDLK  NIL++     K++DFG+AR FG+      T+ +V
Sbjct: 107 LLRGLAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 65.2 bits (159), Expect = 4e-12
 Identities = 48/189 (25%), Positives = 83/189 (43%), Gaps = 37/189 (19%)

Query: 51  VAIKRLA-WTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN----- 104
           VA+K L    S   + +FQ EA L+A+  + N+VKLLG    G+   L++E+M       
Sbjct: 38  VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97

Query: 105 -------KSLDSSFSGTFK---------DLLCLHK-------------YSRLRVIHRDLK 135
                  ++  S    T            L C  +              S  + +HRDL 
Sbjct: 98  FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157

Query: 136 ASNILLDDQLNTKISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVF 194
             N L+ + +  KI+DFG++R I+  +   A+ N  +    +M  E       + ++DV+
Sbjct: 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR-WMPPESIFYNRYTTESDVW 216

Query: 195 GFGVLVLKI 203
            +GV++ +I
Sbjct: 217 AYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 64.9 bits (158), Expect = 5e-12
 Identities = 55/181 (30%), Positives = 85/181 (46%), Gaps = 21/181 (11%)

Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           V+  GK+  + +VAIK +   S     EF  EAK++ KL +  LV+L G         +V
Sbjct: 19  VVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77

Query: 99  YEFMPNKSLDSSFSGTFKDL-------LC------LHKYSRLRVIHRDLKASNILLDDQL 145
            E+M N  L +      K         +C      +      + IHRDL A N L+DDQ 
Sbjct: 78  TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG 137

Query: 146 NTKISDFGMARIFGVNESGANTNRIVGT---YGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
             K+SDFG++R    +E  ++    VG+     +   E  +    S K+DV+ FGVL+ +
Sbjct: 138 CVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWE 193

Query: 203 I 203
           +
Sbjct: 194 V 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 64.8 bits (158), Expect = 6e-12
 Identities = 32/88 (36%), Positives = 50/88 (56%), Gaps = 12/88 (13%)

Query: 124 YSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI----VGTYGYMSL 179
           Y+  R++HRD+K SNIL++ +   K+ DFG+        SG   N I    VGT  YMS 
Sbjct: 120 YNVHRIMHRDIKPSNILVNSRGQIKLCDFGV--------SGELINSIADTFVGTSTYMSP 171

Query: 180 EYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           E    G  ++K+DV+  G+ ++++  GK
Sbjct: 172 ERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 64.7 bits (158), Expect = 6e-12
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 16/106 (15%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMP---NKSLDSSFSGTFKDLLCLHKY- 124
           E  L+ +LQ+ N+V L    +  E RL L++EF+     K LDS   G + D   +  Y 
Sbjct: 49  EISLLKELQHPNIVCLQDV-LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYL 107

Query: 125 ----------SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
                        RV+HRDLK  N+L+D++   K++DFG+AR FG+
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 64.6 bits (157), Expect = 6e-12
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 19/180 (10%)

Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           + +G +    +VA+K L    G    E F  EA+++ KL++  LV+L    +  E   +V
Sbjct: 22  VWMGTWNGNTKVAVKTL--KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV-VSEEPIYIV 78

Query: 99  YEFMPNKSL-DSSFSGTFKDLLC-------------LHKYSRLRVIHRDLKASNILLDDQ 144
            E+M   SL D    G  + L               +    R+  IHRDL+++NIL+ D 
Sbjct: 79  TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG 138

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           L  KI+DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++V
Sbjct: 139 LVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 64.9 bits (159), Expect = 7e-12
 Identities = 42/168 (25%), Positives = 62/168 (36%), Gaps = 52/168 (30%)

Query: 81  NLVKLLGCSIHGEERL-LVYEFMPNKSLDSSFSGTFKDLLCLHKYSRL------------ 127
            ++KL   +   EE L  V E+ PN        G     +   KY  L            
Sbjct: 63  GIIKLY-YTFQDEENLYFVLEYAPN--------GELLQYI--RKYGSLDEKCTRFYAAEI 111

Query: 128 ----------RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES-------------- 163
                      +IHRDLK  NILLD  ++ KI+DFG A++   N S              
Sbjct: 112 LLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 164 ----GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
                      VGT  Y+S E          +D++  G ++ +++ GK
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 64.3 bits (156), Expect = 8e-12
 Identities = 57/180 (31%), Positives = 89/180 (49%), Gaps = 19/180 (10%)

Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           + +  +    +VA+K +    G   VE F  EA ++  LQ+  LVKL    +  E   ++
Sbjct: 22  VWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYII 78

Query: 99  YEFMPNKSLD---SSFSGTFKDLLCLHKYS-----------RLRVIHRDLKASNILLDDQ 144
            EFM   SL     S  G+ + L  L  +S           +   IHRDL+A+NIL+   
Sbjct: 79  TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS 138

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           L  KI+DFG+AR+   NE  A          + + E    G+ +IK+DV+ FG+L+++IV
Sbjct: 139 LVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 56/182 (30%), Positives = 81/182 (44%), Gaps = 23/182 (12%)

Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           V+ +GK+  + +VAIK +         +F  EAK++ KL +  LV+L G     +   +V
Sbjct: 19  VVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77

Query: 99  YEFMPNKSLDSSF---SGTF-KDLL-------C--LHKYSRLRVIHRDLKASNILLDDQL 145
            EFM N  L +      G   KD+L       C  +    R   IHRDL A N L+    
Sbjct: 78  TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG 137

Query: 146 NTKISDFGMARIF----GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVL 201
             K+SDFGM R        + SGA          +   E       S K+DV+ FGVL+ 
Sbjct: 138 VVKVSDFGMTRYVLDDEYTSSSGAKF-----PVKWSPPEVFNFSKYSSKSDVWSFGVLMW 192

Query: 202 KI 203
           ++
Sbjct: 193 EV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 30/90 (33%), Positives = 44/90 (48%), Gaps = 6/90 (6%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LH   + R+++RDLK  N+LLDD  N +ISD G+A      + G       GT GYM
Sbjct: 108 LEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL---KGGKKIKGRAGTPGYM 161

Query: 178 SLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E           D F  G  + +++ G+
Sbjct: 162 APEVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 30/186 (16%)

Query: 49  QEVAIKRL---AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL-VYEFMPN 104
            EVAIK L   A      R  F+ E  L A+L + N+V LL         L  V+E++P 
Sbjct: 4   HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63

Query: 105 KSL------DSSFSG---------TFKDLLCLHKYSRLRVIHRDLKASNILL---DDQLN 146
           ++L      D +                L C H      ++HRDLK  NI++     + +
Sbjct: 64  RTLREVLAADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 147 TKISDFGMARIF-GVNESGAN----TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVL 201
            K+ DFG+  +  GV ++       T  ++GT  Y + E      V+  +D++ +G++ L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180

Query: 202 KIVCGK 207
           + + G+
Sbjct: 181 ECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 29/164 (17%)

Query: 64  RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSG--------TF 115
           R +   E +++  + + N+VK      H  E  ++ EFM   SL+ +             
Sbjct: 116 RRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR 175

Query: 116 KDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG 175
           + L  +    R  ++HRD+K SN+L++   N KI+DFG++RI  + ++    N  VGT  
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIA 233

Query: 176 YMSLEYTMSGTVSIKT------------DVFGFGVLVLKIVCGK 207
           YMS E        I T            D++  GV +L+   G+
Sbjct: 234 YMSPE-------RINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 51/192 (26%), Positives = 83/192 (43%), Gaps = 25/192 (13%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQN---EAKLIAKLQYTNLVKLLGCSIHGEE 94
           RV L  K       AIK +       + +      E  ++++ Q   +VKL   S  G++
Sbjct: 8   RVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGKK 66

Query: 95  RL-LVYEFMPN---KSLDSSFSGTFKD----------LLCLHKYSRLRVIHRDLKASNIL 140
            L LV E++P     SL  +  G+  +          +L L       +IHRDLK  NIL
Sbjct: 67  NLYLVMEYLPGGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL 125

Query: 141 LDDQLNTKISDFG------MARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVF 194
           +D   + K++DFG      + R   +N+      RIVGT  Y++ E  +    S   D +
Sbjct: 126 IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWW 185

Query: 195 GFGVLVLKIVCG 206
             G ++ + + G
Sbjct: 186 SLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 22/157 (14%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERLLVY-EFMPNKSLDS--------------SFSG- 113
           E + +  L + N+V+ LG     EE L ++ E++P  S+ S               F+  
Sbjct: 58  EIETLKDLDHLNIVQYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ 116

Query: 114 TFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
             + L  LH      ++HRDLKA N+L+D     KISDFG+++             + G+
Sbjct: 117 VLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173

Query: 174 YGYMSLE--YTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
             +M+ E  ++ S   S K D++  G +VL++  G++
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 33/185 (17%)

Query: 48  EQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK 105
           E  VAIK +    +  + R+EF NEA ++ +    ++V+LLG    G+  L+V E M   
Sbjct: 36  ETRVAIKTVNENASMRE-RIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKG 94

Query: 106 SLDSSFSGT--------FKDLLCLHKY--------------SRLRVIHRDLKASNILLDD 143
            L S                   L K+              +  + +HRDL A N ++ +
Sbjct: 95  DLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE 154

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGT----YGYMSLEYTMSGTVSIKTDVFGFGVL 199
            L  KI DFGM R   + E+  +  R  G       +M+ E    G  + K+DV+ FGV+
Sbjct: 155 DLTVKIGDFGMTR--DIYET--DYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVV 210

Query: 200 VLKIV 204
           + ++ 
Sbjct: 211 LWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 63.2 bits (153), Expect = 3e-11
 Identities = 50/169 (29%), Positives = 88/169 (52%), Gaps = 17/169 (10%)

Query: 51  VAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L  T+G +  VEF +EA ++A + + +LV+LLG  +    +L V + MP+  L  
Sbjct: 39  VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCL-L 96

Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 97  DYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLA 156

Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           R+   +E   N +       +M+LE       + ++DV+ +GV + +++
Sbjct: 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 3e-11
 Identities = 45/161 (27%), Positives = 71/161 (44%), Gaps = 29/161 (18%)

Query: 68  QNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLH----- 122
           + E +L+  LQ+  +V+  GC    E   +  E+MP         G+ KD L  +     
Sbjct: 52  ECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMP--------GGSVKDQLKAYGALTE 103

Query: 123 ----KYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA-RIFGVNESGAN 166
               KY+R             ++HRD+K +NIL D   N K+ DFG + R+  +  SG  
Sbjct: 104 TVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTG 163

Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
              + GT  +MS E         K DV+  G  V++++  K
Sbjct: 164 MKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 41/105 (39%), Positives = 61/105 (58%), Gaps = 15/105 (14%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHKY 124
           E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  SG    L+  + +
Sbjct: 49  EISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLF 107

Query: 125 SRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
             L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 62.8 bits (152), Expect = 4e-11
 Identities = 51/190 (26%), Positives = 89/190 (46%), Gaps = 20/190 (10%)

Query: 48  EQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           +Q VAIK +     +  +E  Q E  ++++     + K  G  + G +  ++ E++   S
Sbjct: 29  QQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS 88

Query: 107 -LDSSFSGTF-------------KDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF 152
            LD   +G F             K L  LH   +   IHRD+KA+N+LL +Q + K++DF
Sbjct: 89  ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADF 145

Query: 153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKS 212
           G+A    + ++    N  VGT  +M+ E         K D++  G+  +++  G+  N  
Sbjct: 146 GVAG--QLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203

Query: 213 YHTERPLNLV 222
            H  R L L+
Sbjct: 204 MHPMRVLFLI 213

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 18/177 (10%)

Query: 43  GKFPNEQEVAIKRLAWTSGQG-RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF 101
           G      EVA+K    T     + +F  EA+++ +  + N+VKL+G  +  +   +V E 
Sbjct: 14  GVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL 73

Query: 102 MPNKSLDSSFSG-----TFKDLL--CLHKYSRLR------VIHRDLKASNILLDDQLNTK 148
           +P  SL +         T K LL   L   + +        IHRDL A N L+ +    K
Sbjct: 74  VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLK 133

Query: 149 ISDFGMAR--IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           ISDFGM+R    G+        +I     + + E    G  + ++DV+ +G+L+ + 
Sbjct: 134 ISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTSESDVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 38/158 (24%), Positives = 75/158 (47%), Gaps = 17/158 (10%)

Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKDLLCLHK 123
             + E +L+A+L + +++++LG +       L  E+M   S+    S  G FK+ + +  
Sbjct: 49  ALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAV-IIN 107

Query: 124 YSRL-----------RVIHRDLKASNILLDDQ-LNTKISDFGMARIFGVNESGAN--TNR 169
           Y+             ++IHRD+K +N+L+D      +I+DFG A       +GA     +
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167

Query: 170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           ++GT  +M+ E           DV+  G +++++   K
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 46/170 (27%), Positives = 82/170 (48%), Gaps = 24/170 (14%)

Query: 49  QEVAIKRLAW-TSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           Q+VA+K +    + Q    F  E  ++ KL + NLV+LLG  +H     +V E M   +L
Sbjct: 30  QKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNL 85

Query: 108 DSSFSGTFKDLLCLHKYSRL--------------RVIHRDLKASNILLDDQLNTKISDFG 153
            +      + L+ + +  +               +++HRDL A NIL+ +    K+SDFG
Sbjct: 86  VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFG 145

Query: 154 MARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           +AR   V   G + +++     + + E       S K+DV+ +GVL+ ++
Sbjct: 146 LAR---VGSMGVDNSKL--PVKWTAPEALKHKKFSSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 62.8 bits (152), Expect = 4e-11
 Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 30/178 (16%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQN---EAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP 103
           N + VAIK+++++  Q   ++Q+   E + + KL++ N ++  GC +      LV E+  
Sbjct: 39  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98

Query: 104 NKSLD---------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTK 148
             + D               +   G  + L  LH ++   +IHRD+KA NILL +    K
Sbjct: 99  GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVK 155

Query: 149 ISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS---GTVSIKTDVFGFGVLVLKI 203
           + DFG A I       A  N  VGT  +M+ E  ++   G    K DV+  G+  +++
Sbjct: 156 LGDFGSASIM------APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 16/183 (8%)

Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
            QEVAIK++       +    NE  ++ + ++ N+V  L   + G+E  +V E++   SL
Sbjct: 44  GQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103

Query: 108 DSSFSGTFKD--------LLCLHKYSRL---RVIHRDLKASNILLDDQLNTKISDFGMAR 156
               + T  D          CL     L   +VIHRD+K+ NILL    + K++DFG   
Sbjct: 104 TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163

Query: 157 IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTE 216
                +S  +T  +VGT  +M+ E         K D++  G++ +++V G+     Y  E
Sbjct: 164 QITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE---PPYLNE 218

Query: 217 RPL 219
            PL
Sbjct: 219 NPL 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 48/173 (27%), Positives = 82/173 (47%), Gaps = 30/173 (17%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQN---EAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP 103
             + VAIK+++++  Q   ++Q+   E + + +L++ N ++  GC +      LV E+  
Sbjct: 39  TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL 98

Query: 104 NKSLD---------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTK 148
             + D               +   G  + L  LH + R   IHRD+KA NILL +    K
Sbjct: 99  GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVK 155

Query: 149 ISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS---GTVSIKTDVFGFGV 198
           ++DFG A +     S AN+   VGT  +M+ E  ++   G    K DV+  G+
Sbjct: 156 LADFGSASLV----SPANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 39/127 (30%), Positives = 56/127 (44%), Gaps = 26/127 (20%)

Query: 100 EFMPNKSLDSSF-------------------SGTFKDLLCLHKYSRLRVIHRDLKASNIL 140
           E+    SLDS +                       K L  LH  SR ++IHRD+K SNIL
Sbjct: 81  EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--SR-KIIHRDIKPSNIL 137

Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           L  +   K+ DFG++       S A T    GT  YM+ E       SI +DV+  G+ +
Sbjct: 138 LTRKGQVKLCDFGVSGELV--NSLAGT--FTGTSFYMAPERIQGKPYSITSDVWSLGLTL 193

Query: 201 LKIVCGK 207
           L++   +
Sbjct: 194 LEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 61.9 bits (150), Expect = 6e-11
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 28/181 (15%)

Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS 110
           VA+K L   +   R +FQ EA+L+  LQ+ ++VK  G    G+  ++V+E+M +  L+  
Sbjct: 38  VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 97

Query: 111 FSGTFKDLLC------------------LHKYSRL----------RVIHRDLKASNILLD 142
                 D +                   LH  S++            +HRDL   N L+ 
Sbjct: 98  LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157

Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
             L  KI DFGM+R     +        +    +M  E  M    + ++DV+ FGV++ +
Sbjct: 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 217

Query: 203 I 203
           I
Sbjct: 218 I 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 8e-11
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 20/189 (10%)

Query: 49  QEVAIKRLAWTSGQGRVEF-QNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS- 106
           Q VAIK +     +  +E  Q E + +++ +   + K  G  + G +  ++ E+    S 
Sbjct: 27  QVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC 86

Query: 107 LDSSFSGTF---------KDLL----CLHKYSRLRVIHRDLKASNILLDDQLNTKISDFG 153
           LD    G           +++L     LH+      IHRD+KA+NILL ++ + K++DFG
Sbjct: 87  LDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFG 143

Query: 154 MARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSY 213
           ++       S  NT   VGT  +M+ E         K D++  G+  +++  G+      
Sbjct: 144 VSGQLTSTMSKRNT--FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201

Query: 214 HTERPLNLV 222
           H  R L L+
Sbjct: 202 HPMRVLFLI 210

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 61.7 bits (150), Expect = 8e-11
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 16/182 (8%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           ++VA+K++     Q R    NE  ++   Q+ N+V++    + G+E  +V EF+   +L 
Sbjct: 45  RQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104

Query: 109 SSFSGTFKD--------LLCLHKYSRL---RVIHRDLKASNILLDDQLNTKISDFGMARI 157
              + T  +        L  L   S L    VIHRD+K+ +ILL      K+SDFG    
Sbjct: 105 DIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA- 163

Query: 158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER 217
             V++       +VGT  +M+ E         + D++  G++V+++V G+     Y  E 
Sbjct: 164 -QVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE---PPYFNEP 219

Query: 218 PL 219
           PL
Sbjct: 220 PL 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 61.3 bits (149), Expect = 8e-11
 Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 18/179 (10%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY-EF 101
           G F   +EV++     T  +   + + E  L++KLQ+ N+V+ LG +   E+ L ++ E 
Sbjct: 25  GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLG-TEREEDNLYIFLEL 83

Query: 102 MPNKSLDSSFS--GTFKD----------LLCLHKYSRLRVIHRDLKASNILLDDQLNTKI 149
           +P  SL       G+F +          LL L        +HRD+K +NIL+D     K+
Sbjct: 84  VPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKL 143

Query: 150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGK 207
           +DFGMA+        +      G+  +M+ E     G   +  D++  G  VL++  GK
Sbjct: 144 ADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 17/154 (11%)

Query: 70  EAKLIAKLQYTNLVKLLGC-SIHGEERLLVY-EFMPNKSLDSSFS--GTFKDLLCLHKYS 125
           E +L+  LQ+  +V+  GC     E+ L ++ E+MP  S+       G   + +   KY+
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVT-RKYT 112

Query: 126 RL-----------RVIHRDLKASNILLDDQLNTKISDFGMA-RIFGVNESGANTNRIVGT 173
           R             ++HRD+K +NIL D   N K+ DFG + R+  +  SG     + GT
Sbjct: 113 RQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             +MS E         K DV+  G  V++++  K
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 22/183 (12%)

Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS 110
           VA+K++     Q R    NE  ++   Q+ N+V++    + G+E  +V EF+   +L   
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 107

Query: 111 FSGT--------------FKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
            + T               K L  LH      VIHRD+K+ +ILL      K+SDFG   
Sbjct: 108 VTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA 164

Query: 157 IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTE 216
              V++       +VGT  +M+ E         + D++  G++V+++V G+     Y  E
Sbjct: 165 --QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---PPYFNE 219

Query: 217 RPL 219
            PL
Sbjct: 220 PPL 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 48/191 (25%), Positives = 89/191 (46%), Gaps = 20/191 (10%)

Query: 47  NEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK 105
            ++ VAIK +     +  +E  Q E  ++++     + +  G  + G +  ++ E++   
Sbjct: 28  TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGG 87

Query: 106 S---------LDSSFSGT-----FKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISD 151
           S         L+ ++  T      K L  LH     R IHRD+KA+N+LL +Q + K++D
Sbjct: 88  SALDLLKPGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLAD 144

Query: 152 FGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNK 211
           FG+A    + ++    N  VGT  +M+ E         K D++  G+  +++  G+  N 
Sbjct: 145 FGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS 202

Query: 212 SYHTERPLNLV 222
             H  R L L+
Sbjct: 203 DLHPMRVLFLI 213

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 43/169 (25%), Positives = 73/169 (43%), Gaps = 23/169 (13%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF---- 101
              Q VAIK +         E   E  ++ +     +VK  G      +  +V E+    
Sbjct: 26  ETGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG 83

Query: 102 -------MPNKSLDSS-----FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKI 149
                  + NK+L           T K L  LH     + IHRD+KA NILL+++   K+
Sbjct: 84  SVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKL 140

Query: 150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGV 198
           +DFG++    + ++ A  N ++GT  +M+ E       + K D++  G+
Sbjct: 141 ADFGVSGQ--LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGI 187

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 3/81 (3%)

Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
            +IHRD+K  NILLD+Q +  I+DF +A           T    GT GYM+ E       
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEVLCRQGY 176

Query: 188 SIKTDVFGFGVLVLKIVCGKK 208
           S+  D +  GV   + + GK+
Sbjct: 177 SVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 60.7 bits (148), Expect = 2e-10
 Identities = 39/131 (29%), Positives = 64/131 (48%), Gaps = 23/131 (17%)

Query: 49  QEVAIKRL---AWTSGQGRVEFQ--NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP 103
           + VAIK++        +  + F    E KL+ +L++ N++ LL    H     LV+EFM 
Sbjct: 26  RIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME 85

Query: 104 --------NKSLDSSFSG-------TFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTK 148
                   +KS+  + +        T + L  LH      ++HRDLK +N+L+      K
Sbjct: 86  TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLK 142

Query: 149 ISDFGMARIFG 159
           ++DFG+AR FG
Sbjct: 143 LADFGLARSFG 153

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 41/154 (26%), Positives = 68/154 (44%), Gaps = 19/154 (12%)

Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLL------ 119
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L        +  +      
Sbjct: 48  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 107

Query: 120 --------CLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF--GVNESGANTNR 169
                    +    +   IHRDL A N L+ +    K++DFG++R+       + A    
Sbjct: 108 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 167

Query: 170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
            +      SL Y      SIK+DV+ FGVL+ +I
Sbjct: 168 PIKWTAPESLAYN---KFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 17/172 (9%)

Query: 46  PNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMP 103
             +   A+K L   +    VE F  E  ++    + N++ LLG  +  E   L+V  +M 
Sbjct: 21  GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80

Query: 104 NKSL-----DSSFSGTFKDLLCL-------HKY-SRLRVIHRDLKASNILLDDQLNTKIS 150
           +  L       + + T KDL+          +Y +  + +HRDL A N +LD+    K++
Sbjct: 81  HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVA 140

Query: 151 DFGMARIFGVNE--SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           DFG+AR     E  S  N         +M+LE   +   + K+DV+ FGVL+
Sbjct: 141 DFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 192

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 60.5 bits (146), Expect = 2e-10
 Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 16/182 (8%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           QEVAIK++       +    NE  ++ + +  N+V  L   + G+E  +V E++   SL 
Sbjct: 45  QEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104

Query: 109 SSFSGTFKD--------LLCLHKYSRL---RVIHRDLKASNILLDDQLNTKISDFGMARI 157
              + T  D          CL     L   +VIHRD+K+ NILL    + K++DFG    
Sbjct: 105 DVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164

Query: 158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER 217
               +S  +T  +VGT  +M+ E         K D++  G++ +++V G+     Y  E 
Sbjct: 165 ITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE---PPYLNEN 219

Query: 218 PL 219
           PL
Sbjct: 220 PL 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 46/174 (26%), Positives = 83/174 (47%), Gaps = 30/174 (17%)

Query: 51  VAIKRLAWTSGQGRVEFQN---EAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           VAIK+++++  Q   ++Q+   E K + ++++ N ++  GC +      LV E+    + 
Sbjct: 53  VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSAS 112

Query: 108 D---------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF 152
           D               +   G  + L  LH ++   +IHRD+KA NILL +    K++DF
Sbjct: 113 DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADF 169

Query: 153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMS---GTVSIKTDVFGFGVLVLKI 203
           G A I       +  N  VGT  +M+ E  ++   G    K DV+  G+  +++
Sbjct: 170 GSASI------ASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 17/157 (10%)

Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS-SFSGTFKDLLCLHKYSR- 126
           +E K++  L++ NLVK  G  +H E+  +  E+    +L+     G   D   +  Y+  
Sbjct: 48  DEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQ 107

Query: 127 -LR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNES--GANTNRIVGTY 174
            L          ++HRD+K +NI LD     K+ DFG A     N +  G     + GT 
Sbjct: 108 LLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167

Query: 175 GYMSLEYTMSGTVSIK---TDVFGFGVLVLKIVCGKK 208
            YM+ E    G         D++  G +VL++  GK+
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 60.5 bits (146), Expect = 2e-10
 Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 25/178 (14%)

Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS 110
           VA+K L   S   R +F  EA+L+  LQ+ ++VK  G  + G+  ++V+E+M +  L+  
Sbjct: 38  VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97

Query: 111 FSGTFKDLLC---------------LHKYSRL----------RVIHRDLKASNILLDDQL 145
                 D +                LH   ++            +HRDL   N L+ + L
Sbjct: 98  LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157

Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             KI DFGM+R     +        +    +M  E  M    + ++DV+  GV++ +I
Sbjct: 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 23/179 (12%)

Query: 48  EQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VAIK +    S + R+EF NEA ++ +    ++V+LLG    G+  L++ E M    
Sbjct: 36  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 95

Query: 107 LDSSF--------SGTFKDLLCLHKYSRL--------------RVIHRDLKASNILLDDQ 144
           L S          +   +    L K  ++              + +HRDL A N ++ + 
Sbjct: 96  LKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 155

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
              KI DFGM R     +      + +    +MS E    G  +  +DV+ FGV++ +I
Sbjct: 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 59.5 bits (144), Expect = 3e-10
 Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 37/185 (20%)

Query: 64  RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL--------------DS 109
           R+  QNE +++  L + N+++     +  +  ++V E+ P  +L              D+
Sbjct: 43  RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT 102

Query: 110 SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDD-QLNTKISDFGMARIFGVNESGANTN 168
                 + LL LH      ++HRDLK  NILLD  ++  KI DFG+++I   ++S A T 
Sbjct: 103 ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYT- 160

Query: 169 RIVGTYGYMSLEYTMSGTVSIKTDVFGFG-------------------VLVLKIVCGKKN 209
            +VGT  Y+S E       + K+D++  G                    LVLKI+ G   
Sbjct: 161 -VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA 219

Query: 210 NKSYH 214
             S  
Sbjct: 220 PISDR 224

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 4e-10
 Identities = 37/131 (28%), Positives = 60/131 (45%), Gaps = 20/131 (15%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQN--EAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-- 102
             + VAIK++        +      E KL+ +L + N++KLL    H  +  LV+EFM  
Sbjct: 23  TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82

Query: 103 -------------PNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKI 149
                        P   + S      + L   H +    ++HRDLK  N+L++ +   K+
Sbjct: 83  DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKL 139

Query: 150 SDFGMARIFGV 160
           +DFG+AR FG 
Sbjct: 140 ADFGLARSFGS 150

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 59.5 bits (144), Expect = 4e-10
 Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 24/177 (13%)

Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD- 108
           VA+K L    +   R +F  E K++++L+  N+++LL   I  +   ++ E+M N  L+ 
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 109 --------------SSFSGTFKDLLCL-------HKY-SRLRVIHRDLKASNILLDDQLN 146
                            + ++  L+ +        KY S L  +HRDL   N L+     
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT 168

Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
            KI+DFGM+R     +      R V    +MS E  + G  +  +DV+ FGV + +I
Sbjct: 169 IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 44/192 (22%)

Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L LV E++P     
Sbjct: 36  VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP----- 90

Query: 109 SSFSGTFKDLLCLHK----YSRL-----------------RVIHRDLKASNILLDDQLNT 147
               G+ +D L  H+    + +L                 R +HRDL   NIL++ +   
Sbjct: 91  ---YGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRV 147

Query: 148 KISDFGMARI-------FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           KI DFG+ ++       + V E G +    +  Y   SL        S+ +DV+ FGV++
Sbjct: 148 KIGDFGLTKVLPQDKEYYKVREPGESP---IFWYAPESLT---ESKFSVASDVWSFGVVL 201

Query: 201 LKIVCGKKNNKS 212
            ++      + S
Sbjct: 202 YELFTYSDKSCS 213

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 49/186 (26%), Positives = 84/186 (45%), Gaps = 32/186 (17%)

Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VA+K L    +   R +F  E K++++L+  N+++LLG  +  +   ++ E+M N  L+ 
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 110 SFSG-----------------------TFKDLLCL-------HKY-SRLRVIHRDLKASN 138
             S                        ++  LL +        KY S L  +HRDL   N
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRN 168

Query: 139 ILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGV 198
            L+ + L  KI+DFGM+R     +      R V    +M+ E  + G  +  +DV+ FGV
Sbjct: 169 CLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV 228

Query: 199 LVLKIV 204
            + +I+
Sbjct: 229 TLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 50/181 (27%), Positives = 78/181 (43%), Gaps = 32/181 (17%)

Query: 51  VAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL-- 107
           VA+K L    S   R +F  E K++++L   N+ +LLG         ++ E+M N  L  
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 108 --------DSSFSGTFKDLL--CL----------HKY-SRLRVIHRDLKASNILLDDQLN 146
                    S  +   K L    L           +Y   L  +HRDL   N L+     
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT 168

Query: 147 TKISDFGMARIFGVNESGANTNRIVGT----YGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
            KI+DFGM+R    N   ++  R+ G       +M+ E  + G  + K+DV+ FGV + +
Sbjct: 169 IKIADFGMSR----NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224

Query: 203 I 203
           I
Sbjct: 225 I 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 45/174 (25%), Positives = 81/174 (46%), Gaps = 30/174 (17%)

Query: 51  VAIKRLAWTSGQGRVEFQN---EAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           VA+K+++++  Q   ++Q+   E K + +L++ N ++  GC +      LV E+    + 
Sbjct: 49  VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSAS 108

Query: 108 D---------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF 152
           D               +   G  + L  LH ++    IHRD+KA NILL +    K++DF
Sbjct: 109 DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADF 165

Query: 153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMS---GTVSIKTDVFGFGVLVLKI 203
           G A         +  N  VGT  +M+ E  ++   G    K DV+  G+  +++
Sbjct: 166 GSASK------SSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 16/182 (8%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           ++VA+K++     Q R    NE  ++    + N+V +    + G+E  +V EF+   +L 
Sbjct: 48  KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107

Query: 109 SSFSGTFKD-----LLCLHKYSRLR------VIHRDLKASNILLDDQLNTKISDFGMARI 157
              + T  +      +CL     L       VIHRD+K+ +ILL      K+SDFG    
Sbjct: 108 DIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA- 166

Query: 158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER 217
             V++       +VGT  +M+ E         + D++  G++V++++ G+     Y  E 
Sbjct: 167 -QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE---PPYFNEP 222

Query: 218 PL 219
           PL
Sbjct: 223 PL 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 40/110 (36%), Positives = 63/110 (57%), Gaps = 24/110 (21%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMP---NKSLDSS--FSGTFKDLLCLHK 123
           E  L+ ++Q+ N+V+L    +H E+RL LV+E++     K +DSS  F+   K+   +  
Sbjct: 51  EISLLKEMQHGNIVRLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSPDFA---KNPRLIKT 106

Query: 124 Y------------SRLRVIHRDLKASNILLDDQLNT-KISDFGMARIFGV 160
           Y            S  RV+HRDLK  N+L+D + N  K++DFG+AR FG+
Sbjct: 107 YLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155

Length = 294

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 16/182 (8%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           QEVAI+++       +    NE  ++ + +  N+V  L   + G+E  +V E++   SL 
Sbjct: 46  QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105

Query: 109 SSFSGTFKD--------LLCLHKYSRL---RVIHRDLKASNILLDDQLNTKISDFGMARI 157
              + T  D          CL     L   +VIHRD+K+ NILL    + K++DFG    
Sbjct: 106 DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA- 164

Query: 158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER 217
             +    +  + +VGT  +M+ E         K D++  G++ ++++ G+     Y  E 
Sbjct: 165 -QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE---PPYLNEN 220

Query: 218 PL 219
           PL
Sbjct: 221 PL 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 38/124 (30%), Positives = 60/124 (48%), Gaps = 6/124 (4%)

Query: 92  GEERLLVYEFMPNKSLDSSFSGTFKDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKI 149
           G+ +  +Y  M N   D   +  +   LC  L    R R+++RDLK  NILLDD+ + +I
Sbjct: 85  GDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRI 143

Query: 150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN 209
           SD G+A        G      VGT GYM+ E   +   +   D +G G L+ +++ G+  
Sbjct: 144 SDLGLAVQI---PEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Query: 210 NKSY 213
            +  
Sbjct: 201 FRKR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 47/224 (20%)

Query: 41  LVGKFPNEQEVAIKRLA-WTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLV 98
           ++ K   +   AIK L  + S     +F  E +++ KL  + N++ LLG   +     + 
Sbjct: 22  MIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81

Query: 99  YEFMPNKSL------------DSSFS---GTFKDLLC-------------LHKYSRLRVI 130
            E+ P  +L            D +F+   GT   L               +   S  + I
Sbjct: 82  IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFI 141

Query: 131 HRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK 190
           HRDL A N+L+ + L +KI+DFG++R   V          V      SL Y++  T   K
Sbjct: 142 HRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTT---K 198

Query: 191 TDVFGFGVLVLKIV-------CG-------KKNNKSYHTERPLN 220
           +DV+ FGVL+ +IV       CG       +K  + Y  E+P N
Sbjct: 199 SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRN 242

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)

Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L + + MP   L  
Sbjct: 39  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCL-L 96

Query: 110 SFSGTFKDLLC--------------LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +               ++     R++HRDL A N+L+    + KI+DFG+A
Sbjct: 97  DYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLA 156

Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G +E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 47/186 (25%), Positives = 85/186 (45%), Gaps = 22/186 (11%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           ++VA+K +     Q R    NE  ++   Q+ N+V++    + GEE  ++ EF+   +L 
Sbjct: 47  RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106

Query: 109 SSFSGT--------------FKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGM 154
              S T               + L  LH      VIHRD+K+ +ILL      K+SDFG 
Sbjct: 107 DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGF 163

Query: 155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH 214
                +++       +VGT  +M+ E         + D++  G++V+++V G+     Y 
Sbjct: 164 CA--QISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE---PPYF 218

Query: 215 TERPLN 220
           ++ P+ 
Sbjct: 219 SDSPVQ 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 56.2 bits (135), Expect = 5e-09
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 6/96 (6%)

Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H ++R  V++RDLK +NILLD+  + +ISD G+A  F   +  A+    VGT+GYM+ E 
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166

Query: 182 TMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTE 216
              GT      D F  G ++ K++ G    + + T+
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 56.1 bits (135), Expect = 6e-09
 Identities = 48/193 (24%), Positives = 85/193 (44%), Gaps = 41/193 (21%)

Query: 51  VAIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VA+K L   +    + +  +E  L+ ++ + +++KL G        LL+ E+    SL S
Sbjct: 33  VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92

Query: 110 ----------SFSG------------------TFKDLLC--------LHKYSRLRVIHRD 133
                     S+ G                  T  DL+         +   + ++++HRD
Sbjct: 93  FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRD 152

Query: 134 LKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKT 191
           L A N+L+ +    KISDFG++R   V E  +   R  G     +M++E       + ++
Sbjct: 153 LAARNVLVAEGRKMKISDFGLSR--DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQS 210

Query: 192 DVFGFGVLVLKIV 204
           DV+ FGVL+ +IV
Sbjct: 211 DVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 55.5 bits (134), Expect = 6e-09
 Identities = 48/165 (29%), Positives = 70/165 (42%), Gaps = 19/165 (11%)

Query: 51  VAIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL-- 107
           VA+K L        + +F  EA ++  L + NL++L G  +     ++V E  P  SL  
Sbjct: 26  VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGV-VLTHPLMMVTELAPLGSLLD 84

Query: 108 ---DSSFSGTFKDLLCLH--------KYSRL-RVIHRDLKASNILLDDQLNTKISDFGMA 155
                +        LC +        +Y    R IHRDL A NILL      KI DFG+ 
Sbjct: 85  RLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLM 144

Query: 156 RIFGVNESG--ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGV 198
           R    NE       +  V  + + + E   + T S  +DV+ FGV
Sbjct: 145 RALPQNEDHYVMEEHLKV-PFAWCAPESLRTRTFSHASDVWMFGV 188

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.7 bits (134), Expect = 6e-09
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 4/93 (4%)

Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           LH +S + +++RD+K  N+LLDDQ N ++SD G+A      + G    +  GT GYM+ E
Sbjct: 109 LHLHS-MDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL---KDGKTITQRAGTNGYMAPE 164

Query: 181 YTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSY 213
                  S   D F  G  + ++V G+   K +
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 41/183 (22%), Positives = 76/183 (41%), Gaps = 30/183 (16%)

Query: 49  QEVAIKRLAWT-SGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEER------LLVYE 100
            +VA+K +         +E F +EA  +    + N++KL+G              +++  
Sbjct: 28  LKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILP 87

Query: 101 FMPNKSLDS----------SFSGTFKDLL-------CLHKY-SRLRVIHRDLKASNILLD 142
           FM +  L S                + LL          +Y S    IHRDL A N +L 
Sbjct: 88  FMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR 147

Query: 143 DQLNTKISDFGMAR-IFGVNESGANTNRIVGT-YGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           + +   ++DFG+++ I+  +       RI      ++++E       + K+DV+ FGV +
Sbjct: 148 EDMTVCVADFGLSKKIY--SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 205

Query: 201 LKI 203
            +I
Sbjct: 206 WEI 208

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 17/154 (11%)

Query: 70  EAKLIAKLQYTNLVKLLGC-SIHGEERLLVY-EFMPNKSLDSSFS--GTFKDLLCLHKYS 125
           E +L+  L++  +V+  GC     E++L ++ E+MP  S+       G   + +   +Y+
Sbjct: 54  EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVT-RRYT 112

Query: 126 RL-----------RVIHRDLKASNILLDDQLNTKISDFGMA-RIFGVNESGANTNRIVGT 173
           R             ++HRD+K +NIL D   N K+ DFG + RI  +  SG     + GT
Sbjct: 113 RQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172

Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             +MS E         K DV+     V++++  K
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 22/153 (14%)

Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSLDSSFSGTFKDLL---CLH 122
           F  EA ++ +L+++NLV+LLG  +  +  L +V E+M   SL        + +L   CL 
Sbjct: 46  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105

Query: 123 KYSRLRV------------IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI 170
           K+S L V            +HRDL A N+L+ +    K+SDFG+ +     E+ +  +  
Sbjct: 106 KFS-LDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTG 159

Query: 171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
                + + E       S K+DV+ FG+L+ +I
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LH+   L +I+RD+K  NILLD + +  ++DFG+++ F + E         GT  YM
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIEYM 173

Query: 178 SLEYTMSGTV--SIKTDVFGFGVLVLKIVCG 206
           + E    G+       D +  GVL  +++ G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 3/90 (3%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           +L         +I+RDLK  N+LLD     K+ DFG A+      SG  T    GT  Y+
Sbjct: 103 VLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK---SGQKTWTFCGTPEYV 159

Query: 178 SLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E  ++       D +  G+L+ +++ G+
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 44/179 (24%), Positives = 79/179 (44%), Gaps = 23/179 (12%)

Query: 48  EQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VA+K +  + S + R+EF NEA ++      ++V+LLG    G+  L+V E M +  
Sbjct: 36  ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 95

Query: 107 LDSSFSG--------------TFKDLLCLHK--------YSRLRVIHRDLKASNILLDDQ 144
           L S                  T ++++ +           +  + +HRDL A N ++   
Sbjct: 96  LKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 155

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
              KI DFGM R     +      + +    +M+ E    G  +  +D++ FGV++ +I
Sbjct: 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 48/212 (22%)

Query: 33  EQTRDRVILVGK-----------FPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTN 81
           ++  +RV+L GK              +  +AIK +     +       E  L + L++ N
Sbjct: 8   DENGERVVL-GKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 82  LVKLLGCSIHGEERLLVYEFMPNKSLDS---SFSGTFKD---------------LLCLHK 123
           +V+ LG         +  E +P  SL +   S  G  KD               L  LH 
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126

Query: 124 YSRLRVIHRDLKASNILLDDQLNT-----KISDFGMA-RIFGVNESGANTNRIVGTYGYM 177
               +++HRD+K  N+L    +NT     KISDFG + R+ G+N     T    GT  YM
Sbjct: 127 ---NQIVHRDIKGDNVL----VNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYM 176

Query: 178 SLEYTMSGT--VSIKTDVFGFGVLVLKIVCGK 207
           + E    G        D++  G  ++++  GK
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 32/86 (37%), Positives = 49/86 (56%), Gaps = 6/86 (6%)

Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H ++R  V++RDLK +NILLD+  + +ISD G+A  F   +  A+    VGT+GYM+ E 
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166

Query: 182 TMSGTV-SIKTDVFGFGVLVLKIVCG 206
              G       D F  G ++ K++ G
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 12/92 (13%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMA-RIFGVNESGANTNRIVGTYGYMSLEY----TM 183
           VIHRD+K SNILLD   N K+ DFG++ R+    +S A T R  G   YM+ E       
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYMAPERIDPPDP 191

Query: 184 SGTVSIKTDVFGFGVLVLKIVCGK---KNNKS 212
           +    I+ DV+  G+ ++++  G+   KN K+
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFPYKNCKT 223

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 37/235 (15%)

Query: 51  VAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEER--LLVYEFMPNKSL 107
           VA+K L    GQ     ++ E  ++  L + N+VK  GC      +   L+ E++P  SL
Sbjct: 36  VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95

Query: 108 DSSFSGT---------FKDLLC-----LHKYSRLRVIHRDLKASNILLDDQLNTKISDFG 153
                           F   +C     LH       IHRDL A N+LLD+    KI DFG
Sbjct: 96  RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG 152

Query: 154 MAR-------IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           +A+        + V E G +         + ++E       S  +DV+ FGV + +++  
Sbjct: 153 LAKAVPEGHEYYRVREDGDS------PVFWYAVECLKENKFSYASDVWSFGVTLYELLTH 206

Query: 207 KKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCP---PNEDAFLLVSC 258
             + +S    +   ++G         + +EL++  +   CP   P E   L+ +C
Sbjct: 207 CDSKQSPPK-KFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNC 260

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 29/159 (18%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN------------KSLDSSFSGTF- 115
           E  L+ +L++ N+V+L    IH E +L LV+E+M               +LD +   +F 
Sbjct: 48  EISLMKELKHENIVRLHDV-IHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFT 106

Query: 116 ----KDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT--NR 169
               K +   H+    RV+HRDLK  N+L++ +   K++DFG+AR FG+     NT  N 
Sbjct: 107 YQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---VNTFSNE 160

Query: 170 IVGTYGYMSLEYTM-SGTVSIKTDVFGFGVLVLKIVCGK 207
           +V T  Y + +  + S T S   D++  G ++ +++ G+
Sbjct: 161 VV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 34/113 (30%), Positives = 53/113 (46%), Gaps = 24/113 (21%)

Query: 68  QNEAKLIAKLQYTNLVKLLGCSI-----HGEERLLVYEFMPNKSLDSSFSGTF------- 115
             E K++ KL++ N+V L+  ++        +R  VY   P   +D   SG         
Sbjct: 55  LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP--YMDHDLSGLLENPSVKL 112

Query: 116 ---------KDLLCLHKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMARIF 158
                      LL    Y     ++HRD+KA+NIL+D+Q   KI+DFG+AR +
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 3/90 (3%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
              L    R R+++RDLK  NILLDD  + +ISD G+A    + E      R VGT GYM
Sbjct: 112 TCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGR-VGTVGYM 168

Query: 178 SLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E   +   +   D +G G L+ +++ GK
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 25/178 (14%)

Query: 47  NEQEVAIKRLA---WTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP 103
           + + VA+K++        + R +   E  L+ +L + N++K L   I   E  +V E   
Sbjct: 26  DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELAD 85

Query: 104 NKSLDSSFSGTFKD---------------LLCL---HKYSRLRVIHRDLKASNILLDDQL 145
              L S     FK                 LC    H +SR RV+HRD+K +N+ +    
Sbjct: 86  AGDL-SQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATG 143

Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             K+ D G+ R F    + A++  +VGT  YMS E       + K+D++  G L+ ++
Sbjct: 144 VVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 19/157 (12%)

Query: 65  VEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD------- 117
           V+   EA+L++KL +  +VK     +  +   ++ E+   + LD                
Sbjct: 47  VQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSEN 106

Query: 118 ---------LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTN 168
                    LL +H   + R++HRDLKA NI L + L  KI DFG++R+   +   A T 
Sbjct: 107 QVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT- 164

Query: 169 RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC 205
              GT  YMS E         K+D++  G ++ ++ C
Sbjct: 165 -FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 48/169 (28%), Positives = 87/169 (51%), Gaps = 17/169 (10%)

Query: 51  VAIKRLAW-TSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL-- 107
           VAIK L   TS +   E  +EA ++A +    + +LLG  +    +L V + MP   L  
Sbjct: 39  VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLD 97

Query: 108 ----DSSFSGTFKDLL--CLH------KYSRLRVIHRDLKASNILLDDQLNTKISDFGMA 155
               +    G+ +DLL  C+           +R++HRDL A N+L+    + KI+DFG+A
Sbjct: 98  YVRENKDRIGS-QDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLA 156

Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           R+  ++E+  + +       +M+LE  +    + ++DV+ +GV V +++
Sbjct: 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 64/230 (27%), Positives = 97/230 (42%), Gaps = 51/230 (22%)

Query: 50  EVAIKRLA-WTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           + AIKR+  + S     +F  E +++ KL  + N++ LLG   H     L  E+ P+ +L
Sbjct: 36  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 95

Query: 108 ------------DSSFS------GTFKDLLCLH----------KYSRLRVIHRDLKASNI 139
                       D +F+       T      LH            S+ + IHRDL A NI
Sbjct: 96  LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 155

Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
           L+ +    KI+DFG++R   V          V      SL Y++  T S   DV+ +GVL
Sbjct: 156 LVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS---DVWSYGVL 212

Query: 200 VLKIV-------CG-------KKNNKSYHTERPLN----LVGIAWQLWNE 231
           + +IV       CG       +K  + Y  E+PLN    +  +  Q W E
Sbjct: 213 LWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWRE 262

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 3/87 (3%)

Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           L    + R+++RDLK  NILLDD  + +ISD G+A    V E      R VGT GYM+ E
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPE 171

Query: 181 YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
              +   +   D +  G L+ +++ G+
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 47/178 (26%), Positives = 76/178 (42%), Gaps = 23/178 (12%)

Query: 48  EQEVAIKRLAWTSGQG-RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF----- 101
           E  V +K L  T  +  + EF+ E  +  KL + N+V+LLG     E   ++ E+     
Sbjct: 35  ETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGD 94

Query: 102 -----MPNKSLDSS-----FSGTFKDLLC------LHKYSRLRVIHRDLKASNILLDDQL 145
                   KS D        S   K  LC      +   S  R +HRDL A N L+  Q 
Sbjct: 95  LKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR 154

Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             K+S   +++    +E     N ++    +++ E       S K+DV+ FGVL+ ++
Sbjct: 155 EVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 52.9 bits (128), Expect = 8e-08
 Identities = 19/38 (50%), Positives = 24/38 (63%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN 166
           VIHRDLK SNIL++   + KI DFG+AR    +E    
Sbjct: 124 VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 52.2 bits (125), Expect = 9e-08
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 24/182 (13%)

Query: 49  QEVAIKRLAW-TSGQGRVE-----FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           Q +A+K++   TS     E      Q E  L+  L++ N+V+ LG  +      +  EF+
Sbjct: 25  QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84

Query: 103 PNKSLDSSFS--GTFKDLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKI 149
           P  S+ S  +  G   + +   KY++             V+HRD+K +N++L      K+
Sbjct: 85  PGGSISSILNRFGPLPEPV-FCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKL 143

Query: 150 SDFGMAR---IFGVNESGANTNRIV-GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC 205
            DFG AR     G++ + +N  + + GT  +M+ E         K+D++  G  V ++  
Sbjct: 144 IDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMAT 203

Query: 206 GK 207
           GK
Sbjct: 204 GK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 5/90 (5%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LH+     +I+RDLK  N+LLD + + KI+DFGM +  G+   G  T+   GT  Y+
Sbjct: 109 LQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILG-GVTTSTFCGTPDYI 163

Query: 178 SLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E           D +  GVL+ +++ G+
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 30/161 (18%)

Query: 72  KLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL------------DSSFSG------ 113
           K+I K  + N++ LLG         +V E+  + +L             +S         
Sbjct: 70  KMIGK--HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127

Query: 114 --TFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES 163
             T KDL+   ++ +R        + IHRDL A N+L+ +    KI+DFG+AR     + 
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187

Query: 164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
              T        +M+ E       + ++DV+ FGVL+ +I 
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 29/104 (27%), Positives = 51/104 (49%), Gaps = 19/104 (18%)

Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV-----GTYGY 176
           + +S+L VIHRD+K SN+L++     K+ DFG+        SG   + +      G   Y
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGI--------SGYLVDSVAKTIDAGCKPY 169

Query: 177 MSLE-----YTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHT 215
           M+ E         G   +K+DV+  G+ ++++  G+    S+ T
Sbjct: 170 MAPERINPELNQKG-YDVKSDVWSLGITMIELATGRFPYDSWKT 212

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 20/190 (10%)

Query: 48  EQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           ++ VAIK +     +  +E  Q E  ++++     + K  G  +   +  ++ E++   S
Sbjct: 29  QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 88

Query: 107 ---------LDSSFSGT-----FKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF 152
                    LD +   T      K L  LH   +   IHRD+KA+N+LL +    K++DF
Sbjct: 89  ALDLLEPGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADF 145

Query: 153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKS 212
           G+A    + ++    N  VGT  +M+ E         K D++  G+  +++  G+  +  
Sbjct: 146 GVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203

Query: 213 YHTERPLNLV 222
            H  + L L+
Sbjct: 204 LHPMKVLFLI 213

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 35/103 (33%), Positives = 48/103 (46%), Gaps = 30/103 (29%)

Query: 81  NLVKLL----GCSIHGEERL-LVYEFM-----------PNKSLDSSFSGTFKDLL----- 119
           N+V+LL    G     E +L LV+E +           P   L      T KDL+     
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPE---TIKDLMRQLLR 118

Query: 120 ---CLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG 159
               LH +   R++HRDLK  NIL+      KI+DFG+ARI+ 
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 32/178 (17%)

Query: 50  EVAIKRLAWTSGQGRVE-FQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYE------- 100
           +VA+K L  T+     E   +E K+++ L  + N+V LLG    G   L++ E       
Sbjct: 67  KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126

Query: 101 --FMPNKSLDSSFSGTFKDLLC--------LHKYSRLRVIHRDLKASNILLDDQLNTKIS 150
             F+  K    SF  T +DLL         +   +    IHRDL A N+LL      KI 
Sbjct: 127 LNFLRRKR--ESFL-TLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKIC 183

Query: 151 DFGMARIFGVNESGANTNRIVG-----TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           DFG+AR   +N+S    N +V         +M+ E   +   + ++DV+ +G+L+ +I
Sbjct: 184 DFGLARDI-MNDS----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 4/92 (4%)

Query: 117 DLLC-LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG 175
           ++LC L    R   ++RDLK  NILLDD  + +ISD G+A    + E  +   R VGT G
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGR-VGTVG 166

Query: 176 YMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           YM+ E   +   ++  D +G G L+ +++ G+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 45/165 (27%), Positives = 71/165 (43%), Gaps = 27/165 (16%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERLL--VYEFMPNKSLDSSFS--GTFKDLLCLHKYS 125
           E +L+  L +  +V+  GC     ER L    E MP  S+       G   + +   KY+
Sbjct: 54  EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVT-RKYT 112

Query: 126 RL-----------RVIHRDLKASNILLDDQLNTKISDFGMA-RIFGVNESGANTNRIVGT 173
           R             ++HRD+K +NIL D   N K+ DFG + R+  +  SG     + GT
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172

Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERP 218
             +MS E         K D++  G  V++++          TE+P
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEML----------TEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 32/85 (37%), Positives = 47/85 (55%), Gaps = 8/85 (9%)

Query: 127 LRVIHRDLKASNILLDDQLNTKISDFGMARIFG-VNESGANTNRIVGTYGYMSLEYTMSG 185
           L++IHRD+K SNILLD   N K+ DFG   I G + +S A T R  G   YM+ E     
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKT-RDAGCRPYMAPERIDPS 182

Query: 186 TVS---IKTDVFGFGVLVLKIVCGK 207
                 +++DV+  G+ + ++  GK
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 20/153 (13%)

Query: 64  RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHK 123
           +++F +EA+++ +  + N+VKL+G     +   +V E +P      SF    KD L   +
Sbjct: 36  KIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF-LSFLRKKKDELKTKQ 94

Query: 124 YSRLRV--------------IHRDLKASNILLDDQLNTKISDFGMARIF--GVNESGANT 167
             +  +              IHRDL A N L+ +    KISDFGM+R    G+  S    
Sbjct: 95  LVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154

Query: 168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
              +      +L Y   G  S ++DV+ +G+L+
Sbjct: 155 QIPIKWTAPEALNY---GRYSSESDVWSYGILL 184

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 47/184 (25%), Positives = 83/184 (45%), Gaps = 34/184 (18%)

Query: 44  KFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           K   E+EV +K +   + + +V     E+ L+  L + N++ +L   I   E   V    
Sbjct: 31  KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY 90

Query: 103 PNK-------------SLDSSFSGTFKDLLC-----------LHKYSRLRVIHRDLKASN 138
            N                ++  + + + L+            LHK     VIH+D+ A N
Sbjct: 91  MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARN 147

Query: 139 ILLDDQLNTKISDFGMAR-IFGVNES--GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFG 195
            ++D++L  KI+D  ++R +F ++    G N NR V    +M+LE  ++   S  +DV+ 
Sbjct: 148 CVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV---KWMALESLVNKEYSSASDVWS 204

Query: 196 FGVL 199
           FGVL
Sbjct: 205 FGVL 208

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 5/87 (5%)

Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           LHK     +I+RDLK  N+LLD   + KI+DFGM +     E  A+T    GT  Y++ E
Sbjct: 112 LHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPE 166

Query: 181 YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
                  +   D + FGVL+ +++ G+
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 26/80 (32%), Positives = 42/80 (52%), Gaps = 2/80 (2%)

Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           R+I+RDLK  N+LLD+  N +ISD G+A    + +  + T    GT G+M+ E       
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEEY 174

Query: 188 SIKTDVFGFGVLVLKIVCGK 207
               D F  GV + +++  +
Sbjct: 175 DFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 28/183 (15%)

Query: 39  VILVGKFPNEQEVAIKR--LAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           V  V +  + Q  A+K   L   S + R +  NE +++A + + N++      + G +  
Sbjct: 16  VYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLC 75

Query: 97  LVYEFMPNKSLD-------------------SSFSGTFKDLLCLHKYSRLRVIHRDLKAS 137
           +V E+ P   L                      F    + L  LH+    +++HRDLK++
Sbjct: 76  IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSA 132

Query: 138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFG 197
           NILL      KI D G++++             +GT  YM+ E       S K+D++  G
Sbjct: 133 NILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLG 188

Query: 198 VLV 200
            L+
Sbjct: 189 CLL 191

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 17/151 (11%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSSFSGTFKDLLCLHKYS 125
           EA L+  L++ N+V LL   IH +E L LV+E++     + +D    G   + + L  + 
Sbjct: 53  EASLLKGLKHANIV-LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQ 111

Query: 126 RLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            LR         ++HRDLK  N+L+ D    K++DFG+AR   V  S   +N +V T  Y
Sbjct: 112 LLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVV-TLWY 169

Query: 177 MSLEYTMSGT-VSIKTDVFGFGVLVLKIVCG 206
              +  +  T  S   D++G G + ++++ G
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 50.5 bits (121), Expect = 4e-07
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 18/106 (16%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDS-----------SFSGT 114
           E  L+ +L++ N+V+L    +H +++L LV+E+      K  DS           SF   
Sbjct: 49  EICLLKELKHKNIVRLYDV-LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSF--M 105

Query: 115 FKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
           F+ L  L       V+HRDLK  N+L++     K++DFG+AR FG+
Sbjct: 106 FQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 50.5 bits (120), Expect = 4e-07
 Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 47/213 (22%)

Query: 52  AIKRLA-WTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNKSL-- 107
           AIKR+  + S     +F  E +++ KL  + N++ LLG   H     L  E+ P+ +L  
Sbjct: 26  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85

Query: 108 ----------DSSFS---GTFKDLLC-------------LHKYSRLRVIHRDLKASNILL 141
                     D +F+    T   L               +   S+ + IHRDL A NIL+
Sbjct: 86  FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 145

Query: 142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVL 201
            +    KI+DFG++R   V          V      SL Y++  T    +DV+ +GVL+ 
Sbjct: 146 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT---NSDVWSYGVLLW 202

Query: 202 KIV-------CG-------KKNNKSYHTERPLN 220
           +IV       CG       +K  + Y  E+PLN
Sbjct: 203 EIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 235

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 50.3 bits (120), Expect = 4e-07
 Identities = 39/126 (30%), Positives = 59/126 (46%), Gaps = 16/126 (12%)

Query: 44  KFPNEQE--VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
           K P+++E  VAI  L A  S + R  F  EA  + +  ++N+V+L G    G   ++V E
Sbjct: 27  KLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE 86

Query: 101 FMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLNT 147
           +M N +LDS               G    L    KY S +  +H+ L A  +L++  L  
Sbjct: 87  YMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVC 146

Query: 148 KISDFG 153
           KIS F 
Sbjct: 147 KISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 2/79 (2%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +++RDLK  NILLD   + KI+DFGM +   + +  A T    GT  Y++ E  +    +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILLGQKYN 174

Query: 189 IKTDVFGFGVLVLKIVCGK 207
              D + FGVL+ +++ G+
Sbjct: 175 TSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 32/158 (20%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDL-------LC-- 120
           E +++A   +  +VKLLG      +  ++ EF P  ++D+      + L       +C  
Sbjct: 59  EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118

Query: 121 ----LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT------NRI 170
               L     +++IHRDLKA N+LL    + K++DFG+        S  N       +  
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGV--------SAKNVKTLQRRDSF 170

Query: 171 VGTYGYMSLEYTMSGTVS-----IKTDVFGFGVLVLKI 203
           +GT  +M+ E  M  T+       K D++  G+ ++++
Sbjct: 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 39/126 (30%), Positives = 62/126 (49%), Gaps = 21/126 (16%)

Query: 49  QEVAIKRLA---WTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFM-- 102
           Q VAIK++     T    +  ++ E KL+  L++ N++ L    I   E +  V E +  
Sbjct: 36  QNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94

Query: 103 ------PNKSLDSSFSGTF-----KDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISD 151
                  ++ L+  F   F     + L  +H      V+HRDLK SNIL+++  + KI D
Sbjct: 95  DLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICD 151

Query: 152 FGMARI 157
           FG+ARI
Sbjct: 152 FGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 50.7 bits (122), Expect = 4e-07
 Identities = 18/29 (62%), Positives = 22/29 (75%)

Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMAR 156
            VIHRDLK SNILL+     K++DFG+AR
Sbjct: 127 NVIHRDLKPSNILLNSDCRVKLADFGLAR 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 45/149 (30%), Positives = 57/149 (38%), Gaps = 53/149 (35%)

Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
            Q VAIK+L+         FQN     AK  Y  LV L+    H     L+  F P KSL
Sbjct: 41  GQNVAIKKLS-------RPFQNVTH--AKRAYRELV-LMKLVNHKNIIGLLNVFTPQKSL 90

Query: 108 DSSFSGTFKDL-------------------------------LC----LHKYSRLRVIHR 132
           +      F+D+                               LC    LH      +IHR
Sbjct: 91  E-----EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHR 142

Query: 133 DLKASNILLDDQLNTKISDFGMARIFGVN 161
           DLK SNI++      KI DFG+AR  G +
Sbjct: 143 DLKPSNIVVKSDCTLKILDFGLARTAGTS 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 17/33 (51%), Positives = 25/33 (75%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVN 161
           ++HRDLK SN+LL+++   KI DFG+AR +G  
Sbjct: 127 ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 27/82 (32%), Positives = 46/82 (56%), Gaps = 3/82 (3%)

Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H +SR RV+HRD+K +N+ +      K+ D G+ R F    + A++  +VGT  YMS E 
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177

Query: 182 TMSGTVSIKTDVFGFGVLVLKI 203
                 + K+D++  G L+ ++
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 28/81 (34%), Positives = 47/81 (58%), Gaps = 4/81 (4%)

Query: 127 LRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGT 186
           L+++HRD+K SN+L++ +   K+ DFG++    VN S A T   VGT  YM+ E      
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VN-SIAKT--YVGTNAYMAPERISGEQ 169

Query: 187 VSIKTDVFGFGVLVLKIVCGK 207
             I +DV+  G+  +++  G+
Sbjct: 170 YGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 29/91 (31%), Positives = 47/91 (51%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           LL +H      +IHRD+K++NILL      K+ DFG ++++    S        GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 178 SLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           + E       S K D+F  GVL+ +++  K+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 49.9 bits (119), Expect = 5e-07
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 20/166 (12%)

Query: 50  EVAIKRLAWTSGQG-RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           +VAIK L   + +  R E   EA+++ +L    +V+++G     E  +LV E      L+
Sbjct: 24  DVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLN 82

Query: 109 SSFSGTFKD-------LLCLHKYS-------RLRVIHRDLKASNILLDDQLNTKISDFGM 154
              SG  KD       +  +H+ S           +HRDL A N+LL +Q   KISDFG+
Sbjct: 83  KFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGL 141

Query: 155 ARIFGVNESGANTNRIVGTY--GYMSLEYTMSGTVSIKTDVFGFGV 198
           ++  G ++S     R  G +   + + E       S ++DV+ +G+
Sbjct: 142 SKALGADDS-YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGI 186

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 49.7 bits (119), Expect = 7e-07
 Identities = 21/54 (38%), Positives = 36/54 (66%), Gaps = 3/54 (5%)

Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN---TNRIV 171
           L+   R +++HRD+KA+NIL+      K++DFG+AR F ++++      TNR+V
Sbjct: 132 LYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 32/161 (19%)

Query: 72  KLIAKLQYTNLVKLLG-CSIHGEERLLV--------YEFMPNK---SLDSSFSG------ 113
           K+I K  + N++ LLG C+  G   +LV         E++  +    +D SF        
Sbjct: 72  KMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE 129

Query: 114 --TFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNE 162
             TFKDL+ C ++ +R        + IHRDL A N+L+ +    KI+DFG+AR +  ++ 
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY 189

Query: 163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
               TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 190 YKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 9/92 (9%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR--IFGVNESGANTNRIVGTYG 175
           L  LH      +I+RDLK  N++LD + + KI+DFGM +  IFG    G  T    GT  
Sbjct: 114 LFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG----GKTTRTFCGTPD 166

Query: 176 YMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           Y++ E           D + FGVL+ +++ G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 49.6 bits (118), Expect = 8e-07
 Identities = 26/79 (32%), Positives = 45/79 (56%), Gaps = 2/79 (2%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +I+RDLK  N++LD   + KI+DFGM +     ++ A+T    GT  Y++ E       +
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQGLKYT 174

Query: 189 IKTDVFGFGVLVLKIVCGK 207
              D + FGVL+ +++ G+
Sbjct: 175 FSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 9e-07
 Identities = 27/99 (27%), Positives = 47/99 (47%), Gaps = 12/99 (12%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN---KSLDSSFSG---------TFKD 117
           E K++ +L++ N+V L           LV+E++     + L++S  G          ++ 
Sbjct: 50  EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL 109

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
           L  +       +IHRD+K  NIL+ +    K+ DFG AR
Sbjct: 110 LQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 38/147 (25%), Positives = 65/147 (44%), Gaps = 23/147 (15%)

Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS 110
           VAIK +    G      Q E  ++ + ++ N+V   G  +  ++  +V E+    SL   
Sbjct: 31  VAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDI 90

Query: 111 FSGT----------------FKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGM 154
           +  T                 K L  LH+      IHRD+K +NILL +  + K++DFG+
Sbjct: 91  YQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGV 147

Query: 155 -ARIFGVNESGANTNRIVGTYGYMSLE 180
            A++     + A     +GT  +M+ E
Sbjct: 148 SAQLT---ATIAKRKSFIGTPYWMAPE 171

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 43/153 (28%), Positives = 77/153 (50%), Gaps = 19/153 (12%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSLDSSFSGT-------------F 115
           E  L+  L++ N+V L    IH E+ L LV+E++ +K L                    F
Sbjct: 54  EVSLLKDLKHANIVTLHDI-IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLF 111

Query: 116 KDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG 175
           + L  L+   R +V+HRDLK  N+L++++   K++DFG+AR   +  +   +N +V T  
Sbjct: 112 QLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLW 169

Query: 176 YMSLEYTMSGT-VSIKTDVFGFGVLVLKIVCGK 207
           Y   +  +  T  S + D++G G +  ++  G+
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 39/153 (25%), Positives = 66/153 (43%), Gaps = 20/153 (13%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD------------ 117
           E  L+ +L + N++K L   I   E  +V E      L        K             
Sbjct: 52  EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111

Query: 118 --LLCL---HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG 172
              LC    H +S+ R++HRD+K +N+ +      K+ D G+ R F    + A++  +VG
Sbjct: 112 FVQLCSALEHMHSK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVG 168

Query: 173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC 205
           T  YMS E       + K+D++  G L+ ++  
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 27/98 (27%), Positives = 47/98 (47%), Gaps = 6/98 (6%)

Query: 102 MPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN 161
           +P +++        + L  LH +   RV+HRDLK  NIL+      K++DFG+ARI+   
Sbjct: 107 VPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 163

Query: 162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
                   +V T  Y + E  +  + +   D++  G +
Sbjct: 164 ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 32/150 (21%), Positives = 64/150 (42%), Gaps = 21/150 (14%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERLLV--------YEFMPNKS----LDSSFS---GT 114
           EA L+  + + +++++    + G    +V        Y ++  +S    +D +       
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQI 166

Query: 115 FKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTY 174
            + L  LH     R+IHRD+K  NI ++D     I D G A+ F V         + GT 
Sbjct: 167 LEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAP--AFLGLAGTV 220

Query: 175 GYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
              + E       + K D++  G+++ +++
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L+ LH++    VI+RDLK  NILLD + + K++DFGM +  G+   G  T    GT  Y+
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK-EGILN-GVTTTTFCGTPDYI 163

Query: 178 SLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E           D +  GVL+ +++ G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 14/100 (14%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSSFSG---------TFK 116
           EA L+  L++ N+V  L   IH ++ L LV+E++     + +D    G          F+
Sbjct: 53  EASLLKDLKHANIV-TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQ 111

Query: 117 DLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
            L  L    + RV+HRDLK  N+L+ ++   K++DFG+AR
Sbjct: 112 LLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 53/187 (28%), Positives = 76/187 (40%), Gaps = 40/187 (21%)

Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           E+ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P KSL
Sbjct: 49  ERNVAIKKLS-------RPFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSL 98

Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158

Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 159 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 215

Query: 201 LKIVCGK 207
            +++ G 
Sbjct: 216 GEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 26/80 (32%), Positives = 50/80 (62%), Gaps = 4/80 (5%)

Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +++HRD+K SNIL++ +   K+ DFG++    + +S AN+   VGT  YMS E       
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPERLQGTHY 179

Query: 188 SIKTDVFGFGVLVLKIVCGK 207
           S+++D++  G+ ++++  G+
Sbjct: 180 SVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 27/84 (32%), Positives = 47/84 (55%), Gaps = 2/84 (2%)

Query: 124 YSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM 183
           +S   V++RDLK  N++LD   + KI+DFG+ +  G+ + GA      GT  Y++ E   
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKD-GATMKTFCGTPEYLAPEVLE 169

Query: 184 SGTVSIKTDVFGFGVLVLKIVCGK 207
                   D +G GV++ +++CG+
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 26/80 (32%), Positives = 50/80 (62%), Gaps = 4/80 (5%)

Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +++HRD+K SNIL++ +   K+ DFG++    + +S AN+   VGT  YMS E       
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPERLQGTHY 179

Query: 188 SIKTDVFGFGVLVLKIVCGK 207
           S+++D++  G+ ++++  G+
Sbjct: 180 SVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 26/82 (31%), Positives = 51/82 (62%), Gaps = 6/82 (7%)

Query: 127 LRVIHRDLKASNILLDDQLNTKISDFGMARIFG-VNESGANTNRIVGTYGYMSLEYTMSG 185
            +++HRD+K SNIL++ +   K+ DFG++   G + +S AN+   VGT  YMS E     
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANS--FVGTRSYMSPERLQGT 173

Query: 186 TVSIKTDVFGFGVLVLKIVCGK 207
             ++++D++  G+ ++++  G+
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 35/107 (32%), Positives = 51/107 (47%), Gaps = 20/107 (18%)

Query: 70  EAKLIAKLQYTNLVKLLGCSI--HGEERLLVYEF-----------MPNKSLDSSFSG--- 113
           E  L+  L++ N+V+L    +  H +   LV E+           MP    +S       
Sbjct: 56  EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML 115

Query: 114 -TFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG 159
              + L  LH      +IHRDLK SN+LL D+   KI+DFG+AR +G
Sbjct: 116 QLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 2/78 (2%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +I+RDLK  N+LLD + + K++DFGM +  G+   G  T+   GT  Y++ E        
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFN-GKTTSTFCGTPDYIAPEILQEMLYG 174

Query: 189 IKTDVFGFGVLVLKIVCG 206
              D +  GVL+ +++CG
Sbjct: 175 PSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 2/88 (2%)

Query: 119 LCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMS 178
           L L     L +I+RDLK  NILLD++ + K++DFG+++    +E  A +    GT  YM+
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMA 166

Query: 179 LEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            E       +   D + FGVL+ +++ G
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 41/157 (26%), Positives = 78/157 (49%), Gaps = 27/157 (17%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSSFSGTFKDLLCLHKYS 125
           E  L+  L++ N+V L    IH E  L LV+E++ +   + LD+       +L+ +H   
Sbjct: 53  EVSLLKNLKHANIVTLHDI-IHTERCLTLVFEYLDSDLKQYLDNC-----GNLMSMHNVK 106

Query: 126 --------------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
                         + +++HRDLK  N+L++++   K++DFG+AR   V  +   +N +V
Sbjct: 107 IFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV 165

Query: 172 GTYGYMSLEYTMSGT-VSIKTDVFGFGVLVLKIVCGK 207
            T  Y   +  +  T  S   D++G G ++ ++  G+
Sbjct: 166 -TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 19/42 (45%), Positives = 32/42 (76%)

Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           +HRD+K SNILL+++   K++DFG+AR++   ES   TN+++
Sbjct: 138 LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 39/132 (29%), Positives = 59/132 (44%), Gaps = 25/132 (18%)

Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKL---LGCSIHGEERLL---------- 97
           VA+K++  T  Q       E K+I +L + N+VK+   LG S       +          
Sbjct: 33  VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92

Query: 98  -VYEFMPNKSLDSSFSGTF-KDLLCLHKYSRLR---------VIHRDLKASNILLD-DQL 145
            V E+M     +    G   ++   L  Y  LR         V+HRDLK +N+ ++ + L
Sbjct: 93  IVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL 152

Query: 146 NTKISDFGMARI 157
             KI DFG+ARI
Sbjct: 153 VLKIGDFGLARI 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 17/169 (10%)

Query: 51  VAIKRLA-WTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYEFMPNKSLD 108
           VAIK +   +  Q   E  +    +  L +  +V+LLG C   G    LV +  P  SL 
Sbjct: 39  VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--GASLQLVTQLSPLGSLL 96

Query: 109 SSF---SGTFKDLLCL----------HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMA 155
                   +      L          +     R++HR+L A NILL      +I+DFG+A
Sbjct: 97  DHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156

Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
            +   ++     +       +M+LE  + G  + ++DV+ +GV V +++
Sbjct: 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 36/130 (27%), Positives = 64/130 (49%), Gaps = 20/130 (15%)

Query: 97  LVYEFMPNK---SLDSSFSGTFKD----------LLCLHKYSRLRVIHRDLKASNILLDD 143
           LV E+ P     SL + +   F +          +L +H   ++  +HRD+K  N+L+D 
Sbjct: 78  LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR 137

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY--TMSG----TVSIKTDVFGFG 197
             + K++DFG A     N+   N+   VGT  Y++ E   TM+G    T  ++ D +  G
Sbjct: 138 TGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLG 196

Query: 198 VLVLKIVCGK 207
           V+  +++ G+
Sbjct: 197 VIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 38/143 (26%), Positives = 62/143 (43%), Gaps = 46/143 (32%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEFQN---------EAKLIAKLQYTNLVKLLG-------CS 89
           P   +VAIK+++         F++         E K++ + ++ N++ +L         S
Sbjct: 28  PTGVKVAIKKIS--------PFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79

Query: 90  IHGEERLLVYEFMPN------KSLDSSFSGTFKDLLCLHKYSRLR---------VIHRDL 134
            +  +  +V E M        K+   S      D +    Y  LR         V+HRDL
Sbjct: 80  FN--DVYIVQELMETDLYKLIKTQHLS-----NDHIQYFLYQILRGLKYIHSANVLHRDL 132

Query: 135 KASNILLDDQLNTKISDFGMARI 157
           K SN+LL+   + KI DFG+ARI
Sbjct: 133 KPSNLLLNTNCDLKICDFGLARI 155

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 40/165 (24%)

Query: 72  KLIAKLQYTNLVKLLG-CSIHGEERLLVYEFMPNKSL------------DSSFSGT---- 114
           KLI K  + N++ LLG C+  G   ++V E+    +L            D +F  T    
Sbjct: 72  KLIGK--HKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPE 128

Query: 115 ----FKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE 162
               FKDL+ C ++ +R        R IHRDL A N+L+ +    KI+DFG+AR  GV++
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--GVHD 186

Query: 163 ----SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
                  +  R+     +M+ E       + ++DV+ FG+L+ +I
Sbjct: 187 IDYYKKTSNGRL--PVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 46/186 (24%), Positives = 88/186 (47%), Gaps = 22/186 (11%)

Query: 38  RVILVGKFPNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE 94
           RV LV    +E   A+K +A       +      NE +++ ++ +  +++L   + H + 
Sbjct: 16  RVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF-WTEHDQR 74

Query: 95  RL-LVYEFMPNKSLDSSF--SGTFK---------DLLCLHKY-SRLRVIHRDLKASNILL 141
            L ++ E++P   L S    SG F          +++C  +Y     +++RDLK  NILL
Sbjct: 75  FLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL 134

Query: 142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVL 201
           D + + K++DFG A+     +    T  + GT  Y++ E   S   +   D +  G+L+ 
Sbjct: 135 DKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIY 189

Query: 202 KIVCGK 207
           +++ G 
Sbjct: 190 EMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 36/132 (27%), Positives = 62/132 (46%), Gaps = 30/132 (22%)

Query: 100 EFMPNKSLDSSFSG------------------TFKDLLCLHKYSRLRVIHRDLKASNILL 141
           E+M   SLD  ++G                    K L  L +     +IHRD+K +N+L+
Sbjct: 79  EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLV 136

Query: 142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG------TVSIKTDVFG 195
           +     K+ DFG++    +  S A TN  +G   YM+ E   SG      T ++++DV+ 
Sbjct: 137 NGNGQVKLCDFGVSG--NLVASLAKTN--IGCQSYMAPERIKSGGPNQNPTYTVQSDVWS 192

Query: 196 FGVLVLKIVCGK 207
            G+ +L++  G+
Sbjct: 193 LGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 46.2 bits (110), Expect = 3e-06
 Identities = 30/130 (23%), Positives = 53/130 (40%), Gaps = 14/130 (10%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLV-KLLGCSIHGEER 95
           RV L+G    +++  +K     S +   + + E  ++  L +    V K+L         
Sbjct: 13  RVYLLGT--KDEDYVLKI--NPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWS 68

Query: 96  LLVYEFMPNKSLDSSFSGTFKDLLC--------LHKYSRLRVIHRDLKASNILLDDQLNT 147
            L+ E++  ++LD       +D+          LH+   L + H DL   NIL+DD    
Sbjct: 69  YLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKIL 128

Query: 148 KISDFGMARI 157
            I D+  A  
Sbjct: 129 GIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 3e-06
 Identities = 44/193 (22%), Positives = 81/193 (41%), Gaps = 34/193 (17%)

Query: 52  AIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSF 111
           A K +   S +   +F  E  ++++ ++ N+V L     +  +  ++ EF    +LDS  
Sbjct: 34  AAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIM 93

Query: 112 SGT----------------FKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMA 155
                               + L  LH +   +VIHRDLKA NILL    + K++D    
Sbjct: 94  LELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLAD---- 146

Query: 156 RIFGVNESGANTNR----IVGTYGYMSLEYTMSGTVS-----IKTDVFGFGVLVLKIVCG 206
             FGV+    +T +     +GT  +M+ E     T        K D++  G+ ++++   
Sbjct: 147 --FGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQM 204

Query: 207 KKNNKSYHTERPL 219
           +  +   +  R L
Sbjct: 205 EPPHHELNPMRVL 217

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 47.5 bits (114), Expect = 3e-06
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 32/190 (16%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTS--GQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEE 94
           RV+LV    + +  A+K L+        +VE   NE +++  +++  LV L G       
Sbjct: 16  RVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN 75

Query: 95  RLLVYEFMPNKSLDSSF--SGTFKD----------LLCLHKYSRLRVIHRDLKASNILLD 142
             LV E++P   L S    SG F +          +L L     L +++RDLK  N+LLD
Sbjct: 76  LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD 135

Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE------YTMSGTVSIKTDVFGF 196
                KI+DFG A+   V      T  + GT  Y++ E      Y  +       D +  
Sbjct: 136 SDGYIKITDFGFAKR--VKG---RTYTLCGTPEYLAPEIILSKGYGKA------VDWWAL 184

Query: 197 GVLVLKIVCG 206
           G+L+ +++ G
Sbjct: 185 GILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 19/168 (11%)

Query: 49  QEVAIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNK 105
           ++VA+K L   SG   + + + E +++  L + N+VK  G C+  G   + L+ EF+P+ 
Sbjct: 34  EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 93

Query: 106 SLDSSFSGTFK--DLLCLHKYS-----------RLRVIHRDLKASNILLDDQLNTKISDF 152
           SL           +L    KY+             + +HRDL A N+L++ +   KI DF
Sbjct: 94  SLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF 153

Query: 153 GMARIFGVNES--GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGV 198
           G+ +    ++       +     + Y + E  +     I +DV+ FGV
Sbjct: 154 GLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGV 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 2/90 (2%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           +L L    +L +++RD+K  NILLD + +  ++DFG+++ F ++E    T    GT  YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYM 173

Query: 178 SLEYTMSGTVSIK-TDVFGFGVLVLKIVCG 206
           + E         K  D +  G+L+ +++ G
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 8/98 (8%)

Query: 114 TFKDLLC--------LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA 165
           T +DL+C        +   +  + IHRDL A NILL +    KI DFG+AR    +    
Sbjct: 177 TLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236

Query: 166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
                     +M+ E       +I++DV+ FGVL+ +I
Sbjct: 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 50/186 (26%), Positives = 84/186 (45%), Gaps = 27/186 (14%)

Query: 39  VILVGKFPNEQEVAIKRLAW--TSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           V LV    + ++  IK+L     S + R   + EA+L+++L++ N+V     S  GE+ L
Sbjct: 16  VSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE-SWEGEDGL 74

Query: 97  L-----------VY--------EFMPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKAS 137
           L           +Y        + +P   +   F      L  LH+     ++HRDLK  
Sbjct: 75  LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQ 131

Query: 138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFG 197
           N+ L      K+ D G+AR+       A+T  ++GT  YMS E   +   + K+DV+  G
Sbjct: 132 NVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNYKSDVWALG 189

Query: 198 VLVLKI 203
             V ++
Sbjct: 190 CCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LHK++   VI+RDLK  NILLD Q +  + DFG+ ++   ++    TN   GT  Y+
Sbjct: 106 LENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYL 160

Query: 178 SLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           + E  +    +   D +  GVL+ +++ G
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 19/174 (10%)

Query: 49  QEVAIKRLAWTSGQGRVE--FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           Q VAIK+   +     V+     E +++ +L++ NLV L+      +   LV+EF+ +  
Sbjct: 27  QIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTV 86

Query: 107 LD--SSFSGTFKDLLCLHKY--SRLR---------VIHRDLKASNILLDDQLNTKISDFG 153
           LD    +     D   + KY    LR         +IHRD+K  NIL+      K+ DFG
Sbjct: 87  LDDLEKYPNGL-DESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFG 145

Query: 154 MARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-TDVFGFGVLVLKIVCG 206
            AR   +   G      V T  Y + E  +  T   +  D++  G LV +++ G
Sbjct: 146 FART--LAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 29/98 (29%), Positives = 45/98 (45%), Gaps = 8/98 (8%)

Query: 114 TFKDLLC--------LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA 165
           T +DL+         +   +  + IHRDL A NILL +    KI DFG+AR    +    
Sbjct: 171 TLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 230

Query: 166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
                     +M+ E       + ++DV+ FGVL+ +I
Sbjct: 231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 24/172 (13%)

Query: 48  EQEVAIKRLAWTSGQGRV--EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP-- 103
           E+ VA+K L   +    +  E   EA ++ +L    +V+++G     E  +LV E     
Sbjct: 22  EKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELG 80

Query: 104 --NKSLDSSFSGTFKDLLCL-HKYS-------RLRVIHRDLKASNILLDDQLNTKISDFG 153
             NK L  +   T K++  L H+ S           +HRDL A N+LL  Q   KISDFG
Sbjct: 81  PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFG 140

Query: 154 MARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV-----SIKTDVFGFGVLV 200
           +++  G +E+         T+G   +++     +     S K+DV+ FGVL+
Sbjct: 141 LSKALGADENYYKAK----THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLM 188

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 47.4 bits (112), Expect = 4e-06
 Identities = 37/148 (25%), Positives = 67/148 (45%), Gaps = 20/148 (13%)

Query: 64  RVEFQNEAKLIAKLQYTN----LVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLL 119
           +  FQ + +L   ++Y N       L    +  E+R   Y      +LD   SG      
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG------ 114

Query: 120 CLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSL 179
                   ++++RDLK  N++LD   + KI+DFG+ +  G+ ++ A      GT  Y++ 
Sbjct: 115 --------KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDA-ATMKTFCGTPEYLAP 164

Query: 180 EYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           E           D +G GV++ +++CG+
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 2/94 (2%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           V++RD+K  N++LD   + KI+DFG+ +  G+++ GA      GT  Y++ E        
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISD-GATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 189 IKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
              D +G GV++ +++CG+    +   ER   L+
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 5/90 (5%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LH+     +I+RDLK  N++LD + + KI+DFGM +   V+  G  T    GT  Y+
Sbjct: 114 LFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--GVTTRTFCGTPDYI 168

Query: 178 SLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E           D + +GVL+ +++ G+
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 47.4 bits (112), Expect = 5e-06
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 23/158 (14%)

Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYS 125
           FQ E++L   ++Y N   L+    H + +R L  E     S + S +  +     LH+  
Sbjct: 65  FQTESRLFFVIEYVNGGDLM---FHMQRQRKLPEEHARFYSAEISLALNY-----LHERG 116

Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
              +I+RDLK  N+LLD + + K++D+GM +  G+   G  T+   GT  Y++ E     
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGL-RPGDTTSTFCGTPNYIAPEILRGE 171

Query: 186 TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVG 223
                 D +  GVL+ +++ G+          P ++VG
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRS---------PFDIVG 200

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 6e-06
 Identities = 30/87 (34%), Positives = 42/87 (48%), Gaps = 14/87 (16%)

Query: 82  LVKLLGCSIHGEERL-LVYEFMPNKSLDS--SFSGTFKD----------LLCLHKYSRLR 128
           +VKL   S   EE L LV E+MP   L +       F +          +L L    +L 
Sbjct: 63  IVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMA 155
            IHRD+K  NIL+D   + K++DFG+ 
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLC 148

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 10/99 (10%)

Query: 114 TFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESG 164
           TFKDL+ C ++ +R        + IHRDL A N+L+ +    KI+DFG+AR +  ++   
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYK 194

Query: 165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 195 KTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 6e-06
 Identities = 23/89 (25%), Positives = 46/89 (51%), Gaps = 6/89 (6%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           +L +    +  +IHRD+K  N+L+D   + K++DFG++R    N+      + VGT  Y+
Sbjct: 107 VLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYL 160

Query: 178 SLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           + E  +       +D +  G ++ + + G
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 17/28 (60%), Positives = 22/28 (78%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMAR 156
           VIHRDLK SN+L+++    +I DFGMAR
Sbjct: 128 VIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 8/88 (9%)

Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES-GANTNRIVGTYGYMSL 179
           LHKY    +++RDLK  NILLD   +  + DFG+++    N +    TN   GT  Y++ 
Sbjct: 112 LHKYD---IVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYLAP 165

Query: 180 EYTMSGTVSIK-TDVFGFGVLVLKIVCG 206
           E  +      K  D +  GVLV ++ CG
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 46.3 bits (110), Expect = 9e-06
 Identities = 36/156 (23%), Positives = 65/156 (41%), Gaps = 25/156 (16%)

Query: 69  NEAKLIAK-LQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS------GTFKD---- 117
           +E  +I + L++ N+V+     +  +   +V + +    L   F+        F +    
Sbjct: 57  SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116

Query: 118 ---------LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTN 168
                    L  LHK  R  ++HRDL  +NI+L +     I+DFG+A+            
Sbjct: 117 NIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LT 171

Query: 169 RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
            +VGT  Y   E   +     K DV+ FG ++ ++ 
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMC 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 44/185 (23%), Positives = 84/185 (45%), Gaps = 32/185 (17%)

Query: 49  QEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER------LLVYE 100
           Q+VA+K L     S     EF  EA  + +  + N++KL+G S+    +      +++  
Sbjct: 28  QKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILP 87

Query: 101 FMPNKSL----------DSSFSGTFK-------DLLCLHKY-SRLRVIHRDLKASNILLD 142
           FM +  L          +  F+   +       D+    +Y S    IHRDL A N +L+
Sbjct: 88  FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN 147

Query: 143 DQLNTKISDFGMAR-IFGVN--ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
           + +   ++DFG+++ I+  +    G  +   V    +++LE       +  +DV+ FGV 
Sbjct: 148 ENMTVCVADFGLSKKIYSGDYYRQGCASKLPV---KWLALESLADNVYTTHSDVWAFGVT 204

Query: 200 VLKIV 204
           + +I+
Sbjct: 205 MWEIM 209

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 35/161 (21%)

Query: 64  RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHK 123
           + +F  EA+++ +  + N+V+L+G     +   +V E +          G F   L   +
Sbjct: 37  KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ--------GGDFLTFL-RTE 87

Query: 124 YSRLRV----------------------IHRDLKASNILLDDQLNTKISDFGMAR--IFG 159
             RL+V                      IHRDL A N L+ ++   KISDFGM+R    G
Sbjct: 88  GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147

Query: 160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           V  S     +I     + + E    G  S ++DV+ FG+L+
Sbjct: 148 VYASTGGMKQI--PVKWTAPEALNYGRYSSESDVWSFGILL 186

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 7/98 (7%)

Query: 102 MPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNT-KISDFGMARIFGV 160
           +P K++ S      K +   HK+    V+HRDLK  N+L+D Q    KI+D G+ R F +
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163

Query: 161 NESGANTNRIVGTYGYMSLEYTMSGT-VSIKTDVFGFG 197
               + T+ IV T  Y + E  +  T  S   D++  G
Sbjct: 164 -PVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVG 199

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 16/34 (47%), Positives = 23/34 (67%), Gaps = 4/34 (11%)

Query: 129 VIHRDLKASNILL----DDQLNTKISDFGMARIF 158
           V+HRDLK +NIL+     ++   KI D G+AR+F
Sbjct: 129 VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 38/140 (27%), Positives = 57/140 (40%), Gaps = 44/140 (31%)

Query: 48  EQEVAIKRLAWTSGQGRVEFQN---------EAKLIAKLQYTNLVKLLGCSIHGEERL-- 96
            ++VAIK+L+      R  FQ+         E +L+  + + N++ LL         L  
Sbjct: 40  GRKVAIKKLS------R-PFQSAIHAKRTYRELRLLKHMDHENVIGLLDV-FTPASSLED 91

Query: 97  -----LVYEFMPNKSLDSSFSGTFK------DLLCLHKYSRLR---------VIHRDLKA 136
                LV   M      +  +   K      D +    Y  LR         +IHRDLK 
Sbjct: 92  FQDVYLVTHLM-----GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKP 146

Query: 137 SNILLDDQLNTKISDFGMAR 156
           SNI +++    KI DFG+AR
Sbjct: 147 SNIAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 27/82 (32%), Positives = 44/82 (53%), Gaps = 8/82 (9%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNES---GANTNRIVGTYGYMSLEYTMSG 185
           +I+RDLK  N++LD + + KI+DFGM +     E+   G  T    GT  Y++ E     
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYIAPEIIAYQ 176

Query: 186 TVSIKTDVFGFGVLVLKIVCGK 207
                 D + FGVL+ +++ G+
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 21/183 (11%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           R +LV    ++Q+ A+K +        VE  + EA L+AK+++ N+V     S   +  L
Sbjct: 15  RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE-SFEADGHL 73

Query: 97  -LVYEFMPNKSLDSSFSGTFKDL------------LCL---HKYSRLRVIHRDLKASNIL 140
            +V E+     L          L            +CL   H + + RV+HRD+K+ NI 
Sbjct: 74  YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIF 132

Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           L      K+ DFG AR+  +   GA     VGT  Y+  E   +   + K+D++  G ++
Sbjct: 133 LTQNGKVKLGDFGSARL--LTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCIL 190

Query: 201 LKI 203
            ++
Sbjct: 191 YEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 36/116 (31%), Positives = 61/116 (52%), Gaps = 12/116 (10%)

Query: 97  LVYEFMPNKSLDSSFSGTFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTK 148
           + Y + P +  +   S  FKDL+ C ++ +R        + IHRDL A N+L+ +    K
Sbjct: 123 MEYCYNPTQVPEEQLS--FKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 180

Query: 149 ISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           I+DFG+AR I  ++     TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 181 IADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 22/72 (30%), Positives = 37/72 (51%), Gaps = 3/72 (4%)

Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
            ++HRDLK  NIL+      K++DFG+ARI+    +      +V T  Y + E  +  T 
Sbjct: 128 CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTY 184

Query: 188 SIKTDVFGFGVL 199
           +   D++  G +
Sbjct: 185 ATPVDMWSVGCI 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 11/89 (12%)

Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES---GANTNRIVGTYGYM 177
           LH+     +I+RDLK  NILLD Q + K++DFG+ +     ES   G  T+   GT  YM
Sbjct: 116 LHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK-----ESIHEGTVTHTFCGTIEYM 167

Query: 178 SLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           + E  M        D +  G L+  ++ G
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 8/98 (8%)

Query: 114 TFKDLLC--------LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA 165
           T +DL+C        +   +  + IHRDL A NILL +    KI DFG+AR    +    
Sbjct: 172 TMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 231

Query: 166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
                     +M+ E       + ++DV+ FGVL+ +I
Sbjct: 232 RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 51/185 (27%), Positives = 82/185 (44%), Gaps = 23/185 (12%)

Query: 43  GKFPNEQEVAIKRLAWTSG--QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVY 99
            K  +E  V IK +  T    + +   + E  L+AK+++ N+V     S     RL +V 
Sbjct: 21  AKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA-SFQENGRLFIVM 78

Query: 100 EFMPNKSL--------------DSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLD-DQ 144
           E+     L              D   S   +  L L      +++HRD+K+ NI L  + 
Sbjct: 79  EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNG 138

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +  K+ DFG+AR   +N+S       VGT  Y+S E   +   + KTD++  G  VL  +
Sbjct: 139 MVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGC-VLYEL 195

Query: 205 CGKKN 209
           C  K+
Sbjct: 196 CTLKH 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 44/168 (26%), Positives = 81/168 (48%), Gaps = 19/168 (11%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSLDSSFSGT-------------F 115
           E  L+  L++ N+V L    +H ++ L LV+E++ +K L                    +
Sbjct: 54  EVSLLKDLKHANIVTLHDI-VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLY 111

Query: 116 KDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG 175
           + L  L    R +V+HRDLK  N+L++++   K++DFG+AR   V  +   +N +V T  
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLW 169

Query: 176 YMSLEYTM-SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
           Y   +  + S   S + D++G G +  ++  G+        E  L+L+
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 26/78 (33%), Positives = 43/78 (55%), Gaps = 5/78 (6%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +I+RDLK  N+LLD++ + K++DFG A+   V +    T  + GT  Y++ E   S    
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPD---RTFTLCGTPEYLAPEVIQSKGHG 193

Query: 189 IKTDVFGFGVLVLKIVCG 206
              D +  GVL+ + + G
Sbjct: 194 KAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 44/183 (24%), Positives = 82/183 (44%), Gaps = 26/183 (14%)

Query: 38  RVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           +++ + KF  +E +  IK++A            E +++ +L++ NLV L+       +  
Sbjct: 27  QIVAIKKFVESEDDPVIKKIAL----------REIRMLKQLKHPNLVNLIEVFRRKRKLH 76

Query: 97  LVYEFMPN---KSLDSSFSG---------TFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
           LV+E+  +     L+ +  G          ++ L  ++   +   IHRD+K  NIL+  Q
Sbjct: 77  LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ 136

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKI 203
              K+ DFG ARI  +   G +    V T  Y + E  +  T      DV+  G +  ++
Sbjct: 137 GQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAEL 194

Query: 204 VCG 206
           + G
Sbjct: 195 LTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 38/165 (23%)

Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSF-------------- 111
           ++  E  ++A   + N+VKLL    +     ++ EF    ++D+                
Sbjct: 48  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV 107

Query: 112 --SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNR 169
               T + L  LH+    ++IHRDLKA NIL     + K++DFG+        S  NT  
Sbjct: 108 VCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGV--------SAKNTRT 156

Query: 170 I------VGTYGYMSLEYTMSGT-----VSIKTDVFGFGVLVLKI 203
           I      +GT  +M+ E  M  T        K DV+  G+ ++++
Sbjct: 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 26/79 (32%), Positives = 46/79 (58%), Gaps = 2/79 (2%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           V++RDLK  N++LD   + KI+DFG+ +  G+++ GA      GT  Y++ E        
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISD-GATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 189 IKTDVFGFGVLVLKIVCGK 207
              D +G GV++ +++CG+
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 45/163 (27%), Positives = 72/163 (44%), Gaps = 21/163 (12%)

Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSR 126
           FQ + KL   L Y N  +L    +   ER    E          +SG    +L L    +
Sbjct: 74  FQTDTKLHLILDYINGGELF-THLSQRERFKEQEV-------QIYSGEI--VLALEHLHK 123

Query: 127 LRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGT 186
           L +I+RD+K  NILLD   +  ++DFG+++ F  +E         GT  YM+ +    G 
Sbjct: 124 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGD 182

Query: 187 V--SIKTDVFGFGVLVLKI--------VCGKKNNKSYHTERPL 219
                  D +  GVL+ ++        V G+KN+++  + R L
Sbjct: 183 GGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL 225

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 20/177 (11%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQ--NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMP 103
           N Q VA+K ++  + +G V F    EA L+  L++ N+V LL   IH +E L  V+E+M 
Sbjct: 29  NGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIV-LLHDIIHTKETLTFVFEYMH 86

Query: 104 NKSLD--SSFSG----------TFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISD 151
                      G           F+ L  L       ++HRDLK  N+L+      K++D
Sbjct: 87  TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLAD 146

Query: 152 FGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGT-VSIKTDVFGFGVLVLKIVCGK 207
           FG+AR   +  S   ++ +V T  Y   +  +  T  S   D++G G + ++++ G+
Sbjct: 147 FGLARAKSI-PSQTYSSEVV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 34/139 (24%), Positives = 61/139 (43%), Gaps = 31/139 (22%)

Query: 49  QEVAIKRLAWTSGQGRVEFQN--------------EAKLIAKLQYTNLVKLLGCSIHGEE 94
           + VAIK++        V                  E K++ ++++ N++ L+   + G+ 
Sbjct: 35  KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF 94

Query: 95  RLLVYEFMPN---KSLDSSFSGTFKDLLC-----------LHKYSRLRVIHRDLKASNIL 140
             LV + M +   K +D     T   + C           LHK+     +HRDL  +NI 
Sbjct: 95  INLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIF 151

Query: 141 LDDQLNTKISDFGMARIFG 159
           ++ +   KI+DFG+AR +G
Sbjct: 152 INSKGICKIADFGLARRYG 170

Length = 335

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 20/157 (12%)

Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSLDSSFSG-----------T 114
           F  E  ++A      +V+L  C+   ++ L +V E+MP   L +  S            T
Sbjct: 90  FWEERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYT 148

Query: 115 FKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG-ANTNRIVGT 173
            + +L L     + +IHRD+K  N+LLD   + K++DFG      ++E+G    +  VGT
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGT 206

Query: 174 YGYMSLEYTMS----GTVSIKTDVFGFGVLVLKIVCG 206
             Y+S E   S    G    + D +  GV + +++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 44.3 bits (104), Expect = 5e-05
 Identities = 35/143 (24%), Positives = 65/143 (45%), Gaps = 16/143 (11%)

Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLC--LHKY 124
           FQ  ++L   ++Y N          G+   L++     + L    +  +   +C  L+  
Sbjct: 65  FQTTSRLFLVIEYVN---------GGD---LMFHMQRQRKLPEEHARFYAAEICIALNFL 112

Query: 125 SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS 184
               +I+RDLK  N+LLD   + K++D+GM +  G+   G  T+   GT  Y++ E    
Sbjct: 113 HERGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLG-PGDTTSTFCGTPNYIAPEILRG 170

Query: 185 GTVSIKTDVFGFGVLVLKIVCGK 207
                  D +  GVL+ +++ G+
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 43.9 bits (103), Expect = 5e-05
 Identities = 29/107 (27%), Positives = 52/107 (48%), Gaps = 10/107 (9%)

Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           LH++   +VIHRD+K  N+LL +    K+ DFG++    ++ +    N  +GT  +M+ E
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPE 181

Query: 181 YTM-----SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
                     T   K+D++  G+  +++  G       H  R L L+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 24/62 (38%), Positives = 33/62 (53%), Gaps = 12/62 (19%)

Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT--NRIVGTYGYMS 178
           LH    L  IHRDLK  N L+D   + K++DFG++        G  T  N +VG+  YM+
Sbjct: 117 LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLS-------KGIVTYANSVVGSPDYMA 166

Query: 179 LE 180
            E
Sbjct: 167 PE 168

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 43.7 bits (103), Expect = 6e-05
 Identities = 27/88 (30%), Positives = 48/88 (54%), Gaps = 6/88 (6%)

Query: 119 LCL---HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG 175
           +CL   H + R +++HRD+K+ NI L      K+ DFG+AR+       A T   +GT  
Sbjct: 110 ICLALKHVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPY 166

Query: 176 YMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           Y+S E   +   + K+D++  G ++ ++
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 21/45 (46%), Positives = 27/45 (60%), Gaps = 1/45 (2%)

Query: 118 LLCLHKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN 161
           +LC  KY     V+HRDLK  N+L++     KI DFG+AR F  N
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 37/163 (22%), Positives = 71/163 (43%), Gaps = 26/163 (15%)

Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEER------LLVYEFMPNKSLDS---------- 109
           +F +EA  + +  + N+++L+G  +   E       +++  FM +  L S          
Sbjct: 46  DFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC 105

Query: 110 -------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN 161
                         D+    +Y S    IHRDL A N +L++ +N  ++DFG+++    N
Sbjct: 106 PQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YN 164

Query: 162 ESGANTNRIVGT-YGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
                  RI      ++++E       + K+DV+ FGV + +I
Sbjct: 165 GDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 30/107 (28%), Positives = 54/107 (50%), Gaps = 11/107 (10%)

Query: 119 LCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMS 178
           L L+      +I+RDLK  N+LLD + + K++D+GM +  G+   G  T+   GT  Y++
Sbjct: 107 LALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRP-GDTTSTFCGTPNYIA 164

Query: 179 LEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIA 225
            E           D +  GVL+ +++ G+          P ++VG++
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRS---------PFDIVGMS 202

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 21/56 (37%), Positives = 32/56 (57%), Gaps = 1/56 (1%)

Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM 183
            ++HRD+K  N+L++     KI DFG+AR+   +ES   T  +V  Y Y + E  M
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILM 177

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 43.5 bits (103), Expect = 9e-05
 Identities = 17/28 (60%), Positives = 22/28 (78%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMAR 156
           V+HRDLK SN+LL+   + KI DFG+AR
Sbjct: 129 VLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 12/86 (13%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF----------GVNESGANT 167
           +L +    +L  IHRD+K  NIL+D   + K+SDFG++  F           + +  +N 
Sbjct: 111 VLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNK 170

Query: 168 NRIVGTYGYM--SLEYTMSGTVSIKT 191
           NRI         S+  TMS    I T
Sbjct: 171 NRIDNRNSVAVDSINLTMSSKDQIAT 196

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 42.9 bits (102), Expect = 1e-04
 Identities = 30/107 (28%), Positives = 44/107 (41%), Gaps = 24/107 (22%)

Query: 69  NEAKLIAKLQ-YTNLVKLLGCSIHGEERLLVYEFM----------------PNKSLDSSF 111
            E K + KL  + N+VKL       +E   V+E+M                    + S  
Sbjct: 46  REVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSII 105

Query: 112 SGTFKDLLCLHK--YSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
               + L  +HK  +      HRDLK  N+L+      KI+DFG+AR
Sbjct: 106 YQILQGLAHIHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 10/79 (12%)

Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMS 184
           IHRDL A NILL     TKI DFG+AR     +   ++N +V         +M+ E   +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKGNARLPVKWMAPESIFN 290

Query: 185 GTVSIKTDVFGFGVLVLKI 203
              + ++DV+ +G+L+ +I
Sbjct: 291 CVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 30/144 (20%), Positives = 63/144 (43%), Gaps = 19/144 (13%)

Query: 76  KLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS------------GTFKDLLCLHK 123
           KLQ+ N+VKL+G     +   L++E++  K+L                 G  K L  LH 
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHC 798

Query: 124 YSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM 183
                V+  +L    I++D +    +          +        +   +  Y++ E   
Sbjct: 799 RCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRE 851

Query: 184 SGTVSIKTDVFGFGVLVLKIVCGK 207
           +  ++ K+D++GFG+++++++ GK
Sbjct: 852 TKDITEKSDIYGFGLILIELLTGK 875

Length = 968

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 45/143 (31%), Positives = 60/143 (41%), Gaps = 47/143 (32%)

Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS 110
           VA+K+L+         FQN+    AK  Y  LV LL C  H     L+  F P KSL+  
Sbjct: 49  VAVKKLS-------RPFQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSLEE- 97

Query: 111 FSGTFKDL----------LC--LH---KYSRLR-----------------VIHRDLKASN 138
               F+D+          LC  +H    + R+                  +IHRDLK SN
Sbjct: 98  ----FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 153

Query: 139 ILLDDQLNTKISDFGMARIFGVN 161
           I++      KI DFG+AR    N
Sbjct: 154 IVVKSDCTLKILDFGLARTACTN 176

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 41/164 (25%), Positives = 69/164 (42%), Gaps = 15/164 (9%)

Query: 51  VAIKRLAWTSGQGRVEFQN--EAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF------- 101
           VAIK+   +     V+     E K++  L+  N+V+L        +  LV+E+       
Sbjct: 29  VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE 88

Query: 102 ----MPNKSL-DSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
               MPN    +   S  ++ +  +H   +  ++HRD+K  N+L+      K+ DFG AR
Sbjct: 89  LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR 148

Query: 157 IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
                 S AN    V T  Y S E  +        D++  G ++
Sbjct: 149 NLS-EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCIL 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.8 bits (100), Expect = 2e-04
 Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 22/99 (22%)

Query: 128 RVIHRDLKASNILLD-------------DQLN----TKISDFGMARIFGVNESGANTNRI 170
           RV+HRDLK  NI L              + LN     KI DFG+++  G+ ES A++   
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI-ESMAHS--C 201

Query: 171 VGTYGYMSLEYTMSGTVSI--KTDVFGFGVLVLKIVCGK 207
           VGT  Y S E  +  T S   K+D++  G ++ ++  GK
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 35/144 (24%), Positives = 62/144 (43%), Gaps = 20/144 (13%)

Query: 52  AIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSF 111
           A+K +    G      Q E  ++ + ++ N+V   G  +  E+  +  E+    SL   +
Sbjct: 38  AVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIY 97

Query: 112 ---------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
                            T + L  LH   ++   HRD+K +NILL D  + K++DFG+A 
Sbjct: 98  HVTGPLSELQIAYVCRETLQGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAA 154

Query: 157 IFGVNESGANTNRIVGTYGYMSLE 180
              +  + A     +GT  +M+ E
Sbjct: 155 --KITATIAKRKSFIGTPYWMAPE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 10/79 (12%)

Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMS 184
           IHRD+ A N+LL D    KI DFG+AR   +N+S    N +V         +M+ E    
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDI-MNDS----NYVVKGNARLPVKWMAPESIFD 288

Query: 185 GTVSIKTDVFGFGVLVLKI 203
              ++++DV+ +G+L+ +I
Sbjct: 289 CVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 21/64 (32%), Positives = 34/64 (53%), Gaps = 3/64 (4%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA-NTNRIVGTYGY 176
           +L +    +L  +HRD+K  N+LLD   + +++DFG      +   G   +N  VGT  Y
Sbjct: 112 VLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSC--LRLLADGTVQSNVAVGTPDY 169

Query: 177 MSLE 180
           +S E
Sbjct: 170 ISPE 173

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 35/144 (24%), Positives = 63/144 (43%), Gaps = 20/144 (13%)

Query: 52  AIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSF 111
           AIK +    G+     Q E  ++   +++N+V   G  +  ++  +  EF    SL   +
Sbjct: 38  AIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY 97

Query: 112 ---------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
                            T + L  LH   +   +HRD+K +NILL D  + K++DFG++ 
Sbjct: 98  HVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSA 154

Query: 157 IFGVNESGANTNRIVGTYGYMSLE 180
              +  + A     +GT  +M+ E
Sbjct: 155 --QITATIAKRKSFIGTPYWMAPE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 52/184 (28%), Positives = 75/184 (40%), Gaps = 40/184 (21%)

Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           ++ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P KSL
Sbjct: 42  DRNVAIKKLS-------RPFQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKSL 91

Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 92  EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151

Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 152 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 208

Query: 201 LKIV 204
            ++V
Sbjct: 209 GEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 25/81 (30%), Positives = 44/81 (54%), Gaps = 8/81 (9%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNES---GANTNRIVGTYGYMSLEYTMSG 185
           +++RDLK  N+LLD +   KI+DFG+ +     E    G  T+   GT  +++ E     
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTSTFCGTPEFLAPEVLTET 176

Query: 186 TVSIKTDVFGFGVLVLKIVCG 206
           + +   D +G GVL+ +++ G
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 28/92 (30%), Positives = 42/92 (45%), Gaps = 16/92 (17%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARI----------FGVNESGANTN------RIVG 172
           V+HRDLK  NILL       I D+G A              V+E     +      +IVG
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193

Query: 173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           T  YM+ E  +    S  TD++  GV++ +++
Sbjct: 194 TPDYMAPERLLGVPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 27/96 (28%), Positives = 50/96 (52%), Gaps = 8/96 (8%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI-VGTYGY 176
           +L +H   +L  +HRD+K  N+LLD   + +++DFG      +N+ G   + + VGT  Y
Sbjct: 112 VLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC--LKMNQDGTVQSSVAVGTPDY 169

Query: 177 MSLEYTMS-----GTVSIKTDVFGFGVLVLKIVCGK 207
           +S E   +     G    + D +  GV + +++ G+
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 53/189 (28%), Positives = 81/189 (42%), Gaps = 48/189 (25%)

Query: 50  EVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           +VAIK+L          FQ+E  L AK  Y  L +LL    H     L+  F P+ SLD 
Sbjct: 42  KVAIKKL-------YRPFQSE--LFAKRAYREL-RLLKHMKHENVIGLLDVFTPDLSLDR 91

Query: 110 --------SFSGTFKDLLCLHKYSRLR----------------------VIHRDLKASNI 139
                    F GT  DL  L K+ +L                       +IHRDLK  N+
Sbjct: 92  FHDFYLVMPFMGT--DLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNL 149

Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGV 198
            +++    KI DFG+AR     ++ +     V T  Y + E  ++     +T D++  G 
Sbjct: 150 AVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGC 204

Query: 199 LVLKIVCGK 207
           ++ +++ GK
Sbjct: 205 IMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 26/100 (26%), Positives = 48/100 (48%), Gaps = 7/100 (7%)

Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM---- 183
           +VIHRD+K  N+LL +    K+ DFG++    ++ +    N  +GT  +M+ E       
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDEN 198

Query: 184 -SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
              T   ++D++  G+  +++  G       H  R L L+
Sbjct: 199 PDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 16/37 (43%), Positives = 25/37 (67%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGM 154
           +L +    +L  IHRD+K  N+LLD + + K+SDFG+
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 23/67 (34%), Positives = 36/67 (53%), Gaps = 5/67 (7%)

Query: 114 TFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
           T + L  LH+    +VIHRD+K  NILL      K+ DFG++    ++ +    N  +GT
Sbjct: 122 TLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGT 176

Query: 174 YGYMSLE 180
             +M+ E
Sbjct: 177 PYWMAPE 183

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 26/97 (26%), Positives = 40/97 (41%), Gaps = 6/97 (6%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRD+K  NI LD+  N  + DFG A     +          GT    S E        
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265

Query: 189 IKTDVFGFGVLVLKIVC------GKKNNKSYHTERPL 219
            KTD++  G+++ ++        GK+   S    R +
Sbjct: 266 AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSI 302

Length = 392

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 34/127 (26%), Positives = 52/127 (40%), Gaps = 24/127 (18%)

Query: 50  EVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP----- 103
            V +K L A  +   ++ F  E +   +L + N+++ LG  I     LLV EF P     
Sbjct: 24  RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLK 83

Query: 104 -----NKSLDSSFSGT----------FKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTK 148
                N+ + +  +               LL LH   +   IH DL   N  L   L+ K
Sbjct: 84  NYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVK 140

Query: 149 ISDFGMA 155
           I D+G+A
Sbjct: 141 IGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 36/126 (28%), Positives = 57/126 (45%), Gaps = 18/126 (14%)

Query: 97  LVYEFMPNKSLDSSFSG-----------TFKDLLCLHKYSRLRVIHRDLKASNILLDDQL 145
           +V E+MP   L +  S            T + +L L     +  IHRD+K  N+LLD   
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 179

Query: 146 NTKISDFGMARIFGVNESG-ANTNRIVGTYGYMSLEYTMS----GTVSIKTDVFGFGVLV 200
           + K++DFG      +N+ G    +  VGT  Y+S E   S    G    + D +  GV +
Sbjct: 180 HLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237

Query: 201 LKIVCG 206
            +++ G
Sbjct: 238 YEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 50/219 (22%), Positives = 91/219 (41%), Gaps = 25/219 (11%)

Query: 9   CQTWSEGAKFVENSSLDWHMYI------QQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQ 62
           C    EG +  E+++   HMY+      +   T   V   G  P E+ VA K +     +
Sbjct: 49  CVDLPEGEEVPESNNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVA-KFVMLNDER 107

Query: 63  GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLH 122
                ++E   +A   +  +VK        ++ LL+ E+     L+       K+ L   
Sbjct: 108 QAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ 167

Query: 123 KY-----------------SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA 165
           +Y                 SR +++HRDLK++NI L      K+ DFG ++ +  + S  
Sbjct: 168 EYEVGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226

Query: 166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             +   GT  Y++ E       S K D++  GV++ +++
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265

Length = 478

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 16/29 (55%), Positives = 19/29 (65%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARI 157
           V HRDLK  NIL +     KI DFG+AR+
Sbjct: 124 VFHRDLKPKNILANADCKLKICDFGLARV 152

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 14/37 (37%), Positives = 28/37 (75%), Gaps = 3/37 (8%)

Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARI 157
           LH++    +IHRDLK  N+L+ ++ + K++DFG++++
Sbjct: 120 LHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 22/54 (40%), Positives = 32/54 (59%), Gaps = 2/54 (3%)

Query: 127 LRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           L +I+RDLK  NILLD Q +  ++DFG+ +  GV      T+   GT  Y++ E
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEE-TTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 22/74 (29%), Positives = 37/74 (50%)

Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI 189
           +HRDL A N+LL      KI DFG+AR    + +  +         +M+ E       + 
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318

Query: 190 KTDVFGFGVLVLKI 203
            +DV+ +G+L+ +I
Sbjct: 319 LSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 42/172 (24%), Positives = 75/172 (43%), Gaps = 24/172 (13%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE-RL 96
           R + + K    + V      +TS     EFQ+   L+     T+L K++G  +  ++ + 
Sbjct: 63  RELTLLKHMQHENVIGLLDVFTSAVSGDEFQD-FYLVMPYMQTDLQKIMGHPLSEDKVQY 121

Query: 97  LVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
           LVY+                 L  +H      +IHRDLK  N+ +++    KI DFG+AR
Sbjct: 122 LVYQ-------------MLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165

Query: 157 IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
                 + A     V T  Y + E  ++     +T D++  G ++ +++ GK
Sbjct: 166 -----HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 22/54 (40%), Positives = 33/54 (61%), Gaps = 2/54 (3%)

Query: 127 LRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           L +I+RDLK  NILLD Q +  ++DFG+ +  G+  S   T+   GT  Y++ E
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSK-TTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 37/130 (28%), Positives = 55/130 (42%), Gaps = 24/130 (18%)

Query: 47  NEQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK 105
              +V +K L  ++  Q +++F  EA+    LQ++NL++ LG        LLV EF P  
Sbjct: 21  TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80

Query: 106 SLDSSFSG------------TFKDLLC--------LHKYSRLRVIHRDLKASNILLDDQL 145
            L                  T + + C        LHK +    IH DL   N LL   L
Sbjct: 81  DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADL 137

Query: 146 NTKISDFGMA 155
             KI D+G++
Sbjct: 138 TVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 23/80 (28%), Positives = 41/80 (51%), Gaps = 5/80 (6%)

Query: 127 LRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGT 186
           L +++RDLK  N+LLD     K++DFG A++         T  + GT  Y++ E  ++  
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVG 204

Query: 187 VSIKTDVFGFGVLVLKIVCG 206
                D +  G+ + +I+ G
Sbjct: 205 HGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 38.2 bits (89), Expect = 0.003
 Identities = 36/122 (29%), Positives = 54/122 (44%), Gaps = 17/122 (13%)

Query: 50  EVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
            VA+K     TS   R +F  EA ++ +  + ++VKL+G  I      +V E  P   L 
Sbjct: 36  AVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGV-ITENPVWIVMELAPLGEL- 93

Query: 109 SSFSGTFKD---LLCLHKYS-----------RLRVIHRDLKASNILLDDQLNTKISDFGM 154
            S+    K    L  L  YS             R +HRD+ A N+L+      K+ DFG+
Sbjct: 94  RSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGL 153

Query: 155 AR 156
           +R
Sbjct: 154 SR 155

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 30/100 (30%), Positives = 46/100 (46%), Gaps = 14/100 (14%)

Query: 97  LVYEFMPNKSLDSSFSG-----------TFKDLLCLHKYSRLRVIHRDLKASNILLDDQL 145
           +V E+MP   L +  S            T + +L L     +  IHRD+K  N+LLD   
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 179

Query: 146 NTKISDFGMARIFGVNESG-ANTNRIVGTYGYMSLEYTMS 184
           + K++DFG      ++ +G    +  VGT  Y+S E   S
Sbjct: 180 HLKLADFGTC--MKMDANGMVRCDTAVGTPDYISPEVLKS 217

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 38.5 bits (89), Expect = 0.004
 Identities = 45/199 (22%), Positives = 78/199 (39%), Gaps = 31/199 (15%)

Query: 29  YIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGC 88
             ++ + R  V    +   + E  I +      +  ++ +NE   + +L + N++K+   
Sbjct: 172 STEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI--- 228

Query: 89  SIHGEERLL---------------VYEFMPNKSLDSSFS-------GTFKDLLCLHKYSR 126
               EE L                +Y FM +++ D              K LLC  +Y  
Sbjct: 229 ----EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284

Query: 127 LR-VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
            + +IHRD+K  NI L+      + DFG A  F   E  A     VGT    S E     
Sbjct: 285 DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE-KEREAFDYGWVGTVATNSPEILAGD 343

Query: 186 TVSIKTDVFGFGVLVLKIV 204
                TD++  G+++L ++
Sbjct: 344 GYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 38.1 bits (88), Expect = 0.004
 Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 7/94 (7%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           LL L      R+IHRD+K +NILL  +   K+ DFG++          NT+  VGT  +M
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWM 195

Query: 178 -----SLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
                + E     +   + DV+  G+  +++  G
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	345
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.98
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
PRK10345	210	hypothetical protein; Provisional	99.81
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.76
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.72
smart00090	237	RIO RIO-like kinase.	99.72
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.7
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.64
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.55
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.52
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.43
KOG1243	690	consensus Protein kinase [General function predict	99.3
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.29
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.29
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.16
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.15
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.13
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.11
KOG3087	229	consensus Serine/threonine protein kinase [General	99.05
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.03
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.99
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.84
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.66
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.64
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.51
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.46
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.46
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.41
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.4
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.37
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.36
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.35
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.3
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.28
PF01636	239	APH: Phosphotransferase enzyme family This family	98.27
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.14
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.1
PRK09902	216	hypothetical protein; Provisional	98.08
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.07
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.07
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.04
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.04
PLN02876	822	acyl-CoA dehydrogenase	98.02
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.96
PRK10593	297	hypothetical protein; Provisional	97.95
COG4248	637	Uncharacterized protein with protein kinase and he	97.85
PRK05231	319	homoserine kinase; Provisional	97.84
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.79
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.76
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.65
PLN02236	344	choline kinase	97.56
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.41
PLN02756	418	S-methyl-5-thioribose kinase	97.32
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.27
PRK12396	409	5-methylribose kinase; Reviewed	97.23
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.18
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.17
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.04
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	97.03
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.84
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.75
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.69
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.68
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.6
KOG2270	520	consensus Serine/threonine protein kinase involved	96.52
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.4
COG2334	331	Putative homoserine kinase type II (protein kinase	96.26
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.17
PRK06148	1013	hypothetical protein; Provisional	96.17
PRK11768	325	serine/threonine protein kinase; Provisional	96.09
PTZ00296	442	choline kinase; Provisional	95.86
PTZ00384	383	choline kinase; Provisional	95.57
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.02
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	94.69

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-55  Score=408.07  Aligned_cols=271  Identities=34%  Similarity=0.518  Sum_probs=235.0

Q ss_pred             CCcceeecccccccccCCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeE
Q 039516            6 NTGCQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKL   85 (345)
Q Consensus         6 ~~~~~s~~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~   85 (345)
                      ....|++.|+.++|++|+.+    ..||+|+||.||+|.+.+|+.||||++.........+|.+|+.++.+++|||+|++
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~----~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~L  136 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSES----NLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKL  136 (361)
T ss_pred             CcceeeHHHHHHHHhCCchh----cceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccE
Confidence            45679999999999997654    44999999999999999999999998876543314569999999999999999999


Q ss_pred             EEEEEECC-eeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCE
Q 039516           86 LGCSIHGE-ERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNT  147 (345)
Q Consensus        86 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~  147 (345)
                      +|||.+.+ +.+||+|||++|+|.+++.                 +++++|.|||......|||||||++|||+|+++.+
T Consensus       137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            99999988 5999999999999988754                 67899999999998899999999999999999999


Q ss_pred             EEEccccceeecCCCCCCcccce-eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 039516          148 KISDFGMARIFGVNESGANTNRI-VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAW  226 (345)
Q Consensus       148 kl~Dfgl~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~  226 (345)
                      ||+|||+++..+..  ....... .||.+|+|||+...+..+.|+||||||+++.|++||+.+.+........++.+|++
T Consensus       217 KlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~  294 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK  294 (361)
T ss_pred             EccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence            99999999765431  1111112 79999999999999999999999999999999999999988766566677999999


Q ss_pred             HHHhcCCccccccccCC-CCCCh-hHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          227 QLWNEGKDLELIDLTLD-GSCPP-NEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       227 ~~~~~~~~~~~~d~~l~-~~~~~-~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                      ..+..+.+.+++|+.+. +.++. .++.+ ..++++|++.+|..||+|.+|+..|..+.
T Consensus       295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            99999999999999997 65665 57777 99999999999999999998877774433

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-48  Score=345.99  Aligned_cols=232  Identities=22%  Similarity=0.305  Sum_probs=188.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-eeEEEEe
Q 039516           24 LDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYE  100 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-~~~lv~e  100 (345)
                      .+.+.+..||+|..|+||++. .++++.+|+|.+... .....+++.+|+++++..+||+||++||+|.... .++|+||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            367888899999999999995 568999999999654 4455778999999999999999999999999988 5999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ||++|||+.++.               ++.++|.|||..+  +||||||||+|||++..|.+||||||.++.+...    
T Consensus       159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            999999998876               5778899999754  7999999999999999999999999999887432    


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      ...++.||..|||||.+.+..|+.++||||||++++|+++|+.||.... .......+...... .+.     .|.+...
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~Ll~~Iv-~~p-----pP~lP~~  305 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFELLCAIV-DEP-----PPRLPEG  305 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHHHHHHh-cCC-----CCCCCcc
Confidence            4567899999999999999999999999999999999999999997641 11112222211111 111     1222222


Q ss_pred             -CChhHHHHHHHHhhccCCCCCcCCCC
Q 039516          246 -CPPNEDAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       246 -~~~~~~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                       ++++-   ..++-.||++||.+|||+
T Consensus       306 ~fS~ef---~~FV~~CL~Kdp~~R~s~  329 (364)
T KOG0581|consen  306 EFSPEF---RSFVSCCLRKDPSERPSA  329 (364)
T ss_pred             cCCHHH---HHHHHHHhcCCcccCCCH
Confidence             44333   499999999999999994

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-48  Score=356.69  Aligned_cols=239  Identities=23%  Similarity=0.334  Sum_probs=191.6

Q ss_pred             eeeEEEeeccCCeEEEEEEcCCCcE-EEEEEeccCCc--cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-eeEEEEec
Q 039516           26 WHMYIQQEQTRDRVILVGKFPNEQE-VAIKRLAWTSG--QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEF  101 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~~~~~-VaiK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-~~~lv~e~  101 (345)
                      ..+...||+|+||+||+|.+. |+. ||||++.....  ...+.|.+|+.+|++++|||||+++|+|.+.. ..++||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            445566999999999999997 555 99999975432  22568999999999999999999999998887 79999999


Q ss_pred             CCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC-CEEEEccccceeecCCCC
Q 039516          102 MPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL-NTKISDFGMARIFGVNES  163 (345)
Q Consensus       102 ~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~  163 (345)
                      +++|+|.+++.                 ++++|+.|||....  |||||||++|||++.++ ++||+|||+++...... 
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            99999999873                 67888899998732  99999999999999997 99999999998764322 


Q ss_pred             CCcccceeecCCccccchhc--cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          164 GANTNRIVGTYGYMSLEYTM--SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                       ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.....      ...+......+         
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~---------  262 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGG---------  262 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcC---------
Confidence             2233368999999999999  56999999999999999999999999987653      11122221111         


Q ss_pred             CCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          242 LDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       242 l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      .+...+...... ..++..||+.||..||++.+++..|..+...
T Consensus       263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            111122223333 5888999999999999999998888877663

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-46  Score=336.28  Aligned_cols=188  Identities=28%  Similarity=0.388  Sum_probs=166.4

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ...+|...++||.|+||+||+|+. .++..||||.+.+.  .....+-...|+.+|+.++|||||++++++..++.+|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            345789999999999999999965 46899999999766  455667788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC------CCEEEEcccccee
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ------LNTKISDFGMARI  157 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~------~~~kl~Dfgl~~~  157 (345)
                      ||||.||+|.++++               +++.++.+||..   +||||||||.|||++..      -.+||+|||+++.
T Consensus        88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            99999999988776               778888888887   59999999999999764      4589999999998


Q ss_pred             ecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 039516          158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHT  215 (345)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~  215 (345)
                      +.   ......+.+|++.|||||++....|+.|+|+||+|+++|++++|+.||.....
T Consensus       165 L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  165 LQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             CC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            75   33345568999999999999999999999999999999999999999986553

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-46  Score=352.13  Aligned_cols=230  Identities=18%  Similarity=0.224  Sum_probs=189.3

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      +.-...|++.+.||+|||+.||.++. .+|+.||+|++.+.   .....+...+|+++.++|+|||||+++++|++.++.
T Consensus        14 D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nV   93 (592)
T KOG0575|consen   14 DPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNV   93 (592)
T ss_pred             cCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCce
Confidence            33337799999999999999999976 88999999999653   455677899999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           96 LLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      |||.|+|+.++|.++++               +++.|+.|||..   +|||||||..|++++++.++||+|||+|..+..
T Consensus        94 YivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   94 YIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            99999999999987765               778888888887   799999999999999999999999999998854


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      +..  ...+.+|||.|.|||++.....++.+||||+||++|-|++|++||....-.+.       .........   .  
T Consensus       171 ~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket-------y~~Ik~~~Y---~--  236 (592)
T KOG0575|consen  171 DGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET-------YNKIKLNEY---S--  236 (592)
T ss_pred             ccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH-------HHHHHhcCc---c--
Confidence            332  34458999999999999999999999999999999999999999986432111       111111111   0  


Q ss_pred             cCCCCCChhHHHH-HHHHhhccCCCCCcCCCC
Q 039516          241 TLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       241 ~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~  271 (345)
                           .|...... .+++...|+.||.+|||.
T Consensus       237 -----~P~~ls~~A~dLI~~lL~~~P~~Rpsl  263 (592)
T KOG0575|consen  237 -----MPSHLSAEAKDLIRKLLRPNPSERPSL  263 (592)
T ss_pred             -----cccccCHHHHHHHHHHhcCCcccCCCH
Confidence                 11111112 589999999999999994

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-48  Score=334.40  Aligned_cols=242  Identities=19%  Similarity=0.264  Sum_probs=188.3

Q ss_pred             CCeeeEEEeeccCCeEEEEE-EcCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEE-EEEECCe-eEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVG-KFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEE-RLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~-~~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~-~~~~~~~-~~lv   98 (345)
                      .+|.++++||.|+||.||++ .+.+|..||.|.++..  +.....++..|+.+|++|+|||||++++ .+.++.+ ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            45899999999999999999 5678999999999755  4455678999999999999999999999 4556666 8999


Q ss_pred             EecCCCCChHHHHH-------------------hHHHHHHHHHhcCCC-ceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           99 YEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRL-RVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        99 ~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~-~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      ||||..|+|...++                   +.+.+|..+|+.-.+ -|+||||||.||+++.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999988765                   344445555542222 3999999999999999999999999999988


Q ss_pred             cCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                      ....  ....+..|||+||+||.+.+.+|++||||||+||++|||+.-+.||.+.      ++.+.... ...+....  
T Consensus       179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~K-I~qgd~~~--  247 (375)
T KOG0591|consen  179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKK-IEQGDYPP--  247 (375)
T ss_pred             cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHH-HHcCCCCC--
Confidence            5433  2345679999999999999999999999999999999999999999864      33332222 22332211  


Q ss_pred             cccCCCCCChhHHHH--HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          239 DLTLDGSCPPNEDAF--LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       239 d~~l~~~~~~~~~~~--~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                             ++.+....  ..++..|+..||..||+....+..+..-++
T Consensus       248 -------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l~  287 (375)
T KOG0591|consen  248 -------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSELD  287 (375)
T ss_pred             -------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHhc
Confidence                   12122222  578999999999999996555555554333

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-47  Score=352.02  Aligned_cols=236  Identities=26%  Similarity=0.323  Sum_probs=189.7

Q ss_pred             CeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCC
Q 039516           25 DWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN  104 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  104 (345)
                      .+...++||+|.||.|+.|.+.....||+|.++... .....|.+|+++|++|+|+|||+++|+|..+..++||||||+.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            345567899999999999999877799999997653 4457899999999999999999999999998899999999999


Q ss_pred             CChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          105 KSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       105 gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      |+|.++++                 ++++|++||...   ++|||||.++|||++++..+||+|||+++...++.... .
T Consensus       286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~-~  361 (468)
T KOG0197|consen  286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA-S  361 (468)
T ss_pred             CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceee-c
Confidence            99999887                 778888888887   69999999999999999999999999999554332222 2


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      ....-+..|.|||.+..+.++.|||||||||+||||+| |+.||......+.      ...          ++...+-..
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev------~~~----------le~GyRlp~  425 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV------LEL----------LERGYRLPR  425 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH------HHH----------HhccCcCCC
Confidence            22234667999999999999999999999999999999 8999887653321      111          222222223


Q ss_pred             ChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          247 PPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       247 ~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                      |..+... .+++..||+.+|++|||+......+.++
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            4444455 6999999999999999986544444443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-46  Score=337.16  Aligned_cols=234  Identities=20%  Similarity=0.209  Sum_probs=180.3

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCc-------cCHHHHHHHHHHHHhcCCCCeeeEEEEEEE
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSG-------QGRVEFQNEAKLIAKLQYTNLVKLLGCSIH   91 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~   91 (345)
                      +.+...|.+.+.||+|+||.|-+|. ..+|+.||||++++...       ......++|+++|++|+|||||+++++|..
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            3455667888899999999999995 56899999999976521       122345799999999999999999999999


Q ss_pred             CCeeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC---CCEEEEccc
Q 039516           92 GEERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ---LNTKISDFG  153 (345)
Q Consensus        92 ~~~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfg  153 (345)
                      .+..|+||||+.||+|.+.+-               +++.++.|||..   ||+||||||+|||+..+   ..+||+|||
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence            999999999999999987643               555666666665   99999999999999766   679999999


Q ss_pred             cceeecCCCCCCcccceeecCCccccchhccCCc---CcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh
Q 039516          154 MARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV---SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWN  230 (345)
Q Consensus       154 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  230 (345)
                      +|+..+   ......+++||+.|.|||++.+..+   ..++|+||+||+||-+++|.+||.....  +.++.+.    ..
T Consensus       325 lAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~--~~sl~eQ----I~  395 (475)
T KOG0615|consen  325 LAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT--DPSLKEQ----IL  395 (475)
T ss_pred             hhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC--CccHHHH----Hh
Confidence            999875   3345667899999999999987654   3478999999999999999999986542  2222222    11


Q ss_pred             cCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCC
Q 039516          231 EGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       231 ~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~  271 (345)
                      .|+...  -|...    ..-... +.++.++|..||+.|||.
T Consensus       396 ~G~y~f--~p~~w----~~Iseea~dlI~~mL~VdP~~R~s~  431 (475)
T KOG0615|consen  396 KGRYAF--GPLQW----DRISEEALDLINWMLVVDPENRPSA  431 (475)
T ss_pred             cCcccc--cChhh----hhhhHHHHHHHHHhhEeCcccCcCH
Confidence            222211  01000    011223 799999999999999994

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=322.28  Aligned_cols=231  Identities=19%  Similarity=0.174  Sum_probs=182.5

Q ss_pred             CCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      -.+|++++.||+|+||.||.++ .++++.+|+|++++.   ..........|..+|.+++||.||+++-.|++.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4679999999999999999995 457999999999765   234566788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516           99 YEFMPNKSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus        99 ~e~~~~gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      +||+.||.|..++.            .+++.+.+|-++|+.|||||||||+|||++.+|+++|+|||+++....  ....
T Consensus       104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~~~~  181 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--DGDA  181 (357)
T ss_pred             EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--CCCc
Confidence            99999999988776            345555555555555899999999999999999999999999986432  2234


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      +.+++||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+..      .+....... +.     +....-.
T Consensus       182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~~-k~-----~~~p~~l  249 (357)
T KOG0598|consen  182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILKG-KL-----PLPPGYL  249 (357)
T ss_pred             cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhcC-cC-----CCCCccC
Confidence            45589999999999999999999999999999999999999999865421      121121111 10     0000001


Q ss_pred             ChhHHHHHHHHhhccCCCCCcCCC
Q 039516          247 PPNEDAFLLVSCVCKSKQQIDVQC  270 (345)
Q Consensus       247 ~~~~~~~~~l~~~Cl~~~P~~RPs  270 (345)
                      +.+.   ..++..-|+.||.+|-.
T Consensus       250 s~~a---rdll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  250 SEEA---RDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             CHHH---HHHHHHHhccCHHHhcC
Confidence            1111   58888889999999963

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=320.18  Aligned_cols=236  Identities=22%  Similarity=0.304  Sum_probs=186.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ..+|++...||.|..++||+|. .+.++.||||+++.+. ....+.+.+|+..|+.++||||++++.+|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4679999999999999999995 5678999999998763 3346889999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          101 FMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       101 ~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      ||.+||+.++++                 +++++|.|||..   |.||||||+.||||+.+|.|||+|||.+..+-....
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            999999988776                 566777888776   899999999999999999999999999876643332


Q ss_pred             CC--cccceeecCCccccchhcc--CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          164 GA--NTNRIVGTYGYMSLEYTMS--GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       164 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      ..  ..+.+.||+.|||||++..  ..|+.|+||||||++..||.+|..||..+.+..-.      ...+ .+...... 
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL------l~tL-qn~pp~~~-  253 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL------LLTL-QNDPPTLL-  253 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH------HHHh-cCCCCCcc-
Confidence            21  1155789999999999553  57999999999999999999999999876543211      1111 12111111 


Q ss_pred             ccCCCCCChhHHH----H-HHHHhhccCCCCCcCCCCC
Q 039516          240 LTLDGSCPPNEDA----F-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       240 ~~l~~~~~~~~~~----~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                         .+..+.++..    . .+++-.||+.||.+|||+.
T Consensus       254 ---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAs  288 (516)
T KOG0582|consen  254 ---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTAS  288 (516)
T ss_pred             ---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHH
Confidence               0111222211    2 6889999999999999953

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.7e-45  Score=354.11  Aligned_cols=242  Identities=24%  Similarity=0.322  Sum_probs=204.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCCcc-CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTSGQ-GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      .+-...+.||+|.||.||+|+..      +.+.||||.++..... ...+|++|+++|+.|+|||||+++|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            44566678999999999999763      3478999999877544 7889999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHH-----------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCE
Q 039516           97 LVYEFMPNKSLDSSFS-----------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNT  147 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~-----------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~  147 (345)
                      +|+|||..|+|.++|.                             +|+.|+.||...|   +|||||..+|+|+.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence            9999999999999987                             6788888998885   9999999999999999999


Q ss_pred             EEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 039516          148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAW  226 (345)
Q Consensus       148 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~  226 (345)
                      ||+|||+++.+-..+.......-.-..+|||||.+..++||.+||||||||+|||+++ |+.||.+...++.       .
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-------I  715 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-------I  715 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-------H
Confidence            9999999997754444433323345779999999999999999999999999999998 9999998765442       3


Q ss_pred             HHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          227 QLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       227 ~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      .....|++.+         ++..+... ..+++.||+.+|.+|||+.++...|..+.++
T Consensus       716 e~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  716 ECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            3334554432         44455555 7999999999999999999999999987764

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.1e-43  Score=327.16  Aligned_cols=282  Identities=15%  Similarity=0.139  Sum_probs=217.1

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ..-.||+++..||+|+||.||.++ ..+|..+|+|++++.   .....+.+..|-.+|....+|.||++|-.|++.+.+|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            355789999999999999999995 457999999999766   3455677899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC---
Q 039516           97 LVYEFMPNKSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN---  161 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~---  161 (345)
                      |||||++||++..+|.            .+++.+.++..+|+.|+|||||||+|+|||..|++||+||||+..+...   
T Consensus       218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence            9999999999988765            5677777777777779999999999999999999999999999653210   


Q ss_pred             --------------------CCC----C------------------cccceeecCCccccchhccCCcCcccchhhHHHH
Q 039516          162 --------------------ESG----A------------------NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL  199 (345)
Q Consensus       162 --------------------~~~----~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~i  199 (345)
                                          ...    .                  ......|||.|+|||++.+..|+..+|+||||||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I  377 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI  377 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence                                000    0                  0113579999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCccc-HHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhh
Q 039516          200 VLKIVCGKKNNKSYHTERPLN-LVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       200 l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      +|||+.|-+||.+..+.+... +..|...+-      ..-+..    ...+   ..+++.+|+- ||++|-..    .-+
T Consensus       378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~------fP~~~~----~s~e---A~DLI~rll~-d~~~RLG~----~G~  439 (550)
T KOG0605|consen  378 MYEMLVGYPPFCSETPQETYRKIVNWRETLK------FPEEVD----LSDE---AKDLITRLLC-DPENRLGS----KGA  439 (550)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc------CCCcCc----ccHH---HHHHHHHHhc-CHHHhcCc----ccH
Confidence            999999999999866544321 222211110      000000    1111   1588888887 99999882    345


Q ss_pred             hcccccccccceeeEEecCCCCCCCCCCCCCCccceeccccc
Q 039516          279 MNLLPGLYLKNLHFLLMLPPKNQKLPKTSQKFVPYIKNRLQR  320 (345)
Q Consensus       279 ~~ll~~~~~~~~~~~~~l~~~~~~~p~~~~p~~~~~~~~~~~  320 (345)
                      .++..+..+...+|-......++..|....+.++-+++....
T Consensus       440 ~EIK~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yFddF~e  481 (550)
T KOG0605|consen  440 EEIKKHPFFKGVDWDHLREMPAPFVPQVNSELDTQYFDDFPE  481 (550)
T ss_pred             HHHhcCCccccCCcchhhcCCCCCCCCCCCcccccccccCcc
Confidence            666777777777777766777777888777777776665543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.1e-44  Score=312.66  Aligned_cols=245  Identities=20%  Similarity=0.240  Sum_probs=187.8

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .|+.+.++|+|+||+||+++. .+|+.||||++...  ++...+-.++|+++|++|+|+|+|.++.+|.....++||+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            478888999999999999965 57999999999644  233455678999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccc
Q 039516          102 MPNKSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNR  169 (345)
Q Consensus       102 ~~~gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  169 (345)
                      |+..-|.++-.            .+.+.+.++|.+|+.++|||||||+|||++.+|.+||||||+|+.+..  .....+.
T Consensus        83 ~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTD  160 (396)
T KOG0593|consen   83 CDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYTD  160 (396)
T ss_pred             cchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccchhhh
Confidence            98766654322            445566666666677899999999999999999999999999998753  3334555


Q ss_pred             eeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHHhcCCccc-c--
Q 039516          170 IVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIA--------WQLWNEGKDLE-L--  237 (345)
Q Consensus       170 ~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~-~--  237 (345)
                      ...|..|.|||++.+ .+|+..+||||+||++.||++|.+-|.+.++-++..++.-.        ...+..+.... +  
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l  240 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL  240 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence            788999999999887 78999999999999999999999999887766555444322        22222222211 1  


Q ss_pred             ---cccc-CCCCCChhHHHHHHHHhhccCCCCCcCCCC
Q 039516          238 ---IDLT-LDGSCPPNEDAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       238 ---~d~~-l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                         -++. +...++.-....++++..||+.||++|+|-
T Consensus       241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc  278 (396)
T KOG0593|consen  241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSC  278 (396)
T ss_pred             CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccH
Confidence               1111 111222211222899999999999999994

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=326.56  Aligned_cols=248  Identities=20%  Similarity=0.250  Sum_probs=195.2

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~   96 (345)
                      ...||...+.||.|+|++|++++ ..+++.+|||++.+.   .....+.+..|-.+|.+| .||.|+++|-.|++...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            35789999999999999999995 457999999999655   334456778899999999 8999999999999999999


Q ss_pred             EEEecCCCCChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516           97 LVYEFMPNKSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      +|+||+++|+|.++++            ..++.+.+|.++|+.|||||||||+|||++++|++||+|||.++.+......
T Consensus       151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence            9999999999999887            3455555555555569999999999999999999999999999987532221


Q ss_pred             ---------Cc--ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 039516          165 ---------AN--TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGK  233 (345)
Q Consensus       165 ---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (345)
                               ..  ...++||..|.+||++..+..+..+|+|+|||++|.|+.|++||...++--.+              
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF--------------  296 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF--------------  296 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH--------------
Confidence                     11  14589999999999999999999999999999999999999999875421110              


Q ss_pred             ccccc--cccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceeeEE
Q 039516          234 DLELI--DLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLL  294 (345)
Q Consensus       234 ~~~~~--d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~~~  294 (345)
                       ..++  +-.....+++..   .+++.+-|..||.+|+|.       ..+.++.++.+.+|..
T Consensus       297 -qkI~~l~y~fp~~fp~~a---~dLv~KLLv~dp~~Rlt~-------~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  297 -QKIQALDYEFPEGFPEDA---RDLIKKLLVRDPSDRLTS-------QQIKAHPFFEGVDWEN  348 (604)
T ss_pred             -HHHHHhcccCCCCCCHHH---HHHHHHHHccCccccccH-------HHHhhCcccccCChhh
Confidence             0111  111222233222   588888999999999994       4555666666655554

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=329.84  Aligned_cols=231  Identities=24%  Similarity=0.342  Sum_probs=187.2

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      -...|....+||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|..++.+|+|||
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            34568888999999999999995 56789999999988876777778999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          101 FMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       101 ~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      ||+||+|.+.+.              .+++||.+||..   ||+|||||.+|||++.+|.+||+|||++..+.....  .
T Consensus       351 ym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K  425 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K  425 (550)
T ss_pred             ecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence            999999987765              445566666655   899999999999999999999999999998765443  2


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      -.+..||++|||||++....|++|+||||||++++||+-|++||-...+-....++      ...|..      .+.   
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI------a~ng~P------~lk---  490 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGTP------KLK---  490 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH------hhcCCC------CcC---
Confidence            34579999999999999999999999999999999999999999764432221111      112221      111   


Q ss_pred             ChhHH-HH-HHHHhhccCCCCCcCCCCC
Q 039516          247 PPNED-AF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       247 ~~~~~-~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .++.+ .. .++..+||+.|+.+|||+.
T Consensus       491 ~~~klS~~~kdFL~~cL~~dv~~RasA~  518 (550)
T KOG0578|consen  491 NPEKLSPELKDFLDRCLVVDVEQRASAK  518 (550)
T ss_pred             CccccCHHHHHHHHHHhhcchhcCCCHH
Confidence            11111 12 5999999999999999953

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=321.51  Aligned_cols=229  Identities=22%  Similarity=0.278  Sum_probs=191.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ..|.....||+|.||.||+|.. .+++.||+|++.... ....+..+.|+.+|.+++++||.++|+.+..+..+|++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4477778899999999999965 468999999998763 44567899999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          102 MPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       102 ~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      |.||++.+.+.               .+..++.|||..   +.+|||||+.|||+..+|.+||+|||++.........  
T Consensus        93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--  167 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--  167 (467)
T ss_pred             hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc--
Confidence            99999988776               556677777766   7999999999999999999999999999887544333  


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      ..++.||++|||||++.+..|+.|+||||||++.+||++|.+|+...++.....++            ..-..|.+.+.+
T Consensus       168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------pk~~PP~L~~~~  235 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------PKSAPPRLDGDF  235 (467)
T ss_pred             cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec------------cCCCCCcccccc
Confidence            25689999999999999889999999999999999999999999988764433221            122344555544


Q ss_pred             ChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          247 PPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       247 ~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ++.-   .+++..||+.||+.|||+.
T Consensus       236 S~~~---kEFV~~CL~k~P~~RpsA~  258 (467)
T KOG0201|consen  236 SPPF---KEFVEACLDKNPEFRPSAK  258 (467)
T ss_pred             CHHH---HHHHHHHhhcCcccCcCHH
Confidence            4322   5999999999999999964

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.5e-43  Score=325.21  Aligned_cols=242  Identities=20%  Similarity=0.232  Sum_probs=183.9

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC-Ce
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHG-EE   94 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~-~~   94 (345)
                      .+|++.++||+|+||.||+|..      .+++.||+|+++... ......+.+|+.++.++ +||||++++++|... ..
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            3588999999999999999963      235789999997542 23345789999999999 899999999988764 46


Q ss_pred             eEEEEecCCCCChHHHHH--------------------------------------------------------------
Q 039516           95 RLLVYEFMPNKSLDSSFS--------------------------------------------------------------  112 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~--------------------------------------------------------------  112 (345)
                      .++||||+++|+|.+++.                                                              
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            899999999999976653                                                              


Q ss_pred             ---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCcc
Q 039516          113 ---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM  177 (345)
Q Consensus       113 ---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~  177 (345)
                                     +++.+|.|||.   .||+||||||+|||++.++.+||+|||+++...............++..|+
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence                           45566666765   489999999999999999999999999998653322222222335567899


Q ss_pred             ccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HH
Q 039516          178 SLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LL  255 (345)
Q Consensus       178 aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~  255 (345)
                      |||++.+..++.++|||||||++|||++ |..||......+      ........+....     ....++    .. ..
T Consensus       244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~~-----~~~~~~----~~l~~  308 (338)
T cd05102         244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRMR-----APENAT----PEIYR  308 (338)
T ss_pred             CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCCC-----CCCCCC----HHHHH
Confidence            9999999999999999999999999997 999997643211      1111222221111     111122    23 59


Q ss_pred             HHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          256 VSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       256 l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ++..||+.||.+|||+.+++..|.+++.
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999988888887665

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-42  Score=309.12  Aligned_cols=233  Identities=19%  Similarity=0.296  Sum_probs=177.5

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--eeEEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE--ERLLVY   99 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--~~~lv~   99 (345)
                      ..+|...+.||+|+||.||++... +|...|||.+...+....+.+.+|+.+|++++|||||+++|......  .+++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            455888899999999999999764 48999999997664333677899999999999999999999755444  689999


Q ss_pred             ecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC-CCCEEEEccccceeecC-C
Q 039516          100 EFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD-QLNTKISDFGMARIFGV-N  161 (345)
Q Consensus       100 e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgl~~~~~~-~  161 (345)
                      ||+++|+|.+++.                +++++|.|||.   +|||||||||+|||++. ++.+||+|||+++.... .
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999988765                56667777774   49999999999999999 79999999999987653 1


Q ss_pred             CCCCcccceeecCCccccchhccCC-cCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGT-VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ..........||+.|||||++..+. ...++|||||||++.||+||+.||...     .....+..........     |
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~-----P  242 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL-----P  242 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-----C
Confidence            1112233478999999999998643 335999999999999999999999864     1111222222212211     1


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCC
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                      .+....+.+.   .+++..|++.||+.|||+
T Consensus       243 ~ip~~ls~~a---~~Fl~~C~~~~p~~Rpta  270 (313)
T KOG0198|consen  243 EIPDSLSDEA---KDFLRKCFKRDPEKRPTA  270 (313)
T ss_pred             CCCcccCHHH---HHHHHHHhhcCcccCcCH
Confidence            2222222222   499999999999999994

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-42  Score=314.44  Aligned_cols=247  Identities=19%  Similarity=0.230  Sum_probs=184.3

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--Cee
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--EER   95 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~   95 (345)
                      .....|+.+++||+|.||.||+++ ..+|+.||+|++....  .....-..+|+.+|++|.||||+++.+...+.  ..+
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            345679999999999999999995 5689999999997664  44566678999999999999999999988776  689


Q ss_pred             EEEEecCCCCCh----------------HHHHHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           96 LLVYEFMPNKSL----------------DSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        96 ~lv~e~~~~gsL----------------~~~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      |||+|||+. +|                ..++++++.+|.|+|.   +||+|||||.+|||||++|.+||+|||+|+.+.
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeecc
Confidence            999999975 22                2234455555555555   489999999999999999999999999999876


Q ss_pred             CCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-----HHHhcCC
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAW-----QLWNEGK  233 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~  233 (345)
                      ...... .+...-|..|.|||++.+ ..|+.++|+||.|||+.||++|++.|.+..+-+++..+-...     ..|...+
T Consensus       270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            544433 344567999999999887 479999999999999999999999999877666555443322     1122111


Q ss_pred             c--cccccc------cCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          234 D--LELIDL------TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       234 ~--~~~~d~------~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +  ...+.+      ++.+.+..-....+.++...|..||.+|.|+.
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~  395 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTAS  395 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHH
Confidence            1  111111      11111111111116888888999999999953

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=9.5e-43  Score=323.59  Aligned_cols=247  Identities=20%  Similarity=0.242  Sum_probs=190.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      .+|.+++.||+|+||+||||+. .+.+.||+|.+.+.  .....+.+.+|+++++.|+|||||.++++|+...++|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            3588889999999999999965 46899999999765  33456678999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCccc
Q 039516          101 FMPNKSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTN  168 (345)
Q Consensus       101 ~~~~gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  168 (345)
                      ||.| +|..++.            -..+.+.+||++|+.+|+|||+||.|||++..|.+|+||||+++..+.+  ....+
T Consensus        82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t~vlt  158 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--TSVLT  158 (808)
T ss_pred             hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC--ceeee
Confidence            9988 8988776            1223345666666679999999999999999999999999999987542  23445


Q ss_pred             ceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          169 RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       169 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      ...|||.|||||++.+.+|+..+|.||+||++||+++|++||....      ....+.....        |+..   .+.
T Consensus       159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~--------d~v~---~p~  221 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILK--------DPVK---PPS  221 (808)
T ss_pred             eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhc--------CCCC---Ccc
Confidence            6789999999999999999999999999999999999999997432      1111111111        1111   122


Q ss_pred             hHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccccccccceeeEEecC
Q 039516          249 NEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLLMLP  297 (345)
Q Consensus       249 ~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~~~~l~  297 (345)
                      ..... ..+...-|++||.+|-|..       .|+.+.++...-.....+
T Consensus       222 ~~S~~f~nfl~gLL~kdP~~RltW~-------~Ll~HpF~k~~~~~~~~~  264 (808)
T KOG0597|consen  222 TASSSFVNFLQGLLIKDPAQRLTWT-------DLLGHPFWKGKINIAELP  264 (808)
T ss_pred             cccHHHHHHHHHHhhcChhhcccHH-------HHhcChHHhhhhhhhccc
Confidence            22222 6888889999999999943       445554444433333333

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.9e-41  Score=307.50  Aligned_cols=228  Identities=21%  Similarity=0.262  Sum_probs=177.4

Q ss_pred             EEeeccCCeEEEEEEcCCCcEEEEEEeccCCccC---HHHHHHHHHHHHhcCCCCeeeEEEEEEE----CCeeEEEEecC
Q 039516           30 IQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQG---RVEFQNEAKLIAKLQYTNLVKLLGCSIH----GEERLLVYEFM  102 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~~  102 (345)
                      ..||+|++|.||+|.+ +|+.||||.++......   .+.|.+|+.+|++++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5699999999999998 58999999997653333   4678899999999999999999999877    34689999999


Q ss_pred             CCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          103 PNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       103 ~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      ++|+|.+++.               +++.++.+||...  +++||||||+||+++.++.+||+|||+++......     
T Consensus       105 ~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----  177 (283)
T PHA02988        105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----  177 (283)
T ss_pred             CCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----
Confidence            9999988764               5677788888753  68899999999999999999999999987653221     


Q ss_pred             cceeecCCccccchhcc--CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          168 NRIVGTYGYMSLEYTMS--GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......      .........+..     +.+   
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~i~~~~~~-----~~~---  243 (283)
T PHA02988        178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDLIINKNNS-----LKL---  243 (283)
T ss_pred             ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCCC-----CCC---
Confidence            12467899999999876  68899999999999999999999999864321      111111111110     111   


Q ss_pred             CChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          246 CPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       246 ~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                       +...... .+++.+||+.||++|||+.++...|..
T Consensus       244 -~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        244 -PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             -CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence             1112223 699999999999999998776665554

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-42  Score=320.58  Aligned_cols=241  Identities=20%  Similarity=0.294  Sum_probs=191.2

Q ss_pred             CeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           25 DWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ...+...||+|+||+||+|.|.  ..||||.++..  +++..+.|.+|+..+++-+|.||+-+.|+|..... .||+.+|
T Consensus       393 ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwC  469 (678)
T KOG0193|consen  393 EVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWC  469 (678)
T ss_pred             Hhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhc
Confidence            3556778999999999999996  57999999876  44567889999999999999999999999987666 9999999


Q ss_pred             CCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          103 PNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       103 ~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      +|.+|..+++                ++++++.|||..   +|||||||..||++.+++.|||+|||++...........
T Consensus       470 eGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q  546 (678)
T KOG0193|consen  470 EGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQ  546 (678)
T ss_pred             cCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccccc
Confidence            9999988776                788899999987   799999999999999999999999999987655444444


Q ss_pred             ccceeecCCccccchhc---cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          167 TNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                      .....|...|||||+++   ..+|++.+|||||||++|||++|..||.....+.....         -|+-.-..|... 
T Consensus       547 ~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm---------VGrG~l~pd~s~-  616 (678)
T KOG0193|consen  547 LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM---------VGRGYLMPDLSK-  616 (678)
T ss_pred             cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE---------ecccccCccchh-
Confidence            55567889999999887   46799999999999999999999999984332222111         111111111111 


Q ss_pred             CCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          244 GSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       244 ~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                        ....+... .+++..||..++++||++.++...|+.+++
T Consensus       617 --~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  617 --IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             --hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence              11223333 689999999999999998777666666554

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.6e-40  Score=307.52  Aligned_cols=240  Identities=18%  Similarity=0.153  Sum_probs=185.8

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      -.+|++.+.||+|+||.||++.. .+|+.||+|.+...   .......+.+|+.++++++||||+++++++.+++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            46799999999999999999976 46899999998643   223456788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |||+++++|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||++......  
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--  171 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence            99999999987664               456667777765   8999999999999999999999999999875321  


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                         .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......      . .......+...      +.
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~-~~~~i~~~~~~------~p  235 (329)
T PTZ00263        172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------R-IYEKILAGRLK------FP  235 (329)
T ss_pred             ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------H-HHHHHhcCCcC------CC
Confidence               12357899999999999999999999999999999999999999753311      1 11111122110      11


Q ss_pred             CCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccccccccc
Q 039516          244 GSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKN  289 (345)
Q Consensus       244 ~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~  289 (345)
                      ..++    .. .+++..||+.||.+||+..  ...+.+++.+..+..
T Consensus       236 ~~~~----~~~~~li~~~L~~dP~~R~~~~--~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        236 NWFD----GRARDLVKGLLQTDHTKRLGTL--KGGVADVKNHPYFHG  276 (329)
T ss_pred             CCCC----HHHHHHHHHHhhcCHHHcCCCC--CCCHHHHhcCCccCC
Confidence            1122    22 5899999999999999831  223455555544443

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.3e-41  Score=318.98  Aligned_cols=239  Identities=21%  Similarity=0.257  Sum_probs=181.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCee
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~   95 (345)
                      .+|.+.++||+|+||.||++..      .++..||||+++... ....+.+.+|+.+++.+ +||||++++++|...+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4689999999999999999863      346789999996542 33456788999999999 899999999999999999


Q ss_pred             EEEEecCCCCChHHHHH---------------------------------------------------------------
Q 039516           96 LLVYEFMPNKSLDSSFS---------------------------------------------------------------  112 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------------------------------------------------------  112 (345)
                      ++||||+++|+|.+++.                                                               
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999976652                                                               


Q ss_pred             ---------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          113 ---------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       113 ---------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                                                 +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                                       455566666654   89999999999999999999999999998764322221


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ......++..|+|||++.+..++.++|||||||++|||++ |..||.......      ........+...  ..+    
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~--~~~----  339 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYRM--LSP----  339 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCccC--CCC----
Confidence            2222345667999999999999999999999999999998 888887543211      111222222110  001    


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                      ...+   .. .+++..||+.||++|||+.++...|.+
T Consensus       340 ~~~~---~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         340 ECAP---SEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            0111   23 599999999999999998877766664

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=340.00  Aligned_cols=242  Identities=23%  Similarity=0.257  Sum_probs=197.4

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCC--C----cEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPN--E----QEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~--~----~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      ...-+..+.||+|.||.||.|...+  |    ..||||.++.. +.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3445677789999999999997643  3    35999999765 455677899999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHH----------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccc
Q 039516           96 LLVYEFMPNKSLDSSFS----------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFG  153 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~----------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg  153 (345)
                      +|++|||.+|+|..+++                      ++++++.||+..|   .|||||.++|+|++....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999887                      7888999999985   9999999999999999999999999


Q ss_pred             cceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcC
Q 039516          154 MARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEG  232 (345)
Q Consensus       154 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (345)
                      +|+.+.............-...|||||.+..+.++.|+|||||||++||++| |..||...+..+.      ......+|
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~~gg  921 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVLEGG  921 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHHhCC
Confidence            9996544333333332234568999999999999999999999999999999 8999987654332      11223344


Q ss_pred             CccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          233 KDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       233 ~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ++.          .+..+... .+++..||+.+|++||++..++.++..+..
T Consensus       922 RL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  922 RLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             ccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence            221          34455566 799999999999999999888877777665

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-42  Score=319.01  Aligned_cols=220  Identities=22%  Similarity=0.329  Sum_probs=177.2

Q ss_pred             EEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCChHH
Q 039516           30 IQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS  109 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  109 (345)
                      +-||+|+.|.||.|++. ++.||||+++.-       -..+++-|++|+|+||+.|.|+|....-+|||||||+.|.|.+
T Consensus       130 eWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~  201 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE  201 (904)
T ss_pred             hhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence            34899999999999996 799999998522       2357888999999999999999999999999999999999988


Q ss_pred             HHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecC
Q 039516          110 SFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTY  174 (345)
Q Consensus       110 ~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~  174 (345)
                      .|+               +|+.++.|||..   .|||||||.-||||+.+..+||+|||-++.....   ...-.+.||.
T Consensus       202 VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTV  275 (904)
T KOG4721|consen  202 VLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTV  275 (904)
T ss_pred             HHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhH
Confidence            776               778888888876   6999999999999999999999999999876432   2234589999


Q ss_pred             CccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-
Q 039516          175 GYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-  253 (345)
Q Consensus       175 ~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-  253 (345)
                      .|||||++...+.+.|+|||||||+||||+||..||...+.....         |.-|      ...|.--.+..+..- 
T Consensus       276 aWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---------wGVG------sNsL~LpvPstcP~Gf  340 (904)
T KOG4721|consen  276 AWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---------WGVG------SNSLHLPVPSTCPDGF  340 (904)
T ss_pred             hhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---------Eecc------CCcccccCcccCchHH
Confidence            999999999999999999999999999999999999876543321         1111      111111122222222 


Q ss_pred             HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          254 LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       254 ~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      .-++.+||+..|..|||+.++...|
T Consensus       341 klL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  341 KLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             HHHHHHHHhcCCCCCccHHHHHHHH
Confidence            4788899999999999987654433

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.6e-40  Score=303.87  Aligned_cols=243  Identities=21%  Similarity=0.294  Sum_probs=181.1

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-----------------CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-----------------NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKL   85 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-----------------~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~   85 (345)
                      .+|.+.++||+|+||.||++...                 ++..||+|.+.... ......|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            46888999999999999999743                 23479999997643 3345679999999999999999999


Q ss_pred             EEEEEECCeeEEEEecCCCCChHHHH----------------------------------HhHHHHHHHHHhcCCCceEE
Q 039516           86 LGCSIHGEERLLVYEFMPNKSLDSSF----------------------------------SGTFKDLLCLHKYSRLRVIH  131 (345)
Q Consensus        86 ~~~~~~~~~~~lv~e~~~~gsL~~~l----------------------------------~~~~~~l~~lh~~~~~~ivH  131 (345)
                      ++++.+.+..++||||+++++|.+++                                  .+++.+|.|||..   ||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            99999999999999999999997654                                  2556677777765   8999


Q ss_pred             eccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh--CCCC
Q 039516          132 RDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC--GKKN  209 (345)
Q Consensus       132 rdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t--g~~p  209 (345)
                      |||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986533222122223345788999999988899999999999999999987  5567


Q ss_pred             CCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          210 NKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      |......   .....+...+..... ... ..    .++..... .+++.+||+.||.+|||+.+++..|
T Consensus       242 ~~~~~~~---~~~~~~~~~~~~~~~-~~~-~~----~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l  302 (304)
T cd05096         242 YGELTDE---QVIENAGEFFRDQGR-QVY-LF----RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL  302 (304)
T ss_pred             CCcCCHH---HHHHHHHHHhhhccc-ccc-cc----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence            7654322   122222222211111 000 00    11112233 6999999999999999987765554

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.7e-41  Score=317.24  Aligned_cols=242  Identities=21%  Similarity=0.265  Sum_probs=182.9

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEE   94 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~   94 (345)
                      ..+|++.+.||+|+||.||++..      .++..||+|.++... ......+.+|+.+++.+ +|+||++++++|.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            34689999999999999999863      234689999997542 33355788999999999 89999999999999999


Q ss_pred             eEEEEecCCCCChHHHHH--------------------------------------------------------------
Q 039516           95 RLLVYEFMPNKSLDSSFS--------------------------------------------------------------  112 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~--------------------------------------------------------------  112 (345)
                      .++||||+++|+|.+++.                                                              
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999977642                                                              


Q ss_pred             -----------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccc
Q 039516          113 -----------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNR  169 (345)
Q Consensus       113 -----------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  169 (345)
                                             +++.+|.|||..   ||+||||||+|||+++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                                   355666677754   899999999999999999999999999986543222111222


Q ss_pred             eeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       170 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||........      .......+.     .+......+ 
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~-----~~~~~~~~~-  341 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGY-----QMSRPDFAP-  341 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHccc-----CccCCCCCC-
Confidence            335667999999998899999999999999999997 9999976432111      111111110     000111112 


Q ss_pred             hHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          249 NEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       249 ~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                         .. .+++..||+.||.+|||+.++++.|.+++
T Consensus       342 ---~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         342 ---PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence               23 58999999999999999988877777653

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-40  Score=307.95  Aligned_cols=232  Identities=20%  Similarity=0.232  Sum_probs=181.1

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccC----Cc-cCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCe
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWT----SG-QGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEE   94 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~   94 (345)
                      ....|.+.+.||+|+||.|+.|. ..+|+.||+|.++..    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            34569999999999999999995 457899999977653    11 23445678999999998 9999999999999999


Q ss_pred             eEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC-CCEEEEccccceee
Q 039516           95 RLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ-LNTKISDFGMARIF  158 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgl~~~~  158 (345)
                      +++||||+.||+|.+++.               +++.++.|+|..   ||+||||||+|||++.+ +.+||+|||++...
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence            999999999999977654               556666666665   89999999999999999 99999999999876


Q ss_pred             cCCCCCCcccceeecCCccccchhccCC-cC-cccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTMSGT-VS-IKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                      .  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.....   ..+.   .. ...+... 
T Consensus       172 ~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---~~l~---~k-i~~~~~~-  241 (370)
T KOG0583|consen  172 P--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---PNLY---RK-IRKGEFK-  241 (370)
T ss_pred             C--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH---HHHH---HH-HhcCCcc-
Confidence            3  2233455679999999999999877 85 779999999999999999999986321   1111   11 1122110 


Q ss_pred             cccccCCCCC-ChhHHHHHHHHhhccCCCCCcCCCCCcc
Q 039516          237 LIDLTLDGSC-PPNEDAFLLVSCVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       237 ~~d~~l~~~~-~~~~~~~~~l~~~Cl~~~P~~RPs~~~~  274 (345)
                           +.... +++.   ..++.+|+..||..|+|+.++
T Consensus       242 -----~p~~~~S~~~---~~Li~~mL~~~P~~R~t~~~i  272 (370)
T KOG0583|consen  242 -----IPSYLLSPEA---RSLIEKMLVPDPSTRITLLEI  272 (370)
T ss_pred             -----CCCCcCCHHH---HHHHHHHcCCCcccCCCHHHH
Confidence                 11111 2222   599999999999999995443

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.5e-40  Score=305.58  Aligned_cols=185  Identities=22%  Similarity=0.309  Sum_probs=160.1

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ..+|++.+.||+|+||.||++.. .+|..||+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            46799999999999999999965 468899999987552 2345679999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |+++++|.+++.               +++.++.|||..+  +|+||||||+||+++.++.+||+|||++......    
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----  157 (331)
T cd06649          84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----  157 (331)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc----
Confidence            999999988764               5677788888654  6999999999999999999999999998765322    


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            123356899999999999989999999999999999999999999654

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.2e-40  Score=284.59  Aligned_cols=242  Identities=21%  Similarity=0.239  Sum_probs=182.7

Q ss_pred             CeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCcc--CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSGQ--GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .|...+.||+|.||+||+|. ..+|+.||||+++.....  .....++|++.|+.++|+||+.++++|...+.+.||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            47778889999999999995 467999999999766322  244678999999999999999999999999999999999


Q ss_pred             CCCCChHHHH----------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSF----------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l----------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ++. +|+..+                ..++++++|+|..   .|+||||||.|+|++.+|.+||+|||+++.++......
T Consensus        83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence            974 454443                3667777777776   69999999999999999999999999999987554443


Q ss_pred             cccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC-----------
Q 039516          166 NTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGK-----------  233 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------  233 (345)
                      ...  .-|..|.|||++-| ..|+..+|+||.||++.||+-|.+-|.+.++-++...+-.+........           
T Consensus       159 ~~~--V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  159 THQ--VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             ccc--eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence            332  67889999998876 5689999999999999999999988877665554444332221111111           


Q ss_pred             -ccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          234 -DLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       234 -~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                       +.....+.+..-++......++++...+..||.+|.|..
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~  276 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITAS  276 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHH
Confidence             111111222222222222227999999999999999954

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-41  Score=317.36  Aligned_cols=249  Identities=19%  Similarity=0.210  Sum_probs=194.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~l   97 (345)
                      -.+|..++.||+|.||.|+++.. .+++.+|||.+++.   .....+....|.+++... +||.+++++.+|+..+++|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            35799999999999999999965 56899999999877   456678888999998877 59999999999999999999


Q ss_pred             EEecCCCCChHHHHH-----------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516           98 VYEFMPNKSLDSSFS-----------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus        98 v~e~~~~gsL~~~l~-----------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      ||||+.||++..+.+           ..+..+.+|..+|.+|||+||||.+|||+|.+|.+||+|||+++.-..  ....
T Consensus       447 vmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~--~g~~  524 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG--QGDR  524 (694)
T ss_pred             EEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC--CCCc
Confidence            999999999643322           334444444444555999999999999999999999999999986432  3345


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC-
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS-  245 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-  245 (345)
                      +.+++||+.|+|||++.+..|+..+|+|||||+||||+.|+.||.+.+++                   +++|..+.++ 
T Consensus       525 TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------------------e~FdsI~~d~~  585 (694)
T KOG0694|consen  525 TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------------------EVFDSIVNDEV  585 (694)
T ss_pred             cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-------------------HHHHHHhcCCC
Confidence            67799999999999999999999999999999999999999999875533                   2333333322 


Q ss_pred             -CChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccccccccceeeEE
Q 039516          246 -CPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLL  294 (345)
Q Consensus       246 -~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~~~  294 (345)
                       +|...... +.++.+.|..+|+.|-.+.+  .--..+..+..+....|..
T Consensus       586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~~e--~d~~~i~~hpFFr~i~w~~  634 (694)
T KOG0694|consen  586 RYPRFLSKEAIAIMRRLLRKNPEKRLGSGE--RDAEDIKKHPFFRSIDWDD  634 (694)
T ss_pred             CCCCcccHHHHHHHHHHhccCcccccCCCC--CCchhhhhCCccccCCHHH
Confidence             33333333 79999999999999998642  1122333444444444433

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.8e-40  Score=298.19  Aligned_cols=229  Identities=21%  Similarity=0.222  Sum_probs=175.8

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      |...+.||+|+||.||++.. .+|+.||+|.+....   ......+.+|+.++++++|+||+++++++.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            78889999999999999965 579999999986432   22344678999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          102 MPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       102 ~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      +++|+|...+.                 +++.++.|||.   .+|+||||||+|||++.++.+||+|||++.......  
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence            99999976542                 44555666665   489999999999999999999999999998753221  


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                       ......||..|+|||++.+..++.++|||||||++|+|++|+.||.........   ............      ....
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~------~~~~  226 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQE------EYSE  226 (285)
T ss_pred             -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhcccc------cCCc
Confidence             122346899999999999999999999999999999999999999865432111   111111111100      0111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .++.+.   ..++..||+.||.+|||..
T Consensus       227 ~~s~~~---~~li~~~l~~~P~~R~~~~  251 (285)
T cd05631         227 KFSEDA---KSICRMLLTKNPKERLGCR  251 (285)
T ss_pred             cCCHHH---HHHHHHHhhcCHHHhcCCC
Confidence            122211   5899999999999999843

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=320.58  Aligned_cols=238  Identities=24%  Similarity=0.272  Sum_probs=185.9

Q ss_pred             eeEEEeeccCCeEEEEEEcCC--C---cEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           27 HMYIQQEQTRDRVILVGKFPN--E---QEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        27 ~~~~~lG~G~~g~vy~~~~~~--~---~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ...++||+|+||.||+|.+..  +   ..||||..+..   ......+|.+|+++|++++|||||++||++....++++|
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv  239 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV  239 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence            344789999999999997642  2   23899999753   456677899999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           99 YEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        99 ~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      ||+|+||+|.++|+                +++.||.|||..   ++|||||.++|+|++.++.+||+|||+++.-....
T Consensus       240 mEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~  316 (474)
T KOG0194|consen  240 MELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV  316 (474)
T ss_pred             EEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence            99999999999987                677888888887   69999999999999999999999999987642111


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      .  ......-...|+|||.+..+.|+.++|||||||++||+++ |..||.+....      ........++-..      
T Consensus       317 ~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~~~r~------  382 (474)
T KOG0194|consen  317 M--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKNGYRM------  382 (474)
T ss_pred             e--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhcCccC------
Confidence            1  1101134578999999999999999999999999999999 88899875422      1111111111111      


Q ss_pred             CCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          242 LDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       242 l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                         ..+...... ..++..||..+|++||||.++...+..+...
T Consensus       383 ---~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  383 ---PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             ---CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence               112222233 4777799999999999999999888887663

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.5e-40  Score=305.84  Aligned_cols=242  Identities=21%  Similarity=0.296  Sum_probs=183.8

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-CCc----EEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-NEQ----EVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~~~----~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ..+|++.+.||+|+||.||+|.+. ++.    .||+|.++... ......+.+|+.+++.++||||++++|+|... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            356999999999999999999753 333    48999986542 34456789999999999999999999998764 578


Q ss_pred             EEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           97 LVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      +++||+++|+|.+++.                +++.+|.|||..   +|+||||||+||+++.++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence            9999999999987654                566677777764   899999999999999999999999999987643


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      ...........++..|+|||++.+..++.++||||||+++|||++ |+.||......+      . ......+...  ..
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~------~-~~~~~~~~~~--~~  232 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------I-SSILEKGERL--PQ  232 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------H-HHHHhCCCCC--CC
Confidence            322222222234678999999999999999999999999999998 999987543111      1 1111111100  00


Q ss_pred             ccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          240 LTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       240 ~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                         ...++    .. ..++..||+.+|++|||+.++...+..+...
T Consensus       233 ---~~~~~----~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         233 ---PPICT----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             ---CCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence               01122    23 5899999999999999999888887776653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.7e-40  Score=298.12  Aligned_cols=238  Identities=21%  Similarity=0.248  Sum_probs=181.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC----CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP----NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~----~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      .+|++.+.||+|+||.||+|.+.    .+..||+|.++... ......|.+|+..+++++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            45889999999999999999652    36799999997653 23345789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           99 YEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        99 ~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      |||+++|+|.+++.                +++.++.+||..   |++||||||+||+++.++.++++|||.+.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            99999999987764                556677777765   79999999999999999999999999876532211


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      . .......++..|+|||++.+..++.++|||||||++||+++ |..||......+   .   .. ....+..     ..
T Consensus       162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~---~~-~~~~~~~-----~~  228 (266)
T cd05064         162 I-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---V---IK-AVEDGFR-----LP  228 (266)
T ss_pred             h-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H---HH-HHHCCCC-----CC
Confidence            1 11112245678999999999999999999999999999775 999997643211   1   11 1112111     01


Q ss_pred             CCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          242 LDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       242 l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                      ....++    .. .+++..||+.+|.+|||+.++...|.++
T Consensus       229 ~~~~~~----~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         229 APRNCP----NLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCC----HHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            111122    23 5899999999999999988777666543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6e-42  Score=328.14  Aligned_cols=258  Identities=20%  Similarity=0.283  Sum_probs=206.5

Q ss_pred             CcceeecccccccccCC-----CCeeeEEEeeccCCeEEEEEEcCC----CcEEEEEEeccC-CccCHHHHHHHHHHHHh
Q 039516            7 TGCQTWSEGAKFVENSS-----LDWHMYIQQEQTRDRVILVGKFPN----EQEVAIKRLAWT-SGQGRVEFQNEAKLIAK   76 (345)
Q Consensus         7 ~~~~s~~~~~~~~~~~~-----~~~~~~~~lG~G~~g~vy~~~~~~----~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~   76 (345)
                      ...++|++-.++...|.     ..-.+.+.||.|.||.|++|.++-    ...||||.++.. ....+.+|+.|+.||.+
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ  686 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ  686 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence            34567777666665553     334577789999999999998742    368999999877 44567789999999999


Q ss_pred             cCCCCeeeEEEEEEECCeeEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCee
Q 039516           77 LQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNIL  140 (345)
Q Consensus        77 l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nil  140 (345)
                      ++||||+++-|+........||+|||++|+|+.+|+                +++.++.||..+   ++|||||.++|||
T Consensus       687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNIL  763 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNIL  763 (996)
T ss_pred             CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhee
Confidence            999999999999999999999999999999999987                566677777766   8999999999999


Q ss_pred             eCCCCCEEEEccccceeecCCCCCCcccceee--cCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q 039516          141 LDDQLNTKISDFGMARIFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTER  217 (345)
Q Consensus       141 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~  217 (345)
                      ++.+..+|++|||+++.+.++... ..++.-|  ..+|.|||.+...+++.+||||||||++||.++ |.+||-.+...+
T Consensus       764 VNsnLvCKVsDFGLSRvledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd  842 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD  842 (996)
T ss_pred             eccceEEEeccccceeecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence            999999999999999977544322 1222222  468999999999999999999999999999887 999998776544


Q ss_pred             cccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          218 PLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      ..+-++                ...+--.+.++... .++++.|||+|-++||.+.+++..|.+|+..
T Consensus       843 VIkaIe----------------~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  843 VIKAIE----------------QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             HHHHHH----------------hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            322221                11111133455555 7999999999999999999999999998874

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-40  Score=285.43  Aligned_cols=221  Identities=22%  Similarity=0.209  Sum_probs=178.9

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc---cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG---QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      -.+|++++.||.|+||.|...+. .+|..+|+|++++..-   ...+...+|..+|+.+.||+++++++.|.+.+.+|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            46799999999999999999854 5789999999976632   2345678999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |||.+||.|..+++               +++.+++|||.+   +|++|||||+|||+|.+|.+||+|||+++....   
T Consensus       123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---  196 (355)
T ss_pred             EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence            99999999999887               445566666666   799999999999999999999999999998732   


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                        .+.+.+|||.|+|||++...+|+.++|+|||||++|||+.|.+||...++..       .....-.++..        
T Consensus       197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~KI~~~~v~--------  259 (355)
T KOG0616|consen  197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYEKILEGKVK--------  259 (355)
T ss_pred             --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHHHHHhCccc--------
Confidence              3556899999999999999999999999999999999999999998654311       11111122211        


Q ss_pred             CCCChhHHHH-HHHHhhccCCCCCcC
Q 039516          244 GSCPPNEDAF-LLVSCVCKSKQQIDV  268 (345)
Q Consensus       244 ~~~~~~~~~~-~~l~~~Cl~~~P~~R  268 (345)
                        +|..-... ..++..-|+.|-..|
T Consensus       260 --fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  260 --FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --CCcccCHHHHHHHHHHHhhhhHhh
Confidence              22222222 477777788888888

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.8e-40  Score=319.72  Aligned_cols=238  Identities=18%  Similarity=0.168  Sum_probs=181.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CC-CcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PN-EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~-~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ...|.+.+.||+|+||.||++.. .+ ++.||+|.+..........+.+|+.+++.++|||||++++++...+..|+|||
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence            44599999999999999999964 34 67899998765554455678889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          101 FMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       101 ~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |+++|+|.+++.                .+.+.+.+|+++|+.+|+||||||+|||++.++.+||+|||+++........
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            999999977543                1123334444455558999999999999999999999999999876433222


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....      ........ .+...    + ...
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~-~~~~~----~-~~~  293 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVL-YGKYD----P-FPC  293 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCCC----C-CCc
Confidence            223446799999999999999999999999999999999999999975331      11111111 11111    0 001


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCcch
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPMLFP  275 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~  275 (345)
                      .++.+.   .+++..||+.||+.|||+.++.
T Consensus       294 ~~s~~~---~~li~~~L~~dP~~Rps~~~~l  321 (478)
T PTZ00267        294 PVSSGM---KALLDPLLSKNPALRPTTQQLL  321 (478)
T ss_pred             cCCHHH---HHHHHHHhccChhhCcCHHHHH
Confidence            122111   5899999999999999976543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-40  Score=300.41  Aligned_cols=237  Identities=19%  Similarity=0.175  Sum_probs=181.4

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +|++.+.||+|+||.||++... +|+.||+|.+....   ......+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            5889999999999999999764 68999999986432   2234568899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |+++++|.+++.               +++.+|.+||..   ||+||||||+|||++.++.+||+|||++......    
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----  154 (291)
T cd05612          82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----  154 (291)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence            999999987764               455666666654   8999999999999999999999999998765321    


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                       .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ....... .+..      .+...
T Consensus       155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~-~~~~------~~~~~  220 (291)
T cd05612         155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKIL-AGKL------EFPRH  220 (291)
T ss_pred             -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hCCc------CCCcc
Confidence             22356899999999999988999999999999999999999999764321      1111111 1111      11111


Q ss_pred             CChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccc
Q 039516          246 CPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYL  287 (345)
Q Consensus       246 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~  287 (345)
                      .++..   .+++..||+.||.+||+.+  ...+.+++.+..+
T Consensus       221 ~~~~~---~~li~~~l~~dp~~R~~~~--~~~~~~~l~h~~~  257 (291)
T cd05612         221 LDLYA---KDLIKKLLVVDRTRRLGNM--KNGADDVKNHRWF  257 (291)
T ss_pred             CCHHH---HHHHHHHcCCCHHHccCCc--cCCHHHHhcCccc
Confidence            22111   5899999999999999732  1233444444333

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-40  Score=305.80  Aligned_cols=229  Identities=21%  Similarity=0.246  Sum_probs=177.9

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +|++.+.||+|+||.||++... +++.||||+++...   ......+.+|++++..++||||+++++++...+..|+|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            6899999999999999999764 68999999996542   2345578899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |+++++|.+++.               +++.+|.+||..   ||+||||||+||+++.++.+||+|||++.....     
T Consensus        82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----  153 (333)
T cd05600          82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----  153 (333)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence            999999988764               455666666654   899999999999999999999999999976532     


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC--
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD--  243 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--  243 (345)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..||......+..      .........  +..+...  
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~~~~--~~~~~~~~~  225 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW------ENLKYWKET--LQRPVYDDP  225 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH------HHHHhcccc--ccCCCCCcc
Confidence            223457899999999999999999999999999999999999999764321111      111100000  0011100  


Q ss_pred             -CCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          244 -GSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       244 -~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                       ...+.+.   .+++..||+.+|.+|||+.
T Consensus       226 ~~~~s~~~---~~li~~~l~~~~~rr~s~~  252 (333)
T cd05600         226 RFNLSDEA---WDLITKLINDPSRRFGSLE  252 (333)
T ss_pred             ccccCHHH---HHHHHHHhhChhhhcCCHH
Confidence             0112211   5889999999999999943

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.5e-40  Score=294.62  Aligned_cols=268  Identities=21%  Similarity=0.221  Sum_probs=192.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-----eeE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE-----ERL   96 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----~~~   96 (345)
                      ...|...+.+|.|+||+||+|... +++.||||++-....    .--+|+++|+.++|||||++.-+|....     ...
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            455888899999999999999764 579999999854432    2237999999999999999999887532     235


Q ss_pred             EEEecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC-CCEEEEccccce
Q 039516           97 LVYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ-LNTKISDFGMAR  156 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgl~~  156 (345)
                      +||||||. +|.+.++                   +++++|.|||..   ||+||||||.|+|+|.+ |.+||||||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            89999987 5555444                   788899999984   89999999999999976 889999999999


Q ss_pred             eecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc-
Q 039516          157 IFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKD-  234 (345)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  234 (345)
                      .+..+...   .....|.+|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.+..++...+--+........+ 
T Consensus       175 ~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  175 VLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             eeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            88654433   34678999999998886 57999999999999999999999999886544433332221111100000 


Q ss_pred             ------cccccccC---------CCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceeeEEecCCC
Q 039516          235 ------LELIDLTL---------DGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLLMLPPK  299 (345)
Q Consensus       235 ------~~~~d~~l---------~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~~~~l~~~  299 (345)
                            .+...+.+         ....+++.   ++++.++++.+|.+|.|+.             .++.+++...|...
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~---~dll~~~L~Y~P~~R~~~~-------------~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDA---LDLLSKLLQYSPSKRLSAL-------------EALAHPFFDELRDP  315 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHH---HHHHHHHhccChhhcCCHH-------------HHhcchhhHHhhCc
Confidence                  11111111         12223333   5999999999999999953             22333555556665


Q ss_pred             CCCCCCCCCCCccceeccc
Q 039516          300 NQKLPKTSQKFVPYIKNRL  318 (345)
Q Consensus       300 ~~~~p~~~~p~~~~~~~~~  318 (345)
                      +..+|.-. +.|+.++-..
T Consensus       316 ~~~l~~g~-~lp~lf~f~~  333 (364)
T KOG0658|consen  316 NTKLPNGR-PLPPLFNFKR  333 (364)
T ss_pred             CccCcCCC-cCCCccCchH
Confidence            55555533 5556665443

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.9e-40  Score=299.18  Aligned_cols=238  Identities=21%  Similarity=0.304  Sum_probs=182.2

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCC------CcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPN------EQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~------~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      .+|++.+.||+|+||.||+|....      ...||+|.++... ......|.+|+.++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            368888999999999999997532      2679999986543 234567899999999999999999999999889999


Q ss_pred             EEEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC
Q 039516           97 LVYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL  145 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~  145 (345)
                      ++|||+++++|.+++.                               +++.++.+||.   .+++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence            9999999999977652                               34455556655   4899999999999999999


Q ss_pred             CEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHH
Q 039516          146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGI  224 (345)
Q Consensus       146 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~  224 (345)
                      .+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||......+       
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------  234 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------  234 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999999999986533222222333456788999999988899999999999999999998 999997644211       


Q ss_pred             HHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          225 AWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       225 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                      ....+..+....     ....++    .. .+++..||+.||++|||+.++...|.+
T Consensus       235 ~~~~i~~~~~~~-----~~~~~~----~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 VIEMIRSRQLLP-----CPEDCP----ARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcCCcCC-----CcccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            111121221111     111122    33 599999999999999998877766654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.7e-40  Score=312.38  Aligned_cols=243  Identities=19%  Similarity=0.229  Sum_probs=184.4

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEE   94 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~   94 (345)
                      ...|.+.++||+|+||.||+|...      .+..||||+++... ....+.+.+|+++++++. ||||++++++|.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            456788899999999999999742      23579999997543 233567999999999996 9999999999999999


Q ss_pred             eEEEEecCCCCChHHHHH--------------------------------------------------------------
Q 039516           95 RLLVYEFMPNKSLDSSFS--------------------------------------------------------------  112 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~--------------------------------------------------------------  112 (345)
                      .|+|||||++|+|.+++.                                                              
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999976543                                                              


Q ss_pred             -------------------------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC
Q 039516          113 -------------------------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD  143 (345)
Q Consensus       113 -------------------------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~  143 (345)
                                                                       +++.++.|||..   +|+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence                                                             345666677654   8999999999999999


Q ss_pred             CCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHH
Q 039516          144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLV  222 (345)
Q Consensus       144 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~  222 (345)
                      ++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......     
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-----  347 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-----  347 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-----
Confidence            99999999999987543222222233456788999999998899999999999999999997 999987543211     


Q ss_pred             HHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          223 GIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       223 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                       ........+..     ..    .+...... .+++..||+.||++|||+.+++..|..+++
T Consensus       348 -~~~~~~~~~~~-----~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         348 -TFYNKIKSGYR-----MA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             -HHHHHHhcCCC-----CC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence             01111111110     00    11111223 689999999999999999888877776654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=291.67  Aligned_cols=236  Identities=23%  Similarity=0.300  Sum_probs=182.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      .+|.+.+.||+|++|.||+|...+++.||+|.++... .....+.+|+.++++++||||+++++++...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            4588999999999999999988778899999997543 346679999999999999999999999999999999999999


Q ss_pred             CCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          104 NKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       104 ~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      +++|.+++.                 +++.++.+||..   |++|+||||+||+++.++.+||+|||+++......... 
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~-  160 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA-  160 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc-
Confidence            999988764                 355566666654   89999999999999999999999999998764221111 


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      ......+..|+|||++.+..++.++||||||+++|||++ |+.||.......       .......+...         .
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~---------~  224 (261)
T cd05068         161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGYRM---------P  224 (261)
T ss_pred             cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC---------C
Confidence            111223457999999998899999999999999999999 999997543211       11111111100         0


Q ss_pred             CChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          246 CPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       246 ~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                      .+...... .+++.+|++.+|.+||++.++...|++
T Consensus       225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            11112233 689999999999999998877666654

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.5e-39  Score=291.87  Aligned_cols=236  Identities=24%  Similarity=0.331  Sum_probs=182.8

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      .+|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            5689999999999999999988888899999986543 345789999999999999999999999999999999999999


Q ss_pred             CCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          104 NKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       104 ~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      +++|.+++.                 +++.++.|||..   +++||||||+||+++.++.++|+|||++......... .
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~  160 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-A  160 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee-c
Confidence            999987753                 556667777765   7999999999999999999999999999876432211 1


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      .....++..|+|||++.+..++.++||||||+++|+|++ |..||.......   ..    .....+...    + ....
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~~----~-~~~~  228 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VM----SALQRGYRM----P-RMEN  228 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HH----HHHHcCCCC----C-CCCC
Confidence            122345678999999988889999999999999999998 999997543211   11    111111100    1 1111


Q ss_pred             CChhHHHHHHHHhhccCCCCCcCCCCCcchhhhh
Q 039516          246 CPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLM  279 (345)
Q Consensus       246 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~  279 (345)
                      ++.+.   .+++.+||+.+|++|||+.++...|.
T Consensus       229 ~~~~~---~~li~~~l~~~p~~Rp~~~~i~~~l~  259 (261)
T cd05072         229 CPDEL---YDIMKTCWKEKAEERPTFDYLQSVLD  259 (261)
T ss_pred             CCHHH---HHHHHHHccCCcccCcCHHHHHHHHh
Confidence            22211   58999999999999999876655544

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.4e-39  Score=295.85  Aligned_cols=238  Identities=24%  Similarity=0.311  Sum_probs=181.2

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-----CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-----PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-----~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      .+|++.++||+|+||.||+|..     .++..||+|.+... .......+.+|+.++++++||||+++++++..+...|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4588899999999999999974     24689999999743 23344678999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH--------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC
Q 039516           98 VYEFMPNKSLDSSFS--------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL  145 (345)
Q Consensus        98 v~e~~~~gsL~~~l~--------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~  145 (345)
                      ||||+++++|.+++.                                +++.++.|||..   +++||||||+||+++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            999999999987752                                456667777765   799999999999999999


Q ss_pred             CEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHH
Q 039516          146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGI  224 (345)
Q Consensus       146 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~  224 (345)
                      .+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......   ...  
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~--  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVI--  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH--
Confidence            999999999986543222222223345678999999988889999999999999999998 98898654311   111  


Q ss_pred             HHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhh
Q 039516          225 AWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLM  279 (345)
Q Consensus       225 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~  279 (345)
                        ..........     ....+++..   .+++..||+.||.+||++.++...+.
T Consensus       237 --~~~~~~~~~~-----~~~~~~~~~---~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         237 --EMVRKRQLLP-----CSEDCPPRM---YSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             --HHHHcCCcCC-----CCCCCCHHH---HHHHHHHcccCcccCcCHHHHHHHhh
Confidence              1111111110     111122211   58999999999999999876655544

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.4e-40  Score=297.50  Aligned_cols=233  Identities=29%  Similarity=0.370  Sum_probs=173.8

Q ss_pred             eeEEEeeccCCeEEEEEEcC-----CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           27 HMYIQQEQTRDRVILVGKFP-----NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        27 ~~~~~lG~G~~g~vy~~~~~-----~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ++.+.||.|.||.||+|.+.     .+..|+||.++... ....+.|.+|++.+++++||||++++|++...+..++|||
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            45678999999999999875     36789999996543 3347789999999999999999999999998888999999


Q ss_pred             cCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          101 FMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       101 ~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |+++|+|.+++.                 +++.+|.|||..   +++|++|+++||+++.++.+||+|||++........
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            999999988765                 677888888876   799999999999999999999999999987632222


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                      ........+...|+|||.+.+..++.++||||||+++||+++ |+.||.....      ....... ..+....      
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~-~~~~~~~------  225 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKL-KQGQRLP------  225 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHH-HTTEETT------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc-cccccce------
Confidence            222223456778999999999999999999999999999999 7888865421      1222222 2222211      


Q ss_pred             CCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          243 DGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       243 ~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                         .+...... ..++..||+.||.+|||+.++..+|
T Consensus       226 ---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 ---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               11111223 5899999999999999987665543

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.7e-39  Score=290.96  Aligned_cols=233  Identities=24%  Similarity=0.261  Sum_probs=179.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+... ......|.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            358888999999999999999888889999998643 2345679999999999999999999999999999999999999


Q ss_pred             CCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          104 NKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       104 ~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      +|+|.+++.                +++.+|.+||..   |++||||||+||+++.++.+||+|||.+......... ..
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~  158 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee-cc
Confidence            999987764                455666777755   7999999999999999999999999998765322111 11


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      ....++..|+|||++.+..++.++||||||+++|+|++ |+.||......      ....... .+.  ....+..   .
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~------~~~~~i~-~~~--~~~~~~~---~  226 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY------EVVEMIS-RGF--RLYRPKL---A  226 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHH-CCC--CCCCCCC---C
Confidence            12234568999999988889999999999999999999 89998754321      1111111 111  0111111   1


Q ss_pred             ChhHHHH-HHHHhhccCCCCCcCCCCCcchhh
Q 039516          247 PPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCL  277 (345)
Q Consensus       247 ~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~  277 (345)
                          ... ..++.+||+.+|.+|||+.++...
T Consensus       227 ----~~~~~~li~~c~~~~p~~Rps~~~l~~~  254 (256)
T cd05114         227 ----SMTVYEVMYSCWHEKPEGRPTFAELLRA  254 (256)
T ss_pred             ----CHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                123 699999999999999998765443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.9e-39  Score=301.01  Aligned_cols=185  Identities=22%  Similarity=0.302  Sum_probs=158.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ..+|++.++||+|+||.||++... ++..||+|.+... .......+.+|++++++++|+||++++++|..++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            457999999999999999999754 6889999998754 22345678999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |+++++|.+++.               +++.++.|||..+  +++||||||+|||++.++.+||+|||++......    
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----  157 (333)
T cd06650          84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----  157 (333)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----
Confidence            999999988764               5567777888643  6999999999999999999999999998754321    


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            122346899999999999888999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.7e-39  Score=300.38  Aligned_cols=248  Identities=18%  Similarity=0.179  Sum_probs=185.9

Q ss_pred             cccCCCCeeeEEEeeccCCeEEEEEEcC-C-CcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Q 039516           19 VENSSLDWHMYIQQEQTRDRVILVGKFP-N-EQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE   93 (345)
Q Consensus        19 ~~~~~~~~~~~~~lG~G~~g~vy~~~~~-~-~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~   93 (345)
                      ......+|.+.+.||+|+||.||+|... + +..||+|.+...   .......+.+|+.+++.++||||+++++++.+.+
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            3334567999999999999999999653 2 368999998643   2234567889999999999999999999999999


Q ss_pred             eeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           94 ERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      ..++||||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||++...
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            9999999999999987764               455566666654   8999999999999999999999999999865


Q ss_pred             cCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                      ..     ......||+.|+|||++.+..++.++|||||||++|||++|..||......       ........+...   
T Consensus       182 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~~~---  246 (340)
T PTZ00426        182 DT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGIIY---  246 (340)
T ss_pred             CC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCCC---
Confidence            32     123357899999999999888999999999999999999999999764321       111111111110   


Q ss_pred             cccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceee
Q 039516          239 DLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHF  292 (345)
Q Consensus       239 d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~  292 (345)
                         +....+...   .+++..|++.||.+|++-  ....+.+++.+..+.+.++
T Consensus       247 ---~p~~~~~~~---~~li~~~l~~dp~~R~~~--~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        247 ---FPKFLDNNC---KHLMKKLLSHDLTKRYGN--LKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             ---CCCCCCHHH---HHHHHHHcccCHHHcCCC--CCCCHHHHHcCCCcCCCCH
Confidence               111122221   589999999999999741  1112445555554444333

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-41  Score=306.78  Aligned_cols=241  Identities=21%  Similarity=0.203  Sum_probs=181.1

Q ss_pred             CCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCccCHHH--HHHHHHHHHhcC-CCCeeeEEEEEEECC-eeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSGQGRVE--FQNEAKLIAKLQ-YTNLVKLLGCSIHGE-ERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~~~~~~--~~~E~~~l~~l~-H~niv~~~~~~~~~~-~~~l   97 (345)
                      ...|.++++||.|+||.||+|+ ..+|..||||+++..-.. .++  -++|+..|++|+ |||||+++.++.+.+ .+++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            4458889999999999999996 457899999999755222 333  468999999998 999999999998887 9999


Q ss_pred             EEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           98 VYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        98 v~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      |||||+. +|.++++                +++++|.++|..   |+.|||+||+|||+.....+||+|||+|+.+...
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccC
Confidence            9999965 5554444                777777777776   8999999999999999889999999999987433


Q ss_pred             CCCCcccceeecCCccccchhc-cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-----HHHhcC---
Q 039516          162 ESGANTNRIVGTYGYMSLEYTM-SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAW-----QLWNEG---  232 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~---  232 (345)
                         ...+....|..|.|||++. .+-|+.+.|+||+||+++|+.+-++-|.+.++.++..-+-.+.     ..|..|   
T Consensus       164 ---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  164 ---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence               3345568899999999766 5788999999999999999999999998876655443332221     111111   


Q ss_pred             ------CccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          233 ------KDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       233 ------~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                            ++-......+..-. +..... ++++..|++.||++|||+.
T Consensus       241 a~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~  286 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTAS  286 (538)
T ss_pred             HHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHH
Confidence                  00011111111111 122333 6999999999999999954

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.2e-39  Score=303.33  Aligned_cols=187  Identities=19%  Similarity=0.244  Sum_probs=155.3

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      .|.+++.||+|+||.||++.. .+++.||||++...   .......+.+|++++++++||||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588999999999999999964 56899999999653   22335578899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC--
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES--  163 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--  163 (345)
                      |+++|+|.+++.               +++.+|.|||.   .||+||||||+|||++.++.+||+|||+++.+.....  
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            999999987764               44556666665   4899999999999999999999999999754311000  


Q ss_pred             -------------------------------------------CCcccceeecCCccccchhccCCcCcccchhhHHHHH
Q 039516          164 -------------------------------------------GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV  200 (345)
Q Consensus       164 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il  200 (345)
                                                                 ........||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                       0001235799999999999988899999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 039516          201 LKIVCGKKNNKSYH  214 (345)
Q Consensus       201 ~el~tg~~p~~~~~  214 (345)
                      |||++|+.||....
T Consensus       239 ~elltG~~Pf~~~~  252 (381)
T cd05626         239 FEMLVGQPPFLAPT  252 (381)
T ss_pred             HHHHhCCCCCcCCC
Confidence            99999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5e-39  Score=304.24  Aligned_cols=188  Identities=19%  Similarity=0.238  Sum_probs=156.1

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ++|++.++||+|+||.||++.. .+++.||||.+...   .......+.+|++++++++|+||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3699999999999999999965 46899999998643   2234566889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC--
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE--  162 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--  162 (345)
                      ||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||++..+....  
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            9999999988764               455666666654   89999999999999999999999999975321000  


Q ss_pred             ---------------------------------------CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHH
Q 039516          163 ---------------------------------------SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI  203 (345)
Q Consensus       163 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el  203 (345)
                                                             .........||+.|+|||++.+..++.++|||||||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                   00011234799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCC
Q 039516          204 VCGKKNNKSYH  214 (345)
Q Consensus       204 ~tg~~p~~~~~  214 (345)
                      ++|+.||....
T Consensus       238 l~G~~Pf~~~~  248 (376)
T cd05598         238 LVGQPPFLADT  248 (376)
T ss_pred             hhCCCCCCCCC
Confidence            99999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.3e-39  Score=293.88  Aligned_cols=186  Identities=22%  Similarity=0.286  Sum_probs=156.5

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +|++.+.||+|+||.||++... +++.||+|++...  .......+.+|+.++++++||||+++++++..++..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            5899999999999999999764 6889999998654  233456788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          102 MPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       102 ~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      ++++++..+..               +++.+|.+||..   +++||||||+||+++.++.+||+|||++........ ..
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~  157 (287)
T cd07848          82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-AN  157 (287)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-cc
Confidence            99887654322               556667777755   899999999999999999999999999987543221 12


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~  205 (287)
T cd07848         158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES  205 (287)
T ss_pred             ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence            233578999999999998889999999999999999999999997644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8e-39  Score=297.57  Aligned_cols=243  Identities=19%  Similarity=0.185  Sum_probs=180.1

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|+||.||++.. .+++.||+|.++..   .......+..|..++.++ +||||+++++++...+..|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            589999999999965 46899999999754   223345688999999998 7999999999999999999999999999


Q ss_pred             ChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          106 SLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       106 sL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      +|.+++.               +++.+|.|||..   |++||||||+||+++.++.+||+|||+++.....  .......
T Consensus        82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~  156 (329)
T cd05588          82 DLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTF  156 (329)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC--CCccccc
Confidence            9977653               556667777755   8999999999999999999999999998753211  1222345


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCC--cccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER--PLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      .||+.|+|||++.+..++.++|+|||||++|+|++|+.||.......  ......+..........      .+....+.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~~~~~  230 (329)
T cd05588         157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPRSLSV  230 (329)
T ss_pred             cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCCCCCH
Confidence            78999999999999999999999999999999999999997433221  11222233333222211      11111222


Q ss_pred             hHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccccccc
Q 039516          249 NEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLK  288 (345)
Q Consensus       249 ~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~  288 (345)
                      +.   .+++..||+.||.+|||... ...+.+++.+..+.
T Consensus       231 ~~---~~li~~~L~~dP~~R~~~~~-~~~~~~i~~hp~~~  266 (329)
T cd05588         231 KA---SSVLKGFLNKDPKERLGCHP-QTGFRDIKSHPFFR  266 (329)
T ss_pred             HH---HHHHHHHhccCHHHcCCCCC-CCCHHHHhcCCCCC
Confidence            21   58999999999999999432 12344555554443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=300.65  Aligned_cols=188  Identities=21%  Similarity=0.254  Sum_probs=157.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|++.+.||+|+||.||++.. .+|+.||||++...   .......+.+|+.++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            3689999999999999999965 46899999999643   2234456889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||++.........
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            9999999987764               556667777765   8999999999999999999999999998764321100


Q ss_pred             C------------------------------------cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCC
Q 039516          165 A------------------------------------NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK  208 (345)
Q Consensus       165 ~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~  208 (345)
                      .                                    ......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence            0                                    0112468999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 039516          209 NNKSYH  214 (345)
Q Consensus       209 p~~~~~  214 (345)
                      ||....
T Consensus       238 Pf~~~~  243 (364)
T cd05599         238 PFCSDN  243 (364)
T ss_pred             CCCCCC
Confidence            997643

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.3e-39  Score=298.58  Aligned_cols=219  Identities=20%  Similarity=0.218  Sum_probs=170.4

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCC
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS  106 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gs  106 (345)
                      .||+|+||.||++.. .+|+.||+|+++..   .......+.+|+.++++++||||+++++++...+..|+||||+++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            589999999999965 57899999999653   22334568899999999999999999999999999999999999999


Q ss_pred             hHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCccccee
Q 039516          107 LDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV  171 (345)
Q Consensus       107 L~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~  171 (345)
                      |.+++.               +++.+|.|||..   ||+||||||+||+++.++.+||+|||+++.....  ........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~  156 (323)
T cd05571          82 LFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFC  156 (323)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCccccee
Confidence            977654               455666666654   8999999999999999999999999998753221  12233467


Q ss_pred             ecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHH
Q 039516          172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNED  251 (345)
Q Consensus       172 gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  251 (345)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .   . .....+.      ..+....+.+. 
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~---~-~~~~~~~------~~~p~~~~~~~-  222 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---L---F-ELILMEE------IRFPRTLSPEA-  222 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---H---H-HHHHcCC------CCCCCCCCHHH-
Confidence            9999999999999999999999999999999999999997533111   1   1 1111111      11111122222 


Q ss_pred             HHHHHHhhccCCCCCcCCC
Q 039516          252 AFLLVSCVCKSKQQIDVQC  270 (345)
Q Consensus       252 ~~~~l~~~Cl~~~P~~RPs  270 (345)
                        .+++..||+.||++||+
T Consensus       223 --~~li~~~L~~dP~~R~~  239 (323)
T cd05571         223 --KSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             --HHHHHHHccCCHHHcCC
Confidence              58999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.2e-39  Score=293.81  Aligned_cols=185  Identities=22%  Similarity=0.318  Sum_probs=153.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .+|.+.++||.|+||.||+|.. .+++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            4589999999999999999965 468999999996543 23345678999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      +++ +|.+++.                +++.+|.+||..   ||+||||||+|||++.++.+||+|||+++......  .
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~  158 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--K  158 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--c
Confidence            985 7766543                556667777754   89999999999999999999999999997653222  1


Q ss_pred             cccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||....
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~  208 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST  208 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2233468999999998865 568999999999999999999999997644

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.6e-39  Score=302.70  Aligned_cols=233  Identities=20%  Similarity=0.252  Sum_probs=175.1

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ..+|+..++||+|+||.||++.. .+|+.||||.+.... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            35688889999999999999975 468999999996543 2335678999999999999999999999999999999999


Q ss_pred             cCCCCChHH-----------HHHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccc
Q 039516          101 FMPNKSLDS-----------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNR  169 (345)
Q Consensus       101 ~~~~gsL~~-----------~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  169 (345)
                      |+++++|..           ++.+++.+|.|||..   ||+||||||+|||++.++.+||+|||++.......  .....
T Consensus       153 ~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~  227 (353)
T PLN00034        153 FMDGGSLEGTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCNS  227 (353)
T ss_pred             cCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc--ccccc
Confidence            999998853           233677778888865   89999999999999999999999999998753221  11233


Q ss_pred             eeecCCccccchhcc-----CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          170 IVGTYGYMSLEYTMS-----GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       170 ~~gt~~y~aPE~~~~-----~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ..||..|+|||++..     ...+.++|||||||++|||++|+.||.......   ............      .+....
T Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~------~~~~~~  298 (353)
T PLN00034        228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICMSQ------PPEAPA  298 (353)
T ss_pred             cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhccC------CCCCCC
Confidence            578999999998743     234568999999999999999999997432211   111111110000      011111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .++.+.   .+++..||+.||++|||+.
T Consensus       299 ~~~~~l---~~li~~~l~~~P~~Rpt~~  323 (353)
T PLN00034        299 TASREF---RHFISCCLQREPAKRWSAM  323 (353)
T ss_pred             ccCHHH---HHHHHHHccCChhhCcCHH
Confidence            122111   5899999999999999954

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-39  Score=291.01  Aligned_cols=242  Identities=20%  Similarity=0.167  Sum_probs=181.5

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      .|++.+.||+|+||.||++.. .+++.||+|.+....   ......+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            378899999999999999975 468999999986432   2233467889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          101 FMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       101 ~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |+++++|.+++.                 +++.++.|||..   +++||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999976653                 456667777765   89999999999999999999999999998753221 


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                        ......|+..|+|||++.+..++.++||||+|+++|||++|+.||.........   ...........      ..  
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~------~~--  223 (285)
T cd05605         157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQ------EE--  223 (285)
T ss_pred             --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhcc------cc--
Confidence              122347899999999999888999999999999999999999999864322111   11111111110      00  


Q ss_pred             CCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccccccc
Q 039516          244 GSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYL  287 (345)
Q Consensus       244 ~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~  287 (345)
                        ++...... .+++..||+.||++||++.+  ..+.+++.+..+
T Consensus       224 --~~~~~~~~~~~li~~~l~~~P~~R~~~~~--~~~~~l~~~~~~  264 (285)
T cd05605         224 --YSEKFSEAARSICRQLLTKDPGFRLGCRG--EGAEEVKAHPFF  264 (285)
T ss_pred             --cCcccCHHHHHHHHHHccCCHHHhcCCCC--CCHHHHhcCcCc
Confidence              11111122 58999999999999997532  133444444333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-39  Score=295.52  Aligned_cols=220  Identities=20%  Similarity=0.185  Sum_probs=171.5

Q ss_pred             eeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCCh
Q 039516           32 QEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL  107 (345)
Q Consensus        32 lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL  107 (345)
                      ||+|+||.||++.. .+++.||+|.++..   .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999975 46889999998643   233456788999999999999999999999999999999999999999


Q ss_pred             HHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceee
Q 039516          108 DSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG  172 (345)
Q Consensus       108 ~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g  172 (345)
                      .+++.               +++.+|.|||..   +|+||||||+||+++.++.+||+|||+++......  .......|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g  155 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCG  155 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccC
Confidence            87764               455666666654   89999999999999999999999999987542211  12234578


Q ss_pred             cCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHH
Q 039516          173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDA  252 (345)
Q Consensus       173 t~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  252 (345)
                      |+.|+|||++.+..++.++|||||||++|+|++|+.||.....      ......... +..      .+....+++.  
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~-~~~------~~~~~~~~~~--  220 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQ-EPL------RFPDGFDRDA--  220 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHc-CCC------CCCCcCCHHH--
Confidence            9999999999999999999999999999999999999975431      111122111 110      1111122211  


Q ss_pred             HHHHHhhccCCCCCcCCCCC
Q 039516          253 FLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       253 ~~~l~~~Cl~~~P~~RPs~~  272 (345)
                       .+++..||+.||.+||+..
T Consensus       221 -~~li~~~L~~dp~~R~~~~  239 (312)
T cd05585         221 -KDLLIGLLSRDPTRRLGYN  239 (312)
T ss_pred             -HHHHHHHcCCCHHHcCCCC
Confidence             5899999999999999854

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-39  Score=290.87  Aligned_cols=239  Identities=22%  Similarity=0.293  Sum_probs=182.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCC----CcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPN----EQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~----~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      .+|.+.+.||+|+||.||+|.+..    ...||+|.++... ......|.+|+.++++++||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            458889999999999999997642    4689999987543 33456789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           99 YEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        99 ~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      |||+++++|.+++.                +++.++.+||..   +|+|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            99999999988763                455666677764   89999999999999999999999999998764211


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      .........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .    ......+...    + 
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~----~~~~~~~~~~----~-  228 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---V----IKAVEDGYRL----P-  228 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---H----HHHHHcCCCC----C-
Confidence            1111112234678999999998899999999999999999998 999986543111   1    1111111100    0 


Q ss_pred             CCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          242 LDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       242 l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                          .+...... .+++.+||+.+|++|||+.++.+.|.++
T Consensus       229 ----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         229 ----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                01111223 6999999999999999988877776654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.3e-39  Score=295.35  Aligned_cols=242  Identities=22%  Similarity=0.325  Sum_probs=186.2

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      .+|.+.+.||+|+||.||++..      .++..||+|.+..........+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            4688889999999999999964      2356799999976655556789999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH----------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEE
Q 039516           98 VYEFMPNKSLDSSFS----------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKI  149 (345)
Q Consensus        98 v~e~~~~gsL~~~l~----------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl  149 (345)
                      ||||+++++|.+++.                            +++.+|.+||..   |++||||||+||+++.++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence            999999999977653                            456667777754   8999999999999999999999


Q ss_pred             EccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHH
Q 039516          150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQL  228 (345)
Q Consensus       150 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~  228 (345)
                      +|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.......       ....
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence            99999876533222111222345778999999998889999999999999999998 899986543211       1111


Q ss_pred             HhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          229 WNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       229 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ...+....     ....++.+-   .+++.+||+.||.+|||+.++...|.++..
T Consensus       235 i~~~~~~~-----~~~~~~~~l---~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         235 ITQGRVLQ-----RPRTCPKEV---YDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHcCCcCC-----CCCCCCHHH---HHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            11222111     111122211   699999999999999999888777776654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.1e-39  Score=299.40  Aligned_cols=219  Identities=18%  Similarity=0.191  Sum_probs=170.1

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCC
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS  106 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gs  106 (345)
                      .||+|+||.||++.. .+|+.||+|++...   .......+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            589999999999964 57899999999654   23345678899999999999999999999999999999999999999


Q ss_pred             hHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCccccee
Q 039516          107 LDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV  171 (345)
Q Consensus       107 L~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~  171 (345)
                      |...+.               +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++.....  ........
T Consensus        82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~  156 (328)
T cd05593          82 LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFC  156 (328)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccccccc
Confidence            976653               456666666654   8999999999999999999999999998753221  11223357


Q ss_pred             ecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHH
Q 039516          172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNED  251 (345)
Q Consensus       172 gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  251 (345)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ....... .+      +..+....+.+. 
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~-~~------~~~~p~~~~~~~-  222 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELIL-ME------DIKFPRTLSADA-  222 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhc-cC------CccCCCCCCHHH-
Confidence            899999999999989999999999999999999999999754321      1111111 11      111111122222 


Q ss_pred             HHHHHHhhccCCCCCcCCC
Q 039516          252 AFLLVSCVCKSKQQIDVQC  270 (345)
Q Consensus       252 ~~~~l~~~Cl~~~P~~RPs  270 (345)
                        .+++..||+.||.+||+
T Consensus       223 --~~li~~~L~~dP~~R~~  239 (328)
T cd05593         223 --KSLLSGLLIKDPNKRLG  239 (328)
T ss_pred             --HHHHHHHcCCCHHHcCC
Confidence              58999999999999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3e-39  Score=315.39  Aligned_cols=239  Identities=19%  Similarity=0.213  Sum_probs=181.8

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-----
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE-----   93 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----   93 (345)
                      ...+|.+.+.||+|+||+||++.. .+|+.||||.+...  .......+.+|+.++..++|+||++++..+....     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            346899999999999999999964 57999999998654  3344567889999999999999999988765432     


Q ss_pred             ---eeEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccc
Q 039516           94 ---ERLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGM  154 (345)
Q Consensus        94 ---~~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl  154 (345)
                         ..++||||+++|+|.+++.                .+.+.+.+|+++|+.+|+||||||+|||++.++.+||+|||+
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl  189 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF  189 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence               3689999999999987764                123445555566666999999999999999999999999999


Q ss_pred             ceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 039516          155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKD  234 (345)
Q Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (345)
                      ++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ........ .+..
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~-~~~~  262 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTL-AGRY  262 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHh-cCCC
Confidence            9876433223333446799999999999999999999999999999999999999975321      11111111 1111


Q ss_pred             cccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcch
Q 039516          235 LELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFP  275 (345)
Q Consensus       235 ~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~  275 (345)
                      .    + +...++++.   ..++..||+.||.+|||+.++.
T Consensus       263 ~----~-~~~~~~~~l---~~li~~~L~~dP~~RPs~~ell  295 (496)
T PTZ00283        263 D----P-LPPSISPEM---QEIVTALLSSDPKRRPSSSKLL  295 (496)
T ss_pred             C----C-CCCCCCHHH---HHHHHHHcccChhhCcCHHHHH
Confidence            1    1 111122221   5899999999999999976543

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=314.74  Aligned_cols=242  Identities=19%  Similarity=0.153  Sum_probs=189.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCC-cEEEEEEeccCCccCHHHHHHHHHHHHhcC-CCCeeeEEEE-EEE------CC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNE-QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGC-SIH------GE   93 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~-~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~-~~~------~~   93 (345)
                      .....+.+.|.+|||+.||.+....+ ..||+|++-..+......+.+|+++|++|+ |+|||.+++. ...      .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            34577889999999999999987665 999999987667778889999999999997 9999999993 221      12


Q ss_pred             eeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516           94 ERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                      +.+|.||||.||+|-++|.                 ++++++.+||++. .+|||||||.+||||+.+|..||||||.+.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            5689999999999988876                 6788999999974 579999999999999999999999999987


Q ss_pred             eecCCCCCCcc-------cceeecCCccccchhc---cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 039516          157 IFGVNESGANT-------NRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAW  226 (345)
Q Consensus       157 ~~~~~~~~~~~-------~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~  226 (345)
                      ...........       -....|+.|+|||++.   +.+.+.|+|||+|||+||-|+....||+...            
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------  262 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------  262 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------------
Confidence            64322211000       0124689999999765   6788999999999999999999999998532            


Q ss_pred             HHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          227 QLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       227 ~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                             ...|++....--..+..... ..|+..||+.||.+||++-+|...+.+|...
T Consensus       263 -------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  263 -------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             -------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                   12223222221011233344 7999999999999999987777777776654

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=297.07  Aligned_cols=231  Identities=21%  Similarity=0.220  Sum_probs=178.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--------------ccCHHHHHHHHHHHHhcCCCCeeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--------------GQGRVEFQNEAKLIAKLQYTNLVKLLGC   88 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--------------~~~~~~~~~E~~~l~~l~H~niv~~~~~   88 (345)
                      +.|++.+.||+|.||.|-+|.. .+++.||||++.+..              ....+...+|+.+|++++|||||+++.+
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            4589999999999999999964 579999999995431              1124578899999999999999999999


Q ss_pred             EEE--CCeeEEEEecCCCCCh---------------HHHHHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEc
Q 039516           89 SIH--GEERLLVYEFMPNKSL---------------DSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISD  151 (345)
Q Consensus        89 ~~~--~~~~~lv~e~~~~gsL---------------~~~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~D  151 (345)
                      ..+  .+.+|||+|||..|.+               ..++.++..+|+|||+.   |||||||||+|+|++.+|.+||+|
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeec
Confidence            865  4578999999988755               34566889999999997   899999999999999999999999


Q ss_pred             cccceeecCCC---CCCcccceeecCCccccchhccCC----cCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHH
Q 039516          152 FGMARIFGVNE---SGANTNRIVGTYGYMSLEYTMSGT----VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGI  224 (345)
Q Consensus       152 fgl~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~  224 (345)
                      ||.+.......   .........|||.|+|||.+.++.    .+.+.||||+||+||.|+.|+.||.+....+       
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-------  326 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-------  326 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-------
Confidence            99998763321   112223468999999999988743    2578999999999999999999997643111       


Q ss_pred             HHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          225 AWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       225 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                         +     ...++...|.-...++..+. .+++++.|.+||..|-+..
T Consensus       327 ---l-----~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~  367 (576)
T KOG0585|consen  327 ---L-----FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLP  367 (576)
T ss_pred             ---H-----HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehh
Confidence               0     11222222221122233445 7899999999999999943

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.2e-39  Score=291.60  Aligned_cols=252  Identities=20%  Similarity=0.247  Sum_probs=181.1

Q ss_pred             eeeEEEeeccCCeEEEEEEc-----CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CeeEE
Q 039516           26 WHMYIQQEQTRDRVILVGKF-----PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--EERLL   97 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-----~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~l   97 (345)
                      |.+.+.||+|+||+||++..     .+++.||+|.++... ......|.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37888999999999987542     357899999997543 23456788999999999999999999988753  45799


Q ss_pred             EEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           98 VYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        98 v~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      +|||+++++|.+++.              +++.++.+||..   +++||||||+||+++.++.++|+|||++........
T Consensus        86 v~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          86 IMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             EecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence            999999999987754              566677777765   899999999999999999999999999986543221


Q ss_pred             CCc-ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          164 GAN-TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       164 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                      ... .....++..|+|||.+.+..++.++||||||+++|+|++|..|+....... .................+.++...
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLERGM  241 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhcCC
Confidence            111 112245667999999988889999999999999999999999986543210 001110000000111111111111


Q ss_pred             CCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          243 DGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       243 ~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                      ....+...... .+++..||+.+|++|||+.++...|.++
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            11112222233 6999999999999999998877776654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.1e-39  Score=293.81  Aligned_cols=236  Identities=23%  Similarity=0.331  Sum_probs=179.9

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCCcc-CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTSGQ-GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      .+|.+.+.||+|+||.||+|...      ++..||+|.++..... ....|.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            35778888999999999999753      3578999999765433 4568999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHH-----------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCE
Q 039516           97 LVYEFMPNKSLDSSFS-----------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNT  147 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~-----------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~  147 (345)
                      +||||+++++|.+++.                             +++.++.+||..   |++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            9999999999987653                             445566666654   89999999999999999999


Q ss_pred             EEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 039516          148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAW  226 (345)
Q Consensus       148 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~  226 (345)
                      ||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..||......+   ...   
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~---  235 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIE---  235 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH---
Confidence            9999999976532222111223345778999999999999999999999999999998 999987543211   111   


Q ss_pred             HHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          227 QLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       227 ~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                       ....+.....     ...++    .. .+++..||+.||++|||+.++...+
T Consensus       236 -~~~~~~~~~~-----~~~~~----~~~~~li~~~l~~~p~~Rp~~~eil~~l  278 (280)
T cd05049         236 -CITQGRLLQR-----PRTCP----SEVYDIMLGCWKRDPQQRINIKDIHERL  278 (280)
T ss_pred             -HHHcCCcCCC-----CCCCC----HHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence             1112211111     01122    23 5999999999999999976554433

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.8e-38  Score=294.59  Aligned_cols=227  Identities=18%  Similarity=0.208  Sum_probs=173.0

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHH---HhcCCCCeeeEEEEEEECCeeEEE
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLI---AKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l---~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      |.+.+.||+|+||.||++.. .+|+.||||.++..   .....+.+..|++++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            67889999999999999965 46899999999653   223345667776665   466899999999999999999999


Q ss_pred             EecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516           99 YEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus        99 ~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||+++++|...+.              +++.+|.|||..   ||+||||||+||+++.++.+||+|||+++.....  .
T Consensus        81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--G  155 (324)
T ss_pred             EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC--C
Confidence            99999999976554              455666666654   8999999999999999999999999998753221  1


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      .......|++.|+|||++.+..++.++|||||||++|+|++|+.||......+      ...... .+..      ....
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~i~-~~~~------~~p~  222 (324)
T cd05589         156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDSIV-NDEV------RYPR  222 (324)
T ss_pred             CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hCCC------CCCC
Confidence            22234678999999999999899999999999999999999999997543211      111111 1111      1111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      ..+.+.   .+++.+||+.||.+||++.+
T Consensus       223 ~~~~~~---~~li~~~L~~dP~~R~~~~~  248 (324)
T cd05589         223 FLSREA---ISIMRRLLRRNPERRLGSGE  248 (324)
T ss_pred             CCCHHH---HHHHHHHhhcCHhHcCCCCC
Confidence            122222   58999999999999998654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.6e-39  Score=291.66  Aligned_cols=237  Identities=23%  Similarity=0.314  Sum_probs=185.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ..+|.+.++||.|+||.||+|...++..||+|.+..........+.+|+.+++.++|+||+++++++......++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            45688899999999999999988779999999997766555678999999999999999999999999999999999999


Q ss_pred             CCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          103 PNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       103 ~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ++++|.+++.                 +++.++.+||.   .|++|+||||+||++++++.+||+|||++......... 
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-  160 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-  160 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence            9999988764                 45566667765   48999999999999999999999999999765332111 


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                       .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+   ....   .. .+..     ..   
T Consensus       161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~---~~-~~~~-----~~---  224 (261)
T cd05148         161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQ---IT-AGYR-----MP---  224 (261)
T ss_pred             -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH---HH-hCCc-----CC---
Confidence             112345678999999988889999999999999999998 899997543211   1111   11 1100     00   


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                       .+...... .+++.+||+.||.+|||+.++...|..
T Consensus       225 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         225 -CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             -CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence             11122233 699999999999999998776666543

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2e-39  Score=302.58  Aligned_cols=241  Identities=21%  Similarity=0.260  Sum_probs=182.7

Q ss_pred             CeeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEE-CCee
Q 039516           25 DWHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIH-GEER   95 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~-~~~~   95 (345)
                      .|++.+.||+|+||.||+|..      .+++.||+|+++... ......+..|+.++.++ +|+||++++++|.. +..+
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~   87 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL   87 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence            588899999999999999853      235789999986442 22345678899999999 89999999998865 4568


Q ss_pred             EEEEecCCCCChHHHHH---------------------------------------------------------------
Q 039516           96 LLVYEFMPNKSLDSSFS---------------------------------------------------------------  112 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------------------------------------------------------  112 (345)
                      +++|||+++++|.+++.                                                               
T Consensus        88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (337)
T cd05054          88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK  167 (337)
T ss_pred             EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence            89999999999987652                                                               


Q ss_pred             -------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCcccc
Q 039516          113 -------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSL  179 (345)
Q Consensus       113 -------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aP  179 (345)
                                   +++.+|.|||..   ||+||||||+||+++.++.++|+|||++..+.............++..|+||
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence                         466777777755   8999999999999999999999999999875432222222334567789999


Q ss_pred             chhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHH
Q 039516          180 EYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVS  257 (345)
Q Consensus       180 E~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~  257 (345)
                      |++.+..++.++|||||||++|||++ |..||......+.      .......+...     .    .+...... .+++
T Consensus       245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~-----~----~~~~~~~~~~~l~  309 (337)
T cd05054         245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRM-----R----APEYATPEIYSIM  309 (337)
T ss_pred             HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCC-----C----CCccCCHHHHHHH
Confidence            99999999999999999999999998 9999975432211      11111111110     0    11111223 6999


Q ss_pred             hhccCCCCCcCCCCCcchhhhhcccc
Q 039516          258 CVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       258 ~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .+||+.+|++|||+.++...|..+++
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999888888777664

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.1e-39  Score=288.55  Aligned_cols=237  Identities=23%  Similarity=0.287  Sum_probs=182.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      .+|.+.+.||+|+||.||++... +++.||+|.+... ......+.+|++++++++|+||+++++++...+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45888899999999999999754 5889999998644 334567999999999999999999999999999999999999


Q ss_pred             CCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          103 PNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       103 ~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ++++|.+++.                 +++.++.+||..   |++||||||+||+++.++.+||+|||++......... 
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence            9999987764                 456667777754   8999999999999999999999999998865432111 


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ......++..|+|||++.+..++.++||||||+++|||++ |..||......      +. +.....+     ..+....
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~-~~~~~~~-----~~~~~~~  228 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QV-YELLEKG-----YRMERPE  228 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HH-HHHHHCC-----CCCCCCC
Confidence            1111234567999999998999999999999999999998 89998654311      11 1111111     0111111


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                      .++    .. .+++.+||+.+|++|||+.++.+.|..+
T Consensus       229 ~~~----~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         229 GCP----PKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCC----HHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            122    23 5899999999999999988777666543

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.2e-38  Score=289.98  Aligned_cols=186  Identities=23%  Similarity=0.305  Sum_probs=152.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ..+|++.++||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            457999999999999999999764 68999999997543 2334567899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          101 FMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       101 ~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |+++ +|.+++.                +++.+|.|||..   +|+||||||+|||++.++.+||+|||++.......  
T Consensus        84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            9964 5544432                556666677754   89999999999999999999999999987643221  


Q ss_pred             CcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  208 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK  208 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            12233468999999998865 457889999999999999999999998643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-40  Score=308.88  Aligned_cols=259  Identities=22%  Similarity=0.216  Sum_probs=205.4

Q ss_pred             CcceeecccccccccCCCCeeeEEEeeccCCeEEEEEEcCC-CcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeE
Q 039516            7 TGCQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKFPN-EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKL   85 (345)
Q Consensus         7 ~~~~s~~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~~~-~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~   85 (345)
                      .+.|+++....--+--..+...-.+||.|.||.||.|.|.. ...||||.++.. ....++|+.|+.+|+.++|||+|++
T Consensus       250 ptvygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqL  328 (1157)
T KOG4278|consen  250 PTVYGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL  328 (1157)
T ss_pred             CceeeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHH
Confidence            34555555543322233445566789999999999998863 678999999654 3567899999999999999999999


Q ss_pred             EEEEEECCeeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEE
Q 039516           86 LGCSIHGEERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTK  148 (345)
Q Consensus        86 ~~~~~~~~~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~k  148 (345)
                      +|+|.....+|||+|||..|+|.++++                 +|..+++||...   ++|||||.++|+|+.++..+|
T Consensus       329 LGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVK  405 (1157)
T KOG4278|consen  329 LGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVK  405 (1157)
T ss_pred             hhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEE
Confidence            999999999999999999999999987                 677788888887   599999999999999999999


Q ss_pred             EEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHH
Q 039516          149 ISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQ  227 (345)
Q Consensus       149 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~  227 (345)
                      ++|||+++.+..+... ......-.+.|.|||-+..+.++.|+|||+|||+|||+.| |-.||.+.+..       .+..
T Consensus       406 vADFGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-------qVY~  477 (1157)
T KOG4278|consen  406 VADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYG  477 (1157)
T ss_pred             eeccchhhhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-------HHHH
Confidence            9999999987543222 1222233567999999999999999999999999999998 77888775422       2222


Q ss_pred             HHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccccc
Q 039516          228 LWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLY  286 (345)
Q Consensus       228 ~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~  286 (345)
                      ++.         ...+.+.+..+... .++++.||+.+|++||++.++.+.++.|.....
T Consensus       478 LLE---------kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS  528 (1157)
T KOG4278|consen  478 LLE---------KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS  528 (1157)
T ss_pred             HHh---------ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence            222         22222344555566 799999999999999999999999998887544

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.7e-39  Score=293.74  Aligned_cols=241  Identities=23%  Similarity=0.298  Sum_probs=186.8

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      .+|.+...||+|+||.||++..      .++..|++|.+........+.+.+|+.++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            4688889999999999999964      2356799999876655556789999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC
Q 039516           98 VYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN  146 (345)
Q Consensus        98 v~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~  146 (345)
                      ||||+++++|.+++.                               +++.++.+||..   |++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            999999999988752                               455566667654   8999999999999999999


Q ss_pred             EEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHH
Q 039516          147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIA  225 (345)
Q Consensus       147 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~  225 (345)
                      ++|+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.||......+       .
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~  234 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V  234 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence            99999999976533222112223456788999999998899999999999999999999 999987543211       1


Q ss_pred             HHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          226 WQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       226 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ......+.....     ...++    .. .+++.+||+.+|++|||+.++...|.++..
T Consensus       235 ~~~~~~~~~~~~-----~~~~~----~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         235 IECITQGRVLER-----PRVCP----KEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHhCCCCCCC-----CccCC----HHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            112222222111     11122    23 599999999999999999888877777643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.1e-38  Score=294.50  Aligned_cols=243  Identities=19%  Similarity=0.194  Sum_probs=182.1

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|+||.||++.. .+++.||+|++...   .......+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            599999999999975 46889999999754   223345688999999888 6999999999999999999999999999


Q ss_pred             ChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          106 SLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       106 sL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      +|..++.               +++.++.|||..   ||+||||||+|||++.++.+||+|||+++.....  .......
T Consensus        82 ~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~  156 (327)
T cd05617          82 DLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTSTF  156 (327)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCceecc
Confidence            9976553               556667777664   8999999999999999999999999998753211  1222345


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhH
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE  250 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  250 (345)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||.............+...........      +....+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~p~~~~~~~  230 (327)
T cd05617         157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR------IPRFLSVKA  230 (327)
T ss_pred             cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC------CCCCCCHHH
Confidence            78999999999999999999999999999999999999997654433333333444333222111      111122221


Q ss_pred             HHHHHHHhhccCCCCCcCCCCCcchhhhhccccccccc
Q 039516          251 DAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLK  288 (345)
Q Consensus       251 ~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~  288 (345)
                         .+++.+||+.||.+||++.. ......++.+..+.
T Consensus       231 ---~~li~~~L~~dP~~R~~~~~-~~~~~~i~~h~~f~  264 (327)
T cd05617         231 ---SHVLKGFLNKDPKERLGCQP-QTGFSDIKSHTFFR  264 (327)
T ss_pred             ---HHHHHHHhccCHHHcCCCCC-CCCHHHHHcCCCCC
Confidence               58999999999999999532 22334445544333

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.4e-39  Score=294.39  Aligned_cols=240  Identities=20%  Similarity=0.255  Sum_probs=183.0

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      +|.+...||+|+||.||+|...      ....||+|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4678888999999999999752      23579999886543 2335678999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH---------------------------------------hHHHHHHHHHhcCCCceEEeccCCCC
Q 039516           98 VYEFMPNKSLDSSFS---------------------------------------GTFKDLLCLHKYSRLRVIHRDLKASN  138 (345)
Q Consensus        98 v~e~~~~gsL~~~l~---------------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~N  138 (345)
                      +|||+++++|.+++.                                       +++.++.+||..   +++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            999999999987642                                       456666777754   89999999999


Q ss_pred             eeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q 039516          139 ILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTER  217 (345)
Q Consensus       139 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~  217 (345)
                      |++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999876532222111222345678999999988889999999999999999999 99998654321 


Q ss_pred             cccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          218 PLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                            ..+.....+.     .......++    .. .+++..||+.+|.+|||+.++...|.+++.
T Consensus       237 ------~~~~~~~~~~-----~~~~~~~~~----~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         237 ------RLFNLLKTGY-----RMERPENCS----EEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             ------HHHHHHhCCC-----CCCCCCCCC----HHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                  1122221111     011111122    23 699999999999999999888888877654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.1e-39  Score=291.84  Aligned_cols=236  Identities=23%  Similarity=0.329  Sum_probs=177.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      .+|++...||+|+||.||+|...      ++..||+|.++... ......|.+|+.+++.++||||+++++++..+...+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            45899999999999999998642      35689999986432 233456899999999999999999999999899999


Q ss_pred             EEEecCCCCChHHHHH-------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEc
Q 039516           97 LVYEFMPNKSLDSSFS-------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISD  151 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~-------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~D  151 (345)
                      +||||+++++|.+++.                         +++.++.|||..   +++|+||||+||+++.++.++|+|
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECC
Confidence            9999999999987653                         355566677654   899999999999999999999999


Q ss_pred             cccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHh
Q 039516          152 FGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWN  230 (345)
Q Consensus       152 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  230 (345)
                      ||++................++..|+|||++.+..++.++|||||||++|||++ |..||.......   ..    ....
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~----~~~~  235 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VL----RFVM  235 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHH
Confidence            999876533222111122345778999999998899999999999999999999 788886543211   11    1111


Q ss_pred             cCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          231 EGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       231 ~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      .+....     .....    ... .+++.+||+.+|++|||+.++...+
T Consensus       236 ~~~~~~-----~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l  275 (277)
T cd05062         236 EGGLLD-----KPDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSI  275 (277)
T ss_pred             cCCcCC-----CCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence            111111     11112    223 6899999999999999976554433

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-39  Score=289.26  Aligned_cols=237  Identities=19%  Similarity=0.255  Sum_probs=178.1

Q ss_pred             eeeEEEeeccCCeEEEEEEcC-C---CcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCe-----
Q 039516           26 WHMYIQQEQTRDRVILVGKFP-N---EQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE-----   94 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~-~---~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~-----   94 (345)
                      |++.+.||+|+||.||+|... +   +..||+|.++...  ......+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            456778999999999999753 2   4789999987542  2335678999999999999999999998876554     


Q ss_pred             -eEEEEecCCCCChHHHHH---------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcc
Q 039516           95 -RLLVYEFMPNKSLDSSFS---------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF  152 (345)
Q Consensus        95 -~~lv~e~~~~gsL~~~l~---------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Df  152 (345)
                       .+++|||+++++|..++.                     +++.+|.|||..   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             799999999999976652                     556677777765   8999999999999999999999999


Q ss_pred             ccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhc
Q 039516          153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNE  231 (345)
Q Consensus       153 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (345)
                      |+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......      ....... .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~~~~~~-~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EIYDYLR-H  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH-c
Confidence            99987643322222222334678999999988889999999999999999999 88888654321      1111111 1


Q ss_pred             CCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          232 GKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       232 ~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                      +....         .+...... .+++.+||+.||.+|||+.++...|..+
T Consensus       231 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11111         11112223 6999999999999999988777666654

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1e-38  Score=296.16  Aligned_cols=219  Identities=19%  Similarity=0.192  Sum_probs=170.1

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCC
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS  106 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gs  106 (345)
                      .||+|+||.||++.. .+|+.||+|.+...   .......+.+|+.++++++||||+++++++...+..|+||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            589999999999965 57899999999654   22345567889999999999999999999999999999999999999


Q ss_pred             hHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCccccee
Q 039516          107 LDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV  171 (345)
Q Consensus       107 L~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~  171 (345)
                      |..++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||++.......  .......
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~  156 (323)
T cd05595          82 LFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFC  156 (323)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccccc
Confidence            976654               456666666654   89999999999999999999999999987532211  1223357


Q ss_pred             ecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHH
Q 039516          172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNED  251 (345)
Q Consensus       172 gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  251 (345)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .   ..... .+..      .+...++++. 
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~---~~~~~-~~~~------~~p~~~~~~~-  222 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L---FELIL-MEEI------RFPRTLSPEA-  222 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHh-cCCC------CCCCCCCHHH-
Confidence            8999999999999999999999999999999999999997543211   1   11111 1110      1111223222 


Q ss_pred             HHHHHHhhccCCCCCcCCC
Q 039516          252 AFLLVSCVCKSKQQIDVQC  270 (345)
Q Consensus       252 ~~~~l~~~Cl~~~P~~RPs  270 (345)
                        .+++..||+.||.+||+
T Consensus       223 --~~li~~~L~~dP~~R~~  239 (323)
T cd05595         223 --KSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             --HHHHHHHccCCHHHhCC
Confidence              58999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.6e-39  Score=286.68  Aligned_cols=231  Identities=26%  Similarity=0.314  Sum_probs=177.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      .+|.+...||+|+||.||.+...++..||+|.+.... .....|.+|+.++++++||||+++++++...+..++||||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4688999999999999999988777789999986443 345679999999999999999999999998889999999999


Q ss_pred             CCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          104 NKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       104 ~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      +++|.+++.                +++.++.+||..   |++|+||||+||+++.++.+||+|||+++........ ..
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~  158 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SS  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee-ec
Confidence            999887764                455666667654   8999999999999999999999999998865332211 11


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      ....++..|+|||++.+..++.++||||||+++|+|++ |..||.......      ..... ..+....     .    
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~-~~~~~~~-----~----  222 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TVEKV-SQGLRLY-----R----  222 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHH-hcCCCCC-----C----
Confidence            11235667999999988889999999999999999999 999987543211      11111 1111100     0    


Q ss_pred             ChhHHHH-HHHHhhccCCCCCcCCCCCcch
Q 039516          247 PPNEDAF-LLVSCVCKSKQQIDVQCPMLFP  275 (345)
Q Consensus       247 ~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~  275 (345)
                      +...... .+++.+||+.+|.+|||+.++.
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll  252 (256)
T cd05113         223 PHLASEKVYAIMYSCWHEKAEERPTFQQLL  252 (256)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence            0011123 6999999999999999976544

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3e-38  Score=293.87  Aligned_cols=231  Identities=17%  Similarity=0.202  Sum_probs=175.4

Q ss_pred             CeeeEEEeeccCCeEEEEEEc----CCCcEEEEEEeccC----CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCee
Q 039516           25 DWHMYIQQEQTRDRVILVGKF----PNEQEVAIKRLAWT----SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~----~~~~~VaiK~~~~~----~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~   95 (345)
                      +|++.+.||+|+||.||++..    .+++.||+|.+...    .....+.+..|+.++..+ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            488999999999999999864    35899999998643    223345688899999999 599999999999999999


Q ss_pred             EEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           96 LLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      ++||||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            99999999999987653               456667777754   899999999999999999999999999976532


Q ss_pred             CCCCCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      ... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.........  ........ .      .+
T Consensus       158 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~-~------~~  227 (332)
T cd05614         158 EEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRIL-K------CD  227 (332)
T ss_pred             cCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHh-c------CC
Confidence            221 122335789999999998764 4788999999999999999999999754322211  11111111 1      11


Q ss_pred             ccCCCCCChhHHHHHHHHhhccCCCCCcCCCC
Q 039516          240 LTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       240 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                      +.+....++..   .+++.+||+.||++||+.
T Consensus       228 ~~~~~~~~~~~---~~li~~~l~~dp~~R~~~  256 (332)
T cd05614         228 PPFPSFIGPEA---QDLLHKLLRKDPKKRLGA  256 (332)
T ss_pred             CCCCCCCCHHH---HHHHHHHcCCCHHHcCCC
Confidence            11211222222   589999999999999974

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.9e-39  Score=294.82  Aligned_cols=236  Identities=23%  Similarity=0.313  Sum_probs=179.5

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCCc-cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      +|.+.++||+|+||.||+|...      ++..||+|.++.... .....+.+|+.++++++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4677788999999999999753      257899999975432 234568899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC
Q 039516           98 VYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN  146 (345)
Q Consensus        98 v~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~  146 (345)
                      ++||+++++|.+++.                               +++.+|.+||..   |++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            999999999877752                               556677777754   8999999999999999999


Q ss_pred             EEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHH
Q 039516          147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIA  225 (345)
Q Consensus       147 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~  225 (345)
                      +||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||......      .+.
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~  236 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DVI  236 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HHH
Confidence            99999999876533222222223345778999999988889999999999999999998 88888654321      111


Q ss_pred             HHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhh
Q 039516          226 WQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLM  279 (345)
Q Consensus       226 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~  279 (345)
                       .....+....         ++...... ..++..||+.+|.+|||+.++...|.
T Consensus       237 -~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         237 -EMIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             -HHHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence             1111221111         11122233 59999999999999999876665553

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-38  Score=297.28  Aligned_cols=186  Identities=22%  Similarity=0.279  Sum_probs=151.0

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CeeE
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG-----EERL   96 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~~~   96 (345)
                      .|++.++||+|+||.||+|.. .+|+.||||+++..  .......+.+|+.++++++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            388899999999999999964 57899999998643  223445788999999999999999999988643     2479


Q ss_pred             EEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           97 LVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      +||||+. ++|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.....
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            9999996 57766543               566777777765   8999999999999999999999999999764322


Q ss_pred             CCC-CcccceeecCCccccchhcc--CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          162 ESG-ANTNRIVGTYGYMSLEYTMS--GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       162 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ... .......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~  212 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN  212 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            111 11233578999999999875  678999999999999999999999997643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=297.73  Aligned_cols=230  Identities=22%  Similarity=0.265  Sum_probs=177.3

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +|.+.+.||+|+||.||++... +|+.||||+++..   .......+.+|++++..++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            6899999999999999999764 6899999999653   22345678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC---
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE---  162 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---  162 (345)
                      |+++++|.+++.               +++.+|.|||.   .||+||||||+|||++.++.+||+|||++.......   
T Consensus        82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            999999987764               55666777776   489999999999999999999999999998654322   


Q ss_pred             ------------------------CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCc
Q 039516          163 ------------------------SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERP  218 (345)
Q Consensus       163 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~  218 (345)
                                              .........||+.|+|||++.+..++.++|||||||++|||++|+.||......  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~--  236 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ--  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH--
Confidence                                    001223357899999999999999999999999999999999999999764321  


Q ss_pred             ccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCC
Q 039516          219 LNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQC  270 (345)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs  270 (345)
                          .............. + +. ...++++.   ..++..|++ ||.+||+
T Consensus       237 ----~~~~~i~~~~~~~~-~-p~-~~~~~~~~---~~li~~ll~-dp~~R~~  277 (350)
T cd05573         237 ----ETYNKIINWKESLR-F-PP-DPPVSPEA---IDLICRLLC-DPEDRLG  277 (350)
T ss_pred             ----HHHHHHhccCCccc-C-CC-CCCCCHHH---HHHHHHHcc-ChhhcCC
Confidence                11111111000000 0 00 00122222   588889997 9999999

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.8e-38  Score=288.12  Aligned_cols=233  Identities=19%  Similarity=0.242  Sum_probs=177.9

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      +|++.+.||+|+||.||++.. .+++.||+|.+... .......+.+|++++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            578888999999999999964 57899999998654 2334567899999999999999999999999999999999999


Q ss_pred             CCCChHHHH-----------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCccccee
Q 039516          103 PNKSLDSSF-----------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV  171 (345)
Q Consensus       103 ~~gsL~~~l-----------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~  171 (345)
                      ++++|..+.           .+++.++.+||..   ||+|+||||+||+++.++.++|+|||++......    ......
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~  154 (279)
T cd06619          82 DGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYV  154 (279)
T ss_pred             CCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCCC
Confidence            999886432           2566777777765   8999999999999999999999999999865322    223357


Q ss_pred             ecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC-CCCCChhH
Q 039516          172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL-DGSCPPNE  250 (345)
Q Consensus       172 gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~  250 (345)
                      |+..|+|||++.+..++.++|+||||+++|+|++|+.||.......................     .+.+ ....+++.
T Consensus       155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~  229 (279)
T cd06619         155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLPVGQFSEKF  229 (279)
T ss_pred             CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCCCCcCCHHH
Confidence            89999999999988899999999999999999999999976432221111111111111111     1111 11122211


Q ss_pred             HHHHHHHhhccCCCCCcCCCCC
Q 039516          251 DAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       251 ~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                         .+++.+||+.+|.+||++.
T Consensus       230 ---~~li~~~l~~~P~~Rp~~~  248 (279)
T cd06619         230 ---VHFITQCMRKQPKERPAPE  248 (279)
T ss_pred             ---HHHHHHHhhCChhhCCCHH
Confidence               5899999999999999954

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.3e-39  Score=280.82  Aligned_cols=243  Identities=20%  Similarity=0.222  Sum_probs=179.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc--cCHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG--QGRVEFQNEAKLIAKLQYTNLVKLLGCSIH--GEERLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv   98 (345)
                      ..|+.++.|++|+||+||+|+. .+++.||+|++++...  ......++|+.+|.+++|||||.+-.+...  -+.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            3477788899999999999965 5789999999987632  234456899999999999999999988653  4579999


Q ss_pred             EecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           99 YEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        99 ~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      ||||+. +|..++.                +++.++.|||..   .|+|||||++|+|+++.|.+||+|||+|+.++...
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            999975 5555544                556666666665   69999999999999999999999999999987542


Q ss_pred             CCCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH-----HHhcCCccc
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQ-----LWNEGKDLE  236 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~  236 (345)
                        ...+...-|..|.|||++.+. .|+.+.|+||+|||+.||+++++-|.+..+.++...+-....     .|.+-....
T Consensus       232 --k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  232 --KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             --ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence              234456789999999998874 589999999999999999999999988765554443322111     111111111


Q ss_pred             cc---------cccCCCCCChhH-HHH-HHHHhhccCCCCCcCCCCC
Q 039516          237 LI---------DLTLDGSCPPNE-DAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       237 ~~---------d~~l~~~~~~~~-~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .+         -..++..+.... ... .++....+..||.+|-|+.
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~  356 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAE  356 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHH
Confidence            11         111222222221 123 6788888999999999953

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.4e-39  Score=291.27  Aligned_cols=183  Identities=22%  Similarity=0.324  Sum_probs=148.3

Q ss_pred             CeeeEEEeeccCCeEEEEEEc--CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhc---CCCCeeeEEEEEEE-----C
Q 039516           25 DWHMYIQQEQTRDRVILVGKF--PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKL---QYTNLVKLLGCSIH-----G   92 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~--~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~~-----~   92 (345)
                      .|++.+.||+|+||.||++..  .+|+.||+|.++...  ......+.+|+.+++.+   +||||++++++|..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            588999999999999999975  347889999986542  22344667788877766   69999999999853     3


Q ss_pred             CeeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccc
Q 039516           93 EERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMA  155 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~  155 (345)
                      ...++||||+++ +|.+++.                 +++.+|.|||..   ||+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            468999999974 6655442                 566677777765   8999999999999999999999999999


Q ss_pred             eeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ......   .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  213 (290)
T cd07862         158 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  213 (290)
T ss_pred             EeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence            875432   22234578999999999988899999999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-40  Score=296.12  Aligned_cols=235  Identities=20%  Similarity=0.225  Sum_probs=191.7

Q ss_pred             ccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Q 039516           18 FVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE   93 (345)
Q Consensus        18 ~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~   93 (345)
                      -+.+....|++.+.||+|.||.|-++.. ..|+.||||.+++.   +.++...+.+|+++|+.|+||||+++|.+|++.+
T Consensus        47 hkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd  126 (668)
T KOG0611|consen   47 HKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD  126 (668)
T ss_pred             cccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence            3455677899999999999999999965 57999999999765   4556677899999999999999999999999999


Q ss_pred             eeEEEEecCCCCChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           94 ERLLVYEFMPNKSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      .+.|||||..+|.|.+++.            -..+...+.|++|..+++|||||.+|||+|.++++||+|||++..+.  
T Consensus       127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~--  204 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA--  204 (668)
T ss_pred             eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc--
Confidence            9999999999999998876            22344566777777799999999999999999999999999998774  


Q ss_pred             CCCCcccceeecCCccccchhccCCcC-cccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVS-IKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                       .....++++|++-|.+||++.+.+|. +.+|.|||||+||.|+.|..||++.+..   .++    ..+..|...+    
T Consensus       205 -~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lv----rQIs~GaYrE----  272 (668)
T KOG0611|consen  205 -DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLV----RQISRGAYRE----  272 (668)
T ss_pred             -cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHH----HHhhcccccC----
Confidence             33445678999999999999999985 7799999999999999999999876421   111    1222333221    


Q ss_pred             cCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          241 TLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       241 ~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                             ++.... ..++.++|..+|.+|-|..+
T Consensus       273 -------P~~PSdA~gLIRwmLmVNP~RRATieD  299 (668)
T KOG0611|consen  273 -------PETPSDASGLIRWMLMVNPERRATIED  299 (668)
T ss_pred             -------CCCCchHHHHHHHHHhcCcccchhHHH
Confidence                   222222 58999999999999999543

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-38  Score=298.33  Aligned_cols=187  Identities=21%  Similarity=0.259  Sum_probs=154.5

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +|.+.++||+|+||.||++.. .+|+.||||++...   .......+.+|++++++++||||+++++++.+....|+|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            689999999999999999964 57899999998543   22334568899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC-
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG-  164 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-  164 (345)
                      |+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            999999987653               455556666654   8999999999999999999999999998643110000 


Q ss_pred             -----------C---------------------------------cccceeecCCccccchhccCCcCcccchhhHHHHH
Q 039516          165 -----------A---------------------------------NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV  200 (345)
Q Consensus       165 -----------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il  200 (345)
                                 .                                 ......||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence                       0                                 00124689999999999998999999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 039516          201 LKIVCGKKNNKSYH  214 (345)
Q Consensus       201 ~el~tg~~p~~~~~  214 (345)
                      |||++|..||....
T Consensus       239 ~elltG~~Pf~~~~  252 (377)
T cd05629         239 FECLIGWPPFCSEN  252 (377)
T ss_pred             hhhhcCCCCCCCCC
Confidence            99999999997543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=303.09  Aligned_cols=246  Identities=21%  Similarity=0.304  Sum_probs=200.7

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCc-cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ......+.++||+|.||.|..+....+.+||||.++.... ..+.+|.+|+++|.+|+|||||+++|+|..++.+++|+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            3455677888999999999999987789999999987743 456899999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          101 FMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       101 ~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      ||++|+|.+++.                 +++.++.||..+   ++|||||.++|+|++.++++||+|||.++.+-....
T Consensus       616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence            999999999875                 678888898888   699999999999999999999999999997765555


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh--CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC--GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      ........-..+|||+|.+.-++++.+||+|+||+++||+++  ...||....+++   .++-+..+++.+...-++.  
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~l~--  767 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVVLS--  767 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcceecc--
Confidence            555666677889999999999999999999999999999876  788998766433   2333333443333222221  


Q ss_pred             CCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhh
Q 039516          242 LDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLM  279 (345)
Q Consensus       242 l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~  279 (345)
                          .++.+... .++++.||..+-.+|||+.+++..|.
T Consensus       768 ----~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq  802 (807)
T KOG1094|consen  768 ----RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQ  802 (807)
T ss_pred             ----CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence                12223333 59999999999999999876554443

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.2e-38  Score=293.92  Aligned_cols=226  Identities=20%  Similarity=0.237  Sum_probs=174.7

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCC-CCeeeEEEEEEECCeeEEEE
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQY-TNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~   99 (345)
                      +|.+.+.||+|+||.||+|... +++.||+|++...   .......+..|.+++..+.| ++|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5889999999999999999754 5789999999653   23345678889999999976 56888999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||++......  .
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~  155 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--G  155 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC--C
Confidence            9999999987654               456667777764   8999999999999999999999999998753211  1


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+      ...... ...      ..+..
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~-~~~------~~~~~  222 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQSIM-EHN------VSYPK  222 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHH-cCC------CCCCC
Confidence            12234578999999999999999999999999999999999999997543211      111111 111      01111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCC
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                      ..+.+.   .+++.+||+.||.+||+.
T Consensus       223 ~~~~~~---~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         223 SLSKEA---VSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCHHH---HHHHHHHhhcCHHHcCCC
Confidence            122211   589999999999999985

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.8e-39  Score=288.81  Aligned_cols=264  Identities=18%  Similarity=0.213  Sum_probs=205.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|++++.||+|.-|+||++++. ++..+|+|++.+.   ......+.+.|.+||+.++||.++.+|+.|+.+...|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            56888899999999999999875 4689999999765   3445567888999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC-
Q 039516          100 EFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN-  161 (345)
Q Consensus       100 e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~-  161 (345)
                      |||+||+|..+.+                 .+.-+|+|||.+   |||.|||||+|||+.++|++.|+||.++...... 
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            9999999987765                 344556666665   9999999999999999999999999987553110 


Q ss_pred             ---------------------------------C--------------------CCCcccceeecCCccccchhccCCcC
Q 039516          162 ---------------------------------E--------------------SGANTNRIVGTYGYMSLEYTMSGTVS  188 (345)
Q Consensus       162 ---------------------------------~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~~  188 (345)
                                                       .                    .......+.||-.|.|||++.+...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                             0                    00112347899999999999999999


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCc
Q 039516          189 IKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQID  267 (345)
Q Consensus       189 ~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~  267 (345)
                      .++|+|+|||++|||+.|..||.+....+..               ..++-..+.-...+..... .+++..-|.+||.+
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence            9999999999999999999999987654432               1222222211011122223 69999999999999


Q ss_pred             CCCCCcchhhhhcccccccccceeeEEecCCCCCCCCCCCC
Q 039516          268 VQCPMLFPCLLMNLLPGLYLKNLHFLLMLPPKNQKLPKTSQ  308 (345)
Q Consensus       268 RPs~~~~~~~l~~ll~~~~~~~~~~~~~l~~~~~~~p~~~~  308 (345)
                      |-.-.   .-..++.++..+.+.+|.+.--.+++.+|.|-.
T Consensus       379 Rlg~~---rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d  416 (459)
T KOG0610|consen  379 RLGSK---RGAAEIKRHPFFEGVNWALIRCARPPEIPKPVD  416 (459)
T ss_pred             hhccc---cchHHhhcCccccCCChhheeccCCCcCCCccc
Confidence            99832   334566778888888888766777777777654

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.6e-38  Score=294.06  Aligned_cols=234  Identities=19%  Similarity=0.208  Sum_probs=173.8

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +|.+.+.||+|+||.||++.. .+|+.||+|.++...   ......+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            689999999999999999965 478999999997542   2345568899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH-------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          101 FMPNKSLDSSFS-------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       101 ~~~~gsL~~~l~-------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      |+++++|.+++.             .+.+.+.+|+++|+.+|+||||||+||+++.++.+||+|||++......... ..
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~  160 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NS  160 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-ee
Confidence            999999988764             1123334444444558999999999999999999999999999876432221 22


Q ss_pred             cceeecCCccccchhc------cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          168 NRIVGTYGYMSLEYTM------SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~------~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      ....||+.|+|||++.      ...++.++|||||||++|+|++|+.||......      ................+  
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~~~--  232 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLKFPE--  232 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccCCCC--
Confidence            2346899999999886      456789999999999999999999999754321      11111211111111000  


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                       ....+.+.   .+++..|++ +|.+|||+.
T Consensus       233 -~~~~~~~~---~~li~~ll~-~p~~R~t~~  258 (330)
T cd05601         233 -DPKVSSDF---LDLIQSLLC-GQKERLGYE  258 (330)
T ss_pred             -CCCCCHHH---HHHHHHHcc-ChhhCCCHH
Confidence             00112111   478888997 999999954

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.3e-39  Score=290.14  Aligned_cols=241  Identities=21%  Similarity=0.258  Sum_probs=180.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCc----EEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQ----EVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~----~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      .+|++.+.||+|+||+||+|.+. +++    .|++|.+.... ......+..|+..++++.||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46888899999999999999763 444    57888875432 223456788888999999999999999875 456789


Q ss_pred             EEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           98 VYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        98 v~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      ++||+++|+|.+++.                +++.++.|||..   +++||||||+||+++.++.+||+|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            999999999987764                556677777765   7999999999999999999999999999876433


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ..........++..|+|||++.++.++.++||||||+++||+++ |..||.......   .    ...+..+...  ..+
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~--~~~  233 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---V----PDLLEKGERL--AQP  233 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCcC--CCC
Confidence            22222233456778999999998899999999999999999998 999997643211   1    1112222111  111


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .   .++.+.   ..++..||+.+|++|||+.++...+..+..
T Consensus       234 ~---~~~~~~---~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         234 Q---ICTIDV---YMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             C---CCCHHH---HHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            1   122211   588899999999999999887776666543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.1e-38  Score=293.64  Aligned_cols=243  Identities=19%  Similarity=0.200  Sum_probs=179.3

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|+||.||++.. .+++.||+|.++..   .......+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~   81 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG   81 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence            599999999999975 46889999999754   223345678899988877 8999999999999999999999999999


Q ss_pred             ChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          106 SLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       106 sL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      +|..++.               +++.++.|||..   +|+||||||+||+++.++.+||+|||+++.....  .......
T Consensus        82 ~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~~~~  156 (329)
T cd05618          82 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTF  156 (329)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCccccc
Confidence            9976653               566677777765   8999999999999999999999999998753221  1122345


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCC--cccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER--PLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ......+..........      .    .+.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~----~p~  226 (329)
T cd05618         157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R----IPR  226 (329)
T ss_pred             cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------C----CCC
Confidence            78999999999999999999999999999999999999996432211  11122223322222211      1    111


Q ss_pred             hHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccccccccc
Q 039516          249 NEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKN  289 (345)
Q Consensus       249 ~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~  289 (345)
                      ..... .+++.+||+.||.+|||... ...+.+++.+..+.+
T Consensus       227 ~~~~~~~~ll~~~L~~dP~~R~~~~~-~~~~~~i~~hp~f~~  267 (329)
T cd05618         227 SLSVKAASVLKSFLNKDPKERLGCHP-QTGFADIQGHPFFRN  267 (329)
T ss_pred             CCCHHHHHHHHHHhcCCHHHcCCCCC-CCCHHHHhcCCCCCC
Confidence            11223 58999999999999999421 122344455544433

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.4e-38  Score=291.19  Aligned_cols=226  Identities=20%  Similarity=0.232  Sum_probs=174.9

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEE
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      +|.+...||+|+||.||++.. .+++.||+|.+....   ......+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            588999999999999999965 467899999997542   22344567788888777 5899999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||+++|+|.+.+.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.....  .
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--~  155 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--G  155 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC--C
Confidence            9999999977653               566677777765   8999999999999999999999999998754321  1


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +   ..... ....      ....
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~---~~~i~-~~~~------~~p~  222 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L---FQSIM-EHNV------AYPK  222 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---H---HHHHH-hCCC------CCCC
Confidence            12234578999999999999999999999999999999999999997643211   1   11111 1111      0111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCC
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                      ..+.+.   ..++.+||+.||.+|++.
T Consensus       223 ~~s~~~---~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         223 SMSKEA---VAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             cCCHHH---HHHHHHHcccCHHhcCCC
Confidence            122221   589999999999999995

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.7e-39  Score=292.29  Aligned_cols=241  Identities=20%  Similarity=0.227  Sum_probs=184.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccC-CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEE   94 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~   94 (345)
                      ..+|++...||+|+||.||++...      ....||+|.+... .......+.+|+++++++ +|+||+++++++..++.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            356889999999999999999753      2368999998754 223345688999999999 89999999999999999


Q ss_pred             eEEEEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC
Q 039516           95 RLLVYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD  143 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~  143 (345)
                      .+++|||+++|+|.+++.                               +++.++.|||..   +|+||||||+||+++.
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence            999999999999987762                               456677777754   8999999999999999


Q ss_pred             CCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHH
Q 039516          144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLV  222 (345)
Q Consensus       144 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~  222 (345)
                      ++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+     
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----  242 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-----  242 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-----
Confidence            99999999999986543222111222234678999999988889999999999999999998 999986543211     


Q ss_pred             HHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          223 GIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       223 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                        .......+...         ..+...... .+++.+||+.||++|||+.++...|.+++
T Consensus       243 --~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 --LFKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence              11111111110         111222233 69999999999999999988888777653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.4e-39  Score=286.82  Aligned_cols=229  Identities=20%  Similarity=0.250  Sum_probs=171.8

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCChH
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD  108 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~  108 (345)
                      .||+|+||.||++.. .+++.||+|.+... .......+.+|++++++++||||+++++++......++||||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            589999999999976 47899999988644 2334567999999999999999999999999999999999999999998


Q ss_pred             HHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceee
Q 039516          109 SSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG  172 (345)
Q Consensus       109 ~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g  172 (345)
                      +++.                +++.+|.|||..   +++|+||||+||+++.++.+||+|||++................+
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          82 TFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            8764                455666777654   899999999999999999999999999875432111111111123


Q ss_pred             cCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHH
Q 039516          173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNED  251 (345)
Q Consensus       173 t~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  251 (345)
                      +..|+|||.+.++.++.++||||||+++|+|++ |..||.......       .......+..     ..    .+....
T Consensus       159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~~-----~~----~~~~~~  222 (252)
T cd05084         159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGVR-----LP----CPELCP  222 (252)
T ss_pred             ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCC-----CC----CcccCC
Confidence            456999999998889999999999999999998 888886543211       1111111100     00    111112


Q ss_pred             HH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          252 AF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       252 ~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      .. .+++.+||+.+|++|||+.++...|
T Consensus       223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l  250 (252)
T cd05084         223 DAVYRLMERCWEYDPGQRPSFSTVHQEL  250 (252)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            23 6899999999999999987655443

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.6e-38  Score=297.73  Aligned_cols=187  Identities=19%  Similarity=0.255  Sum_probs=154.5

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      .|.++++||+|+||.||++.. .+++.||+|.+....   ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            488999999999999999965 568999999996432   2334578899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC---
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE---  162 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---  162 (345)
                      |+++|+|.+++.               +++.+|.|||.   .+|+||||||+|||++.++.+||+|||++..+....   
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            999999987764               34555566665   489999999999999999999999999975321000   


Q ss_pred             ------------------------------------------CCCcccceeecCCccccchhccCCcCcccchhhHHHHH
Q 039516          163 ------------------------------------------SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV  200 (345)
Q Consensus       163 ------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il  200 (345)
                                                                .........||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                      00001234689999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 039516          201 LKIVCGKKNNKSYH  214 (345)
Q Consensus       201 ~el~tg~~p~~~~~  214 (345)
                      |||++|+.||....
T Consensus       239 ~elltG~~Pf~~~~  252 (382)
T cd05625         239 YEMLVGQPPFLAQT  252 (382)
T ss_pred             HHHHhCCCCCCCCC
Confidence            99999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.5e-38  Score=292.54  Aligned_cols=220  Identities=20%  Similarity=0.204  Sum_probs=170.1

Q ss_pred             EEeeccCCeEEEEEEc----CCCcEEEEEEeccC----CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           30 IQQEQTRDRVILVGKF----PNEQEVAIKRLAWT----SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~----~~~~~VaiK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ++||+|+||.||++..    .+++.||+|.++..    .......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            4699999999999864    35789999998643    223345678999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          102 MPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       102 ~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      +++++|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++......  ..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  156 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TV  156 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--Cc
Confidence            99999977654               455666666654   89999999999999999999999999987542211  12


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......      ....... .+..      .+....
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~-~~~~------~~~~~~  223 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKIL-KGKL------NLPPYL  223 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHH-cCCC------CCCCCC
Confidence            23357899999999999888999999999999999999999999754321      1111111 1111      111112


Q ss_pred             ChhHHHHHHHHhhccCCCCCcCCC
Q 039516          247 PPNEDAFLLVSCVCKSKQQIDVQC  270 (345)
Q Consensus       247 ~~~~~~~~~l~~~Cl~~~P~~RPs  270 (345)
                      ++..   .+++..||+.+|.+||+
T Consensus       224 ~~~~---~~li~~~l~~~p~~R~~  244 (323)
T cd05584         224 TPEA---RDLLKKLLKRNPSSRLG  244 (323)
T ss_pred             CHHH---HHHHHHHcccCHhHcCC
Confidence            2211   59999999999999995

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.8e-38  Score=296.89  Aligned_cols=187  Identities=21%  Similarity=0.241  Sum_probs=155.8

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +|++.+.||+|+||.||++.. .+++.||+|++...   .......+.+|+.++.+++|+||+++++++.+....|+|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            689999999999999999964 46899999999653   22334568889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC--
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES--  163 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--  163 (345)
                      |+++|+|.+++.               +++.+|.|||.   .||+||||||+|||++.++.+||+|||+++.......  
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            999999988764               44555556655   5899999999999999999999999999875432100  


Q ss_pred             -------------------------------CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 039516          164 -------------------------------GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKS  212 (345)
Q Consensus       164 -------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~  212 (345)
                                                     ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                           0001235799999999999999999999999999999999999999976


Q ss_pred             CC
Q 039516          213 YH  214 (345)
Q Consensus       213 ~~  214 (345)
                      ..
T Consensus       239 ~~  240 (363)
T cd05628         239 ET  240 (363)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-38  Score=292.74  Aligned_cols=242  Identities=19%  Similarity=0.223  Sum_probs=185.4

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc--------CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF--------PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHG   92 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~--------~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~   92 (345)
                      ..+|.+...||+|+||.||++..        .++..||+|.+... .......+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            45688999999999999999863        13457999998654 233456789999999999 899999999999999


Q ss_pred             CeeEEEEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeee
Q 039516           93 EERLLVYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILL  141 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill  141 (345)
                      ...++||||+++++|.+++.                               +++.++.|||..   |++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence            99999999999999987753                               456667777765   89999999999999


Q ss_pred             CCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCccc
Q 039516          142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLN  220 (345)
Q Consensus       142 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~  220 (345)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.....     
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----  245 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----  245 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence            9999999999999987643222222222345678999999988889999999999999999998 7888765321     


Q ss_pred             HHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          221 LVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                       ..... ....+....         .+...... ..++.+||+.+|.+|||+.++...|.+++.
T Consensus       246 -~~~~~-~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         246 -EELFK-LLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             -HHHHH-HHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence             11111 111221110         11112223 589999999999999999988888877654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-39  Score=301.87  Aligned_cols=235  Identities=19%  Similarity=0.217  Sum_probs=182.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCe-eEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE-RLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~-~~lv~   99 (345)
                      .+|+.++++|+|+||.++..+ ..++..+++|.+....  ...+....+|+.++++++|||||.+++.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            358899999999999998874 4568899999997653  3345568899999999999999999999998888 89999


Q ss_pred             ecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          100 EFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       100 e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      +||+||++.+.+.              +..+++.++.++|+.+|+|||||+.||+++.++.+||+|||+++......  .
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~  161 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--S  161 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch--h
Confidence            9999999988765              33344444444444579999999999999999999999999999875433  2


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      ...+..||+.|+.||++.+.+|+.|+|||||||++|||++-+++|...+...      .+......     .+.|.. +.
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~ki~~~-----~~~Plp-~~  229 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILKINRG-----LYSPLP-SM  229 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HHHHHhhc-----cCCCCC-cc
Confidence            3456799999999999999999999999999999999999999998754221      11111111     112211 11


Q ss_pred             CChhHHHHHHHHhhccCCCCCcCCCCCcch
Q 039516          246 CPPNEDAFLLVSCVCKSKQQIDVQCPMLFP  275 (345)
Q Consensus       246 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~  275 (345)
                      +..+.   ..++..|++.+|..||++.++.
T Consensus       230 ys~el---~~lv~~~l~~~P~~RPsa~~LL  256 (426)
T KOG0589|consen  230 YSSEL---RSLVKSMLRKNPEHRPSALELL  256 (426)
T ss_pred             ccHHH---HHHHHHHhhcCCccCCCHHHHh
Confidence            22111   5889999999999999965443

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-38  Score=287.63  Aligned_cols=236  Identities=19%  Similarity=0.292  Sum_probs=175.8

Q ss_pred             eeEEEeeccCCeEEEEEEcCC-Cc--EEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC------Cee
Q 039516           27 HMYIQQEQTRDRVILVGKFPN-EQ--EVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG------EER   95 (345)
Q Consensus        27 ~~~~~lG~G~~g~vy~~~~~~-~~--~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------~~~   95 (345)
                      .+.+.||+|+||.||+|...+ +.  .||+|.++..  .......+.+|+.+++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            356679999999999998653 33  6999998654  234456789999999999999999999987532      246


Q ss_pred             EEEEecCCCCChHHHHH---------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccc
Q 039516           96 LLVYEFMPNKSLDSSFS---------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGM  154 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl  154 (345)
                      +++|||+++|+|.+++.                     +++.++.|||..   +|+||||||+||+++.++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence            89999999999876641                     566777788764   899999999999999999999999999


Q ss_pred             ceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 039516          155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGK  233 (345)
Q Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (345)
                      ++...............+++.|+|||+..+..++.++||||||+++|||++ |+.||......       ........+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------EIYDYLRQGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcCC
Confidence            987643222111122345678999999998899999999999999999999 88898753321       1112222221


Q ss_pred             ccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          234 DLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       234 ~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                      ...         .++..... .+++.+||+.||.+|||+.++...|..+
T Consensus       232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111         11112223 6999999999999999988776666543

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-38  Score=289.13  Aligned_cols=237  Identities=23%  Similarity=0.347  Sum_probs=180.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      .++....+||+|+||.||++..      .++..||+|.+..........|.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            4577788899999999999853      2367899999876665667789999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCE
Q 039516           98 VYEFMPNKSLDSSFS------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNT  147 (345)
Q Consensus        98 v~e~~~~gsL~~~l~------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~  147 (345)
                      +|||+++++|.+++.                              +++.++.|||..   |++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence            999999999876642                              455667777754   89999999999999999999


Q ss_pred             EEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 039516          148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAW  226 (345)
Q Consensus       148 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~  226 (345)
                      ||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||......+.      ..
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~  235 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------IE  235 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------HH
Confidence            9999999876532221111222345678999999998899999999999999999998 8999865432111      11


Q ss_pred             HHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhh
Q 039516          227 QLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       227 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      .. ..+...     .....+++..   .+++.+||+.||.+||++.++...|
T Consensus       236 ~~-~~~~~~-----~~~~~~~~~~---~~li~~cl~~~P~~Rp~~~~l~~~l  278 (280)
T cd05092         236 CI-TQGREL-----ERPRTCPPEV---YAIMQGCWQREPQQRMVIKDIHSRL  278 (280)
T ss_pred             HH-HcCccC-----CCCCCCCHHH---HHHHHHHccCChhhCCCHHHHHHHH
Confidence            11 111111     0011122222   5999999999999999987665544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=284.91  Aligned_cols=233  Identities=24%  Similarity=0.292  Sum_probs=177.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      .+|.+.+.||+|+||.||++...++..+|+|.+.... .....|.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            3577888899999999999988777889999986432 234578899999999999999999999999999999999999


Q ss_pred             CCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          104 NKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       104 ~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      +++|.+++.                +++.++.+||..   +++||||||+||+++.++.+||+|||+++........ ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~  158 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SS  158 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc-cc
Confidence            999987753                455666677665   8999999999999999999999999998765322111 11


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      ....++..|+|||++.+..++.++|+||||+++|+|++ |+.||......+   .   ... ...+     ....    .
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~-~~~~-----~~~~----~  222 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V---VES-VSAG-----YRLY----R  222 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H---HHH-HHcC-----CcCC----C
Confidence            11123457999999998899999999999999999999 899987543211   1   111 1111     0111    1


Q ss_pred             ChhHHHH-HHHHhhccCCCCCcCCCCCcchhh
Q 039516          247 PPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCL  277 (345)
Q Consensus       247 ~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~  277 (345)
                      +...... .+++.+||+.+|++|||+.++...
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            1112223 699999999999999997655443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.5e-38  Score=284.35  Aligned_cols=227  Identities=19%  Similarity=0.186  Sum_probs=171.6

Q ss_pred             eeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCCh
Q 039516           32 QEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL  107 (345)
Q Consensus        32 lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL  107 (345)
                      ||+|+||.||++.. .+|+.||+|.+....   ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999965 468999999986431   12233456799999999999999999999999999999999999999


Q ss_pred             HHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          108 DSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       108 ~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      .+++.                 +++.++.+||..   |++||||||+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            76542                 556667777764   89999999999999999999999999988764321   12234


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhH
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE  250 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  250 (345)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.||.......  ........... ...    .. ....++.+.
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~-~~~----~~-~~~~~~~~~  226 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLE-DEV----KF-EHQNFTEES  226 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhc-ccc----cc-ccccCCHHH
Confidence            68899999999998889999999999999999999999997543211  11111111111 110    00 001122222


Q ss_pred             HHHHHHHhhccCCCCCcCCCCCcch
Q 039516          251 DAFLLVSCVCKSKQQIDVQCPMLFP  275 (345)
Q Consensus       251 ~~~~~l~~~Cl~~~P~~RPs~~~~~  275 (345)
                         .+++..||+.||.+|||+.++.
T Consensus       227 ---~~li~~~L~~~P~~R~~~~~~~  248 (277)
T cd05607         227 ---KDICRLFLAKKPEDRLGSREKN  248 (277)
T ss_pred             ---HHHHHHHhccCHhhCCCCccch
Confidence               5999999999999999976543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.1e-38  Score=291.99  Aligned_cols=221  Identities=19%  Similarity=0.188  Sum_probs=169.7

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|+||.||++.. .+++.||+|.++..   .......+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            599999999999975 46889999999653   223344566777777654 8999999999999999999999999999


Q ss_pred             ChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          106 SLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       106 sL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      +|..++.               +++.+|.|||..   +|+||||||+||+++.++.+||+|||+++......  ......
T Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~  156 (316)
T cd05592          82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTF  156 (316)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccccc
Confidence            9987654               566677777764   89999999999999999999999999998643222  223345


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhH
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE  250 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  250 (345)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||......      ....... ...      +.+...++.+.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~i~-~~~------~~~~~~~~~~~  223 (316)
T cd05592         157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDSIL-NDR------PHFPRWISKEA  223 (316)
T ss_pred             cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-cCC------CCCCCCCCHHH
Confidence            7899999999999989999999999999999999999999764321      1111111 110      11111122221


Q ss_pred             HHHHHHHhhccCCCCCcCCCCC
Q 039516          251 DAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       251 ~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                         .+++..||+.||.+||++.
T Consensus       224 ---~~ll~~~l~~~P~~R~~~~  242 (316)
T cd05592         224 ---KDCLSKLFERDPTKRLGVD  242 (316)
T ss_pred             ---HHHHHHHccCCHHHcCCCh
Confidence               5899999999999999963

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.8e-38  Score=291.62  Aligned_cols=240  Identities=21%  Similarity=0.253  Sum_probs=182.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCee
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~   95 (345)
                      .+|.+.+.||+|+||.||++..      .++..||+|.++... ....+.+.+|+.+++++ +|+||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            4688999999999999999863      235689999987543 23356789999999999 799999999999999999


Q ss_pred             EEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           96 LLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      +++|||+++++|.+++.                 +++.++.|||..   +++|+||||+||+++.++.++|+|||+++..
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            99999999999987764                 456667777765   7999999999999999999999999999865


Q ss_pred             cCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLEL  237 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
                      .............++..|+|||.+.+..++.++|||||||++|+|++ |..||.......  .+    ......+..   
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~----~~~~~~~~~---  262 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KF----YKLIKEGYR---  262 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HH----HHHHHcCCc---
Confidence            43221111222345678999999998889999999999999999998 999987543211  01    111111110   


Q ss_pred             ccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          238 IDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       238 ~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                        ..    .+...... .+++.+||+.+|++|||+.++...|.++
T Consensus       263 --~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 --MA----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --CC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence              00    01111123 6999999999999999988877776654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.1e-38  Score=291.71  Aligned_cols=222  Identities=19%  Similarity=0.227  Sum_probs=171.8

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|+||.||++.. .+++.||+|.+...   .......+..|..++..+ +||||+++++++...+..|+||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            589999999999975 46899999998643   233456678898888876 7999999999999999999999999999


Q ss_pred             ChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          106 SLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       106 sL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      +|.+++.               +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++.....  .......
T Consensus        82 ~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~~~~  156 (320)
T cd05590          82 DLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTF  156 (320)
T ss_pred             hHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCccccc
Confidence            9987654               566677777765   8999999999999999999999999998754221  1122345


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhH
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE  250 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  250 (345)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ..... ...+..      ......+.+.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~-i~~~~~------~~~~~~~~~~  223 (320)
T cd05590         157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEA-ILNDEV------VYPTWLSQDA  223 (320)
T ss_pred             ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHH-HhcCCC------CCCCCCCHHH
Confidence            7899999999999989999999999999999999999999764321      11111 111111      0111122211


Q ss_pred             HHHHHHHhhccCCCCCcCCCCCc
Q 039516          251 DAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       251 ~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                         .+++..||+.||.+||+..+
T Consensus       224 ---~~li~~~L~~dP~~R~~~~~  243 (320)
T cd05590         224 ---VDILKAFMTKNPTMRLGSLT  243 (320)
T ss_pred             ---HHHHHHHcccCHHHCCCCCC
Confidence               58999999999999999643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.1e-38  Score=297.28  Aligned_cols=187  Identities=22%  Similarity=0.278  Sum_probs=156.1

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ..+|++.+.||+|+||.||++.. .+++.||+|.+...   .......+.+|+.+++.++||||+++++++.++...|+|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            46799999999999999999975 46889999998642   223345688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516           99 YEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus        99 ~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||+++|+|.+++.              +++.+|.+||.   .+|+||||||+|||++.++.+||+|||++........ 
T Consensus       122 ~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-  197 (370)
T cd05621         122 MEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-  197 (370)
T ss_pred             EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCCc-
Confidence            99999999987765              45556666665   4899999999999999999999999999987532211 


Q ss_pred             CcccceeecCCccccchhccC----CcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSG----TVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      .......||+.|+|||++.+.    .++.++||||+||++|+|++|+.||...
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~  250 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD  250 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence            122345799999999998754    3788999999999999999999999754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-38  Score=295.59  Aligned_cols=235  Identities=18%  Similarity=0.177  Sum_probs=176.7

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|+||.||+|.. .+++.||+|.++..   .......+..|.+++..+ +||||+++++++...+..|+||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            489999999999975 46889999999653   233455678899998866 8999999999999999999999999999


Q ss_pred             ChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          106 SLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       106 sL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      +|...+.               +++.+|.|||..   ||+||||||+||+++.++.+||+|||++.......  ......
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~  156 (321)
T cd05591          82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTF  156 (321)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccccc
Confidence            9976653               556667777765   89999999999999999999999999987642221  122335


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhH
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE  250 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  250 (345)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      ...... .+..   .   .....+.+.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~-~~~~---~---~p~~~~~~~  223 (321)
T cd05591         157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESIL-HDDV---L---YPVWLSKEA  223 (321)
T ss_pred             ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHH-cCCC---C---CCCCCCHHH
Confidence            78999999999999899999999999999999999999997643211      111111 1110   0   011122211


Q ss_pred             HHHHHHHhhccCCCCCcCCCCCcchhhhhccccccc
Q 039516          251 DAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLY  286 (345)
Q Consensus       251 ~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~  286 (345)
                         .+++..||+.||.+||+.........+++.+..
T Consensus       224 ---~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~  256 (321)
T cd05591         224 ---VSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF  256 (321)
T ss_pred             ---HHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence               589999999999999975443334445555443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.5e-37  Score=293.56  Aligned_cols=233  Identities=20%  Similarity=0.226  Sum_probs=175.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ..+|++.+.||+|+||.||++.. .+++.||+|.+...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            45799999999999999999965 46899999999643   223345678999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516           99 YEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus        99 ~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||+++|+|.+++.              +++.+|.|||..   ||+||||||+|||++.++.+||+|||++........ 
T Consensus       122 ~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-  197 (370)
T cd05596         122 MEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-  197 (370)
T ss_pred             EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-
Confidence            99999999987764              455666666654   899999999999999999999999999986532211 


Q ss_pred             CcccceeecCCccccchhccC----CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          165 ANTNRIVGTYGYMSLEYTMSG----TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||......      ............... ..
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~~~-~~  270 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNSLTF-PD  270 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCcCCC-CC
Confidence            122335799999999988653    4789999999999999999999999764321      111111111100000 00


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCc--CCCC
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQID--VQCP  271 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~  271 (345)
                      .  ..++.+.   .+++..||+.+|.+  |||+
T Consensus       271 ~--~~~s~~~---~~li~~~L~~~p~r~~R~s~  298 (370)
T cd05596         271 D--IEISKQA---KDLICAFLTDREVRLGRNGV  298 (370)
T ss_pred             c--CCCCHHH---HHHHHHHccChhhccCCCCH
Confidence            0  0112111   58999999999987  8984

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-38  Score=289.54  Aligned_cols=246  Identities=20%  Similarity=0.252  Sum_probs=179.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-----CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-----PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH--GEERL   96 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-----~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~   96 (345)
                      .+|++.+.||+|+||.||++..     .++..||+|.+..........|.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4688999999999999999864     3578999999976665566789999999999999999999998754  34689


Q ss_pred             EEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           97 LVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      +||||+++++|.+++.                +++.+|.+||..   |++||||||+||+++.++.+||+|||++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            9999999999988764                455666677654   899999999999999999999999999987643


Q ss_pred             CCCCCc-ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCc---------ccHHHHHHHHHh
Q 039516          161 NESGAN-TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERP---------LNLVGIAWQLWN  230 (345)
Q Consensus       161 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~---------~~~~~~~~~~~~  230 (345)
                      ...... .....++..|+|||++.+..++.++||||||+++|||++|..++........         ............
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            222111 1111234569999999988899999999999999999998876543221000         000000001111


Q ss_pred             cCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          231 EGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       231 ~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                      .+         .....+...... .+++.+||+.+|++|||+.++...|.++
T Consensus       241 ~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         241 NN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            11         000011111223 6999999999999999988877776643

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1e-37  Score=288.78  Aligned_cols=221  Identities=20%  Similarity=0.217  Sum_probs=171.3

Q ss_pred             EeeccCCeEEEEEEcC-CCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKFP-NEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|+||.||++... +++.||||.++..   .......+..|..++..+ +||||+++++++...+..++||||++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5999999999999764 5889999999754   233455678899999888 7999999999999999999999999999


Q ss_pred             ChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          106 SLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       106 sL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      +|...+.               +++.+|.|||..   +|+||||||+||+++.++.+||+|||++......  .......
T Consensus        82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~  156 (318)
T cd05570          82 DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTSTF  156 (318)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcccce
Confidence            9976654               566677777755   8999999999999999999999999998753221  1122335


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhH
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE  250 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  250 (345)
                      .|++.|+|||++.+..++.++|||||||++|+|++|+.||......      . ..........      ......+.+.
T Consensus       157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~-~~~~i~~~~~------~~~~~~~~~~  223 (318)
T cd05570         157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------E-LFQSILEDEV------RYPRWLSKEA  223 (318)
T ss_pred             ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------H-HHHHHHcCCC------CCCCcCCHHH
Confidence            7899999999999999999999999999999999999999754311      1 1111111111      1111122211


Q ss_pred             HHHHHHHhhccCCCCCcCCCCC
Q 039516          251 DAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       251 ~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                         .+++.+||+.||++|||+.
T Consensus       224 ---~~li~~~l~~dP~~R~s~~  242 (318)
T cd05570         224 ---KSILKSFLTKNPEKRLGCL  242 (318)
T ss_pred             ---HHHHHHHccCCHHHcCCCC
Confidence               5999999999999999963

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-38  Score=300.69  Aligned_cols=230  Identities=20%  Similarity=0.226  Sum_probs=185.3

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      +--.-|++.+.||.|+.|.|-.|+ ..+|+.+|||++.+.   +......+.+|+-+|+-|.||||+++|++|.+..++|
T Consensus         9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly   88 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY   88 (786)
T ss_pred             ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence            334569999999999999999995 468999999999765   2334556889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           97 LVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      +|.||+++|.|.+++-               ++..++.|+|..   +|+||||||+|+|++..+.+||+|||+|..-.  
T Consensus        89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--  163 (786)
T KOG0588|consen   89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV--  163 (786)
T ss_pred             EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence            9999999999977653               777788888887   59999999999999999999999999998643  


Q ss_pred             CCCCcccceeecCCccccchhccCCc-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                       .+....+-+|++.|.|||++.+.+| +.++||||.|||||.|+||+.||++.+   .    .........|.+. +.  
T Consensus       164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---i----r~LLlKV~~G~f~-MP--  232 (786)
T KOG0588|consen  164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---I----RVLLLKVQRGVFE-MP--  232 (786)
T ss_pred             -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---H----HHHHHHHHcCccc-CC--
Confidence             3344556799999999999999998 488999999999999999999998532   1    1112222233221 11  


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                         ...+++.   ..++.+++..||+.|-|+.
T Consensus       233 ---s~Is~ea---QdLLr~ml~VDp~~RiT~~  258 (786)
T KOG0588|consen  233 ---SNISSEA---QDLLRRMLDVDPSTRITTE  258 (786)
T ss_pred             ---CcCCHHH---HHHHHHHhccCccccccHH
Confidence               1123332   4899999999999999964

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.5e-38  Score=302.59  Aligned_cols=241  Identities=19%  Similarity=0.218  Sum_probs=182.8

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCee
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEER   95 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~   95 (345)
                      .+|.+.++||+|+||.||++.+.      .+..||+|+++... ......+.+|+.+|.++. ||||++++++|...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            45777789999999999999753      34689999997543 223457889999999997 99999999999999999


Q ss_pred             EEEEecCCCCChHHHHH---------------------------------------------------------------
Q 039516           96 LLVYEFMPNKSLDSSFS---------------------------------------------------------------  112 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------------------------------------------------------  112 (345)
                      ++||||+++|+|.+++.                                                               
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999987763                                                               


Q ss_pred             --------------------------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC
Q 039516          113 --------------------------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD  142 (345)
Q Consensus       113 --------------------------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~  142 (345)
                                                                        +++.+|.|||.   .+++||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEe
Confidence                                                              34556666765   4899999999999999


Q ss_pred             CCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccH
Q 039516          143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNL  221 (345)
Q Consensus       143 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~  221 (345)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+    
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~----  349 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE----  349 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH----
Confidence            999999999999986532222112223356788999999998889999999999999999998 888986543211    


Q ss_pred             HHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          222 VGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       222 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                        ........+..     +.    .+...... .+++..||+.+|.+|||+.+++..|..++
T Consensus       350 --~~~~~~~~~~~-----~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 --QFYNAIKRGYR-----MA----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             --HHHHHHHcCCC-----CC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence              11111111110     00    11111223 58999999999999999988877777654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5e-38  Score=283.57  Aligned_cols=234  Identities=22%  Similarity=0.266  Sum_probs=169.8

Q ss_pred             EeeccCCeEEEEEEcC---CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCC
Q 039516           31 QQEQTRDRVILVGKFP---NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS  106 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~---~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gs  106 (345)
                      .||+|+||.||+|...   ++..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            4899999999999754   34679999986543 2334578899999999999999999999999899999999999999


Q ss_pred             hHHHHH--------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          107 LDSSFS--------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       107 L~~~l~--------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      |.+++.                    +++.++.|||.   .+++|+||||+||+++.++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            987653                    34455566665   4899999999999999999999999999875432222112


Q ss_pred             ccceeecCCccccchhccC-------CcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          167 TNRIVGTYGYMSLEYTMSG-------TVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~-------~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                      .....++..|+|||++.+.       .++.++|+||||+++|||++ |+.||......+.   ...   .. .+....+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~---~~-~~~~~~~~  231 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY---TV-REQQLKLP  231 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH---Hh-hcccCCCC
Confidence            2234567889999988642       35789999999999999996 9999975432211   111   11 11122222


Q ss_pred             cccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhh
Q 039516          239 DLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       239 d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      ++.+....+..   ..+++..|+ .+|++|||+.+++..|
T Consensus       232 ~~~~~~~~~~~---~~~l~~~c~-~~P~~Rpt~~~l~~~l  267 (269)
T cd05087         232 KPRLKLPLSDR---WYEVMQFCW-LQPEQRPSAEEVHLLL  267 (269)
T ss_pred             CCccCCCCChH---HHHHHHHHh-cCcccCCCHHHHHHHh
Confidence            33332212211   147888998 5899999987766544

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.7e-38  Score=282.18  Aligned_cols=236  Identities=25%  Similarity=0.353  Sum_probs=179.8

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ...+|++.++||+|+||.||++...+++.||+|.+.... .....+.+|+.++++++|+||+++++++ ..+..+++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence            345789999999999999999998889999999986543 3456899999999999999999999986 45678999999


Q ss_pred             CCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          102 MPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       102 ~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      +++++|.+++.                 +++.+|.+||.   .|++|+||||+||+++.++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            99999987653                 44555556654   58999999999999999999999999999876422111


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                       ......++..|+|||++.+..++.++||||||+++||+++ |+.||......+   ..    .....+...     ...
T Consensus       159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~-----~~~  225 (260)
T cd05067         159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VI----QNLERGYRM-----PRP  225 (260)
T ss_pred             -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HH----HHHHcCCCC-----CCC
Confidence             1122345678999999998889999999999999999999 999997543211   11    111111110     011


Q ss_pred             CCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhh
Q 039516          244 GSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLM  279 (345)
Q Consensus       244 ~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~  279 (345)
                      ...+    .. .+++.+||+.+|++|||+.++...|.
T Consensus       226 ~~~~----~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  258 (260)
T cd05067         226 DNCP----EELYELMRLCWKEKPEERPTFEYLRSVLE  258 (260)
T ss_pred             CCCC----HHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence            1111    23 69999999999999999776555443

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-41  Score=290.53  Aligned_cols=227  Identities=21%  Similarity=0.272  Sum_probs=189.0

Q ss_pred             CCCCeeeEEEeeccCCeEEEEE-EcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           22 SSLDWHMYIQQEQTRDRVILVG-KFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~-~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ...-|.++.+||+|+||.||++ +..+|+.||||.+...  .+..++.+|+.+|.+++.|++|++||.+.....+|+|||
T Consensus        31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            3445889999999999999999 4567999999999654  457889999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          101 FMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       101 ~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||..||+.+.++                ..+.+|.|||.+   .-||||||+.|||++.+|..||+|||.+..+.+.-. 
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-  184 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-  184 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence            999999988765                567889999998   589999999999999999999999999987643222 


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                       ..++..||+.|||||++..-.|+.++||||||++..||..|++||...++.....+                +.-....
T Consensus       185 -KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM----------------IPT~PPP  247 (502)
T KOG0574|consen  185 -KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM----------------IPTKPPP  247 (502)
T ss_pred             -hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe----------------ccCCCCC
Confidence             23457899999999999999999999999999999999999999998775443221                1111112


Q ss_pred             CC-ChhHHHH--HHHHhhccCCCCCcCCCC
Q 039516          245 SC-PPNEDAF--LLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       245 ~~-~~~~~~~--~~l~~~Cl~~~P~~RPs~  271 (345)
                      .+ .+++...  -+++..||-.+|++|-|+
T Consensus       248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA  277 (502)
T KOG0574|consen  248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTA  277 (502)
T ss_pred             CCCChHhhhhHHHHHHHHHhcCCHHHHHHH
Confidence            22 2344333  799999999999999994

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.3e-38  Score=287.08  Aligned_cols=235  Identities=24%  Similarity=0.260  Sum_probs=175.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      .+|.+.+.||+|++|.||+|...      .+..||+|.+.... ......|.+|+.++++++|+||+++++++.+....+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            45889999999999999999764      35789999886443 233457999999999999999999999999988999


Q ss_pred             EEEecCCCCChHHHHH----------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC---CEEEEc
Q 039516           97 LVYEFMPNKSLDSSFS----------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL---NTKISD  151 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~----------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~---~~kl~D  151 (345)
                      +||||+++++|.+++.                      +++.++.+||..   +++||||||+||+++.++   .+||+|
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEecc
Confidence            9999999999987653                      455666677655   799999999999998654   589999


Q ss_pred             cccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHh
Q 039516          152 FGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWN  230 (345)
Q Consensus       152 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  230 (345)
                      ||+++................+..|+|||++.+..++.++|||||||++|||++ |..||.......      .......
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~  236 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VMEFVTG  236 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHc
Confidence            999986532211111112233567999999998899999999999999999997 999987543221      1111111


Q ss_pred             cCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhh
Q 039516          231 EGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCL  277 (345)
Q Consensus       231 ~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~  277 (345)
                      ....          ..+...... .+++.+||+.+|++|||+.++...
T Consensus       237 ~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         237 GGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1111          111112233 689999999999999997654433

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.1e-38  Score=281.47  Aligned_cols=228  Identities=21%  Similarity=0.261  Sum_probs=174.2

Q ss_pred             EeeccCCeEEEEEEcCCCcEEEEEEeccCCc-cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCChHH
Q 039516           31 QQEQTRDRVILVGKFPNEQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS  109 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  109 (345)
                      .||+|+||.||+|...++..||+|.++.... .....+.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   81 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS   81 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence            4899999999999888889999999875532 334578999999999999999999999999999999999999999987


Q ss_pred             HHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeec
Q 039516          110 SFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT  173 (345)
Q Consensus       110 ~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt  173 (345)
                      ++.                +++.++.++|..   |++|+||||+||+++.++.+||+|||++......... ......++
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~  157 (250)
T cd05085          82 FLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIP  157 (250)
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCc
Confidence            653                455566777654   8999999999999999999999999998754322111 11112345


Q ss_pred             CCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHH
Q 039516          174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDA  252 (345)
Q Consensus       174 ~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  252 (345)
                      ..|+|||++.++.++.++||||||+++|++++ |..||.......       .......+...         ..+.....
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~  221 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGYRM---------SCPQKCPD  221 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCCC---------CCCCCCCH
Confidence            67999999998889999999999999999998 999987543211       11111111100         01111223


Q ss_pred             H-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          253 F-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       253 ~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      . .+++.+|++.+|.+|||+.++...+
T Consensus       222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l  248 (250)
T cd05085         222 DVYKVMQRCWDYKPENRPKFSELQKEL  248 (250)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHHHh
Confidence            3 6899999999999999987665544

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.5e-38  Score=288.57  Aligned_cols=240  Identities=23%  Similarity=0.308  Sum_probs=180.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      .+|++.+.||+|+||.||+|...      .+..||+|.++... ......+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            45889999999999999998642      24589999986442 223456889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHH-------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEc
Q 039516           97 LVYEFMPNKSLDSSFS-------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISD  151 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~-------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~D  151 (345)
                      +||||+++|+|.+++.                         +++.++.|||.   .+++||||||+||+++.++.++|+|
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECc
Confidence            9999999999988764                         34455666665   4899999999999999999999999


Q ss_pred             cccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHh
Q 039516          152 FGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWN  230 (345)
Q Consensus       152 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  230 (345)
                      ||+++...............++..|+|||.+.++.++.++|+|||||++|||++ |..||......+      .. ....
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~------~~-~~~~  235 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------VL-KFVM  235 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HH-HHHH
Confidence            999876533222111222345678999999998899999999999999999998 788886543211      11 1111


Q ss_pred             cCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          231 EGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       231 ~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                      .+....     .    +...... .+++.+||+.||.+|||+.++...+.+.+
T Consensus       236 ~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         236 DGGYLD-----Q----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             cCCCCC-----C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            111110     1    1111233 69999999999999999887766666544

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-38  Score=286.06  Aligned_cols=237  Identities=24%  Similarity=0.334  Sum_probs=179.9

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      ..+|.+...||+|+||.||+|...      ++..||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            356899999999999999999753      24789999986542 23355788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHH-------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEE
Q 039516           96 LLVYEFMPNKSLDSSFS-------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKIS  150 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~-------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~  150 (345)
                      ++||||+++++|.+++.                         +++.++.|||.   .+++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence            99999999999987652                         34455666664   489999999999999999999999


Q ss_pred             ccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHH
Q 039516          151 DFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLW  229 (345)
Q Consensus       151 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  229 (345)
                      |||+++...............++..|+|||.+.++.++.++|||||||++||+++ |..||.......   .    ....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~----~~~~  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---V----LKFV  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---H----HHHH
Confidence            9999876543222222233456788999999988889999999999999999998 999986543211   1    1111


Q ss_pred             hcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          230 NEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       230 ~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      ..+....     ....+    ... .+++..||+.+|++|||+.++...|
T Consensus       235 ~~~~~~~-----~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l  275 (277)
T cd05032         235 IDGGHLD-----LPENC----PDKLLELMRMCWQYNPKMRPTFLEIVSSL  275 (277)
T ss_pred             hcCCCCC-----CCCCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence            1221111     11112    233 6999999999999999976554443

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.9e-38  Score=282.75  Aligned_cols=233  Identities=24%  Similarity=0.349  Sum_probs=177.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      .+|++.++||+|+||.||++...++..||+|.+.... .....|.+|+.++++++|+|++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            4688899999999999999988888899999997543 24567999999999999999999999874 566899999999


Q ss_pred             CCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          104 NKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       104 ~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      +++|.+++.                 +++.++.+||..   +++||||||+||++++++.++|+|||++......... .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~  159 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A  159 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence            999987653                 455666677655   7999999999999999999999999999876432211 1


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      .....++..|+|||++.+..++.++||||||+++|+|++ |..||......      +.... +..+.     ..    .
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~-~~~~~-----~~----~  223 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVLEQ-VERGY-----RM----P  223 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHHHH-HHcCC-----CC----C
Confidence            112245667999999988889999999999999999999 88998654311      11111 11110     00    0


Q ss_pred             CChhHHHH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          246 CPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       246 ~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      .+...... .+++.+|++.+|.+|||+.++...|
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l  257 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFL  257 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence            11122233 6999999999999999976544433

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.5e-38  Score=286.91  Aligned_cols=244  Identities=20%  Similarity=0.266  Sum_probs=179.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-----------------CCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-----------------NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKL   85 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-----------------~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~   85 (345)
                      .+|++.++||+|+||.||++...                 ++..||+|.+... .......|.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            45899999999999999997532                 2457999999754 23345679999999999999999999


Q ss_pred             EEEEEECCeeEEEEecCCCCChHHHHH--------------------------hHHHHHHHHHhcCCCceEEeccCCCCe
Q 039516           86 LGCSIHGEERLLVYEFMPNKSLDSSFS--------------------------GTFKDLLCLHKYSRLRVIHRDLKASNI  139 (345)
Q Consensus        86 ~~~~~~~~~~~lv~e~~~~gsL~~~l~--------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Ni  139 (345)
                      ++++...+..++||||+++++|.+++.                          +++.++.+||..   |++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            999999999999999999999987653                          455566677755   899999999999


Q ss_pred             eeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh--CCCCCCCCCCCC
Q 039516          140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC--GKKNNKSYHTER  217 (345)
Q Consensus       140 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t--g~~p~~~~~~~~  217 (345)
                      +++.++.++|+|||++................++..|++||...++.++.++|||||||++|||++  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999876533221111222344678999999888899999999999999999998  778886543222


Q ss_pred             cccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhh
Q 039516          218 PLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLM  279 (345)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~  279 (345)
                      .   .......+..... ....+.     +...... .+++.+||+.||.+|||+.++...|.
T Consensus       242 ~---~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 V---IENTGEFFRDQGR-QVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             H---HHHHHHHHhhccc-cccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1   1111111111100 001111     1111233 69999999999999999887666553

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.6e-38  Score=285.78  Aligned_cols=224  Identities=21%  Similarity=0.219  Sum_probs=170.5

Q ss_pred             eeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCCh
Q 039516           32 QEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL  107 (345)
Q Consensus        32 lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL  107 (345)
                      ||+|+||+||++.. .+|+.||+|.+....   ......+..|++++++++|+||+++++++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999965 478999999986432   22345678899999999999999999999999999999999999999


Q ss_pred             HHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCccc
Q 039516          108 DSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTN  168 (345)
Q Consensus       108 ~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  168 (345)
                      ...+.                   +++.+|.|||..   +|+||||||+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            76542                   456667777765   899999999999999999999999999976543221  223


Q ss_pred             ceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          169 RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       169 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ......... .+.      ......++.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~-~~~------~~~~~~~~~  226 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRIL-NDS------VTYPDKFSP  226 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhc-ccC------CCCcccCCH
Confidence            35789999999999999999999999999999999999999975432111  111111111 000      001111222


Q ss_pred             hHHHHHHHHhhccCCCCCcCCCCC
Q 039516          249 NEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       249 ~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..   .+++..||+.||++||+..
T Consensus       227 ~~---~~li~~~l~~~P~~R~~~~  247 (280)
T cd05608         227 AS---KSFCEALLAKDPEKRLGFR  247 (280)
T ss_pred             HH---HHHHHHHhcCCHHHhcCCC
Confidence            22   5899999999999999854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.4e-38  Score=281.95  Aligned_cols=235  Identities=24%  Similarity=0.364  Sum_probs=178.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      ..|.+.++||+|+||.||+|...++..||+|.++... .....|.+|++++++++|+||+++++++. ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            4589999999999999999987766789999997533 34567999999999999999999999874 456899999999


Q ss_pred             CCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          104 NKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       104 ~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      +++|.+++.                 +++.+|.+||.   .+++|+||||+||+++.++.++|+|||.+......... .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~  159 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A  159 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc-c
Confidence            999987764                 44556666665   48999999999999999999999999999866432211 1


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      .....++..|+|||+..+..++.++||||||+++|+|++ |..||.......       .......+..     ..    
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~~~-----~~----  223 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYR-----MP----  223 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-------HHHHHhcCCC-----CC----
Confidence            122345678999999988889999999999999999999 888886543211       1111111100     00    


Q ss_pred             CChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          246 CPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       246 ~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                      .+...... .+++.+|++.+|++|||+.++.+.|..
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            11122233 699999999999999998766655544

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.2e-37  Score=314.62  Aligned_cols=245  Identities=20%  Similarity=0.203  Sum_probs=182.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|++.++||+|+||.||+|.. .+|+.||+|++....   ....++|.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            4689999999999999999975 468999999996542   223457999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH--------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccc
Q 039516          100 EFMPNKSLDSSFS--------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFG  153 (345)
Q Consensus       100 e~~~~gsL~~~l~--------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg  153 (345)
                      ||++|++|.+++.                          +++.+|.|||..   ||+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            9999999987653                          455667777765   89999999999999999999999999


Q ss_pred             cceeecCCCC----------------CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 039516          154 MARIFGVNES----------------GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER  217 (345)
Q Consensus       154 l~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~  217 (345)
                      +++.......                ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9987621110                001123468999999999999999999999999999999999999997532211


Q ss_pred             cccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCC-CCcchhhhhccccc
Q 039516          218 PLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQC-PMLFPCLLMNLLPG  284 (345)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~~~~~~l~~ll~~  284 (345)
                      .   .   .    ........+.......++.-   .+++.+|++.||++||+ +.++...+..++.+
T Consensus       239 i---~---~----~~~i~~P~~~~p~~~iP~~L---~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 I---S---Y----RDVILSPIEVAPYREIPPFL---SQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             h---h---h----hhhccChhhccccccCCHHH---HHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            0   0   0    00000000000001122111   58899999999999976 44444555555443

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.7e-38  Score=283.39  Aligned_cols=230  Identities=23%  Similarity=0.305  Sum_probs=172.3

Q ss_pred             EeeccCCeEEEEEEc---CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKF---PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~---~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      +||+|+||.||+|.+   .++..||+|+++...  ....+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            489999999999964   357899999986543  223567899999999999999999999875 55779999999999


Q ss_pred             ChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC-cccc
Q 039516          106 SLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA-NTNR  169 (345)
Q Consensus       106 sL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~  169 (345)
                      +|.+++.               +++.++.+||..   |++||||||.||+++.++.+||+|||++.......... ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            9987764               456667777754   89999999999999999999999999998754322211 1111


Q ss_pred             eeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       170 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      ..++..|+|||.+....++.++|+||||+++|||++ |+.||......      .... ....+...     .....+++
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~-~i~~~~~~-----~~~~~~~~  225 (257)
T cd05116         158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------EVTQ-MIESGERM-----ECPQRCPP  225 (257)
T ss_pred             CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHH-HHHCCCCC-----CCCCCCCH
Confidence            234578999999988889999999999999999998 99999754321      1111 11121111     11112222


Q ss_pred             hHHHHHHHHhhccCCCCCcCCCCCcchhhhh
Q 039516          249 NEDAFLLVSCVCKSKQQIDVQCPMLFPCLLM  279 (345)
Q Consensus       249 ~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~  279 (345)
                      +.   .+++..||+.||++|||+..|+..|.
T Consensus       226 ~l---~~li~~~~~~~p~~Rp~~~~i~~~l~  253 (257)
T cd05116         226 EM---YDLMKLCWTYGVDERPGFAVVELRLR  253 (257)
T ss_pred             HH---HHHHHHHhccCchhCcCHHHHHHHHh
Confidence            22   59999999999999999876665554

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.4e-38  Score=302.24  Aligned_cols=181  Identities=18%  Similarity=0.248  Sum_probs=144.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--------C
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--------E   93 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--------~   93 (345)
                      ..+|.+.+.||+|+||.||+|.. .+++.||||++....    ....+|+.+|+.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            45799999999999999999965 468999999985432    2345799999999999999999876432        2


Q ss_pred             eeEEEEecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC-CEEEEccc
Q 039516           94 ERLLVYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL-NTKISDFG  153 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg  153 (345)
                      .+++||||+++ +|.+++.                   +++.+|.|||..   +|+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46799999986 4543321                   566677777765   899999999999998665 69999999


Q ss_pred             cceeecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          154 MARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       154 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      +++......   ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+..
T Consensus       217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  275 (440)
T PTZ00036        217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS  275 (440)
T ss_pred             cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            998664322   1223578999999998875 468999999999999999999999997654

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.1e-38  Score=282.77  Aligned_cols=239  Identities=18%  Similarity=0.246  Sum_probs=182.8

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|++.+.||+|+||.||+|.. .+++.||||.++..   .......+.+|++++++++||||+++++++...+..+++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            3689999999999999999975 47899999988543   2233457889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516          100 EFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus       100 e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      ||+++++|.+++.                   +++.++.|||..   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999976652                   456677777754   899999999999999999999999999887643


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ...  ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....    ....+.... .....    .+
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~-~~~~~----~~  227 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKI-EQCDY----PP  227 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHH-hcCCC----CC
Confidence            221  11234678899999999888899999999999999999999999864321    111211111 11111    01


Q ss_pred             cCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          241 TLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       241 ~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                      ..    ....... .+++.+||+.+|++|||+.++...+..
T Consensus       228 ~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~  264 (267)
T cd08228         228 LP----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ  264 (267)
T ss_pred             CC----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence            11    1111223 699999999999999998776665554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8e-38  Score=289.25  Aligned_cols=220  Identities=19%  Similarity=0.184  Sum_probs=169.1

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|+||.||++.. .+|+.||+|.++...   ......+..|..++..+ +||||+++++++.+.+..|+||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g   81 (316)
T cd05620           2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence            599999999999976 468999999996531   23345677788888754 8999999999999999999999999999


Q ss_pred             ChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          106 SLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       106 sL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      +|..++.               +++.+|.|||..   ||+||||||+||+++.++.+||+|||+++.....  .......
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~  156 (316)
T cd05620          82 DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRASTF  156 (316)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCceecc
Confidence            9976654               456666777654   8999999999999999999999999998753211  1122345


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhH
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE  250 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  250 (345)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +    ......+      .+.+....+.+.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~----~~~~~~~------~~~~~~~~~~~~  223 (316)
T cd05620         157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---L----FESIRVD------TPHYPRWITKES  223 (316)
T ss_pred             CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H----HHHHHhC------CCCCCCCCCHHH
Confidence            78999999999999999999999999999999999999997543211   1    1111111      111111122221


Q ss_pred             HHHHHHHhhccCCCCCcCCCC
Q 039516          251 DAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       251 ~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                         .+++..||+.||.+||++
T Consensus       224 ---~~li~~~l~~dP~~R~~~  241 (316)
T cd05620         224 ---KDILEKLFERDPTRRLGV  241 (316)
T ss_pred             ---HHHHHHHccCCHHHcCCC
Confidence               589999999999999995

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.6e-37  Score=283.06  Aligned_cols=229  Identities=21%  Similarity=0.223  Sum_probs=175.3

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      .|++.+.||+|+||.||++.. .+++.||+|.+....   ......+.+|+.++++++|+||+.+++.+..++..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            377888999999999999865 478999999986542   2223457889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          101 FMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       101 ~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |+++++|.+++.                 +++.++.|||..   +|+||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            999999987653                 456667777754   89999999999999999999999999987653222 


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                        ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.........   ..........      .....
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~~------~~~~~  225 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEV------QEEYS  225 (285)
T ss_pred             --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhhh------hhhcC
Confidence              122346899999999999999999999999999999999999999764321110   0011111000      00111


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCC
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                      ..++++.   .+++..||+.||.+|||.
T Consensus       226 ~~~~~~~---~~li~~~l~~~p~~R~s~  250 (285)
T cd05630         226 EKFSPDA---RSLCKMLLCKDPKERLGC  250 (285)
T ss_pred             ccCCHHH---HHHHHHHhhcCHHHccCC
Confidence            1122221   589999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.8e-38  Score=293.36  Aligned_cols=220  Identities=19%  Similarity=0.195  Sum_probs=170.6

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCC
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS  106 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gs  106 (345)
                      .||+|+||.||++.. .+|+.||+|.+...   .......+.+|++++..++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            589999999999964 57899999999653   22334567889999999999999999999999999999999999999


Q ss_pred             hHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCccccee
Q 039516          107 LDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV  171 (345)
Q Consensus       107 L~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~  171 (345)
                      |..++.               +++.+|.|||..  .||+||||||+|||++.++.+||+|||+++......  .......
T Consensus        82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~  157 (325)
T cd05594          82 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFC  157 (325)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccccccc
Confidence            976653               566677777752  389999999999999999999999999987542211  1223357


Q ss_pred             ecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHH
Q 039516          172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNED  251 (345)
Q Consensus       172 gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  251 (345)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      .. .....+.      ..+....+++. 
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~------~~-~~i~~~~------~~~p~~~~~~~-  223 (325)
T cd05594         158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LF-ELILMEE------IRFPRTLSPEA-  223 (325)
T ss_pred             CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH------HH-HHHhcCC------CCCCCCCCHHH-
Confidence            8999999999999999999999999999999999999997543211      11 1111111      11111122222 


Q ss_pred             HHHHHHhhccCCCCCcCCC
Q 039516          252 AFLLVSCVCKSKQQIDVQC  270 (345)
Q Consensus       252 ~~~~l~~~Cl~~~P~~RPs  270 (345)
                        .+++.+||+.||.+|++
T Consensus       224 --~~li~~~L~~dP~~R~~  240 (325)
T cd05594         224 --KSLLSGLLKKDPKQRLG  240 (325)
T ss_pred             --HHHHHHHhhcCHHHhCC
Confidence              58999999999999984

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.1e-37  Score=280.66  Aligned_cols=235  Identities=19%  Similarity=0.249  Sum_probs=179.2

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ...+|++..+||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++|||
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            345799999999999999999975 5789999999976554556678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |+++++|.+++.               +++.++.+||..   +|+||||||+||+++.++.++|+|||++........  
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--  161 (267)
T cd06646          87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--  161 (267)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence            999999987753               556677777764   899999999999999999999999999987632211  


Q ss_pred             cccceeecCCccccchhc---cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          166 NTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                      ......|+..|+|||.+.   ...++.++|+||||+++|||++|+.||..........       .+...   ....+.+
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~---~~~~~~~  231 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKS---NFQPPKL  231 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecC---CCCCCCC
Confidence            122346888999999874   3457889999999999999999999986543211100       00000   0011111


Q ss_pred             CCCCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          243 DGSCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       243 ~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      ...  ...... .+++.+||+.+|++|||+.+
T Consensus       232 ~~~--~~~~~~~~~li~~~l~~~P~~Rp~~~~  261 (267)
T cd06646         232 KDK--TKWSSTFHNFVKISLTKNPKKRPTAER  261 (267)
T ss_pred             ccc--cccCHHHHHHHHHHhhCChhhCcCHHH
Confidence            110  011123 68999999999999999653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-38  Score=286.39  Aligned_cols=242  Identities=21%  Similarity=0.314  Sum_probs=178.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCC---------------CcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPN---------------EQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLG   87 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~---------------~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~   87 (345)
                      .+|++.+.||+|+||.||++....               ...||+|.++.. .......|.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            568999999999999999986532               235899999754 2334557999999999999999999999


Q ss_pred             EEEECCeeEEEEecCCCCChHHHHH---------------------------hHHHHHHHHHhcCCCceEEeccCCCCee
Q 039516           88 CSIHGEERLLVYEFMPNKSLDSSFS---------------------------GTFKDLLCLHKYSRLRVIHRDLKASNIL  140 (345)
Q Consensus        88 ~~~~~~~~~lv~e~~~~gsL~~~l~---------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nil  140 (345)
                      ++...+..++||||+++++|.+++.                           +++.++.|||..   +++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence            9999999999999999999977642                           455666777754   8999999999999


Q ss_pred             eCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh--CCCCCCCCCCCCc
Q 039516          141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC--GKKNNKSYHTERP  218 (345)
Q Consensus       141 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t--g~~p~~~~~~~~~  218 (345)
                      ++.++.+||+|||++................++..|+|||++.++.++.++||||||+++|+|++  |..||....... 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence            99999999999999876533222222222345678999999988889999999999999999998  566776543211 


Q ss_pred             ccHHHHHHHHHhcC-CccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          219 LNLVGIAWQLWNEG-KDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       219 ~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                        .+......+... ......   .....+    .. .+++.+||+.||++||||.++...|
T Consensus       241 --~~~~~~~~~~~~~~~~~~~---~~~~~~----~~l~~li~~~l~~~p~~RPs~~~i~~~l  293 (295)
T cd05097         241 --VIENTGEFFRNQGRQIYLS---QTPLCP----SPVFKLMMRCWSRDIKDRPTFNKIHHFL  293 (295)
T ss_pred             --HHHHHHHhhhhccccccCC---CCCCCC----HHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence              111111111111 100000   011112    23 6999999999999999987765554

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.5e-38  Score=279.62  Aligned_cols=229  Identities=22%  Similarity=0.285  Sum_probs=179.2

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +|.+.+.||+|++|.||++.. .+++.|++|.+...  .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            478889999999999999976 46899999998643  334566789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          102 MPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       102 ~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      +++++|.+++.                 +++.++.+||..   |++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            99999987764                 455666677754   899999999999999999999999999887643221 


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                       ......|++.|+|||+..+..++.++|+||||+++|+|++|+.||......      . .......+...     .+..
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~-----~~~~  223 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------A-LILKIIRGVFP-----PVSQ  223 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCCCC-----CCcc
Confidence             123346888999999999988999999999999999999999999754311      1 11111111111     1111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .++...   .+++.+||+.+|++||++.+
T Consensus       224 ~~~~~~---~~~i~~~l~~~p~~Rp~~~~  249 (256)
T cd08529         224 MYSQQL---AQLIDQCLTKDYRQRPDTFQ  249 (256)
T ss_pred             ccCHHH---HHHHHHHccCCcccCcCHHH
Confidence            122111   69999999999999999653

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-39  Score=303.00  Aligned_cols=223  Identities=21%  Similarity=0.290  Sum_probs=180.6

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCChHH
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS  109 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  109 (345)
                      .||+|.||+||.|+. .+...+|||.+..........+.+|+.+-++|+|.|||+++|++.+++.+-|.||-++||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            499999999999965 4567899999977766667788999999999999999999999999999999999999999998


Q ss_pred             HHH------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC-CCCCEEEEccccceeecCCCCCCcccce
Q 039516          110 SFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD-DQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       110 ~l~------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      +++                  +++++|.|||..+   |||||||-+|+|++ -.|.+||+|||-++.+.  .....+.++
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCcccccc
Confidence            876                  7788888888874   99999999999996 47889999999998763  233445678


Q ss_pred             eecCCccccchhccCC--cCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          171 VGTYGYMSLEYTMSGT--VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~--~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      .||..|||||++..++  |+.++|||||||++.||.||++||-.......        .+++-|-.  .+.|.    .+.
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmy--KvHP~----iPe  802 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMY--KVHPP----IPE  802 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcce--ecCCC----CcH
Confidence            9999999999998764  78999999999999999999999976543221        11111111  01111    233


Q ss_pred             hHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          249 NEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       249 ~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +-.+. ..++++|..+||.+||++.
T Consensus       803 elsaeak~FilrcFepd~~~R~sA~  827 (1226)
T KOG4279|consen  803 ELSAEAKNFILRCFEPDPCDRPSAK  827 (1226)
T ss_pred             HHHHHHHHHHHHHcCCCcccCccHH
Confidence            33334 8999999999999999964

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.4e-38  Score=285.43  Aligned_cols=240  Identities=22%  Similarity=0.303  Sum_probs=179.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCc----EEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQ----EVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~----~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ..+|++.++||+|+||+||+|.+ .+|.    .||+|.++.. .......+.+|+.+++.++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            35689999999999999999974 3444    5899998654 33345678899999999999999999999865 4578


Q ss_pred             EEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           97 LVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      ++|||+++|+|.+++.                +++.+|.|||..   +++||||||+||++++++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            9999999999987764                556666677654   899999999999999999999999999987643


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      ...........++..|+|||...+..++.++|||||||++|||++ |..||......   .+.    ..+..+....   
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~~---  231 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIP----DLLEKGERLP---  231 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHHCCCcCC---
Confidence            222211222234678999999988889999999999999999998 89998654311   111    1111111110   


Q ss_pred             ccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          240 LTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       240 ~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                        ....++    .. .+++..||+.||++|||+.++...+..+.
T Consensus       232 --~~~~~~----~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         232 --QPPICT----IDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             --CCccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence              001122    23 58999999999999999887766665543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-37  Score=294.52  Aligned_cols=179  Identities=17%  Similarity=0.207  Sum_probs=150.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ..+|.+.+.||+|+||.||++.. .+++.||+|...      ...+.+|++++++++||||+++++++......++|||+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            35799999999999999999964 578999999753      23578999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          102 MPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       102 ~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      +. ++|..++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||++....... ...
T Consensus       165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~  239 (391)
T PHA03212        165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANK  239 (391)
T ss_pred             CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccc
Confidence            96 56655432               567777777765   89999999999999999999999999987532211 112


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKS  212 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~  212 (345)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            2335799999999999999999999999999999999999988754

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.8e-38  Score=284.18  Aligned_cols=238  Identities=21%  Similarity=0.290  Sum_probs=178.9

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CC---cEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NE---QEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~---~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      .+|++.+.||+|+||.||+|... ++   ..||||.++.. .......|..|+.++++++||||+++++++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            35888999999999999999764 23   36999998754 334466899999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           99 YEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        99 ~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      |||+++++|.+++.                +++.++.+||..   |++|+||||+||+++.++.+||+|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            99999999987764                455667777754   89999999999999999999999999987653322


Q ss_pred             CCCccccee---ecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          163 SGANTNRIV---GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       163 ~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                      .........   .+..|+|||++.+..++.++||||||+++||+++ |..||......   ....+.    ....     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i----~~~~-----  228 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI----EQDY-----  228 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH----HcCC-----
Confidence            111111111   2357999999998999999999999999999886 99998754321   111111    1110     


Q ss_pred             cccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          239 DLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       239 d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                      .......++    .. .+++..||+.+|++||++.++...|.+
T Consensus       229 ~~~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         229 RLPPPMDCP----TALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             cCCCcccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            000011122    23 589999999999999998776665544

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.3e-38  Score=282.49  Aligned_cols=238  Identities=21%  Similarity=0.311  Sum_probs=180.4

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CC---cEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NE---QEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~---~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      +|+..+.||+|+||.||+|... ++   ..||+|.+... .......+.+|++++++++|+||+++++++...+..++||
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT   85 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence            5788889999999999999764 33   37999998654 2334567899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          100 EFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       100 e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      ||+++++|.+++.                +++.++.+||..   +++|+||||+||+++.++.+||+|||++........
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          86 EYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence            9999999987764                455666677655   899999999999999999999999999886643221


Q ss_pred             CCcc-cceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          164 GANT-NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       164 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      .... .....+..|+|||++.+..++.++||||||+++|||++ |+.||......      .. ......+..    .+.
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~-~~~i~~~~~----~~~  231 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EV-MKAINDGFR----LPA  231 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HH-HHHHhcCCC----CCC
Confidence            1111 11123457999999988889999999999999999998 99999654321      11 111111110    000


Q ss_pred             CCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          242 LDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       242 l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                       ...++    .. .+++.+||+.+|++||++.++.+.|.++
T Consensus       232 -~~~~~----~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         232 -PMDCP----SAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -CCCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             01122    23 6999999999999999998888777665

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-38  Score=296.38  Aligned_cols=242  Identities=21%  Similarity=0.222  Sum_probs=181.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC-Ce
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHG-EE   94 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~-~~   94 (345)
                      .+|.+.+.||+|+||.||+|..      .+++.||||.++... ......+.+|+.++.++ +|+||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            4588999999999999999963      357899999997543 22345688999999999 689999999988654 56


Q ss_pred             eEEEEecCCCCChHHHHH--------------------------------------------------------------
Q 039516           95 RLLVYEFMPNKSLDSSFS--------------------------------------------------------------  112 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~--------------------------------------------------------------  112 (345)
                      .+++|||+++|+|.+++.                                                              
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            789999999999987653                                                              


Q ss_pred             --------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceee
Q 039516          113 --------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG  172 (345)
Q Consensus       113 --------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g  172 (345)
                                          +++.++.|||.   .+|+||||||+||+++.++.+||+|||++................+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                                45556667765   4899999999999999999999999999876532222122222345


Q ss_pred             cCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHH
Q 039516          173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNED  251 (345)
Q Consensus       173 t~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  251 (345)
                      +..|+|||.+.+..++.++||||||+++|+|++ |..||.......      ........+.....     ....+    
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~-----~~~~~----  308 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA-----PDYTT----  308 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCCCC-----CCCCC----
Confidence            677999999988899999999999999999997 999986543211      11111112111100     00111    


Q ss_pred             HH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          252 AF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       252 ~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .. .+++..||+.+|.+|||+.++...|..+++
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            23 589999999999999999988888887765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-37  Score=289.16  Aligned_cols=221  Identities=19%  Similarity=0.177  Sum_probs=168.9

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHH-HHHhcCCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAK-LIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|+||.||++.. .+|+.||+|.+....   ......+..|.. +++.++||||+++++++...+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            599999999999976 478999999996431   222344555655 567899999999999999999999999999999


Q ss_pred             ChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          106 SLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       106 sL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      +|..++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||++......  .......
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~  156 (323)
T cd05575          82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTSTF  156 (323)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccccc
Confidence            9976653               566677777765   8999999999999999999999999998753221  1223345


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhH
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE  250 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  250 (345)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||.....      ........ .+.      ..+....+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~-~~~------~~~~~~~~~~~  223 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNIL-NKP------LRLKPNISVSA  223 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHH-cCC------CCCCCCCCHHH
Confidence            789999999999999999999999999999999999999975431      11111111 111      11111122222


Q ss_pred             HHHHHHHhhccCCCCCcCCCCC
Q 039516          251 DAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       251 ~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                         .+++..||+.||.+||++.
T Consensus       224 ---~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         224 ---RHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ---HHHHHHHhhcCHHhCCCCC
Confidence               5899999999999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.3e-38  Score=291.97  Aligned_cols=223  Identities=21%  Similarity=0.209  Sum_probs=173.2

Q ss_pred             EEeeccCCeEEEEEEc----CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           30 IQQEQTRDRVILVGKF----PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~----~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      +.||+|+||.||++..    .+|+.||+|++....  ......+.+|++++++++||||+++++++...+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4699999999999864    368999999996532  2234567889999999999999999999999999999999999


Q ss_pred             CCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCccc
Q 039516          104 NKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTN  168 (345)
Q Consensus       104 ~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  168 (345)
                      +++|.+++.               +++.+|.|||..   +|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~  156 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAY  156 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Ccee
Confidence            999977653               566777777765   89999999999999999999999999987653221  1223


Q ss_pred             ceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          169 RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       169 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......      ....... ....      .+....+.
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i~-~~~~------~~p~~~~~  223 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMIL-KAKL------GMPQFLSP  223 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHHH-cCCC------CCCCCCCH
Confidence            457899999999999888999999999999999999999999754321      1111111 1111      01111222


Q ss_pred             hHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          249 NEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       249 ~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      +.   ..++..||+.||.+|||+.+
T Consensus       224 ~~---~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         224 EA---QSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             HH---HHHHHHHhhcCHhHcCCCCC
Confidence            21   58999999999999999765

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.1e-38  Score=290.61  Aligned_cols=241  Identities=19%  Similarity=0.226  Sum_probs=182.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC--------CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP--------NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGE   93 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~--------~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~   93 (345)
                      .+|.+.++||+|+||.||++...        ++..||+|.++... ......+.+|+.+++++ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            56999999999999999998642        23579999997542 33455788999999999 7999999999999999


Q ss_pred             eeEEEEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC
Q 039516           94 ERLLVYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD  142 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~  142 (345)
                      ..|+||||+++++|.+++.                               +++.+|.+||..   |++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence            9999999999999977653                               345566677754   899999999999999


Q ss_pred             CCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccH
Q 039516          143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNL  221 (345)
Q Consensus       143 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~  221 (345)
                      .++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.....      
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------  248 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------  248 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------
Confidence            999999999999876532211111111234568999999998889999999999999999998 8888864321      


Q ss_pred             HHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          222 VGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       222 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .... .....+...+         .+...... .+++..||+.+|.+||||.++...|.++++
T Consensus       249 ~~~~-~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         249 EELF-KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             HHHH-HHHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence            1111 1111111100         11111223 589999999999999999988888887765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.8e-38  Score=281.54  Aligned_cols=230  Identities=22%  Similarity=0.285  Sum_probs=172.2

Q ss_pred             EeeccCCeEEEEEEcC---CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCC
Q 039516           31 QQEQTRDRVILVGKFP---NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS  106 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~---~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gs  106 (345)
                      .||+|+||.||+|.+.   .+..||+|.+.... ....+.|.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999653   35679999997553 233567999999999999999999999885 457899999999999


Q ss_pred             hHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc-ccc
Q 039516          107 LDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN-TNR  169 (345)
Q Consensus       107 L~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~~~  169 (345)
                      |.+++.                +++.++.+||..   |++||||||+||+++.++.+||+|||++........... ...
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            988764                456667777654   899999999999999999999999999976533221111 111


Q ss_pred             eeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       170 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      ..++..|+|||++.+..++.++||||||+++|++++ |..||.......      . ......+..         ...+.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~-~~~~~~~~~---------~~~~~  221 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------V-MSFIEQGKR---------LDCPA  221 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------H-HHHHHCCCC---------CCCCC
Confidence            223568999999988889999999999999999996 999997643211      1 111112211         01112


Q ss_pred             hHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          249 NEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       249 ~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                      ..... .+++..||+.+|++||++.++...|..
T Consensus       222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            22233 589999999999999998776665543

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.5e-37  Score=286.23  Aligned_cols=183  Identities=22%  Similarity=0.316  Sum_probs=157.3

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      +|++.+.||+|+||.||++.. .++..||+|.+... .......+.+|++++++++||||+++++++..++..++||||+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            589999999999999999965 46889999998654 2233456889999999999999999999999999999999999


Q ss_pred             CCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          103 PNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       103 ~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      ++++|.+++.               +++.+|.|||..+  +++|+||||+||+++.++.+||+|||++......    ..
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~  155 (308)
T cd06615          82 DGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA  155 (308)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc----cc
Confidence            9999988764               5677888888643  7999999999999999999999999998754321    12


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      ....|+..|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~  201 (308)
T cd06615         156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP  201 (308)
T ss_pred             ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence            3357889999999998888999999999999999999999998654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-37  Score=328.14  Aligned_cols=246  Identities=18%  Similarity=0.247  Sum_probs=199.9

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCC
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN  104 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  104 (345)
                      +.....||+|+||.||+|.. .+|..||||+++.....    ...|++.+++++|||||+++++|.+....++||||+++
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~  767 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG  767 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence            45567799999999999975 57899999998644321    23568899999999999999999999999999999999


Q ss_pred             CChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceee
Q 039516          105 KSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG  172 (345)
Q Consensus       105 gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g  172 (345)
                      |+|.++++            +++.++.|||..++.+|+||||||+||+++.++.+++. ||.......      .....|
T Consensus       768 g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~  840 (968)
T PLN00113        768 KNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFI  840 (968)
T ss_pred             CcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccc
Confidence            99988764            67889999998878899999999999999999888876 665543211      112367


Q ss_pred             cCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC--CChhH
Q 039516          173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS--CPPNE  250 (345)
Q Consensus       173 t~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~  250 (345)
                      |+.|+|||++.+..++.++|||||||++|||+||+.||.... ........|+...+.......++|+.+...  .+..+
T Consensus       841 t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  919 (968)
T PLN00113        841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNE  919 (968)
T ss_pred             cccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHH
Confidence            899999999999999999999999999999999999995432 234457778777666666667778777543  23345


Q ss_pred             HHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          251 DAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       251 ~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ... .+++.+||+.||++||||.+++..|.++.+
T Consensus       920 ~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        920 IVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             HHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            555 899999999999999999999888887765

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.3e-37  Score=286.77  Aligned_cols=185  Identities=22%  Similarity=0.338  Sum_probs=152.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .+|.+.++||+|+||.||+|.. .+++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            4589999999999999999975 468899999987543 23345678999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      +++ +|.+.+.                +++.+|.+||..   ||+||||||+||+++.++.+||+|||++........  
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence            985 5655432                556667777754   899999999999999999999999999876532221  


Q ss_pred             cccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  209 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST  209 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            1223467899999998865 468899999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.3e-37  Score=287.90  Aligned_cols=221  Identities=20%  Similarity=0.197  Sum_probs=169.1

Q ss_pred             EeeccCCeEEEEEEcC-CCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKFP-NEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|+||.||+|... +++.||||.++..   .......+..|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            5999999999999764 5789999999654   123345677788888764 9999999999999999999999999999


Q ss_pred             ChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          106 SLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       106 sL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      +|.+++.               +++.+|.|||.   .+|+||||||+|||++.++.+||+|||++.......  ......
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~  156 (316)
T cd05619          82 DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTF  156 (316)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cceeee
Confidence            9987764               45556666665   489999999999999999999999999987542211  122345


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhH
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE  250 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  250 (345)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.    .....+.      +......+.+.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~----~~i~~~~------~~~~~~~~~~~  223 (316)
T cd05619         157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LF----QSIRMDN------PCYPRWLTREA  223 (316)
T ss_pred             cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhCC------CCCCccCCHHH
Confidence            78999999999999899999999999999999999999997643211   11    1111111      11111122111


Q ss_pred             HHHHHHHhhccCCCCCcCCCCC
Q 039516          251 DAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       251 ~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                         .+++.+||+.||.+||++.
T Consensus       224 ---~~li~~~l~~~P~~R~~~~  242 (316)
T cd05619         224 ---KDILVKLFVREPERRLGVK  242 (316)
T ss_pred             ---HHHHHHHhccCHhhcCCCh
Confidence               5899999999999999964

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.5e-37  Score=287.84  Aligned_cols=220  Identities=19%  Similarity=0.157  Sum_probs=168.1

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHH-HHHhcCCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAK-LIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|+||.||++.. .+|+.||+|.+....   ......+..|.. +++.++||||+++++++.+.+..++||||++++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            599999999999976 468999999986431   222344555654 678899999999999999999999999999999


Q ss_pred             ChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          106 SLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       106 sL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      +|...+.               +++.+|.|||..   ||+||||||+||+++.++.+||+|||+++.....  .......
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~  156 (321)
T cd05603          82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTSTF  156 (321)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccccc
Confidence            9976543               566677777754   8999999999999999999999999998753221  1122345


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhH
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE  250 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  250 (345)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||...+.      ........ ....      .    .++..
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~-~~~~------~----~~~~~  219 (321)
T cd05603         157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNIL-HKPL------Q----LPGGK  219 (321)
T ss_pred             cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHh-cCCC------C----CCCCC
Confidence            789999999999988999999999999999999999999975431      11111111 1110      0    11222


Q ss_pred             HHH-HHHHhhccCCCCCcCCCCC
Q 039516          251 DAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       251 ~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ... .+++..||+.||.+||+..
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         220 TVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CHHHHHHHHHHccCCHhhcCCCC
Confidence            223 6899999999999999954

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.7e-37  Score=281.43  Aligned_cols=230  Identities=21%  Similarity=0.209  Sum_probs=175.5

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      |...+.||+|+||.||++.. .+++.||+|.+....   ......+.+|++++++++|+||+.+++++..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            67888899999999999965 578999999986542   22344578899999999999999999999999999999999


Q ss_pred             CCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          102 MPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       102 ~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      +++++|.+++.                 +++.++.+||.   .+|+||||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999976653                 45556666665   489999999999999999999999999987653221  


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                       ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.........   ............      ....
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~~------~~~~  226 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETEE------VYSA  226 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhcccc------ccCc
Confidence             122347899999999999889999999999999999999999999764321111   111111111110      0111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .++.+.   .+++..||+.||.+|||+.+
T Consensus       227 ~~~~~~---~~li~~~l~~~P~~R~~~~~  252 (285)
T cd05632         227 KFSEEA---KSICKMLLTKDPKQRLGCQE  252 (285)
T ss_pred             cCCHHH---HHHHHHHccCCHhHcCCCcc
Confidence            122222   58999999999999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=298.45  Aligned_cols=235  Identities=20%  Similarity=0.277  Sum_probs=192.5

Q ss_pred             EEeeccCCeEEEEEEcCC---C--cEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           30 IQQEQTRDRVILVGKFPN---E--QEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~~---~--~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      +.||+|.||.||+|.+.+   |  -.||||..+.+ .....+.|+.|+.+|++++|||||+++|+|.+ ...|||||.++
T Consensus       395 r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~  473 (974)
T KOG4257|consen  395 RLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAP  473 (974)
T ss_pred             HhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEeccc
Confidence            568999999999997643   2  46899999875 45568889999999999999999999999954 67899999999


Q ss_pred             CCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          104 NKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       104 ~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      -|.|..++.                +++.+|.|||+.   ..|||||..+|||+.....+||+|||+++.+.........
T Consensus       474 ~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS  550 (974)
T KOG4257|consen  474 LGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS  550 (974)
T ss_pred             chhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccchhhcc
Confidence            999998887                667778888876   7999999999999999999999999999988655443332


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                       ...-...|||||.+.-..++.+||||-|||++||++. |..||.+....+..-                .+...-+-.+
T Consensus       551 -~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~----------------~iEnGeRlP~  613 (974)
T KOG4257|consen  551 -RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG----------------HIENGERLPC  613 (974)
T ss_pred             -ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE----------------EecCCCCCCC
Confidence             2344678999999999999999999999999999987 999998865433211                1111112225


Q ss_pred             ChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccccc
Q 039516          247 PPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGL  285 (345)
Q Consensus       247 ~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~  285 (345)
                      ++.+... ..++.+||..+|.+||++.++.+.|..+++.+
T Consensus       614 P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee  653 (974)
T KOG4257|consen  614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE  653 (974)
T ss_pred             CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence            5566666 79999999999999999999999999988743

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.5e-37  Score=290.95  Aligned_cols=187  Identities=21%  Similarity=0.253  Sum_probs=155.8

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +|++.+.||+|+||.||++.. .+++.||+|.++..   .......+.+|+.++..++|+||+++++++.+.+..|+|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            689999999999999999965 46899999999643   23345678889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC--
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES--  163 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--  163 (345)
                      |+++|+|.+++.               +++.+|.|||.   .||+||||||+|||++.++.+||+|||++........  
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            999999988764               44455556654   5899999999999999999999999999875421110  


Q ss_pred             -------------------------------CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 039516          164 -------------------------------GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKS  212 (345)
Q Consensus       164 -------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~  212 (345)
                                                     ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                           0011234789999999999999999999999999999999999999976


Q ss_pred             CC
Q 039516          213 YH  214 (345)
Q Consensus       213 ~~  214 (345)
                      ..
T Consensus       239 ~~  240 (360)
T cd05627         239 ET  240 (360)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.8e-37  Score=275.56  Aligned_cols=238  Identities=18%  Similarity=0.252  Sum_probs=183.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|++.+.||+|+||.||+|... +|+.||+|.++..   .......+.+|++++++++|+||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            36899999999999999999765 7999999988643   2334667999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516          100 EFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus       100 e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      ||+++++|.+++.                   +++.++.+||..   |++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999987653                   456667777764   899999999999999999999999999876533


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....    ......... ...+..    .+
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~-~~~~~~----~~  227 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKK-IEKCDY----PP  227 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhh-hhcCCC----CC
Confidence            221  1223467889999999998889999999999999999999999986432    111111111 111111    11


Q ss_pred             cCCCCCCh-hHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          241 TLDGSCPP-NEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       241 ~l~~~~~~-~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                           .+. ..... .+++.+||+.+|++|||+.++...+..
T Consensus       228 -----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~  264 (267)
T cd08224         228 -----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE  264 (267)
T ss_pred             -----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence                 111 11123 689999999999999998766555544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.8e-37  Score=282.93  Aligned_cols=234  Identities=21%  Similarity=0.309  Sum_probs=182.0

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      +....|.+.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.+.|+||+++++.+..+...++||
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            3456799999999999999999974 578999999997665555678999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          100 EFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       100 e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ||+++++|.+++.              +++.++.+||..   ||+|+||||+||+++.++.++|+|||++........  
T Consensus        97 e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--  171 (296)
T cd06654          97 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (296)
T ss_pred             cccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc--
Confidence            9999999987764              456666777654   899999999999999999999999999876432211  


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......      ........+..      .+.  
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~~~------~~~--  237 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP------ELQ--  237 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCCCC------CCC--
Confidence            1123468889999999998889999999999999999999999997543211      11111111110      000  


Q ss_pred             CChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          246 CPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       246 ~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .+...... .+++.+||+.+|.+|||+.+
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~e  266 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKE  266 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHH
Confidence            11111122 58999999999999999643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.4e-37  Score=284.17  Aligned_cols=243  Identities=20%  Similarity=0.281  Sum_probs=180.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCC-----------------CcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPN-----------------EQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKL   85 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~-----------------~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~   85 (345)
                      .+|++.++||+|+||.||++....                 +..||+|.+.... ......+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            468899999999999999986532                 2568999987553 3346678999999999999999999


Q ss_pred             EEEEEECCeeEEEEecCCCCChHHHHH--------------------------hHHHHHHHHHhcCCCceEEeccCCCCe
Q 039516           86 LGCSIHGEERLLVYEFMPNKSLDSSFS--------------------------GTFKDLLCLHKYSRLRVIHRDLKASNI  139 (345)
Q Consensus        86 ~~~~~~~~~~~lv~e~~~~gsL~~~l~--------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Ni  139 (345)
                      ++++..++..+++|||+++++|.+++.                          +++.++.|||..   +++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence            999999999999999999999877642                          456667777754   899999999999


Q ss_pred             eeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh--CCCCCCCCCCCC
Q 039516          140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC--GKKNNKSYHTER  217 (345)
Q Consensus       140 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t--g~~p~~~~~~~~  217 (345)
                      +++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++  |..||...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ-  240 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-
Confidence            999999999999999876533222222233456778999999988889999999999999999998  66777654321 


Q ss_pred             cccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          218 PLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                        .........+..........      .++..... .+++.+||+.||.+|||+.++...|
T Consensus       241 --~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L  294 (296)
T cd05051         241 --QVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL  294 (296)
T ss_pred             --HHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence              11222222211111111111      11111123 6999999999999999987655443

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.3e-38  Score=288.73  Aligned_cols=241  Identities=20%  Similarity=0.241  Sum_probs=182.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc--------CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF--------PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGE   93 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~--------~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~   93 (345)
                      .+|.+.++||+|+||.||++..        ..+..||+|.++.. .......+.+|+.+++++ +||||+++++++...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            4688999999999999999863        12457999998754 233456788999999999 6999999999999889


Q ss_pred             eeEEEEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC
Q 039516           94 ERLLVYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD  142 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~  142 (345)
                      ..+++|||+++|+|.+++.                               +++.+|.|||..   |++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence            9999999999999987753                               456667777754   899999999999999


Q ss_pred             CCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccH
Q 039516          143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNL  221 (345)
Q Consensus       143 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~  221 (345)
                      .++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||......+    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----  244 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE----  244 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence            999999999999986532221111112234567999999998889999999999999999999 888886543211    


Q ss_pred             HHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          222 VGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       222 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                         .......+....         .+...... .+++.+||+.+|++|||+.++...|.++..
T Consensus       245 ---~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         245 ---LFKLLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ---HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence               111111221111         11111223 589999999999999998888877777654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.9e-38  Score=286.41  Aligned_cols=237  Identities=23%  Similarity=0.314  Sum_probs=180.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      .+|++...||+|+||.||++...      ++..||+|.+.... ......+.+|+.++++++||||+++++++..+...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            46889999999999999999753      46899999986543 233567899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHH-------------------------------------hHHHHHHHHHhcCCCceEEeccCCCCe
Q 039516           97 LVYEFMPNKSLDSSFS-------------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNI  139 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~-------------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Ni  139 (345)
                      ++|||+++++|.+++.                                     +++.+|.+||.   .+++||||||+||
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ni  161 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNC  161 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhhe
Confidence            9999999999977753                                     34555666665   4899999999999


Q ss_pred             eeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCc
Q 039516          140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERP  218 (345)
Q Consensus       140 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~  218 (345)
                      +++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......  
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~--  239 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE--  239 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            999999999999999876532221111222234667999999988899999999999999999998 88888654321  


Q ss_pred             ccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhh
Q 039516          219 LNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLM  279 (345)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~  279 (345)
                          +.. .....+....         .+...... .+++.+||+.+|.+|||+.++...|.
T Consensus       240 ----~~~-~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         240 ----EVI-YYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             ----HHH-HHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence                111 1122222111         11111223 68999999999999999887666554

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.1e-38  Score=287.80  Aligned_cols=240  Identities=21%  Similarity=0.278  Sum_probs=180.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CC--cEEEEEEeccC-CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NE--QEVAIKRLAWT-SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~--~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv   98 (345)
                      .+|++.+.||+|+||.||+|... ++  ..+++|.++.. .......|.+|+.++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            46888999999999999999764 33  35799988643 333456789999999999 799999999999999999999


Q ss_pred             EecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCE
Q 039516           99 YEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNT  147 (345)
Q Consensus        99 ~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~  147 (345)
                      |||+++++|.+++.                               +++.++.+||.   .|++||||||+||+++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence            99999999977652                               34556666665   489999999999999999999


Q ss_pred             EEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 039516          148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAW  226 (345)
Q Consensus       148 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~  226 (345)
                      ||+|||++......   ........+..|+|||++.+..++.++|||||||++|||++ |..||.......      . .
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~-~  228 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------L-Y  228 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------H-H
Confidence            99999998643111   01111123457999999988889999999999999999997 999997543211      1 1


Q ss_pred             HHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          227 QLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       227 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      .....+.     .......++...   .+++..||+.+|.+|||+.+++..|..++++
T Consensus       229 ~~~~~~~-----~~~~~~~~~~~~---~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         229 EKLPQGY-----RMEKPRNCDDEV---YELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             HHHhcCC-----CCCCCCCCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            1111111     011111122211   5999999999999999999998888887764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.5e-37  Score=278.90  Aligned_cols=232  Identities=20%  Similarity=0.227  Sum_probs=166.7

Q ss_pred             EeeccCCeEEEEEEcCC---CcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCC
Q 039516           31 QQEQTRDRVILVGKFPN---EQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS  106 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~~---~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gs  106 (345)
                      .||+|+||.||+|...+   ...||+|.+.... ......|.+|+.+++.++|+||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            48999999999996533   4578999876443 2334578899999999999999999999999999999999999999


Q ss_pred             hHHHHH--------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          107 LDSSFS--------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       107 L~~~l~--------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      |.+++.                    +++.++.|||..   +|+||||||+||+++.++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            987653                    455667777765   899999999999999999999999999865422211111


Q ss_pred             ccceeecCCccccchhcc-------CCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          167 TNRIVGTYGYMSLEYTMS-------GTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||......+      ....... .....+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~-~~~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVR-EQDIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhh-ccCccCC
Confidence            222345678999998753       356789999999999999999 788886543211      1111111 1112222


Q ss_pred             cccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchh
Q 039516          239 DLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPC  276 (345)
Q Consensus       239 d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~  276 (345)
                      ++.+...++...   ..++..|+ .||++|||+.++..
T Consensus       232 ~~~~~~~~~~~~---~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         232 KPQLDLKYSDRW---YEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             CCcccccCCHHH---HHHHHHHh-cCcccccCHHHHHH
Confidence            333322222222   46788888 59999999765443

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.8e-37  Score=285.55  Aligned_cols=227  Identities=19%  Similarity=0.228  Sum_probs=174.3

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEEE
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~   99 (345)
                      +|+..+.||+|+||.||++.. .+|+.||+|++...   .......+..|..++..+. |++|+++++++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            477888999999999999965 46899999999653   2234456788999998885 578889999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||+++|+|.+++.               +++.++.|||..   ||+||||||+|||++.++.+||+|||++.......  
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--  155 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--  155 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC--
Confidence            9999999987654               556667777754   89999999999999999999999999987542211  


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ....... ....      ....
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~-~~~~------~~p~  222 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQSIM-EHNV------SYPK  222 (323)
T ss_pred             ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hCCC------CCCc
Confidence            1223356899999999999989999999999999999999999999764321      1111111 1111      0111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..+.+.   .+++.+||+.+|.+|++..
T Consensus       223 ~~~~~~---~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         223 SLSKEA---VSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             cCCHHH---HHHHHHHcccCHhhCCCCC
Confidence            122211   5899999999999999953

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.2e-37  Score=277.91  Aligned_cols=233  Identities=25%  Similarity=0.342  Sum_probs=176.8

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      .+|.+..+||+|++|.||++....+..||+|.+.... .....+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            3588999999999999999988777789999986543 34567899999999999999999999874 566899999999


Q ss_pred             CCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          104 NKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       104 ~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      +++|.+++.                 +++.++.|||..   |++|+||||+||++++++.++|+|||++......... .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-A  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc-c
Confidence            999987763                 445566666654   8999999999999999999999999999865332211 1


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      .....++..|+|||+..+..++.++||||||+++|+|++ |..||......+   ...    ....+..     +.    
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~-----~~----  223 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLE----QVERGYR-----MP----  223 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCC-----CC----
Confidence            122345678999999988889999999999999999999 899987543211   111    1111100     00    


Q ss_pred             CChhHHHH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          246 CPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       246 ~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      .+...... .+++.+||+.||.+|||+.++...|
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l  257 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFL  257 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence            11111223 6899999999999999976555444

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.7e-38  Score=284.28  Aligned_cols=235  Identities=22%  Similarity=0.301  Sum_probs=181.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .+|++.+.||+|+||.||++.. .+|+.||+|.+.... ......+.+|+++++.++||||+++++++...+.+++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            4688888999999999999965 468999999886543 34467899999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          102 MPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       102 ~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      +++++|.+++.               +++.++.|||..+  +++|+||+|+||+++.++.++|+|||++......    .
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~  158 (284)
T cd06620          85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----I  158 (284)
T ss_pred             CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh----c
Confidence            99999977653               5567788888654  7999999999999999999999999998654221    1


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCC-----cccHHHHHHHHHhcCCcccccccc
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER-----PLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      .....|+..|+|||++.+..++.++|+|||||++|++++|+.||.......     .....++........      .+.
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~  232 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPR  232 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCC
Confidence            223578999999999988889999999999999999999999998654321     111122222222111      011


Q ss_pred             CCCCCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          242 LDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       242 l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      +..   ...... .+++.+||+.||++|||+.+
T Consensus       233 ~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e  262 (284)
T cd06620         233 LPS---SDFPEDLRDFVDACLLKDPTERPTPQQ  262 (284)
T ss_pred             CCc---hhcCHHHHHHHHHHhcCCcccCcCHHH
Confidence            100   011123 68999999999999999643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.1e-38  Score=288.78  Aligned_cols=240  Identities=22%  Similarity=0.266  Sum_probs=180.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCc--EEEEEEeccC-CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQ--EVAIKRLAWT-SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~--~VaiK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ++|++.+.||+|+||.||+|... ++.  .+|+|.++.. .......+.+|++++.++ +|+||+++++++..++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46888999999999999999753 454  4688877543 233456788999999999 899999999999999999999


Q ss_pred             EecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCE
Q 039516           99 YEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNT  147 (345)
Q Consensus        99 ~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~  147 (345)
                      |||+++++|.+++.                               +++.++.+||.   .|++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence            99999999987653                               45566677775   489999999999999999999


Q ss_pred             EEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 039516          148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAW  226 (345)
Q Consensus       148 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~  226 (345)
                      ||+|||++......   .......++..|+|||++.+..++.++|||||||++|||+| |..||......+      ...
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~  234 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE  234 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HHH
Confidence            99999998643111   11111234567999999988889999999999999999998 999986543211      111


Q ss_pred             HHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccccc
Q 039516          227 QLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGL  285 (345)
Q Consensus       227 ~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~  285 (345)
                       ....+...     ......+    .. .+++.+||+.+|.+|||+.++...+..++++.
T Consensus       235 -~~~~~~~~-----~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         235 -KLPQGYRL-----EKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             -HHhcCCcC-----CCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence             11111000     0001112    23 58999999999999999988888888777643

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.5e-37  Score=288.41  Aligned_cols=224  Identities=18%  Similarity=0.161  Sum_probs=168.1

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHH-HHHhcCCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAK-LIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|+||.||++.. .+++.||+|.+....   ......+..|.. +++.++||||+++++++...+..++||||++++
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            599999999999965 467899999986431   122334445544 567889999999999999999999999999999


Q ss_pred             ChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          106 SLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       106 sL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      +|.+++.               +++.+|.|||.   .||+||||||+|||++.++.+||+|||+++.....  .......
T Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~~~  156 (325)
T cd05602          82 ELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTSTF  156 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCcccc
Confidence            9977654               45566666665   48999999999999999999999999998754221  1123345


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhH
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE  250 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  250 (345)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ....... ....      .+....+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~-~~~~------~~~~~~~~~~  223 (325)
T cd05602         157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNIL-NKPL------QLKPNITNSA  223 (325)
T ss_pred             cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHH-hCCc------CCCCCCCHHH
Confidence            7999999999999999999999999999999999999999754321      1111111 1110      0111122211


Q ss_pred             HHHHHHHhhccCCCCCcCCCCCcch
Q 039516          251 DAFLLVSCVCKSKQQIDVQCPMLFP  275 (345)
Q Consensus       251 ~~~~~l~~~Cl~~~P~~RPs~~~~~  275 (345)
                         .+++..||+.||.+||+..+..
T Consensus       224 ---~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         224 ---RHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             ---HHHHHHHcccCHHHCCCCCCCH
Confidence               4899999999999999976543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.1e-37  Score=281.03  Aligned_cols=238  Identities=23%  Similarity=0.313  Sum_probs=179.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-C---CcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-N---EQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~---~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      .+|++.+.||+|+||.||+|... +   +..||+|.++... ......+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            45888999999999999999753 2   3479999986542 23356789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           99 YEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        99 ~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      |||+++++|.+++.                +++.++.+||..   +++||||||+||+++.++.++|+|||++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            99999999987764                456667777765   79999999999999999999999999998764322


Q ss_pred             CCCc-ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          163 SGAN-TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       163 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      .... .....++..|+|||++.+..++.++|+||||+++|++++ |..||......+   ...    ....+.  .   .
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~----~~~~~~--~---~  228 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIK----AIEEGY--R---L  228 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHH----HHhCCC--c---C
Confidence            1111 111223567999999998889999999999999999887 999987643221   111    111110  0   0


Q ss_pred             cCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          241 TLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       241 ~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                      ......+    .. .+++.+|++.+|.+||||.++...|.+
T Consensus       229 ~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         229 PAPMDCP----AALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             CCCCCCC----HHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence            0011122    23 589999999999999998876666554

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8e-38  Score=283.71  Aligned_cols=242  Identities=21%  Similarity=0.268  Sum_probs=183.2

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCC-----CcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPN-----EQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH-GEERL   96 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~-----~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~   96 (345)
                      .+|.+.+.||+|+||.||+|....     +..|++|.+... .......+.+|+.++++++|+||+++++++.. +...+
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            458888999999999999998654     688999998644 33345678899999999999999999998776 46789


Q ss_pred             EEEecCCCCChHHHHH-----------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccc
Q 039516           97 LVYEFMPNKSLDSSFS-----------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFG  153 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~-----------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg  153 (345)
                      +++||+++++|.+++.                       +++.++.|||..   +++|+||||+||+++.++.+||+|||
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g  162 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNA  162 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCC
Confidence            9999999999987653                       455666677754   89999999999999999999999999


Q ss_pred             cceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcC
Q 039516          154 MARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEG  232 (345)
Q Consensus       154 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (345)
                      +++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||.....   ..+..    ....+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~----~~~~~  235 (280)
T cd05043         163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAA----YLKDG  235 (280)
T ss_pred             CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHH----HHHcC
Confidence            9986532221111122345678999999988889999999999999999999 9999975432   11111    11111


Q ss_pred             CccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          233 KDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       233 ~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .     .......++.+.   .+++.+||+.||++|||+.++...|.++.+
T Consensus       236 ~-----~~~~~~~~~~~~---~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         236 Y-----RLAQPINCPDEL---FAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             C-----CCCCCCcCCHHH---HHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1     000111122211   599999999999999999888887776653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.6e-37  Score=288.36  Aligned_cols=223  Identities=18%  Similarity=0.142  Sum_probs=169.0

Q ss_pred             EeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHH-HHHhcCCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAK-LIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|+||.||++.. .+|+.||+|++...   .......+..|.. +++.++||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            589999999999965 57899999999643   2223345566655 467789999999999999999999999999999


Q ss_pred             ChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          106 SLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       106 sL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      +|...+.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.....  .......
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~  156 (325)
T cd05604          82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTF  156 (325)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcccc
Confidence            9976553               556667777754   8999999999999999999999999998753221  1122345


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhH
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE  250 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  250 (345)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ....... .+..      .+....+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~-~~~~------~~~~~~~~~~  223 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNIL-HKPL------VLRPGASLTA  223 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHH-cCCc------cCCCCCCHHH
Confidence            7899999999999999999999999999999999999999754311      1111111 1110      1111122211


Q ss_pred             HHHHHHHhhccCCCCCcCCCCCcc
Q 039516          251 DAFLLVSCVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       251 ~~~~~l~~~Cl~~~P~~RPs~~~~  274 (345)
                         .+++..|++.+|.+||++...
T Consensus       224 ---~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         224 ---WSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             ---HHHHHHHhccCHHhcCCCCCC
Confidence               589999999999999997643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-39  Score=269.39  Aligned_cols=226  Identities=20%  Similarity=0.234  Sum_probs=180.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      -.+|++.+.||+|-||.||.|+. .++-.||+|++.+.   ..+...++.+|+++-+.|+||||+++|++|.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            36799999999999999999965 56889999999654   334456788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           99 YEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        99 ~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      +||.++|++...+.                 +++.++.|+|   .+++|||||||+|+|++..+..||+|||-+..-+  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999987765                 4455555555   4579999999999999999999999999987643  


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                        ...-.+.+||..|.+||...+...+..+|+|++|++.||++.|.+||......+..       ..+..   .++.+| 
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY-------krI~k---~~~~~p-  242 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY-------KRIRK---VDLKFP-  242 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH-------HHHHH---ccccCC-
Confidence              22334579999999999999999999999999999999999999999875422211       11111   111111 


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCC
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                        ...+.+.   .+++..|+..+|.+|.+.
T Consensus       243 --~~is~~a---~dlI~~ll~~~p~~r~~l  267 (281)
T KOG0580|consen  243 --STISGGA---ADLISRLLVKNPIERLAL  267 (281)
T ss_pred             --cccChhH---HHHHHHHhccCccccccH
Confidence              1122222   499999999999999984

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.3e-37  Score=282.56  Aligned_cols=234  Identities=23%  Similarity=0.312  Sum_probs=182.6

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      .+...+|.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            44557899999999999999999974 57999999999766555567789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516           99 YEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus        99 ~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||+++++|.+++.              +++.++.+||..   |++||||||+||+++.++.++|+|||++........ 
T Consensus        95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-  170 (297)
T cd06656          95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (297)
T ss_pred             ecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence            99999999987754              455666777754   899999999999999999999999999876533221 


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                       ......+++.|+|||.+.+..++.++|+||||+++|++++|..||...........      ....+      .+.+. 
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~------~~~~~-  236 (297)
T cd06656         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG------TPELQ-  236 (297)
T ss_pred             -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC------CCCCC-
Confidence             12234678899999999988899999999999999999999999975432111100      00000      00000 


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                       .+...... .+++.+||+.+|++|||+.
T Consensus       237 -~~~~~~~~~~~li~~~l~~~p~~Rps~~  264 (297)
T cd06656         237 -NPERLSAVFRDFLNRCLEMDVDRRGSAK  264 (297)
T ss_pred             -CccccCHHHHHHHHHHccCChhhCcCHH
Confidence             01111122 5899999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.5e-38  Score=288.00  Aligned_cols=241  Identities=25%  Similarity=0.344  Sum_probs=180.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCc----EEEEEEeccCCc-cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQ----EVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~----~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      .+|+..+.||+|+||.||++.. .+|.    .||+|.+..... .....+.+|+.++++++||||++++++|.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCcee
Confidence            4678888999999999999975 3444    579998865432 233468899999999999999999999865 45679


Q ss_pred             EEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           98 VYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        98 v~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      ++||+++|+|.+++.                +++.+|.|||..   +|+|+||||+||+++.++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCc
Confidence            999999999887653                556667777654   8999999999999999999999999999876432


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ..........++..|+|||++.+..++.++||||||+++|||++ |..||.......       .......+....    
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~----  231 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGERLP----  231 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCCC----
Confidence            22222222345678999999998899999999999999999998 899986542111       111121111100    


Q ss_pred             cCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          241 TLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       241 ~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                           .++..... ..++..||..+|++|||+.++...+.++.+.
T Consensus       232 -----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         232 -----QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                 01111223 6899999999999999999888888776653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-37  Score=278.58  Aligned_cols=230  Identities=23%  Similarity=0.312  Sum_probs=179.9

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      .+|++.+.||+|+||.||++... |+.||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            46888999999999999999875 89999999976543 56789999999999999999999999998899999999999


Q ss_pred             CCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          104 NKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       104 ~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      +++|.+++.                 +++.++.+||..   +++|+||||+||+++.++.+||+|||.+........   
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---  157 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---  157 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence            999988763                 456667777765   899999999999999999999999999986532211   


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                        ...++..|+|||++.++.++.++||||||+++|++++ |..||.......   +    ......+..     ......
T Consensus       158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~~~~~~~-----~~~~~~  223 (256)
T cd05039         158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPHVEKGYR-----MEAPEG  223 (256)
T ss_pred             --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHhcCCC-----CCCccC
Confidence              1234567999999988889999999999999999997 999986543111   1    111111100     001111


Q ss_pred             CChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhh
Q 039516          246 CPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLM  279 (345)
Q Consensus       246 ~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~  279 (345)
                      ++    .. .+++.+||+.+|.+|||+.++...|.
T Consensus       224 ~~----~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  254 (256)
T cd05039         224 CP----PEVYKVMKDCWELDPAKRPTFKQLREQLA  254 (256)
T ss_pred             CC----HHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence            22    23 58999999999999999876555543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=9.1e-37  Score=287.04  Aligned_cols=188  Identities=21%  Similarity=0.215  Sum_probs=153.6

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC----
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE----   93 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----   93 (345)
                      ....+|.+.++||+|+||.||++.. .+|+.||+|.+...  .......+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            4457799999999999999999965 46899999999643  2334567889999999999999999999986543    


Q ss_pred             --eeEEEEecCCCCChHH------------HHHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           94 --ERLLVYEFMPNKSLDS------------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        94 --~~~lv~e~~~~gsL~~------------~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                        ..|+||||++++.+..            ++.+++.+|.|||..   ||+||||||+||+++.++.+||+|||+++...
T Consensus        98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876          98 FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             cceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence              5799999998653321            122566677777765   89999999999999999999999999997643


Q ss_pred             CCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ..   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus       175 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~  226 (359)
T cd07876         175 TN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD  226 (359)
T ss_pred             cC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            21   12233578999999999999999999999999999999999999998653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.5e-37  Score=293.77  Aligned_cols=185  Identities=21%  Similarity=0.238  Sum_probs=150.5

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-----eeE
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE-----ERL   96 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----~~~   96 (345)
                      +|++.++||+|+||.||++.. .+|+.||||++...  .......+.+|+.+++.++|+||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999975 57999999998643  2234567889999999999999999999998766     789


Q ss_pred             EEEecCCCCChHHHH---------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           97 LVYEFMPNKSLDSSF---------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        97 lv~e~~~~gsL~~~l---------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      +||||+.+ +|.+.+               .+++.+|.|||..   |++||||||+|||++.++.+||+|||++......
T Consensus        81 lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          81 VVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             EEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            99999974 554433               2566667777755   8999999999999999999999999999865322


Q ss_pred             CCCCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      .. .......+++.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       157 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  209 (372)
T cd07853         157 ES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS  209 (372)
T ss_pred             cc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence            21 122234678899999998764 47899999999999999999999997654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=269.07  Aligned_cols=244  Identities=17%  Similarity=0.153  Sum_probs=188.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CeeE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG-----EERL   96 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~~~   96 (345)
                      ...|.+.++||+|||+-||.++ ..++..+|+|++...+.++.+..++|++..++++||||++++++...+     ...|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            4569999999999999999996 678999999999877777888999999999999999999999876543     3489


Q ss_pred             EEEecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516           97 LVYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      |+++|...|||.+.+.                   +++++|.+||.... ++.||||||.|||+++++.++|.|||.++.
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCccc
Confidence            9999999999987765                   67788888888743 599999999999999999999999999876


Q ss_pred             ecCCCCCC-------cccceeecCCccccchhc---cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 039516          158 FGVNESGA-------NTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQ  227 (345)
Q Consensus       158 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  227 (345)
                      ....-...       .......|..|.|||++.   +...+.++|||||||++|.|+.|..||+....            
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------------  246 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------------  246 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh------------
Confidence            54221111       111235688999999886   44568999999999999999999999975322            


Q ss_pred             HHhcCCccc-cccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          228 LWNEGKDLE-LIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       228 ~~~~~~~~~-~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                        .++++.- +..+.+.-.-...-.+. .+++..|++.||.+||+..++...+..+
T Consensus       247 --~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  247 --QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             --cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence              1233222 22222211001112223 6999999999999999987766666554

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-37  Score=277.51  Aligned_cols=235  Identities=25%  Similarity=0.324  Sum_probs=180.1

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ..+|.+.++||+|+||.||++...+++.||||.+.... .....+.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            35689999999999999999988778899999987543 34578999999999999999999999998888999999999


Q ss_pred             CCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          103 PNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       103 ~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ++++|.+++.                 +++.++.+||..   +++|+||||+||+++.++.+||+|||++........ .
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~  159 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-T  159 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh-h
Confidence            9999987753                 445566667655   799999999999999999999999999887643211 1


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ......++..|+|||.+.+..++.++|+||||+++|++++ |+.||.......   ..   .... .+.     ...   
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~---~~~~-~~~-----~~~---  224 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VL---EQVE-RGY-----RMP---  224 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHH-cCC-----CCC---
Confidence            1112234568999999998889999999999999999999 999986543111   11   1111 110     000   


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                       .+...... .+++.+|++.+|.+|||+.++...+
T Consensus       225 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l  258 (261)
T cd05034         225 -RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFL  258 (261)
T ss_pred             -CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence             01111223 6899999999999999976655444

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.2e-36  Score=287.49  Aligned_cols=187  Identities=22%  Similarity=0.263  Sum_probs=155.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ..+|.+.+.||+|+||.||++.. .+++.||+|.+...   .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            46799999999999999999965 46899999998642   223345678999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516           99 YEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus        99 ~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||+++|+|.+++.              +++.+|.|||.   .||+||||||+|||++.++.+||+|||++........ 
T Consensus       122 ~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-  197 (371)
T cd05622         122 MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-  197 (371)
T ss_pred             EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-
Confidence            99999999987764              44555666665   4899999999999999999999999999987642211 


Q ss_pred             CcccceeecCCccccchhccC----CcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSG----TVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  250 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence            122345799999999998753    3789999999999999999999999754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.4e-37  Score=276.96  Aligned_cols=229  Identities=21%  Similarity=0.311  Sum_probs=175.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEE-ECCeeEEEEecC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSI-HGEERLLVYEFM  102 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~-~~~~~~lv~e~~  102 (345)
                      .+|.+.+.||+|+||.||++... |..||+|.++..  ...+.|.+|+.++++++|+|++++++++. .++..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            36888999999999999999774 888999998643  23567999999999999999999999765 456789999999


Q ss_pred             CCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          103 PNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       103 ~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ++++|.+++.                 +++.++.+||.   .|++||||||+||+++.++.+||+|||++.......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            9999987654                 44556666665   489999999999999999999999999987653221   


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                        ....++..|+|||++.+..++.++|||||||++|+|++ |+.||....      ........ ..+..     +....
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~-~~~~~-----~~~~~  222 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRV-EKGYK-----MDAPD  222 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHH-hcCCC-----CCCCC
Confidence              12344668999999998889999999999999999998 999986432      11111111 11110     11111


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhh
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLM  279 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~  279 (345)
                      .++    .. .+++.+||+.+|++|||+.++...|.
T Consensus       223 ~~~----~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  254 (256)
T cd05082         223 GCP----PVVYDVMKQCWHLDAATRPSFLQLREQLE  254 (256)
T ss_pred             CCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence            122    23 58999999999999999877665554

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-37  Score=276.76  Aligned_cols=228  Identities=20%  Similarity=0.225  Sum_probs=171.6

Q ss_pred             EeeccCCeEEEEEEcCCCcEEEEEEeccCCcc-CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCChHH
Q 039516           31 QQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQ-GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS  109 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  109 (345)
                      +||+|+||.||++...+++.||+|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~   81 (251)
T cd05041           2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT   81 (251)
T ss_pred             ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence            58999999999998766999999998755332 45679999999999999999999999999999999999999999987


Q ss_pred             HHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeec
Q 039516          110 SFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT  173 (345)
Q Consensus       110 ~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt  173 (345)
                      ++.                +++.++.+||   +.+++||||||+||+++.++.+||+|||++................++
T Consensus        82 ~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (251)
T cd05041          82 FLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP  158 (251)
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence            763                3344555555   458999999999999999999999999998765322111111112335


Q ss_pred             CCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHH
Q 039516          174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDA  252 (345)
Q Consensus       174 ~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  252 (345)
                      ..|+|||.+.++.++.++|+||||+++|+|++ |..||.......      . ......+.  .   ..    .+.....
T Consensus       159 ~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~------~-~~~~~~~~--~---~~----~~~~~~~  222 (251)
T cd05041         159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------T-RERIESGY--R---MP----APQLCPE  222 (251)
T ss_pred             eccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH------H-HHHHhcCC--C---CC----CCccCCH
Confidence            67999999988899999999999999999999 888886543211      1 11111110  0   00    1111122


Q ss_pred             H-HHHHhhccCCCCCcCCCCCcchhh
Q 039516          253 F-LLVSCVCKSKQQIDVQCPMLFPCL  277 (345)
Q Consensus       253 ~-~~l~~~Cl~~~P~~RPs~~~~~~~  277 (345)
                      . .+++.+||+.+|.+|||+.++...
T Consensus       223 ~~~~li~~~l~~~p~~Rp~~~ell~~  248 (251)
T cd05041         223 EIYRLMLQCWAYDPENRPSFSEIYNE  248 (251)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHHH
Confidence            3 689999999999999997654443

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-37  Score=277.40  Aligned_cols=231  Identities=20%  Similarity=0.286  Sum_probs=175.8

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc-----cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG-----QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      +|.+.+.||+|++|.||.+.. .+++.||+|.+.....     .....+.+|++++++++||||+++++++.++...++|
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            488889999999999999965 4689999999864421     1245688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |||+++++|.+.+.               +++.++.+||..   |++|+||+|+||+++.++.++|+|||+++.......
T Consensus        83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence            99999999987664               455666666655   899999999999999999999999999876532211


Q ss_pred             CCc-ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          164 GAN-TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       164 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                      ... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||......      ............     +.+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~-----~~~  228 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPTN-----PQL  228 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCCC-----CCC
Confidence            111 12345788999999999888999999999999999999999999754221      111111111110     111


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ...++...   ..++..||+.+|.+|||+.
T Consensus       229 ~~~~~~~~---~~li~~~l~~~p~~Rpt~~  255 (263)
T cd06625         229 PSHVSPDA---RNFLRRTFVENAKKRPSAE  255 (263)
T ss_pred             CccCCHHH---HHHHHHHhhcCcccCCCHH
Confidence            11122211   5899999999999999954

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.5e-37  Score=279.75  Aligned_cols=239  Identities=18%  Similarity=0.239  Sum_probs=181.8

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +|.+.+.||+|+||.||++.. .++..||||.+...   .......+.+|+.+++.++|+||+++++++..++..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            577888899999999999974 57899999988643   22334578899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516          101 FMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus       101 ~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      |+++++|.+++.                   +++.++.+||..   |++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            999999987653                   455666677654   8999999999999999999999999998765432


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      ..  ......|+..|+|||++.+..++.++|+||||+++|+|++|..||......    ........      .....+.
T Consensus       160 ~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~------~~~~~~~  227 (267)
T cd08229         160 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI------EQCDYPP  227 (267)
T ss_pred             Cc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhh------hcCCCCC
Confidence            21  122346888999999998888999999999999999999999998653211    11111111      0111111


Q ss_pred             CCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          242 LDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       242 l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                      +..   ...... ..++.+||+.+|.+||||.++...+.++
T Consensus       228 ~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         228 LPS---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCc---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            110   111223 5899999999999999988766665543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.8e-37  Score=276.28  Aligned_cols=229  Identities=18%  Similarity=0.213  Sum_probs=177.8

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      +|++.+.||+|+||.||++.. .+++.||+|.++.. .....+.+.+|+.++++++|+||+++++++..++..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            478899999999999999965 46899999998643 3344567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          103 PNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       103 ~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ++++|.+++.                 +++.++.+||.   .|++|+||||+||+++.++.++|+|||++........  
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            9999877653                 45555666665   4899999999999999999999999999976643221  


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.....      ........ .+....     +...
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~-----~~~~  223 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVC-QGSYKP-----LPSH  223 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHh-cCCCCC-----CCcc
Confidence            12235688899999999988899999999999999999999999975321      11111111 121111     1111


Q ss_pred             CChhHHHH-HHHHhhccCCCCCcCCCCCcc
Q 039516          246 CPPNEDAF-LLVSCVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       246 ~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~  274 (345)
                      ++    .. .+++.+||+.||.+|||+.++
T Consensus       224 ~~----~~~~~li~~~l~~~P~~Rp~~~~i  249 (255)
T cd08219         224 YS----YELRSLIKQMFKRNPRSRPSATTI  249 (255)
T ss_pred             cC----HHHHHHHHHHHhCCcccCCCHHHH
Confidence            22    22 589999999999999996543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.5e-37  Score=275.61  Aligned_cols=232  Identities=24%  Similarity=0.323  Sum_probs=177.9

Q ss_pred             CeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCC
Q 039516           25 DWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN  104 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  104 (345)
                      +|.+.+.||+|+||.||++...++..+|+|.+.... .....|.+|++++++++|||++++++++......++||||+++
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            588889999999999999988778899999986442 3356799999999999999999999999999999999999999


Q ss_pred             CChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCccc
Q 039516          105 KSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTN  168 (345)
Q Consensus       105 gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  168 (345)
                      ++|.+++.                +++.++.+||..   +++|+||||+||+++.++.++|+|||++......... ...
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~  159 (256)
T cd05112          84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SST  159 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc-ccC
Confidence            99987663                344556666654   7999999999999999999999999998765332111 111


Q ss_pred             ceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCC
Q 039516          169 RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCP  247 (345)
Q Consensus       169 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  247 (345)
                      ...++..|+|||++.++.++.++||||||+++|||++ |..||......      ...... ..+  .....+..   . 
T Consensus       160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~-~~~--~~~~~~~~---~-  226 (256)
T cd05112         160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVETI-NAG--FRLYKPRL---A-  226 (256)
T ss_pred             CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHH-hCC--CCCCCCCC---C-
Confidence            2234678999999998889999999999999999998 99998753311      111111 111  01111111   1 


Q ss_pred             hhHHHH-HHHHhhccCCCCCcCCCCCcchhh
Q 039516          248 PNEDAF-LLVSCVCKSKQQIDVQCPMLFPCL  277 (345)
Q Consensus       248 ~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~  277 (345)
                         ... .+++.+||+.+|++|||+.++.+.
T Consensus       227 ---~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         227 ---SQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ---CHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence               123 699999999999999997655443

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=301.41  Aligned_cols=220  Identities=24%  Similarity=0.325  Sum_probs=175.6

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc---cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG---QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      |.-+..||-|+||.||-+.. .+.+.||||++.....   +.+.++++|+.+|.+++|||+|.+.|||......||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            55566799999999998864 5789999999976643   3466789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |-| |-.+++.                +++++|.|||+.   +.||||||+.|||+++.|.|||+|||.+....      
T Consensus       108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------  177 (948)
T KOG0577|consen  108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA------  177 (948)
T ss_pred             Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC------
Confidence            965 4444433                567788888887   79999999999999999999999999998652      


Q ss_pred             cccceeecCCccccchhc---cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          166 NTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                      ..+.+.|||+|||||++.   .+.|+.++||||||++..||.-.++|...++..       .+...+..+.     .|.|
T Consensus       178 PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-------SALYHIAQNe-----sPtL  245 (948)
T KOG0577|consen  178 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNE-----SPTL  245 (948)
T ss_pred             chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-------HHHHHHHhcC-----CCCC
Confidence            345689999999999876   588999999999999999999999998765421       1111111111     1222


Q ss_pred             CCCCChhHHHH--HHHHhhccCCCCCcCCCC
Q 039516          243 DGSCPPNEDAF--LLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       243 ~~~~~~~~~~~--~~l~~~Cl~~~P~~RPs~  271 (345)
                          ...+...  .+++-.||+.-|.+|||.
T Consensus       246 ----qs~eWS~~F~~Fvd~CLqKipqeRpts  272 (948)
T KOG0577|consen  246 ----QSNEWSDYFRNFVDSCLQKIPQERPTS  272 (948)
T ss_pred             ----CCchhHHHHHHHHHHHHhhCcccCCcH
Confidence                2233333  799999999999999994

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=280.29  Aligned_cols=185  Identities=21%  Similarity=0.246  Sum_probs=154.2

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +|++.+.||+|+||.||++.. .+++.||+|.+...   .......+.+|+.++..++|+||+++++++.+++..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            689999999999999999975 46899999999642   22334568899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          101 FMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       101 ~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |+++|+|.+++.                +++.+|.|||..   +|+||||||+|||++.++.+||+|||++.........
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            999999987764                455566666654   8999999999999999999999999998765332211


Q ss_pred             CcccceeecCCccccchhcc-----CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMS-----GTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                       ......||+.|+|||++..     ..++.++|||||||++|+|++|+.||...
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         159 -QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             -cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence             1223468999999999863     45788999999999999999999999753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7e-37  Score=288.32  Aligned_cols=189  Identities=22%  Similarity=0.229  Sum_probs=153.5

Q ss_pred             cccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC---
Q 039516           19 VENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG---   92 (345)
Q Consensus        19 ~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~---   92 (345)
                      +-....+|.+.+.||+|+||.||++.. .+++.||||++...  .......+.+|+.+++.++||||+++++++...   
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~   98 (364)
T cd07875          19 TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   98 (364)
T ss_pred             hhchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence            334456799999999999999999965 46899999999653  233456788999999999999999999987543   


Q ss_pred             ---CeeEEEEecCCCCChHHHH-------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516           93 ---EERLLVYEFMPNKSLDSSF-------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus        93 ---~~~~lv~e~~~~gsL~~~l-------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                         ...|+||||+++ +|.+.+             .+++.+|.+||..   ||+||||||+||+++.++.+||+|||+++
T Consensus        99 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875          99 EEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             cccCeEEEEEeCCCC-CHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence               357999999976 444332             2566666677654   89999999999999999999999999997


Q ss_pred             eecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          157 IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      .....   .......||..|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus       175 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  229 (364)
T cd07875         175 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  229 (364)
T ss_pred             ccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence            65322   12233578999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.1e-37  Score=276.21  Aligned_cols=234  Identities=24%  Similarity=0.324  Sum_probs=178.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ..+|.+.++||+|+||.||++...++..||+|.+.... .....|.+|++++++++|+||+++++++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            34689999999999999999988778889999986542 335678999999999999999999999877 7789999999


Q ss_pred             CCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          103 PNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       103 ~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ++++|.+++.                 +++.++.+||.   .|++|+||||+||+++.++.+||+|||++......... 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-
Confidence            9999987753                 45566666665   48999999999999999999999999999765432211 


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ......++..|+|||++.+..++.++|+||||+++|++++ |..||.......   +    ......+....     ...
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~----~~~~~~~~~~~-----~~~  226 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V----IRALERGYRMP-----RPE  226 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHhCCCCCC-----Ccc
Confidence            1122345677999999998889999999999999999999 899987543211   1    11111111110     011


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      ..+    .. .+++.+|++.+|++|||+.++...|
T Consensus       227 ~~~----~~~~~~i~~~l~~~p~~Rp~~~~l~~~L  257 (260)
T cd05073         227 NCP----EELYNIMMRCWKNRPEERPTFEYIQSVL  257 (260)
T ss_pred             cCC----HHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence            122    22 5899999999999999976554444

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-37  Score=280.52  Aligned_cols=240  Identities=23%  Similarity=0.288  Sum_probs=182.9

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CC----cEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NE----QEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~----~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      .+|++.+.||+|+||.||+|... +|    ..||+|.+.... ......+.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            46888999999999999999753 33    368999886553 3345678999999999999999999999876 78899


Q ss_pred             EEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           98 VYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        98 v~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      ||||+++|+|.+++.                +++.++.|||.   .+++|+||||+||+++.++.+||+|||+++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            999999999987764                56677777876   48999999999999999999999999999876432


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ..........++..|+|||.+....++.++|+||||+++||+++ |+.||......      +... ....+...     
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~-~~~~~~~~-----  230 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------EIPD-LLEKGERL-----  230 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------HHHH-HHhCCCCC-----
Confidence            22111111233567999999988889999999999999999998 99999764321      1111 11111110     


Q ss_pred             cCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          241 TLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       241 ~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .    .+...... ..++..||..+|+.|||+.++...+..++.
T Consensus       231 ~----~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         231 P----QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             C----CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            0    11111223 588999999999999999888777777654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-37  Score=288.79  Aligned_cols=241  Identities=19%  Similarity=0.215  Sum_probs=183.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC--------CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP--------NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGE   93 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~--------~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~   93 (345)
                      ..|.+.+.||+|+||.||++...        .+..||+|.++... ......+.+|+.+++++ +||||++++++|...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            35889999999999999999631        12479999886542 33456789999999999 8999999999999999


Q ss_pred             eeEEEEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC
Q 039516           94 ERLLVYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD  142 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~  142 (345)
                      ..+++|||+++|+|.+++.                               +++.++.|||..   |++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence            9999999999999987753                               456677777765   899999999999999


Q ss_pred             CCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccH
Q 039516          143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNL  221 (345)
Q Consensus       143 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~  221 (345)
                      .++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....      
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------  242 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------  242 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------
Confidence            999999999999986543221111222334567999999999899999999999999999998 8888865431      


Q ss_pred             HHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          222 VGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       222 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ...... ...+....         .+...... .+++..||+.+|.+|||+.++...|.++..
T Consensus       243 ~~~~~~-~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         243 EELFKL-LKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHHHHH-HHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            111111 11111111         11111223 589999999999999999888877776653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=276.50  Aligned_cols=244  Identities=22%  Similarity=0.223  Sum_probs=179.1

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEec--cCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCee
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLA--WTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH-----GEER   95 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-----~~~~   95 (345)
                      ..|...+.||+|+||+|..+.. .+|+.||||++.  .......++..+|+++|+.++|+||+.+++++..     -+.+
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            3455678899999999999954 579999999997  4455667788999999999999999999998765     3467


Q ss_pred             EEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           96 LLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      |+|+|+| +.+|...++               ++++||.|+|+.   +|+||||||.|++++.+..+||+|||+|+....
T Consensus       102 YiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~  177 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDK  177 (359)
T ss_pred             EEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccc
Confidence            9999999 445555444               555566666655   899999999999999999999999999998754


Q ss_pred             CCCCCcccceeecCCccccchhc-cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH--------HHHhc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTM-SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAW--------QLWNE  231 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~  231 (345)
                      .......+....|..|.|||++. ...|+...||||.|||+.||++|++-|.+.+.-++..++....        .....
T Consensus       178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s  257 (359)
T KOG0660|consen  178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS  257 (359)
T ss_pred             cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            32223335567899999999776 5689999999999999999999999998876555544442211        11111


Q ss_pred             CCccccccccC-------CCCCChhHHHHHHHHhhccCCCCCcCCCC
Q 039516          232 GKDLELIDLTL-------DGSCPPNEDAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       232 ~~~~~~~d~~l-------~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                      ......+....       ...++......+++..++|..||.+|+|.
T Consensus       258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita  304 (359)
T KOG0660|consen  258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITA  304 (359)
T ss_pred             HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCH
Confidence            11111111000       01111111222699999999999999993

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.1e-37  Score=290.72  Aligned_cols=184  Identities=17%  Similarity=0.226  Sum_probs=152.8

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC---CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP---NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~---~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ...|.+..+||+|+||.||++...   .+..||+|.+...     ..+.+|++++++++||||+++++++......+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            456999999999999999998642   4678999998543     24568999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |++.+ +|.+++.               +++.+|.|||..   ||+||||||+|||++.++.++|+|||++.........
T Consensus       166 e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        166 PKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             hhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            99964 5555442               556667777754   8999999999999999999999999999766443332


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHT  215 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~  215 (345)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~  292 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV  292 (392)
T ss_pred             ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence            233345799999999999999999999999999999999999999976543

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.1e-37  Score=277.24  Aligned_cols=232  Identities=22%  Similarity=0.309  Sum_probs=176.4

Q ss_pred             eeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHH--HHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           26 WHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRV--EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~--~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      |++.+.||+|+||+||++... +++.||+|.+.........  ...+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            788999999999999999764 5679999999776433222  3456999999999999999999999999999999999


Q ss_pred             CCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          103 PNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       103 ~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      ++++|.+++.               +++.+|.+||..   +++|+||||+||+++.++.++|+|||.+....  ......
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~  155 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENF  155 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEB
T ss_pred             ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cccccc
Confidence            9999987764               566677777775   89999999999999999999999999998641  122233


Q ss_pred             cceeecCCccccchhc-cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          168 NRIVGTYGYMSLEYTM-SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      ....++..|+|||++. +..++.++||||+|+++|+|++|..||.............   .....    .......   .
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~----~~~~~~~---~  225 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKR----PLPSSSQ---Q  225 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHT----HHHHHTT---S
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcccc----ccccccc---c
Confidence            4457889999999988 7889999999999999999999999998651111111111   01000    0000000   0


Q ss_pred             ChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          247 PPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       247 ~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ....... .+++..||+.||++|||+.
T Consensus       226 ~~~~~~~l~~li~~~l~~~p~~R~~~~  252 (260)
T PF00069_consen  226 SREKSEELRDLIKKMLSKDPEQRPSAE  252 (260)
T ss_dssp             HTTSHHHHHHHHHHHSSSSGGGSTTHH
T ss_pred             cchhHHHHHHHHHHHccCChhHCcCHH
Confidence            0000133 7999999999999999954

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-37  Score=282.87  Aligned_cols=246  Identities=23%  Similarity=0.282  Sum_probs=181.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-----CCcEEEEEEeccCCcc-CHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCee
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-----NEQEVAIKRLAWTSGQ-GRVEFQNEAKLIAKLQYTNLVKLLGCSIH--GEER   95 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-----~~~~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~   95 (345)
                      .+|++.+.||+|+||.||++...     ++..||||.+...... ....|.+|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35777888999999999999753     3689999999765433 46689999999999999999999999877  5578


Q ss_pred             EEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           96 LLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      +++|||+++++|.+++.                +++.+|.+||.   .|++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            99999999999987764                45556666665   489999999999999999999999999998764


Q ss_pred             CCCCCC-cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcc--------cHHHHHHHHHh
Q 039516          160 VNESGA-NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPL--------NLVGIAWQLWN  230 (345)
Q Consensus       160 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~--------~~~~~~~~~~~  230 (345)
                      ...... ......++..|+|||...+..++.++||||||+++|||++|..|+.........        ...........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            221111 111123456799999998889999999999999999999999998653221100        00111111111


Q ss_pred             cCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          231 EGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       231 ~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                      .+.         ....+...... .+++.+||+.+|.+|||+.++...|..+
T Consensus       241 ~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         241 EGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111         00011111233 6999999999999999988777766653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.4e-37  Score=279.26  Aligned_cols=232  Identities=19%  Similarity=0.233  Sum_probs=176.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ...|++.++||.|+||.||+|... ++..||+|.+..........+.+|+.+++.++|+||+++++++..+...++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            356899999999999999999764 5899999999776666677899999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      +++++|..++.                +++.++.+||.   .+++||||||+||+++.++.+||+|||++......  ..
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~  165 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ  165 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence            99999876542                45566666665   48999999999999999999999999998754321  11


Q ss_pred             cccceeecCCccccchhc-----cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          166 NTNRIVGTYGYMSLEYTM-----SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ......++..|+|||++.     ...++.++|||||||++|+|++|..||......      ....... ......... 
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~~-  237 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIA-KSEPPTLSQ-  237 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHh-cCCCccCCC-
Confidence            223356788999999874     345688999999999999999999998754321      1111111 111100000 


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                        ...++.+.   .+++.+||+.+|++||++.
T Consensus       238 --~~~~~~~~---~~li~~~l~~~p~~Rp~~~  264 (292)
T cd06644         238 --PSKWSMEF---RDFLKTALDKHPETRPSAA  264 (292)
T ss_pred             --CcccCHHH---HHHHHHHhcCCcccCcCHH
Confidence              01111111   5899999999999999954

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9e-37  Score=279.62  Aligned_cols=231  Identities=23%  Similarity=0.324  Sum_probs=179.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ..|.+.+.||.|++|.||++.. .+|+.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4599999999999999999964 578999999997665555678899999999999999999999999999999999999


Q ss_pred             CCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCccc
Q 039516          103 PNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTN  168 (345)
Q Consensus       103 ~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  168 (345)
                      ++++|.+++.              +++.++.+||..   |++|+||||+||+++.++.+||+|||++........  ...
T Consensus        99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~  173 (296)
T cd06655          99 AGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRS  173 (296)
T ss_pred             CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCC
Confidence            9999987654              455566666654   899999999999999999999999999876533221  122


Q ss_pred             ceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          169 RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       169 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      ...++..|+|||.+.+..++.++|||||||++|+|++|+.||........      ........ ......   ...+++
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~~~~-~~~~~~---~~~~~~  243 (296)
T cd06655         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNG-TPELQN---PEKLSP  243 (296)
T ss_pred             CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcC-CcccCC---cccCCH
Confidence            34678899999999888899999999999999999999999976432111      11111111 000000   011222


Q ss_pred             hHHHHHHHHhhccCCCCCcCCCCC
Q 039516          249 NEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       249 ~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..   .+++.+||+.||.+|||+.
T Consensus       244 ~~---~~li~~~l~~dp~~Rpt~~  264 (296)
T cd06655         244 IF---RDFLNRCLEMDVEKRGSAK  264 (296)
T ss_pred             HH---HHHHHHHhhcChhhCCCHH
Confidence            11   5889999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-37  Score=279.17  Aligned_cols=230  Identities=23%  Similarity=0.292  Sum_probs=173.4

Q ss_pred             EeeccCCeEEEEEEcC-CCc--EEEEEEeccC-CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKFP-NEQ--EVAIKRLAWT-SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~-~~~--~VaiK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|+||.||+|... ++.  .+|+|.++.. .......+.+|++++.++ +||||+++++++...+..+++|||++++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            4899999999999764 343  5789988643 234456788999999999 8999999999999999999999999999


Q ss_pred             ChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccc
Q 039516          106 SLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGM  154 (345)
Q Consensus       106 sL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl  154 (345)
                      +|.+++.                               +++.++.|||..   |++||||||+||+++.++.+||+|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence            9977652                               456677777764   899999999999999999999999999


Q ss_pred             ceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 039516          155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGK  233 (345)
Q Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (345)
                      +......   ........+..|+|||++.+..++.++||||||+++|||++ |..||......      .... ....+.
T Consensus       159 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~-~~~~~~  228 (270)
T cd05047         159 SRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYE-KLPQGY  228 (270)
T ss_pred             ccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHH-HHhCCC
Confidence            8632111   11111233567999999988889999999999999999997 99998653211      1111 111110


Q ss_pred             ccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          234 DLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       234 ~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                      ..     ..    +...... .+++.+||+.+|.+|||+.++...|..++
T Consensus       229 ~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 RL-----EK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CC-----CC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            00     01    1111123 69999999999999999988888877765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.8e-36  Score=282.14  Aligned_cols=185  Identities=20%  Similarity=0.253  Sum_probs=153.2

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +|.+.++||+|+||.||++... +++.||+|.+...   .......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            6899999999999999999764 5789999998542   22234458889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          101 FMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       101 ~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |+++|+|.+++.                +++.++.|||.   .+|+||||||+|||++.++.+||+|||++........ 
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-  157 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-  157 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc-
Confidence            999999988764                34455566665   4899999999999999999999999999876532221 


Q ss_pred             CcccceeecCCccccchhc-----cCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTM-----SGTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            1222357899999999886     346789999999999999999999999754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=8.3e-37  Score=286.83  Aligned_cols=187  Identities=22%  Similarity=0.238  Sum_probs=152.9

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG-----   92 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----   92 (345)
                      ....+|.+.+.||+|+||.||++.. .+++.||||.+...  .......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            4456799999999999999999965 46899999999654  223456788999999999999999999988643     


Q ss_pred             -CeeEEEEecCCCCChHHH-------------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           93 -EERLLVYEFMPNKSLDSS-------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        93 -~~~~lv~e~~~~gsL~~~-------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                       ...++||||++++ |.+.             +.+++.+|.|||..   ||+||||||+||+++.++.+||+|||+++..
T Consensus        94 ~~~~~lv~e~~~~~-l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          94 FQDVYLVMELMDAN-LCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             cceeEEEhhhhccc-HHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence             3579999999764 4332             22566677777764   8999999999999999999999999999865


Q ss_pred             cCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ...   .......||..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus       170 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  222 (355)
T cd07874         170 GTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_pred             CCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            322   12233578999999999999899999999999999999999999997643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.8e-37  Score=277.36  Aligned_cols=243  Identities=21%  Similarity=0.270  Sum_probs=178.2

Q ss_pred             eeeEEEeeccCCeEEEEEEc-----CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CeeEE
Q 039516           26 WHMYIQQEQTRDRVILVGKF-----PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--EERLL   97 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-----~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~l   97 (345)
                      |.+.+.||+|+||.||.+..     .++..||+|.++... ......+.+|+.++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL   85 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence            67888999999999999863     357899999987553 33456799999999999999999999998775  56899


Q ss_pred             EEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           98 VYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        98 v~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      ||||+++++|.+++.                +++.+|.+||.   .|++||||||+||+++.++.++|+|||++......
T Consensus        86 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05079          86 IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  162 (284)
T ss_pred             EEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence            999999999987763                45556666665   48999999999999999999999999999866432


Q ss_pred             CCC-CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCC---------CcccHHHHHHHHHhc
Q 039516          162 ESG-ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTE---------RPLNLVGIAWQLWNE  231 (345)
Q Consensus       162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~---------~~~~~~~~~~~~~~~  231 (345)
                      ... .......++..|+|||++.+..++.++||||||+++|+|++++.|+......         ...... ........
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  241 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT-RLVRVLEE  241 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH-HHHHHHHc
Confidence            211 1112345677899999998888999999999999999999987765332110         000111 11111111


Q ss_pred             CCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          232 GKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       232 ~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                      +....         .+...... .+++.+||+.+|.+|||+.++...+..+
T Consensus       242 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         242 GKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             CccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11110         11112233 6999999999999999987776665543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-37  Score=275.31  Aligned_cols=230  Identities=25%  Similarity=0.333  Sum_probs=173.5

Q ss_pred             EeeccCCeEEEEEEcC--C--CcEEEEEEeccCCc-cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKFP--N--EQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~--~--~~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      +||+|+||.||+|...  +  +..||+|.+..... ...+.+.+|+.+++++.|+||+++++++. .+..++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~   80 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG   80 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence            5999999999999652  2  37899999875533 24567899999999999999999999875 55789999999999


Q ss_pred             ChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC-cccc
Q 039516          106 SLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA-NTNR  169 (345)
Q Consensus       106 sL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~  169 (345)
                      +|.+++.               +++.++.+||..   +++|+||||+||+++.++.+||+|||+++......... ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            9988764               566677777765   79999999999999999999999999998764322211 1111


Q ss_pred             eeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       170 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .+..+    ...+....         .+.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~----~~~~~~~~---------~~~  221 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAM----LESGERLP---------RPE  221 (257)
T ss_pred             ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----HHcCCcCC---------CCC
Confidence            223567999999998899999999999999999998 99999764321   11111    11111110         111


Q ss_pred             hHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          249 NEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       249 ~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                      ..... .+++.+||+.+|++|||+.++...|.+
T Consensus       222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~  254 (257)
T cd05060         222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR  254 (257)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            11223 699999999999999998776666654

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-37  Score=279.67  Aligned_cols=231  Identities=19%  Similarity=0.253  Sum_probs=177.1

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      .+|.+.+.||+|+||.||++.. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4678888899999999999965 468999999997665455567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          103 PNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       103 ~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      ++++|.+++.               +++.++.+||..   |++|+||||+||+++.++.++|+|||++.......  ...
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~  163 (267)
T cd06645          89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKR  163 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--ccc
Confidence            9999988754               456666777665   89999999999999999999999999987653221  122


Q ss_pred             cceeecCCccccchhc---cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          168 NRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ....|+..|+|||++.   ...++.++|+|||||++|+|++|..||.........      .... ....   ..+....
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~-~~~~---~~~~~~~  233 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMT-KSNF---QPPKLKD  233 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------Hhhh-ccCC---CCCcccc
Confidence            3357899999999874   456889999999999999999999998654321110      0000 0100   0111111


Q ss_pred             --CCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          245 --SCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       245 --~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                        .++...   .+++.+||+.+|++|||+.
T Consensus       234 ~~~~~~~~---~~li~~~l~~~P~~R~~~~  260 (267)
T cd06645         234 KMKWSNSF---HHFVKMALTKNPKKRPTAE  260 (267)
T ss_pred             cCCCCHHH---HHHHHHHccCCchhCcCHH
Confidence              122111   5899999999999999954

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1e-36  Score=274.11  Aligned_cols=232  Identities=21%  Similarity=0.303  Sum_probs=177.6

Q ss_pred             CeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCc------cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           25 DWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSG------QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      +|.+.+.||+|+||.||+|...+|+.||+|.+.....      .....+.+|++++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4778889999999999999887899999999864421      1234688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |||+++++|.+++.               +++.++.+||..   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence            99999999988764               556677777765   799999999999999999999999999876432111


Q ss_pred             ----CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          164 ----GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       164 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                          ........|+..|+|||++.+..++.++|+||||+++|+|++|..||........     . ........    ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~-~~~~~~~~----~~  227 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----M-FYIGAHRG----LM  227 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----H-HHhhhccC----CC
Confidence                1112234688899999999988899999999999999999999999975432110     0 00000000    01


Q ss_pred             ccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          240 LTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       240 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +.+...++.+.   ..++.+||+.+|.+|||+.
T Consensus       228 ~~~~~~~~~~~---~~~i~~~l~~~p~~Rp~~~  257 (265)
T cd06631         228 PRLPDSFSAAA---IDFVTSCLTRDQHERPSAL  257 (265)
T ss_pred             CCCCCCCCHHH---HHHHHHHhcCCcccCCCHH
Confidence            11211222222   5899999999999999964

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.4e-36  Score=274.14  Aligned_cols=234  Identities=17%  Similarity=0.204  Sum_probs=168.5

Q ss_pred             EeeccCCeEEEEEEcCCC---cEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCC
Q 039516           31 QQEQTRDRVILVGKFPNE---QEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS  106 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~~~---~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gs  106 (345)
                      +||+|+||.||++...++   ..+++|.+.... ......|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            489999999999965433   356777775443 3345689999999999999999999999999999999999999999


Q ss_pred             hHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          107 LDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       107 L~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      |.+++.                   +++.+|.|||..   +++||||||+|||++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            987653                   455667777754   7999999999999999999999999997643211111112


Q ss_pred             cceeecCCccccchhcc-------CCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          168 NRIVGTYGYMSLEYTMS-------GTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~-------~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..||.....      .+.....+. +......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~-~~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIK-DQQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHh-hcccccCC
Confidence            23467889999998753       245788999999999999997 5667754332      111222222 22233344


Q ss_pred             ccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhh
Q 039516          240 LTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       240 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      +.+...++...   .+++..|| .+|++|||+.+++..|
T Consensus       232 ~~~~~~~~~~~---~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         232 PQLELPYSERW---YEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             CccCCCCcHHH---HHHHHHHh-hCcccCCCHHHHHHHh
Confidence            44433333222   47888899 6799999987654443

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.6e-37  Score=284.13  Aligned_cols=189  Identities=21%  Similarity=0.241  Sum_probs=154.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|.+.+.||+|+||.||++.. .+++.||+|.+...   .......+.+|..++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            3689999999999999999975 46889999998642   2223445888999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH-------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          100 EFMPNKSLDSSFS-------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       100 e~~~~gsL~~~l~-------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      ||+++|+|.+++.             .+.+.+.+|+++|+.+|+||||||+|||++.++.+||+|||++......... .
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~  159 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-Q  159 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-e
Confidence            9999999988764             1223344444445568999999999999999999999999999876432211 1


Q ss_pred             ccceeecCCccccchhcc-----CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMS-----GTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      .....||+.|+|||++.+     +.++.++|||||||++|+|++|+.||...
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence            223568999999998875     56788999999999999999999999754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8e-37  Score=278.13  Aligned_cols=183  Identities=21%  Similarity=0.292  Sum_probs=146.7

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhc---CCCCeeeEEEEEEE-----CC
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKL---QYTNLVKLLGCSIH-----GE   93 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~~-----~~   93 (345)
                      .|++.+.||+|+||.||++.. .+|+.||+|.++...  ......+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            378899999999999999965 478999999986542  22234566788777766   69999999998864     24


Q ss_pred             eeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516           94 ERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                      ..+++|||+++ +|.+++.                 +++.+|.|||..   |++||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57999999985 6655442                 556666677665   89999999999999999999999999998


Q ss_pred             eecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          157 IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ......   ......||..|+|||++.+..++.++|||||||++|+|++|++||....
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~  211 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS  211 (288)
T ss_pred             cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence            653221   1223467899999999998899999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.5e-36  Score=277.62  Aligned_cols=232  Identities=16%  Similarity=0.190  Sum_probs=175.2

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +|++.+.||+|+||.||++.. .+++.||+|.+....   ......+.+|+++++.++||||+++++.+..++..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            688999999999999999965 468899999986542   2334578899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC--
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES--  163 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--  163 (345)
                      |+++++|.+++.               +++.++.+||..   +++||||||+||+++.++.+||+|||+++.......  
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence            999999987764               445666777754   899999999999999999999999998864211000  


Q ss_pred             -----------CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC
Q 039516          164 -----------GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEG  232 (345)
Q Consensus       164 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (345)
                                 ........++..|+|||++.+..++.++|+||||+++|||++|..||.+....      ....... .+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~-~~  231 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVI-SD  231 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hc
Confidence                       00111235788899999998888999999999999999999999999753211      1111111 11


Q ss_pred             CccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          233 KDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       233 ~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .   ...+.....++.+.   ..++.+||+.+|++|||+.
T Consensus       232 ~---~~~~~~~~~~~~~~---~~li~~~l~~~P~~R~~~~  265 (305)
T cd05609         232 D---IEWPEGDEALPADA---QDLISRLLRQNPLERLGTG  265 (305)
T ss_pred             c---cCCCCccccCCHHH---HHHHHHHhccChhhccCcc
Confidence            1   01111111122222   5999999999999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=299.40  Aligned_cols=233  Identities=24%  Similarity=0.265  Sum_probs=187.0

Q ss_pred             eeeEEEeeccCCeEEEEEEcC--CC--cEEEEEEeccCCcc-CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           26 WHMYIQQEQTRDRVILVGKFP--NE--QEVAIKRLAWTSGQ-GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~--~~--~~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ..+.++||+|.||+|++|.|.  +|  ..||||.+...... ...+|++|+.+|.+|+|+|++++||+..+ ....+|||
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            345567999999999999874  34  47899999876544 67889999999999999999999999876 77889999


Q ss_pred             cCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          101 FMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       101 ~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      +++.|||.+.|+                 +++.++.||...   ++|||||..+|+|+.....+||+|||+.+.++.+..
T Consensus       191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            999999988776                 677788888776   699999999999999999999999999998876544


Q ss_pred             CCccc-ceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          164 GANTN-RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       164 ~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      ..... ...-.+.|+|||.+....++.++|||+|||++|||+| |+.||.+.....                +.+.+|..
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD~~  331 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNIDAG  331 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhcccc
Confidence            33221 1223567999999999999999999999999999999 889998765322                22233322


Q ss_pred             CCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          242 LDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       242 l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      -+-.-+..+.+. .+++..||..+|++|||+..+++.+
T Consensus       332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            222244556666 8999999999999999988765433

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.7e-36  Score=273.29  Aligned_cols=226  Identities=19%  Similarity=0.257  Sum_probs=171.6

Q ss_pred             EEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCCh
Q 039516           29 YIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL  107 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL  107 (345)
                      ...||+|+||.||+|.. .++..||+|.+..........+.+|+.++++++|+||+++++++..++..++||||+++++|
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   92 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL   92 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence            35699999999999974 46889999998766555667899999999999999999999999999999999999999999


Q ss_pred             HHHHH------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC-CCCEEEEccccceeecCCCCCCccc
Q 039516          108 DSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD-QLNTKISDFGMARIFGVNESGANTN  168 (345)
Q Consensus       108 ~~~l~------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~  168 (345)
                      .+++.                  +++.++.+||.   .+|+||||||+||+++. ++.++|+|||++........  ...
T Consensus        93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~  167 (268)
T cd06624          93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTE  167 (268)
T ss_pred             HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccc
Confidence            87654                  45566667765   48999999999999976 67899999999876532211  122


Q ss_pred             ceeecCCccccchhccCC--cCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          169 RIVGTYGYMSLEYTMSGT--VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       169 ~~~gt~~y~aPE~~~~~~--~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      ...|+..|+|||++.+..  ++.++|+||||+++|+|++|+.||........   ..+......       ..+.    .
T Consensus       168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~-------~~~~----~  233 (268)
T cd06624         168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK-------IHPE----I  233 (268)
T ss_pred             cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc-------cCCC----C
Confidence            345788999999987644  78899999999999999999999875332110   011000000       0111    1


Q ss_pred             ChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          247 PPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       247 ~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      +...... ..++.+||+.+|.+|||+.+
T Consensus       234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~  261 (268)
T cd06624         234 PESLSAEAKNFILRCFEPDPDKRASAHD  261 (268)
T ss_pred             CcccCHHHHHHHHHHcCCCchhCCCHHH
Confidence            1112223 58999999999999999643

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-36  Score=275.96  Aligned_cols=228  Identities=22%  Similarity=0.261  Sum_probs=178.6

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      .|+..+.||.|+||.||+|.. .++..||+|.+.... ......+.+|+.+++++.|+||+++++++.++...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            477778899999999999975 468999999987542 344567899999999999999999999999999999999999


Q ss_pred             CCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCccc
Q 039516          103 PNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTN  168 (345)
Q Consensus       103 ~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  168 (345)
                      ++++|.+++.              +++.++.+||..   +++|+||+|+||+++.++.++|+|||++........  ...
T Consensus        85 ~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~  159 (277)
T cd06640          85 GGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRN  159 (277)
T ss_pred             CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccc
Confidence            9999987664              456667777754   899999999999999999999999999977643221  122


Q ss_pred             ceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          169 RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       169 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      ...++..|+|||++.+..++.++|+||||+++|||++|..||..........       ....+.     .+.    ...
T Consensus       160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~~-----~~~----~~~  223 (277)
T cd06640         160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------LIPKNN-----PPT----LTG  223 (277)
T ss_pred             cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-------hhhcCC-----CCC----Cch
Confidence            3467889999999988889999999999999999999999997543221110       000110     111    122


Q ss_pred             hHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          249 NEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       249 ~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      ..... .+++..||+.+|.+|||+.+
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~  249 (277)
T cd06640         224 EFSKPFKEFIDACLNKDPSFRPTAKE  249 (277)
T ss_pred             hhhHHHHHHHHHHcccCcccCcCHHH
Confidence            22333 69999999999999999653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=279.71  Aligned_cols=237  Identities=18%  Similarity=0.175  Sum_probs=180.8

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCc---cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSG---QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +|++.+.||+|++|.||++... +++.||+|.+.....   .....+.+|+++++.++|+||+++++.+......++|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            5889999999999999999764 589999999975432   245578899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          101 FMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       101 ~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |+.+++|.+++.                 +++.+|.|||..   |++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            999999987754                 566777777765   899999999999999999999999999875432111


Q ss_pred             C---------------------------CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 039516          164 G---------------------------ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTE  216 (345)
Q Consensus       164 ~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~  216 (345)
                      .                           .......|+..|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence            0                           0112346788999999999888999999999999999999999999754321


Q ss_pred             CcccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhh
Q 039516          217 RPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLM  279 (345)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~  279 (345)
                      ..      ..... ....      ....  ....... .+++.+||+.||++|||+...+..+.
T Consensus       239 ~~------~~~~~-~~~~------~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll  287 (316)
T cd05574         239 ET------FSNIL-KKEV------TFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK  287 (316)
T ss_pred             HH------HHHHh-cCCc------cCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence            11      01111 1100      0000  0001223 69999999999999999654433333

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=271.22  Aligned_cols=233  Identities=20%  Similarity=0.261  Sum_probs=180.8

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +.+|++.+.||+|+||.||++.. .+++.+++|.+..........+.+|++++++++||||+++++++......+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            35699999999999999999975 46789999999776555677899999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      +++++|.+++.                +++.++.+||..   +++|+||+|+||+++.++.+||+|||++.......  .
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  156 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A  156 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence            99999987654                456667777754   89999999999999999999999999987653221  1


Q ss_pred             cccceeecCCccccchhccC---CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          166 NTNRIVGTYGYMSLEYTMSG---TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                      ......++..|+|||.+.+.   .++.++|+||||+++|+|++|+.||.........      .. ......   ..+.+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~------~~-~~~~~~---~~~~~  226 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL------FL-ISKSNF---PPPKL  226 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHhccC---CCccc
Confidence            12234678899999998776   7889999999999999999999999764421110      00 001100   01111


Q ss_pred             CCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          243 DGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       243 ~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .  ........ .+++.+||+.+|.+|||+.
T Consensus       227 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~  255 (262)
T cd06613         227 K--DKEKWSPVFHDFIKKCLTKDPKKRPTAT  255 (262)
T ss_pred             c--chhhhhHHHHHHHHHHcCCChhhCCCHH
Confidence            1  11111223 6999999999999999964

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=289.12  Aligned_cols=189  Identities=20%  Similarity=0.240  Sum_probs=156.8

Q ss_pred             CCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-C-----CCeeeEEEEEEECCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-Y-----TNLVKLLGCSIHGEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~~~~~~~~~~~~   95 (345)
                      ...|++.+.||+|+||.|-++. ..+++.||||++++.. ....+-+.|+.+|..|+ |     -|+|+++++|...+++
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            3468999999999999999995 4679999999997553 33456678999999996 4     4899999999999999


Q ss_pred             EEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC--CEEEEccccce
Q 039516           96 LLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL--NTKISDFGMAR  156 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~--~~kl~Dfgl~~  156 (345)
                      |||+|.+. .+|.++++                 +++.+|..||.+   +|||+||||+|||+.+.+  .+||+|||.++
T Consensus       264 ciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  264 CIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccc
Confidence            99999984 46777665                 667777777765   899999999999997544  59999999998


Q ss_pred             eecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccH
Q 039516          157 IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNL  221 (345)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~  221 (345)
                      .....     .....-+.+|.|||++.+.+|+.+.||||||||+.||++|.+-|.+.++.+++..
T Consensus       340 ~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~  399 (586)
T KOG0667|consen  340 FESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLAR  399 (586)
T ss_pred             ccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHH
Confidence            75321     1246778899999999999999999999999999999999988887766554443

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.9e-37  Score=275.08  Aligned_cols=241  Identities=18%  Similarity=0.207  Sum_probs=179.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCc--cCHHHHHHHHHHHHhcCCCC-eeeEEEEEEECC------
Q 039516           24 LDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSG--QGRVEFQNEAKLIAKLQYTN-LVKLLGCSIHGE------   93 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~------   93 (345)
                      ..|..+++||+|+||+||+|. ..+|+.||+|++.....  .......+|+.+|+.|+|+| ||++++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            347777889999999999995 46799999999976643  23456789999999999999 999999998877      


Q ss_pred             eeEEEEecCCC---------------CC---hHHHHHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccc
Q 039516           94 ERLLVYEFMPN---------------KS---LDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMA  155 (345)
Q Consensus        94 ~~~lv~e~~~~---------------gs---L~~~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~  155 (345)
                      .+++|+||++.               .+   ...++.+++.++.|||..   +|+||||||.|||++++|.+||+|||++
T Consensus        91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence            78999999742               11   334455777788888776   8999999999999999999999999999


Q ss_pred             eeecCCCCCCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC--
Q 039516          156 RIFGVNESGANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEG--  232 (345)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  232 (345)
                      +.+..+..  ......+|..|.|||++.+. .|+...||||+||++.||++++.-|.+..+.++   ...+...+...  
T Consensus       168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q---l~~If~~lGtP~e  242 (323)
T KOG0594|consen  168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ---LFRIFRLLGTPNE  242 (323)
T ss_pred             HHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH---HHHHHHHcCCCCc
Confidence            97653332  24446889999999999876 789999999999999999999999987665322   22222222211  


Q ss_pred             -Ccccc-----ccccCCCCC-----C---hhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          233 -KDLEL-----IDLTLDGSC-----P---PNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       233 -~~~~~-----~d~~l~~~~-----~---~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                       .+..+     .+.......     .   +.-... .+++..||+.+|..|.|+.
T Consensus       243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~  297 (323)
T KOG0594|consen  243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAK  297 (323)
T ss_pred             cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHH
Confidence             11000     010000000     0   011124 7899999999999999953

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.6e-36  Score=275.54  Aligned_cols=229  Identities=20%  Similarity=0.242  Sum_probs=175.4

Q ss_pred             eeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCC
Q 039516           26 WHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN  104 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  104 (345)
                      |++.+.||+|+||.||++... ++..+++|.+..........+.+|+++++.++||||+++++++..++..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            677788999999999999764 5788999999766555667899999999999999999999999999999999999999


Q ss_pred             CChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCccc
Q 039516          105 KSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTN  168 (345)
Q Consensus       105 gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  168 (345)
                      ++|..++.                +++.+|.+||..   |++||||||+||+++.++.+||+|||++.......  ....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~  161 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD  161 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence            99977542                566677777765   89999999999999999999999999987653221  1223


Q ss_pred             ceeecCCccccchhc-----cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          169 RIVGTYGYMSLEYTM-----SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       169 ~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                      ...++..|+|||++.     +..++.++|||||||++|+|++|+.||......+      ...... ......+..+   
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~-~~~~~~~~~~---  231 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIA-KSEPPTLAQP---  231 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHh-hcCCCCCCCc---
Confidence            356889999999874     3457889999999999999999999987543211      111111 1111111111   


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..++.+.   .+++..||+.+|.+|||+.
T Consensus       232 ~~~~~~~---~~li~~~l~~~p~~Rp~~~  257 (282)
T cd06643         232 SRWSSEF---KDFLKKCLEKNVDARWTTT  257 (282)
T ss_pred             cccCHHH---HHHHHHHccCChhhCcCHH
Confidence            1122111   5899999999999999953

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-37  Score=279.70  Aligned_cols=229  Identities=18%  Similarity=0.230  Sum_probs=174.6

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      +|++.+.||+|+||.||++... +|+.||+|.+... .......+.+|+.++++++|+||+++++++...+..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5788889999999999999764 7899999998654 3333567899999999999999999999999999999999999


Q ss_pred             CCCChHHHHH------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          103 PNKSLDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       103 ~~gsL~~~l~------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ++++|..++.                  +++.++.|||..  .+++|+||||+||+++.++.+||+|||++......   
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  156 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---  156 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence            9999876653                  456677788753  38999999999999999999999999998765322   


Q ss_pred             CcccceeecCCccccchhccCC------cCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGT------VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~------~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                       ......++..|+|||++.+..      ++.++|+|||||++|+|++|+.||.......   ...... ....+..    
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~-~~~~~~~----  227 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLS-AIVDGDP----  227 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHH-HHhhcCC----
Confidence             122245788999999886543      4789999999999999999999997543211   111111 1111111    


Q ss_pred             cccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          239 DLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       239 d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                       +.    .++..... ..++..||+.+|++||++.
T Consensus       228 -~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~  257 (286)
T cd06622         228 -PT----LPSGYSDDAQDFVAKCLNKIPNRRPTYA  257 (286)
T ss_pred             -CC----CCcccCHHHHHHHHHHcccCcccCCCHH
Confidence             11    11122222 5899999999999999954

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.3e-36  Score=278.88  Aligned_cols=185  Identities=21%  Similarity=0.315  Sum_probs=152.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .+|.+.++||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            4699999999999999999965 468999999986543 23345688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      +++ +|.+++.                +++.+|.+||..   +++|+||||+||+++.++.+||+|||++........  
T Consensus        86 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (301)
T cd07873          86 LDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--  159 (301)
T ss_pred             ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence            974 6765442                556667777764   899999999999999999999999999876432211  


Q ss_pred             cccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~  209 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST  209 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            1223457889999998765 457889999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.9e-37  Score=275.74  Aligned_cols=239  Identities=21%  Similarity=0.251  Sum_probs=180.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCC----CcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPN----EQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~----~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      .+|.+.+.||+|+||.||+|...+    ...||||...... ....+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            458888999999999999997533    3579999986554 3456689999999999999999999998864 567899


Q ss_pred             EecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           99 YEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        99 ~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      |||+++++|.+++.                +++.++.+||..   +++|+||||+||+++.++.+||+|||++.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            99999999988764                456667777754   89999999999999999999999999988654322


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      ... .....++..|+|||.+....++.++||||||+++||+++ |..||......+.      ... ...+...     .
T Consensus       162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~-~~~~~~~-----~  228 (270)
T cd05056         162 YYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------IGR-IENGERL-----P  228 (270)
T ss_pred             cee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHH-HHcCCcC-----C
Confidence            111 112234567999999988889999999999999999986 9999976542211      111 1111111     1


Q ss_pred             CCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          242 LDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       242 l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ....++    .. .+++.+|+..+|.+|||+.++...|.++..
T Consensus       229 ~~~~~~----~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         229 MPPNCP----PTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             CCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            111222    23 589999999999999998877777766544

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.4e-36  Score=273.43  Aligned_cols=183  Identities=26%  Similarity=0.362  Sum_probs=151.2

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +|.+.+.||+|++|.||+|.. .+++.||+|.+....  ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            588899999999999999975 468999999986542  23356788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          102 MPNKSLDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       102 ~~~gsL~~~l~------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      ++ ++|.+++.                  +++.+|.|||..   +++|+||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 46654432                  566777777765   89999999999999999999999999997653221 


Q ss_pred             CCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                       .......+++.|+|||++.+. .++.++||||||+++|+|+||+.||...
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~  205 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD  205 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence             112223568899999987654 5788999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.9e-37  Score=280.95  Aligned_cols=229  Identities=22%  Similarity=0.306  Sum_probs=176.9

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      |...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            55666799999999999965 468899999986543 3345578999999999999999999999999999999999999


Q ss_pred             CCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccc
Q 039516          104 NKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNR  169 (345)
Q Consensus       104 ~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  169 (345)
                      +++|.+++.              +++.++.+||.   .+++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~  160 (277)
T cd06642          86 GGSALDLLKPGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNT  160 (277)
T ss_pred             CCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhhhc
Confidence            999977654              55666777765   489999999999999999999999999987654221  11223


Q ss_pred             eeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChh
Q 039516          170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPN  249 (345)
Q Consensus       170 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  249 (345)
                      ..|+..|+|||++.+..++.++|+||||+++|||++|+.|+.........      . ....+.     .+.+.+.++  
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~-~~~~~~-----~~~~~~~~~--  226 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------F-LIPKNS-----PPTLEGQYS--  226 (277)
T ss_pred             ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH------h-hhhcCC-----CCCCCcccC--
Confidence            46788999999999888999999999999999999999998754322110      0 011111     111222122  


Q ss_pred             HHHH-HHHHhhccCCCCCcCCCCCcch
Q 039516          250 EDAF-LLVSCVCKSKQQIDVQCPMLFP  275 (345)
Q Consensus       250 ~~~~-~~l~~~Cl~~~P~~RPs~~~~~  275 (345)
                        .. .+++.+||+.+|++||||.++.
T Consensus       227 --~~~~~li~~~l~~~p~~Rp~~~~il  251 (277)
T cd06642         227 --KPFKEFVEACLNKDPRFRPTAKELL  251 (277)
T ss_pred             --HHHHHHHHHHccCCcccCcCHHHHH
Confidence              23 5899999999999999976543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-37  Score=285.81  Aligned_cols=236  Identities=20%  Similarity=0.211  Sum_probs=185.0

Q ss_pred             ccccCCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCc---cCHHHHHHHHHHHHhcC-CCCeeeEEEEEEEC
Q 039516           18 FVENSSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSG---QGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHG   92 (345)
Q Consensus        18 ~~~~~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~   92 (345)
                      ....+...|++.+.||+|.||+||++... +|+.+|+|.+.+...   .....+.+|+.+|++++ |||||.+++.|.+.
T Consensus        29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            34556677999999999999999999654 599999999976533   24568999999999998 99999999999999


Q ss_pred             CeeEEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC----CCEEEEcccc
Q 039516           93 EERLLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ----LNTKISDFGM  154 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~----~~~kl~Dfgl  154 (345)
                      ...++|||+|.||.|.+.+.              +++.++.|+|.   .||+||||||+|+|+...    +.+|++|||+
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999999999987643              34444555555   599999999999999643    4799999999


Q ss_pred             ceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 039516          155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKD  234 (345)
Q Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (345)
                      +.....   .......+||+.|+|||++.+..|+..+||||+|+++|.|++|..||..........       ....+.+
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~  255 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF  255 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC
Confidence            998754   334566799999999999999999999999999999999999999998765332211       1112222


Q ss_pred             cccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          235 LELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       235 ~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                       ++-++.    .+ ..... ..++..++..||..|+|..
T Consensus       256 -~f~~~~----w~-~is~~akd~i~~ll~~dp~~R~ta~  288 (382)
T KOG0032|consen  256 -DFTSEP----WD-DISESAKDFIRKLLEFDPRKRLTAA  288 (382)
T ss_pred             -CCCCCC----cc-ccCHHHHHHHHHhcccCcccCCCHH
Confidence             111111    11 11122 5899999999999999953

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-37  Score=276.06  Aligned_cols=229  Identities=21%  Similarity=0.272  Sum_probs=179.3

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      +|++...||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            4778888999999999999754 68999999987553 334567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCccc
Q 039516          103 PNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTN  168 (345)
Q Consensus       103 ~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  168 (345)
                      ++++|.+++.              +++.++.+||..   +++|+||+|+||+++.++.++|+|||+++.......  ...
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~  156 (274)
T cd06609          82 GGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRN  156 (274)
T ss_pred             CCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccc
Confidence            9999987765              556667777754   799999999999999999999999999987753321  223


Q ss_pred             ceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC-CC
Q 039516          169 RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS-CP  247 (345)
Q Consensus       169 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~  247 (345)
                      ...++..|+|||++.+..++.++||||||+++|+|++|+.||...+...      ... ....+     ..+.+... ++
T Consensus       157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~-~~~~~-----~~~~~~~~~~~  224 (274)
T cd06609         157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLF-LIPKN-----NPPSLEGNKFS  224 (274)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHH-Hhhhc-----CCCCCcccccC
Confidence            3567889999999998889999999999999999999999997543211      111 11111     11111111 22


Q ss_pred             hhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          248 PNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       248 ~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .+.   .+++..||+.+|++|||+.+
T Consensus       225 ~~~---~~~l~~~l~~~p~~Rpt~~~  247 (274)
T cd06609         225 KPF---KDFVSLCLNKDPKERPSAKE  247 (274)
T ss_pred             HHH---HHHHHHHhhCChhhCcCHHH
Confidence            222   58999999999999999643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.6e-37  Score=275.03  Aligned_cols=229  Identities=25%  Similarity=0.319  Sum_probs=172.9

Q ss_pred             EeeccCCeEEEEEEcCC--C--cEEEEEEeccCCc-cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKFPN--E--QEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~~--~--~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|++|.||+|.+.+  +  ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||++++
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~   80 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG   80 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence            48999999999997643  3  3699999976654 556789999999999999999999999887 8899999999999


Q ss_pred             ChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC-Ccc
Q 039516          106 SLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG-ANT  167 (345)
Q Consensus       106 sL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~  167 (345)
                      +|.+.+.                 +++.+|.+||.   .+++|+||||+||+++.++.+||+|||++......... ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9987653                 44555666665   48999999999999999999999999999876432211 111


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      ....++..|+|||++.+..++.++||||||+++|+|++ |+.||......+      ............  .   .....
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~--~---~~~~~  226 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGERL--E---RPEAC  226 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCcC--C---CCccC
Confidence            12356788999999998899999999999999999999 999986543211      111111111100  0   00111


Q ss_pred             ChhHHHH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          247 PPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       247 ~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      +    .. .+++.+||+.+|++|||+.++...|
T Consensus       227 ~----~~~~~li~~~l~~~p~~Rps~~~~~~~l  255 (257)
T cd05040         227 P----QDIYNVMLQCWAHNPADRPTFAALREFL  255 (257)
T ss_pred             C----HHHHHHHHHHCCCCcccCCCHHHHHHHh
Confidence            1    23 5899999999999999977665544

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-36  Score=290.13  Aligned_cols=179  Identities=20%  Similarity=0.238  Sum_probs=148.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ..|.+...||+|+||.||++... +++.||||...      ...+.+|+++|++++|+|||++++++..++..++|||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            36999999999999999999764 58899999643      234678999999999999999999999999999999999


Q ss_pred             CCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          103 PNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       103 ~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      . ++|.+++.                +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++..........
T Consensus       243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            5 56655542                455666666654   899999999999999999999999999987543222222


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKS  212 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~  212 (345)
                      .....||..|+|||++.+..++.++|||||||++|||++|..|+..
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~  364 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS  364 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence            2345799999999999999999999999999999999998876543

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-36  Score=273.75  Aligned_cols=228  Identities=21%  Similarity=0.297  Sum_probs=175.0

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCcc---------CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQ---------GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      |.+...||+|++|.||+|.. .+++.||+|.+......         ..+.+.+|+.++++++||||+++++++......
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            66777899999999999965 46899999988654222         124688999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           96 LLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      +++|||+++++|.+++.               +++.++.+||..   |++||||+|+||+++.++.++|+|||+++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEA  158 (267)
T ss_pred             EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence            99999999999977764               556677777765   899999999999999999999999999887642


Q ss_pred             CCCCC----cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          161 NESGA----NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       161 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                      .....    ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.......      ...... .     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~-----  226 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIFKIG-E-----  226 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHHHHh-c-----
Confidence            21111    1122457889999999998889999999999999999999999997543211      011111 0     


Q ss_pred             cccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          237 LIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       237 ~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ...+.+....+    .. ..++.+||+.||.+|||+.
T Consensus       227 ~~~~~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~  259 (267)
T cd06628         227 NASPEIPSNIS----SEAIDFLEKTFEIDHNKRPTAA  259 (267)
T ss_pred             cCCCcCCcccC----HHHHHHHHHHccCCchhCcCHH
Confidence            11111111122    23 5899999999999999954

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-38  Score=290.79  Aligned_cols=232  Identities=21%  Similarity=0.262  Sum_probs=180.2

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEEEe
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ..|+++++||+||.+.||++...+.+.+|+|++...  +.+....|.+|+.+|.+|+ |.+||++++|-..++.+|+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            459999999999999999999888899999988543  4556778999999999994 8999999999989999999999


Q ss_pred             cCCCCChHHHHH-------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          101 FMPNKSLDSSFS-------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       101 ~~~~gsL~~~l~-------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      |=+ .+|..+++             ..-+.|.+++..|..||||.||||.|+|+-. |.+||+|||.|..+..+.+....
T Consensus       441 ~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~k  518 (677)
T KOG0596|consen  441 CGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVK  518 (677)
T ss_pred             ccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccccceee
Confidence            753 35554443             2233444455555559999999999999854 68999999999988766666555


Q ss_pred             cceeecCCccccchhccCC-----------cCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          168 NRIVGTYGYMSLEYTMSGT-----------VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~-----------~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                      ...+||+.||+||.+....           .+.++||||+|||||+|+.|+.||.....       .|       .++..
T Consensus       519 dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~-------aKl~a  584 (677)
T KOG0596|consen  519 DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QI-------AKLHA  584 (677)
T ss_pred             ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HH-------HHHHh
Confidence            6679999999999876322           46889999999999999999999975321       11       22445


Q ss_pred             cccccCCCCCChhH-HH-HHHHHhhccCCCCCcCCCC
Q 039516          237 LIDLTLDGSCPPNE-DA-FLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       237 ~~d~~l~~~~~~~~-~~-~~~l~~~Cl~~~P~~RPs~  271 (345)
                      +.||...-.++.-. .. .++++..||+.||.+|||.
T Consensus       585 I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si  621 (677)
T KOG0596|consen  585 ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSI  621 (677)
T ss_pred             hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCc
Confidence            56665443343211 12 3799999999999999994

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.9e-37  Score=277.27  Aligned_cols=221  Identities=20%  Similarity=0.213  Sum_probs=165.3

Q ss_pred             EeeccCCeEEEEEEcCC-------------------------CcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeE
Q 039516           31 QQEQTRDRVILVGKFPN-------------------------EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKL   85 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~~-------------------------~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~   85 (345)
                      .||+|+||.||+|.+..                         ...||+|.+..........|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            48999999999997421                         24689999876544445678899999999999999999


Q ss_pred             EEEEEECCeeEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC----
Q 039516           86 LGCSIHGEERLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL----  145 (345)
Q Consensus        86 ~~~~~~~~~~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~----  145 (345)
                      +++|......++||||+++++|..++.                +++.++.|||..   +|+||||||+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence            999999999999999999999987653                566677777754   899999999999997643    


Q ss_pred             ---CEEEEccccceeecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHH-hCCCCCCCCCCCCccc
Q 039516          146 ---NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIV-CGKKNNKSYHTERPLN  220 (345)
Q Consensus       146 ---~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~-tg~~p~~~~~~~~~~~  220 (345)
                         .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......+.  
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--  230 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--  230 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence               3799999987643211      12356788999998865 56899999999999999995 69999875432211  


Q ss_pred             HHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          221 LVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                       ..    .....       ..+....    ... .+++..||+.+|++|||+.++...|
T Consensus       231 -~~----~~~~~-------~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         231 -ER----FYEKK-------HRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             -HH----HHHhc-------cCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence             11    11100       0010101    123 6899999999999999986654433

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4e-37  Score=277.23  Aligned_cols=229  Identities=24%  Similarity=0.332  Sum_probs=171.5

Q ss_pred             EeeccCCeEEEEEEcCC-------CcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           31 QQEQTRDRVILVGKFPN-------EQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~~-------~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      .||+|+||.||+|...+       ++.||||.+.... ......+.+|+.+++.++||||+++++++......++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            48999999999997632       3679999886542 234667999999999999999999999999989999999999


Q ss_pred             CCCChHHHHH----------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC-----CEEEEccccc
Q 039516          103 PNKSLDSSFS----------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL-----NTKISDFGMA  155 (345)
Q Consensus       103 ~~gsL~~~l~----------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~-----~~kl~Dfgl~  155 (345)
                      ++++|.+++.                      +++.++.|||.   .+++|+||||+||+++.++     .++|+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999987653                      34455666664   4899999999999999877     8999999998


Q ss_pred             eeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 039516          156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKD  234 (345)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (345)
                      ................++..|+|||++.++.++.++||||||+++|+|++ |+.||......   ...   .. ...+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~---~~-~~~~~~  231 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVL---QH-VTAGGR  231 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHH---HH-HhcCCc
Confidence            76533222222222345678999999999999999999999999999998 99998643311   111   11 111110


Q ss_pred             cccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          235 LELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       235 ~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      .     .    .+...... .+++.+||+.+|.+|||+.++...|
T Consensus       232 ~-----~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l  267 (269)
T cd05044         232 L-----Q----KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL  267 (269)
T ss_pred             c-----C----CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence            0     0    11111223 6999999999999999987655544

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=266.86  Aligned_cols=236  Identities=20%  Similarity=0.193  Sum_probs=180.8

Q ss_pred             CCCCeeeEEEeeccCCeEEEEE-EcCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVG-KFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~-~~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      |...|++-+.||+|.|++||+. +.++|+.+|+|.++..  +..+.+.+.+|+++.+.|+||||+++...+.+....|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4455778888999999999998 5678999999998543  445678899999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC---CCCEEEEccccceeecCCCC
Q 039516           99 YEFMPNKSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD---QLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        99 ~e~~~~gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      +|+|.|++|..-+-            .+.+.|++|.++|.++|||||+||.|+++..   ..-+||+|||++..+.   .
T Consensus        89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~  165 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---D  165 (355)
T ss_pred             EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC---C
Confidence            99999999853221            3344455555555569999999999999953   3348999999999885   3


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                      ......+.|||+|||||++...+|+..+|||+.||+||-|+.|..||.+.+...       .......+...  +++.--
T Consensus       166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------lye~I~~g~yd--~~~~~w  236 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYEQIKAGAYD--YPSPEW  236 (355)
T ss_pred             ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------HHHHHhccccC--CCCccc
Confidence            334456789999999999999999999999999999999999999998743221       11111122211  111111


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +..+++.   .+++.++|..||++|-|..
T Consensus       237 ~~is~~A---k~LvrrML~~dP~kRIta~  262 (355)
T KOG0033|consen  237 DTVTPEA---KSLIRRMLTVNPKKRITAD  262 (355)
T ss_pred             CcCCHHH---HHHHHHHhccChhhhccHH
Confidence            1122222   5899999999999999953

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-36  Score=272.04  Aligned_cols=230  Identities=21%  Similarity=0.265  Sum_probs=179.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ..+|++.+.||+|+||.||++... +++.|++|.+.....  ...+.+|++++++++|+||+++++++..+...|+++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            356888899999999999999875 479999999965432  67899999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      +++++|.+++.                +++.++.+||..   +++|+||+|+||+++.++.++|+|||++........  
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            99999987764                456667777765   799999999999999999999999999887643221  


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      ......++..|+|||++.+..++.++||||||+++|+|++|+.||..........       .....     ..+.+.  
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~~-----~~~~~~--  220 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPNK-----PPPTLS--  220 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhccC-----CCCCCC--
Confidence            2223457889999999998899999999999999999999999997643221100       00000     000110  


Q ss_pred             CChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          246 CPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       246 ~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .+...... .+++.+||+.||++|||+.+
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~  249 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQ  249 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHH
Confidence            11111123 68999999999999999653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.7e-37  Score=275.19  Aligned_cols=233  Identities=21%  Similarity=0.261  Sum_probs=170.7

Q ss_pred             EeeccCCeEEEEEEcC----CCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEE-ECCeeEEEEecCCC
Q 039516           31 QQEQTRDRVILVGKFP----NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSI-HGEERLLVYEFMPN  104 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~----~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~-~~~~~~lv~e~~~~  104 (345)
                      .||+|+||.||+|...    ++..||+|.+... .......+.+|+.+++.++||||+++++++. .++..+++|||+.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   81 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH   81 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence            4899999999999752    2468999998543 2334567889999999999999999999876 45568999999999


Q ss_pred             CChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC--Cc
Q 039516          105 KSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG--AN  166 (345)
Q Consensus       105 gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~--~~  166 (345)
                      ++|.+++.                +++.++.|||.   .+++||||||+||+++.++.+||+|||++.........  ..
T Consensus        82 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          82 GDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            99987764                45556666665   48999999999999999999999999998754321110  11


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhC-CCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG-KKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      .....++..|+|||++.+..++.++||||||+++|||++| .+||....   .   .............      .....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~---~~~~~~~~~~~~~------~~~~~  226 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---S---FDITVYLLQGRRL------LQPEY  226 (262)
T ss_pred             cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---H---HHHHHHHhcCCCC------CCCCc
Confidence            1123456789999999888999999999999999999995 55554322   1   1111112111110      00111


Q ss_pred             CChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          246 CPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       246 ~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                      .+    .. .+++..||+.+|++|||+.++...+.+++
T Consensus       227 ~~----~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         227 CP----DPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            11    23 59999999999999999888777776654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.1e-36  Score=274.00  Aligned_cols=240  Identities=20%  Similarity=0.224  Sum_probs=176.3

Q ss_pred             eeecccccccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEE
Q 039516           10 QTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLG   87 (345)
Q Consensus        10 ~s~~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~   87 (345)
                      ++.+.+....++    |++...||+|+||.||++.. .+++.||+|.+.... .....+.+|+.+++++ +||||+++++
T Consensus         8 ~~~~~~~~~~~~----~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~   82 (286)
T cd06638           8 IIFDSFPDPSDT----WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYG   82 (286)
T ss_pred             EEeecCCCcccc----eeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeee
Confidence            344455555444    89999999999999999965 468999999986432 2245688999999999 6999999999


Q ss_pred             EEE-----ECCeeEEEEecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC
Q 039516           88 CSI-----HGEERLLVYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD  143 (345)
Q Consensus        88 ~~~-----~~~~~~lv~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~  143 (345)
                      ++.     .++..++||||+++++|.+++.                   +++.++.+||..   +++||||||+||+++.
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~  159 (286)
T cd06638          83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTT  159 (286)
T ss_pred             eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECC
Confidence            874     3456899999999999976542                   455667777764   8999999999999999


Q ss_pred             CCCEEEEccccceeecCCCCCCcccceeecCCccccchhcc-----CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCc
Q 039516          144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-----GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERP  218 (345)
Q Consensus       144 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~  218 (345)
                      ++.+||+|||++........  ......|+..|+|||++..     ..++.++|||||||++|+|++|+.||........
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~  237 (286)
T cd06638         160 EGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA  237 (286)
T ss_pred             CCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence            99999999999886543211  1223468999999998753     4578899999999999999999999976432111


Q ss_pred             ccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          219 LNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                            ... ..........++.   .++    .. ..++.+||+.||++|||+.+
T Consensus       238 ------~~~-~~~~~~~~~~~~~---~~~----~~~~~li~~~l~~~p~~Rps~~e  279 (286)
T cd06638         238 ------LFK-IPRNPPPTLHQPE---LWS----NEFNDFIRKCLTKDYEKRPTVSD  279 (286)
T ss_pred             ------Hhh-ccccCCCcccCCC---CcC----HHHHHHHHHHccCCcccCCCHHH
Confidence                  000 0011101111110   011    23 58999999999999999654

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-36  Score=272.57  Aligned_cols=227  Identities=23%  Similarity=0.329  Sum_probs=174.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      .+|.+.+.||+|+||.||++.. +++.||+|.++..  .....+.+|+.++++++||||+++++++... ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4588999999999999999975 5888999998643  2346789999999999999999999998654 5799999999


Q ss_pred             CCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          104 NKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       104 ~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      +++|.+++.                 +++.++.+||..   |++||||||+||+++.++.+||+|||++.......    
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----  154 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----  154 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence            999987764                 456667777754   89999999999999999999999999987643211    


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                       .....+..|+|||++.++.++.++|+||||+++|+|++ |+.||......      .... ....+..   .+  ....
T Consensus       155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~-~~~~~~~---~~--~~~~  221 (254)
T cd05083         155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKE-CVEKGYR---ME--PPEG  221 (254)
T ss_pred             -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHH-HHhCCCC---CC--CCCc
Confidence             11234567999999988899999999999999999998 99998754321      1111 1111110   00  1111


Q ss_pred             CChhHHHH-HHHHhhccCCCCCcCCCCCcchhhh
Q 039516          246 CPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       246 ~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      ++    .. .+++.+||+.+|..|||+.++...+
T Consensus       222 ~~----~~~~~li~~~l~~~p~~Rp~~~~l~~~l  251 (254)
T cd05083         222 CP----ADVYVLMTSCWETEPKKRPSFHKLREKL  251 (254)
T ss_pred             CC----HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            22    23 5999999999999999976554443

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-36  Score=273.56  Aligned_cols=217  Identities=20%  Similarity=0.228  Sum_probs=164.1

Q ss_pred             EeeccCCeEEEEEEcCC-------------CcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           31 QQEQTRDRVILVGKFPN-------------EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~~-------------~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      .||+|+||.||+|...+             ...|++|.+..........|.+|+.+++.++||||+++++++......++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            48999999999997532             23689999876655556678999999999999999999999999889999


Q ss_pred             EEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC-------EEEEcccc
Q 039516           98 VYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN-------TKISDFGM  154 (345)
Q Consensus        98 v~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~-------~kl~Dfgl  154 (345)
                      ||||+++++|..++.                +++.++.|||.   .+|+||||||+|||++.++.       ++++|||+
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          82 VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            999999999876653                55666666665   48999999999999987654       89999999


Q ss_pred             ceeecCCCCCCcccceeecCCccccchhc-cCCcCcccchhhHHHHHHHHH-hCCCCCCCCCCCCcccHHHHHHHHHhcC
Q 039516          155 ARIFGVNESGANTNRIVGTYGYMSLEYTM-SGTVSIKTDVFGFGVLVLKIV-CGKKNNKSYHTERPLNLVGIAWQLWNEG  232 (345)
Q Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (345)
                      +.....      .....++..|+|||++. +..++.++|||||||++|||+ +|..||......+.       .... .+
T Consensus       159 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~-~~  224 (262)
T cd05077         159 PITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFY-EG  224 (262)
T ss_pred             CccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHH-hc
Confidence            875421      12245788899999886 567899999999999999998 58888765321110       0111 11


Q ss_pred             CccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcc
Q 039516          233 KDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       233 ~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~  274 (345)
                      .. ...        .+ .... .+++.+||+.||.+||++.++
T Consensus       225 ~~-~~~--------~~-~~~~~~~li~~cl~~dp~~Rp~~~~i  257 (262)
T cd05077         225 QC-MLV--------TP-SCKELADLMTHCMNYDPNQRPFFRAI  257 (262)
T ss_pred             Cc-cCC--------CC-ChHHHHHHHHHHcCCChhhCcCHHHH
Confidence            10 000        11 1123 689999999999999997654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=9.8e-37  Score=272.56  Aligned_cols=226  Identities=26%  Similarity=0.323  Sum_probs=174.1

Q ss_pred             EeeccCCeEEEEEEcCC----CcEEEEEEeccCCcc-CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQTRDRVILVGKFPN----EQEVAIKRLAWTSGQ-GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~~----~~~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|+||.||++....    +..|++|.++..... ....+.+|++.++.++|+||+++++++......++||||++++
T Consensus         2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (262)
T cd00192           2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG   81 (262)
T ss_pred             ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence            58999999999997653    789999999765433 3678999999999999999999999999999999999999999


Q ss_pred             ChHHHHH------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516          106 SLDSSFS------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus       106 sL~~~l~------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      +|.+++.                        +++.++.+||.   .+++|+||||+||+++.++.+||+|||.+......
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            9987753                        23445555555   58999999999999999999999999999876543


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ..........++..|+|||.+....++.++||||+|+++|+|++ |..||......      . .......+...     
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~~-----  226 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------E-VLEYLRKGYRL-----  226 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCCC-----
Confidence            22222333467889999999988889999999999999999999 69999765321      1 11111111110     


Q ss_pred             cCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcch
Q 039516          241 TLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFP  275 (345)
Q Consensus       241 ~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~  275 (345)
                      .....+    ... .+++..||+.+|.+|||+.++.
T Consensus       227 ~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~l~  258 (262)
T cd00192         227 PKPEYC----PDELYELMLSCWQLDPEDRPTFSELV  258 (262)
T ss_pred             CCCccC----ChHHHHHHHHHccCCcccCcCHHHHH
Confidence            111112    223 5999999999999999976543

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.6e-36  Score=269.96  Aligned_cols=228  Identities=20%  Similarity=0.238  Sum_probs=174.7

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH-GEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e  100 (345)
                      +|++.+.||+|++|.||++.. .+++.||+|.+...  .......+.+|++++++++|+|++++++.+.. +...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            488999999999999999965 45789999998654  23345578899999999999999999998764 446899999


Q ss_pred             cCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          101 FMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       101 ~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |+++++|.+++.                 +++.++.+||.   .|++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            999999987653                 34455556665   4899999999999999999999999999987643221


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                        ......+++.|+|||++.+..++.++|+||||+++++|++|+.||....      ......... .+...     .+.
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~-~~~~~-----~~~  223 (257)
T cd08223         158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRII-EGKLP-----PMP  223 (257)
T ss_pred             --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHH-hcCCC-----CCc
Confidence              2233568899999999999899999999999999999999999987432      111112221 11111     111


Q ss_pred             CCCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          244 GSCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       244 ~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      ...+    .. .+++.+|++.+|.+|||+.+
T Consensus       224 ~~~~----~~~~~li~~~l~~~p~~Rp~~~~  250 (257)
T cd08223         224 KDYS----PELGELIATMLSKRPEKRPSVKS  250 (257)
T ss_pred             cccC----HHHHHHHHHHhccCcccCCCHHH
Confidence            1122    23 69999999999999999643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.5e-36  Score=272.24  Aligned_cols=235  Identities=19%  Similarity=0.266  Sum_probs=176.5

Q ss_pred             CeeeEEEeeccCCeEEEEEEcCC--CcEEEEEEeccCC----------ccCHHHHHHHHHHHHh-cCCCCeeeEEEEEEE
Q 039516           25 DWHMYIQQEQTRDRVILVGKFPN--EQEVAIKRLAWTS----------GQGRVEFQNEAKLIAK-LQYTNLVKLLGCSIH   91 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~~--~~~VaiK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~niv~~~~~~~~   91 (345)
                      +|++.+.||+|+||.||++....  ++.||+|.+....          ......+..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37788889999999999998654  6889999885321          2234457789888865 799999999999999


Q ss_pred             CCeeEEEEecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcc
Q 039516           92 GEERLLVYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF  152 (345)
Q Consensus        92 ~~~~~lv~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Df  152 (345)
                      ++..+++|||+++++|.+++.                   +++.++.+||..  .+++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence            999999999999999977652                   455566666642  47999999999999999999999999


Q ss_pred             ccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC
Q 039516          153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEG  232 (345)
Q Consensus       153 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (345)
                      |++.......   ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||.....      ....... ..+
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~-~~~  228 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKI-VEA  228 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHH-hhc
Confidence            9998754322   22335688899999999988899999999999999999999999864321      1111111 111


Q ss_pred             CccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhh
Q 039516          233 KDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLL  278 (345)
Q Consensus       233 ~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l  278 (345)
                      ...    +.....+++..   .+++.+||+.||++|||+.++.+.+
T Consensus       229 ~~~----~~~~~~~~~~l---~~li~~cl~~~p~~Rp~~~e~~~~~  267 (269)
T cd08528         229 VYE----PLPEGMYSEDV---TDVITSCLTPDAEARPDIIQVSAMI  267 (269)
T ss_pred             cCC----cCCcccCCHHH---HHHHHHHCCCCCccCCCHHHHHHHh
Confidence            111    11111122111   5899999999999999977655443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.6e-36  Score=271.80  Aligned_cols=231  Identities=21%  Similarity=0.257  Sum_probs=178.0

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCeeEEEE
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH--GEERLLVY   99 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~   99 (345)
                      +|++.+.||.|+||.||++.. .+|+.||+|.+...  .....+.+.+|++++++++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478889999999999999964 56899999998654  23345678899999999999999999998764  45679999


Q ss_pred             ecCCCCChHHHHH-------------------hHHHHHHHHHhcC--CCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516          100 EFMPNKSLDSSFS-------------------GTFKDLLCLHKYS--RLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus       100 e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~--~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      ||+++++|.+++.                   +++.++.+||..+  ..+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            9999999977653                   4566677777443  668999999999999999999999999999876


Q ss_pred             cCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                      ......  .....++..|+|||++.+..++.++|+||||+++|+|++|+.||.....      .... .....+..    
T Consensus       161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~-~~~~~~~~----  227 (265)
T cd08217         161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQLA-SKIKEGKF----  227 (265)
T ss_pred             cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HHHH-HHHhcCCC----
Confidence            433221  2234688999999999988899999999999999999999999976431      1111 11111111    


Q ss_pred             cccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          239 DLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       239 d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                       +.+    +...... .+++..|++.+|++|||+.+
T Consensus       228 -~~~----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~  258 (265)
T cd08217         228 -RRI----PYRYSSELNEVIKSMLNVDPDKRPSTEE  258 (265)
T ss_pred             -CCC----ccccCHHHHHHHHHHccCCcccCCCHHH
Confidence             111    1111223 69999999999999999653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.5e-36  Score=270.38  Aligned_cols=236  Identities=20%  Similarity=0.265  Sum_probs=174.9

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc----------cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG----------QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE   93 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~   93 (345)
                      .|.+.+.||+|+||.||+|.. .+|+.||+|.++....          ...+.+..|+.++++++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            477888999999999999965 4689999998854211          01346788999999999999999999999999


Q ss_pred             eeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           94 ERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      ..++||||+++++|.+++.               +++.++.+||.   .+++|+||+|+||+++.++.++|+|||++...
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            9999999999999987654               45566666765   48999999999999999999999999998765


Q ss_pred             cCCCCCCcccceeecCCccccchhccCC--cCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTMSGT--VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                      .............|+..|+|||++....  ++.++|+||||+++|++++|..||......      ....... ......
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~  231 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLG-NKRSAP  231 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhh-ccccCC
Confidence            3222222223346788999999887654  789999999999999999999998643211      1111111 111111


Q ss_pred             cccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          237 LIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       237 ~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .++......++...   .+++..||+.+|.+|||+.+
T Consensus       232 ~~~~~~~~~~~~~~---~~li~~~l~~~p~~Rps~~~  265 (272)
T cd06629         232 PIPPDVSMNLSPVA---LDFLNACFTINPDNRPTARE  265 (272)
T ss_pred             cCCccccccCCHHH---HHHHHHHhcCChhhCCCHHH
Confidence            11121211122211   58999999999999999653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-36  Score=283.85  Aligned_cols=175  Identities=19%  Similarity=0.267  Sum_probs=145.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      .+|.+.+.||+|+||.||+|... +++.||+|.....      ....|+.++++++|+||+++++++......++||||+
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            46999999999999999999764 5789999985432      2357999999999999999999999999999999999


Q ss_pred             CCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          103 PNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       103 ~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      .+ +|.+++.                +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.....   ..
T Consensus       140 ~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~  212 (357)
T PHA03209        140 SS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PA  212 (357)
T ss_pred             CC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC---cc
Confidence            64 6655442                566677777765   8999999999999999999999999998753211   12


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNK  211 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~  211 (345)
                      .....||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence            223568999999999999999999999999999999999665543

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-36  Score=307.74  Aligned_cols=236  Identities=18%  Similarity=0.288  Sum_probs=176.4

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCee
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH--GEER   95 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~   95 (345)
                      .+..+|.+..+||+|+||.||++.. .++..||+|.+...  .......|..|+.++++|+|||||+++++|..  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            3446799999999999999999965 46789999998654  23345678999999999999999999998865  3568


Q ss_pred             EEEEecCCCCChHHHHH-------------------hHHHHHHHHHhcC----CCceEEeccCCCCeeeCC---------
Q 039516           96 LLVYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYS----RLRVIHRDLKASNILLDD---------  143 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~----~~~ivHrdlk~~Nill~~---------  143 (345)
                      ||||||+++++|.+++.                   +++.+|.|||...    ..+||||||||+|||++.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            99999999999977653                   5677888888753    246999999999999964         


Q ss_pred             --------CCCEEEEccccceeecCCCCCCcccceeecCCccccchhcc--CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          144 --------QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS--GTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       144 --------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                              .+.+||+|||++.......   ......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    3348999999998653221   1233578999999998864  45789999999999999999999999753


Q ss_pred             CCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcc
Q 039516          214 HTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~  274 (345)
                      ..     .... ...+..+...     .+ ..++.+.   ..++..||+.+|.+|||+.++
T Consensus       247 ~~-----~~ql-i~~lk~~p~l-----pi-~~~S~eL---~dLI~~~L~~dPeeRPSa~Ql  292 (1021)
T PTZ00266        247 NN-----FSQL-ISELKRGPDL-----PI-KGKSKEL---NILIKNLLNLSAKERPSALQC  292 (1021)
T ss_pred             Cc-----HHHH-HHHHhcCCCC-----Cc-CCCCHHH---HHHHHHHhcCChhHCcCHHHH
Confidence            32     1111 1111111100     00 1112111   589999999999999996543

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.3e-36  Score=269.29  Aligned_cols=229  Identities=18%  Similarity=0.241  Sum_probs=178.1

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .|+..+.||.|+||.||.+.. .+++.|++|.+...  +......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            378899999999999988864 46899999998654  344566789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          102 MPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       102 ~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      +++++|.+++.                 +++.++.+||..   +++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            99999987764                 345666677654   899999999999999999999999999987643321 


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                       ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.....      .+...... .+......     .
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-~~~~~~~~-----~  223 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIV-QGNYTPVV-----S  223 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-cCCCCCCc-----c
Confidence             22335688999999999888889999999999999999999999865321      11111111 12111110     1


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .++.+.   .+++..||+.+|.+|||+.+
T Consensus       224 ~~~~~~---~~~i~~~l~~~p~~R~s~~~  249 (256)
T cd08221         224 VYSSEL---ISLVHSLLQQDPEKRPTADE  249 (256)
T ss_pred             ccCHHH---HHHHHHHcccCcccCCCHHH
Confidence            112111   58999999999999999653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=284.81  Aligned_cols=224  Identities=17%  Similarity=0.244  Sum_probs=184.2

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      -|.+.+.||+|-|++|-.++. =+|.+||||++.+..  ......+..|++.|+.++|||||++|.+...+..+|||+|+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            377888899999999998853 479999999997663  33455788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC-CCCCEEEEccccceeecCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD-DQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      -++|+|.+++-                ++..++.|.|++|   +|||||||+|+.+- .-|-|||.|||++..+.   ..
T Consensus        99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~---PG  172 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ---PG  172 (864)
T ss_pred             cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC---Cc
Confidence            99999988753                6777888889887   99999999999775 56889999999998774   34


Q ss_pred             CcccceeecCCccccchhccCCcC-cccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVS-IKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                      ....+.+|+..|-|||++.+..|+ +++||||||||||.|++|+.||...++.+...++               +|....
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------mDCKYt  237 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------MDCKYT  237 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------------hccccc
Confidence            455668999999999999999987 6799999999999999999999987665543332               332221


Q ss_pred             CCCChhHHH-H-HHHHhhccCCCCCcCCCCC
Q 039516          244 GSCPPNEDA-F-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       244 ~~~~~~~~~-~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                         .|.... . .+++..+|..||.+|-|..
T Consensus       238 ---vPshvS~eCrdLI~sMLvRdPkkRAslE  265 (864)
T KOG4717|consen  238 ---VPSHVSKECRDLIQSMLVRDPKKRASLE  265 (864)
T ss_pred             ---CchhhhHHHHHHHHHHHhcCchhhccHH
Confidence               122222 2 5899999999999999943

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=288.15  Aligned_cols=223  Identities=19%  Similarity=0.194  Sum_probs=166.2

Q ss_pred             eeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhc---CCCCeeeEEEEEEECCeeEEEEecCCC
Q 039516           32 QEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL---QYTNLVKLLGCSIHGEERLLVYEFMPN  104 (345)
Q Consensus        32 lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~~~~~~~lv~e~~~~  104 (345)
                      ||+|+||.||++.. .+|+.||+|++...   .......+..|..++..+   .||||+++++++...+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999965 46899999998643   122234456677777665   699999999999999999999999999


Q ss_pred             CChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccc
Q 039516          105 KSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNR  169 (345)
Q Consensus       105 gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  169 (345)
                      |+|.+++.               +++.++.|||..   ||+||||||+|||++.++.+||+|||++.......  .....
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~  155 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNT  155 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccC
Confidence            99976553               566677777765   89999999999999999999999999987542211  12234


Q ss_pred             eeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          170 IVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       170 ~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||......      . .......+... +.    ....+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~-~~~~i~~~~~~-~~----~~~~~~  223 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------Q-MYRNIAFGKVR-FP----KNVLSD  223 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------H-HHHHHHcCCCC-CC----CccCCH
Confidence            5799999999988754 4789999999999999999999999754311      1 11111112110 00    011222


Q ss_pred             hHHHHHHHHhhccCCCCCcCCCCCcc
Q 039516          249 NEDAFLLVSCVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       249 ~~~~~~~l~~~Cl~~~P~~RPs~~~~  274 (345)
                      +.   .+++..||+.||.+||+....
T Consensus       224 ~~---~~li~~~L~~~P~~R~~~~~~  246 (330)
T cd05586         224 EG---RQFVKGLLNRNPQHRLGAHRD  246 (330)
T ss_pred             HH---HHHHHHHcCCCHHHCCCCCCC
Confidence            22   489999999999999986543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.9e-36  Score=273.02  Aligned_cols=185  Identities=23%  Similarity=0.286  Sum_probs=155.2

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .|++...||+|++|.||++... +|+.||+|++....  ....+.+.+|+.++++++|+||+++++++......++||||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            5888999999999999999764 68999999986432  23345688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          102 MPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       102 ~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      +++++|..++.               +++.+|.+||..   +++|+||||+||+++.++.++|+|||++........  .
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~  156 (286)
T cd07847          82 CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--D  156 (286)
T ss_pred             cCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc--c
Confidence            99988766543               567777788775   899999999999999999999999999987643221  1


Q ss_pred             ccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~  205 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS  205 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            223457889999998876 457899999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.6e-36  Score=273.77  Aligned_cols=228  Identities=21%  Similarity=0.290  Sum_probs=172.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC------Cee
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHG------EER   95 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~------~~~   95 (345)
                      ..|.+.+.||+|+||.||+|.. .+++.||+|.+.... .....+..|+.+++++ +|+||+++++++...      ...
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            3477778899999999999975 468999999986543 3456788999999998 799999999998753      468


Q ss_pred             EEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           96 LLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      |++|||+++++|.+++.                 +++.++.|||..   +|+|+||||+||+++.++.++|+|||++...
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            99999999999987654                 456667777765   8999999999999999999999999998765


Q ss_pred             cCCCCCCcccceeecCCccccchhc-----cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTM-----SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGK  233 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (345)
                      ....  .......|+..|+|||++.     +..++.++|||||||++|||++|+.||........     . .... ...
T Consensus       162 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~-~~~~-~~~  232 (272)
T cd06637         162 DRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----L-FLIP-RNP  232 (272)
T ss_pred             cccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----H-HHHh-cCC
Confidence            3221  1223357899999999886     34578899999999999999999999975432111     0 0111 111


Q ss_pred             ccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          234 DLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       234 ~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .....    ...++    .. .+++.+||+.+|.+|||+.
T Consensus       233 ~~~~~----~~~~~----~~~~~li~~~l~~~p~~Rpt~~  264 (272)
T cd06637         233 APRLK----SKKWS----KKFQSFIESCLVKNHSQRPTTE  264 (272)
T ss_pred             CCCCC----CCCcC----HHHHHHHHHHcCCChhhCCCHH
Confidence            11111    11122    23 6899999999999999964

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.8e-36  Score=271.73  Aligned_cols=187  Identities=24%  Similarity=0.375  Sum_probs=153.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-----ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCee
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-----GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH--GEER   95 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~   95 (345)
                      .+|+..+.||+|+||.||++.. .++..||+|.+....     ......+.+|+.++++++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4688899999999999999965 468999999986432     1234568899999999999999999998875  3578


Q ss_pred             EEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           96 LLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      +++|||+++++|.+++.               +++.++.+||..   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            99999999999987654               566677777754   799999999999999999999999999875432


Q ss_pred             CC-CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          161 NE-SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       161 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      .. .........++..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~  212 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY  212 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence            11 111112245788999999999888999999999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-35  Score=270.29  Aligned_cols=236  Identities=19%  Similarity=0.204  Sum_probs=176.5

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--EERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~e  100 (345)
                      +|+..+.||.|++|.||++.. .+++.||+|.+.... ......+.+|++++++++||||++++++|...  +.+++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            588899999999999999976 468999999987543 23456789999999999999999999988653  46899999


Q ss_pred             cCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516          101 FMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus       101 ~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      |+++++|.+++.                   +++.+|.|||..   +++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            999999976543                   466677777765   8999999999999999999999999998754321


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      .    .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....+...... ...... +...
T Consensus       159 ~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~-~~~~  231 (287)
T cd06621         159 L----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIV-NMPNPE-LKDE  231 (287)
T ss_pred             c----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHh-cCCchh-hccC
Confidence            1    123457888999999998899999999999999999999999998653211 11111111111 111111 1111


Q ss_pred             CCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          242 LDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       242 l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ....  ..-... .+++.+||+.+|++|||+.
T Consensus       232 ~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~  261 (287)
T cd06621         232 PGNG--IKWSEEFKDFIKQCLEKDPTRRPTPW  261 (287)
T ss_pred             CCCC--CchHHHHHHHHHHHcCCCcccCCCHH
Confidence            1000  011223 6999999999999999964

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.2e-36  Score=274.65  Aligned_cols=237  Identities=20%  Similarity=0.270  Sum_probs=175.6

Q ss_pred             eeeEEEeeccCCeEEEEEEcC----CCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC------
Q 039516           26 WHMYIQQEQTRDRVILVGKFP----NEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE------   93 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~----~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------   93 (345)
                      |.+.+.||+|+||.||+|.+.    +++.||||.+...  .....+.+.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456778999999999999752    4689999998654  3334667899999999999999999999886532      


Q ss_pred             eeEEEEecCCCCChHHHHH---------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcc
Q 039516           94 ERLLVYEFMPNKSLDSSFS---------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF  152 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~---------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Df  152 (345)
                      ..++++||+.+|+|.+++.                     +++.++.|||..   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999866531                     556677777754   8999999999999999999999999


Q ss_pred             ccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhc
Q 039516          153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNE  231 (345)
Q Consensus       153 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (345)
                      |+++...............+++.|++||.+.+..++.++||||||+++|+|++ |+.||......   ....+    ...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~----~~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNY----LIK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHH----HHc
Confidence            99886543222212222345678999999988889999999999999999999 88888654321   11111    111


Q ss_pred             CCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          232 GKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       232 ~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                      +....         .++..... .+++.+||+.+|++|||+.++...|.++
T Consensus       231 ~~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11100         11122234 6999999999999999988776666543

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-36  Score=283.55  Aligned_cols=188  Identities=22%  Similarity=0.259  Sum_probs=152.8

Q ss_pred             cccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-
Q 039516           17 KFVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG-   92 (345)
Q Consensus        17 ~~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-   92 (345)
                      +........|.+.+.||+|+||.||++.. .+++.||||.+....  ......+.+|+.++++++||||+++++++... 
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07878           8 KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT   87 (343)
T ss_pred             HHHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence            33334456799999999999999999964 578899999986532  22345678999999999999999999987543 


Q ss_pred             -----CeeEEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccc
Q 039516           93 -----EERLLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFG  153 (345)
Q Consensus        93 -----~~~~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg  153 (345)
                           ...+++|+++ +++|.+++.              +++.+|.|||..   ||+||||||+||+++.++.+||+|||
T Consensus        88 ~~~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          88 SIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cccccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence                 3568999988 677765543              567777777765   89999999999999999999999999


Q ss_pred             cceeecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          154 MARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       154 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      ++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  219 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN  219 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            99865321     223578999999999876 56889999999999999999999999754

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.3e-36  Score=277.41  Aligned_cols=180  Identities=20%  Similarity=0.302  Sum_probs=142.4

Q ss_pred             EEEeeccCCeEEEEEEcC---CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCeeEEEEecCC
Q 039516           29 YIQQEQTRDRVILVGKFP---NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH--GEERLLVYEFMP  103 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~---~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~  103 (345)
                      ..+||+|+||+||+|...   +++.||+|.+....  ....+.+|+.++++++||||+++++++..  +...+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            346999999999999753   46899999986442  23567899999999999999999998864  456899999986


Q ss_pred             CCChHHH------------------------HHhHHHHHHHHHhcCCCceEEeccCCCCeee----CCCCCEEEEccccc
Q 039516          104 NKSLDSS------------------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILL----DDQLNTKISDFGMA  155 (345)
Q Consensus       104 ~gsL~~~------------------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill----~~~~~~kl~Dfgl~  155 (345)
                      + +|.++                        +.+++.+|.|||..   ||+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 44332                        23666777777765   89999999999999    45678999999999


Q ss_pred             eeecCCCC-CCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          156 RIFGVNES-GANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       156 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ........ ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            87643221 112234578999999999876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.4e-35  Score=270.58  Aligned_cols=235  Identities=20%  Similarity=0.207  Sum_probs=181.2

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +|.+.+.||+|+||.||++.. .+++.||+|.+...   .......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            588999999999999999975 46899999998643   22345678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |+++++|.+++.               +++.+|.+||..   |++|+||+|+||+++.++.+||+|||++......    
T Consensus        82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----  154 (290)
T cd05580          82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----  154 (290)
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence            999999987764               456667777764   8999999999999999999999999998875432    


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                       .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||......       ........+..      .+...
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~------~~~~~  220 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKILEGKV------RFPSF  220 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCc------cCCcc
Confidence             22346889999999998888899999999999999999999999754311       11111111111      11111


Q ss_pred             CChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccccc
Q 039516          246 CPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLY  286 (345)
Q Consensus       246 ~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~  286 (345)
                      .    ... .+++.+||+.||.+||+..  ...+.+++.+..
T Consensus       221 ~----~~~l~~li~~~l~~~p~~R~~~~--~~~~~~l~~~~~  256 (290)
T cd05580         221 F----SPDAKDLIRNLLQVDLTKRLGNL--KNGVNDIKNHPW  256 (290)
T ss_pred             C----CHHHHHHHHHHccCCHHHccCcc--cCCHHHHHcCcc
Confidence            1    223 5899999999999999632  223444444433

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8.2e-36  Score=272.80  Aligned_cols=234  Identities=23%  Similarity=0.317  Sum_probs=181.0

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ......|.+.+.||+|+||.||++.. .++..||+|.+..........+.+|+.++++++||||+++++++...+..|+|
T Consensus        15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            44457899999999999999999964 46889999998765545567789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516           99 YEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus        99 ~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      +||+++++|.+++.              +++.++.+||..   |++|+||||+||+++.++.++|+|||++........ 
T Consensus        95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            99999999987654              455566666654   899999999999999999999999999876543221 


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                       ......|++.|+|||.+....++.++|+||||+++|++++|+.||...........      ....+.      +... 
T Consensus       171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~~------~~~~-  236 (293)
T cd06647         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGT------PELQ-  236 (293)
T ss_pred             -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCCC------CCCC-
Confidence             12234688899999999888899999999999999999999999976443221110      000110      0000 


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                       .+...... .+++..||+.+|.+||++.
T Consensus       237 -~~~~~~~~l~~li~~~l~~~p~~Rp~~~  264 (293)
T cd06647         237 -NPEKLSAIFRDFLNRCLEMDVEKRGSAK  264 (293)
T ss_pred             -CccccCHHHHHHHHHHccCChhhCcCHH
Confidence             01111122 5899999999999999954

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.4e-35  Score=266.41  Aligned_cols=234  Identities=23%  Similarity=0.314  Sum_probs=179.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .+|++.+.||.|+||.||+|.. .++..||+|++.... ......+.+|+++++.++|+||+++++.+...+..++||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            3688999999999999999975 468899999996542 23567799999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          102 MPNKSLDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       102 ~~~gsL~~~l~------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      +++++|.+++.                  +++.++.+||..   |++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999877753                  456667777754   899999999999999999999999999876643322


Q ss_pred             CC--cccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          164 GA--NTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       164 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ..  ......|+..|+|||++... .++.++|+||||+++|+|++|+.||........      ........      .+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~~------~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQND------PP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHhcCC------CC
Confidence            21  22334688999999998876 789999999999999999999999976533211      11111110      11


Q ss_pred             cCCCCCC-hhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          241 TLDGSCP-PNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       241 ~l~~~~~-~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .+..... ...... .+++..||+.||++|||+.
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  259 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAE  259 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHH
Confidence            1111110 011123 6999999999999999954

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=274.22  Aligned_cols=232  Identities=19%  Similarity=0.236  Sum_probs=177.5

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ..+|++...||.|+||.||++.. .++..||+|.+..........|..|++++++++||||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            34588889999999999999976 46899999999766655667899999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      +++++|.+++.                +++.++.+||..   +|+|+||||+||+++.++.++|+|||++.......  .
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence            99999987754                455666677665   89999999999999999999999999886543221  1


Q ss_pred             cccceeecCCccccchhc-----cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          166 NTNRIVGTYGYMSLEYTM-----SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ......+++.|+|||++.     ...++.++|+||||+++|+|++|+.||.......      ...... .+....+..+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~~~~~  231 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKIL-KSEPPTLDQP  231 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHHh-cCCCCCcCCc
Confidence            223356899999999875     3456789999999999999999999997643211      111111 1111000000


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                         ..++.+.   .+++..||+.+|.+|||+.
T Consensus       232 ---~~~~~~~---~~li~~~l~~~p~~Rps~~  257 (280)
T cd06611         232 ---SKWSSSF---NDFLKSCLVKDPDDRPTAA  257 (280)
T ss_pred             ---ccCCHHH---HHHHHHHhccChhhCcCHH
Confidence               0112111   5899999999999999964

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5e-36  Score=271.74  Aligned_cols=228  Identities=20%  Similarity=0.277  Sum_probs=175.6

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      |.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++..+...++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            67788899999999999965 468999999986442 2334578899999999999999999999999999999999999


Q ss_pred             CCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccc
Q 039516          104 NKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNR  169 (345)
Q Consensus       104 ~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  169 (345)
                      +++|.+++.              +++.++.+||.   .|++|+||+|+||+++.++.++|+|||++........  ....
T Consensus        86 ~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~  160 (277)
T cd06641          86 GGSALDLLEPGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNT  160 (277)
T ss_pred             CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhcc
Confidence            999987764              44555556654   5899999999999999999999999999876533211  1223


Q ss_pred             eeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChh
Q 039516          170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPN  249 (345)
Q Consensus       170 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  249 (345)
                      ..++..|+|||++.+..++.++|+|||||++|+|++|..||.......      .... ...+.     .+.+...++.+
T Consensus       161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~~~~-----~~~~~~~~~~~  228 (277)
T cd06641         161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFL-IPKNN-----PPTLEGNYSKP  228 (277)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHH-HhcCC-----CCCCCcccCHH
Confidence            467889999999988888999999999999999999999997543211      1111 11111     11122222222


Q ss_pred             HHHHHHHHhhccCCCCCcCCCCCc
Q 039516          250 EDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       250 ~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .   .+++.+||+.+|.+||++.+
T Consensus       229 ~---~~~i~~~l~~~p~~Rp~~~~  249 (277)
T cd06641         229 L---KEFVEACLNKEPSFRPTAKE  249 (277)
T ss_pred             H---HHHHHHHccCChhhCcCHHH
Confidence            2   58999999999999999654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.5e-36  Score=277.26  Aligned_cols=183  Identities=18%  Similarity=0.221  Sum_probs=146.7

Q ss_pred             eEEEeecc--CCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           28 MYIQQEQT--RDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        28 ~~~~lG~G--~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      +.+.||+|  +|++||++.. .+|+.||+|.++...  ......+.+|+.+++.++||||++++++|..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            34568999  6789999965 578999999997542  233456778999999999999999999999999999999999


Q ss_pred             CCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC-
Q 039516          103 PNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG-  164 (345)
Q Consensus       103 ~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-  164 (345)
                      ++++|.+++.                 +++.+|.|||..   +|+||||||+||+++.++.++++||+........... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999987753                 456677777764   8999999999999999999999999865443211110 


Q ss_pred             ----CcccceeecCCccccchhcc--CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          165 ----ANTNRIVGTYGYMSLEYTMS--GTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       165 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                          .......++..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence                01112346778999999876  45889999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=9.2e-36  Score=271.80  Aligned_cols=240  Identities=20%  Similarity=0.221  Sum_probs=175.6

Q ss_pred             ceeecccccccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEE
Q 039516            9 CQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLL   86 (345)
Q Consensus         9 ~~s~~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~   86 (345)
                      .++..++.+.    ..+|.+...||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|||+++++
T Consensus        11 ~~~~~~~~~~----~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~   85 (291)
T cd06639          11 MLGLESLGDP----TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFY   85 (291)
T ss_pred             hhhcccCCCC----CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            3444455554    45599999999999999999975 568999999986432 2345678899999999 899999999


Q ss_pred             EEEEEC-----CeeEEEEecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC
Q 039516           87 GCSIHG-----EERLLVYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD  142 (345)
Q Consensus        87 ~~~~~~-----~~~~lv~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~  142 (345)
                      +++...     +..++||||+++++|.+++.                   +++.++.+||.   .+++|+||||+||+++
T Consensus        86 ~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~  162 (291)
T cd06639          86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLT  162 (291)
T ss_pred             EEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEc
Confidence            998753     35899999999999987653                   34455556654   5899999999999999


Q ss_pred             CCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCC-----cCcccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 039516          143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGT-----VSIKTDVFGFGVLVLKIVCGKKNNKSYHTER  217 (345)
Q Consensus       143 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~SlG~il~el~tg~~p~~~~~~~~  217 (345)
                      .++.+||+|||++........  ......|+..|+|||++....     ++.++|||||||++|+|++|+.||.......
T Consensus       163 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~  240 (291)
T cd06639         163 TEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK  240 (291)
T ss_pred             CCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence            999999999999876532211  112246788999999876433     6889999999999999999999997543211


Q ss_pred             cccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          218 PLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .      ... +..+....+.+       +...... .+++.+||+.+|++|||+.
T Consensus       241 ~------~~~-~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~  282 (291)
T cd06639         241 T------LFK-IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVT  282 (291)
T ss_pred             H------HHH-HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHH
Confidence            1      111 11111111111       1111123 6899999999999999964

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=273.87  Aligned_cols=185  Identities=21%  Similarity=0.280  Sum_probs=156.1

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +|++.+.||+|+||.||++... +++.||+|.++..  .......+.+|++++++++|+||+++++++..++..++||||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            5899999999999999999764 6889999998654  333457889999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          102 MPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       102 ~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      ++++.+..+..               +++.++.+||..   +++|+||+|+||++++++.+||+|||++........ ..
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~  157 (288)
T cd07833          82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SP  157 (288)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-cc
Confidence            99877654332               566777777765   899999999999999999999999999887643322 12


Q ss_pred             ccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      .....++..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus       158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  205 (288)
T cd07833         158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD  205 (288)
T ss_pred             ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            2335678899999999887 7899999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.7e-36  Score=290.66  Aligned_cols=184  Identities=18%  Similarity=0.157  Sum_probs=145.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCC------CCeeeEEEEEEEC-Ce
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY------TNLVKLLGCSIHG-EE   94 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~~~~~~~~~-~~   94 (345)
                      ..+|++.++||+|+||.||++.. .+++.||||+++... .....+..|+.++..++|      .+++++++++... .+
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            45799999999999999999965 468899999996432 223456678888877755      4588999988754 57


Q ss_pred             eEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC--------------
Q 039516           95 RLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL--------------  145 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~--------------  145 (345)
                      .++|||++ +++|.+++.               +++.+|.|||..  .|||||||||+|||++.++              
T Consensus       207 ~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~  283 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPD  283 (467)
T ss_pred             EEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence            89999988 556655432               566777777752  3899999999999998765              


Q ss_pred             --CEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 039516          146 --NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHT  215 (345)
Q Consensus       146 --~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~  215 (345)
                        .+||+|||.+....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       284 ~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        284 PCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             CceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence              49999999875421     122346789999999999999999999999999999999999999976543

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.2e-36  Score=268.43  Aligned_cols=227  Identities=20%  Similarity=0.266  Sum_probs=175.7

Q ss_pred             eeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC-----ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           26 WHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS-----GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      |...+.||+|++|.||+|... +++.|++|.+....     ....+.+.+|+.+++.++|+||+++++++......+++|
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            566678999999999999765 78999999986542     224567899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||+++++|.+++.               +++.++.+||..   |++|+||+|+||+++.++.+||+|||++.......  
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--  156 (258)
T cd06632          82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--  156 (258)
T ss_pred             EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence            9999999987764               466677777765   89999999999999999999999999988653322  


Q ss_pred             CcccceeecCCccccchhccCC-cCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGT-VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                       ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||.....      ..............     .+.
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~-----~~~  224 (258)
T cd06632         157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELP-----PIP  224 (258)
T ss_pred             -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCC-----CcC
Confidence             123356888999999887766 89999999999999999999999975431      11111111111111     111


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..++++.   .+++.+||+.+|++|||+.
T Consensus       225 ~~~~~~~---~~li~~~l~~~p~~Rp~~~  250 (258)
T cd06632         225 DHLSDEA---KDFILKCLQRDPSLRPTAA  250 (258)
T ss_pred             CCcCHHH---HHHHHHHhhcCcccCcCHH
Confidence            1122111   5899999999999999964

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.7e-36  Score=268.34  Aligned_cols=229  Identities=16%  Similarity=0.217  Sum_probs=177.5

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +|.+.+.||+|+||.+|++.. .+|+.||+|.+...  .......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478899999999999999865 46899999998643  233456789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          102 MPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       102 ~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      +++++|.+.+.                 +++.++.+||..   +++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999876653                 456666777754   899999999999999999999999999986543211 


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                       ......|++.|+|||++.+..++.++|+||||+++++|++|+.||.....      .+...... .+....     ...
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-~~~~~~-----~~~  223 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKII-RGSYPP-----VSS  223 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHh-cCCCCC-----Ccc
Confidence             12234678899999999888899999999999999999999999864321      11111111 111110     111


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCCCCcc
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~  274 (345)
                      .+    ... .+++.+||+.+|++||+|.++
T Consensus       224 ~~----~~~~~~li~~~l~~~p~~Rp~~~~v  250 (256)
T cd08218         224 HY----SYDLRNLVSQLFKRNPRDRPSVNSI  250 (256)
T ss_pred             cC----CHHHHHHHHHHhhCChhhCcCHHHH
Confidence            12    222 589999999999999997543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.4e-35  Score=264.42  Aligned_cols=232  Identities=23%  Similarity=0.281  Sum_probs=181.7

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCc-cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      +|++.+.||+|++|.||++... +++.|++|++..... .....+.+|+..+.+++|+||+++++++...+..++||||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            5888999999999999999765 599999999976543 44678999999999999999999999999999999999999


Q ss_pred             CCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          103 PNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       103 ~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      ++++|.+++.               +++.++.+||..  .+++|+||+|+||+++.++.++|+|||++.........  .
T Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~  157 (264)
T cd06623          82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--C  157 (264)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--c
Confidence            9999988764               455666666661  48999999999999999999999999999876432222  1


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC-C
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS-C  246 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~  246 (345)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.............   ... ....     +.+... +
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~-~~~~-----~~~~~~~~  228 (264)
T cd06623         158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ---AIC-DGPP-----PSLPAEEF  228 (264)
T ss_pred             cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH---HHh-cCCC-----CCCCcccC
Confidence            23568889999999998889999999999999999999999997654311111111   111 1111     111111 2


Q ss_pred             ChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          247 PPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       247 ~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      +    .. .+++..||+.+|++|||+.+
T Consensus       229 ~----~~l~~li~~~l~~~p~~R~~~~~  252 (264)
T cd06623         229 S----PEFRDFISACLQKDPKKRPSAAE  252 (264)
T ss_pred             C----HHHHHHHHHHccCChhhCCCHHH
Confidence            2    23 58999999999999999643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-36  Score=271.64  Aligned_cols=185  Identities=23%  Similarity=0.323  Sum_probs=151.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .+|.+.+.||+|++|.||++... +++.||||.+.... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56899999999999999999764 68999999986543 22334578899999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      +++ +|.+++.                +++.+|.+||..   +++||||||+||+++.++.+||+|||++........  
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--  158 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--  158 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence            985 7866543                556667777754   899999999999999999999999999875432111  


Q ss_pred             cccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||....
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            1122346788999998875 457899999999999999999999996543

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.7e-36  Score=267.40  Aligned_cols=230  Identities=25%  Similarity=0.296  Sum_probs=172.4

Q ss_pred             eeEEEeeccCCeEEEEEEcCC-----CcEEEEEEeccCCcc-CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           27 HMYIQQEQTRDRVILVGKFPN-----EQEVAIKRLAWTSGQ-GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        27 ~~~~~lG~G~~g~vy~~~~~~-----~~~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      .+.+.||.|+||.||++....     +..||+|.+...... ....+..|+.++..++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            456679999999999997653     388999999765433 56789999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHh--------------HHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          101 FMPNKSLDSSFSG--------------TFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       101 ~~~~gsL~~~l~~--------------~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      |+++++|.+++..              +.+.+.+|+.+|+.+++|+||||+||+++.++.++|+|||++...........
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  161 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK  161 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccccc
Confidence            9999999877641              12233344444555899999999999999999999999999987654322211


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      . ...+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.....      ...... ...+....     ....
T Consensus       162 ~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~~~~-~~~~~~~~-----~~~~  228 (258)
T smart00219      162 K-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEVLEY-LKKGYRLP-----KPEN  228 (258)
T ss_pred             c-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH-HhcCCCCC-----CCCc
Confidence            1 1236789999999988889999999999999999998 7888865321      111111 11111110     0111


Q ss_pred             CChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          246 CPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       246 ~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .    ... .+++.+|++.+|.+|||+.+
T Consensus       229 ~----~~~~~~~i~~~l~~~p~~Rpt~~~  253 (258)
T smart00219      229 C----PPEIYKLMLQCWAEDPEDRPTFSE  253 (258)
T ss_pred             C----CHHHHHHHHHHCcCChhhCcCHHH
Confidence            1    223 58999999999999999654

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.6e-36  Score=269.49  Aligned_cols=233  Identities=20%  Similarity=0.313  Sum_probs=175.7

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc------cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG------QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      +|+..+.||+|++|.||++.. .+++.||+|.+.....      .....+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            377788899999999999964 5789999999864321      124578899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC-CEEEEccccceeecCC
Q 039516           98 VYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL-NTKISDFGMARIFGVN  161 (345)
Q Consensus        98 v~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgl~~~~~~~  161 (345)
                      ||||+++++|.+++.               +++.++.+||..   |++|+||+|+||+++.++ .+||+|||.+......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            999999999987764               455666666654   899999999999998776 5899999998776432


Q ss_pred             CCC--CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          162 ESG--ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      ...  .......|+..|+|||++.+..++.++|+||+|+++|+|++|..||.........   ...........      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~------  228 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASATT------  228 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhccCC------
Confidence            111  1122346788999999998888999999999999999999999999654322111   11111110000      


Q ss_pred             ccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          240 LTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       240 ~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                         ....+...... .+++..|++.+|++|||+.
T Consensus       229 ---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~  259 (268)
T cd06630         229 ---APSIPEHLSPGLRDVTLRCLELQPEDRPPSR  259 (268)
T ss_pred             ---CCCCchhhCHHHHHHHHHHcCCCcccCcCHH
Confidence               01112222223 5899999999999999954

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.4e-36  Score=271.44  Aligned_cols=235  Identities=21%  Similarity=0.240  Sum_probs=177.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCCcc-CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTSGQ-GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      .+|.+..+||+|+||.||++...      +.+.|++|.+...... ....+.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46889999999999999999753      3468999998654333 4567999999999999999999999999888999


Q ss_pred             EEEecCCCCChHHHHH------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcc
Q 039516           97 LVYEFMPNKSLDSSFS------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF  152 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Df  152 (345)
                      +||||+++++|.+++.                        +++.+|.|||..   +|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999987653                        345556666654   8999999999999999999999999


Q ss_pred             ccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhc
Q 039516          153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNE  231 (345)
Q Consensus       153 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (345)
                      |++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .    ......
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~----~~~~~~  233 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---V----LNRLQA  233 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---H----HHHHHc
Confidence            9987542211 112223456778999999988888999999999999999999 788886543211   1    111111


Q ss_pred             CCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhh
Q 039516          232 GKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCL  277 (345)
Q Consensus       232 ~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~  277 (345)
                      +......    ...++    .. .+++.+||+.+|.+|||+.++...
T Consensus       234 ~~~~~~~----~~~~~----~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         234 GKLELPV----PEGCP----SRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCcCCCC----CCCCC----HHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            2111110    11122    23 699999999999999997654443

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.2e-37  Score=275.34  Aligned_cols=220  Identities=19%  Similarity=0.195  Sum_probs=165.7

Q ss_pred             EeeccCCeEEEEEEcC-C-------CcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           31 QQEQTRDRVILVGKFP-N-------EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~-~-------~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      .||+|+||.||+|... .       ...||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            4899999999999653 2       2358999886555455667899999999999999999999999989999999999


Q ss_pred             CCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC--------EEEEccccceee
Q 039516          103 PNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN--------TKISDFGMARIF  158 (345)
Q Consensus       103 ~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~--------~kl~Dfgl~~~~  158 (345)
                      ++|+|.+++.                +++.++.|||..   ||+||||||+||+++.++.        ++++|||++...
T Consensus        82 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          82 KFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             CCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            9999987764                556667777755   8999999999999987765        699999988654


Q ss_pred             cCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCC-CCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGK-KNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                      ..      .....++..|+|||++.+ ..++.++||||||+++|+|++|. .|+.......      .. ......    
T Consensus       159 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~-~~~~~~----  221 (258)
T cd05078         159 LP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KL-QFYEDR----  221 (258)
T ss_pred             CC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HH-HHHHcc----
Confidence            21      123467889999999886 45789999999999999999985 5554332111      00 011110    


Q ss_pred             cccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhh
Q 039516          237 LIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCL  277 (345)
Q Consensus       237 ~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~  277 (345)
                         ..    .+...... .+++..||+.+|++|||+.+++..
T Consensus       222 ---~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         222 ---HQ----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ---cc----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence               00    11111223 699999999999999997765443

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.5e-36  Score=275.10  Aligned_cols=228  Identities=21%  Similarity=0.287  Sum_probs=175.4

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCC
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN  104 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  104 (345)
                      |+...+||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            44555799999999999965 46899999999765555567789999999999999999999999999999999999999


Q ss_pred             CChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          105 KSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       105 gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      ++|..++.              +++.++.+||..   +++||||||+||+++.++.+||+|||++........  .....
T Consensus       103 ~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~  177 (297)
T cd06659         103 GALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSL  177 (297)
T ss_pred             CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccce
Confidence            99977653              456666677654   899999999999999999999999999875532221  12235


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhH
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE  250 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  250 (345)
                      .|+..|+|||++.+..++.++||||||+++|||++|+.||.......      .... +........   ......+   
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~-~~~~~~~~~---~~~~~~~---  244 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AMKR-LRDSPPPKL---KNAHKIS---  244 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HhccCCCCc---cccCCCC---
Confidence            68999999999998889999999999999999999999997533211      1111 111110000   0000111   


Q ss_pred             HHH-HHHHhhccCCCCCcCCCCC
Q 039516          251 DAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       251 ~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                       .. .+++..||+.+|.+|||+.
T Consensus       245 -~~l~~~i~~~l~~~P~~Rps~~  266 (297)
T cd06659         245 -PVLRDFLERMLTREPQERATAQ  266 (297)
T ss_pred             -HHHHHHHHHHhcCCcccCcCHH
Confidence             22 5899999999999999954

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.3e-36  Score=274.74  Aligned_cols=184  Identities=23%  Similarity=0.292  Sum_probs=154.3

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +|++.++||+|+||.||++... +++.||+|.+....  ....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            5889999999999999999764 58999999986442  22356788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          102 MPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       102 ~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      +++++|.++..               +++.++.|||..   +++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~  156 (286)
T cd07846          82 VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EV  156 (286)
T ss_pred             CCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cc
Confidence            99988876542               667778888865   89999999999999999999999999988754322  12


Q ss_pred             ccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      .....++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~  204 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD  204 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence            223467889999998875 45788999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.1e-36  Score=269.61  Aligned_cols=217  Identities=20%  Similarity=0.261  Sum_probs=165.2

Q ss_pred             EeeccCCeEEEEEEcCC-C----------cEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           31 QQEQTRDRVILVGKFPN-E----------QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~~-~----------~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .||+|+||.||+|...+ +          ..|++|.+...... ...|.+|+.++++++||||+++++++.. ...++||
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            48999999999998753 3          35888887654333 6789999999999999999999999887 7789999


Q ss_pred             ecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC-------CEEEEccccce
Q 039516          100 EFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL-------NTKISDFGMAR  156 (345)
Q Consensus       100 e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~-------~~kl~Dfgl~~  156 (345)
                      ||+++++|.+++.                +++.+|.|||.   .+|+||||||+||+++.++       .+||+|||++.
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            9999999987764                55666777775   4899999999999999887       79999999988


Q ss_pred             eecCCCCCCcccceeecCCccccchhccC--CcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 039516          157 IFGVNESGANTNRIVGTYGYMSLEYTMSG--TVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGK  233 (345)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (345)
                      ....      .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||........   .    ..+....
T Consensus       157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~----~~~~~~~  223 (259)
T cd05037         157 TVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---E----RFYQDQH  223 (259)
T ss_pred             cccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---H----HHHhcCC
Confidence            6532      1223567789999998876  78999999999999999999 5777765432111   0    0111110


Q ss_pred             ccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchh
Q 039516          234 DLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPC  276 (345)
Q Consensus       234 ~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~  276 (345)
                      .       +    +...... .+++..||+.+|.+|||+.++..
T Consensus       224 ~-------~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         224 R-------L----PMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             C-------C----CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0       0    0000133 69999999999999999765443

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.6e-35  Score=273.28  Aligned_cols=179  Identities=21%  Similarity=0.318  Sum_probs=141.5

Q ss_pred             EEeeccCCeEEEEEEcC---CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCeeEEEEecCCC
Q 039516           30 IQQEQTRDRVILVGKFP---NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH--GEERLLVYEFMPN  104 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~---~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~  104 (345)
                      .+||+|+||.||+|...   ++..||+|.+....  ....+.+|+.++++++||||+++++++..  +...++||||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            56999999999999754   45789999986442  23467899999999999999999998854  5678999999875


Q ss_pred             CChHHH------------------------HHhHHHHHHHHHhcCCCceEEeccCCCCeee----CCCCCEEEEccccce
Q 039516          105 KSLDSS------------------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILL----DDQLNTKISDFGMAR  156 (345)
Q Consensus       105 gsL~~~------------------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill----~~~~~~kl~Dfgl~~  156 (345)
                       +|.++                        +.+++.+|.+||..   +|+||||||+||++    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             43332                        22566667777654   89999999999999    456789999999998


Q ss_pred             eecCCCCC-CcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          157 IFGVNESG-ANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       157 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ........ .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            76432211 12234578999999998876 457899999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=268.76  Aligned_cols=229  Identities=22%  Similarity=0.337  Sum_probs=176.1

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcC---CCCeeeEEEEEEECCeeEEEE
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQ---YTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .|++.+.||+|+||.||+|.. .+++.||+|.++.. .......+.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            367788899999999999975 57899999998654 3345667889999999996   999999999999999999999


Q ss_pred             ecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          100 EFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       100 e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ||+++++|.+++.              +++.++.+||..   |++|+||+|+||+++.++.++|+|||++........  
T Consensus        82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06917          82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--  156 (277)
T ss_pred             ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--
Confidence            9999999987664              456667777755   899999999999999999999999999987643321  


Q ss_pred             cccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ......|+..|+|||.+.++ .++.++|+||||+++|+|++|..||........      .. ..     .....+.+..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~-~~-----~~~~~~~~~~  224 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MM-LI-----PKSKPPRLED  224 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hh-cc-----ccCCCCCCCc
Confidence            12234688899999988754 468999999999999999999999975432111      00 00     0001112211


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      +   ..... .+++..||+.||++|||+.+
T Consensus       225 ~---~~~~~~~~~i~~~l~~~p~~R~~~~~  251 (277)
T cd06917         225 N---GYSKLLREFVAACLDEEPKERLSAEE  251 (277)
T ss_pred             c---cCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            1   01123 58999999999999999643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.3e-35  Score=265.23  Aligned_cols=228  Identities=19%  Similarity=0.293  Sum_probs=175.2

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +|...+.||+|+||.||++.. .+++.||+|.+...  .......+.+|++++++++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478899999999999999865 46899999998654  233466789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC-CEEEEccccceeecCCCC
Q 039516          102 MPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL-NTKISDFGMARIFGVNES  163 (345)
Q Consensus       102 ~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~  163 (345)
                      +++++|.+++.                 +++.++.+||.   .|++|+||+|+||+++.++ .+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999987654                 44555666665   4899999999999998654 579999999987643221


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                         .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||......      ..+.... .+....     +.
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~-~~~~~~-----~~  222 (256)
T cd08220         158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIM-SGTFAP-----IS  222 (256)
T ss_pred             ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHH-hcCCCC-----CC
Confidence               22346788999999999888899999999999999999999998754321      1111111 111111     11


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      ..++.+.   .+++..||+.+|++|||+.+
T Consensus       223 ~~~~~~l---~~li~~~l~~~p~~Rpt~~~  249 (256)
T cd08220         223 DRYSPDL---RQLILSMLNLDPSKRPQLSQ  249 (256)
T ss_pred             CCcCHHH---HHHHHHHccCChhhCCCHHH
Confidence            1122222   58999999999999999653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.4e-35  Score=266.91  Aligned_cols=230  Identities=19%  Similarity=0.262  Sum_probs=171.1

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-----ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--Cee
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-----GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--EER   95 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~   95 (345)
                      .+|.+.+.||+|+||.||++.. .+|..||||.+....     ......+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            3588999999999999999975 468999999885431     12245788899999999999999999998763  467


Q ss_pred             EEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           96 LLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      +++|||+++++|.+++.               +++.+|.+||..   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence            89999999999987764               455666677654   799999999999999999999999999876432


Q ss_pred             CCC-CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          161 NES-GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       161 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      ... ........|+..|+|||++.+..++.++||||||+++|+|++|+.||......     .. ........     ..
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~~~-----~~  227 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AA-IFKIATQP-----TN  227 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HH-HHHHhcCC-----CC
Confidence            111 11122345888999999998888999999999999999999999999753211     11 11111010     01


Q ss_pred             ccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          240 LTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       240 ~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +.    .+...... ..++..|+. +|++|||+.
T Consensus       228 ~~----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~  256 (265)
T cd06652         228 PV----LPPHVSDHCRDFLKRIFV-EAKLRPSAD  256 (265)
T ss_pred             CC----CchhhCHHHHHHHHHHhc-ChhhCCCHH
Confidence            11    12222223 577788884 899999954

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.1e-36  Score=276.64  Aligned_cols=230  Identities=19%  Similarity=0.271  Sum_probs=177.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ..|.....||+|+||.||++.. .++..||||.+........+.+.+|+.++++++|+||+++++.+..++..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            3355567799999999999965 468999999987655555667899999999999999999999999999999999999


Q ss_pred             CCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCccc
Q 039516          103 PNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTN  168 (345)
Q Consensus       103 ~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  168 (345)
                      ++++|.+++.              +++.++.+||..   +|+||||||+||+++.++.++|+|||++.......  ....
T Consensus       102 ~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  176 (292)
T cd06658         102 EGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRK  176 (292)
T ss_pred             CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCc
Confidence            9999987653              566677777765   79999999999999999999999999987543222  1223


Q ss_pred             ceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          169 RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       169 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      ...|+..|+|||++.+..++.++|+||||+++|||++|+.||.......   ..   . ....     .+.+.+....  
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~---~-~~~~-----~~~~~~~~~~--  242 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AM---R-RIRD-----NLPPRVKDSH--  242 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---H-HHHh-----cCCCcccccc--
Confidence            3568899999999988889999999999999999999999987533211   11   1 1101     1111111100  


Q ss_pred             hHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          249 NEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       249 ~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..... ..++..||+.||.+|||+.
T Consensus       243 ~~~~~~~~li~~~l~~~P~~Rpt~~  267 (292)
T cd06658         243 KVSSVLRGFLDLMLVREPSQRATAQ  267 (292)
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHH
Confidence            01112 5888999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.1e-35  Score=264.93  Aligned_cols=231  Identities=22%  Similarity=0.311  Sum_probs=178.0

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc--cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG--QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      |.+.+.||+|+||.||++.. .+++.||+|.++....  .....+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            78889999999999999975 4689999999976543  25678999999999999999999999999999999999999


Q ss_pred             CCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc-
Q 039516          103 PNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN-  166 (345)
Q Consensus       103 ~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-  166 (345)
                      ++++|.+++.               +++.++.+||..   +++|+||+|+||+++.++.+||+|||++........... 
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          82 SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence            9999988764               566777777765   799999999999999999999999999887643322111 


Q ss_pred             -ccceeecCCccccchhccCC---cCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          167 -TNRIVGTYGYMSLEYTMSGT---VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       167 -~~~~~gt~~y~aPE~~~~~~---~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                       .....++..|+|||++.+..   ++.++||||||+++|++++|+.||.......     ....... .+.     .+.+
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~-~~~-----~~~~  227 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVG-AGH-----KPPI  227 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHh-cCC-----CCCC
Confidence             11246788999999988766   7899999999999999999999997543111     1111111 110     1111


Q ss_pred             CCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          243 DGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       243 ~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ....  ..... .+++..||+.+|.+|||+.
T Consensus       228 ~~~~--~~~~~~~~li~~~l~~~p~~R~~~~  256 (264)
T cd06626         228 PDSL--QLSPEGKDFLDRCLESDPKKRPTAS  256 (264)
T ss_pred             Cccc--ccCHHHHHHHHHHccCCcccCCCHH
Confidence            1100  01222 5899999999999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-35  Score=270.48  Aligned_cols=187  Identities=21%  Similarity=0.251  Sum_probs=150.3

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC---CCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CeeE
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP---NEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--EERL   96 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~---~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~   96 (345)
                      .|.+..+||+|+||.||+|...   +++.||+|.+....   ......+.+|+.++++++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3788899999999999999764   47999999997632   34456788999999999999999999999987  7899


Q ss_pred             EEEecCCCCChHHHH--------------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCC----CCCEEEEcc
Q 039516           97 LVYEFMPNKSLDSSF--------------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDD----QLNTKISDF  152 (345)
Q Consensus        97 lv~e~~~~gsL~~~l--------------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~----~~~~kl~Df  152 (345)
                      +||||+++ +|.+.+                    .+++.++.|||.   .+|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 443322                    245556666665   48999999999999999    899999999


Q ss_pred             ccceeecCCCC-CCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 039516          153 GMARIFGVNES-GANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHT  215 (345)
Q Consensus       153 gl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~~  215 (345)
                      |++........ ........++..|+|||++.+ ..++.++||||||+++|+|++|+.||.....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            99986543222 112233567889999998776 4578999999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-38  Score=293.47  Aligned_cols=230  Identities=20%  Similarity=0.242  Sum_probs=180.5

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ...|+++..||.|+||.||++... ++-..|.|++...+....++|+-|++||+.+.||+||++++.|...+.+|++.||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            345889999999999999999654 4566688999888888899999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |.||-.+..+-                +++.+|.|||..   +|||||||+.|||++-+|.++|+|||.+.....  ...
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~q  185 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQ  185 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh--HHh
Confidence            99998776543                445566666655   799999999999999999999999999865422  222


Q ss_pred             cccceeecCCccccchhc-----cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          166 NTNRIVGTYGYMSLEYTM-----SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      .-..+.|||+|||||++.     ..+|+.++||||||++|.||..+.+|....++...  ++    ..-...      .|
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--ll----KiaKSe------PP  253 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LL----KIAKSE------PP  253 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--HH----HHhhcC------CC
Confidence            234589999999999765     56899999999999999999999999876543211  11    111111      12


Q ss_pred             cCCCCCChhHHHH--HHHHhhccCCCCCcCCCCC
Q 039516          241 TLDGSCPPNEDAF--LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       241 ~l~~~~~~~~~~~--~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .|   ..|....+  .++..+||..||..||+..
T Consensus       254 TL---lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aa  284 (1187)
T KOG0579|consen  254 TL---LQPSHWSRSFSDFLKRCLVKNPRNRPPAA  284 (1187)
T ss_pred             cc---cCcchhhhHHHHHHHHHHhcCCccCCCHH
Confidence            22   12233333  6899999999999999953

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-35  Score=269.62  Aligned_cols=182  Identities=23%  Similarity=0.312  Sum_probs=149.3

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .|++.+.||+|+||.||++.. .+|+.||+|.++...  ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            378889999999999999975 468999999986542  22345678899999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      +++ +|.+++.                +++++|.+||..   +++||||||+||+++.++.+||+|||++........  
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            975 5655432                567777788765   799999999999999999999999999886533211  


Q ss_pred             cccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKS  212 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~  212 (345)
                      ......++..|+|||++.+. .++.++|||||||++|+|++|..|+..
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~  202 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  202 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            12234578899999988764 468999999999999999999988654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.2e-35  Score=268.83  Aligned_cols=231  Identities=19%  Similarity=0.269  Sum_probs=178.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ...|...+.||+|++|.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++++||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            34567778899999999999974 57899999998765545566789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          102 MPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       102 ~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      +++++|.+++.              +++.++.+||..   |++||||+|+||+++.++.++|+|||++........  ..
T Consensus        98 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~  172 (285)
T cd06648          98 LEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RR  172 (285)
T ss_pred             cCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cc
Confidence            99999987653              456677777765   899999999999999999999999998875432211  12


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCP  247 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  247 (345)
                      ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....      ........ ...     .+.+..  .
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~-~~~-----~~~~~~--~  238 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIR-DNL-----PPKLKN--L  238 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHH-hcC-----CCCCcc--c
Confidence            234688999999999888899999999999999999999999865321      11111111 111     011110  1


Q ss_pred             hhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          248 PNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       248 ~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ...... .+++.+||+.+|.+|||+.
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~  264 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAA  264 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHH
Confidence            111123 6999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-35  Score=267.02  Aligned_cols=231  Identities=20%  Similarity=0.269  Sum_probs=177.0

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      +|+..+.||+|++|.||++... +++.||+|.+.... ......+.+|++++++++||||+++++.+...+..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            4677788999999999999764 68999999987653 344567899999999999999999999999999999999999


Q ss_pred             CCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          103 PNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       103 ~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      ++++|.+++.                +++.++.+||..  .+++|+||||+||+++.++.++|+|||.+........   
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---  156 (265)
T cd06605          82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---  156 (265)
T ss_pred             CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---
Confidence            9999988764                345556666651  5899999999999999999999999999876532111   


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                       ....++..|+|||++.+..++.++||||||+++|+|++|+.||....... ..............      .+.+    
T Consensus       157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~------~~~~----  224 (265)
T cd06605         157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP------PPRL----  224 (265)
T ss_pred             -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC------CCCC----
Confidence             11567889999999998899999999999999999999999997543211 11222222111111      0111    


Q ss_pred             Chh-HHHH-HHHHhhccCCCCCcCCCCC
Q 039516          247 PPN-EDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       247 ~~~-~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +.. .... .+++..||..+|.+|||+.
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~  252 (265)
T cd06605         225 PSGKFSPDFQDFVNLCLIKDPRERPSYK  252 (265)
T ss_pred             ChhhcCHHHHHHHHHHcCCCchhCcCHH
Confidence            111 1122 5899999999999999954

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.3e-35  Score=266.19  Aligned_cols=184  Identities=24%  Similarity=0.334  Sum_probs=154.0

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +|++.+.||+|+||.||+|.. .+|+.||+|++....  ......+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            478899999999999999975 468999999997653  33456799999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      + +++|.+++.                +++.+|.+||..   +++|+||||+||+++.++.++|+|||++........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 999987653                556677777754   899999999999999999999999999987643321 1


Q ss_pred             cccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      ......|+..|+|||++.+. .++.++||||+|+++|+|++|.+||...
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~  204 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE  204 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence            12334688999999987654 4689999999999999999998877653

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.6e-35  Score=267.18  Aligned_cols=185  Identities=22%  Similarity=0.284  Sum_probs=150.1

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .+|.+.+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.+++.++|+||+++++++..+...++||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            5699999999999999999965 468999999986543 23344678999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      +. ++|.+.+.                +++.+|.+||..   +++|+||||+||+++.++.+||+|||+++.......  
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--  158 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--  158 (291)
T ss_pred             cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--
Confidence            96 45543321                555666666654   899999999999999999999999999876432211  


Q ss_pred             cccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence            1223457889999998875 357889999999999999999999997543

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.2e-35  Score=259.64  Aligned_cols=228  Identities=22%  Similarity=0.285  Sum_probs=178.4

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      +|...+.||+|++|.||++... ++..|++|++..........+.+|++++++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4788899999999999999764 689999999976654566789999999999999999999999999999999999999


Q ss_pred             CCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          104 NKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       104 ~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      +++|.+++.                +++.++.+||.   .+++|+||+|+||+++.++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            999987753                34555556655   5899999999999999999999999999887643321   2


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCP  247 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  247 (345)
                      ....++..|+|||++.+..++.++|+||||+++|+|++|+.||.......      ...... .........+     . 
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~~~~~-----~-  221 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK------ALFKIA-TNGPPGLRNP-----E-  221 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHH-hcCCCCcCcc-----c-
Confidence            34578899999999988888999999999999999999999987543111      000110 1111111100     0 


Q ss_pred             hhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          248 PNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       248 ~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                       ..... .+++..||+.||.+|||+.
T Consensus       222 -~~~~~~~~~i~~~l~~~p~~R~t~~  246 (253)
T cd05122         222 -KWSDEFKDFLKKCLQKNPEKRPTAE  246 (253)
T ss_pred             -ccCHHHHHHHHHHccCChhhCCCHH
Confidence             00122 5899999999999999964

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.3e-34  Score=258.09  Aligned_cols=232  Identities=20%  Similarity=0.294  Sum_probs=181.1

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCc--cCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CeeEEEE
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSG--QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--EERLLVY   99 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~   99 (345)
                      +|.+.+.||+|++|.||+|... +++.|++|.+.....  .....+.+|+.++++++|+||+++++++...  ...+++|
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778889999999999999765 789999999865542  4467889999999999999999999999988  8899999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||+++++|.+++.               +++.++.+||.   .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            9999999987754               45666777776   48999999999999999999999999999877543321


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      .......++..|+|||.+.+...+.++||||||+++|+|++|..||....     ......+..........        
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~--------  224 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPPE--------  224 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCcC--------
Confidence            11233567889999999988889999999999999999999999997654     11111121111111111        


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                       .+...... .+++.+|++.+|++|||+.+
T Consensus       225 -~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~  253 (260)
T cd06606         225 -IPEHLSEEAKDFLRKCLRRDPKKRPTADE  253 (260)
T ss_pred             -CCcccCHHHHHHHHHhCcCChhhCCCHHH
Confidence             11111233 69999999999999999653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.8e-37  Score=287.77  Aligned_cols=230  Identities=18%  Similarity=0.253  Sum_probs=180.0

Q ss_pred             EEeeccCCeEEEEEEc-CCCcEEEEEEeccC----CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCe--eEEEEecC
Q 039516           30 IQQEQTRDRVILVGKF-PNEQEVAIKRLAWT----SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE--RLLVYEFM  102 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~--~~lv~e~~  102 (345)
                      ..||+|+|-+||+|.. .+|..||--.++..    ++...++|..|+.+|+.|+|||||++|.+|.+...  +.+|+|.+
T Consensus        46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~  125 (632)
T KOG0584|consen   46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF  125 (632)
T ss_pred             hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence            4499999999999965 35888876544322    44556899999999999999999999999987655  78999999


Q ss_pred             CCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC-CCCEEEEccccceeecCCCCCCc
Q 039516          103 PNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD-QLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       103 ~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      ..|+|..+.+               +++.||.|||.. .++|||||||.+||+|+. .|.|||+|+|||+...    ...
T Consensus       126 TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r----~s~  200 (632)
T KOG0584|consen  126 TSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR----KSH  200 (632)
T ss_pred             cCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh----ccc
Confidence            9999998765               778889999985 468999999999999976 5889999999998763    223


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC----ccccccccC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGK----DLELIDLTL  242 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~d~~l  242 (345)
                      .....|||.|||||++. ..|+..+||||||++++||+|+..||.......      .+......|.    +..+-||.+
T Consensus       201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A------QIYKKV~SGiKP~sl~kV~dPev  273 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA------QIYKKVTSGIKPAALSKVKDPEV  273 (632)
T ss_pred             cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH------HHHHHHHcCCCHHHhhccCCHHH
Confidence            34479999999999876 889999999999999999999999998775432      2222222332    122222222


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccce
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNL  290 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~  290 (345)
                                 .+++.+|+.. .++|||.       .+||.+.++...
T Consensus       274 -----------r~fIekCl~~-~~~R~sa-------~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  274 -----------REFIEKCLAT-KSERLSA-------KELLKDPFFDED  302 (632)
T ss_pred             -----------HHHHHHHhcC-chhccCH-------HHHhhChhhccc
Confidence                       4999999999 8999994       456666555543

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=265.38  Aligned_cols=231  Identities=22%  Similarity=0.274  Sum_probs=172.8

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECC------e
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGE------E   94 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~------~   94 (345)
                      ..+|++.+.||+|++|.||++... +++.|++|.+..... ....+.+|+.+++++ +|+||+++++++....      .
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            356999999999999999999764 678999999875543 356799999999999 7999999999997644      4


Q ss_pred             eEEEEecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccc
Q 039516           95 RLLVYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMA  155 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~  155 (345)
                      .++||||+++++|.+++.                   +++.++.+||.   .+++|+||+|+||+++.++.++|+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccc
Confidence            899999999999877643                   35556666665   48999999999999999999999999998


Q ss_pred             eeecCCCCCCcccceeecCCccccchhcc-----CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh
Q 039516          156 RIFGVNESGANTNRIVGTYGYMSLEYTMS-----GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWN  230 (345)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  230 (345)
                      ........  ......|+..|+|||++..     ..++.++||||||+++|+|++|+.||.......   .   ..... 
T Consensus       161 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~---~~~~~-  231 (275)
T cd06608         161 AQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---A---LFKIP-  231 (275)
T ss_pred             eecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH---H---HHHhh-
Confidence            76533221  1223468899999998753     346788999999999999999999997532211   0   00111 


Q ss_pred             cCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          231 EGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       231 ~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .+..     +.+.  .+...... .+++.+||+.||++|||+.+
T Consensus       232 ~~~~-----~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~  268 (275)
T cd06608         232 RNPP-----PTLK--SPENWSKKFNDFISECLIKNYEQRPFMEE  268 (275)
T ss_pred             ccCC-----CCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHH
Confidence            1111     1111  11111223 68999999999999999653

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-36  Score=286.14  Aligned_cols=190  Identities=25%  Similarity=0.330  Sum_probs=158.3

Q ss_pred             cccCCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC----
Q 039516           19 VENSSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG----   92 (345)
Q Consensus        19 ~~~~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~----   92 (345)
                      +.+-...|..-+.||+|+||.||+|+ ..+|+.||||.++.. .....+...+|+++|++++|+|||+++++=.+.    
T Consensus         8 ~~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~   87 (732)
T KOG4250|consen    8 TSGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGL   87 (732)
T ss_pred             ccCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCc
Confidence            33444668888889999999999997 568999999999765 345577788999999999999999999975443    


Q ss_pred             --CeeEEEEecCCCCChHHHHH------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC--CCC--CEE
Q 039516           93 --EERLLVYEFMPNKSLDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD--DQL--NTK  148 (345)
Q Consensus        93 --~~~~lv~e~~~~gsL~~~l~------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~--~~~--~~k  148 (345)
                        ....+|||||.+|||...+.                  ++..||.|||.   .||+||||||.||++-  .+|  ..|
T Consensus        88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyK  164 (732)
T KOG4250|consen   88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYK  164 (732)
T ss_pred             ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEe
Confidence              35689999999999988776                  45556666664   4899999999999983  334  379


Q ss_pred             EEccccceeecCCCCCCcccceeecCCccccchhc-cCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          149 ISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM-SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       149 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      |+|||.|+....+.   ....+.||..|.+||++. ++.|+..+|.|||||++|+.+||..||....
T Consensus       165 LtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  165 LTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             eecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            99999999875443   456689999999999998 5889999999999999999999999997654

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.1e-34  Score=272.15  Aligned_cols=186  Identities=23%  Similarity=0.240  Sum_probs=152.7

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC------
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG------   92 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------   92 (345)
                      ...+|++.+.||+|+||.||++.. .+|+.||+|.+...  .......+.+|+.++++++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            456799999999999999999965 57899999998643  233445678899999999999999999988643      


Q ss_pred             CeeEEEEecCCCCChHHHH-------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           93 EERLLVYEFMPNKSLDSSF-------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l-------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      ...|+||||+.+ +|.+.+             .+++.+|.+||..   |++||||||+||+++.++.+||+|||++....
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence            357999999975 665543             2566677777765   89999999999999999999999999998753


Q ss_pred             CCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ...   ......++..|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus       170 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~  221 (353)
T cd07850         170 TSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD  221 (353)
T ss_pred             CCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence            321   1223467889999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.4e-35  Score=267.73  Aligned_cols=228  Identities=21%  Similarity=0.276  Sum_probs=171.8

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEE------CCee
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIH------GEER   95 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~------~~~~   95 (345)
                      ..|++...||.|+||.||+|.. .+++.||+|.+.... .....+..|+.+++++ +|+||+++++++..      ....
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            4588889999999999999975 568999999986543 2345688999999998 79999999999853      4578


Q ss_pred             EEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           96 LLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      +++|||+++|+|.+++.                 +++.++.|||..   +++|+||+|+||+++.++.++|+|||++...
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            99999999999987654                 456667777765   8999999999999999999999999998755


Q ss_pred             cCCCCCCcccceeecCCccccchhc-----cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTM-----SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGK  233 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (345)
                      ....  .......|+..|+|||.+.     +..++.++|+|||||++|+|++|..||..........      ... .. 
T Consensus       172 ~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~------~~~-~~-  241 (282)
T cd06636         172 DRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF------LIP-RN-  241 (282)
T ss_pred             hccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh------hHh-hC-
Confidence            3211  1223356899999999875     3467889999999999999999999997543211110      000 00 


Q ss_pred             ccccccccC-CCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          234 DLELIDLTL-DGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       234 ~~~~~d~~l-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                          ..+.+ ...++.+.   .+++..||+.||.+|||+.
T Consensus       242 ----~~~~~~~~~~~~~~---~~li~~cl~~~p~~Rp~~~  274 (282)
T cd06636         242 ----PPPKLKSKKWSKKF---IDFIEGCLVKNYLSRPSTE  274 (282)
T ss_pred             ----CCCCCcccccCHHH---HHHHHHHhCCChhhCcCHH
Confidence                01111 11122211   6999999999999999954

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.3e-35  Score=266.94  Aligned_cols=183  Identities=25%  Similarity=0.348  Sum_probs=150.1

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +|+..+.||.|++|.||++.. .+|+.||||.+....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            478899999999999999965 468999999986542  23345788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          102 MPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       102 ~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      +. ++|.+++.                 +++.++.|||..   +++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            96 46655432                 566677777765   899999999999999999999999999876532211 


Q ss_pred             CcccceeecCCccccchhccCC-cCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGT-VSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                       ......++..|+|||++.+.. ++.++||||||+++|+|+||+.||...
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~  204 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  204 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence             122235688899999877644 588999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.6e-35  Score=266.49  Aligned_cols=230  Identities=21%  Similarity=0.257  Sum_probs=167.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHH-HHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKL-IAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      .+|.+.+.||+|+||.||++.. .+|+.||+|.++... ......+..|+.. ++.++||||+++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            3689999999999999999975 469999999987542 2233456667665 566799999999999999999999999


Q ss_pred             cCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516          101 FMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus       101 ~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      |++ ++|.+++.                   +++.++.|||...  +++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 56654432                   4566677777532  7999999999999999999999999998765322


Q ss_pred             CCCCcccceeecCCccccchhcc----CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMS----GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLEL  237 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
                      .   ......|+..|+|||++.+    ..++.++|+||||+++|+|++|+.||......    . ........ +....+
T Consensus       158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~-~~~~~~~~-~~~~~~  228 (283)
T cd06617         158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----F-QQLKQVVE-EPSPQL  228 (283)
T ss_pred             c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----H-HHHHHHHh-cCCCCC
Confidence            1   1122467889999998764    45688999999999999999999998643211    0 11111111 111111


Q ss_pred             ccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          238 IDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       238 ~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .    ...++.+.   ..++..||+.+|.+|||+.
T Consensus       229 ~----~~~~~~~l---~~li~~~l~~~p~~Rp~~~  256 (283)
T cd06617         229 P----AEKFSPEF---QDFVNKCLKKNYKERPNYP  256 (283)
T ss_pred             C----ccccCHHH---HHHHHHHccCChhhCcCHH
Confidence            0    11122211   5899999999999999954

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.1e-35  Score=268.60  Aligned_cols=185  Identities=23%  Similarity=0.320  Sum_probs=152.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--EERLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv   98 (345)
                      .+|++.+.||+|+||.||+|... +++.||+|.++...  ......+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            35888889999999999999765 68999999996543  22344678899999999999999999998877  889999


Q ss_pred             EecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           99 YEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        99 ~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      |||+++ +|.+++.                +++.+|.|||..   +++|+||||+||+++.++.+||+|||++.......
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999975 7765543                567778888865   79999999999999999999999999998764432


Q ss_pred             CCCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                        .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||....
T Consensus       161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~  211 (293)
T cd07843         161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS  211 (293)
T ss_pred             --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence              112234678899999988754 46899999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=257.18  Aligned_cols=227  Identities=22%  Similarity=0.313  Sum_probs=173.0

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +.+.+..||.|+.|.|+++.. .+|..+|||.+... +.+..++++..++++.+-+ .|.||+.+|+|..+...++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            345566799999999999965 56899999999655 4556778888888877664 89999999999999999999998


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |.. -++.+++                .+..+|.||...|  +|+|||+||+|||+|+.|.+||||||++..+.+...  
T Consensus       173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--  247 (391)
T KOG0983|consen  173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--  247 (391)
T ss_pred             HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence            742 1222222                4567888998888  899999999999999999999999999988754332  


Q ss_pred             cccceeecCCccccchhcc---CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          166 NTNRIVGTYGYMSLEYTMS---GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                       .+...|.+.|||||.+.-   ..|+..+||||||++++||+||+.||.....+-  ...   ...+.+.      .|.|
T Consensus       248 -htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~l---tkvln~e------PP~L  315 (391)
T KOG0983|consen  248 -HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVL---TKVLNEE------PPLL  315 (391)
T ss_pred             -cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHH---HHHHhcC------CCCC
Confidence             233478999999998863   468899999999999999999999998865321  111   1111111      1233


Q ss_pred             CCC--CChhHHHHHHHHhhccCCCCCcCCCC
Q 039516          243 DGS--CPPNEDAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       243 ~~~--~~~~~~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                      .+.  +++.-   ++++..||+.|+.+||.-
T Consensus       316 ~~~~gFSp~F---~~fv~~CL~kd~r~RP~Y  343 (391)
T KOG0983|consen  316 PGHMGFSPDF---QSFVKDCLTKDHRKRPKY  343 (391)
T ss_pred             CcccCcCHHH---HHHHHHHhhcCcccCcch
Confidence            211  22222   699999999999999983

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=277.42  Aligned_cols=188  Identities=21%  Similarity=0.282  Sum_probs=150.6

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----Ce
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG-----EE   94 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~   94 (345)
                      +..+|++.++||+|+||.||+|.. .+|+.||+|.++.. .......+.+|+.++++++|+||+++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            346799999999999999999964 57899999998643 223455688999999999999999999987643     35


Q ss_pred             eEEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           95 RLLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      .+++|||+.+ +|.+.+.              +++.+|.+||..   ||+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          83 VYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             EEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            7999999975 5554433              566677777765   899999999999999999999999999987543


Q ss_pred             CCCCC-cccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          161 NESGA-NTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       161 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      ..... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~  213 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK  213 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            22111 1223468899999998654 56889999999999999999999999654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5e-35  Score=262.11  Aligned_cols=227  Identities=20%  Similarity=0.196  Sum_probs=179.6

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +|++.+.||.|+||.||++... +++.||+|.+....   ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4889999999999999999764 68999999996542   2346688999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |+.+++|.+++.               ++++++.+||..   +++|+||+|+||++++++.++|+|||++.......   
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---  154 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---  154 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence            999999987664               567777888865   79999999999999999999999999987654322   


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      ......|+..|+|||++.+..++.++|+||||+++|+|++|..||......    ...+.......  ..    +.    
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~--~~----~~----  220 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET--AD----VL----  220 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc--cc----cc----
Confidence            122346788999999998888999999999999999999999999865432    11111111111  00    01    


Q ss_pred             CChhHHHH-HHHHhhccCCCCCcCCCC
Q 039516          246 CPPNEDAF-LLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       246 ~~~~~~~~-~~l~~~Cl~~~P~~RPs~  271 (345)
                      .+...... .+++.+||+.||.+||+.
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~  247 (258)
T cd05578         221 YPATWSTEAIDAINKLLERDPQKRLGD  247 (258)
T ss_pred             CcccCcHHHHHHHHHHccCChhHcCCc
Confidence            11111133 699999999999999995

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.9e-35  Score=263.42  Aligned_cols=223  Identities=17%  Similarity=0.171  Sum_probs=172.2

Q ss_pred             eeccCCeEEEEEEcC-CCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCCh
Q 039516           32 QEQTRDRVILVGKFP-NEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL  107 (345)
Q Consensus        32 lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL  107 (345)
                      ||.|++|.||++... +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.++...+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999764 58999999986542   23456789999999999999999999999999999999999999999


Q ss_pred             HHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceee
Q 039516          108 DSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG  172 (345)
Q Consensus       108 ~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g  172 (345)
                      .+++.               +++.+|.+||.   .+++|+||+|+||+++.++.++|+|||++.......   ......+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~  154 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCG  154 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccC
Confidence            88764               45556666665   589999999999999999999999999998764322   1223467


Q ss_pred             cCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHH
Q 039516          173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDA  252 (345)
Q Consensus       173 t~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  252 (345)
                      +..|++||.+.+..++.++|+||||+++|+|++|..||.......    ............         ...++.....
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~---------~~~~~~~~~~  221 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILKGNG---------KLEFPNYIDK  221 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhccCC---------CCCCCcccCH
Confidence            889999999988889999999999999999999999997654211    111111110000         0111111222


Q ss_pred             H-HHHHhhccCCCCCcCCCCCc
Q 039516          253 F-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       253 ~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      . ..++..||+.+|++|||+.+
T Consensus       222 ~~~~~i~~~l~~~p~~R~~~~~  243 (262)
T cd05572         222 AAKDLIKQLLRRNPEERLGNLK  243 (262)
T ss_pred             HHHHHHHHHccCChhhCcCCcc
Confidence            3 69999999999999999643

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.7e-35  Score=269.41  Aligned_cols=226  Identities=22%  Similarity=0.319  Sum_probs=170.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc---cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG---QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ..|...+.||+|+||.||+|.. .+|+.||+|.+.....   .....+.+|+++++.++||||++++++|..++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4488889999999999999975 4689999999864422   23456889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          100 EFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       100 e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      ||+++ ++.+.+.                +++.+|.|||..   +++|+||+|+||+++.++.++|+|||++......  
T Consensus        95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            99975 5444322                566677777755   8999999999999999999999999998764321  


Q ss_pred             CCcccceeecCCccccchhc---cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          164 GANTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                          ....++..|+|||++.   ...++.++||||||+++|||++|+.||.......      ...... .+..     +
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~~~-~~~~-----~  232 (307)
T cd06607         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIA-QNDS-----P  232 (307)
T ss_pred             ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHHHh-cCCC-----C
Confidence                2346788999999874   4568899999999999999999999987543111      111110 1100     1


Q ss_pred             cCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcc
Q 039516          241 TLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       241 ~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~  274 (345)
                      .+.   ....... ..++..||+.+|++|||+.++
T Consensus       233 ~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  264 (307)
T cd06607         233 TLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEEL  264 (307)
T ss_pred             CCC---chhhCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            110   1111223 689999999999999996543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.4e-35  Score=266.63  Aligned_cols=183  Identities=24%  Similarity=0.323  Sum_probs=150.5

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCcc-----CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQ-----GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      |++.+.||+|++|.||+|.. .+|+.||||.+......     ....+..|++++++++|+||+++++++.+.+..++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            77888999999999999975 46899999999755322     3445778999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          100 EFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       100 e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      ||+ +++|.+++.                +++.+|.+||..   |++|+||+|+||+++.++.++|+|||++........
T Consensus        82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            999 888877654                456666667655   899999999999999999999999999987643221


Q ss_pred             CCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                        ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||....
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~  207 (298)
T cd07841         158 --KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS  207 (298)
T ss_pred             --cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence              1222356788999998864 467899999999999999999987776543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4e-35  Score=267.10  Aligned_cols=231  Identities=22%  Similarity=0.253  Sum_probs=169.4

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +|.....||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.++. |+||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            455667799999999999965 468999999986542 234557889999999996 99999999999998999999999


Q ss_pred             CCCCChHHH--------------------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516          102 MPNKSLDSS--------------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus       102 ~~~gsL~~~--------------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      +.. ++.++                    ..+++.++.|||..+  +++||||||+||+++.++.+||+|||++......
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 33322                    115566777777543  8999999999999999999999999998765322


Q ss_pred             CCCCcccceeecCCccccchhccC---CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSG---TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                      ..   .....|+..|+|||++.+.   .++.++||||||+++|+|++|+.||....     ........... +.     
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~-----  227 (288)
T cd06616         162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GD-----  227 (288)
T ss_pred             Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CC-----
Confidence            11   1223678899999998866   68899999999999999999999997542     11111111111 11     


Q ss_pred             cccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          239 DLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       239 d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .+.+........... .+++.+||+.+|++|||+.
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  262 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYK  262 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence            111111111112223 6999999999999999954

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.1e-35  Score=264.19  Aligned_cols=224  Identities=20%  Similarity=0.197  Sum_probs=170.0

Q ss_pred             eeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCCh
Q 039516           32 QEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL  107 (345)
Q Consensus        32 lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL  107 (345)
                      ||+|+||.||++.. .+|+.||+|.+....   ......+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999964 468999999986432   22345678899999999999999999999999999999999999999


Q ss_pred             HHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          108 DSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       108 ~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      .+++.                 +++.++.+||..   |++|+||+|+||+++.++.++|+|||++......   ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence            87653                 455666777765   8999999999999999999999999998765321   112234


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhH
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE  250 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  250 (345)
                      .++..|+|||++.+..++.++|+||||+++|+|++|+.||..........  . ..    .....  ........+++..
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~-~~----~~~~~--~~~~~~~~~~~~~  225 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--E-LK----RRTLE--MAVEYPDKFSPEA  225 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--H-HH----hcccc--ccccCCccCCHHH
Confidence            67889999999988889999999999999999999999997643211100  0 00    00000  0111111122222


Q ss_pred             HHHHHHHhhccCCCCCcCCCCCc
Q 039516          251 DAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       251 ~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                         .+++..||+.+|.+||+..+
T Consensus       226 ---~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         226 ---KDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             ---HHHHHHHccCChhHccCCCc
Confidence               58999999999999998665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-35  Score=278.50  Aligned_cols=225  Identities=22%  Similarity=0.220  Sum_probs=180.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ...|.+...||+|.|+.|..+.. .++..||||.+++..  ...+..+.+|+++|+.|+|||||+++.+......+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            45689999999999999999954 579999999997763  333456889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||+.+|.+.+++.               ++..+++|+|..   +|||||||++|||++.+.++||+|||++..+.   ..
T Consensus       135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~~  208 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD---YG  208 (596)
T ss_pred             EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec---cc
Confidence            9999999998875               445555555554   79999999999999999999999999999885   33


Q ss_pred             CcccceeecCCccccchhccCCc-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                      ....+++|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||++..-                   .++-++.+.
T Consensus       209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-------------------k~Lr~rvl~  269 (596)
T KOG0586|consen  209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-------------------KELRPRVLR  269 (596)
T ss_pred             ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------------------ccccchhee
Confidence            34556799999999999998887 4789999999999999999999986432                   112222222


Q ss_pred             CCCChhH--HHH-HHHHhhccCCCCCcCCCCC
Q 039516          244 GSCPPNE--DAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       244 ~~~~~~~--~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +.+-...  ... -+++.+.|-.+|..|+++.
T Consensus       270 gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~d  301 (596)
T KOG0586|consen  270 GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCD  301 (596)
T ss_pred             eeecccceeechhHHHHHHhhccCccccCCHH
Confidence            2211100  001 2777888889999999954

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.6e-35  Score=267.60  Aligned_cols=187  Identities=22%  Similarity=0.314  Sum_probs=148.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-------
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE-------   93 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-------   93 (345)
                      .+|++..+||+|+||.||++.. .+++.||||.+....  ......+.+|+.++++++||||+++++++....       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            4599999999999999999975 468999999986432  223445678999999999999999999987644       


Q ss_pred             -eeEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516           94 -ERLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus        94 -~~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                       ..++||||+.+ +|.+.+.                +++.++.+||..   |++|+||||+||+++.++.+||+|||++.
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence             45999999975 5544332                566777777765   89999999999999999999999999998


Q ss_pred             eecCCCCC--CcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          157 IFGVNESG--ANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       157 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ........  .......++..|+|||++.+. .++.++||||||+++|+|++|+.||....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~  228 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT  228 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            66432211  112234578889999988764 46889999999999999999999997644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-35  Score=265.98  Aligned_cols=184  Identities=23%  Similarity=0.327  Sum_probs=151.5

Q ss_pred             eeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CeeEEEEe
Q 039516           26 WHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--EERLLVYE  100 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~e  100 (345)
                      |++..+||+|++|.||+|... +|+.||+|.+....  ......+.+|++++++++|+|++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678889999999999999764 58999999997652  33456788999999999999999999999887  88999999


Q ss_pred             cCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          101 FMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       101 ~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |+++ +|.+++.                +++.++.+||..   +++|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            9975 6665542                566777777765   8999999999999999999999999999876433211


Q ss_pred             CcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                       ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~  206 (287)
T cd07840         157 -DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST  206 (287)
T ss_pred             -cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence             1222356788999997764 457899999999999999999999997644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.9e-35  Score=265.82  Aligned_cols=232  Identities=21%  Similarity=0.255  Sum_probs=179.1

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .....|+....||+|++|.||++... ++..|++|.+..... ....+.+|++++++++|+||+++++++...+..++++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34555888889999999999999775 689999999976544 5667899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          100 EFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       100 e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      ||+++++|.+++.                +++.++.+||.   .|++|+||+|+||+++.++.++|+|||++........
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            9999999987765                45566667765   4899999999999999999999999998875532211


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                        ......++..|++||++.+..++.++|+||||+++|+|++|+.||.......      .... ..........++   
T Consensus       172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~~~~~---  239 (286)
T cd06614         172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFL-ITTKGIPPLKNP---  239 (286)
T ss_pred             --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhcCCCCCcch---
Confidence              1123457889999999988889999999999999999999999987543211      0011 101111100000   


Q ss_pred             CCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          244 GSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       244 ~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..++    .. .+++.+||+.+|..|||+.
T Consensus       240 ~~~~----~~l~~li~~~l~~~p~~Rpt~~  265 (286)
T cd06614         240 EKWS----PEFKDFLNKCLVKDPEKRPSAE  265 (286)
T ss_pred             hhCC----HHHHHHHHHHhccChhhCcCHH
Confidence            0011    22 5899999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.8e-35  Score=261.65  Aligned_cols=228  Identities=19%  Similarity=0.229  Sum_probs=176.3

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +|++.+.||+|+||.||++... +|..||+|.+...  .....+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788999999999999999764 5889999998654  223456788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC-EEEEccccceeecCCCC
Q 039516          102 MPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN-TKISDFGMARIFGVNES  163 (345)
Q Consensus       102 ~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~-~kl~Dfgl~~~~~~~~~  163 (345)
                      +++++|.+++.                 +++.++.+||..   +++|+||||+||++++++. +||+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999877653                 456677777765   7999999999999988864 69999999876543221


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                        ......|++.|+|||++.+..++.++|+||||+++|+|++|..||....      .......... +...    + ..
T Consensus       158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~----~-~~  223 (257)
T cd08225         158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQ-GYFA----P-IS  223 (257)
T ss_pred             --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc-ccCC----C-CC
Confidence              1222468889999999988889999999999999999999999986532      1222222221 1111    1 01


Q ss_pred             CCCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          244 GSCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       244 ~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      ...+    .. .+++.+||+.+|++|||+.+
T Consensus       224 ~~~~----~~~~~~i~~~l~~~p~~Rpt~~~  250 (257)
T cd08225         224 PNFS----RDLRSLISQLFKVSPRDRPSITS  250 (257)
T ss_pred             CCCC----HHHHHHHHHHhccChhhCcCHHH
Confidence            1112    23 58999999999999999653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.4e-34  Score=261.27  Aligned_cols=241  Identities=19%  Similarity=0.184  Sum_probs=170.4

Q ss_pred             eeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHh---cCCCCeeeEEEEEEECCeeEEEEecCCC
Q 039516           32 QEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAK---LQYTNLVKLLGCSIHGEERLLVYEFMPN  104 (345)
Q Consensus        32 lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~---l~H~niv~~~~~~~~~~~~~lv~e~~~~  104 (345)
                      ||+|+||.||++.. .+++.||+|.+....   ......+.+|..+++.   ..||||+.+++++...+..++||||+++
T Consensus         2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (279)
T cd05633           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG   81 (279)
T ss_pred             cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence            89999999999975 468999999986542   1122334555544433   4799999999999999999999999999


Q ss_pred             CChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccc
Q 039516          105 KSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNR  169 (345)
Q Consensus       105 gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  169 (345)
                      ++|.+++.               +++.++.+||..   +++||||||+||+++.++.++|+|||++.......    ...
T Consensus        82 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~  154 (279)
T cd05633          82 GDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHA  154 (279)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccC
Confidence            99987653               566777788765   79999999999999999999999999987553221    122


Q ss_pred             eeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          170 IVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       170 ~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      ..|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.........    .......      ..+..+...++.
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~------~~~~~~~~~~~~  224 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTL------TVNVELPDSFSP  224 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhh------cCCcCCccccCH
Confidence            468999999998864 56789999999999999999999999764322211    1111100      011112111222


Q ss_pred             hHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceeeEE
Q 039516          249 NEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLL  294 (345)
Q Consensus       249 ~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~~~  294 (345)
                      +.   .+++..||+.||.+||+-..  ..+.+++++..+...++..
T Consensus       225 ~~---~~li~~~l~~~p~~R~~~~~--~~~~~~~~h~~~~~~~~~~  265 (279)
T cd05633         225 EL---KSLLEGLLQRDVSKRLGCLG--RGAQEVKEHVFFKGIDWQQ  265 (279)
T ss_pred             HH---HHHHHHHhcCCHHHhcCCCC--CCHHHHHhCccccCCCHhH
Confidence            22   58899999999999996211  1133455555554444333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.4e-34  Score=264.32  Aligned_cols=184  Identities=22%  Similarity=0.315  Sum_probs=148.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      .+|++...||+|++|.||+|... +|+.||+|.+....  ......+.+|++++++++||||+++++++..+...++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            35899999999999999999764 68999999986542  2334678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHH-----------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCC-CCCEEEEccccceeecCCC
Q 039516          101 FMPNKSLDSSF-----------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDD-QLNTKISDFGMARIFGVNE  162 (345)
Q Consensus       101 ~~~~gsL~~~l-----------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~  162 (345)
                      |+++ +|.+++                 .+++.+|.+||..   +++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9964 554433                 2556666677654   8999999999999985 4568999999997653321


Q ss_pred             CCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                        .......+++.|+|||++.+ ..++.++||||||+++|+|+||+.||...
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~  207 (294)
T PLN00009        158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD  207 (294)
T ss_pred             --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence              11223457889999998865 45789999999999999999999999754

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.9e-34  Score=265.51  Aligned_cols=186  Identities=24%  Similarity=0.333  Sum_probs=149.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CeeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--EERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~l   97 (345)
                      -.+|++.+.||+|+||.||+|.. .+|+.||+|.++...  ......+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            35699999999999999999976 468999999986542  22234567899999999999999999998754  56899


Q ss_pred             EEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           98 VYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        98 v~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      ||||+.+ +|.+++.                +++.++.+||..   |++||||||+||+++.++.+||+|||++......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9999975 5654432                556666677765   8999999999999999999999999999876432


Q ss_pred             CCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ..  ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus       162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~  213 (309)
T cd07845         162 AK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS  213 (309)
T ss_pred             cC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            21  1122345788999998865 557899999999999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1e-34  Score=265.24  Aligned_cols=183  Identities=21%  Similarity=0.254  Sum_probs=147.7

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCe-----e
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEE-----R   95 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~-----~   95 (345)
                      +|++.+.||+|+||.||++.. .+|+.||+|.+....  ......+.+|+.+++++. ||||+++++++...+.     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            588999999999999999975 468999999986542  223467889999999995 6999999999887665     8


Q ss_pred             EEEEecCCCCChHHHHH--------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC-CCCEEEEcccc
Q 039516           96 LLVYEFMPNKSLDSSFS--------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD-QLNTKISDFGM  154 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~--------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgl  154 (345)
                      |+||||+++ +|.+++.                    +++.+|.|||..   +++||||+|+||+++. ++.+||+|||+
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccc
Confidence            999999986 6655432                    566677777765   8999999999999998 88999999999


Q ss_pred             ceeecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          155 ARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      +........  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  215 (295)
T cd07837         158 GRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD  215 (295)
T ss_pred             ceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence            886532211  1122356888999998765 45789999999999999999999999754

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.2e-34  Score=263.16  Aligned_cols=184  Identities=23%  Similarity=0.377  Sum_probs=151.3

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCc-cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      +|++.++||+|++|.||+|... +|+.||||.++.... .....+.+|+.++++++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4889999999999999999764 689999999976532 33566788999999999999999999999999999999999


Q ss_pred             CCCChHHHHH------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          103 PNKSLDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       103 ~~gsL~~~l~------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ++ +|.+++.                  +++.++.+||..   +++|+||||+||++++++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 6655432                  456667777754   899999999999999999999999999876532211 


Q ss_pred             CcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                       ......++..|++||++.+. .++.++||||||+++|+|++|+.||....
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~  205 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN  205 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence             11224568899999988654 56889999999999999999999997654

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.8e-34  Score=262.80  Aligned_cols=242  Identities=16%  Similarity=0.163  Sum_probs=165.5

Q ss_pred             cccccCCCCeeeEEEeeccCCeEEEEEEcCC----CcEEEEEEeccCCccCH-H----------HHHHHHHHHHhcCCCC
Q 039516           17 KFVENSSLDWHMYIQQEQTRDRVILVGKFPN----EQEVAIKRLAWTSGQGR-V----------EFQNEAKLIAKLQYTN   81 (345)
Q Consensus        17 ~~~~~~~~~~~~~~~lG~G~~g~vy~~~~~~----~~~VaiK~~~~~~~~~~-~----------~~~~E~~~l~~l~H~n   81 (345)
                      ...+.....|.+.++||+|+||.||+|...+    +..+|+|.......... +          ....+...+..+.|+|
T Consensus         5 ~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~   84 (294)
T PHA02882          5 PLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG   84 (294)
T ss_pred             eeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence            3445556789999999999999999997643    45667776443322111 1          1223334456678999


Q ss_pred             eeeEEEEEEECC----eeEEEEecCCCCChHH---------------HHHhHHHHHHHHHhcCCCceEEeccCCCCeeeC
Q 039516           82 LVKLLGCSIHGE----ERLLVYEFMPNKSLDS---------------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLD  142 (345)
Q Consensus        82 iv~~~~~~~~~~----~~~lv~e~~~~gsL~~---------------~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~  142 (345)
                      ++++++++....    ..+++++++.. ++.+               ++.+++.++.|||..   +|+||||||+|||++
T Consensus        85 i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~  160 (294)
T PHA02882         85 IPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD  160 (294)
T ss_pred             CCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence            999999876543    34778887643 3322               223566777777765   899999999999999


Q ss_pred             CCCCEEEEccccceeecCCCCC-----CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 039516          143 DQLNTKISDFGMARIFGVNESG-----ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER  217 (345)
Q Consensus       143 ~~~~~kl~Dfgl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~  217 (345)
                      .++.++|+|||+++.+......     .......||+.|+|||+..+..++.++|||||||++|||++|+.||.......
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            9999999999999876432211     11223469999999999999999999999999999999999999998753221


Q ss_pred             cccHHHHH----HHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcch
Q 039516          218 PLNLVGIA----WQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFP  275 (345)
Q Consensus       218 ~~~~~~~~----~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~  275 (345)
                      .  +....    ......+...      + ..+    ... .+++..|++.+|.+||++.++.
T Consensus       241 ~--~~~~~~~~~~~~~~~~~~~------~-~~~----~~~~~~~~~~~~~~~~~~rp~~~~l~  290 (294)
T PHA02882        241 N--LIHAAKCDFIKRLHEGKIK------I-KNA----NKFIYDFIECVTKLSYEEKPDYDALI  290 (294)
T ss_pred             H--HHHHhHHHHHHHhhhhhhc------c-CCC----CHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence            1  11111    1111111110      0 111    223 6899999999999999976543

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-35  Score=287.49  Aligned_cols=185  Identities=18%  Similarity=0.210  Sum_probs=143.4

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEcC--CCcEEEEEEec-----------------cCCccCHHHHHHHHHHHHhcCCCC
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKFP--NEQEVAIKRLA-----------------WTSGQGRVEFQNEAKLIAKLQYTN   81 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~~--~~~~VaiK~~~-----------------~~~~~~~~~~~~E~~~l~~l~H~n   81 (345)
                      .+..+|.+.++||+|+||.||++...  ++..+++|.+.                 .........+.+|+.+|++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            34567999999999999999998542  22222222110                 011123456889999999999999


Q ss_pred             eeeEEEEEEECCeeEEEEecCCCCChHH--------------------HHHhHHHHHHHHHhcCCCceEEeccCCCCeee
Q 039516           82 LVKLLGCSIHGEERLLVYEFMPNKSLDS--------------------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILL  141 (345)
Q Consensus        82 iv~~~~~~~~~~~~~lv~e~~~~gsL~~--------------------~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill  141 (345)
                      |+++++++...+..|+|++++.+ +|.+                    ++.+++.+|.|||..   ||+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            99999999999999999998854 3322                    223566777777764   89999999999999


Q ss_pred             CCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCC
Q 039516          142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNN  210 (345)
Q Consensus       142 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~  210 (345)
                      +.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999999999876432221 122357899999999999999999999999999999999987543

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.5e-34  Score=267.35  Aligned_cols=226  Identities=22%  Similarity=0.315  Sum_probs=170.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ..|...+.||+|+||.||++.. .++..||+|.+....   ......+.+|++++++++|||++++++++..+...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            4477888899999999999975 468999999986442   223457889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          100 EFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       100 e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      ||+++ +|.+.+.                +++.++.+||..   +++||||+|+||+++.++.++|+|||++.....   
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---  177 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP---  177 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence            99975 5554432                456666777755   899999999999999999999999999875422   


Q ss_pred             CCcccceeecCCccccchhc---cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          164 GANTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                         .....|+..|+|||++.   .+.++.++|||||||++|+|++|+.||.......      ........+.      +
T Consensus       178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~------~  242 (317)
T cd06635         178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNES------P  242 (317)
T ss_pred             ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhccC------C
Confidence               12346788999999874   4568899999999999999999999987542111      1111111111      0


Q ss_pred             cCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcc
Q 039516          241 TLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       241 ~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~  274 (345)
                      ..   ........ .+++.+||+.+|.+|||+.++
T Consensus       243 ~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i  274 (317)
T cd06635         243 TL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEEL  274 (317)
T ss_pred             CC---CCccccHHHHHHHHHHccCCcccCcCHHHH
Confidence            00   01111122 689999999999999996543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-37  Score=307.30  Aligned_cols=236  Identities=22%  Similarity=0.260  Sum_probs=184.0

Q ss_pred             ccccccCCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC
Q 039516           16 AKFVENSSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG   92 (345)
Q Consensus        16 ~~~~~~~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~   92 (345)
                      +....+....|....+||+|.||.||-+. ..+|...|+|.++..  .........+|..++..|+|||+|++||+-.++
T Consensus      1227 a~~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1227 ASSLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR 1306 (1509)
T ss_pred             HHHhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH
Confidence            33445556778999999999999999985 567999999988654  233455678999999999999999999999999


Q ss_pred             CeeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516           93 EERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      +..+|.||||.+|+|.+.+.               +.+.++.|||..   |||||||||+||+++.+|.+|++|||.|..
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeE
Confidence            99999999999999988765               556667777765   899999999999999999999999999998


Q ss_pred             ecCCCC--CCcccceeecCCccccchhccCC---cCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-Hhc
Q 039516          158 FGVNES--GANTNRIVGTYGYMSLEYTMSGT---VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQL-WNE  231 (345)
Q Consensus       158 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~  231 (345)
                      +.....  ....+...||+.|||||++.+..   -..+.||||+||++.||+||+.||...+.+       |+..+ ...
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~ 1456 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAA 1456 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhc
Confidence            754321  12334578999999999998643   457899999999999999999999876532       22211 112


Q ss_pred             CCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCC
Q 039516          232 GKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQC  270 (345)
Q Consensus       232 ~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs  270 (345)
                      |..     |.    .|..-... .+++..||+.||..|=+
T Consensus      1457 gh~-----Pq----~P~~ls~~g~dFle~Cl~~dP~~Rw~ 1487 (1509)
T KOG4645|consen 1457 GHK-----PQ----IPERLSSEGRDFLEHCLEQDPKMRWT 1487 (1509)
T ss_pred             cCC-----CC----CchhhhHhHHHHHHHHHhcCchhhhH
Confidence            211     11    22221222 69999999999999943

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-34  Score=255.33  Aligned_cols=223  Identities=17%  Similarity=0.166  Sum_probs=166.4

Q ss_pred             EEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc---cCHHHHHHHHHHH-HhcCCCCeeeEEEEEEECCeeEEEEecCCC
Q 039516           30 IQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG---QGRVEFQNEAKLI-AKLQYTNLVKLLGCSIHGEERLLVYEFMPN  104 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~---~~~~~~~~E~~~l-~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  104 (345)
                      +.||+|+||.||++.. .+|+.||+|.+.....   .....+..|..++ ...+|+|++++++++..++..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4589999999999976 4689999999865421   1223345555544 455899999999999999999999999999


Q ss_pred             CChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccc
Q 039516          105 KSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNR  169 (345)
Q Consensus       105 gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  169 (345)
                      ++|.+++.               +++.+|.+||..   +++|+||+|+||+++.++.++|+|||++.....      ...
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~  152 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKK  152 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc------ccc
Confidence            99987764               566677777765   899999999999999999999999999876432      223


Q ss_pred             eeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChh
Q 039516          170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPN  249 (345)
Q Consensus       170 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  249 (345)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|..||.......       .+.....+...  ........++.+
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~--~~~~~~~~~~~~  223 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRIN--WPEEVKEFCSPE  223 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccC--CCCcccccCCHH
Confidence            467889999999988888999999999999999999999997543211       11111111111  011111112222


Q ss_pred             HHHHHHHHhhccCCCCCcCCCCCc
Q 039516          250 EDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       250 ~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .   .+++..||+.+|++|||+..
T Consensus       224 ~---~~~i~~~l~~~p~~R~~~~~  244 (260)
T cd05611         224 A---VDLINRLLCMDPAKRLGANG  244 (260)
T ss_pred             H---HHHHHHHccCCHHHccCCCc
Confidence            1   59999999999999999653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-34  Score=270.60  Aligned_cols=195  Identities=23%  Similarity=0.240  Sum_probs=158.4

Q ss_pred             eeecccccccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEE
Q 039516           10 QTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLL   86 (345)
Q Consensus        10 ~s~~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~   86 (345)
                      |+..++.+++..+..+|.+...||+|+||.||+|.. .+|+.||+|++...  .......+.+|+.++++++||||++++
T Consensus         1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~   80 (342)
T cd07879           1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL   80 (342)
T ss_pred             CchhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchh
Confidence            455677777777788899999999999999999975 57899999998643  223345688999999999999999999


Q ss_pred             EEEEECC------eeEEEEecCCCCChHHHH-------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCE
Q 039516           87 GCSIHGE------ERLLVYEFMPNKSLDSSF-------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNT  147 (345)
Q Consensus        87 ~~~~~~~------~~~lv~e~~~~gsL~~~l-------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~  147 (345)
                      +++....      ..++||||+.. +|....             .+++.++.+||..   +++||||||+||+++.++.+
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~  156 (342)
T cd07879          81 DVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCEL  156 (342)
T ss_pred             heecccccCCCCceEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence            9987543      46999999864 554432             2566777777765   89999999999999999999


Q ss_pred             EEEccccceeecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       148 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      ||+|||+++....     ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       157 kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~  218 (342)
T cd07879         157 KILDFGLARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  218 (342)
T ss_pred             EEeeCCCCcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999875422     1223467889999998876 46889999999999999999999999754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.8e-35  Score=268.35  Aligned_cols=227  Identities=21%  Similarity=0.304  Sum_probs=174.5

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCC
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN  104 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  104 (345)
                      |....+||+|+||.||++.. .+|+.||||++..........+.+|+.+++.++|+||+++++++...+..++||||+++
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            33445699999999999966 57899999998655545566799999999999999999999999999999999999999


Q ss_pred             CChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccce
Q 039516          105 KSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI  170 (345)
Q Consensus       105 gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  170 (345)
                      ++|.+++.              +++.++.+||..   |++|+||+|+||+++.++.++|+|||++........  .....
T Consensus       102 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~  176 (292)
T cd06657         102 GALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL  176 (292)
T ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence            99987653              455666666654   899999999999999999999999999876543221  12335


Q ss_pred             eecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC--CCCCh
Q 039516          171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD--GSCPP  248 (345)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~  248 (345)
                      .|+..|+|||++.+..++.++|+||||+++|+|++|..||.......   ...    ....+     +.+.+.  ...++
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~----~~~~~-----~~~~~~~~~~~~~  244 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK----MIRDN-----LPPKLKNLHKVSP  244 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhh-----CCcccCCcccCCH
Confidence            68899999999988888999999999999999999999987533211   111    11111     011110  01222


Q ss_pred             hHHHHHHHHhhccCCCCCcCCCCC
Q 039516          249 NEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       249 ~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..   .+++.+||+.+|.+|||+.
T Consensus       245 ~l---~~li~~~l~~~P~~R~~~~  265 (292)
T cd06657         245 SL---KGFLDRLLVRDPAQRATAA  265 (292)
T ss_pred             HH---HHHHHHHHhCCcccCcCHH
Confidence            11   4889999999999999954

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.9e-34  Score=259.73  Aligned_cols=230  Identities=19%  Similarity=0.229  Sum_probs=173.6

Q ss_pred             CeeeEEEeeccCCeEEEEEEc----CCCcEEEEEEeccCC----ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCee
Q 039516           25 DWHMYIQQEQTRDRVILVGKF----PNEQEVAIKRLAWTS----GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~----~~~~~VaiK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~   95 (345)
                      +|++.+.||+|+||.||.+..    .+|..||+|.+....    ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            378889999999999999875    368999999986532    22346788999999999 599999999999999999


Q ss_pred             EEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           96 LLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      ++||||+++++|.+++.               +++.+|.+||.   .|++||||+|+||+++.++.+||+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            99999999999988764               45566666665   4899999999999999999999999999986533


Q ss_pred             CCCCCcccceeecCCccccchhccC--CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSG--TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                      ... .......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||......  ...............     
T Consensus       158 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~-----  229 (290)
T cd05613         158 DEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP-----  229 (290)
T ss_pred             ccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccCC-----
Confidence            221 112235688999999988753  4678999999999999999999999643221  112222222221111     


Q ss_pred             cccCCCCCChhHHHH-HHHHhhccCCCCCcCCCC
Q 039516          239 DLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       239 d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~  271 (345)
                        .    ++...... ..++..||+.||.+||+.
T Consensus       230 --~----~~~~~~~~~~~ll~~~l~~~p~~R~~~  257 (290)
T cd05613         230 --P----YPQEMSALAKDIIQRLLMKDPKKRLGC  257 (290)
T ss_pred             --C----CCccCCHHHHHHHHHHhcCCHHHhcCC
Confidence              0    11111223 589999999999999963

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7.8e-35  Score=260.90  Aligned_cols=225  Identities=21%  Similarity=0.232  Sum_probs=173.0

Q ss_pred             eeccCCeEEEEEEcC-CCcEEEEEEeccCCc---cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCCh
Q 039516           32 QEQTRDRVILVGKFP-NEQEVAIKRLAWTSG---QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL  107 (345)
Q Consensus        32 lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL  107 (345)
                      ||+|+||.||++... +|+.|++|.+.....   .....+.+|++++++++||||+++++.+..+...+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999875 599999999965432   3456789999999999999999999999999999999999999999


Q ss_pred             HHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC------CCc
Q 039516          108 DSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES------GAN  166 (345)
Q Consensus       108 ~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~------~~~  166 (345)
                      .+++.               +++.+|.+||..   +++|+||+|+||+++.++.++|+|||++........      ...
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence            77654               567777788865   899999999999999999999999999876432211      012


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      .....++..|+|||...+...+.++|+||||+++|++++|..||......      ....... .+...      .....
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~------~~~~~  224 (265)
T cd05579         158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNIL-NGKIE------WPEDV  224 (265)
T ss_pred             ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHh-cCCcC------CCccc
Confidence            22346788999999998888899999999999999999999999754321      1111111 11110      00000


Q ss_pred             ChhHHHH-HHHHhhccCCCCCcCCCCCcc
Q 039516          247 PPNEDAF-LLVSCVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       247 ~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~  274 (345)
                        ..... ..++..||+.+|.+|||+..+
T Consensus       225 --~~~~~~~~~i~~~l~~~p~~Rpt~~~~  251 (265)
T cd05579         225 --EVSDEAIDLISKLLVPDPEKRLGAKSI  251 (265)
T ss_pred             --cCCHHHHHHHHHHhcCCHhhcCCCccH
Confidence              00122 599999999999999997543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1e-34  Score=259.13  Aligned_cols=225  Identities=21%  Similarity=0.269  Sum_probs=176.2

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +|++.+.||+|+||.||++.. .+++.+|+|.+...  .......+.+|++++++++|+||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            478899999999999999854 47899999998654  233455788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516          102 MPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus       102 ~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      +++++|.+++.                   +++.++.+||.   .|++|+||+|.||+++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999977653                   35556666665   48999999999999999999999999999876433 


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                         ......++..|++||.+.+..++.++|+||||+++|+|++|+.||......      .... ....+....      
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~~------  220 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DLRY-KVQRGKYPP------  220 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-HHhcCCCCC------
Confidence               122245788999999999888999999999999999999999999754321      1111 111111111      


Q ss_pred             CCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          243 DGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       243 ~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                         .+...... ..++..|++.+|++|||+.
T Consensus       221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~  248 (256)
T cd08530         221 ---IPPIYSQDLQNFIRSMLQVKPKLRPNCD  248 (256)
T ss_pred             ---CchhhCHHHHHHHHHHcCCCcccCCCHH
Confidence               11112223 6999999999999999964

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-36  Score=272.32  Aligned_cols=247  Identities=21%  Similarity=0.262  Sum_probs=179.8

Q ss_pred             eeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhc--CCCCeeeEEEEEEECC----eeEEEE
Q 039516           26 WHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL--QYTNLVKLLGCSIHGE----ERLLVY   99 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~~~~~~~~~~----~~~lv~   99 (345)
                      .....+||+|+||.||+|.+. ++.||||++..   +....|++|-++.+..  +|+||++|++.-....    .+|||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            345567999999999999996 69999999964   3467899999888764  8999999999865444    889999


Q ss_pred             ecCCCCChHHHHH--------------hHHHHHHHHHhc------CCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516          100 EFMPNKSLDSSFS--------------GTFKDLLCLHKY------SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus       100 e~~~~gsL~~~l~--------------~~~~~l~~lh~~------~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      +|.+.|+|.++++              .++++|+|||..      |+++|+|||||..|||+.+++++.|+|||++..+.
T Consensus       288 ~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~  367 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE  367 (534)
T ss_pred             eeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence            9999999999987              568899999975      45679999999999999999999999999999886


Q ss_pred             CCCCCCcccceeecCCccccchhccCC-cC-----cccchhhHHHHHHHHHhCCCCCCC-CCCCCccc---------HHH
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTMSGT-VS-----IKTDVFGFGVLVLKIVCGKKNNKS-YHTERPLN---------LVG  223 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Di~SlG~il~el~tg~~p~~~-~~~~~~~~---------~~~  223 (345)
                      ........-...||.+|||||++.+.. +.     .+.||||+|.++|||+++-.-+.. ..++-+..         -.+
T Consensus       368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e  447 (534)
T KOG3653|consen  368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE  447 (534)
T ss_pred             CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence            555444444578999999999988642 21     358999999999999997654421 11110000         111


Q ss_pred             HHHHHHhcCCccccccccCCCCCCh-hHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          224 IAWQLWNEGKDLELIDLTLDGSCPP-NEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       224 ~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                      ..+...-..+.    .|.+.+..-. ..+.. .+.+.-||..||+.|-|+.=+...+.+
T Consensus       448 ~mq~~VV~kK~----RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~  502 (534)
T KOG3653|consen  448 EMQELVVRKKQ----RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAE  502 (534)
T ss_pred             HHHHHHHhhcc----CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence            12222211111    1222111111 22333 788999999999999996544433333

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5e-35  Score=272.88  Aligned_cols=185  Identities=23%  Similarity=0.298  Sum_probs=149.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----Ce
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG-----EE   94 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~   94 (345)
                      ...|.+.+.||+|+||+||++.. .+|+.||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            34699999999999999999964 57899999998653  233455678899999999999999999987644     34


Q ss_pred             eEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           95 RLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      .++||||+. ++|.+++.               +++.+|.+||..   +++||||||+||+++.++.+||+|||++....
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            799999996 56655542               556666777755   89999999999999999999999999998654


Q ss_pred             CCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      ...  .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus       160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  212 (337)
T cd07858         160 EKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK  212 (337)
T ss_pred             CCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence            321  11223467889999998764 46889999999999999999999999754

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-34  Score=254.07  Aligned_cols=227  Identities=21%  Similarity=0.263  Sum_probs=176.5

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCc--cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSG--QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +|++.+.||+|++|.||++... +++.|++|.+.....  .....+.+|++++++++|+|++++++++.+++..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999654 688999999976543  3556799999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          102 MPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       102 ~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      +++++|.+++.               +++.++.+||   +.|++|+||+|+||+++.++.++|+|||++.........  
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  155 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--  155 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence            99999987654               4445555555   458999999999999999999999999999876433221  


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      .....++..|+|||...+..++.++||||+|+++|+|++|+.||......      ...+... ....     +.+....
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~~~-----~~~~~~~  223 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRIV-QDDH-----PPLPEGI  223 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHh-ccCC-----CCCCCCC
Confidence            22356788999999988878899999999999999999999998754311      1111111 1111     1111111


Q ss_pred             ChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          247 PPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       247 ~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                          ... ..++.+||+.+|++|||+.
T Consensus       224 ----~~~~~~~i~~~l~~~p~~R~~~~  246 (254)
T cd06627         224 ----SPELKDFLMQCFQKDPNLRPTAK  246 (254)
T ss_pred             ----CHHHHHHHHHHHhCChhhCcCHH
Confidence                223 5899999999999999964

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.6e-35  Score=273.05  Aligned_cols=189  Identities=24%  Similarity=0.314  Sum_probs=151.9

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC--CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC--Cee
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHG--EER   95 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~--~~~   95 (345)
                      +..+|++.+.||+|+||.||+|... +|+.||+|++...  .......+.+|+.+++++ +||||++++++|...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3456888899999999999999764 6889999988542  233445677899999999 999999999988653  368


Q ss_pred             EEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           96 LLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      ++||||+++ +|..++.              +++.+|.+||..   ||+||||||+||+++.++.+||+|||++......
T Consensus        85 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~  160 (337)
T cd07852          85 YLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL  160 (337)
T ss_pred             EEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence            999999974 7766543              567777777765   8999999999999999999999999999866432


Q ss_pred             CCC---CcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          162 ESG---ANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       162 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ...   .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~  217 (337)
T cd07852         161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS  217 (337)
T ss_pred             cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence            211   12233568899999998764 567889999999999999999999997543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.8e-36  Score=260.02  Aligned_cols=233  Identities=22%  Similarity=0.250  Sum_probs=181.3

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEE-EcCCCcEEEEEEeccCC----ccC----HHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVG-KFPNEQEVAIKRLAWTS----GQG----RVEFQNEAKLIAKL-QYTNLVKLLGCS   89 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~-~~~~~~~VaiK~~~~~~----~~~----~~~~~~E~~~l~~l-~H~niv~~~~~~   89 (345)
                      +.|...|+.-+.||+|..++|-++ +..+|+..|+|++....    ...    .+.-..|+.+|+++ -||||+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            456777888888999999999887 45678999999985431    112    33456799999998 699999999999


Q ss_pred             EECCeeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccc
Q 039516           90 IHGEERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGM  154 (345)
Q Consensus        90 ~~~~~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl  154 (345)
                      +.+...++|+|.|+.|.|.+++.               ++..+++|||..   .||||||||+|||++++.++||+|||+
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence            99999999999999999988776               677888899887   699999999999999999999999999


Q ss_pred             ceeecCCCCCCcccceeecCCccccchhc------cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 039516          155 ARIFGVNESGANTNRIVGTYGYMSLEYTM------SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQL  228 (345)
Q Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  228 (345)
                      ++.+..   +......+|||+|.|||.+.      ...|+..+|+||.||++|.|+.|.+||-...       .-....+
T Consensus       170 a~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~  239 (411)
T KOG0599|consen  170 ACQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRM  239 (411)
T ss_pred             eeccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHH
Confidence            998753   33445679999999999775      2457888999999999999999999996321       1112222


Q ss_pred             HhcCCccccccccCCCCCChhH-HHH-HHHHhhccCCCCCcCCCCC
Q 039516          229 WNEGKDLELIDLTLDGSCPPNE-DAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       229 ~~~~~~~~~~d~~l~~~~~~~~-~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .-+|+... -.|.      ... ... .+++.+||+.||.+|-|..
T Consensus       240 ImeGkyqF-~spe------Wadis~~~KdLIsrlLqVdp~~Ritak  278 (411)
T KOG0599|consen  240 IMEGKYQF-RSPE------WADISATVKDLISRLLQVDPTKRITAK  278 (411)
T ss_pred             HHhccccc-CCcc------hhhccccHHHHHHHHHeeCchhcccHH
Confidence            32333211 0111      111 112 6999999999999999943

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.6e-34  Score=255.39  Aligned_cols=227  Identities=18%  Similarity=0.256  Sum_probs=178.4

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCc--cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSG--QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +|.+.+.||.|+||.||++... ++..||+|++.....  .....+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999764 689999999975532  4566789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516          102 MPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus       102 ~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      +++++|.+.+.                   +++.++.+||..   |++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999977653                   445566666655   89999999999999999999999999998764332


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                        .......|++.|+|||...+..++.++|+||+|+++++|++|+.||.....      ........ ......     +
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~-----~  223 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKIL-KGQYPP-----I  223 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHh-cCCCCC-----C
Confidence              122335788899999999888899999999999999999999999865431      11111111 111111     1


Q ss_pred             CCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          243 DGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       243 ~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ...++    .. .+++.+||+.+|.+|||+.
T Consensus       224 ~~~~~----~~~~~~i~~~l~~~p~~Rp~~~  250 (258)
T cd08215         224 PSQYS----SELRNLVSSLLQKDPEERPSIA  250 (258)
T ss_pred             CCCCC----HHHHHHHHHHcCCChhhCcCHH
Confidence            11122    22 5899999999999999954

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-35  Score=263.80  Aligned_cols=183  Identities=24%  Similarity=0.313  Sum_probs=151.5

Q ss_pred             eeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCc--cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           26 WHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSG--QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      |++.+.||+|++|.||++... +|+.+++|.+.....  .....+.+|++++++++|+||+++++++..++..++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566778999999999999764 689999999865432  24567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          103 PNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       103 ~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      ++ +|.+++.                +++.++.+||..   +++|+||||+||+++.++.++|+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            76 6655432                566677777765   79999999999999999999999999998764432  11


Q ss_pred             ccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~  203 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS  203 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2224578889999988776 78999999999999999999999997544

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=262.50  Aligned_cols=182  Identities=24%  Similarity=0.339  Sum_probs=149.8

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      |++.+.||.|++|.||+|.. .+|..||+|++....  ......+.+|++++++++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            56778899999999999975 479999999986543  233457889999999999999999999999999999999999


Q ss_pred             CCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          103 PNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       103 ~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      + ++|.+++.                 +++.+|.+||..   +++|+||+|+||+++.++.++|+|||++........  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 57766543                 566777778765   799999999999999999999999999876532211  


Q ss_pred             cccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      ......++..|+|||++.+. .++.++|+||||+++|+|++|+.||...
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  203 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD  203 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            11223568899999987654 5688999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9e-35  Score=270.80  Aligned_cols=187  Identities=20%  Similarity=0.251  Sum_probs=151.9

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE----CCeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH----GEERL   96 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~   96 (345)
                      .+|++.+.||+|+||.||++.. .+|+.||+|++....  ......+.+|+.++++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            5689999999999999999965 469999999986542  2345678889999999999999999998753    35689


Q ss_pred             EEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           97 LVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      +||||+. ++|.+++.               +++.+|.+||..   +++||||||+||+++.++.+||+|||++......
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence            9999996 46766553               667777888765   8999999999999999999999999999876432


Q ss_pred             CCC--CcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          162 ESG--ANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       162 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ...  .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~  216 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN  216 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence            211  11123468889999998765 468899999999999999999999997643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=7.8e-34  Score=258.69  Aligned_cols=235  Identities=17%  Similarity=0.186  Sum_probs=175.6

Q ss_pred             CeeeEEEeeccCCeEEEEEEc----CCCcEEEEEEeccCC----ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCee
Q 039516           25 DWHMYIQQEQTRDRVILVGKF----PNEQEVAIKRLAWTS----GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~----~~~~~VaiK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~   95 (345)
                      +|.+.+.||+|++|.||++..    .++..||||.++...    ......+.+|+.++.++ +||||+++++++..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            478889999999999999864    357899999986432    22345688999999999 599999999999999999


Q ss_pred             EEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           96 LLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      ++||||+++++|.+++.               +++++|.+||..   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            99999999999977653               556677777754   899999999999999999999999999876533


Q ss_pred             CCCCCcccceeecCCccccchhccCC--cCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGT--VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                      .... ......|+..|+|||.+.+..  .+.++|+||||+++|+|++|..||.......  ............       
T Consensus       158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~-------  227 (288)
T cd05583         158 EEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS-------  227 (288)
T ss_pred             cccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc-------
Confidence            2211 122346788999999987654  6889999999999999999999996432111  111222221111       


Q ss_pred             cccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcch
Q 039516          239 DLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFP  275 (345)
Q Consensus       239 d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~  275 (345)
                      .+.....++...   .+++.+||+.||++|||+..+.
T Consensus       228 ~~~~~~~~~~~l---~~li~~~l~~~p~~R~t~~~~~  261 (288)
T cd05583         228 KPPFPKTMSAEA---RDFIQKLLEKDPKKRLGANGAD  261 (288)
T ss_pred             CCCCCcccCHHH---HHHHHHHhcCCHhhccCcchHH
Confidence            011111122221   5899999999999999976443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.6e-34  Score=262.80  Aligned_cols=184  Identities=20%  Similarity=0.168  Sum_probs=147.0

Q ss_pred             eeEEEeeccCCeEEEEEEcCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCC
Q 039516           27 HMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN  104 (345)
Q Consensus        27 ~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  104 (345)
                      .+.+.+|+|+++.|+++.. +++.||||+++..  .......+.+|++++++++|+||+++++++...+..+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            3344455566666666655 6999999999754  344567899999999999999999999999999999999999999


Q ss_pred             CChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC----
Q 039516          105 KSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES----  163 (345)
Q Consensus       105 gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----  163 (345)
                      ++|.+++.                 +++.+|.|||..   +|+||||||+||+++.++.+||+|||.+........    
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            99987754                 566677777765   799999999999999999999999998876532111    


Q ss_pred             -CCcccceeecCCccccchhcc--CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          164 -GANTNRIVGTYGYMSLEYTMS--GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       164 -~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                       ........++..|+|||++.+  ..++.++|+|||||++|||++|+.||....
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~  214 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP  214 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence             111123456778999999876  357899999999999999999999998643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=8e-34  Score=256.21  Aligned_cols=221  Identities=19%  Similarity=0.215  Sum_probs=163.7

Q ss_pred             CCeeeEEEe--eccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQ--EQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~l--G~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|++.+++  |+|+||.||++.. .++..+|+|.+........     |+.....+ +||||+++++++...+..++||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~   88 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM   88 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence            446666666  9999999999964 5688999999865421111     22222222 7999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC-CEEEEccccceeecCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL-NTKISDFGMARIFGVNES  163 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~  163 (345)
                      ||+++++|.+++.               +++.++.+||..   |++||||||+||+++.++ .++|+|||++......  
T Consensus        89 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--  163 (267)
T PHA03390         89 DYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--  163 (267)
T ss_pred             EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence            9999999987765               566677777765   799999999999999988 9999999998865322  


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                          ....++..|+|||++.+..++.++||||||+++|+|++|+.||..... +......+....  .. .....     
T Consensus       164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~--~~-~~~~~-----  230 (267)
T PHA03390        164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ--QK-KLPFI-----  230 (267)
T ss_pred             ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh--cc-cCCcc-----
Confidence                123678899999999988999999999999999999999999984432 222222221111  10 00000     


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCC
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQC  270 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs  270 (345)
                      ...++..   .+++..||+.+|.+||+
T Consensus       231 ~~~~~~~---~~li~~~l~~~p~~R~~  254 (267)
T PHA03390        231 KNVSKNA---NDFVQSMLKYNINYRLT  254 (267)
T ss_pred             cccCHHH---HHHHHHHhccChhhCCc
Confidence            1122222   58899999999999997

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.7e-34  Score=258.29  Aligned_cols=181  Identities=21%  Similarity=0.259  Sum_probs=145.0

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEEC--CeeEEEEe
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHG--EERLLVYE  100 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~--~~~~lv~e  100 (345)
                      |++.++||+|+||.||++.. .+++.||+|.++... ........+|+.++.++. |+||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            57788899999999999975 468999999986542 222334567899999885 99999999999887  88999999


Q ss_pred             cCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          101 FMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       101 ~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |+++ +|.+.+.                +++.+|.+||..   +++||||+|+||+++. +.+||+|||++........ 
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            9975 5554432                556667777765   8999999999999999 9999999999986533221 


Q ss_pred             CcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                        .....++..|+|||++.. ..++.++|||||||++|||++|..||...+
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~  203 (282)
T cd07831         155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN  203 (282)
T ss_pred             --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence              122457889999997654 557889999999999999999999997643

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-34  Score=258.30  Aligned_cols=182  Identities=22%  Similarity=0.317  Sum_probs=148.7

Q ss_pred             eeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC--ccCHHHHHHHHHHHHhc---CCCCeeeEEEEEEECCe-----
Q 039516           26 WHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKL---QYTNLVKLLGCSIHGEE-----   94 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~~~~~-----   94 (345)
                      |++.+.||+|+||.||++... +++.||+|.+....  ......+.+|+.+++++   +|+||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678889999999999999875 58999999996442  22234567788877666   59999999999988776     


Q ss_pred             eEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516           95 RLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      .+++|||+++ +|.+++.                 +++.+|.+||..   +++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999975 5655432                 567777788775   799999999999999999999999999987


Q ss_pred             ecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ......   .....++..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus       157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~  210 (287)
T cd07838         157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS  210 (287)
T ss_pred             ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence            643221   122357889999999999899999999999999999999999987644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-34  Score=255.01  Aligned_cols=229  Identities=18%  Similarity=0.268  Sum_probs=171.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC-----CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--Cee
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT-----SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--EER   95 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~   95 (345)
                      .+|.+.+.||+|+||.||++.. .++..||+|.+...     .......+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4689999999999999999975 46899999987532     122345788999999999999999999998764  468


Q ss_pred             EEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           96 LLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      +++|||+++++|.+.+.               +++.++.+||..   |++|+||||+||+++.++.++|+|||+++....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            89999999999987653               456666667654   899999999999999999999999999976532


Q ss_pred             CCC-CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          161 NES-GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       161 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      ... ........++..|+|||++.+..++.++|+||||+++|+|++|+.||......      .......... ..    
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~----  227 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIATQP-TK----  227 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHcCC-CC----
Confidence            111 11122346888999999998888899999999999999999999999754211      1111111111 00    


Q ss_pred             ccCCCCCChhHHHH-HHHHhhccCCCCCcCCCC
Q 039516          240 LTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       240 ~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~  271 (345)
                      +.    .+...... .+++..|++ +|..|||.
T Consensus       228 ~~----~p~~~~~~~~~~i~~~l~-~~~~r~~~  255 (264)
T cd06653         228 PM----LPDGVSDACRDFLKQIFV-EEKRRPTA  255 (264)
T ss_pred             CC----CCcccCHHHHHHHHHHhc-CcccCccH
Confidence            11    11122223 589999999 57999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.2e-34  Score=262.73  Aligned_cols=186  Identities=23%  Similarity=0.295  Sum_probs=148.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC------
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE------   93 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------   93 (345)
                      ..+|++.+.||+|+||.||+|... +|+.||+|.++...  ......+.+|++++++++||||+++++++.+..      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            346889999999999999999764 68999999997542  233456788999999999999999999987654      


Q ss_pred             ----eeEEEEecCCCCChHHHH----------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccc
Q 039516           94 ----ERLLVYEFMPNKSLDSSF----------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFG  153 (345)
Q Consensus        94 ----~~~lv~e~~~~gsL~~~l----------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg  153 (345)
                          ..++|+||+++ ++...+                .+++.+|.+||..   ||+|+||||+||++++++.+||+|||
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg  161 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFG  161 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCccc
Confidence                78999999987 343322                2566677777765   89999999999999999999999999


Q ss_pred             cceeecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          154 MARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       154 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      ++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~  221 (302)
T cd07864         162 LARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN  221 (302)
T ss_pred             ccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9986643221 11122356788999998764 45789999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.9e-34  Score=266.79  Aligned_cols=189  Identities=23%  Similarity=0.304  Sum_probs=150.7

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--------
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--------   92 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--------   92 (345)
                      +...|.+.+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|++++++++||||+++++++...        
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            356799999999999999999965 56899999999766656677899999999999999999999876543        


Q ss_pred             ------CeeEEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC-CCCEEEEc
Q 039516           93 ------EERLLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD-QLNTKISD  151 (345)
Q Consensus        93 ------~~~~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~-~~~~kl~D  151 (345)
                            ...++||||+++ +|.+++.              +++.++.+||..   |++||||||+||+++. ++.+||+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          83 GSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECC
Confidence                  357899999974 7765543              566777777765   8999999999999974 55789999


Q ss_pred             cccceeecCCCCCC-cccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          152 FGMARIFGVNESGA-NTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       152 fgl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ||++.......... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~  223 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH  223 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99997653221111 1122357889999997654 567889999999999999999999997554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.3e-33  Score=258.35  Aligned_cols=231  Identities=22%  Similarity=0.269  Sum_probs=169.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEEEe
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      .+|++.+.||+|+||.||++... +++.||||.++... ......+..|+.++.+.. |+||+++++++.++...+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            56899999999999999999875 48999999997543 233456777887776764 9999999999999999999999


Q ss_pred             cCCCCChHHHH----------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          101 FMPNKSLDSSF----------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       101 ~~~~gsL~~~l----------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |+.+ +|.+++                .+++.++.|||..+  ||+||||+|+||++++++.+||+|||++........ 
T Consensus        95 ~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~-  170 (296)
T cd06618          95 LMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-  170 (296)
T ss_pred             ccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence            9864 443322                26677788888643  799999999999999999999999999876532221 


Q ss_pred             CcccceeecCCccccchhccCC----cCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGT----VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                        .....++..|+|||++.+..    ++.++||||||+++|+|++|+.||......     .+......... ...+-..
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~~~~~  242 (296)
T cd06618         171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PPSLPPN  242 (296)
T ss_pred             --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CCCCCCC
Confidence              12235778899999987543    789999999999999999999999653211     11111111111 0000000


Q ss_pred             cCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          241 TLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       241 ~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                         ..++    .. .+++.+||+.||.+|||+.+
T Consensus       243 ---~~~~----~~l~~li~~~l~~~p~~Rp~~~~  269 (296)
T cd06618         243 ---EGFS----PDFCSFVDLCLTKDHRKRPKYRE  269 (296)
T ss_pred             ---CCCC----HHHHHHHHHHccCChhhCCCHHH
Confidence               0112    23 68999999999999999653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=285.02  Aligned_cols=240  Identities=24%  Similarity=0.270  Sum_probs=196.5

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCC----cEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNE----QEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~----~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      .....++||+|+||+||+|.+ +.|    -+||||++... ..+...+++.|+-+|.+++|||+++++|+|.... +-||
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            345567899999999999965 443    57899998544 5556788999999999999999999999997655 8899


Q ss_pred             EecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           99 YEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        99 ~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      ++|++.|+|.++++                ++++++.|||..   +++||||..+|||+.....+||.|||+++......
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            99999999998876                789999999965   79999999999999999999999999999876554


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      .........-.+.|||-|.+....|+.++|||||||++||++| |..|+.+....+..++.                ...
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll----------------e~g  916 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL----------------EKG  916 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH----------------hcc
Confidence            4444443445678999999999999999999999999999999 99999887644332222                111


Q ss_pred             CCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          242 LDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       242 l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      .+-..++.+... ..++..||..|++.||++.+..+...+++..
T Consensus       917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            122255555556 7999999999999999999888888887764

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-36  Score=296.26  Aligned_cols=269  Identities=19%  Similarity=0.191  Sum_probs=197.1

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ..||++++.||+|+||.|...+. .+++.+|+|++++.   ......-|..|-++|..-+.+=|++++-.|++..++|+|
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV  153 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV  153 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence            57899999999999999999865 57899999999763   445567799999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516           99 YEFMPNKSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus        99 ~e~~~~gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      |||++||+|-.++.            +++..+.+|+..|+.|+|||||||+|||+|..|++||+|||.+-.+..+. ...
T Consensus       154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-~V~  232 (1317)
T KOG0612|consen  154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-TVR  232 (1317)
T ss_pred             EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC-cEE
Confidence            99999999988775            67788888999999999999999999999999999999999987765332 233


Q ss_pred             ccceeecCCccccchhc----c-CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          167 TNRIVGTYGYMSLEYTM----S-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~----~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      .....|||.|++||++.    + +.|+..+|+||+||++|||+.|..||....      +++--.....-.....+.+..
T Consensus       233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~hk~~l~FP~~~  306 (1317)
T KOG0612|consen  233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMNHKESLSFPDET  306 (1317)
T ss_pred             eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhchhhhcCCCccc
Confidence            45578999999999887    3 678999999999999999999999997533      221111111111111111110


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceeeEEecCCCCCCCCCCCCC
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLLMLPPKNQKLPKTSQK  309 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~~~~l~~~~~~~p~~~~p  309 (345)
                      .   .+ ++.  .+++.. +-.+|..|-.    ..-+.++..+.++.+.+|...-...|+.+|.-+.|
T Consensus       307 ~---VS-eea--kdLI~~-ll~~~e~RLg----rngiedik~HpFF~g~~W~~iR~~~pP~vPevssd  363 (1317)
T KOG0612|consen  307 D---VS-EEA--KDLIEA-LLCDREVRLG----RNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSD  363 (1317)
T ss_pred             c---cC-HHH--HHHHHH-HhcChhhhcc----cccHHHHHhCccccCCChhhhhhcCCCCCCcCCCC
Confidence            0   11 222  233333 2346777776    22345666677777777644334444455544443

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2e-33  Score=255.07  Aligned_cols=219  Identities=21%  Similarity=0.215  Sum_probs=161.1

Q ss_pred             eeccCCeEEEEEEc-CCCcEEEEEEeccCCc---cCHHHHHHHHH---HHHhcCCCCeeeEEEEEEECCeeEEEEecCCC
Q 039516           32 QEQTRDRVILVGKF-PNEQEVAIKRLAWTSG---QGRVEFQNEAK---LIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN  104 (345)
Q Consensus        32 lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~---~~~~~~~~E~~---~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  104 (345)
                      ||+|+||.||++.. .+++.||+|.+.....   .....+..|..   .++...||||+++++++...+..++||||+++
T Consensus         2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g   81 (278)
T cd05606           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG   81 (278)
T ss_pred             cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence            89999999999965 4689999999865421   11223444544   34445799999999999999999999999999


Q ss_pred             CChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccc
Q 039516          105 KSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNR  169 (345)
Q Consensus       105 gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  169 (345)
                      ++|.+++.               +++.++.|||..   +++||||||+||+++.++.+||+|||++.......    ...
T Consensus        82 ~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~  154 (278)
T cd05606          82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHA  154 (278)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcC
Confidence            99987653               456667777764   89999999999999999999999999987653221    223


Q ss_pred             eeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          170 IVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       170 ~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      ..|+..|+|||++.++ .++.++||||+|+++|+|++|+.||...........    ......      .++.+....+.
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~------~~~~~~~~~s~  224 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT------MAVELPDSFSP  224 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhc------cCCCCCCcCCH
Confidence            4689999999998754 689999999999999999999999976532221110    111100      11112111222


Q ss_pred             hHHHHHHHHhhccCCCCCcCCC
Q 039516          249 NEDAFLLVSCVCKSKQQIDVQC  270 (345)
Q Consensus       249 ~~~~~~~l~~~Cl~~~P~~RPs  270 (345)
                      +.   .+++..|++.+|.+||.
T Consensus       225 ~~---~~li~~~l~~~p~~R~~  243 (278)
T cd05606         225 EL---RSLLEGLLQRDVNRRLG  243 (278)
T ss_pred             HH---HHHHHHHhhcCHHhccC
Confidence            21   58999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3e-34  Score=266.59  Aligned_cols=181  Identities=18%  Similarity=0.233  Sum_probs=143.3

Q ss_pred             Eeecc--CCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           31 QQEQT--RDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        31 ~lG~G--~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .||+|  +||+||++.. .+|+.||+|.+....  ....+.+.+|+.+++.++||||++++++|..++..++||||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            36666  8999999975 579999999986542  233567889999999999999999999999999999999999999


Q ss_pred             ChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC---
Q 039516          106 SLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA---  165 (345)
Q Consensus       106 sL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~---  165 (345)
                      +|.+++.                 +++.+|.|||..   +++||||||+||+++.++.++++||+.+..........   
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            9887654                 456677777754   89999999999999999999999997653321111100   


Q ss_pred             --cccceeecCCccccchhccC--CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          166 --NTNRIVGTYGYMSLEYTMSG--TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       166 --~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                        ......++..|+|||++.+.  .++.++|||||||++|+|++|+.||....
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  214 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML  214 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence              01112345679999998763  47899999999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7e-34  Score=257.14  Aligned_cols=228  Identities=23%  Similarity=0.268  Sum_probs=178.1

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC---CccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv   98 (345)
                      ++|.+.+.||+|+||.||++... +|+.||+|.+...   .......+.+|++++++++ |+||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36899999999999999999764 7899999998653   2233457889999999998 99999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |||+++++|.+++.               +++.++.+||..   |++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            99999999987764               566677777755   899999999999999999999999999886543221


Q ss_pred             C------------------CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 039516          164 G------------------ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIA  225 (345)
Q Consensus       164 ~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~  225 (345)
                      .                  .......++..|+|||......++.++|+||||++++++++|+.||.......   .   .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~---~  231 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---T---F  231 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---H---H
Confidence            1                  12233467889999999888889999999999999999999999998653110   0   0


Q ss_pred             HHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCC
Q 039516          226 WQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       226 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~  271 (345)
                      .... ..      ...    .+...... ..++..||+.+|.+|||+
T Consensus       232 ~~~~-~~------~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~  267 (280)
T cd05581         232 QKIL-KL------EYS----FPPNFPPDAKDLIEKLLVLDPQDRLGV  267 (280)
T ss_pred             HHHH-hc------CCC----CCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence            1111 00      000    11111223 599999999999999996

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-36  Score=256.64  Aligned_cols=231  Identities=21%  Similarity=0.262  Sum_probs=172.2

Q ss_pred             eeeEEEeeccCCeEEEEE-EcCCCcEEEEEEeccCCc-cCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEEecC
Q 039516           26 WHMYIQQEQTRDRVILVG-KFPNEQEVAIKRLAWTSG-QGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~-~~~~~~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      .+-+.+||.|+||+|++. +.+.|+..|||++..... ...++++.|.+...+- +.||||++||.+...+..|+.||.|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            344566999999999998 456899999999976643 4567888898866554 7899999999999999999999999


Q ss_pred             CCCChHHHHH--------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516          103 PNKSLDSSFS--------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus       103 ~~gsL~~~l~--------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      + .||+.+.+                    .+..+|.||...+  .|||||+||+|||++..|.+||||||.+..+..+ 
T Consensus       146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-  221 (361)
T KOG1006|consen  146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-  221 (361)
T ss_pred             h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence            5 47766544                    3456888998876  7999999999999999999999999998765322 


Q ss_pred             CCCcccceeecCCccccchhcc--CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          163 SGANTNRIVGTYGYMSLEYTMS--GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                        ...+.-.|...|||||.+..  ..|+.+|||||||++|||+.||+.|+..-.     +..++......+....-..+.
T Consensus       222 --iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gdpp~l~~~~  294 (361)
T KOG1006|consen  222 --IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGDPPILLFDK  294 (361)
T ss_pred             --HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCCCCeecCcc
Confidence              12233478889999998863  358999999999999999999999997532     233333333322211111111


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCC
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                      .    +-......+.++-.|+-+|-++||+.
T Consensus       295 ~----~~~~s~~~~~fintCl~Kd~~~Rpky  321 (361)
T KOG1006|consen  295 E----CVHYSFSMVRFINTCLIKDRSDRPKY  321 (361)
T ss_pred             c----ccccCHHHHHHHHHHhhcccccCcch
Confidence            0    01111222688999999999999994

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.6e-34  Score=263.21  Aligned_cols=187  Identities=21%  Similarity=0.322  Sum_probs=147.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-------
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE-------   93 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-------   93 (345)
                      .+|.+.++||+|+||.||++.. .+++.||+|.+....  ......+.+|++++++++||||+++++++....       
T Consensus         8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   87 (311)
T cd07866           8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR   87 (311)
T ss_pred             ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence            5699999999999999999975 468999999986442  222346789999999999999999999875433       


Q ss_pred             -eeEEEEecCCCCChHHH----------------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516           94 -ERLLVYEFMPNKSLDSS----------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus        94 -~~~lv~e~~~~gsL~~~----------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                       ..++||||+.+ +|...                +.+++++|.+||..   |++|+||||+||+++.++.++|+|||++.
T Consensus        88 ~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          88 GSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             ceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccch
Confidence             46999999875 34332                22667777788765   89999999999999999999999999997


Q ss_pred             eecCCCCC---------CcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          157 IFGVNESG---------ANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       157 ~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ........         .......+++.|+|||++.+. .++.++||||||+++|+|++|+.||....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~  231 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS  231 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence            65322111         111234678889999987654 57899999999999999999999997644

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.4e-33  Score=262.23  Aligned_cols=184  Identities=24%  Similarity=0.299  Sum_probs=149.7

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCeeEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH-GEERLL   97 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~l   97 (345)
                      +...|.+.+.||.|+||.||++.. .+++.||+|++...  .......+..|++++++++||||+++++++.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            345699999999999999999964 57999999988543  23345678899999999999999999999875 567899


Q ss_pred             EEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           98 VYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        98 v~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      +|||+ +++|.+++.              +++.+|.+||..   +++||||+|+||+++.++.++|+|||++.....   
T Consensus        88 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---  160 (328)
T cd07856          88 VTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP---  160 (328)
T ss_pred             Eeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCC---
Confidence            99998 457766543              455666666654   899999999999999999999999999875421   


Q ss_pred             CCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                        ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus       161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~  210 (328)
T cd07856         161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD  210 (328)
T ss_pred             --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence              1122457888999998765 568999999999999999999999997543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=257.23  Aligned_cols=226  Identities=20%  Similarity=0.235  Sum_probs=177.8

Q ss_pred             CCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|+.++.||+|.||.|..++ ..+|+.+|+|++++..   ......-+.|-++|...+||.+..+.-.|+..+.+|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            568888999999999999885 4579999999998763   333445678999999999999999998999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||+.||.|.-++.               .+..+|.|||+   .+||.||||.+|.|+|.+|++||+|||+++.--  ...
T Consensus       248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~g  322 (516)
T KOG0690|consen  248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KYG  322 (516)
T ss_pred             EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc--ccc
Confidence            9999999965554               44555556655   589999999999999999999999999998532  234


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ...++++|||.|.|||++....|+..+|+|.+||++|||++|+.||...+......++--       +      |-....
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~-------e------d~kFPr  389 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM-------E------DLKFPR  389 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-------h------hccCCc
Confidence            456779999999999999999999999999999999999999999987654332222210       0      111111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCC
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQC  270 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs  270 (345)
                      ..+++..   .+....|..||.+|-.
T Consensus       390 ~ls~eAk---tLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  390 TLSPEAK---TLLSGLLKKDPKKRLG  412 (516)
T ss_pred             cCCHHHH---HHHHHHhhcChHhhcC
Confidence            2233322   5666667899999965

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.6e-33  Score=260.13  Aligned_cols=222  Identities=21%  Similarity=0.306  Sum_probs=167.4

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc---cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG---QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      |....+||+|+||.||+|+. .+|+.|++|.+.....   .....+.+|+++++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            55567799999999999975 4689999999865422   2335688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      +.+ ++.+.+.                +++.++.+||..   |++|+||+|+||+++.++.+||+|||++....      
T Consensus       103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------  172 (313)
T cd06633         103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS------  172 (313)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC------
Confidence            964 5544332                566677777765   89999999999999999999999999886432      


Q ss_pred             cccceeecCCccccchhc---cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          166 NTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                      ......|+..|+|||++.   .+.++.++||||||+++|+|++|..||.......      ......... ....    .
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~-~~~~----~  241 (313)
T cd06633         173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQND-SPTL----Q  241 (313)
T ss_pred             CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcC-CCCC----C
Confidence            122356888999999874   4568889999999999999999999987543211      111111111 1000    0


Q ss_pred             CCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          243 DGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       243 ~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ...++    .. .+++.+||+.+|.+|||+.
T Consensus       242 ~~~~~----~~l~~li~~~l~~~P~~Rp~~~  268 (313)
T cd06633         242 SNEWT----DSFRGFVDYCLQKIPQERPASA  268 (313)
T ss_pred             ccccC----HHHHHHHHHHccCChhhCcCHH
Confidence            11111    22 5899999999999999964

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-34  Score=258.33  Aligned_cols=182  Identities=23%  Similarity=0.273  Sum_probs=148.2

Q ss_pred             eeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCc-cCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEEEecC
Q 039516           26 WHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      |.+.+.||+|++|.||+|... +++.|+||++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567788999999999999875 578999999865422 22334567999999999 999999999999999999999999


Q ss_pred             CCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          103 PNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       103 ~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                       +++|.+.+.                 +++.++.+||..   +++|+||+|+||+++.++.++|+|||++.......   
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---  153 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---  153 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence             778866543                 455666677654   89999999999999999999999999998653221   


Q ss_pred             cccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ......++..|+|||++.+ ..++.++|+||||+++++|++|+.||....
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~  203 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS  203 (283)
T ss_pred             CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence            1223467889999998754 457899999999999999999999986543

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6.2e-34  Score=265.16  Aligned_cols=188  Identities=22%  Similarity=0.287  Sum_probs=148.4

Q ss_pred             CCCeee-EEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccC--------------HHHHHHHHHHHHhcCCCCeeeEE
Q 039516           23 SLDWHM-YIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQG--------------RVEFQNEAKLIAKLQYTNLVKLL   86 (345)
Q Consensus        23 ~~~~~~-~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~~~   86 (345)
                      +..|.. .+.||+|+||+||++.. .+++.||||.+.......              ...+.+|++++++++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            445654 45699999999999975 468999999986542111              12477899999999999999999


Q ss_pred             EEEEECCeeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEc
Q 039516           87 GCSIHGEERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISD  151 (345)
Q Consensus        87 ~~~~~~~~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~D  151 (345)
                      +++...+..++||||+. ++|.+++.               +++.+|.+||..   |++|+||+|+||+++.++.++|+|
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECC
Confidence            99999999999999997 57766553               556666677654   899999999999999999999999


Q ss_pred             cccceeecCCC------------CCCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          152 FGMARIFGVNE------------SGANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       152 fgl~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ||++.......            .........++..|+|||++.+. .++.++|+||||+++|+|++|..||....
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99998764111            01111223567889999988764 46899999999999999999999997654

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=263.91  Aligned_cols=241  Identities=20%  Similarity=0.186  Sum_probs=180.3

Q ss_pred             ccccccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 039516           14 EGAKFVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCS   89 (345)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~   89 (345)
                      |.+..|.+.   |.....||+||||.||.+.. .+|+.+|.|++.+.   ...+..-.++|-.+|.+++.+.||.+--.|
T Consensus       178 E~qpvt~n~---F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf  254 (591)
T KOG0986|consen  178 ELQPVTKNT---FRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF  254 (591)
T ss_pred             Hhhhccccc---eeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence            344555554   66677799999999999854 57999999998544   233444578999999999999999998889


Q ss_pred             EECCeeEEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccc
Q 039516           90 IHGEERLLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMA  155 (345)
Q Consensus        90 ~~~~~~~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~  155 (345)
                      ...+.+++||..|.||+|.-++.              ..++.+..|.++|+.+||.|||||+|||+|+.|+++|+|+|+|
T Consensus       255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLA  334 (591)
T KOG0986|consen  255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLA  334 (591)
T ss_pred             cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceE
Confidence            99999999999999999965443              4455555555556668999999999999999999999999999


Q ss_pred             eeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 039516          156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDL  235 (345)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (345)
                      ..++.....   ....||.+|||||++.++.|+...|+||+||++|||+.|+.||....+.....-+   .......   
T Consensus       335 vei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv---drr~~~~---  405 (591)
T KOG0986|consen  335 VEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV---DRRTLED---  405 (591)
T ss_pred             EecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH---HHHHhcc---
Confidence            988654332   3348999999999999999999999999999999999999999764322110000   0000000   


Q ss_pred             ccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          236 ELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       236 ~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                         .....+.++++.   ..+...-|+.||.+|-.-.
T Consensus       406 ---~~ey~~kFS~ea---kslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  406 ---PEEYSDKFSEEA---KSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             ---hhhcccccCHHH---HHHHHHHHccCHHHhccCC
Confidence               011112233222   3666677899999998754

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-33  Score=263.06  Aligned_cols=190  Identities=23%  Similarity=0.247  Sum_probs=153.0

Q ss_pred             cccccccCCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE
Q 039516           15 GAKFVENSSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH   91 (345)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~   91 (345)
                      +......+...|.+.+.||+|+||.||++. ..+|..||||.+....  ......+.+|+.++++++||||+++++++..
T Consensus         6 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07880           6 VNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTP   85 (343)
T ss_pred             hhhhhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence            333444456679999999999999999996 4579999999986432  2234568899999999999999999999875


Q ss_pred             CC------eeEEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEc
Q 039516           92 GE------ERLLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISD  151 (345)
Q Consensus        92 ~~------~~~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~D  151 (345)
                      ..      ..++||||+ +++|.+++.              +++.++.+||..   ||+||||||+||+++.++.++|+|
T Consensus        86 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          86 DLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             CccccccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence            43      458999999 667766543              556667777764   899999999999999999999999


Q ss_pred             cccceeecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          152 FGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       152 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      ||++......     .....+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||...
T Consensus       162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  219 (343)
T cd07880         162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH  219 (343)
T ss_pred             cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9998765321     123467889999998875 45789999999999999999999999754

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.6e-35  Score=291.37  Aligned_cols=235  Identities=19%  Similarity=0.210  Sum_probs=171.2

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG-----   92 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----   92 (345)
                      .....+|+.+..||+||||.||+++.. ||+.+|||++... +........+|+.+|++|+|||||++|..|.+.     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            456788999999999999999999654 8999999999765 333455688999999999999999999443210     


Q ss_pred             --------------------------------------------------------------------------------
Q 039516           93 --------------------------------------------------------------------------------   92 (345)
Q Consensus        93 --------------------------------------------------------------------------------   92 (345)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CeeEEEEecCCCCChHHHHH----------------hHHHHHHHHH
Q 039516           93 ----------------------------------EERLLVYEFMPNKSLDSSFS----------------GTFKDLLCLH  122 (345)
Q Consensus        93 ----------------------------------~~~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh  122 (345)
                                                        ..+||-||||+..+|.++++                +++.||.|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                              12467788887776655443                5667777777


Q ss_pred             hcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec------C----------CCCCCcccceeecCCccccchhccC-
Q 039516          123 KYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG------V----------NESGANTNRIVGTYGYMSLEYTMSG-  185 (345)
Q Consensus       123 ~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~------~----------~~~~~~~~~~~gt~~y~aPE~~~~~-  185 (345)
                      ..   |||||||||.||+++.++.|||+|||+++...      .          .......+...||.-|+|||++.+. 
T Consensus       715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            76   89999999999999999999999999998721      0          0111134557899999999998864 


Q ss_pred             --CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccC
Q 039516          186 --TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKS  262 (345)
Q Consensus       186 --~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~  262 (345)
                        .|+.|+|+||+||+++||+.   ||...  .+.   +. +..-++.+.+..-  +    ++....... ..++.+.++
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MER---a~-iL~~LR~g~iP~~--~----~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTS--MER---AS-ILTNLRKGSIPEP--A----DFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCch--HHH---HH-HHHhcccCCCCCC--c----ccccccchHHHHHHHHHhc
Confidence              49999999999999999985   44421  111   11 1122223333222  1    122233333 699999999


Q ss_pred             CCCCcCCCCC
Q 039516          263 KQQIDVQCPM  272 (345)
Q Consensus       263 ~~P~~RPs~~  272 (345)
                      .||++|||+.
T Consensus       857 hdP~kRPtA~  866 (1351)
T KOG1035|consen  857 HDPSKRPTAT  866 (1351)
T ss_pred             CCCccCCCHH
Confidence            9999999953

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-34  Score=266.18  Aligned_cols=186  Identities=25%  Similarity=0.297  Sum_probs=153.6

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-----eeE
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE-----ERL   96 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----~~~   96 (345)
                      .|.+...||+|++|.||++... +++.||||.+....  ....+.+.+|+.+++.++|+||+++++++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            3788899999999999999764 58999999987543  344567999999999999999999999988765     789


Q ss_pred             EEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           97 LVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      ++|||+++ +|.+++.               +++.++.+||..   ||+|+||||.||+++.++.++|+|||++......
T Consensus        81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            99999984 6665443               556666777665   8999999999999999999999999999876443


Q ss_pred             CCC-CcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          162 ESG-ANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       162 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ... .......++..|+|||++.+. .++.++|+||||+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~  211 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD  211 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence            210 112334678899999999877 78999999999999999999999997654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.1e-33  Score=260.67  Aligned_cols=225  Identities=23%  Similarity=0.328  Sum_probs=168.5

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ...|.....||+|+||.||+|.. .+++.||+|.+...   .......+.+|+++++.++|+|++++++++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            34477778899999999999975 46889999998643   222345688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           99 YEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        99 ~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      |||+. |++.+.+.                +++.++.+||..   +++||||+|+||+++.++.++|+|||++.....  
T Consensus        94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--  167 (308)
T cd06634          94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (308)
T ss_pred             EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence            99997 46655432                455666677654   899999999999999999999999999876532  


Q ss_pred             CCCcccceeecCCccccchhc---cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          163 SGANTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                          .....++..|+|||++.   .+.++.++|||||||++|+|++|..||.......      .... +..+..     
T Consensus       168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~-~~~~~~-----  231 (308)
T cd06634         168 ----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH-IAQNES-----  231 (308)
T ss_pred             ----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHH-HhhcCC-----
Confidence                12346788999999874   3567889999999999999999999986532111      1111 111111     


Q ss_pred             ccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          240 LTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       240 ~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +...   ....... ..++.+||+.+|.+|||+.
T Consensus       232 ~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~  262 (308)
T cd06634         232 PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSE  262 (308)
T ss_pred             CCcC---cccccHHHHHHHHHHhhCCcccCCCHH
Confidence            1110   0111122 5899999999999999954

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=261.40  Aligned_cols=228  Identities=19%  Similarity=0.218  Sum_probs=176.8

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv   98 (345)
                      .||..+..||+|+||.|.++.. .+.+.+|||++++.   ...+.+--..|-++|... +-|.+++++.+|+..+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            5688889999999999999965 45789999999876   233445556788887666 578999999999999999999


Q ss_pred             EecCCCCChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516           99 YEFMPNKSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus        99 ~e~~~~gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      |||+.||+|--.+.            ..++....|-.+|++|||.||||.+|||++.+|.+||+|||+++.--  .....
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--~~~~T  506 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--FDGVT  506 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc--cCCcc
Confidence            99999999977666            23344444555566699999999999999999999999999998532  23445


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      +.+++||+.|+|||++...+|+..+|+|||||+||||+.|++||++.++.+...               .+.+....  +
T Consensus       507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~---------------aI~ehnvs--y  569 (683)
T KOG0696|consen  507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ---------------AIMEHNVS--Y  569 (683)
T ss_pred             eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------HHHHccCc--C
Confidence            667999999999999999999999999999999999999999999866433211               11111111  2


Q ss_pred             ChhHHHH-HHHHhhccCCCCCcCCC
Q 039516          247 PPNEDAF-LLVSCVCKSKQQIDVQC  270 (345)
Q Consensus       247 ~~~~~~~-~~l~~~Cl~~~P~~RPs  270 (345)
                      +..-... ..+...-+...|..|-.
T Consensus       570 PKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  570 PKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             cccccHHHHHHHHHHhhcCCccccC
Confidence            2222222 56666677888998865

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=256.36  Aligned_cols=248  Identities=17%  Similarity=0.196  Sum_probs=181.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHh--cCCCCeeeEEEEEEECC----eeEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAK--LQYTNLVKLLGCSIHGE----ERLL   97 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~~~~~~~~~~----~~~l   97 (345)
                      ..-.+.+.||+|.||.||+|.+. |+.||||++....   ...+.+|.++...  |+|+||+.|++.-..++    ++||
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             heeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            45567788999999999999997 9999999996443   4567889888876  49999999998754432    6899


Q ss_pred             EEecCCCCChHHHHH--------------hHHHHHHHHHhc-----CCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           98 VYEFMPNKSLDSSFS--------------GTFKDLLCLHKY-----SRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        98 v~e~~~~gsL~~~l~--------------~~~~~l~~lh~~-----~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      |++|-+.|||.++|.              .++.+|.+||..     ..+.|.|||||+.|||+..++.+.|+|+|+|...
T Consensus       287 vTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h  366 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  366 (513)
T ss_pred             eeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence            999999999999987              567788899864     3457999999999999999999999999999887


Q ss_pred             cCCCC--CCcccceeecCCccccchhccCC----c-C-cccchhhHHHHHHHHHhC----------CCCCCCCCCCCccc
Q 039516          159 GVNES--GANTNRIVGTYGYMSLEYTMSGT----V-S-IKTDVFGFGVLVLKIVCG----------KKNNKSYHTERPLN  220 (345)
Q Consensus       159 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~-~-~~~Di~SlG~il~el~tg----------~~p~~~~~~~~~~~  220 (345)
                      .....  ....+...||.+|||||++....    + + ..+||||||.++||++.+          +.||.+.-+.++..
T Consensus       367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~  446 (513)
T KOG2052|consen  367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF  446 (513)
T ss_pred             cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH
Confidence            54322  22334568999999999987432    1 2 348999999999999853          35776554333211


Q ss_pred             HHHHHHHHHhcCCccccccccCCCCCChhH-HHH-HHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          221 LVGIAWQLWNEGKDLELIDLTLDGSCPPNE-DAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~-~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                        +......-..    -+.|.+.......+ +.. .+++.-||..+|+.|-|+--+-..+.++
T Consensus       447 --eeMrkVVCv~----~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  447 --EEMRKVVCVQ----KLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             --HHHhcceeec----ccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence              1111111111    12333333333333 444 8999999999999999965444444443

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-33  Score=263.68  Aligned_cols=184  Identities=20%  Similarity=0.261  Sum_probs=148.8

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG-----   92 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----   92 (345)
                      ....+|.+.+.||+|+||.||++.. .+|+.||+|++....  ....+.+.+|+.++++++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            3456699999999999999999964 578999999996532  22345688999999999999999999988643     


Q ss_pred             -CeeEEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516           93 -EERLLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus        93 -~~~~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                       ...+++++++ +++|.+++.              +++.++.|||..   |++||||||+||+++.++.+||+|||++..
T Consensus        94 ~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~  169 (345)
T cd07877          94 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH  169 (345)
T ss_pred             cccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccc
Confidence             3467888887 677765433              566777777765   899999999999999999999999999876


Q ss_pred             ecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          158 FGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      ...     ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus       170 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  221 (345)
T cd07877         170 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  221 (345)
T ss_pred             ccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            422     1223467889999998765 56789999999999999999999999654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.7e-34  Score=266.45  Aligned_cols=192  Identities=23%  Similarity=0.266  Sum_probs=155.8

Q ss_pred             cccccccccCCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 039516           13 SEGAKFVENSSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCS   89 (345)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~   89 (345)
                      ++..+.+..+..+|.+...||+|++|.||+|... +++.||+|.+...  .......+.+|+.++++++|+||+++++++
T Consensus         4 ~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07851           4 QELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF   83 (343)
T ss_pred             hhhccceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence            3455556667788999999999999999999764 6889999998643  223445678899999999999999999987


Q ss_pred             EECCe------eEEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEE
Q 039516           90 IHGEE------RLLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKI  149 (345)
Q Consensus        90 ~~~~~------~~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl  149 (345)
                      ...+.      .++|+||+ +++|.+++.              +++.++.+||..   ||+||||||+||+++.++.++|
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL  159 (343)
T cd07851          84 TPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKI  159 (343)
T ss_pred             hccccccccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEE
Confidence            66554      89999998 568876543              556666777764   8999999999999999999999


Q ss_pred             EccccceeecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       150 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      +|||++......     .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus       160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~  219 (343)
T cd07851         160 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS  219 (343)
T ss_pred             cccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            999998865322     223467888999998765 46789999999999999999999999754

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=254.84  Aligned_cols=183  Identities=24%  Similarity=0.338  Sum_probs=151.4

Q ss_pred             eeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           26 WHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      |...+.||+|++|.||+|... +++.||+|.+....  ......+..|+.++++++|+||+++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566778999999999999764 58999999997653  334567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          103 PNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       103 ~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      ++ +|.+++.                +++.++.+||..   |++|+||+|+||++++++.++|+|||++........  .
T Consensus        81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            84 7876653                455667777765   899999999999999999999999999887543221  1


Q ss_pred             ccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      .....++..|+|||.+.+. .++.++|+||||+++||+++|+.||....
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  203 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS  203 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence            2223557789999988766 78999999999999999999999997643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.8e-33  Score=259.62  Aligned_cols=186  Identities=25%  Similarity=0.296  Sum_probs=147.3

Q ss_pred             CeeeEEEeeccCCeEEEEEEcC-C--CcEEEEEEeccC--CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC----Ce
Q 039516           25 DWHMYIQQEQTRDRVILVGKFP-N--EQEVAIKRLAWT--SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHG----EE   94 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~-~--~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~----~~   94 (345)
                      .|.+.+.||+|+||.||++... +  +..||+|.+...  .......+.+|+.+++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            3788899999999999999764 4  789999998643  222355788999999999 599999999975432    35


Q ss_pred             eEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           95 RLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      .++++||+. ++|.+.+.               +++.+|.+||..   |++||||||+||+++.++.+||+|||++....
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            788999986 46766543               566777777765   89999999999999999999999999998654


Q ss_pred             CCCCC--CcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          160 VNESG--ANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       160 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      .....  .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~  214 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD  214 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence            32111  11233578999999998765 468899999999999999999999987543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.3e-32  Score=274.53  Aligned_cols=130  Identities=22%  Similarity=0.280  Sum_probs=113.1

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|.+.++||+|+||.||+|... +++.||||+++...   ......+..|+.++..++||||+++++++......|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            45899999999999999999764 68999999996542   223467889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                      ||+.+++|.+++.               +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999987764               456677777764   89999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=279.45  Aligned_cols=238  Identities=19%  Similarity=0.215  Sum_probs=184.9

Q ss_pred             eeEEEeeccCCeEEEEEEcC--------CCcEEEEEEeccC-CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeE
Q 039516           27 HMYIQQEQTRDRVILVGKFP--------NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        27 ~~~~~lG~G~~g~vy~~~~~--------~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~   96 (345)
                      .+.+.||+|.||.|++|...        ....||||.++.. .....+.+..|+++|+.+ +|+||+.++|+|..++..+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            44558999999999999642        1468999999765 334567899999999998 6999999999999999999


Q ss_pred             EEEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC
Q 039516           97 LVYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL  145 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~  145 (345)
                      +|+||+..|+|.++++                               +++.+++||+..   ++|||||.++|||+..+.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence            9999999998876543                               567788888877   699999999999999999


Q ss_pred             CEEEEccccceeecCCCCCCccccee--ecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHH
Q 039516          146 NTKISDFGMARIFGVNESGANTNRIV--GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLV  222 (345)
Q Consensus       146 ~~kl~Dfgl~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~  222 (345)
                      .+||+|||+++............ -.  -...|||||.+....|+.+||||||||++||++| |..||.+...     ..
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-----~~  529 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-----TE  529 (609)
T ss_pred             EEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-----HH
Confidence            99999999999654332222111 11  2345999999999999999999999999999999 8899876321     11


Q ss_pred             HHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          223 GIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       223 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      +. ...++.|.-.         ..|..+... ..++..||+.+|.+||++.+.+..+..++.
T Consensus       530 ~l-~~~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  530 EL-LEFLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             HH-HHHHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            11 2233333221         123333333 599999999999999999988888887665

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-32  Score=244.18  Aligned_cols=219  Identities=23%  Similarity=0.234  Sum_probs=171.0

Q ss_pred             eeccCCeEEEEEEcC-CCcEEEEEEeccCCc---cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCCh
Q 039516           32 QEQTRDRVILVGKFP-NEQEVAIKRLAWTSG---QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL  107 (345)
Q Consensus        32 lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL  107 (345)
                      ||+|+||.||++... +++.||+|.+.....   .....+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999764 589999999865432   2455789999999999999999999999999999999999999999


Q ss_pred             HHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceee
Q 039516          108 DSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG  172 (345)
Q Consensus       108 ~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g  172 (345)
                      .+++.               +++.++.+||.   .+++|+||+|+||+++.++.++|+|||++.......  .......+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~  155 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCG  155 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcC
Confidence            87764               45666777776   489999999999999999999999999998754321  12233567


Q ss_pred             cCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHH
Q 039516          173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDA  252 (345)
Q Consensus       173 t~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  252 (345)
                      +..|++||...+...+.++|+||||+++|++++|+.||.....      ........ .+.      ..+    +.....
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~-~~~------~~~----~~~~~~  218 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKIL-KDP------LRF----PEFLSP  218 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHh-cCC------CCC----CCCCCH
Confidence            8899999999888889999999999999999999999975432      11111111 110      011    111122


Q ss_pred             H-HHHHhhccCCCCCcCCCCC
Q 039516          253 F-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       253 ~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      . .+++..||..||++|||+.
T Consensus       219 ~l~~~i~~~l~~~p~~R~~~~  239 (250)
T cd05123         219 EARDLISGLLQKDPTKRLGSG  239 (250)
T ss_pred             HHHHHHHHHhcCCHhhCCCcc
Confidence            2 5999999999999999974

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-32  Score=265.88  Aligned_cols=233  Identities=21%  Similarity=0.260  Sum_probs=178.5

Q ss_pred             CCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEE-----CCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIH-----GEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~-----~~~~   95 (345)
                      ...|++.+.||.|.+|.||+++ ..+|+.+|+|+....... .++...|.++|+.+ .|||++.+||++..     ++++
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            4559999999999999999995 567999999999776433 45677889999888 69999999999864     5789


Q ss_pred             EEEEecCCCCChHHHHHh--------------HHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           96 LLVYEFMPNKSLDSSFSG--------------TFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~~--------------~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      |||||||.+||..++++.              +..++..|.++|...++|||||-.|||++.++.|||+|||++..+...
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT  176 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST  176 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence            999999999999887761              112233444444456999999999999999999999999999887543


Q ss_pred             CCCCcccceeecCCccccchhcc-----CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMS-----GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                      .  ....+..||+.|||||++.-     ..|+..+|+||||++..||.-|.+|+..+++...+..+            ..
T Consensus       177 ~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I------------pR  242 (953)
T KOG0587|consen  177 V--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------------PR  242 (953)
T ss_pred             c--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC------------CC
Confidence            2  33455799999999998863     34678899999999999999999999988754322111            11


Q ss_pred             cccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          237 LIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       237 ~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      -..|.|.  -+..=... .+++..||..|-.+||+++
T Consensus       243 NPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~  277 (953)
T KOG0587|consen  243 NPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTE  277 (953)
T ss_pred             CCCcccc--chhhHHHHHHHHHHHHHhhccccCcchh
Confidence            1112221  11122233 7999999999999999964

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.3e-33  Score=249.87  Aligned_cols=225  Identities=20%  Similarity=0.274  Sum_probs=167.7

Q ss_pred             eeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC-----CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           26 WHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT-----SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      |.+.+.||+|+||.||++... .+..+++|.++..     .......+..|+.++++++||||+++++++.+....++||
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            778889999999999999654 3455666665432     2223446778999999999999999999999889999999


Q ss_pred             ecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516          100 EFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus       100 e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      ||+++++|.+.+.                   +++.++.+||..   |++|+||+|+||+++. +.++|+|||++.....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence            9999999986543                   455666677654   8999999999999975 5699999999876533


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ...  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....      ......... .+.     .+
T Consensus       158 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~-~~~-----~~  223 (260)
T cd08222         158 SCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIV-EGP-----TP  223 (260)
T ss_pred             Ccc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHH-cCC-----CC
Confidence            221  1223467889999999888888999999999999999999999986432      111111111 111     11


Q ss_pred             cCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          241 TLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       241 ~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .+...++    .. .+++.+||+.+|++||++.
T Consensus       224 ~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~  252 (260)
T cd08222         224 SLPETYS----RQLNSIMQSMLNKDPSLRPSAA  252 (260)
T ss_pred             CCcchhc----HHHHHHHHHHhcCChhhCcCHH
Confidence            1111122    23 6899999999999999954

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-32  Score=257.86  Aligned_cols=283  Identities=14%  Similarity=0.175  Sum_probs=205.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .-|-.++.||-|+||.|-++. ..+...+|.|.+.+.+   .........|-+||....++=||++|-.|++++.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            347888999999999998885 4557789999997653   334556788999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC-----
Q 039516          100 EFMPNKSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE-----  162 (345)
Q Consensus       100 e~~~~gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-----  162 (345)
                      +|++||++-.+|.            .|++.-.++.+.|.+|+|||||||+|||||.+|.+||.||||++-+.-..     
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence            9999999877643            34444444444455599999999999999999999999999997642100     


Q ss_pred             ---C--------------------------------CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCC
Q 039516          163 ---S--------------------------------GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK  207 (345)
Q Consensus       163 ---~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~  207 (345)
                         .                                ........||+.|+|||++....|+..+|+||.|||||||+.|+
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~  868 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ  868 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence               0                                00112357999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCc-ccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccccc
Q 039516          208 KNNKSYHTERP-LNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLY  286 (345)
Q Consensus       208 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~  286 (345)
                      .||-...+.+. ...+.|.          ..++-...+..+.++..  -|...|..  ++.|-. .....   .+..+..
T Consensus       869 ~pf~~~tp~~tq~kv~nw~----------~~l~~~~~~~ls~e~~~--li~kLc~s--ad~RLG-kng~d---~vKaHpf  930 (1034)
T KOG0608|consen  869 PPFLADTPGETQYKVINWR----------NFLHIPYQGNLSKEALD--LIQKLCCS--ADSRLG-KNGAD---QVKAHPF  930 (1034)
T ss_pred             CCccCCCCCcceeeeeehh----------hccccccccccCHHHHH--HHHHHhcC--hhhhhc-ccchh---hhhcCcc
Confidence            99987655432 2333332          22232333334455443  33444654  557776 32222   3445677


Q ss_pred             ccceeeEEecCCCCCCCCCCCCCCccceeccccccccC
Q 039516          287 LKNLHFLLMLPPKNQKLPKTSQKFVPYIKNRLQRLKQD  324 (345)
Q Consensus       287 ~~~~~~~~~l~~~~~~~p~~~~p~~~~~~~~~~~~~~~  324 (345)
                      +...+|..|-..++.-+|.-++|.++--++-+...+-|
T Consensus       931 FkgIDfsslRkq~ApYIP~ItHptDTSNFdpvdpeklw  968 (1034)
T KOG0608|consen  931 FKGIDFSSLRKQRAPYIPRITHPTDTSNFDPVDPEKLW  968 (1034)
T ss_pred             ccccchHhhhhccCCcCccccCCCccccCCcCCccccc
Confidence            77788888777777788888887666666555543333

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-33  Score=242.97  Aligned_cols=181  Identities=22%  Similarity=0.255  Sum_probs=151.7

Q ss_pred             EeeccCCeEEEEE-EcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEEEecCCCCChH
Q 039516           31 QQEQTRDRVILVG-KFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLVYEFMPNKSLD  108 (345)
Q Consensus        31 ~lG~G~~g~vy~~-~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~gsL~  108 (345)
                      .||+|+|+.|--+ .+.+|..+|||++.+.....+.+..+|++++.+.+ |+||++++.+|+++..+|||||-|.||+|.
T Consensus        85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplL  164 (463)
T KOG0607|consen   85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLL  164 (463)
T ss_pred             HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHH
Confidence            3899999999887 46789999999998887777889999999999995 999999999999999999999999999997


Q ss_pred             HHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC---EEEEccccceeecCCC-----CCC
Q 039516          109 SSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN---TKISDFGMARIFGVNE-----SGA  165 (345)
Q Consensus       109 ~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfgl~~~~~~~~-----~~~  165 (345)
                      .++.               +++.+|.+||..   ||.||||||+|||-.....   +|||||.+...+....     ...
T Consensus       165 shI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP  241 (463)
T KOG0607|consen  165 SHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP  241 (463)
T ss_pred             HHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence            7654               567777777776   8999999999999976554   7999998876543221     112


Q ss_pred             cccceeecCCccccchhc-----cCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTM-----SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ...+.+|+..|||||++.     ...|+.+.|.||||+++|-|++|.+||.+.-
T Consensus       242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C  295 (463)
T KOG0607|consen  242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC  295 (463)
T ss_pred             cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence            233467888999999764     2357889999999999999999999998754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=264.31  Aligned_cols=228  Identities=16%  Similarity=0.097  Sum_probs=173.7

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEE
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~l   97 (345)
                      ..|..+|+....+|.|+|++|-.+. ..+++..++|++....    .+-.+|+.++... +||||+++++.+.++.+.|+
T Consensus       318 ~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  318 APFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             CCcchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeee
Confidence            3567789988899999999998884 5678999999997552    2234677666555 79999999999999999999


Q ss_pred             EEecCCCCChHHHHH-----------hHHHHHHHHHhcCCCceEEeccCCCCeee-CCCCCEEEEccccceeecCCCCCC
Q 039516           98 VYEFMPNKSLDSSFS-----------GTFKDLLCLHKYSRLRVIHRDLKASNILL-DDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus        98 v~e~~~~gsL~~~l~-----------~~~~~l~~lh~~~~~~ivHrdlk~~Nill-~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |||.+.++-+.+.+.           ..++.+.+++++|..|+|||||||+|||+ +..++++|+|||.++.....    
T Consensus       394 v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----  469 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----  469 (612)
T ss_pred             eehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence            999999987755432           23344445555555699999999999999 68999999999999876432    


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                       ..+.+-|..|.|||++....|+.++||||||++||+|++|+.||......      .........++..        ..
T Consensus       470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s--------~~  534 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFS--------EC  534 (612)
T ss_pred             -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccc--------cc
Confidence             22235588899999999999999999999999999999999999865432      1122222222222        11


Q ss_pred             CChhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          246 CPPNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       246 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .+.+.   .+++.+||+.||.+||+|.+
T Consensus       535 vS~~A---KdLl~~LL~~dP~~Rl~~~~  559 (612)
T KOG0603|consen  535 VSDEA---KDLLQQLLQVDPALRLGADE  559 (612)
T ss_pred             cCHHH---HHHHHHhccCChhhCcChhh
Confidence            11111   59999999999999999763

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=9.1e-32  Score=238.50  Aligned_cols=204  Identities=18%  Similarity=0.112  Sum_probs=155.6

Q ss_pred             cCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCChHHHHH-
Q 039516           35 TRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS-  112 (345)
Q Consensus        35 G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~-  112 (345)
                      |.+|.||++.. .+++.||+|.+....     .+.+|...+....||||+++++++.+....++||||+++++|.+++. 
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999965 578999999996543     23455556666789999999999999999999999999999977653 


Q ss_pred             --------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccc
Q 039516          113 --------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMS  178 (345)
Q Consensus       113 --------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~a  178 (345)
                                    +++.++.+||.   .+++||||||+||+++.++.++++|||.+......     .....++..|+|
T Consensus        79 ~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~a  150 (237)
T cd05576          79 FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCA  150 (237)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccC
Confidence                          45566666665   48999999999999999999999999987655321     112345678999


Q ss_pred             cchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHH
Q 039516          179 LEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVS  257 (345)
Q Consensus       179 PE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~  257 (345)
                      ||...+..++.++|+||+|+++|||++|..|+.......                 .......+...++    .. ..++
T Consensus       151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~~~~~~~~~----~~~~~li  209 (237)
T cd05576         151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTTLNIPEWVS----EEARSLL  209 (237)
T ss_pred             CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccccccCCcccCC----HHHHHHH
Confidence            999888889999999999999999999998875321100                 0000001111122    22 5899


Q ss_pred             hhccCCCCCcCCCCC
Q 039516          258 CVCKSKQQIDVQCPM  272 (345)
Q Consensus       258 ~~Cl~~~P~~RPs~~  272 (345)
                      .+|++.||++|||+.
T Consensus       210 ~~~l~~dp~~R~~~~  224 (237)
T cd05576         210 QQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHccCCHHHhcCCC
Confidence            999999999999964

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.4e-32  Score=239.66  Aligned_cols=258  Identities=18%  Similarity=0.188  Sum_probs=196.1

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~l   97 (345)
                      -++|.++..||+|+|+.|..+.+ .+.+.+|+|+++++   ..++..-.+.|-.+..+. +||.+|.++.+|+....+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            47899999999999999998865 46789999999765   445566678888888776 79999999999999999999


Q ss_pred             EEecCCCCChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516           98 VYEFMPNKSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus        98 v~e~~~~gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |.||++||+|--++.            ..++...+||.+|+.|||.||||.+|+|++..|.+||.|+|.++.--  ....
T Consensus       329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l--~~gd  406 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--GPGD  406 (593)
T ss_pred             EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC--CCCc
Confidence            999999999954443            44566677888888899999999999999999999999999998632  2344


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCC-CcccHHHHHHHHHhcCCccccccccCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTE-RPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      .+.+++||+.|.|||++.+..|++.+|+|++|++++||+.|+.||+-.... ...+.-++..+..-+..+.         
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir---------  477 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR---------  477 (593)
T ss_pred             ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---------
Confidence            566799999999999999999999999999999999999999999754322 2223334444433232221         


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccccccccceeeE
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFL  293 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~~  293 (345)
                       .+..-..+ ..+...-|++||.+|-.- ....-+..+.++..+...+|.
T Consensus       478 -iprslsvkas~vlkgflnkdp~erlgc-~~~~g~~dik~h~ffr~idwd  525 (593)
T KOG0695|consen  478 -IPRSLSVKASHVLKGFLNKDPKERLGC-RPQTGFSDIKSHAFFRSIDWD  525 (593)
T ss_pred             -ccceeehhhHHHHHHhhcCCcHHhcCC-CcccchhhhhcchhhhhCCHH
Confidence             11111112 467777889999998652 122345566666666555443

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=8.5e-34  Score=261.10  Aligned_cols=226  Identities=19%  Similarity=0.195  Sum_probs=182.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCC-cEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNE-QEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~-~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+++++..||-||||.|-....+.. ..+|+|.+++.   .....+....|-.+|..++.|.||++|..|.+....|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            5678888899999999998876532 34899988765   3445667889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |-|-||.|-..++               .+.+++.|||..   |||.|||||+|++++.+|.+||.|||+++.+.   ..
T Consensus       500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---SG  573 (732)
T ss_pred             HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc---cC
Confidence            9999999877765               345566666665   79999999999999999999999999999885   34


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ..+.+++||+.|.|||++.....+.++|.||||+++|||++|.+||.+.++....+++--....+      +        
T Consensus       574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------~--------  639 (732)
T KOG0614|consen  574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------E--------  639 (732)
T ss_pred             CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh------h--------
Confidence            55677999999999999999999999999999999999999999999877655544442211111      0        


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCC
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQC  270 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs  270 (345)
                       +|...... ..++......+|.+|-.
T Consensus       640 -~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  640 -FPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -cccccchhHHHHHHHHHhcCcHhhhc
Confidence             12111222 57777777889999987

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-32  Score=253.37  Aligned_cols=178  Identities=24%  Similarity=0.308  Sum_probs=149.2

Q ss_pred             EEeeccCCeEEEEEE-cCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCC
Q 039516           30 IQQEQTRDRVILVGK-FPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS  106 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gs  106 (345)
                      +.||+|.||+||-|+ ..+|+.||||++.+.  ......++.+|+.+|.++.||.||.+--.|+..+..++|||-+.|.-
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            459999999999995 568999999999654  34455788999999999999999999999999999999999997755


Q ss_pred             hHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC---CCEEEEccccceeecCCCCCCcc
Q 039516          107 LDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ---LNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       107 L~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      |+-.+.                +++.+|.|||..   +|+|+||||+|||+...   -.+||||||+++.++....   -
T Consensus       650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---R  723 (888)
T KOG4236|consen  650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---R  723 (888)
T ss_pred             HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh---h
Confidence            443332                455555555554   89999999999999654   3589999999999864332   2


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      ....||+.|.|||+++...|...-|+||.|||+|.-++|..||...
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd  769 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED  769 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence            3478999999999999999999999999999999999999999753

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-32  Score=223.75  Aligned_cols=183  Identities=23%  Similarity=0.284  Sum_probs=148.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccC-CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEEe
Q 039516           24 LDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      .+...+..||+|++|+|-+.+ ..+|+..|+|.+... +.+..++.++|+++..+. ..|.+|.+||........|+.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            445666779999999998774 468999999999765 344566788899877655 78999999999888899999999


Q ss_pred             cCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516          101 FMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus       101 ~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      .|+ .||+.+.+                   .+..+|.+||..-  .+||||+||+|||++.+|.+|+||||.+..+.++
T Consensus       126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            995 36665544                   3456777787764  6999999999999999999999999999887432


Q ss_pred             CCCCcccceeecCCccccchhcc----CCcCcccchhhHHHHHHHHHhCCCCCCC
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMS----GTVSIKTDVFGFGVLVLKIVCGKKNNKS  212 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~SlG~il~el~tg~~p~~~  212 (345)
                      -   ..+.-.|...|||||.+..    ..|+.+|||||||+++.||.+++.||..
T Consensus       203 i---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  203 I---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             h---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            1   1122467888999998763    4789999999999999999999999975

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-32  Score=236.09  Aligned_cols=226  Identities=16%  Similarity=0.097  Sum_probs=168.5

Q ss_pred             eeeEE-EeeccCCeEEEEEE-cCCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEE----CCeeEEE
Q 039516           26 WHMYI-QQEQTRDRVILVGK-FPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIH----GEERLLV   98 (345)
Q Consensus        26 ~~~~~-~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~----~~~~~lv   98 (345)
                      |.+.. .||-|-.|.|..+. ..+|+.+|+|++..     .....+|+++--.. .|||||.++++|.+    ...+.+|
T Consensus        63 Y~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV  137 (400)
T KOG0604|consen   63 YSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV  137 (400)
T ss_pred             heehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence            44333 38999999999884 56899999999943     23456788765444 69999999998764    3457899


Q ss_pred             EecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC---CCCEEEEccccceee
Q 039516           99 YEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD---QLNTKISDFGMARIF  158 (345)
Q Consensus        99 ~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgl~~~~  158 (345)
                      ||.|+||.|...+.                 ++..++.|||.+   +|.||||||+|+|...   +..+||+|||+++..
T Consensus       138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccccccc
Confidence            99999999976654                 667788888887   6999999999999964   455899999999875


Q ss_pred             cCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                      ..   .....+.+-|++|.|||++....|+...|+||+||++|-|++|.+||.+.+..   .+.--....+..|... +.
T Consensus       215 ~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gqy~-FP  287 (400)
T KOG0604|consen  215 QE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQYE-FP  287 (400)
T ss_pred             CC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccCcc-CC
Confidence            32   23344567899999999999999999999999999999999999999876532   1222222222223221 00


Q ss_pred             cccCCCCCChhHHHH--HHHHhhccCCCCCcCCCCC
Q 039516          239 DLTLDGSCPPNEDAF--LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       239 d~~l~~~~~~~~~~~--~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +      ....+...  .+++...|..+|.+|-|+.
T Consensus       288 ~------pEWs~VSe~aKdlIR~LLkt~PteRlTI~  317 (400)
T KOG0604|consen  288 E------PEWSCVSEAAKDLIRKLLKTEPTERLTIE  317 (400)
T ss_pred             C------hhHhHHHHHHHHHHHHHhcCCchhheeHH
Confidence            1      11223333  6888888999999999954

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=6.1e-31  Score=231.74  Aligned_cols=219  Identities=22%  Similarity=0.209  Sum_probs=168.9

Q ss_pred             CCeEEEEEEcC-CCcEEEEEEeccCCccC-HHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCChHHHHH-
Q 039516           36 RDRVILVGKFP-NEQEVAIKRLAWTSGQG-RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS-  112 (345)
Q Consensus        36 ~~g~vy~~~~~-~~~~VaiK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~-  112 (345)
                      +||.||++... +|+.||+|.+....... ...+.+|++.+++++|+||+++++++......+++|||+++++|.+++. 
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999875 58999999997665444 6789999999999999999999999999999999999999999987653 


Q ss_pred             --------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccc
Q 039516          113 --------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMS  178 (345)
Q Consensus       113 --------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~a  178 (345)
                                    +++.++.+||..   +++|+||+|+||+++.++.++|+|||.+.......   ......++..|++
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~  154 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMA  154 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCC
Confidence                          455666677665   89999999999999999999999999998764332   2233467889999


Q ss_pred             cchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHH
Q 039516          179 LEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVS  257 (345)
Q Consensus       179 PE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~  257 (345)
                      ||...+..++.++||||||++++++++|..||......      .........+.....    .   ........ .+++
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~~~----~---~~~~~~~~~~~~i  221 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKPPFP----P---PEWKISPEAKDLI  221 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCCCc----c---ccccCCHHHHHHH
Confidence            99998888899999999999999999999998753211      111111111111100    0   00001123 6899


Q ss_pred             hhccCCCCCcCCCCCc
Q 039516          258 CVCKSKQQIDVQCPML  273 (345)
Q Consensus       258 ~~Cl~~~P~~RPs~~~  273 (345)
                      .+|+..+|++||++.+
T Consensus       222 ~~~l~~~p~~Rp~~~~  237 (244)
T smart00220      222 RKLLVKDPEKRLTAEE  237 (244)
T ss_pred             HHHccCCchhccCHHH
Confidence            9999999999999654

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=8.4e-32  Score=218.48  Aligned_cols=241  Identities=19%  Similarity=0.209  Sum_probs=171.6

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .|...++||+|.||+||+|+. .+++.||+|++...  .+......++|+-+|+.++|+|||+++++.-.+..+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            467778899999999999964 56899999998765  333456788999999999999999999999889999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |.. +|..++.                +..+++.+.|..   ++.|||+||.|.||+.+|..||+|||+++.++....  
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr--  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--  156 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE--
Confidence            964 3333332                455555555554   699999999999999999999999999998764321  


Q ss_pred             cccceeecCCccccchhccCC-cCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCC---ccccccc
Q 039516          166 NTNRIVGTYGYMSLEYTMSGT-VSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGK---DLELIDL  240 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d~  240 (345)
                      ......-|..|.+|.++-+.. |+...|+||.||++.|+.. |++-|.+.+-.++..-+-|......+..   +..+.|-
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            223346688999999988754 7899999999999999998 5655655443332222222221111221   1122222


Q ss_pred             cCCCCCCh---------hHHHH-HHHHhhccCCCCCcCCCC
Q 039516          241 TLDGSCPP---------NEDAF-LLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       241 ~l~~~~~~---------~~~~~-~~l~~~Cl~~~P~~RPs~  271 (345)
                      ..-..+++         .-... .++...-+..+|.+|-++
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisa  277 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISA  277 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCH
Confidence            22222221         11122 567777788899999994

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=5.8e-32  Score=236.01  Aligned_cols=186  Identities=20%  Similarity=0.265  Sum_probs=149.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC---C--CcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCee
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP---N--EQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH-GEER   95 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~---~--~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~   95 (345)
                      ..|+...+||+|.||.||++...   +  ...+|||+++.+.  ........+|+.+++.|+||||+.+..++.+ +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            45889999999999999999542   2  2378999997552  2334567899999999999999999999887 7889


Q ss_pred             EEEEecCCCCChHHHHH--------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC----CCEEEEc
Q 039516           96 LLVYEFMPNKSLDSSFS--------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ----LNTKISD  151 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~--------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~----~~~kl~D  151 (345)
                      |+++||.+. +|.+.++                    ++..++.|||..   =|+||||||.|||+..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            999999976 4444333                    555666666665   49999999999999877    8999999


Q ss_pred             cccceeecCCCCCC-cccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          152 FGMARIFGVNESGA-NTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       152 fgl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      ||+++.+...-... ......-|..|.|||++.+. .||.+.||||.|||+.||+|-++-|.+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            99999875432221 33446779999999999875 5899999999999999999999888654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.7e-30  Score=255.12  Aligned_cols=181  Identities=17%  Similarity=0.206  Sum_probs=125.9

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-C----CcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEE------EEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-N----EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGC------SIH   91 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~----~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~------~~~   91 (345)
                      ..+|.+.++||+|+||.||+|... +    +..||+|++.....  .+.+.+|  .+....+.++..++..      +..
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence            467999999999999999999764 4    68999999864321  1222222  1122222333222221      245


Q ss_pred             CCeeEEEEecCCCCChHHHHH-----------------------------------hHHHHHHHHHhcCCCceEEeccCC
Q 039516           92 GEERLLVYEFMPNKSLDSSFS-----------------------------------GTFKDLLCLHKYSRLRVIHRDLKA  136 (345)
Q Consensus        92 ~~~~~lv~e~~~~gsL~~~l~-----------------------------------~~~~~l~~lh~~~~~~ivHrdlk~  136 (345)
                      ....++||||+++++|.+++.                                   +++.+|.|||   +.+|+||||||
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP  283 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKP  283 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCH
Confidence            668899999999999876543                                   2344555555   45899999999


Q ss_pred             CCeeeCC-CCCEEEEccccceeecCCCCCCcccceeecCCccccchhccC----------------------CcCcccch
Q 039516          137 SNILLDD-QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG----------------------TVSIKTDV  193 (345)
Q Consensus       137 ~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Di  193 (345)
                      +|||++. ++.+||+|||+++....... .......+++.|+|||.+...                      .++.++||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            9999986 57899999999986533222 223446789999999965422                      23446699


Q ss_pred             hhHHHHHHHHHhCCCCCC
Q 039516          194 FGFGVLVLKIVCGKKNNK  211 (345)
Q Consensus       194 ~SlG~il~el~tg~~p~~  211 (345)
                      |||||++|||+++..++.
T Consensus       363 wSlGviL~el~~~~~~~~  380 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             HHHHHHHHHHHhCcCCCc
Confidence            999999999999776643

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=243.27  Aligned_cols=236  Identities=19%  Similarity=0.204  Sum_probs=172.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCC-------ccCHHHHHHHHHHHHhcCCCCeeeEEEEEE-ECCe
Q 039516           24 LDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTS-------GQGRVEFQNEAKLIAKLQYTNLVKLLGCSI-HGEE   94 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~-~~~~   94 (345)
                      ..|-++.+||+|||+.||++. +...+.||+|+-....       ....+...+|.++-+.|.||.||++|++|. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            347777889999999999994 5567899999864331       112335678999999999999999999986 5567


Q ss_pred             eEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC---CCCCEEEEccccce
Q 039516           95 RLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD---DQLNTKISDFGMAR  156 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfgl~~  156 (345)
                      +|-|+|||+|.+|+-+++               ++..+|.||.... .+|||.||||.|||+-   ..|.+||.|||+++
T Consensus       543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence            899999999999987776               5666777777663 5899999999999994   45789999999999


Q ss_pred             eecCCCCCC-----cccceeecCCccccchhccC----CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 039516          157 IFGVNESGA-----NTNRIVGTYGYMSLEYTMSG----TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQ  227 (345)
Q Consensus       157 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  227 (345)
                      .+.......     .+....||..|++||.+.-+    ..+.|+||||+|||+|..+.|+.||........  .... ..
T Consensus       622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--ILqe-NT  698 (775)
T KOG1151|consen  622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--ILQE-NT  698 (775)
T ss_pred             hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HHhh-hc
Confidence            876443321     23456899999999977643    468999999999999999999999986432211  1100 00


Q ss_pred             HHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCC
Q 039516          228 LWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQC  270 (345)
Q Consensus       228 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs  270 (345)
                      .++.........|.    .+++   ...++.+||+..-.+|-.
T Consensus       699 IlkAtEVqFP~KPv----Vsse---AkaFIRRCLaYRKeDR~D  734 (775)
T KOG1151|consen  699 ILKATEVQFPPKPV----VSSE---AKAFIRRCLAYRKEDRID  734 (775)
T ss_pred             hhcceeccCCCCCc----cCHH---HHHHHHHHHHhhhhhhhh
Confidence            11111111111111    1111   258999999999888887

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=7.4e-30  Score=246.74  Aligned_cols=186  Identities=22%  Similarity=0.257  Sum_probs=135.9

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-----------------CCCcEEEEEEeccCCccCHHHH--------------HHHH
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-----------------PNEQEVAIKRLAWTSGQGRVEF--------------QNEA   71 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-----------------~~~~~VaiK~~~~~~~~~~~~~--------------~~E~   71 (345)
                      ..+|.+.++||+|+||+||+|..                 ..++.||||+++.......+.|              ..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56799999999999999999953                 2357899999975543333333              3467


Q ss_pred             HHHHhcCCCCe-----eeEEEEEEE--------CCeeEEEEecCCCCChHHHHH--------------------------
Q 039516           72 KLIAKLQYTNL-----VKLLGCSIH--------GEERLLVYEFMPNKSLDSSFS--------------------------  112 (345)
Q Consensus        72 ~~l~~l~H~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~--------------------------  112 (345)
                      .++.+++|.++     ++++++|..        .+..|+||||+++++|.++++                          
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777876654     677777653        356899999999999977653                          


Q ss_pred             -------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCcccc
Q 039516          113 -------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSL  179 (345)
Q Consensus       113 -------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aP  179 (345)
                                   +++.++.|||.   .+|+||||||+||+++.++.+||+|||++......... ......+++.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence                         23345555554   48999999999999999999999999999754322111 11122347899999


Q ss_pred             chhccCC--------------------c--CcccchhhHHHHHHHHHhCCC-CCCC
Q 039516          180 EYTMSGT--------------------V--SIKTDVFGFGVLVLKIVCGKK-NNKS  212 (345)
Q Consensus       180 E~~~~~~--------------------~--~~~~Di~SlG~il~el~tg~~-p~~~  212 (345)
                      |.+....                    +  ..+.||||+||++++|++|.. |+..
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            9875432                    1  124799999999999999875 6653

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.2e-32  Score=234.17  Aligned_cols=246  Identities=19%  Similarity=0.252  Sum_probs=175.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE--------C
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH--------G   92 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--------~   92 (345)
                      ..|+...+||+|.||.||+++. ++|+.||+|++-.+  .......-++|+++|..|+|+|++.++..|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4578888999999999999964 56889999987443  33345567899999999999999999887753        2


Q ss_pred             CeeEEEEecCCCC------------Ch---HHHHHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516           93 EERLLVYEFMPNK------------SL---DSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus        93 ~~~~lv~e~~~~g------------sL---~~~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      ..+|+||.+|+..            +|   ...+++...+|.|+|..   .|+|||+|++|+||+.+|.+||+|||+++.
T Consensus        97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            3579999999752            12   22344566667777766   799999999999999999999999999987


Q ss_pred             ecCCCCC--CcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-----H
Q 039516          158 FGVNESG--ANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQL-----W  229 (345)
Q Consensus       158 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-----~  229 (345)
                      +......  ...+...-|..|.+||.+.+ ..|+.+.|||..||++.||+||.+-+.+..+..+..++......     |
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            7543222  22233456899999998876 56899999999999999999999999887776666666543221     1


Q ss_pred             hcCC---ccccc--cccCCCCC-------Ch-hHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          230 NEGK---DLELI--DLTLDGSC-------PP-NEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       230 ~~~~---~~~~~--d~~l~~~~-------~~-~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .+-.   +.+.+  .|...+.+       .+ ..... ++++...+..||.+|++..
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad  310 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDAD  310 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchH
Confidence            1111   11111  11111110       00 00112 5788888999999999954

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=7.1e-31  Score=234.93  Aligned_cols=246  Identities=15%  Similarity=0.111  Sum_probs=179.2

Q ss_pred             cccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-C-CC----eeeEEEEE
Q 039516           17 KFVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-Y-TN----LVKLLGCS   89 (345)
Q Consensus        17 ~~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H-~n----iv~~~~~~   89 (345)
                      +..+.+...|.+++++|+|.||.|-.... ..+..||||+++.-. ...+...-|+++|.+|. + |+    +|++.+||
T Consensus        82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            34455678899999999999999999854 357999999996432 33556678999999993 2 33    78888899


Q ss_pred             EECCeeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC---------
Q 039516           90 IHGEERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD---------  143 (345)
Q Consensus        90 ~~~~~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~---------  143 (345)
                      ...++.|||+|.+ |-|+.+++.                 ++++++.+||.+   +++|-||||+|||+.+         
T Consensus       161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEecc
Confidence            9999999999988 456666665                 556667777776   7999999999999931         


Q ss_pred             -----------CCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 039516          144 -----------QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKS  212 (345)
Q Consensus       144 -----------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~  212 (345)
                                 +..++|+|||.++....     .......|..|.|||++.+-.++.++||||+||||+|++||..-|..
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                       23489999999987432     22456789999999999999999999999999999999999999987


Q ss_pred             CCCCCcccHHHHHH--------------HHHhcCCc-----------cccccccCC----CCCChhHHHH-HHHHhhccC
Q 039516          213 YHTERPLNLVGIAW--------------QLWNEGKD-----------LELIDLTLD----GSCPPNEDAF-LLVSCVCKS  262 (345)
Q Consensus       213 ~~~~~~~~~~~~~~--------------~~~~~~~~-----------~~~~d~~l~----~~~~~~~~~~-~~l~~~Cl~  262 (345)
                      ..+.+.+.+.+-+.              ..+..+++           ..+.++...    ......+... .+++...|.
T Consensus       312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence            76555433332221              11111111           111111110    0112233444 899999999


Q ss_pred             CCCCcCCCCC
Q 039516          263 KQQIDVQCPM  272 (345)
Q Consensus       263 ~~P~~RPs~~  272 (345)
                      .||.+|+|..
T Consensus       392 fDP~~RiTl~  401 (415)
T KOG0671|consen  392 FDPARRITLR  401 (415)
T ss_pred             cCccccccHH
Confidence            9999999943

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-30  Score=250.09  Aligned_cols=230  Identities=20%  Similarity=0.234  Sum_probs=170.1

Q ss_pred             EeeccCCe-EEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEEecCCCCChH
Q 039516           31 QQEQTRDR-VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNKSLD  108 (345)
Q Consensus        31 ~lG~G~~g-~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~  108 (345)
                      .+|.|+.| .||+|.+. |+.||||++-.+   ...-.++|+..|..- +|||||++|+.-.++...||..|.|.. +|.
T Consensus       516 ilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~  590 (903)
T KOG1027|consen  516 ILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQ  590 (903)
T ss_pred             HcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHH
Confidence            37888887 58999994 899999998433   233457899999877 699999999998888899999999954 554


Q ss_pred             HHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC---C--CCEEEEccccceeecCCCCC
Q 039516          109 SSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD---Q--LNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       109 ~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~---~--~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      +++.                   +++.|++.||.+   +||||||||.||||+.   +  ..++|+|||+++....+...
T Consensus       591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS  667 (903)
T KOG1027|consen  591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS  667 (903)
T ss_pred             HHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence            4433                   677788888886   7999999999999975   3  45899999999987644322


Q ss_pred             -CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhC-CCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          165 -ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG-KKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       165 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                       .......||-+|+|||++....-+.++||||+||++|+.++| ..||......+ .+.       +.+.....-+.   
T Consensus       668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NI-------l~~~~~L~~L~---  736 (903)
T KOG1027|consen  668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANI-------LTGNYTLVHLE---  736 (903)
T ss_pred             hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhh-------hcCccceeeec---
Confidence             234556899999999999988888899999999999999996 89997643211 111       11111110010   


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccce
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNL  290 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~  290 (345)
                         ..+++ ...+++.++++.+|..|||+.       ++|.+..+|..
T Consensus       737 ---~~~d~-eA~dLI~~ml~~dP~~RPsa~-------~VL~HPlFW~~  773 (903)
T KOG1027|consen  737 ---PLPDC-EAKDLISRMLNPDPQLRPSAT-------DVLNHPLFWDS  773 (903)
T ss_pred             ---cCchH-HHHHHHHHhcCCCcccCCCHH-------HHhCCCccCCh
Confidence               11111 236999999999999999954       44555555553

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=247.48  Aligned_cols=235  Identities=20%  Similarity=0.246  Sum_probs=184.6

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      +...+|+.+..+|+|.||.||+++. .+++..|+|.++.....+..-.+.|+-+++..+|||||.++|.+.....+|+.|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            5677899999999999999999964 579999999999988788888899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||.+|+|.+..+               ...+++.||   |++|-+|||||-.||++++.|.+|++|||.+..++.  ..
T Consensus        92 EycgggslQdiy~~TgplselqiayvcRetl~gl~yl---hs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti  166 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYL---HSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI  166 (829)
T ss_pred             EecCCCcccceeeecccchhHHHHHHHhhhhccchhh---hcCCcccccccccceeecccCceeecccCchhhhhh--hh
Confidence            9999999987644               233444455   455899999999999999999999999999887643  22


Q ss_pred             CcccceeecCCccccchhc---cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          165 ANTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      .....+.||++|||||+..   .+.|..++|||++|++..|+.--++|....++.+...+       .....   .-.+.
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L-------mTkS~---~qpp~  236 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL-------MTKSG---FQPPT  236 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH-------hhccC---CCCCc
Confidence            3345589999999999764   57789999999999999999988888766554332211       11111   11223


Q ss_pred             CCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          242 LDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       242 l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +++.-..  ... -+++..|+-.+|..|||..
T Consensus       237 lkDk~kw--s~~fh~fvK~altknpKkRptae  266 (829)
T KOG0576|consen  237 LKDKTKW--SEFFHNFVKGALTKNPKKRPTAE  266 (829)
T ss_pred             ccCCccc--hHHHHHHHHHHhcCCCccCCChh
Confidence            3221111  112 5889999999999999954

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-30  Score=232.30  Aligned_cols=235  Identities=23%  Similarity=0.223  Sum_probs=180.8

Q ss_pred             eeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-CeeEE
Q 039516           26 WHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG-EERLL   97 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-~~~~l   97 (345)
                      +.....+-+|.||.||.|.+      ++.+.|-+|.++.. ++-....++.|.-.+..+.|||+..+.+++.+. ..++.
T Consensus       286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V  365 (563)
T KOG1024|consen  286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFV  365 (563)
T ss_pred             eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceE
Confidence            55556688999999999954      44577888888654 444566788999999999999999999998754 56789


Q ss_pred             EEecCCCCChHHHHH-----------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccc
Q 039516           98 VYEFMPNKSLDSSFS-----------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGM  154 (345)
Q Consensus        98 v~e~~~~gsL~~~l~-----------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl  154 (345)
                      ++.++.-|+|..++.                       +++.++++||..   |+||.||..+|++|++...+||+|=.+
T Consensus       366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaL  442 (563)
T KOG1024|consen  366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSAL  442 (563)
T ss_pred             EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchh
Confidence            999999999999876                       556677777776   899999999999999999999999999


Q ss_pred             ceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 039516          155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGK  233 (345)
Q Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (345)
                      ++..-....+........+..||+||.+....|+.++|+||||+++|||+| |+.|+...++.+-.       .++.+|.
T Consensus       443 SRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-------~ylkdGy  515 (563)
T KOG1024|consen  443 SRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-------HYLKDGY  515 (563)
T ss_pred             ccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-------HHHhccc
Confidence            987643333332222344678999999999999999999999999999999 99999876654322       2222331


Q ss_pred             ccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhh
Q 039516          234 DLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLM  279 (345)
Q Consensus       234 ~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~  279 (345)
                        ++.       .+..+... ..++.-||...|++||+..+++.-|.
T Consensus       516 --Rla-------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs  553 (563)
T KOG1024|consen  516 --RLA-------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLS  553 (563)
T ss_pred             --eec-------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence              111       12223333 58999999999999999876655444

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=2.2e-27  Score=207.21  Aligned_cols=183  Identities=26%  Similarity=0.345  Sum_probs=153.5

Q ss_pred             eeeEEEeeccCCeEEEEEEcCC-CcEEEEEEeccCCcc-CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           26 WHMYIQQEQTRDRVILVGKFPN-EQEVAIKRLAWTSGQ-GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~~-~~~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      |.+...||+|++|.||++.... ++.+|+|.+...... ....+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5667889999999999997754 899999999766544 57789999999999999999999999998899999999999


Q ss_pred             CCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          104 NKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       104 ~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      +++|.+++.                +++.++.+||.   .+++|+|++|.||+++.++.++|+|||.+......... ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence            999887754                33444555555   48999999999999999999999999999877543211 22


Q ss_pred             cceeecCCccccchh-ccCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 039516          168 NRIVGTYGYMSLEYT-MSGTVSIKTDVFGFGVLVLKIVCGKKNNKS  212 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~-~~~~~~~~~Di~SlG~il~el~tg~~p~~~  212 (345)
                      ....++..|++||.+ ....++.++|+||||+++++|++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            335678889999988 667778899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=5.6e-29  Score=209.07  Aligned_cols=188  Identities=19%  Similarity=0.340  Sum_probs=152.1

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEEC--CeeE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHG--EERL   96 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~--~~~~   96 (345)
                      +...+|++.+++|+|.++.||.|. ..++++++||.+++-   ..+.+.+|+.+|..|. ||||++++++..+.  ..+.
T Consensus        35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            456789999999999999999995 567899999999754   3567889999999997 99999999998764  3568


Q ss_pred             EEEecCCCCChHHHHH---------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC-CEEEEccccceeecCCCCCCc
Q 039516           97 LVYEFMPNKSLDSSFS---------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL-NTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~---------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      ||+||+.+.+...+..         .+.+.|.+|-.+|++||+|||+||.|++|+... .++|+|+|++..+...   ..
T Consensus       112 LiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~---~e  188 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---KE  188 (338)
T ss_pred             hHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC---ce
Confidence            9999999887655432         344555555555666999999999999998754 5899999999887433   33


Q ss_pred             ccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      .+....+..|..||++.. ..|+..-|+|||||++..|+..+.||...+
T Consensus       189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~  237 (338)
T KOG0668|consen  189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  237 (338)
T ss_pred             eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence            444567888999998764 567899999999999999999999986544

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=2.9e-27  Score=203.10  Aligned_cols=189  Identities=26%  Similarity=0.341  Sum_probs=156.6

Q ss_pred             eeccCCeEEEEEEcCC-CcEEEEEEeccCCcc-CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCChHH
Q 039516           32 QEQTRDRVILVGKFPN-EQEVAIKRLAWTSGQ-GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS  109 (345)
Q Consensus        32 lG~G~~g~vy~~~~~~-~~~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  109 (345)
                      ||+|++|.||++...+ ++.+++|.+...... ....+.+|++.++.++|++|+++++++......+++|||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998754 899999999765432 34679999999999999999999999999899999999999999987


Q ss_pred             HHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC-CCCEEEEccccceeecCCCCCCcccceee
Q 039516          110 SFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD-QLNTKISDFGMARIFGVNESGANTNRIVG  172 (345)
Q Consensus       110 ~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g  172 (345)
                      ++.                +++.++.+||..   |++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            754                344455555554   8999999999999999 89999999999987643221  1223457


Q ss_pred             cCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHH
Q 039516          173 TYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNED  251 (345)
Q Consensus       173 t~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  251 (345)
                      ...|++||..... ..+.++|+|++|++++++                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            8889999998877 788999999999999998                                                


Q ss_pred             HH-HHHHhhccCCCCCcCCCCCc
Q 039516          252 AF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       252 ~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .. .+++..|++.+|++||++.+
T Consensus       188 ~~~~~~l~~~l~~~p~~R~~~~~  210 (215)
T cd00180         188 PELKDLIRKMLQKDPEKRPSAKE  210 (215)
T ss_pred             HHHHHHHHHHhhCCcccCcCHHH
Confidence            12 48999999999999999643

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=230.42  Aligned_cols=184  Identities=20%  Similarity=0.208  Sum_probs=148.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--------ccCHHHHHHHHHHHHhcC---CCCeeeEEEEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--------GQGRVEFQNEAKLIAKLQ---YTNLVKLLGCSIH   91 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--------~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~   91 (345)
                      .+|..+..+|+|+||.|+.+.. .+...|+||.+.++.        ....-..-.|+++|+.++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            5699999999999999999965 457899999986542        111223456999999997   9999999999999


Q ss_pred             CCeeEEEEecC-CCCChHHHHH-----------h-HHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           92 GEERLLVYEFM-PNKSLDSSFS-----------G-TFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        92 ~~~~~lv~e~~-~~gsL~~~l~-----------~-~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      ++.+||+||-- ++.+|.+++.           . ..+..+...++|..||||||||-+|++++.+|-+||+|||.+...
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~  720 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT  720 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence            99999999976 4456766654           1 123333445555669999999999999999999999999999875


Q ss_pred             cCCCCCCcccceeecCCccccchhccCCcC-cccchhhHHHHHHHHHhCCCCCC
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTMSGTVS-IKTDVFGFGVLVLKIVCGKKNNK  211 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~SlG~il~el~tg~~p~~  211 (345)
                      ..    .....+.||..|.|||++.+.+|- ..-|||++|++||.++....||.
T Consensus       721 ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  721 KS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            32    234458999999999999999885 55899999999999999998875

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1e-29  Score=218.63  Aligned_cols=193  Identities=21%  Similarity=0.249  Sum_probs=150.7

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-----eeE
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE-----ERL   96 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----~~~   96 (345)
                      |-+.-+.||-|+||+||..+. .+|+.||+|++..-  +-...+.+.+|+++|..++|.|++..++..+-..     ++|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            344456699999999999865 57999999998543  2334667899999999999999999988765432     346


Q ss_pred             EEEecCCCCCh---------------HHHHHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           97 LVYEFMPNKSL---------------DSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        97 lv~e~~~~gsL---------------~~~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      +++|.|.. +|               .-++.+++++|.|||..   +|.||||||.|.|++.+..+||||||+++.....
T Consensus       134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence            77777643 22               22344788888888887   8999999999999999999999999999875433


Q ss_pred             CCCCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHH
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV  222 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~  222 (345)
                      ... ..+...-|.+|.|||++.+. .|+.+.||||.||++.||+.++.-|....+-++..++
T Consensus       210 ~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI  270 (449)
T KOG0664|consen  210 DRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI  270 (449)
T ss_pred             hhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH
Confidence            222 23334668899999999874 6899999999999999999999988877665555444

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=9.8e-28  Score=221.82  Aligned_cols=188  Identities=20%  Similarity=0.198  Sum_probs=148.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcC------CCCeeeEEEEEEECCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ------YTNLVKLLGCSIHGEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~~~~~~~~~~~~   95 (345)
                      ...|.+....|+|-|++|-+|... -|+.||||++.... .-.+.=+.|+++|++|+      --|+++++..|...+++
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            466999999999999999999654 48899999997542 22344578999999995      24799999999999999


Q ss_pred             EEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC-CCEEEEccccceeec
Q 039516           96 LLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ-LNTKISDFGMARIFG  159 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgl~~~~~  159 (345)
                      |||+|-+. -+|.+.++               +..+.+.+|..+..-||+|.||||+|||+++. ..+||||||.|....
T Consensus       510 ClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~  588 (752)
T KOG0670|consen  510 CLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFAS  588 (752)
T ss_pred             EEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccc
Confidence            99999874 46777665               22233334433333389999999999999875 457999999998764


Q ss_pred             CCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTE  216 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~  216 (345)
                      .+.    .+.+.-+.+|.|||++.+-+|+...|+||.||+||||.||+..|.+....
T Consensus       589 ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN  641 (752)
T KOG0670|consen  589 ENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN  641 (752)
T ss_pred             ccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence            332    22345577899999999999999999999999999999999999876544

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=4.9e-27  Score=206.00  Aligned_cols=183  Identities=23%  Similarity=0.260  Sum_probs=143.2

Q ss_pred             CCeeeEEEeeccCCeEEEEE-EcCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC------e
Q 039516           24 LDWHMYIQQEQTRDRVILVG-KFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE------E   94 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~-~~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------~   94 (345)
                      ..|--+..+|.|.. .|-.+ ..-.++.||+|++...  .....++..+|..++..++|+||++++.+|.-..      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            34666777899988 44444 3346899999998543  2334567789999999999999999999986443      5


Q ss_pred             eEEEEecCCCCChHHH-------------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           95 RLLVYEFMPNKSLDSS-------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~-------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      .|+|||||.. +|...             +-+.+.++.+||..   ||+||||||+||++..+..+||.|||++..-...
T Consensus        96 ~y~v~e~m~~-nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVILMELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD  171 (369)
T ss_pred             HHHHHHhhhh-HHHHHHHHhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc
Confidence            6999999964 44333             22555566666655   8999999999999999999999999999864322


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                         ...+....|..|.|||++.+-.+...+||||+||++.||++|..-|.+.+
T Consensus       172 ---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d  221 (369)
T KOG0665|consen  172 ---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD  221 (369)
T ss_pred             ---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch
Confidence               23445678889999999998889999999999999999999998887544

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.1e-27  Score=203.08  Aligned_cols=245  Identities=20%  Similarity=0.214  Sum_probs=166.4

Q ss_pred             cceeecccccccccCCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeE
Q 039516            8 GCQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKL   85 (345)
Q Consensus         8 ~~~s~~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~   85 (345)
                      ....-.|+.+.+  +...|.+.+++|+|.||.+.++. .++++.+++|-+.... -...+|.+|...--.| .|.||+.-
T Consensus        10 h~I~~~el~kv~--l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~t   86 (378)
T KOG1345|consen   10 HLIPMEELKKVD--LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDT   86 (378)
T ss_pred             cccccccccccc--hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHH
Confidence            334444555543  34558899999999999999995 4578999999986442 3467899998766566 58999988


Q ss_pred             EEE-EEECCeeEEEEecCCCCChHHHHH-----------hHHHHHHHHHhcCCCceEEeccCCCCeeeC--CCCCEEEEc
Q 039516           86 LGC-SIHGEERLLVYEFMPNKSLDSSFS-----------GTFKDLLCLHKYSRLRVIHRDLKASNILLD--DQLNTKISD  151 (345)
Q Consensus        86 ~~~-~~~~~~~~lv~e~~~~gsL~~~l~-----------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~--~~~~~kl~D  151 (345)
                      |++ |+..+.+++++||+|.|+|.+.+.           -..+.+.++..+|+.++||||||.+||||-  +...+||||
T Consensus        87 Y~vaFqt~d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcD  166 (378)
T KOG1345|consen   87 YEVAFQTSDAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCD  166 (378)
T ss_pred             HHHHhhcCceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeee
Confidence            875 677788899999999999987654           112233344445555899999999999993  334699999


Q ss_pred             cccceeecCCCCCCcccceeecCCccccchhcc---C--CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 039516          152 FGMARIFGVNESGANTNRIVGTYGYMSLEYTMS---G--TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAW  226 (345)
Q Consensus       152 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~  226 (345)
                      ||++...+....     ...-+..|.+||.+..   +  ...+.+|+|.||+++|.++||..||......+   -..|-|
T Consensus       167 FG~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---~~Y~~~  238 (378)
T KOG1345|consen  167 FGLTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---KPYWEW  238 (378)
T ss_pred             cccccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC---chHHHH
Confidence            999886542211     1233567899997653   2  23577999999999999999999998543222   234455


Q ss_pred             HHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcC
Q 039516          227 QLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDV  268 (345)
Q Consensus       227 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~R  268 (345)
                      ..|..+......+..  ..+++..   ..+-.+-+..+|++|
T Consensus       239 ~~w~~rk~~~~P~~F--~~fs~~a---~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  239 EQWLKRKNPALPKKF--NPFSEKA---LRLFKKSLTPRFKDR  275 (378)
T ss_pred             HHHhcccCccCchhh--cccCHHH---HHHHHHhcCCccccc
Confidence            556555433222111  0122211   344455566666666

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=9.5e-25  Score=200.89  Aligned_cols=118  Identities=23%  Similarity=0.277  Sum_probs=96.5

Q ss_pred             ccCC-CCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-----C---CCeeeEEEEE
Q 039516           20 ENSS-LDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-----Y---TNLVKLLGCS   89 (345)
Q Consensus        20 ~~~~-~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~~~~~~   89 (345)
                      +.|. ..|.+.++||-|-|++||++. ..+.+.||+|+.+.. ....+..+.|+++|++++     |   ..||++++.|
T Consensus        73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            4455 789999999999999999995 457899999998643 344566789999999983     3   4699999998


Q ss_pred             EE----CCeeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeee
Q 039516           90 IH----GEERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILL  141 (345)
Q Consensus        90 ~~----~~~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill  141 (345)
                      ..    +.++|+|+|++ |.+|..++.                 +++.+|.|||..+  ||||-||||+|||+
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            74    55899999998 445544443                 7788999999998  89999999999999

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1.2e-24  Score=202.40  Aligned_cols=156  Identities=17%  Similarity=0.163  Sum_probs=120.5

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcC--CCcEEEEEEeccC-----CccCHHHHHHHHHHHHhcCCCCeee-EEEEEEECC
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFP--NEQEVAIKRLAWT-----SGQGRVEFQNEAKLIAKLQYTNLVK-LLGCSIHGE   93 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~--~~~~VaiK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~-~~~~~~~~~   93 (345)
                      +..+|.+...||+|+||+||+|...  +++.||||++...     .......|.+|+++|++++|+|++. +++    .+
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TG   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cC
Confidence            4556999999999999999999653  5788899987533     1223556899999999999999985 443    24


Q ss_pred             eeEEEEecCCCCChHH--------HHHhHHHHHHHHHhcCCCceEEecc-CCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516           94 ERLLVYEFMPNKSLDS--------SFSGTFKDLLCLHKYSRLRVIHRDL-KASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~--------~l~~~~~~l~~lh~~~~~~ivHrdl-k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ..|+||||++|++|..        ++.+++++|.+||..   ||+|||| ||+|||++.++.+||+|||+++.+......
T Consensus        92 ~~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~  168 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGAL  168 (365)
T ss_pred             CcEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcch
Confidence            5799999999998863        233566677777764   8999999 999999999999999999999977543211


Q ss_pred             Cc------ccceeecCCccccchhcc
Q 039516          165 AN------TNRIVGTYGYMSLEYTMS  184 (345)
Q Consensus       165 ~~------~~~~~gt~~y~aPE~~~~  184 (345)
                      ..      .....+++.|+|||++.-
T Consensus       169 ~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        169 YRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             hhhhhhhhhhhhhccCccCCcccCCh
Confidence            11      124567888999998763

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=8.1e-26  Score=233.00  Aligned_cols=177  Identities=12%  Similarity=0.114  Sum_probs=116.2

Q ss_pred             hcCC-CCeeeEEEEE-------EECCeeEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEE
Q 039516           76 KLQY-TNLVKLLGCS-------IHGEERLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIH  131 (345)
Q Consensus        76 ~l~H-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivH  131 (345)
                      .++| +||++++++|       .....++++|||+ +++|.+++.                +++.+|.|||.   .||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeee
Confidence            4556 6888888877       2334677888887 558877763                56666666665   48999


Q ss_pred             eccCCCCeeeCCC-------------------CCEEEEccccceeecCCCC--------------CCcccceeecCCccc
Q 039516          132 RDLKASNILLDDQ-------------------LNTKISDFGMARIFGVNES--------------GANTNRIVGTYGYMS  178 (345)
Q Consensus       132 rdlk~~Nill~~~-------------------~~~kl~Dfgl~~~~~~~~~--------------~~~~~~~~gt~~y~a  178 (345)
                      |||||+|||++..                   +.+|++|||+++.......              ........||+.|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            9999999999654                   4456666666653211000              000111357889999


Q ss_pred             cchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHH
Q 039516          179 LEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVS  257 (345)
Q Consensus       179 PE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~  257 (345)
                      ||++.+..++.++|||||||++|||++|..|+....    .....     +...    .+++..     ...... ..++
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~-----~~~~----~~~~~~-----~~~~~~~~~~~  245 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSS-----LRHR----VLPPQI-----LLNWPKEASFC  245 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHH-----HHHh----hcChhh-----hhcCHHHHHHH
Confidence            999999999999999999999999999988764311    00000     0000    111111     011222 5788


Q ss_pred             hhccCCCCCcCCCCCcc
Q 039516          258 CVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       258 ~~Cl~~~P~~RPs~~~~  274 (345)
                      .+||+.+|.+||||.++
T Consensus       246 ~~~L~~~P~~Rps~~ei  262 (793)
T PLN00181        246 LWLLHPEPSCRPSMSEL  262 (793)
T ss_pred             HHhCCCChhhCcChHHH
Confidence            89999999999998765

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=3.3e-25  Score=200.98  Aligned_cols=199  Identities=18%  Similarity=0.256  Sum_probs=152.9

Q ss_pred             ccccccccCCCCeeeEEEeeccCCeEEEEEEcC----CCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEE
Q 039516           14 EGAKFVENSSLDWHMYIQQEQTRDRVILVGKFP----NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGC   88 (345)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~~----~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~   88 (345)
                      ++..........|...++||+|.|++||++...    ..+.||+|.+...+  ......+|+++|..+ -+.||+++.++
T Consensus        26 ~l~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~  103 (418)
T KOG1167|consen   26 QLRQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGC  103 (418)
T ss_pred             HHHhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhh
Confidence            344444455778999999999999999999653    46899999996553  345688999999999 58999999999


Q ss_pred             EEECCeeEEEEecCCCCChHHHHH---------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC-CCEEEEccccceee
Q 039516           89 SIHGEERLLVYEFMPNKSLDSSFS---------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ-LNTKISDFGMARIF  158 (345)
Q Consensus        89 ~~~~~~~~lv~e~~~~gsL~~~l~---------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgl~~~~  158 (345)
                      +..+++..+|+||++.....+++.         .....+.+|.+.|..|||||||||.|+|.+.. +.-.|+|||++...
T Consensus       104 ~rnnd~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  104 FRNNDQVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY  183 (418)
T ss_pred             hccCCeeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence            999999999999999877666544         22333334444555699999999999999864 56799999999731


Q ss_pred             cCCC-------------CC-----------------------------CcccceeecCCccccchhcc-CCcCcccchhh
Q 039516          159 GVNE-------------SG-----------------------------ANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFG  195 (345)
Q Consensus       159 ~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~S  195 (345)
                      ....             ..                             .......||++|.|||++.. ...++++||||
T Consensus       184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws  263 (418)
T KOG1167|consen  184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS  263 (418)
T ss_pred             HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence            1000             00                             00012469999999998875 45689999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC
Q 039516          196 FGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       196 lG~il~el~tg~~p~~~~~  214 (345)
                      .|++++.+++++.||....
T Consensus       264 ~GVI~Lslls~~~PFf~a~  282 (418)
T KOG1167|consen  264 AGVILLSLLSRRYPFFKAK  282 (418)
T ss_pred             ccceeehhhccccccccCc
Confidence            9999999999999997544

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.7e-24  Score=186.35  Aligned_cols=234  Identities=13%  Similarity=0.183  Sum_probs=180.1

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ..+.....+|.+.-.|..|+|+++ |..+++|+++..  +.....+|..|.-.|+-+.||||..++|.|....++.++..
T Consensus       189 ~~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq  267 (448)
T KOG0195|consen  189 VSSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ  267 (448)
T ss_pred             hhhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence            344556677899999999999997 677788887644  33345679999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEE--ccccceeecCC
Q 039516          101 FMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKIS--DFGMARIFGVN  161 (345)
Q Consensus       101 ~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~--Dfgl~~~~~~~  161 (345)
                      ||+.|||...++                 ++++++.|||.+.. -|..--|.+..+++|++.+.+|+  |--++..    
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfq----  342 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----  342 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeee----
Confidence            999999998887                 67899999999862 23444688999999999887765  2222111    


Q ss_pred             CCCCcccceeecCCccccchhccCCcC---cccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVS---IKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                           .....-.+.|++||.++..+-+   .++|+|||++++|||.|...||....+.+-.               ..+.
T Consensus       343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkia  402 (448)
T KOG0195|consen  343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIA  402 (448)
T ss_pred             -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhh
Confidence                 1112346789999999876643   5689999999999999999999876543311               1111


Q ss_pred             cccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          239 DLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       239 d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                      -..++...+|..... .+++..|++.||.+||.+..++-+|++|.
T Consensus       403 leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  403 LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            223344456666666 79999999999999999998888888763

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=3.6e-23  Score=179.80  Aligned_cols=165  Identities=12%  Similarity=0.123  Sum_probs=126.0

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHH---H------HHHHHHHHHhcCCCCeeeEEEEEEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRV---E------FQNEAKLIAKLQYTNLVKLLGCSIH   91 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~---~------~~~E~~~l~~l~H~niv~~~~~~~~   91 (345)
                      -.+..|.+.+.+|+|+||.||.... ++..+|||.+.........   .      +.+|+..+.++.|++|..+..++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3467899999999999999999766 5778999999755322222   2      6789999999999999999988664


Q ss_pred             C--------CeeEEEEecCCCCChHHHH-------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516           92 G--------EERLLVYEFMPNKSLDSSF-------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus        92 ~--------~~~~lv~e~~~~gsL~~~l-------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                      .        ...+++|||++|.+|.+..       .++..++..+|   ..|++|||++|+||+++.++ ++|+|||...
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~liDfg~~~  182 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKR  182 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEEECCCcc
Confidence            3        3578999999999997653       34455555555   45999999999999999988 9999999887


Q ss_pred             eecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHH
Q 039516          157 IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV  204 (345)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~  204 (345)
                      .......              ...++....+..++|+||||+++..+.
T Consensus       183 ~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        183 CTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence            5421110              011344556778999999999876553

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=9.3e-21  Score=172.75  Aligned_cols=239  Identities=22%  Similarity=0.250  Sum_probs=172.7

Q ss_pred             eeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCcc---CHHHHHHHHHHHHhcCCC-CeeeEEEEEEECCeeEEEEec
Q 039516           26 WHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQ---GRVEFQNEAKLIAKLQYT-NLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~~~~~~~~~~~~~lv~e~  101 (345)
                      |.+...||.|+||.||++...  ..+++|.+......   ....|.+|+.+++.+.|+ +++++++.+......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677888999999999999876  88999999765332   367899999999999988 799999999777778999999


Q ss_pred             CCCCChHHHHH------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC-CEEEEccccceeecCCC
Q 039516          102 MPNKSLDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL-NTKISDFGMARIFGVNE  162 (345)
Q Consensus       102 ~~~gsL~~~l~------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~  162 (345)
                      +.++++.+++.                  +++.++.++|..   +++|||+||+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999885543                  333444455554   799999999999999988 69999999998654332


Q ss_pred             CCC----cccceeecCCccccchhcc---CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 039516          163 SGA----NTNRIVGTYGYMSLEYTMS---GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDL  235 (345)
Q Consensus       163 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (345)
                      ...    ......|+..|++||.+.+   ..++...|+||+|++++++++|..||......   ................
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence            221    2355689999999999887   57889999999999999999999996654321   0111111111111110


Q ss_pred             ccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          236 ELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       236 ~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                       ................. ..++..|+..+|..|.++..
T Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~  271 (384)
T COG0515         234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS  271 (384)
T ss_pred             -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHH
Confidence             00000100000111123 68888999999999999653

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.87  E-value=2.8e-22  Score=169.26  Aligned_cols=143  Identities=14%  Similarity=0.062  Sum_probs=98.9

Q ss_pred             HHHHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcC
Q 039516          109 SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS  188 (345)
Q Consensus       109 ~~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  188 (345)
                      .++.+++.+|.|||...         ||+|||++.++.+|+  ||++.......       ..||+.|+|||++.+..++
T Consensus        21 ~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~g~~~y~aPE~~~~~~~~   82 (176)
T smart00750       21 AVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------SRVDPYFMAPEVIQGQSYT   82 (176)
T ss_pred             HHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-------CCCcccccChHHhcCCCCc
Confidence            34457888888888773         999999999999999  99988753211       2578999999999999999


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHH--HH-HHHHhhccCCCC
Q 039516          189 IKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNED--AF-LLVSCVCKSKQQ  265 (345)
Q Consensus       189 ~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~--~~-~~l~~~Cl~~~P  265 (345)
                      .++|||||||++|||++|+.||.......  .............      ++.... ......  .. .+++.+||+.+|
T Consensus        83 ~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~------~~~~~~-~~~~~~~~~~~~~~i~~cl~~~p  153 (176)
T smart00750       83 EKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD------DPRDRS-NLESVSAARSFADFMRVCASRLP  153 (176)
T ss_pred             chhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC------Cccccc-cHHHHHhhhhHHHHHHHHHhccc
Confidence            99999999999999999999996543211  1111111111000      000000 011111  13 799999999999


Q ss_pred             CcCCCCCcchhhh
Q 039516          266 IDVQCPMLFPCLL  278 (345)
Q Consensus       266 ~~RPs~~~~~~~l  278 (345)
                      .+|||+.++...+
T Consensus       154 ~~Rp~~~~ll~~~  166 (176)
T smart00750      154 QRREAANHYLAHC  166 (176)
T ss_pred             ccccCHHHHHHHH
Confidence            9999976654444

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=7.2e-21  Score=176.40  Aligned_cols=190  Identities=18%  Similarity=0.228  Sum_probs=146.1

Q ss_pred             CeeeEEEeeccCCeEEEEEEcCC--CcEEEEEEeccCCccCHHHHHHHHHHHHhcCC----CCeeeEEEEE-EECCeeEE
Q 039516           25 DWHMYIQQEQTRDRVILVGKFPN--EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY----TNLVKLLGCS-IHGEERLL   97 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~~--~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~~~~~~-~~~~~~~l   97 (345)
                      .|.+..+||+|+||.||.+....  ...+|+|............+..|+.++..+..    +++..+++.. ......|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            79999999999999999997644  35789998865533322367889999999873    6899999988 46778899


Q ss_pred             EEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC-----CCEEEEccccce--
Q 039516           98 VYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ-----LNTKISDFGMAR--  156 (345)
Q Consensus        98 v~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~-----~~~kl~Dfgl~~--  156 (345)
                      ||+.+ |.+|.++..              -..+.+..|..+|+.|++||||||.|+++...     ..+.|.|||+++  
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            99987 667776553              22233444555555699999999999999765     358999999998  


Q ss_pred             eecCCCCC----C-c-ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 039516          157 IFGVNESG----A-N-TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHT  215 (345)
Q Consensus       157 ~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~  215 (345)
                      .+......    . . ...+.||..|+++....+...+.+.|+||++.++.+++.|..||.....
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~  242 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM  242 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence            33221111    1 1 2235699999999999999999999999999999999999999976543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=6.2e-22  Score=167.91  Aligned_cols=186  Identities=19%  Similarity=0.254  Sum_probs=151.0

Q ss_pred             CCeeeEEEeeccCCeEEEEE-EcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCC-CCeeeEEEEEEECCeeEEEEec
Q 039516           24 LDWHMYIQQEQTRDRVILVG-KFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY-TNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~-~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .+|.++++||+|+||.+|.| ...+|..||||.-+....  -.++.-|..+...|++ ..|..+..+..+...-.+||+.
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL   92 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL   92 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence            46999999999999999999 467899999999754422  2356789999999976 6788888888888889999998


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC---CCCEEEEccccceeecCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD---QLNTKISDFGMARIFGVNE  162 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgl~~~~~~~~  162 (345)
                      + |.||++++.                ++..-++|+|..   +.|||||||+|+|..-   ...+.|+|||+++.+-+..
T Consensus        93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~  168 (341)
T KOG1163|consen   93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR  168 (341)
T ss_pred             c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence            8 779988776                555667788877   6999999999999953   4568999999999875433


Q ss_pred             CC-----CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 039516          163 SG-----ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHT  215 (345)
Q Consensus       163 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~  215 (345)
                      +.     .......||..|.+-....+...+...|+=|+|.++...-.|..||.+...
T Consensus       169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            22     223446799999887777777778899999999999999999999998653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=4.8e-21  Score=169.32  Aligned_cols=185  Identities=21%  Similarity=0.302  Sum_probs=151.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEEEec
Q 039516           24 LDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ..|.+.++||+|+||+.+.|+ +-+++.||||.-...+.  .-++..|.+..+.|. .++|..+|-+..++-+-.||||+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            469999999999999999995 55799999998654432  345678888888884 69999999888888888999998


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC-----CEEEEccccceeecC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL-----NTKISDFGMARIFGV  160 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~-----~~kl~Dfgl~~~~~~  160 (345)
                      + |.||++++.                ++...++++|..   .+|.|||||+|+||...+     .+.++|||+++.+.+
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            8 779998876                333445666666   599999999999997543     489999999998765


Q ss_pred             CCCC-----CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          161 NESG-----ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       161 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ..+.     ...+...||..||+-....+...+...|.=|+|-++.+.+.|..||.+..
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            4433     23455789999999888888889999999999999999999999998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=7.2e-22  Score=195.17  Aligned_cols=247  Identities=18%  Similarity=0.129  Sum_probs=167.4

Q ss_pred             ecccccccccCCCCe-eeEEEeeccCCeEEEEEEc-CCCcEEEEEEecc----C-CccC-HHHHHHHHHHHHhcCCCCee
Q 039516           12 WSEGAKFVENSSLDW-HMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAW----T-SGQG-RVEFQNEAKLIAKLQYTNLV   83 (345)
Q Consensus        12 ~~~~~~~~~~~~~~~-~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~----~-~~~~-~~~~~~E~~~l~~l~H~niv   83 (345)
                      ...+.+....+...| .....+|.|.+|.|+.... ......+.|.+..    . .... ...+..|+.+-..++|+|++
T Consensus       305 ~~~~~~~~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~  384 (601)
T KOG0590|consen  305 SLTIAKSPIGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNII  384 (601)
T ss_pred             ccccccCccccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchh
Confidence            334444444444445 3556689999997776643 3344445554321    1 1111 11256677777889999998


Q ss_pred             eEEEEEEECCeeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEE
Q 039516           84 KLLGCSIHGEERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTK  148 (345)
Q Consensus        84 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~k  148 (345)
                      ..+..+.+.....-.||||++ +|..++.               ++..++.|+|..   ||.|||+|++|+++..+|.+|
T Consensus       385 e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lk  460 (601)
T KOG0590|consen  385 ETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILK  460 (601)
T ss_pred             hhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceE
Confidence            877766665555555999999 7765543               667777888887   899999999999999999999


Q ss_pred             EEccccceeecCCCCC--CcccceeecCCccccchhccCCcCc-ccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 039516          149 ISDFGMARIFGVNESG--ANTNRIVGTYGYMSLEYTMSGTVSI-KTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIA  225 (345)
Q Consensus       149 l~Dfgl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~  225 (345)
                      |+|||.+..+......  .......|+..|+|||++.+..|.+ ..||||.|++++.|.+|+.||......+....    
T Consensus       461 i~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~----  536 (601)
T KOG0590|consen  461 IIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK----  536 (601)
T ss_pred             EeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh----
Confidence            9999999877544443  4455678999999999999999875 48999999999999999999987654433210    


Q ss_pred             HHHHhcCCccccccccCCCCCC-hhH-HHH-HHHHhhccCCCCCcCCCCC
Q 039516          226 WQLWNEGKDLELIDLTLDGSCP-PNE-DAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       226 ~~~~~~~~~~~~~d~~l~~~~~-~~~-~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                        .........+.    .+... ... ... ..++.+.|+.||.+|-|+.
T Consensus       537 --~~~~~~~~~~~----~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~  580 (601)
T KOG0590|consen  537 --TNNYSDQRNIF----EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIE  580 (601)
T ss_pred             --hhccccccccc----cChHHHHHhchhhHHHHHHHHccCChhheecHH
Confidence              00000000000    00000 111 222 6888999999999999964

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=1.4e-20  Score=161.00  Aligned_cols=124  Identities=17%  Similarity=0.163  Sum_probs=90.2

Q ss_pred             EEeeccCCeEEEEEEcCCCcEEEEEEeccCCcc--C-------HHHH-----------------HHHHHHHHhcCCCCee
Q 039516           30 IQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQ--G-------RVEF-----------------QNEAKLIAKLQYTNLV   83 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~--~-------~~~~-----------------~~E~~~l~~l~H~niv   83 (345)
                      ..||+|+||.||+|...+|+.||||+++.....  .       ...|                 ..|++++.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            459999999999998878999999999754211  1       1122                 3499999999887764


Q ss_pred             eEEEEEEECCeeEEEEecCCCCChHHH-H--------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEE
Q 039516           84 KLLGCSIHGEERLLVYEFMPNKSLDSS-F--------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTK  148 (345)
Q Consensus        84 ~~~~~~~~~~~~~lv~e~~~~gsL~~~-l--------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~k  148 (345)
                      ....+..  ...++||||++++++... +              .+++.+|.++|  |+.||+||||||+|||++ ++.++
T Consensus        83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~--H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILY--QDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHH--HhCCcccCCCCHHHEEEE-CCcEE
Confidence            4333322  223899999998765432 1              14555666663  234899999999999998 47899


Q ss_pred             EEccccceee
Q 039516          149 ISDFGMARIF  158 (345)
Q Consensus       149 l~Dfgl~~~~  158 (345)
                      |+|||++...
T Consensus       158 LiDFG~a~~~  167 (190)
T cd05147         158 IIDVSQSVEH  167 (190)
T ss_pred             EEEccccccC
Confidence            9999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=9.4e-20  Score=155.45  Aligned_cols=179  Identities=17%  Similarity=0.101  Sum_probs=129.3

Q ss_pred             eeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCcc----CHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEEEec
Q 039516           27 HMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQ----GRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        27 ~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~----~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .+...|++|+||+||.+.. .+.+++.+.+......    ....|.+|+++|++|. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4556799999999998766 5889998888654321    1225789999999995 5889999886    346999999


Q ss_pred             CCCCChHHHH--------HhHHHHHHHHHhcCCCceEEecc-CCCCeeeCCCCCEEEEccccceeecCCCCC----Cc--
Q 039516          102 MPNKSLDSSF--------SGTFKDLLCLHKYSRLRVIHRDL-KASNILLDDQLNTKISDFGMARIFGVNESG----AN--  166 (345)
Q Consensus       102 ~~~gsL~~~l--------~~~~~~l~~lh~~~~~~ivHrdl-k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~----~~--  166 (345)
                      +.|.+|.+..        .++..++.++|.   .||+|||| ||+|||++.++.++|+|||++.........    ..  
T Consensus        80 I~G~~L~~~~~~~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rD  156 (218)
T PRK12274         80 LAGAAMYQRPPRGDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLARED  156 (218)
T ss_pred             ecCccHHhhhhhhhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHH
Confidence            9999986432        244555555555   48999999 799999999999999999999865322110    00  


Q ss_pred             -----ccceeecCCccccchhccC-CcC-cccchhhHHHHHHHHHhCCCCCCCC
Q 039516          167 -----TNRIVGTYGYMSLEYTMSG-TVS-IKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       167 -----~~~~~gt~~y~aPE~~~~~-~~~-~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                           ......++.|++|+...-- ..+ ...++++.|.-+|.++||..++-..
T Consensus       157 l~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        157 LRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                 0112356777777743321 223 4568889999999999999886543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=1.2e-19  Score=155.58  Aligned_cols=125  Identities=15%  Similarity=0.130  Sum_probs=94.2

Q ss_pred             EEEeeccCCeEEEEEEcCCCcEEEEEEeccCCcc---------------------C-----HHHHHHHHHHHHhcCCCCe
Q 039516           29 YIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQ---------------------G-----RVEFQNEAKLIAKLQYTNL   82 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~ni   82 (345)
                      ...||+|++|.||+|...+|+.||||+++.....                     .     ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3569999999999998778999999999765211                     0     1124578999999999987


Q ss_pred             eeEEEEEEECCeeEEEEecCCCCChHHH-H--------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCE
Q 039516           83 VKLLGCSIHGEERLLVYEFMPNKSLDSS-F--------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNT  147 (345)
Q Consensus        83 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l--------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~  147 (345)
                      .....+...  ..++||||++++++... +              .+++.++.++|..  .||+||||||+||+++ ++.+
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CCCE
Confidence            554444332  24899999998754221 1              2455666667662  3899999999999998 7899


Q ss_pred             EEEccccceee
Q 039516          148 KISDFGMARIF  158 (345)
Q Consensus       148 kl~Dfgl~~~~  158 (345)
                      +|+|||++...
T Consensus       157 ~liDFG~a~~~  167 (190)
T cd05145         157 YIIDVSQAVEL  167 (190)
T ss_pred             EEEEcccceec
Confidence            99999999865

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=2.2e-19  Score=155.41  Aligned_cols=126  Identities=19%  Similarity=0.160  Sum_probs=94.7

Q ss_pred             eEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-----CCCCeeeEEEEEEECC---e-eEEE
Q 039516           28 MYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-----QYTNLVKLLGCSIHGE---E-RLLV   98 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~~~~~~~~~~---~-~~lv   98 (345)
                      -..+||+|+||.||+ +..++.. +||++........+.+.+|+.+++.+     .||||++++|++.++.   . ..+|
T Consensus         6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            345699999999996 4445555 69998765445567899999999999     5799999999998763   4 3478


Q ss_pred             Eec--CCCCChHHHHH---------hHHHHHHHH-HhcCCCceEEeccCCCCeeeCC----CCCEEEEccccc
Q 039516           99 YEF--MPNKSLDSSFS---------GTFKDLLCL-HKYSRLRVIHRDLKASNILLDD----QLNTKISDFGMA  155 (345)
Q Consensus        99 ~e~--~~~gsL~~~l~---------~~~~~l~~l-h~~~~~~ivHrdlk~~Nill~~----~~~~kl~Dfgl~  155 (345)
                      |||  +++++|.+++.         .+.+.+..+ .++|+.+|+||||||+|||++.    +..++|+||+.+
T Consensus        84 ~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             ecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            999  66899988875         123444333 3444458999999999999974    347999995433

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=1.6e-19  Score=182.61  Aligned_cols=180  Identities=18%  Similarity=0.236  Sum_probs=142.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC---CCCeeeEEEEEEECCeeEEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ---YTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ..+|.+-..||+|+||.||+|...+|+.||+|+-+..+...   |.-=.+++.+|+   -+-|..+..++.-.+.-+||+
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~  773 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS  773 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence            46789999999999999999988889999999987665442   222233444554   234555555556677779999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC-------CCCEEEEcccccee
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD-------QLNTKISDFGMARI  157 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~-------~~~~kl~Dfgl~~~  157 (345)
                      ||.+.|+|.++++               +++..+..||..   +|||+||||+|+||..       ...++|+|||.+-.
T Consensus       774 ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD  850 (974)
T KOG1166|consen  774 EYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID  850 (974)
T ss_pred             eccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence            9999999998776               556667777776   7999999999999942       34589999999976


Q ss_pred             ecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCC
Q 039516          158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK  208 (345)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~  208 (345)
                      +..-..........+|-.+-.+|+..+.+++..+|.|.++.+++.|+.|+.
T Consensus       851 m~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            654444445566788999999999999999999999999999999999974

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=1.5e-18  Score=155.36  Aligned_cols=218  Identities=15%  Similarity=0.140  Sum_probs=133.0

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCC----------CCeeeEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQY----------TNLVKLL   86 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H----------~niv~~~   86 (345)
                      .....+.....||.|+++.||.++.. +|+++|+|.+....   ....+.+.+|.-....+.+          -.++..+
T Consensus         9 ~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~   88 (288)
T PF14531_consen    9 QRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL   88 (288)
T ss_dssp             --EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred             CCceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence            33445678888999999999999764 68999999985432   2345667777655544332          1222222


Q ss_pred             EEEE---------ECC--------eeEEEEecCCCCChHHHHH----------------------hHHHHHHHHHhcCCC
Q 039516           87 GCSI---------HGE--------ERLLVYEFMPNKSLDSSFS----------------------GTFKDLLCLHKYSRL  127 (345)
Q Consensus        87 ~~~~---------~~~--------~~~lv~e~~~~gsL~~~l~----------------------~~~~~l~~lh~~~~~  127 (345)
                      +...         ...        +.+++|+-+ .++|.+++.                      ++.+.+++||..   
T Consensus        89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---  164 (288)
T PF14531_consen   89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---  164 (288)
T ss_dssp             EEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             EEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---
Confidence            2221         111        225677766 456665533                      334556677776   


Q ss_pred             ceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhcc--------CCcCcccchhhHHHH
Q 039516          128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS--------GTVSIKTDVFGFGVL  199 (345)
Q Consensus       128 ~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~SlG~i  199 (345)
                      |++|+||+|+|++++.+|.++|+||+.....+..     ......+..|.+||....        -.++.+.|.|++|++
T Consensus       165 GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~  239 (288)
T PF14531_consen  165 GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT  239 (288)
T ss_dssp             TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred             ceEecccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence            8999999999999999999999999887764321     111234567999997643        247889999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcC
Q 039516          200 VLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDV  268 (345)
Q Consensus       200 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~R  268 (345)
                      +|.|.+|..||...........               .+     ..|. +-.+. ..++...|+.||.+|
T Consensus       240 ly~lWC~~lPf~~~~~~~~~~~---------------~f-----~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  240 LYSLWCGRLPFGLSSPEADPEW---------------DF-----SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHSS-STCCCGGGSTSGG---------------GG-----TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHccCCCCCCCccccccc---------------cc-----hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999999986543221110               11     1244 33344 688888999999988

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=5.6e-19  Score=167.75  Aligned_cols=202  Identities=19%  Similarity=0.249  Sum_probs=144.7

Q ss_pred             HHhcCCCCeeeEEEEEEECCeeEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCC
Q 039516           74 IAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKAS  137 (345)
Q Consensus        74 l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~  137 (345)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.                ++..++.|+|.-.  .-.|+.+++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence            457899999999999999999999999999999988654                6788899998763  2399999999


Q ss_pred             CeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCC-------cCcccchhhHHHHHHHHHhCCCCC
Q 039516          138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGT-------VSIKTDVFGFGVLVLKIVCGKKNN  210 (345)
Q Consensus       138 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~SlG~il~el~tg~~p~  210 (345)
                      |++++....+||+|||+.................-..-|.|||.+....       .+.+.||||||++++|+++.+.||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9999999999999999988764211111111122345699999887631       367799999999999999999999


Q ss_pred             CCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          211 KSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .........  .+.+....+  .....+.|.+....  +.... +.++..||..+|..||++..+...+..+..
T Consensus       159 ~~~~~~~~~--~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  159 DLRNLVEDP--DEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccCCh--HHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            875433322  222222222  11222233322110  11113 699999999999999998776666665554

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=8e-20  Score=173.92  Aligned_cols=173  Identities=23%  Similarity=0.237  Sum_probs=141.4

Q ss_pred             eeccCCeEEEEEEc----CCCcEEEEEEeccCCcc--CHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEEEecCCC
Q 039516           32 QEQTRDRVILVGKF----PNEQEVAIKRLAWTSGQ--GRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLVYEFMPN  104 (345)
Q Consensus        32 lG~G~~g~vy~~~~----~~~~~VaiK~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~  104 (345)
                      +|+|.||.|+....    ..|..+|+|.+++....  .......|..++..++ ||.+|++.-.++.+...+++++|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            69999999998633    24778899988665221  1225667888888886 99999999999999999999999999


Q ss_pred             CChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceee
Q 039516          105 KSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG  172 (345)
Q Consensus       105 gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g  172 (345)
                      |.|...+.            ..++.+..+-..|+.+|+|||+|++||+++.+|.+++.|||+++..-...      ..+|
T Consensus        82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~cg  155 (612)
T KOG0603|consen   82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IACG  155 (612)
T ss_pred             chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh------hccc
Confidence            98865443            44556666666677799999999999999999999999999998753222      1289


Q ss_pred             cCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 039516          173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKS  212 (345)
Q Consensus       173 t~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~  212 (345)
                      |..|||||++.  .....+|.||||++.+||+||..||..
T Consensus       156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            99999999988  557789999999999999999999986

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.76  E-value=5.8e-19  Score=176.02  Aligned_cols=241  Identities=16%  Similarity=0.195  Sum_probs=158.8

Q ss_pred             cccCCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           19 VENSSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        19 ~~~~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      ......+|+.++.|-.|+||.||..+.. +.+.+|+ ++++.+..    ..+   ++.....|.+|              
T Consensus        78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li----lRn---ilt~a~npfvv--------------  135 (1205)
T KOG0606|consen   78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI----LRN---ILTFAGNPFVV--------------  135 (1205)
T ss_pred             cCCCccccceeEeeccCCCCceeeeeccccccchhh-cccccchh----hhc---cccccCCccee--------------
Confidence            3445678999999999999999998654 5788888 44333211    111   33444555554              


Q ss_pred             EEecCCCCChHHHHH-------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC-------
Q 039516           98 VYEFMPNKSLDSSFS-------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES-------  163 (345)
Q Consensus        98 v~e~~~~gsL~~~l~-------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-------  163 (345)
                             |+-...++       +.+.+++|||.+   ||+|||+||+|.+|+.-|.+|+.|||+++.......       
T Consensus       136 -------gDc~tllk~~g~lPvdmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~  205 (1205)
T KOG0606|consen  136 -------GDCATLLKNIGPLPVDMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH  205 (1205)
T ss_pred             -------chhhhhcccCCCCcchhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence                   12222222       235567777777   899999999999999999999999999987432111       


Q ss_pred             ------CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 039516          164 ------GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLEL  237 (345)
Q Consensus       164 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
                            ....+..+||+.|.|||++....|+..+|+|++|+++||.+.|..||.+..+++.+..+-...-.|.++     
T Consensus       206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~-----  280 (1205)
T KOG0606|consen  206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE-----  280 (1205)
T ss_pred             hHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc-----
Confidence                  112345689999999999999999999999999999999999999998865544222111111111111     


Q ss_pred             ccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceeeEEecCCCCCCCCCCCC
Q 039516          238 IDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLLMLPPKNQKLPKTSQ  308 (345)
Q Consensus       238 ~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~~~~l~~~~~~~p~~~~  308 (345)
                       |.    ..+++.   ..++..-|+.+|.+|--..    --..+..+..+...+|...|.+++...|.-..
T Consensus       281 -de----a~p~Ea---~dli~~LL~qnp~~Rlgt~----ga~evk~h~ff~~LDw~~llRqkaefvpql~~  339 (1205)
T KOG0606|consen  281 -DE----ALPPEA---QDLIEQLLRQNPLCRLGTG----GALEVKQHGFFQLLDWKSLLRQKAEFVPQLES  339 (1205)
T ss_pred             -Cc----CCCHHH---HHHHHHHHHhChHhhcccc----hhhhhhhccceeecccchhhhhhccccccccc
Confidence             11    122222   3777778899999997532    22334445555555666666666666665443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.75  E-value=2.7e-19  Score=178.70  Aligned_cols=230  Identities=16%  Similarity=0.133  Sum_probs=158.0

Q ss_pred             CeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCC-ccCHHHHHHHHHH--HHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTS-GQGRVEFQNEAKL--IAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ++...+.||++.|=.|.+++.+.|. |+||++-+.. .-....|.++++-  ...++|||.+.+.-+...+.-.|||=+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            6778888999999999999988777 9999985543 3345555544433  4445899999988776666666777777


Q ss_pred             CCCCChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc-cc
Q 039516          102 MPNKSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN-TN  168 (345)
Q Consensus       102 ~~~gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~~  168 (345)
                      ... +|.+.+.            .+++.|.+|.+.|..||+|+|||.+|||++.-+.+.|+||...+..-....... ..
T Consensus       103 vkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~  181 (1431)
T KOG1240|consen  103 VKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFT  181 (1431)
T ss_pred             Hhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccce
Confidence            744 4544433            556778888888888999999999999999999999999987765432222211 11


Q ss_pred             cee----ecCCccccchhccC----------C-cCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcC
Q 039516          169 RIV----GTYGYMSLEYTMSG----------T-VSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEG  232 (345)
Q Consensus       169 ~~~----gt~~y~aPE~~~~~----------~-~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (345)
                      -+.    .-..|.|||.+...          . .+++-||||+||++.||++ |++||...          ....+...+
T Consensus       182 fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----------QL~aYr~~~  251 (1431)
T KOG1240|consen  182 FFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----------QLLAYRSGN  251 (1431)
T ss_pred             EEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----------HHHhHhccC
Confidence            111    22359999976531          1 5678899999999999998 68877521          111111111


Q ss_pred             C------ccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhh
Q 039516          233 K------DLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCL  277 (345)
Q Consensus       233 ~------~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~  277 (345)
                      .      +..+-|..+           .++++.+++.||+.|-|+.+..+.
T Consensus       252 ~~~~e~~Le~Ied~~~-----------Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  252 ADDPEQLLEKIEDVSL-----------RNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ccCHHHHHHhCcCccH-----------HHHHHHHHccCchhccCHHHHHHh
Confidence            1      111112211           488999999999999996544433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.5e-17  Score=144.59  Aligned_cols=123  Identities=20%  Similarity=0.253  Sum_probs=99.2

Q ss_pred             EEeeccCCeEEEEEEcCCCcEEEEEEeccCCcc--------CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           30 IQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQ--------GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +.||+|++|.||+|.. +|..|++|........        ....+.+|+.++..+.|+|++....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4589999999999987 6888999986543211        123578899999999999988877777777888999999


Q ss_pred             CCCCChHHHHH-----------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          102 MPNKSLDSSFS-----------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       102 ~~~gsL~~~l~-----------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      ++|++|.+.+.           +++.++.++|.   .+++|+|++|.||+++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNGMEELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999987653           34444555554   5899999999999999 78899999998864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=1.1e-17  Score=144.31  Aligned_cols=126  Identities=20%  Similarity=0.181  Sum_probs=97.3

Q ss_pred             eeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCcc----------------------CHHHHHHHHHHHHhcCCC--C
Q 039516           26 WHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQ----------------------GRVEFQNEAKLIAKLQYT--N   81 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H~--n   81 (345)
                      |.+.+.||+|+||.||++...+|+.||||++......                      ....+..|..++.++.|+  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            6677889999999999998888999999987643210                      112367889999999887  4


Q ss_pred             eeeEEEEEEECCeeEEEEecCCCCChHHHH---------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcc
Q 039516           82 LVKLLGCSIHGEERLLVYEFMPNKSLDSSF---------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF  152 (345)
Q Consensus        82 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l---------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Df  152 (345)
                      ++..++.    ...++||||+++++|....         .+++.++.++|.   .|++||||||+||+++.++.++|+||
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~~~~~liDf  169 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDDEKIYIIDW  169 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCCCcEEEEEC
Confidence            4554442    3458999999999886553         244555555665   58999999999999999999999999


Q ss_pred             ccceee
Q 039516          153 GMARIF  158 (345)
Q Consensus       153 gl~~~~  158 (345)
                      |.+...
T Consensus       170 g~~~~~  175 (198)
T cd05144         170 PQMVST  175 (198)
T ss_pred             CccccC
Confidence            998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=4e-17  Score=140.70  Aligned_cols=121  Identities=22%  Similarity=0.333  Sum_probs=96.2

Q ss_pred             eeccCCeEEEEEEcCCCcEEEEEEeccCCc--c------CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           32 QEQTRDRVILVGKFPNEQEVAIKRLAWTSG--Q------GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        32 lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~--~------~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      ||+|+||.||+|.+ +|..|++|.......  .      ....+.+|++++..++|+++.....++...+..++||||++
T Consensus         2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            89999999999986 578999998643311  1      12457789999999998876655555666777899999999


Q ss_pred             CCChHHHH--------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          104 NKSLDSSF--------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       104 ~gsL~~~l--------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      |++|.+.+        .+++.++.++|..   |++|+|++|.||+++ ++.++++|||++..
T Consensus        81 g~~l~~~~~~~~~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        81 GKPLKDVIEEGNDELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CccHHHHHhhcHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99998654        3455566666654   899999999999999 78999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.72  E-value=4.8e-17  Score=160.75  Aligned_cols=128  Identities=19%  Similarity=0.223  Sum_probs=101.3

Q ss_pred             eeeEEEeeccCCeEEEEEEcCCCcEEEEEEe-ccC-Cc------cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           26 WHMYIQQEQTRDRVILVGKFPNEQEVAIKRL-AWT-SG------QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~-~~~-~~------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      |...+.||+|+||.||+|.+... .+++|+. ... ..      .....+.+|+++++.++|+|++....++......++
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l  413 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI  413 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence            34567899999999999987543 4444433 211 11      123468899999999999999988888777778899


Q ss_pred             EEecCCCCChHHHH-------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           98 VYEFMPNKSLDSSF-------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        98 v~e~~~~gsL~~~l-------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      ||||+++++|.+++       .+++.++.+||..   +++||||||+|||+ .++.++|+|||+++..
T Consensus       414 v~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        414 VMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            99999999998876       3667777777765   89999999999999 6778999999998753

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=2e-17  Score=146.29  Aligned_cols=126  Identities=17%  Similarity=0.150  Sum_probs=94.0

Q ss_pred             CeeeEEEeeccCCeEEEEEE--cCCCcEEEEEEeccCCcc------------------------CHHHHHHHHHHHHhcC
Q 039516           25 DWHMYIQQEQTRDRVILVGK--FPNEQEVAIKRLAWTSGQ------------------------GRVEFQNEAKLIAKLQ   78 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~--~~~~~~VaiK~~~~~~~~------------------------~~~~~~~E~~~l~~l~   78 (345)
                      .|.+.+.||+|++|.||+|.  ..+|+.||+|.++.....                        ....+..|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47888999999999999998  568999999998754210                        0123568999999997


Q ss_pred             CC--CeeeEEEEEEECCeeEEEEecCCCCChHHH---------------HHhHHHHHHHHHhcCCCc-eEEeccCCCCee
Q 039516           79 YT--NLVKLLGCSIHGEERLLVYEFMPNKSLDSS---------------FSGTFKDLLCLHKYSRLR-VIHRDLKASNIL  140 (345)
Q Consensus        79 H~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~---------------l~~~~~~l~~lh~~~~~~-ivHrdlk~~Nil  140 (345)
                      +.  .+.+++++    ...++||||+++++|...               +.+++.++.+||   ..| ++||||||+||+
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIl  181 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNIL  181 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEE
Confidence            53  34455543    235899999999876432               224444444555   458 999999999999


Q ss_pred             eCCCCCEEEEccccceee
Q 039516          141 LDDQLNTKISDFGMARIF  158 (345)
Q Consensus       141 l~~~~~~kl~Dfgl~~~~  158 (345)
                      ++ ++.++|+|||.+...
T Consensus       182 i~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      182 VH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EE-CCCEEEEEChhhhcc
Confidence            99 788999999998754

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=6.7e-17  Score=146.34  Aligned_cols=180  Identities=20%  Similarity=0.154  Sum_probs=118.4

Q ss_pred             CCCCeeeEEEEEEE---------------------------CCeeEEEEecCCCCChHHHHH-----------hHHHHHH
Q 039516           78 QYTNLVKLLGCSIH---------------------------GEERLLVYEFMPNKSLDSSFS-----------GTFKDLL  119 (345)
Q Consensus        78 ~H~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~-----------~~~~~l~  119 (345)
                      +|||||+++++|.+                           ...+|+||.-.+. +|.+++.           .+++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence            69999999988754                           2256888887754 6666654           3445555


Q ss_pred             HHHhcCCCceEEeccCCCCeee--CCCCC--EEEEccccceeecCCCCCC----cccceeecCCccccchhccCC--c--
Q 039516          120 CLHKYSRLRVIHRDLKASNILL--DDQLN--TKISDFGMARIFGVNESGA----NTNRIVGTYGYMSLEYTMSGT--V--  187 (345)
Q Consensus       120 ~lh~~~~~~ivHrdlk~~Nill--~~~~~--~kl~Dfgl~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~--~--  187 (345)
                      +..++|+.||.|||+|++|||+  ++++.  +.|+|||++-.-....-..    ..-..-|.-..||||+...-+  .  
T Consensus       353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av  432 (598)
T KOG4158|consen  353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV  432 (598)
T ss_pred             HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence            5555555599999999999999  44444  6899999986532211100    001123566789999876422  1  


Q ss_pred             --CcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCC
Q 039516          188 --SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQ  265 (345)
Q Consensus       188 --~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P  265 (345)
                        -.|+|.|+.|.+.||+++...||....+. ..+          .....+--=|.+.+.+++...   +++..-|+.||
T Consensus       433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~----------~r~Yqe~qLPalp~~vpp~~r---qlV~~lL~r~p  498 (598)
T KOG4158|consen  433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLD----------TRTYQESQLPALPSRVPPVAR---QLVFDLLKRDP  498 (598)
T ss_pred             eccchhhhhhhhhhHHHHhccCCcccccchh-eec----------hhhhhhhhCCCCcccCChHHH---HHHHHHhcCCc
Confidence              26799999999999999999999762211 111          111222223444455555444   78888899999


Q ss_pred             CcCCCCC
Q 039516          266 IDVQCPM  272 (345)
Q Consensus       266 ~~RPs~~  272 (345)
                      ++|||+.
T Consensus       499 skRvsp~  505 (598)
T KOG4158|consen  499 SKRVSPN  505 (598)
T ss_pred             cccCCcc
Confidence            9999964

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.69  E-value=3.8e-18  Score=159.67  Aligned_cols=228  Identities=18%  Similarity=0.153  Sum_probs=141.4

Q ss_pred             eeeEEEeeccCCeEEEEEEcCCC----cEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEE-------EEEE---
Q 039516           26 WHMYIQQEQTRDRVILVGKFPNE----QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-------CSIH---   91 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~~~----~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~-------~~~~---   91 (345)
                      ..+.+..+.++++.++.+...++    ..++-|..+..+........+++-.+....|-+..-+..       .+..   
T Consensus       246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v  325 (516)
T KOG1033|consen  246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV  325 (516)
T ss_pred             ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence            44556677778887776644332    344444444433222333344444444444433332222       1111   


Q ss_pred             --CCeeEEEEecCCCCChHHHHH--------hHHHHHHHHHhcCC----CceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516           92 --GEERLLVYEFMPNKSLDSSFS--------GTFKDLLCLHKYSR----LRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus        92 --~~~~~lv~e~~~~gsL~~~l~--------~~~~~l~~lh~~~~----~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                        ...+|+.|++|...+|.+++.        .....+...+....    ++.+|+|+||.||++..+..+||+|||+...
T Consensus       326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~yk~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEYKGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhhccchhhhccccccccccchhhhhhhhhheee
Confidence              225789999999999999985        11222222333221    6899999999999999999999999999887


Q ss_pred             ecCCC----CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcC
Q 039516          158 FGVNE----SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEG  232 (345)
Q Consensus       158 ~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (345)
                      .....    .....+.-.||..||+||.+.+..|+.++||||||++++|+++ -...+....          +..-++.+
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~r~g  475 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDIRDG  475 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhhhcC
Confidence            64433    1223344689999999999999999999999999999999998 333322111          11111222


Q ss_pred             CccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCC
Q 039516          233 KDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       233 ~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                      .+.    |....+++ .+   ..+.++.+...|.+||+.
T Consensus       476 ~ip----~~~~~d~p-~e---~~ll~~lls~~p~~RP~~  506 (516)
T KOG1033|consen  476 IIP----PEFLQDYP-EE---YTLLQQLLSPSPEERPSA  506 (516)
T ss_pred             CCC----hHHhhcCc-HH---HHHHHHhcCCCcccCchH
Confidence            221    11111111 11   478899999999999963

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=3.9e-16  Score=127.33  Aligned_cols=126  Identities=19%  Similarity=0.174  Sum_probs=106.9

Q ss_pred             EEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCC--CCeeeEEEEEEECCeeEEEEecCCCCC
Q 039516           29 YIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY--TNLVKLLGCSIHGEERLLVYEFMPNKS  106 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~~~~~~~~~~~~~lv~e~~~~gs  106 (345)
                      .+.||+|.++.||++... +..+++|.......  ...+.+|+.++..++|  .+++++++++...+..+++|||+++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            466999999999999875 47899999865433  5678999999999976  589999998887788999999999987


Q ss_pred             hHH--------HHHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          107 LDS--------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       107 L~~--------~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      +..        ....++..+..+|..+..+++|+|++|.||+++..+.++++|||.+..
T Consensus        80 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            752        234677788899988777899999999999999988999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.64  E-value=1.4e-15  Score=129.67  Aligned_cols=122  Identities=19%  Similarity=0.187  Sum_probs=85.9

Q ss_pred             EEeeccCCeEEEEEEcCCCcEEEEEEeccCCcc--CHHH----------------------HHHHHHHHHhcCCC--Cee
Q 039516           30 IQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQ--GRVE----------------------FQNEAKLIAKLQYT--NLV   83 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~--niv   83 (345)
                      +.||+|+||.||++...+|+.||||++......  ....                      ...|...+.++.+.  .+.
T Consensus         3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~   82 (187)
T cd05119           3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP   82 (187)
T ss_pred             cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence            459999999999998888999999998654211  1111                      13566666666443  355


Q ss_pred             eEEEEEEECCeeEEEEecCCCC-----ChHHH---------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEE
Q 039516           84 KLLGCSIHGEERLLVYEFMPNK-----SLDSS---------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKI  149 (345)
Q Consensus        84 ~~~~~~~~~~~~~lv~e~~~~g-----sL~~~---------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl  149 (345)
                      +.+++    ...++||||++++     +|.+.         +.+++.++.++|..  .+|+|+||||+||+++ ++.++|
T Consensus        83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~~~~l  155 (187)
T cd05119          83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DGKVYI  155 (187)
T ss_pred             ceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CCcEEE
Confidence            55543    2458999999993     34332         22344445555541  5899999999999999 889999


Q ss_pred             Eccccceee
Q 039516          150 SDFGMARIF  158 (345)
Q Consensus       150 ~Dfgl~~~~  158 (345)
                      +|||.+...
T Consensus       156 iDfg~a~~~  164 (187)
T cd05119         156 IDVPQAVEI  164 (187)
T ss_pred             EECcccccc
Confidence            999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=7.7e-15  Score=130.02  Aligned_cols=124  Identities=19%  Similarity=0.188  Sum_probs=94.1

Q ss_pred             Eee-ccCCeEEEEEEcCCCcEEEEEEeccCC-------------ccCHHHHHHHHHHHHhcCCCCe--eeEEEEEEECC-
Q 039516           31 QQE-QTRDRVILVGKFPNEQEVAIKRLAWTS-------------GQGRVEFQNEAKLIAKLQYTNL--VKLLGCSIHGE-   93 (345)
Q Consensus        31 ~lG-~G~~g~vy~~~~~~~~~VaiK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~~~~~~~~~~-   93 (345)
                      .|| .||.|+||..... +..++||.+....             ......+.+|++++.+|.|++|  ++.+++..... 
T Consensus        38 ~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         38 VVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             eeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            477 8888999988774 7889999885321             1223467889999999998875  77777654432 


Q ss_pred             ---eeEEEEecCCC-CChHHHHH----------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           94 ---ERLLVYEFMPN-KSLDSSFS----------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        94 ---~~~lv~e~~~~-gsL~~~l~----------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                         ..++||||+++ .+|.+++.          +++.++.+||..   ||+||||||.|||++.++.++|+|||.+...
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence               23599999997 68876643          455555556654   8999999999999999889999999988753

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.55  E-value=2.1e-14  Score=137.94  Aligned_cols=130  Identities=19%  Similarity=0.191  Sum_probs=93.2

Q ss_pred             EEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCH----------------------------------------HHHHH
Q 039516           30 IQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGR----------------------------------------VEFQN   69 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~----------------------------------------~~~~~   69 (345)
                      +.||.|++|.||+|++.+|+.||||+.++......                                        -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            56999999999999999999999999865421100                                        02556


Q ss_pred             HHHHHHhc----CCCCeeeEEEEEE-ECCeeEEEEecCCCCChHHHHH---------hHHHHH--HHHHhcCCCceEEec
Q 039516           70 EAKLIAKL----QYTNLVKLLGCSI-HGEERLLVYEFMPNKSLDSSFS---------GTFKDL--LCLHKYSRLRVIHRD  133 (345)
Q Consensus        70 E~~~l~~l----~H~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~---------~~~~~l--~~lh~~~~~~ivHrd  133 (345)
                      |+..+.++    +|.+-+.+-.++. ..+..+|||||++|++|.+...         .++..+  .+++..|..|++|+|
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~D  282 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHAD  282 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeCC
Confidence            66666665    2333233333322 2345799999999999977643         122221  246666777999999


Q ss_pred             cCCCCeeeCCCCCEEEEccccceeec
Q 039516          134 LKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus       134 lk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      ++|.||+++.++.++++|||++..++
T Consensus       283 ~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       283 LHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCcccEEECCCCcEEEEeCCCeeECC
Confidence            99999999999999999999998763

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=1.2e-15  Score=151.04  Aligned_cols=234  Identities=18%  Similarity=0.139  Sum_probs=168.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC--CCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP--NEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~--~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~l   97 (345)
                      ...|.+...||+|+|+.|-.....  ....+|.|.+....  .........|..+-..+. |+|++++++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            566888888999999999877553  34567777765443  223334455777777776 9999999999999999999


Q ss_pred             EEecCCCCChHHHH-H----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC-CEEEEccccceeec
Q 039516           98 VYEFMPNKSLDSSF-S----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL-NTKISDFGMARIFG  159 (345)
Q Consensus        98 v~e~~~~gsL~~~l-~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgl~~~~~  159 (345)
                      +++|..++++.+.+ .                +...++.|+|.  ..++.|+|+||+|.+++..+ ..+++|||++..+.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999988876655 2                44455666663  44899999999999999999 99999999999876


Q ss_pred             C-CCCCCcccceee-cCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          160 V-NESGANTNRIVG-TYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       160 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                      . ..........+| ++.|+|||...+. -.....|+||.|+++.-+++|..|+......... ..             .
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~-------------~  242 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YS-------------S  242 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ce-------------e
Confidence            5 444444455678 9999999988874 4467799999999999999999999875533211 11             1


Q ss_pred             cccccCC-CCCChhHHH-H-HHHHhhccCCCCCcCCCCC
Q 039516          237 LIDLTLD-GSCPPNEDA-F-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       237 ~~d~~l~-~~~~~~~~~-~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .....-. ...+..... . ..+...++..+|..|.+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~  281 (601)
T KOG0590|consen  243 WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIE  281 (601)
T ss_pred             ecccccccccCccccCChhhhhcccccccCCchhccccc
Confidence            1111100 001111111 1 4777788889999999954

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=5.6e-13  Score=111.58  Aligned_cols=124  Identities=19%  Similarity=0.133  Sum_probs=94.3

Q ss_pred             EEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCe-eeEEEEEEECCeeEEEEecCCCCCh
Q 039516           29 YIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNL-VKLLGCSIHGEERLLVYEFMPNKSL  107 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~gsL  107 (345)
                      ++.|++|.++.||+.... +..|++|....... ....+..|+.+++.+.+.++ .+++.+.  ....++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            356899999999999875 78899999864432 23356789999999865554 4555543  3345899999999988


Q ss_pred             HH-------HHHhHHHHHHHHHhcC--CCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          108 DS-------SFSGTFKDLLCLHKYS--RLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       108 ~~-------~l~~~~~~l~~lh~~~--~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      ..       .+.++++.+..||...  ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTEDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            63       3457777888888764  33579999999999999 66799999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.43  E-value=3.5e-13  Score=131.31  Aligned_cols=136  Identities=15%  Similarity=0.137  Sum_probs=96.0

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCC-CcEEEEEEeccCCcc----------------------------------CH---
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPN-EQEVAIKRLAWTSGQ----------------------------------GR---   64 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~-~~~VaiK~~~~~~~~----------------------------------~~---   64 (345)
                      ..+|+. +.||+|++|.||+|.+.+ |+.||||+..+.-..                                  ..   
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 679999999999999876 999999999754110                                  00   


Q ss_pred             ---HHHHHHHHHHHhcC----CCCeeeEEEEEEE-CCeeEEEEecCCCCChHHH--HH-------hHHH--HHHHHHhcC
Q 039516           65 ---VEFQNEAKLIAKLQ----YTNLVKLLGCSIH-GEERLLVYEFMPNKSLDSS--FS-------GTFK--DLLCLHKYS  125 (345)
Q Consensus        65 ---~~~~~E~~~l~~l~----H~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~--l~-------~~~~--~l~~lh~~~  125 (345)
                         -+|.+|+..+.++.    +.+.+.+-.++.+ ....+|||||++|+++.+.  +.       .++.  .-.++.+..
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence               12455665555552    4444444444432 4567899999999999764  22       1221  123555566


Q ss_pred             CCceEEeccCCCCeeeCCCC----CEEEEccccceeec
Q 039516          126 RLRVIHRDLKASNILLDDQL----NTKISDFGMARIFG  159 (345)
Q Consensus       126 ~~~ivHrdlk~~Nill~~~~----~~kl~Dfgl~~~~~  159 (345)
                      ..|++|+|++|.||+++.++    .++++|||++..++
T Consensus       278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            67999999999999999888    89999999998764

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.30  E-value=1.9e-11  Score=118.17  Aligned_cols=179  Identities=12%  Similarity=0.160  Sum_probs=124.9

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEE-EcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVG-KFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~-~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ++..-|.+ ...+-++.+.+-.| ...++.+|.|...+..+........+-++.|+.++||||++++..+...+..|||+
T Consensus        10 ~~~fpY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvT   88 (690)
T KOG1243|consen   10 SSQFPYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVT   88 (690)
T ss_pred             cccCCccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEe
Confidence            33444554 33344444433234 45578999999997766544455677789999999999999999999999999999


Q ss_pred             ecCCCCC--hHHH--------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccc
Q 039516          100 EFMPNKS--LDSS--------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNR  169 (345)
Q Consensus       100 e~~~~gs--L~~~--------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  169 (345)
                      |-+.--.  |.+.        +.+++.+|.+||..+  +++|++|.-..|+++..|..||++|.++........  ....
T Consensus        89 ErV~Pl~~~lk~l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~  164 (690)
T KOG1243|consen   89 ERVRPLETVLKELGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKS  164 (690)
T ss_pred             eccccHHHHHHHhHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--cccc
Confidence            9885422  1111        237778888888665  799999999999999999999999988765422111  0111


Q ss_pred             eeecCCccccchhccCCcCcccchhhHHHHHHHHHhC
Q 039516          170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG  206 (345)
Q Consensus       170 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg  206 (345)
                      ..--..|..|+.+....  ...|.|-|||+++|++.|
T Consensus       165 ~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  165 LYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            11222355666433222  346999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.29  E-value=4.1e-12  Score=121.43  Aligned_cols=189  Identities=17%  Similarity=0.194  Sum_probs=142.6

Q ss_pred             CCCCeeeEEEeec--cCCeEEEEEEc---CCCcEEEEEEec--cCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECC
Q 039516           22 SSLDWHMYIQQEQ--TRDRVILVGKF---PNEQEVAIKRLA--WTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGE   93 (345)
Q Consensus        22 ~~~~~~~~~~lG~--G~~g~vy~~~~---~~~~~VaiK~~~--~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~   93 (345)
                      +...|.+..-+|.  |.+|.+|.+..   .++..+|+|+-+  .........=.+|+...+++ .|+|.++.+..+...+
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            4455666677999  99999999876   468899999843  23334444455677777777 5999999999999999


Q ss_pred             eeEEEEecCCCCChHHHHH-------------hHHHHHH----HHHhcCCCceEEeccCCCCeeeCCC-CCEEEEccccc
Q 039516           94 ERLLVYEFMPNKSLDSSFS-------------GTFKDLL----CLHKYSRLRVIHRDLKASNILLDDQ-LNTKISDFGMA  155 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~-------------~~~~~l~----~lh~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgl~  155 (345)
                      ..++-+|+|. .+|..+..             ....-+.    +|+..|+.+++|-|+||.||+...+ ..++++|||+.
T Consensus       192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence            9999999986 45544433             1222233    6777788899999999999999999 88999999999


Q ss_pred             eeecCCCCCCcc---cceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 039516          156 RIFGVNESGANT---NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKS  212 (345)
Q Consensus       156 ~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~  212 (345)
                      ..++........   ....|...|++||... +.++..+|+||+|.++.+..+|...+..
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSV  329 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccC
Confidence            988654422221   2235677899999654 5678999999999999999998766543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.29  E-value=1.8e-12  Score=115.26  Aligned_cols=135  Identities=19%  Similarity=0.235  Sum_probs=100.2

Q ss_pred             HHHhcCCCCeeeEEEEEEEC-----CeeEEEEecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCc
Q 039516           73 LIAKLQYTNLVKLLGCSIHG-----EERLLVYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLR  128 (345)
Q Consensus        73 ~l~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~  128 (345)
                      -|-++-|.|||+++.++.+.     ....+++|||..|++..+|+                   ++..+|.|||... ..
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence            45566799999999998653     35689999999999988776                   6778899999864 68


Q ss_pred             eEEeccCCCCeeeCCCCCEEEEccccceeecCC--CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhC
Q 039516          129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVN--ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG  206 (345)
Q Consensus       129 ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg  206 (345)
                      |+|+++..+-|++..+|-+|++--.-.......  ..........+-++|.+||+=.....+.++|||+||....+|..+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            999999999999999988887532111110000  001112224567889999976666677889999999999999988


Q ss_pred             CC
Q 039516          207 KK  208 (345)
Q Consensus       207 ~~  208 (345)
                      ..
T Consensus       279 Ei  280 (458)
T KOG1266|consen  279 EI  280 (458)
T ss_pred             ee
Confidence            75

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.16  E-value=2e-10  Score=95.20  Aligned_cols=122  Identities=21%  Similarity=0.309  Sum_probs=89.0

Q ss_pred             EeeccCCeEEEEEEcCCCcEEEEEEec-cC--Ccc-----CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           31 QQEQTRDRVILVGKFPNEQEVAIKRLA-WT--SGQ-----GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~~~~~VaiK~~~-~~--~~~-----~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      .+++|+-+.+|.+.+- |.++++|.-. +.  .+.     ...+..+|+.++.+++--.|....=+..+.+...|+|||.
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            4789999999999774 5557777532 22  111     2335678999999986555544444555777788999999


Q ss_pred             CCCChHHHHH--------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          103 PNKSLDSSFS--------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       103 ~~gsL~~~l~--------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      +|..|.+.+.        .+-..+.-||.   .||+|+||.++||++.... +.++|||++..
T Consensus        82 ~G~~lkd~l~~~~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEARPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhcchHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999987665        23333444555   4999999999999998875 99999999874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.15  E-value=4.2e-11  Score=114.57  Aligned_cols=186  Identities=17%  Similarity=0.063  Sum_probs=139.6

Q ss_pred             cccCCCCeeeEEEeeccCCeEEEEEEc--CCCcEEEEEEeccCCccCHH--HHHHHHHHHHhc-CCCCeeeEEEEEEECC
Q 039516           19 VENSSLDWHMYIQQEQTRDRVILVGKF--PNEQEVAIKRLAWTSGQGRV--EFQNEAKLIAKL-QYTNLVKLLGCSIHGE   93 (345)
Q Consensus        19 ~~~~~~~~~~~~~lG~G~~g~vy~~~~--~~~~~VaiK~~~~~~~~~~~--~~~~E~~~l~~l-~H~niv~~~~~~~~~~   93 (345)
                      +.....+|..+.+||.|.|+.|+....  .++..+++|.+.........  .-..|+.+...+ .|.++++++..|...+
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            555677899999999999999998754  36789999988654222211  224566666555 6899999998888888


Q ss_pred             eeEEEEecCCCCChHHHH------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCC-CCEEEEccccceeecC
Q 039516           94 ERLLVYEFMPNKSLDSSF------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ-LNTKISDFGMARIFGV  160 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgl~~~~~~  160 (345)
                      +.|+--|||.++++....            ...++.+..+|..|++.++|+|+||+||++.++ +..+++|||+.+.+.-
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence            889999999999875432            255677888888889999999999999999886 7789999999864321


Q ss_pred             CCCCCcccceeecCCcc--ccchhccCCcCcccchhhHHHHHHHHHhCCCC
Q 039516          161 NESGANTNRIVGTYGYM--SLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN  209 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p  209 (345)
                      ..     ......-++.  ++.......+..+.|++|||..+.+.++|..-
T Consensus       420 ~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  420 SS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             ec-----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence            11     1112223333  55555667788999999999999999998753

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.13  E-value=6.3e-10  Score=94.91  Aligned_cols=121  Identities=17%  Similarity=0.186  Sum_probs=83.8

Q ss_pred             EeeccCCeEEEEEEcCC-------CcEEEEEEeccCC------------c----------cCHHHHH----HHHHHHHhc
Q 039516           31 QQEQTRDRVILVGKFPN-------EQEVAIKRLAWTS------------G----------QGRVEFQ----NEAKLIAKL   77 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~~-------~~~VaiK~~~~~~------------~----------~~~~~~~----~E~~~l~~l   77 (345)
                      .||.|--+.||.|...+       +..+|||+.+...            .          .....+.    +|++.|+++
T Consensus         4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl   83 (197)
T cd05146           4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM   83 (197)
T ss_pred             ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            48999999999997543       4799999874321            0          0122233    799999998


Q ss_pred             CC--CCeeeEEEEEEECCeeEEEEecCCCCC-----hHH----------HHHhHHHHHHHHHhcCCCceEEeccCCCCee
Q 039516           78 QY--TNLVKLLGCSIHGEERLLVYEFMPNKS-----LDS----------SFSGTFKDLLCLHKYSRLRVIHRDLKASNIL  140 (345)
Q Consensus        78 ~H--~niv~~~~~~~~~~~~~lv~e~~~~gs-----L~~----------~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nil  140 (345)
                      ..  -++.+++++    ..-++||||+.++.     |.+          .+.++...+..++  |..|+||+||++.||+
T Consensus        84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~--H~~glVHGDLs~~NIL  157 (197)
T cd05146          84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLY--KECNLVHADLSEYNML  157 (197)
T ss_pred             HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHH--HhCCeecCCCCHHHEE
Confidence            53  567777765    45689999997642     211          1224444444442  3448999999999999


Q ss_pred             eCCCCCEEEEccccceee
Q 039516          141 LDDQLNTKISDFGMARIF  158 (345)
Q Consensus       141 l~~~~~~kl~Dfgl~~~~  158 (345)
                      ++ ++.+.|+|||.+...
T Consensus       158 ~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             EE-CCcEEEEECCCceeC
Confidence            97 467999999988764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.11  E-value=3.7e-10  Score=98.42  Aligned_cols=128  Identities=16%  Similarity=0.185  Sum_probs=95.4

Q ss_pred             EEeeccCCeEEEEEEcCCCcEEEEEEeccCCc-cCHHHHHHHHHHHHhcCC--CCeeeEEEEEEECC---eeEEEEecCC
Q 039516           30 IQQEQTRDRVILVGKFPNEQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQY--TNLVKLLGCSIHGE---ERLLVYEFMP  103 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~~~~~~~~~~---~~~lv~e~~~  103 (345)
                      ..||.|.++.+|+....+|..+++|....... .....+..|+++++.+.+  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            45899999999999887678999999865422 235578899999999975  44677787765532   5689999999


Q ss_pred             CCChHHH--------------HHhHHHHHHHHHhc---------------------------------------------
Q 039516          104 NKSLDSS--------------FSGTFKDLLCLHKY---------------------------------------------  124 (345)
Q Consensus       104 ~gsL~~~--------------l~~~~~~l~~lh~~---------------------------------------------  124 (345)
                      |.++.+.              ..++++.+..||..                                             
T Consensus        84 G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (223)
T cd05154          84 GRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRW  163 (223)
T ss_pred             CEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHH
Confidence            8877543              23455555555532                                             


Q ss_pred             --------CCCceEEeccCCCCeeeCC--CCCEEEEcccccee
Q 039516          125 --------SRLRVIHRDLKASNILLDD--QLNTKISDFGMARI  157 (345)
Q Consensus       125 --------~~~~ivHrdlk~~Nill~~--~~~~kl~Dfgl~~~  157 (345)
                              ....++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       164 ~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         164 LEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                    1246899999999999998  56689999987753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.05  E-value=2.2e-09  Score=88.79  Aligned_cols=126  Identities=23%  Similarity=0.231  Sum_probs=89.9

Q ss_pred             eEEEeeccCCeEEEEEEcCCCcEEEEEEe-ccC-------CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           28 MYIQQEQTRDRVILVGKFPNEQEVAIKRL-AWT-------SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~~~~~VaiK~~-~~~-------~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+..+-+|+-+.|+++.+. |+...||.- .+.       ..-...+..+|+++|.++.--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4566899999999999985 888788753 222       1123456788999999986555544444556666778999


Q ss_pred             ecCCCC-ChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC---EEEEcccccee
Q 039516          100 EFMPNK-SLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN---TKISDFGMARI  157 (345)
Q Consensus       100 e~~~~g-sL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfgl~~~  157 (345)
                      ||++|. ++.+++.                 .+-+.+.-||..   +|||+||..+||++..++.   +.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999883 4444433                 334445555555   7999999999999965543   68999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.03  E-value=1.8e-10  Score=116.15  Aligned_cols=194  Identities=13%  Similarity=0.170  Sum_probs=132.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ..++.+.+-+-+|.++.++..... .|...++|.....   .....+....+-.++-...||-++...-.+......+|+
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            345667777889999999887543 3544455544222   111222223333333334557777666555567788999


Q ss_pred             EecCCCCChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC-----
Q 039516           99 YEFMPNKSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN-----  161 (345)
Q Consensus        99 ~e~~~~gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~-----  161 (345)
                      ++|+.+++|...++            .++.....+.+++...+.|+|++|.|+++..++..++.|||.....+..     
T Consensus       883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~  962 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD  962 (1205)
T ss_pred             hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence            99999999988766            2333333344444445899999999999999999999999844332110     


Q ss_pred             C----------------C--------CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 039516          162 E----------------S--------GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTE  216 (345)
Q Consensus       162 ~----------------~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~  216 (345)
                      .                .        ........||+.|.+||...+......+|+|++|++++|.++|..||....++
T Consensus       963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen  963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred             cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence            0                0        01122357899999999999999999999999999999999999999876543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.99  E-value=6.1e-09  Score=88.48  Aligned_cols=113  Identities=22%  Similarity=0.278  Sum_probs=71.7

Q ss_pred             EEEEEEcCCCcEEEEEEeccCC--------------c-------c-----CHHHHHHHHHHHHhcCCC--CeeeEEEEEE
Q 039516           39 VILVGKFPNEQEVAIKRLAWTS--------------G-------Q-----GRVEFQNEAKLIAKLQYT--NLVKLLGCSI   90 (345)
Q Consensus        39 ~vy~~~~~~~~~VaiK~~~~~~--------------~-------~-----~~~~~~~E~~~l~~l~H~--niv~~~~~~~   90 (345)
                      .||.|...+|..||||..+...              .       .     ......+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899988889999999875421              0       0     022457899999999765  567777552 


Q ss_pred             ECCeeEEEEecCC--CCChHHH-------------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccc
Q 039516           91 HGEERLLVYEFMP--NKSLDSS-------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMA  155 (345)
Q Consensus        91 ~~~~~~lv~e~~~--~gsL~~~-------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~  155 (345)
                         .-+|||||++  |..+..+             +..+...+..+  +|..||+|+||.+.||+++++ .+.++|||.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~--~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa  153 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKM--LHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA  153 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHH--HHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred             ---CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHH--HHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence               3479999998  5444322             22333322222  234599999999999999887 8999999988


Q ss_pred             eee
Q 039516          156 RIF  158 (345)
Q Consensus       156 ~~~  158 (345)
                      ...
T Consensus       154 v~~  156 (188)
T PF01163_consen  154 VDS  156 (188)
T ss_dssp             EET
T ss_pred             eec
Confidence            754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.84  E-value=2.6e-08  Score=87.60  Aligned_cols=124  Identities=17%  Similarity=0.195  Sum_probs=90.9

Q ss_pred             eeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCC----------------------ccCHHHHHHHHHHHHhcCCC--Ce
Q 039516           27 HMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTS----------------------GQGRVEFQNEAKLIAKLQYT--NL   82 (345)
Q Consensus        27 ~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~----------------------~~~~~~~~~E~~~l~~l~H~--ni   82 (345)
                      .+..+||-|--+.||.|..+.|.++|||.=+...                      ...+...++|.++|.+|...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            4567899999999999999999999999532210                      01133467899999999655  77


Q ss_pred             eeEEEEEEECCeeEEEEecCCCCChHHH----------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcc
Q 039516           83 VKLLGCSIHGEERLLVYEFMPNKSLDSS----------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF  152 (345)
Q Consensus        83 v~~~~~~~~~~~~~lv~e~~~~gsL~~~----------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Df  152 (345)
                      .+.+++    +.-.+||||++|..|...          +..+.+-+.-+.   ..||||+|+++-||+++++|.+.++||
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~~~vIDw  246 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGDIVVIDW  246 (304)
T ss_pred             CCcccc----ccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCCEEEEeC
Confidence            777765    455799999988666433          233333333333   348999999999999999999999999


Q ss_pred             cccee
Q 039516          153 GMARI  157 (345)
Q Consensus       153 gl~~~  157 (345)
                      --+..
T Consensus       247 PQ~v~  251 (304)
T COG0478         247 PQAVP  251 (304)
T ss_pred             ccccc
Confidence            65543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.66  E-value=7.1e-08  Score=93.85  Aligned_cols=130  Identities=15%  Similarity=0.131  Sum_probs=90.7

Q ss_pred             EEeeccCCeEEEEEEcCCCcEEEEEEeccCCccC----------------------------------------HHHHHH
Q 039516           30 IQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQG----------------------------------------RVEFQN   69 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~----------------------------------------~~~~~~   69 (345)
                      ..|+.++-|.||+|++.+|+.||||+..++-...                                        .-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            3589999999999999999999999876531000                                        012455


Q ss_pred             HHHHHHhcC-----CCCeeeEEEEEEECCeeEEEEecCCCCChHHHH--H-------hHHHHH--HHHHhcCCCceEEec
Q 039516           70 EAKLIAKLQ-----YTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSF--S-------GTFKDL--LCLHKYSRLRVIHRD  133 (345)
Q Consensus        70 E~~~l~~l~-----H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~-------~~~~~l--~~lh~~~~~~ivHrd  133 (345)
                      |+..+.++.     .+++.--.=++.-.+...|+|||++|..+.+..  +       .++..+  .++...-..|++|.|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dgffHaD  290 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDGFFHAD  290 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcCccccC
Confidence            766666652     344322222333356779999999998887763  2       222221  234444445899999


Q ss_pred             cCCCCeeeCCCCCEEEEccccceeec
Q 039516          134 LKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus       134 lk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      ..|.||+++.+|.+.+.|||+...+.
T Consensus       291 pHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         291 PHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             CCccceEEecCCcEEEEcCcceecCC
Confidence            99999999999999999999988764

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.64  E-value=5.8e-07  Score=80.82  Aligned_cols=122  Identities=16%  Similarity=0.109  Sum_probs=80.5

Q ss_pred             eeccCCeEEEEEEcCCCcEEEEEEeccCCc-----------cCHHHHHHHHHHHHhcCCCC--eeeEEEEEEE-----CC
Q 039516           32 QEQTRDRVILVGKFPNEQEVAIKRLAWTSG-----------QGRVEFQNEAKLIAKLQYTN--LVKLLGCSIH-----GE   93 (345)
Q Consensus        32 lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~n--iv~~~~~~~~-----~~   93 (345)
                      +-......|++..+ +|+.|.||......-           .....+.+|...+.+|..-+  .+..+++...     ..
T Consensus        30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            33334444667666 578999997743221           11124789999998884333  3444555443     23


Q ss_pred             eeEEEEecCCCC-ChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC-------CCCEE
Q 039516           94 ERLLVYEFMPNK-SLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD-------QLNTK  148 (345)
Q Consensus        94 ~~~lv~e~~~~g-sL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~-------~~~~k  148 (345)
                      ..++|||++++. +|.+++.                 .++..+   ..+|..||+|+|+++.|||++.       +..+.
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i---~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMV---RDMHAAGINHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHH---HHHHHCcCccCCCChhhEEEeccccCCCCCceEE
Confidence            568999999986 7877653                 223333   3445559999999999999975       46789


Q ss_pred             EEcccccee
Q 039516          149 ISDFGMARI  157 (345)
Q Consensus       149 l~Dfgl~~~  157 (345)
                      |+||+.+..
T Consensus       186 LIDl~r~~~  194 (268)
T PRK15123        186 VIDLHRAQI  194 (268)
T ss_pred             EEECCcccc
Confidence            999998754

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.51  E-value=1.3e-06  Score=76.75  Aligned_cols=121  Identities=14%  Similarity=0.058  Sum_probs=85.1

Q ss_pred             EEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCC--eeeEEEEEEECCeeEEEEecCCCCC-
Q 039516           30 IQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTN--LVKLLGCSIHGEERLLVYEFMPNKS-  106 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~gs-  106 (345)
                      .+||+|..+.||+.   .|..+++|......  ......+|.++++.+..-+  +.+.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            56999999999984   25567889886433  3455789999999986433  4777888877778889999999963 


Q ss_pred             hHH-----------HHHhHHHHHHHHHhc----------------------------------------CCCceEEeccC
Q 039516          107 LDS-----------SFSGTFKDLLCLHKY----------------------------------------SRLRVIHRDLK  135 (345)
Q Consensus       107 L~~-----------~l~~~~~~l~~lh~~----------------------------------------~~~~ivHrdlk  135 (345)
                      +..           ....+++.+.-||..                                        ....++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            211           111222222222221                                        12247899999


Q ss_pred             CCCeeeCCCCCEEEEccccce
Q 039516          136 ASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus       136 ~~Nill~~~~~~kl~Dfgl~~  156 (345)
                      |.||++++++ +.++||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999888 9999998775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.46  E-value=5.3e-07  Score=87.65  Aligned_cols=128  Identities=16%  Similarity=0.184  Sum_probs=88.8

Q ss_pred             EEeeccCCeEEEEEEcCCCcEEEEEEeccCCccC-------------------------------------HHHHHHHHH
Q 039516           30 IQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQG-------------------------------------RVEFQNEAK   72 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~-------------------------------------~~~~~~E~~   72 (345)
                      +.||..+.|.||++++++|+.||||+-++.-...                                     .-+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            3499999999999999999999999865431100                                     013556666


Q ss_pred             HHHhc----CCCC------eeeEEEEEEECCeeEEEEecCCCCChHHHHH---------hHHHH--HHHHHhcCCCceEE
Q 039516           73 LIAKL----QYTN------LVKLLGCSIHGEERLLVYEFMPNKSLDSSFS---------GTFKD--LLCLHKYSRLRVIH  131 (345)
Q Consensus        73 ~l~~l----~H~n------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~---------~~~~~--l~~lh~~~~~~ivH  131 (345)
                      -..++    .|-+      |.++|-.  -.....|+||||+|..+.+.-.         .++..  -.|++.+-..|.+|
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~GffH  324 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKTGFFH  324 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhcCCcc
Confidence            55444    4555      3333332  2456799999999987766522         22222  23555555569999


Q ss_pred             eccCCCCeeeC----CCCCEEEEccccceeec
Q 039516          132 RDLKASNILLD----DQLNTKISDFGMARIFG  159 (345)
Q Consensus       132 rdlk~~Nill~----~~~~~kl~Dfgl~~~~~  159 (345)
                      .|-.|.||++.    .++.+.+-|||+...+.
T Consensus       325 aDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  325 ADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             CCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            99999999998    36779999999988763

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.46  E-value=1.6e-06  Score=82.37  Aligned_cols=155  Identities=18%  Similarity=0.207  Sum_probs=109.7

Q ss_pred             CCeEEEEEE-cCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEE----ECCeeEEEEecCCC-CChHH
Q 039516           36 RDRVILVGK-FPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSI----HGEERLLVYEFMPN-KSLDS  109 (345)
Q Consensus        36 ~~g~vy~~~-~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~----~~~~~~lv~e~~~~-gsL~~  109 (345)
                      ...+.|++. ..||..|.+|+++............-++.++++.|+|||++..++.    .+..+++|++|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            345678885 4589999999995443333333445678899999999999999876    35578999999986 45544


Q ss_pred             HHH---------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516          110 SFS---------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus       110 ~l~---------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      ..-                           .+.+...+|...|+.|+.-+-|.+.+|+++.+.+++|+..|.......+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~  447 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP  447 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence            321                           33444555555666699999999999999999999998888776553221


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN  209 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p  209 (345)
                                    .+|  +.+   -.+-|.=.||.++.-|.||...
T Consensus       448 --------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  448 --------------TEP--LES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             --------------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence                          011  111   2345888899999999999643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.41  E-value=6.1e-08  Score=94.63  Aligned_cols=95  Identities=21%  Similarity=0.340  Sum_probs=72.4

Q ss_pred             hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC-------cccceeecCCccccchhccC
Q 039516          113 GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA-------NTNRIVGTYGYMSLEYTMSG  185 (345)
Q Consensus       113 ~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~  185 (345)
                      .++.|+.++|..-  ++||++|.|++|.++..+..||+.|+++..........       ..........|.|||++...
T Consensus       107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            4557888998764  89999999999999999999999999876543211100       00112234569999999988


Q ss_pred             CcCcccchhhHHHHHHHHHhCCCC
Q 039516          186 TVSIKTDVFGFGVLVLKIVCGKKN  209 (345)
Q Consensus       186 ~~~~~~Di~SlG~il~el~tg~~p  209 (345)
                      ..+.++|+||+|+++|.+..|..+
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~  208 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKS  208 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcc
Confidence            889999999999999999954443

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.40  E-value=4.3e-06  Score=72.13  Aligned_cols=134  Identities=12%  Similarity=0.114  Sum_probs=84.6

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHH---------HHHHHHHHhcCC---CCeeeEEEEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEF---------QNEAKLIAKLQY---TNLVKLLGCS   89 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~---------~~E~~~l~~l~H---~niv~~~~~~   89 (345)
                      .+.+|...+.+-.....-|.+-.. +|+.+.+|..........+.|         .+++..+.+++.   .....++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            456677777777777777776666 578999999866543222222         233333334422   2333333332


Q ss_pred             E-----ECCeeEEEEecCCCCChHHHHH---hH-HHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516           90 I-----HGEERLLVYEFMPNKSLDSSFS---GT-FKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus        90 ~-----~~~~~~lv~e~~~~gsL~~~l~---~~-~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      .     -....+++|||++|..|.+...   .+ -...+++...|..|+.|+|..|.|+++++++ ++++||+..+.
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence            2     2234579999999988865421   11 1233455666666999999999999998655 99999986654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.37  E-value=6.6e-06  Score=71.84  Aligned_cols=121  Identities=17%  Similarity=0.219  Sum_probs=83.2

Q ss_pred             EeeccCCeEEEEEEcCCCcEEEEEEeccCCcc-------------------CHHH-----HHHHHHHHHhcC--CCCeee
Q 039516           31 QQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQ-------------------GRVE-----FQNEAKLIAKLQ--YTNLVK   84 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~-------------------~~~~-----~~~E~~~l~~l~--H~niv~   84 (345)
                      .|..|--+.||+|...++..||+|+++.....                   +..+     ..+|..-|+++.  +-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            47778888999998878999999998653211                   1111     235777787773  445556


Q ss_pred             EEEEEEECCeeEEEEecCCCC-----ChHH----------HHHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEE
Q 039516           85 LLGCSIHGEERLLVYEFMPNK-----SLDS----------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKI  149 (345)
Q Consensus        85 ~~~~~~~~~~~~lv~e~~~~g-----sL~~----------~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl  149 (345)
                      .+++.    +-.|||||+...     .|.+          .+..+.+.+.-|...  .++||+||+.-|||+. ++.+.+
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p~i  207 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEPYI  207 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeEEE
Confidence            66554    237999998643     1221          233444555545442  3899999999999999 889999


Q ss_pred             Eccccceee
Q 039516          150 SDFGMARIF  158 (345)
Q Consensus       150 ~Dfgl~~~~  158 (345)
                      +|||-+...
T Consensus       208 ID~~QaV~~  216 (268)
T COG1718         208 IDVSQAVTI  216 (268)
T ss_pred             EECcccccc
Confidence            999988654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.36  E-value=6.8e-06  Score=72.97  Aligned_cols=121  Identities=16%  Similarity=0.130  Sum_probs=83.9

Q ss_pred             eeccCC-eEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEEEecCCCCChHH
Q 039516           32 QEQTRD-RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLVYEFMPNKSLDS  109 (345)
Q Consensus        32 lG~G~~-g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  109 (345)
                      |-.|.+ +.||+.... +..+.+|......   ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444545 789998764 5788888875432   335678999988883 4456788888776667899999999987764


Q ss_pred             H---------HHhHHHHHHHHHhc-------------------------------------------------------C
Q 039516          110 S---------FSGTFKDLLCLHKY-------------------------------------------------------S  125 (345)
Q Consensus       110 ~---------l~~~~~~l~~lh~~-------------------------------------------------------~  125 (345)
                      .         ..++++.+..||..                                                       .
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            3         11222222222211                                                       1


Q ss_pred             CCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516          126 RLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus       126 ~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                      ...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            2348999999999999998778999998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.35  E-value=1.9e-06  Score=71.23  Aligned_cols=124  Identities=19%  Similarity=0.223  Sum_probs=87.9

Q ss_pred             eeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCe-eeEEEEEEECCeeEEEEecCCCC
Q 039516           27 HMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNL-VKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        27 ~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .+...||+|.+|.||.|.+. |..+|+|+-...  .....+..|+++|..++--++ .++|.+..    -++.|||+.|.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence            44566999999999999996 668999987544  346778999999999976655 34555432    24669999998


Q ss_pred             ChHHHHH-----hHHHHHHHHHhcCCCceEEeccCC-CCeeeCCCCCEEEEcccccee
Q 039516          106 SLDSSFS-----GTFKDLLCLHKYSRLRVIHRDLKA-SNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       106 sL~~~l~-----~~~~~l~~lh~~~~~~ivHrdlk~-~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      .|.+...     .+...++.-..+...||-|+.|.- ...++-+++.+.|+||..++.
T Consensus        98 ~L~~~~~~~~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcccHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            8876643     233344433334445899999874 444444555899999998874

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.30  E-value=6.1e-06  Score=71.47  Aligned_cols=112  Identities=19%  Similarity=0.178  Sum_probs=74.1

Q ss_pred             CCcEEEEEEeccC-C------ccCHHHHHHHHHHHHhcCC--CCeeeEEEEEEECC----eeEEEEecCCCC-ChHHHHH
Q 039516           47 NEQEVAIKRLAWT-S------GQGRVEFQNEAKLIAKLQY--TNLVKLLGCSIHGE----ERLLVYEFMPNK-SLDSSFS  112 (345)
Q Consensus        47 ~~~~VaiK~~~~~-~------~~~~~~~~~E~~~l~~l~H--~niv~~~~~~~~~~----~~~lv~e~~~~g-sL~~~l~  112 (345)
                      .++.+-+|..... .      ........+|...+..|..  =.+++.+++.....    ..++|+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            3566666654221 1      1233467889988888843  33556666665432    458999999984 7877654


Q ss_pred             h-----------HHHH-HHHHHhcCCCceEEeccCCCCeeeCCCC---CEEEEccccceee
Q 039516          113 G-----------TFKD-LLCLHKYSRLRVIHRDLKASNILLDDQL---NTKISDFGMARIF  158 (345)
Q Consensus       113 ~-----------~~~~-l~~lh~~~~~~ivHrdlk~~Nill~~~~---~~kl~Dfgl~~~~  158 (345)
                      .           ++.. ...+..+|..||+|+|+++.|||++.+.   .+.++||+.++..
T Consensus       111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  111 QWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            2           1111 2234445555999999999999999887   7999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.28  E-value=2e-05  Score=67.26  Aligned_cols=125  Identities=20%  Similarity=0.237  Sum_probs=88.4

Q ss_pred             CCeeeEEEeeccCC-eEEEEEEcCCCcEEEEEEecc---CCc------------------cCHHHHHHHHHHHHhcC---
Q 039516           24 LDWHMYIQQEQTRD-RVILVGKFPNEQEVAIKRLAW---TSG------------------QGRVEFQNEAKLIAKLQ---   78 (345)
Q Consensus        24 ~~~~~~~~lG~G~~-g~vy~~~~~~~~~VaiK~~~~---~~~------------------~~~~~~~~E~~~l~~l~---   78 (345)
                      .+++.++.||.|.. |.||+.+.. |+.+|+|.+..   ...                  .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67899999999999 999999985 88999999321   110                  11235888999988884   


Q ss_pred             CCCe--eeEEEEEEEC------------------CeeEEEEecCCCCChHHHHHhHHHHHHHHHhcCCCceEEeccCCCC
Q 039516           79 YTNL--VKLLGCSIHG------------------EERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASN  138 (345)
Q Consensus        79 H~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~lh~~~~~~ivHrdlk~~N  138 (345)
                      +.++  |+.+||..-.                  ....||.||.+... .-....+.+.+.-++.+|..||+-+|+++.|
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-~~~~~~~~~~~~dl~~~~k~gI~~~Dv~~~n  194 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-PLQIRDIPQMLRDLKILHKLGIVPRDVKPRN  194 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-ccchhHHHHHHHHHHHHHHCCeeeccCcccc
Confidence            4566  9999987422                  12368999998776 1112233334444444445599999999999


Q ss_pred             eeeCCCCCEEEEccccc
Q 039516          139 ILLDDQLNTKISDFGMA  155 (345)
Q Consensus       139 ill~~~~~~kl~Dfgl~  155 (345)
                      ..     .-||+|||.+
T Consensus       195 y~-----~G~lvDfs~~  206 (207)
T PF13095_consen  195 YR-----GGKLVDFSSS  206 (207)
T ss_pred             cc-----CCEEEecccC
Confidence            86     4589999864

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.27  E-value=1.2e-05  Score=70.25  Aligned_cols=126  Identities=19%  Similarity=0.170  Sum_probs=81.8

Q ss_pred             EEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCC--CeeeEEEEEEE---CCeeEEEEecCC
Q 039516           29 YIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYT--NLVKLLGCSIH---GEERLLVYEFMP  103 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~~~~~~~~---~~~~~lv~e~~~  103 (345)
                      +..|++|..+.||+....+ ..+++|.....  .....+.+|..+++.+...  .+.+++.+...   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4569999999999998876 69999997543  3456788899999888533  35677775533   335689999999


Q ss_pred             CCChHH---------HHHh--------------------------------------------------HHH-HHHHHHh
Q 039516          104 NKSLDS---------SFSG--------------------------------------------------TFK-DLLCLHK  123 (345)
Q Consensus       104 ~gsL~~---------~l~~--------------------------------------------------~~~-~l~~lh~  123 (345)
                      +.++..         .+..                                                  +.+ .+..+..
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            987766         1110                                                  000 1112221


Q ss_pred             ----cCCCceEEeccCCCCeeeC-CCCCEEEEcccccee
Q 039516          124 ----YSRLRVIHRDLKASNILLD-DQLNTKISDFGMARI  157 (345)
Q Consensus       124 ----~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgl~~~  157 (345)
                          .....++|+|+.+.||+++ +++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                1345799999999999999 556567999987754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.14  E-value=3.9e-05  Score=67.59  Aligned_cols=74  Identities=15%  Similarity=0.184  Sum_probs=50.1

Q ss_pred             EEEeeccCCeEEEEEEcCC--CcEEEEEEeccCCccCHHHHHHHHHHHHhcCC-CCeeeEEEEEEECCeeEEEEecCCCC
Q 039516           29 YIQQEQTRDRVILVGKFPN--EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY-TNLVKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~~--~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      ++.|.+|-...+|+....+  +..|++|........ .....+|+.+++.+.. .-.+++++.+.    -.++|||++|.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            3558888899999988764  678999987543221 2234578888888843 33455555432    24899999887


Q ss_pred             Ch
Q 039516          106 SL  107 (345)
Q Consensus       106 sL  107 (345)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            65

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.10  E-value=2.2e-05  Score=70.35  Aligned_cols=120  Identities=17%  Similarity=0.075  Sum_probs=77.6

Q ss_pred             eeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCe-eeEEEEEEECCeeEEEEecCCCCChHH-
Q 039516           32 QEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNL-VKLLGCSIHGEERLLVYEFMPNKSLDS-  109 (345)
Q Consensus        32 lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~~-  109 (345)
                      +..|-.+.+|+... ++..+++|..............+|..+++.+...++ .+++..+.    -++||||++|..+.. 
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            56788888998874 577888988654332211245789999998854333 44454432    379999999876542 


Q ss_pred             ------HHHhHHHHHHHHHhc--------------------------------------------CCCceEEeccCCCCe
Q 039516          110 ------SFSGTFKDLLCLHKY--------------------------------------------SRLRVIHRDLKASNI  139 (345)
Q Consensus       110 ------~l~~~~~~l~~lh~~--------------------------------------------~~~~ivHrdlk~~Ni  139 (345)
                            .+..+++.+.-||..                                            ....++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                  122222222222211                                            012589999999999


Q ss_pred             eeCCCCCEEEEcccccee
Q 039516          140 LLDDQLNTKISDFGMARI  157 (345)
Q Consensus       140 ll~~~~~~kl~Dfgl~~~  157 (345)
                      ++++++ +.|+||..+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999877 78999987754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09902 hypothetical protein; Provisional

Probab=98.08  E-value=7.6e-05  Score=64.20  Aligned_cols=121  Identities=16%  Similarity=0.105  Sum_probs=83.2

Q ss_pred             eccCCeEEEEEEcCCCcEEEEEEeccC------CccCHHHHHHHHHHHHhcCC--CCeeeEEEEEEE----CCeeEEEEe
Q 039516           33 EQTRDRVILVGKFPNEQEVAIKRLAWT------SGQGRVEFQNEAKLIAKLQY--TNLVKLLGCSIH----GEERLLVYE  100 (345)
Q Consensus        33 G~G~~g~vy~~~~~~~~~VaiK~~~~~------~~~~~~~~~~E~~~l~~l~H--~niv~~~~~~~~----~~~~~lv~e  100 (345)
                      |+||-+-|+.-.+. |..+-+|.-...      .+.....|.+|...|.+|..  -.+.+...+...    ....+||+|
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            67888888887764 557888876421      14467789999999999953  234454422212    123579999


Q ss_pred             cCCC-CChHHHH-----------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC--EEEEcccccee
Q 039516          101 FMPN-KSLDSSF-----------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN--TKISDFGMARI  157 (345)
Q Consensus       101 ~~~~-gsL~~~l-----------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~--~kl~Dfgl~~~  157 (345)
                      -+++ .+|.+++                 ..++..+.-||..   |+.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            7654 4665554                 2444555555555   8999999999999986667  99999986654

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.07  E-value=0.00011  Score=69.60  Aligned_cols=76  Identities=11%  Similarity=-0.046  Sum_probs=56.3

Q ss_pred             EEEeeccCCeEEEEEEcCCC-cEEEEEEeccC-----C--ccCHHHHHHHHHHHHhcC---CCCeeeEEEEEEECCeeEE
Q 039516           29 YIQQEQTRDRVILVGKFPNE-QEVAIKRLAWT-----S--GQGRVEFQNEAKLIAKLQ---YTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~~~-~~VaiK~~~~~-----~--~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~l   97 (345)
                      .+.||.|.+..||+....+| +.|.||.-...     .  +-...++..|.+.|..+.   ..++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35699999999999988776 58999985321     1  224567788998888762   3567888887  3455789


Q ss_pred             EEecCCCCC
Q 039516           98 VYEFMPNKS  106 (345)
Q Consensus        98 v~e~~~~gs  106 (345)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.07  E-value=3.7e-05  Score=67.93  Aligned_cols=122  Identities=15%  Similarity=0.177  Sum_probs=76.8

Q ss_pred             EEeeccCCe-EEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCC---CeeeEEEEEEEC---CeeEEEEecC
Q 039516           30 IQQEQTRDR-VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYT---NLVKLLGCSIHG---EERLLVYEFM  102 (345)
Q Consensus        30 ~~lG~G~~g-~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~~~~~~~~~---~~~~lv~e~~  102 (345)
                      ..|+.|+.. .||+.    +..+++|.....  .....+.+|.+++..+...   -+.++++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            457777766 58874    235677775432  2345788999999888532   345555544322   2358999999


Q ss_pred             CCCChHHH--------HHhHHHHHHHHHhc--------------------------------------------------
Q 039516          103 PNKSLDSS--------FSGTFKDLLCLHKY--------------------------------------------------  124 (345)
Q Consensus       103 ~~gsL~~~--------l~~~~~~l~~lh~~--------------------------------------------------  124 (345)
                      +|.++.+.        ...+++.+..||..                                                  
T Consensus        77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  156 (235)
T cd05155          77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL  156 (235)
T ss_pred             cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence            99776321        12222222222211                                                  


Q ss_pred             -----CCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          125 -----SRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       125 -----~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                           ...+++|+|+.+.||++++....-|+||+.+..
T Consensus       157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence                 123489999999999998776678999997653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.04  E-value=2.1e-05  Score=71.90  Aligned_cols=126  Identities=15%  Similarity=0.073  Sum_probs=82.1

Q ss_pred             eEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCC--CeeeEEEE------EEECCeeEEEE
Q 039516           28 MYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYT--NLVKLLGC------SIHGEERLLVY   99 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~~~~~------~~~~~~~~lv~   99 (345)
                      -...|.+|....+|+.... +..+++|....   ........|++++..+.+.  .+.+++..      ....+..++|+
T Consensus        18 ~i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          18 SFEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             heecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            3556888888889988654 45788898754   2345667788888888433  24555442      12345668999


Q ss_pred             ecCCCCChHH----HHHhHHHHHH----------------------------------------------HHHh----cC
Q 039516          100 EFMPNKSLDS----SFSGTFKDLL----------------------------------------------CLHK----YS  125 (345)
Q Consensus       100 e~~~~gsL~~----~l~~~~~~l~----------------------------------------------~lh~----~~  125 (345)
                      +|++|..+..    ....+.+.+.                                              .+..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999876532    1221111111                                              1111    11


Q ss_pred             CCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          126 RLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       126 ~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      ..+++|+|+.|.||++++++.+.|+||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            23699999999999999987789999987653

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.04  E-value=1.1e-06  Score=85.34  Aligned_cols=167  Identities=16%  Similarity=0.083  Sum_probs=118.3

Q ss_pred             eeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCC-eeeEEEEEEECCeeEEEEecCCCC-ChHH
Q 039516           32 QEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTN-LVKLLGCSIHGEERLLVYEFMPNK-SLDS  109 (345)
Q Consensus        32 lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~~~~lv~e~~~~g-sL~~  109 (345)
                      .++|+.+.++|.+....+....+.+...     ....-++++|.+++||| .+..++-+..+...+++|+++.++ +-..
T Consensus       250 fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~  324 (829)
T KOG0576|consen  250 FVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL  324 (829)
T ss_pred             HHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence            6899999999986543344445555322     44556889999999999 777788777788899999999887 2111


Q ss_pred             H-------HH------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCc
Q 039516          110 S-------FS------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY  176 (345)
Q Consensus       110 ~-------l~------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y  176 (345)
                      .       +.      ........|++.|+..=+|+|    ||+..+ +..+..||+....+....   ......+++.|
T Consensus       325 ~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~  396 (829)
T KOG0576|consen  325 EMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEP  396 (829)
T ss_pred             cCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCC
Confidence            0       11      111223334444433347887    777665 678999999887664332   34456889999


Q ss_pred             cccchhccCCcCcccchhhHHHHHHHHHhCCCCCC
Q 039516          177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNK  211 (345)
Q Consensus       177 ~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~  211 (345)
                      +|||+...+.+....|.|++|+-..++.-|-+|-.
T Consensus       397 ~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  397 LAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            99999999999999999999987777777776644

>PLN02876 acyl-CoA dehydrogenase

Probab=98.02  E-value=7.2e-05  Score=78.06  Aligned_cols=79  Identities=10%  Similarity=0.113  Sum_probs=58.5

Q ss_pred             eEEEeeccCCeEEEEEEcCCC---cEEEEEEeccCC-ccCHHHHHHHHHHHHhcC-CCCe--eeEEEEEEEC---CeeEE
Q 039516           28 MYIQQEQTRDRVILVGKFPNE---QEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQ-YTNL--VKLLGCSIHG---EERLL   97 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~~~---~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~~~~~~~~~---~~~~l   97 (345)
                      ...+++.|.++.+|+....++   ..+++|+..... ......+.+|+++|+.+. |.++  .+++.+|.+.   +..|+
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            356789999999998876543   467888764432 223457889999999995 6665  8888887654   46789


Q ss_pred             EEecCCCCC
Q 039516           98 VYEFMPNKS  106 (345)
Q Consensus        98 v~e~~~~gs  106 (345)
                      ||||++|..
T Consensus       122 VME~v~G~~  130 (822)
T PLN02876        122 IMEYLEGRI  130 (822)
T ss_pred             EEEecCCcc
Confidence            999998864

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.96  E-value=0.00018  Score=61.69  Aligned_cols=120  Identities=18%  Similarity=0.223  Sum_probs=84.7

Q ss_pred             EEeeccCCeEEEEEEcCCCcEEEEEEeccCC----------------ccCHHHHHHHHHHHHhcC------CCCeeeEEE
Q 039516           30 IQQEQTRDRVILVGKFPNEQEVAIKRLAWTS----------------GQGRVEFQNEAKLIAKLQ------YTNLVKLLG   87 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~~~~   87 (345)
                      ..||+|+.-.||.-  ++.....||+.....                .....++.+|+.....+.      +.+|.+++|
T Consensus         7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            45999999999974  345567888886554                223566778888777776      788999999


Q ss_pred             EEEECCeeEEEEecCCC------CChHHHHH------hHHHHH----HHHHhcCCCceEEeccCCCCeeeCCC--C--CE
Q 039516           88 CSIHGEERLLVYEFMPN------KSLDSSFS------GTFKDL----LCLHKYSRLRVIHRDLKASNILLDDQ--L--NT  147 (345)
Q Consensus        88 ~~~~~~~~~lv~e~~~~------gsL~~~l~------~~~~~l----~~lh~~~~~~ivHrdlk~~Nill~~~--~--~~  147 (345)
                      +..++--.-+|+|.+.+      .+|.+++.      ...++|    .+|...   +|+.+|++|.||++...  +  .+
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~~~~~~~l  161 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDH---HIVIRDLNPHNIVVQRRDSGEFRL  161 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHc---CCeecCCCcccEEEEecCCCceEE
Confidence            99998888999998743      35666654      222332    244444   69999999999999533  2  46


Q ss_pred             EEEc-ccc
Q 039516          148 KISD-FGM  154 (345)
Q Consensus       148 kl~D-fgl  154 (345)
                      .|+| ||.
T Consensus       162 vlIDG~G~  169 (199)
T PF10707_consen  162 VLIDGLGE  169 (199)
T ss_pred             EEEeCCCC
Confidence            7777 343

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=97.95  E-value=0.00023  Score=65.26  Aligned_cols=77  Identities=12%  Similarity=-0.057  Sum_probs=57.3

Q ss_pred             eEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCC---CCeeeEEEEEEE---CCeeEEEEec
Q 039516           28 MYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY---TNLVKLLGCSIH---GEERLLVYEF  101 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~~~~~~~~---~~~~~lv~e~  101 (345)
                      -...||+|..+.||+-...++ .+.+|..+..  .....|..|++.|+.|.-   -.+.+++++|..   .+..+||||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            345699999999999876555 4666775321  123578999999999853   368899988754   3568999999


Q ss_pred             CCCCCh
Q 039516          102 MPNKSL  107 (345)
Q Consensus       102 ~~~gsL  107 (345)
                      ++++++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998765

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=97.85  E-value=5.5e-05  Score=70.59  Aligned_cols=174  Identities=13%  Similarity=0.091  Sum_probs=107.2

Q ss_pred             EEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEE------EECC-eeEEEEec
Q 039516           30 IQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCS------IHGE-ERLLVYEF  101 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~------~~~~-~~~lv~e~  101 (345)
                      ..||+|+-+.+|.---  -...+.|++.........+   .+..|... .||-+-.-+.+=      -+.. ..-+.|..
T Consensus        17 r~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~   91 (637)
T COG4248          17 RPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK   91 (637)
T ss_pred             ccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence            3489999999996421  1223557765443222221   22233333 565443312211      1122 25567777


Q ss_pred             CCCCC-hH-----------------HHHH----hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516          102 MPNKS-LD-----------------SSFS----GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus       102 ~~~gs-L~-----------------~~l~----~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      +++.. +.                 +++-    .++.+...||..   |.+-+|+.++|+|+++++.+.|.|-..-... 
T Consensus        92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~-  167 (637)
T COG4248          92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN-  167 (637)
T ss_pred             CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec-
Confidence            66541 11                 1111    444555566665   8899999999999999999999985543332 


Q ss_pred             CCCCCCcccceeecCCccccchhc-----cCCcCcccchhhHHHHHHHHHhC-CCCCCCCC
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTM-----SGTVSIKTDVFGFGVLVLKIVCG-KKNNKSYH  214 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~el~tg-~~p~~~~~  214 (345)
                        .......+..|...|.+||...     +..-+...|-|.||+++++++.| +.||.+..
T Consensus       168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~  226 (637)
T COG4248         168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP  226 (637)
T ss_pred             --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence              2233344567899999999765     23346779999999999999986 99998753

>PRK05231 homoserine kinase; Provisional

Probab=97.84  E-value=9.8e-05  Score=68.30  Aligned_cols=143  Identities=15%  Similarity=0.070  Sum_probs=83.2

Q ss_pred             eeecccccccccCCC-CeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCC--CeeeEE
Q 039516           10 QTWSEGAKFVENSSL-DWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYT--NLVKLL   86 (345)
Q Consensus        10 ~s~~~~~~~~~~~~~-~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~~~   86 (345)
                      .|.+++..+...+.. .....+.|+.|....+|+....+| .+++|++. .  ........|..++..|...  .+.+++
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i   82 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPV   82 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcce
Confidence            345556555555433 223345577788888998876545 68889875 2  1223444556666665321  233444


Q ss_pred             E------EEEECCeeEEEEecCCCCChHH----HHH------------------------------hHHH----------
Q 039516           87 G------CSIHGEERLLVYEFMPNKSLDS----SFS------------------------------GTFK----------  116 (345)
Q Consensus        87 ~------~~~~~~~~~lv~e~~~~gsL~~----~l~------------------------------~~~~----------  116 (345)
                      .      +....+..+++++|++|..+..    ...                              ....          
T Consensus        83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (319)
T PRK05231         83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ  162 (319)
T ss_pred             eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence            2      1223566799999999875311    010                              0000          


Q ss_pred             ----------HHHHHHhc----CCCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516          117 ----------DLLCLHKY----SRLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus       117 ----------~l~~lh~~----~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                                .+..+...    -..++||+|+.+.||+++++...-|+||+.+.
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                      00111100    23479999999999999977666899998775

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.79  E-value=0.00013  Score=67.16  Aligned_cols=141  Identities=18%  Similarity=0.097  Sum_probs=84.9

Q ss_pred             cccccccccCCCC-eeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCC--CeeeEEEEE
Q 039516           13 SEGAKFVENSSLD-WHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYT--NLVKLLGCS   89 (345)
Q Consensus        13 ~~~~~~~~~~~~~-~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~~~~~~   89 (345)
                      +++..+.+.+..+ ......++.|....+|+....+| .+++|......  .......|.+++..|...  .+.+++...
T Consensus        10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~   86 (307)
T TIGR00938        10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSR   86 (307)
T ss_pred             HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCC
Confidence            4555554544332 33355577787788998876544 57788875432  234456677777777432  244554421


Q ss_pred             ------EECCeeEEEEecCCCCChH----HHHHhH---------------------------------------------
Q 039516           90 ------IHGEERLLVYEFMPNKSLD----SSFSGT---------------------------------------------  114 (345)
Q Consensus        90 ------~~~~~~~lv~e~~~~gsL~----~~l~~~---------------------------------------------  114 (345)
                            ...+..+++++|++|.++.    .....+                                             
T Consensus        87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~  166 (307)
T TIGR00938        87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM  166 (307)
T ss_pred             CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence                  1245678999999886432    111100                                             


Q ss_pred             ----HHHHHHHHh----cCCCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516          115 ----FKDLLCLHK----YSRLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus       115 ----~~~l~~lh~----~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                          ...+.++..    ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                001112211    123579999999999999988877899998765

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.76  E-value=0.00028  Score=64.72  Aligned_cols=73  Identities=18%  Similarity=0.228  Sum_probs=49.3

Q ss_pred             EEeeccCCeEEEEEEcCC-------CcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCC-eeeEEEEEEECCeeEEEEec
Q 039516           30 IQQEQTRDRVILVGKFPN-------EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTN-LVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~~-------~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~~~~lv~e~  101 (345)
                      +.+.+|-...+|+....+       ++.+++|...... .......+|.+++..+...+ ..++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            457777778899887654       5789999975543 22345678888888885332 3455665532    468999


Q ss_pred             CCCCCh
Q 039516          102 MPNKSL  107 (345)
Q Consensus       102 ~~~gsL  107 (345)
                      ++|.++
T Consensus        79 i~G~~l   84 (302)
T cd05156          79 IPSRTL   84 (302)
T ss_pred             eCCCcC
Confidence            888665

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.65  E-value=0.00053  Score=62.37  Aligned_cols=75  Identities=15%  Similarity=0.092  Sum_probs=49.8

Q ss_pred             eeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC---CCCeeeEEEEEEECCeeEEEEecCC
Q 039516           27 HMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ---YTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        27 ~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      .....++.|....+|+.. .+++.+.||.-..   .....|..|++-|+.|.   --.+++++++....+..+|||||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            345568999999999988 5688999998752   23356889999988883   4568899998887777899999998


Q ss_pred             CC
Q 039516          104 NK  105 (345)
Q Consensus       104 ~g  105 (345)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            76

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=97.56  E-value=0.001  Score=62.36  Aligned_cols=125  Identities=19%  Similarity=0.235  Sum_probs=79.4

Q ss_pred             eEEEeeccCCeEEEEEEcCC-----CcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCe-eeEEEEEEECCeeEEEEec
Q 039516           28 MYIQQEQTRDRVILVGKFPN-----EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNL-VKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~~-----~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~  101 (345)
                      ....+-+|-...+|+....+     ++.|++|......... -...+|..+++.+..-++ .++++.+..+    .|++|
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ef  114 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEF  114 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEe
Confidence            34456678888999987532     3689999886544322 234689999988854333 4556665332    58999


Q ss_pred             CCCCChHHH-------HHhHHHHHHHHH----------------------------------------------------
Q 039516          102 MPNKSLDSS-------FSGTFKDLLCLH----------------------------------------------------  122 (345)
Q Consensus       102 ~~~gsL~~~-------l~~~~~~l~~lh----------------------------------------------------  122 (345)
                      +++.++...       ...+++.+.-+|                                                    
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            987766321       111111111111                                                    


Q ss_pred             h-cCCCceEEeccCCCCeeeCC-CCCEEEEcccccee
Q 039516          123 K-YSRLRVIHRDLKASNILLDD-QLNTKISDFGMARI  157 (345)
Q Consensus       123 ~-~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgl~~~  157 (345)
                      . .+...++|+|+++.|||+++ ++.+.++||..+..
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            1 12336899999999999976 46799999987764

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.41  E-value=9.9e-05  Score=66.98  Aligned_cols=126  Identities=15%  Similarity=0.122  Sum_probs=88.5

Q ss_pred             eeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccC-----------------Ccc-----CHHHHHHHHHHHHhcCC-C-C
Q 039516           26 WHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWT-----------------SGQ-----GRVEFQNEAKLIAKLQY-T-N   81 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~-----------------~~~-----~~~~~~~E~~~l~~l~H-~-n   81 (345)
                      +.+.++||-|--+-+|.+-..+|++.++|.-...                 ...     .+-...+|...|+.|.. . -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            5678899999999999999989999999843221                 000     12245679999998843 2 2


Q ss_pred             eeeEEEEEEECCeeEEEEecCCCCChHHHHH-----hHHH-HHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccc
Q 039516           82 LVKLLGCSIHGEERLLVYEFMPNKSLDSSFS-----GTFK-DLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMA  155 (345)
Q Consensus        82 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~-----~~~~-~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~  155 (345)
                      +.+.+++    +..++|||++.+-.|...-+     .+.. .+..+-.+...|+||+|..-=||++++++.++++||--.
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHh
Confidence            4444443    45689999999887765421     1222 222334444459999999999999999999999999644

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.32  E-value=0.0031  Score=59.84  Aligned_cols=74  Identities=7%  Similarity=-0.038  Sum_probs=51.4

Q ss_pred             eEEEeeccCCeEEEEEEcCCCcEEEEEEeccC----Cc---cCHHHHHHHHHHHHhcC---CCCeeeEEEEEEECCeeEE
Q 039516           28 MYIQQEQTRDRVILVGKFPNEQEVAIKRLAWT----SG---QGRVEFQNEAKLIAKLQ---YTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~----~~---~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~l   97 (345)
                      ..+.||.|....||+.... +..|+||.-...    +.   ....+-..|++.|+.+.   ..++.+++.++.  +..++
T Consensus        36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            4567999999999998764 567999976421    11   13334445577776653   357889999876  44678


Q ss_pred             EEecCCC
Q 039516           98 VYEFMPN  104 (345)
Q Consensus        98 v~e~~~~  104 (345)
                      +|||+++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            9999977

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.27  E-value=0.0024  Score=59.51  Aligned_cols=72  Identities=7%  Similarity=-0.034  Sum_probs=49.6

Q ss_pred             EeeccCCeEEEEEEcCCC-cEEEEEEecc-------CCccCHHHHHHHHHHHHhcC--CC-CeeeEEEEEEECCeeEEEE
Q 039516           31 QQEQTRDRVILVGKFPNE-QEVAIKRLAW-------TSGQGRVEFQNEAKLIAKLQ--YT-NLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~~~-~~VaiK~~~~-------~~~~~~~~~~~E~~~l~~l~--H~-niv~~~~~~~~~~~~~lv~   99 (345)
                      .||.|....||++..++| +.|+||.-..       .-+-...+..-|...|+...  -| .++++|.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            379999999999987654 6899996421       11334556667888886653  23 56666665  455667999


Q ss_pred             ecCCC
Q 039516          100 EFMPN  104 (345)
Q Consensus       100 e~~~~  104 (345)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99965

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.23  E-value=0.0012  Score=62.37  Aligned_cols=74  Identities=8%  Similarity=-0.074  Sum_probs=52.2

Q ss_pred             EEEeeccCCeEEEEEEcCC-CcEEEEEEecc------CCccCHHHHHHHHHHHHhcC--CC-CeeeEEEEEEECCeeEEE
Q 039516           29 YIQQEQTRDRVILVGKFPN-EQEVAIKRLAW------TSGQGRVEFQNEAKLIAKLQ--YT-NLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~~-~~~VaiK~~~~------~~~~~~~~~~~E~~~l~~l~--H~-niv~~~~~~~~~~~~~lv   98 (345)
                      ...||.|.-..||++...+ ++.|+||.-..      .-+-...+..-|.+.|+...  -| .++++|.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            5669999999999998743 56899996421      11334667777888887763  23 56677765  45566799


Q ss_pred             EecCCC
Q 039516           99 YEFMPN  104 (345)
Q Consensus        99 ~e~~~~  104 (345)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999865

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.18  E-value=0.001  Score=56.63  Aligned_cols=87  Identities=23%  Similarity=0.166  Sum_probs=63.1

Q ss_pred             HHHHHHHHhcCC-CCeeeEEEEEEECCeeEEEEecCCCCCh-------HHHH--------H---hHHHHHHHHHhcCCCc
Q 039516           68 QNEAKLIAKLQY-TNLVKLLGCSIHGEERLLVYEFMPNKSL-------DSSF--------S---GTFKDLLCLHKYSRLR  128 (345)
Q Consensus        68 ~~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~gsL-------~~~l--------~---~~~~~l~~lh~~~~~~  128 (345)
                      .+|.-++..+++ +++++++|+|-.    ++|.||...+++       .+++        +   ++++.+..++......
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            468888888976 699999999932    678999987644       2322        2   2333344444433345


Q ss_pred             eEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516          129 VIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus       129 ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      +.-.|++++|+-+++++.+|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.17  E-value=0.0089  Score=54.90  Aligned_cols=30  Identities=30%  Similarity=0.366  Sum_probs=25.6

Q ss_pred             CCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516          126 RLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus       126 ~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                      ..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            357999999999999987 568899998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.04  E-value=0.0066  Score=56.53  Aligned_cols=124  Identities=19%  Similarity=0.246  Sum_probs=79.4

Q ss_pred             EEEeeccCCeEEEEEEcCC----CcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCe-eeEEEEEEECCeeEEEEecCC
Q 039516           29 YIQQEQTRDRVILVGKFPN----EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNL-VKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~~----~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~  103 (345)
                      +..|.+|-...+|+....+    +..|++|....... ..-...+|..+++.+..-++ .++++++. .+   +|.+|++
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~   93 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFIN   93 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhhc
Confidence            3446667778889876532    24899998855433 22345689999988865444 45666653 22   5899998


Q ss_pred             CCChHH-------HHHhHHHHHHHHHhc----------------------------------------------------
Q 039516          104 NKSLDS-------SFSGTFKDLLCLHKY----------------------------------------------------  124 (345)
Q Consensus       104 ~gsL~~-------~l~~~~~~l~~lh~~----------------------------------------------------  124 (345)
                      +.+|..       .+..+++.+..||..                                                    
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            776532       233333333333321                                                    


Q ss_pred             ------CCCceEEeccCCCCeeeCC-CCCEEEEcccccee
Q 039516          125 ------SRLRVIHRDLKASNILLDD-QLNTKISDFGMARI  157 (345)
Q Consensus       125 ------~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgl~~~  157 (345)
                            ...-.+|.|+.+.|||+++ ++.++++||..+..
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                  0113689999999999975 46899999988764

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=97.03  E-value=0.004  Score=53.80  Aligned_cols=150  Identities=16%  Similarity=0.183  Sum_probs=88.1

Q ss_pred             cCCeEEEEEEcCCCcEEEEEEeccCCcc-CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCChH--HHH
Q 039516           35 TRDRVILVGKFPNEQEVAIKRLAWTSGQ-GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD--SSF  111 (345)
Q Consensus        35 G~~g~vy~~~~~~~~~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~--~~l  111 (345)
                      |+-++.-+++..-| +..+|++....-. ...-|.++.+++++++  .|+++..-  +....-++.|+|-.....  .++
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~~~N~i  147 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKINFSNFI  147 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccchhHHH
Confidence            44444444443323 3344555333222 4456788999998875  46766631  333556899998654332  222


Q ss_pred             HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCccc
Q 039516          112 SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKT  191 (345)
Q Consensus       112 ~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  191 (345)
                      ..-...|.-.|..+ .+.+|+|..|+||+-|..|.+||.|-+.--.-              +..|.--   .....+.++
T Consensus       148 ~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~--------------~V~~vN~---~Y~~lT~~a  209 (308)
T PF07387_consen  148 TAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN--------------QVNMVNI---EYESLTQEA  209 (308)
T ss_pred             HHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhhh--------------eeeEEee---eccccChHH
Confidence            22244555566544 47999999999999999999999997653210              1112221   123346667


Q ss_pred             chhhHHHHHHHHHhCC
Q 039516          192 DVFGFGVLVLKIVCGK  207 (345)
Q Consensus       192 Di~SlG~il~el~tg~  207 (345)
                      .+-+|=.-++++....
T Consensus       210 E~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  210 EVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             HHHHHHHHHHHHHHHH
Confidence            7777766666666543

The function of this family is unknown.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.84  E-value=0.005  Score=53.33  Aligned_cols=105  Identities=23%  Similarity=0.215  Sum_probs=60.3

Q ss_pred             CcEEEEEEeccCCccCHHHHHHHHHHHHhcCC-CCeeeEEEEEEECCeeEEEEecCCCCChHH-------HHHhHHHHHH
Q 039516           48 EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY-TNLVKLLGCSIHGEERLLVYEFMPNKSLDS-------SFSGTFKDLL  119 (345)
Q Consensus        48 ~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-------~l~~~~~~l~  119 (345)
                      ++.|+|++.... .........|..+++.+.. ..-.++++++.+    ..|++|+++.+|..       .+..++..|.
T Consensus         2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence            467888888655 3455677889999998854 334566666422    26779997765421       2222222222


Q ss_pred             HHHhc-----------------------------------------------------------CCCceEEeccCCCCee
Q 039516          120 CLHKY-----------------------------------------------------------SRLRVIHRDLKASNIL  140 (345)
Q Consensus       120 ~lh~~-----------------------------------------------------------~~~~ivHrdlk~~Nil  140 (345)
                      -||..                                                           ....++|+|+.+.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence            22221                                                           1124789999999999


Q ss_pred             e-CCCCCEEEEcccccee
Q 039516          141 L-DDQLNTKISDFGMARI  157 (345)
Q Consensus       141 l-~~~~~~kl~Dfgl~~~  157 (345)
                      + +.++.++++||..+..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8889999999988764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.75  E-value=0.026  Score=51.95  Aligned_cols=130  Identities=13%  Similarity=0.113  Sum_probs=80.5

Q ss_pred             eeeEEEeeccCCeEEEEEEcCCCcEEEEEEecc--CCccCHHHHHHHHHHHHhcCC--CCeeeEEEEEEECC--eeEEEE
Q 039516           26 WHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAW--TSGQGRVEFQNEAKLIAKLQY--TNLVKLLGCSIHGE--ERLLVY   99 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~--~~~~~~~~~~~E~~~l~~l~H--~niv~~~~~~~~~~--~~~lv~   99 (345)
                      ..+.+++-+|..-.+|..... ++++++. ...  ..........+|..+|+.+.-  --+...+++|.++.  ..|.||
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             CceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            445555544444444444433 7788888 321  122334556778888887743  34556677777666  679999


Q ss_pred             ecCCCCCh---------H-HHHH-hHHHH--------------------------------------------------H
Q 039516          100 EFMPNKSL---------D-SSFS-GTFKD--------------------------------------------------L  118 (345)
Q Consensus       100 e~~~~gsL---------~-~~l~-~~~~~--------------------------------------------------l  118 (345)
                      +|++|..+         . .+.. .....                                                  .
T Consensus       105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~  184 (321)
T COG3173         105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI  184 (321)
T ss_pred             EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence            99987322         2 1211 11111                                                  2


Q ss_pred             HHHHhc-----CCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          119 LCLHKY-----SRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       119 ~~lh~~-----~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      .+++..     +...++|+|+.+.|++++..+-+-+.||+++..
T Consensus       185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            233222     234699999999999999988899999998865

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.69  E-value=0.032  Score=50.58  Aligned_cols=31  Identities=29%  Similarity=0.558  Sum_probs=25.6

Q ss_pred             CceEEeccCCCCeeeCCCCC-EEEEcccccee
Q 039516          127 LRVIHRDLKASNILLDDQLN-TKISDFGMARI  157 (345)
Q Consensus       127 ~~ivHrdlk~~Nill~~~~~-~kl~Dfgl~~~  157 (345)
                      ..++|+|+.+.||++++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 57999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.68  E-value=0.038  Score=50.89  Aligned_cols=32  Identities=25%  Similarity=0.365  Sum_probs=28.1

Q ss_pred             CCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          126 RLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       126 ~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      ..+++|+|+.+.|+++++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34799999999999999999999999987753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.60  E-value=0.028  Score=48.95  Aligned_cols=72  Identities=17%  Similarity=0.153  Sum_probs=49.4

Q ss_pred             eccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC---CCCeeeEEEEEEECCeeEEEEecCCCCChH
Q 039516           33 EQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ---YTNLVKLLGCSIHGEERLLVYEFMPNKSLD  108 (345)
Q Consensus        33 G~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~~~~gsL~  108 (345)
                      -.|.--..|.... ...++-+|+=.   ......|..|+.-|..|.   --++.+++.+..+..+.|+||||++.+.+.
T Consensus        25 ~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          25 SGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             CCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            3333333444333 35678888742   233457888988877773   356788888888899999999999987765

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.52  E-value=0.014  Score=54.30  Aligned_cols=123  Identities=17%  Similarity=0.163  Sum_probs=81.5

Q ss_pred             EEeeccCCeEEEEEEcCCCcEEEEEEeccC-----C----------------ccC-HH----HHHHHHHHHHhcCCCCee
Q 039516           30 IQQEQTRDRVILVGKFPNEQEVAIKRLAWT-----S----------------GQG-RV----EFQNEAKLIAKLQYTNLV   83 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~-----~----------------~~~-~~----~~~~E~~~l~~l~H~niv   83 (345)
                      ..|..|--+.||.+.-.+|..+|||+++..     .                ... ++    -...|++-|++|..-.|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            347778889999999989999999987532     0                001 11    123577888888655543


Q ss_pred             eEEEEEEECCeeEEEEecCCCC---------------ChHHHHHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEE
Q 039516           84 KLLGCSIHGEERLLVYEFMPNK---------------SLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTK  148 (345)
Q Consensus        84 ~~~~~~~~~~~~~lv~e~~~~g---------------sL~~~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~k  148 (345)
                      -.--...  ....|||+|+...               .+..+..++...+.-|.+.+  ++||.||+--|+|+.+ |.+.
T Consensus       230 ~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G~ly  304 (520)
T KOG2270|consen  230 CPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-GKLY  304 (520)
T ss_pred             CCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-CEEE
Confidence            2111111  2236999998532               12344456666677777766  7999999999998854 6799


Q ss_pred             EEcccccee
Q 039516          149 ISDFGMARI  157 (345)
Q Consensus       149 l~Dfgl~~~  157 (345)
                      ++|-+-+..
T Consensus       305 iIDVSQSVE  313 (520)
T KOG2270|consen  305 IIDVSQSVE  313 (520)
T ss_pred             EEEcccccc
Confidence            999876654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.40  E-value=0.011  Score=61.99  Aligned_cols=176  Identities=20%  Similarity=0.143  Sum_probs=107.9

Q ss_pred             HHHHHHHHHhcCCCCeeeEEEEEEECCee----EEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCC
Q 039516           67 FQNEAKLIAKLQYTNLVKLLGCSIHGEER----LLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRL  127 (345)
Q Consensus        67 ~~~E~~~l~~l~H~niv~~~~~~~~~~~~----~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~  127 (345)
                      ...|+..+.++.|+|++.++.+-.+....    .+..++|..-++...+.               ....++.++|..+  
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~--  306 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS--  306 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc--
Confidence            34577788889999999999987654322    23456777666655443               4456778888773  


Q ss_pred             ceEEeccCCC---CeeeCCCCCEEEE--ccccceeecCCCCCCcccceeecCCccccchhccCCcCc--ccchhhHHHHH
Q 039516          128 RVIHRDLKAS---NILLDDQLNTKIS--DFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI--KTDVFGFGVLV  200 (345)
Q Consensus       128 ~ivHrdlk~~---Nill~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Di~SlG~il  200 (345)
                       ..|.-+..+   +.-.+..+.+.++  ||+.++.........   ....+..+.++|......+..  ..|+|.+|...
T Consensus       307 -l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  307 -LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             -cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence             344434443   4444556666666  888887664332221   123345577888776655544  47999999999


Q ss_pred             HHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          201 LKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       201 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      ..+..|..+-....                      ...+.+...+..   ........|+..++++|++..+
T Consensus       383 ~~~~~~~~i~~~~~----------------------~~~~~l~~~~~~---~~~d~~~~~~~~~~~~Rl~~~~  430 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSA----------------------VPVSLLDVLSTS---ELLDALPKCLDEDSEERLSALE  430 (1351)
T ss_pred             hhhhhcCccccccc----------------------chhhhhccccch---hhhhhhhhhcchhhhhccchhh
Confidence            99998876533211                      000111100111   1136677899999999999643

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.26  E-value=0.027  Score=52.20  Aligned_cols=121  Identities=21%  Similarity=0.253  Sum_probs=73.4

Q ss_pred             eeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCC------eeeEEEEE--EECC--eeEEEEec
Q 039516           32 QEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTN------LVKLLGCS--IHGE--ERLLVYEF  101 (345)
Q Consensus        32 lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~~~~~~--~~~~--~~~lv~e~  101 (345)
                      |.+ .-..+|+....+|.. ++|.....  ....+...|...|..|.-.+      +...=|-.  .-..  ..+-+++|
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            444 455678877766666 89988765  34556667777777773211      22222211  1123  77889999


Q ss_pred             CCCCChHH-----HHHhHHH--------------------------------------------------HHHHHHh---
Q 039516          102 MPNKSLDS-----SFSGTFK--------------------------------------------------DLLCLHK---  123 (345)
Q Consensus       102 ~~~gsL~~-----~l~~~~~--------------------------------------------------~l~~lh~---  123 (345)
                      ++|..+..     .+..+.+                                                  .+..+..   
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99987762     1110101                                                  1111111   


Q ss_pred             -c-CCCc--eEEeccCCCCeeeCCCCC-EEEEccccce
Q 039516          124 -Y-SRLR--VIHRDLKASNILLDDQLN-TKISDFGMAR  156 (345)
Q Consensus       124 -~-~~~~--ivHrdlk~~Nill~~~~~-~kl~Dfgl~~  156 (345)
                       . ...+  +||+|+.|.||+++.+.. +.++||+-+.
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence             1 1113  999999999999998874 8999999765

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.17  E-value=0.00046  Score=73.73  Aligned_cols=143  Identities=11%  Similarity=-0.034  Sum_probs=100.9

Q ss_pred             HHHHHHHHHhcCCCCeeeEEEEEEE--CCeeEEEEecCCCCChHHHHH-hH-------HHHHHHHHh-----------cC
Q 039516           67 FQNEAKLIAKLQYTNLVKLLGCSIH--GEERLLVYEFMPNKSLDSSFS-GT-------FKDLLCLHK-----------YS  125 (345)
Q Consensus        67 ~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~-~~-------~~~l~~lh~-----------~~  125 (345)
                      ...|.+.++...|+++...+.=...  ..+.|.+++|+.+|.+.+.+- +.       -.-...+|+           ..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            4456666667789998876654432  335688999999998877643 10       000111111           11


Q ss_pred             --CCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHH
Q 039516          126 --RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI  203 (345)
Q Consensus       126 --~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el  203 (345)
                        ..-.+|+++|+-|.+|..+..+|++++|+.+....  .....+...+++.|+.|++...-.++.++|+|+.|+-+|+.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence              12368999999999999999999999999984321  11223345778889999988888888889999999999999


Q ss_pred             HhCCCCCC
Q 039516          204 VCGKKNNK  211 (345)
Q Consensus       204 ~tg~~p~~  211 (345)
                      ..|..+|-
T Consensus      1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred             hcccHHHH
Confidence            88877653

>PRK06148 hypothetical protein; Provisional

Probab=96.17  E-value=0.072  Score=57.03  Aligned_cols=101  Identities=10%  Similarity=0.051  Sum_probs=55.4

Q ss_pred             CCcceeecccccccccCCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhc--CCCC--
Q 039516            6 NTGCQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL--QYTN--   81 (345)
Q Consensus         6 ~~~~~s~~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l--~H~n--   81 (345)
                      ....+|..++.++......--.....|++ ..-.+|+....+|..+++|+.+....  ......|...|..|  +++.  
T Consensus         7 ~~p~~s~~~~~~~~~~~ygl~~~~~~L~s-~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glp   83 (1013)
T PRK06148          7 PAPEFTTKDAEALLAQHFGISATATPLDG-ERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLP   83 (1013)
T ss_pred             CCCCCCHHHHHHHHHHHcCCceEEeecCC-cCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCC
Confidence            33445555555555433221123355754 45778888777788999999975432  23334455566544  2122  


Q ss_pred             eeeEEE--------EEEE-CC--eeEEEEecCCCCChHH
Q 039516           82 LVKLLG--------CSIH-GE--ERLLVYEFMPNKSLDS  109 (345)
Q Consensus        82 iv~~~~--------~~~~-~~--~~~lv~e~~~~gsL~~  109 (345)
                      +.+++-        .... .+  ..+.+++|++|..+.+
T Consensus        84 vP~~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~  122 (1013)
T PRK06148         84 VPRLIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAE  122 (1013)
T ss_pred             cCeeeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHh
Confidence            223321        1111 12  4678899999987654

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.09  E-value=0.15  Score=47.32  Aligned_cols=71  Identities=13%  Similarity=0.066  Sum_probs=44.1

Q ss_pred             cCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCC--CeeeEE---E--EEEECCeeEEEEecCCCCC
Q 039516           35 TRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYT--NLVKLL---G--CSIHGEERLLVYEFMPNKS  106 (345)
Q Consensus        35 G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~~~---~--~~~~~~~~~lv~e~~~~gs  106 (345)
                      +.-..||+....+|..+++|...... ........|++.+..|...  .++...   |  ....++..+.++++++|..
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            34456888877778889999885332 3456677788888777321  122211   1  1223456788999988754

>PTZ00296 choline kinase; Provisional

Probab=95.86  E-value=0.1  Score=50.51  Aligned_cols=75  Identities=9%  Similarity=0.001  Sum_probs=48.3

Q ss_pred             eEEEeeccCCeEEEEEEcCC---------CcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCee-eEEEEEEECCeeEE
Q 039516           28 MYIQQEQTRDRVILVGKFPN---------EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLV-KLLGCSIHGEERLL   97 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~~---------~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~~~~~~~~~~~~~l   97 (345)
                      .+..|.+|-.-.+|+....+         ++.|.+++.-.....- .....|..+++.+...+|- ++++.+.    -+.
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~  183 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL-YNPISEFEVYKTMSKYRIAPQLLNTFS----GGR  183 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce-eCHHHHHHHHHHHHHCCCCCceEEEeC----CCE
Confidence            45567778788888886542         4678899885543322 2456788888888544443 4555542    246


Q ss_pred             EEecCCCCCh
Q 039516           98 VYEFMPNKSL  107 (345)
Q Consensus        98 v~e~~~~gsL  107 (345)
                      |.||++|.+|
T Consensus       184 I~efi~g~~l  193 (442)
T PTZ00296        184 IEEWLYGDPL  193 (442)
T ss_pred             EEEeeCCccC
Confidence            7899887644

>PTZ00384 choline kinase; Provisional

Probab=95.57  E-value=0.16  Score=48.30  Aligned_cols=76  Identities=11%  Similarity=0.093  Sum_probs=47.4

Q ss_pred             eEEEeeccCCeEEEEEEcCCC--c-----EEEEEEeccCCccCHHHHHHHHHHHHhcCCCC-eeeEEEEEEECCeeEEEE
Q 039516           28 MYIQQEQTRDRVILVGKFPNE--Q-----EVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTN-LVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~~~--~-----~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~~~~lv~   99 (345)
                      .+..|.+|-...+|+....++  .     .|.++...... ...-.-.+|.++++.+...+ -.++++.+..    +++.
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~  128 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ  128 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence            445576788889999875433  2     24444432221 22223467899999996544 4566666532    6999


Q ss_pred             ecCCCCChH
Q 039516          100 EFMPNKSLD  108 (345)
Q Consensus       100 e~~~~gsL~  108 (345)
                      ||++|.+|.
T Consensus       129 efIeGr~l~  137 (383)
T PTZ00384        129 EWVEGNTMG  137 (383)
T ss_pred             EEeccccCC
Confidence            999887663

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.02  E-value=0.1  Score=46.59  Aligned_cols=73  Identities=18%  Similarity=0.186  Sum_probs=52.8

Q ss_pred             EeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHH---HHHHhcCCCCeeeEEEEEEECCeeEEEEecC-CCCC
Q 039516           31 QQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEA---KLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-PNKS  106 (345)
Q Consensus        31 ~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~---~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~-~~gs  106 (345)
                      .+..|..+.|+.+...+|+++++|.......     +..|.   ..|+..+-...|++++.-  ...-.+++|.+ ++.+
T Consensus         9 ~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~-----~~~E~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~   81 (253)
T PF04655_consen    9 PPAHGSSSLVVPVRRADGTPAVLKLAPPHAE-----AEHEARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRS   81 (253)
T ss_pred             CCCCCcceEEEEEEcCCCCeEEEEecCCccc-----chhhhhHHhHhheeCCCCceeeeccc--cccchhhhhhccCCCc
Confidence            3567899999999999999999999864432     22333   457777778889999864  34557888988 5556


Q ss_pred             hHHH
Q 039516          107 LDSS  110 (345)
Q Consensus       107 L~~~  110 (345)
                      |.+.
T Consensus        82 L~~~   85 (253)
T PF04655_consen   82 LASL   85 (253)
T ss_pred             hhhc
Confidence            6544

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=94.69  E-value=0.0056  Score=58.70  Aligned_cols=74  Identities=12%  Similarity=0.143  Sum_probs=61.3

Q ss_pred             cccCCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC
Q 039516           19 VENSSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG   92 (345)
Q Consensus        19 ~~~~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~   92 (345)
                      +..+.++|+....+|.|+||+|+.+... ++..+|||.+... ......+..+|+..+.++.|+++++++..|...
T Consensus        44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~  119 (516)
T KOG1033|consen   44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYER  119 (516)
T ss_pred             hhhhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecC
Confidence            6677889999999999999999998654 4568999998655 334556788999999999999999999887654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	345
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-25
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-25
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-23
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-23
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-22
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-17
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		9e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		9e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-10
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-10
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-07
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-07
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-07
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-07
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-07
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-07
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-07
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-07
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-07
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-07
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-07
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-07
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-07
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-07
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-07
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		9e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-06
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-06
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-06
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-06
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-06
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-06
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-06
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-06
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-06
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-06
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-06
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-06
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-06
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-06
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-06
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-06
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-06
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-06
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-06
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-06
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-06
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-06
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-06
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-06
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-06
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-06
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		8e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-05
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-05
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-05
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-05
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-05
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-05
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-04
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-04
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-04
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-04
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-04
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-04
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-04
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-04
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-04
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-04
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-04
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-04
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-04
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-04
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-04
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-04
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-04
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-04
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-04
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-04
3soa_A	444	Full-Length Human Camkii Length = 444		5e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-04
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-04
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 128/244 (52%), Gaps = 30/244 (12%)
Query: 43  GKFPNEQEVAIKRLAWTSGQG-RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF 101
           G+  +   VA+KRL     QG  ++FQ E ++I+   + NL++L G  +   ERLLVY +
Sbjct: 57  GRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 116
Query: 102 MPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD 142
           M N S+ S                      G+ + L  LH +   ++IHRD+KA+NILLD
Sbjct: 117 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 176
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           ++    + DFG+A++    +       + GT G+++ EY  +G  S KTDVFG+GV++L+
Sbjct: 177 EEFEAVVGDFGLAKLMDYKDXHVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 235
Query: 203 IVCGKKNNKSYHTERPLNLVGIAWQLWNEG----KDLE-LIDLTLDGSCPPNE-DAFLLV 256
           ++ G+   +++   R  N   +    W +G    K LE L+D+ L G+    E +  + V
Sbjct: 236 LITGQ---RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQV 292
Query: 257 SCVC 260
           + +C
Sbjct: 293 ALLC 296

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 127/244 (52%), Gaps = 30/244 (12%)
Query: 43  GKFPNEQEVAIKRLAWTSGQG-RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF 101
           G+  +   VA+KRL     QG  ++FQ E ++I+   + NL++L G  +   ERLLVY +
Sbjct: 49  GRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 108
Query: 102 MPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD 142
           M N S+ S                      G+ + L  LH +   ++IHRD+KA+NILLD
Sbjct: 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           ++    + DFG+A++    +       + G  G+++ EY  +G  S KTDVFG+GV++L+
Sbjct: 169 EEFEAVVGDFGLAKLMDYKDXHVXXA-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227
Query: 203 IVCGKKNNKSYHTERPLNLVGIAWQLWNEG----KDLE-LIDLTLDGSCPPNE-DAFLLV 256
           ++ G+   +++   R  N   +    W +G    K LE L+D+ L G+    E +  + V
Sbjct: 228 LITGQ---RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQV 284
Query: 257 SCVC 260
           + +C
Sbjct: 285 ALLC 288

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 71/187 (37%), Positives = 105/187 (56%), Gaps = 32/187 (17%)
Query: 45  FPNEQEVAIKRLAW----TSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
           + N   VA+K+LA     T+ + + +F  E K++AK Q+ NLV+LLG S  G++  LVY 
Sbjct: 51  YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110
Query: 101 FMPNKSLDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD 142
           +MPN SL    S                  G    +  LH+      IHRD+K++NILLD
Sbjct: 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLD 167
Query: 143 DQLNTKISDFGMARIFGVNESGANT---NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
           +    KISDFG+AR    +E  A T   +RIVGT  YM+ E  + G ++ K+D++ FGV+
Sbjct: 168 EAFTAKISDFGLAR---ASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVV 223
Query: 200 VLKIVCG 206
           +L+I+ G
Sbjct: 224 LLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/187 (37%), Positives = 104/187 (55%), Gaps = 32/187 (17%)
Query: 45  FPNEQEVAIKRLAW----TSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
           + N   VA+K+LA     T+ + + +F  E K++AK Q+ NLV+LLG S  G++  LVY 
Sbjct: 51  YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110
Query: 101 FMPNKSLDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD 142
           +MPN SL    S                  G    +  LH+      IHRD+K++NILLD
Sbjct: 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLD 167
Query: 143 DQLNTKISDFGMARIFGVNESGANT---NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
           +    KISDFG+AR    +E  A T    RIVGT  YM+ E  + G ++ K+D++ FGV+
Sbjct: 168 EAFTAKISDFGLAR---ASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVV 223
Query: 200 VLKIVCG 206
           +L+I+ G
Sbjct: 224 LLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 68/184 (36%), Positives = 100/184 (54%), Gaps = 26/184 (14%)
Query: 45  FPNEQEVAIKRLAW----TSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
           + N   VA+K+LA     T+ + + +F  E K++AK Q+ NLV+LLG S  G++  LVY 
Sbjct: 45  YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 104
Query: 101 FMPNKSLDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD 142
           +MPN SL    S                  G    +  LH+      IHRD+K++NILLD
Sbjct: 105 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLD 161
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           +    KISDFG+AR            RIVGT  YM+ E  + G ++ K+D++ FGV++L+
Sbjct: 162 EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLE 220
Query: 203 IVCG 206
           I+ G
Sbjct: 221 IITG 224

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 66/184 (35%), Positives = 98/184 (53%), Gaps = 26/184 (14%)
Query: 45  FPNEQEVAIKRLAW----TSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
           + N   VA+K+LA     T+ + + +F  E K+ AK Q+ NLV+LLG S  G++  LVY 
Sbjct: 42  YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYV 101
Query: 101 FMPNKSLDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD 142
           + PN SL    S                  G    +  LH+      IHRD+K++NILLD
Sbjct: 102 YXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLD 158
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           +    KISDFG+AR           +RIVGT  Y + E  + G ++ K+D++ FGV++L+
Sbjct: 159 EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLE 217
Query: 203 IVCG 206
           I+ G
Sbjct: 218 IITG 221

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G   +  +VA+KR    S QG  EF+ E + ++  ++ +LV L+G      E +L+Y++M
Sbjct: 58  GVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 103 PNKSLDSSFSGTFKDL------------LC------LHKYSRLRVIHRDLKASNILLDDQ 144
            N +L     G+  DL            +C      LH      +IHRD+K+ NILLD+ 
Sbjct: 118 ENGNLKRHLYGS--DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN 175
Query: 145 LNTKISDFGMARIFGVNESGANTNRIV-GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
              KI+DFG+++  G      +   +V GT GY+  EY + G ++ K+DV+ FGV++ ++
Sbjct: 176 FVPKITDFGISKK-GTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 204 VCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP 248
           +C +           +NL   A +  N G+  +++D  L     P
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP 279

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G   +  +VA+KR    S QG  EF+ E + ++  ++ +LV L+G      E +L+Y++M
Sbjct: 58  GVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 103 PNKSLDSSFSGTFKDL------------LC------LHKYSRLRVIHRDLKASNILLDDQ 144
            N +L     G+  DL            +C      LH      +IHRD+K+ NILLD+ 
Sbjct: 118 ENGNLKRHLYGS--DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN 175
Query: 145 LNTKISDFGMARIFGVNESGANTNRIV-GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
              KI+DFG+++  G      +   +V GT GY+  EY + G ++ K+DV+ FGV++ ++
Sbjct: 176 FVPKITDFGISKK-GTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 204 VCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP 248
           +C +           +NL   A +  N G+  +++D  L     P
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP 279

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 92/183 (50%), Gaps = 25/183 (13%)
Query: 44  KFPNEQEVAIKRLAWTSG---QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
           + P +++V +   A  +G   + R +F +EA ++ +  + N+++L G    G   ++V E
Sbjct: 71  RVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE 130
Query: 101 FMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLNT 147
           +M N SLD+               G  + +    +Y S L  +HRDL A N+L+D  L  
Sbjct: 131 YMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVC 190
Query: 148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKT-----DVFGFGVLVLK 202
           K+SDFG++R+   +   A T     T G + + +T    ++ +T     DV+ FGV++ +
Sbjct: 191 KVSDFGLSRVLEDDPDAAXTT----TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246
Query: 203 IVC 205
           ++ 
Sbjct: 247 VLA 249

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 92/183 (50%), Gaps = 25/183 (13%)
Query: 44  KFPNEQEVAIKRLAWTSG---QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
           + P +++V +   A  +G   + R +F +EA ++ +  + N+++L G    G   ++V E
Sbjct: 71  RVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE 130
Query: 101 FMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLNT 147
           +M N SLD+               G  + +    +Y S L  +HRDL A N+L+D  L  
Sbjct: 131 YMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVC 190
Query: 148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKT-----DVFGFGVLVLK 202
           K+SDFG++R+   +   A T     T G + + +T    ++ +T     DV+ FGV++ +
Sbjct: 191 KVSDFGLSRVLEDDPDAAYTT----TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246
Query: 203 IVC 205
           ++ 
Sbjct: 247 VLA 249

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 41/210 (19%)
Query: 44  KFPNEQE--VAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           K P+++E  VAIK  ++ +T  Q R +F  EA ++ +  + N+++L G     +  ++V 
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRR-DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 100 EFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLN 146
           E+M N SLDS               G  + +    KY S +  +HRDL A NIL++  L 
Sbjct: 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV 185
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TDVFGFGVLVL 201
            K+SDFG+AR+   +   A T R     G + + +T    ++ +     +DV+ +G+++ 
Sbjct: 186 CKVSDFGLARVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
           +++         + ERP       W++ N+
Sbjct: 242 EVMS--------YGERPY------WEMSNQ 257

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 89/183 (48%), Gaps = 23/183 (12%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           + +G +    +VA+K L     QG +    F  EA L+ +LQ+  LV+L    +  E   
Sbjct: 35  VWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIY 89
Query: 97  LVYEFMPNKSL------DSSFSGTFKDLLCLHK--------YSRLRVIHRDLKASNILLD 142
           ++ E+M N SL       S    T   LL +                IHRDL+A+NIL+ 
Sbjct: 90  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 149
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           D L+ KI+DFG+AR+   NE  A          + + E    GT +IK+DV+ FG+L+ +
Sbjct: 150 DTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTE 208
Query: 203 IVC 205
           IV 
Sbjct: 209 IVT 211

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 109/229 (47%), Gaps = 51/229 (22%)
Query: 35  TRDRVILVGKF----------PNEQE--VAIK--RLAWTSGQGRVEFQNEAKLIAKLQYT 80
           T +RVI  G+F          P ++E  VAIK  ++ +T  Q R +F  EA ++ +  + 
Sbjct: 25  TIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRR-DFLGEASIMGQFDHP 83
Query: 81  NLVKLLGCSIHGEERLLVYEFMPNKSLDS------------SFSGTFKDLLCLHKY-SRL 127
           N++ L G     +  ++V E+M N SLD+               G  + +    KY S +
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDM 143
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
             +HRDL A NIL++  L  K+SDFG++R+   +   A T R     G + + +T    +
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTAPEAI 199
Query: 188 SIK-----TDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
           + +     +DV+ +G+++ ++V         + ERP       W++ N+
Sbjct: 200 AFRKFTSASDVWSYGIVMWEVVS--------YGERPY------WEMTNQ 234

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 89/183 (48%), Gaps = 23/183 (12%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           + +G +    +VA+K L     QG +    F  EA L+ +LQ+  LV+L    +  E   
Sbjct: 37  VWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIY 91
Query: 97  LVYEFMPNKSL------DSSFSGTFKDLLCLHK--------YSRLRVIHRDLKASNILLD 142
           ++ E+M N SL       S    T   LL +                IHRDL+A+NIL+ 
Sbjct: 92  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 151
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           D L+ KI+DFG+AR+   NE  A          + + E    GT +IK+DV+ FG+L+ +
Sbjct: 152 DTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTE 210
Query: 203 IVC 205
           IV 
Sbjct: 211 IVT 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 89/183 (48%), Gaps = 23/183 (12%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           + +G +    +VA+K L     QG +    F  EA L+ +LQ+  LV+L    +  E   
Sbjct: 38  VWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIY 92
Query: 97  LVYEFMPNKSL------DSSFSGTFKDLLCLHK--------YSRLRVIHRDLKASNILLD 142
           ++ E+M N SL       S    T   LL +                IHRDL+A+NIL+ 
Sbjct: 93  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 152
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           D L+ KI+DFG+AR+   NE  A          + + E    GT +IK+DV+ FG+L+ +
Sbjct: 153 DTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTE 211
Query: 203 IVC 205
           IV 
Sbjct: 212 IVT 214

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 89/183 (48%), Gaps = 23/183 (12%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           + +G +    +VA+K L     QG +    F  EA L+ +LQ+  LV+L    +  E   
Sbjct: 29  VWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIY 83
Query: 97  LVYEFMPNKSL------DSSFSGTFKDLLCLHK--------YSRLRVIHRDLKASNILLD 142
           ++ E+M N SL       S    T   LL +                IHRDL+A+NIL+ 
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           D L+ KI+DFG+AR+   NE  A          + + E    GT +IK+DV+ FG+L+ +
Sbjct: 144 DTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTE 202
Query: 203 IVC 205
           IV 
Sbjct: 203 IVT 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 89/183 (48%), Gaps = 23/183 (12%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           + +G +    +VA+K L     QG +    F  EA L+ +LQ+  LV+L    +  E   
Sbjct: 31  VWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIY 85
Query: 97  LVYEFMPNKSL------DSSFSGTFKDLLCLHK--------YSRLRVIHRDLKASNILLD 142
           ++ E+M N SL       S    T   LL +                IHRDL+A+NIL+ 
Sbjct: 86  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 145
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           D L+ KI+DFG+AR+   NE  A          + + E    GT +IK+DV+ FG+L+ +
Sbjct: 146 DTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTE 204
Query: 203 IVC 205
           IV 
Sbjct: 205 IVT 207

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 41/210 (19%)
Query: 44  KFPNEQE--VAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           K P+++E  VAIK  ++ +T  Q R +F  EA ++ +  + N+++L G     +  ++V 
Sbjct: 55  KLPSKKEISVAIKTLKVGYTEKQRR-DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 113
Query: 100 EFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLN 146
           E+M N SLDS               G  + +    KY S +  +HRDL A NIL++  L 
Sbjct: 114 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV 173
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TDVFGFGVLVL 201
            K+SDFG++R+   +   A T R     G + + +T    ++ +     +DV+ +G+++ 
Sbjct: 174 CKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 229
Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
           +++         + ERP       W++ N+
Sbjct: 230 EVMS--------YGERPY------WEMSNQ 245

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 89/183 (48%), Gaps = 23/183 (12%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           + +G +    +VA+K L     QG +    F  EA L+ +LQ+  LV+L    +  E   
Sbjct: 39  VWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIY 93
Query: 97  LVYEFMPNKSL------DSSFSGTFKDLLCLHK--------YSRLRVIHRDLKASNILLD 142
           ++ E+M N SL       S    T   LL +                IHRDL+A+NIL+ 
Sbjct: 94  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 153
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           D L+ KI+DFG+AR+   NE  A          + + E    GT +IK+DV+ FG+L+ +
Sbjct: 154 DTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTE 212
Query: 203 IVC 205
           IV 
Sbjct: 213 IVT 215

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 89/183 (48%), Gaps = 23/183 (12%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           + +G +    +VA+K L     QG +    F  EA L+ +LQ+  LV+L    +  E   
Sbjct: 34  VWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIY 88
Query: 97  LVYEFMPNKSL------DSSFSGTFKDLLCLHK--------YSRLRVIHRDLKASNILLD 142
           ++ E+M N SL       S    T   LL +                IHRDL+A+NIL+ 
Sbjct: 89  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 148
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           D L+ KI+DFG+AR+   NE  A          + + E    GT +IK+DV+ FG+L+ +
Sbjct: 149 DTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTE 207
Query: 203 IVC 205
           IV 
Sbjct: 208 IVT 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 89/183 (48%), Gaps = 23/183 (12%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           + +G +    +VA+K L     QG +    F  EA L+ +LQ+  LV+L    +  E   
Sbjct: 30  VWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIY 84
Query: 97  LVYEFMPNKSL------DSSFSGTFKDLLCLHK--------YSRLRVIHRDLKASNILLD 142
           ++ E+M N SL       S    T   LL +                IHRDL+A+NIL+ 
Sbjct: 85  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 144
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           D L+ KI+DFG+AR+   NE  A          + + E    GT +IK+DV+ FG+L+ +
Sbjct: 145 DTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTE 203
Query: 203 IVC 205
           IV 
Sbjct: 204 IVT 206

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 89/183 (48%), Gaps = 23/183 (12%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           + +G +    +VA+K L     QG +    F  EA L+ +LQ+  LV+L    +  E   
Sbjct: 29  VWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIY 83
Query: 97  LVYEFMPNKSL------DSSFSGTFKDLLCLHK--------YSRLRVIHRDLKASNILLD 142
           ++ E+M N SL       S    T   LL +                IHRDL+A+NIL+ 
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           D L+ KI+DFG+AR+   NE  A          + + E    GT +IK+DV+ FG+L+ +
Sbjct: 144 DTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTE 202
Query: 203 IVC 205
           IV 
Sbjct: 203 IVT 205

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 41/210 (19%)
Query: 44  KFPNEQE--VAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           K P+++E  VAIK  ++ +T  Q R +F  EA ++ +  + N+++L G     +  ++V 
Sbjct: 65  KLPSKKEISVAIKTLKVGYTEKQRR-DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 123
Query: 100 EFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLN 146
           E+M N SLDS               G  + +    KY S +  +HRDL A NIL++  L 
Sbjct: 124 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV 183
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TDVFGFGVLVL 201
            K+SDFG++R+   +   A T R     G + + +T    ++ +     +DV+ +G+++ 
Sbjct: 184 CKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 239
Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
           +++         + ERP       W++ N+
Sbjct: 240 EVMS--------YGERPY------WEMSNQ 255

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 89/183 (48%), Gaps = 23/183 (12%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           + +G +    +VA+K L     QG +    F  EA L+ +LQ+  LV+L    +  E   
Sbjct: 35  VWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIY 89
Query: 97  LVYEFMPNKSL------DSSFSGTFKDLLCLHK--------YSRLRVIHRDLKASNILLD 142
           ++ E+M N SL       S    T   LL +                IHRDL+A+NIL+ 
Sbjct: 90  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 149
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           D L+ KI+DFG+AR+   NE  A          + + E    GT +IK+DV+ FG+L+ +
Sbjct: 150 DTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTE 208
Query: 203 IVC 205
           IV 
Sbjct: 209 IVT 211

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 41/210 (19%)
Query: 44  KFPNEQE--VAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           K P+++E  VAIK  ++ +T  Q R +F  EA ++ +  + N+++L G     +  ++V 
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRR-DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 100 EFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLN 146
           E+M N SLDS               G  + +    KY S +  +HRDL A NIL++  L 
Sbjct: 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV 185
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TDVFGFGVLVL 201
            K+SDFG++R+   +   A T R     G + + +T    ++ +     +DV+ +G+++ 
Sbjct: 186 CKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
           +++         + ERP       W++ N+
Sbjct: 242 EVMS--------YGERPY------WEMSNQ 257

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 41/210 (19%)
Query: 44  KFPNEQE--VAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           K P+++E  VAIK  ++ +T  Q R +F  EA ++ +  + N+++L G     +  ++V 
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRR-DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 100 EFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLN 146
           E+M N SLDS               G  + +    KY S +  +HRDL A NIL++  L 
Sbjct: 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV 185
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TDVFGFGVLVL 201
            K+SDFG++R+   +   A T R     G + + +T    ++ +     +DV+ +G+++ 
Sbjct: 186 CKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
           +++         + ERP       W++ N+
Sbjct: 242 EVMS--------YGERPY------WEMSNQ 257

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 41/210 (19%)
Query: 44  KFPNEQE--VAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           K P+++E  VAIK  ++ +T  Q R +F  EA ++ +  + N+++L G     +  ++V 
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRR-DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 100 EFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLN 146
           E+M N SLDS               G  + +    KY S +  +HRDL A NIL++  L 
Sbjct: 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV 185
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TDVFGFGVLVL 201
            K+SDFG++R+   +   A T R     G + + +T    ++ +     +DV+ +G+++ 
Sbjct: 186 CKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
           +++         + ERP       W++ N+
Sbjct: 242 EVMS--------YGERPY------WEMSNQ 257

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 41/210 (19%)
Query: 44  KFPNEQE--VAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           K P+++E  VAIK  ++ +T  Q R +F  EA ++ +  + N+++L G     +  ++V 
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRR-DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 100 EFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLN 146
           E+M N SLDS               G  + +    KY S +  +HRDL A NIL++  L 
Sbjct: 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV 185
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TDVFGFGVLVL 201
            K+SDFG++R+   +   A T R     G + + +T    ++ +     +DV+ +G+++ 
Sbjct: 186 CKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
           +++         + ERP       W++ N+
Sbjct: 242 EVMS--------YGERPY------WEMSNQ 257

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 41/210 (19%)
Query: 44  KFPNEQE--VAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           K P+++E  VAIK  ++ +T  Q R +F  EA ++ +  + N+++L G     +  ++V 
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRR-DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 100 EFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLN 146
           E+M N SLDS               G  + +    KY S +  +HRDL A NIL++  L 
Sbjct: 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLV 185
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TDVFGFGVLVL 201
            K+SDFG++R+   +   A T R     G + + +T    ++ +     +DV+ +G+++ 
Sbjct: 186 CKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
           +++         + ERP       W++ N+
Sbjct: 242 EVMS--------YGERPY------WEMSNQ 257

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 41/210 (19%)
Query: 44  KFPNEQE--VAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           K P+++E  VAIK  ++ +T  Q R +F  EA ++ +  + N+++L G     +  ++V 
Sbjct: 38  KLPSKKEISVAIKTLKVGYTEKQRR-DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 96
Query: 100 EFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLN 146
           E+M N SLDS               G  + +    KY S +  +HRDL A NIL++  L 
Sbjct: 97  EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV 156
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TDVFGFGVLVL 201
            K+SDFG++R+   +   A T R     G + + +T    ++ +     +DV+ +G+++ 
Sbjct: 157 CKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 212
Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
           +++         + ERP       W++ N+
Sbjct: 213 EVMS--------YGERPY------WEMSNQ 228

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 41/210 (19%)
Query: 44  KFPNEQE--VAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           K P+++E  VAIK  ++ +T  Q R +F  EA ++ +  + N+++L G     +  ++V 
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRR-DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 100 EFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLN 146
           E+M N SLDS               G  + +    KY S +  +HRDL A NIL++  L 
Sbjct: 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV 185
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TDVFGFGVLVL 201
            K+SDFG+ R+   +   A T R     G + + +T    ++ +     +DV+ +G+++ 
Sbjct: 186 CKVSDFGLGRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
           +++         + ERP       W++ N+
Sbjct: 242 EVMS--------YGERPY------WEMSNQ 257

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 89/183 (48%), Gaps = 23/183 (12%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           + +G +    +VA+K L     QG +    F  EA L+ +LQ+  LV+L    +  E   
Sbjct: 29  VWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIY 83
Query: 97  LVYEFMPNKSL------DSSFSGTFKDLLCLHK--------YSRLRVIHRDLKASNILLD 142
           ++ E+M N SL       S    T   LL +                IHRDL+A+NIL+ 
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           D L+ KI+DFG+AR+   NE  A          + + E    GT +IK+DV+ FG+L+ +
Sbjct: 144 DTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTE 202
Query: 203 IVC 205
           IV 
Sbjct: 203 IVT 205

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 89/183 (48%), Gaps = 23/183 (12%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           + +G +    +VA+K L     QG +    F  EA L+ +LQ+  LV+L    +  E   
Sbjct: 24  VWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIY 78
Query: 97  LVYEFMPNKSL------DSSFSGTFKDLLCLHK--------YSRLRVIHRDLKASNILLD 142
           ++ E+M N SL       S    T   LL +                IHRDL+A+NIL+ 
Sbjct: 79  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 138
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           D L+ KI+DFG+AR+   NE  A          + + E    GT +IK+DV+ FG+L+ +
Sbjct: 139 DTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTE 197
Query: 203 IVC 205
           IV 
Sbjct: 198 IVT 200

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 41/210 (19%)
Query: 44  KFPNEQE--VAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           K P+++E  VAIK  ++ +T  Q R +F  EA ++ +  + N+++L G     +  ++V 
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRR-DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 100 EFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLN 146
           E M N SLDS               G  + +    KY S +  +HRDL A NIL++  L 
Sbjct: 126 EXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLV 185
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TDVFGFGVLVL 201
            K+SDFG++R+   +   A T R     G + + +T    ++ +     +DV+ +G+++ 
Sbjct: 186 CKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
           +++         + ERP       W++ N+
Sbjct: 242 EVMS--------YGERPY------WEMSNQ 257

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 90/185 (48%), Gaps = 27/185 (14%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           + +G +    +VA+K L     QG +    F  EA L+ +LQ+  LV+L    +  E   
Sbjct: 29  VWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIY 83
Query: 97  LVYEFMPNKSL------DSSFSGTFKDLLCLHK--------YSRLRVIHRDLKASNILLD 142
           ++ E+M N SL       S    T   LL +                IHRDL+A+NIL+ 
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYG--YMSLEYTMSGTVSIKTDVFGFGVLV 200
           D L+ KI+DFG+AR+    E    T R    +   + + E    GT +IK+DV+ FG+L+
Sbjct: 144 DTLSCKIADFGLARLI---EDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 201 LKIVC 205
            +IV 
Sbjct: 201 TEIVT 205

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 100/199 (50%), Gaps = 35/199 (17%)
Query: 37  DRVILVGKF----------PNEQE--VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLV 83
           ++VI VG+F          P ++E  VAIK L A  + + R +F +EA ++ +  + N++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 84  KLLGCSIHGEERLLVYEFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVI 130
            L G     +  +++ E+M N SLD+               G  + +    KY S +  +
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAV 153
Query: 131 HRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK 190
           HRDL A NIL++  L  K+SDFGM+R+   +   A T R     G + + +T    ++ +
Sbjct: 154 HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR----GGKIPIRWTAPEAIAYR 209
Query: 191 -----TDVFGFGVLVLKIV 204
                +DV+ +G+++ +++
Sbjct: 210 KFTSASDVWSYGIVMWEVM 228

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 41/210 (19%)
Query: 44  KFPNEQE--VAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           K P+++E  VAIK  ++ +T  Q R +F  EA ++ +  + N+++L G     +  ++V 
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRR-DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 100 EFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLN 146
           E M N SLDS               G  + +    KY S +  +HRDL A NIL++  L 
Sbjct: 126 EXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV 185
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TDVFGFGVLVL 201
            K+SDFG++R+   +   A T R     G + + +T    ++ +     +DV+ +G+++ 
Sbjct: 186 CKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
           +++         + ERP       W++ N+
Sbjct: 242 EVMS--------YGERPY------WEMSNQ 257

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 41/210 (19%)
Query: 44  KFPNEQE--VAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           K P+++E  VAIK  ++ +T  Q R +F  EA ++ +  + N+++L G     +  ++V 
Sbjct: 38  KLPSKKEISVAIKTLKVGYTEKQRR-DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 96
Query: 100 EFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLN 146
           E M N SLDS               G  + +    KY S +  +HRDL A NIL++  L 
Sbjct: 97  EXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV 156
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TDVFGFGVLVL 201
            K+SDFG++R+   +   A T R     G + + +T    ++ +     +DV+ +G+++ 
Sbjct: 157 CKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 212
Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
           +++         + ERP       W++ N+
Sbjct: 213 EVMS--------YGERPY------WEMSNQ 228

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 100/199 (50%), Gaps = 35/199 (17%)
Query: 37  DRVILVGKF----------PNEQE--VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLV 83
           ++VI VG+F          P ++E  VAIK L A  + + R +F +EA ++ +  + N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 84  KLLGCSIHGEERLLVYEFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVI 130
            L G     +  +++ E+M N SLD+               G  + +    KY S +  +
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYV 138
Query: 131 HRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK 190
           HRDL A NIL++  L  K+SDFGM+R+   +   A T R     G + + +T    ++ +
Sbjct: 139 HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR----GGKIPIRWTAPEAIAYR 194
Query: 191 -----TDVFGFGVLVLKIV 204
                +DV+ +G+++ +++
Sbjct: 195 KFTSASDVWSYGIVMWEVM 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 100/199 (50%), Gaps = 35/199 (17%)
Query: 37  DRVILVGKF----------PNEQE--VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLV 83
           ++VI VG+F          P ++E  VAIK L A  + + R +F +EA ++ +  + N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 84  KLLGCSIHGEERLLVYEFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVI 130
            L G     +  +++ E+M N SLD+               G  + +    KY S +  +
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYV 132
Query: 131 HRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK 190
           HRDL A NIL++  L  K+SDFGM+R+   +   A T R     G + + +T    ++ +
Sbjct: 133 HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR----GGKIPIRWTAPEAIAYR 188
Query: 191 -----TDVFGFGVLVLKIV 204
                +DV+ +G+++ +++
Sbjct: 189 KFTSASDVWSYGIVMWEVM 207

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 95/192 (49%), Gaps = 25/192 (13%)
Query: 33  EQTRDRVILVGKFPNEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSI 90
           E  R R+   GK   E  VAIK L   +T  Q R EF +EA ++ + ++ N+++L G   
Sbjct: 31  EVCRGRLKAPGK--KESCVAIKTLKGGYTERQRR-EFLSEASIMGQFEHPNIIRLEGVVT 87
Query: 91  HGEERLLVYEFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKAS 137
           +    +++ EFM N +LDS               G  + +    +Y + +  +HRDL A 
Sbjct: 88  NSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAAR 147
Query: 138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TD 192
           NIL++  L  K+SDFG++R    N S       +G  G + + +T    ++ +     +D
Sbjct: 148 NILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG--GKIPIRWTAPEAIAFRKFTSASD 205
Query: 193 VFGFGVLVLKIV 204
            + +G+++ +++
Sbjct: 206 AWSYGIVMWEVM 217

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 89/183 (48%), Gaps = 23/183 (12%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           + +G +    +VA+K L     QG +    F  EA L+ +LQ+  LV+L    +  E   
Sbjct: 25  VWMGYYNGHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIY 79
Query: 97  LVYEFMPNKSL------DSSFSGTFKDLLCLHK--------YSRLRVIHRDLKASNILLD 142
           ++ E+M N SL       S    T   LL +                IHR+L+A+NIL+ 
Sbjct: 80  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANILVS 139
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           D L+ KI+DFG+AR+   NE  A          + + E    GT +IK+DV+ FG+L+ +
Sbjct: 140 DTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTE 198
Query: 203 IVC 205
           IV 
Sbjct: 199 IVT 201

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 95/192 (49%), Gaps = 25/192 (13%)
Query: 33  EQTRDRVILVGKFPNEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSI 90
           E  R R+   GK   E  VAIK L   +T  Q R EF +EA ++ + ++ N+++L G   
Sbjct: 29  EVCRGRLKAPGK--KESCVAIKTLKGGYTERQRR-EFLSEASIMGQFEHPNIIRLEGVVT 85
Query: 91  HGEERLLVYEFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKAS 137
           +    +++ EFM N +LDS               G  + +    +Y + +  +HRDL A 
Sbjct: 86  NSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAAR 145
Query: 138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TD 192
           NIL++  L  K+SDFG++R    N S       +G  G + + +T    ++ +     +D
Sbjct: 146 NILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG--GKIPIRWTAPEAIAFRKFTSASD 203
Query: 193 VFGFGVLVLKIV 204
            + +G+++ +++
Sbjct: 204 AWSYGIVMWEVM 215

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 50/228 (21%)
Query: 35  TRDRVILVGKF-------------PNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYT 80
           TR +VI  G+F               E  VAIK L A  + + RV+F  EA ++ +  + 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 81  NLVKLLGCSIHGEERLLVYEFMPNKSLD-------SSFS-----GTFKDLLCLHKY-SRL 127
           N+++L G     +  +++ E+M N +LD         FS     G  + +    KY + +
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
             +HRDL A NIL++  L  K+SDFG++R+   +     T     + G + + +T    +
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT----SGGKIPIRWTAPEAI 222
Query: 188 SIK-----TDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWN 230
           S +     +DV+ FG+++ +++         + ERP       W+L N
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMT--------YGERPY------WELSN 256

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 22/182 (12%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           + +G + N  +VA+K L    G   V+ F  EA L+  LQ+  LV+L       E   ++
Sbjct: 29  VWMGYYNNSTKVAVKTL--KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYII 86
Query: 99  YEFMPNKSLDS----------------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLD 142
            E+M   SL                   FS    + +      R   IHRDL+A+N+L+ 
Sbjct: 87  TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY--IERKNYIHRDLRAANVLVS 144
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           + L  KI+DFG+AR+   NE  A          + + E    G  +IK+DV+ FG+L+ +
Sbjct: 145 ESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTIKSDVWSFGILLYE 203
Query: 203 IV 204
           IV
Sbjct: 204 IV 205

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 97/200 (48%), Gaps = 37/200 (18%)
Query: 37  DRVILVGKF----------PNEQEVAIK----RLAWTSGQGRVEFQNEAKLIAKLQYTNL 82
           +RVI  G+F          P +++VA+     ++ +T  Q R +F  EA ++ +  + N+
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRR-DFLCEASIMGQFDHPNV 106
Query: 83  VKLLGCSIHGEERLLVYEFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRV 129
           V L G    G+  ++V EFM N +LD+               G  + +    +Y + +  
Sbjct: 107 VHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY 166
Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI 189
           +HRDL A NIL++  L  K+SDFG++R+   +     T     T G + + +T    +  
Sbjct: 167 VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTT----TGGKIPVRWTAPEAIQY 222
Query: 190 K-----TDVFGFGVLVLKIV 204
           +     +DV+ +G+++ +++
Sbjct: 223 RKFTSASDVWSYGIVMWEVM 242

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 90/183 (49%), Gaps = 25/183 (13%)
Query: 44  KFPNEQE--VAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           K P ++E  VAIK L   +T  Q R +F +EA ++ +  + N++ L G        +++ 
Sbjct: 55  KLPGKREIFVAIKTLKSGYTEKQRR-DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 113
Query: 100 EFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLN 146
           EFM N SLDS               G  + +    KY + +  +HRDL A NIL++  L 
Sbjct: 114 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV 173
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TDVFGFGVLVL 201
            K+SDFG++R    + S       +G  G + + +T    +  +     +DV+ +G+++ 
Sbjct: 174 CKVSDFGLSRFLEDDTSDPTYTSALG--GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 231
Query: 202 KIV 204
           +++
Sbjct: 232 EVM 234

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 22/182 (12%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           + +G + N  +VA+K L    G   V+ F  EA L+  LQ+  LV+L       E   ++
Sbjct: 28  VWMGYYNNSTKVAVKTL--KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 85
Query: 99  YEFMPNKSLDS----------------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLD 142
            EFM   SL                   FS    + +      R   IHRDL+A+N+L+ 
Sbjct: 86  TEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY--IERKNYIHRDLRAANVLVS 143
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           + L  KI+DFG+AR+   NE  A          + + E    G  +IK++V+ FG+L+ +
Sbjct: 144 ESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTIKSNVWSFGILLYE 202
Query: 203 IV 204
           IV
Sbjct: 203 IV 204

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 34  VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVI 91
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 92  EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 151
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 152 VCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 209

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 25  VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVT 82
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 83  EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 142
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 143 VCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 200

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 50/214 (23%)
Query: 41  LVGKFPNEQ--EVAIKRLA-WTSGQGRVEFQNEAKLIAKLQYTNLVKLLG---------- 87
           L G  P EQ   VAIK L     G  R EF++EA L A+LQ+ N+V LLG          
Sbjct: 47  LFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106
Query: 88  ----CSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLC-------------------LHKY 124
               CS HG+    ++EF+  +S  S    T  D                      +   
Sbjct: 107 IFSYCS-HGD----LHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 161
Query: 125 SRLRVIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTM 183
           S   V+H+DL   N+L+ D+LN KISD G+ R ++  +      N ++    +M+ E  M
Sbjct: 162 SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI-RWMAPEAIM 220
Query: 184 SGTVSIKTDVFGFGVLV-------LKIVCGKKNN 210
            G  SI +D++ +GV++       L+  CG  N 
Sbjct: 221 YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 34  VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVI 91
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 92  EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 151
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 152 VCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 209

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 23  VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVT 80
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 81  EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 140
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 141 VCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 198

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 34  VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVT 91
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 92  EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 151
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 152 VCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 209

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 34  VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVC 91
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 92  EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 151
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 152 VCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 209

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 24  VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIXIVT 81
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 82  EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 141
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 142 VCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 199

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 50/214 (23%)
Query: 41  LVGKFPNEQ--EVAIKRLA-WTSGQGRVEFQNEAKLIAKLQYTNLVKLLG---------- 87
           L G  P EQ   VAIK L     G  R EF++EA L A+LQ+ N+V LLG          
Sbjct: 30  LFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 89
Query: 88  ----CSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLC-------------------LHKY 124
               CS HG+    ++EF+  +S  S    T  D                      +   
Sbjct: 90  IFSYCS-HGD----LHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 144
Query: 125 SRLRVIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTM 183
           S   V+H+DL   N+L+ D+LN KISD G+ R ++  +      N ++    +M+ E  M
Sbjct: 145 SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR-WMAPEAIM 203
Query: 184 SGTVSIKTDVFGFGVLV-------LKIVCGKKNN 210
            G  SI +D++ +GV++       L+  CG  N 
Sbjct: 204 YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 237

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 97/249 (38%), Gaps = 53/249 (21%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS 110
           VA+K L   S   R +FQ EA+L+  LQ+ ++V+  G    G   L+V+E+M +  L+  
Sbjct: 51  VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 110
Query: 111 FSGTFKD-------------------LLCLHK--------YSRLRVIHRDLKASNILLDD 143
                 D                   LL +           + L  +HRDL   N L+  
Sbjct: 111 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 170
Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
            L  KI DFGM+R     +      R +    +M  E  +    + ++DV+ FGV++ +I
Sbjct: 171 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEI 230
Query: 204 VCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG-------SCPPNEDAFLLV 256
               K                  Q W +  + E ID    G       +CPP   A ++ 
Sbjct: 231 FTYGK------------------QPWYQLSNTEAIDCITQGRELERPRACPPEVYA-IMR 271
Query: 257 SCVCKSKQQ 265
            C  +  QQ
Sbjct: 272 GCWQREPQQ 280

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 27  VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVT 84
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 85  EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 144
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 145 VCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 202

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 97/249 (38%), Gaps = 53/249 (21%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS 110
           VA+K L   S   R +FQ EA+L+  LQ+ ++V+  G    G   L+V+E+M +  L+  
Sbjct: 45  VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 104
Query: 111 FSGTFKD-------------------LLCLHK--------YSRLRVIHRDLKASNILLDD 143
                 D                   LL +           + L  +HRDL   N L+  
Sbjct: 105 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 164
Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
            L  KI DFGM+R     +      R +    +M  E  +    + ++DV+ FGV++ +I
Sbjct: 165 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEI 224
Query: 204 VCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG-------SCPPNEDAFLLV 256
               K                  Q W +  + E ID    G       +CPP   A ++ 
Sbjct: 225 FTYGK------------------QPWYQLSNTEAIDCITQGRELERPRACPPEVYA-IMR 265
Query: 257 SCVCKSKQQ 265
            C  +  QQ
Sbjct: 266 GCWQREPQQ 274

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ K+++  LV+L    +  E   +V 
Sbjct: 34  VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQLYAV-VSEEPIYIVT 91
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 92  EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 151
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 152 VCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 209

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 34  VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVT 91
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL A+NIL+ + L
Sbjct: 92  EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANILVGENL 151
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 152 VCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 209

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 89/181 (49%), Gaps = 19/181 (10%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           + +  +    +VA+K +    G   VE F  EA ++  LQ+  LVKL    +  E   ++
Sbjct: 31  VWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYII 87
Query: 99  YEFMPNKSLDS---SFSGTFKDLLCLHKYS-----------RLRVIHRDLKASNILLDDQ 144
            EFM   SL     S  G+ + L  L  +S           +   IHRDL+A+NIL+   
Sbjct: 88  TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS 147
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           L  KI+DFG+AR+   NE  A          + + E    G+ +IK+DV+ FG+L+++IV
Sbjct: 148 LVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 206
Query: 205 C 205
Sbjct: 207 T 207

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 97/249 (38%), Gaps = 53/249 (21%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS 110
           VA+K L   S   R +FQ EA+L+  LQ+ ++V+  G    G   L+V+E+M +  L+  
Sbjct: 74  VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 133
Query: 111 FSGTFKD-------------------LLCLHK--------YSRLRVIHRDLKASNILLDD 143
                 D                   LL +           + L  +HRDL   N L+  
Sbjct: 134 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193
Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
            L  KI DFGM+R     +      R +    +M  E  +    + ++DV+ FGV++ +I
Sbjct: 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEI 253
Query: 204 VCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG-------SCPPNEDAFLLV 256
               K                  Q W +  + E ID    G       +CPP   A ++ 
Sbjct: 254 FTYGK------------------QPWYQLSNTEAIDCITQGRELERPRACPPEVYA-IMR 294
Query: 257 SCVCKSKQQ 265
            C  +  QQ
Sbjct: 295 GCWQREPQQ 303

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 31  VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVT 88
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 89  EYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENL 148
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 149 VCKVADFGLARLIEDNEWTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 206

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 31  VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVT 88
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 89  EYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENL 148
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 149 VCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 206

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 200 VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVT 257
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 317
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 318 VCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 200 VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVT 257
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 317
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 318 VCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 34  VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVM 91
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M    L     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 92  EYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 151
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 152 VCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 209

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 34  VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVT 91
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M    L     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 92  EYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 151
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 152 VCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 209

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 201 VWMGTWNGTTRVAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVT 258
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 259 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 318
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+ R+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 319 VCKVADFGLGRLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 376

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 33/197 (16%)
Query: 44  KFPNEQE--VAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           K P ++E  VAIK L   +T  Q R +F +EA ++ +  + N++ L G        +++ 
Sbjct: 29  KLPGKREIFVAIKTLKSGYTEKQRR-DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 87
Query: 100 EFMPNKSLDS------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLN 146
           EFM N SLDS               G  + +    KY + +  +HR L A NIL++  L 
Sbjct: 88  EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLV 147
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK-----TDVFGFGVLVL 201
            K+SDFG++R    + S       +G  G + + +T    +  +     +DV+ +G+++ 
Sbjct: 148 CKVSDFGLSRFLEDDTSDPTYTSALG--GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 205
Query: 202 KIVCGKKNNKSYHTERP 218
           +++         + ERP
Sbjct: 206 EVMS--------YGERP 214

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 200 VWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVG 257
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 317
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 318 VCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 88/169 (52%), Gaps = 17/169 (10%)
Query: 51  VAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L  T+G +  VEF +EA ++A + + +LV+LLG  +    +L V + MP+  L  
Sbjct: 47  VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCL-L 104
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 105 EYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLA 164
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           R+   +E   N +       +M+LE       + ++DV+ +GV + +++
Sbjct: 165 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 213

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 89/181 (49%), Gaps = 19/181 (10%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           + +  +    +VA+K +    G   VE F  EA ++  LQ+  LVKL    +  E   ++
Sbjct: 204 VWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYII 260
Query: 99  YEFMPNKSLDS---SFSGTFKDLLCLHKYS-----------RLRVIHRDLKASNILLDDQ 144
            EFM   SL     S  G+ + L  L  +S           +   IHRDL+A+NIL+   
Sbjct: 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS 320
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           L  KI+DFG+AR+   NE  A          + + E    G+ +IK+DV+ FG+L+++IV
Sbjct: 321 LVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
Query: 205 C 205
Sbjct: 380 T 380

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 17/179 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +     VAIK L   +      F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 283 VWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVT 340
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHK--------------YSRLRVIHRDLKASNILLDDQL 145
           E+M   SL     G     L L +                R+  +HRDL+A+NIL+ + L
Sbjct: 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 400
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
             K++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 401 VCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 88/169 (52%), Gaps = 17/169 (10%)
Query: 51  VAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L  T+G +  VEF +EA ++A + + +LV+LLG  +    +L V + MP+  L  
Sbjct: 70  VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCL-L 127
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 128 EYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLA 187
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           R+   +E   N +       +M+LE       + ++DV+ +GV + +++
Sbjct: 188 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 236

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 30/179 (16%)
Query: 47  NEQEVAIKRLAWTSGQGRVEFQN---EAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP 103
           N + VAIK+++++  Q   ++Q+   E + + KL++ N ++  GC +      LV E+  
Sbjct: 78  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137
Query: 104 NKSLD---------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTK 148
             + D               +   G  + L  LH ++   +IHRD+KA NILL +    K
Sbjct: 138 GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVK 194
Query: 149 ISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS---GTVSIKTDVFGFGVLVLKIV 204
           + DFG A I       A  N  VGT  +M+ E  ++   G    K DV+  G+  +++ 
Sbjct: 195 LGDFGSASIM------APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 30/179 (16%)
Query: 47  NEQEVAIKRLAWTSGQGRVEFQN---EAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP 103
           N + VAIK+++++  Q   ++Q+   E + + KL++ N ++  GC +      LV E+  
Sbjct: 39  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98
Query: 104 NKSLD---------------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTK 148
             + D               +   G  + L  LH ++   +IHRD+KA NILL +    K
Sbjct: 99  GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVK 155
Query: 149 ISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS---GTVSIKTDVFGFGVLVLKIV 204
           + DFG A I       A  N  VGT  +M+ E  ++   G    K DV+  G+  +++ 
Sbjct: 156 LGDFGSASIM------APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 26/162 (16%)
Query: 68  QNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSG--TFKDLLC----- 120
           + EAKL A L++ N++ L G  +      LV EF     L+   SG     D+L      
Sbjct: 54  RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ 113
Query: 121 -------LHKYSRLRVIHRDLKASNILLDDQLNT--------KISDFGMARIFGVNESGA 165
                  LH  + + +IHRDLK+SNIL+  ++          KI+DFG+AR +       
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRT 169
Query: 166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
                 G Y +M+ E   +   S  +DV+ +GVL+ +++ G+
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 87/180 (48%), Gaps = 17/180 (9%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           + +G +    +VAIK L          F  EA+++ KL++  LV+L    +  E   +V 
Sbjct: 25  VWMGTWNGNTKVAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQLYAV-VSEEPIYIVT 82
Query: 100 EFMPNKSL-DSSFSGTFKDL-------------LCLHKYSRLRVIHRDLKASNILLDDQL 145
           E+M   SL D    G  + L               +    R+  IHRDL+++NIL+ + L
Sbjct: 83  EYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGL 142
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC 205
             KI+DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++V 
Sbjct: 143 ICKIADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 201

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 80/181 (44%), Gaps = 23/181 (12%)
Query: 46  PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-- 102
           P+  +VA+K L    S Q  ++F  EA +I+KL + N+V+ +G S+    R ++ E M  
Sbjct: 59  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAG 118
Query: 103 -----------PNKSLDSSFS-----GTFKDLLCLHKY-SRLRVIHRDLKASNILLD--- 142
                      P  S  SS +        +D+ C  +Y      IHRD+ A N LL    
Sbjct: 119 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 178
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
                KI DFGMAR              +    +M  E  M G  + KTD + FGVL+ +
Sbjct: 179 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 238
Query: 203 I 203
           I
Sbjct: 239 I 239

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 80/181 (44%), Gaps = 23/181 (12%)
Query: 46  PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-- 102
           P+  +VA+K L    S Q  ++F  EA +I+KL + N+V+ +G S+    R ++ E M  
Sbjct: 73  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAG 132
Query: 103 -----------PNKSLDSSFS-----GTFKDLLCLHKY-SRLRVIHRDLKASNILL---D 142
                      P  S  SS +        +D+ C  +Y      IHRD+ A N LL    
Sbjct: 133 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 192
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
                KI DFGMAR              +    +M  E  M G  + KTD + FGVL+ +
Sbjct: 193 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 252
Query: 203 I 203
           I
Sbjct: 253 I 253

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 46/78 (58%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     + S
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAS 212
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 25/178 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS 110
           VA+K L   S   R +F  EA+L+  LQ+ ++VK  G  + G+  ++V+E+M +  L+  
Sbjct: 46  VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 105
Query: 111 FSGTFKDLLC---------------LHKYSRL----------RVIHRDLKASNILLDDQL 145
                 D +                LH   ++            +HRDL   N L+ + L
Sbjct: 106 LRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             KI DFGM+R     +        +    +M  E  M    + ++DV+  GV++ +I
Sbjct: 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 223

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 24/174 (13%)
Query: 46  PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK 105
           P E+E  +KR           F+ E    ++L + N+V ++      +   LV E++   
Sbjct: 48  PREKEETLKR-----------FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGP 96
Query: 106 SL------------DSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFG 153
           +L            D++ + T + L  +     +R++HRD+K  NIL+D     KI DFG
Sbjct: 97  TLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFG 156
Query: 154 MARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           +A+      S   TN ++GT  Y S E          TD++  G+++ +++ G+
Sbjct: 157 IAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 46  PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-- 102
           P+  +VA+K L    S Q  ++F  EA +I+K  + N+V+ +G S+    R ++ E M  
Sbjct: 58  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAG 117
Query: 103 -----------PNKSLDSSFS-----GTFKDLLCLHKY-SRLRVIHRDLKASNILL---D 142
                      P  S  SS +        +D+ C  +Y      IHRD+ A N LL    
Sbjct: 118 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 177
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
                KI DFGMAR              +    +M  E  M G  + KTD + FGVL+ +
Sbjct: 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 237
Query: 203 I 203
           I
Sbjct: 238 I 238

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 46  PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-- 102
           P+  +VA+K L    S Q  ++F  EA +I+K  + N+V+ +G S+    R ++ E M  
Sbjct: 50  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 109
Query: 103 -----------PNKSLDSSFS-----GTFKDLLCLHKY-SRLRVIHRDLKASNILL---D 142
                      P  S  SS +        +D+ C  +Y      IHRD+ A N LL    
Sbjct: 110 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 169
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
                KI DFGMAR              +    +M  E  M G  + KTD + FGVL+ +
Sbjct: 170 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 229
Query: 203 I 203
           I
Sbjct: 230 I 230

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 46  PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-- 102
           P+  +VA+K L    S Q  ++F  EA +I+K  + N+V+ +G S+    R ++ E M  
Sbjct: 58  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 117
Query: 103 -----------PNKSLDSSFS-----GTFKDLLCLHKY-SRLRVIHRDLKASNILL---D 142
                      P  S  SS +        +D+ C  +Y      IHRD+ A N LL    
Sbjct: 118 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 177
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
                KI DFGMAR              +    +M  E  M G  + KTD + FGVL+ +
Sbjct: 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 237
Query: 203 I 203
           I
Sbjct: 238 I 238

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 68  QNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS-LDSSFSGTF----------- 115
           Q E  ++++   + + K  G  + G +  ++ E++   S LD   +G F           
Sbjct: 69  QQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKE 128
Query: 116 --KDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
             K L  LH   +   IHRD+KA+N+LL +Q + K++DFG+A    + ++    N  VGT
Sbjct: 129 ILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGT 183
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
             +M+ E         K D++  G+  +++  G+  N   H  R L L+
Sbjct: 184 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 232

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 46  PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-- 102
           P+  +VA+K L    S Q  ++F  EA +I+K  + N+V+ +G S+    R ++ E M  
Sbjct: 75  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 134
Query: 103 -----------PNKSLDSSFS-----GTFKDLLCLHKY-SRLRVIHRDLKASNILLD--- 142
                      P  S  SS +        +D+ C  +Y      IHRD+ A N LL    
Sbjct: 135 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 194
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
                KI DFGMAR              +    +M  E  M G  + KTD + FGVL+ +
Sbjct: 195 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 254
Query: 203 I 203
           I
Sbjct: 255 I 255

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 81/184 (44%), Gaps = 29/184 (15%)
Query: 46  PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-- 102
           P+  +VA+K L    S Q  ++F  EA +I+K  + N+V+ +G S+    R ++ E M  
Sbjct: 99  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 158
Query: 103 -----------PNKSLDSSFS-----GTFKDLLCLHKY-SRLRVIHRDLKASNILL---D 142
                      P  S  SS +        +D+ C  +Y      IHRD+ A N LL    
Sbjct: 159 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 218
Query: 143 DQLNTKISDFGMARIF---GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
                KI DFGMAR     G    G      V    +M  E  M G  + KTD + FGVL
Sbjct: 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFGVL 275
Query: 200 VLKI 203
           + +I
Sbjct: 276 LWEI 279

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 46  PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-- 102
           P+  +VA+K L    S Q  ++F  EA +I+K  + N+V+ +G S+    R ++ E M  
Sbjct: 73  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAG 132
Query: 103 -----------PNKSLDSSFS-----GTFKDLLCLHKY-SRLRVIHRDLKASNILL---D 142
                      P  S  SS +        +D+ C  +Y      IHRD+ A N LL    
Sbjct: 133 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 192
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
                KI DFGMAR              +    +M  E  M G  + KTD + FGVL+ +
Sbjct: 193 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 252
Query: 203 I 203
           I
Sbjct: 253 I 253

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 122/272 (44%), Gaps = 46/272 (16%)
Query: 51  VAIKRLAWTSGQGRVEFQ-NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---K 105
           VA+K +   S +G       E  L+ +L++ N+V+L    IH E +L LV+EFM N   K
Sbjct: 33  VALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV-IHTENKLTLVFEFMDNDLKK 91
Query: 106 SLDSSFSG-TFKDL-LCLHKYSRL------------RVIHRDLKASNILLDDQLNTKISD 151
            +DS   G T + L L L KY +             +++HRDLK  N+L++ +   K+ D
Sbjct: 92  YMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGD 151
Query: 152 FGMARIFGVNESGANTNRIVGTYGYMSLEYTM-SGTVSIKTDVFGFGVLVLKIVCGKKNN 210
           FG+AR FG+  +  ++   V T  Y + +  M S T S   D++  G ++ +++ GK   
Sbjct: 152 FGLARAFGIPVNTFSSE--VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKP-- 207
Query: 211 KSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQC 270
                            L+    D E + L  D    PNE  +  V+ + K    I  + 
Sbjct: 208 -----------------LFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRP 250
Query: 271 PMLFPCLLM----NLLPGLYLKNLHFLLMLPP 298
           P     +L       L G  +  LH LL L P
Sbjct: 251 PRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNP 282

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 46  PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-- 102
           P+  +VA+K L    S Q  ++F  EA +I+K  + N+V+ +G S+    R ++ E M  
Sbjct: 59  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 118
Query: 103 -----------PNKSLDSSFS-----GTFKDLLCLHKY-SRLRVIHRDLKASNILLD--- 142
                      P  S  SS +        +D+ C  +Y      IHRD+ A N LL    
Sbjct: 119 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 178
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
                KI DFGMAR              +    +M  E  M G  + KTD + FGVL+ +
Sbjct: 179 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 238
Query: 203 I 203
           I
Sbjct: 239 I 239

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 46  PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-- 102
           P+  +VA+K L    S Q  ++F  EA +I+K  + N+V+ +G S+    R ++ E M  
Sbjct: 85  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 144
Query: 103 -----------PNKSLDSSFS-----GTFKDLLCLHKY-SRLRVIHRDLKASNILLD--- 142
                      P  S  SS +        +D+ C  +Y      IHRD+ A N LL    
Sbjct: 145 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 204
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
                KI DFGMAR              +    +M  E  M G  + KTD + FGVL+ +
Sbjct: 205 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 264
Query: 203 I 203
           I
Sbjct: 265 I 265

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 81/184 (44%), Gaps = 29/184 (15%)
Query: 46  PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-- 102
           P+  +VA+K L    S Q  ++F  EA +I+K  + N+V+ +G S+    R ++ E M  
Sbjct: 76  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 135
Query: 103 -----------PNKSLDSSFS-----GTFKDLLCLHKY-SRLRVIHRDLKASNILL---D 142
                      P  S  SS +        +D+ C  +Y      IHRD+ A N LL    
Sbjct: 136 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 195
Query: 143 DQLNTKISDFGMARIF---GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
                KI DFGMAR     G    G      V    +M  E  M G  + KTD + FGVL
Sbjct: 196 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFGVL 252
Query: 200 VLKI 203
           + +I
Sbjct: 253 LWEI 256

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 46  PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-- 102
           P+  +VA+K L    S Q  ++F  EA +I+K  + N+V+ +G S+    R ++ E M  
Sbjct: 65  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 124
Query: 103 -----------PNKSLDSSFS-----GTFKDLLCLHKY-SRLRVIHRDLKASNILLD--- 142
                      P  S  SS +        +D+ C  +Y      IHRD+ A N LL    
Sbjct: 125 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 184
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
                KI DFGMAR              +    +M  E  M G  + KTD + FGVL+ +
Sbjct: 185 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 244
Query: 203 I 203
           I
Sbjct: 245 I 245

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 46  PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-- 102
           P+  +VA+K L    S Q  ++F  EA +I+K  + N+V+ +G S+    R ++ E M  
Sbjct: 73  PSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 132
Query: 103 -----------PNKSLDSSFS-----GTFKDLLCLHKY-SRLRVIHRDLKASNILL---D 142
                      P  S  SS +        +D+ C  +Y      IHRD+ A N LL    
Sbjct: 133 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 192
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
                KI DFGMAR              +    +M  E  M G  + KTD + FGVL+ +
Sbjct: 193 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 252
Query: 203 I 203
           I
Sbjct: 253 I 253

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 83/192 (43%), Gaps = 15/192 (7%)
Query: 30  IQQEQTRDRVILVGKFPNEQEVAIKRLAWTS--GQGRVEF-QNEAKLIAKLQYTNLVKLL 86
           I  E +   V+L  +    +E AIK L       + +V +   E  ++++L +   VKL 
Sbjct: 44  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 103
Query: 87  GCSIHGEERLLVYEFMPNKSL------DSSFSGTFKDLLCLHKYSRLR------VIHRDL 134
            C    E+      +  N  L        SF  T          S L       +IHRDL
Sbjct: 104 FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 163
Query: 135 KASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVF 194
           K  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +    +D++
Sbjct: 164 KPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLW 223
Query: 195 GFGVLVLKIVCG 206
             G ++ ++V G
Sbjct: 224 ALGCIIYQLVAG 235

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 131 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 190
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 191 KSSDLWALGCIIYQLVAG 208

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 130 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 189
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 190 KSSDLWALGCIIYQLVAG 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 188
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 189 KSSDLWALGCIIYQLVAG 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 128 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 187
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 188 KSSDLWALGCIIYQLVAG 205

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 17/179 (9%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           ++ +G + N+ +VAIK +         +F  EA+++ KL +  LV+L G  +      LV
Sbjct: 25  LVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83
Query: 99  YEFMPNKSLDSSFSGTFKDL--------LCLHKYSRLR------VIHRDLKASNILLDDQ 144
           +EFM +  L S +  T + L        +CL     +       VIHRDL A N L+ + 
Sbjct: 84  FEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN 142
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
              K+SDFGM R F +++   ++        + S E       S K+DV+ FGVL+ ++
Sbjct: 143 QVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 200

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 23/181 (12%)
Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VAIK +    S + R+EF NEA ++ +    ++V+LLG    G+  L++ E M    
Sbjct: 40  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 99
Query: 107 LDSSFSGTFKDL-----LCLHKYSRL-----------------RVIHRDLKASNILLDDQ 144
           L S       ++     L     S++                 + +HRDL A N ++ + 
Sbjct: 100 LKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 159
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
              KI DFGM R     +      + +    +MS E    G  +  +DV+ FGV++ +I 
Sbjct: 160 FTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 219
Query: 205 C 205
Sbjct: 220 T 220

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 17/179 (9%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           ++ +G + N+ +VAIK +         +F  EA+++ KL +  LV+L G  +      LV
Sbjct: 20  LVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78
Query: 99  YEFMPNKSLDSSFSGTFKDL--------LCLHKYSRLR------VIHRDLKASNILLDDQ 144
           +EFM +  L S +  T + L        +CL     +       VIHRDL A N L+ + 
Sbjct: 79  FEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN 137
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
              K+SDFGM R F +++   ++        + S E       S K+DV+ FGVL+ ++
Sbjct: 138 QVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 195

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 29/181 (16%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           + +  +    +VA+K +    G   VE F  EA ++  LQ+  LVKL    +  E   ++
Sbjct: 198 VWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYII 254
Query: 99  YEFMPNKSLDS---SFSGTFKDLLCLHKYS-----------RLRVIHRDLKASNILLDDQ 144
            EFM   SL     S  G+ + L  L  +S           +   IHRDL+A+NIL+   
Sbjct: 255 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS 314
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           L  KI+DFG+AR+      GA          + + E    G+ +IK+DV+ FG+L+++IV
Sbjct: 315 LVCKIADFGLARV------GAKF-----PIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 363
Query: 205 C 205
Sbjct: 364 T 364

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 194
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 195 KSSDLWALGCIIYQLVAG 212

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 16/180 (8%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS 110
           VA+K++     Q R    NE  ++   Q+ N+V++    + G+E  +V EF+   +L   
Sbjct: 57  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 116
Query: 111 FSGTFKD--------LLCLHKYSRLR---VIHRDLKASNILLDDQLNTKISDFGMARIFG 159
            + T  +        L  L   S L    VIHRD+K+ +ILL      K+SDFG      
Sbjct: 117 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQ 174
Query: 160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPL 219
           V++       +VGT  +M+ E         + D++  G++V+++V G+     Y  E PL
Sbjct: 175 VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---PPYFNEPPL 231

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 213
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 214 KSSDLWALGCIIYQLVAG 231

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 16/180 (8%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS 110
           VA+K++     Q R    NE  ++   Q+ N+V++    + G+E  +V EF+   +L   
Sbjct: 59  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 118
Query: 111 FSGTFKD--------LLCLHKYSRLR---VIHRDLKASNILLDDQLNTKISDFGMARIFG 159
            + T  +        L  L   S L    VIHRD+K+ +ILL      K+SDFG      
Sbjct: 119 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQ 176
Query: 160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPL 219
           V++       +VGT  +M+ E         + D++  G++V+++V G+     Y  E PL
Sbjct: 177 VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---PPYFNEPPL 233

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 17/179 (9%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           ++ +G + N+ +VAIK +         +F  EA+++ KL +  LV+L G  +      LV
Sbjct: 22  LVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 80
Query: 99  YEFMPNKSLDSSFSGTFKDL--------LCLHKYSRLR------VIHRDLKASNILLDDQ 144
           +EFM +  L S +  T + L        +CL     +       VIHRDL A N L+ + 
Sbjct: 81  FEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN 139
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
              K+SDFGM R F +++   ++        + S E       S K+DV+ FGVL+ ++
Sbjct: 140 QVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 197

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 16/180 (8%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS 110
           VA+K++     Q R    NE  ++   Q+ N+V++    + G+E  +V EF+   +L   
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 107
Query: 111 FSGTFKD--------LLCLHKYSRLR---VIHRDLKASNILLDDQLNTKISDFGMARIFG 159
            + T  +        L  L   S L    VIHRD+K+ +ILL      K+SDFG      
Sbjct: 108 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA--Q 165
Query: 160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPL 219
           V++       +VGT  +M+ E         + D++  G++V+++V G+     Y  E PL
Sbjct: 166 VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---PPYFNEPPL 222

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 211 KSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 27/183 (14%)
Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VAIK +    S + R+EF NEA ++ +    ++V+LLG    G+  L++ E M    
Sbjct: 49  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 108
Query: 107 LDS------------------------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLD 142
           L S                          +G   D +     ++   +HRDL A N ++ 
Sbjct: 109 LKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKF--VHRDLAARNCMVA 166
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           +    KI DFGM R     +      + +    +MS E    G  +  +DV+ FGV++ +
Sbjct: 167 EDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 226
Query: 203 IVC 205
           I  
Sbjct: 227 IAT 229

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 211 KSSDLWALGCIIYQLVAG 228

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 16/180 (8%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS 110
           VA+K++     Q R    NE  ++   Q+ N+V++    + G+E  +V EF+   +L   
Sbjct: 179 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 238
Query: 111 FSGTFKD--------LLCLHKYSRLR---VIHRDLKASNILLDDQLNTKISDFGMARIFG 159
            + T  +        L  L   S L    VIHRD+K+ +ILL      K+SDFG      
Sbjct: 239 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQ 296
Query: 160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPL 219
           V++       +VGT  +M+ E         + D++  G++V+++V G+     Y  E PL
Sbjct: 297 VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---PPYFNEPPL 353

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 209
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 210 KSSDLWALGCIIYQLVAG 227

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 211 KSSDLWALGCIIYQLVAG 228

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 86/179 (48%), Gaps = 17/179 (9%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           ++ +G + N+ +VAIK +         +F  EA+++ KL +  LV+L G  +      LV
Sbjct: 22  LVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 80
Query: 99  YEFMPNKSLDSSFSGTFKDL--------LCLH------KYSRLRVIHRDLKASNILLDDQ 144
           +EFM +  L S +  T + L        +CL             VIHRDL A N L+ + 
Sbjct: 81  FEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGEN 139
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
              K+SDFGM R F +++   ++        + S E       S K+DV+ FGVL+ ++
Sbjct: 140 QVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 197

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 213
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 214 KSSDLWALGCIIYQLVAG 231

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAX 212
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSAC 210
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 211 KSSDLWALGCIIYQLVAG 228

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 209
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 210 KSSDLWALGCIIYQLVAG 227

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS 110
           VA+K L   +   R +FQ EA+L+  LQ+ ++VK  G    G+  ++V+E+M +  L+  
Sbjct: 48  VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 107
Query: 111 FSGTFKDLLC------------------LHKYSRL----------RVIHRDLKASNILLD 142
                 D +                   LH  S++            +HRDL   N L+ 
Sbjct: 108 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 167
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
             L  KI DFGM+R     +        +    +M  E  M    + ++DV+ FGV++ +
Sbjct: 168 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 227
Query: 203 I 203
           I
Sbjct: 228 I 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 17/152 (11%)
Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSSFSGTFKDLLCLHKYS 125
           E  L+ +L + N+V L+   IH E  L LV+EFM     K LD + +G     + ++ Y 
Sbjct: 69  EISLLKELHHPNIVSLIDV-IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 126 RLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            LR         ++HRDLK  N+L++     K++DFG+AR FG+    + T+ +V T  Y
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWY 185
Query: 177 MSLEYTM-SGTVSIKTDVFGFGVLVLKIVCGK 207
            + +  M S   S   D++  G +  +++ GK
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 17/152 (11%)
Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSSFSGTFKDLLCLHKYS 125
           E  L+ +L + N+V L+   IH E  L LV+EFM     K LD + +G     + ++ Y 
Sbjct: 69  EISLLKELHHPNIVSLIDV-IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 126 RLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            LR         ++HRDLK  N+L++     K++DFG+AR FG+    + T+ +V T  Y
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWY 185
Query: 177 MSLEYTM-SGTVSIKTDVFGFGVLVLKIVCGK 207
            + +  M S   S   D++  G +  +++ GK
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 16/180 (8%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS 110
           VA+K++     Q R    NE  ++   Q+ N+V++    + G+E  +V EF+   +L   
Sbjct: 102 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 161
Query: 111 FSGTFKD--------LLCLHKYSRLR---VIHRDLKASNILLDDQLNTKISDFGMARIFG 159
            + T  +        L  L   S L    VIHRD+K+ +ILL      K+SDFG      
Sbjct: 162 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQ 219
Query: 160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPL 219
           V++       +VGT  +M+ E         + D++  G++V+++V G+     Y  E PL
Sbjct: 220 VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---PPYFNEPPL 276

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 90/188 (47%), Gaps = 28/188 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L L+ E++P  SL 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 109 SSFSGTFK--DLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA 155
                  +  D + L +Y+             R IHRDL   NIL++++   KI DFG+ 
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
Query: 156 RI-------FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++       F V E G +       + Y     T S   S+ +DV+ FGV++ ++    +
Sbjct: 162 KVLPQDKEFFKVKEPGESP-----IFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 215
Query: 209 NNKSYHTE 216
            +KS   E
Sbjct: 216 KSKSPPAE 223

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 16/180 (8%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS 110
           VA+K++     Q R    NE  ++   Q+ N+V++    + G+E  +V EF+   +L   
Sbjct: 52  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 111
Query: 111 FSGTFKD--------LLCLHKYSRLR---VIHRDLKASNILLDDQLNTKISDFGMARIFG 159
            + T  +        L  L   S L    VIHRD+K+ +ILL      K+SDFG      
Sbjct: 112 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA--Q 169
Query: 160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPL 219
           V++       +VGT  +M+ E         + D++  G++V+++V G+     Y  E PL
Sbjct: 170 VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---PPYFNEPPL 226

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 215
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 216 KSSDLWALGCIIYQLVAG 233

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 61  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 120
Query: 108 ---DSSFSGTFKDLLCL-------HKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+          KY +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 121 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 181 DMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           ++ +G + N+ +VAIK +   S     +F  EA+++ KL +  LV+L G  +      LV
Sbjct: 42  LVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 100
Query: 99  YEFMPNKSLDSSFSGTFKDL--------LCLHKYSRLR------VIHRDLKASNILLDDQ 144
           +EFM +  L S +  T + L        +CL     +       VIHRDL A N L+ + 
Sbjct: 101 FEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN 159
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
              K+SDFGM R F +++   ++        + S E       S K+DV+ FGVL+ ++
Sbjct: 160 QVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 217

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 45/78 (57%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK  NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +  
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 189 IKTDVFGFGVLVLKIVCG 206
             +D++  G ++ ++V G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 16/182 (8%)
Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           QEVAI+++       +    NE  ++ + +  N+V  L   + G+E  +V E++   SL 
Sbjct: 46  QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 109 SSFSGTFKD--------LLCLHKYSRL---RVIHRDLKASNILLDDQLNTKISDFGMARI 157
              + T  D          CL     L   +VIHRD+K+ NILL    + K++DFG    
Sbjct: 106 DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165
Query: 158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER 217
               +S  +T  +VGT  +M+ E         K D++  G++ ++++ G+     Y  E 
Sbjct: 166 ITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE---PPYLNEN 220
Query: 218 PL 219
           PL
Sbjct: 221 PL 222

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 46  PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM-- 102
           P+  +VA+K L    S Q  ++F  EA +I+K  + N+V+ +G S+    R ++ E M  
Sbjct: 59  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 118
Query: 103 -----------PNKSLDSSFS-----GTFKDLLCLHKY-SRLRVIHRDLKASNILLD--- 142
                      P  S  SS +        +D+ C  +Y      IHRD+ A N LL    
Sbjct: 119 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 178
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
                KI DFGMA+              +    +M  E  M G  + KTD + FGVL+ +
Sbjct: 179 PGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 238
Query: 203 I 203
           I
Sbjct: 239 I 239

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 2/95 (2%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           R IHRD+KA+N+LL +Q + K++DFG+A    + ++    N  VGT  +M+ E       
Sbjct: 136 RKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPEVIKQSAY 193
Query: 188 SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
             K D++  G+  +++  G+  N   H  R L L+
Sbjct: 194 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 228

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 15/178 (8%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           V+  GK+  + +VAIK +         EF  EAK++  L +  LV+L G         ++
Sbjct: 39  VVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97
Query: 99  YEFMPNKSL------------DSSFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQL 145
            E+M N  L                    KD+    +Y    + +HRDL A N L++DQ 
Sbjct: 98  TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG 157
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             K+SDFG++R    +E  ++         +   E  M    S K+D++ FGVL+ +I
Sbjct: 158 VVKVSDFGLSRYVLDDEETSSVGSKFPVR-WSPPEVLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 28/188 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L L+ E++P  SL 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 109 SSFSGTFK--DLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA 155
                  +  D + L +Y+             R IHRDL   NIL++++   KI DFG+ 
Sbjct: 105 DYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 164
Query: 156 RIF-------GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++         V E G +       + Y     T S   S+ +DV+ FGV++ ++    +
Sbjct: 165 KVLPQDKEXXKVKEPGESP-----IFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 218
Query: 209 NNKSYHTE 216
            +KS   E
Sbjct: 219 KSKSPPAE 226

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 89/188 (47%), Gaps = 28/188 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L L+ EF+P  SL 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLR 104
Query: 109 SSFSGTFK--DLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA 155
                  +  D + L +Y+             R IHRDL   NIL++++   KI DFG+ 
Sbjct: 105 EYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 164
Query: 156 RIF-------GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++         V E G +       + Y     T S   S+ +DV+ FGV++ ++    +
Sbjct: 165 KVLPQDKEXXKVKEPGESP-----IFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 218
Query: 209 NNKSYHTE 216
            +KS   E
Sbjct: 219 KSKSPPAE 226

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 15/178 (8%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           V+  GK+  + +VAIK +         EF  EAK++  L +  LV+L G         ++
Sbjct: 23  VVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 81
Query: 99  YEFMPN-------KSLDSSFSG-----TFKDLLCLHKY-SRLRVIHRDLKASNILLDDQL 145
            E+M N       + +   F         KD+    +Y    + +HRDL A N L++DQ 
Sbjct: 82  TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG 141
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             K+SDFG++R    +E  ++         +   E  M    S K+D++ FGVL+ +I
Sbjct: 142 VVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSDIWAFGVLMWEI 198

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 15/178 (8%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           V+  GK+  + +VAIK +         EF  EAK++  L +  LV+L G         ++
Sbjct: 24  VVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 82
Query: 99  YEFMPNKSL------------DSSFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQL 145
            E+M N  L                    KD+    +Y    + +HRDL A N L++DQ 
Sbjct: 83  TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG 142
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             K+SDFG++R + +++   ++        +   E  M    S K+D++ FGVL+ +I
Sbjct: 143 VVKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 23/181 (12%)
Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VAIK +    S + R+EF NEA ++ +    ++V+LLG    G+  L++ E M    
Sbjct: 55  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 114
Query: 107 LDSSFSGTFKDL-----LCLHKYSRL-----------------RVIHRDLKASNILLDDQ 144
           L S       ++     L     S++                 + +HRDL A N ++ + 
Sbjct: 115 LKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
              KI DFGM R     +      + +    +MS E    G  +  +DV+ FGV++ +I 
Sbjct: 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
Query: 205 C 205
Sbjct: 235 T 235

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 15/178 (8%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           V+  GK+  + +VAIK +         EF  EAK++  L +  LV+L G         ++
Sbjct: 24  VVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 82
Query: 99  YEFMPNKSL------------DSSFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQL 145
            E+M N  L                    KD+    +Y    + +HRDL A N L++DQ 
Sbjct: 83  TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG 142
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             K+SDFG++R    +E  ++         +   E  M    S K+D++ FGVL+ +I
Sbjct: 143 VVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 15/178 (8%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           V+  GK+  + +VAIK +         EF  EAK++  L +  LV+L G         ++
Sbjct: 19  VVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77
Query: 99  YEFMPNKSL------------DSSFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQL 145
            E+M N  L                    KD+    +Y    + +HRDL A N L++DQ 
Sbjct: 78  TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG 137
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             K+SDFG++R    +E  ++         +   E  M    S K+D++ FGVL+ +I
Sbjct: 138 VVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSDIWAFGVLMWEI 194

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 81  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 140
Query: 108 ---DSSFSGTFKDLLCL-------HKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+          KY +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 141 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 201 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 250

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 121
Query: 108 ---DSSFSGTFKDLLCL-------HKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+          KY +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 122 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 182 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 57  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 116
Query: 108 ---DSSFSGTFKDLLCL-------HKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+          KY +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 117 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 86/179 (48%), Gaps = 17/179 (9%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           ++ +G + N+ +VAIK +         +F  EA+++ KL +  LV+L G  +      LV
Sbjct: 23  LVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81
Query: 99  YEFMPNKSLDSSFSGTFKDL--------LCLHKYSRLR------VIHRDLKASNILLDDQ 144
            EFM +  L S +  T + L        +CL     +       VIHRDL A N L+ + 
Sbjct: 82  TEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN 140
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
              K+SDFGM R F +++   ++        + S E       S K+DV+ FGVL+ ++
Sbjct: 141 QVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 198

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 61  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 120
Query: 108 ---DSSFSGTFKDLLCL-------HKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+          KY +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 121 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 181 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 121
Query: 108 ---DSSFSGTFKDLLCL-------HKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+          KY +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 122 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 182 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 15/178 (8%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           V+  GK+  + +VAIK +         EF  EAK++  L +  LV+L G         ++
Sbjct: 39  VVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97
Query: 99  YEFMPNKSL------------DSSFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQL 145
            E+M N  L                    KD+    +Y    + +HRDL A N L++DQ 
Sbjct: 98  TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG 157
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             K+SDFG++R    +E  ++         +   E  M    S K+D++ FGVL+ +I
Sbjct: 158 VVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 15/178 (8%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           V+  GK+  + +VAIK +         EF  EAK++  L +  LV+L G         ++
Sbjct: 30  VVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 88
Query: 99  YEFMPNKSL------------DSSFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQL 145
            E+M N  L                    KD+    +Y    + +HRDL A N L++DQ 
Sbjct: 89  TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG 148
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             K+SDFG++R    +E  ++         +   E  M    S K+D++ FGVL+ +I
Sbjct: 149 VVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSDIWAFGVLMWEI 205

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 59  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 118
Query: 108 ---DSSFSGTFKDLLCL-------HKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+          KY +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 119 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 179 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 228

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 27/183 (14%)
Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VAIK +    S + R+EF NEA ++ +    ++V+LLG    G+  L++ E M    
Sbjct: 55  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 114
Query: 107 LDS------------------------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLD 142
           L S                          +G   D +     ++   +HRDL A N ++ 
Sbjct: 115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF--VHRDLAARNCMVA 172
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           +    KI DFGM R     +      + +    +MS E    G  +  +DV+ FGV++ +
Sbjct: 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 232
Query: 203 IVC 205
           I  
Sbjct: 233 IAT 235

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 27/183 (14%)
Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VAIK +    S + R+EF NEA ++ +    ++V+LLG    G+  L++ E M    
Sbjct: 46  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 105
Query: 107 LDS------------------------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLD 142
           L S                          +G   D +     ++   +HRDL A N ++ 
Sbjct: 106 LKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKF--VHRDLAARNCMVA 163
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           +    KI DFGM R     +      + +    +MS E    G  +  +DV+ FGV++ +
Sbjct: 164 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 223
Query: 203 IVC 205
           I  
Sbjct: 224 IAT 226

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 54  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 113
Query: 108 ---DSSFSGTFKDLLCL-------HKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+          KY +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 114 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 174 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 223

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 80  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 139
Query: 108 ---DSSFSGTFKDLLCL-------HKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+          KY +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 140 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 200 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 249

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 27/183 (14%)
Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VAIK +    S + R+EF NEA ++ +    ++V+LLG    G+  L++ E M    
Sbjct: 45  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 104
Query: 107 LDS------------------------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLD 142
           L S                          +G   D +     ++   +HRDL A N ++ 
Sbjct: 105 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF--VHRDLAARNCMVA 162
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           +    KI DFGM R     +      + +    +MS E    G  +  +DV+ FGV++ +
Sbjct: 163 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 222
Query: 203 IVC 205
           I  
Sbjct: 223 IAT 225

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 23/181 (12%)
Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VAIK +    S + R+EF NEA ++ +    ++V+LLG    G+  L++ E M    
Sbjct: 48  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 107
Query: 107 LDSSFSGTFKDL-----LCLHKYSRL-----------------RVIHRDLKASNILLDDQ 144
           L S       ++     L     S++                 + +HRDL A N ++ + 
Sbjct: 108 LKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 167
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
              KI DFGM R     +      + +    +MS E    G  +  +DV+ FGV++ +I 
Sbjct: 168 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 227
Query: 205 C 205
Sbjct: 228 T 228

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 27/183 (14%)
Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VAIK +    S + R+EF NEA ++ +    ++V+LLG    G+  L++ E M    
Sbjct: 42  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 101
Query: 107 LDS------------------------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLD 142
           L S                          +G   D +     ++   +HRDL A N ++ 
Sbjct: 102 LKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKF--VHRDLAARNCMVA 159
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           +    KI DFGM R     +      + +    +MS E    G  +  +DV+ FGV++ +
Sbjct: 160 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 219
Query: 203 IVC 205
           I  
Sbjct: 220 IAT 222

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 60  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 119
Query: 108 ---DSSFSGTFKDLLCL-------HKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+          KY +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 120 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 180 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 23/181 (12%)
Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VAIK +    S + R+EF NEA ++ +    ++V+LLG    G+  L++ E M    
Sbjct: 48  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 107
Query: 107 LDSSFSGTFKDL-----LCLHKYSRL-----------------RVIHRDLKASNILLDDQ 144
           L S       ++     L     S++                 + +HRDL A N ++ + 
Sbjct: 108 LKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 167
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
              KI DFGM R     +      + +    +MS E    G  +  +DV+ FGV++ +I 
Sbjct: 168 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 227
Query: 205 C 205
Sbjct: 228 T 228

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 27/183 (14%)
Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VAIK +    S + R+EF NEA ++ +    ++V+LLG    G+  L++ E M    
Sbjct: 49  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 108
Query: 107 LDS------------------------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLD 142
           L S                          +G   D +     ++   +HRDL A N ++ 
Sbjct: 109 LKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKF--VHRDLAARNCMVA 166
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           +    KI DFGM R     +      + +    +MS E    G  +  +DV+ FGV++ +
Sbjct: 167 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 226
Query: 203 IVC 205
           I  
Sbjct: 227 IAT 229

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           QEVAI+++       +    NE  ++ + +  N+V  L   + G+E  +V E++   SL 
Sbjct: 46  QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 109 SSFSGTFKD--------LLCLHKYSRL---RVIHRDLKASNILLDDQLNTKISDFGMARI 157
              + T  D          CL     L   +VIHRD+K+ NILL    + K++DFG    
Sbjct: 106 DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165
Query: 158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER 217
               +S    + +VGT  +M+ E         K D++  G++ ++++ G+     Y  E 
Sbjct: 166 ITPEQS--KRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE---PPYLNEN 220
Query: 218 PL 219
           PL
Sbjct: 221 PL 222

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 90/189 (47%), Gaps = 36/189 (19%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER---LLVYEFMPNKSL 107
           VA+K+L  +    + +FQ E +++  L    +VK  G S +G  R    LV E++P    
Sbjct: 39  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS-YGPGRPELRLVMEYLP---- 93
Query: 108 DSSFSGTFKDLLCLHKY----SRL-----------------RVIHRDLKASNILLDDQLN 146
               SG  +D L  H+     SRL                 R +HRDL A NIL++ + +
Sbjct: 94  ----SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH 149
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIV- 204
            KI+DFG+A++  +++          +  +     ++S  + S ++DV+ FGV++ ++  
Sbjct: 150 VKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209
Query: 205 -CGKKNNKS 212
            C K  + S
Sbjct: 210 YCDKSCSPS 218

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           ++VA+K++     Q R    NE  ++    + N+V +    + G+E  +V EF+   +L 
Sbjct: 71  KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALT 130
Query: 109 SSFSGTFKD--------LLCLHKYSRLR---VIHRDLKASNILLDDQLNTKISDFGMARI 157
              + T  +        L  L   S L    VIHRD+K+ +ILL      K+SDFG    
Sbjct: 131 DIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA- 189
Query: 158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER 217
             V++       +VGT  +M+ E         + D++  G++V++++ G+     Y  E 
Sbjct: 190 -QVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE---PPYFNEP 245
Query: 218 PLN-LVGIAWQLWNEGKDLELIDLTLDG 244
           PL  +  I   L    KDL  +   L G
Sbjct: 246 PLQAMRRIRDSLPPRVKDLHKVSSVLRG 273

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 27/183 (14%)
Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VAIK +    S + R+EF NEA ++ +    ++V+LLG    G+  L++ E M    
Sbjct: 77  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 136
Query: 107 LDS------------------------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLD 142
           L S                          +G   D +     ++   +HRDL A N ++ 
Sbjct: 137 LKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKF--VHRDLAARNCMVA 194
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           +    KI DFGM R     +      + +    +MS E    G  +  +DV+ FGV++ +
Sbjct: 195 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 254
Query: 203 IVC 205
           I  
Sbjct: 255 IAT 257

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 28/188 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L L+ E++P  SL 
Sbjct: 40  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 99
Query: 109 SSFSGTFK--DLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA 155
                  +  D + L +Y+             R IHRDL   NIL++++   KI DFG+ 
Sbjct: 100 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 159
Query: 156 RIF-------GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++         V E G +       + Y     T S   S+ +DV+ FGV++ ++    +
Sbjct: 160 KVLPQDKEXXKVKEPGESP-----IFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 213
Query: 209 NNKSYHTE 216
            +KS   E
Sbjct: 214 KSKSPPAE 221

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 28/188 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L L+ E++P  SL 
Sbjct: 46  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 105
Query: 109 SSFSGTFK--DLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA 155
                  +  D + L +Y+             R IHRDL   NIL++++   KI DFG+ 
Sbjct: 106 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 165
Query: 156 RIF-------GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++         V E G +       + Y     T S   S+ +DV+ FGV++ ++    +
Sbjct: 166 KVLPQDKEXXKVKEPGESP-----IFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 219
Query: 209 NNKSYHTE 216
            +KS   E
Sbjct: 220 KSKSPPAE 227

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 28/188 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L L+ E++P  SL 
Sbjct: 41  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 100
Query: 109 SSFSGTFK--DLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA 155
                  +  D + L +Y+             R IHRDL   NIL++++   KI DFG+ 
Sbjct: 101 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 160
Query: 156 RIF-------GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++         V E G +    +  Y   SL        S+ +DV+ FGV++ ++    +
Sbjct: 161 KVLPQDKEXXKVKEPGESP---IFWYAPESL---TESKFSVASDVWSFGVVLYELFTYIE 214
Query: 209 NNKSYHTE 216
            +KS   E
Sbjct: 215 KSKSPPAE 222

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           QEVAI+++       +    NE  ++ + +  N+V  L   + G+E  +V E++   SL 
Sbjct: 46  QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 109 SSFSGTFKD--------LLCLHKYSRL---RVIHRDLKASNILLDDQLNTKISDFGMARI 157
              + T  D          CL     L   +VIHRD+K+ NILL    + K++DFG    
Sbjct: 106 DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165
Query: 158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER 217
               +S    + +VGT  +M+ E         K D++  G++ ++++ G+     Y  E 
Sbjct: 166 ITPEQS--KRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE---PPYLNEN 220
Query: 218 PL 219
           PL
Sbjct: 221 PL 222

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 121
Query: 108 ---DSSFSGTFKDLLC--------LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+         +   +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 122 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 182 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 60  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 119
Query: 108 ---DSSFSGTFKDLLC--------LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+         +   +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 120 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 180 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           QEVAI+++       +    NE  ++ + +  N+V  L   + G+E  +V E++   SL 
Sbjct: 47  QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 106
Query: 109 SSFSGTFKD--------LLCLHKYSRL---RVIHRDLKASNILLDDQLNTKISDFGMARI 157
              + T  D          CL     L   +VIHRD+K+ NILL    + K++DFG    
Sbjct: 107 DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 166
Query: 158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER 217
               +S    + +VGT  +M+ E         K D++  G++ ++++ G+     Y  E 
Sbjct: 167 ITPEQS--KRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE---PPYLNEN 221
Query: 218 PL 219
           PL
Sbjct: 222 PL 223

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 28/188 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L L+ E++P  SL 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 109 SSFSGTFK--DLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA 155
                  +  D + L +Y+             R IHRDL   NIL++++   KI DFG+ 
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
Query: 156 RIF-------GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++         V E G +       + Y     T S   S+ +DV+ FGV++ ++    +
Sbjct: 162 KVLPQDKEXXKVKEPGESP-----IFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 215
Query: 209 NNKSYHTE 216
            +KS   E
Sbjct: 216 KSKSPPAE 223

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 121
Query: 108 ---DSSFSGTFKDLLC--------LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+         +   +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 122 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 182 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 19/167 (11%)
Query: 54  KRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD----- 108
           K LA +  QGR+E   E   +  L++ +++KL       +E ++V E+  N+  D     
Sbjct: 40  KVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR 97
Query: 109 -----SSFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE 162
                      F+ ++   +Y  R +++HRDLK  N+LLD+ LN KI+DFG++ I     
Sbjct: 98  DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM---T 154
Query: 163 SGANTNRIVGTYGYMSLEYTMSGTVSI--KTDVFGFGVLVLKIVCGK 207
            G       G+  Y + E  +SG +    + DV+  GV++  ++C +
Sbjct: 155 DGNFLKTSCGSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 28/188 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L L+ E++P  SL 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 109 SSFSGTFK--DLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA 155
                  +  D + L +Y+             R IHRDL   NIL++++   KI DFG+ 
Sbjct: 105 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 164
Query: 156 RIF-------GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++         V E G +       + Y     T S   S+ +DV+ FGV++ ++    +
Sbjct: 165 KVLPQDKEXXKVKEPGESP-----IFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 218
Query: 209 NNKSYHTE 216
            +KS   E
Sbjct: 219 KSKSPPAE 226

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 67  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 126
Query: 108 ---DSSFSGTFKDLLC--------LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+         +   +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 127 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 186
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 187 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 236

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 28/188 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L L+ E++P  SL 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 109 SSFSGTFK--DLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA 155
                  +  D + L +Y+             R IHRDL   NIL++++   KI DFG+ 
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
Query: 156 RIF-------GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++         V E G +       + Y     T S   S+ +DV+ FGV++ ++    +
Sbjct: 162 KVLPQDKEXXKVKEPGESP-----IFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 215
Query: 209 NNKSYHTE 216
            +KS   E
Sbjct: 216 KSKSPPAE 223

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 63  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 122
Query: 108 ---DSSFSGTFKDLLC--------LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+         +   +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 123 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 183 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 232

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 28/188 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L L+ E++P  SL 
Sbjct: 48  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 107
Query: 109 SSFSGTFK--DLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA 155
                  +  D + L +Y+             R IHRDL   NIL++++   KI DFG+ 
Sbjct: 108 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 167
Query: 156 RIF-------GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++         V E G +       + Y     T S   S+ +DV+ FGV++ ++    +
Sbjct: 168 KVLPQDKEXXKVKEPGESP-----IFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 221
Query: 209 NNKSYHTE 216
            +KS   E
Sbjct: 222 KSKSPPAE 229

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 82/191 (42%), Gaps = 39/191 (20%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VA+K L    S   + +FQ EA L+A+    N+VKLLG    G+   L++E+M    L+ 
Sbjct: 80  VAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 139
Query: 110 SFSGTFKDLLCLHKYS----RLRV--------------------------------IHRD 133
                    +C   +S    R RV                                +HRD
Sbjct: 140 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199
Query: 134 LKASNILLDDQLNTKISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTD 192
           L   N L+ + +  KI+DFG++R I+  +   A+ N  +    +M  E       + ++D
Sbjct: 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI-RWMPPESIFYNRYTTESD 258
Query: 193 VFGFGVLVLKI 203
           V+ +GV++ +I
Sbjct: 259 VWAYGVVLWEI 269

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 28/188 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L L+ E++P  SL 
Sbjct: 47  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 106
Query: 109 SSFSGTFK--DLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA 155
                  +  D + L +Y+             R IHRDL   NIL++++   KI DFG+ 
Sbjct: 107 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 166
Query: 156 RIF-------GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++         V E G +       + Y     T S   S+ +DV+ FGV++ ++    +
Sbjct: 167 KVLPQDKEXXKVKEPGESP-----IFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 220
Query: 209 NNKSYHTE 216
            +KS   E
Sbjct: 221 KSKSPPAE 228

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 180
Query: 108 ---DSSFSGTFKDLLC--------LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+         +   +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 181 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 90/188 (47%), Gaps = 34/188 (18%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSI-HGEERL-LVYEFMPNKSLD 108
           VA+K+L  +    + +FQ E +++  L    +VK  G S   G + L LV E++P     
Sbjct: 42  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP----- 96
Query: 109 SSFSGTFKDLLCLHKY----SRL-----------------RVIHRDLKASNILLDDQLNT 147
              SG  +D L  H+     SRL                 R +HRDL A NIL++ + + 
Sbjct: 97  ---SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHV 153
Query: 148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIV-- 204
           KI+DFG+A++  +++          +  +     ++S  + S ++DV+ FGV++ ++   
Sbjct: 154 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY 213
Query: 205 CGKKNNKS 212
           C K  + S
Sbjct: 214 CDKSCSPS 221

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 28/188 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L L+ E++P  SL 
Sbjct: 73  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132
Query: 109 SSFSGTFK--DLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA 155
                  +  D + L +Y+             R IHRDL   NIL++++   KI DFG+ 
Sbjct: 133 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
Query: 156 RIF-------GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++         V E G +       + Y     T S   S+ +DV+ FGV++ ++    +
Sbjct: 193 KVLPQDKEXXKVKEPGESP-----IFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 246
Query: 209 NNKSYHTE 216
            +KS   E
Sbjct: 247 KSKSPPAE 254

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 19/149 (12%)
Query: 75  AKLQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLL 119
           A L + N+VK  G    G  + L  E+               MP       F      ++
Sbjct: 60  AMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 120 CLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSL 179
            LH    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ 
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 180 EYTMSGTVSIK-TDVFGFGVLVLKIVCGK 207
           E         +  DV+  G+++  ++ G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 90/188 (47%), Gaps = 34/188 (18%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSI-HGEERL-LVYEFMPNKSLD 108
           VA+K+L  +    + +FQ E +++  L    +VK  G S   G + L LV E++P     
Sbjct: 43  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP----- 97
Query: 109 SSFSGTFKDLLCLHKY----SRL-----------------RVIHRDLKASNILLDDQLNT 147
              SG  +D L  H+     SRL                 R +HRDL A NIL++ + + 
Sbjct: 98  ---SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHV 154
Query: 148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIV-- 204
           KI+DFG+A++  +++          +  +     ++S  + S ++DV+ FGV++ ++   
Sbjct: 155 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY 214
Query: 205 CGKKNNKS 212
           C K  + S
Sbjct: 215 CDKSCSPS 222

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 77/181 (42%), Gaps = 23/181 (12%)
Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VAIK +    S + R+EF NEA ++ +    ++V+LLG    G+  L++ E M    
Sbjct: 42  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 101
Query: 107 LDSSFSGTFKDL-----LCLHKYSRL-----------------RVIHRDLKASNILLDDQ 144
           L S       ++     L     S++                 + +HRDL A N  + + 
Sbjct: 102 LKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAED 161
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
              KI DFGM R     +      + +    +MS E    G  +  +DV+ FGV++ +I 
Sbjct: 162 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 221
Query: 205 C 205
Sbjct: 222 T 222

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 52  AIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSL-- 107
           A+K L   +  G V +F  E  ++    + N++ LLG  +  E   L+V  +M +  L  
Sbjct: 63  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 122
Query: 108 ---DSSFSGTFKDLLC--------LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              + + + T KDL+         +   +  + +HRDL A N +LD++   K++DFG+AR
Sbjct: 123 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182
Query: 157 IFGVNESGANTNRIVG--TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
                E  +  N+        +M+LE   +   + K+DV+ FGVL+ +++
Sbjct: 183 DMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 232

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 19/165 (11%)
Query: 54  KRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD----- 108
           K LA +  QGR+E   E   +  L++ +++KL       +E ++V E+  N+  D     
Sbjct: 44  KVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR 101
Query: 109 -----SSFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE 162
                      F+ ++   +Y  R +++HRDLK  N+LLD+ LN KI+DFG++ I     
Sbjct: 102 DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM---T 158
Query: 163 SGANTNRIVGTYGYMSLEYTMSGTVSI--KTDVFGFGVLVLKIVC 205
            G       G+  Y + E  +SG +    + DV+  GV++  ++C
Sbjct: 159 DGNFLKTSCGSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLC 202

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 16/182 (8%)
Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           QEVAI+++       +    NE  ++ + +  N+V  L   + G+E  +V E++   SL 
Sbjct: 47  QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 106
Query: 109 SSFSGTFKD--------LLCLHKYSRL---RVIHRDLKASNILLDDQLNTKISDFGMARI 157
              + T  D          CL     L   +VIHR++K+ NILL    + K++DFG    
Sbjct: 107 DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQ 166
Query: 158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER 217
               +S  +T  +VGT  +M+ E         K D++  G++ ++++ G+     Y  E 
Sbjct: 167 ITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE---PPYLNEN 221
Query: 218 PL 219
           PL
Sbjct: 222 PL 223

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           ++VA+K +     Q R    NE  ++   Q+ N+V++    + GEE  ++ EF+   +L 
Sbjct: 71  RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130
Query: 109 SSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGM 154
              S                 + L  LH      VIHRD+K+ +ILL      K+SDFG 
Sbjct: 131 DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGF 187
Query: 155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH 214
                +++       +VGT  +M+ E       + + D++  G++V+++V G+     Y 
Sbjct: 188 CA--QISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE---PPYF 242
Query: 215 TERPLN 220
           ++ P+ 
Sbjct: 243 SDSPVQ 248

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 28/188 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L L+ E++P  SL 
Sbjct: 49  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 108
Query: 109 SSFSGTFK--DLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA 155
                  +  D + L +Y+             R IHRDL   NIL++++   KI DFG+ 
Sbjct: 109 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 168
Query: 156 RIF-------GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++         V E G +       + Y     T S   S+ +DV+ FGV++ ++    +
Sbjct: 169 KVLPQDKEXXKVKEPGESP-----IFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 222
Query: 209 NNKSYHTE 216
            +KS   E
Sbjct: 223 KSKSPPAE 230

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 28/188 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L L+ E++P  SL 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 109 SSFSGTFK--DLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA 155
                  +  D + L +Y+             R IHRDL   NIL++++   KI DFG+ 
Sbjct: 120 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 179
Query: 156 RIF-------GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++         V E G +       + Y     T S   S+ +DV+ FGV++ ++    +
Sbjct: 180 KVLPQDKEXXKVKEPGESP-----IFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 233
Query: 209 NNKSYHTE 216
            +KS   E
Sbjct: 234 KSKSPPAE 241

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 19/165 (11%)
Query: 54  KRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD----- 108
           K LA +  QGR+E   E   +  L++ +++KL       +E ++V E+  N+  D     
Sbjct: 49  KVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR 106
Query: 109 -----SSFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE 162
                      F+ ++   +Y  R +++HRDLK  N+LLD+ LN KI+DFG++ I     
Sbjct: 107 DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM---T 163
Query: 163 SGANTNRIVGTYGYMSLEYTMSGTVSI--KTDVFGFGVLVLKIVC 205
            G       G+  Y + E  +SG +    + DV+  GV++  ++C
Sbjct: 164 DGNFLKTSCGSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLC 207

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 19/165 (11%)
Query: 54  KRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD----- 108
           K LA +  QGR+E   E   +  L++ +++KL       +E ++V E+  N+  D     
Sbjct: 50  KVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR 107
Query: 109 -----SSFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE 162
                      F+ ++   +Y  R +++HRDLK  N+LLD+ LN KI+DFG++ I     
Sbjct: 108 DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM---T 164
Query: 163 SGANTNRIVGTYGYMSLEYTMSGTVSI--KTDVFGFGVLVLKIVC 205
            G       G+  Y + E  +SG +    + DV+  GV++  ++C
Sbjct: 165 DGNFLKTSCGSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLC 208

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 90/188 (47%), Gaps = 34/188 (18%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSI-HGEERL-LVYEFMPNKSLD 108
           VA+K+L  +    + +FQ E +++  L    +VK  G S   G + L LV E++P     
Sbjct: 55  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP----- 109
Query: 109 SSFSGTFKDLLCLHKY----SRL-----------------RVIHRDLKASNILLDDQLNT 147
              SG  +D L  H+     SRL                 R +HRDL A NIL++ + + 
Sbjct: 110 ---SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHV 166
Query: 148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIV-- 204
           KI+DFG+A++  +++          +  +     ++S  + S ++DV+ FGV++ ++   
Sbjct: 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY 226
Query: 205 CGKKNNKS 212
           C K  + S
Sbjct: 227 CDKSCSPS 234

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 28/188 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L L+ E++P  SL 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 109 SSFSGTFK--DLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA 155
                  +  D + L +Y+             R IHRDL   NIL++++   KI DFG+ 
Sbjct: 120 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 179
Query: 156 RIF-------GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++         V E G +       + Y     T S   S+ +DV+ FGV++ ++    +
Sbjct: 180 KVLPQDKEXXKVKEPGESP-----IFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 233
Query: 209 NNKSYHTE 216
            +KS   E
Sbjct: 234 KSKSPPAE 241

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 89/184 (48%), Gaps = 28/184 (15%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNKSLD 108
           VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G C   G   L L+ E++P  SL 
Sbjct: 43  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 102
Query: 109 SSFSGTFK--DLLCLHKYSRL-----------RVIHRDLKASNILLDDQLNTKISDFGMA 155
                  +  D + L +Y+             R IHR+L   NIL++++   KI DFG+ 
Sbjct: 103 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLT 162
Query: 156 RI-------FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++       + V E G +       + Y     T S   S+ +DV+ FGV++ ++    +
Sbjct: 163 KVLPQDKEYYKVKEPGESP-----IFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 216
Query: 209 NNKS 212
            +KS
Sbjct: 217 KSKS 220

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 120 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 48  EQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VA+K +  ++  + R+EF NEA ++      ++V+LLG    G+  L+V E M +  
Sbjct: 47  ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 106
Query: 107 LDSSFSG--------------TFKDLLCLHK--------YSRLRVIHRDLKASNILLDDQ 144
           L S                  T ++++ +           +  + +HRDL A N ++   
Sbjct: 107 LKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 166
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
              KI DFGM R     +      + +    +M+ E    G  +  +D++ FGV++ +I 
Sbjct: 167 FTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 226
Query: 205 C 205
Sbjct: 227 S 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 48  EQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VA+K +  ++  + R+EF NEA ++      ++V+LLG    G+  L+V E M +  
Sbjct: 44  ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 103
Query: 107 LDSSFSG--------------TFKDLLCLHK--------YSRLRVIHRDLKASNILLDDQ 144
           L S                  T ++++ +           +  + +HRDL A N ++   
Sbjct: 104 LKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 163
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
              KI DFGM R     +      + +    +M+ E    G  +  +D++ FGV++ +I 
Sbjct: 164 FTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 223
Query: 205 C 205
Sbjct: 224 S 224

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 48  EQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VA+K +  ++  + R+EF NEA ++      ++V+LLG    G+  L+V E M +  
Sbjct: 47  ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 106
Query: 107 LDSSFSG--------------TFKDLLCLHK--------YSRLRVIHRDLKASNILLDDQ 144
           L S                  T ++++ +           +  + +HRDL A N ++   
Sbjct: 107 LKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 166
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
              KI DFGM R     +      + +    +M+ E    G  +  +D++ FGV++ +I 
Sbjct: 167 FTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 226
Query: 205 C 205
Sbjct: 227 S 227

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/75 (41%), Positives = 46/75 (61%), Gaps = 2/75 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           V+HRDLK +N+ LD + N K+ DFG+ARI   + S A T   VGT  YMS E     + +
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSYN 194
Query: 189 IKTDVFGFGVLVLKI 203
            K+D++  G L+ ++
Sbjct: 195 EKSDIWSLGCLLYEL 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 77  LQYTNLVKLLGCSIHGEERLLVYEF---------------MPNKSLDSSFSGTFKDLLCL 121
           L + N+VK  G    G  + L  E+               MP       F      ++ L
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y++ E 
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 182 TMSGTVSIK-TDVFGFGVLVLKIVCGK 207
                   +  DV+  G+++  ++ G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 47/87 (54%), Gaps = 3/87 (3%)
Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           L    R R+++RDLK  NILLDD  + +ISD G+A    V E      R VGT GYM+ E
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPE 355
Query: 181 YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
              +   +   D +  G L+ +++ G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 15/153 (9%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD----LLCL 121
           EF  EA ++ ++++ NLV+LLG         +V E+MP  +L        ++    ++ L
Sbjct: 74  EFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLL 133
Query: 122 HKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           +  +++            IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 134 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKF 193
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
               + + E     T SIK+DV+ FGVL+ +I 
Sbjct: 194 PI-KWTAPESLAYNTFSIKSDVWAFGVLLWEIA 225

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 108/237 (45%), Gaps = 42/237 (17%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN----- 104
           + +K L     + +  F  E K++  L++ N++K +G  ++ ++RL  + E++       
Sbjct: 38  MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV-LYKDKRLNFITEYIKGGTLRG 96
Query: 105 --KSLDSSFSGT-----FKDLLCLHKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
             KS+DS +  +      KD+     Y   + +IHRDL + N L+ +  N  ++DFG+AR
Sbjct: 97  IIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLAR 156
Query: 157 IFGVNESGANTNR------------IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +    ++     R            +VG   +M+ E     +   K DVF FG+++ +I+
Sbjct: 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216
Query: 205 CGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPN-EDAFLLVSCVC 260
            G+ N    +  R ++  G+  + +            LD  CPPN   +F  ++  C
Sbjct: 217 -GRVNADPDYLPRTMDF-GLNVRGF------------LDRYCPPNCPPSFFPITVRC 259

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 47/87 (54%), Gaps = 3/87 (3%)
Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           L    R R+++RDLK  NILLDD  + +ISD G+A    V E      R VGT GYM+ E
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPE 355
Query: 181 YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
              +   +   D +  G L+ +++ G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 18/154 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 58  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 116
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTY 174
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV      T+ +V T 
Sbjct: 117 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVV-TL 174
Query: 175 GYMSLEYTMSGT-VSIKTDVFGFGVLVLKIVCGK 207
            Y + E  +     S   D++  G +  ++V  +
Sbjct: 175 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 97/230 (42%), Gaps = 51/230 (22%)
Query: 50  EVAIKRL-AWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           + AIKR+  + S     +F  E +++ KL  + N++ LLG   H     L  E+ P+ +L
Sbjct: 44  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 103
Query: 108 ------------DSSFS------GTFKDLLCLH----------KYSRLRVIHRDLKASNI 139
                       D +F+       T      LH            S+ + IHRDL A NI
Sbjct: 104 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 163
Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
           L+ +    KI+DFG++R   V          V      SL Y++  T    +DV+ +GVL
Sbjct: 164 LVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT---NSDVWSYGVL 220
Query: 200 VLKIV-------CG-------KKNNKSYHTERPLN----LVGIAWQLWNE 231
           + +IV       CG       +K  + Y  E+PLN    +  +  Q W E
Sbjct: 221 LWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWRE 270

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           V+HRDLK +N+ LD + N K+ DFG+ARI   +E  A     VGT  YMS E     + +
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA--KEFVGTPYYMSPEQMNRMSYN 194
Query: 189 IKTDVFGFGVLVLKI 203
            K+D++  G L+ ++
Sbjct: 195 EKSDIWSLGCLLYEL 209

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 97/230 (42%), Gaps = 51/230 (22%)
Query: 50  EVAIKRL-AWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           + AIKR+  + S     +F  E +++ KL  + N++ LLG   H     L  E+ P+ +L
Sbjct: 54  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 113
Query: 108 ------------DSSFS------GTFKDLLCLH----------KYSRLRVIHRDLKASNI 139
                       D +F+       T      LH            S+ + IHRDL A NI
Sbjct: 114 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 173
Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
           L+ +    KI+DFG++R   V          V      SL Y++  T    +DV+ +GVL
Sbjct: 174 LVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT---NSDVWSYGVL 230
Query: 200 VLKIV-------CG-------KKNNKSYHTERPLN----LVGIAWQLWNE 231
           + +IV       CG       +K  + Y  E+PLN    +  +  Q W E
Sbjct: 231 LWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWRE 280

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H ++R  V++RDLK +NILLD+  + +ISD G+A  F   +  A+    VGT+GYM+ E 
Sbjct: 306 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 360
Query: 182 TMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTE 216
              G       D F  G ++ K++ G    + + T+
Sbjct: 361 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 396

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 18/154 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 55  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 113
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTY 174
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV      T+ +V T 
Sbjct: 114 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TL 171
Query: 175 GYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGK 207
            Y + E  +     S   D++  G +  ++V  +
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 22/153 (14%)
Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSLDSSFSGTFKDLL---CLH 122
           F  EA ++ +L+++NLV+LLG  +  +  L +V E+M   SL        + +L   CL 
Sbjct: 52  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 111
Query: 123 KYSRLRV------------IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI 170
           K+S L V            +HRDL A N+L+ +    K+SDFG+ +     E+ +  +  
Sbjct: 112 KFS-LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTG 165
Query: 171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
                + + E       S K+DV+ FG+L+ +I
Sbjct: 166 KLPVKWTAPEALREAAFSTKSDVWSFGILLWEI 198

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 48  EQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VA+K +  ++  + R+EF NEA ++      ++V+LLG    G+  L+V E M +  
Sbjct: 47  ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 106
Query: 107 LDSSFSG--------------TFKDLLCLHK--------YSRLRVIHRDLKASNILLDDQ 144
           L S                  T ++++ +           +  + +HRDL A N ++   
Sbjct: 107 LKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 166
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
              KI DFGM R     +      + +    +M+ E    G  +  +D++ FGV++ +I 
Sbjct: 167 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 226
Query: 205 C 205
Sbjct: 227 S 227

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H ++R  V++RDLK +NILLD+  + +ISD G+A  F   +  A+    VGT+GYM+ E 
Sbjct: 307 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 361
Query: 182 TMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTE 216
              G       D F  G ++ K++ G    + + T+
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H ++R  V++RDLK +NILLD+  + +ISD G+A  F   +  A+    VGT+GYM+ E 
Sbjct: 307 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 361
Query: 182 TMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTE 216
              G       D F  G ++ K++ G    + + T+
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 18/154 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 51  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTY 174
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV      T+ +V T 
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TL 167
Query: 175 GYMSLEYTMSGT-VSIKTDVFGFGVLVLKIVCGK 207
            Y + E  +     S   D++  G +  ++V  +
Sbjct: 168 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H ++R  V++RDLK +NILLD+  + +ISD G+A  F   +  A+    VGT+GYM+ E 
Sbjct: 307 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 361
Query: 182 TMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTE 216
              G       D F  G ++ K++ G    + + T+
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 15/178 (8%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
           V+ +GK+  + +VA+K +         EF  EA+ + KL +  LVK  G         +V
Sbjct: 23  VVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81
Query: 99  YEFMPNKSLDSSFSGTFKDL-------LC------LHKYSRLRVIHRDLKASNILLDDQL 145
            E++ N  L +      K L       +C      +      + IHRDL A N L+D  L
Sbjct: 82  TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL 141
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             K+SDFGM R + +++   ++        + + E       S K+DV+ FG+L+ ++
Sbjct: 142 CVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEV 198

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 18/154 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 51  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTY 174
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV      T+ +V T 
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TL 167
Query: 175 GYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGK 207
            Y + E  +     S   D++  G +  ++V  +
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 18/154 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 50  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTY 174
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV      T+ +V T 
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TL 166
Query: 175 GYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGK 207
            Y + E  +     S   D++  G +  ++V  +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 18/154 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 51  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTY 174
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV      T+ +V T 
Sbjct: 110 FQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TL 167
Query: 175 GYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGK 207
            Y + E  +     S   D++  G +  ++V  +
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 15/106 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMP---NKSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 54  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL 112
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV 158

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 18/154 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 51  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTY 174
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV      T+ +V T 
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TL 167
Query: 175 GYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGK 207
            Y + E  +     S   D++  G +  ++V  +
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 18/154 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 50  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTY 174
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV      T+ +V T 
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TL 166
Query: 175 GYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGK 207
            Y + E  +     S   D++  G +  ++V  +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 85/190 (44%), Gaps = 23/190 (12%)
Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF------- 101
           Q VAIK++   S     E   E  ++ +    ++VK  G      +  +V E+       
Sbjct: 55  QIVAIKQVPVESDLQ--EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS 112
Query: 102 ----MPNKSLDSS-----FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF 152
               + NK+L           T K L  LH    +R IHRD+KA NILL+ + + K++DF
Sbjct: 113 DIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADF 169
Query: 153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKS 212
           G+A    + +  A  N ++GT  +M+ E       +   D++  G+  +++  GK     
Sbjct: 170 GVAG--QLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227
Query: 213 YHTERPLNLV 222
            H  R + ++
Sbjct: 228 IHPMRAIFMI 237

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 15/106 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMP---NKSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 52  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL 110
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV 156

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 18/154 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 58  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 116
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTY 174
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV      T+ +V T 
Sbjct: 117 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVV-TL 174
Query: 175 GYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGK 207
            Y + E  +     S   D++  G +  ++V  +
Sbjct: 175 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +IHRD+K +NIL+      K+ DFG+AR I     S   T  ++GT  Y+S E     +V
Sbjct: 137 IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSV 196
Query: 188 SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
             ++DV+  G ++ +++ G+     +  + P   V +A+Q   E
Sbjct: 197 DARSDVYSLGCVLYEVLTGE---PPFTGDSP---VSVAYQHVRE 234

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 18/154 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 50  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTY 174
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV      T+ +V T 
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TL 166
Query: 175 GYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGK 207
            Y + E  +     S   D++  G +  ++V  +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 18/154 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 51  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTY 174
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV      T+ +V T 
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TL 167
Query: 175 GYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGK 207
            Y + E  +     S   D++  G +  ++V  +
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 18/154 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 52  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTY 174
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV      T+ +V T 
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TL 168
Query: 175 GYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGK 207
            Y + E  +     S   D++  G +  ++V  +
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 48  EQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VA+K +  ++  + R+EF NEA ++      ++V+LLG    G+  L+V E M +  
Sbjct: 46  ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 105
Query: 107 LDSSFSG--------------TFKDLLCLHK--------YSRLRVIHRDLKASNILLDDQ 144
           L S                  T ++++ +           +  + +HRDL A N ++   
Sbjct: 106 LKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 165
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
              KI DFGM R     +      + +    +M+ E    G  +  +D++ FGV++ +I 
Sbjct: 166 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 225
Query: 205 C 205
Sbjct: 226 S 226

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           V+HRDLK +N+ LD + N K+ DFG+ARI   + S A     VGT  YMS E     + +
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRMSYN 194
Query: 189 IKTDVFGFGVLVLKI 203
            K+D++  G L+ ++
Sbjct: 195 EKSDIWSLGCLLYEL 209

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 15/106 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 50  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 83/169 (49%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L++ + MP   L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL-L 104
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 105 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 15/106 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 53  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 157

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 61/105 (58%), Gaps = 15/105 (14%)
Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHKY 124
           E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + +
Sbjct: 52  EISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 125 SRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
             L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 15/106 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 53  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV 157

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 59/105 (56%), Gaps = 15/105 (14%)
Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSLD----SSFSGTFKDLLCLHKY 124
           E  L+ +L + N+VKLL   IH E +L LV+EF+     D    S+ +G    L+  + +
Sbjct: 52  EISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLF 110
Query: 125 SRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
             L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV 155

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 15/106 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 54  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 112
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 158

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 15/106 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 54  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 112
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 158

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 15/106 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 53  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 157

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 83/169 (49%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L++ + MP   L  
Sbjct: 51  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL-L 108
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 109 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 168
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 169 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 217

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 83/169 (49%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L++ + MP   L  
Sbjct: 48  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXL-L 105
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 106 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 165
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 166 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 214

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 15/106 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 50  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 15/106 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 52  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV 156

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 15/106 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 51  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 83/169 (49%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L++ + MP   L  
Sbjct: 48  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL-L 105
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 106 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 165
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 166 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 214

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 15/106 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 51  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 61/105 (58%), Gaps = 15/105 (14%)
Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHKY 124
           E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + +
Sbjct: 53  EISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 111
Query: 125 SRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
             L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 112 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 156

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 15/106 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 55  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 113
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 114 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 159

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 15/106 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + 
Sbjct: 52  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 156

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 28/194 (14%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSL----------DSSFSGT 114
           + + E ++ + L++ N++++     H  +R+ L+ EF P   L          D   S T
Sbjct: 60  QLRREIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT 118
Query: 115 FKDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG 172
           F + L   LH     +VIHRD+K  N+L+  +   KI+DFG    + V+        + G
Sbjct: 119 FMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCG 174
Query: 173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN-NKSYHTERPLNLVGIAWQLWNE 231
           T  Y+  E     T   K D++  GVL  + + G    +   HTE    +V +       
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------- 227
Query: 232 GKDLELIDLTLDGS 245
             DL+      DGS
Sbjct: 228 --DLKFPPFLSDGS 239

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 57  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 114
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 115 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 174
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 175 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 223

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 28/194 (14%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSL----------DSSFSGT 114
           + + E ++ + L++ N++++     H  +R+ L+ EF P   L          D   S T
Sbjct: 61  QLRREIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT 119
Query: 115 FKDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG 172
           F + L   LH     +VIHRD+K  N+L+  +   KI+DFG    + V+        + G
Sbjct: 120 FMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCG 175
Query: 173 TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN-NKSYHTERPLNLVGIAWQLWNE 231
           T  Y+  E     T   K D++  GVL  + + G    +   HTE    +V +       
Sbjct: 176 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------- 228
Query: 232 GKDLELIDLTLDGS 245
             DL+      DGS
Sbjct: 229 --DLKFPPFLSDGS 240

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 83/169 (49%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L++ + MP   L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL-L 107
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 108 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 167
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 168 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 104
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 105 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 83/169 (49%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L++ + MP   L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL-L 111
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 112 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 171
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 172 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXL-L 104
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 105 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 51  VAIKRLAW-TSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL-- 107
           VAIK L   TS +   E  +EA ++A +    + +LLG  +    +L V + MP   L  
Sbjct: 49  VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLD 107
Query: 108 ---DSSFSGTFKDLL--CLH------KYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
              ++      +DLL  C+           +R++HRDL A N+L+    + KI+DFG+AR
Sbjct: 108 HVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLAR 167
Query: 157 IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +  ++E+  + +       +M+LE  +    + ++DV+ +GV V +++
Sbjct: 168 LLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELM 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 83/169 (49%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L++ + MP   L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL-L 106
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 107 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 166
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 167 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 59/106 (55%), Gaps = 15/106 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSLD----SSFSGTFKDLLCLHK 123
            E  L+ +L + N+VKLL   IH E +L LV+EF+     D    S+ +G    L+  + 
Sbjct: 54  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYL 112
Query: 124 YSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
           +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 158

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 61/105 (58%), Gaps = 15/105 (14%)
Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHKY 124
           E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S  +G    L+  + +
Sbjct: 52  EISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 125 SRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
             L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 53  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 110
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 111 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 170
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 171 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 219

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 21  NSSLDWHMYIQQEQTRDRV-------ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKL 73
           +SS DW +   Q     R+       +  GK+  +  V +  +   + Q    F+NE  +
Sbjct: 3   DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGV 62
Query: 74  IAKLQYTNLVKLLG----------------CSIHGEERLLVYEFMPNKSLDSSFSGTFKD 117
           + K ++ N++  +G                 S++    ++  +F   K +D +   T + 
Sbjct: 63  LRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA-RQTAQG 121
Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           +  LH  S   +IHRDLK++NI L + L  KI DFG+A +           ++ G+  +M
Sbjct: 122 MDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 178 SLEYTM---SGTVSIKTDVFGFGVLVLKIVCGK 207
           + E          S ++DV+ FG+++ +++ G+
Sbjct: 179 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 20  ENSSLDWHMYIQQEQTRDRV-------ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAK 72
            +SS DW +   Q     R+       +  GK+  +  V +  +   + Q    F+NE  
Sbjct: 25  RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 73  LIAKLQYTNLVKLLG----------------CSIHGEERLLVYEFMPNKSLDSSFSGTFK 116
           ++ K ++ N++  +G                 S++    ++  +F   K +D +   T +
Sbjct: 85  VLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ-TAQ 143
Query: 117 DLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +  LH  S   +IHRDLK++NI L + L  KI DFG+A +           ++ G+  +
Sbjct: 144 GMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 200
Query: 177 MSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGK 207
           M+ E          S ++DV+ FG+++ +++ G+
Sbjct: 201 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 78/181 (43%), Gaps = 23/181 (12%)
Query: 48  EQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VA+K +  ++  + R+EF NEA ++      ++V+LLG    G+  L+V E M +  
Sbjct: 47  ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 106
Query: 107 LDSSFSG--------------TFKDLLCLHK--------YSRLRVIHRDLKASNILLDDQ 144
           L S                  T ++++ +           +  + +HRDL A N ++   
Sbjct: 107 LKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 166
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
              KI DFGM R            + +    +M+ E    G  +  +D++ FGV++ +I 
Sbjct: 167 FTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 226
Query: 205 C 205
Sbjct: 227 S 227

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 104
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 105 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 21  NSSLDWHMYIQQEQTRDRV-------ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKL 73
           +SS DW +   Q     R+       +  GK+  +  V +  +   + Q    F+NE  +
Sbjct: 3   DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGV 62
Query: 74  IAKLQYTNLVKLLG----------------CSIHGEERLLVYEFMPNKSLDSSFSGTFKD 117
           + K ++ N++  +G                 S++    ++  +F   K +D +   T + 
Sbjct: 63  LRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA-RQTAQG 121
Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           +  LH  S   +IHRDLK++NI L + L  KI DFG+A +           ++ G+  +M
Sbjct: 122 MDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 178 SLEYTM---SGTVSIKTDVFGFGVLVLKIVCGK 207
           + E          S ++DV+ FG+++ +++ G+
Sbjct: 179 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 20  ENSSLDWHMYIQQEQTRDRV-------ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAK 72
            +SS DW +   Q     R+       +  GK+  +  V +  +   + Q    F+NE  
Sbjct: 24  RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVG 83
Query: 73  LIAKLQYTNLVKLLG----------------CSIHGEERLLVYEFMPNKSLDSSFSGTFK 116
           ++ K ++ N++  +G                 S++    ++  +F   K +D +   T +
Sbjct: 84  VLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA-RQTAQ 142
Query: 117 DLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +  LH  S   +IHRDLK++NI L + L  KI DFG+A +           ++ G+  +
Sbjct: 143 GMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 199
Query: 177 MSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGK 207
           M+ E          S ++DV+ FG+++ +++ G+
Sbjct: 200 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 59/105 (56%), Gaps = 15/105 (14%)
Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSLD----SSFSGTFKDLLCLHKY 124
           E  L+ +L + N+VKLL   IH E +L LV+EF+     D    S+ +G    L+  + +
Sbjct: 54  EISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLF 112
Query: 125 SRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
             L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 113 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 157

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +IHRD+K +NI++      K+ DFG+AR I     S   T  ++GT  Y+S E     +V
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196
Query: 188 SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
             ++DV+  G ++ +++ G+     +  + P   V +A+Q   E
Sbjct: 197 DARSDVYSLGCVLYEVLTGE---PPFTGDSP---VSVAYQHVRE 234

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 38  RVILVGKFPNEQEVAIK---RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE 94
           +V L   +  +Q+VA+K   R         +  + E   +  L++ +++KL        +
Sbjct: 24  KVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD 83
Query: 95  RLLVYEFMPNKSLDSSFSGT----------FKDLLCLHKY-SRLRVIHRDLKASNILLDD 143
            ++V E+   +  D                F+ ++C  +Y  R +++HRDLK  N+LLDD
Sbjct: 84  IVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDD 143
Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI--KTDVFGFGVLVL 201
            LN KI+DFG++ I      G       G+  Y + E  ++G +    + DV+  G+++ 
Sbjct: 144 NLNVKIADFGLSNIMT---DGNFLKTSCGSPNYAAPE-VINGKLYAGPEVDVWSCGIVLY 199
Query: 202 KIVCGK 207
            ++ G+
Sbjct: 200 VMLVGR 205

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +IHRD+K +NI++      K+ DFG+AR I     S   T  ++GT  Y+S E     +V
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196
Query: 188 SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
             ++DV+  G ++ +++ G+     +  + P   V +A+Q   E
Sbjct: 197 DARSDVYSLGCVLYEVLTGE---PPFTGDSP---VSVAYQHVRE 234

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 106
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 107 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 166
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 167 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 107
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 108 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 167
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 168 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +IHRD+K +NI++      K+ DFG+AR I     S   T  ++GT  Y+S E     +V
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196
Query: 188 SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
             ++DV+  G ++ +++ G+     +  + P   V +A+Q   E
Sbjct: 197 DARSDVYSLGCVLYEVLTGE---PPFTGDSP---VSVAYQHVRE 234

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 44  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 101
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 102 DYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 161
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 162 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 210

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 107
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 108 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 167
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 168 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 107
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 108 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 167
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 168 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 72  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 129
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 130 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 189
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 190 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 238

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 41  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 98
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 99  DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 158
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 207

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 111
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 112 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 171
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 172 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 22/153 (14%)
Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSLDSSFSGTFKDLL---CLH 122
           F  EA ++ +L+++NLV+LLG  +  +  L +V E+M   SL        + +L   CL 
Sbjct: 46  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105
Query: 123 KYSRLRV------------IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI 170
           K+S L V            +HRDL A N+L+ +    K+SDFG+ +     E+ +  +  
Sbjct: 106 KFS-LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTG 159
Query: 171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
                + + E       S K+DV+ FG+L+ +I
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 104
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 105 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 111
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG+A
Sbjct: 112 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 171
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 172 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 22/153 (14%)
Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSLDSSFSGTFKDLL---CLH 122
           F  EA ++ +L+++NLV+LLG  +  +  L +V E+M   SL        + +L   CL 
Sbjct: 233 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 292
Query: 123 KYSRLRV------------IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI 170
           K+S L V            +HRDL A N+L+ +    K+SDFG+ +     E+ +  +  
Sbjct: 293 KFS-LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTG 346
Query: 171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
                + + E       S K+DV+ FG+L+ +I
Sbjct: 347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 379

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 46/80 (57%), Gaps = 1/80 (1%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +IHRD+K +NI++      K+ DFG+AR I     S   T  ++GT  Y+S E     +V
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196
Query: 188 SIKTDVFGFGVLVLKIVCGK 207
             ++DV+  G ++ +++ G+
Sbjct: 197 DARSDVYSLGCVLYEVLTGE 216

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 22  SSLDWHMYIQQEQTRDRV-------ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLI 74
           SS DW +   Q     R+       +  GK+  +  V +  +   + Q    F+NE  ++
Sbjct: 1   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 60
Query: 75  AKLQYTNLVKLLG----------------CSIHGEERLLVYEFMPNKSLDSSFSGTFKDL 118
            K ++ N++  +G                 S++    ++  +F   K +D +   T + +
Sbjct: 61  RKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA-RQTAQGM 119
Query: 119 LCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMS 178
             LH  S   +IHRDLK++NI L + L  KI DFG+A +           ++ G+  +M+
Sbjct: 120 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 176
Query: 179 LEYTM---SGTVSIKTDVFGFGVLVLKIVCGK 207
            E          S ++DV+ FG+++ +++ G+
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 22/153 (14%)
Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSLDSSFSGTFKDLL---CLH 122
           F  EA ++ +L+++NLV+LLG  +  +  L +V E+M   SL        + +L   CL 
Sbjct: 61  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 120
Query: 123 KYSRLRV------------IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI 170
           K+S L V            +HRDL A N+L+ +    K+SDFG+ +     E+ +  +  
Sbjct: 121 KFS-LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTG 174
Query: 171 VGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
                + + E       S K+DV+ FG+L+ +I
Sbjct: 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 207

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +IHRD+K +NI++      K+ DFG+AR I     S   T  ++GT  Y+S E     +V
Sbjct: 154 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 213
Query: 188 SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNE 231
             ++DV+  G ++ +++ G+     +  + P   V +A+Q   E
Sbjct: 214 DARSDVYSLGCVLYEVLTGE---PPFTGDSP---VSVAYQHVRE 251

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L++ + MP   L  
Sbjct: 51  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL-L 108
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG A
Sbjct: 109 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA 168
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 169 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 217

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 51/230 (22%)
Query: 50  EVAIKRL-AWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           + AIKR+  + S     +F  E +++ KL  + N++ LLG   H     L  E+ P+ +L
Sbjct: 51  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 110
Query: 108 ------------DSSFS------GTFKDLLCLH----------KYSRLRVIHRDLKASNI 139
                       D +F+       T      LH            S+ + IHR+L A NI
Sbjct: 111 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNI 170
Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
           L+ +    KI+DFG++R   V          V      SL Y++  T    +DV+ +GVL
Sbjct: 171 LVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT---NSDVWSYGVL 227
Query: 200 VLKIV-------CG-------KKNNKSYHTERPLN----LVGIAWQLWNE 231
           + +IV       CG       +K  + Y  E+PLN    +  +  Q W E
Sbjct: 228 LWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWRE 277

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 86/179 (48%), Gaps = 25/179 (13%)
Query: 50  EVAIKRLAWTSG--QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           +VA+K L  T+   Q    F+NE  ++ K ++ N++  +G S    +  +V ++    SL
Sbjct: 32  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSL 90
Query: 108 -------DSSFS---------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISD 151
                  ++ F           T + +  LH  S   +IHRDLK++NI L + L  KI D
Sbjct: 91  YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 147
Query: 152 FGMARIFGVNESGANTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGK 207
           FG+A +           ++ G+  +M+ E          S ++DV+ FG+++ +++ G+
Sbjct: 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 86/179 (48%), Gaps = 25/179 (13%)
Query: 50  EVAIKRLAWTSG--QGRVEFQNEAKLIAKLQYTNLVKLLG----------------CSIH 91
           +VA+K L  T+   Q    F+NE  ++ K ++ N++  +G                 S++
Sbjct: 32  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLY 91
Query: 92  GEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISD 151
               ++  +F   K +D +   T + +  LH  S   +IHRDLK++NI L + L  KI D
Sbjct: 92  HHLHIIETKFEMIKLIDIA-RQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 147
Query: 152 FGMARIFGVNESGANTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGK 207
           FG+A +           ++ G+  +M+ E          S ++DV+ FG+++ +++ G+
Sbjct: 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L++ + MP   L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL-L 106
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG A
Sbjct: 107 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA 166
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 167 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L++ + MP   L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL-L 106
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG A
Sbjct: 107 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA 166
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 167 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 48  EQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VA+K +  ++  + R+EF NEA ++      ++V+LLG    G+  L+V E M +  
Sbjct: 47  ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 106
Query: 107 LDSSFSG--------------TFKDLLCLHK--------YSRLRVIHRDLKASNILLDDQ 144
           L S                  T ++++ +           +  + +HR+L A N ++   
Sbjct: 107 LKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHD 166
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
              KI DFGM R     +      + +    +M+ E    G  +  +D++ FGV++ +I 
Sbjct: 167 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 226
Query: 205 C 205
Sbjct: 227 S 227

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/82 (36%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
           R RVIHRDLK  N+ L++ L  KI DFG+A    V   G     + GT  Y++ E     
Sbjct: 139 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKTLCGTPNYIAPEVLSKK 196
Query: 186 TVSIKTDVFGFGVLVLKIVCGK 207
             S + DV+  G ++  ++ GK
Sbjct: 197 GHSFEVDVWSIGCIMYTLLVGK 218

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 21/186 (11%)
Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
            VIL      ++ VAIK +A  + +G+    +NE  ++ K+++ N+V L      G    
Sbjct: 33  EVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 92
Query: 97  LVYEFMPNKSL-------------DSSFSGTFKDLLCLHKYSRLRVIHRDLKASNIL--- 140
           L+ + +    L             D+S    F+ L  +     L ++HRDLK  N+L   
Sbjct: 93  LIMQLVSGGELFDRIVEKGFYTERDAS-RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 151
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           LD+     ISDFG++++    + G+  +   GT GY++ E       S   D +  GV+ 
Sbjct: 152 LDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208
Query: 201 LKIVCG 206
             ++CG
Sbjct: 209 YILLCG 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/82 (36%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
           R RVIHRDLK  N+ L++ L  KI DFG+A    V   G     + GT  Y++ E     
Sbjct: 135 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKTLCGTPNYIAPEVLSKK 192
Query: 186 TVSIKTDVFGFGVLVLKIVCGK 207
             S + DV+  G ++  ++ GK
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGK 214

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/82 (36%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
           R RVIHRDLK  N+ L++ L  KI DFG+A    V   G     + GT  Y++ E     
Sbjct: 135 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKTLCGTPNYIAPEVLSKK 192
Query: 186 TVSIKTDVFGFGVLVLKIVCGK 207
             S + DV+  G ++  ++ GK
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGK 214

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 48  EQEVAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VA+K +  ++  + R+EF NEA ++      ++V+LLG    G+  L+V E M +  
Sbjct: 48  ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 107
Query: 107 LDSSFSG--------------TFKDLLCLHK--------YSRLRVIHRDLKASNILLDDQ 144
           L S                  T ++++ +           +  + +HR+L A N ++   
Sbjct: 108 LKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHD 167
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
              KI DFGM R     +      + +    +M+ E    G  +  +D++ FGV++ +I 
Sbjct: 168 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 227
Query: 205 C 205
Sbjct: 228 S 228

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 104
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG A
Sbjct: 105 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA 164
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 9/113 (7%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +++RDLK  NILLD   + KI+DFGM +   + +  A TN   GT  Y++ E  +    +
Sbjct: 140 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNEFCGTPDYIAPEILLGQKYN 197
Query: 189 IKTDVFGFGVLVLKIVCGKK------NNKSYHTERPLNLVGIAWQLWNEGKDL 235
              D + FGVL+ +++ G+         + +H+ R  N     W L  E KDL
Sbjct: 198 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW-LEKEAKDL 249

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 21/186 (11%)
Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
            VIL      ++ VAIK +A  + +G+    +NE  ++ K+++ N+V L      G    
Sbjct: 33  EVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 92
Query: 97  LVYEFMPNKSL-------------DSSFSGTFKDLLCLHKYSRLRVIHRDLKASNIL--- 140
           L+ + +    L             D+S    F+ L  +     L ++HRDLK  N+L   
Sbjct: 93  LIMQLVSGGELFDRIVEKGFYTERDAS-RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 151
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           LD+     ISDFG++++    + G+  +   GT GY++ E       S   D +  GV+ 
Sbjct: 152 LDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208
Query: 201 LKIVCG 206
             ++CG
Sbjct: 209 YILLCG 214

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 61/107 (57%), Gaps = 17/107 (15%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSLD-----SSFSGTFKDLLCLH 122
            E  L+ +L + N+VKLL   IH E +L LV+EF+ ++ L      S+ +G    L+  +
Sbjct: 54  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSY 111
Query: 123 KYSRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
            +  L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 112 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 158

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 21  NSSLDWHMYIQQEQTRDRV-------ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKL 73
           +SS DW +   Q     R+       +  GK+  +  V +  +   + Q    F+NE  +
Sbjct: 2   DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGV 61
Query: 74  IAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL-------DSSFS---------GTFKD 117
           + K ++ N++  +G S    +  +V ++    SL       ++ F           T + 
Sbjct: 62  LRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 120
Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           +  LH  S   +IHRDLK++NI L +    KI DFG+A +           ++ G+  +M
Sbjct: 121 MDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 177
Query: 178 SLEYTM---SGTVSIKTDVFGFGVLVLKIVCGK 207
           + E      S   S ++DV+ FG+++ +++ G+
Sbjct: 178 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E+MP   + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   K++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 106
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG A
Sbjct: 107 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA 166
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 167 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 21/186 (11%)
Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
            VIL      ++ VAIK +A  + +G+    +NE  ++ K+++ N+V L      G    
Sbjct: 33  EVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 92
Query: 97  LVYEFMPNKSL-------------DSSFSGTFKDLLCLHKYSRLRVIHRDLKASNIL--- 140
           L+ + +    L             D+S    F+ L  +     L ++HRDLK  N+L   
Sbjct: 93  LIMQLVSGGELFDRIVEKGFYTERDAS-RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 151
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           LD+     ISDFG++++    + G+  +   GT GY++ E       S   D +  GV+ 
Sbjct: 152 LDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208
Query: 201 LKIVCG 206
             ++CG
Sbjct: 209 YILLCG 214

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 21/186 (11%)
Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
            VIL      ++ VAIK +A  + +G+    +NE  ++ K+++ N+V L      G    
Sbjct: 33  EVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 92
Query: 97  LVYEFMPNKSL-------------DSSFSGTFKDLLCLHKYSRLRVIHRDLKASNIL--- 140
           L+ + +    L             D+S    F+ L  +     L ++HRDLK  N+L   
Sbjct: 93  LIMQLVSGGELFDRIVEKGFYTERDAS-RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 151
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           LD+     ISDFG++++    + G+  +   GT GY++ E       S   D +  GV+ 
Sbjct: 152 LDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208
Query: 201 LKIVCG 206
             ++CG
Sbjct: 209 YILLCG 214

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E+MP   + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   K++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 25/176 (14%)
Query: 51  VAIKRLA---WTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           VA+K++        + R +   E  L+ +L + N++K     I   E  +V E      L
Sbjct: 60  VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL 119
Query: 108 DSSFSGTFKDL---------------LCL---HKYSRLRVIHRDLKASNILLDDQLNTKI 149
            S     FK                 LC    H +SR RV+HRD+K +N+ +      K+
Sbjct: 120 -SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKL 177
Query: 150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC 205
            D G+ R F    + A++  +VGT  YMS E       + K+D++  G L+ ++  
Sbjct: 178 GDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/82 (36%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
           R RVIHRDLK  N+ L++ L  KI DFG+A    V   G     + GT  Y++ E     
Sbjct: 157 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKK 214
Query: 186 TVSIKTDVFGFGVLVLKIVCGK 207
             S + DV+  G ++  ++ GK
Sbjct: 215 GHSFEVDVWSIGCIMYTLLVGK 236

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-L 111
Query: 110 SFSGTFKDLL--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMA 155
            +    KD +        C+     +      R++HRDL A N+L+    + KI+DFG A
Sbjct: 112 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA 171
Query: 156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++ G  E   +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 172 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 9/113 (7%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +++RDLK  NILLD   + KI+DFGM +   + +  A TN   GT  Y++ E  +    +
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNXFCGTPDYIAPEILLGQKYN 196
Query: 189 IKTDVFGFGVLVLKIVCGKK------NNKSYHTERPLNLVGIAWQLWNEGKDL 235
              D + FGVL+ +++ G+         + +H+ R  N     W L  E KDL
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW-LEKEAKDL 248

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/82 (36%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
           R RVIHRDLK  N+ L++ L  KI DFG+A    V   G     + GT  Y++ E     
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKK 216
Query: 186 TVSIKTDVFGFGVLVLKIVCGK 207
             S + DV+  G ++  ++ GK
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGK 238

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/82 (36%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
           R RVIHRDLK  N+ L++ L  KI DFG+A    V   G     + GT  Y++ E     
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKK 190
Query: 186 TVSIKTDVFGFGVLVLKIVCGK 207
             S + DV+  G ++  ++ GK
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGK 212

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 88/188 (46%), Gaps = 31/188 (16%)
Query: 38  RVILVGKFPNEQEVAIK-----RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG 92
           R IL G+     EVAIK     +L  TS Q   +   E +++  L + N+VKL    I  
Sbjct: 32  RHILTGR-----EVAIKIIDKTQLNPTSLQ---KLFREVRIMKILNHPNIVKLFEV-IET 82
Query: 93  EERL-LVYEFMPNKSL-----------DSSFSGTFKDLLCLHKY-SRLRVIHRDLKASNI 139
           E+ L L+ E+     +           +      F+ ++   +Y  + R++HRDLKA N+
Sbjct: 83  EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL 142
Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE-YTMSGTVSIKTDVFGFGV 198
           LLD  +N KI+DFG +  F V   G   +   G+  Y + E +        + DV+  GV
Sbjct: 143 LLDADMNIKIADFGFSNEFTV---GGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGV 199
Query: 199 LVLKIVCG 206
           ++  +V G
Sbjct: 200 ILYTLVSG 207

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 70/158 (44%), Gaps = 21/158 (13%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD----------------- 108
           EF  E  ++ +L++ N+V  +G         +V E++   SL                  
Sbjct: 80  EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRR 139
Query: 109 -SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT 167
            S      K +  LH  +   ++HRDLK+ N+L+D +   K+ DFG++R+         +
Sbjct: 140 LSMAYDVAKGMNYLHNRNP-PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--SXFLXS 196
Query: 168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC 205
               GT  +M+ E       + K+DV+ FGV++ ++  
Sbjct: 197 KXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 41/79 (51%), Gaps = 2/79 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +I+RDLK  N+LLDD  N +ISD G+A      ++   T    GT G+M+ E  +     
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYD 367
Query: 189 IKTDVFGFGVLVLKIVCGK 207
              D F  GV + +++  +
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 41/79 (51%), Gaps = 2/79 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +I+RDLK  N+LLDD  N +ISD G+A      ++   T    GT G+M+ E  +     
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYD 367
Query: 189 IKTDVFGFGVLVLKIVCGK 207
              D F  GV + +++  +
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 41/79 (51%), Gaps = 2/79 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +I+RDLK  N+LLDD  N +ISD G+A      ++   T    GT G+M+ E  +     
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYD 367
Query: 189 IKTDVFGFGVLVLKIVCGK 207
              D F  GV + +++  +
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 41/79 (51%), Gaps = 2/79 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +I+RDLK  N+LLDD  N +ISD G+A      ++   T    GT G+M+ E  +     
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYD 367
Query: 189 IKTDVFGFGVLVLKIVCGK 207
              D F  GV + +++  +
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 31/188 (16%)
Query: 38  RVILVGKFPNEQEVAIK-----RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG 92
           R IL G+     EVAIK     +L  TS Q   +   E +++  L + N+VKL    I  
Sbjct: 35  RHILTGR-----EVAIKIIDKTQLNPTSLQ---KLFREVRIMKILNHPNIVKLFEV-IET 85
Query: 93  EERL-LVYEFMPNKSL-----------DSSFSGTFKDLLCLHKY-SRLRVIHRDLKASNI 139
           E+ L L+ E+     +           +      F+ ++   +Y  + R++HRDLKA N+
Sbjct: 86  EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL 145
Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE-YTMSGTVSIKTDVFGFGV 198
           LLD  +N KI+DFG +  F V   G   +   G   Y + E +        + DV+  GV
Sbjct: 146 LLDADMNIKIADFGFSNEFTV---GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGV 202
Query: 199 LVLKIVCG 206
           ++  +V G
Sbjct: 203 ILYTLVSG 210

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 16/160 (10%)
Query: 59  TSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDL 118
           TS +   E  +EA ++A +   ++ +LLG  +    +L+  + MP   L   +    KD 
Sbjct: 90  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL-LDYVREHKDN 147
Query: 119 L--------CLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG 164
           +        C+     +      R++HRDL A N+L+    + KI+DFG+A++ G  E  
Sbjct: 148 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 207
Query: 165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
            +         +M+LE  +    + ++DV+ +GV V +++
Sbjct: 208 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 247

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 80/190 (42%), Gaps = 29/190 (15%)
Query: 42  VGKFPNEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLV 98
           + K    + VA+K L    T  + R        LI    + N+V LLG C+  G   +++
Sbjct: 51  IDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110
Query: 99  YEF-----------------MPNKSLDSSFSGTFKDLLC--------LHKYSRLRVIHRD 133
            EF                 +P K L   F  T + L+C        +   +  + IHRD
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKDLYKDFL-TLEHLICYSFQVAKGMEFLASRKXIHRD 169
Query: 134 LKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDV 193
           L A NILL ++   KI DFG+AR    +              +M+ E       +I++DV
Sbjct: 170 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 229
Query: 194 FGFGVLVLKI 203
           + FGVL+ +I
Sbjct: 230 WSFGVLLWEI 239

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 2/80 (2%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           RVIHRDLK  N+ L+D ++ KI DFG+A    +   G     + GT  Y++ E       
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKXLCGTPNYIAPEVLCKKGH 219
Query: 188 SIKTDVFGFGVLVLKIVCGK 207
           S + D++  G ++  ++ GK
Sbjct: 220 SFEVDIWSLGCILYTLLVGK 239

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 2/80 (2%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           RVIHRDLK  N+ L+D ++ KI DFG+A    +   G     + GT  Y++ E       
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKTLCGTPNYIAPEVLCKKGH 219
Query: 188 SIKTDVFGFGVLVLKIVCGK 207
           S + D++  G ++  ++ GK
Sbjct: 220 SFEVDIWSLGCILYTLLVGK 239

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 20  ENSSLDWHMYIQQEQTRDRV-------ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAK 72
            +SS DW +   Q     R+       +  GK+  +  V +  +   + Q    F+NE  
Sbjct: 17  RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVG 76
Query: 73  LIAKLQYTNLVKLLG----------------CSIHGEERLLVYEFMPNKSLDSSFSGTFK 116
           ++ K ++ N++  +G                 S++    ++  +F   K +D +   T +
Sbjct: 77  VLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA-RQTAQ 135
Query: 117 DLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +  LH  S   +IHRDLK++NI L + L  KI DFG+A             ++ G+  +
Sbjct: 136 GMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 192
Query: 177 MSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGK 207
           M+ E          S ++DV+ FG+++ +++ G+
Sbjct: 193 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 125 SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG--TYGYMSLEYT 182
           + ++++HRDL A NIL+ +    KISDFG++R   V E  +   R  G     +M++E  
Sbjct: 167 AEMKLVHRDLAARNILVAEGRKMKISDFGLSR--DVYEEDSXVKRSQGRIPVKWMAIESL 224
Query: 183 MSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLV 222
                + ++DV+ FGVL+ +IV  G         ER  NL+
Sbjct: 225 FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL 265

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/93 (29%), Positives = 49/93 (52%), Gaps = 2/93 (2%)
Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI 189
           IHRD+KA+N+LL +    K++DFG+A    + ++    N  VGT  +M+ E         
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPEVIKQSAYDS 183
Query: 190 KTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
           K D++  G+  +++  G+  +   H  + L L+
Sbjct: 184 KADIWSLGITAIELARGEPPHSELHPMKVLFLI 216

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 21  NSSLDWHMYIQQEQTRDRV-------ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKL 73
           +SS DW +   Q     R+       +  GK+  +  V +  +   + Q    F+NE  +
Sbjct: 26  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGV 85
Query: 74  IAKLQYTNLVKLLG----------------CSIHGEERLLVYEFMPNKSLDSSFSGTFKD 117
           + K ++ N++  +G                 S++    ++  +F   K +D +   T + 
Sbjct: 86  LRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ-TAQG 144
Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           +  LH  S   +IHRDLK++NI L + L  KI DFG+A             ++ G+  +M
Sbjct: 145 MDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 201
Query: 178 SLEYTM---SGTVSIKTDVFGFGVLVLKIVCGK 207
           + E          S ++DV+ FG+++ +++ G+
Sbjct: 202 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 50/95 (52%), Gaps = 2/95 (2%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           + IHRD+KA+N+LL +    K++DFG+A    + ++    N  VGT  +M+ E       
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPEVIKQSAY 196
Query: 188 SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
             K D++  G+  +++  G+  +   H  + L L+
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 231

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/158 (23%), Positives = 72/158 (45%), Gaps = 21/158 (13%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD----------------- 108
           EF  E  ++ +L++ N+V  +G         +V E++   SL                  
Sbjct: 80  EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRR 139
Query: 109 -SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT 167
            S      K +  LH  +   ++HR+LK+ N+L+D +   K+ DFG++R+     +  ++
Sbjct: 140 LSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSS 196
Query: 168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC 205
               GT  +M+ E       + K+DV+ FGV++ ++  
Sbjct: 197 KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 2/80 (2%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           RVIHRDLK  N+ L+D ++ KI DFG+A    +   G     + GT  Y++ E       
Sbjct: 146 RVIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKDLCGTPNYIAPEVLCKKGH 203
Query: 188 SIKTDVFGFGVLVLKIVCGK 207
           S + D++  G ++  ++ GK
Sbjct: 204 SFEVDIWSLGCILYTLLVGK 223

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL--------DSSFSGTFKD 117
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L            S     
Sbjct: 53  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLL 112
Query: 118 LLCLHKYSRLR------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
            +     S +        IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF 172
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 173 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER 231
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 232 PEGCPEKVYELMRACWQ-WN 250

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/93 (29%), Positives = 49/93 (52%), Gaps = 2/93 (2%)
Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI 189
           IHRD+KA+N+LL +    K++DFG+A    + ++    N  VGT  +M+ E         
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 183
Query: 190 KTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
           K D++  G+  +++  G+  +   H  + L L+
Sbjct: 184 KADIWSLGITAIELARGEPPHSELHPMKVLFLI 216

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD----LLCL 121
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L        +     ++ L
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 122 HKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           +  +++            IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF 179
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 180 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 239 PEGCPEKVYELMRACWQ-WN 257

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 2/80 (2%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           RVIHRDLK  N+ L+D ++ KI DFG+A    +   G     + GT  Y++ E       
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKDLCGTPNYIAPEVLCKKGH 219
Query: 188 SIKTDVFGFGVLVLKIVCGK 207
           S + D++  G ++  ++ GK
Sbjct: 220 SFEVDIWSLGCILYTLLVGK 239

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 80/152 (52%), Gaps = 19/152 (12%)
Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSSFSG----TFKDLL-- 119
           E  ++ +L+++N+VKL    IH ++RL LV+E +     K LD    G    T K  L  
Sbjct: 50  EISILKELKHSNIVKLYDV-IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 120 ----CLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG 175
                 + + R RV+HRDLK  N+L++ +   KI+DFG+AR FG+      T+ IV T  
Sbjct: 109 LLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLW 165
Query: 176 YMSLEYTM-SGTVSIKTDVFGFGVLVLKIVCG 206
           Y + +  M S   S   D++  G +  ++V G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD----LLCL 121
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L        +     ++ L
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 122 HKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           +  +++            IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 180 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 239 PEGCPEKVYELMRACWQ-WN 257

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD----LLCL 121
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L        +     ++ L
Sbjct: 56  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLL 115
Query: 122 HKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           +  +++            IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 116 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF 175
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 176 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 234
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 235 PEGCPEKVYELMRACWQ-WN 253

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 125 SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG--TYGYMSLEYT 182
           + ++++HRDL A NIL+ +    KISDFG++R   V E  +   R  G     +M++E  
Sbjct: 167 AEMKLVHRDLAARNILVAEGRKMKISDFGLSR--DVYEEDSYVKRSQGRIPVKWMAIESL 224
Query: 183 MSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLV 222
                + ++DV+ FGVL+ +IV  G         ER  NL+
Sbjct: 225 FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL 265

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 31/214 (14%)
Query: 37  DRVILVGKF------------PNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLV 83
           DRVI  G F             N  + AIK L+  +   +VE F  E  L+  L + N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 84  KLLGCSI--------------HGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRV 129
            L+G  +              HG+    +     N ++    S   +    +   +  + 
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF 145
Query: 130 IHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESGANTNRIVG-TYGYMSLEYTMSGTV 187
           +HRDL A N +LD+    K++DFG+AR I          +R       + +LE   +   
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRF 205
Query: 188 SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNL 221
           + K+DV+ FGVL+ +++   +    Y    P +L
Sbjct: 206 TTKSDVWSFGVLLWELLT--RGAPPYRHIDPFDL 237

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL--------DSSFSGTFKD 117
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L            S     
Sbjct: 53  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 112
Query: 118 LLCLHKYSRLR------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
            +     S +        IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF 172
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 173 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER 231
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 232 PEGCPEKVYELMRACWQ-WN 250

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 94/213 (44%), Gaps = 40/213 (18%)
Query: 46  PNEQEVAIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN 104
           P +++VAIKR+     Q  + E   E + +++  + N+V      +  +E  LV + +  
Sbjct: 38  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97
Query: 105 KSL-------------------DSSFSGTFKDLL----CLHKYSRLRVIHRDLKASNILL 141
            S+                   +S+ +   +++L     LHK  +   IHRD+KA NILL
Sbjct: 98  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 154
Query: 142 DDQLNTKISDFGMARIFGVNESGANTNR------IVGTYGYMSLEYT-MSGTVSIKTDVF 194
            +  + +I+DFG++       +G +  R       VGT  +M+ E          K D++
Sbjct: 155 GEDGSVQIADFGVSAFLA---TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 211
Query: 195 GFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQ 227
            FG+  +++  G      YH   P+ ++ +  Q
Sbjct: 212 SFGITAIELATGA---APYHKYPPMKVLMLTLQ 241

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 60/105 (57%), Gaps = 15/105 (14%)
Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS-FSGTFKDLLCLHKY 124
           E  L+ +L + N+VKLL   IH E +L LV+E +     K +D+S  +G    L+  + +
Sbjct: 55  EISLLKELNHPNIVKLLDV-IHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLF 113
Query: 125 SRL---------RVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
             L         RV+HRDLK  N+L++ +   K++DFG+AR FGV
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 158

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD----LLCL 121
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L        +     ++ L
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 122 HKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           +  +++            IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 180 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 239 PEGCPEKVYELMRACWQ-WN 257

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD----LLCL 121
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L        +     ++ L
Sbjct: 59  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 118
Query: 122 HKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           +  +++            IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 119 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 179 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 237
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 238 PEGCPEKVYELMRACWQ-WN 256

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 94/213 (44%), Gaps = 40/213 (18%)
Query: 46  PNEQEVAIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN 104
           P +++VAIKR+     Q  + E   E + +++  + N+V      +  +E  LV + +  
Sbjct: 33  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 92
Query: 105 KSL-------------------DSSFSGTFKDLL----CLHKYSRLRVIHRDLKASNILL 141
            S+                   +S+ +   +++L     LHK  +   IHRD+KA NILL
Sbjct: 93  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 149
Query: 142 DDQLNTKISDFGMARIFGVNESGANTNR------IVGTYGYMSLEYT-MSGTVSIKTDVF 194
            +  + +I+DFG++       +G +  R       VGT  +M+ E          K D++
Sbjct: 150 GEDGSVQIADFGVSAFLA---TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 206
Query: 195 GFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQ 227
            FG+  +++  G      YH   P+ ++ +  Q
Sbjct: 207 SFGITAIELATGA---APYHKYPPMKVLMLTLQ 236

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD----LLCL 121
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L        +     ++ L
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 114
Query: 122 HKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           +  +++            IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 175 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 234 PEGCPEKVYELMRACWQ-WN 252

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 80/152 (52%), Gaps = 19/152 (12%)
Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSSFSG----TFKDLL-- 119
           E  ++ +L+++N+VKL    IH ++RL LV+E +     K LD    G    T K  L  
Sbjct: 50  EISILKELKHSNIVKLYDV-IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 120 ----CLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG 175
                 + + R RV+HRDLK  N+L++ +   KI+DFG+AR FG+      T+ +V T  
Sbjct: 109 LLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVV-TLW 165
Query: 176 YMSLEYTM-SGTVSIKTDVFGFGVLVLKIVCG 206
           Y + +  M S   S   D++  G +  ++V G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 80/152 (52%), Gaps = 19/152 (12%)
Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSSFSG----TFKDLL-- 119
           E  ++ +L+++N+VKL    IH ++RL LV+E +     K LD    G    T K  L  
Sbjct: 50  EISILKELKHSNIVKLYDV-IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 120 ----CLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG 175
                 + + R RV+HRDLK  N+L++ +   KI+DFG+AR FG+      T+ +V T  
Sbjct: 109 LLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVV-TLW 165
Query: 176 YMSLEYTM-SGTVSIKTDVFGFGVLVLKIVCG 206
           Y + +  M S   S   D++  G +  ++V G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/93 (29%), Positives = 49/93 (52%), Gaps = 2/93 (2%)
Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI 189
           IHRD+KA+N+LL +    K++DFG+A    + ++    N  VGT  +M+ E         
Sbjct: 146 IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 203
Query: 190 KTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
           K D++  G+  +++  G+  +   H  + L L+
Sbjct: 204 KADIWSLGITAIELARGEPPHSELHPMKVLFLI 236

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 91/189 (48%), Gaps = 42/189 (22%)
Query: 50  EVAIKRLAWTSGQGRVE-FQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYE------- 100
           +VA+K L  T+     E   +E K+++ L Q+ N+V LLG   HG   L++ E       
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 101 --FMPNKS----LDSSFS-----GTFKDLLCLHKYSRL----------RVIHRDLKASNI 139
             F+  KS     D +F+      + +DLL  H  S++            IHRD+ A N+
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTASTRDLL--HFSSQVAQGMAFLASKNCIHRDVAARNV 195
Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKTDVF 194
           LL +    KI DFG+AR   +N+S    N IV         +M+ E       ++++DV+
Sbjct: 196 LLTNGHVAKIGDFGLARDI-MNDS----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250
Query: 195 GFGVLVLKI 203
            +G+L+ +I
Sbjct: 251 SYGILLWEI 259

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 25/177 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL--- 107
           V + +   + G    + + EA +   L++ ++V+LL          +V+EFM    L   
Sbjct: 57  VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFE 116
Query: 108 -----DSSFSGTFKDLLCLHKYSRL----------RVIHRDLKASNILLDDQLNT---KI 149
                D+ F   + + +  H   ++           +IHRD+K  N+LL  + N+   K+
Sbjct: 117 IVKRADAGF--VYSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKL 174
Query: 150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            DFG+A   G  ESG      VGT  +M+ E           DV+G GV++  ++ G
Sbjct: 175 GDFGVAIQLG--ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 116 KDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG 175
           +D+  L    +  + HRD+K+ N+LL + L   I+DFG+A  F   +S  +T+  VGT  
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 176 YMSLEYTMSGTVSIKTDVF 194
           YM+ E  + G ++ + D F
Sbjct: 199 YMAPE-VLEGAINFQRDAF 216

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD----LLCL 121
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L        +     ++ L
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 114
Query: 122 HKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           +  +++            IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 175 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 234 PEGCPEKVYELMRACWQ-WN 252

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL--------DSSFSGTFKD 117
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L            S     
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 118 LLCLHKYSRLR------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
            +     S +        IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 175 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 234 PEGCPEKVYELMRACWQ-WN 252

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 30/185 (16%)
Query: 49  QEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYEF---- 101
           + VA+K L    T  + R        LI    + N+V LLG C+  G   +++ EF    
Sbjct: 59  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 118
Query: 102 -------------MPNKSLDSSFSG--TFKDLLC--------LHKYSRLRVIHRDLKASN 138
                        +P K+ +  +    T + L+C        +   +  + IHRDL A N
Sbjct: 119 NLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178
Query: 139 ILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGV 198
           ILL ++   KI DFG+AR    +              +M+ E       +I++DV+ FGV
Sbjct: 179 ILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 199 LVLKI 203
           L+ +I
Sbjct: 239 LLWEI 243

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL--------DSSFSGTFKD 117
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L            S     
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 118 LLCLHKYSRLR------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
            +     S +        IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 175 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 234 PEGCPEKVYELMRACWQ-WN 252

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD----LLCL 121
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L        +     ++ L
Sbjct: 57  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 116
Query: 122 HKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           +  +++            IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 176
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 177 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 235
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 236 PEGCPEKVYELMRACWQ-WN 254

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 78/189 (41%), Gaps = 27/189 (14%)
Query: 42  VGKFPNEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLV 98
           + K    + VA+K L    T  + R        LI    + N+V LLG C+  G   +++
Sbjct: 51  IDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110
Query: 99  YEFMPNKSLDS----------SFSGTFKDLLCLHKY--------------SRLRVIHRDL 134
            EF    +L +           +   +KD L L                 +  + IHRDL
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDL 170
Query: 135 KASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVF 194
            A NILL ++   KI DFG+AR    +              +M+ E       +I++DV+
Sbjct: 171 AARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 230
Query: 195 GFGVLVLKI 203
            FGVL+ +I
Sbjct: 231 SFGVLLWEI 239

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   K++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL--------DSSFSGTFKD 117
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L            S     
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 118 LLCLHKYSRLR------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
            +     S +        IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 175 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 234 PEGCPEKVYELMRACWQ-WN 252

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD----LLCL 121
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L        +     ++ L
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 122 HKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           +  +++            IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 180 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 239 PEGCPEKVYELMRACWQ-WN 257

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL--------DSSFSGTFKD 117
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L            S     
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 119
Query: 118 LLCLHKYSRLR------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
            +     S +        IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 180 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 239 PEGCPEKVYELMRACWQ-WN 257

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 38/187 (20%)
Query: 50  EVAIKRLAWTSGQGRVE-FQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYE------- 100
           +VA+K L  T+     E   +E K+++ L Q+ N+V LLG   HG   L++ E       
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 101 --FMPNKS----LDSSFS---GTFKDLLCLHKYSRL----------RVIHRDLKASNILL 141
             F+  KS     D +F+    T      LH  S++            IHRD+ A N+LL
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197
Query: 142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKTDVFGF 196
            +    KI DFG+AR   +N+S    N IV         +M+ E       ++++DV+ +
Sbjct: 198 TNGHVAKIGDFGLARDI-MNDS----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252
Query: 197 GVLVLKI 203
           G+L+ +I
Sbjct: 253 GILLWEI 259

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD----LLCL 121
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L        +     ++ L
Sbjct: 57  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 116
Query: 122 HKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           +  +++            IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 176
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 177 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 235
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 236 PEGCPEKVYELMRACWQ-WN 254

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL--------DSSFSGTFKD 117
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L            S     
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 118 LLCLHKYSRLR------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
            +     S +        IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 175 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 234 PEGCPEKVYELMRACWQ-WN 252

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 83/175 (47%), Gaps = 21/175 (12%)
Query: 49  QEVAIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNK 105
           ++VA+K L   SG   + + + E +++  L + N+VK  G C+  G   + L+ EF+P+ 
Sbjct: 51  EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 110
Query: 106 SLDSSFSGTFKDLLCLHKYSRLRV--------------IHRDLKASNILLDDQLNTKISD 151
           SL        K+ + L +  +  V              +HRDL A N+L++ +   KI D
Sbjct: 111 SLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGD 169
Query: 152 FGMARIFGVNESGANT--NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           FG+ +    ++       +R    + Y + E  M     I +DV+ FGV + +++
Sbjct: 170 FGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 83/175 (47%), Gaps = 21/175 (12%)
Query: 49  QEVAIKRLAWTSGQGRV-EFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPNK 105
           ++VA+K L   SG   + + + E +++  L + N+VK  G C+  G   + L+ EF+P+ 
Sbjct: 39  EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 98
Query: 106 SLDSSFSGTFKDLLCLHKYSRLRV--------------IHRDLKASNILLDDQLNTKISD 151
           SL        K+ + L +  +  V              +HRDL A N+L++ +   KI D
Sbjct: 99  SLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGD 157
Query: 152 FGMARIFGVNESGANT--NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           FG+ +    ++       +R    + Y + E  M     I +DV+ FGV + +++
Sbjct: 158 FGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTLHELL 211

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 125 SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG--TYGYMSLEYT 182
           + + ++HRDL A NIL+ +    KISDFG++R   V E  +   R  G     +M++E  
Sbjct: 167 AEMSLVHRDLAARNILVAEGRKMKISDFGLSR--DVYEEDSXVKRSQGRIPVKWMAIESL 224
Query: 183 MSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLV 222
                + ++DV+ FGVL+ +IV  G         ER  NL+
Sbjct: 225 FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL 265

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD----LLCL 121
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L        +     ++ L
Sbjct: 68  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 127
Query: 122 HKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           +  +++            IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 128 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 187
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 188 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 246
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 247 PEGCPEKVYELMRACWQ-WN 265

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN----------KSLDSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P              D   + T+
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY 118
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 174
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 85/179 (47%), Gaps = 25/179 (13%)
Query: 50  EVAIKRLAWTSG--QGRVEFQNEAKLIAKLQYTNLVKLLG----------------CSIH 91
           +VA+K L  T+   Q    F+NE  ++ K ++ N++  +G                 S++
Sbjct: 32  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLY 91
Query: 92  GEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISD 151
               ++  +F   K +D +   T + +  LH  S   +IHRDLK++NI L + L  KI D
Sbjct: 92  HHLHIIETKFEMIKLIDIA-RQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 147
Query: 152 FGMARIFGVNESGANTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGK 207
           FG+A             ++ G+  +M+ E          S ++DV+ FG+++ +++ G+
Sbjct: 148 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 139
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +  + + GT
Sbjct: 140 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGT 195
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN----------KSLDSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P              D   + T+
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY 118
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGT 174
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 21  NSSLDWHMYIQQEQTRDRV-------ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKL 73
           +SS DW +   Q     R+       +  GK+  +  V +  +   + Q    F+NE  +
Sbjct: 14  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 74  IAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL-------DSSFS---------GTFKD 117
           + K ++ N++  +G S    +  +V ++    SL       ++ F           T + 
Sbjct: 74  LRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           +  LH  S   +IHRDLK++NI L +    KI DFG+A             ++ G+  +M
Sbjct: 133 MDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 178 SLEYTM---SGTVSIKTDVFGFGVLVLKIVCGK 207
           + E      S   S ++DV+ FG+++ +++ G+
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 37/200 (18%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL--------DSSFSGTFKD 117
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L            S     
Sbjct: 53  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 112
Query: 118 LLCLHKYSRLR------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
            +     S +        IHRDL A N L+ +    K++DFG++R+   +   A+     
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF 172
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYHTER 217
               + + E       SIK+DV+ FGVL+ +I     +               K Y  ER
Sbjct: 173 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER 231
Query: 218 P-------LNLVGIAWQLWN 230
           P         L+   WQ WN
Sbjct: 232 PEGCPEKVYELMRACWQ-WN 250

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGT 169
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 77/191 (40%), Gaps = 29/191 (15%)
Query: 42  VGKFPNEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLV 98
           + K    + VA+K L    T  + R        LI    + N+V LLG C+  G   +++
Sbjct: 53  IDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 112
Query: 99  YEFMPNKSLDSSFSGT------------FKDLLCLHKY--------------SRLRVIHR 132
            EF    +L +                 +KD L L                 +  + IHR
Sbjct: 113 VEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHR 172
Query: 133 DLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTD 192
           DL A NILL ++   KI DFG+AR    +              +M+ E       +I++D
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSD 232
Query: 193 VFGFGVLVLKI 203
           V+ FGVL+ +I
Sbjct: 233 VWSFGVLLWEI 243

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 75/156 (48%), Gaps = 24/156 (15%)
Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYE--------FM--------PNKSLDSSFS 112
           E  L+ +L + N+VKLL   IH E +L LV+E        FM        P   + S   
Sbjct: 51  EISLLKELNHPNIVKLLDV-IHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLF 109
Query: 113 GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG 172
              + L   H +   RV+HRDLK  N+L++ +   K++DFG+AR FGV      T+ +V 
Sbjct: 110 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV- 164
Query: 173 TYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGK 207
           T  Y + E  +     S   D++  G +  ++V  +
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 139
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 140 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 195
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E+ P   + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+++D Q   K++DFG+A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 84/203 (41%), Gaps = 43/203 (21%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD----LLCL 121
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L        +     ++ L
Sbjct: 56  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 115
Query: 122 HKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           +  +++            IHRDL A N L+ +    K++DFG++R+     +G       
Sbjct: 116 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAPA 171
Query: 172 GT---YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYH 214
           G      + + E       SIK+DV+ FGVL+ +I     +               K Y 
Sbjct: 172 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 231
Query: 215 TERP-------LNLVGIAWQLWN 230
            ERP         L+   WQ WN
Sbjct: 232 MERPEGCPEKVYELMRACWQ-WN 253

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 114
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +  + + GT
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGT 170
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 84/203 (41%), Gaps = 43/203 (21%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKD----LLCL 121
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L        +     ++ L
Sbjct: 57  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 116
Query: 122 HKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           +  +++            IHRDL A N L+ +    K++DFG++R+     +G       
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAPA 172
Query: 172 GT---YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN--------------NKSYH 214
           G      + + E       SIK+DV+ FGVL+ +I     +               K Y 
Sbjct: 173 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 232
Query: 215 TERP-------LNLVGIAWQLWN 230
            ERP         L+   WQ WN
Sbjct: 233 MERPEGCPEKVYELMRACWQ-WN 254

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +  + + GT
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGT 172
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 169
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 53  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 112
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 113 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 168
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 169 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGT 169
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 172
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 85/179 (47%), Gaps = 25/179 (13%)
Query: 50  EVAIKRLAWTSG--QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           +VA+K L  T+   Q    F+NE  ++ K ++ N++  +G S    +  +V ++    SL
Sbjct: 48  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSL 106
Query: 108 -------DSSFS---------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISD 151
                  ++ F           T + +  LH  S   +IHRDLK++NI L +    KI D
Sbjct: 107 YHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGD 163
Query: 152 FGMARIFGVNESGANTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGK 207
           FG+A             ++ G+  +M+ E      S   S ++DV+ FG+++ +++ G+
Sbjct: 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 71  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 130
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 131 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 186
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 187 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 87/188 (46%), Gaps = 31/188 (16%)
Query: 38  RVILVGKFPNEQEVAIK-----RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG 92
           R +L G+     EVA+K     +L  TS Q   +   E +++  L + N+VKL    I  
Sbjct: 35  RHVLTGR-----EVAVKIIDKTQLNPTSLQ---KLFREVRIMKILNHPNIVKLFEV-IET 85
Query: 93  EERL-LVYEFMPNKSL-----------DSSFSGTFKDLLCLHKYSRLR-VIHRDLKASNI 139
           E+ L LV E+     +           +      F+ ++   +Y   + ++HRDLKA N+
Sbjct: 86  EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENL 145
Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE-YTMSGTVSIKTDVFGFGV 198
           LLD  +N KI+DFG +  F V   G   +   G+  Y + E +        + DV+  GV
Sbjct: 146 LLDGDMNIKIADFGFSNEFTV---GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGV 202
Query: 199 LVLKIVCG 206
           ++  +V G
Sbjct: 203 ILYTLVSG 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGT 169
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 118
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 174
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 175 LDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 118
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 174
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGT 169
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LHK     +I+RDLK  N++LD + + KI+DFGM +   ++  G  T    GT  Y+
Sbjct: 133 LFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD--GVTTREFCGTPDYI 187
Query: 178 SLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E           D + +GVL+ +++ G+
Sbjct: 188 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 75/186 (40%), Gaps = 31/186 (16%)
Query: 49  QEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYEFMPNK 105
           + VA+K L    T  + R        LI    + N+V LLG C+  G   +++ EF    
Sbjct: 58  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 106 SLDSSFSGT--------------FKDLLCLHKY--------------SRLRVIHRDLKAS 137
           +L +                   +KD L L                 +  + IHRDL A 
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177
Query: 138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFG 197
           NILL ++   KI DFG+AR    +              +M+ E       +I++DV+ FG
Sbjct: 178 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 198 VLVLKI 203
           VL+ +I
Sbjct: 238 VLLWEI 243

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 83  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 142
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 143 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 197
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 198 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 56  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 115
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 116 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGT 171
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 22/173 (12%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS---- 106
            A K +   S +   ++  E +++A   +  +VKLLG   H  +  ++ EF P  +    
Sbjct: 39  AAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAI 98
Query: 107 ---LDSSFSGTFKDLLCLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMARI 157
              LD   +     ++C      L      R+IHRDLKA N+L+  + + +++DFG++  
Sbjct: 99  MLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS-- 156
Query: 158 FGVN-ESGANTNRIVGTYGYMSLEYTMSGTV-----SIKTDVFGFGVLVLKIV 204
              N ++    +  +GT  +M+ E  M  T+       K D++  G+ ++++ 
Sbjct: 157 -AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 208

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E+ P   + S     G F +         
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+++D Q   K++DFG A+          T  + GT  Y
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 76  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 135
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 136 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEY 190
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 191 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E+ P   + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+++D Q   K++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E+ P   + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+++D Q   K++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 83  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ 142
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 143 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 197
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 198 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 172
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ 150
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 74/154 (48%), Gaps = 22/154 (14%)
Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS-------LDSSFSGTFKDLLCLH 122
           E +++A   +  +VKLLG   H  +  ++ EF P  +       LD   +     ++C  
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 125
Query: 123 KYSRL------RVIHRDLKASNILLDDQLNTKISDFGMARIFGVN-ESGANTNRIVGTYG 175
               L      R+IHRDLKA N+L+  + + +++DFG++     N ++    +  +GT  
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQKRDSFIGTPY 182
Query: 176 YMSLEYTMSGTV-----SIKTDVFGFGVLVLKIV 204
           +M+ E  M  T+       K D++  G+ ++++ 
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 114
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGT 170
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGT 172
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 85/196 (43%), Gaps = 26/196 (13%)
Query: 50  EVAIK----RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK 105
           EVAIK    +  + +G  +   QNE K+  +L++ ++++L           LV E   N 
Sbjct: 38  EVAIKMIDKKAMYKAGMVQ-RVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNG 96
Query: 106 SLDSSFSGTFK----------------DLLCLHKYSRLRVIHRDLKASNILLDDQLNTKI 149
            ++       K                 +L LH +    ++HRDL  SN+LL   +N KI
Sbjct: 97  EMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKI 153
Query: 150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN 209
           +DFG+A    +      T  + GT  Y+S E        +++DV+  G +   ++ G+  
Sbjct: 154 ADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
Query: 210 NKSYHTERPLNLVGIA 225
             +   +  LN V +A
Sbjct: 212 FDTDTVKNTLNKVVLA 227

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGT 169
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEY 205
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 118
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGT 174
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 51  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 110
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 111 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 166
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 167 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++P   + S     G F +         
Sbjct: 111 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 170
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 171 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 225
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 117
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 118 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGT 173
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGT 169
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 25/185 (13%)
Query: 38  RVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER 95
           R IL GK     EVA+K +  T  +     +   E +++  L + N+VKL    I  E+ 
Sbjct: 34  RHILTGK-----EVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV-IETEKT 87
Query: 96  L-LVYEFMPNKSL-----------DSSFSGTFKDLLCLHKYSRLR-VIHRDLKASNILLD 142
           L LV E+     +           +      F+ ++   +Y   + ++HRDLKA N+LLD
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE-YTMSGTVSIKTDVFGFGVLVL 201
             +N KI+DFG +  F     G   +   G+  Y + E +        + DV+  GV++ 
Sbjct: 148 ADMNIKIADFGFSNEFTF---GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 202 KIVCG 206
            +V G
Sbjct: 205 TLVSG 209

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 47/84 (55%), Gaps = 2/84 (2%)
Query: 124 YSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM 183
           +S   V++RDLK  N++LD   + KI+DFG+ +  G+ + GA      GT  Y++ E   
Sbjct: 268 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKTFCGTPEYLAPEVLE 325
Query: 184 SGTVSIKTDVFGFGVLVLKIVCGK 207
                   D +G GV++ +++CG+
Sbjct: 326 DNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 34/183 (18%)
Query: 50  EVAIKRLAWTSGQGRVE-FQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYE------- 100
           +VA+K L  T+     E   +E K+++ L Q+ N+V LLG   HG   L++ E       
Sbjct: 70  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 129
Query: 101 --FMPNKS---LDSSFSGTFKDLLCLHKYSRL----------RVIHRDLKASNILLDDQL 145
             F+  K+   LD       +    LH  S++            IHRD+ A N+LL +  
Sbjct: 130 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 189
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKTDVFGFGVLV 200
             KI DFG+AR   +N+S    N IV         +M+ E       ++++DV+ +G+L+
Sbjct: 190 VAKIGDFGLARDI-MNDS----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 244
Query: 201 LKI 203
            +I
Sbjct: 245 WEI 247

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 25/185 (13%)
Query: 38  RVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER 95
           R IL GK     EVA+K +  T  +     +   E +++  L + N+VKL    I  E+ 
Sbjct: 34  RHILTGK-----EVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV-IETEKT 87
Query: 96  L-LVYEFMPNKSL-----------DSSFSGTFKDLLCLHKYSRLR-VIHRDLKASNILLD 142
           L LV E+     +           +      F+ ++   +Y   + ++HRDLKA N+LLD
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE-YTMSGTVSIKTDVFGFGVLVL 201
             +N KI+DFG +  F     G   +   G+  Y + E +        + DV+  GV++ 
Sbjct: 148 ADMNIKIADFGFSNEFTF---GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 202 KIVCG 206
            +V G
Sbjct: 205 TLVSG 209

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 47/84 (55%), Gaps = 2/84 (2%)
Query: 124 YSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM 183
           +S   V++RDLK  N++LD   + KI+DFG+ +  G+ + GA      GT  Y++ E   
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKTFCGTPEYLAPEVLE 322
Query: 184 SGTVSIKTDVFGFGVLVLKIVCGK 207
                   D +G GV++ +++CG+
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGT 172
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 83/187 (44%), Gaps = 27/187 (14%)
Query: 51  VAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGC-SIHGEERL-LVYEFMPNKSL 107
           VA+K L    G Q R  +Q E +++  L + ++VK  GC    GE+ + LV E++P  SL
Sbjct: 40  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL 99
Query: 108 DSSFSGT---------FKDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
                           F   +C  +        IHR L A N+LLD+    KI DFG+A+
Sbjct: 100 RDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAK 159
Query: 157 I-------FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN 209
                   + V E G +         + + E          +DV+ FGV + +++    +
Sbjct: 160 AVPEGHEYYRVREDGDS------PVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDS 213
Query: 210 NKSYHTE 216
           N+S HT+
Sbjct: 214 NQSPHTK 220

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 83/187 (44%), Gaps = 27/187 (14%)
Query: 51  VAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGC-SIHGEERL-LVYEFMPNKSL 107
           VA+K L    G Q R  +Q E +++  L + ++VK  GC    GE+ + LV E++P  SL
Sbjct: 41  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL 100
Query: 108 DSSFSGT---------FKDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
                           F   +C  +        IHR L A N+LLD+    KI DFG+A+
Sbjct: 101 RDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAK 160
Query: 157 I-------FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN 209
                   + V E G +         + + E          +DV+ FGV + +++    +
Sbjct: 161 AVPEGHEYYRVREDGDS------PVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDS 214
Query: 210 NKSYHTE 216
           N+S HT+
Sbjct: 215 NQSPHTK 221

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 34/183 (18%)
Query: 50  EVAIKRLAWTSGQGRVE-FQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYE------- 100
           +VA+K L  T+     E   +E K+++ L Q+ N+V LLG   HG   L++ E       
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 101 --FMPNKS---LDSSFSGTFKDLLCLHKYSRL----------RVIHRDLKASNILLDDQL 145
             F+  K+   LD       +    LH  S++            IHRD+ A N+LL +  
Sbjct: 138 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 197
Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKTDVFGFGVLV 200
             KI DFG+AR   +N+S    N IV         +M+ E       ++++DV+ +G+L+
Sbjct: 198 VAKIGDFGLARDI-MNDS----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 252
Query: 201 LKI 203
            +I
Sbjct: 253 WEI 255

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 75/186 (40%), Gaps = 31/186 (16%)
Query: 49  QEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYEFMPNK 105
           + VA+K L    T  + R        LI    + N+V LLG C+  G   +++ EF    
Sbjct: 58  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 106 SLDSSFSGT--------------FKDLLCLHKY--------------SRLRVIHRDLKAS 137
           +L +                   +KD L L                 +  + IHRDL A 
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177
Query: 138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFG 197
           NILL ++   KI DFG+AR    +              +M+ E       +I++DV+ FG
Sbjct: 178 NILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 198 VLVLKI 203
           VL+ +I
Sbjct: 238 VLLWEI 243

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 75/186 (40%), Gaps = 31/186 (16%)
Query: 49  QEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYEFMPNK 105
           + VA+K L    T  + R        LI    + N+V LLG C+  G   +++ EF    
Sbjct: 49  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 108
Query: 106 SLDSSFSGT--------------FKDLLCLHKY--------------SRLRVIHRDLKAS 137
           +L +                   +KD L L                 +  + IHRDL A 
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 168
Query: 138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFG 197
           NILL ++   KI DFG+AR    +              +M+ E       +I++DV+ FG
Sbjct: 169 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 228
Query: 198 VLVLKI 203
           VL+ +I
Sbjct: 229 VLLWEI 234

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 61  GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP----------NKSLDSS 110
           G+ R E QN    +   ++ +++KL        +  +V E++           N  LD  
Sbjct: 61  GKIRREIQN----LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK 116
Query: 111 FSGT-FKDLLCLHKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTN 168
            S   F+ +L    Y  R  V+HRDLK  N+LLD  +N KI+DFG++ +      G    
Sbjct: 117 ESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLR 173
Query: 169 RIVGTYGYMSLEYTMSGTV--SIKTDVFGFGVLVLKIVCG 206
              G+  Y + E  +SG +    + D++  GV++  ++CG
Sbjct: 174 XSCGSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 25/185 (13%)
Query: 38  RVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER 95
           R IL GK     EVA+K +  T  +     +   E +++  L + N+VKL    I  E+ 
Sbjct: 27  RHILTGK-----EVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV-IETEKT 80
Query: 96  L-LVYEFMPNKSL-----------DSSFSGTFKDLLCLHKYSRLR-VIHRDLKASNILLD 142
           L LV E+     +           +      F+ ++   +Y   + ++HRDLKA N+LLD
Sbjct: 81  LYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 140
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE-YTMSGTVSIKTDVFGFGVLVL 201
             +N KI+DFG +  F     G   +   G+  Y + E +        + DV+  GV++ 
Sbjct: 141 ADMNIKIADFGFSNEFTF---GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 197
Query: 202 KIVCG 206
            +V G
Sbjct: 198 TLVSG 202

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E+ P   + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+++D Q   +++DFG+A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 114 TFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA 165
           TFKDL+ C ++ +R        + IHRDL A N+L+ +    KI+DFG+AR     +   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           NT        +M+ E       + ++DV+ FGVL+ +I
Sbjct: 215 NTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 25/185 (13%)
Query: 38  RVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER 95
           R IL GK     EVA++ +  T  +     +   E +++  L + N+VKL    I  E+ 
Sbjct: 34  RHILTGK-----EVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV-IETEKT 87
Query: 96  L-LVYEFMPNKSL-----------DSSFSGTFKDLLCLHKYSRLR-VIHRDLKASNILLD 142
           L LV E+     +           +      F+ ++   +Y   + ++HRDLKA N+LLD
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE-YTMSGTVSIKTDVFGFGVLVL 201
             +N KI+DFG +  F     G   +   G+  Y + E +        + DV+  GV++ 
Sbjct: 148 ADMNIKIADFGFSNEFTF---GNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 202 KIVCG 206
            +V G
Sbjct: 205 TLVSG 209

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 83/185 (44%), Gaps = 25/185 (13%)
Query: 38  RVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER 95
           R IL GK     EVA+K +  T  +     +   E +++  L + N+VKL    I  E+ 
Sbjct: 34  RHILTGK-----EVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV-IETEKT 87
Query: 96  L-LVYEFMPNKSL-----------DSSFSGTFKDLLCLHKYSRLR-VIHRDLKASNILLD 142
           L LV E+     +           +      F+ ++   +Y   + ++HRDLKA N+LLD
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE-YTMSGTVSIKTDVFGFGVLVL 201
             +N KI+DFG +  F     G   +   G   Y + E +        + DV+  GV++ 
Sbjct: 148 ADMNIKIADFGFSNEFTF---GNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 202 KIVCG 206
            +V G
Sbjct: 205 TLVSG 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 47/84 (55%), Gaps = 2/84 (2%)
Query: 124 YSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM 183
           +S   V++RDLK  N++LD   + KI+DFG+ +  G+ + GA      GT  Y++ E   
Sbjct: 127 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKXFCGTPEYLAPEVLE 184
Query: 184 SGTVSIKTDVFGFGVLVLKIVCGK 207
                   D +G GV++ +++CG+
Sbjct: 185 DNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 30/197 (15%)
Query: 51  VAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGC-SIHGEERL-LVYEFMPNKSL 107
           VA+K L    G Q R  ++ E  ++  L + +++K  GC    GE+ L LV E++P  SL
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 108 DSSFSGT---------FKDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
                           F   +C  +        IHR+L A N+LLD+    KI DFG+A+
Sbjct: 106 RDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165
Query: 157 I-------FGVNESGANTNRIVGTYGYMSL-EYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
                   + V E G +    V  Y    L EY         +DV+ FGV + +++    
Sbjct: 166 AVPEGHEYYRVREDGDSP---VFWYAPECLKEYKF----YYASDVWSFGVTLYELLTHCD 218
Query: 209 NNKSYHTERPLNLVGIA 225
           +++S  T + L L+GIA
Sbjct: 219 SSQSPPT-KFLELIGIA 234

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 75/186 (40%), Gaps = 31/186 (16%)
Query: 49  QEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYEFMPNK 105
           + VA+K L    T  + R        LI    + N+V LLG C+  G   +++ EF    
Sbjct: 49  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 106 SLDSSFSGT--------------FKDLLCLHKY--------------SRLRVIHRDLKAS 137
           +L +                   +KD L L                 +  + IHRDL A 
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 168
Query: 138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFG 197
           NILL ++   KI DFG+AR    +              +M+ E       +I++DV+ FG
Sbjct: 169 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 228
Query: 198 VLVLKI 203
           VL+ +I
Sbjct: 229 VLLWEI 234

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 64/150 (42%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE ++   + +  LVKL           +V E+ P   + S     G F +         
Sbjct: 91  NEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   K++DFG A+          T  + GT  Y
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEY 205
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 31/222 (13%)
Query: 50  EVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           +VAIK L   + +   E    EA+++ +L    +V+L+G     E  +LV E      L 
Sbjct: 39  DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLH 97
Query: 109 SSFSGTFKDLLC------LHKYS-------RLRVIHRDLKASNILLDDQLNTKISDFGMA 155
               G  +++        LH+ S           +HRDL A N+LL ++   KISDFG++
Sbjct: 98  KFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
Query: 156 RIFGVNESGANTNRIVGTY--GYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKS 212
           +  G ++S   T R  G +   + + E       S ++DV+ +GV + + +  G+K  K 
Sbjct: 158 KALGADDS-YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216
Query: 213 YHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFL 254
                 +  +        +GK +E         CPP   A +
Sbjct: 217 MKGPEVMAFI-------EQGKRME-----CPPECPPELYALM 246

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 2/88 (2%)
Query: 119 LCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMS 178
           L L     L +I+RDLK  NILLD++ + K++DFG+++    +E  A +    GT  YM+
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMA 194
Query: 179 LEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            E       +   D + FGVL+ +++ G
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 47/84 (55%), Gaps = 2/84 (2%)
Query: 124 YSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM 183
           +S   V++RDLK  N++LD   + KI+DFG+ +  G+ + GA      GT  Y++ E   
Sbjct: 125 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKXFCGTPEYLAPEVLE 182
Query: 184 SGTVSIKTDVFGFGVLVLKIVCGK 207
                   D +G GV++ +++CG+
Sbjct: 183 DNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 47/84 (55%), Gaps = 2/84 (2%)
Query: 124 YSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM 183
           +S   V++RDLK  N++LD   + KI+DFG+ +  G+ + GA      GT  Y++ E   
Sbjct: 126 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKXFCGTPEYLAPEVLE 183
Query: 184 SGTVSIKTDVFGFGVLVLKIVCGK 207
                   D +G GV++ +++CG+
Sbjct: 184 DNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 30/197 (15%)
Query: 51  VAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGC-SIHGEERL-LVYEFMPNKSL 107
           VA+K L    G Q R  ++ E  ++  L + +++K  GC    GE+ L LV E++P  SL
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 108 DSSFSGT---------FKDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
                           F   +C  +        IHR+L A N+LLD+    KI DFG+A+
Sbjct: 106 RDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165
Query: 157 I-------FGVNESGANTNRIVGTYGYMSL-EYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
                   + V E G +    V  Y    L EY         +DV+ FGV + +++    
Sbjct: 166 AVPEGHEYYRVREDGDSP---VFWYAPECLKEYKF----YYASDVWSFGVTLYELLTHCD 218
Query: 209 NNKSYHTERPLNLVGIA 225
           +++S  T + L L+GIA
Sbjct: 219 SSQSPPT-KFLELIGIA 234

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 48/193 (24%)
Query: 50  EVAIKRLAWTSGQGRVE-FQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLV--------- 98
           +VA+K L  T+     E   +E K+++ L Q+ N+V LLG   HG   L++         
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 99  -------------YEFMPNKSLDSSFSGTFKDLLCLHKYSRL----------RVIHRDLK 135
                        Y + P+ + +   S   +DLL  H  S++            IHRD+ 
Sbjct: 138 LNFLRRKRPPGLEYSYNPSHNPEEQLSS--RDLL--HFSSQVAQGMAFLASKNCIHRDVA 193
Query: 136 ASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIK 190
           A N+LL +    KI DFG+AR   +N+S    N IV         +M+ E       +++
Sbjct: 194 ARNVLLTNGHVAKIGDFGLARDI-MNDS----NYIVKGNARLPVKWMAPESIFDCVYTVQ 248
Query: 191 TDVFGFGVLVLKI 203
           +DV+ +G+L+ +I
Sbjct: 249 SDVWSYGILLWEI 261

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 24/158 (15%)
Query: 67  FQNEAKLIAKLQYTNLVKL-------------LGCSIHGE--ERLLVYEFMPNKSLDSSF 111
            +NE  ++ K+++ N+V L             +     GE  +R++   F   K   +  
Sbjct: 67  IENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLI 126
Query: 112 SGTFKDLLCLHKYSRLRVIHRDLKASNILL---DDQLNTKISDFGMARIFGVNESGANTN 168
                 +  LH   R+ ++HRDLK  N+L    D++    ISDFG++++ G    G   +
Sbjct: 127 RQVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEG---KGDVMS 180
Query: 169 RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
              GT GY++ E       S   D +  GV+   ++CG
Sbjct: 181 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 75/186 (40%), Gaps = 31/186 (16%)
Query: 49  QEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYEFMPNK 105
           + VA+K L    T  + R        LI    + N+V LLG C+  G   +++ EF    
Sbjct: 58  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 106 SLDSSFSGT--------------FKDLLCLHKY--------------SRLRVIHRDLKAS 137
           +L +                   +KD L L                 +  + IHRDL A 
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177
Query: 138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFG 197
           NILL ++   KI DFG+AR    +              +M+ E       +I++DV+ FG
Sbjct: 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 198 VLVLKI 203
           VL+ +I
Sbjct: 238 VLLWEI 243

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E+ P   + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+++D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 25/185 (13%)
Query: 38  RVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER 95
           R IL GK     EVA++ +  T  +     +   E +++  L + N+VKL    I  E+ 
Sbjct: 34  RHILTGK-----EVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV-IETEKT 87
Query: 96  L-LVYEFMPNKSL-----------DSSFSGTFKDLLCLHKYSRLR-VIHRDLKASNILLD 142
           L LV E+     +           +      F+ ++   +Y   + ++HRDLKA N+LLD
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE-YTMSGTVSIKTDVFGFGVLVL 201
             +N KI+DFG +  F     G   +   G+  Y + E +        + DV+  GV++ 
Sbjct: 148 ADMNIKIADFGFSNEFTF---GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 202 KIVCG 206
            +V G
Sbjct: 205 TLVSG 209

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 77/187 (41%), Gaps = 40/187 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           E+ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P KSL
Sbjct: 43  ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSL 92
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 93  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 152
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 153 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIM 209
Query: 201 LKIVCGK 207
            ++VC K
Sbjct: 210 GEMVCHK 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 77/187 (41%), Gaps = 40/187 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           E+ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P KSL
Sbjct: 54  ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSL 103
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 104 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 163
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 164 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIM 220
Query: 201 LKIVCGK 207
            ++VC K
Sbjct: 221 GEMVCHK 227

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 74/184 (40%), Gaps = 31/184 (16%)
Query: 51  VAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYEFMPNKSL 107
           VA+K L    T  + R        LI    + N+V LLG C+  G   +++ EF    +L
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 108 DSSFSGT--------------FKDLLCLHKY--------------SRLRVIHRDLKASNI 139
            +                   +KD L L                 +  + IHRDL A NI
Sbjct: 122 STYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 181
Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
           LL ++   KI DFG+AR    +              +M+ E       +I++DV+ FGVL
Sbjct: 182 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 241
Query: 200 VLKI 203
           + +I
Sbjct: 242 LWEI 245

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 114 TFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESG 164
           TFKDL+ C ++ +R        + IHRDL A N+L+ +    KI+DFG+AR I  ++   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 215 KTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 2/88 (2%)
Query: 119 LCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMS 178
           L L     L +I+RDLK  NILLD++ + K++DFG+++    +E  A +    GT  YM+
Sbjct: 138 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMA 195
Query: 179 LEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            E       +   D + FGVL+ +++ G
Sbjct: 196 PEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 2/94 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           V++RD+K  N++LD   + KI+DFG+ +  G+++ GA      GT  Y++ E        
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 189 IKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
              D +G GV++ +++CG+    +   ER   L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 68/154 (44%), Gaps = 15/154 (9%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLL------ 119
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L        +  +      
Sbjct: 301 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 360
Query: 120 --------CLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
                    +    +   IHR+L A N L+ +    K++DFG++R+   +   A+     
Sbjct: 361 YMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 420
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC 205
               + + E       SIK+DV+ FGVL+ +I  
Sbjct: 421 -PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 16/153 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY 117
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +  + + GT
Sbjct: 118 ITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGT 173
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
             Y+  E         K D++  GVL  + + G
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 2/94 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           V++RD+K  N++LD   + KI+DFG+ +  G+++ GA      GT  Y++ E        
Sbjct: 131 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKXFCGTPEYLAPEVLEDNDYG 188
Query: 189 IKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
              D +G GV++ +++CG+    +   ER   L+
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 222

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 68/154 (44%), Gaps = 15/154 (9%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL--------DSSFSGTFKD 117
           EF  EA ++ ++++ NLV+LLG         ++ EFM   +L            S     
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 321
Query: 118 LLCLHKYSRLR------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
            +     S +        IHR+L A N L+ +    K++DFG++R+   +   A+     
Sbjct: 322 YMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 381
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC 205
               + + E       SIK+DV+ FGVL+ +I  
Sbjct: 382 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 114 TFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESG 164
           TFKDL+ C ++ +R        + IHRDL A N+L+ +    KI+DFG+AR I  ++   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 215 KTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 2/88 (2%)
Query: 119 LCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMS 178
           L L     L +I+RDLK  NILLD++ + K++DFG+++    +E  A +    GT  YM+
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMA 194
Query: 179 LEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            E       +   D + FGVL+ +++ G
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 25/159 (15%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL-----------DSSFSGT 114
           E  NE  L+  L + N++KL       +   LV EF     L           +   +  
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151
Query: 115 FKDLLC----LHKYSRLRVIHRDLKASNILLDDQ---LNTKISDFGMARIFGVNESGANT 167
            K +L     LHK++   ++HRD+K  NILL+++   LN KI DFG++  F  +    + 
Sbjct: 152 MKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208
Query: 168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
              +GT  Y++ E  +    + K DV+  GV++  ++CG
Sbjct: 209 ---LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 23/158 (14%)
Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYS 125
           FQ E++L   ++Y N   L+    H + +R L  E     S + S        L L+   
Sbjct: 79  FQTESRLFFVIEYVNGGDLM---FHMQRQRKLPEEHARFYSAEIS--------LALNYLH 127
Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
              +I+RDLK  N+LLD + + K++D+GM +  G+   G  T+   GT  Y++ E     
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLR-PGDTTSXFCGTPNYIAPEILRGE 185
Query: 186 TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVG 223
                 D +  GVL+ +++ G+          P ++VG
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRS---------PFDIVG 214

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 64/150 (42%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  L KL           +V E+ P   + S     G F +         
Sbjct: 91  NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+++D Q   K++DFG A+          T  + GT  Y
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 23/158 (14%)
Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYS 125
           FQ E++L   ++Y N   L+    H + +R L  E     S + S        L L+   
Sbjct: 122 FQTESRLFFVIEYVNGGDLM---FHMQRQRKLPEEHARFYSAEIS--------LALNYLH 170
Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
              +I+RDLK  N+LLD + + K++D+GM +  G+   G  T+   GT  Y++ E     
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLR-PGDTTSTFCGTPNYIAPEILRGE 228
Query: 186 TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVG 223
                 D +  GVL+ +++ G+          P ++VG
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRS---------PFDIVG 257

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 11/85 (12%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM-------SLEY 181
           ++HRDLK  NILLDD +  ++SDFG +      E G     + GT GY+       S++ 
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHL---EPGEKLRELCGTPGYLAPEILKCSMDE 277
Query: 182 TMSGTVSIKTDVFGFGVLVLKIVCG 206
           T  G    + D++  GV++  ++ G
Sbjct: 278 THPG-YGKEVDLWACGVILFTLLAG 301

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 89/197 (45%), Gaps = 30/197 (15%)
Query: 51  VAIKRLAWTSG-QGRVEFQNEAKLIAKLQYTNLVKLLGC-SIHGEERL-LVYEFMPNKSL 107
           VA+K L   +G Q R  ++ E  ++  L + +++K  GC    G   L LV E++P  SL
Sbjct: 63  VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
Query: 108 DSSFSGT---------FKDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR 156
                           F   +C  +        IHRDL A N+LLD+    KI DFG+A+
Sbjct: 123 RDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182
Query: 157 I-------FGVNESGANTNRIVGTYGYMSL-EYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
                   + V E G   +  V  Y    L EY         +DV+ FGV + +++    
Sbjct: 183 AVPEGHEXYRVREDG---DSPVFWYAPECLKEYKF----YYASDVWSFGVTLYELLTHCD 235
Query: 209 NNKSYHTERPLNLVGIA 225
           +++S  T + L L+GIA
Sbjct: 236 SSQSPPT-KFLELIGIA 251

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 64/150 (42%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  L KL           +V E+ P   + S     G F +         
Sbjct: 91  NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+++D Q   K++DFG A+          T  + GT  Y
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 23/158 (14%)
Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYS 125
           FQ E++L   ++Y N   L+    H + +R L  E     S + S        L L+   
Sbjct: 75  FQTESRLFFVIEYVNGGDLM---FHMQRQRKLPEEHARFYSAEIS--------LALNYLH 123
Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
              +I+RDLK  N+LLD + + K++D+GM +  G+   G  T+   GT  Y++ E     
Sbjct: 124 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLR-PGDTTSXFCGTPNYIAPEILRGE 181
Query: 186 TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVG 223
                 D +  GVL+ +++ G+          P ++VG
Sbjct: 182 DYGFSVDWWALGVLMFEMMAGRS---------PFDIVG 210

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 64/150 (42%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  L KL           +V E+ P   + S     G F +         
Sbjct: 91  NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQ 150
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+++D Q   K++DFG A+          T  + GT  Y
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 56  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 115
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI++FG    + V+   +    + GT
Sbjct: 116 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGT 171
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 85/178 (47%), Gaps = 28/178 (15%)
Query: 49  QEVAIKRLAW------TSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           Q VAIK++          G  R   + E KL+ +L + N++ LL    H     LV++FM
Sbjct: 36  QIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94
Query: 103 PN---------------KSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNT 147
                              + +    T + L  LH++    ++HRDLK +N+LLD+    
Sbjct: 95  ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVL 151
Query: 148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIV 204
           K++DFG+A+ FG + + A  +++V T  Y + E      +  +  D++  G ++ +++
Sbjct: 152 KLADFGLAKSFG-SPNRAYXHQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 23/158 (14%)
Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYS 125
           FQ E++L   ++Y N   L+    H + +R L  E     S + S        L L+   
Sbjct: 90  FQTESRLFFVIEYVNGGDLM---FHMQRQRKLPEEHARFYSAEIS--------LALNYLH 138
Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
              +I+RDLK  N+LLD + + K++D+GM +  G+   G  T+   GT  Y++ E     
Sbjct: 139 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLR-PGDTTSXFCGTPNYIAPEILRGE 196
Query: 186 TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVG 223
                 D +  GVL+ +++ G+          P ++VG
Sbjct: 197 DYGFSVDWWALGVLMFEMMAGRS---------PFDIVG 225

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 75/186 (40%), Gaps = 31/186 (16%)
Query: 49  QEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYEFMPNK 105
           + VA+K L    T  + R        LI    + N+V LLG C+  G   +++ EF    
Sbjct: 95  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 154
Query: 106 SLDSSFSGT--------------FKDLLCLHKY--------------SRLRVIHRDLKAS 137
           +L +                   +KD L L                 +  + IHRDL A 
Sbjct: 155 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214
Query: 138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFG 197
           NILL ++   KI DFG+AR    +              +M+ E       +I++DV+ FG
Sbjct: 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 274
Query: 198 VLVLKI 203
           VL+ +I
Sbjct: 275 VLLWEI 280

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 91/192 (47%), Gaps = 36/192 (18%)
Query: 51  VAIKRLAWTSGQGRVE-------FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP 103
           VAIK L     +G  E       FQ E  +++ L + N+VKL G  +H   R +V EF+P
Sbjct: 47  VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL-MHNPPR-MVMEFVP 104
Query: 104 -----NKSLDSSFSGTFK-------DLLCLHKYSRLR---VIHRDLKASNILL-----DD 143
                ++ LD +    +        D+    +Y + +   ++HRDL++ NI L     + 
Sbjct: 105 CGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENA 164
Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI--KTDVFGFGVLVL 201
            +  K++DFG+++     +S  + + ++G + +M+ E   +   S   K D + F +++ 
Sbjct: 165 PVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY 219
Query: 202 KIVCGKKNNKSY 213
            I+ G+     Y
Sbjct: 220 TILTGEGPFDEY 231

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 2/94 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           V++RD+K  N++LD   + KI+DFG+ +  G+++ GA      GT  Y++ E        
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 189 IKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
              D +G GV++ +++CG+    +   ER   L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 42/78 (53%), Gaps = 2/78 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +I+RDLK  N+LLD + + K++DFGM +    N  G  T    GT  Y++ E        
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN--GVTTATFCGTPDYIAPEILQEMLYG 202
Query: 189 IKTDVFGFGVLVLKIVCG 206
              D +  GVL+ +++CG
Sbjct: 203 PAVDWWAMGVLLYEMLCG 220

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 25/80 (31%), Positives = 48/80 (60%), Gaps = 4/80 (5%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +++HRD+K SNIL++ +   K+ DFG++    ++E     N  VGT  YMS E       
Sbjct: 128 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDEM---ANEFVGTRSYMSPERLQGTHY 183
Query: 188 SIKTDVFGFGVLVLKIVCGK 207
           S+++D++  G+ ++++  G+
Sbjct: 184 SVQSDIWSMGLSLVEMAVGR 203

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 2/94 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           V++RD+K  N++LD   + KI+DFG+ +  G+++ GA      GT  Y++ E        
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 189 IKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
              D +G GV++ +++CG+    +   ER   L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 75/186 (40%), Gaps = 31/186 (16%)
Query: 49  QEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYEFMPNK 105
           + VA+K L    T  + R        LI    + N+V LLG C+  G   +++ EF    
Sbjct: 49  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 106 SLDSSFSGT--------------FKDLLCLHKY--------------SRLRVIHRDLKAS 137
           +L +                   +KD L L                 +  + IHRDL A 
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 168
Query: 138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFG 197
           NILL ++   KI DFG+AR    +              +M+ E       +I++DV+ FG
Sbjct: 169 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 228
Query: 198 VLVLKI 203
           VL+ +I
Sbjct: 229 VLLWEI 234

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 76/187 (40%), Gaps = 40/187 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           E+ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P KSL
Sbjct: 49  ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSL 98
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S      +V  Y Y + E  +        D++  G ++
Sbjct: 159 VKSDCTLKILDFGLARTAGT--SFMMEPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 215
Query: 201 LKIVCGK 207
            ++VC K
Sbjct: 216 GEMVCHK 222

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 50/80 (62%), Gaps = 4/80 (5%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +++HRD+K SNIL++ +   K+ DFG++    + +S AN+   VGT  YMS E       
Sbjct: 187 KIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPERLQGTHY 242
Query: 188 SIKTDVFGFGVLVLKIVCGK 207
           S+++D++  G+ ++++  G+
Sbjct: 243 SVQSDIWSMGLSLVEMAVGR 262

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 75/186 (40%), Gaps = 31/186 (16%)
Query: 49  QEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYEFMPNK 105
           + VA+K L    T  + R        LI    + N+V LLG C+  G   +++ EF    
Sbjct: 49  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 106 SLDSSFSGT--------------FKDLLCLHKY--------------SRLRVIHRDLKAS 137
           +L +                   +KD L L                 +  + IHRDL A 
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 168
Query: 138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFG 197
           NILL ++   KI DFG+AR    +              +M+ E       +I++DV+ FG
Sbjct: 169 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 228
Query: 198 VLVLKI 203
           VL+ +I
Sbjct: 229 VLLWEI 234

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 2/88 (2%)
Query: 119 LCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMS 178
           L L     L +I+RDLK  NILLD++ + K++DFG+++    +E  A +    GT  YM+
Sbjct: 141 LGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEYMA 198
Query: 179 LEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            E       S   D + +GVL+ +++ G
Sbjct: 199 PEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 2/94 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           V++RD+K  N++LD   + KI+DFG+ +  G+++ GA      GT  Y++ E        
Sbjct: 129 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKTFCGTPEYLAPEVLEDNDYG 186
Query: 189 IKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
              D +G GV++ +++CG+    +   ER   L+
Sbjct: 187 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 220

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI++FG    + V+   +    + GT
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGT 172
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 2/94 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           V++RD+K  N++LD   + KI+DFG+ +  G+++ GA      GT  Y++ E        
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 189 IKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
              D +G GV++ +++CG+    +   ER   L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 69/162 (42%), Gaps = 32/162 (19%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSLDSSFSGTFKDLLCLHKY 124
           + + E ++ + L++ N+++L G   H   R+ L+ E+ P           +++L  L K+
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGY-FHDSTRVYLILEYAP-------LGTVYRELQKLSKF 105
Query: 125 SRLR-------------------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA 165
              R                   VIHRD+K  N+LL      KI+DFG    + V+   +
Sbjct: 106 DEQRTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSS 161
Query: 166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
               + GT  Y+  E         K D++  GVL  + + GK
Sbjct: 162 RRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 66/153 (43%), Gaps = 16/153 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY 117
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    + V+   +    + GT
Sbjct: 118 ITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGT 173
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
             Y+  E         K D++  GVL  + + G
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 50/80 (62%), Gaps = 4/80 (5%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +++HRD+K SNIL++ +   K+ DFG++    + +S AN+   VGT  YMS E       
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPERLQGTHY 207
Query: 188 SIKTDVFGFGVLVLKIVCGK 207
           S+++D++  G+ ++++  G+
Sbjct: 208 SVQSDIWSMGLSLVEMAVGR 227

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 35/208 (16%)
Query: 27  HMYIQQEQTRDRVILVGKFP-------NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY 79
           HM   +E   + V+  G F          ++VAIK++   S   R  F  E + ++++ +
Sbjct: 4   HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQI--ESESERKAFIVELRQLSRVNH 61
Query: 80  TNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGT------------------FKDLLCL 121
            N+VKL G  ++     LV E+    SL +   G                    + +  L
Sbjct: 62  PNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNT-KISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           H      +IHRDLK  N+LL       KI DFG A      ++    N+  G+  +M+ E
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GSAAWMAPE 174
Query: 181 YTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
                  S K DVF +G+++ +++  +K
Sbjct: 175 VFEGSNYSEKCDVFSWGIILWEVITRRK 202

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 47/98 (47%)
Query: 106 SLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA 165
           +++   S +F+    +   S  + IHRDL A NILL +    KI DFG+AR    N    
Sbjct: 197 TMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYV 256
Query: 166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
                     +M+ E       S K+DV+ +GVL+ +I
Sbjct: 257 RKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEI 294

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 35/208 (16%)
Query: 27  HMYIQQEQTRDRVILVGKFP-------NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY 79
           HM   +E   + V+  G F          ++VAIK++   S   R  F  E + ++++ +
Sbjct: 3   HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQI--ESESERKAFIVELRQLSRVNH 60
Query: 80  TNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGT------------------FKDLLCL 121
            N+VKL G  ++     LV E+    SL +   G                    + +  L
Sbjct: 61  PNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNT-KISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           H      +IHRDLK  N+LL       KI DFG A      ++    N+  G+  +M+ E
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GSAAWMAPE 173
Query: 181 YTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
                  S K DVF +G+++ +++  +K
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRK 201

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 2/94 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           V++RD+K  N++LD   + KI+DFG+ +  G+++ GA      GT  Y++ E        
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 189 IKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
              D +G GV++ +++CG+    +   ER   L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 6/81 (7%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMAR--IFGVNESGANTNRIVGTYGYMSLEYTMSGT 186
           +I+RDLK  N++LD + + KI+DFGM +  I+     G  T    GT  Y++ E      
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW----DGVTTKXFCGTPDYIAPEIIAYQP 518
Query: 187 VSIKTDVFGFGVLVLKIVCGK 207
                D + FGVL+ +++ G+
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQ 539

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 78/184 (42%), Gaps = 26/184 (14%)
Query: 38  RVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           R++ + KF  ++ +  +K++A            E KL+ +L++ NLV LL      +   
Sbjct: 51  RIVAIKKFLESDDDKMVKKIA----------MREIKLLKQLRHENLVNLLEVCKKKKRWY 100
Query: 97  LVYEFMPNKSLDS-SFSGTFKDLLCLHKY-----------SRLRVIHRDLKASNILLDDQ 144
           LV+EF+ +  LD         D   + KY               +IHRD+K  NIL+   
Sbjct: 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS 160
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKI 203
              K+ DFG AR       G   +  V T  Y + E  +      K  DV+  G LV ++
Sbjct: 161 GVVKLCDFGFARTLAA--PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEM 218
Query: 204 VCGK 207
             G+
Sbjct: 219 FMGE 222

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 60/116 (51%), Gaps = 17/116 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLR 128
           NE  +I +L  T+L +++   +  ++ +  + +            T + +  LH  +   
Sbjct: 87  NEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ-----------TLRAVKVLHGSN--- 132
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS 184
           VIHRDLK SN+L++   + K+ DFG+ARI  ++ES A+ +   G    M+ EY  +
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMT-EYVAT 185

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 50/80 (62%), Gaps = 4/80 (5%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +++HRD+K SNIL++ +   K+ DFG++    + +S AN+   VGT  YMS E       
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPERLQGTHY 180
Query: 188 SIKTDVFGFGVLVLKIVCGK 207
           S+++D++  G+ ++++  G+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGR 200

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 66/154 (42%), Gaps = 16/154 (10%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL----------DSSFSGTF 115
           + + E ++ + L++ N+++L G         L+ E+ P  ++          D   + T+
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 114
Query: 116 KDLLC--LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
              L   L      RVIHRD+K  N+LL      KI+DFG    +  +   +    + GT
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGT 170
Query: 174 YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
             Y+  E         K D++  GVL  + + GK
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 23/82 (28%), Positives = 46/82 (56%), Gaps = 3/82 (3%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM---SG 185
           +IHRD+K++NI L + L  KI DFG+A +           +  G+  +M+ E      + 
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212
Query: 186 TVSIKTDVFGFGVLVLKIVCGK 207
             S ++DV+ +G+++ +++ G+
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGE 234

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 114 TFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESG 164
           TFKDL+ C ++ +R        + IHRDL A N+L+ +    KI+DFG+AR I  ++   
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 203
Query: 165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 204 KTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 241

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 78/192 (40%), Gaps = 53/192 (27%)
Query: 64  RVEFQNE-----AKLIAKLQYTNLVKLLGC-------SIHGEERLLVYEFMPNKSLDSSF 111
           RV++ NE      K +AKL + N+V   GC           ++ L   ++ P  S +SS 
Sbjct: 44  RVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSR 103
Query: 112 SGT--------------------------FKDLLCLHKYSRL----------RVIHRDLK 135
           S T                             +L L  + ++          ++IHRDLK
Sbjct: 104 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLK 163
Query: 136 ASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFG 195
            SNI L D    KI DFG+  +  +   G  T R  GT  YMS E   S     + D++ 
Sbjct: 164 PSNIFLVDTKQVKIGDFGL--VTSLKNDGKRT-RSKGTLRYMSPEQISSQDYGKEVDLYA 220
Query: 196 FGVLVLKI--VC 205
            G+++ ++  VC
Sbjct: 221 LGLILAELLHVC 232

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 114 TFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESG 164
           TFKDL+ C ++ +R        + IHRDL A N+L+ +    KI+DFG+AR I  ++   
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYK 201
Query: 165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 202 KTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 239

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 50/80 (62%), Gaps = 4/80 (5%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +++HRD+K SNIL++ +   K+ DFG++    + +S AN+   VGT  YMS E       
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPERLQGTHY 180
Query: 188 SIKTDVFGFGVLVLKIVCGK 207
           S+++D++  G+ ++++  G+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGR 200

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 115 FKDLLCLHKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
           F+ +L    Y  R  V+HRDLK  N+LLD  +N KI+DFG++ +    E   ++    G+
Sbjct: 117 FQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGS 173
Query: 174 YGYMSLEYTMSGTVSI--KTDVFGFGVLVLKIVCG 206
             Y + E  +SG +    + D++  GV++  ++CG
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 50/80 (62%), Gaps = 4/80 (5%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +++HRD+K SNIL++ +   K+ DFG++    + +S AN+   VGT  YMS E       
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPERLQGTHY 180
Query: 188 SIKTDVFGFGVLVLKIVCGK 207
           S+++D++  G+ ++++  G+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGR 200

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 31/222 (13%)
Query: 50  EVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           +VAIK L   + +   E    EA+++ +L    +V+L+G     E  +LV E      L 
Sbjct: 365 DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLH 423
Query: 109 SSFSGTFKDLLC------LHKYS-------RLRVIHRDLKASNILLDDQLNTKISDFGMA 155
               G  +++        LH+ S           +HR+L A N+LL ++   KISDFG++
Sbjct: 424 KFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483
Query: 156 RIFGVNESGANTNRIVGTYG--YMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKS 212
           +  G ++S   T R  G +   + + E       S ++DV+ +GV + + +  G+K  K 
Sbjct: 484 KALGADDS-YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542
Query: 213 YHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFL 254
                 +  +        +GK +E         CPP   A +
Sbjct: 543 MKGPEVMAFI-------EQGKRME-----CPPECPPELYALM 572

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 50/80 (62%), Gaps = 4/80 (5%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +++HRD+K SNIL++ +   K+ DFG++    + +S AN+   VGT  YMS E       
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPERLQGTHY 180
Query: 188 SIKTDVFGFGVLVLKIVCGK 207
           S+++D++  G+ ++++  G+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 50/80 (62%), Gaps = 4/80 (5%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +++HRD+K SNIL++ +   K+ DFG++    + +S AN+   VGT  YMS E       
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPERLQGTHY 180
Query: 188 SIKTDVFGFGVLVLKIVCGK 207
           S+++D++  G+ ++++  G+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGR 200

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 114 TFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESG 164
           TFKDL+ C ++ +R        + IHRDL A N+L+ +    KI+DFG+AR I  ++   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 215 KTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 115 FKDLLCLHKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
           F+ +L    Y  R  V+HRDLK  N+LLD  +N KI+DFG++ +      G       G+
Sbjct: 117 FQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRTSCGS 173
Query: 174 YGYMSLEYTMSGTVSI--KTDVFGFGVLVLKIVCG 206
             Y + E  +SG +    + D++  GV++  ++CG
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 120 CLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSL 179
           C  +  +  + HRD K+ N+LL   L   ++DFG+A  F   +   +T+  VGT  YM+ 
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194
Query: 180 EYTMSGTVSIKTDVF 194
           E  + G ++ + D F
Sbjct: 195 E-VLEGAINFQRDAF 208

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 114 TFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESG 164
           TFKDL+ C ++ +R        + IHRDL A N+L+ +    KI+DFG+AR I  ++   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 215 KTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 32/163 (19%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYS 125
           + + EA++  KLQ+ N+V+L           LV++ +    L       F+D++    YS
Sbjct: 50  KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-------FEDIVAREFYS 102
Query: 126 RLR-------------------VIHRDLKASNILLDDQLN---TKISDFGMARIFGVNES 163
                                 ++HR+LK  N+LL  +      K++DFG+A    VN+S
Sbjct: 103 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDS 160
Query: 164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            A  +   GT GY+S E       S   D++  GV++  ++ G
Sbjct: 161 EA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 114 TFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESG 164
           TFKDL+ C ++ +R        + IHRDL A N+L+ +    KI+DFG+AR I  ++   
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 261 KTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 57/110 (51%), Gaps = 16/110 (14%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLR 128
           NE  +I +L  T+L +++   +  ++ +  + +            T + +  LH  +   
Sbjct: 87  NEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ-----------TLRAVKVLHGSN--- 132
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMS 178
           VIHRDLK SN+L++   + K+ DFG+ARI  ++ES A+ +   G    M+
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMT 180

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 114 TFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESG 164
           TFKDL+ C ++ +R        + IHRDL A N+L+ +    KI+DFG+AR I  ++   
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 206
Query: 165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 207 KTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 244

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 13/97 (13%)
Query: 117 DLLC-LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG 175
           +++C LHK   L ++HRDLK  NILLDD +N K++DFG +      + G     + GT  
Sbjct: 122 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPS 175
Query: 176 YMS---LEYTMSGT---VSIKTDVFGFGVLVLKIVCG 206
           Y++   +E +M+        + D++  GV++  ++ G
Sbjct: 176 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 40/76 (52%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           + IHRDL A NILL ++   KI DFG+AR    +              +M+ E       
Sbjct: 218 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 277
Query: 188 SIKTDVFGFGVLVLKI 203
           +I++DV+ FGVL+ +I
Sbjct: 278 TIQSDVWSFGVLLWEI 293

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 114 TFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESG 164
           TFKDL+ C ++ +R        + IHRDL A N+L+ +    KI+DFG+AR I  ++   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 215 KTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 114 TFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESG 164
           TFKDL+ C ++ +R        + IHRDL A N+L+ +    KI+DFG+AR I  ++   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 215 KTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 77  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 136
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D+Q   +++DFG A+          T  + GT  Y
Sbjct: 137 IVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 191
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 192 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 90/192 (46%), Gaps = 36/192 (18%)
Query: 51  VAIKRLAWTSGQGRVE-------FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP 103
           VAIK L     +G  E       FQ E  +++ L + N+VKL G  +H   R +V EF+P
Sbjct: 47  VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL-MHNPPR-MVMEFVP 104
Query: 104 -----NKSLDSSFSGTFK-------DLLCLHKYSRLR---VIHRDLKASNILL-----DD 143
                ++ LD +    +        D+    +Y + +   ++HRDL++ NI L     + 
Sbjct: 105 CGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENA 164
Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI--KTDVFGFGVLVL 201
            +  K++DFG ++     +S  + + ++G + +M+ E   +   S   K D + F +++ 
Sbjct: 165 PVCAKVADFGTSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY 219
Query: 202 KIVCGKKNNKSY 213
            I+ G+     Y
Sbjct: 220 TILTGEGPFDEY 231

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 40/76 (52%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           + IHRDL A NILL ++   KI DFG+AR    +              +M+ E       
Sbjct: 213 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 272
Query: 188 SIKTDVFGFGVLVLKI 203
           +I++DV+ FGVL+ +I
Sbjct: 273 TIQSDVWSFGVLLWEI 288

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 32/163 (19%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYS 125
           + + EA++  KLQ+ N+V+L           LV++ +    L       F+D++    YS
Sbjct: 51  KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-------FEDIVAREFYS 103
Query: 126 RLR-------------------VIHRDLKASNILLDDQLN---TKISDFGMARIFGVNES 163
                                 ++HR+LK  N+LL  +      K++DFG+A    VN+S
Sbjct: 104 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDS 161
Query: 164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            A  +   GT GY+S E       S   D++  GV++  ++ G
Sbjct: 162 EA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 6/81 (7%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMAR--IFGVNESGANTNRIVGTYGYMSLEYTMSGT 186
           +I+RDLK  N++LD + + KI+DFGM +  I+     G  T    GT  Y++ E      
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW----DGVTTKXFCGTPDYIAPEIIAYQP 197
Query: 187 VSIKTDVFGFGVLVLKIVCGK 207
                D + FGVL+ +++ G+
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQ 218

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 13/97 (13%)
Query: 117 DLLC-LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG 175
           +++C LHK   L ++HRDLK  NILLDD +N K++DFG +      + G     + GT  
Sbjct: 135 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPS 188
Query: 176 YMS---LEYTMSGT---VSIKTDVFGFGVLVLKIVCG 206
           Y++   +E +M+        + D++  GV++  ++ G
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 81/185 (43%), Gaps = 25/185 (13%)
Query: 38  RVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER 95
           R IL GK     EVA+K +  T  +     +   E ++   L + N+VKL    I  E+ 
Sbjct: 34  RHILTGK-----EVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV-IETEKT 87
Query: 96  L-LVYEFMPNKSL-----------DSSFSGTFKDLLCLHKYSRLR-VIHRDLKASNILLD 142
           L LV E+     +           +      F+ ++   +Y   + ++HRDLKA N+LLD
Sbjct: 88  LYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE-YTMSGTVSIKTDVFGFGVLVL 201
              N KI+DFG +  F     G   +   G   Y + E +        + DV+  GV++ 
Sbjct: 148 ADXNIKIADFGFSNEFTF---GNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 202 KIVCG 206
            +V G
Sbjct: 205 TLVSG 209

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 47  NEQEVAIKRLAWTSGQGR--VEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN 104
            +QE A+K +   S + +       E +L+ KL + N++KL           +V E    
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 105 KSL-------------DSS--FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ---LN 146
             L             D++      F  +  +HK++   ++HRDLK  NILL+ +    +
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCD 162
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            KI DFG++  F  N    +    +GT  Y++ E  + GT   K DV+  GV++  ++ G
Sbjct: 163 IKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 47  NEQEVAIKRLAWTSGQGR--VEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN 104
            +QE A+K +   S + +       E +L+ KL + N++KL           +V E    
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 105 KSL-------------DSS--FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ---LN 146
             L             D++      F  +  +HK++   ++HRDLK  NILL+ +    +
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCD 162
Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            KI DFG++  F  N    +    +GT  Y++ E  + GT   K DV+  GV++  ++ G
Sbjct: 163 IKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 114 TFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESG 164
           TFKDL+ C ++ +R        + IHRDL A N+L+ +    KI+DFG+AR I  ++   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 215 KTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 40/76 (52%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           + IHRDL A NILL ++   KI DFG+AR    +              +M+ E       
Sbjct: 220 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 279
Query: 188 SIKTDVFGFGVLVLKI 203
           +I++DV+ FGVL+ +I
Sbjct: 280 TIQSDVWSFGVLLWEI 295

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 76/187 (40%), Gaps = 40/187 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           E+ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P KSL
Sbjct: 49  ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSL 98
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S      +V  Y Y + E  +        D++  G ++
Sbjct: 159 VKSDCTLKILDFGLARTAGT--SFMMEPEVVTRY-YRAPEVILGMGYKENVDLWSVGCIM 215
Query: 201 LKIVCGK 207
            ++VC K
Sbjct: 216 GEMVCHK 222

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 32/163 (19%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYS 125
           + + EA++  KLQ+ N+V+L           LV++ +    L       F+D++    YS
Sbjct: 51  KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-------FEDIVAREFYS 103
Query: 126 RLR-------------------VIHRDLKASNILLDDQLN---TKISDFGMARIFGVNES 163
                                 ++HR+LK  N+LL  +      K++DFG+A    VN+S
Sbjct: 104 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDS 161
Query: 164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            A  +   GT GY+S E       S   D++  GV++  ++ G
Sbjct: 162 EA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 40/76 (52%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           + IHRDL A NILL ++   KI DFG+AR    +              +M+ E       
Sbjct: 211 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 270
Query: 188 SIKTDVFGFGVLVLKI 203
           +I++DV+ FGVL+ +I
Sbjct: 271 TIQSDVWSFGVLLWEI 286

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 55/104 (52%), Gaps = 16/104 (15%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLR 128
           NE  +I +L  T+L +++   +  ++ +  + +            T + +  LH  +   
Sbjct: 87  NEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ-----------TLRAVKVLHGSN--- 132
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVG 172
           VIHRDLK SN+L++   + K+ DFG+ARI  ++ES A+ +   G
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTG 174

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 50/80 (62%), Gaps = 4/80 (5%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +++HRD+K SNIL++ +   K+ DFG++    + +S AN+   VGT  YMS E       
Sbjct: 144 KIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPERLQGTHY 199
Query: 188 SIKTDVFGFGVLVLKIVCGK 207
           S+++D++  G+ ++++  G+
Sbjct: 200 SVQSDIWSMGLSLVEMAVGR 219

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 13/97 (13%)
Query: 117 DLLC-LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG 175
           +++C LHK   L ++HRDLK  NILLDD +N K++DFG +      + G     + GT  
Sbjct: 135 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLRSVCGTPS 188
Query: 176 YMS---LEYTMSGT---VSIKTDVFGFGVLVLKIVCG 206
           Y++   +E +M+        + D++  GV++  ++ G
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 7/90 (7%)
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H    L++IHRD+K SNILLD   N K+ DFG++   G         R  G   YM+ E 
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPER 196
Query: 182 TMSGT----VSIKTDVFGFGVLVLKIVCGK 207
                      +++DV+  G+ + ++  G+
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 114 TFKDLLCLH-------KYSRLR-VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA 165
           TF+DLLC         ++   +  +HRDL A N+L+      KI DFG+AR    + +  
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
                     +M+ E    G  +IK+DV+ +G+L+ +I
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 32/163 (19%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYS 125
           + + EA++  KLQ+ N+V+L           LV++ +    L       F+D++    YS
Sbjct: 74  KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-------FEDIVAREFYS 126
Query: 126 RLR-------------------VIHRDLKASNILLDDQLN---TKISDFGMARIFGVNES 163
                                 ++HR+LK  N+LL  +      K++DFG+A    VN+S
Sbjct: 127 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDS 184
Query: 164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            A  +   GT GY+S E       S   D++  GV++  ++ G
Sbjct: 185 EA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 79/189 (41%), Gaps = 23/189 (12%)
Query: 39  VILVGK-FPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL 97
           ++  G+   N+  +AIK +     +       E  L   L++ N+V+ LG         +
Sbjct: 37  IVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96
Query: 98  VYEFMPNKSLDS---SFSGTFKD------------LLCLHKYSRLRVIHRDLKASNILLD 142
             E +P  SL +   S  G  KD            L  L      +++HRD+K  N+L++
Sbjct: 97  FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN 156
Query: 143 DQLNT-KISDFGMA-RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI--KTDVFGFGV 198
                 KISDFG + R+ G+N     T    GT  YM+ E    G        D++  G 
Sbjct: 157 TYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGC 213
Query: 199 LVLKIVCGK 207
            ++++  GK
Sbjct: 214 TIIEMATGK 222

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 32/179 (17%)
Query: 51  VAIKRLAWTSGQGRVEFQN--EAKLIAKLQ---YTNLVKLLG-CSIHGEER----LLVYE 100
           VA+KR+   +G+  +      E  ++  L+   + N+V+L   C++   +R     LV+E
Sbjct: 40  VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE 99
Query: 101 FM----------------PNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
            +                P +++        + L  LH +   RV+HRDLK  NIL+   
Sbjct: 100 HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS 156
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
              K++DFG+ARI+    +      +V T  Y + E  +  + +   D++  G +  ++
Sbjct: 157 GQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 85  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 144
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 145 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 199
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 200 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 35/161 (21%)
Query: 64  RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHK 123
           + +F  EA+++ +  + N+V+L+G     +   +V E +          G F   L    
Sbjct: 156 KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG--------GDFLTFLRTEG 207
Query: 124 YSRLRV----------------------IHRDLKASNILLDDQLNTKISDFGMAR--IFG 159
            +RLRV                      IHRDL A N L+ ++   KISDFGM+R    G
Sbjct: 208 -ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266
Query: 160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           V  +     ++     + + E    G  S ++DV+ FG+L+
Sbjct: 267 VXAASGGLRQV--PVKWTAPEALNYGRYSSESDVWSFGILL 305

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 114 TFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTKISDFGMAR-IFGVNESG 164
           TFKDL+ C ++ +R        + IHRDL A N+L+ +    +I+DFG+AR I  ++   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYK 214
Query: 165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 215 KTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 205
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 61/116 (52%), Gaps = 12/116 (10%)
Query: 97  LVYEFMPNKSLDSSFSGTFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTK 148
           L + F P+ + +   S   KDL+ C ++ +R        + IHRDL A N+L+ +    K
Sbjct: 133 LEFSFNPSHNPEEQLSS--KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 190
Query: 149 ISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           I+DFG+AR I  ++     TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 191 IADFGLARDIHHIDXXKKTTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/80 (31%), Positives = 50/80 (62%), Gaps = 4/80 (5%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +++HRD+K SNIL++ +   K+ DFG++    + +S AN+   VGT  YM+ E       
Sbjct: 135 QIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMAPERLQGTHY 190
Query: 188 SIKTDVFGFGVLVLKIVCGK 207
           S+++D++  G+ ++++  G+
Sbjct: 191 SVQSDIWSMGLSLVELAVGR 210

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 79/189 (41%), Gaps = 23/189 (12%)
Query: 39  VILVGK-FPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL 97
           ++  G+   N+  +AIK +     +       E  L   L++ N+V+ LG         +
Sbjct: 23  IVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 82
Query: 98  VYEFMPNKSLDS---SFSGTFKD------------LLCLHKYSRLRVIHRDLKASNILLD 142
             E +P  SL +   S  G  KD            L  L      +++HRD+K  N+L++
Sbjct: 83  FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN 142
Query: 143 DQLNT-KISDFGMA-RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI--KTDVFGFGV 198
                 KISDFG + R+ G+N     T    GT  YM+ E    G        D++  G 
Sbjct: 143 TYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGC 199
Query: 199 LVLKIVCGK 207
            ++++  GK
Sbjct: 200 TIIEMATGK 208

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 80/172 (46%), Gaps = 18/172 (10%)
Query: 50  EVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP-----N 104
           ++A K +     + + E +NE  ++ +L + NL++L        + +LV E++      +
Sbjct: 116 KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD 175
Query: 105 KSLDSSFSGTFKDLLCLHK--------YSRLRVIHRDLKASNILL--DDQLNTKISDFGM 154
           + +D S++ T  D +   K          ++ ++H DLK  NIL    D    KI DFG+
Sbjct: 176 RIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGL 235
Query: 155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           AR +   E     N   GT  +++ E      VS  TD++  GV+   ++ G
Sbjct: 236 ARRYKPREK-LKVN--FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 76/186 (40%), Gaps = 40/186 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           E+ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P KSL
Sbjct: 49  ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSL 98
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 159 VKSDCTLKILDFGLARTAGT--SFMMTPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 215
Query: 201 LKIVCG 206
            +++ G
Sbjct: 216 GEMIKG 221

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 27/179 (15%)
Query: 48  EQEVAIKRLAWTSGQGR--VEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK 105
           +QE A+K +   S + +       E +L+ KL + N++KL           +V E     
Sbjct: 47  QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106
Query: 106 SL-------------DSS--FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ---LNT 147
            L             D++      F  +  +HK++   ++HRDLK  NILL+ +    + 
Sbjct: 107 ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDI 163
Query: 148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           KI DFG++  F  N    +    +GT  Y++ E  + GT   K DV+  GV++  ++ G
Sbjct: 164 KIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 78/175 (44%), Gaps = 32/175 (18%)
Query: 51  VAIKRLAWTSGQGRVEFQN--EAKLIAKLQ---YTNLVKLLG-CSIHGEER----LLVYE 100
           VA+KR+   +G+  +      E  ++  L+   + N+V+L   C++   +R     LV+E
Sbjct: 40  VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE 99
Query: 101 FM----------------PNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
            +                P +++        + L  LH +   RV+HRDLK  NIL+   
Sbjct: 100 HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS 156
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
              K++DFG+ARI+    +      +V T  Y + E  +  + +   D++  G +
Sbjct: 157 GQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 208

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 61/116 (52%), Gaps = 12/116 (10%)
Query: 97  LVYEFMPNKSLDSSFSGTFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTK 148
           L Y + P+ + +   S   KDL+ C ++ +R        + IHRDL A N+L+ +    K
Sbjct: 122 LEYSYNPSHNPEEQLSS--KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 179
Query: 149 ISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           I+DFG+AR I  ++     TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 180 IADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 234

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSLDSSFSG-------------TF 115
           E  L+  L++ N+V L    IH E+ L LV+E++ +K L                    F
Sbjct: 50  EVSLLKDLKHANIVTLHDI-IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLF 107
Query: 116 KDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG 175
           + L  L    R +V+HRDLK  N+L++++   K++DFG+AR   +  +    N +V T  
Sbjct: 108 QLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLW 165
Query: 176 YMSLEYTMSGT-VSIKTDVFGFGVLVLKIVCGK 207
           Y   +  +  T  S + D++G G +  ++  G+
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 78/175 (44%), Gaps = 32/175 (18%)
Query: 51  VAIKRLAWTSGQGRVEFQN--EAKLIAKLQ---YTNLVKLLG-CSIHGEER----LLVYE 100
           VA+KR+   +G+  +      E  ++  L+   + N+V+L   C++   +R     LV+E
Sbjct: 40  VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE 99
Query: 101 FM----------------PNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
            +                P +++        + L  LH +   RV+HRDLK  NIL+   
Sbjct: 100 HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS 156
Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
              K++DFG+ARI+    +      +V T  Y + E  +  + +   D++  G +
Sbjct: 157 GQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 208

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 27/156 (17%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL---DSSFSGTFKDLLC-- 120
           +F+NE ++I  ++    +   G   + +E  ++YE+M N S+   D  F    K+  C  
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 121 ------------LHKYSRLR----VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG 164
                       L+ +S +     + HRD+K SNIL+D     K+SDFG +  + V++  
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE-YMVDKKI 207
Query: 165 ANTNRIVGTYGYMSLEY--TMSGTVSIKTDVFGFGV 198
             +    GTY +M  E+    S     K D++  G+
Sbjct: 208 KGSR---GTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 35/161 (21%)
Query: 64  RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHK 123
           + +F  EA+++ +  + N+V+L+G     +   +V E +          G F   L    
Sbjct: 156 KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG--------GDFLTFLRTEG 207
Query: 124 YSRLRV----------------------IHRDLKASNILLDDQLNTKISDFGMAR--IFG 159
            +RLRV                      IHRDL A N L+ ++   KISDFGM+R    G
Sbjct: 208 -ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266
Query: 160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           V  +     ++     + + E    G  S ++DV+ FG+L+
Sbjct: 267 VYAASGGLRQV--PVKWTAPEALNYGRYSSESDVWSFGILL 305

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 42/78 (53%), Gaps = 5/78 (6%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +I+RDLK  NILLD   + KI+DFG A+          T  + GT  Y++ E   +   +
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYXLCGTPDYIAPEVVSTKPYN 181
Query: 189 IKTDVFGFGVLVLKIVCG 206
              D + FG+L+ +++ G
Sbjct: 182 KSIDWWSFGILIYEMLAG 199

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 111 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 170
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 171 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 225
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 19/151 (12%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 111 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 170
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMA-RIFGVNESGANTNRIVGTYG 175
            +L       L +I+RDLK  N+L+D Q   +++DFG A R+ G       T  + GT  
Sbjct: 171 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA------TWTLCGTPE 224
Query: 176 YMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           Y++ E  +S   +   D +  GVL+ ++  G
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 61/116 (52%), Gaps = 12/116 (10%)
Query: 97  LVYEFMPNKSLDSSFSGTFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTK 148
           L Y + P+ + +   S   KDL+ C ++ +R        + IHRDL A N+L+ +    K
Sbjct: 126 LEYSYNPSHNPEEQLSS--KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 183
Query: 149 ISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           I+DFG+AR I  ++     TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 184 IADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 79/186 (42%), Gaps = 40/186 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           E+ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P KSL
Sbjct: 49  ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSL 98
Query: 108 -------------DSSFSGTFK-------------DLLCLHKY-SRLRVIHRDLKASNIL 140
                        D++ S   +              +LC  K+     +IHRDLK SNI+
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 159 VKSDATLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 215
Query: 201 LKIVCG 206
            +++ G
Sbjct: 216 GEMIKG 221

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 61/116 (52%), Gaps = 12/116 (10%)
Query: 97  LVYEFMPNKSLDSSFSGTFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTK 148
           L Y + P+ + +   S   KDL+ C ++ +R        + IHRDL A N+L+ +    K
Sbjct: 133 LEYSYNPSHNPEEQLSS--KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 190
Query: 149 ISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           I+DFG+AR I  ++     TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 61/116 (52%), Gaps = 12/116 (10%)
Query: 97  LVYEFMPNKSLDSSFSGTFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTK 148
           L Y + P+ + +   S   KDL+ C ++ +R        + IHRDL A N+L+ +    K
Sbjct: 125 LEYSYNPSHNPEEQLSS--KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 182
Query: 149 ISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           I+DFG+AR I  ++     TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 183 IADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 61/116 (52%), Gaps = 12/116 (10%)
Query: 97  LVYEFMPNKSLDSSFSGTFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTK 148
           L Y + P+ + +   S   KDL+ C ++ +R        + IHRDL A N+L+ +    K
Sbjct: 133 LEYSYNPSHNPEEQLSS--KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 190
Query: 149 ISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           I+DFG+AR I  ++     TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 79/186 (42%), Gaps = 40/186 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           E+ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P KSL
Sbjct: 49  ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSL 98
Query: 108 -------------DSSFSGTFK-------------DLLCLHKY-SRLRVIHRDLKASNIL 140
                        D++ S   +              +LC  K+     +IHRDLK SNI+
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 159 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 215
Query: 201 LKIVCG 206
            +++ G
Sbjct: 216 GEMIKG 221

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 90/192 (46%), Gaps = 36/192 (18%)
Query: 51  VAIKRLAWTSGQGRVE-------FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP 103
           VAIK L     +G  E       FQ E  +++ L + N+VKL G  +H   R +V EF+P
Sbjct: 47  VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL-MHNPPR-MVMEFVP 104
Query: 104 -----NKSLDSSFSGTFK-------DLLCLHKYSRLR---VIHRDLKASNILL-----DD 143
                ++ LD +    +        D+    +Y + +   ++HRDL++ NI L     + 
Sbjct: 105 CGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENA 164
Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI--KTDVFGFGVLVL 201
            +  K++DF +++     +S  + + ++G + +M+ E   +   S   K D + F +++ 
Sbjct: 165 PVCAKVADFSLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY 219
Query: 202 KIVCGKKNNKSY 213
            I+ G+     Y
Sbjct: 220 TILTGEGPFDEY 231

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 76/178 (42%), Gaps = 32/178 (17%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS- 109
            A K +   S +   ++  E  ++A   + N+VKLL    +     ++ EF    ++D+ 
Sbjct: 65  AAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV 124
Query: 110 ------SFSGTFKDLLCLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMARI 157
                   + +   ++C      L      ++IHRDLKA NIL     + K++DFG+   
Sbjct: 125 MLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV--- 181
Query: 158 FGVNESGANTNRI------VGTYGYMSLEYTMSGT-----VSIKTDVFGFGVLVLKIV 204
                S  NT  I      +GT  +M+ E  M  T        K DV+  G+ ++++ 
Sbjct: 182 -----SAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 44/90 (48%), Gaps = 7/90 (7%)
Query: 120 CLHKYSRLRVIHRDLKASNILLDD---QLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            L  +    V+H+DLK  NIL  D       KI DFG+A +F  +E   N     GT  Y
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTALY 192
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           M+ E      V+ K D++  GV++  ++ G
Sbjct: 193 MAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 76/178 (42%), Gaps = 32/178 (17%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS- 109
            A K +   S +   ++  E  ++A   + N+VKLL    +     ++ EF    ++D+ 
Sbjct: 65  AAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV 124
Query: 110 ------SFSGTFKDLLCLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMARI 157
                   + +   ++C      L      ++IHRDLKA NIL     + K++DFG+   
Sbjct: 125 MLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV--- 181
Query: 158 FGVNESGANTNRI------VGTYGYMSLEYTMSGT-----VSIKTDVFGFGVLVLKIV 204
                S  NT  I      +GT  +M+ E  M  T        K DV+  G+ ++++ 
Sbjct: 182 -----SAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 76/177 (42%), Gaps = 25/177 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL--- 107
           V + +   + G    + + EA +   L++ ++V+LL          +V+EFM    L   
Sbjct: 57  VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFE 116
Query: 108 -----DSSFSGTFKDLLCLHKYSRL----------RVIHRDLKASNILLDDQLNT---KI 149
                D+ F   + + +  H   ++           +IHRD+K   +LL  + N+   K+
Sbjct: 117 IVKRADAGF--VYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKL 174
Query: 150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
             FG+A   G  ESG      VGT  +M+ E           DV+G GV++  ++ G
Sbjct: 175 GGFGVAIQLG--ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/150 (24%), Positives = 65/150 (43%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+++D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 76/178 (42%), Gaps = 32/178 (17%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS- 109
            A K +   S +   ++  E  ++A   + N+VKLL    +     ++ EF    ++D+ 
Sbjct: 65  AAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV 124
Query: 110 ------SFSGTFKDLLCLHKYSRL------RVIHRDLKASNILLDDQLNTKISDFGMARI 157
                   + +   ++C      L      ++IHRDLKA NIL     + K++DFG+   
Sbjct: 125 MLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV--- 181
Query: 158 FGVNESGANTNRI------VGTYGYMSLEYTMSGT-----VSIKTDVFGFGVLVLKIV 204
                S  NT  I      +GT  +M+ E  M  T        K DV+  G+ ++++ 
Sbjct: 182 -----SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 76/186 (40%), Gaps = 40/186 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           E+ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P KSL
Sbjct: 50  ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSL 99
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 100 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 159
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 160 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 216
Query: 201 LKIVCG 206
            +++ G
Sbjct: 217 GEMIKG 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 76/186 (40%), Gaps = 40/186 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           E+ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P KSL
Sbjct: 49  ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSL 98
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 159 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 215
Query: 201 LKIVCG 206
            +++ G
Sbjct: 216 GEMIKG 221

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 9/90 (10%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS--- 184
           R+IHRD+K  NILLD+  +  I+DF +A +    E+   T  + GT  YM+ E   S   
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-RETQITT--MAGTKPYMAPEMFSSRKG 191
Query: 185 GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH 214
              S   D +  GV   +++ G+   + YH
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGR---RPYH 218

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 20/157 (12%)
Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKSLDSSFSG-----------T 114
           F  E  ++A      +V+L  C+   ++ L +V E+MP   L +  S            T
Sbjct: 122 FWEERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYT 180
Query: 115 FKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG-ANTNRIVGT 173
            + +L L     + +IHRD+K  N+LLD   + K++DFG      ++E+G  + +  VGT
Sbjct: 181 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVHCDTAVGT 238
Query: 174 YGYMSLEYTMS----GTVSIKTDVFGFGVLVLKIVCG 206
             Y+S E   S    G    + D +  GV + +++ G
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 61/116 (52%), Gaps = 12/116 (10%)
Query: 97  LVYEFMPNKSLDSSFSGTFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTK 148
           L Y + P+ + +   S   KDL+ C ++ +R        + IHRDL A N+L+ +    K
Sbjct: 174 LEYSYNPSHNPEEQLSS--KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 231
Query: 149 ISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           I+DFG+AR I  ++     TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 19/160 (11%)
Query: 63  GRVEFQ---NEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYEFMPNKSL---DSSFSGTF 115
           GR  FQ   +    I  L + ++V+LLG C   G    LV +++P  SL        G  
Sbjct: 73  GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP--GSSLQLVTQYLPLGSLLDHVRQHRGAL 130
Query: 116 KDLLCLHKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA 165
              L L+   ++           ++HR+L A N+LL      +++DFG+A +   ++   
Sbjct: 131 GPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 190
Query: 166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC 205
             +       +M+LE    G  + ++DV+ +GV V +++ 
Sbjct: 191 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 76/186 (40%), Gaps = 40/186 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           E+ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P KSL
Sbjct: 49  ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSL 98
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 159 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 215
Query: 201 LKIVCG 206
            +++ G
Sbjct: 216 GEMIKG 221

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 54/113 (47%), Gaps = 10/113 (8%)
Query: 115 FKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTY 174
            + L  LH++   +VIHRD+K  N+LL +    K+ DFG++    ++ +    N  +GT 
Sbjct: 139 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTP 193
Query: 175 GYMSLEYTM-----SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV 222
            +M+ E          T   K+D++  G+  +++  G       H  R L L+
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 49/107 (45%), Gaps = 12/107 (11%)
Query: 103 PNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLD---DQLNTKISDFGMARIFG 159
           P ++L S  S   +    LH+    R+IHRDLK  NI+L     +L  KI D G A+   
Sbjct: 123 PIRTLLSDISSALR---YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL- 175
Query: 160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
             + G      VGT  Y++ E       ++  D + FG L  + + G
Sbjct: 176 --DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 76/177 (42%), Gaps = 25/177 (14%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL--- 107
           V + +   + G    + + EA +   L++ ++V+LL          +V+EFM    L   
Sbjct: 59  VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFE 118
Query: 108 -----DSSFSGTFKDLLCLHKYSRL----------RVIHRDLKASNILLDDQLNT---KI 149
                D+ F   + + +  H   ++           +IHRD+K   +LL  + N+   K+
Sbjct: 119 IVKRADAGF--VYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKL 176
Query: 150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
             FG+A   G  ESG      VGT  +M+ E           DV+G GV++  ++ G
Sbjct: 177 GGFGVAIQLG--ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 49/107 (45%), Gaps = 12/107 (11%)
Query: 103 PNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLD---DQLNTKISDFGMARIFG 159
           P ++L S  S   +    LH+    R+IHRDLK  NI+L     +L  KI D G A+   
Sbjct: 122 PIRTLLSDISSALR---YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL- 174
Query: 160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
             + G      VGT  Y++ E       ++  D + FG L  + + G
Sbjct: 175 --DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 64/142 (45%), Gaps = 13/142 (9%)
Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSR 126
           FQ E KL   L Y N  +L    +   ER   +E          + G    +L L    +
Sbjct: 128 FQTETKLHLILDYINGGELF-THLSQRERFTEHEV-------QIYVGEI--VLALEHLHK 177
Query: 127 LRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGT 186
           L +I+RD+K  NILLD   +  ++DFG+++ F  +E+        GT  YM+ +    G 
Sbjct: 178 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGD 236
Query: 187 VS--IKTDVFGFGVLVLKIVCG 206
                  D +  GVL+ +++ G
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTG 258

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 61/116 (52%), Gaps = 12/116 (10%)
Query: 97  LVYEFMPNKSLDSSFSGTFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTK 148
           L Y + P+ + +   S   KDL+ C ++ +R        + IHRDL A N+L+ +    K
Sbjct: 118 LEYCYNPSHNPEEQLSS--KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 175
Query: 149 ISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           I+DFG+AR I  ++     TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/200 (21%), Positives = 97/200 (48%), Gaps = 22/200 (11%)
Query: 23  SLDWHMYIQQ--EQTRDRVILVGKFPNEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQ 78
           S++ ++ +Q+  E +  + ILV    + ++  IK +  +  S + R E + E  ++A ++
Sbjct: 22  SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK 81
Query: 79  YTNLVKLLGCSIHGEERLLVYEFMPN----KSLDSSFSGTFKD--------LLCL---HK 123
           + N+V+            +V ++       K +++     F++         +CL   H 
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 124 YSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM 183
           + R +++HRD+K+ NI L      ++ DFG+AR+  +N +       +GT  Y+S E   
Sbjct: 142 HDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEICE 198
Query: 184 SGTVSIKTDVFGFGVLVLKI 203
           +   + K+D++  G ++ ++
Sbjct: 199 NKPYNNKSDIWALGCVLYEL 218

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 52/102 (50%), Gaps = 11/102 (10%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           ++HRDLK  NIL+      K++DFG+ARI+    + A    +V T  Y + E  +  T +
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP---VVVTLWYRAPEVLLQSTYA 189
Query: 189 IKTDVFGFGVLVLK------IVCGKKNNKSYHTERPLNLVGI 224
              D++  G +  +      + CG  N+++    +  +L+G+
Sbjct: 190 TPVDMWSVGCIFAEMFRRKPLFCG--NSEADQLGKIFDLIGL 229

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 19/160 (11%)
Query: 63  GRVEFQ---NEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYEFMPNKSL---DSSFSGTF 115
           GR  FQ   +    I  L + ++V+LLG C   G    LV +++P  SL        G  
Sbjct: 55  GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP--GSSLQLVTQYLPLGSLLDHVRQHRGAL 112
Query: 116 KDLLCLHKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA 165
              L L+   ++           ++HR+L A N+LL      +++DFG+A +   ++   
Sbjct: 113 GPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172
Query: 166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC 205
             +       +M+LE    G  + ++DV+ +GV V +++ 
Sbjct: 173 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 85/196 (43%), Gaps = 47/196 (23%)
Query: 50  EVAIKRLAWTSGQGRVE-FQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEF------ 101
           +VA+K L  T+     E   +E K+++ L Q+ N+V LLG   HG   L++ E+      
Sbjct: 63  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 122
Query: 102 ----------------MPNK---SLDSSFSGTFKDLLCLHKYSRL----------RVIHR 132
                            P +    LD       +    LH  S++            IHR
Sbjct: 123 LNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHR 182
Query: 133 DLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTV 187
           D+ A N+LL +    KI DFG+AR   +N+S    N IV         +M+ E       
Sbjct: 183 DVAARNVLLTNGHVAKIGDFGLARDI-MNDS----NYIVKGNARLPVKWMAPESIFDCVY 237
Query: 188 SIKTDVFGFGVLVLKI 203
           ++++DV+ +G+L+ +I
Sbjct: 238 TVQSDVWSYGILLWEI 253

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 20/99 (20%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIF------------GVNESGANTN-------R 169
           ++HRD+K SNILL+ + + K++DFG++R F             +NE+  N +        
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 170 IVGTYGYMSLEYTMSGTVSIK-TDVFGFGVLVLKIVCGK 207
            V T  Y + E  +  T   K  D++  G ++ +I+CGK
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 13/89 (14%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMAR-------IFGVNE-----SGANTNRIVGTYGY 176
           +IHRDLK  NI +D+  N KI DFG+A+       I  ++      S  N    +GT  Y
Sbjct: 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMY 196
Query: 177 MSLEY-TMSGTVSIKTDVFGFGVLVLKIV 204
           ++ E    +G  + K D++  G++  +++
Sbjct: 197 VATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 52/102 (50%), Gaps = 11/102 (10%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           ++HRDLK  NIL+      K++DFG+ARI+    +    + +V T  Y + E  +  T +
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LDPVVVTLWYRAPEVLLQSTYA 189
Query: 189 IKTDVFGFGVLVLK------IVCGKKNNKSYHTERPLNLVGI 224
              D++  G +  +      + CG  N+++    +  +L+G+
Sbjct: 190 TPVDMWSVGCIFAEMFRRKPLFCG--NSEADQLGKIFDLIGL 229

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 115 FKDLLCLHKYSRL-RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
           F+DL+   +Y    ++IHRD+K SN+L+ +  + KI+DFG++  F    S A  +  VGT
Sbjct: 143 FQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF--KGSDALLSNTVGT 200
Query: 174 YGYMSLEYTMSGTVSIKT----DVFGFGVLVLKIVCGK 207
             +M+ E ++S T  I +    DV+  GV +   V G+
Sbjct: 201 PAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 61/116 (52%), Gaps = 12/116 (10%)
Query: 97  LVYEFMPNKSLDSSFSGTFKDLL-CLHKYSR-------LRVIHRDLKASNILLDDQLNTK 148
           L Y + P+ + +   S   KDL+ C ++ +R        + IHRDL A N+L+ +    K
Sbjct: 133 LEYCYNPSHNPEEQLSS--KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 190
Query: 149 ISDFGMAR-IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
           I+DFG+AR I  ++     TN  +    +M+ E       + ++DV+ FGVL+ +I
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 78/186 (41%), Gaps = 40/186 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           E+ VAIK+L+         FQN+    AK  Y  LV L+    H     L+  F P KSL
Sbjct: 49  ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKVVNHKNIIGLLNVFTPQKSL 98
Query: 108 -------------DSSFSGTFKDLLCLHKYSRL--------------RVIHRDLKASNIL 140
                        D++ S   +  L   + S L               +IHRDLK SNI+
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIV 158
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  GV++
Sbjct: 159 VKSDATLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIM 215
Query: 201 LKIVCG 206
            +++ G
Sbjct: 216 GEMIKG 221

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 13/89 (14%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMAR-------IFGVNE-----SGANTNRIVGTYGY 176
           +IHRDLK  NI +D+  N KI DFG+A+       I  ++      S  N    +GT  Y
Sbjct: 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMY 196
Query: 177 MSLEY-TMSGTVSIKTDVFGFGVLVLKIV 204
           ++ E    +G  + K D++  G++  +++
Sbjct: 197 VATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 78/186 (41%), Gaps = 40/186 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           E+ VAIK+L+         FQN+    AK  Y  LV L+    H     L+  F P KSL
Sbjct: 49  ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKVVNHKNIIGLLNVFTPQKSL 98
Query: 108 -------------DSSFSGTFKDLLCLHKYSRL--------------RVIHRDLKASNIL 140
                        D++ S   +  L   + S L               +IHRDLK SNI+
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIV 158
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  GV++
Sbjct: 159 VKSDATLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIM 215
Query: 201 LKIVCG 206
            +++ G
Sbjct: 216 GEMIKG 221

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 65/128 (50%), Gaps = 22/128 (17%)
Query: 51  VAIKRLAWTSGQGRVEFQ--NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMP---- 103
           VA+KR+        V      E  L+ +L++ N+V+L    +H +++L LV+EF      
Sbjct: 30  VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-LHSDKKLTLVFEFCDQDLK 88
Query: 104 ------NKSLDSSFSGTFKDLLCLHK-----YSRLRVIHRDLKASNILLDDQLNTKISDF 152
                 N  LD     +F  L  L K     +SR  V+HRDLK  N+L++     K++DF
Sbjct: 89  KYFDSCNGDLDPEIVKSF--LFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLADF 145
Query: 153 GMARIFGV 160
           G+AR FG+
Sbjct: 146 GLARAFGI 153

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/150 (24%), Positives = 64/150 (42%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT  Y
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++    +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 5/94 (5%)
Query: 113 GTFKD-LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           G  +D LL L       ++H D+K +NI L  +   K+ DFG+    G   +G       
Sbjct: 161 GYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--- 217
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC 205
           G   YM+ E  + G+     DVF  G+ +L++ C
Sbjct: 218 GDPRYMAPEL-LQGSYGTAADVFSLGLTILEVAC 250

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/188 (21%), Positives = 79/188 (42%), Gaps = 21/188 (11%)
Query: 22  SSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTN 81
           S  +   Y Q+     +++L  +F +E  + I  +        +E   +  ++  L  T+
Sbjct: 61  SPFEHQTYCQRTLREIKILL--RFRHENIIGINDIIRAPT---IEQMKDVYIVQDLMETD 115
Query: 82  LVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILL 141
           L KLL C     + +  + +   + L    S                V+HRDLK SN+LL
Sbjct: 116 LYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN--------------VLHRDLKPSNLLL 161
Query: 142 DDQLNTKISDFGMARIFGVNESGAN-TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVL 199
           +   + KI DFG+AR+   +          V T  Y + E  ++     K+ D++  G +
Sbjct: 162 NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 221
Query: 200 VLKIVCGK 207
           + +++  +
Sbjct: 222 LAEMLSNR 229

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/163 (21%), Positives = 69/163 (42%), Gaps = 24/163 (14%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEER------LLVYEFMPNKSLDSSFSGT----- 114
           EF  EA  + +  + ++ KL+G S+    +      +++  FM +  L +    +     
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 115 ------------FKDLLCLHKY-SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN 161
                         D+ C  +Y S    IHRDL A N +L + +   ++DFG++R     
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           +             +++LE       ++ +DV+ FGV + +I+
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 19/155 (12%)
Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL-----------DSSFSGTF 115
           F+ E +++  L + N+++L        +  LV E      L           +S  +   
Sbjct: 53  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIM 112
Query: 116 KDLLCLHKY-SRLRVIHRDLKASNIL-LDDQLNT--KISDFGMARIFGVNESGANTNRIV 171
           KD+L    Y  +L V HRDLK  N L L D  ++  K+ DFG+A  F   + G      V
Sbjct: 113 KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRTKV 169
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           GT  Y+S +  + G    + D +  GV++  ++CG
Sbjct: 170 GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 22/152 (14%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP----NKSLDSSFSGTFKDLLCL 121
           E   EA ++ +L    +V+++G     E  +LV E       NK L  +     K+++ L
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 116
Query: 122 -HKYS-------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
            H+ S           +HRDL A N+LL  Q   KISDFG+++    +E+         T
Sbjct: 117 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQ----T 172
Query: 174 YGYMSLEYTMSGTV-----SIKTDVFGFGVLV 200
           +G   +++     +     S K+DV+ FGVL+
Sbjct: 173 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 204

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 19/155 (12%)
Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL-----------DSSFSGTF 115
           F+ E +++  L + N+++L        +  LV E      L           +S  +   
Sbjct: 70  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIM 129
Query: 116 KDLLCLHKY-SRLRVIHRDLKASNIL-LDDQLNT--KISDFGMARIFGVNESGANTNRIV 171
           KD+L    Y  +L V HRDLK  N L L D  ++  K+ DFG+A  F   + G      V
Sbjct: 130 KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRTKV 186
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           GT  Y+S +  + G    + D +  GV++  ++CG
Sbjct: 187 GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 51/102 (50%), Gaps = 11/102 (10%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           ++HRDLK  NIL+      K++DFG+ARI+    +      +V T  Y + E  +  T +
Sbjct: 141 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYA 197
Query: 189 IKTDVFGFGVLVLK------IVCGKKNNKSYHTERPLNLVGI 224
              D++  G +  +      + CG  N+++    +  +L+G+
Sbjct: 198 TPVDMWSVGCIFAEMFRRKPLFCG--NSEADQLGKIFDLIGL 237

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 22/152 (14%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP----NKSLDSSFSGTFKDLLCL 121
           E   EA ++ +L    +V+++G     E  +LV E       NK L  +     K+++ L
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 130
Query: 122 -HKYS-------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
            H+ S           +HRDL A N+LL  Q   KISDFG+++    +E+         T
Sbjct: 131 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----T 186
Query: 174 YGYMSLEYTMSGTV-----SIKTDVFGFGVLV 200
           +G   +++     +     S K+DV+ FGVL+
Sbjct: 187 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 218

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY-----TM 183
           VIHRD+K SNILLD++   K+ DFG++   G        +R  G   YM+ E        
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 184 SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTE 216
                I+ DV+  G+ ++++  G+   K+  T+
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 22/152 (14%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP----NKSLDSSFSGTFKDLLCL 121
           E   EA ++ +L    +V+++G     E  +LV E       NK L  +     K+++ L
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 132
Query: 122 -HKYS-------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
            H+ S           +HRDL A N+LL  Q   KISDFG+++    +E+         T
Sbjct: 133 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----T 188
Query: 174 YGYMSLEYTMSGTV-----SIKTDVFGFGVLV 200
           +G   +++     +     S K+DV+ FGVL+
Sbjct: 189 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 220

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 22/152 (14%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP----NKSLDSSFSGTFKDLLCL 121
           E   EA ++ +L    +V+++G     E  +LV E       NK L  +     K+++ L
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 132
Query: 122 -HKYS-------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
            H+ S           +HRDL A N+LL  Q   KISDFG+++    +E+         T
Sbjct: 133 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----T 188
Query: 174 YGYMSLEYTMSGTV-----SIKTDVFGFGVLV 200
           +G   +++     +     S K+DV+ FGVL+
Sbjct: 189 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 220

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 90/199 (45%), Gaps = 48/199 (24%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQN---EAKLIAKLQYTNLVKLLGCSIHGEER 95
           VIL       QE A+K ++    + + + ++   E +L+ +L + N++KL          
Sbjct: 48  VILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL---------- 97
Query: 96  LLVYEFMPNKS----LDSSFSGT--FKDLLCLHKYSRL-------------------RVI 130
              YEF  +K     +   ++G   F +++   ++S +                   +++
Sbjct: 98  ---YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIV 154
Query: 131 HRDLKASNILLDDQ---LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           HRDLK  N+LL+ +    N +I DFG++  F   E+       +GT  Y++ E  + GT 
Sbjct: 155 HRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPE-VLHGTY 210
Query: 188 SIKTDVFGFGVLVLKIVCG 206
             K DV+  GV++  ++ G
Sbjct: 211 DEKCDVWSTGVILYILLSG 229

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 2/78 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +I+RDLK  NI+L+ Q + K++DFG+ +       G  T+   GT  YM+ E  M    +
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAPEILMRSGHN 199
Query: 189 IKTDVFGFGVLVLKIVCG 206
              D +  G L+  ++ G
Sbjct: 200 RAVDWWSLGALMYDMLTG 217

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 22/152 (14%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP----NKSLDSSFSGTFKDLLCL 121
           E   EA ++ +L    +V+++G     E  +LV E       NK L  +     K+++ L
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 122
Query: 122 -HKYS-------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
            H+ S           +HRDL A N+LL  Q   KISDFG+++    +E+         T
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----T 178
Query: 174 YGYMSLEYTMSGTV-----SIKTDVFGFGVLV 200
           +G   +++     +     S K+DV+ FGVL+
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 210

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 90/199 (45%), Gaps = 48/199 (24%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQN---EAKLIAKLQYTNLVKLLGCSIHGEER 95
           VIL       QE A+K ++    + + + ++   E +L+ +L + N++KL          
Sbjct: 42  VILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL---------- 91
Query: 96  LLVYEFMPNKS----LDSSFSGT--FKDLLCLHKYSRL-------------------RVI 130
              YEF  +K     +   ++G   F +++   ++S +                   +++
Sbjct: 92  ---YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIV 148
Query: 131 HRDLKASNILLDDQ---LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           HRDLK  N+LL+ +    N +I DFG++  F   E+       +GT  Y++ E  + GT 
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPE-VLHGTY 204
Query: 188 SIKTDVFGFGVLVLKIVCG 206
             K DV+  GV++  ++ G
Sbjct: 205 DEKCDVWSTGVILYILLSG 223

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 22/152 (14%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP----NKSLDSSFSGTFKDLLCL 121
           E   EA ++ +L    +V+++G     E  +LV E       NK L  +     K+++ L
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 116
Query: 122 -HKYS-------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
            H+ S           +HRDL A N+LL  Q   KISDFG+++    +E+         T
Sbjct: 117 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----T 172
Query: 174 YGYMSLEYTMSGTV-----SIKTDVFGFGVLV 200
           +G   +++     +     S K+DV+ FGVL+
Sbjct: 173 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 204

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 22/152 (14%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP----NKSLDSSFSGTFKDLLCL 121
           E   EA ++ +L    +V+++G     E  +LV E       NK L  +     K+++ L
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 110
Query: 122 -HKYS-------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
            H+ S           +HRDL A N+LL  Q   KISDFG+++    +E+         T
Sbjct: 111 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----T 166
Query: 174 YGYMSLEYTMSGTV-----SIKTDVFGFGVLV 200
           +G   +++     +     S K+DV+ FGVL+
Sbjct: 167 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 198

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 2/78 (2%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +I+RDLK  NI+L+ Q + K++DFG+ +       G  T+   GT  YM+ E  M    +
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEILMRSGHN 199
Query: 189 IKTDVFGFGVLVLKIVCG 206
              D +  G L+  ++ G
Sbjct: 200 RAVDWWSLGALMYDMLTG 217

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 26/134 (19%)
Query: 49  QEVAIKRLAWTSGQGRVEFQ--NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN-- 104
           + VAIKR+     +  V      E  L+ +LQ+ N+++L     H     L++E+  N  
Sbjct: 60  ETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDL 119
Query: 105 -KSLDSSFSGTFKDL------------LCLHKYSRLRVIHRDLKASNILL--DDQLNT-- 147
            K +D +   + + +             C   +SR R +HRDLK  N+LL   D   T  
Sbjct: 120 KKYMDKNPDVSMRVIKSFLYQLINGVNFC---HSR-RCLHRDLKPQNLLLSVSDASETPV 175
Query: 148 -KISDFGMARIFGV 160
            KI DFG+AR FG+
Sbjct: 176 LKIGDFGLARAFGI 189

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 22/152 (14%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP----NKSLDSSFSGTFKDLLCL 121
           E   EA ++ +L    +V+++G     E  +LV E       NK L  +     K+++ L
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 112
Query: 122 -HKYS-------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
            H+ S           +HRDL A N+LL  Q   KISDFG+++    +E+         T
Sbjct: 113 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----T 168
Query: 174 YGYMSLEYTMSGTV-----SIKTDVFGFGVLV 200
           +G   +++     +     S K+DV+ FGVL+
Sbjct: 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 200

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 75/186 (40%), Gaps = 40/186 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           E+ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P KSL
Sbjct: 51  ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSL 100
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 101 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 160
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S      +V  Y Y + E  +        D++  G ++
Sbjct: 161 VKSDCTLKILDFGLARTAGT--SFMMVPFVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 217
Query: 201 LKIVCG 206
            +++ G
Sbjct: 218 GEMIKG 223

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 22/152 (14%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP----NKSLDSSFSGTFKDLLCL 121
           E   EA ++ +L    +V+++G     E  +LV E       NK L  +     K+++ L
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 474
Query: 122 -HKYS-------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
            H+ S           +HRDL A N+LL  Q   KISDFG+++    +E+         T
Sbjct: 475 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----T 530
Query: 174 YGYMSLEYTMSGTV-----SIKTDVFGFGVLV 200
           +G   +++     +     S K+DV+ FGVL+
Sbjct: 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 562

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 90/199 (45%), Gaps = 48/199 (24%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQN---EAKLIAKLQYTNLVKLLGCSIHGEER 95
           VIL       QE A+K ++    + + + ++   E +L+ +L + N++KL          
Sbjct: 65  VILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL---------- 114
Query: 96  LLVYEFMPNKS----LDSSFSGT--FKDLLCLHKYSRL-------------------RVI 130
              YEF  +K     +   ++G   F +++   ++S +                   +++
Sbjct: 115 ---YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIV 171
Query: 131 HRDLKASNILLDDQ---LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           HRDLK  N+LL+ +    N +I DFG++  F   E+       +GT  Y++ E  + GT 
Sbjct: 172 HRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPE-VLHGTY 227
Query: 188 SIKTDVFGFGVLVLKIVCG 206
             K DV+  GV++  ++ G
Sbjct: 228 DEKCDVWSTGVILYILLSG 246

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 22/152 (14%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP----NKSLDSSFSGTFKDLLCL 121
           E   EA ++ +L    +V+++G     E  +LV E       NK L  +     K+++ L
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 475
Query: 122 -HKYS-------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
            H+ S           +HRDL A N+LL  Q   KISDFG+++    +E+         T
Sbjct: 476 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----T 531
Query: 174 YGYMSLEYTMSGTV-----SIKTDVFGFGVLV 200
           +G   +++     +     S K+DV+ FGVL+
Sbjct: 532 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 563

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 90/199 (45%), Gaps = 48/199 (24%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQN---EAKLIAKLQYTNLVKLLGCSIHGEER 95
           VIL       QE A+K ++    + + + ++   E +L+ +L + N++KL          
Sbjct: 66  VILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL---------- 115
Query: 96  LLVYEFMPNKS----LDSSFSGT--FKDLLCLHKYSRL-------------------RVI 130
              YEF  +K     +   ++G   F +++   ++S +                   +++
Sbjct: 116 ---YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIV 172
Query: 131 HRDLKASNILLDDQ---LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           HRDLK  N+LL+ +    N +I DFG++  F   E+       +GT  Y++ E  + GT 
Sbjct: 173 HRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPE-VLHGTY 228
Query: 188 SIKTDVFGFGVLVLKIVCG 206
             K DV+  GV++  ++ G
Sbjct: 229 DEKCDVWSTGVILYILLSG 247

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 89/199 (44%), Gaps = 48/199 (24%)
Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQN---EAKLIAKLQYTNLVKLLGCSIHGEER 95
           VIL       QE A+K ++    + + + ++   E +L+ +L + N+ KL          
Sbjct: 42  VILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL---------- 91
Query: 96  LLVYEFMPNKS----LDSSFSGT--FKDLLCLHKYSRL-------------------RVI 130
              YEF  +K     +   ++G   F +++   ++S +                   +++
Sbjct: 92  ---YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIV 148
Query: 131 HRDLKASNILLDDQ---LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           HRDLK  N+LL+ +    N +I DFG++  F   E+       +GT  Y++ E  + GT 
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKXKDKIGTAYYIAPE-VLHGTY 204
Query: 188 SIKTDVFGFGVLVLKIVCG 206
             K DV+  GV++  ++ G
Sbjct: 205 DEKCDVWSTGVILYILLSG 223

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/150 (24%), Positives = 64/150 (42%), Gaps = 17/150 (11%)
Query: 69  NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--GTFKD--------- 117
           NE +++  + +  LVKL           +V E++    + S     G F +         
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 118 -LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            +L       L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT   
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEA 204
Query: 177 MSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           ++ E  +S   +   D +  GVL+ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 76/187 (40%), Gaps = 40/187 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           ++ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P K+L
Sbjct: 43  DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTL 92
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 93  EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 152
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 153 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 209
Query: 201 LKIVCGK 207
            ++V  K
Sbjct: 210 GEMVRHK 216

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 82/190 (43%), Gaps = 36/190 (18%)
Query: 40  ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           +L G+    + +  K+L   S +   + + EA++   L++ N+V+L           L++
Sbjct: 44  VLAGQEYAAKIINTKKL---SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 100
Query: 100 EFMPNKSLDSSFSGTFKDLLCLHKYS-------------------RLRVIHRDLKASNIL 140
           + +    L       F+D++    YS                   ++ V+HRDLK  N+L
Sbjct: 101 DLVTGGEL-------FEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLL 153
Query: 141 LDDQLN---TKISDFGMA-RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGF 196
           L  +L     K++DFG+A  + G  ++        GT GY+S E           D++  
Sbjct: 154 LASKLKGAAVKLADFGLAIEVEGEQQAWFG---FAGTPGYLSPEVLRKDPYGKPVDLWAC 210
Query: 197 GVLVLKIVCG 206
           GV++  ++ G
Sbjct: 211 GVILYILLVG 220

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 76/187 (40%), Gaps = 40/187 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           ++ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P K+L
Sbjct: 49  DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTL 98
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 99  EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 159 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 215
Query: 201 LKIVCGK 207
            ++V  K
Sbjct: 216 GEMVRHK 222

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 76/187 (40%), Gaps = 40/187 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           ++ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P K+L
Sbjct: 42  DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTL 91
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 92  EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 152 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 208
Query: 201 LKIVCGK 207
            ++V  K
Sbjct: 209 GEMVRHK 215

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 76/187 (40%), Gaps = 40/187 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           ++ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P K+L
Sbjct: 43  DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTL 92
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 93  EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 152
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 153 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 209
Query: 201 LKIVCGK 207
            ++V  K
Sbjct: 210 GEMVRHK 216

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 76/187 (40%), Gaps = 40/187 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           ++ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P K+L
Sbjct: 48  DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTL 97
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 98  EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 157
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 158 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 214
Query: 201 LKIVCGK 207
            ++V  K
Sbjct: 215 GEMVRHK 221

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 76/187 (40%), Gaps = 40/187 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           ++ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P K+L
Sbjct: 50  DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTL 99
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 100 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 159
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 160 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 216
Query: 201 LKIVCGK 207
            ++V  K
Sbjct: 217 GEMVRHK 223

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 76/187 (40%), Gaps = 40/187 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           ++ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P K+L
Sbjct: 50  DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTL 99
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 100 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 159
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 160 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 216
Query: 201 LKIVCGK 207
            ++V  K
Sbjct: 217 GEMVRHK 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 76/187 (40%), Gaps = 40/187 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           ++ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P K+L
Sbjct: 49  DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTL 98
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 99  EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 159 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 215
Query: 201 LKIVCGK 207
            ++V  K
Sbjct: 216 GEMVRHK 222

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 10/89 (11%)
Query: 121 LHKYSRLRVIHRDLKASNILLDDQLN---TKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           LHK++   ++HRDLK  N+LL+ +      KI DFG++  F   E G      +GT  Y+
Sbjct: 137 LHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYYI 190
Query: 178 SLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           + E  +      K DV+  GV++  ++CG
Sbjct: 191 APE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 76/187 (40%), Gaps = 40/187 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           ++ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P K+L
Sbjct: 87  DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTL 136
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 137 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 197 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 253
Query: 201 LKIVCGK 207
            ++V  K
Sbjct: 254 GEMVRHK 260

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 51/102 (50%), Gaps = 11/102 (10%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           ++HRDLK  NIL+      K++DFG+ARI+    +      +V T  Y + E  +  T +
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LFPVVVTLWYRAPEVLLQSTYA 189
Query: 189 IKTDVFGFGVLVLK------IVCGKKNNKSYHTERPLNLVGI 224
              D++  G +  +      + CG  N+++    +  +L+G+
Sbjct: 190 TPVDMWSVGCIFAEMFRRKPLFCG--NSEADQLGKIFDLIGL 229

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 75/184 (40%), Gaps = 40/184 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           ++ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P K+L
Sbjct: 87  DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTL 136
Query: 108 DS--------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNIL 140
           +                             S     +LC  K+     +IHRDLK SNI+
Sbjct: 137 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 197 VKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 253
Query: 201 LKIV 204
            ++V
Sbjct: 254 GEMV 257

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 27/202 (13%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVK---LLGCSIH------GEERLLV 98
           ++ VAIK++  T  Q       E K+I +L + N+VK   +LG S        G    L 
Sbjct: 36  DKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95
Query: 99  YEFMPNKSLDSSFSGTFKDLLCLHKYSRL---------------RVIHRDLKASNILLD- 142
             ++  + +++  +   +    L +++RL                V+HRDLK +N+ ++ 
Sbjct: 96  SVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT 155
Query: 143 DQLNTKISDFGMARIFGVNESG-ANTNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLV 200
           + L  KI DFG+ARI   + S   + +  + T  Y S    +S     K  D++  G + 
Sbjct: 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 215
Query: 201 LKIVCGKKNNKSYHTERPLNLV 222
            +++ GK      H    + L+
Sbjct: 216 AEMLTGKTLFAGAHELEQMQLI 237

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 74/183 (40%), Gaps = 40/183 (21%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS- 109
           VA+K+L+         FQN+    AK  Y  LV LL C  H     L+  F P K+L+  
Sbjct: 52  VAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEF 101
Query: 110 -------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDD 143
                                      S     +LC  K+     +IHRDLK SNI++  
Sbjct: 102 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
               KI DFG+AR    N     T  +V  Y Y + E  +    +   D++  G ++ ++
Sbjct: 162 DCTLKILDFGLARTACTN--FMMTPYVVTRY-YRAPEVILGMGYAANVDIWSVGCIMGEL 218
Query: 204 VCG 206
           V G
Sbjct: 219 VKG 221

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 61/161 (37%), Gaps = 31/161 (19%)
Query: 51  VAIKRLAWTSGQGRV-----------EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           VAIKR+  T   GR                E +L+    + N++ L    +H EE  +  
Sbjct: 49  VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHK 108
Query: 100 EFMPNKSLDSSFSGTFKD-----------------LLCLHKYSRLRVIHRDLKASNILLD 142
            ++  + + +  +    D                 LL LH      V+HRDL   NILL 
Sbjct: 109 LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA 168
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM 183
           D  +  I DF +AR    + + AN    V    Y + E  M
Sbjct: 169 DNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPELVM 206

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 78/186 (41%), Gaps = 32/186 (17%)
Query: 38  RVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           +++ + KF  +E +  IK++A            E +++ +L++ NLV LL          
Sbjct: 29  QIVAIKKFLESEDDPVIKKIAL----------REIRMLKQLKHPNLVNLLEVFRRKRRLH 78
Query: 97  LVYEF---------------MPNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILL 141
           LV+E+               +P   + S    T + +   HK++    IHRD+K  NIL+
Sbjct: 79  LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILI 135
Query: 142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGT-VSIKTDVFGFGVLV 200
                 K+ DFG AR+        +    V T  Y S E  +  T      DV+  G + 
Sbjct: 136 TKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPELLVGDTQYGPPVDVWAIGCVF 193
Query: 201 LKIVCG 206
            +++ G
Sbjct: 194 AELLSG 199

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 61/161 (37%), Gaps = 31/161 (19%)
Query: 51  VAIKRLAWTSGQGRV-----------EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY 99
           VAIKR+  T   GR                E +L+    + N++ L    +H EE  +  
Sbjct: 49  VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHK 108
Query: 100 EFMPNKSLDSSFSGTFKD-----------------LLCLHKYSRLRVIHRDLKASNILLD 142
            ++  + + +  +    D                 LL LH      V+HRDL   NILL 
Sbjct: 109 LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA 168
Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM 183
           D  +  I DF +AR    + + AN    V    Y + E  M
Sbjct: 169 DNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPELVM 206

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 78/186 (41%), Gaps = 40/186 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           E+ VAIK+L+         FQN+    AK  Y  LV L+    H     L+  F P KSL
Sbjct: 49  ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKVVNHKNIIGLLNVFTPQKSL 98
Query: 108 -------------DSSFSGTFK-------------DLLCLHKY-SRLRVIHRDLKASNIL 140
                        D++ S   +              +LC  K+     +IHRDLK SNI+
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 159 VKSDATLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 215
Query: 201 LKIVCG 206
            +++ G
Sbjct: 216 GEMIKG 221

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 10/89 (11%)
Query: 121 LHKYSRLRVIHRDLKASNILLDDQLN---TKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           LHK++   ++HRDLK  N+LL+ +      KI DFG++  F   E G      +GT  Y+
Sbjct: 120 LHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYYI 173
Query: 178 SLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           + E  +      K DV+  GV++  ++CG
Sbjct: 174 APE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 65/128 (50%), Gaps = 22/128 (17%)
Query: 51  VAIKRLAWTSGQGRVEFQ--NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMP---- 103
           VA+KR+        V      E  L+ +L++ N+V+L    +H +++L LV+EF      
Sbjct: 30  VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-LHSDKKLTLVFEFCDQDLK 88
Query: 104 ------NKSLDSSFSGTFKDLLCLHK-----YSRLRVIHRDLKASNILLDDQLNTKISDF 152
                 N  LD     +F  L  L K     +SR  V+HRDLK  N+L++     K+++F
Sbjct: 89  KYFDSCNGDLDPEIVKSF--LFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANF 145
Query: 153 GMARIFGV 160
           G+AR FG+
Sbjct: 146 GLARAFGI 153

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 77/186 (41%), Gaps = 40/186 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           E+ VAIK+L+         FQN+    AK  Y  LV L+    H     L+  F P KSL
Sbjct: 49  ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKVVNHKNIIGLLNVFTPQKSL 98
Query: 108 -------------DSSFSGTFKDLLCLHKYSRL--------------RVIHRDLKASNIL 140
                        D++ S   +  L   + S L               +IHRDLK SNI+
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIV 158
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 159 VKSDATLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 215
Query: 201 LKIVCG 206
            +++ G
Sbjct: 216 GEMIKG 221

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 13/89 (14%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMAR-------IFGVNE-----SGANTNRIVGTYGY 176
           +IHR+LK  NI +D+  N KI DFG+A+       I  ++      S  N    +GT  Y
Sbjct: 137 IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXY 196
Query: 177 MSLEY-TMSGTVSIKTDVFGFGVLVLKIV 204
           ++ E    +G  + K D +  G++  + +
Sbjct: 197 VATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 124 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGF 183
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 19/155 (12%)
Query: 67  FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL-----------DSSFSGTF 115
            +NE  ++ K+++ N+V L           LV + +    L           +   S   
Sbjct: 53  LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI 112
Query: 116 KDLLCLHKYSRLR-VIHRDLKASNIL-LDDQLNTKI--SDFGMARIFGVNESGANTNRIV 171
           + +L   KY     ++HRDLK  N+L L  + N+KI  +DFG++++    E     +   
Sbjct: 113 QQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTAC 168
Query: 172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           GT GY++ E       S   D +  GV+   ++CG
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 124 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 183
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 40/86 (46%), Gaps = 10/86 (11%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNE----------SGANTNRIVGTYGYMS 178
           ++HRDLK SNI        K+ DFG+      +E          + A     VGT  YMS
Sbjct: 139 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMS 198
Query: 179 LEYTMSGTVSIKTDVFGFGVLVLKIV 204
            E     + S K D+F  G+++ +++
Sbjct: 199 PEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 124 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 183
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 187
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 187
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 124 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 183
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 77/187 (41%), Gaps = 40/187 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           ++ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P K+L
Sbjct: 42  DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTL 91
Query: 108 -------------DSSFSGTFKDLLCLHKYSRLR--------------VIHRDLKASNIL 140
                        D++     +  L   + S L               +IHRDLK SNI+
Sbjct: 92  EEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIV 151
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 152 VKSDXTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 208
Query: 201 LKIVCGK 207
            ++V  K
Sbjct: 209 GEMVRHK 215

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 46/106 (43%), Gaps = 20/106 (18%)
Query: 119 LCLHKYSRLR----------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNE------ 162
           +CLH + ++           ++HRDLK SNI        K+ DFG+      +E      
Sbjct: 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 163 ----SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
               + A     VGT  YMS E       S K D+F  G+++ +++
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 129 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 188
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 189 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 122 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 181
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 182 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 130 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 189
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 190 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 121 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 180
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 181 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           ++I+RDLK SNI L D    KI DFG+       ++     R  GT  YMS E   S   
Sbjct: 142 KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRXRSKGTLRYMSPEQISSQDY 198
Query: 188 SIKTDVFGFGVLVLKI--VC 205
             + D++  G+++ ++  VC
Sbjct: 199 GKEVDLYALGLILAELLHVC 218

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 73/183 (39%), Gaps = 40/183 (21%)
Query: 51  VAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS- 109
           VA+K+L+         FQN+    AK  Y  LV LL C  H     L+  F P K+L+  
Sbjct: 50  VAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEF 99
Query: 110 -------------------------SFSGTFKDLLCLHKY-SRLRVIHRDLKASNILLDD 143
                                      S     +LC  K+     +IHRDLK SNI++  
Sbjct: 100 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 159
Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
               KI DFG+AR    N     T  +V  Y Y + E  +        D++  G ++ ++
Sbjct: 160 DCTLKILDFGLARTASTN--FMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEL 216
Query: 204 VCG 206
           V G
Sbjct: 217 VKG 219

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 70/169 (41%), Gaps = 31/169 (18%)
Query: 60  SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLL 119
           S +   + + EA++   L+++N+V+L           LV++ +    L       F+D++
Sbjct: 43  SARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGEL-------FEDIV 95
Query: 120 CLHKYS-------------------RLRVIHRDLKASNILLDDQLN---TKISDFGMARI 157
               YS                   ++ V+HRDLK  N+LL  +      K++DFG+A  
Sbjct: 96  AREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-- 153
Query: 158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
             V           GT GY+S E           D++  GV++  ++ G
Sbjct: 154 IEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 122 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 181
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 182 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 144 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 203
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 204 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 19/154 (12%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSF---SGTFKDLLCLH 122
           +F  E   +  L + NL++L G  +    ++ V E  P  SL        G F  L  L 
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLS 114
Query: 123 KYS-----------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA--NTNR 169
           +Y+             R IHRDL A N+LL  +   KI DFG+ R    N+       +R
Sbjct: 115 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHR 174
Query: 170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
            V  + + + E   + T S  +D + FGV + ++
Sbjct: 175 KV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 126 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 185
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 186 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 77/187 (41%), Gaps = 40/187 (21%)
Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           ++ VAIK+L+         FQN+    AK  Y  LV L+ C  H     L+  F P K+L
Sbjct: 49  DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTL 98
Query: 108 -------------DSSFSGTFKDLLCLHKYSRLR--------------VIHRDLKASNIL 140
                        D++     +  L   + S L               +IHRDLK SNI+
Sbjct: 99  EEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIV 158
Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G   S   T  +V  Y Y + E  +        D++  G ++
Sbjct: 159 VKSDXTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 215
Query: 201 LKIVCGK 207
            ++V  K
Sbjct: 216 GEMVRHK 222

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 132 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 191
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 192 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 124 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 183
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 126 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 185
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 186 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 19/154 (12%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSF---SGTFKDLLCLH 122
           +F  E   +  L + NL++L G  +    ++ V E  P  SL        G F  L  L 
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLS 124
Query: 123 KYS-----------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA--NTNR 169
           +Y+             R IHRDL A N+LL  +   KI DFG+ R    N+       +R
Sbjct: 125 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHR 184
Query: 170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
            V  + + + E   + T S  +D + FGV + ++
Sbjct: 185 KV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEM 217

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 19/154 (12%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSF---SGTFKDLLCLH 122
           +F  E   +  L + NL++L G  +    ++ V E  P  SL        G F  L  L 
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLS 114
Query: 123 KYS-----------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG--ANTNR 169
           +Y+             R IHRDL A N+LL  +   KI DFG+ R    N+       +R
Sbjct: 115 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
            V  + + + E   + T S  +D + FGV + ++
Sbjct: 175 KV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/98 (27%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H +S+L VIHRD+K SN+L++     K+ DFG++  + V++   + +   G   YM+ E 
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDID--AGCKPYMAPER 180
Query: 182 T----MSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHT 215
                     S+K+D++  G+ ++++   +    S+ T
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 144 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 203
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 204 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 19/154 (12%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSF---SGTFKDLLCLH 122
           +F  E   +  L + NL++L G  +    ++ V E  P  SL        G F  L  L 
Sbjct: 61  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLS 118
Query: 123 KYS-----------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG--ANTNR 169
           +Y+             R IHRDL A N+LL  +   KI DFG+ R    N+       +R
Sbjct: 119 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 178
Query: 170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
            V  + + + E   + T S  +D + FGV + ++
Sbjct: 179 KV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 65/138 (47%), Gaps = 24/138 (17%)
Query: 73  LIAKLQYTNLVKLLGCSIHGEERL--LVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRVI 130
           L+     T+L KL+     GE+R+  LVY+ +             K L  +H      +I
Sbjct: 107 LVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML-------------KGLRYIHAAG---II 150
Query: 131 HRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIK 190
           HRDLK  N+ +++    KI DFG+AR     ++ +     V T  Y + E  ++     +
Sbjct: 151 HRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYRAPEVILNWMRYTQ 205
Query: 191 T-DVFGFGVLVLKIVCGK 207
           T D++  G ++ +++ GK
Sbjct: 206 TVDIWSVGCIMAEMITGK 223

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 188 LXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 129 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 188
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 189 LXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 19/154 (12%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSF---SGTFKDLLCLH 122
           +F  E   +  L + NL++L G  +    ++ V E  P  SL        G F  L  L 
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLS 114
Query: 123 KYS-----------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG--ANTNR 169
           +Y+             R IHRDL A N+LL  +   KI DFG+ R    N+       +R
Sbjct: 115 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
            V  + + + E   + T S  +D + FGV + ++
Sbjct: 175 KV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 73/170 (42%), Gaps = 33/170 (19%)
Query: 60  SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGTFKDLL 119
           S +   + + EA++   L++ N+V+L           L+++ +    L       F+D++
Sbjct: 50  SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL-------FEDIV 102
Query: 120 CLHKYS-------------------RLRVIHRDLKASNILLDDQLN---TKISDFGMA-R 156
               YS                   ++ V+HR+LK  N+LL  +L     K++DFG+A  
Sbjct: 103 AREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162
Query: 157 IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           + G  ++        GT GY+S E           D++  GV++  ++ G
Sbjct: 163 VEGEQQAWFG---FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 19/154 (12%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSF---SGTFKDLLCLH 122
           +F  E   +  L + NL++L G  +    ++ V E  P  SL        G F  L  L 
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLS 124
Query: 123 KYS-----------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG--ANTNR 169
           +Y+             R IHRDL A N+LL  +   KI DFG+ R    N+       +R
Sbjct: 125 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184
Query: 170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
            V  + + + E   + T S  +D + FGV + ++
Sbjct: 185 KV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEM 217

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/187 (23%), Positives = 74/187 (39%), Gaps = 33/187 (17%)
Query: 44  KFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF 101
           K P  QE A K +     S +   + + EA++   L++ N+V+L           LV++ 
Sbjct: 25  KIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDL 84
Query: 102 MPNKSLDSSFSGTFKDLLCLHKYSRLR-------------------VIHRDLKASNILLD 142
           +    L       F+D++    YS                      ++HRDLK  N+LL 
Sbjct: 85  VTGGEL-------FEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLA 137
Query: 143 DQ---LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
            +      K++DFG+A    V           GT GY+S E           D++  GV+
Sbjct: 138 SKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVI 195
Query: 200 VLKIVCG 206
           +  ++ G
Sbjct: 196 LYILLVG 202

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 23/137 (16%)
Query: 73  LIAKLQYTNLVKLLGCSIHGEE-RLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRVIH 131
           L+     T+L K++G     E+ + LVY+ +             K L  +H      V+H
Sbjct: 106 LVMPFMQTDLQKIMGLKFSEEKIQYLVYQML-------------KGLKYIHSAG---VVH 149
Query: 132 RDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKT 191
           RDLK  N+ +++    KI DFG+AR      + A     V T  Y + E  +S     +T
Sbjct: 150 RDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMHYNQT 204
Query: 192 -DVFGFGVLVLKIVCGK 207
            D++  G ++ +++ GK
Sbjct: 205 VDIWSVGCIMAEMLTGK 221

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/187 (23%), Positives = 74/187 (39%), Gaps = 33/187 (17%)
Query: 44  KFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF 101
           K P  QE A K +     S +   + + EA++   L++ N+V+L           LV++ 
Sbjct: 25  KIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDL 84
Query: 102 MPNKSLDSSFSGTFKDLLCLHKYSRLR-------------------VIHRDLKASNILLD 142
           +    L       F+D++    YS                      ++HRDLK  N+LL 
Sbjct: 85  VTGGEL-------FEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLA 137
Query: 143 DQ---LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
            +      K++DFG+A    V           GT GY+S E           D++  GV+
Sbjct: 138 SKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVI 195
Query: 200 VLKIVCG 206
           +  ++ G
Sbjct: 196 LYILLVG 202

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 23/137 (16%)
Query: 73  LIAKLQYTNLVKLLGCSIHGEE-RLLVYEFMPNKSLDSSFSGTFKDLLCLHKYSRLRVIH 131
           L+     T+L K++G     E+ + LVY+ +             K L  +H      V+H
Sbjct: 124 LVMPFMQTDLQKIMGMEFSEEKIQYLVYQML-------------KGLKYIHSAG---VVH 167
Query: 132 RDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKT 191
           RDLK  N+ +++    KI DFG+AR      + A     V T  Y + E  +S     +T
Sbjct: 168 RDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMHYNQT 222
Query: 192 -DVFGFGVLVLKIVCGK 207
            D++  G ++ +++ GK
Sbjct: 223 VDIWSVGCIMAEMLTGK 239

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 19/154 (12%)
Query: 66  EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSF---SGTFKDLLCLH 122
           +F  E   +  L + NL++L G  +    ++ V E  P  SL        G F  L  L 
Sbjct: 61  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLS 118
Query: 123 KYS-----------RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG--ANTNR 169
           +Y+             R IHRDL A N+LL  +   KI DFG+ R    N+       +R
Sbjct: 119 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 178
Query: 170 IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
            V  + + + E   + T S  +D + FGV + ++
Sbjct: 179 KV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 18/29 (62%), Positives = 23/29 (79%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMAR 156
           +VIHRDLK SN+L+++    KI DFGMAR
Sbjct: 179 QVIHRDLKPSNLLVNENCELKIGDFGMAR 207

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+LL+   + KI DFG+AR+   +      
Sbjct: 126 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGF 185
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
               V T  Y + E  ++     K+ D++  G ++ +++  +
Sbjct: 186 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 85/202 (42%), Gaps = 53/202 (26%)
Query: 47  NEQEVAIKRLAWTSGQGRVEFQNEAKL--IAKLQYTNLVKLLGCSIHGEER--------- 95
           +E+ VA+K  ++ + Q    F NE  +  +  +++ N+ +     I G+ER         
Sbjct: 35  DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARF----IVGDERVTADGRMEY 87
Query: 96  LLVYEFMPNKSLDSSFS--------------GTFKDLLCLH------KYSRLRVIHRDLK 135
           LLV E+ PN SL    S                 + L  LH       + +  + HRDL 
Sbjct: 88  LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLN 147
Query: 136 ASNILLDDQLNTKISDFGMA------RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI 189
           + N+L+ +     ISDFG++      R+    E        VGT  YM+ E  + G V++
Sbjct: 148 SRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE-VLEGAVNL 206
Query: 190 K--------TDVFGFGVLVLKI 203
           +         D++  G++  +I
Sbjct: 207 RDXESALKQVDMYALGLIYWEI 228

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 12/94 (12%)
Query: 129 VIHRDLKASNILLDDQL---NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
           ++H DLK  NILL       + KI DFGM+R  G          I+GT  Y++ E     
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG---HACELREIMGTPEYLAPEILNYD 208
Query: 186 TVSIKTDVFGFGVLVLKIV------CGKKNNKSY 213
            ++  TD++  G++   ++       G+ N ++Y
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY 242

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 18/29 (62%), Positives = 23/29 (79%)
Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMAR 156
           +VIHRDLK SN+L+++    KI DFGMAR
Sbjct: 178 QVIHRDLKPSNLLVNENCELKIGDFGMAR 206

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/87 (28%), Positives = 47/87 (54%), Gaps = 7/87 (8%)
Query: 122 HKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           H +S+L VIHRD+K SN+L++     K+ DFG++  + V+      +   G   YM+ E 
Sbjct: 168 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDSVAKTID--AGCKPYMAPER 224
Query: 182 TMS----GTVSIKTDVFGFGVLVLKIV 204
                     S+K+D++  G+ ++++ 
Sbjct: 225 INPELNQKGYSVKSDIWSLGITMIELA 251

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 22/170 (12%)
Query: 68  QNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGT--FKDLLC-LHKY 124
           + E +++ KL +  ++K+       E+  +V E M    L     G    K+  C L+ Y
Sbjct: 188 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 125 SRL---------RVIHRDLKASNILLDDQLN---TKISDFGMARIFGVNESGANTNRIVG 172
             L          +IHRDLK  N+LL  Q      KI+DFG ++I G     +    + G
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 303
Query: 173 TYGYMSLEYTMS-GTVSI--KTDVFGFGVLVLKIVCGKKNNKSYHTERPL 219
           T  Y++ E  +S GT       D +  GV++   + G      + T+  L
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 353

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 30/198 (15%)
Query: 49  QEVAIKRLA---WTSGQGR-----VEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
           ++VAIK ++   +  G  R     +  + E +++ KL +  ++K+       E+  +V E
Sbjct: 36  KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLE 94
Query: 101 FMPNKSLDSSFSGT--FKDLLC-LHKYSRL---------RVIHRDLKASNILLDDQLN-- 146
            M    L     G    K+  C L+ Y  L          +IHRDLK  N+LL  Q    
Sbjct: 95  LMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDC 154
Query: 147 -TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSI--KTDVFGFGVLVLK 202
             KI+DFG ++I G     +    + GT  Y++ E  +S GT       D +  GV++  
Sbjct: 155 LIKITDFGHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 211
Query: 203 IVCGKKNNKSYHTERPLN 220
            + G      + T+  L 
Sbjct: 212 CLSGYPPFSEHRTQVSLK 229

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 22/171 (12%)
Query: 68  QNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGT--FKDLLC-LHKY 124
           + E +++ KL +  ++K+       E+  +V E M    L     G    K+  C L+ Y
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 125 SRL---------RVIHRDLKASNILLDDQLN---TKISDFGMARIFGVNESGANTNRIVG 172
             L          +IHRDLK  N+LL  Q      KI+DFG ++I G     +    + G
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 178
Query: 173 TYGYMSLEYTMS-GTVSI--KTDVFGFGVLVLKIVCGKKNNKSYHTERPLN 220
           T  Y++ E  +S GT       D +  GV++   + G      + T+  L 
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 30/198 (15%)
Query: 49  QEVAIKRLA---WTSGQGR-----VEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
           ++VAIK ++   +  G  R     +  + E +++ KL +  ++K+       E+  +V E
Sbjct: 36  KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLE 94
Query: 101 FMPNKSLDSSFSGT--FKDLLC-LHKYSRL---------RVIHRDLKASNILLDDQLN-- 146
            M    L     G    K+  C L+ Y  L          +IHRDLK  N+LL  Q    
Sbjct: 95  LMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDC 154
Query: 147 -TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSI--KTDVFGFGVLVLK 202
             KI+DFG ++I G     +    + GT  Y++ E  +S GT       D +  GV++  
Sbjct: 155 LIKITDFGHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 211
Query: 203 IVCGKKNNKSYHTERPLN 220
            + G      + T+  L 
Sbjct: 212 CLSGYPPFSEHRTQVSLK 229

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 22/171 (12%)
Query: 68  QNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGT--FKDLLC-LHKY 124
           + E +++ KL +  ++K+       E+  +V E M    L     G    K+  C L+ Y
Sbjct: 62  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 125 SRL---------RVIHRDLKASNILLDDQLN---TKISDFGMARIFGVNESGANTNRIVG 172
             L          +IHRDLK  N+LL  Q      KI+DFG ++I G     +    + G
Sbjct: 121 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 177
Query: 173 TYGYMSLEYTMS-GTVSI--KTDVFGFGVLVLKIVCGKKNNKSYHTERPLN 220
           T  Y++ E  +S GT       D +  GV++   + G      + T+  L 
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 228

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 55/120 (45%), Gaps = 12/120 (10%)
Query: 117 DLLCLHKYSRLR---------VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN- 166
           D +C   Y  LR         V+HRDLK SN+L++   + KI DFG+ARI          
Sbjct: 144 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGF 203
Query: 167 TNRIVGTYGYMSLEYTMSGTVSIKT-DVFGFGVLVLKIVCGKKNNKSYHTERPLN-LVGI 224
               V T  Y + E  ++     K+ D++  G ++ +++  +      H    LN ++GI
Sbjct: 204 LTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 263

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 40/79 (50%), Gaps = 3/79 (3%)
Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVS 188
           +IHRDLK SNI++      KI DFG+AR  G   S   T  +V  Y Y + E  +     
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYK 203
Query: 189 IKTDVFGFGVLVLKIVCGK 207
              D++  G ++ ++V  K
Sbjct: 204 ENVDIWSVGCIMGEMVRHK 222

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 22/171 (12%)
Query: 68  QNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGT--FKDLLC-LHKY 124
           + E +++ KL +  ++K+       E+  +V E M    L     G    K+  C L+ Y
Sbjct: 69  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 125 SRL---------RVIHRDLKASNILLDDQLN---TKISDFGMARIFGVNESGANTNRIVG 172
             L          +IHRDLK  N+LL  Q      KI+DFG ++I G     +    + G
Sbjct: 128 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 184
Query: 173 TYGYMSLEYTMS-GTVSI--KTDVFGFGVLVLKIVCGKKNNKSYHTERPLN 220
           T  Y++ E  +S GT       D +  GV++   + G      + T+  L 
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 235

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 22/170 (12%)
Query: 68  QNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFSGT--FKDLLC-LHKY 124
           + E +++ KL +  ++K+       E+  +V E M    L     G    K+  C L+ Y
Sbjct: 202 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 125 SRL---------RVIHRDLKASNILLDDQLN---TKISDFGMARIFGVNESGANTNRIVG 172
             L          +IHRDLK  N+LL  Q      KI+DFG ++I G     +    + G
Sbjct: 261 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 317
Query: 173 TYGYMSLEYTMS-GTVSI--KTDVFGFGVLVLKIVCGKKNNKSYHTERPL 219
           T  Y++ E  +S GT       D +  GV++   + G      + T+  L
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 367

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 38/74 (51%)
Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI 189
           IHRDL A NILL     TKI DFG+AR    + +            +M+ E   +   + 
Sbjct: 190 IHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 249
Query: 190 KTDVFGFGVLVLKI 203
           ++DV+ +G+ + ++
Sbjct: 250 ESDVWSYGIFLWEL 263

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 38/74 (51%)
Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI 189
           IHRDL A NILL     TKI DFG+AR    + +            +M+ E   +   + 
Sbjct: 185 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 244
Query: 190 KTDVFGFGVLVLKI 203
           ++DV+ +G+ + ++
Sbjct: 245 ESDVWSYGIFLWEL 258

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 38/74 (51%)
Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI 189
           IHRDL A NILL     TKI DFG+AR    + +            +M+ E   +   + 
Sbjct: 183 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 242
Query: 190 KTDVFGFGVLVLKI 203
           ++DV+ +G+ + ++
Sbjct: 243 ESDVWSYGIFLWEL 256

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 81/189 (42%), Gaps = 30/189 (15%)
Query: 36  RDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKL---------- 85
           RD+V  V     E+ + I R    S     +   E  ++  L + N++KL          
Sbjct: 57  RDKVTHV-----ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111
Query: 86  ---LGCSIHGEERLLVYEFMPNKSLDSS--FSGTFKDLLCLHKYSRLRVIHRDLKASNIL 140
              + C   GE    +   M    +D++         +  LHK++   ++HRDLK  N+L
Sbjct: 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLL 168
Query: 141 LDDQLN---TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFG 197
           L+ +      KI DFG++ +F   E+       +GT  Y++ E  +      K DV+  G
Sbjct: 169 LESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIG 224
Query: 198 VLVLKIVCG 206
           V++  ++ G
Sbjct: 225 VILFILLAG 233

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 38/74 (51%)
Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI 189
           IHRDL A NILL     TKI DFG+AR    + +            +M+ E   +   + 
Sbjct: 190 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 249
Query: 190 KTDVFGFGVLVLKI 203
           ++DV+ +G+ + ++
Sbjct: 250 ESDVWSYGIFLWEL 263

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	345
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-78
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-77
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-66
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-48
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-39
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-32
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-30
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-29
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-29
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-28
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-28
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-27
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-26
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-25
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-25
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-24
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-24
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-24
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-24
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-24
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-24
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-24
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-24
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-24
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-23
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-23
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-23
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-23
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-23
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-23
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-23
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-23
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-23
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-23
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-23
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-22
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-22
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-22
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-22
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-22
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-22
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-22
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-22
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-22
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-22
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-22
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-21
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-21
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-21
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-21
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-21
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-20
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-19
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-19
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-18
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-17
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-16
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-16
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-16
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-16
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-16
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-16
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-16
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-15
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-15
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-15
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-15
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-15
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-15
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-15
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-15
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-15
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-14
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-14
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-14
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-14
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-14
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-13
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-13
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-13
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-13
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-13
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-13
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-12
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-12
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-12
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-12
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-12
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-12
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-12
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-12
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-12
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-12
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-12
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-12
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-12
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-12
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-12
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-12
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-12
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-12
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-12
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-11
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-11
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-11
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-11
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-11
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-11
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-11
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-11
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-11
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-11
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-11
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-11
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-11
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-10
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-10
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-10
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-10
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-10
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-10
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-10
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-10
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-10
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-10
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-10
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-10
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-10
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-10
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-10
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-10
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-10
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-10
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-09
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-09
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-09
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-09
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-09
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-09
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-09
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-09
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-09
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-08
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-08
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-08
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-08
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-08
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-08
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-08
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-08
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-08
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-08
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-08
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-08
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-08
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-08
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-08
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-08
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-08
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-08
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-08
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-08
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-08
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-08
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-08
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-08
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-08
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-07
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-07
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-07
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-07
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-07
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-07
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-07
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-07
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-07
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-07
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-07
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-07
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-06
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-06
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-06
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-06
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-06
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  240 bits (614), Expect = 6e-78
 Identities = 76/227 (33%), Positives = 114/227 (50%), Gaps = 30/227 (13%)

Query: 47  NEQEVAIKRLAW----TSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           N   VA+K+LA     T+ + + +F  E K++AK Q+ NLV+LLG S  G++  LVY +M
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112

Query: 103 PNKSLDSS-FS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ 144
           PN SL                       G    +  LH+      IHRD+K++NILLD+ 
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEA 169

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
              KISDFG+AR          T+RIVGT  YM+ E  + G ++ K+D++ FGV++L+I+
Sbjct: 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEII 228

Query: 205 CGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE-LIDLTLDGSCPPNE 250
            G           P  L+ I  ++ +E K +E  ID  +        
Sbjct: 229 TGLPAVDE--HREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTS 272

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  237 bits (608), Expect = 9e-77
 Identities = 73/241 (30%), Positives = 124/241 (51%), Gaps = 24/241 (9%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGR-VEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF 101
           G+  +   VA+KRL     QG  ++FQ E ++I+   + NL++L G  +   ERLLVY +
Sbjct: 49  GRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 108

Query: 102 MPNKSLDSSFSGTFKD-------------------LLCLHKYSRLRVIHRDLKASNILLD 142
           M N S+ S      +                    L  LH +   ++IHRD+KA+NILLD
Sbjct: 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168

Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           ++    + DFG+A++    ++   T  + GT G+++ EY  +G  S KTDVFG+GV++L+
Sbjct: 169 EEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227

Query: 203 IVCGKKN--NKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE-DAFLLVSCV 259
           ++ G++         +  + L+     L  E K   L+D+ L G+    E +  + V+ +
Sbjct: 228 LITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALL 287

Query: 260 C 260
           C
Sbjct: 288 C 288

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  211 bits (540), Expect = 1e-66
 Identities = 61/224 (27%), Positives = 109/224 (48%), Gaps = 16/224 (7%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G   +  +VA+KR    S QG  EF+ E + ++  ++ +LV L+G      E +L+Y++M
Sbjct: 58  GVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117

Query: 103 PNKSLDSSFSGTFKDLLCLHKYSRLR----------------VIHRDLKASNILLDDQLN 146
            N +L     G+    + +    RL                 +IHRD+K+ NILLD+   
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV 177

Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            KI+DFG+++     +    +  + GT GY+  EY + G ++ K+DV+ FGV++ +++C 
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237

Query: 207 KKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE 250
           +           +NL   A +  N G+  +++D  L     P  
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPES 281

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  163 bits (414), Expect = 6e-48
 Identities = 45/253 (17%), Positives = 86/253 (33%), Gaps = 40/253 (15%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE----ERLLVYEF 101
              + VA+K       Q   + + E   +  +++ N+++ +G    G     +  L+  F
Sbjct: 45  LLNEYVAVKIFPIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103

Query: 102 MPNKSLDS-------SFSGTFK-------DLLCLH-------KYSRLRVIHRDLKASNIL 140
               SL         S++            L  LH          +  + HRD+K+ N+L
Sbjct: 104 HEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL 163

Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG-----TVSIKTDVFG 195
           L + L   I+DFG+A  F   +S  +T+  VGT  YM+ E             ++ D++ 
Sbjct: 164 LKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223

Query: 196 FGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGK-----DLELIDLTLDGSCPPNE 250
            G+++ ++            E  L       Q  +          +     L      + 
Sbjct: 224 MGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHA 283

Query: 251 D----AFLLVSCV 259
                   +  C 
Sbjct: 284 GMAMLCETIEECW 296

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  139 bits (352), Expect = 8e-39
 Identities = 51/267 (19%), Positives = 93/267 (34%), Gaps = 59/267 (22%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQNEAK--LIAKLQYTNLVKLLGCSIHGE-----ERLLVY 99
           +E+ VA+K  ++ + Q    F NE     +  +++ N+ + +            E LLV 
Sbjct: 35  DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91

Query: 100 EFMPNKSLDSSFSGTFKD--------------LLCLH------KYSRLRVIHRDLKASNI 139
           E+ PN SL    S    D              L  LH       + +  + HRDL + N+
Sbjct: 92  EYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNV 151

Query: 140 LLDDQLNTKISDFGMARIF------GVNESGANTNRIVGTYGYMSLEYTMSGTVSI---- 189
           L+ +     ISDFG++            E        VGT  YM+ E  + G V++    
Sbjct: 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXE 210

Query: 190 ----KTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL----- 240
               + D++  G++  +I     +     +     +     ++ N     ++  L     
Sbjct: 211 SALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREK 269

Query: 241 ---TLDGSCPPNEDAF-----LLVSCV 259
                  +   N  A       +  C 
Sbjct: 270 QRPKFPEAWKENSLAVRSLKETIEDCW 296

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  121 bits (306), Expect = 2e-32
 Identities = 49/235 (20%), Positives = 98/235 (41%), Gaps = 41/235 (17%)

Query: 47  NEQEVAIKRLAW--TSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN 104
           +  +VA+K L       +   EF  E  ++ +L++ N+V  +G         +V E++  
Sbjct: 59  HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118

Query: 105 KSL-------DSSFSGTFKDLL-----------CLHKYSRLRVIHRDLKASNILLDDQLN 146
            SL        +      +  L            LH      ++HR+LK+ N+L+D +  
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYT 177

Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            K+ DFG++R+     +  ++    GT  +M+ E       + K+DV+ FGV++ ++   
Sbjct: 178 VKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235

Query: 207 KKNNKSYHTERP---LNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSC 258
                    ++P   LN   +   +  + K LE+       +  P + A ++  C
Sbjct: 236 ---------QQPWGNLNPAQVVAAVGFKCKRLEIPR-----NLNP-QVAAIIEGC 275

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  120 bits (302), Expect = 4e-32
 Identities = 59/241 (24%), Positives = 98/241 (40%), Gaps = 48/241 (19%)

Query: 47  NEQEVAIKRLAWTSGQGRV----EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
              EVA+K       +         + EAKL A L++ N++ L G  +      LV EF 
Sbjct: 29  IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA 88

Query: 103 PNKSLDSSFSGTFKDL--------------LCLHKYSRLRVIHRDLKASNILLDDQLNT- 147
               L+   SG                     LH  + + +IHRDLK+SNIL+  ++   
Sbjct: 89  RGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENG 148

Query: 148 -------KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
                  KI+DFG+AR +      +      G Y +M+ E   +   S  +DV+ +GVL+
Sbjct: 149 DLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPEVIRASMFSKGSDVWSYGVLL 204

Query: 201 LKIVCGKKNNKSYHTERP---LNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVS 257
            +++ G         E P   ++ + +A+ +      L +       +CP    A L+  
Sbjct: 205 WELLTG---------EVPFRGIDGLAVAYGVAMNKLALPIPS-----TCPE-PFAKLMED 249

Query: 258 C 258
           C
Sbjct: 250 C 250

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  115 bits (289), Expect = 5e-30
 Identities = 46/182 (25%), Positives = 85/182 (46%), Gaps = 31/182 (17%)

Query: 50  EVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNKS 106
           +VA+K L  T  + Q    F+NE  ++ K ++ N++  +G S     +L +V ++    S
Sbjct: 48  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--APQLAIVTQWCEGSS 105

Query: 107 L-------DSSFSGTFKDLL-----------CLHKYSRLRVIHRDLKASNILLDDQLNTK 148
           L       ++ F    K L+            LH      +IHRDLK++NI L +    K
Sbjct: 106 LYHHLHASETKFE--MKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVK 160

Query: 149 ISDFGMARIFGVNESGANTNRIVGTYGYMS---LEYTMSGTVSIKTDVFGFGVLVLKIVC 205
           I DFG+A             ++ G+  +M+   +    S   S ++DV+ FG+++ +++ 
Sbjct: 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220

Query: 206 GK 207
           G+
Sbjct: 221 GQ 222

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  113 bits (286), Expect = 2e-29
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 28/181 (15%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
             ++VAIK++   S   R  F  E + ++++ + N+VKL G  +      LV E+    S
Sbjct: 30  RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGS 85

Query: 107 L-------DSSFSGTFKDLL-----------CLHKYSRLRVIHRDLKASNILLDDQLNT- 147
           L       +     T    +            LH      +IHRDLK  N+LL       
Sbjct: 86  LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVL 145

Query: 148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           KI DFG A      +   +     G+  +M+ E       S K DVF +G+++ +++  +
Sbjct: 146 KICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200

Query: 208 K 208
           K
Sbjct: 201 K 201

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  113 bits (284), Expect = 4e-29
 Identities = 38/190 (20%), Positives = 77/190 (40%), Gaps = 31/190 (16%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
             + + +K L     + +  F  E K++  L++ N++K +G     +    + E++   +
Sbjct: 34  TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT 93

Query: 107 L-----DSSFSGTFKDLL-----------CLHKYSRLRVIHRDLKASNILLDDQLNTKIS 150
           L            +   +            LH    + +IHRDL + N L+ +  N  ++
Sbjct: 94  LRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVA 150

Query: 151 DFGMARIFGVNESGANTNR------------IVGTYGYMSLEYTMSGTVSIKTDVFGFGV 198
           DFG+AR+    ++     R            +VG   +M+ E     +   K DVF FG+
Sbjct: 151 DFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGI 210

Query: 199 LVLKIVCGKK 208
           ++ +I+    
Sbjct: 211 VLCEIIGRVN 220

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  110 bits (276), Expect = 3e-28
 Identities = 28/185 (15%), Positives = 65/185 (35%), Gaps = 32/185 (17%)

Query: 47  NEQEVAIKRLAW--TSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL--VYEFM 102
              ++ +K L     S +   +F  E   +    + N++ +LG            +  +M
Sbjct: 32  QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM 91

Query: 103 PNKSL------DSSFSGTFKDLL-----------CLHKYSRLRVIHRDLKASNILLDDQL 145
           P  SL       ++F       +            LH    L +    L + ++++D+ +
Sbjct: 92  PYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDM 150

Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMS---LEYTMSGTVSIKTDVFGFGVLVLK 202
             +IS   +   F        +   +    +++   L+     T     D++ F VL+ +
Sbjct: 151 TARISMADVKFSF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWE 203

Query: 203 IVCGK 207
           +V  +
Sbjct: 204 LVTRE 208

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  107 bits (268), Expect = 4e-27
 Identities = 43/193 (22%), Positives = 82/193 (42%), Gaps = 38/193 (19%)

Query: 46  PNEQEVAIKRLAWTSGQGRV-------EFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
            ++  VAIK L     +G         EFQ E  +++ L + N+VKL G         +V
Sbjct: 42  KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMV 99

Query: 99  YEFMPNKSL-----DSSFSGTFKDLL-----------CLHKYSRLRVIHRDLKASNILLD 142
            EF+P   L     D +    +   L            +       ++HRDL++ NI L 
Sbjct: 100 MEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQ 158

Query: 143 DQ-----LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE--YTMSGTVSIKTDVFG 195
                  +  K++DFG+++     +S  + + ++G + +M+ E       + + K D + 
Sbjct: 159 SLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYS 213

Query: 196 FGVLVLKIVCGKK 208
           F +++  I+ G+ 
Sbjct: 214 FAMILYTILTGEG 226

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  106 bits (266), Expect = 2e-26
 Identities = 44/243 (18%), Positives = 84/243 (34%), Gaps = 52/243 (21%)

Query: 49  QEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
            EVAI+ +     +      F+ E     + ++ N+V  +G  +      ++      ++
Sbjct: 56  GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115

Query: 107 L-----DSSFSGTFKDLL-----------CLHKYSRLRVIHRDLKASNILLDDQLNTKIS 150
           L     D+                      LH      ++H+DLK+ N+  D+     I+
Sbjct: 116 LYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVIT 171

Query: 151 DFGMARIFGVNESGANTNRI---VGTYGYMSLE---------YTMSGTVSIKTDVFGFGV 198
           DFG+  I GV ++G   +++    G   +++ E                S  +DVF  G 
Sbjct: 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231

Query: 199 LVLKIVCGKKNNKSYHTERP---LNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLL 255
           +  ++            E P        I WQ+   G    L  +         E + +L
Sbjct: 232 IWYELHAR---------EWPFKTQPAEAIIWQM-GTGMKPNLSQIG----MGK-EISDIL 276

Query: 256 VSC 258
           + C
Sbjct: 277 LFC 279

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  104 bits (262), Expect = 1e-25
 Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 19/178 (10%)

Query: 40  ILVGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
            L      E  VAIK L    + + R +F  EA ++ +  + N+++L G     +  ++V
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124

Query: 99  YEFMPNKSLDS---SFSGTFKDLLCLH---------KY-SRLRVIHRDLKASNILLDDQL 145
            E+M N SLDS        F  +  +          KY S +  +HRDL A NIL++  L
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL 184

Query: 146 NTKISDFGMARIFGVNESGANTNRIVGT---YGYMSLEYTMSGTVSIKTDVFGFGVLV 200
             K+SDFG+ R+   +   A T R  G      + S E       +  +DV+ +G+++
Sbjct: 185 VCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  103 bits (258), Expect = 2e-25
 Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 25/173 (14%)

Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VAIK L A  + + RV+F  EA ++ +  + N+++L G     +  +++ E+M N +
Sbjct: 73  EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA 132

Query: 107 LDS---SFSGTFKDLLCLH---------KY-SRLRVIHRDLKASNILLDDQLNTKISDFG 153
           LD       G F  L  +          KY + +  +HRDL A NIL++  L  K+SDFG
Sbjct: 133 LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 192

Query: 154 MARIFGVNESGANTNRIVGTYG------YMSLEYTMSGTVSIKTDVFGFGVLV 200
           ++R+   +     T     T G      + + E       +  +DV+ FG+++
Sbjct: 193 LSRVLEDDPEATYT-----TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVM 240

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  102 bits (257), Expect = 4e-25
 Identities = 55/180 (30%), Positives = 87/180 (48%), Gaps = 25/180 (13%)

Query: 40  ILVGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV 98
            L      +  VAIK L A  + + R +F +EA ++ +  + N+++L G    G   ++V
Sbjct: 69  RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128

Query: 99  YEFMPNKSLDS---SFSGTFK--DLL--CLH-----KY-SRLRVIHRDLKASNILLDDQL 145
            E+M N SLD+   +  G F    L+          +Y S L  +HRDL A N+L+D  L
Sbjct: 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL 188

Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYG------YMSLEYTMSGTVSIKTDVFGFGVL 199
             K+SDFG++R+   +   A T     T G      + + E     T S  +DV+ FGV+
Sbjct: 189 VCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVV 243

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  102 bits (256), Expect = 1e-24
 Identities = 41/167 (24%), Positives = 69/167 (41%), Gaps = 14/167 (8%)

Query: 47  NEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK 105
           +   VA+K          + +F  EA+++ +  + N+V+L+G     +   +V E +   
Sbjct: 138 DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197

Query: 106 SLDS-----SFSGTFKDLL--CLH-----KY-SRLRVIHRDLKASNILLDDQLNTKISDF 152
              +           K LL          +Y      IHRDL A N L+ ++   KISDF
Sbjct: 198 DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDF 257

Query: 153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
           GM+R        A+         + + E    G  S ++DV+ FG+L
Sbjct: 258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGIL 304

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  100 bits (252), Expect = 1e-24
 Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 38/189 (20%)

Query: 44  KFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP 103
              ++  VA+K L   +   R +FQ EA+L+  LQ+ ++VK  G    G+  ++V+E+M 
Sbjct: 41  PTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMK 100

Query: 104 NKSLDS--------------------SFSGTFKDLLCLH-------KY-SRLRVIHRDLK 135
           +  L+                             +L +         Y +    +HRDL 
Sbjct: 101 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLA 160

Query: 136 ASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIK 190
             N L+   L  KI DFGM+R   V  +       VG +      +M  E  M    + +
Sbjct: 161 TRNCLVGANLLVKIGDFGMSRD--VYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTE 215

Query: 191 TDVFGFGVL 199
           +DV+ FGV+
Sbjct: 216 SDVWSFGVI 224

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  100 bits (252), Expect = 1e-24
 Identities = 40/188 (21%), Positives = 67/188 (35%), Gaps = 37/188 (19%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQNEAKL--IAKLQYTNLVKLLGCSIHGE----ERLLVYE 100
             + VA+K     S +    +  E +L     L++ N++  +   +       +  L+  
Sbjct: 30  QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86

Query: 101 FMPNKSLDS---SFSGTFKDLL-----------CLH-----KYSRLRVIHRDLKASNILL 141
           +    SL       +      L            LH        +  + HRDLK+ NIL+
Sbjct: 87  YHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146

Query: 142 DDQLNTKISDFGMARIF--GVNESGANTNRIVGTYGYMSLE------YTMSGTVSIKTDV 193
                  I+D G+A +     N+     N  VGT  YM+ E               + D+
Sbjct: 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206

Query: 194 FGFGVLVL 201
           + FG LVL
Sbjct: 207 WAFG-LVL 213

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  101 bits (253), Expect = 1e-24
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 25/173 (14%)

Query: 47  NEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK 105
            +  VAIK L   TS +   E  +EA ++A +   ++ +LLG  +      L+ + MP  
Sbjct: 43  VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFG 101

Query: 106 SLDS-----SFSGTFKDLL--CLH-----KY-SRLRVIHRDLKASNILLDDQLNTKISDF 152
            L         +   + LL  C+       Y    R++HRDL A N+L+    + KI+DF
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161

Query: 153 GMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKTDVFGFGVLV 200
           G+A++ G  E   +        G     +M+LE  +    + ++DV+ +GV V
Sbjct: 162 GLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTV 209

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  100 bits (251), Expect = 1e-24
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)

Query: 40  ILVGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL- 97
             + +  N  + AIK L   T  Q    F  E  L+  L + N++ L+G  +  E     
Sbjct: 41  EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100

Query: 98  VYEFMPNKSLDS-----SFSGTFKDLL--CLH-----KY-SRLRVIHRDLKASNILLDDQ 144
           +  +M +  L         + T KDL+   L      +Y +  + +HRDL A N +LD+ 
Sbjct: 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES 160

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKTDVFGFGVL 199
              K++DFG+AR   + +    + +    +      + +LE   +   + K+DV+ FGVL
Sbjct: 161 FTVKVADFGLARD--ILDREYYSVQ-QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVL 217

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 99.6 bits (249), Expect = 3e-24
 Identities = 48/181 (26%), Positives = 83/181 (45%), Gaps = 25/181 (13%)

Query: 40  ILVGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE-RLL 97
            L+     +   A+K L   T      +F  E  ++    + N++ LLG  +  E   L+
Sbjct: 45  TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104

Query: 98  VYEFMPNKSLDS-----SFSGTFKDLL--CLH-----KY-SRLRVIHRDLKASNILLDDQ 144
           V  +M +  L +     + + T KDL+   L      KY +  + +HRDL A N +LD++
Sbjct: 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 164

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYG------YMSLEYTMSGTVSIKTDVFGFGV 198
              K++DFG+AR   + +       +    G      +M+LE   +   + K+DV+ FGV
Sbjct: 165 FTVKVADFGLAR--DMYDK--EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 220

Query: 199 L 199
           L
Sbjct: 221 L 221

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  100 bits (250), Expect = 3e-24
 Identities = 43/190 (22%), Positives = 72/190 (37%), Gaps = 41/190 (21%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQNEAK--LIAKLQYTNLVKLLGCSIHGEER----LLVYE 100
             ++VA+K            +  E +      +++ N++  +   I G        L+ +
Sbjct: 59  RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115

Query: 101 FMPNKSL-----DSSFSGTFKDLL-----------CLH-----KYSRLRVIHRDLKASNI 139
           +  N SL      ++     K +L            LH        +  + HRDLK+ NI
Sbjct: 116 YHENGSLYDYLKSTTLD--AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173

Query: 140 LLDDQLNTKISDFGMARIF--GVNESGANTNRIVGTYGYMS---LEYTM---SGTVSIKT 191
           L+       I+D G+A  F    NE     N  VGT  YM    L+ ++        I  
Sbjct: 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA 233

Query: 192 DVFGFGVLVL 201
           D++ FG L+L
Sbjct: 234 DMYSFG-LIL 242

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 98.9 bits (247), Expect = 5e-24
 Identities = 51/227 (22%), Positives = 93/227 (40%), Gaps = 32/227 (14%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER--LLVYEFMPN 104
             + VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G       R   L+ E++P 
Sbjct: 38  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 97

Query: 105 KSLDS---SFSGTFKDLLCLH---------KY-SRLRVIHRDLKASNILLDDQLNTKISD 151
            SL             +  L          +Y    R IHRDL   NIL++++   KI D
Sbjct: 98  GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 157

Query: 152 FGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           FG+ ++   ++        V   G     + + E       S+ +DV+ FGV++ ++   
Sbjct: 158 FGLTKVLPQDKEFF----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 213

Query: 207 KKNNKSYHTERPLNLVGIA-WQLWNEGKDLELIDLTLDG---SCPPN 249
            + +KS   E    +      Q+        LI+L  +      P  
Sbjct: 214 IEKSKSPPAEFMRMIGNDKQGQMIVF----HLIELLKNNGRLPRPDG 256

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 99.3 bits (248), Expect = 6e-24
 Identities = 48/188 (25%), Positives = 77/188 (40%), Gaps = 37/188 (19%)

Query: 44  KFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP 103
              ++  VA+K L   S   R +FQ EA+L+  LQ+ ++V+  G    G   L+V+E+M 
Sbjct: 67  PEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMR 126

Query: 104 NKSLDS-------------------SFSGTFKDLLCLH-------KY-SRLRVIHRDLKA 136
           +  L+                            LL +         Y + L  +HRDL  
Sbjct: 127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLAT 186

Query: 137 SNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKT 191
            N L+   L  KI DFGM+R   +  +       VG        +M  E  +    + ++
Sbjct: 187 RNCLVGQGLVVKIGDFGMSR--DIYSTDYYR---VGGRTMLPIRWMPPESILYRKFTTES 241

Query: 192 DVFGFGVL 199
           DV+ FGV+
Sbjct: 242 DVWSFGVV 249

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 98.9 bits (247), Expect = 7e-24
 Identities = 50/186 (26%), Positives = 78/186 (41%), Gaps = 33/186 (17%)

Query: 42  VGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
           V K   E  VAIK +    S + R+EF NEA ++ +    ++V+LLG    G+  L++ E
Sbjct: 49  VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 108

Query: 101 FMPNKSLDS--------------SFSGTFKDLLCLH-------KY-SRLRVIHRDLKASN 138
            M    L S                  +   ++ +         Y +  + +HRDL A N
Sbjct: 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 168

Query: 139 ILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY-----MSLEYTMSGTVSIKTDV 193
            ++ +    KI DFGM R   + E+        G  G      MS E    G  +  +DV
Sbjct: 169 CMVAEDFTVKIGDFGMTRD--IYETDYYR---KGGKGLLPVRWMSPESLKDGVFTTYSDV 223

Query: 194 FGFGVL 199
           + FGV+
Sbjct: 224 WSFGVV 229

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 99.0 bits (247), Expect = 7e-24
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 32/227 (14%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER--LLVYEFMPN 104
             + VA+K+L  ++ +   +F+ E +++  LQ+ N+VK  G       R   L+ E++P 
Sbjct: 69  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 128

Query: 105 KSLDS-----SFSGTFKDLLCLH-------KY-SRLRVIHRDLKASNILLDDQLNTKISD 151
            SL               LL          +Y    R IHRDL   NIL++++   KI D
Sbjct: 129 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 188

Query: 152 FGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           FG+ ++   ++        V   G     + + E       S+ +DV+ FGV++ ++   
Sbjct: 189 FGLTKVLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 244

Query: 207 KKNNKSYHTERPLNLVGIAW-QLWNEGKDLELIDLTLDG---SCPPN 249
            + +KS   E    +      Q+        LI+L  +      P  
Sbjct: 245 IEKSKSPPAEFMRMIGNDKQGQMIVF----HLIELLKNNGRLPRPDG 287

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 99.8 bits (249), Expect = 7e-24
 Identities = 49/180 (27%), Positives = 84/180 (46%), Gaps = 23/180 (12%)

Query: 40  ILVGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE-RLL 97
            L+     +   A+K L   T      +F  E  ++    + N++ LLG  +  E   L+
Sbjct: 109 TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168

Query: 98  VYEFMPNKSLDS-----SFSGTFKDLL--CLH-----KY-SRLRVIHRDLKASNILLDDQ 144
           V  +M +  L +     + + T KDL+   L      K+ +  + +HRDL A N +LD++
Sbjct: 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 228

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKTDVFGFGVL 199
              K++DFG+AR     E  +  N+   T       +M+LE   +   + K+DV+ FGVL
Sbjct: 229 FTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 285

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  100 bits (251), Expect = 9e-24
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 16/172 (9%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
               VA+K L   + +   EF  EA ++ ++++ NLV+LLG         ++ EFM   +
Sbjct: 244 YSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 302

Query: 107 LDS---SFSG---TFKDLL--CLH-----KY-SRLRVIHRDLKASNILLDDQLNTKISDF 152
           L       +    +   LL          +Y  +   IHR+L A N L+ +    K++DF
Sbjct: 303 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADF 362

Query: 153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           G++R+   +   A+         + + E       SIK+DV+ FGVL+ +I 
Sbjct: 363 GLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 413

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 43/181 (23%), Positives = 63/181 (34%), Gaps = 24/181 (13%)

Query: 40  ILVGKFPNEQEVAIKRL---AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEER 95
                      VA+K L     +  +   +F  E   +  L + NL++L G         
Sbjct: 38  EWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL--TPPM 95

Query: 96  LLVYEFMPNKSLDS---SFSGTFKDLLCLH---------KY-SRLRVIHRDLKASNILLD 142
            +V E  P  SL        G F                 Y    R IHRDL A N+LL 
Sbjct: 96  KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA 155

Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGT---YGYMSLEYTMSGTVSIKTDVFGFGVL 199
            +   KI DFG+ R    N+              + + + E   + T S  +D + FGV 
Sbjct: 156 TRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVT 213

Query: 200 V 200
           +
Sbjct: 214 L 214

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 98.2 bits (245), Expect = 1e-23
 Identities = 48/171 (28%), Positives = 68/171 (39%), Gaps = 23/171 (13%)

Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPN 104
            + VA+K L A    Q R  ++ E  ++  L + +++K  G C   G   L LV E++P 
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119

Query: 105 KSLDS---SFSGTFKDLLCLH-------KY-SRLRVIHRDLKASNILLDDQLNTKISDFG 153
            SL       S     LL           Y      IHRDL A N+LLD+    KI DFG
Sbjct: 120 GSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179

Query: 154 MARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKTDVFGFGVL 199
           +A+              V   G     + + E          +DV+ FGV 
Sbjct: 180 LAKAVPEGHEYYR----VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 226

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 96.9 bits (242), Expect = 1e-23
 Identities = 57/174 (32%), Positives = 82/174 (47%), Gaps = 21/174 (12%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G + N+ +VAIK +   +     +F  EA+++ KL +  LV+L G  +      LV EFM
Sbjct: 27  GYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85

Query: 103 PNKSLDS---SFSGTFK--DLL--CLH-----KY-SRLRVIHRDLKASNILLDDQLNTKI 149
            +  L     +  G F    LL  CL       Y     VIHRDL A N L+ +    K+
Sbjct: 86  EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKV 145

Query: 150 SDFGMARIFGVNESGANTNRIVGT---YGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           SDFGM R    ++  ++T    GT     + S E       S K+DV+ FGVL+
Sbjct: 146 SDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 195

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 97.3 bits (243), Expect = 2e-23
 Identities = 51/188 (27%), Positives = 80/188 (42%), Gaps = 39/188 (20%)

Query: 46  PNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN 104
              Q VAIK L     G  R EF++EA L A+LQ+ N+V LLG     +   +++ +  +
Sbjct: 37  EQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSH 96

Query: 105 KSLDS--------------------SFSGTFKDLLCLH-------KY-SRLRVIHRDLKA 136
             L                        +    D + L        +Y S   V+H+DL  
Sbjct: 97  GDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLAT 156

Query: 137 SNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKT 191
            N+L+ D+LN KISD G+ R   V  +       +         +M+ E  M G  SI +
Sbjct: 157 RNVLVYDKLNVKISDLGLFRE--VYAADYYK---LLGNSLLPIRWMAPEAIMYGKFSIDS 211

Query: 192 DVFGFGVL 199
           D++ +GV+
Sbjct: 212 DIWSYGVV 219

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 97.8 bits (244), Expect = 2e-23
 Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 24/174 (13%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMPN 104
               VA+K+L  +    + +FQ E +++  L    +VK  G     G + L LV E++P+
Sbjct: 51  TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS 110

Query: 105 KSLDS---SFSGTFKDLLCLH---------KY-SRLRVIHRDLKASNILLDDQLNTKISD 151
             L                L          +Y    R +HRDL A NIL++ + + KI+D
Sbjct: 111 GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIAD 170

Query: 152 FGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKTDVFGFGVLV 200
           FG+A++  +++       +V   G     + + E       S ++DV+ FGV++
Sbjct: 171 FGLAKLLPLDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 96.9 bits (242), Expect = 2e-23
 Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 21/173 (12%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           GK+  + +VAIK +   S     EF  EAK++  L +  LV+L G         ++ E+M
Sbjct: 43  GKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101

Query: 103 PNKSLDS---SFSGTFK--DLL--CLH-----KY-SRLRVIHRDLKASNILLDDQLNTKI 149
            N  L +        F+   LL  C       +Y    + +HRDL A N L++DQ   K+
Sbjct: 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 161

Query: 150 SDFGMARIFGVNESGANTNRIVGT---YGYMSLEYTMSGTVSIKTDVFGFGVL 199
           SDFG++R    +E        VG+     +   E  M    S K+D++ FGVL
Sbjct: 162 SDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 210

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.9 bits (242), Expect = 3e-23
 Identities = 47/195 (24%), Positives = 74/195 (37%), Gaps = 42/195 (21%)

Query: 42  VGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVY 99
           + K      VA+K L        R    +E K+++ L  + N+V LLG    G   L++ 
Sbjct: 47  LIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106

Query: 100 EFMPNKSL----------------------DSSFSGTFKDLLCLH-------KY-SRLRV 129
           E+     L                      D   +   +DLL           + +    
Sbjct: 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC 166

Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMS 184
           IHRDL A NILL     TKI DFG+AR   +       N +V         +M+ E   +
Sbjct: 167 IHRDLAARNILLTHGRITKICDFGLARD--IKNDS---NYVVKGNARLPVKWMAPESIFN 221

Query: 185 GTVSIKTDVFGFGVL 199
              + ++DV+ +G+ 
Sbjct: 222 CVYTFESDVWSYGIF 236

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 47/191 (24%), Positives = 82/191 (42%), Gaps = 38/191 (19%)

Query: 42  VGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVY 99
           +GK     +VA+K L +      +    +E K+++ L Q+ N+V LLG   HG   L++ 
Sbjct: 70  LGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVIT 129

Query: 100 EFMPNKSL------------------DSSFSGTFKDLLCLH-------KY-SRLRVIHRD 133
           E+     L                   ++ + + +DLL           + +    IHRD
Sbjct: 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRD 189

Query: 134 LKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVS 188
           + A N+LL +    KI DFG+AR   +       N IV         +M+ E       +
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARD--IMNDS---NYIVKGNARLPVKWMAPESIFDCVYT 244

Query: 189 IKTDVFGFGVL 199
           +++DV+ +G+L
Sbjct: 245 VQSDVWSYGIL 255

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 99.2 bits (247), Expect = 4e-23
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 17/176 (9%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G +     VAIK L   +      F  EA+++ KL++  LV+L    +  E   +V E+M
Sbjct: 286 GTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYM 343

Query: 103 PNKSLDS---SFSGTFKDLLCLHKYSR-----------LRVIHRDLKASNILLDDQLNTK 148
              SL       +G +  L  L   +            +  +HRDL+A+NIL+ + L  K
Sbjct: 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCK 403

Query: 149 ISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 404 VADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 96.1 bits (240), Expect = 4e-23
 Identities = 38/188 (20%), Positives = 67/188 (35%), Gaps = 42/188 (22%)

Query: 40  ILVGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLL 97
           +       +  VA+K      +   + +F +EA ++  L + ++VKL+G      E   +
Sbjct: 32  VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE--EEPTWI 89

Query: 98  VYEFMPNKSLDS---SFSGTFK--DLL--CLH-----KY-SRLRVIHRDLKASNILLDDQ 144
           + E  P   L         + K   L+   L       Y   +  +HRD+   NIL+   
Sbjct: 90  IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP 149

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGY------------MSLEYTMSGTVSIKTD 192
              K+ DFG++R     +             Y            MS E       +  +D
Sbjct: 150 ECVKLGDFGLSRYIEDED-------------YYKASVTRLPIKWMSPESINFRRFTTASD 196

Query: 193 VFGFGVLV 200
           V+ F V +
Sbjct: 197 VWMFAVCM 204

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 96.2 bits (240), Expect = 5e-23
 Identities = 43/175 (24%), Positives = 74/175 (42%), Gaps = 25/175 (14%)

Query: 47  NEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFMP 103
             ++VA+K L   + G    + + E +++  L + N+VK  G C+  G   + L+ EF+P
Sbjct: 49  TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 108

Query: 104 NKSLDS-----SFSGTFKDLLCLH-------KY-SRLRVIHRDLKASNILLDDQLNTKIS 150
           + SL             K  L           Y    + +HRDL A N+L++ +   KI 
Sbjct: 109 SGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 168

Query: 151 DFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKTDVFGFGVLV 200
           DFG+ +    ++        V         + + E  M     I +DV+ FGV +
Sbjct: 169 DFGLTKAIETDKEYYT----VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 219

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 95.8 bits (239), Expect = 6e-23
 Identities = 44/187 (23%), Positives = 70/187 (37%), Gaps = 50/187 (26%)

Query: 46  PNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYEFMP 103
             + +VAIK L   T      E   EA+++ +L    +V+L+G C    E  +LV E   
Sbjct: 35  KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--AEALMLVMEMAG 92

Query: 104 NKSLDS---SFSGTFK--DLL--CLH-----KY-SRLRVIHRDLKASNILLDDQLNTKIS 150
              L              ++           KY      +HRDL A N+LL ++   KIS
Sbjct: 93  GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKIS 152

Query: 151 DFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-----------------GTVSIKTDV 193
           DFG+++  G ++S                 YT                      S ++DV
Sbjct: 153 DFGLSKALGADDS----------------YYTARSAGKWPLKWYAPECINFRKFSSRSDV 196

Query: 194 FGFGVLV 200
           + +GV +
Sbjct: 197 WSYGVTM 203

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 95.8 bits (239), Expect = 7e-23
 Identities = 44/174 (25%), Positives = 72/174 (41%), Gaps = 28/174 (16%)

Query: 48  EQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYEFMPN 104
            + VA+K L         + E   EA ++ +L    +V+++G C    E  +LV E    
Sbjct: 44  VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAEL 101

Query: 105 KSLDS----SFSGTFKDLL--CLH-----KY-SRLRVIHRDLKASNILLDDQLNTKISDF 152
             L+     +     K+++          KY      +HRDL A N+LL  Q   KISDF
Sbjct: 102 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDF 161

Query: 153 GMARIFGVNESGANTNRIVGTYG------YMSLEYTMSGTVSIKTDVFGFGVLV 200
           G+++    +E+                  + + E       S K+DV+ FGVL+
Sbjct: 162 GLSKALRADENYYKAQT-----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 210

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 96.4 bits (240), Expect = 7e-23
 Identities = 38/188 (20%), Positives = 73/188 (38%), Gaps = 37/188 (19%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQNEAK--LIAKLQYTNLVKLLGCSIHGE----ERLLVYE 100
             +EVA+K  +    +    +  EA+      L++ N++  +           +  LV +
Sbjct: 64  RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 120

Query: 101 FMPNKSLDS---SFSGTFKDLL-----------CLH-----KYSRLRVIHRDLKASNILL 141
           +  + SL      ++ T + ++            LH        +  + HRDLK+ NIL+
Sbjct: 121 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180

Query: 142 DDQLNTKISDFGMARIF--GVNESGANTNRIVGTYGYMS---LEYTMSGT---VSIKTDV 193
                  I+D G+A       +      N  VGT  YM+   L+ +++        + D+
Sbjct: 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 240

Query: 194 FGFGVLVL 201
           +  G LV 
Sbjct: 241 YAMG-LVF 247

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 96.2 bits (240), Expect = 8e-23
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)

Query: 47  NEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK 105
            +  VAIK L   TS +   E  +EA ++A +   ++ +LLG  +      L+ + MP  
Sbjct: 43  VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFG 101

Query: 106 SLDS-----SFSGTFKDLL-CLH------KY-SRLRVIHRDLKASNILLDDQLNTKISDF 152
            L         +   + LL           Y    R++HRDL A N+L+    + KI+DF
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161

Query: 153 GMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKTDVFGFGVLV 200
           G+A++ G  E   +        G     +M+LE  +    + ++DV+ +GV V
Sbjct: 162 GLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTV 209

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 17/176 (9%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G +     VAIK L   +      F  EA+++ KL++  LV+L    +  E   +V E+M
Sbjct: 203 GTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYM 260

Query: 103 PNKSLDS---SFSGTFKDLLCLHKYSR-----------LRVIHRDLKASNILLDDQLNTK 148
              SL       +G +  L  L   +            +  +HRDL+A+NIL+ + L  K
Sbjct: 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCK 320

Query: 149 ISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           ++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++ 
Sbjct: 321 VADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 44/200 (22%), Positives = 79/200 (39%), Gaps = 47/200 (23%)

Query: 42  VGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
           +        VA+K L    S     +  +E  ++ ++ + +++KL G        LL+ E
Sbjct: 47  LKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106

Query: 101 FMPNKSL----------------------------DSSFSGTFKDLLCLH-------KY- 124
           +    SL                                + T  DL+          +Y 
Sbjct: 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL 166

Query: 125 SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSL 179
           + ++++HRDL A NIL+ +    KISDFG++R   V E  +       + G     +M++
Sbjct: 167 AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD--VYEEDSYV---KRSQGRIPVKWMAI 221

Query: 180 EYTMSGTVSIKTDVFGFGVL 199
           E       + ++DV+ FGVL
Sbjct: 222 ESLFDHIYTTQSDVWSFGVL 241

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 45/195 (23%), Positives = 78/195 (40%), Gaps = 40/195 (20%)

Query: 40  ILVGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLL 97
           I   K      VA+K L    + +   +  +E +++  + ++ N++ LLG         +
Sbjct: 59  IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118

Query: 98  VYEFMPNKSL--------------------DSSFSGTFKDLLCLH-------KY-SRLRV 129
           + E+    +L                          TFKDL+          +Y +  + 
Sbjct: 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 178

Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMS 184
           IHRDL A N+L+ +    KI+DFG+AR   +N           T G     +M+ E    
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLARD--INNID---YYKKTTNGRLPVKWMAPEALFD 233

Query: 185 GTVSIKTDVFGFGVL 199
              + ++DV+ FGVL
Sbjct: 234 RVYTHQSDVWSFGVL 248

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 94.2 bits (235), Expect = 2e-22
 Identities = 51/173 (29%), Positives = 74/173 (42%), Gaps = 21/173 (12%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           GK+  + +VA+K +   S     EF  EA+ + KL +  LVK  G         +V E++
Sbjct: 27  GKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85

Query: 103 PNKSLDS-----SFSGTFKDLL--CLH-----KY-SRLRVIHRDLKASNILLDDQLNTKI 149
            N  L +             LL  C        +    + IHRDL A N L+D  L  K+
Sbjct: 86  SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKV 145

Query: 150 SDFGMARIFGVNESGANTNRIVGT---YGYMSLEYTMSGTVSIKTDVFGFGVL 199
           SDFGM R    ++        VGT     + + E       S K+DV+ FG+L
Sbjct: 146 SDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGIL 194

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 95.0 bits (237), Expect = 2e-22
 Identities = 40/191 (20%), Positives = 78/191 (40%), Gaps = 37/191 (19%)

Query: 40  ILVGKFPNEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE---- 93
            L  +     +VA+K +    +S +   EF +EA  +    + N+++LLG  I       
Sbjct: 54  NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113

Query: 94  -ERLLVYEFMPNKSLDS----------SFSGTFKDLL--CLH-----KY-SRLRVIHRDL 134
            + +++  FM    L +                + LL   +      +Y S    +HRDL
Sbjct: 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDL 173

Query: 135 KASNILLDDQLNTKISDFGMAR-IFGVNESGANTN-----RIVGTYGYMSLEYTMSGTVS 188
            A N +L D +   ++DFG+++ I+  +            +      ++++E       +
Sbjct: 174 AARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK------WIAIESLADRVYT 227

Query: 189 IKTDVFGFGVL 199
            K+DV+ FGV 
Sbjct: 228 SKSDVWAFGVT 238

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 95.5 bits (238), Expect = 2e-22
 Identities = 45/195 (23%), Positives = 78/195 (40%), Gaps = 40/195 (20%)

Query: 40  ILVGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLL 97
           I   K      VA+K L    + +   +  +E +++  + ++ N++ LLG         +
Sbjct: 105 IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 164

Query: 98  VYEFMPNKSL--------------------DSSFSGTFKDLLCLH-------KY-SRLRV 129
           + E+    +L                          TFKDL+          +Y +  + 
Sbjct: 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 224

Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMS 184
           IHRDL A N+L+ +    KI+DFG+AR   +N           T G     +M+ E    
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFGLARD--INNID---YYKKTTNGRLPVKWMAPEALFD 279

Query: 185 GTVSIKTDVFGFGVL 199
              + ++DV+ FGVL
Sbjct: 280 RVYTHQSDVWSFGVL 294

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 93.9 bits (234), Expect = 3e-22
 Identities = 39/191 (20%), Positives = 70/191 (36%), Gaps = 40/191 (20%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL 97
           R +      +E EV +K L          F   A +++KL + +LV   G  + G+E +L
Sbjct: 30  REVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL 89

Query: 98  VYEFMPNKSLDS---SFSGTFK--DLLCLH-------KY-SRLRVIHRDLKASNILLDDQ 144
           V EF+   SLD+              L +         +     +IH ++ A NILL  +
Sbjct: 90  VQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE 149

Query: 145 LNT--------KISDFGMARIFGVNESGANTNRIVGTYGY------MSLE-YTMSGTVSI 189
            +         K+SD G++              ++           +  E       +++
Sbjct: 150 EDRKTGNPPFIKLSDPGISIT------------VLPKDILQERIPWVPPECIENPKNLNL 197

Query: 190 KTDVFGFGVLV 200
            TD + FG  +
Sbjct: 198 ATDKWSFGTTL 208

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 94.3 bits (235), Expect = 3e-22
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 25/173 (14%)

Query: 47  NEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK 105
            +  V IK +   +  Q      +    I  L + ++V+LLG    G    LV +++P  
Sbjct: 41  IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLG 99

Query: 106 SLDS-----SFSGTFKDLL--CLH-----KY-SRLRVIHRDLKASNILLDDQLNTKISDF 152
           SL         +   + LL   +       Y     ++HR+L A N+LL      +++DF
Sbjct: 100 SLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADF 159

Query: 153 GMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKTDVFGFGVLV 200
           G+A +   ++     +            +M+LE    G  + ++DV+ +GV V
Sbjct: 160 GVADLLPPDDKQLLYSE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTV 207

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 93.5 bits (233), Expect = 3e-22
 Identities = 42/178 (23%), Positives = 68/178 (38%), Gaps = 22/178 (12%)

Query: 40  ILVGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLL 97
           I +        VAIK     TS   R +F  EA  + +  + ++VKL+G  +       +
Sbjct: 35  IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWI 92

Query: 98  VYEFMPNKSLDS-----SFSGTFKDLL--CLH-----KY-SRLRVIHRDLKASNILLDDQ 144
           + E      L S      +S     L+           Y    R +HRD+ A N+L+   
Sbjct: 93  IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN 152

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTY--GYMSLEYTMSGTVSIKTDVFGFGVLV 200
              K+ DFG++R     E         G     +M+ E       +  +DV+ FGV +
Sbjct: 153 DCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 207

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 94.3 bits (235), Expect = 4e-22
 Identities = 54/186 (29%), Positives = 76/186 (40%), Gaps = 33/186 (17%)

Query: 42  VGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
           +   P+  +VA+K L    S Q  ++F  EA +I+K  + N+V+ +G S+    R ++ E
Sbjct: 54  MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILME 113

Query: 101 FMPNKSLDS-----------SFSGTFKDLLCLH-------KY-SRLRVIHRDLKASNILL 141
            M    L S             S    DLL +        +Y      IHRD+ A N LL
Sbjct: 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 173

Query: 142 D---DQLNTKISDFGMARIFGVNESGANTNRIVGTYGY-----MSLEYTMSGTVSIKTDV 193
                    KI DFGMAR   +  +        G         M  E  M G  + KTD 
Sbjct: 174 TCPGPGRVAKIGDFGMAR--DIYRASYYR---KGGCAMLPVKWMPPEAFMEGIFTSKTDT 228

Query: 194 FGFGVL 199
           + FGVL
Sbjct: 229 WSFGVL 234

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 94.3 bits (235), Expect = 5e-22
 Identities = 44/198 (22%), Positives = 75/198 (37%), Gaps = 47/198 (23%)

Query: 44  KFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
            +     VA+K L    S   + +FQ EA L+A+    N+VKLLG    G+   L++E+M
Sbjct: 73  PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 132

Query: 103 PNKSLDS----------------------------SFSGTFKDLLCLH-------KY-SR 126
               L+                                 +  + LC+         Y S 
Sbjct: 133 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 192

Query: 127 LRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY-----MSLEY 181
            + +HRDL   N L+ + +  KI+DFG++R   +  +                  M  E 
Sbjct: 193 RKFVHRDLATRNCLVGENMVVKIADFGLSR--NIYSADYYK---ADGNDAIPIRWMPPES 247

Query: 182 TMSGTVSIKTDVFGFGVL 199
                 + ++DV+ +GV+
Sbjct: 248 IFYNRYTTESDVWAYGVV 265

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 94.4 bits (235), Expect = 6e-22
 Identities = 41/195 (21%), Positives = 80/195 (41%), Gaps = 40/195 (20%)

Query: 40  ILVGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLL 97
           +   K     +VA+K L +  + +   +  +E +++  + ++ N++ LLG         +
Sbjct: 93  LDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 152

Query: 98  VYEFMPNKSL--------------------DSSFSGTFKDLLCLH-------KY-SRLRV 129
           + E+    +L                    +     + KDL+          +Y +  + 
Sbjct: 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 212

Query: 130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMS 184
           IHRDL A N+L+ +    KI+DFG+AR   ++           T G     +M+ E    
Sbjct: 213 IHRDLAARNVLVTEDNVMKIADFGLARD--IHHIDYYK---KTTNGRLPVKWMAPEALFD 267

Query: 185 GTVSIKTDVFGFGVL 199
              + ++DV+ FGVL
Sbjct: 268 RIYTHQSDVWSFGVL 282

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 93.6 bits (233), Expect = 7e-22
 Identities = 40/192 (20%), Positives = 81/192 (42%), Gaps = 38/192 (19%)

Query: 40  ILVGKFPNEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER-- 95
            L  +  +  +VA+K L     +     EF  EA  + +  + ++ KL+G S+    +  
Sbjct: 43  QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102

Query: 96  ----LLVYEFMPNKSL----------DSSFSGTFKDLL--CLH-----KY-SRLRVIHRD 133
               +++  FM +  L          ++ F+   + L+   +      +Y S    IHRD
Sbjct: 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRD 162

Query: 134 LKASNILLDDQLNTKISDFGMAR-IFGVNESGANTN-----RIVGTYGYMSLEYTMSGTV 187
           L A N +L + +   ++DFG++R I+  +            +      +++LE       
Sbjct: 163 LAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK------WLALESLADNLY 216

Query: 188 SIKTDVFGFGVL 199
           ++ +DV+ FGV 
Sbjct: 217 TVHSDVWAFGVT 228

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 93.1 bits (232), Expect = 7e-22
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 41/194 (21%)

Query: 42  VGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLG-CSIHGEERLLV 98
           + K    + VA+K L    +        +E K++  +  + N+V LLG C+  G   +++
Sbjct: 51  IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110

Query: 99  YEFMPNKSL--------------------DSSFSGTFKDLLCLH-------KY-SRLRVI 130
            EF    +L                          T + L+C         ++ +  + I
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 170

Query: 131 HRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSG 185
           HRDL A NILL ++   KI DFG+AR   + +     + +          +M+ E     
Sbjct: 171 HRDLAARNILLSEKNVVKICDFGLARD--IYKDP---DYVRKGDARLPLKWMAPETIFDR 225

Query: 186 TVSIKTDVFGFGVL 199
             +I++DV+ FGVL
Sbjct: 226 VYTIQSDVWSFGVL 239

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 92.7 bits (231), Expect = 7e-22
 Identities = 55/173 (31%), Positives = 80/173 (46%), Gaps = 21/173 (12%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G +    +VA+K L   S      F  EA L+ +LQ+  LV+L    +  E   ++ E+M
Sbjct: 32  GYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYM 89

Query: 103 PNKSLDS------SFSGTFKDLL--CLH-----KY-SRLRVIHRDLKASNILLDDQLNTK 148
            N SL            T   LL           +      IHRDL+A+NIL+ D L+ K
Sbjct: 90  ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCK 149

Query: 149 ISDFGMARIFGVNESGANTNRIVGTYGY--MSLEYTMSGTVSIKTDVFGFGVL 199
           I+DFG+AR+    E    T R    +     + E    GT +IK+DV+ FG+L
Sbjct: 150 IADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 93.1 bits (232), Expect = 9e-22
 Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 39/189 (20%)

Query: 44  KFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEF 101
           K     + AIKR+  + S     +F  E +++ KL  + N++ LLG   H     L  E+
Sbjct: 48  KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 107

Query: 102 MPNKSLDS--------------------SFSGTFKDLLCLH-------KY-SRLRVIHRD 133
            P+ +L                      + + + + LL           Y S+ + IHRD
Sbjct: 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 167

Query: 134 LKASNILLDDQLNTKISDFGMARIFGVNESGANTN---RIVGTYGYMSLEYTMSGTVSIK 190
           L A NIL+ +    KI+DFG++R   V           R      +M++E       +  
Sbjct: 168 LAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR------WMAIESLNYSVYTTN 221

Query: 191 TDVFGFGVL 199
           +DV+ +GVL
Sbjct: 222 SDVWSYGVL 230

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 43/168 (25%), Positives = 74/168 (44%), Gaps = 22/168 (13%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNK 105
              +VA+K +   +      F  EA ++ +L+++NLV+LLG  +  +  L +V E+M   
Sbjct: 215 RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272

Query: 106 SLDS------SFSGTFKDLL--CLH-----KY-SRLRVIHRDLKASNILLDDQLNTKISD 151
           SL                LL   L      +Y      +HRDL A N+L+ +    K+SD
Sbjct: 273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 332

Query: 152 FGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
           FG+ +     +      ++     + + E       S K+DV+ FG+L
Sbjct: 333 FGLTKEASSTQDTG---KL--PVKWTAPEALREKKFSTKSDVWSFGIL 375

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 93.2 bits (232), Expect = 1e-21
 Identities = 55/186 (29%), Positives = 77/186 (41%), Gaps = 33/186 (17%)

Query: 42  VGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
           +   P+  +VA+K L    S Q  ++F  EA +I+K  + N+V+ +G S+    R ++ E
Sbjct: 95  MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 154

Query: 101 FMPNKSLDS-----------SFSGTFKDLLCLH-------KY-SRLRVIHRDLKASNILL 141
            M    L S             S    DLL +        +Y      IHRD+ A N LL
Sbjct: 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 214

Query: 142 D---DQLNTKISDFGMARIFGVNESGANTNRIVGTYGY-----MSLEYTMSGTVSIKTDV 193
                    KI DFGMAR   +  +G       G         M  E  M G  + KTD 
Sbjct: 215 TCPGPGRVAKIGDFGMAR--DIYRAGYYR---KGGCAMLPVKWMPPEAFMEGIFTSKTDT 269

Query: 194 FGFGVL 199
           + FGVL
Sbjct: 270 WSFGVL 275

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 94.6 bits (235), Expect = 2e-21
 Identities = 45/190 (23%), Positives = 73/190 (38%), Gaps = 51/190 (26%)

Query: 44  KFPNEQ-EVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYE 100
           +   +Q +VAIK L   T      E   EA+++ +L    +V+L+G C    E  +LV E
Sbjct: 358 RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--AEALMLVME 415

Query: 101 FMPNKSLDS---SFSGTFK--DLLCLH-------KY-SRLRVIHRDLKASNILLDDQLNT 147
                 L              ++  L        KY      +HR+L A N+LL ++   
Sbjct: 416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYA 475

Query: 148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-----------------GTVSIK 190
           KISDFG+++  G ++S                 YT                      S +
Sbjct: 476 KISDFGLSKALGADDS----------------YYTARSAGKWPLKWYAPECINFRKFSSR 519

Query: 191 TDVFGFGVLV 200
           +DV+ +GV +
Sbjct: 520 SDVWSYGVTM 529

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 91.5 bits (228), Expect = 2e-21
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 26/171 (15%)

Query: 48  EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
              VA+K L   + +   EF  EA ++ ++++ NLV+LLG         ++ EFM   +L
Sbjct: 38  SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96

Query: 108 DS------SFSGTFKDLL--CLH-----KY-SRLRVIHRDLKASNILLDDQLNTKISDFG 153
                       +   LL          +Y  +   IHRDL A N L+ +    K++DFG
Sbjct: 97  LDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156

Query: 154 MARIFGVNESGANTN-----RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
           ++R+   +   A+       +      + + E       SIK+DV+ FGVL
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVL 201

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 92.4 bits (230), Expect = 2e-21
 Identities = 47/200 (23%), Positives = 75/200 (37%), Gaps = 47/200 (23%)

Query: 42  VGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVY 99
           + K     +VA+K L        R    +E K++ +L  + N+V LLG         L++
Sbjct: 69  ISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 128

Query: 100 EFMPNKSL---------------------------DSSFSGTFKDLLCLH-------KY- 124
           E+     L                           +     TF+DLLC         ++ 
Sbjct: 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 188

Query: 125 SRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSL 179
                +HRDL A N+L+      KI DFG+AR   +          V         +M+ 
Sbjct: 189 EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD--IMSDSNYV---VRGNARLPVKWMAP 243

Query: 180 EYTMSGTVSIKTDVFGFGVL 199
           E    G  +IK+DV+ +G+L
Sbjct: 244 ESLFEGIYTIKSDVWSYGIL 263

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 92.8 bits (231), Expect = 4e-21
 Identities = 56/179 (31%), Positives = 85/179 (47%), Gaps = 23/179 (12%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
             +    +VA+K +   S      F  EA ++  LQ+  LVKL    +  E   ++ EFM
Sbjct: 207 ATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFM 264

Query: 103 PNKSLDS---SFSGTFKDLLCLHKYSR-----------LRVIHRDLKASNILLDDQLNTK 148
              SL     S  G+ + L  L  +S               IHRDL+A+NIL+   L  K
Sbjct: 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCK 324

Query: 149 ISDFGMARIFGVNESGANTNRIVGT---YGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV 204
           I+DFG+AR+   NE  A      G      + + E    G+ +IK+DV+ FG+L+++IV
Sbjct: 325 IADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 42/181 (23%), Positives = 70/181 (38%), Gaps = 28/181 (15%)

Query: 40  ILVGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLL 97
           I +        VAIK     TS   R +F  EA  + +  + ++VKL+G  +       +
Sbjct: 410 IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWI 467

Query: 98  VYEFMPNKSLDS-----SFSGTFKDLLCLH-------KY-SRLRVIHRDLKASNILLDDQ 144
           + E      L S      FS     L+           Y    R +HRD+ A N+L+   
Sbjct: 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN 527

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKTDVFGFGVL 199
              K+ DFG++R         ++     + G     +M+ E       +  +DV+ FGV 
Sbjct: 528 DCVKLGDFGLSRYM------EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 581

Query: 200 V 200
           +
Sbjct: 582 M 582

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 89.2 bits (222), Expect = 1e-20
 Identities = 42/174 (24%), Positives = 68/174 (39%), Gaps = 34/174 (19%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERLLVYEFMPNK 105
              +VA+K +   +      F  EA ++ +L+++NLV+LLG          +V E+M   
Sbjct: 43  RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100

Query: 106 SLDS------SFSGTFKDLL--CLH-----KY-SRLRVIHRDLKASNILLDDQLNTKISD 151
           SL                LL   L      +Y      +HRDL A N+L+ +    K+SD
Sbjct: 101 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 160

Query: 152 FGMARIFGVNESGANTNRIVGTYG------YMSLEYTMSGTVSIKTDVFGFGVL 199
           FG+ +                         + + E       S K+DV+ FG+L
Sbjct: 161 FGLTK-----------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 203

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 87.0 bits (216), Expect = 1e-19
 Identities = 42/192 (21%), Positives = 74/192 (38%), Gaps = 27/192 (14%)

Query: 38  RVILVGKFPNEQEVAIKRL---AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE 94
            V       +   VA+K++        + R +   E  L+ +L + N++K     I   E
Sbjct: 47  EVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106

Query: 95  RLLVYEFMPNKSLDSSFSGTFKD-------------------LLCLHKYSRLRVIHRDLK 135
             +V E      L        K                    L  +H     RV+HRD+K
Sbjct: 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIK 163

Query: 136 ASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFG 195
            +N+ +      K+ D G+ R F    + A++  +VGT  YMS E       + K+D++ 
Sbjct: 164 PANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWS 221

Query: 196 FGVLVLKIVCGK 207
            G L+ ++   +
Sbjct: 222 LGCLLYEMAALQ 233

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 38/189 (20%), Positives = 78/189 (41%), Gaps = 24/189 (12%)

Query: 38  RVILVGKFPNEQEVAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER 95
           + ILV    + ++  IK   ++  S + R E + E  ++A +++ N+V+           
Sbjct: 39  KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSL 98

Query: 96  LLVYEFMPNKSLDSSFSGTFKDLL-----------------CLHKYSRLRVIHRDLKASN 138
            +V ++     L    +     L                   +H     +++HRD+K+ N
Sbjct: 99  YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQN 155

Query: 139 ILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGV 198
           I L      ++ DFG+AR+       A     +GT  Y+S E   +   + K+D++  G 
Sbjct: 156 IFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGC 213

Query: 199 LVLKIVCGK 207
           ++ ++   K
Sbjct: 214 VLYELCTLK 222

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 81.2 bits (201), Expect = 7e-18
 Identities = 44/195 (22%), Positives = 74/195 (37%), Gaps = 27/195 (13%)

Query: 38  RVILVGKFPNEQEVAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER 95
           R   + +  + + +  K       +   +    +E  L+ +L++ N+V+     I     
Sbjct: 21  RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80

Query: 96  LL--VYEFMPN----------KSLDSSFS-----GTFKDLLC----LH--KYSRLRVIHR 132
            L  V E+                               L       H        V+HR
Sbjct: 81  TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 140

Query: 133 DLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTD 192
           DLK +N+ LD + N K+ DFG+ARI   + S A T   VGT  YMS E     + + K+D
Sbjct: 141 DLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSYNEKSD 198

Query: 193 VFGFGVLVLKIVCGK 207
           ++  G L+ ++    
Sbjct: 199 IWSLGCLLYELCALM 213

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 78.4 bits (194), Expect = 9e-17
 Identities = 43/189 (22%), Positives = 80/189 (42%), Gaps = 48/189 (25%)

Query: 50  EVAIK--RLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIH--GEERLLVY---EF 101
           +VAIK   +     +  ++ F+ E    ++L + N+V     S+    EE    Y   E+
Sbjct: 38  KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV-----SMIDVDEEDDCYYLVMEY 92

Query: 102 MPNKSLDSSFSGTFKDLLCLHKYSRL----------------------RVIHRDLKASNI 139
           +   +L         + +    +  L                      R++HRD+K  NI
Sbjct: 93  IEGPTL--------SEYI--ESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI 142

Query: 140 LLDDQLNTKISDFGMARIFGVNESG-ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGV 198
           L+D     KI DFG+A+   ++E+    TN ++GT  Y S E          TD++  G+
Sbjct: 143 LIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGI 200

Query: 199 LVLKIVCGK 207
           ++ +++ G+
Sbjct: 201 VLYEMLVGE 209

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 42/193 (21%), Positives = 70/193 (36%), Gaps = 37/193 (19%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL 97
           +V       + +   IKR+         + + E K +AKL + N+V   GC    +    
Sbjct: 26  QVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81

Query: 98  VYEFMPNKSLDSSF--------SGTFKDLLCLHKYSRL---------------------- 127
                 ++S              GT +  +   +  +L                      
Sbjct: 82  TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK 141

Query: 128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           ++I+RDLK SNI L D    KI DFG+       ++     R  GT  YMS E   S   
Sbjct: 142 KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSKGTLRYMSPEQISSQDY 198

Query: 188 SIKTDVFGFGVLV 200
             + D++  G+++
Sbjct: 199 GKEVDLYALGLIL 211

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 78.2 bits (193), Expect = 1e-16
 Identities = 42/206 (20%), Positives = 74/206 (35%), Gaps = 42/206 (20%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSI----HGE 93
            V LV    +    A+KR+     Q R E Q EA +     + N+++L+   +       
Sbjct: 44  YVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103

Query: 94  ERLLVYEFMPNKSLDSS-------------------FSGTFKDLLCLHKYSRLRVIHRDL 134
           E  L+  F    +L +                      G  + L  +H        HRDL
Sbjct: 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDL 160

Query: 135 KASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV-------GTYGYMSLE------Y 181
           K +NILL D+    + D G      ++  G+     +        T  Y + E      +
Sbjct: 161 KPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSH 220

Query: 182 TMSGTVSIKTDVFGFGVLVLKIVCGK 207
            +      +TDV+  G ++  ++ G+
Sbjct: 221 CVIDE---RTDVWSLGCVLYAMMFGE 243

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 36/181 (19%), Positives = 57/181 (31%), Gaps = 48/181 (26%)

Query: 50  EVAIK--RLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIH--GEERLLVY---EF 101
            VA+K      +S        Q EA+   +LQ  ++V      IH  GE    +Y     
Sbjct: 61  IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV-----PIHDFGEIDGQLYVDMRL 115

Query: 102 MPNKSLDSSFSGTFKDLLCLHKYSRL----------------------RVIHRDLKASNI 139
           +    L          +L   +   L                         HRD+K  NI
Sbjct: 116 INGVDL--------AAML--RRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165

Query: 140 LLDDQLNTKISDFGMARIFGVNESGA-NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGV 198
           L+       + DFG+A      +         VGT  YM+ E       + + D++    
Sbjct: 166 LVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTC 223

Query: 199 L 199
           +
Sbjct: 224 V 224

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 77.3 bits (191), Expect = 2e-16
 Identities = 39/151 (25%), Positives = 60/151 (39%), Gaps = 24/151 (15%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
             +AIK +     +       E  L   L++ N+V+ LG         +  E +P  SL 
Sbjct: 48  VRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107

Query: 109 S---SFSGTFKD---------------LLCLHKYSRLRVIHRDLKASNILLDDQLNT-KI 149
           +   S  G  KD               L  LH     +++HRD+K  N+L++      KI
Sbjct: 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKI 164

Query: 150 SDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           SDFG ++   +      T    GT  YM+ E
Sbjct: 165 SDFGTSKR--LAGINPCTETFTGTLQYMAPE 193

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 78.0 bits (192), Expect = 2e-16
 Identities = 49/239 (20%), Positives = 90/239 (37%), Gaps = 27/239 (11%)

Query: 46  PNEQEVAIKRLAWTSGQG-RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN 104
           P+   +A K +        R +   E +++ +     +V   G      E  +  E M  
Sbjct: 56  PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115

Query: 105 KSLDS--SFSGTF-------------KDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKI 149
            SLD     +G               K L  L    + +++HRD+K SNIL++ +   K+
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKL 173

Query: 150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK-- 207
            DFG++      +S AN+   VGT  YMS E       S+++D++  G+ ++++  G+  
Sbjct: 174 CDFGVSGQL--IDSMANSF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

Query: 208 ---KNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSK 263
               + K         + G A +     +              P    F L+  +    
Sbjct: 230 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP 288

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 76.7 bits (189), Expect = 5e-16
 Identities = 40/178 (22%), Positives = 65/178 (36%), Gaps = 27/178 (15%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
            + A+K++     +       E    A L    +V L G    G    +  E +   SL 
Sbjct: 84  FQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138

Query: 109 S--SFSGTFKD-------------LLCLHKYSRLRVIHRDLKASNILLDDQ-LNTKISDF 152
                 G   +             L  LH     R++H D+KA N+LL        + DF
Sbjct: 139 QLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDF 195

Query: 153 GMARIF---GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           G A      G+ +S    + I GT  +M+ E  M      K D++    ++L ++ G 
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 76.2 bits (188), Expect = 6e-16
 Identities = 45/188 (23%), Positives = 76/188 (40%), Gaps = 33/188 (17%)

Query: 49  QEVAIKR--LAWTSGQGRVEFQNEAKLIAKLQYTNL--VKLLGCSIHGEERLLVYEF--- 101
           Q  AIK   L     Q    ++NE   + KLQ  +   ++L    I  +   +V E    
Sbjct: 53  QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI 112

Query: 102 ------MPNKSLDSSFSGTF-KDLLC----LHKYSRLRVIHRDLKASNILLDDQLNTKIS 150
                    KS+D     ++ K++L     +H++    ++H DLK +N L+ D    K+ 
Sbjct: 113 DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLI 168

Query: 151 DFGMARIFGVNESGANTNRIVGTYGYMS-----------LEYTMSGTVSIKTDVFGFGVL 199
           DFG+A     + +    +  VGT  YM                    +S K+DV+  G +
Sbjct: 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228

Query: 200 VLKIVCGK 207
           +  +  GK
Sbjct: 229 LYYMTYGK 236

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 45/188 (23%), Positives = 77/188 (40%), Gaps = 42/188 (22%)

Query: 49  QEVAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGC---SIHGEERLLVY-EFM 102
            EVA    +    +   R  F+ EA+++  LQ+ N+V+       ++ G++ +++  E M
Sbjct: 52  VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111

Query: 103 PNKSLDSSFSGTFKDLLCLHK---------YSR-------------LRVIHRDLKASNIL 140
                    SGT K  L   K         + R               +IHRDLK  NI 
Sbjct: 112 T--------SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 163

Query: 141 LDDQLNT-KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
           +     + KI D G+A +     S A    ++GT  +M+ E           DV+ FG+ 
Sbjct: 164 ITGPTGSVKIGDLGLATL--KRASFAKA--VIGTPEFMAPEMYEEK-YDESVDVYAFGMC 218

Query: 200 VLKIVCGK 207
           +L++   +
Sbjct: 219 MLEMATSE 226

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 46/188 (24%), Positives = 77/188 (40%), Gaps = 33/188 (17%)

Query: 49  QEVAIKR--LAWTSGQGRVEFQNEAKLIAKLQYTNL--VKLLGCSIHGEERLLVYEF--- 101
           Q  AIK   L     Q    ++NE   + KLQ  +   ++L    I  +   +V E    
Sbjct: 34  QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI 93

Query: 102 ------MPNKSLDSSFSGTF-KDLLC----LHKYSRLRVIHRDLKASNILLDDQLNTKIS 150
                    KS+D     ++ K++L     +H++    ++H DLK +N L+ D    K+ 
Sbjct: 94  DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLI 149

Query: 151 DFGMARIFGVNESGANTNRIVGTYGYMSLE-----------YTMSGTVSIKTDVFGFGVL 199
           DFG+A     + +    +  VGT  YM  E                 +S K+DV+  G +
Sbjct: 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 209

Query: 200 VLKIVCGK 207
           +  +  GK
Sbjct: 210 LYYMTYGK 217

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 37/178 (20%), Positives = 69/178 (38%), Gaps = 42/178 (23%)

Query: 47  NEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIH--GEERL------- 96
           N + V +K L  +           E + +A++ + ++V      I    E          
Sbjct: 105 NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIV-----QIFNFVEHTDRHGDPVG 159

Query: 97  -LVYEFMPNKSLDSSFSGTF---------KDLL----CLHKYSRLRVIHRDLKASNILL- 141
            +V E++  +SL  S               ++L     LH    + +++ DLK  NI+L 
Sbjct: 160 YIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLT 216

Query: 142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
           ++QL  K+ D G      +N  G     + GT G+ + E       ++ TD++  G  
Sbjct: 217 EEQL--KLIDLGAVS--RINSFGY----LYGTPGFQAPEIVR-TGPTVATDIYTVGRT 265

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 74.9 bits (185), Expect = 2e-15
 Identities = 42/119 (35%), Positives = 62/119 (52%), Gaps = 22/119 (18%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSSFSGTFKD-------- 117
           E  L+ +L + N+VKLL   IH E +L LV+EF+     K +D+S               
Sbjct: 52  EISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 110

Query: 118 -LLC----LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
            LL      H +   RV+HRDLK  N+L++ +   K++DFG+AR FGV      T+ +V
Sbjct: 111 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV 165

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 54/195 (27%)

Query: 50  EVAIK--RLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIH--GEERL-------L 97
           +VA+K  R            F+ EA+  A L +  +V     +++  GE          +
Sbjct: 39  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV-----AVYDTGEAETPAGPLPYI 93

Query: 98  VYEFMPNKSLDSSFSGTFKDLLCLHKYSRL----------------------RVIHRDLK 135
           V E++   +L        +D++  H    +                       +IHRD+K
Sbjct: 94  VMEYVDGVTL--------RDIV--HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVK 143

Query: 136 ASNILLDDQLNTKISDFGMARIFGVNESGA---NTNRIVGTYGYMSLEYTMSGTVSIKTD 192
            +NI++      K+ DFG+AR   + +SG     T  ++GT  Y+S E     +V  ++D
Sbjct: 144 PANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201

Query: 193 VFGFGVLVLKIVCGK 207
           V+  G ++ +++ G+
Sbjct: 202 VYSLGCVLYEVLTGE 216

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 45/188 (23%), Positives = 76/188 (40%), Gaps = 33/188 (17%)

Query: 49  QEVAIKR--LAWTSGQGRVEFQNEAKLIAKLQYTNL--VKLLGCSIHGEERLLVYEF--- 101
           Q  AIK   L     Q    ++NE   + KLQ  +   ++L    I  +   +V E    
Sbjct: 81  QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI 140

Query: 102 ------MPNKSLDSSFSGT-FKDLLC----LHKYSRLRVIHRDLKASNILLDDQLNTKIS 150
                    KS+D     + +K++L     +H++    ++H DLK +N L+ D    K+ 
Sbjct: 141 DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLI 196

Query: 151 DFGMARIFGVNESGANTNRIVGTYGYMSLE-----------YTMSGTVSIKTDVFGFGVL 199
           DFG+A     + +    +  VG   YM  E                 +S K+DV+  G +
Sbjct: 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256

Query: 200 VLKIVCGK 207
           +  +  GK
Sbjct: 257 LYYMTYGK 264

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 74.9 bits (185), Expect = 2e-15
 Identities = 38/118 (32%), Positives = 62/118 (52%), Gaps = 21/118 (17%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSSFSG------------ 113
           E  L+ +L + N+V L+   IH E  L LV+EFM     K LD + +G            
Sbjct: 69  EISLLKELHHPNIVSLIDV-IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ 127

Query: 114 TFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
             + +   H++   R++HRDLK  N+L++     K++DFG+AR FG+    + T+ +V
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV 181

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 74.5 bits (184), Expect = 2e-15
 Identities = 34/118 (28%), Positives = 56/118 (47%), Gaps = 21/118 (17%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSSFSG------------ 113
           E  L+ +L++ N+V+L    +H +++L LV+EF      K  DS                
Sbjct: 51  EICLLKELKHKNIVRLHDV-LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 114 TFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
             K L   H      V+HRDLK  N+L++     K+++FG+AR FG+      +  +V
Sbjct: 110 LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV 163

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 74.9 bits (185), Expect = 2e-15
 Identities = 38/148 (25%), Positives = 59/148 (39%), Gaps = 37/148 (25%)

Query: 49  QEVAIKRLAWTSGQGRVEFQN---------EAKLIAKLQYTNLVKLLGCSIHGEERL-LV 98
           Q VAIK+             +         E +++ +L++ NLV LL      + RL LV
Sbjct: 29  QIVAIKKF-------LESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV-FRRKRRLHLV 80

Query: 99  YEFMPN---KSLDSSFSG------------TFKDLLCLHKYSRLRVIHRDLKASNILLDD 143
           +E+  +     LD    G            T + +   HK+     IHRD+K  NIL+  
Sbjct: 81  FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITK 137

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIV 171
               K+ DFG AR+     S    + + 
Sbjct: 138 HSVIKLCDFGFARLLTG-PSDYYDDEVA 164

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 45/221 (20%), Positives = 72/221 (32%), Gaps = 31/221 (14%)

Query: 38  RVILVGKFPNEQEVAIK--RLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEE 94
            V  V    + +  A+K     +   + R     E     K+ Q+   V+L      G  
Sbjct: 72  EVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131

Query: 95  RLLVYEFMPNKSLDS-------SFS-----GTFKDLLC----LHKYSRLRVIHRDLKASN 138
             L  E     SL         S       G  +D L     LH      ++H D+K +N
Sbjct: 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPAN 187

Query: 139 ILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGV 198
           I L  +   K+ DFG+    G            G   YM+ E           DVF  G+
Sbjct: 188 IFLGPRGRCKLGDFGLLVELG-TAGAGEV--QEGDPRYMAPELLQGSY-GTAADVFSLGL 243

Query: 199 LVLKIVCGKK---NNKSYHTERPLNLVGIAWQLW-NEGKDL 235
            +L++ C  +     + +   R   L         +E + +
Sbjct: 244 TILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSV 284

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 74.6 bits (184), Expect = 2e-15
 Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 36/149 (24%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQN--------EAKLIAKLQYTNLVKLLGCSIHGEERL-L 97
            +  VA+K +       R+E +         E  L+  L++ N+V L    IH E+ L L
Sbjct: 26  TDNLVALKEI-------RLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI-IHTEKSLTL 77

Query: 98  VYEFMPN---KSLDSSFSG------------TFKDLLCLHKYSRLRVIHRDLKASNILLD 142
           V+E++     + LD   +               + L   H+    +V+HRDLK  N+L++
Sbjct: 78  VFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLIN 134

Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIV 171
           ++   K++DFG+AR   +  +    N +V
Sbjct: 135 ERGELKLADFGLARAKSI-PTKTYDNEVV 162

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 73.7 bits (182), Expect = 3e-15
 Identities = 39/118 (33%), Positives = 60/118 (50%), Gaps = 21/118 (17%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSSFSG------------ 113
           E  ++ +L+++N+VKL    IH ++RL LV+E +     K LD    G            
Sbjct: 50  EISILKELKHSNIVKLYDV-IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 114 TFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
               +   H     RV+HRDLK  N+L++ +   KI+DFG+AR FG+      T+ IV
Sbjct: 109 LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV 162

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 73.9 bits (182), Expect = 3e-15
 Identities = 41/203 (20%), Positives = 70/203 (34%), Gaps = 44/203 (21%)

Query: 38  RVILVGKFPNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGC-------- 88
            V       ++   AIKR+        R +   E K +AKL++  +V+            
Sbjct: 20  VVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79

Query: 89  -SIHGEERLLVY---EFMPNKSL----DSSFSGTFKD--------------LLCLHKYSR 126
                  ++ +Y   +    ++L    +   +   ++              +  LH    
Sbjct: 80  KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS--- 136

Query: 127 LRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT----------NRIVGTYGY 176
             ++HRDLK SNI        K+ DFG+      +E                  VGT  Y
Sbjct: 137 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLY 196

Query: 177 MSLEYTMSGTVSIKTDVFGFGVL 199
           MS E     + S K D+F  G++
Sbjct: 197 MSPEQIHGNSYSHKVDIFSLGLI 219

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 74.2 bits (183), Expect = 4e-15
 Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 41/154 (26%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQN--------EAKLIAKLQYTNLVKLLGCSIHGEERL-L 97
               VA+K +       +++ +         E  L+ +L++ N+V+L    IH E +L L
Sbjct: 29  TGVYVALKEV-------KLDSEEGTPSTAIREISLMKELKHENIVRLYDV-IHTENKLTL 80

Query: 98  VYEFMPN---KSLDSSFSGTFKD-------------LLC----LHKYSRLRVIHRDLKAS 137
           V+EFM N   K +DS   G                 LL      H+    +++HRDLK  
Sbjct: 81  VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQ 137

Query: 138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           N+L++ +   K+ DFG+AR FG+      ++ +V
Sbjct: 138 NLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV 170

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 73.1 bits (180), Expect = 6e-15
 Identities = 41/168 (24%), Positives = 71/168 (42%), Gaps = 20/168 (11%)

Query: 46  PNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN 104
             ++ VAIK +     +  +E  Q E  ++++     + K  G  +   +  ++ E++  
Sbjct: 45  RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 104

Query: 105 KSL-DSSFSGTF-------------KDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKIS 150
            S  D    G               K L  LH     + IHRD+KA+N+LL +    K++
Sbjct: 105 GSALDLLEPGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLA 161

Query: 151 DFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGV 198
           DFG+A      +   NT   VGT  +M+ E         K D++  G+
Sbjct: 162 DFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGI 207

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 73.0 bits (180), Expect = 9e-15
 Identities = 35/148 (23%), Positives = 57/148 (38%), Gaps = 37/148 (25%)

Query: 49  QEVAIKRLAWTSGQGRVEFQN---------EAKLIAKLQYTNLVKLLGCSIHGEERL-LV 98
           + VAIK+             +         E KL+ +L++ NLV LL      ++R  LV
Sbjct: 51  RIVAIKKF-------LESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV-CKKKKRWYLV 102

Query: 99  YEFMPN---KSLDSSFSG------------TFKDLLCLHKYSRLRVIHRDLKASNILLDD 143
           +EF+ +     L+   +G                +   H +    +IHRD+K  NIL+  
Sbjct: 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQ 159

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIV 171
               K+ DFG AR           + + 
Sbjct: 160 SGVVKLCDFGFARTLAA-PGEVYDDEVA 186

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 73.4 bits (181), Expect = 9e-15
 Identities = 34/118 (28%), Positives = 60/118 (50%), Gaps = 21/118 (17%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN--KSLDSSFSGTFKD--------- 117
           E KL+ +L + N++ LL      +  + LV++FM    + +    S              
Sbjct: 62  EIKLLQELSHPNIIGLLDA-FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 118 LLC----LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
            L     LH++    ++HRDLK +N+LLD+    K++DFG+A+ FG   + A T+++V
Sbjct: 121 TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVV 174

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 19/173 (10%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL- 107
           QEVAI+++       +    NE  ++ + +  N+V  L   + G+E  +V E++   SL 
Sbjct: 46  QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105

Query: 108 DSSFSGTF-------------KDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGM 154
           D                    + L  LH     +VIHRD+K+ NILL    + K++DFG 
Sbjct: 106 DVVTETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGF 162

Query: 155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
                  +S  +T  +VGT  +M+ E         K D++  G++ ++++ G+
Sbjct: 163 CAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 19/173 (10%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           ++VA+K +     Q R    NE  ++   Q+ N+V++    + GEE  ++ EF+   +L 
Sbjct: 71  RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130

Query: 109 SSFSGT--------------FKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGM 154
              S                 + L  LH      VIHRD+K+ +ILL      K+SDFG 
Sbjct: 131 DIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGF 187

Query: 155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
                 +     +  +VGT  +M+ E       + + D++  G++V+++V G+
Sbjct: 188 CAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 71.2 bits (175), Expect = 3e-14
 Identities = 42/204 (20%), Positives = 79/204 (38%), Gaps = 46/204 (22%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL- 96
           +V+      + +  AIK++  T  +      +E  L+A L +  +V+     +     + 
Sbjct: 21  QVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79

Query: 97  ------------LVYEFMPNKSL-------DSSFS-----GTFKDLLC----LHKYSRLR 128
                       +  E+  N +L       + +         F+ +L     +H      
Sbjct: 80  PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QG 136

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIF------------GVNESGANTNRIVGTYGY 176
           +IHRDLK  NI +D+  N KI DFG+A+               +  S  N    +GT  Y
Sbjct: 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMY 196

Query: 177 MSLE-YTMSGTVSIKTDVFGFGVL 199
           ++ E    +G  + K D++  G++
Sbjct: 197 VATEVLDGTGHYNEKIDMYSLGII 220

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 37/193 (19%), Positives = 76/193 (39%), Gaps = 32/193 (16%)

Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLL 97
           ++  G F + ++VA+KR+     +       E +L+ +  ++ N+++        + + +
Sbjct: 40  IVYRGMF-DNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95

Query: 98  VYEFMPN------KSLDSSFSGT-----FKDLLC----LHKYSRLRVIHRDLKASNILLD 142
             E          +  D +  G       +        LH    L ++HRDLK  NIL+ 
Sbjct: 96  AIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILIS 152

Query: 143 DQ-----LNTKISDFGMARIFGVNE-SGANTNRIVGTYGYMS---LEYTMSGTVSIKTDV 193
                  +   ISDFG+ +   V   S +  + + GT G+++   L        +   D+
Sbjct: 153 MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDI 212

Query: 194 FGFGVLVLKIVCG 206
           F  G +   ++  
Sbjct: 213 FSAGCVFYYVISE 225

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 70.4 bits (173), Expect = 6e-14
 Identities = 40/155 (25%), Positives = 66/155 (42%), Gaps = 30/155 (19%)

Query: 46  PNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN 104
           P +++VAIKR+     Q  ++    E + +++  + N+V      +  +E  LV + +  
Sbjct: 38  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97

Query: 105 KSL----------DSSFSGTF-------------KDLLCLHKYSRLRVIHRDLKASNILL 141
            S+              SG               + L  LHK      IHRD+KA NILL
Sbjct: 98  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILL 154

Query: 142 DDQLNTKISDFGM-ARIFGVNESGANTNR--IVGT 173
            +  + +I+DFG+ A +    +   N  R   VGT
Sbjct: 155 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 70.3 bits (173), Expect = 8e-14
 Identities = 33/129 (25%), Positives = 60/129 (46%), Gaps = 31/129 (24%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL---------LVYEFMPN--KSLDSSFSGTFKD- 117
           E K++  L++ N+V L+      +            LV++F  +    L S+    F   
Sbjct: 66  EIKILQLLKHENVVNLIEI-CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124

Query: 118 --------LLC----LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA 165
                   LL     +H+    +++HRD+KA+N+L+      K++DFG+AR F + ++  
Sbjct: 125 EIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181

Query: 166 N---TNRIV 171
               TNR+V
Sbjct: 182 PNRYTNRVV 190

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 40/209 (19%), Positives = 72/209 (34%), Gaps = 40/209 (19%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEER- 95
            V       + +E A+KRL     +       E   + KL  + N+V+    +  G+E  
Sbjct: 43  FVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102

Query: 96  -------LLV--------YEFMPNKSLDSSFS-----GTFKDLL----CLHKYSRLRVIH 131
                  LL+         EF+         S       F         +H   +  +IH
Sbjct: 103 DTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIH 161

Query: 132 RDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI----------VGTYGYMS--- 178
           RDLK  N+LL +Q   K+ DFG A         + + +             T  Y +   
Sbjct: 162 RDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEI 221

Query: 179 LEYTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           ++   +  +  K D++  G ++  +   +
Sbjct: 222 IDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 39/122 (31%), Positives = 57/122 (46%), Gaps = 25/122 (20%)

Query: 70  EAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN---KSLDSS--FS-GTFKDLL--- 119
           E  L+ +LQ+ N+++L    IH   RL L++E+  N   K +D +   S    K  L   
Sbjct: 83  EVSLLKELQHRNIIELKSV-IHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL 141

Query: 120 -----CLHKYSRLRVIHRDLKASNILLDDQLNT-----KISDFGMARIFGVNESGANTNR 169
                  H     R +HRDLK  N+LL     +     KI DFG+AR FG+      T+ 
Sbjct: 142 INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHE 197

Query: 170 IV 171
           I+
Sbjct: 198 II 199

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 29/159 (18%), Positives = 51/159 (32%), Gaps = 27/159 (16%)

Query: 46  PNEQEVAIKR--LAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP 103
           P  + V ++R  L   S +     Q E  +     + N+V      I   E  +V  FM 
Sbjct: 50  PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 109

Query: 104 NKS----LDSSFSGTF---------KDLLC----LHKYSRLRVIHRDLKASNILLDDQLN 146
             S    + + F             + +L     +H    +  +HR +KAS+IL+     
Sbjct: 110 YGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGK 166

Query: 147 TKISDFGMARIFGVNESGANT-----NRIVGTYGYMSLE 180
             +S          +              V    ++S E
Sbjct: 167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 10/89 (11%), Positives = 25/89 (28%), Gaps = 10/89 (11%)

Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           L       ++H      N+ +       + D          + G           Y   E
Sbjct: 210 LQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW-----KVGTRGPASSVPVTYAPRE 261

Query: 181 YTMSGT--VSIKTDVFGFGVLVLKIVCGK 207
           +  + T   +   + +  G+ + ++ C  
Sbjct: 262 FLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 68.0 bits (167), Expect = 3e-13
 Identities = 41/187 (21%), Positives = 76/187 (40%), Gaps = 31/187 (16%)

Query: 46  PNEQEVAIKRLAWTSG-QGRVEFQNEAK-LIAKLQYTNLVKLLGCSIHGEERLLVYEFMP 103
           P+ Q +A+KR+  T   Q +     +    +  +     V   G      +  +  E M 
Sbjct: 30  PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM- 88

Query: 104 NKSLDSSFSGTFKD-------------------LLCLHKYSRLRVIHRDLKASNILLDDQ 144
           + SLD  +                         L  LH  S+L VIHRD+K SN+L++  
Sbjct: 89  DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINAL 146

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE----YTMSGTVSIKTDVFGFGVLV 200
              K+ DFG++    V++   + +   G   YM+ E           S+K+D++  G+ +
Sbjct: 147 GQVKMCDFGISGYL-VDDVAKDID--AGCKPYMAPERINPELNQKGYSVKSDIWSLGITM 203

Query: 201 LKIVCGK 207
           +++   +
Sbjct: 204 IELAILR 210

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 14/92 (15%), Positives = 29/92 (31%), Gaps = 9/92 (9%)

Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           LH      ++H  L+  +I+LD +    ++ F      G +       R        +  
Sbjct: 227 LH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSP-IGRGFAPPETTAER 282

Query: 181 -----YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
                      ++   D +  G+ +  I C  
Sbjct: 283 MLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 68.1 bits (167), Expect = 4e-13
 Identities = 33/141 (23%), Positives = 62/141 (43%), Gaps = 21/141 (14%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
              A K +   S +   ++  E +++A   +  +VKLLG   H  +  ++ EF P  ++D
Sbjct: 45  ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD 104

Query: 109 S---SFSGTF-------------KDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF 152
           +                      + L  LH     R+IHRDLKA N+L+  + + +++DF
Sbjct: 105 AIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADF 161

Query: 153 GMARIFGVNESGANTNRIVGT 173
           G++          ++   +GT
Sbjct: 162 GVSAKNLKTLQKRDS--FIGT 180

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 27/92 (29%), Positives = 36/92 (39%), Gaps = 13/92 (14%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTN--------- 168
           +  LH      ++HRDLK SNI        K+ DFG+      +E               
Sbjct: 177 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233

Query: 169 -RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
              VGT  YMS E       S K D+F  G++
Sbjct: 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLI 265

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 17/96 (17%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LH+     +I+RDLK  N+LLDD  N +ISD G+A      ++        GT G+M
Sbjct: 302 LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFM 356

Query: 178 SLE------YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E      Y  S       D F  GV + +++  +
Sbjct: 357 APELLLGEEYDFS------VDYFALGVTLYEMIAAR 386

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 34/96 (35%), Positives = 48/96 (50%), Gaps = 18/96 (18%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LH+    R+++RDLK  NILLDD  + +ISD G+A        G      VGT GYM
Sbjct: 299 LEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTVGYM 352

Query: 178 SLE------YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E      YT S       D +  G L+ +++ G+
Sbjct: 353 APEVVKNERYTFS------PDWWALGCLLYEMIAGQ 382

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 36/176 (20%), Positives = 65/176 (36%), Gaps = 24/176 (13%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP----- 103
              A K +       +   + E + ++ L++  LV L        E +++YEFM      
Sbjct: 183 NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242

Query: 104 NKSLDSSFSGTFKD-----------LLCLHKYSRLRVIHRDLKASNILLDDQLNT--KIS 150
            K  D     +  +           L  +H+      +H DLK  NI+   + +   K+ 
Sbjct: 243 EKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLI 299

Query: 151 DFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           DFG+       +   +     GT  + + E      V   TD++  GVL   ++ G
Sbjct: 300 DFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 44/192 (22%), Positives = 73/192 (38%), Gaps = 39/192 (20%)

Query: 49  QEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGC--SIHGEERLLVYEFMPNK 105
              AIK     S    V+    E +++ KL + N+VKL           ++L+ EF P  
Sbjct: 35  DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG 94

Query: 106 SL--------------DSSFSGTFKDLLC----LHKYSRLRVIHRDLKASNILL----DD 143
           SL              +S F    +D++     L +     ++HR++K  NI+     D 
Sbjct: 95  SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDG 151

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMS---LEYTMSGTVSIKT-----DVFG 195
           Q   K++DFG AR    ++    +  + GT  Y+     E  +      K      D++ 
Sbjct: 152 QSVYKLTDFGAARELE-DDEQFVS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS 208

Query: 196 FGVLVLKIVCGK 207
            GV       G 
Sbjct: 209 IGVTFYHAATGS 220

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 66.8 bits (164), Expect = 1e-12
 Identities = 32/115 (27%), Positives = 49/115 (42%), Gaps = 27/115 (23%)

Query: 70  EAKLIAKLQYT---NLVKLL----GCSIHGEERL-LVYEFM-----------PNKSLDSS 110
           E  ++  L+     N+V+L           E +L LV+E +           P   + + 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 120

Query: 111 FSGTF-KDLLC----LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV 160
                   LL     LH +   RV+HRDLK  NIL+      K++DFG+ARI+  
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 49/192 (25%), Positives = 84/192 (43%), Gaps = 29/192 (15%)

Query: 38  RVILVGKFPNEQEVAIKRL--AWTSGQGRVEF-QNEAKLIAKLQYTNLVKLLGCSIHGEE 94
            V+L  +    +E AIK L       + +V +   E  ++++L +   VKL   +   +E
Sbjct: 45  TVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDE 103

Query: 95  RL-LVYEFMPNKSLDSSFS-----GTFKD-------------LLCLHKYSRLRVIHRDLK 135
           +L     +  N  L          G+F +             L  LH      +IHRDLK
Sbjct: 104 KLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLK 157

Query: 136 ASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFG 195
             NILL++ ++ +I+DFG A++       A  N  VGT  Y+S E     +    +D++ 
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 217

Query: 196 FGVLVLKIVCGK 207
            G ++ ++V G 
Sbjct: 218 LGCIIYQLVAGL 229

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 8/91 (8%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  +H      V++RDLK +NILLD+  + +ISD G+A     + S    +  VGT+GYM
Sbjct: 305 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYM 357

Query: 178 SLEYTMSGTVSIKT-DVFGFGVLVLKIVCGK 207
           + E    G     + D F  G ++ K++ G 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 65.7 bits (161), Expect = 2e-12
 Identities = 32/126 (25%), Positives = 53/126 (42%), Gaps = 29/126 (23%)

Query: 70  EAKLIAKLQYT---NLVKLL----GCSIHGEERL-LVYEFM-----------PNKSLDSS 110
           E  L+ +L+     N+V+L+          E ++ LV+E +           P   L + 
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120

Query: 111 FSGTF-KDLLC----LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA 165
                 +  L     LH      ++HRDLK  NIL+      K++DFG+ARI+    +  
Sbjct: 121 TIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-- 175

Query: 166 NTNRIV 171
            T  +V
Sbjct: 176 LTPVVV 181

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 42/188 (22%), Positives = 77/188 (40%), Gaps = 32/188 (17%)

Query: 46  PNEQEVAIKRLAWTSG-QGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMP 103
           P+ Q +A+KR+  T   + + +   +  ++ +      +V+  G      +  +  E M 
Sbjct: 45  PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM- 103

Query: 104 NKSLDSSFSGTFKD--------------------LLCLHKYSRLRVIHRDLKASNILLDD 143
           + S D  +   +                      L  L     L++IHRD+K SNILLD 
Sbjct: 104 STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDR 161

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE----YTMSGTVSIKTDVFGFGVL 199
             N K+ DFG++      +S A T    G   YM+ E            +++DV+  G+ 
Sbjct: 162 SGNIKLCDFGISGQL--VDSIAKTR-DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGIT 218

Query: 200 VLKIVCGK 207
           + ++  G+
Sbjct: 219 LYELATGR 226

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 43/192 (22%), Positives = 71/192 (36%), Gaps = 39/192 (20%)

Query: 49  QEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGC--SIHGEERLLVYEFMPNK 105
              AIK     S    V+    E +++ KL + N+VKL           ++L+ EF P  
Sbjct: 35  DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG 94

Query: 106 SL--------------DSSFSGTFKDLLC----LHKYSRLRVIHRDLKASNILL----DD 143
           SL              +S F    +D++     L +     ++HR++K  NI+     D 
Sbjct: 95  SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDG 151

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMS--------LEYTMSGTVSIKTDVFG 195
           Q   K++DFG AR    ++    +  + GT  Y+         L            D++ 
Sbjct: 152 QSVYKLTDFGAARELE-DDEQFVS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS 208

Query: 196 FGVLVLKIVCGK 207
            GV       G 
Sbjct: 209 IGVTFYHAATGS 220

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 15/98 (15%), Positives = 31/98 (31%), Gaps = 20/98 (20%)

Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           LH      ++H  L+  +I+LD +    ++ F      G             + G+   E
Sbjct: 222 LH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV------SSVSRGFEPPE 272

Query: 181 YTMS-----------GTVSIKTDVFGFGVLVLKIVCGK 207
                            ++   D +  G+++  I C  
Sbjct: 273 LEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 65.1 bits (159), Expect = 4e-12
 Identities = 33/125 (26%), Positives = 55/125 (44%), Gaps = 21/125 (16%)

Query: 49  QEVAIKRLAWTSGQGRVEF---QNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK 105
           + VAIK+++++  Q   ++     E + + KL++ N ++  GC +      LV E+    
Sbjct: 80  EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS 139

Query: 106 SLD--SSFSGTF-------------KDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKIS 150
           + D                      + L  LH      +IHRD+KA NILL +    K+ 
Sbjct: 140 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLG 196

Query: 151 DFGMA 155
           DFG A
Sbjct: 197 DFGSA 201

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 64.6 bits (158), Expect = 6e-12
 Identities = 33/101 (32%), Positives = 56/101 (55%), Gaps = 14/101 (13%)

Query: 115 FKDLLC----LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI 170
           F+DL+     LH     ++IHRD+K SN+L+ +  + KI+DFG++  F  +++  +    
Sbjct: 143 FQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT-- 197

Query: 171 VGTYGYMSLEYTMSGTVSI----KTDVFGFGVLVLKIVCGK 207
           VGT  +M+ E ++S T  I      DV+  GV +   V G+
Sbjct: 198 VGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 65.9 bits (160), Expect = 6e-12
 Identities = 44/187 (23%), Positives = 70/187 (37%), Gaps = 34/187 (18%)

Query: 49  QEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLL------GCSIHGEERLLVYEF 101
           ++VAIK+          E +  E +++ KL + N+V               +  LL  E+
Sbjct: 40  EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEY 99

Query: 102 MPNKSL--------------DSSFSGTFKDLLC----LHKYSRLRVIHRDLKASNILLD- 142
                L              +        D+      LH+    R+IHRDLK  NI+L  
Sbjct: 100 CEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQP 156

Query: 143 --DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
              +L  KI D G A+     + G      VGT  Y++ E       ++  D + FG L 
Sbjct: 157 GPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213

Query: 201 LKIVCGK 207
            + + G 
Sbjct: 214 FECITGF 220

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 64.6 bits (158), Expect = 7e-12
 Identities = 40/181 (22%), Positives = 67/181 (37%), Gaps = 31/181 (17%)

Query: 49  QEVAIKRLAWTS-GQGRVE--FQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN 104
           +  A K +  +   +         E  +   L + ++V   G      + + +V E    
Sbjct: 67  EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRR 125

Query: 105 KSLDSSFS-----GTFKD-------------LLCLHKYSRLRVIHRDLKASNILLDDQLN 146
           +SL              +                LH   R RVIHRDLK  N+ L++ L 
Sbjct: 126 RSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLE 179

Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            KI DFG+A     +        + GT  Y++ E       S + DV+  G ++  ++ G
Sbjct: 180 VKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237

Query: 207 K 207
           K
Sbjct: 238 K 238

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 64.8 bits (158), Expect = 7e-12
 Identities = 33/142 (23%), Positives = 58/142 (40%), Gaps = 36/142 (25%)

Query: 49  QEVAIKRLAWTSGQGR-VEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL-LVYEFM--- 102
           ++ A+K++    G G  +    E  L+ +L++ N++ L      H + ++ L++++    
Sbjct: 49  KDYALKQI---EGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 105

Query: 103 -----------PNKSLDSSFS-GTFKDLL--------CLHKYSRLRVIHRDLKASNILLD 142
                                 G  K LL         LH      V+HRDLK +NIL+ 
Sbjct: 106 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVM 162

Query: 143 DQLNT----KISDFGMARIFGV 160
            +       KI+D G AR+F  
Sbjct: 163 GEGPERGRVKIADMGFARLFNS 184

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 64.1 bits (157), Expect = 7e-12
 Identities = 40/181 (22%), Positives = 67/181 (37%), Gaps = 31/181 (17%)

Query: 49  QEVAIKRLAWTS-GQGRVE--FQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN 104
           +  A K +  +   +         E  +   L + ++V   G      + + +V E    
Sbjct: 41  EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRR 99

Query: 105 KSLDSSF-----SGTFKD-------------LLCLHKYSRLRVIHRDLKASNILLDDQLN 146
           +SL              +                LH   R RVIHRDLK  N+ L++ L 
Sbjct: 100 RSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLE 153

Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            KI DFG+A     +        + GT  Y++ E       S + DV+  G ++  ++ G
Sbjct: 154 VKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211

Query: 207 K 207
           K
Sbjct: 212 K 212

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 64.3 bits (157), Expect = 7e-12
 Identities = 41/161 (25%), Positives = 68/161 (42%), Gaps = 23/161 (14%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLD 108
           Q VAIK++         E   E  ++ +    ++VK  G      +  +V E+    S+ 
Sbjct: 55  QIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS 112

Query: 109 ---SSFSGTF-------------KDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF 152
                 + T              K L  LH    +R IHRD+KA NILL+ + + K++DF
Sbjct: 113 DIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADF 169

Query: 153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDV 193
           G+A       +  NT  ++GT  +M+ E       +   D+
Sbjct: 170 GVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADI 208

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 63.8 bits (156), Expect = 9e-12
 Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 33/192 (17%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTS-GQGRVEFQ--NEAKLIAKLQYTNLVKLLGCSIHGEE 94
            V L  +  ++  +A+K L      +  VE Q   E ++ + L++ N+++L G   H   
Sbjct: 24  NVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY-FHDAT 82

Query: 95  RL-LVYEFMPNKSLDSSFS-----GTFKD-------------LLCLHKYSRLRVIHRDLK 135
           R+ L+ E+ P  ++   +        F +             L   H     RVIHRD+K
Sbjct: 83  RVYLILEYAPLGTV---YRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIK 136

Query: 136 ASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFG 195
             N+LL      KI+DFG    + V+   +    + GT  Y+  E         K D++ 
Sbjct: 137 PENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWS 192

Query: 196 FGVLVLKIVCGK 207
            GVL  + + GK
Sbjct: 193 LGVLCYEFLVGK 204

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 37/166 (22%), Positives = 65/166 (39%), Gaps = 33/166 (19%)

Query: 68  QNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN----------KSLDSSFSGT-- 114
           +NE ++I  ++    +   G  I   + + ++YE+M N            LD +++    
Sbjct: 91  KNELQIITDIKNEYCLTCEG-IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 115 -------FKDLLC----LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES 163
                   K +L     +H  +   + HRD+K SNIL+D     K+SDFG +        
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM----V 203

Query: 164 GANTNRIVGTYGYMSLE--YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
                   GTY +M  E     S     K D++  G+ +  +    
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 63.3 bits (155), Expect = 1e-11
 Identities = 43/182 (23%), Positives = 77/182 (42%), Gaps = 32/182 (17%)

Query: 49  QEVAIKRLAWTS-GQGRVEFQ--NEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPN 104
            EVAIK +   +  +  +  +  NE K+  +L++ ++++L          + LV E   N
Sbjct: 37  LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHN 95

Query: 105 KSLDSSF------SGTFKD-------------LLCLHKYSRLRVIHRDLKASNILLDDQL 145
             +             F +             +L LH      ++HRDL  SN+LL   +
Sbjct: 96  GEM---NRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNM 149

Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC 205
           N KI+DFG+A    +      T  + GT  Y+S E        +++DV+  G +   ++ 
Sbjct: 150 NIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLI 207

Query: 206 GK 207
           G+
Sbjct: 208 GR 209

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 37/151 (24%), Positives = 60/151 (39%), Gaps = 40/151 (26%)

Query: 49  QEVAIKRLAWTSGQGRVEFQN-EAKLIAKLQYTNLVKLLGC-----SIHGEERL-LVYEF 101
            EVAIK++          F+N E +++  +++ N+V L            E  L LV E+
Sbjct: 65  DEVAIKKVLQDK-----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119

Query: 102 MP---NKSLDSSFSGT---------------FKDLLCLHKYSRLRVIHRDLKASNILLD- 142
           +P    ++                        + L  +H    + + HRD+K  N+LLD 
Sbjct: 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDP 176

Query: 143 --DQLNTKISDFGMARIFGVNESGANTNRIV 171
               L  K+ DFG A+I    E   N + I 
Sbjct: 177 PSGVL--KLIDFGSAKILIAGE--PNVSYIC 203

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 36/154 (23%), Positives = 60/154 (38%), Gaps = 40/154 (25%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEFQN-EAKLIAKLQYTNLVKLLGCSIHGEERL------LV 98
            + + VAIK++          F+N E +++ KL + N+V+L        E+       LV
Sbjct: 77  DSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131

Query: 99  YEFMP---NKSLDSSFSGT---------------FKDLLCLHKYSRLRVIHRDLKASNIL 140
            +++P    +                        F+ L  +H      + HRD+K  N+L
Sbjct: 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLL 188

Query: 141 LD---DQLNTKISDFGMARIFGVNESGANTNRIV 171
           LD     L  K+ DFG A+     E   N + I 
Sbjct: 189 LDPDTAVL--KLCDFGSAKQLVRGE--PNVSYIC 218

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 62.2 bits (152), Expect = 3e-11
 Identities = 48/192 (25%), Positives = 82/192 (42%), Gaps = 33/192 (17%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTS-GQGRVEFQ--NEAKLIAKLQYTNLVKLLGCSIHGEE 94
            V L  +  N+  +A+K L  +   +  VE Q   E ++ + L++ N++++     H  +
Sbjct: 29  NVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN-YFHDRK 87

Query: 95  RL-LVYEFMPNKSLDSSFS-----GTFKD-------------LLCLHKYSRLRVIHRDLK 135
           R+ L+ EF P   L   +      G F +             L   H     +VIHRD+K
Sbjct: 88  RIYLMLEFAPRGEL---YKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIK 141

Query: 136 ASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFG 195
             N+L+  +   KI+DFG    + V+        + GT  Y+  E     T   K D++ 
Sbjct: 142 PENLLMGYKGELKIADFG----WSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWC 197

Query: 196 FGVLVLKIVCGK 207
            GVL  + + G 
Sbjct: 198 AGVLCYEFLVGM 209

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 32/176 (18%), Positives = 65/176 (36%), Gaps = 24/176 (13%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP----- 103
           +    K +       +   +NE  ++ +L +  L+ L        E +L+ EF+      
Sbjct: 77  RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136

Query: 104 NKSLDSSFSGTFKD-----------LLCLHKYSRLRVIHRDLKASNILLDDQLNT--KIS 150
           ++     +  +  +           L  +H+     ++H D+K  NI+ + +  +  KI 
Sbjct: 137 DRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKII 193

Query: 151 DFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           DFG+A                 T  + + E      V   TD++  GVL   ++ G
Sbjct: 194 DFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 62.4 bits (152), Expect = 3e-11
 Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 10/108 (9%)

Query: 114 TFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGT 173
             K L  L    +  VIHRD+K SNILLD++   K+ DFG++      +  A      G 
Sbjct: 133 IVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDR-SAGC 187

Query: 174 YGYMSLE-----YTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTE 216
             YM+ E             I+ DV+  G+ ++++  G+   K+  T+
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 62.3 bits (152), Expect = 3e-11
 Identities = 25/60 (41%), Positives = 35/60 (58%), Gaps = 6/60 (10%)

Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           LHK   L ++HRDLK  NILLDD +N K++DFG +      + G     + GT  Y++ E
Sbjct: 140 LHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAPE 193

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 61.9 bits (151), Expect = 5e-11
 Identities = 37/164 (22%), Positives = 65/164 (39%), Gaps = 42/164 (25%)

Query: 49  QEVAIK-----RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGC-----SIHGEERLLV 98
           Q+ A+K     +   + G    + + EA +   L++ ++V+LL        ++     +V
Sbjct: 50  QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY-----MV 104

Query: 99  YEFMP----------NKSLDSSFS-----GTFKDLLC----LHKYSRLRVIHRDLKASNI 139
           +EFM                  +S        + +L      H      +IHRD+K   +
Sbjct: 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCV 161

Query: 140 LLDDQLNT---KISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           LL  + N+   K+  FG+A      ESG      VGT  +M+ E
Sbjct: 162 LLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPE 203

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 61.9 bits (151), Expect = 6e-11
 Identities = 35/161 (21%), Positives = 61/161 (37%), Gaps = 48/161 (29%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEFQN---------EAKLIAKLQYTNLVKLLGCSIHGEER- 95
                VAIK++           Q+           + +A L + N+V+L        ER 
Sbjct: 46  STGMSVAIKKV----------IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95

Query: 96  ------LLVYEFMP---NKSLDSSFSG---------------TFKDLLCLHKYSRLRVIH 131
                  +V E++P   ++   + +                   + + CLH  S + V H
Sbjct: 96  RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCH 154

Query: 132 RDLKASNILLDDQLNT-KISDFGMARIFGVNESGANTNRIV 171
           RD+K  N+L+++   T K+ DFG A+    +E   N   I 
Sbjct: 155 RDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PNVAYIC 193

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 62.1 bits (151), Expect = 7e-11
 Identities = 43/215 (20%), Positives = 72/215 (33%), Gaps = 57/215 (26%)

Query: 39  VILVGKFPNEQEVAIKRLAWTSGQGRVEF-QNEAKLIAKL-QYTNLVKLLG--------- 87
           V+  G F   + VA+KR+         +    E KL+ +   + N+++            
Sbjct: 31  VVFQGSFQG-RPVAVKRML----IDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85

Query: 88  -----CSIHGE-----ERLLVYEFMPNKSLDSSFSGTFKDLLC----LHKYSRLRVIHRD 133
                C+         E   V +       + +     + +      LH    L++IHRD
Sbjct: 86  IALELCN--LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRD 140

Query: 134 LKASNILLD-------------DQLNTKISDFGMARIFGVNES--GANTNRIVGTYGYMS 178
           LK  NIL+              + L   ISDFG+ +     +S    N N   GT G+ +
Sbjct: 141 LKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRA 200

Query: 179 LEYTMSGTVSI-------KTDVFGFGVLVLKIVCG 206
            E                  D+F  G +   I+  
Sbjct: 201 PELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 61.6 bits (150), Expect = 8e-11
 Identities = 40/169 (23%), Positives = 78/169 (46%), Gaps = 24/169 (14%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP----- 103
            ++A K +     + + E +NE  ++ +L + NL++L        + +LV E++      
Sbjct: 115 LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174

Query: 104 NKSLDSSFSGTFKD-----------LLCLHKYSRLRVIHRDLKASNILLDDQLNT--KIS 150
           ++ +D S++ T  D           +  +H+   + ++H DLK  NIL  ++     KI 
Sbjct: 175 DRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKII 231

Query: 151 DFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
           DFG+AR +   +         GT  +++ E      VS  TD++  GV+
Sbjct: 232 DFGLARRY---KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 61.7 bits (150), Expect = 8e-11
 Identities = 24/60 (40%), Positives = 33/60 (55%), Gaps = 6/60 (10%)

Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           LH      ++HRDLK  NILLDD +  ++SDFG +      E G     + GT GY++ E
Sbjct: 216 LHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHL---EPGEKLRELCGTPGYLAPE 269

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.5 bits (149), Expect = 9e-11
 Identities = 33/125 (26%), Positives = 54/125 (43%), Gaps = 18/125 (14%)

Query: 93  EERLLVYEFMPNKSLDSSFSGTFKDLLC--------LHKYSRLRVIHRDLKASNILLDDQ 144
           E+ L   E             T + L+C        +   +  + IHRDL A NILL ++
Sbjct: 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 229

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYG-----YMSLEYTMSGTVSIKTDVFGFGVL 199
              KI DFG+AR     +   + + +          +M+ E       +I++DV+ FGVL
Sbjct: 230 NVVKICDFGLAR-----DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 284

Query: 200 VLKIV 204
           + +I 
Sbjct: 285 LWEIF 289

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 37/176 (21%), Positives = 71/176 (40%), Gaps = 25/176 (14%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP----- 103
           +    K +    G  +V  + E  ++   ++ N++ L       EE ++++EF+      
Sbjct: 31  KTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF 89

Query: 104 NKSLDSSFSGTFKD-----------LLCLHKYSRLRVIHRDLKASNILLDDQLNT--KIS 150
            +   S+F    ++           L  LH      + H D++  NI+   + ++  KI 
Sbjct: 90  ERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKII 146

Query: 151 DFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
           +FG AR     + G N   +     Y + E      VS  TD++  G LV  ++ G
Sbjct: 147 EFGQARQL---KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 22/83 (26%), Positives = 36/83 (43%), Gaps = 6/83 (7%)

Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
              +IHRD+K  NI++ +    K+ DFG A      E G       GT  Y + E  + G
Sbjct: 148 LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGTIEYCAPE-VLMG 203

Query: 186 T--VSIKTDVFGFGVLVLKIVCG 206
                 + +++  GV +  +V  
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFE 226

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 29/84 (34%), Positives = 43/84 (51%), Gaps = 6/84 (7%)

Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
           + R++HRDLKA N+LLD  +N KI+DFG +  F     G   +   G   Y + E    G
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF---TVGGKLDAFCGAPPYAAPE-LFQG 187

Query: 186 TVSI--KTDVFGFGVLVLKIVCGK 207
                 + DV+  GV++  +V G 
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGS 211

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 46/184 (25%), Positives = 77/184 (41%), Gaps = 38/184 (20%)

Query: 49  QEVAIKRLA---WTSGQGRVEFQNEAKLIAKLQYTNLVKLLGC-----SIHGEERLLVYE 100
           QE A+K ++         +     E +L+ +L + N++KL          +     LV E
Sbjct: 52  QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY-----LVGE 106

Query: 101 FMPNKSL------DSSFS-----GTFKDLLC----LHKYSRLRVIHRDLKASNILL---D 142
                 L         FS        + +L     +HK    +++HRDLK  N+LL    
Sbjct: 107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKS 163

Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
              N +I DFG++  F   E+       +GT  Y++ E  + GT   K DV+  GV++  
Sbjct: 164 KDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYI 219

Query: 203 IVCG 206
           ++ G
Sbjct: 220 LLSG 223

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 40/176 (22%), Positives = 69/176 (39%), Gaps = 31/176 (17%)

Query: 49  QEVAIK------RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
            E A K        A   G  R E + E  ++ ++ + N++ L     +  + +L+ E +
Sbjct: 38  LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELV 97

Query: 103 PNKSL------DSSFS-----GTFKDLL----CLHKYSRLRVIHRDLKASNILL----DD 143
               L        S S        K +L     LH     ++ H DLK  NI+L      
Sbjct: 98  SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIP 154

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
             + K+ DFG+A      E G     I GT  +++ E      + ++ D++  GV+
Sbjct: 155 IPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 36/170 (21%), Positives = 66/170 (38%), Gaps = 40/170 (23%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEFQN---------EAKLIAKLQYTNLVKLLGCSIHGEERL 96
             ++ VAIK++          F++         E  ++ +L + ++VK+L   +  ++  
Sbjct: 76  LEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI-VIPKDVE 127

Query: 97  ------LVYEFMP---NKSLDSSFSGTFKD---------LLCLHKY--SRLRVIHRDLKA 136
                 +V E       K   +       +         LL   KY  S   ++HRDLK 
Sbjct: 128 KFDELYVVLEIADSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA-GILHRDLKP 184

Query: 137 SNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGT 186
           +N L++   + K+ DFG+AR     E+G +   I      M+L       
Sbjct: 185 ANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 31/192 (16%), Positives = 61/192 (31%), Gaps = 34/192 (17%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYT---NLVKLLGCSIHGEERLLVYEFMP 103
           N+Q+  +K           EF    +L+ +L+ +     +K     +     +LV E   
Sbjct: 94  NKQKFVLKVQ---KPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS 150

Query: 104 NKSL----DSSFSGTFKD-------------LLCLHKYSRLRVIHRDLKASNILLDDQLN 146
             +L    +   +   K              L  + +     +IH D+K  N +L +   
Sbjct: 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFL 210

Query: 147 T-----------KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFG 195
                        + D G +    +   G        T G+  +E   +   + + D FG
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFG 270

Query: 196 FGVLVLKIVCGK 207
               V  ++ G 
Sbjct: 271 VAATVYCMLFGT 282

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 58.8 bits (143), Expect = 4e-10
 Identities = 41/186 (22%), Positives = 75/186 (40%), Gaps = 40/186 (21%)

Query: 49  QEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGC-----SIHGEERLLVYEFM 102
            E  IK +     Q  +E  + E +++  L + N++K+        +++     +V E  
Sbjct: 48  LERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY-----IVMETC 102

Query: 103 P----------NKSLDSSFS-----GTFKDLLC----LHKYSRLRVIHRDLKASNILL-- 141
                       ++   + S        K ++      H      V+H+DLK  NIL   
Sbjct: 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQD 159

Query: 142 -DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
                  KI DFG+A +F   +S  ++    GT  YM+ E      V+ K D++  GV++
Sbjct: 160 TSPHSPIKIIDFGLAELF---KSDEHSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215

Query: 201 LKIVCG 206
             ++ G
Sbjct: 216 YFLLTG 221

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 58.8 bits (143), Expect = 5e-10
 Identities = 40/176 (22%), Positives = 69/176 (39%), Gaps = 31/176 (17%)

Query: 49  QEVAIK------RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
            E A K        A   G  R E + E  ++ ++ + N++ L     +  + +L+ E +
Sbjct: 38  LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELV 97

Query: 103 PNKSL------DSSFS-----GTFKDLL----CLHKYSRLRVIHRDLKASNILL----DD 143
               L        S S        K +L     LH     ++ H DLK  NI+L      
Sbjct: 98  SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIP 154

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
             + K+ DFG+A      E G     I GT  +++ E      + ++ D++  GV+
Sbjct: 155 IPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 58.7 bits (143), Expect = 5e-10
 Identities = 22/51 (43%), Positives = 32/51 (62%)

Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 58.9 bits (143), Expect = 5e-10
 Identities = 22/51 (43%), Positives = 32/51 (62%)

Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            + + HRD+K  N+LLD++ N KISDFG+A +F  N      N++ GT  Y
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 58.7 bits (142), Expect = 6e-10
 Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 9/93 (9%)

Query: 121 LHKYSRLRVIHRDLKASNILL--DDQLNTKISDFGMARIFGVNESGANT--NRIVGTYGY 176
           LH      + HRD+K  N L   +     K+ DFG+++ F    +G         GT  +
Sbjct: 184 LHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240

Query: 177 MSLE--YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           ++ E   T + +   K D +  GVL+  ++ G 
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 58.5 bits (142), Expect = 6e-10
 Identities = 38/149 (25%), Positives = 58/149 (38%), Gaps = 30/149 (20%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERL------LVYEF 101
           Q  AIK +   +G    E + E  ++ K   + N+    G  I            LV EF
Sbjct: 50  QLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 108

Query: 102 MPNKS----LDSSFSGTFKD-------------LLCLHKYSRLRVIHRDLKASNILLDDQ 144
               S    + ++   T K+             L  LH+    +VIHRD+K  N+LL + 
Sbjct: 109 CGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTEN 165

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGT 173
              K+ DFG++          NT   +GT
Sbjct: 166 AEVKLVDFGVSAQLDRTVGRRNT--FIGT 192

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 58.4 bits (142), Expect = 7e-10
 Identities = 11/33 (33%), Positives = 17/33 (51%)

Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIF 158
              ++H+D+K  N+LL      KIS  G+A   
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 58.1 bits (141), Expect = 7e-10
 Identities = 40/222 (18%), Positives = 70/222 (31%), Gaps = 54/222 (24%)

Query: 38  RVILVGKFPNEQEVAIKR--LAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEE 94
            V    K  +    AIKR                E    A L Q++++V+        + 
Sbjct: 26  SVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85

Query: 95  RLLVYEFMPNKSLDS------SFSGTF-----KDLLC--------LHKYSRLRVIHRDLK 135
            L+  E+    SL             F     KDLL         +H    + ++H D+K
Sbjct: 86  MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIK 142

Query: 136 ASNILLD-------------------DQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
            SNI +                    +++  KI D G           ++     G   +
Sbjct: 143 PSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT------RISSPQVEEGDSRF 196

Query: 177 MSLEYTM-SGTVSIKTDVFGFGVLVLKIVCGK---KNNKSYH 214
           ++ E    + T   K D+F   + V+     +   +N   +H
Sbjct: 197 LANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 45/184 (24%), Positives = 73/184 (39%), Gaps = 37/184 (20%)

Query: 49  QEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGC-----SIHGEERLLVYEF 101
            E AIK +     S     +   E  ++  L + N++KL        + +     LV E 
Sbjct: 63  VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY-----LVMEC 117

Query: 102 MPNKSL------DSSFS-----GTFKDLLC----LHKYSRLRVIHRDLKASNILL---DD 143
                L         F+        K +L     LHK     ++HRDLK  N+LL   + 
Sbjct: 118 YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEK 174

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
               KI DFG++ +F   E+       +GT  Y++ E  +      K DV+  GV++  +
Sbjct: 175 DALIKIVDFGLSAVF---ENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFIL 230

Query: 204 VCGK 207
           + G 
Sbjct: 231 LAGY 234

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 58.4 bits (142), Expect = 8e-10
 Identities = 19/33 (57%), Positives = 26/33 (78%)

Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIF 158
           R +++HRDLK  N+LLDD LN KI+DFG++ I 
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 58.5 bits (142), Expect = 8e-10
 Identities = 39/158 (24%), Positives = 66/158 (41%), Gaps = 33/158 (20%)

Query: 49  QEVAIK-----RLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
           ++VAIK     + A  S +        + E +++ KL +  ++K+       E+  +V E
Sbjct: 36  KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN-FFDAEDYYIVLE 94

Query: 101 FMPNKSL------DSSFS-----GTFKDLLC----LHKYSRLRVIHRDLKASNILL---D 142
            M    L      +           F  +L     LH      +IHRDLK  N+LL   +
Sbjct: 95  LMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQE 151

Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           +    KI+DFG ++I G     +    + GT  Y++ E
Sbjct: 152 EDCLIKITDFGHSKILG---ETSLMRTLCGTPTYLAPE 186

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 58.5 bits (142), Expect = 8e-10
 Identities = 34/143 (23%), Positives = 49/143 (34%), Gaps = 30/143 (20%)

Query: 49  QEVAIKRL--AWTSGQGRVEFQN---------EAKLIAKLQYTNLVKLLGCSIHGEERL- 96
             VAIKR+    + G+      +         E +L+    + N++ L    +H EE   
Sbjct: 47  IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106

Query: 97  ----LVYEFMPN------KSLDSSFSGTFKD-----LLCLHKY--SRLRVIHRDLKASNI 139
               LV E M               S          +L           V+HRDL   NI
Sbjct: 107 HKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNI 165

Query: 140 LLDDQLNTKISDFGMARIFGVNE 162
           LL D  +  I DF +AR    + 
Sbjct: 166 LLADNNDITICDFNLAREDTADA 188

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 57.6 bits (140), Expect = 9e-10
 Identities = 17/33 (51%), Positives = 24/33 (72%)

Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIF 158
           R  V+HRDLK  N+LLD  +N KI+DFG++ + 
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 42/187 (22%), Positives = 77/187 (41%), Gaps = 36/187 (19%)

Query: 49  QEVAIK-----RLAWTSGQGRVE---FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
           ++VAI+     + A  S +        + E +++ KL +  ++K+       E+  +V E
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN-FFDAEDYYIVLE 219

Query: 101 FMPNKSL------DSSFS-----GTFKDLLC----LHKYSRLRVIHRDLKASNILL---D 142
            M    L      +           F  +L     LH+     +IHRDLK  N+LL   +
Sbjct: 220 LMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQE 276

Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMS---LEYTMSGTVSIKTDVFGFGVL 199
           +    KI+DFG ++I G     +    + GT  Y++   L    +   +   D +  GV+
Sbjct: 277 EDCLIKITDFGHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333

Query: 200 VLKIVCG 206
           +   + G
Sbjct: 334 LFICLSG 340

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 17/33 (51%), Positives = 24/33 (72%)

Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIF 158
           R  V+HRDLK  N+LLD  +N KI+DFG++ + 
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 21/60 (35%), Positives = 29/60 (48%), Gaps = 6/60 (10%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  L      R+IHRD+K  NILLD+  +  I+DF +A +            + GT  YM
Sbjct: 128 LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML---PRETQITTMAGTKPYM 181

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 55.6 bits (135), Expect = 5e-09
 Identities = 40/176 (22%), Positives = 74/176 (42%), Gaps = 31/176 (17%)

Query: 49  QEVAIK-----RLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           +E A K     RL+ +      E  + E  ++ ++++ N++ L     +  + +L+ E +
Sbjct: 31  KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELV 90

Query: 103 PNKSL------DSSFS-----GTFKDLL----CLHKYSRLRVIHRDLKASNILLDDQLNT 147
               L        S +        K +L     LH     R+ H DLK  NI+L D+   
Sbjct: 91  SGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVP 147

Query: 148 ----KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
               K+ DFG+A      E+G     I GT  +++ E      + ++ D++  GV+
Sbjct: 148 NPRIKLIDFGIAHKI---EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 7/81 (8%)

Query: 129 VIHRDLKASNILL---DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
           ++HRD+K  NILL   +  LN KI DFG++  F            +GT  Y++ E  +  
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDYKLRDRLGTAYYIAPE-VLKK 222

Query: 186 TVSIKTDVFGFGVLVLKIVCG 206
             + K DV+  GV++  ++CG
Sbjct: 223 KYNEKCDVWSCGVIMYILLCG 243

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 47/183 (25%), Positives = 75/183 (40%), Gaps = 37/183 (20%)

Query: 49  QEVAIKRLA--WTSGQGRVEFQNEAKLIAKLQYTNLVKLLGC-----SIHGEERLLVYEF 101
           QE A+K +       +       E +L+ KL + N++KL        S +     +V E 
Sbjct: 48  QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY-----IVGEL 102

Query: 102 MPNKSL------DSSFS-----GTFKDLLC----LHKYSRLRVIHRDLKASNILL---DD 143
                L         FS        K +      +HK     ++HRDLK  NILL   + 
Sbjct: 103 YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEK 159

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             + KI DFG++  F   +        +GT  Y++ E  + GT   K DV+  GV++  +
Sbjct: 160 DCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYIL 215

Query: 204 VCG 206
           + G
Sbjct: 216 LSG 218

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 55.9 bits (135), Expect = 7e-09
 Identities = 33/166 (19%), Positives = 60/166 (36%), Gaps = 34/166 (20%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEFQN---------EAKLIAKLQYTNLVKLL-----GCSIH 91
             E+ VAIK++       R+ F++         E  ++ +L+   +++L         + 
Sbjct: 49  NTEKNVAIKKVN------RM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101

Query: 92  GEERLLVYEFMP---------NKSLDSSFSGTFK-DLLCLHKY--SRLRVIHRDLKASNI 139
            +E  +V E               L      T   +LL    +      +IHRDLK +N 
Sbjct: 102 FDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES-GIIHRDLKPANC 160

Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
           LL+   + K+ DFG+AR     +     N +            +  
Sbjct: 161 LLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 54.9 bits (133), Expect = 8e-09
 Identities = 48/183 (26%), Positives = 77/183 (42%), Gaps = 37/183 (20%)

Query: 49  QEVAIKRLAWTSGQGRVE--FQNEAKLIAKLQYTNLVKLLGC-----SIHGEERLLVYEF 101
           QE A+K +   S + +       E +L+ KL + N++KL        S +     +V E 
Sbjct: 48  QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY-----IVGEL 102

Query: 102 MPNKSL------DSSFS-----GTFKDLLC----LHKYSRLRVIHRDLKASNILL---DD 143
                L         FS        K +      +HK     ++HRDLK  NILL   + 
Sbjct: 103 YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEK 159

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
             + KI DFG++  F   +        +GT  Y++ E  + GT   K DV+  GV++  +
Sbjct: 160 DCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYIL 215

Query: 204 VCG 206
           + G
Sbjct: 216 LSG 218

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 55.3 bits (134), Expect = 8e-09
 Identities = 38/176 (21%), Positives = 71/176 (40%), Gaps = 31/176 (17%)

Query: 49  QEVAIKRLA------WTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
            + A K +          G  R + + E  ++ ++Q+ N++ L     +  + +L+ E +
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96

Query: 103 PNKSL------DSSFS-----GTFKDLL----CLHKYSRLRVIHRDLKASNILL----DD 143
               L        S +        K +L     LH    L++ H DLK  NI+L      
Sbjct: 97  AGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVP 153

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
           +   KI DFG+A      + G     I GT  +++ E      + ++ D++  GV+
Sbjct: 154 KPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 54.5 bits (132), Expect = 1e-08
 Identities = 45/181 (24%), Positives = 70/181 (38%), Gaps = 35/181 (19%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGC-----SIHGEERLLVYEFMP 103
              A K++     +    F+ E +++  L + N+++L         I+     LV E   
Sbjct: 35  IRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY-----LVMELCT 89

Query: 104 NKSL------DSSFS-----GTFKDLLC----LHKYSRLRVIHRDLKASNILL---DDQL 145
              L         F         KD+L      HK   L V HRDLK  N L        
Sbjct: 90  GGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDS 146

Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC 205
             K+ DFG+A  F   + G      VGT  Y+S +  + G    + D +  GV++  ++C
Sbjct: 147 PLKLIDFGLAARF---KPGKMMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLC 202

Query: 206 G 206
           G
Sbjct: 203 G 203

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 20/64 (31%), Positives = 28/64 (43%), Gaps = 9/64 (14%)

Query: 121 LHKYSRLRVIHRDLKASNILL----DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGY 176
           LH      V+HRDLK SNIL      +  + +I DFG A+          T     T  +
Sbjct: 132 LHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANF 186

Query: 177 MSLE 180
           ++ E
Sbjct: 187 VAPE 190

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 38/144 (26%), Positives = 55/144 (38%), Gaps = 37/144 (25%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEFQN---------EAKLIAKLQYTNLVKLLGCSIHGEERL 96
             ++ VAIK+L+      R  FQN         E  L+  + + N++ LL      +   
Sbjct: 85  VLDRNVAIKKLS------RP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137

Query: 97  ------LVYEFMP---NKSLDSSFSGTFKDLLCLHKYSRLR---------VIHRDLKASN 138
                 LV E M     + +           L    Y  L          +IHRDLK SN
Sbjct: 138 EFQDVYLVMELMDANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSN 194

Query: 139 ILLDDQLNTKISDFGMARIFGVNE 162
           I++      KI DFG+AR  G + 
Sbjct: 195 IVVKSDCTLKILDFGLARTAGTSF 218

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 54.1 bits (131), Expect = 1e-08
 Identities = 36/157 (22%), Positives = 63/157 (40%), Gaps = 36/157 (22%)

Query: 49  QEVAIKRLA--WTSGQGRVEFQNEAKLIAKLQYTNLVKLLGC-----SIHGEERLLVYEF 101
            E A K +     S +   + + EA++  KLQ+ N+V+L          +     LV++ 
Sbjct: 32  LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY-----LVFDL 86

Query: 102 MPNKSL-D-----SSFS-----GTFKDLLC----LHKYSRLRVIHRDLKASNILLDDQLN 146
           +    L +       +S        + +L      H      ++HR+LK  N+LL  +  
Sbjct: 87  VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAK 143

Query: 147 T---KISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
               K++DFG+A            +   GT GY+S E
Sbjct: 144 GAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSPE 177

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 36/157 (22%), Positives = 63/157 (40%), Gaps = 36/157 (22%)

Query: 49  QEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGC-----SIHGEERLLVYEF 101
            E A K +     S +   + + EA++  KLQ+ N+V+L          +     LV++ 
Sbjct: 55  LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY-----LVFDL 109

Query: 102 MPNKSL-D-----SSFS-----GTFKDLLC----LHKYSRLRVIHRDLKASNILLDDQLN 146
           +    L +       +S        + +L      H      ++HR+LK  N+LL  +  
Sbjct: 110 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAK 166

Query: 147 T---KISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
               K++DFG+A            +   GT GY+S E
Sbjct: 167 GAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSPE 200

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 24/87 (27%), Positives = 36/87 (41%), Gaps = 12/87 (13%)

Query: 126 RLRVIHRDLKASNILLD-DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM- 183
              V+HRD+K  NIL+D ++   K+ DFG   +              GT  Y   E+   
Sbjct: 167 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRY 222

Query: 184 ---SGTVSIKTDVFGFGVLVLKIVCGK 207
               G       V+  G+L+  +VCG 
Sbjct: 223 HRYHGR---SAAVWSLGILLYDMVCGD 246

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 33/165 (20%), Positives = 63/165 (38%), Gaps = 29/165 (17%)

Query: 38  RVILVGKFPNEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTN---LVKLLGCSIHG 92
            V +V     ++  A+K L       +       E + +  L   +   +  L   +   
Sbjct: 89  EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVNGDSKWITTLH-YAFQD 145

Query: 93  EERL-LVYEFMPNK---SLDSSFSGTFKD-------------LLCLHKYSRLRVIHRDLK 135
           +  L LV ++       +L S F     +             +  +H+   L  +HRD+K
Sbjct: 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIK 202

Query: 136 ASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
             NIL+D   + +++DFG      + +    ++  VGT  Y+S E
Sbjct: 203 PDNILMDMNGHIRLADFGSCLK-LMEDGTVQSSVAVGTPDYISPE 246

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 25/82 (30%), Positives = 39/82 (47%), Gaps = 9/82 (10%)

Query: 121 LHKYSRLRVIHRDLKASNILL---DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           LH+     ++H DLK  NILL       + KI DFGM+R             I+GT  Y+
Sbjct: 147 LHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHACELREIMGTPEYL 200

Query: 178 SLEYTMSGTVSIKTDVFGFGVL 199
           + E      ++  TD++  G++
Sbjct: 201 APEILNYDPITTATDMWNIGII 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 22/53 (41%), Positives = 33/53 (62%), Gaps = 3/53 (5%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEY 181
           VIHRDLK SN+L++   + K+ DFG+AR   ++ES A+ +   G    M  E+
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLAR--IIDESAADNSEPTGQQSGMV-EF 182

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 36/156 (23%), Positives = 61/156 (39%), Gaps = 27/156 (17%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLVYEFMPNKSL 107
           QE A+K +    G  R     E +++ + Q + N+++L+      +   LV+E M   S+
Sbjct: 39  QEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98

Query: 108 ------DSSFS-----GTFKDLLC----LHKYSRLRVIHRDLKASNILL---DDQLNTKI 149
                    F+        +D+      LH      + HRDLK  NIL    +     KI
Sbjct: 99  LSHIHKRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKI 155

Query: 150 SDFGMARIFGVNESGANTNR-----IVGTYGYMSLE 180
            DF +     +N   +  +        G+  YM+ E
Sbjct: 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 20/63 (31%), Positives = 33/63 (52%), Gaps = 4/63 (6%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           +  +H+   L  +HRD+K  NILLD   + +++DFG       + +   +   VGT  Y+
Sbjct: 175 IDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYL 230

Query: 178 SLE 180
           S E
Sbjct: 231 SPE 233

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 53.4 bits (129), Expect = 3e-08
 Identities = 22/60 (36%), Positives = 32/60 (53%), Gaps = 4/60 (6%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LHK   L +I+RD+K  NILLD   +  ++DFG+++   V +         GT  YM
Sbjct: 172 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYM 227

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 16/96 (16%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LH  S   V++RDLK  N++LD   + KI+DFG+ +  G+ + GA      GT  Y+
Sbjct: 261 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKTFCGTPEYL 316

Query: 178 SLE------YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E      Y  +       D +G GV++ +++CG+
Sbjct: 317 APEVLEDNDYGRA------VDWWGLGVVMYEMMCGR 346

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 53.0 bits (128), Expect = 4e-08
 Identities = 39/161 (24%), Positives = 61/161 (37%), Gaps = 55/161 (34%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEFQN---------EAKLIAKLQYTNLVKLL---------- 86
             ++ VAIK++            +         E K+I +L + N+VK+           
Sbjct: 34  DCDKRVAIKKIV---------LTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84

Query: 87  GCSIHGEERL----LVYEFMP---NKSLDSSFSGTFKDLLCLHK----YSRLR------- 128
              +     L    +V E+M       L+         LL  H     Y  LR       
Sbjct: 85  TDDVGSLTELNSVYIVQEYMETDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHS 138

Query: 129 --VIHRDLKASNILLD-DQLNTKISDFGMARIFGVNESGAN 166
             V+HRDLK +N+ ++ + L  KI DFG+ARI   + S   
Sbjct: 139 ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 53.2 bits (128), Expect = 5e-08
 Identities = 41/142 (28%), Positives = 58/142 (40%), Gaps = 33/142 (23%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEFQN---------EAKLIAKLQYTNLVKLLGCSIHGEERL 96
             E+ VAIK+L+      R  FQN         E  L+  + + N++ LL      +   
Sbjct: 48  ILERNVAIKKLS------RP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100

Query: 97  ------LVYEFMP-------NKSLDSSFSGTFK-DLLCLHKY--SRLRVIHRDLKASNIL 140
                 +V E M           LD          +LC  K+  S   +IHRDLK SNI+
Sbjct: 101 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIV 159

Query: 141 LDDQLNTKISDFGMARIFGVNE 162
           +      KI DFG+AR  G + 
Sbjct: 160 VKSDCTLKILDFGLARTAGTSF 181

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 35/151 (23%), Positives = 60/151 (39%), Gaps = 44/151 (29%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEFQN---------EAKLIAKLQYTNLVKLLGCSIHGEERL 96
            N+  VAIK+++         F++         E K++ + ++ N++ +           
Sbjct: 50  LNKVRVAIKKIS--------PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101

Query: 97  -----LVYEFMP---NKSLDSSFSGTFKDLLCLHK----YSRLR---------VIHRDLK 135
                +V + M     K L +      + L   H     Y  LR         V+HRDLK
Sbjct: 102 MKDVYIVQDLMETDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155

Query: 136 ASNILLDDQLNTKISDFGMARIFGVNESGAN 166
            SN+LL+   + KI DFG+AR+   +     
Sbjct: 156 PSNLLLNTTCDLKICDFGLARVADPDHDHTG 186

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 52.6 bits (127), Expect = 5e-08
 Identities = 31/150 (20%), Positives = 62/150 (41%), Gaps = 25/150 (16%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSL- 107
           +  A+K +  +        +NE  ++ K+++ N+V L           LV + +    L 
Sbjct: 35  KLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELF 94

Query: 108 D-----SSFS-----GTFKDLLC----LHKYSRLRVIHRDLKASNILL---DDQLNTKIS 150
           D       ++        + +L     LH+     ++HRDLK  N+L    ++     I+
Sbjct: 95  DRILERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMIT 151

Query: 151 DFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           DFG++++          +   GT GY++ E
Sbjct: 152 DFGLSKME----QNGIMSTACGTPGYVAPE 177

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 21/63 (33%), Positives = 31/63 (49%), Gaps = 9/63 (14%)

Query: 121 LHKYSRLRVIHRDLKASNILL---DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           LH+     ++HRDLK  N+L          KI+DFG+++I    E       + GT GY 
Sbjct: 164 LHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYC 217

Query: 178 SLE 180
           + E
Sbjct: 218 APE 220

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 39/138 (28%), Positives = 58/138 (42%), Gaps = 33/138 (23%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEFQN---------EAKLIAKLQYTNLVKLLGCSIHGEERL 96
            + ++VAIK+L+      R  FQ+         E  L+  +Q+ N++ LL          
Sbjct: 47  RSGEKVAIKKLS------RP-FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99

Query: 97  ------LVYEFMP---NKSLDSSFSGTFKD-----LLCLHKY--SRLRVIHRDLKASNIL 140
                 LV  FM     K +   FS          +L   KY  S   V+HRDLK  N+ 
Sbjct: 100 NFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLA 158

Query: 141 LDDQLNTKISDFGMARIF 158
           +++    KI DFG+AR  
Sbjct: 159 VNEDCELKILDFGLARHA 176

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 52.7 bits (127), Expect = 7e-08
 Identities = 47/191 (24%), Positives = 79/191 (41%), Gaps = 34/191 (17%)

Query: 38  RVILVGKFPNEQEVAIKRL--AWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEE 94
           RV+LV    +    A+K L         ++E   NE +++  + +  LVKL   S     
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 114

Query: 95  RL-LVYEFMPNKSLDSSFS-----GTFKD-------------LLCLHKYSRLRVIHRDLK 135
            L +V E++    +   FS     G F +                LH      +I+RDLK
Sbjct: 115 NLYMVMEYVAGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLK 168

Query: 136 ASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFG 195
             N+L+D Q   +++DFG A+          T  + GT   ++ E  +S   +   D + 
Sbjct: 169 PENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWA 223

Query: 196 FGVLVLKIVCG 206
            GVL+ ++  G
Sbjct: 224 LGVLIYEMAAG 234

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 52.3 bits (126), Expect = 7e-08
 Identities = 22/63 (34%), Positives = 30/63 (47%), Gaps = 8/63 (12%)

Query: 121 LHKYSRLRVIHRDLKASNILL---DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           +H    + V+HRDLK  N+L    +D L  KI DFG AR+   +     T     T  Y 
Sbjct: 122 MHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYA 176

Query: 178 SLE 180
           + E
Sbjct: 177 APE 179

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 52.7 bits (127), Expect = 7e-08
 Identities = 35/139 (25%), Positives = 56/139 (40%), Gaps = 34/139 (24%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEFQN---------EAKLIAKLQYTNLVKLLGCSIHGEERL 96
               +VAIK+L       R  FQ+         E +L+  +++ N++ LL      E   
Sbjct: 48  RTGAKVAIKKLY------RP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100

Query: 97  ------LVYEFMP--------NKSLDSSFSGTFK-DLLCLHKY--SRLRVIHRDLKASNI 139
                 LV  FM         ++ L           +L   +Y  +   +IHRDLK  N+
Sbjct: 101 DFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNL 159

Query: 140 LLDDQLNTKISDFGMARIF 158
            +++    KI DFG+AR  
Sbjct: 160 AVNEDCELKILDFGLARQA 178

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 52.3 bits (126), Expect = 7e-08
 Identities = 23/86 (26%), Positives = 34/86 (39%), Gaps = 12/86 (13%)

Query: 126 RLRVIHRDLKASNILLD-DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM- 183
              V+HRD+K  NIL+D  +   K+ DFG   +              GT  Y   E+   
Sbjct: 157 SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPYTDFDGTRVYSPPEWISR 212

Query: 184 ---SGTVSIKTDVFGFGVLVLKIVCG 206
                       V+  G+L+  +VCG
Sbjct: 213 HQYHAL---PATVWSLGILLYDMVCG 235

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 52.2 bits (126), Expect = 8e-08
 Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 17/96 (17%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LH      V++RD+K  N++LD   + KI+DFG+ +  G+++ GA      GT  Y+
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKTFCGTPEYL 172

Query: 178 SLE------YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E      Y  +       D +G GV++ +++CG+
Sbjct: 173 APEVLEDNDYGRA------VDWWGLGVVMYEMMCGR 202

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 52.2 bits (126), Expect = 9e-08
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 17/96 (17%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LH    L +I+RDLK  NILLD++ + K++DFG+++    +E  A +    GT  YM
Sbjct: 139 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 193

Query: 178 SLE------YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E      +T S       D + FGVL+ +++ G 
Sbjct: 194 APEVVNRRGHTQS------ADWWSFGVLMFEMLTGT 223

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 39/166 (23%), Positives = 62/166 (37%), Gaps = 33/166 (19%)

Query: 38  RVILVGKFPNEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTN---LVKLLGCSIHG 92
            V LV      +  A+K L       +    F  E + I  + + N   +V+L   +   
Sbjct: 84  EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI--MAFANSPWVVQLF-YAFQD 140

Query: 93  EERL-LVYEFMPNKSLDSSFS----GTFKD-------------LLCLHKYSRLRVIHRDL 134
           +  L +V E+MP   L    +        +             L  +H    +  IHRD+
Sbjct: 141 DRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDV 194

Query: 135 KASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           K  N+LLD   + K++DFG              +  VGT  Y+S E
Sbjct: 195 KPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPE 239

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 52.3 bits (126), Expect = 9e-08
 Identities = 20/63 (31%), Positives = 30/63 (47%), Gaps = 8/63 (12%)

Query: 121 LHKYSRLRVIHRDLKASNILL---DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
            H+   + V+HR+LK  N+LL         K++DFG+A      +         GT GY+
Sbjct: 126 CHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYL 180

Query: 178 SLE 180
           S E
Sbjct: 181 SPE 183

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 16/54 (29%), Positives = 29/54 (53%)

Query: 129 VIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYT 182
           ++HRD+K SNILL+ + + K++DFG++R F       N   +       + +  
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 14/35 (40%), Positives = 19/35 (54%), Gaps = 2/35 (5%)

Query: 126 RLRVIHRDLKASNILLDDQ--LNTKISDFGMARIF 158
            +++ HRDLK  N LLD       KI DFG ++  
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 51.8 bits (125), Expect = 1e-07
 Identities = 26/96 (27%), Positives = 46/96 (47%), Gaps = 17/96 (17%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LH+     +I+RDLK  NI+L+ Q + K++DFG+ +    + +  +T    GT  YM
Sbjct: 134 LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYM 188

Query: 178 SLE------YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E      +  +       D +  G L+  ++ G 
Sbjct: 189 APEILMRSGHNRA------VDWWSLGALMYDMLTGA 218

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 17/96 (17%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L+ LH      +I+RDLK  N+LLD + + K++DFGM +  G+   G  T    GT  Y+
Sbjct: 137 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICN-GVTTATFCGTPDYI 191

Query: 178 SLE------YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E      Y  +       D +  GVL+ +++CG 
Sbjct: 192 APEILQEMLYGPA------VDWWAMGVLLYEMLCGH 221

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 17/96 (17%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LH+     +I+RDLK  N+LLD + + K++D+GM +  G+   G  T+   GT  Y+
Sbjct: 123 LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRP-GDTTSTFCGTPNYI 177

Query: 178 SLE------YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E      Y  S       D +  GVL+ +++ G+
Sbjct: 178 APEILRGEDYGFS------VDWWALGVLMFEMMAGR 207

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 17/96 (17%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LH+     +I+RDLK  N+LLD + + K++D+GM +         +T    GT  Y+
Sbjct: 166 LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYI 220

Query: 178 SLE------YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E      Y  S       D +  GVL+ +++ G+
Sbjct: 221 APEILRGEDYGFS------VDWWALGVLMFEMMAGR 250

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 20/93 (21%), Positives = 39/93 (41%), Gaps = 22/93 (23%)

Query: 97  LVYEFMPN--KSLDSSFSGTFKDLLCLHK----YSRLR---------VIHRDLKASNILL 141
           ++ E++P+    +  SF  + + +         Y   R         + HRD+K  N+L+
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174

Query: 142 D---DQLNTKISDFGMARIFGVNESGANTNRIV 171
           +   + L  K+ DFG A+    +E   +   I 
Sbjct: 175 NSKDNTL--KLCDFGSAKKLIPSE--PSVAYIC 203

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 35/142 (24%), Positives = 54/142 (38%), Gaps = 44/142 (30%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEFQN---------EAKLIAKLQYTNLVKLLGCSIHGEERL 96
                VA+K+L+         FQ+         E +L+  +++ N++ LL          
Sbjct: 52  KTGLRVAVKKLSRP-------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104

Query: 97  ------LVYEFMP---NKSLDSSFSGTFKDLLCLHK----YSRLR---------VIHRDL 134
                 LV   M    N  +        + L   H     Y  LR         +IHRDL
Sbjct: 105 EFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDL 158

Query: 135 KASNILLDDQLNTKISDFGMAR 156
           K SN+ +++    KI DFG+AR
Sbjct: 159 KPSNLAVNEDCELKILDFGLAR 180

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 17/95 (17%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LH      +++RDLK  NILLD   + KI+DFGM +   + ++  NT    GT  Y+
Sbjct: 131 LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYI 185

Query: 178 SLE------YTMSGTVSIKTDVFGFGVLVLKIVCG 206
           + E      Y  S       D + FGVL+ +++ G
Sbjct: 186 APEILLGQKYNHS------VDWWSFGVLLYEMLIG 214

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 17/96 (17%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  L       +I+RDLK  N++LD + + KI+DFGM +   + + G  T    GT  Y+
Sbjct: 455 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWD-GVTTKTFCGTPDYI 509

Query: 178 SLE------YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E      Y  S       D + FGVL+ +++ G+
Sbjct: 510 APEIIAYQPYGKS------VDWWAFGVLLYEMLAGQ 539

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 17/96 (17%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  LH    L +++RDLK  NILLD Q +  ++DFG+ +    + S  +T    GT  Y+
Sbjct: 152 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYL 206

Query: 178 SLE------YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E      Y  +       D +  G ++ +++ G 
Sbjct: 207 APEVLHKQPYDRT------VDWWCLGAVLYEMLYGL 236

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 49.5 bits (119), Expect = 5e-07
 Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 17/96 (17%)

Query: 118 LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           L  L       +I+RDLK  N++LD + + KI+DFGM +   + + G  T    GT  Y+
Sbjct: 134 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWD-GVTTKTFCGTPDYI 188

Query: 178 SLE------YTMSGTVSIKTDVFGFGVLVLKIVCGK 207
           + E      Y  S       D + FGVL+ +++ G+
Sbjct: 189 APEIIAYQPYGKS------VDWWAFGVLLYEMLAGQ 218

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 48.7 bits (117), Expect = 1e-06
 Identities = 45/197 (22%), Positives = 83/197 (42%), Gaps = 46/197 (23%)

Query: 38  RVILVGKFPNEQEVAIKRL--AWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEE 94
           RV L+    N +  A+K L         +VE   +E  +++ + +  ++++   +    +
Sbjct: 21  RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW-GTFQDAQ 79

Query: 95  RL-LVYEFMPNKSLDSSFS-----GTFKD-------------LLCLHKYSRLRVIHRDLK 135
           ++ ++ +++    L   FS       F +             L  LH      +I+RDLK
Sbjct: 80  QIFMIMDYIEGGEL---FSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLK 133

Query: 136 ASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE------YTMSGTVSI 189
             NILLD   + KI+DFG A+          T  + GT  Y++ E      Y  S     
Sbjct: 134 PENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNKS----- 183

Query: 190 KTDVFGFGVLVLKIVCG 206
             D + FG+L+ +++ G
Sbjct: 184 -IDWWSFGILIYEMLAG 199

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 17/63 (26%), Positives = 27/63 (42%), Gaps = 9/63 (14%)

Query: 121 LHKYSRLRVIHRDLKASNILL---DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           LH    + + HRD+K  N+L          K++DFG A+      S  +      T  Y+
Sbjct: 177 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET---TSHNSLTTPCYTPYYV 230

Query: 178 SLE 180
           + E
Sbjct: 231 APE 233

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 17/63 (26%), Positives = 26/63 (41%), Gaps = 10/63 (15%)

Query: 121 LHKYSRLRVIHRDLKASNILL---DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYM 177
           LH      + HRD+K  N+L    +     K++DFG A+    N           T  Y+
Sbjct: 144 LHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYV 196

Query: 178 SLE 180
           + E
Sbjct: 197 APE 199

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 28/128 (21%), Positives = 55/128 (42%), Gaps = 20/128 (15%)

Query: 46  PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY-TNLVKLLGCSIHGEER--LLVYEFM 102
            N ++V +K L     +   + + E K++  L+   N++ L         R   LV+E +
Sbjct: 59  TNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115

Query: 103 PNKSLDSSFSGTFKD---------LLCLHKY--SRLRVIHRDLKASNILLD-DQLNTKIS 150
            N      +  T  D         +L    Y  S   ++HRD+K  N+++D +    ++ 
Sbjct: 116 NNTDFKQLYQ-TLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLI 173

Query: 151 DFGMARIF 158
           D+G+A  +
Sbjct: 174 DWGLAEFY 181

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 46.7 bits (111), Expect = 4e-06
 Identities = 13/131 (9%), Positives = 35/131 (26%), Gaps = 35/131 (26%)

Query: 50  EVAIKRL---AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           +VA+  +            E  +    ++++    + ++L         L+V E++   S
Sbjct: 58  QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGS 117

Query: 107 LDSSFSGTFKDLL---------------------CLHKYSRLRVIHRDLKASNILLDDQL 145
           L        +++                        H   R  V       S + +    
Sbjct: 118 L--------QEVADTSPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDG 166

Query: 146 NTKISDFGMAR 156
           +  ++      
Sbjct: 167 DVVLAYPATMP 177

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 42.7 bits (101), Expect = 8e-05
 Identities = 13/38 (34%), Positives = 19/38 (50%), Gaps = 6/38 (15%)

Query: 121 LHKYSRLRVIHRDLKASNILL---DDQLNTKISDFGMA 155
           LH    + + HRD+K  N+L          K++DFG A
Sbjct: 133 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.9 bits (100), Expect = 1e-04
 Identities = 56/374 (14%), Positives = 104/374 (27%), Gaps = 103/374 (27%)

Query: 36  RDRVILVGKFPNEQEVAIKRLAW-TSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE 94
               +   K   +       + W           +   ++  LQ   L+  +  +     
Sbjct: 172 LSYKVQC-KMDFK-------IFWLNLKN----CNSPETVLEMLQ--KLLYQIDPNWTSRS 217

Query: 95  RLLVYEFMPNKSLD-SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISD-F 152
                +   N  L   S     + LL    Y         L    ++L +  N K  + F
Sbjct: 218 -----DHSSNIKLRIHSIQAELRRLLKSKPYE------NCL----LVLLNVQNAKAWNAF 262

Query: 153 GM-ARIFGVNESGANTNRIVG-TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNN 210
            +  +I         T+ +   T  ++SL++        +        L+LK +  +  +
Sbjct: 263 NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK-----SLLLKYLDCRPQD 317

Query: 211 --KSYHTERPLNLVGIA---------WQLW---NEGKDLELIDLTLDGSCPPNEDAFLLV 256
             +   T  P  L  IA         W  W   N  K   +I+ +L+    P E   +  
Sbjct: 318 LPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN-VLEPAEYRKMFD 376

Query: 257 SCV-------------CKSKQQIDVQCPMLFPCLLMNL-------------LPGLYL--- 287
                                 +     M+    L                +P +YL   
Sbjct: 377 RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK 436

Query: 288 ------KNLH--------FLLMLPPKNQKLPKTSQKFVPYIKNRLQRLKQDKSNTGSEII 333
                   LH                +   P   Q F  +I + L+ ++  +  T   ++
Sbjct: 437 VKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMV 496

Query: 334 FCID----EAK-RH 342
           F +D    E K RH
Sbjct: 497 F-LDFRFLEQKIRH 509

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 40.5 bits (95), Expect = 6e-04
 Identities = 16/39 (41%), Positives = 20/39 (51%), Gaps = 2/39 (5%)

Query: 119 LCLHKYSRLRVIHRDLKASNILLDDQLNT--KISDFGMA 155
           L       L +IH DLK  NILL +   +  KI DFG +
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 39.9 bits (92), Expect = 8e-04
 Identities = 16/77 (20%), Positives = 20/77 (25%), Gaps = 6/77 (7%)

Query: 111 FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRI 170
                  L        LR  HRDL   N+LL      K+      +   +   G      
Sbjct: 167 LHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCG----LQ 220

Query: 171 VGTYGYMSLEYTMSGTV 187
           V    Y        G V
Sbjct: 221 VSIIDYTLSRLERDGIV 237

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	345
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.69
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.09
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.87
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.85
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.65
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.58
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.51
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.46
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.36
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.34
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.28
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.24
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.24
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	98.02
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.01
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.87
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.69
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.67
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.65
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.6
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.56
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.52
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.38
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.18
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.79
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.96
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	88.59

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.3e-56  Score=409.15  Aligned_cols=241  Identities=23%  Similarity=0.297  Sum_probs=193.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      ..++++.++||+|+||.||+|.+.      +++.||||+++.. .....+.|.+|+.++++++|||||+++|+|.+++.+
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            456788999999999999999862      4689999999754 334567899999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC
Q 039516           96 LLVYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ  144 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~  144 (345)
                      +||||||++|+|.+++.                               +++.||.|||..   +||||||||+|||++++
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~  181 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK  181 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCC
Confidence            99999999999998872                               677888888875   79999999999999999


Q ss_pred             CCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHH
Q 039516          145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVG  223 (345)
Q Consensus       145 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~  223 (345)
                      +.+||+|||+++...............||+.|||||++.++.|+.++|||||||++|||+| |+.||.+....      +
T Consensus       182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~------~  255 (308)
T 4gt4_A          182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------D  255 (308)
T ss_dssp             GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH------H
T ss_pred             CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH------H
Confidence            9999999999987654433333445689999999999999999999999999999999998 89999865421      1


Q ss_pred             HHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          224 IAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       224 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                      .. .....+....     ....++.+-   .+++..||+.||++||||.+++..|..+
T Consensus       256 ~~-~~i~~~~~~~-----~p~~~~~~~---~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          256 VV-EMIRNRQVLP-----CPDDCPAWV---YALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HH-HHHHTTCCCC-----CCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HH-HHHHcCCCCC-----CcccchHHH---HHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            11 2222332211     112233222   5999999999999999998887777654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.8e-57  Score=410.23  Aligned_cols=243  Identities=22%  Similarity=0.317  Sum_probs=195.0

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ..+|.+.++||+|+||.||+|.+.      +++.||||+++..+....+.|.+|+++|++++|||||+++|+|.+++.++
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            357899999999999999999753      47899999998776667788999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHH----------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEE
Q 039516           97 LVYEFMPNKSLDSSFS----------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTK  148 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~----------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~k  148 (345)
                      ||||||++|+|.+++.                            +++.||.|||..   +||||||||+|||++.++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence            9999999999988762                            667788888875   799999999999999999999


Q ss_pred             EEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHH
Q 039516          149 ISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQ  227 (345)
Q Consensus       149 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~  227 (345)
                      |+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||......      +....
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~~  242 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIEC  242 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHH
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH
Confidence            999999987644333333344679999999999999999999999999999999999 89999865421      11222


Q ss_pred             HHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          228 LWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       228 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                       ...+....     ....++.+.   .+++..||+.||++||||.+++..|.++.+
T Consensus       243 -i~~~~~~~-----~p~~~~~~~---~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          243 -ITQGRVLQ-----RPRTCPQEV---YELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             -HHHTCCCC-----CCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHcCCCCC-----CCccchHHH---HHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence             22222111     112233222   599999999999999999888777776654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.8e-56  Score=412.19  Aligned_cols=243  Identities=23%  Similarity=0.334  Sum_probs=189.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ..++.+.++||+|+||.||+|.+.      +++.||||+++..+....+.|.+|+++|++++|||||+++|+|.+.+.++
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            357888999999999999999763      47899999998776667788999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHH------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC
Q 039516           97 LVYEFMPNKSLDSSFS------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN  146 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~  146 (345)
                      ||||||++|+|.+++.                              +++.+|.|||..   +||||||||+|||++.++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence            9999999999987652                              677888888875   7999999999999999999


Q ss_pred             EEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHH
Q 039516          147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIA  225 (345)
Q Consensus       147 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~  225 (345)
                      +||+|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||......      +..
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~  270 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------EAI  270 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------HHH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------HHH
Confidence            99999999987644333333445679999999999999999999999999999999999 89999765421      111


Q ss_pred             HHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          226 WQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       226 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      . ....+..     +.....++++.   .+++.+||+.||++||||.+++..|..+.+
T Consensus       271 ~-~i~~g~~-----~~~p~~~~~~~---~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          271 D-CITQGRE-----LERPRACPPEV---YAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             H-HHHHTCC-----CCCCTTCCHHH---HHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             H-HHHcCCC-----CCCcccccHHH---HHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            1 1222211     11112233322   599999999999999999998888887765

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-54  Score=395.44  Aligned_cols=243  Identities=20%  Similarity=0.285  Sum_probs=183.9

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ..++.+.++||+|+||+||+|.+.  ..||||+++..  +....+.|.+|+.+|++++|||||+++|+|. .+.++||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEE
Confidence            356788999999999999999875  36999998654  3345678999999999999999999999885 467899999


Q ss_pred             cCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          101 FMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       101 ~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||++|+|.+++.                +++.||.|||..   +||||||||+|||+++++.+||+|||+|+........
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            999999998874                677888888875   7999999999999999999999999999876443333


Q ss_pred             CcccceeecCCccccchhcc---CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          165 ANTNRIVGTYGYMSLEYTMS---GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      .......||+.|||||++.+   ++|+.++|||||||++|||+||+.||......      .........+.....+ +.
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~~p~~-~~  261 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYASPDL-SK  261 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCCCCCS-TT
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCCCCc-cc
Confidence            34455689999999999864   46899999999999999999999999764321      1122222222111101 11


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                      +...++.+-   .+++..||+.||++||||.+++..|..|
T Consensus       262 ~~~~~~~~l---~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          262 LYKNCPKAM---KRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             SCTTSCHHH---HHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             ccccchHHH---HHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            112233222   5899999999999999998877776654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.4e-54  Score=391.42  Aligned_cols=248  Identities=19%  Similarity=0.206  Sum_probs=195.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|++.+.||+|+||+||++. ..+|+.||||++++.   .....+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            569999999999999999996 467999999999653   3345678999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||+||+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+|+.+......
T Consensus       112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            9999999988775               566667777765   8999999999999999999999999999987554444


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+.      ........ .+..      .+..
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~-~~~~------~~p~  255 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKII-KLEY------DFPE  255 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HTCC------CCCT
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-cCCC------CCCc
Confidence            455667999999999999999999999999999999999999999976432      11111222 1211      1112


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccccccccee
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLH  291 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~  291 (345)
                      ..+++.   .+++.+||+.||++|||+.++. ....++.+..+.+.+
T Consensus       256 ~~s~~~---~dli~~lL~~dp~~R~t~~e~~-~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          256 KFFPKA---RDLVEKLLVLDATKRLGCEEME-GYGPLKAHPFFESVT  298 (311)
T ss_dssp             TCCHHH---HHHHHHHSCSSGGGSTTSGGGT-CHHHHHTSGGGTTCC
T ss_pred             ccCHHH---HHHHHHHccCCHhHCcChHHHc-CCHHHHCCCCcCCCC
Confidence            233322   5899999999999999965421 122234444444433

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.5e-53  Score=389.81  Aligned_cols=229  Identities=20%  Similarity=0.267  Sum_probs=186.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ...|+++++||+|+||+||+|.. .+|+.||||+++.......+.+.+|+.+|++++|||||+++++|.+++.+||||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            45699999999999999999965 57999999999776556667789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          102 MPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       102 ~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      |++|+|.+++.              +++.+|.|||..   |||||||||+|||++.++.+||+|||+++.+....  ...
T Consensus       153 ~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~  227 (346)
T 4fih_A          153 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRR  227 (346)
T ss_dssp             CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCB
T ss_pred             CCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Ccc
Confidence            99999988765              667777777765   89999999999999999999999999999764332  223


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC--CC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD--GS  245 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~  245 (345)
                      ...+||+.|+|||++.+..|+.++|||||||++|||++|+.||......      ..... ...+.     .+.+.  ..
T Consensus       228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~-i~~~~-----~~~~~~~~~  295 (346)
T 4fih_A          228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKM-IRDNL-----PPRLKNLHK  295 (346)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHSS-----CCCCSCGGG
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHH-HHcCC-----CCCCCcccc
Confidence            4578999999999999999999999999999999999999999764321      11111 11111     11111  11


Q ss_pred             CChhHHHHHHHHhhccCCCCCcCCCC
Q 039516          246 CPPNEDAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       246 ~~~~~~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                      ++++.   .+++.+||+.||++|||+
T Consensus       296 ~s~~~---~dli~~~L~~dP~~R~ta  318 (346)
T 4fih_A          296 VSPSL---KGFLDRLLVRDPAQRATA  318 (346)
T ss_dssp             SCHHH---HHHHHHHSCSSTTTSCCH
T ss_pred             CCHHH---HHHHHHHcCCChhHCcCH
Confidence            22222   589999999999999994

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.4e-53  Score=390.21  Aligned_cols=240  Identities=20%  Similarity=0.172  Sum_probs=186.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ..|.+.++||+|+||.||+|.. .+|+.||||+++....     +.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            4588889999999999999964 5799999999975432     247999999999999999999999999999999999


Q ss_pred             CCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC-CEEEEccccceeecCCCCC--
Q 039516          103 PNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL-NTKISDFGMARIFGVNESG--  164 (345)
Q Consensus       103 ~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~~--  164 (345)
                      +||+|.+++.               +++.+|.|||..   +||||||||+|||++.+| .+||+|||+++.+......  
T Consensus       133 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~  209 (336)
T 4g3f_A          133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS  209 (336)
T ss_dssp             TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence            9999998875               556666666654   899999999999999987 5999999999976433211  


Q ss_pred             -CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          165 -ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       165 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                       ......+||+.|||||++.+..|+.++|||||||++|||+||+.||...........      ........    ..+.
T Consensus       210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------i~~~~~~~----~~~~  279 (336)
T 4g3f_A          210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK------IASEPPPI----REIP  279 (336)
T ss_dssp             ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH------HHHSCCGG----GGSC
T ss_pred             eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH------HHcCCCCc----hhcC
Confidence             122346799999999999999999999999999999999999999986544332111      11111110    1122


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      ..++++.   .+++.+||+.||.+|||+.++...|..+++.
T Consensus       280 ~~~s~~~---~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          280 PSCAPLT---AQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             TTSCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccCCHHH---HHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            2233322   4899999999999999988777777666653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.8e-53  Score=393.23  Aligned_cols=231  Identities=16%  Similarity=0.198  Sum_probs=179.9

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      .+|+++++||+|+||.||++.. .+|+.||||+++..  .....+.|.+|+++|++|+|||||++++++.+++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4699999999999999999964 57999999999755  33446789999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          101 FMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       101 ~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      ||+||+|.+++.                 +++.+|.|||..   |||||||||+|||++.++.+||+|||+++.....  
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence            999999988764                 556667777765   8999999999999999999999999999875321  


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                      .......+||+.|||||++.+..|+.++|||||||++|||+||+.||....      ..+........ ...     .+.
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~-~~~-----~~~  246 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISG-SFP-----PVS  246 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHT-CCC-----CCC
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcC-CCC-----CCC
Confidence            112334689999999999999999999999999999999999999997643      22222222222 111     111


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCCcc
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~  274 (345)
                      ..++++.   .+++.+||+.||++|||+.++
T Consensus       247 ~~~s~~~---~~li~~~L~~dP~~R~s~~e~  274 (350)
T 4b9d_A          247 LHYSYDL---RSLVSQLFKRNPRDRPSVNSI  274 (350)
T ss_dssp             TTSCHHH---HHHHHHHTCSSGGGSCCHHHH
T ss_pred             ccCCHHH---HHHHHHHccCChhHCcCHHHH
Confidence            2233322   589999999999999996543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.3e-53  Score=387.45  Aligned_cols=253  Identities=18%  Similarity=0.153  Sum_probs=187.2

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHH--HHHHHHHhcCCCCeeeEEEEEEECC----eeEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQ--NEAKLIAKLQYTNLVKLLGCSIHGE----ERLL   97 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~--~E~~~l~~l~H~niv~~~~~~~~~~----~~~l   97 (345)
                      .+|.+.++||+|+||.||+|.+ +|+.||||+++...   ...+.  .|+..+.+++|||||+++++|.+++    .+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            4688889999999999999988 58999999996542   33344  4555667889999999999998654    5799


Q ss_pred             EEecCCCCChHHHHH--------------hHHHHHHHHHhc-----CCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           98 VYEFMPNKSLDSSFS--------------GTFKDLLCLHKY-----SRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        98 v~e~~~~gsL~~~l~--------------~~~~~l~~lh~~-----~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      |||||++|+|.++++              +++.+|.|||..     +..+||||||||+|||++.++.+||+|||+++..
T Consensus        79 V~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             EecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            999999999998876              778899999975     4668999999999999999999999999999876


Q ss_pred             cCCCCC--CcccceeecCCccccchhccC------CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcc--------cHH
Q 039516          159 GVNESG--ANTNRIVGTYGYMSLEYTMSG------TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPL--------NLV  222 (345)
Q Consensus       159 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~--------~~~  222 (345)
                      ......  .......||+.|+|||++.+.      .++.++|||||||++|||+||..||.........        ...
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            543221  122345799999999998754      4678999999999999999998877543321110        011


Q ss_pred             HHHHHHHhcCCccccccccCCCCCC-hhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          223 GIAWQLWNEGKDLELIDLTLDGSCP-PNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       223 ~~~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      .........+    .++|.+..... .+.... .+++.+||+.||++||||.+++..|..+.+.
T Consensus       239 ~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          239 EEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            1112222111    12222222111 223344 7899999999999999999998888877653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8.7e-52  Score=391.76  Aligned_cols=229  Identities=20%  Similarity=0.273  Sum_probs=187.8

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ...|+++++||+|+||.||+|.. .+|+.||||+++.......+.+.+|+.+|++++|||||+++++|.+.+.+||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            45699999999999999999965 57999999999877666677899999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          102 MPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       102 ~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      |+||+|.+++.              +++.+|.|||..   |||||||||+|||++.+|.+||+|||+++.+....  ...
T Consensus       230 ~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~  304 (423)
T 4fie_A          230 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRR  304 (423)
T ss_dssp             CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCB
T ss_pred             CCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC--ccc
Confidence            99999988765              667777777765   89999999999999999999999999998764332  233


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC--CC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD--GS  245 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~  245 (345)
                      ...+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....      .... ....+.     .+.+.  ..
T Consensus       305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~-~i~~~~-----~~~~~~~~~  372 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMK-MIRDNL-----PPRLKNLHK  372 (423)
T ss_dssp             CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-HHHHSC-----CCCCSCTTS
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHH-HHHcCC-----CCCCccccc
Confidence            4578999999999999999999999999999999999999999764321      1111 111111     11111  11


Q ss_pred             CChhHHHHHHHHhhccCCCCCcCCCC
Q 039516          246 CPPNEDAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       246 ~~~~~~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                      ++++.   .+++.+||+.||++|||+
T Consensus       373 ~s~~~---~dli~~~L~~dP~~R~ta  395 (423)
T 4fie_A          373 VSPSL---KGFLDRLLVRDPAQRATA  395 (423)
T ss_dssp             SCHHH---HHHHHHHSCSSTTTSCCH
T ss_pred             CCHHH---HHHHHHHcCCChhHCcCH
Confidence            23222   589999999999999994

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.3e-53  Score=395.97  Aligned_cols=245  Identities=21%  Similarity=0.226  Sum_probs=195.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCC-CCeeeEEEEEEEC-C
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQY-TNLVKLLGCSIHG-E   93 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~-~   93 (345)
                      ..+|++.++||+|+||.||+|.+.      +++.||||.++... ....+.|.+|+++|+++.| ||||+++|+|.+. +
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            357999999999999999999753      24689999997653 3345679999999999965 9999999999764 5


Q ss_pred             eeEEEEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC
Q 039516           94 ERLLVYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD  142 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~  142 (345)
                      .++||||||++|+|.++++                               +++.||.|||..   +||||||||+|||++
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~  219 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS  219 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeC
Confidence            7899999999999988763                               567778888776   799999999999999


Q ss_pred             CCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccH
Q 039516          143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNL  221 (345)
Q Consensus       143 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~  221 (345)
                      +++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+    
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~----  295 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----  295 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH----
Confidence            999999999999987654444444456789999999999999999999999999999999998 999998654321    


Q ss_pred             HHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          222 VGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       222 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                        ........+...     .....++++.   .+++..||+.||++|||+.+++..|..+++.
T Consensus       296 --~~~~~i~~g~~~-----~~p~~~~~~~---~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          296 --EFCRRLKEGTRM-----RAPDYTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             --HHHHHHHHTCCC-----CCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHHHcCCCC-----CCCccCCHHH---HHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence              122222222211     1112233322   5899999999999999999999888888763

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.9e-52  Score=375.70  Aligned_cols=229  Identities=21%  Similarity=0.290  Sum_probs=176.0

Q ss_pred             Ce-eeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE----CCeeE
Q 039516           25 DW-HMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH----GEERL   96 (345)
Q Consensus        25 ~~-~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~   96 (345)
                      .| ++.++||+|+||+||+|.. .+++.||+|++...  .....+.|.+|+++|++|+|||||+++++|.+    +..+|
T Consensus        26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence            44 5667899999999999965 57899999999644  33446679999999999999999999999875    34589


Q ss_pred             EEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC-CCCEEEEccccceeecC
Q 039516           97 LVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD-QLNTKISDFGMARIFGV  160 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgl~~~~~~  160 (345)
                      ||||||++|+|.+++.               +++.||.|||... .+||||||||+|||++. ++.+||+|||+|+... 
T Consensus       106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-  183 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-  183 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC-
Confidence            9999999999988775               5677777777652 24999999999999985 7899999999997542 


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                         .......+||+.|||||++.+ .|+.++|||||||++|||+||+.||......      .........+....    
T Consensus       184 ---~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~~~~----  249 (290)
T 3fpq_A          184 ---ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPA----  249 (290)
T ss_dssp             ---TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCG----
T ss_pred             ---CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCCCCC----
Confidence               223445789999999998864 6999999999999999999999999754321      11122222221111    


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .+....+++.   .+++.+||+.||++|||+.
T Consensus       250 ~~~~~~~~~~---~~li~~~L~~dP~~R~s~~  278 (290)
T 3fpq_A          250 SFDKVAIPEV---KEIIEGCIRQNKDERYSIK  278 (290)
T ss_dssp             GGGGCCCHHH---HHHHHHHSCSSGGGSCCHH
T ss_pred             CCCccCCHHH---HHHHHHHccCChhHCcCHH
Confidence            1111122222   5899999999999999953

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9.3e-53  Score=383.42  Aligned_cols=246  Identities=19%  Similarity=0.199  Sum_probs=184.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc----CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF----PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~----~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      .+|++.+.||+|+||+||+++.    .+++.||||+++...  ......+.+|+++|++++|||||++++++.+++.+|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4699999999999999999964    247899999996542  2234468899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           98 VYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        98 v~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      |||||+||+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+|+......
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            999999999988775               566677777765   89999999999999999999999999998653322


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                        ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+.      .+....... +..      ..
T Consensus       181 --~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~-~~~------~~  245 (304)
T 3ubd_A          181 --KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILK-AKL------GM  245 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-CCC------CC
T ss_pred             --ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHc-CCC------CC
Confidence              223446899999999999999999999999999999999999999976432      111122221 111      11


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceee
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHF  292 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~  292 (345)
                      ...++++.   .+++.+||+.||++|||...  ..+.+++.+..+.+.++
T Consensus       246 p~~~s~~~---~~li~~~L~~dP~~R~ta~~--~~~~eil~Hp~f~~idw  290 (304)
T 3ubd_A          246 PQFLSPEA---QSLLRMLFKRNPANRLGAGP--DGVEEIKRHSFFSTIDW  290 (304)
T ss_dssp             CTTSCHHH---HHHHHHHTCSSGGGSTTCST--TTHHHHHTSGGGTTCCH
T ss_pred             CCcCCHHH---HHHHHHHcccCHHHCCCCCc--CCHHHHHcCccccCCCH
Confidence            11233322   59999999999999999532  23455566655554443

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-51  Score=369.36  Aligned_cols=226  Identities=19%  Similarity=0.241  Sum_probs=167.9

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|++.+.||+|+||+||++.. .+|+.||||+++..   .......+.+|+++|++++|||||++++++.+.+.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            4699999999999999999975 57999999999654   2344668999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||| +|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+|+.....   
T Consensus        93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred             eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC---
Confidence            999 678877654               667777777765   8999999999999999999999999999875432   


Q ss_pred             CcccceeecCCccccchhccCCc-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                      ......+||+.|+|||++.+..+ +.++||||+||++|+|+||+.||....      ....... ...+..      .+.
T Consensus       166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~-i~~~~~------~~p  232 (275)
T 3hyh_A          166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKN-ISNGVY------TLP  232 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHH-HHHTCC------CCC
T ss_pred             CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHH-HHcCCC------CCC
Confidence            22344689999999999998876 579999999999999999999997532      1111111 112211      111


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ...+++.   .+++.+||+.||++|||+.
T Consensus       233 ~~~s~~~---~~li~~~L~~dP~~R~s~~  258 (275)
T 3hyh_A          233 KFLSPGA---AGLIKRMLIVNPLNRISIH  258 (275)
T ss_dssp             TTSCHHH---HHHHHHHSCSSGGGSCCHH
T ss_pred             CCCCHHH---HHHHHHHccCChhHCcCHH
Confidence            1233222   5899999999999999943

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.5e-50  Score=369.47  Aligned_cols=228  Identities=21%  Similarity=0.241  Sum_probs=165.9

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--------
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE--------   93 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--------   93 (345)
                      .+|++++.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++|++++|||||+++++|.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4699999999999999999964 579999999997553 334567999999999999999999999987644        


Q ss_pred             ----eeEEEEecCCCCChHHHHH------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEc
Q 039516           94 ----ERLLVYEFMPNKSLDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISD  151 (345)
Q Consensus        94 ----~~~lv~e~~~~gsL~~~l~------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~D  151 (345)
                          .+|+|||||++|+|.+++.                  +++.+|.|||..   ||+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence                3699999999999987764                  456667777765   899999999999999999999999


Q ss_pred             cccceeecCCCCC----------CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccH
Q 039516          152 FGMARIFGVNESG----------ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNL  221 (345)
Q Consensus       152 fgl~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~  221 (345)
                      ||+|+........          ......+||+.|||||++.+..|+.++|||||||++|||++   ||....     ..
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~  233 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ER  233 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HH
Confidence            9999876432211          11234579999999999999999999999999999999996   665311     11


Q ss_pred             HHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          222 VGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       222 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .. ..............         ...... ..++.+||+.||.+|||+.
T Consensus       234 ~~-~~~~~~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~  275 (299)
T 4g31_A          234 VR-TLTDVRNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAI  275 (299)
T ss_dssp             HH-HHHHHHTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HH-HHHHHhcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHH
Confidence            11 11111111111000         111122 5799999999999999953

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6e-48  Score=355.77  Aligned_cols=268  Identities=25%  Similarity=0.344  Sum_probs=228.5

Q ss_pred             ceeecccccccccCCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEE
Q 039516            9 CQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGC   88 (345)
Q Consensus         9 ~~s~~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~   88 (345)
                      .++..++...+++    |.+.+.||+|+||.||+|...+|+.||||++........+.+.+|+.++++++||||++++++
T Consensus        28 ~~~~~~~~~~~~~----y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  103 (321)
T 2qkw_B           28 RVPLVDLEEATNN----FDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGF  103 (321)
T ss_dssp             --CCSCCCCCCCC----CSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEE
T ss_pred             eecHHHHHHHHhc----cCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3445555555544    788888999999999999988899999999987766667889999999999999999999999


Q ss_pred             EEECCeeEEEEecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEE
Q 039516           89 SIHGEERLLVYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKI  149 (345)
Q Consensus        89 ~~~~~~~~lv~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl  149 (345)
                      +.+.+..++||||+++++|.+++.                   +++.+|.|||..   ||+||||||+||+++.++.+||
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl  180 (321)
T 2qkw_B          104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKI  180 (321)
T ss_dssp             CCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEE
T ss_pred             EcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEE
Confidence            999999999999999999876542                   566777788775   8999999999999999999999


Q ss_pred             EccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHH
Q 039516          150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLW  229 (345)
Q Consensus       150 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  229 (345)
                      +|||+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||.............|.....
T Consensus       181 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  260 (321)
T 2qkw_B          181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH  260 (321)
T ss_dssp             CCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred             eecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence            99999987643333333344579999999999999999999999999999999999999998877777778888888777


Q ss_pred             hcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          230 NEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       230 ~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ..+....++++.+.....+..... .+++..||+.||++|||+.++...|..+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            788888888888877777777777 899999999999999999888888877665

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=361.84  Aligned_cols=187  Identities=21%  Similarity=0.259  Sum_probs=155.2

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE------CCe
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH------GEE   94 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~------~~~   94 (345)
                      .+|++.+.||+|+||+||+|.. .+|+.||||+++...  ....+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5699999999999999999964 579999999996542  3345678899999999999999999999764      357


Q ss_pred             eEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           95 RLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      +|||||||+ |+|.+++.               +++.+|.|||..   |||||||||+|||++.++.+||+|||+++.+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            899999996 56776654               667777777765   89999999999999999999999999998764


Q ss_pred             CCC--CCCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          160 VNE--SGANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       160 ~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ...  ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~  267 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN  267 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence            321  22233457899999999998875 56899999999999999999999998654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.7e-47  Score=373.03  Aligned_cols=252  Identities=19%  Similarity=0.185  Sum_probs=188.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHH---HHHHHhcCCCCeeeEEEEEEECCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNE---AKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E---~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      -.+|++.+.||+|+||.||++.. .+|+.||||++++.   .......+.+|   +.+++.++|||||+++++|.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            35799999999999999999964 57999999999643   12233344444   5666778999999999999999999


Q ss_pred             EEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           96 LLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      |+|||||+||+|.+++.               +++.||.|||.   .|||||||||+|||++.+|.+||+|||+|+....
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999988875               44555555555   5899999999999999999999999999987643


Q ss_pred             CCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      .    ...+.+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.........   ......... .      
T Consensus       345 ~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~i~~~i~~~-~------  410 (689)
T 3v5w_A          345 K----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLTM-A------  410 (689)
T ss_dssp             C----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---HHHHHHHHC-C------
T ss_pred             C----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhhcCC-C------
Confidence            2    2344689999999999974 57999999999999999999999999764332211   111111111 1      


Q ss_pred             ccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceeeEEec
Q 039516          240 LTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLLML  296 (345)
Q Consensus       240 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~~~~l  296 (345)
                      ..+...++++.   .+++..||+.||.+|++...  .-..+++.+..+.+.+|....
T Consensus       411 ~~~p~~~S~~a---~dLI~~lL~~dP~~Rl~~~~--~ga~ei~~HpfF~~idW~~l~  462 (689)
T 3v5w_A          411 VELPDSFSPEL---RSLLEGLLQRDVNRRLGCLG--RGAQEVKESPFFRSLDWQMVF  462 (689)
T ss_dssp             CCCCTTSCHHH---HHHHHHHTCSCGGGCTTCSS--STHHHHTTSGGGTTCCHHHHH
T ss_pred             CCCCccCCHHH---HHHHHHHccCCHhHCCCCCC--CCHHHHhcCccccCCCHHHHH
Confidence            11112233332   59999999999999999421  123456667666666655443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.8e-47  Score=354.02  Aligned_cols=189  Identities=18%  Similarity=0.266  Sum_probs=156.4

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc----CCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCee
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF----PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~----~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~   95 (345)
                      .....|++.++||+|+||+||+|..    .+++.||||.+...  .....+.+|+++|+.+ +|||||++++++.+.+++
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            4456799999999999999999964    25789999998654  3456788999999998 699999999999999999


Q ss_pred             EEEEecCCCCChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC-CCEEEEccccceeecCCC
Q 039516           96 LLVYEFMPNKSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ-LNTKISDFGMARIFGVNE  162 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgl~~~~~~~~  162 (345)
                      |+|||||++|+|.++++            +++.+|.|||..   ||+||||||+|||++.+ +.+||+|||+|+......
T Consensus        96 ~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            99999999999987765            566777777765   89999999999999876 789999999998653221


Q ss_pred             C--------------------------CCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          163 S--------------------------GANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       163 ~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      .                          .......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            1                          0112335799999999998875 48999999999999999999999996543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.2e-46  Score=367.74  Aligned_cols=231  Identities=16%  Similarity=0.146  Sum_probs=185.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      .+|++.+.||+|+||+||++.. .+|+.||+|.+........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            5799999999999999999964 579999999998766666778999999999999999999999999999999999999


Q ss_pred             CCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC--CCEEEEccccceeecCCCCC
Q 039516          103 PNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ--LNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       103 ~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~--~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      +||+|.+++.                +++.+|.|||..   +|+||||||+|||++.+  +.+||+|||+++.+..   .
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~---~  310 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---K  310 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT---T
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC---C
Confidence            9999987763                566677777765   89999999999999854  8899999999998742   2


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....+      ...... .+...  ++.....
T Consensus       311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~------~~~~i~-~~~~~--~~~~~~~  381 (573)
T 3uto_A          311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVK-SCDWN--MDDSAFS  381 (573)
T ss_dssp             SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHH-TTCCC--CCSGGGT
T ss_pred             CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHH-hCCCC--CCccccc
Confidence            23445689999999999999999999999999999999999999997643211      111111 11110  1111111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..+.+.   .+++.+||+.||.+|||+.
T Consensus       382 ~~s~~~---~dli~~~L~~dp~~R~t~~  406 (573)
T 3uto_A          382 GISEDG---KDFIRKLLLADPNTRMTIH  406 (573)
T ss_dssp             TSCHHH---HHHHHTTSCSSGGGSCCHH
T ss_pred             CCCHHH---HHHHHHHccCChhHCcCHH
Confidence            122222   5899999999999999953

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.5e-47  Score=348.86  Aligned_cols=269  Identities=28%  Similarity=0.428  Sum_probs=222.6

Q ss_pred             CcceeecccccccccCCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeE
Q 039516            7 TGCQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKL   85 (345)
Q Consensus         7 ~~~~s~~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~   85 (345)
                      ...|+..++...+++    |.+.+.||+|+||.||+|...+|+.||||++.... ......+.+|+.++++++||||+++
T Consensus        17 ~~~~~~~~~~~~~~~----y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   92 (326)
T 3uim_A           17 LKRFSLRELQVASDN----FSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL   92 (326)
T ss_dssp             CEECCTHHHHTTTTS----SCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred             cceecHHHHHHHhhc----cccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence            455677777666555    78888899999999999988889999999997553 2233368999999999999999999


Q ss_pred             EEEEEECCeeEEEEecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC
Q 039516           86 LGCSIHGEERLLVYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN  146 (345)
Q Consensus        86 ~~~~~~~~~~~lv~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~  146 (345)
                      ++++...+..++||||+++|+|.+++.                   +++.+|.|||..+..||+||||||+|||++.++.
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~  172 (326)
T 3uim_A           93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE  172 (326)
T ss_dssp             CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred             EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence            999999999999999999999987764                   5677888999887779999999999999999999


Q ss_pred             EEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCC--CCCCcccHHHH
Q 039516          147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSY--HTERPLNLVGI  224 (345)
Q Consensus       147 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~--~~~~~~~~~~~  224 (345)
                      +||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...  ..........|
T Consensus       173 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW  251 (326)
T ss_dssp             EEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred             EEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence            99999999987643322 2233356899999999999999999999999999999999999999632  22344556777


Q ss_pred             HHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          225 AWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       225 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                      ............+.+..+...++...... .+++..||+.||.+|||+.++...|..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            77777777888888888888888877777 999999999999999998776666654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.8e-45  Score=339.61  Aligned_cols=255  Identities=18%  Similarity=0.226  Sum_probs=193.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC----eeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE----ERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----~~~lv   98 (345)
                      ..+|++.++||+|+||.||+|... ++.||||++.... .....+..|+.++++++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            457999999999999999999875 8999999996543 23445667899999999999999999998744    47999


Q ss_pred             EecCCCCChHHHHH--------------hHHHHHHHHHhc-------CCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516           99 YEFMPNKSLDSSFS--------------GTFKDLLCLHKY-------SRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus        99 ~e~~~~gsL~~~l~--------------~~~~~l~~lh~~-------~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      |||+++|+|.+++.              +++.+|.|||..       |+.+|+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~  180 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK  180 (322)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence            99999999988765              566677777765       344899999999999999999999999999988


Q ss_pred             ecCCCCCCcccceeecCCccccchhcc-----CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHH--------
Q 039516          158 FGVNESGANTNRIVGTYGYMSLEYTMS-----GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGI--------  224 (345)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~--------  224 (345)
                      ..............||+.|+|||++.+     ..++.++|||||||++|||++|+.||..........+...        
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  260 (322)
T 3soc_A          181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE  260 (322)
T ss_dssp             ECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred             cccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchh
Confidence            765444333444679999999999886     3567789999999999999999999987554332222111        


Q ss_pred             -HHHHHhcCCccccccccCCCCCCh-hHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          225 -AWQLWNEGKDLELIDLTLDGSCPP-NEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       225 -~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                       .........    ..+.+...... ..... .+++..||+.||++|||+.++...|..+.+
T Consensus       261 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          261 DMQEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhhhhhccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             111111111    11111111111 22334 799999999999999999888888877654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.3e-44  Score=326.23  Aligned_cols=234  Identities=21%  Similarity=0.295  Sum_probs=187.9

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ......|.+.++||+|+||.||++.. .+|+.||||.+........+.+.+|+.++++++||||+++++++...+..++|
T Consensus        16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            34556799999999999999999974 57999999999776666678899999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516           99 YEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus        99 ~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||+++++|.+++.              +++.+|.|||..   ||+||||||+|||++.++.+||+|||++........ 
T Consensus        96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  171 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (297)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             EECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence            99999999988764              566777777765   899999999999999999999999999987643322 


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......      .........+... ..      
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~-~~------  237 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPE-LQ------  237 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSCC-CS------
T ss_pred             -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCC-CC------
Confidence             233457999999999999999999999999999999999999999754321      1111111111110 00      


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                       .+...... .+++..||+.||.+|||+.
T Consensus       238 -~~~~~~~~~~~li~~~l~~dp~~Rps~~  265 (297)
T 3fxz_A          238 -NPEKLSAIFRDFLNRCLEMDVEKRGSAK  265 (297)
T ss_dssp             -CGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             -CccccCHHHHHHHHHHccCChhHCcCHH
Confidence             11111222 5899999999999999954

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.5e-44  Score=327.04  Aligned_cols=244  Identities=19%  Similarity=0.259  Sum_probs=192.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      .+|.+.+.||+|+||.||++.. .+++.||+|.+..........|.+|++++++++||||+++++++.+++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            5699999999999999999975 468999999997666667788999999999999999999999999999999999999


Q ss_pred             CCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC-
Q 039516          103 PNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA-  165 (345)
Q Consensus       103 ~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-  165 (345)
                      ++++|.+++.                +++.+|.|||..   ||+||||||+||+++.++.+||+|||++.......... 
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence            9999988765                566777777765   89999999999999999999999999998764322211 


Q ss_pred             -----------cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 039516          166 -----------NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKD  234 (345)
Q Consensus       166 -----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (345)
                                 ......||+.|+|||++.+..++.++||||||+++|+|++|..|+............          ..
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~----------~~  236 (310)
T 3s95_A          167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL----------NV  236 (310)
T ss_dssp             -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB----------CH
T ss_pred             ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh----------hh
Confidence                       111357899999999999999999999999999999999999998764332211000          00


Q ss_pred             cccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          235 LELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       235 ~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ....+......+++.-   .+++..||+.||++|||+.++...|..+.+
T Consensus       237 ~~~~~~~~~~~~~~~l---~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          237 RGFLDRYCPPNCPPSF---FPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             HHHHHHTCCTTCCTTH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hccccccCCCCCCHHH---HHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            0011111122233322   489999999999999998888777776654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.1e-44  Score=340.89  Aligned_cols=243  Identities=19%  Similarity=0.247  Sum_probs=191.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc--------CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF--------PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHG   92 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~--------~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~   92 (345)
                      ..+|.+.+.||+|+||.||+|..        .++..||||.++... ......+.+|+.+++++ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            35799999999999999999964        245689999997653 33456799999999999 899999999999999


Q ss_pred             CeeEEEEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeee
Q 039516           93 EERLLVYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILL  141 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill  141 (345)
                      +..|+||||+++|+|.+++.                               +++.+|.|||..   ||+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            99999999999999987753                               456677777765   89999999999999


Q ss_pred             CCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCccc
Q 039516          142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLN  220 (345)
Q Consensus       142 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~  220 (345)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||......+   
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999987654333333334467889999999999999999999999999999999 999997654222   


Q ss_pred             HHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          221 LVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      +.    .....+..     +.....++.+.   .+++..||+.||.+|||+.++...|..++.
T Consensus       314 ~~----~~~~~~~~-----~~~~~~~~~~l---~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          314 LF----KLLKEGHR-----MDKPANCTNEL---YMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             HH----HHHHTTCC-----CCCCTTSCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH----HHHhcCCC-----CCCCCCCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            11    11112211     11111122221   589999999999999999888888887764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.5e-43  Score=325.26  Aligned_cols=247  Identities=20%  Similarity=0.253  Sum_probs=195.4

Q ss_pred             CcceeecccccccccCCC------CeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCC
Q 039516            7 TGCQTWSEGAKFVENSSL------DWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY   79 (345)
Q Consensus         7 ~~~~s~~~~~~~~~~~~~------~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H   79 (345)
                      ...|+.+++.++++....      .|....+||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            457888888888876433      3788889999999999999764 799999999987776778889999999999999


Q ss_pred             CCeeeEEEEEEECCeeEEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC
Q 039516           80 TNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL  145 (345)
Q Consensus        80 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~  145 (345)
                      |||+++++++...+..++||||+++++|.+++.              +++.+|.|||..   ||+||||||+||+++.++
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~  178 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDG  178 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTC
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCC
Confidence            999999999999999999999999999987664              567777888875   899999999999999999


Q ss_pred             CEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 039516          146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIA  225 (345)
Q Consensus       146 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~  225 (345)
                      .+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....      ....
T Consensus       179 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~~~  250 (321)
T 2c30_A          179 RVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAM  250 (321)
T ss_dssp             CEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHH
T ss_pred             cEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHH
Confidence            999999999987643322  22345799999999999999999999999999999999999999975431      1111


Q ss_pred             HHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          226 WQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       226 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .. ......     +.+.  ........ .+++..||+.||.+|||+.
T Consensus       251 ~~-~~~~~~-----~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~  290 (321)
T 2c30_A          251 KR-LRDSPP-----PKLK--NSHKVSPVLRDFLERMLVRDPQERATAQ  290 (321)
T ss_dssp             HH-HHHSSC-----CCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             HH-HhcCCC-----CCcC--ccccCCHHHHHHHHHHccCChhhCcCHH
Confidence            11 111111     1111  00111122 5899999999999999954

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.3e-45  Score=342.51  Aligned_cols=243  Identities=20%  Similarity=0.230  Sum_probs=189.4

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ..+|.+.++||+|+||.||+|... +++.||||.++... ......|.+|+++|++++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            357899999999999999999875 78999999997542 2334568899999999999999999999998899999999


Q ss_pred             cCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          101 FMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       101 ~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |+++|+|.+++.                +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            999999988764                556777777765   8999999999999999999999999999865322111


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                      .......+++.|+|||++.++.++.++|||||||++|||++ |..||......       ........+...     ...
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~-----~~~  337 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKGGRL-----PCP  337 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTTCCC-----CCC
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCC-----CCC
Confidence            11122346788999999999999999999999999999998 99999764321       111222222111     011


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ..++..-   .+++..||+.||++|||+.++...|.++..
T Consensus       338 ~~~~~~l---~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          338 ELCPDAV---FRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             TTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCHHH---HHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            1122221   589999999999999999888877776543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.2e-43  Score=324.45  Aligned_cols=268  Identities=30%  Similarity=0.372  Sum_probs=208.1

Q ss_pred             CcceeecccccccccCCCC--eeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccC----CccCHHHHHHHHHHHHhcCCC
Q 039516            7 TGCQTWSEGAKFVENSSLD--WHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWT----SGQGRVEFQNEAKLIAKLQYT   80 (345)
Q Consensus         7 ~~~~s~~~~~~~~~~~~~~--~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~----~~~~~~~~~~E~~~l~~l~H~   80 (345)
                      ...|++.++.+++++|...  |...++||+|+||.||+|.. +++.||||++...    .......+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3678889999999987655  44457899999999999987 5899999998643    223456799999999999999


Q ss_pred             CeeeEEEEEEECCeeEEEEecCCCCChHHHHH------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC
Q 039516           81 NLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD  142 (345)
Q Consensus        81 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~  142 (345)
                      ||+++++++.+.+..++||||+++++|.+++.                  +++.+|.+||..   ||+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence            99999999999999999999999999987764                  456677777765   899999999999999


Q ss_pred             CCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHH
Q 039516          143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV  222 (345)
Q Consensus       143 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~  222 (345)
                      .++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||..........  
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--  244 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL--  244 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT--
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH--
Confidence            999999999999987644332222334578999999998764 58899999999999999999999998755433222  


Q ss_pred             HHHHHHHh-cCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          223 GIAWQLWN-EGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       223 ~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                      .+...... ...+...+++.+.. .+...... .+++..||+.||.+|||+.++...|.++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          245 DIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHHHTTSCCHHHHSCSSCSC-CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHHhhhhhhhhhhhccccccc-cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            22222211 12233344444432 34444555 89999999999999999887777776653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.1e-44  Score=328.87  Aligned_cols=243  Identities=20%  Similarity=0.274  Sum_probs=183.2

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ....+|.+.++||+|+||.||++.. +|+.||||++....  ......+.+|++++++++||||+++++++.+.+..++|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            3456899999999999999999987 58999999996553  33456789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH------------------hHHHHHHHHHhcCCCc--eEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           99 YEFMPNKSLDSSFS------------------GTFKDLLCLHKYSRLR--VIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        99 ~e~~~~gsL~~~l~------------------~~~~~l~~lh~~~~~~--ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      |||+++++|.+++.                  +++.+|.|||..   |  |+||||||+||+++.++.+||+|||+++..
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            99999999987764                  455666677665   7  999999999999999999999999999764


Q ss_pred             cCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                      ....  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......      ............    
T Consensus       190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~~----  257 (309)
T 3p86_A          190 ASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFKCKR----  257 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHHSCCC----
T ss_pred             cccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCC----
Confidence            3221  1223457999999999999999999999999999999999999999764321      111111111111    


Q ss_pred             cccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          239 DLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       239 d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                       ..+...+++..   .+++..||+.||.+|||+.++...|..+++
T Consensus       258 -~~~~~~~~~~l---~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          258 -LEIPRNLNPQV---AAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             -CCCCTTSCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             -CCCCccCCHHH---HHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             11111223222   599999999999999999888888887765

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.7e-44  Score=330.71  Aligned_cols=243  Identities=24%  Similarity=0.338  Sum_probs=188.8

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC----CCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP----NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~----~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      ...|.+.+.||+|+||.||+|...    .+..||||.++.. .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467999999999999999999763    3456999999765 33446679999999999999999999999998899999


Q ss_pred             EEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           98 VYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        98 v~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      ||||+++++|.+++.                +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.....
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            999999999988774                556677777765   8999999999999999999999999999876433


Q ss_pred             CCCC-cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          162 ESGA-NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       162 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      .... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......      .... ....+..     
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~~~~-~~~~~~~-----  272 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------DVIS-SVEEGYR-----  272 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHH-HHHTTCC-----
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH------HHHH-HHHcCCC-----
Confidence            2211 1222345778999999999999999999999999999999 99999764321      1111 1111110     


Q ss_pred             ccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          240 LTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       240 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ......++...   .+++..||+.||.+|||+.++...|..++.
T Consensus       273 ~~~~~~~~~~l---~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          273 LPAPMGCPHAL---HQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             CCCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCcCHHH---HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11111222222   589999999999999999988888888775

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.3e-44  Score=331.89  Aligned_cols=242  Identities=21%  Similarity=0.300  Sum_probs=183.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCc----EEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQ----EVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~----~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ..+|.+.+.||+|+||.||+|.. .+++    +||+|.+... .......|.+|+.++++++||||++++++|... ..+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence            45799999999999999999975 3444    4688888543 345677899999999999999999999999765 478


Q ss_pred             EEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           97 LVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      +|+||+++|+|.+++.                +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            9999999999987764                566777777765   899999999999999999999999999987654


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      ...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......   +.    .....+..     
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~----~~~~~~~~-----  237 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGER-----  237 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCC-----
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HH----HHHHcCCC-----
Confidence            433333334567889999999999999999999999999999999 999997654322   11    11111110     


Q ss_pred             ccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          240 LTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       240 ~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                          ...+...... ..++.+||+.||.+|||+.++...|..+...
T Consensus       238 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          238 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ----CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             ----CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence                0112222233 6899999999999999999888888877653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.3e-42  Score=321.48  Aligned_cols=227  Identities=21%  Similarity=0.260  Sum_probs=181.8

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      .+|.+.+.||+|+||.||+|.. .+|+.||||++...  .......+.+|+++++.++||||+++++++...+..|+|||
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   94 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME   94 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4599999999999999999975 67999999999654  33445678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |+++++|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||++......   .
T Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~---~  168 (328)
T 3fe3_A           95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---G  168 (328)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS---C
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC---C
Confidence            999999987764               566777777765   8999999999999999999999999999765322   2


Q ss_pred             cccceeecCCccccchhccCCcC-cccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVS-IKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||....      ......... .+..      .+..
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~-~~~~------~~p~  235 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVL-RGKY------RIPF  235 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH-HCCC------CCCT
T ss_pred             ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHH-hCCC------CCCC
Confidence            23446799999999999888765 78999999999999999999997643      122222222 1111      0111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..+++.   .+++.+||+.||.+|||+.
T Consensus       236 ~~s~~~---~~li~~~L~~dP~~R~t~~  260 (328)
T 3fe3_A          236 YMSTDC---ENLLKRFLVLNPIKRGTLE  260 (328)
T ss_dssp             TSCHHH---HHHHHHHCCSSTTTSCCHH
T ss_pred             CCCHHH---HHHHHHHCCCChhHCcCHH
Confidence            122222   5899999999999999943

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.4e-42  Score=320.90  Aligned_cols=247  Identities=17%  Similarity=0.180  Sum_probs=190.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|++.+.||+|+||.||++.. .+|+.||+|+++..   .......+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            4699999999999999999965 47999999999654   2345678899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.....  .
T Consensus        85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~  159 (337)
T 1o6l_A           85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--G  159 (337)
T ss_dssp             ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--T
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC--C
Confidence            9999999977664               556677777765   8999999999999999999999999999864222  2


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......... +..      .+..
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~-~~~------~~p~  226 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILM-EEI------RFPR  226 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-CCC------CCCT
T ss_pred             CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHc-CCC------CCCC
Confidence            233456899999999999999999999999999999999999999975431      111111111 111      1111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceeeE
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFL  293 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~~  293 (345)
                      .++++.   .+++..||+.||.+||+..  .....+++++..+...++.
T Consensus       227 ~~s~~~---~~li~~lL~~dP~~R~g~~--~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          227 TLSPEA---KSLLAGLLKKDPKQRLGGG--PSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             TSCHHH---HHHHHHHTCSSTTTSTTCS--TTTHHHHHTSGGGTTCCHH
T ss_pred             CCCHHH---HHHHHHHhhcCHHHhcCCC--CCCHHHHHcCCCcCCCCHH
Confidence            223222   5899999999999999421  1123455556555544443

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.7e-43  Score=315.15  Aligned_cols=242  Identities=22%  Similarity=0.258  Sum_probs=190.9

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ...+|.+.+.||+|+||.||++...++..||+|.++... .....+.+|++++++++||||+++++++.+....++||||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            345799999999999999999998888899999997553 3457799999999999999999999999998999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      +++++|.+++.                +++.+|.+||..   ||+||||||+||+++.++.+||+|||++......... 
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-  160 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-  160 (268)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh-
Confidence            99999988764                556677777765   8999999999999999999999999999876432211 


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......      ....... .+..  ...+   .
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~-~~~~--~~~~---~  228 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVS-QGHR--LYRP---H  228 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHH-TTCC--CCCC---T
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHH-cCCC--CCCC---C
Confidence            1122345678999999999899999999999999999999 99999754321      1111111 1110  0111   1


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ..+...   .+++..||+.||.+|||+.++...|..+.+
T Consensus       229 ~~~~~l---~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          229 LASDTI---YQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             TSCHHH---HHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             cChHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            122211   589999999999999999888888877765

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.1e-42  Score=316.92  Aligned_cols=248  Identities=19%  Similarity=0.264  Sum_probs=185.2

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      .+...|.+.+.||+|+||.||++.. .+++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            3456799999999999999999964 578999999985442   233567899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           97 LVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      +||||+++++|.+++.               +++.+|.+||..   ||+||||||+||+++.++.+||+|||++......
T Consensus        88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            9999999999988764               556677777765   8999999999999999999999999999765322


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      .. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....      ............ .. ....
T Consensus       165 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~-~~-~~~~  235 (294)
T 4eqm_A          165 SL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDSV-PN-VTTD  235 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSCC-CC-HHHH
T ss_pred             cc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhccC-CC-cchh
Confidence            21 223345799999999999999999999999999999999999999976431      112222222111 11 1111


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCC-CCCcchhhhhcccc
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQ-CPMLFPCLLMNLLP  283 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~~~~~~l~~ll~  283 (345)
                      ....++..-   .+++.+||+.||.+|| ++.++...|..++.
T Consensus       236 ~~~~~~~~l---~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          236 VRKDIPQSL---SNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             SCTTSCHHH---HHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             cccCCCHHH---HHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            222233222   5899999999999999 55555555555444

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.9e-44  Score=328.63  Aligned_cols=243  Identities=20%  Similarity=0.272  Sum_probs=186.1

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCc----EEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQ----EVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~----~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ..+|.+.+.||+|+||.||+|.. .+++    +||+|.+.... ......+.+|+.++++++||||+++++++. ++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            45799999999999999999975 3454    48888875432 333456789999999999999999999985 56789


Q ss_pred             EEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           97 LVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      +||||+++|+|.+++.                +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++....
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            9999999999987764                566777777765   899999999999999999999999999987654


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      ...........||..|+|||++.+..++.++||||||+++|+|++ |+.||.......   ..    .....+....   
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~~---  237 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VP----DLLEKGERLA---  237 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HH----HHHHTTCBCC---
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HH----HHHHcCCCCC---
Confidence            444334445678889999999999999999999999999999999 999998654322   11    1111211110   


Q ss_pred             ccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          240 LTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       240 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                        ....++.+.   ..++..||+.||.+|||+.++...|..+...
T Consensus       238 --~~~~~~~~~---~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          238 --QPQICTIDV---YMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             --CCTTBCTTT---THHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             --CCCcCcHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              000111111   3899999999999999999988888887764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1e-42  Score=319.72  Aligned_cols=249  Identities=20%  Similarity=0.242  Sum_probs=182.9

Q ss_pred             cccccccCCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC
Q 039516           15 GAKFVENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG   92 (345)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~   92 (345)
                      -...+.++..+|.+.++||+|+||.||++...+|+.||+|++....  ......+.+|++++++++||||+++++++.+.
T Consensus        12 ~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   91 (311)
T 3niz_A           12 ENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE   91 (311)
T ss_dssp             ---CEECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred             cceeecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence            3446677888899999999999999999998889999999996542  22346789999999999999999999999999


Q ss_pred             CeeEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516           93 EERLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                      +..++||||+++ +|.+.+.                +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++
T Consensus        92 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           92 RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             SCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCce
Confidence            999999999985 5554432                667777777765   89999999999999999999999999998


Q ss_pred             eecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 039516          157 IFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDL  235 (345)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (345)
                      .......  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+..   .............
T Consensus       168 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~  242 (311)
T 3niz_A          168 AFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPR  242 (311)
T ss_dssp             ETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTT
T ss_pred             ecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChH
Confidence            7643222  2233578999999999876 56899999999999999999999999876544322   2222222111110


Q ss_pred             ccc---------cccC--CCCCC-----hhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          236 ELI---------DLTL--DGSCP-----PNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       236 ~~~---------d~~l--~~~~~-----~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ...         +...  ....+     +..... .+++..||+.||.+|||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  296 (311)
T 3niz_A          243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISAR  296 (311)
T ss_dssp             TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred             HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHH
Confidence            000         0000  00000     011123 5899999999999999953

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-44  Score=335.82  Aligned_cols=245  Identities=24%  Similarity=0.255  Sum_probs=190.6

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCe
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE   94 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~   94 (345)
                      ...+|.+.+.||+|+||.||+|.+.      +++.||||+++.. .......+.+|+.++++++||||+++++++.....
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            3567999999999999999999842      4678999999654 33445678999999999999999999999999999


Q ss_pred             eEEEEecCCCCChHHHHH----------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC---CEEE
Q 039516           95 RLLVYEFMPNKSLDSSFS----------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL---NTKI  149 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~----------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~---~~kl  149 (345)
                      .++||||+++|+|.+++.                      +++.+|.|||..   ||+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999987764                      456677777765   899999999999999554   5999


Q ss_pred             EccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHH
Q 039516          150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQL  228 (345)
Q Consensus       150 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~  228 (345)
                      +|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.....      .......
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~------~~~~~~i  299 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFV  299 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHH
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH
Confidence            99999986543333333344578899999999999999999999999999999998 9999976432      1111111


Q ss_pred             HhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          229 WNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       229 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      . .+...     .....++...   .+++..||+.||.+|||+.++...+..+...
T Consensus       300 ~-~~~~~-----~~~~~~~~~l---~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          300 T-SGGRM-----DPPKNCPGPV---YRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             H-TTCCC-----CCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             H-cCCCC-----CCCccCCHHH---HHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            1 21111     1111122211   5899999999999999998888887776654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.4e-44  Score=333.87  Aligned_cols=246  Identities=21%  Similarity=0.234  Sum_probs=191.2

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECC
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGE   93 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~   93 (345)
                      ...+|.+.+.||+|+||.||++.+      .+++.||||+++... ....+.+.+|++++.++ +||||+++++++.+.+
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~   99 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   99 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence            346799999999999999999962      356899999997643 33456799999999999 7999999999998755


Q ss_pred             -eeEEEEecCCCCChHHHHH------------------------------------------------------------
Q 039516           94 -ERLLVYEFMPNKSLDSSFS------------------------------------------------------------  112 (345)
Q Consensus        94 -~~~lv~e~~~~gsL~~~l~------------------------------------------------------------  112 (345)
                       ..++||||+++|+|.+++.                                                            
T Consensus       100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (359)
T 3vhe_A          100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  179 (359)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred             CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence             4899999999999977653                                                            


Q ss_pred             ---------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCccccee
Q 039516          113 ---------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIV  171 (345)
Q Consensus       113 ---------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~  171 (345)
                                           +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++...............
T Consensus       180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  256 (359)
T 3vhe_A          180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR  256 (359)
T ss_dssp             ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred             ccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence                                 456677777765   89999999999999999999999999998764433333344567


Q ss_pred             ecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhH
Q 039516          172 GTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNE  250 (345)
Q Consensus       172 gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  250 (345)
                      ||+.|+|||++.+..++.++||||||+++|||++ |+.||.......      ........+...     .....++++.
T Consensus       257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~-----~~~~~~~~~l  325 (359)
T 3vhe_A          257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRM-----RAPDYTTPEM  325 (359)
T ss_dssp             ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCC-----CCCTTCCHHH
T ss_pred             CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCC-----CCCCCCCHHH
Confidence            8999999999999999999999999999999998 999997654221      111112122111     1111122222


Q ss_pred             HHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          251 DAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       251 ~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                         .+++..||+.||.+|||+.++...|.+++++
T Consensus       326 ---~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          326 ---YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             ---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence               5899999999999999999888888877753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.2e-42  Score=327.45  Aligned_cols=257  Identities=18%  Similarity=0.203  Sum_probs=191.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~l   97 (345)
                      -.+|++.+.||+|+||.||++.. .+++.||+|+++..   .......+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            35799999999999999999975 46889999999754   222344688999999887 89999999999999999999


Q ss_pred             EEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           98 VYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        98 v~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      ||||+++|+|..++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++....  
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~--  205 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--  205 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc--
Confidence            999999999987664               566677777765   899999999999999999999999999985322  


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCc--ccHHHHHHHHHhcCCccccccc
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERP--LNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ........+||+.|+|||++.+..++.++|||||||++|||++|+.||........  .............+..      
T Consensus       206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------  279 (396)
T 4dc2_A          206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------  279 (396)
T ss_dssp             TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred             CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence            12234456899999999999999999999999999999999999999975432211  1111222222212211      


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceeeEE
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLL  294 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~~~  294 (345)
                      .+...++.+.   ..++..||+.||.+||+... ...+.+++.+..+.+.++..
T Consensus       280 ~~p~~~s~~~---~~li~~lL~~dP~~R~~~~~-~~~~~ei~~Hpff~~i~w~~  329 (396)
T 4dc2_A          280 RIPRSLSVKA---ASVLKSFLNKDPKERLGCHP-QTGFADIQGHPFFRNVDWDM  329 (396)
T ss_dssp             CCCTTSCHHH---HHHHHHHTCSCTTTSTTCST-TTHHHHHHHSTTTTTCCHHH
T ss_pred             CCCCcCCHHH---HHHHHHHhcCCHhHcCCCCC-CCCHHHHhcCccccCCCHHH
Confidence            1111122222   59999999999999999531 12345566666665554433

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.5e-43  Score=324.66  Aligned_cols=236  Identities=21%  Similarity=0.268  Sum_probs=180.9

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      .|..+|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            3567899999999999999999965 479999999996543 23345688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |||+++++|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||++........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            99999999876543               667777888765   899999999999999999999999999987643332


Q ss_pred             CCcccceeecCCccccchhccCCc-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                      ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ...     .+......  ..+  
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~-----~~~~~~~~--~~~--  230 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYS-----DWKEKKTY--LNP--  230 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHH-----HHHTTCTT--STT--
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHH-----HHhccccc--CCc--
Confidence            233344679999999999987775 7889999999999999999999976543221 111     11111100  000  


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ...++...   .+++.+||+.||.+|||+.
T Consensus       231 ~~~~~~~~---~~li~~~L~~dP~~R~t~~  257 (323)
T 3tki_A          231 WKKIDSAP---LALLHKILVENPSARITIP  257 (323)
T ss_dssp             GGGSCHHH---HHHHHHHSCSSTTTSCCHH
T ss_pred             cccCCHHH---HHHHHHHccCChhhCcCHH
Confidence            00122211   5899999999999999953

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.8e-44  Score=336.33  Aligned_cols=243  Identities=23%  Similarity=0.326  Sum_probs=180.0

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC----CCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP----NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~----~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      ..+|.+.+.||+|+||.||+|...    ++..||||.++.. .......|.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357899999999999999999764    5778999999765 33445679999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           98 VYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        98 v~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      ||||+++++|.+++.                +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            999999999988764                566777788765   8999999999999999999999999999876432


Q ss_pred             CCCC-cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          162 ESGA-NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       162 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      .... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......      ... .....+..     
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------~~~-~~i~~~~~-----  268 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------DVI-KAVDEGYR-----  268 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------HHH-HHHHTTEE-----
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------HHH-HHHHcCCC-----
Confidence            2111 1122345778999999999999999999999999999998 99999754321      111 11111110     


Q ss_pred             ccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          240 LTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       240 ~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      ..    .+...... .+++..||+.||.+|||+.+++..|..++..
T Consensus       269 ~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          269 LP----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             CC----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CC----CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            00    11122233 6999999999999999999998888887753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-43  Score=318.66  Aligned_cols=240  Identities=23%  Similarity=0.286  Sum_probs=189.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      .+|.+.+.||+|+||.||++...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            5699999999999999999998789999999997543 345789999999999999999999999999999999999999


Q ss_pred             CCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          104 NKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       104 ~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      +++|.+++.                +++.+|.+||..   ||+||||||+||+++.++.+||+|||++........ ...
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  164 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS  164 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HST
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc-ccc
Confidence            999988764                456667777765   899999999999999999999999999976532211 111


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      ....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......      ....... .+.     ........
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~-~~~-----~~~~~~~~  232 (269)
T 4hcu_A          165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDIS-TGF-----RLYKPRLA  232 (269)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHH-TTC-----CCCCCTTS
T ss_pred             cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHh-cCc-----cCCCCCcC
Confidence            22356778999999999999999999999999999999 99999764321      1111111 110     11111112


Q ss_pred             ChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          247 PPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       247 ~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      +...   .+++..||+.||.+|||+.++...|.++.+
T Consensus       233 ~~~~---~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          233 STHV---YQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHH---HHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            2211   589999999999999999888888877665

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.6e-43  Score=336.20  Aligned_cols=235  Identities=21%  Similarity=0.302  Sum_probs=187.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-eeEEEEec
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE-ERLLVYEF  101 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-~~~lv~e~  101 (345)
                      ..+|.+.+.||+|+||.||+|... |+.||||.++...  ..+.|.+|+.+|++++||||+++++++.... ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            357899999999999999999885 8899999997543  4578999999999999999999999987765 78999999


Q ss_pred             CCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          102 MPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       102 ~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      +++|+|.+++.                 +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++.....   
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  342 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence            99999988765                 556777777775   8999999999999999999999999999864321   


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                        .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+.   .    .....+..     ....
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~----~~i~~~~~-----~~~p  408 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V----PRVEKGYK-----MDAP  408 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---H----HHHHTTCC-----CCCC
T ss_pred             --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHcCCC-----CCCC
Confidence              122356889999999999999999999999999999998 9999986543321   1    11112211     1111


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ..+++..   .+++..||+.||++|||+.++...|..+..
T Consensus       409 ~~~~~~l---~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          409 DGCPPAV---YDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             TTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcCCHHH---HHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            1233222   589999999999999999888888877654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.6e-43  Score=341.67  Aligned_cols=240  Identities=23%  Similarity=0.300  Sum_probs=189.4

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ..+|.+.+.||+|+||.||+|...++..||||.++... ...+.|.+|+.+|++++||||+++++++. .+..++||||+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            45789999999999999999998888999999997654 45788999999999999999999999985 67789999999


Q ss_pred             CCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          103 PNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       103 ~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ++|+|.+++.                 +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus       265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~-  340 (454)
T 1qcf_A          265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-  340 (454)
T ss_dssp             TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH-
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee-
Confidence            9999988765                 556677777765   8999999999999999999999999999865321111 


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ......++..|+|||++.+..++.++|||||||++|||++ |+.||......      +...........      ....
T Consensus       341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~~~~~~------~~~~  408 (454)
T 1qcf_A          341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------EVIRALERGYRM------PRPE  408 (454)
T ss_dssp             TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHHTCCC------CCCT
T ss_pred             ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC------CCCC
Confidence            1122346778999999999999999999999999999999 99999764321      111111111111      0111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .++.+.   .+++..||+.||.+|||+.++...|..+..
T Consensus       409 ~~~~~l---~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          409 NCPEEL---YNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             TSCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             CCCHHH---HHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            122222   589999999999999999888888877664

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=326.42  Aligned_cols=230  Identities=17%  Similarity=0.191  Sum_probs=181.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ..+|.+.+.||+|+||.||++.. .+++.||+|.+...   .......+.+|+.+++.++|||||++++++.+.+..|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            36799999999999999999965 56899999998643   234567899999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |||+.+|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.....  
T Consensus        94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--  168 (384)
T ss_dssp             ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence            99999999987765               556677777765   8999999999999999999999999999876432  


Q ss_pred             CCcccceeecCCccccchhcc---CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          164 GANTNRIVGTYGYMSLEYTMS---GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                       .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||............   .... ....      
T Consensus       169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~---~~~~-~~~~------  237 (384)
T 4fr4_A          169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV---HTFE-TTVV------  237 (384)
T ss_dssp             -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH---HHHH-HCCC------
T ss_pred             -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH---HHHh-hccc------
Confidence             22344689999999999874   45899999999999999999999999765433221111   1111 1110      


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCC
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                      .....++.+.   ..++..||+.||.+||+.
T Consensus       238 ~~p~~~s~~~---~~li~~lL~~dP~~R~s~  265 (384)
T 4fr4_A          238 TYPSAWSQEM---VSLLKKLLEPNPDQRFSQ  265 (384)
T ss_dssp             CCCTTSCHHH---HHHHHHHSCSSGGGSCCS
T ss_pred             CCCCcCCHHH---HHHHHHHhcCCHhHhccc
Confidence            0111122222   599999999999999994

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.4e-42  Score=316.25  Aligned_cols=250  Identities=17%  Similarity=0.201  Sum_probs=185.2

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHh--cCCCCeeeEEEEEEEC----Ce
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAK--LQYTNLVKLLGCSIHG----EE   94 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~~~~~~~~~----~~   94 (345)
                      .+..+|.+.+.||+|+||.||+|.. +|+.||||++...   ....+..|.+++..  ++||||+++++++...    ..
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            4566799999999999999999987 6899999999643   34567778887776  7999999999987653    45


Q ss_pred             eEEEEecCCCCChHHHHH--------------hHHHHHHHHHhc-----CCCceEEeccCCCCeeeCCCCCEEEEccccc
Q 039516           95 RLLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKY-----SRLRVIHRDLKASNILLDDQLNTKISDFGMA  155 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~-----~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~  155 (345)
                      .++||||+++|+|.+++.              +++.+|.|||..     ++.+|+||||||+|||++.++.+||+|||++
T Consensus        81 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             eEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            799999999999988765              667788888832     1568999999999999999999999999999


Q ss_pred             eeecCCCCCC--cccceeecCCccccchhccC------CcCcccchhhHHHHHHHHHhC----------CCCCCCCCCCC
Q 039516          156 RIFGVNESGA--NTNRIVGTYGYMSLEYTMSG------TVSIKTDVFGFGVLVLKIVCG----------KKNNKSYHTER  217 (345)
Q Consensus       156 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~SlG~il~el~tg----------~~p~~~~~~~~  217 (345)
                      +.........  ......||+.|+|||++.+.      .++.++||||||+++|||++|          +.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            8764332211  12234789999999999876      566899999999999999999          78876543322


Q ss_pred             cccHHHHHHHHHhcCCccccccccCCCC-CChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          218 PLNLVGIAWQLWNEGKDLELIDLTLDGS-CPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                      .. ... ..........    .+.+... .+...... .+++..||+.||.+|||+.++...|.+
T Consensus       241 ~~-~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          241 PS-FED-MRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             CC-HHH-HHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cc-hhh-hhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            21 111 1111111111    1111111 11123344 799999999999999998777666654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.7e-42  Score=321.22  Aligned_cols=234  Identities=15%  Similarity=0.137  Sum_probs=183.8

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc------cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG------QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE   93 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~   93 (345)
                      .+...|.+.+.||+|+||.||++.. .+|+.||+|.++....      .....+.+|+.++++++||||+++++++.+..
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   88 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT   88 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence            4456699999999999999999965 4799999999975432      24678999999999999999999999999999


Q ss_pred             eeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC----CEEEEcccc
Q 039516           94 ERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL----NTKISDFGM  154 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfgl  154 (345)
                      ..++||||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++    .+||+|||+
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            9999999999999988764               567777788775   899999999999998877    799999999


Q ss_pred             ceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 039516          155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKD  234 (345)
Q Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (345)
                      +.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......      ..... ...+..
T Consensus       166 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~~-i~~~~~  235 (361)
T 2yab_A          166 AHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLAN-ITAVSY  235 (361)
T ss_dssp             CEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHH-HHTTCC
T ss_pred             ceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhcCC
Confidence            98764322   233457999999999999999999999999999999999999999764321      11111 111111


Q ss_pred             cccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          235 LELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       235 ~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .  +++......+...   .+++..||+.||.+|||+.
T Consensus       236 ~--~~~~~~~~~s~~~---~~li~~~L~~dP~~R~t~~  268 (361)
T 2yab_A          236 D--FDEEFFSQTSELA---KDFIRKLLVKETRKRLTIQ  268 (361)
T ss_dssp             C--CCHHHHTTSCHHH---HHHHHHHSCSSTTTSCCHH
T ss_pred             C--CCchhccCCCHHH---HHHHHHHCCCChhHCcCHH
Confidence            0  0111101122211   5899999999999999954

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.8e-43  Score=322.70  Aligned_cols=243  Identities=21%  Similarity=0.263  Sum_probs=191.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      ..+|.+.+.||+|+||.||++..      .+++.||||.+... .......+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            46799999999999999999964      34589999999754 334456789999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHH---------------------------------------hHHHHHHHHHhcCCCceEEeccCC
Q 039516           96 LLVYEFMPNKSLDSSFS---------------------------------------GTFKDLLCLHKYSRLRVIHRDLKA  136 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------------------------------~~~~~l~~lh~~~~~~ivHrdlk~  136 (345)
                      ++||||+++++|.+++.                                       +++.+|.|||..   ||+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence            99999999999987753                                       455666777765   899999999


Q ss_pred             CCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 039516          137 SNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHT  215 (345)
Q Consensus       137 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~  215 (345)
                      +||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987644332222333467888999999999999999999999999999999 9999976543


Q ss_pred             CCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          216 ERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ..   +.    .....+...     .....++.+.   .+++..||+.||.+|||+.++...|.+++.
T Consensus       259 ~~---~~----~~~~~~~~~-----~~~~~~~~~~---~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          259 ER---LF----NLLKTGHRM-----ERPDNCSEEM---YRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             GG---HH----HHHHTTCCC-----CCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH---HH----HHhhcCCcC-----CCCccCCHHH---HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            22   11    111122111     1111222222   599999999999999999888888877664

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.2e-43  Score=324.14  Aligned_cols=245  Identities=20%  Similarity=0.263  Sum_probs=176.9

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcCC-C---cEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFPN-E---QEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~~-~---~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      ...+|.+.+.||+|+||.||++.... +   ..||||.++..  .....+.+.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            35679999999999999999998653 3   28999999754  334567899999999999999999999999876655


Q ss_pred             ------EEEEecCCCCChHHHHH---------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEE
Q 039516           96 ------LLVYEFMPNKSLDSSFS---------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTK  148 (345)
Q Consensus        96 ------~lv~e~~~~gsL~~~l~---------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~k  148 (345)
                            ++||||+++++|.+++.                     +++.+|.|||..   ||+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence                  99999999999987653                     456667777765   899999999999999999999


Q ss_pred             EEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHH
Q 039516          149 ISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQ  227 (345)
Q Consensus       149 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~  227 (345)
                      |+|||+++...............+++.|+|||.+.+..++.++|||||||++|+|++ |+.||......+   ..   ..
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~---~~  251 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IY---NY  251 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH---HH
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HH---HH
Confidence            999999987644333233333456788999999999999999999999999999999 999998654322   11   11


Q ss_pred             HHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccccc
Q 039516          228 LWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGL  285 (345)
Q Consensus       228 ~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~  285 (345)
                      .. .+...     .    .+...... .+++..||+.||.+|||+.++...|.+++.+.
T Consensus       252 ~~-~~~~~-----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          252 LI-GGNRL-----K----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             HH-TTCCC-----C----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             Hh-cCCCC-----C----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            11 11110     1    11112223 69999999999999999999999999988754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=8.7e-43  Score=317.20  Aligned_cols=250  Identities=20%  Similarity=0.275  Sum_probs=187.3

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-----CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCe
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-----PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH--GEE   94 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-----~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~   94 (345)
                      ...+|++.++||+|+||.||++.+     .+++.||||++..........+.+|+.++++++||||+++++++..  ...
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            346799999999999999999973     3689999999987766667789999999999999999999999864  356


Q ss_pred             eEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           95 RLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      .++||||+++++|.+++.                +++.+|.|||..   ||+||||||+||+++.++.+||+|||++...
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            899999999999988764                566777777765   8999999999999999999999999999876


Q ss_pred             cCCCCC-CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCC---------CcccHHHHHHHH
Q 039516          159 GVNESG-ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTE---------RPLNLVGIAWQL  228 (345)
Q Consensus       159 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~---------~~~~~~~~~~~~  228 (345)
                      ...... .......++..|+|||++.+..++.++||||||+++|+|++|..|+......         ............
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence            432211 1122235677899999999999999999999999999999999988643110         000011111111


Q ss_pred             HhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          229 WNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       229 ~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ...+...     .....++    .. .+++..||+.||++|||+.++...|.++.+
T Consensus       245 ~~~~~~~-----~~~~~~~----~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          245 LKNNGRL-----PRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHTTCCC-----CCCTTCC----HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhccCcC-----CCCcCcC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            1111110     1111122    23 589999999999999999888888887765

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.5e-42  Score=321.07  Aligned_cols=246  Identities=17%  Similarity=0.151  Sum_probs=191.4

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEEe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ..+|.+.+.||+|+||.||+|.. .+|+.||||.+.....  ...+.+|+.+++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            35699999999999999999974 6799999999865432  24588999999999 99999999999999999999999


Q ss_pred             cCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC-----EEEEccccceeec
Q 039516          101 FMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN-----TKISDFGMARIFG  159 (345)
Q Consensus       101 ~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~-----~kl~Dfgl~~~~~  159 (345)
                      |+ +++|.+++.                +++.+|.|||..   ||+||||||+|||++.++.     +||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 999988765                566777777765   8999999999999998887     9999999998764


Q ss_pred             CCCCCC-----cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 039516          160 VNESGA-----NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKD  234 (345)
Q Consensus       160 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (345)
                      ......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||....................... 
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-  240 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-  240 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-
Confidence            432211     12346899999999999999999999999999999999999999987653332222211111100000 


Q ss_pred             cccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          235 LELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       235 ~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                          ...+...+ +    . ..++..||+.||.+|||+.++...+.+++..
T Consensus       241 ----~~~~~~~~-p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          241 ----IEVLCENF-P----EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             ----HHHHTTTC-H----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHhccC-h----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence                00011111 1    3 6899999999999999998888888877664

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-43  Score=326.35  Aligned_cols=245  Identities=20%  Similarity=0.217  Sum_probs=189.9

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEE   94 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~   94 (345)
                      ..+|.+.+.||+|+||.||++..      .++..||||.+... .......+.+|+.+++++ +||||+++++++...+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            46799999999999999999974      24678999999754 233456799999999999 89999999999999999


Q ss_pred             eEEEEecCCCCChHHHHH--------------------------------------hHHHHHHHHHhcCCCceEEeccCC
Q 039516           95 RLLVYEFMPNKSLDSSFS--------------------------------------GTFKDLLCLHKYSRLRVIHRDLKA  136 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~--------------------------------------~~~~~l~~lh~~~~~~ivHrdlk~  136 (345)
                      .++||||+++|+|.+++.                                      +++.+|.+||..   ||+||||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp  200 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA  200 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence            999999999999987653                                      456667777765   899999999


Q ss_pred             CCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 039516          137 SNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHT  215 (345)
Q Consensus       137 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~  215 (345)
                      +||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..||.....
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            999999999999999999987654433333445678889999999999999999999999999999998 9999976542


Q ss_pred             CCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          216 ERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      ..      ........+..     +.....++.+.   ..++..||+.||.+|||+.++...|..++..
T Consensus       281 ~~------~~~~~~~~~~~-----~~~~~~~~~~l---~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          281 DA------NFYKLIQNGFK-----MDQPFYATEEI---YIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             SH------HHHHHHHTTCC-----CCCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             HH------HHHHHHhcCCC-----CCCCCCCCHHH---HHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            21      11111212111     11111122221   5899999999999999998888888877663

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.4e-42  Score=319.06  Aligned_cols=254  Identities=19%  Similarity=0.204  Sum_probs=190.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv   98 (345)
                      .+|++.+.||+|+||.||++.. .+|+.||+|+++...   ......+.+|..++.++ +||||+++++++.+.+..|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            5699999999999999999975 468999999997542   23355688999999988 899999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.....  
T Consensus        89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~--  163 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--  163 (345)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT--
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC--
Confidence            99999999987764               556677777765   8999999999999999999999999999864221  


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcc--cHHHHHHHHHhcCCcccccccc
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPL--NLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ............+..      .
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~  237 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R  237 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------C
T ss_pred             CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------C
Confidence            12234468999999999999999999999999999999999999999753322111  111112222212211      1


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceee
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHF  292 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~  292 (345)
                      +....+.+.   .+++..||+.||.+||+... ...+.+++.+..+.+.++
T Consensus       238 ~p~~~s~~~---~~li~~lL~~dP~~R~~~~~-~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          238 IPRSLSVKA---ASVLKSFLNKDPKERLGCHP-QTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             CCTTSCHHH---HHHHHHHTCSSTTTSTTCCT-TTHHHHHHTSGGGTTCCH
T ss_pred             CCCCCCHHH---HHHHHHHhcCCHhHCCCCCC-cCCHHHHhcCCccCCCCH
Confidence            111122222   58999999999999999531 112345566665555444

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-43  Score=331.40  Aligned_cols=243  Identities=18%  Similarity=0.237  Sum_probs=192.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc--------CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF--------PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHG   92 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~--------~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~   92 (345)
                      ...|.+.++||+|+||.||++..        .++..||||+++.. .......+.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            46799999999999999999974        23468999999765 333456799999999999 999999999999999


Q ss_pred             CeeEEEEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeee
Q 039516           93 EERLLVYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILL  141 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill  141 (345)
                      +..++||||+++|+|.+++.                               +++.+|.|||..   ||+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence            99999999999999987753                               556677777765   89999999999999


Q ss_pred             CCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCccc
Q 039516          142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLN  220 (345)
Q Consensus       142 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~  220 (345)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....     
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-----  299 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  299 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence            9999999999999987654333333344567889999999999999999999999999999999 9999975431     


Q ss_pred             HHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          221 LVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                       .. .......+....     ....++.+.   .+++..||+.||.+|||+.++...|..++.
T Consensus       300 -~~-~~~~~~~~~~~~-----~~~~~~~~l---~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          300 -EE-LFKLLKEGHRMD-----KPSNCTNEL---YMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             -HH-HHHHHHTTCCCC-----CCSSCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HH-HHHHHHcCCCCC-----CCccCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             11 122222221111     111223222   589999999999999999988888888775

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.1e-43  Score=343.17  Aligned_cols=241  Identities=21%  Similarity=0.239  Sum_probs=192.0

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ..+|.+.++||+|+||.||+|... ++..||||.++... ...+.|.+|+.+|++++||||++++++|......++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            457899999999999999999765 48999999997543 3577899999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          102 MPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       102 ~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      +++|+|.+++.                 +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++...... .
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence            99999988764                 556677777765   89999999999999999999999999998764221 1


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||.......   ..    .....+.         .
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~---------~  437 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VY----ELLEKDY---------R  437 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH----HHHHTTC---------C
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCC---------C
Confidence            11223356788999999999999999999999999999999 999997654322   11    1111111         1


Q ss_pred             CCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          244 GSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       244 ~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      ...+...... .+++..||+.||.+|||+.++...|..++..
T Consensus       438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            1111122223 5899999999999999999888888877653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-42  Score=319.52  Aligned_cols=233  Identities=16%  Similarity=0.145  Sum_probs=183.0

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+..+|.+.+.||+|+||.||++.. .+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            3456799999999999999999965 468999999997543 34567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC--CCCEEEEccccceeecCC
Q 039516          100 EFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD--QLNTKISDFGMARIFGVN  161 (345)
Q Consensus       100 e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~--~~~~kl~Dfgl~~~~~~~  161 (345)
                      ||+++++|.+++.                +++.+|.|||..   ||+||||||+|||++.  ++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            9999999987664                566777777765   8999999999999987  789999999999876422


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                         .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....      ........... ..  ++..
T Consensus       158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~-~~--~~~~  225 (321)
T 1tki_A          158 ---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAE-YT--FDEE  225 (321)
T ss_dssp             ---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTC-CC--CCHH
T ss_pred             ---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHcCC-CC--CChh
Confidence               223446789999999999998899999999999999999999999976432      11111111111 10  0000


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .....+.+.   .+++..||+.||.+|||+.
T Consensus       226 ~~~~~s~~~---~~li~~~L~~dp~~Rpt~~  253 (321)
T 1tki_A          226 AFKEISIEA---MDFVDRLLVKERKSRMTAS  253 (321)
T ss_dssp             HHTTSCHHH---HHHHHTTSCSSGGGSCCHH
T ss_pred             hhccCCHHH---HHHHHHHcCCChhHCcCHH
Confidence            001122211   5999999999999999954

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.8e-43  Score=318.43  Aligned_cols=241  Identities=23%  Similarity=0.296  Sum_probs=187.8

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ..+|.+.+.||+|+||.||++...++..||+|+++... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            46799999999999999999998888899999997543 34578999999999999999999999999999999999999


Q ss_pred             CCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          103 PNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       103 ~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      ++++|.+++.                +++.+|.+||..   ||+||||||+||+++.++.+||+|||++......... .
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~  177 (283)
T 3gen_A          102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-S  177 (283)
T ss_dssp             TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-S
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc-c
Confidence            9999988764                556677777765   8999999999999999999999999999765321111 1


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......      ....... .+.     .......
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~-~~~-----~~~~~~~  245 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIA-QGL-----RLYRPHL  245 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHH-TTC-----CCCCCTT
T ss_pred             ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHHHh-ccc-----CCCCCCc
Confidence            112346778999999999999999999999999999998 99999764321      1111111 111     1111111


Q ss_pred             CChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          246 CPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       246 ~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      ++    .. .+++..||+.||.+|||+.++...|.++++.
T Consensus       246 ~~----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          246 AS----EKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            22    23 5899999999999999998888888777653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=322.95  Aligned_cols=248  Identities=18%  Similarity=0.220  Sum_probs=185.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~l   97 (345)
                      -.+|++.+.||+|+||.||++.. .+|+.||||+++..   .......+.+|..+++.+ +||||+++++++.+.+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            35799999999999999999965 56899999999653   234566788999999988 79999999999999999999


Q ss_pred             EEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           98 VYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        98 v~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      ||||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++..... 
T Consensus       102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-  177 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-  177 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccC-
Confidence            999999999987764               556667777765   8999999999999999999999999999853221 


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......      ........ +..      ..
T Consensus       178 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~-~~~------~~  243 (353)
T 3txo_A          178 -GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILN-DEV------VY  243 (353)
T ss_dssp             ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CCC------CC
T ss_pred             -CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHHc-CCC------CC
Confidence             22334468999999999999989999999999999999999999999764321      11112211 111      01


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceee
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHF  292 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~  292 (345)
                      ....+.+.   ..++..||+.||.+||++.+ .....+++.+..+.+.++
T Consensus       244 p~~~~~~~---~~li~~lL~~dP~~R~~~~~-~~~~~~il~hp~f~~~~w  289 (353)
T 3txo_A          244 PTWLHEDA---TGILKSFMTKNPTMRLGSLT-QGGEHAILRHPFFKEIDW  289 (353)
T ss_dssp             CTTSCHHH---HHHHHHHTCSSGGGSTTSGG-GTCTHHHHTSGGGTTCCH
T ss_pred             CCCCCHHH---HHHHHHHhhhCHHHccCCcc-cCCHHHHhhCCcccCCCH
Confidence            11122222   58999999999999999521 111234555555544443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.7e-41  Score=316.86  Aligned_cols=246  Identities=17%  Similarity=0.155  Sum_probs=191.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      -.+|++.+.||+|+||.||++.. .+|+.||+|+++..   .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            46799999999999999999975 47999999999643   234567889999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.....  
T Consensus       120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            99999999988765               556667777765   8999999999999999999999999999876322  


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ........ .+..      .+.
T Consensus       195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~-~~~~------~~p  258 (350)
T 1rdq_E          195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIV-SGKV------RFP  258 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCCC------CCC
T ss_pred             ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHH-cCCC------CCC
Confidence               2346899999999999999999999999999999999999999975431      11111111 2211      111


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceeeEE
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLL  294 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~~~  294 (345)
                      ..++.+.   .+++..||+.||.+||+..  ...+.+++.+..+...++..
T Consensus       259 ~~~~~~~---~~li~~lL~~dp~~R~~~~--~~~~~ei~~h~~f~~~~w~~  304 (350)
T 1rdq_E          259 SHFSSDL---KDLLRNLLQVDLTKRFGNL--KNGVNDIKNHKWFATTDWIA  304 (350)
T ss_dssp             TTCCHHH---HHHHHHHSCSCTTTCTTSS--TTTTHHHHTSGGGTTCCHHH
T ss_pred             CCCCHHH---HHHHHHHhhcCHHhccCCc--cCCHHHHHhCcCcCCCCHHH
Confidence            1223222   5999999999999999831  22344555565555544433

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7e-43  Score=327.66  Aligned_cols=258  Identities=16%  Similarity=0.178  Sum_probs=191.6

Q ss_pred             cccccCCCCeeeEEEeeccCCeEEEEEEcCC------CcEEEEEEeccCCccC-----------HHHHHHHHHHHHhcCC
Q 039516           17 KFVENSSLDWHMYIQQEQTRDRVILVGKFPN------EQEVAIKRLAWTSGQG-----------RVEFQNEAKLIAKLQY   79 (345)
Q Consensus        17 ~~~~~~~~~~~~~~~lG~G~~g~vy~~~~~~------~~~VaiK~~~~~~~~~-----------~~~~~~E~~~l~~l~H   79 (345)
                      ...+....+|.+.++||+|+||.||+|...+      ++.||||.+.......           ...+..|+..++.++|
T Consensus        28 ~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h  107 (364)
T 3op5_A           28 IITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKY  107 (364)
T ss_dssp             EEECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSC
T ss_pred             EeeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccC
Confidence            3344556689999999999999999997654      4789999986553211           1123445566677789


Q ss_pred             CCeeeEEEEEEEC----CeeEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCe
Q 039516           80 TNLVKLLGCSIHG----EERLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNI  139 (345)
Q Consensus        80 ~niv~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Ni  139 (345)
                      |||+++++++...    ...++||||+ +++|.+++.                +++.+|.|||..   ||+||||||+||
T Consensus       108 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Ni  183 (364)
T 3op5_A          108 LGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNL  183 (364)
T ss_dssp             CCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             CCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHE
Confidence            9999999998764    4589999999 999988764                567777788776   899999999999


Q ss_pred             eeC--CCCCEEEEccccceeecCCCCCC-----cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 039516          140 LLD--DQLNTKISDFGMARIFGVNESGA-----NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKS  212 (345)
Q Consensus       140 ll~--~~~~~kl~Dfgl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~  212 (345)
                      |++  .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            998  88999999999998764332211     11334699999999999999999999999999999999999999985


Q ss_pred             CCCCCcccHHHHHHHHHhcCCccccccccCCC-CCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          213 YHTERPLNLVGIAWQLWNEGKDLELIDLTLDG-SCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      ....  ..........+ ...+..++++.+.. .++.+-   ..++..||+.||.+|||+.++...|..++..
T Consensus       264 ~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~---~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          264 NLKD--PKYVRDSKIRY-RENIASLMDKCFPAANAPGEI---AKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             GTTC--HHHHHHHHHHH-HHCHHHHHHHHSCTTCCCHHH---HHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cccC--HHHHHHHHHHh-hhhHHHHHHHhcccccCHHHH---HHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence            3322  11222222222 12234444554432 223222   4899999999999999999998888888774

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=317.04  Aligned_cols=237  Identities=24%  Similarity=0.300  Sum_probs=183.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      .+|++.+.||+|+||.||++... ++.||||.+...  ...+.|.+|+.++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            56999999999999999999875 789999999643  34578999999999999999999999875  45899999999


Q ss_pred             CCChHHHHH------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC-EEEEccccceeecCCCCC
Q 039516          104 NKSLDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN-TKISDFGMARIFGVNESG  164 (345)
Q Consensus       104 ~gsL~~~l~------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~-~kl~Dfgl~~~~~~~~~~  164 (345)
                      +++|.+++.                  +++++|.|||..+..||+||||||+||+++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            999988764                  5678899999977679999999999999988887 799999999765321   


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                        .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......    .....+.... +..     +....
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~-~~~-----~~~~~  227 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAVHN-GTR-----PPLIK  227 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHHHT-TCC-----CCCBT
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHHhc-CCC-----CCccc
Confidence              22346899999999999999999999999999999999999999754321    1111222221 111     11112


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .++...   .+++.+||+.||.+|||+.++...|..+.+
T Consensus       228 ~~~~~l---~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          228 NLPKPI---ESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             TCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             ccCHHH---HHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            233222   589999999999999999888888877765

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-43  Score=326.81  Aligned_cols=244  Identities=21%  Similarity=0.293  Sum_probs=190.9

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCe
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE   94 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~   94 (345)
                      ...+|.+.+.||+|+||.||++...      +++.||||.++... ......+.+|+.++++++||||+++++++.+.+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            4567999999999999999999763      34899999997653 3345679999999999999999999999999999


Q ss_pred             eEEEEecCCCCChHHHHH---------------------------------------hHHHHHHHHHhcCCCceEEeccC
Q 039516           95 RLLVYEFMPNKSLDSSFS---------------------------------------GTFKDLLCLHKYSRLRVIHRDLK  135 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~---------------------------------------~~~~~l~~lh~~~~~~ivHrdlk  135 (345)
                      .++||||+++++|.+++.                                       +++.+|.|||..   ||+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            999999999999988653                                       455666677765   89999999


Q ss_pred             CCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 039516          136 ASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYH  214 (345)
Q Consensus       136 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~  214 (345)
                      |+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            9999999999999999999986543322222334567899999999999999999999999999999999 999997543


Q ss_pred             CCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          215 TERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .      ... ......+....     ....++...   .+++..||+.||.+|||+.++...|.++.+
T Consensus       282 ~------~~~-~~~~~~~~~~~-----~~~~~~~~l---~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          282 H------EEV-IYYVRDGNILA-----CPENCPLEL---YNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             H------HHH-HHHHHTTCCCC-----CCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             h------HHH-HHHHhCCCcCC-----CCCCCCHHH---HHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            2      111 11222222211     111223221   589999999999999999888888888766

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.2e-42  Score=312.26  Aligned_cols=239  Identities=23%  Similarity=0.292  Sum_probs=177.0

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCC----ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTS----GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ..+|.+.+.||+|+||.||++... |+.||||++....    ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            457999999999999999999875 8999999986542    23456799999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC--------CCCEEEEccccce
Q 039516           99 YEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD--------QLNTKISDFGMAR  156 (345)
Q Consensus        99 ~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~--------~~~~kl~Dfgl~~  156 (345)
                      |||+++++|.+++.              +++.+|.+||.....+|+||||||+||+++.        ++.+||+|||++.
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~  164 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR  164 (271)
T ss_dssp             EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred             EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence            99999999987764              6777888888874444999999999999986        6789999999998


Q ss_pred             eecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          157 IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                      ......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....      .............  
T Consensus       165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~--  232 (271)
T 3dtc_A          165 EWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVAMNKLA--  232 (271)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHTSCCC--
T ss_pred             cccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHhhhcCCCC--
Confidence            653322    2235789999999999999999999999999999999999999976431      1111111111111  


Q ss_pred             cccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          237 LIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       237 ~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                         ......++..-   .+++..||+.||.+|||+.++...|.+
T Consensus       233 ---~~~~~~~~~~~---~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          233 ---LPIPSTCPEPF---AKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             ---CCCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             ---CCCCcccCHHH---HHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence               11111222211   599999999999999998766665543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.7e-42  Score=316.89  Aligned_cols=233  Identities=15%  Similarity=0.151  Sum_probs=182.0

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc------cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCe
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG------QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE   94 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~   94 (345)
                      +...|.+.+.||+|+||.||++.. .+|+.||+|.++....      .....+.+|+.++++++||||+++++++.+...
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            445699999999999999999975 4689999999965422      246789999999999999999999999999999


Q ss_pred             eEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC----CEEEEccccc
Q 039516           95 RLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL----NTKISDFGMA  155 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfgl~  155 (345)
                      .++||||+++++|.+++.               +++.+|.|||..   ||+||||||+||+++.++    .+||+|||++
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999988764               566777777765   899999999999999887    7999999999


Q ss_pred             eeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 039516          156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDL  235 (345)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (345)
                      .......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......      ....... .....
T Consensus       166 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~-~~~~~  235 (326)
T 2y0a_A          166 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVS-AVNYE  235 (326)
T ss_dssp             EECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHH-HTCCC
T ss_pred             eECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHH-hcCCC
Confidence            8764322   223457999999999999999999999999999999999999999754321      1111111 11100


Q ss_pred             ccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          236 ELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       236 ~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                        +........+...   .+++..||+.||.+|||+.
T Consensus       236 --~~~~~~~~~~~~~---~~li~~~L~~dP~~Rpt~~  267 (326)
T 2y0a_A          236 --FEDEYFSNTSALA---KDFIRRLLVKDPKKRMTIQ  267 (326)
T ss_dssp             --CCHHHHTTSCHHH---HHHHHHHSCSSGGGSCCHH
T ss_pred             --cCccccccCCHHH---HHHHHHHccCChhhCCCHH
Confidence              0000001122111   5899999999999999954

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=313.43  Aligned_cols=245  Identities=17%  Similarity=0.176  Sum_probs=188.8

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|++.+.||+|+||.||++.. .+|+.||+|+++..   .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            5699999999999999999965 47999999999654   2245677889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||+++|+|.+++.               +++.+|.|||.   .||+||||||+|||++.++.+||+|||+++....    
T Consensus        86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----  158 (318)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence            9999999988765               45566666665   4899999999999999999999999999987532    


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      .......... ..      ....
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~-~~------~~p~  224 (318)
T 1fot_A          159 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNA-EL------RFPP  224 (318)
T ss_dssp             -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHC-CC------CCCT
T ss_pred             -ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-CC------CCCC
Confidence             22345799999999999999999999999999999999999999975431      1111222211 11      1111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceeeEE
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLL  294 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~~~  294 (345)
                      .++.+.   .+++..||+.||.+||+...  ....+++.+..+.+..+..
T Consensus       225 ~~~~~~---~~li~~lL~~dp~~R~~~~~--~~~~~i~~hp~f~~~~~~~  269 (318)
T 1fot_A          225 FFNEDV---KDLLSRLITRDLSQRLGNLQ--NGTEDVKNHPWFKEVVWEK  269 (318)
T ss_dssp             TSCHHH---HHHHHHHTCSCTTTCTTSST--TTTHHHHTSGGGSSCCHHH
T ss_pred             CCCHHH---HHHHHHHhccCHHHcCCCcC--CCHHHHhcCccccCCCHHH
Confidence            122222   58999999999999995321  1234555555555444433

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=311.81  Aligned_cols=245  Identities=20%  Similarity=0.208  Sum_probs=185.3

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--eeEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE--ERLL   97 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--~~~l   97 (345)
                      +...|.+.+.||+|+||.||+|... +|+.||||+++... ......+.+|++++++++||||+++++++....  ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            4567999999999999999999764 58999999997543 345678899999999999999999999998755  7899


Q ss_pred             EEecCCCCChHHHHH------------------hHHHHHHHHHhcCCCceEEeccCCCCeee----CCCCCEEEEccccc
Q 039516           98 VYEFMPNKSLDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILL----DDQLNTKISDFGMA  155 (345)
Q Consensus        98 v~e~~~~gsL~~~l~------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill----~~~~~~kl~Dfgl~  155 (345)
                      ||||+++++|.+++.                  +++.+|.|||..   ||+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            999999999987764                  556677777765   89999999999999    77888999999999


Q ss_pred             eeecCCCCCCcccceeecCCccccchhc--------cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 039516          156 RIFGVNESGANTNRIVGTYGYMSLEYTM--------SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQ  227 (345)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  227 (345)
                      +......   ......||+.|+|||++.        +..++.++|||||||++|||++|+.||.........  ......
T Consensus       164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~  238 (319)
T 4euu_A          164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYK  238 (319)
T ss_dssp             EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHH
T ss_pred             eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHH
Confidence            8764322   223357899999999886        577899999999999999999999999765432221  222222


Q ss_pred             HHhcCC---ccccc---------cccCC--CCCChhHHHH-HHHHhhccCCCCCcCCCCCcc
Q 039516          228 LWNEGK---DLELI---------DLTLD--GSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       228 ~~~~~~---~~~~~---------d~~l~--~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~  274 (345)
                      ......   +..+.         ...+.  ...+...... ..++..||+.||++|||+.++
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~el  300 (319)
T 4euu_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF  300 (319)
T ss_dssp             HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHH
T ss_pred             HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHh
Confidence            222111   11000         00111  1223333344 789999999999999996543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.3e-42  Score=318.37  Aligned_cols=225  Identities=17%  Similarity=0.228  Sum_probs=178.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      -..|.+.+.||+|+||.||+|.. .+|+.||||++...   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35699999999999999999975 67999999998643   223345789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |||+ +|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||++....... 
T Consensus        88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred             EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence            9999 677766543               667778888876   89999999999999999999999999998654322 


Q ss_pred             CCcccceeecCCccccchhccCCc-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc--c
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID--L  240 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~  240 (345)
                        ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........               ..+..  .
T Consensus       163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~~~~  225 (336)
T 3h4j_B          163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNSCVY  225 (336)
T ss_dssp             --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCSSCC
T ss_pred             --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHcCCC
Confidence              2234579999999999988776 68999999999999999999999764322211               00100  0


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .+....+++.   .+++..||+.||.+|||+.
T Consensus       226 ~~p~~~s~~~---~~li~~~L~~dP~~Rpt~~  254 (336)
T 3h4j_B          226 VMPDFLSPGA---QSLIRRMIVADPMQRITIQ  254 (336)
T ss_dssp             CCCTTSCHHH---HHHHHTTSCSSGGGSCCHH
T ss_pred             CCcccCCHHH---HHHHHHHcCCChhHCcCHH
Confidence            1111122222   5999999999999999953

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.8e-42  Score=312.46  Aligned_cols=247  Identities=21%  Similarity=0.263  Sum_probs=185.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-----CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--Cee
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-----PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--EER   95 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-----~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~   95 (345)
                      ..|++.++||+|+||.||++.+     .+++.||+|++... .......+.+|+.++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4589999999999999999983     46899999999754 344567899999999999999999999999876  668


Q ss_pred             EEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           96 LLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      ++||||+++++|.+++.                +++.+|.+||..   ||+||||||+||+++.++.+||+|||++....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccccc
Confidence            99999999999988873                556667777765   89999999999999999999999999998764


Q ss_pred             CCCCC-CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC--------CCCcccHHHHHHHHHh
Q 039516          160 VNESG-ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH--------TERPLNLVGIAWQLWN  230 (345)
Q Consensus       160 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~--------~~~~~~~~~~~~~~~~  230 (345)
                      ..... .......||..|+|||++.+..++.++||||||+++|+|++|..|+....        ................
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK  257 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence            33211 11223467888999999999999999999999999999999998864321        0001111111111111


Q ss_pred             cCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          231 EGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       231 ~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                      .+...         ..+...... .+++..||+.||.+|||+.++...|.+++
T Consensus       258 ~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          258 EGKRL---------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             TTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCCC---------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            11111         111122233 59999999999999999888887777665

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8e-43  Score=336.61  Aligned_cols=239  Identities=23%  Similarity=0.354  Sum_probs=184.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ..+|.+.++||+|+||.||+|...++..||||.++... ...+.|.+|+.+|++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            45689999999999999999998878889999997543 346789999999999999999999999865 7789999999


Q ss_pred             CCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          103 PNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       103 ~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ++|+|.+++.                 +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++....... .
T Consensus       261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~  336 (452)
T 1fmk_A          261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  336 (452)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce-e
Confidence            9999988764                 556677777765   899999999999999999999999999987643221 1


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ......++..|+|||++.++.++.++||||||+++|||++ |+.||......      +... ....+..     ..   
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~-~i~~~~~-----~~---  401 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLD-QVERGYR-----MP---  401 (452)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHH-HHHTTCC-----CC---
T ss_pred             cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HHHH-HHHcCCC-----CC---
Confidence            1223456788999999999999999999999999999999 99999764321      1111 1112211     01   


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                       .+...... .+++..||+.||++|||+.++...|..++.
T Consensus       402 -~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          402 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             -CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence             11222233 589999999999999998887777777654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8.5e-42  Score=318.15  Aligned_cols=229  Identities=20%  Similarity=0.199  Sum_probs=182.4

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~l   97 (345)
                      -.+|.+.+.||+|+||.||++.. .+|+.||||+++..   .......+..|..++..+ +||||+++++++.+.+..|+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            46799999999999999999975 46899999999654   234566788999999887 99999999999999999999


Q ss_pred             EEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           98 VYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        98 v~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      ||||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++......
T Consensus        96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            999999999988765               556677777765   89999999999999999999999999998643221


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||......      ....... .+.      +..
T Consensus       173 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~-~~~------~~~  237 (345)
T 1xjd_A          173 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIR-MDN------PFY  237 (345)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HCC------CCC
T ss_pred             --CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHH-hCC------CCC
Confidence              2234568999999999999999999999999999999999999999764321      1111111 111      111


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ....+.+.   .+++..||+.||.+||++.
T Consensus       238 p~~~s~~~---~~li~~lL~~dp~~R~~~~  264 (345)
T 1xjd_A          238 PRWLEKEA---KDLLVKLFVREPEKRLGVR  264 (345)
T ss_dssp             CTTSCHHH---HHHHHHHSCSSGGGSBTTB
T ss_pred             CcccCHHH---HHHHHHHhcCCHhHcCCCh
Confidence            11122222   5899999999999999964

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=321.69  Aligned_cols=235  Identities=16%  Similarity=0.134  Sum_probs=184.7

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ..+...|.+.+.||+|+||.||+|.. .+|+.||+|.+..........+.+|+.++++++||||+++++++.+....++|
T Consensus        47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            34456799999999999999999965 47899999999766555566899999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC--CCCEEEEccccceeecC
Q 039516           99 YEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD--QLNTKISDFGMARIFGV  160 (345)
Q Consensus        99 ~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~--~~~~kl~Dfgl~~~~~~  160 (345)
                      |||+++++|.+++.                +++.+|.|||..   ||+||||||+|||++.  .+.+||+|||++.....
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            99999999977653                567777788765   8999999999999974  57799999999987643


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      .   .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      ........ ....  .+++
T Consensus       204 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~-~~~~--~~~~  271 (387)
T 1kob_A          204 D---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVK-RCDW--EFDE  271 (387)
T ss_dssp             T---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHH-HCCC--CCCS
T ss_pred             C---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCC--CCCc
Confidence            2   223345789999999999999999999999999999999999999976432      11111111 1111  0111


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ......+++.   .+++..||+.||.+|||+.
T Consensus       272 ~~~~~~s~~~---~~li~~~L~~dP~~Rpt~~  300 (387)
T 1kob_A          272 DAFSSVSPEA---KDFIKNLLQKEPRKRLTVH  300 (387)
T ss_dssp             STTTTSCHHH---HHHHHTTSCSSGGGSCCHH
T ss_pred             cccccCCHHH---HHHHHHHcCCChhHCcCHH
Confidence            1111223222   5999999999999999954

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.6e-41  Score=308.74  Aligned_cols=249  Identities=16%  Similarity=0.178  Sum_probs=192.4

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ...+|.+.+.||+|+||.||+|.. .+|+.||||.+....  ....+.+|+.+++++ +|+|++++++++......++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            456799999999999999999974 679999999986443  234578999999999 8999999999999999999999


Q ss_pred             ecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC-----EEEEccccceee
Q 039516          100 EFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN-----TKISDFGMARIF  158 (345)
Q Consensus       100 e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~-----~kl~Dfgl~~~~  158 (345)
                      ||+ +++|.+++.                +++.+|.+||..   ||+||||||+||+++.++.     +||+|||++...
T Consensus        86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            999 999988765                456666666654   8999999999999987766     999999999876


Q ss_pred             cCCCCC-----CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 039516          159 GVNESG-----ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGK  233 (345)
Q Consensus       159 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (345)
                      ......     .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......................
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  241 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence            543221     123446799999999999999999999999999999999999999987654332222222111111111


Q ss_pred             ccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          234 DLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       234 ~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      .     +.+...++.+-   .+++..||+.||++|||+.++...|.++++.
T Consensus       242 ~-----~~~~~~~~~~l---~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          242 L-----RELCAGFPEEF---YKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             H-----HHHTTTSCHHH---HHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             H-----HHHHhhCcHHH---HHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            1     01111123222   5899999999999999999888888887763

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-42  Score=319.82  Aligned_cols=243  Identities=22%  Similarity=0.308  Sum_probs=189.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      ..+|.+.+.||+|+||.||+|...      +++.||||.+.... ......+.+|+.++++++||||+++++++.+.+..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  103 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT  103 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence            345999999999999999999653      36889999997543 23455789999999999999999999999998999


Q ss_pred             EEEEecCCCCChHHHHH-------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEE
Q 039516           96 LLVYEFMPNKSLDSSFS-------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKIS  150 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~-------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~  150 (345)
                      ++||||+++++|.+++.                         +++.+|.+||..   ||+||||||+||+++.++.+||+
T Consensus       104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~  180 (322)
T 1p4o_A          104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG  180 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEEC
Confidence            99999999999987754                         345566666665   89999999999999999999999


Q ss_pred             ccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHH
Q 039516          151 DFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLW  229 (345)
Q Consensus       151 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  229 (345)
                      |||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....      ... ....
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~-~~~~  253 (322)
T 1p4o_A          181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQV-LRFV  253 (322)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHH-HHHH
T ss_pred             cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH------HHH-HHHH
Confidence            9999986543322222334567889999999999999999999999999999999 8899875432      111 1112


Q ss_pred             hcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          230 NEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       230 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ..+....     ....++..-   .+++..||+.||.+|||+.++...|.++++
T Consensus       254 ~~~~~~~-----~~~~~~~~l---~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          254 MEGGLLD-----KPDNCPDML---FELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HTTCCCC-----CCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HcCCcCC-----CCCCCCHHH---HHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            1221111     111122221   589999999999999999888888887766

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=322.76  Aligned_cols=233  Identities=20%  Similarity=0.238  Sum_probs=174.4

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCC--CCeeeEEEEEEECCeeEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQY--TNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H--~niv~~~~~~~~~~~~~l   97 (345)
                      ....|.+.+.||+|+||.||++...+++.||||++...  .......+.+|+.++++++|  |||+++++++......++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            45569999999999999999998888999999999754  33345678999999999976  999999999999999999


Q ss_pred             EEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           98 VYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        98 v~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      ||| +.+++|.+++.               +++.+|.|||..   ||+||||||+|||++ ++.+||+|||+++......
T Consensus        87 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            999 56778877654               566777777765   899999999999997 5789999999998764433


Q ss_pred             CCCcccceeecCCccccchhcc-----------CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc
Q 039516          163 SGANTNRIVGTYGYMSLEYTMS-----------GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNE  231 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  231 (345)
                      .........||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.....     .........  
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~--  234 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII--  234 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHH--
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHh--
Confidence            3323345679999999999865           6788999999999999999999999975321     111111111  


Q ss_pred             CCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          232 GKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       232 ~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                             ++......+...... .+++..||+.||.+|||+.+
T Consensus       235 -------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e  270 (343)
T 3dbq_A          235 -------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE  270 (343)
T ss_dssp             -------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             -------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence                   111111122222223 58999999999999999654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7.8e-43  Score=319.66  Aligned_cols=244  Identities=20%  Similarity=0.235  Sum_probs=191.5

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccCCc-cCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWTSG-QGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEE   94 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~   94 (345)
                      ..+|.+.+.||+|+||.||++..      .+++.||||.++.... ...+.+.+|+.+++++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            45799999999999999999974      3578999999975532 3456799999999999 99999999999999999


Q ss_pred             eEEEEecCCCCChHHHHH---------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeee
Q 039516           95 RLLVYEFMPNKSLDSSFS---------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILL  141 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~---------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill  141 (345)
                      .++||||+++|+|.+++.                                 +++.+|.+||..   ||+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence            999999999999987653                                 455667777765   89999999999999


Q ss_pred             CCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCccc
Q 039516          142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLN  220 (345)
Q Consensus       142 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~  220 (345)
                      +.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |+.||........  
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--  256 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence            9999999999999987654333223334567889999999999999999999999999999999 9999976542211  


Q ss_pred             HHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          221 LVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                          .......+.     .......++...   .+++..||+.||.+|||+.++...|.++++
T Consensus       257 ----~~~~~~~~~-----~~~~~~~~~~~l---~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          257 ----FYKMIKEGF-----RMLSPEHAPAEM---YDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             ----HHHHHHHTC-----CCCCCTTSCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHhccCC-----CCCCcccCCHHH---HHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence                111111111     011111122211   589999999999999999888888887765

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.8e-41  Score=320.73  Aligned_cols=190  Identities=17%  Similarity=0.194  Sum_probs=160.2

Q ss_pred             CCCeeeEEEeecc--CCeEEEEEEcC-CCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           23 SLDWHMYIQQEQT--RDRVILVGKFP-NEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G--~~g~vy~~~~~-~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      ..+|++.++||+|  +||.||++... +|+.||||+++..  .......+.+|+.++++++|||||++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3569999999999  99999999764 7999999999754  23345678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           98 VYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        98 v~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      ||||+++++|.+++.                 +++.+|.|||..   ||+||||||+|||++.++.+||+|||++.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999988764                 566777777765   899999999999999999999999999875432


Q ss_pred             CC-----CCCcccceeecCCccccchhcc--CCcCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 039516          161 NE-----SGANTNRIVGTYGYMSLEYTMS--GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHT  215 (345)
Q Consensus       161 ~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~el~tg~~p~~~~~~  215 (345)
                      ..     .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.....
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  242 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA  242 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            11     1111223478899999999987  5789999999999999999999999976543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.4e-42  Score=321.74  Aligned_cols=243  Identities=19%  Similarity=0.235  Sum_probs=190.0

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc--------CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF--------PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHG   92 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~--------~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~   92 (345)
                      ..+|.+.+.||+|+||.||++..        .++..||||.++... ......+.+|+.+++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            46799999999999999999975        246789999997553 33456789999999999 899999999999999


Q ss_pred             CeeEEEEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeee
Q 039516           93 EERLLVYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILL  141 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill  141 (345)
                      +..++||||+++++|.+++.                               +++.+|.|||..   ||+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence            99999999999999987753                               456677777765   89999999999999


Q ss_pred             CCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCccc
Q 039516          142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLN  220 (345)
Q Consensus       142 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~  220 (345)
                      +.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....     
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----  265 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----  265 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence            9999999999999987654322222233456788999999999999999999999999999999 9999975431     


Q ss_pred             HHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          221 LVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                       .... .....+..     ......++...   ..++..||+.||.+|||+.++...|.+++.
T Consensus       266 -~~~~-~~~~~~~~-----~~~~~~~~~~l---~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          266 -EELF-KLLKEGHR-----MDKPANCTNEL---YMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             -HHHH-HHHHHTCC-----CCCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHH-HHHhcCCC-----CCCCccCCHHH---HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             1111 11111111     11111222222   589999999999999999988888888775

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.8e-42  Score=310.29  Aligned_cols=248  Identities=21%  Similarity=0.295  Sum_probs=180.2

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      +-....|.+.++||+|+||.||+|...  ..||+|.++...  ......|.+|+.++++++||||+++++++ .....++
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l   96 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI   96 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence            445677999999999999999999864  469999997553  33456799999999999999999999965 5667899


Q ss_pred             EEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           98 VYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        98 v~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      ||||+++++|.+++.                +++.+|.+||..   ||+||||||+||+++.++.+||+|||++......
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence            999999999977763                566677777765   8999999999999999999999999999865432


Q ss_pred             CCCCcccceeecCCccccchhc---cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                      ..........||+.|+|||++.   +..++.++||||||+++|+|++|+.||......      .........+.....+
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~  247 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSLSPDL  247 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSCCCCT
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcccccCcch
Confidence            2233334467899999999986   667889999999999999999999999764321      1112222222221111


Q ss_pred             cccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          239 DLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       239 d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      . .+...++..-   .+++..||+.||.+|||+.++...|.++++
T Consensus       248 ~-~~~~~~~~~l---~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          248 S-KVRSNCPKRM---KRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             T-SSCTTSCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             h-hccccCCHHH---HHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            1 1112233222   599999999999999999888888877654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.8e-42  Score=317.21  Aligned_cols=230  Identities=20%  Similarity=0.208  Sum_probs=174.8

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC------
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE------   93 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------   93 (345)
                      +..+|++.+.||+|+||.||++... +|+.||||+++... ....+.+.+|+.++++++||||++++++|.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3456999999999999999999764 79999999997543 334677999999999999999999999987644      


Q ss_pred             ---------------------------------------------------eeEEEEecCCCCChHHHHH----------
Q 039516           94 ---------------------------------------------------ERLLVYEFMPNKSLDSSFS----------  112 (345)
Q Consensus        94 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~----------  112 (345)
                                                                         ..++||||+++++|.+++.          
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               3799999999999987654          


Q ss_pred             --------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC----------CcccceeecC
Q 039516          113 --------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG----------ANTNRIVGTY  174 (345)
Q Consensus       113 --------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~----------~~~~~~~gt~  174 (345)
                              +++.+|.|||..   ||+||||||+||+++.++.+||+|||+++........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence                    566777777765   8999999999999999999999999999887543211          1223357999


Q ss_pred             CccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-
Q 039516          175 GYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-  253 (345)
Q Consensus       175 ~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-  253 (345)
                      .|+|||++.+..++.++||||||+++|+|++|..|+..        ... .............         ....... 
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~-~~~~~~~~~~~~~---------~~~~~~~~  302 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVR-IITDVRNLKFPLL---------FTQKYPQE  302 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHH-HHHHHHTTCCCHH---------HHHHCHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHH-HHHHhhccCCCcc---------cccCChhH
Confidence            99999999999999999999999999999998766421        011 1111111111000         0111122 


Q ss_pred             HHHHhhccCCCCCcCCCCC
Q 039516          254 LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       254 ~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .+++..||+.||.+|||+.
T Consensus       303 ~~li~~~l~~~p~~Rps~~  321 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEAT  321 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHH
T ss_pred             HHHHHHHccCCCCcCCCHH
Confidence            6899999999999999954

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.2e-42  Score=325.97  Aligned_cols=236  Identities=18%  Similarity=0.194  Sum_probs=182.5

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ..+..+|.+.+.||+|+||.||++.. .+|+.||+|.+....  ......+.+|+.++++++||||+++++++.+.+..+
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            34456799999999999999999965 578999999997542  334567899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC---CCEEEEccccceee
Q 039516           97 LVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ---LNTKISDFGMARIF  158 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfgl~~~~  158 (345)
                      +||||+++|+|.+.+.               +++.+|.|||..   ||+||||||+|||++.+   +.+||+|||++...
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            9999999999976653               667777777775   89999999999999865   45999999999876


Q ss_pred             cCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                      ....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      ... ......+.... .
T Consensus       182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~-~~~i~~~~~~~-~  250 (362)
T 2bdw_A          182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRL-YAQIKAGAYDY-P  250 (362)
T ss_dssp             TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HHHHHHTCCCC-C
T ss_pred             cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHH-HHHHHhCCCCC-C
Confidence            4322   22345799999999999999999999999999999999999999975431      111 11111221110 0


Q ss_pred             cccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          239 DLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       239 d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .+. ...++++.   .+++..||+.||.+|||+.+
T Consensus       251 ~~~-~~~~~~~~---~~li~~~L~~dP~~R~t~~e  281 (362)
T 2bdw_A          251 SPE-WDTVTPEA---KSLIDSMLTVNPKKRITADQ  281 (362)
T ss_dssp             TTG-GGGSCHHH---HHHHHHHSCSSGGGSCCHHH
T ss_pred             ccc-ccCCCHHH---HHHHHHHcCCChhhCcCHHH
Confidence            000 01122211   58999999999999999643

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.1e-42  Score=330.50  Aligned_cols=234  Identities=17%  Similarity=0.155  Sum_probs=177.5

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ..+|++.++||+|+||.||++... +++.||+|+++..   .......+.+|..++..++||||++++++|.+.+..|+|
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            457999999999999999999764 5889999999642   112233488999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           99 YEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        99 ~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      |||+++|+|.+++.                +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++......
T Consensus       153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            99999999988774                455666677765   89999999999999999999999999998764322


Q ss_pred             CCCcccceeecCCccccchhc-----cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 039516          163 SGANTNRIVGTYGYMSLEYTM-----SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLEL  237 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
                      . .......||+.|+|||++.     ...++.++|||||||++|||++|+.||......+      ..........  ..
T Consensus       230 ~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~--~~  300 (437)
T 4aw2_A          230 T-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKE--RF  300 (437)
T ss_dssp             C-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTHHH--HC
T ss_pred             C-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH------HHHhhhhccc--cc
Confidence            2 1223357999999999987     5678999999999999999999999997643211      1111111000  00


Q ss_pred             ccccCCCCCChhHHHHHHHHhhccCCCCCc--CCCC
Q 039516          238 IDLTLDGSCPPNEDAFLLVSCVCKSKQQID--VQCP  271 (345)
Q Consensus       238 ~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~  271 (345)
                      .-|......+++.   .+++.+||..+|++  ||++
T Consensus       301 ~~p~~~~~~s~~~---~dLi~~lL~~~~~r~~r~~~  333 (437)
T 4aw2_A          301 QFPTQVTDVSENA---KDLIRRLICSREHRLGQNGI  333 (437)
T ss_dssp             CCCSSCCCSCHHH---HHHHHTTSSCGGGCTTTTTT
T ss_pred             cCCcccccCCHHH---HHHHHHHhcccccccCCCCH
Confidence            0011111123222   48899999888877  8884

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.3e-41  Score=317.92  Aligned_cols=248  Identities=17%  Similarity=0.182  Sum_probs=191.0

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~   96 (345)
                      .-.+|++.+.||+|+||.||++... +|+.||||+++..   .......+..|..++..+ +||||+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3467999999999999999999764 5889999999654   234567788999999988 8999999999999999999


Q ss_pred             EEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           97 LVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      +||||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.....
T Consensus        98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            9999999999988765               556677777765   8999999999999999999999999999864221


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                        ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......... +..      .
T Consensus       175 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~-~~~------~  239 (353)
T 2i0e_A          175 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIME-HNV------A  239 (353)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-CCC------C
T ss_pred             --CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHh-CCC------C
Confidence              2223456899999999999999999999999999999999999999975432      111112221 111      1


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceee
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHF  292 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~  292 (345)
                      .....+.+.   ..++..||+.||.+||+...  ....+++.+..+...++
T Consensus       240 ~p~~~s~~~---~~li~~lL~~dP~~R~~~~~--~~~~~i~~h~~f~~~~w  285 (353)
T 2i0e_A          240 YPKSMSKEA---VAICKGLMTKHPGKRLGCGP--EGERDIKEHAFFRYIDW  285 (353)
T ss_dssp             CCTTSCHHH---HHHHHHHTCSCTTSCTTCST--THHHHHHTSGGGTTCCH
T ss_pred             CCCCCCHHH---HHHHHHHhhcCHHHcCCCCC--CCHHHHhcCccccCCCH
Confidence            111122222   59999999999999998531  23455555555544443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=326.86  Aligned_cols=251  Identities=17%  Similarity=0.136  Sum_probs=185.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ..+|++.+.||+|+||.||++.. .+|+.||||++++.   .......+.+|..++..++||||+++++++.+.+..|+|
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  139 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV  139 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            46799999999999999999976 57999999999643   122234588999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           99 YEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        99 ~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      |||+++|+|.+++.                +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++......
T Consensus       140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            99999999988764                455666677765   89999999999999999999999999998764322


Q ss_pred             CCCcccceeecCCccccchhc-------cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 039516          163 SGANTNRIVGTYGYMSLEYTM-------SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDL  235 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (345)
                      . .......||+.|+|||++.       +..++.++|||||||++|||++|+.||......+      ..........  
T Consensus       217 ~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~--  287 (412)
T 2vd5_A          217 T-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------TYGKIVHYKE--  287 (412)
T ss_dssp             C-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTHHH--
T ss_pred             c-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH------HHHHHHhccc--
Confidence            1 1223458999999999987       3578999999999999999999999997643211      1111111000  


Q ss_pred             ccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceeeE
Q 039516          236 ELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFL  293 (345)
Q Consensus       236 ~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~~  293 (345)
                      ...-+.....++++.   .+++.+||. +|.+|+...    ...+++.+..+.+.++.
T Consensus       288 ~~~~p~~~~~~s~~~---~dli~~lL~-~p~~Rlgr~----~~~ei~~Hpff~~i~w~  337 (412)
T 2vd5_A          288 HLSLPLVDEGVPEEA---RDFIQRLLC-PPETRLGRG----GAGDFRTHPFFFGLDWD  337 (412)
T ss_dssp             HCCCC----CCCHHH---HHHHHTTSS-CGGGCTTTT----THHHHHTSGGGTTCCST
T ss_pred             CcCCCccccCCCHHH---HHHHHHHcC-ChhhcCCCC----CHHHHhcCCCcCCCCHH
Confidence            000011111233322   489999999 999996411    13455566655554443

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=321.07  Aligned_cols=244  Identities=15%  Similarity=0.103  Sum_probs=190.2

Q ss_pred             CCCCCCCcceeecccccccccCCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCc--------cCHHHHHHHH
Q 039516            1 MDFENNTGCQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSG--------QGRVEFQNEA   71 (345)
Q Consensus         1 ~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~--------~~~~~~~~E~   71 (345)
                      |.....+..++.+.+......+..+|.+.+.||+|+||.||++. ..+++.||||.++....        .....+.+|+
T Consensus         1 m~~~~p~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~   80 (335)
T 3dls_A            1 MALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI   80 (335)
T ss_dssp             --------CEECCHHHHHTTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHH
T ss_pred             CCCcCCcccccccccccCCcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHH
Confidence            44555667778888888888888999999999999999999996 46789999999975521        1334678899


Q ss_pred             HHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCC-ChHHHHH---------------hHHHHHHHHHhcCCCceEEeccC
Q 039516           72 KLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK-SLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLK  135 (345)
Q Consensus        72 ~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk  135 (345)
                      .++++++||||+++++++.+.+..++||||+.+| +|.+++.               +++.+|.|||..   ||+|||||
T Consensus        81 ~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlk  157 (335)
T 3dls_A           81 AILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIK  157 (335)
T ss_dssp             HHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred             HHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccC
Confidence            9999999999999999999999999999999777 8876654               566777777776   89999999


Q ss_pred             CCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCc-CcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          136 ASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       136 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      |+|||++.++.+||+|||++......   .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....
T Consensus       158 p~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  234 (335)
T 3dls_A          158 DENIVIAEDFTIKLIDFGSAAYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE  234 (335)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred             HHHEEEcCCCcEEEeecccceECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence            99999999999999999999876432   22334679999999999988877 789999999999999999999997522


Q ss_pred             CCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          215 TERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..                 ......+  ...++.+.   .+++..||+.||.+|||+.
T Consensus       235 ~~-----------------~~~~~~~--~~~~~~~l---~~li~~~L~~dP~~Rps~~  270 (335)
T 3dls_A          235 ET-----------------VEAAIHP--PYLVSKEL---MSLVSGLLQPVPERRTTLE  270 (335)
T ss_dssp             GG-----------------TTTCCCC--SSCCCHHH---HHHHHHHTCSSGGGSCCHH
T ss_pred             HH-----------------HhhccCC--CcccCHHH---HHHHHHHccCChhhCcCHH
Confidence            10                 0000000  01122222   5899999999999999954

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.5e-42  Score=311.69  Aligned_cols=185  Identities=22%  Similarity=0.326  Sum_probs=153.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .+|.+.++||+|+||.||++...+|+.||+|++....  ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            3699999999999999999988789999999996543  23356788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      +++ +|.+++.                +++.+|.|||..   ||+||||||+||+++.++.+||+|||++.......  .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence            986 6655543                667777777765   89999999999999999999999999997653221  1


Q ss_pred             cccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  205 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS  205 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2233578999999999876 458999999999999999999999997643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.9e-42  Score=326.55  Aligned_cols=232  Identities=20%  Similarity=0.238  Sum_probs=174.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcC--CCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQ--YTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ..|.+.+.||+|+||.||++...+++.||||++...  .......+.+|+.+|++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            459999999999999999998878999999999654  3334577999999999996  599999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      | +.+++|.+++.               +++.+|.|||..   +|+||||||+|||++ ++.+||+|||+++........
T Consensus       136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            9 66788877664               456666666654   899999999999995 578999999999876433322


Q ss_pred             CcccceeecCCccccchhcc-----------CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMS-----------GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGK  233 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (345)
                      .......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....     .........    
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~----  281 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII----  281 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHH----
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHh----
Confidence            22344579999999999865           4688999999999999999999999975321     111112222    


Q ss_pred             ccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcc
Q 039516          234 DLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       234 ~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~  274 (345)
                           ++......+...... .+++..||+.||.+|||+.++
T Consensus       282 -----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~el  318 (390)
T 2zmd_A          282 -----DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL  318 (390)
T ss_dssp             -----CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             -----CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHH
Confidence                 111111111111223 589999999999999996543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.9e-42  Score=312.96  Aligned_cols=243  Identities=21%  Similarity=0.247  Sum_probs=178.2

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcC----CCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFP----NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~----~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ...+|++.+.||+|+||.||+|...    .+..||+|.+... .....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence            3457999999999999999999763    2467999998754 333456799999999999999999999997 456789


Q ss_pred             EEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           97 LVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      +||||+++++|.+++.                +++.+|.+||..   ||+||||||+||+++.++.+||+|||++.....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence            9999999999988764                556677777765   899999999999999999999999999987643


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      .... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+   ...    ....+...    
T Consensus       169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~----~i~~~~~~----  236 (281)
T 1mp8_A          169 STYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG----RIENGERL----  236 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCC----
T ss_pred             cccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHH----HHHcCCCC----
Confidence            2211 1223456788999999998999999999999999999997 999997654322   111    11111111    


Q ss_pred             ccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          240 LTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       240 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                       .+...+++.-   .+++..||+.||.+|||+.++...|..+++.
T Consensus       237 -~~~~~~~~~l---~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          237 -PMPPNCPPTL---YSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             -CCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHH---HHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence             1111223222   5899999999999999998888888877653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=316.73  Aligned_cols=224  Identities=19%  Similarity=0.198  Sum_probs=169.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC--ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|++.++||+|+||+||+|... +|+.||||++....  ......+..|+..+.++ +||||++++++|.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            56999999999999999999764 79999999986542  23344566666666555 9999999999999999999999


Q ss_pred             ecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          100 EFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       100 e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      ||+ +++|.+++.                +++.+|.|||..   +|+||||||+|||++.++.+||+|||++....... 
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            999 567766543                667778888875   89999999999999999999999999998764322 


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                        ......||+.|+|||++.+ .++.++|||||||++|||++|..|+....          .+..+..+..    .+.+.
T Consensus       212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~----~~~~~  274 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYL----PPEFT  274 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCC----CHHHH
T ss_pred             --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCC----Ccccc
Confidence              2233568999999998875 78999999999999999999977664311          1222222211    11111


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..++.+.   .+++..||+.||++|||+.
T Consensus       275 ~~~~~~l---~~li~~~L~~dP~~Rpt~~  300 (311)
T 3p1a_A          275 AGLSSEL---RSVLVMMLEPDPKLRATAE  300 (311)
T ss_dssp             TTSCHHH---HHHHHHHSCSSTTTSCCHH
T ss_pred             cCCCHHH---HHHHHHHcCCChhhCcCHH
Confidence            1122221   5899999999999999954

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=326.85  Aligned_cols=235  Identities=17%  Similarity=0.203  Sum_probs=180.9

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      .+..+|.+.+.||+|+||.||++. ..+|+.||+|.+....  ......+.+|+.++++++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            345679999999999999999995 4579999999997543  2345678999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC---CCCCEEEEccccceeec
Q 039516           98 VYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD---DQLNTKISDFGMARIFG  159 (345)
Q Consensus        98 v~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfgl~~~~~  159 (345)
                      ||||+++|+|.+.+.               +++.+|.|||..   ||+||||||+|||++   .++.+||+|||++....
T Consensus        88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            999999999977653               567777777776   899999999999998   46789999999998764


Q ss_pred             CCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|..||......      . .......+... ...
T Consensus       165 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~-~~~~i~~~~~~-~~~  234 (444)
T 3soa_A          165 GEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------R-LYQQIKAGAYD-FPS  234 (444)
T ss_dssp             TTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-HHHHHHHTCCC-CCT
T ss_pred             CCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------H-HHHHHHhCCCC-CCc
Confidence            322  2223457999999999999999999999999999999999999999754311      1 11111122111 001


Q ss_pred             ccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          240 LTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       240 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +. ....+++.   .+++..||+.||.+|||+.
T Consensus       235 ~~-~~~~s~~~---~~li~~~L~~dP~~Rpta~  263 (444)
T 3soa_A          235 PE-WDTVTPEA---KDLINKMLTINPSKRITAA  263 (444)
T ss_dssp             TT-TTTSCHHH---HHHHHHHSCSSTTTSCCHH
T ss_pred             cc-cccCCHHH---HHHHHHHcCCChhHCCCHH
Confidence            10 11122222   5999999999999999954

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.6e-41  Score=312.56  Aligned_cols=246  Identities=16%  Similarity=0.150  Sum_probs=179.1

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc----CCCcEEEEEEeccCC----ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF----PNEQEVAIKRLAWTS----GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE   94 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~----~~~~~VaiK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~   94 (345)
                      ..+|++.+.||+|+||.||++..    .+|+.||+|+++...    ......+.+|+.++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999976    478999999997542    2344568899999999999999999999999999


Q ss_pred             eEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           95 RLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      .|+||||+++++|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++...
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            999999999999987664               556677777765   89999999999999999999999999987643


Q ss_pred             CCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      ...  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....      .......... ..     
T Consensus       173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~-~~-----  238 (327)
T 3a62_A          173 HDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILKC-KL-----  238 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHT-CC-----
T ss_pred             cCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhC-CC-----
Confidence            221  122345789999999999999999999999999999999999999976432      1111112111 10     


Q ss_pred             ccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccccccccee
Q 039516          240 LTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLH  291 (345)
Q Consensus       240 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~  291 (345)
                       .+....+.+.   .+++..||+.||.+||++..  ....+++.+..+....
T Consensus       239 -~~p~~~~~~~---~~li~~~L~~dp~~R~~~~~--~~~~e~l~hp~f~~~~  284 (327)
T 3a62_A          239 -NLPPYLTQEA---RDLLKKLLKRNAASRLGAGP--GDAGEVQAHPFFRHIN  284 (327)
T ss_dssp             -CCCTTSCHHH---HHHHHHHSCSCGGGSTTSST--TTHHHHHHSGGGSSCC
T ss_pred             -CCCCCCCHHH---HHHHHHHHhcCHhhccCCCC--CCHHHHHcCCcccCCC
Confidence             1111122222   59999999999999997531  1234455555544433

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9.1e-42  Score=318.71  Aligned_cols=234  Identities=19%  Similarity=0.178  Sum_probs=180.2

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC-----CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT-----SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      +...|++.+.||+|+||.||++.. .+|+.||||++...     .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            456799999999999999999965 57999999998542     223467899999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC---EEEEccc
Q 039516           96 LLVYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN---TKISDFG  153 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfg  153 (345)
                      |+||||+++++|.+.+.                   +++.+|.|||..   +|+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence            99999999999965542                   556667777765   8999999999999986654   9999999


Q ss_pred             cceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 039516          154 MARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGK  233 (345)
Q Consensus       154 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (345)
                      ++.......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....       . .......+.
T Consensus       179 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~-~~~~i~~~~  248 (351)
T 3c0i_A          179 VAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------R-LFEGIIKGK  248 (351)
T ss_dssp             TCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------H-HHHHHHHTC
T ss_pred             ceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------H-HHHHHHcCC
Confidence            998764322  122345799999999999999999999999999999999999999975311       1 111111111


Q ss_pred             ccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          234 DLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       234 ~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      ..  .++.....++.+.   .+++.+||+.||++|||+.+
T Consensus       249 ~~--~~~~~~~~~s~~~---~~li~~~L~~dP~~R~s~~e  283 (351)
T 3c0i_A          249 YK--MNPRQWSHISESA---KDLVRRMLMLDPAERITVYE  283 (351)
T ss_dssp             CC--CCHHHHTTSCHHH---HHHHHHHTCSSTTTSCCHHH
T ss_pred             CC--CCccccccCCHHH---HHHHHHHCCCChhHCcCHHH
Confidence            10  0000001122211   58999999999999999543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.5e-42  Score=320.92  Aligned_cols=244  Identities=20%  Similarity=0.240  Sum_probs=190.2

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcC-CC-----cEEEEEEeccCC-ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECC
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFP-NE-----QEVAIKRLAWTS-GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGE   93 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~-~~-----~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~   93 (345)
                      ...+|.+.+.||+|+||.||++... ++     ..||+|.+.... ......+.+|+.+++++ +||||+++++++...+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            3467999999999999999999753 23     489999997553 33456799999999999 8999999999999999


Q ss_pred             eeEEEEecCCCCChHHHHH-----------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC
Q 039516           94 ERLLVYEFMPNKSLDSSFS-----------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ  144 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~-----------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~  144 (345)
                      ..++||||+++|+|.+++.                             +++.+|.|||..   ||+||||||+||+++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence            9999999999999987753                             456667777765   89999999999999999


Q ss_pred             CCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHH
Q 039516          145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVG  223 (345)
Q Consensus       145 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~  223 (345)
                      +.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||........     
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-----  275 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-----  275 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-----
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-----
Confidence            9999999999987644333323334567889999999999999999999999999999999 9999976442211     


Q ss_pred             HHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          224 IAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       224 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                       .......+..     ......++    .. ..++..||+.||.+|||+.++...|.++..
T Consensus       276 -~~~~~~~~~~-----~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          276 -FYKLVKDGYQ-----MAQPAFAP----KNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             -HHHHHHHTCC-----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHhcCCC-----CCCCCCCC----HHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence             1111111110     00111122    23 589999999999999998888777776654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.4e-41  Score=314.09  Aligned_cols=236  Identities=17%  Similarity=0.102  Sum_probs=160.1

Q ss_pred             CCeeeE---EEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEE
Q 039516           24 LDWHMY---IQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        24 ~~~~~~---~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv   98 (345)
                      ..|++.   +.||+|+||.||++.. .+|+.||||++...   ....+.+|+.+++.+. ||||+++++++.+....++|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv   84 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV   84 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence            345554   6699999999999975 46899999999643   3567889999999997 99999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC---CEEEEccccceeecC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL---NTKISDFGMARIFGV  160 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~---~~kl~Dfgl~~~~~~  160 (345)
                      |||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++   .+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           85 MELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             ECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             EEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            99999999987764               566777777765   899999999999997665   799999999986543


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ..  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....................+....  ..
T Consensus       162 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~--~~  237 (325)
T 3kn6_A          162 DN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF--EG  237 (325)
T ss_dssp             ------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC--CS
T ss_pred             CC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC--Cc
Confidence            22  222345789999999999999999999999999999999999999986543222211222222222222110  00


Q ss_pred             cCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          241 TLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       241 ~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .....++    .. .+++..||+.||.+|||+.+
T Consensus       238 ~~~~~~s----~~~~~li~~~L~~dP~~Rpt~~e  267 (325)
T 3kn6_A          238 EAWKNVS----QEAKDLIQGLLTVDPNKRLKMSG  267 (325)
T ss_dssp             HHHHTSC----HHHHHHHHHHHCCCTTTCCCTTT
T ss_pred             ccccCCC----HHHHHHHHHHCCCChhHCCCHHH
Confidence            0000011    22 68999999999999999764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-41  Score=313.39  Aligned_cols=253  Identities=19%  Similarity=0.236  Sum_probs=186.2

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhc--CCCCeeeEEEEEEEC----Cee
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL--QYTNLVKLLGCSIHG----EER   95 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~~~~~~~~~----~~~   95 (345)
                      +..+|.+.++||+|+||.||+|... |+.||||++...   ....+..|.+++..+  +||||+++++++...    ...
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            3457999999999999999999875 899999998543   234556666666555  899999999999887    789


Q ss_pred             EEEEecCCCCChHHHHH--------------hHHHHHHHHHhc-----CCCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516           96 LLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKY-----SRLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~-----~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                      ++||||+++|+|.+++.              +++.+|.|||..     +..||+||||||+|||++.++.+||+|||++.
T Consensus       111 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~  190 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  190 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence            99999999999988765              566777788765     24489999999999999999999999999998


Q ss_pred             eecCCCCCC--cccceeecCCccccchhccCCcCcc------cchhhHHHHHHHHHhC----------CCCCCCCCCCCc
Q 039516          157 IFGVNESGA--NTNRIVGTYGYMSLEYTMSGTVSIK------TDVFGFGVLVLKIVCG----------KKNNKSYHTERP  218 (345)
Q Consensus       157 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~Di~SlG~il~el~tg----------~~p~~~~~~~~~  218 (345)
                      .........  ......||+.|+|||++.+...+.+      +|||||||++|||++|          +.||........
T Consensus       191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  270 (337)
T 3mdy_A          191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP  270 (337)
T ss_dssp             ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence            764322211  1223578999999999987766654      9999999999999999          666654432221


Q ss_pred             ccHHHHHHHHHhcCCccccccccCCCCCCh-hHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          219 LNLVGIAWQLWNEGKDLELIDLTLDGSCPP-NEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      . . ...........    ..+.+...... ..... .+++..||+.||.+|||+.++...|..+++.
T Consensus       271 ~-~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          271 S-Y-EDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             C-H-HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             c-h-hhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            1 1 11111111111    11111111112 33344 7999999999999999999988888887764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.5e-41  Score=308.81  Aligned_cols=184  Identities=21%  Similarity=0.261  Sum_probs=153.9

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      .+|++.++||+|+||.||++.. .+|+.||||++....  ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            3699999999999999999975 468999999997553  2335678999999999999999999999999999999999


Q ss_pred             cCCCCChHHH---------------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          101 FMPNKSLDSS---------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       101 ~~~~gsL~~~---------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |++++.+..+               +.+++.+|.|||..   ||+||||||+||+++.++.+||+|||++.......  .
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  156 (292)
T 3o0g_A           82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--R  156 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--S
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--c
Confidence            9986433322               22667777788776   89999999999999999999999999998764322  2


Q ss_pred             cccceeecCCccccchhccCC-cCcccchhhHHHHHHHHHhCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGT-VSIKTDVFGFGVLVLKIVCGKKNNKS  212 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~SlG~il~el~tg~~p~~~  212 (345)
                      ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~  204 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence            223457899999999988765 79999999999999999999888643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.4e-41  Score=319.87  Aligned_cols=248  Identities=17%  Similarity=0.180  Sum_probs=182.0

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHH-HHhcCCCCeeeEEEEEEECCeeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKL-IAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      ..+|++.+.||+|+||.||++.. .+++.||||+++...   ......+..|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            46799999999999999999975 468999999996542   2334456777776 567899999999999999999999


Q ss_pred             EEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           98 VYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        98 v~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      ||||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++..... 
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence            999999999987764               556667777765   8999999999999999999999999999754222 


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                       ........||+.|+|||++.+..++.++|||||||++|||++|..||.....      .......... ..      .+
T Consensus       193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~-~~------~~  258 (373)
T 2r5t_A          193 -NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNK-PL------QL  258 (373)
T ss_dssp             -CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHS-CC------CC
T ss_pred             -CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc-cc------CC
Confidence             2233456899999999999999999999999999999999999999975431      1111122211 11      11


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceeeEE
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLL  294 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~~~  294 (345)
                      ....+.+.   ..++..||+.||.+||++.+   .+.+++.+..+...++..
T Consensus       259 ~~~~~~~~---~~li~~lL~~dp~~R~~~~~---~~~~i~~h~~f~~~~w~~  304 (373)
T 2r5t_A          259 KPNITNSA---RHLLEGLLQKDRTKRLGAKD---DFMEIKSHVFFSLINWDD  304 (373)
T ss_dssp             CSSSCHHH---HHHHHHHTCSSGGGSTTTTT---THHHHHTSGGGTTCCHHH
T ss_pred             CCCCCHHH---HHHHHHHcccCHHhCCCCCC---CHHHHhCCccccCCCHHH
Confidence            11222222   58999999999999999753   344555565555544433

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.5e-43  Score=320.78  Aligned_cols=258  Identities=21%  Similarity=0.205  Sum_probs=188.1

Q ss_pred             CCCCe-eeEEEeeccCCeEEEEEEc-----CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--
Q 039516           22 SSLDW-HMYIQQEQTRDRVILVGKF-----PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--   92 (345)
Q Consensus        22 ~~~~~-~~~~~lG~G~~g~vy~~~~-----~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--   92 (345)
                      +...| .+.++||+|+||.||++.+     .+|+.||||+++... ......+.+|++++++++||||+++++++.+.  
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            44445 9999999999999998854     268899999997653 34466799999999999999999999999874  


Q ss_pred             CeeEEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           93 EERLLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      ...++||||+++++|.+++.              +++.+|.+||..   ||+||||||+||+++.++.+||+|||++...
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             ceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence            67899999999999987654              566777777775   8999999999999999999999999999876


Q ss_pred             cCCCCC-CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 039516          159 GVNESG-ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLEL  237 (345)
Q Consensus       159 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
                      ...... .......+|..|+|||++.+..++.++||||||+++|+|++|..||....... .....+...........+.
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHH
Confidence            433211 11223457888999999999999999999999999999999999986432100 0000000000000000111


Q ss_pred             ccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          238 IDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       238 ~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ++.......+...... .+++..||+.||.+|||+.++...|..+.+
T Consensus       264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            1111111111222233 699999999999999999888888887765

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.4e-42  Score=315.10  Aligned_cols=250  Identities=22%  Similarity=0.283  Sum_probs=190.5

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-----CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEE--ECCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-----PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSI--HGEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-----~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~--~~~~~   95 (345)
                      ...|++.++||+|+||.||++.+     .+++.||||++........+.+.+|++++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36799999999999999999973     468999999998776666778999999999999999999999987  45678


Q ss_pred             EEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           96 LLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      ++||||+++++|.+++.                +++.+|.+||..   ||+||||||+||+++.++.+||+|||++....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            99999999999988764                556667777765   89999999999999999999999999998764


Q ss_pred             CCCCC-CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCC--------CcccHHHHHHHHHh
Q 039516          160 VNESG-ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTE--------RPLNLVGIAWQLWN  230 (345)
Q Consensus       160 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~--------~~~~~~~~~~~~~~  230 (345)
                      ..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||......        ..............
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            32211 1122345788899999999999999999999999999999999998643210        00001111111111


Q ss_pred             cCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          231 EGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       231 ~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      .+.         ....+...... .+++..||+.||.+|||+.++...|..++..
T Consensus       259 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          259 EGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             ccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            111         11112222233 5999999999999999999888888877664

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6e-42  Score=326.01  Aligned_cols=245  Identities=20%  Similarity=0.235  Sum_probs=183.9

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ..+|++.+.||+|+||.||++.. .+++.||+|+++..   .......+.+|+.+++.++||||++++++|.+....|+|
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV  147 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  147 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            45799999999999999999975 46899999999642   122334588999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516           99 YEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus        99 ~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||+++|+|.+++.              +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++....... 
T Consensus       148 ~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-  223 (410)
T 3v8s_A          148 MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-  223 (410)
T ss_dssp             ECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-
T ss_pred             EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-
Confidence            99999999988765              556666777765   899999999999999999999999999987643211 


Q ss_pred             CcccceeecCCccccchhccCC----cCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGT----VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||......      ...............  +
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~--p  295 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSLTF--P  295 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHHHCCC--C
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHhccccccC--C
Confidence            1223468999999999998655    889999999999999999999999754321      111111111000000  0


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCc--CCCCCcchhhhhcccccccccce
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQID--VQCPMLFPCLLMNLLPGLYLKNL  290 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~~~~~~l~~ll~~~~~~~~  290 (345)
                       ....++.+.   .+++..||+.+|.+  ||++       .+++.+..+.+.
T Consensus       296 -~~~~~s~~~---~~li~~lL~~~~~rlgR~~~-------~ei~~Hp~f~~~  336 (410)
T 3v8s_A          296 -DDNDISKEA---KNLICAFLTDREVRLGRNGV-------EEIKRHLFFKND  336 (410)
T ss_dssp             -TTCCCCHHH---HHHHHHHSSCGGGCTTSSCH-------HHHHTSGGGCCS
T ss_pred             -CcccccHHH---HHHHHHHccChhhhCCCCCH-------HHHhcCccccCC
Confidence             001122222   58999999988888  9994       344555554443

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-42  Score=318.89  Aligned_cols=241  Identities=22%  Similarity=0.310  Sum_probs=180.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCc----EEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQ----EVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~----~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ..+|.+.++||+|+||.||+|.. .+++    +||+|.+... .......+.+|+.++++++||||+++++++... ..+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence            46799999999999999999975 3454    4688877543 445678899999999999999999999999765 488


Q ss_pred             EEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           97 LVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      +|++|+.+|+|.+++.                +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            9999999999988764                566677777765   899999999999999999999999999987654


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      ...........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.......   +.    .....+...    
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~----~~~~~~~~~----  238 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGERL----  238 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCCC----
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCCCC----
Confidence            333333334466888999999999999999999999999999999 999997654322   11    111111100    


Q ss_pred             ccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          240 LTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       240 ~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                           ..+...... ..++..||+.||.+|||+.++...|.++..
T Consensus       239 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          239 -----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             -----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                 011112223 589999999999999999988888887765

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.9e-42  Score=314.05  Aligned_cols=247  Identities=22%  Similarity=0.289  Sum_probs=185.5

Q ss_pred             cccCCCCeeeEEEeeccCCeEEEEEEcCC----CcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEE-EC
Q 039516           19 VENSSLDWHMYIQQEQTRDRVILVGKFPN----EQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSI-HG   92 (345)
Q Consensus        19 ~~~~~~~~~~~~~lG~G~~g~vy~~~~~~----~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~-~~   92 (345)
                      .......|++.+.||+|+||.||+|...+    +..||+|.++... ......+.+|+.++++++||||+++++++. .+
T Consensus        20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE   99 (298)
T ss_dssp             CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence            45556779999999999999999997532    2468999997543 334567999999999999999999999865 45


Q ss_pred             CeeEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516           93 EERLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                      +..++||||+++++|.+++.                +++.+|.+||..   ||+||||||+||+++.++.+||+|||++.
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence            67899999999999988774                456667777765   89999999999999999999999999998


Q ss_pred             eecCCCC--CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 039516          157 IFGVNES--GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGK  233 (345)
Q Consensus       157 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (345)
                      .......  ........||+.|+|||.+.+..++.++||||||+++|+|++ |.+||.......   ...   ... .+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~---~~~-~~~  249 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV---YLL-QGR  249 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHH---HHH-TTC
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHH---HHh-cCC
Confidence            6543221  112233467888999999999999999999999999999999 555665443222   111   111 111


Q ss_pred             ccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          234 DLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       234 ~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .     ......++..-   .+++..||+.||.+|||+.++...|.+++.
T Consensus       250 ~-----~~~~~~~~~~l---~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          250 R-----LLQPEYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             C-----CCCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C-----CCCCccCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            0     00111122211   589999999999999999888888887765

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.5e-41  Score=311.21  Aligned_cols=186  Identities=24%  Similarity=0.349  Sum_probs=144.1

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ..+|++.++||+|+||.||+|.. .+|+.||+|.++... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            45799999999999999999975 468999999997553 3345678999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516          101 FMPNKSLDSSFS---------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      |++ ++|.+++.                     +++.+|.|||..   ||+||||||+|||++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 47766543                     566677777765   89999999999999999999999999998764


Q ss_pred             CCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  213 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN  213 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            3221  2233578999999999876 468999999999999999999999997654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=309.47  Aligned_cols=230  Identities=19%  Similarity=0.183  Sum_probs=173.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc--------------------------cCHHHHHHHHHHHHh
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG--------------------------QGRVEFQNEAKLIAK   76 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~--------------------------~~~~~~~~E~~~l~~   76 (345)
                      .+|.+.+.||+|+||.||++.. .+|+.||||++.....                          ...+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            5699999999999999999965 5789999999965421                          123568899999999


Q ss_pred             cCCCCeeeEEEEEEE--CCeeEEEEecCCCCChHHH--------------HHhHHHHHHHHHhcCCCceEEeccCCCCee
Q 039516           77 LQYTNLVKLLGCSIH--GEERLLVYEFMPNKSLDSS--------------FSGTFKDLLCLHKYSRLRVIHRDLKASNIL  140 (345)
Q Consensus        77 l~H~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~--------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nil  140 (345)
                      ++||||+++++++.+  ....++||||+++++|.++              +.+++.+|.|||..   ||+||||||+||+
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLL  169 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEE
Confidence            999999999999986  5689999999999887543              33677788888876   8999999999999


Q ss_pred             eCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCC---cCcccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 039516          141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGT---VSIKTDVFGFGVLVLKIVCGKKNNKSYHTER  217 (345)
Q Consensus       141 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~SlG~il~el~tg~~p~~~~~~~~  217 (345)
                      ++.++.+||+|||++.......  .......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||....   
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---  244 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER---  244 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred             ECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc---
Confidence            9999999999999998764322  1223457899999999987655   4788999999999999999999997532   


Q ss_pred             cccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          218 PLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                         ......... ......   + ....++.+.   .+++.+||+.||++|||+.
T Consensus       245 ---~~~~~~~~~-~~~~~~---~-~~~~~~~~l---~~li~~~l~~dp~~R~s~~  288 (298)
T 2zv2_A          245 ---IMCLHSKIK-SQALEF---P-DQPDIAEDL---KDLITRMLDKNPESRIVVP  288 (298)
T ss_dssp             ---HHHHHHHHH-HCCCCC---C-SSSCCCHHH---HHHHHHHTCSCTTTSCCHH
T ss_pred             ---HHHHHHHHh-cccCCC---C-CccccCHHH---HHHHHHHhhcChhhCCCHH
Confidence               111111111 111110   0 011122222   5899999999999999954

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.4e-42  Score=320.75  Aligned_cols=195  Identities=23%  Similarity=0.293  Sum_probs=163.2

Q ss_pred             CCcceeecccccccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-----C
Q 039516            6 NTGCQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-----Y   79 (345)
Q Consensus         6 ~~~~~s~~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-----H   79 (345)
                      +...+++.+...+.    .+|.+.++||+|+||.||++.. .+++.||||+++.. ......+..|+.+++.++     |
T Consensus        21 ~~~~~~~~~g~~~~----~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h   95 (360)
T 3llt_A           21 EIVHFSWKKGMLLN----NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINN   95 (360)
T ss_dssp             GGGSCCCCTTCEET----TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTG
T ss_pred             cceeeeeecceEec----CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCC
Confidence            34555665555554    4599999999999999999975 57899999999643 234556788999999996     9


Q ss_pred             CCeeeEEEEEEECCeeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC
Q 039516           80 TNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD  142 (345)
Q Consensus        80 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~  142 (345)
                      |||+++++++...+..++||||+ +++|.+++.                 +++.+|.|||..   ||+||||||+|||++
T Consensus        96 ~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~  171 (360)
T 3llt_A           96 NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLD  171 (360)
T ss_dssp             GGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEES
T ss_pred             CCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEc
Confidence            99999999999999999999999 889877654                 566677777765   899999999999997


Q ss_pred             C-------------------------CCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHH
Q 039516          143 D-------------------------QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFG  197 (345)
Q Consensus       143 ~-------------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG  197 (345)
                      .                         ++.+||+|||++......     .....||+.|+|||++.+..++.++||||||
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  246 (360)
T 3llt_A          172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFG  246 (360)
T ss_dssp             CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred             cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHH
Confidence            5                         788999999999864321     2335789999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCC
Q 039516          198 VLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       198 ~il~el~tg~~p~~~~~  214 (345)
                      |++|+|++|+.||....
T Consensus       247 ~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          247 CVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             HHHHHHHHSSCSCCCSS
T ss_pred             HHHHHHHHCCCCCCCCc
Confidence            99999999999997644

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=318.58  Aligned_cols=227  Identities=19%  Similarity=0.153  Sum_probs=173.3

Q ss_pred             eEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCC
Q 039516           28 MYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS  106 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gs  106 (345)
                      ..+.||+|+||.||++.. .+|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            356799999999999965 5799999999987665567789999999999999999999999999999999999999999


Q ss_pred             hHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeee--CCCCCEEEEccccceeecCCCCCCccc
Q 039516          107 LDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILL--DDQLNTKISDFGMARIFGVNESGANTN  168 (345)
Q Consensus       107 L~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill--~~~~~~kl~Dfgl~~~~~~~~~~~~~~  168 (345)
                      |.+++.                +++.+|.|||..   ||+||||||+|||+  +.++.+||+|||+++......   ...
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~  246 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLK  246 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCC
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccc
Confidence            977653                566777777765   89999999999999  567889999999998764322   223


Q ss_pred             ceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCCh
Q 039516          169 RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPP  248 (345)
Q Consensus       169 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  248 (345)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......      .......... ..  +.......+++
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~-~~--~~~~~~~~~~~  317 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACR-WD--LEDEEFQDISE  317 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTC-CC--SCSGGGTTSCH
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcc-CC--CChhhhccCCH
Confidence            346999999999999999999999999999999999999999764321      1111111111 10  00000111222


Q ss_pred             hHHHHHHHHhhccCCCCCcCCCCC
Q 039516          249 NEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       249 ~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +.   .+++..||+.||.+|||+.
T Consensus       318 ~~---~~li~~~L~~dp~~Rps~~  338 (373)
T 2x4f_A          318 EA---KEFISKLLIKEKSWRISAS  338 (373)
T ss_dssp             HH---HHHHHTTSCSSGGGSCCHH
T ss_pred             HH---HHHHHHHcCCChhhCCCHH
Confidence            22   5999999999999999954

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.5e-41  Score=307.90  Aligned_cols=237  Identities=21%  Similarity=0.198  Sum_probs=183.5

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcC-CC-------cEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFP-NE-------QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE   93 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~-~~-------~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~   93 (345)
                      ...+|.+.+.||+|+||.||++... ++       ..||+|.+........+.+.+|+.++++++||||+++++++.+.+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            3457999999999999999999653 23       579999997766667788999999999999999999999999999


Q ss_pred             eeEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC--------EEE
Q 039516           94 ERLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN--------TKI  149 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~--------~kl  149 (345)
                      ..++||||+++++|.+++.                +++.+|.|||..   ||+||||||+|||++.++.        +||
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence            9999999999999988765                556667777765   8999999999999988877        999


Q ss_pred             EccccceeecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 039516          150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQL  228 (345)
Q Consensus       150 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  228 (345)
                      +|||++....      ......||+.|+|||++.+ ..++.++||||||+++|+|++|..|+.....     .... ...
T Consensus       163 ~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~~-~~~  230 (289)
T 4fvq_A          163 SDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQRK-LQF  230 (289)
T ss_dssp             CCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHH-HHH
T ss_pred             ccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-----hHHH-HHH
Confidence            9999986431      1233568999999999987 7789999999999999999996554432211     1111 111


Q ss_pred             HhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          229 WNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       229 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .....       .+....+.+.   .+++..||+.||.+|||+.++...|.+++.
T Consensus       231 ~~~~~-------~~~~~~~~~l---~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          231 YEDRH-------QLPAPKAAEL---ANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHTTC-------CCCCCSSCTT---HHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             hhccC-------CCCCCCCHHH---HHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            11110       0111111111   489999999999999999888888877665

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9.2e-42  Score=307.82  Aligned_cols=240  Identities=25%  Similarity=0.356  Sum_probs=187.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ..+|.+.+.||+|+||.||+|...++..||+|.+.... .....+.+|++++++++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            35699999999999999999998888899999996543 34678999999999999999999999975 55689999999


Q ss_pred             CCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          103 PNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       103 ~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ++++|.+++.                 +++.+|.+||..   ||+||||||+||+++.++.+||+|||++........ .
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-c
Confidence            9999987653                 456667777765   899999999999999999999999999987643221 1


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |+.||......      ..... ...+.     ......
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~-~~~~~-----~~~~~~  233 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQN-LERGY-----RMVRPD  233 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHH-HHTTC-----CCCCCT
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHHH-Hhccc-----CCCCcc
Confidence            1223456788999999998999999999999999999999 99999764321      11111 11111     011111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .++...   .+++..||+.||++|||+.++...|.+++.
T Consensus       234 ~~~~~l---~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          234 NCPEEL---YQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             TCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccHHH---HHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            222221   589999999999999998888877777665

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-40  Score=300.08  Aligned_cols=234  Identities=19%  Similarity=0.196  Sum_probs=181.8

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      .+..+|.+.+.||+|+||.||++.. .+|+.||+|++...  .......+.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            4567899999999999999999965 56899999999654  33345678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC---EEEEccccceeec
Q 039516           98 VYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN---TKISDFGMARIFG  159 (345)
Q Consensus        98 v~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfgl~~~~~  159 (345)
                      ||||+++++|.+.+.               +++.+|.+||..   ||+||||||+||+++.++.   +||+|||++....
T Consensus        83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            999999999976543               566777777775   8999999999999976655   9999999998764


Q ss_pred             CCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      ...   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......      .... ....+... ...
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~-~~~~~~~~-~~~  228 (284)
T 3kk8_A          160 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYA-QIKAGAYD-YPS  228 (284)
T ss_dssp             SSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH-HHHHTCCC-CCT
T ss_pred             cCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------HHHH-HHHhcccc-CCc
Confidence            322   223357899999999999999999999999999999999999999754311      1111 11111111 000


Q ss_pred             ccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          240 LTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       240 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +. ...++++.   .+++..||+.||.+|||+.
T Consensus       229 ~~-~~~~~~~~---~~li~~~l~~dp~~Rps~~  257 (284)
T 3kk8_A          229 PE-WDTVTPEA---KSLIDSMLTVNPKKRITAD  257 (284)
T ss_dssp             TT-TTTSCHHH---HHHHHHHSCSSTTTSCCHH
T ss_pred             hh-hcccCHHH---HHHHHHHcccChhhCCCHH
Confidence            00 01122222   5899999999999999954

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.6e-41  Score=318.25  Aligned_cols=235  Identities=18%  Similarity=0.157  Sum_probs=172.1

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .....|.+.+.||+|+||.||++.. .+++.||||++..... ....+.+|+.++++++||||+++++++.+.+..++||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            3456799999999999999999975 4799999999975432 3467889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC--EEEEccccceeecCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN--TKISDFGMARIFGVNE  162 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~--~kl~Dfgl~~~~~~~~  162 (345)
                      ||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.  +||+|||+++..... 
T Consensus        96 e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-  171 (361)
T 3uc3_A           96 EYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  171 (361)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence            9999999987764               567777777765   8999999999999987765  999999998753221 


Q ss_pred             CCCcccceeecCCccccchhccCCcCcc-cchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIK-TDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                        .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........  ............ ..  +.. 
T Consensus       172 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~~-~~--~~~-  243 (361)
T 3uc3_A          172 --SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSVK-YS--IPD-  243 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTTC-CC--CCT-
T ss_pred             --CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcCC-CC--CCC-
Confidence              12234579999999999988887655 8999999999999999999986543322  222222221111 10  000 


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                       ....+++.   .+++.+||+.||.+|||+.
T Consensus       244 -~~~~s~~~---~~li~~~L~~dP~~Rps~~  270 (361)
T 3uc3_A          244 -DIRISPEC---CHLISRIFVADPATRISIP  270 (361)
T ss_dssp             -TSCCCHHH---HHHHHHHSCSCTTTSCCHH
T ss_pred             -cCCCCHHH---HHHHHHHccCChhHCcCHH
Confidence             00122222   5999999999999999954

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.5e-41  Score=327.15  Aligned_cols=248  Identities=17%  Similarity=0.163  Sum_probs=179.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ..+|++.+.||+|+||.||++.. .+|+.||||+++..   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            35799999999999999999964 57999999999653   334456788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |||+++|+|.+++.               +++.+|.|||..  .||+||||||+|||++.++.+||+|||+++.....  
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCC--
Confidence            99999999977664               567778888862  38999999999999999999999999999753221  


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||......      .......... .      .+.
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~-~------~~p  369 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEE-I------RFP  369 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-C------CCC
T ss_pred             CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHHhCC-C------CCC
Confidence            12233468999999999999999999999999999999999999999754321      1111111111 1      111


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceee
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHF  292 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~  292 (345)
                      ...+++.   .+++..||+.||.+||+..  .....+++.+..+.+..+
T Consensus       370 ~~~~~~~---~~li~~~L~~dP~~R~~~~--~~t~~ell~hp~f~~~~~  413 (446)
T 4ejn_A          370 RTLGPEA---KSLLSGLLKKDPKQRLGGG--SEDAKEIMQHRFFAGIVW  413 (446)
T ss_dssp             TTSCHHH---HHHHHHHTCSSTTTSTTCS--TTTHHHHHTSGGGTTCCH
T ss_pred             ccCCHHH---HHHHHHHcccCHHHhCCCC--CCCHHHHHhCccccCCCH
Confidence            1122222   5999999999999999311  112445566665555443

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1e-41  Score=312.74  Aligned_cols=238  Identities=19%  Similarity=0.234  Sum_probs=175.6

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc---cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG---QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE--   93 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--   93 (345)
                      ..+..+|.+.+.||+|+||.||++.. .+++.||||+++....   .....+.+|+.++++++||||+++++++....  
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence            44567799999999999999999974 6799999999976532   23457889999999999999999999987654  


Q ss_pred             --eeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516           94 --ERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus        94 --~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                        ..|+||||+++++|.+++.               +++.+|.|||..   ||+||||||+||+++.++.+||+|||++.
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence              3499999999999988764               556677777765   89999999999999999999999999998


Q ss_pred             eecCCCCC-CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 039516          157 IFGVNESG-ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDL  235 (345)
Q Consensus       157 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (345)
                      ........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....      ..............
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~  238 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP  238 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCC
Confidence            76432211 222345789999999999999999999999999999999999999975431      22222222222111


Q ss_pred             ccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          236 ELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       236 ~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .   ......++.+-   ..++.+||+.||.+||+..
T Consensus       239 ~---~~~~~~~~~~l---~~li~~~l~~dP~~R~~~~  269 (311)
T 3ork_A          239 P---SARHEGLSADL---DAVVLKALAKNPENRYQTA  269 (311)
T ss_dssp             H---HHHSTTCCHHH---HHHHHHHTCSSGGGSCSSH
T ss_pred             c---ccccCCCCHHH---HHHHHHHHhcCHhhChhhH
Confidence            0   00011122221   5899999999999999854

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.8e-41  Score=316.76  Aligned_cols=235  Identities=14%  Similarity=0.086  Sum_probs=182.1

Q ss_pred             CCCeeeEEEeeccCCeEEEEEE------cCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC---CCCeeeEEEEEEECC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGK------FPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ---YTNLVKLLGCSIHGE   93 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~------~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~   93 (345)
                      ..+|.+.++||+|+||.||+|.      ..+++.||||+++..   ....+..|++++..++   |+||+++++++...+
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            4679999999999999999993      456899999999654   3567888999998887   999999999999999


Q ss_pred             eeEEEEecCCCCChHHHHH--------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC----------
Q 039516           94 ERLLVYEFMPNKSLDSSFS--------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD----------  143 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~--------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~----------  143 (345)
                      ..++||||+++|+|.+++.                    +++.+|.|||..   ||+||||||+|||++.          
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-----
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccc
Confidence            9999999999999988764                    456667777764   8999999999999998          


Q ss_pred             -CCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHH
Q 039516          144 -QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLV  222 (345)
Q Consensus       144 -~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~  222 (345)
                       ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.......     
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----  292 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-----  292 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence             89999999999987643333333445679999999999999999999999999999999999999986432110     


Q ss_pred             HHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCC-CCcchhhhhcccc
Q 039516          223 GIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQC-PMLFPCLLMNLLP  283 (345)
Q Consensus       223 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~~~~~~l~~ll~  283 (345)
                                   ..+...+......+..  .++...|++.+|.+||+ +.++...+.++++
T Consensus       293 -------------~~~~~~~~~~~~~~~~--~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          293 -------------CKPEGLFRRLPHLDMW--NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             -------------EEECSCCTTCSSHHHH--HHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             -------------eeechhccccCcHHHH--HHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence                         0011111111111111  58888999999999965 3344444554444

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.1e-41  Score=328.23  Aligned_cols=251  Identities=18%  Similarity=0.179  Sum_probs=191.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ..+|.+.+.||+|+||.||++.. .+|+.||+|++...   .......+.+|+.++++++||||+++++++.+...+|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999976 47999999999653   224467789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           99 YEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        99 ~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      |||+++|+|.+++.                   +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999977653                   456667777765   89999999999999999999999999998764


Q ss_pred             CCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ............ ..     
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~-~~-----  410 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQ-AV-----  410 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHC-CC-----
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhc-cc-----
Confidence            3322  2334589999999999999999999999999999999999999998653221  111222222211 11     


Q ss_pred             ccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceee
Q 039516          240 LTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHF  292 (345)
Q Consensus       240 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~  292 (345)
                       .....+++..   ..++..||+.||.+||++.+.  ...+++.+..+.+..+
T Consensus       411 -~~p~~~s~~~---~~li~~lL~~dP~~R~~~~~~--~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          411 -TYPDKFSPAS---KDFCEALLQKDPEKRLGFRDG--SCDGLRTHPLFRDISW  457 (543)
T ss_dssp             -CCCTTSCHHH---HHHHHHHSCSSGGGSCCCBTT--BSHHHHTSGGGTTCCH
T ss_pred             -CCCcccCHHH---HHHHHHhccCCHhHCCCCccc--CHHHHHcCccccCCCH
Confidence             1111222222   589999999999999996431  1233444544444333

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.1e-42  Score=308.59  Aligned_cols=240  Identities=23%  Similarity=0.280  Sum_probs=188.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      .+|.+.+.||+|+||.||++...+++.||+|.+.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            4699999999999999999998888999999997653 345789999999999999999999999999999999999999


Q ss_pred             CCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          104 NKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       104 ~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      +++|.+++.                +++.+|.+||..   |++||||||+||+++.++.+||+|||++........ ...
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~  162 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS  162 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HST
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc-ccc
Confidence            999988764                456667777765   899999999999999999999999999976532111 111


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      ....++..|+|||++.+..++.++||||||+++|+|++ |+.||.....      ....... ..+..     ......+
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~i-~~~~~-----~~~~~~~  230 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDI-STGFR-----LYKPRLA  230 (267)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHH-HTTCC-----CCCCTTS
T ss_pred             ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHHH-hcCCc-----CCCCccC
Confidence            22356778999999998899999999999999999999 8999975431      1111111 11110     0111112


Q ss_pred             ChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          247 PPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       247 ~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      +...   .+++..||+.||.+|||+.++...|.++.+
T Consensus       231 ~~~l---~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          231 STHV---YQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cHHH---HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            2211   589999999999999998888877777654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1e-41  Score=308.81  Aligned_cols=238  Identities=22%  Similarity=0.332  Sum_probs=180.3

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccC-------HHHHHHHHHHHHhcCCCCeeeEEEEEEEC
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQG-------RVEFQNEAKLIAKLQYTNLVKLLGCSIHG   92 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~~~~~~~~~   92 (345)
                      -...+|.+.+.||+|+||.||++.. .+++.||+|.+.......       ...+.+|+.++++++||||+++++++.+.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            3456799999999999999999975 578999999996543221       26789999999999999999999998554


Q ss_pred             CeeEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCc--eEEeccCCCCeeeCCCCC-----EEE
Q 039516           93 EERLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLR--VIHRDLKASNILLDDQLN-----TKI  149 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~--ivHrdlk~~Nill~~~~~-----~kl  149 (345)
                      .  ++||||+++++|.+.+.                +++.+|.+||..   +  |+||||||+||+++.++.     +||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            4  79999999999977653                556666677665   7  999999999999988776     999


Q ss_pred             EccccceeecCCCCCCcccceeecCCccccchhc--cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 039516          150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM--SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQ  227 (345)
Q Consensus       150 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  227 (345)
                      +|||+++....     ......||+.|+|||++.  ...++.++||||||+++|+|++|+.||.......    ......
T Consensus       171 ~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~  241 (287)
T 4f0f_A          171 ADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINM  241 (287)
T ss_dssp             CCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHH
T ss_pred             CCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHH
Confidence            99999975422     233457899999999983  5567899999999999999999999997654221    111111


Q ss_pred             HHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          228 LWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       228 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                      ....+     ..+.+...+++.-   .+++..||+.||.+|||+.++...|.+
T Consensus       242 ~~~~~-----~~~~~~~~~~~~l---~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          242 IREEG-----LRPTIPEDCPPRL---RNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHSC-----CCCCCCTTSCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HhccC-----CCCCCCcccCHHH---HHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            11111     1111222233222   599999999999999998776666654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.9e-42  Score=315.43  Aligned_cols=245  Identities=21%  Similarity=0.235  Sum_probs=190.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECC-
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGE-   93 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~-   93 (345)
                      ..+|.+.+.||+|+||.||++..      .+++.||||.++... ......+.+|+.++.++ +||||+++++++...+ 
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  105 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  105 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence            46799999999999999999963      357899999997653 23456789999999999 7999999999987654 


Q ss_pred             eeEEEEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC
Q 039516           94 ERLLVYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD  142 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~  142 (345)
                      ..++||||+++++|.+++.                               +++.+|.+||..   ||+||||||+||+++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~  182 (316)
T 2xir_A          106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS  182 (316)
T ss_dssp             CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEEC
Confidence            5899999999999987753                               456666677765   899999999999999


Q ss_pred             CCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccH
Q 039516          143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNL  221 (345)
Q Consensus       143 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~  221 (345)
                      .++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.......    
T Consensus       183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----  258 (316)
T 2xir_A          183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----  258 (316)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH----
T ss_pred             CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH----
Confidence            999999999999987644333333344678899999999999999999999999999999998 999997644221    


Q ss_pred             HHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          222 VGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       222 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                        ........+...     .....+++..   .+++..||+.||.+|||+.++...|..+++.
T Consensus       259 --~~~~~~~~~~~~-----~~~~~~~~~l---~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          259 --EFCRRLKEGTRM-----RAPDYTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             --HHHHHHHHTCCC-----CCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHhccCccC-----CCCCCCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence              111111122111     1111122222   5899999999999999999888888887763

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.4e-41  Score=330.84  Aligned_cols=250  Identities=20%  Similarity=0.208  Sum_probs=191.8

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      ..+|.+.+.||+|+||.||++.. .+|+.||+|++...   .......+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            45699999999999999999965 57999999999643   234466789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           99 YEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        99 ~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      |||+++|+|.+++.                 +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999987664                 556677777765   8999999999999999999999999999876432


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........  . .........      ..
T Consensus       340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~-i~~~i~~~~------~~  407 (576)
T 2acx_A          340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--E-VERLVKEVP------EE  407 (576)
T ss_dssp             C---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--H-HHHHHHHCC------CC
T ss_pred             c---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--H-HHHHhhccc------cc
Confidence            2   2234589999999999999999999999999999999999999998654322111  1 111111111      11


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceee
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHF  292 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~  292 (345)
                      ....++++.   ..++..||+.||.+||++..  ....+++.+..+....+
T Consensus       408 ~p~~~s~~~---~dLI~~lL~~dP~~R~g~~~--~sa~eil~HpfF~~i~w  453 (576)
T 2acx_A          408 YSERFSPQA---RSLCSQLLCKDPAERLGCRG--GSAREVKEHPLFKKLNF  453 (576)
T ss_dssp             CCTTSCHHH---HHHHHHHTCSSGGGSTTCSS--SHHHHHHTSGGGTTCCH
T ss_pred             CCccCCHHH---HHHHHHhccCCHHHcCCCCC--CCHHHHHhChhhccCCH
Confidence            111223222   58999999999999997431  12445555655555444

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.5e-42  Score=314.48  Aligned_cols=257  Identities=19%  Similarity=0.253  Sum_probs=180.1

Q ss_pred             ceeecccccccccC---CCCeeeEEEeeccCCeEEEEEEcC----CCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCC
Q 039516            9 CQTWSEGAKFVENS---SLDWHMYIQQEQTRDRVILVGKFP----NEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQY   79 (345)
Q Consensus         9 ~~s~~~~~~~~~~~---~~~~~~~~~lG~G~~g~vy~~~~~----~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H   79 (345)
                      ..+.+|+....+.+   ...|.+.+.||+|+||.||+|...    ++..||+|.++..  .......+.+|+.++++++|
T Consensus        16 ~~~~eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h   95 (313)
T 3brb_A           16 PRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH   95 (313)
T ss_dssp             --------CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCC
T ss_pred             cCchHhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCC
Confidence            34455555555544   367999999999999999999653    3568999999754  23345679999999999999


Q ss_pred             CCeeeEEEEEEECC-----eeEEEEecCCCCChHHHHH---------------------hHHHHHHHHHhcCCCceEEec
Q 039516           80 TNLVKLLGCSIHGE-----ERLLVYEFMPNKSLDSSFS---------------------GTFKDLLCLHKYSRLRVIHRD  133 (345)
Q Consensus        80 ~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~---------------------~~~~~l~~lh~~~~~~ivHrd  133 (345)
                      |||+++++++.+.+     ..++||||+++++|.+++.                     +++.+|.|||..   ||+|||
T Consensus        96 ~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~d  172 (313)
T 3brb_A           96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRD  172 (313)
T ss_dssp             TTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCC
T ss_pred             CCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            99999999988654     3599999999999988762                     456666677654   899999


Q ss_pred             cCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCC
Q 039516          134 LKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKS  212 (345)
Q Consensus       134 lk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~  212 (345)
                      |||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus       173 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  252 (313)
T 3brb_A          173 LAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG  252 (313)
T ss_dssp             CSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCcc
Confidence            999999999999999999999987643332222333467889999999999999999999999999999999 8899876


Q ss_pred             CCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          213 YHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .....   ...   ... .+..     +.....++..-   .+++..||+.||.+|||+.++...|.++++
T Consensus       253 ~~~~~---~~~---~~~-~~~~-----~~~~~~~~~~l---~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          253 VQNHE---MYD---YLL-HGHR-----LKQPEDCLDEL---YEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             CCGGG---HHH---HHH-TTCC-----CCCBTTCCHHH---HHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHH---HHH---HHH-cCCC-----CCCCccccHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            54221   111   111 1111     11111122221   599999999999999999988888887765

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-40  Score=308.78  Aligned_cols=236  Identities=20%  Similarity=0.201  Sum_probs=178.8

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC-----CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT-----SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      +..+|.+.+.||+|+||.||++.. .+++.||+|++...     .......+.+|+.++++++||||+++++++.+.+..
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  103 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI  103 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence            345699999999999999999965 57899999998643     234567899999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHH-------------------------------------------------------HhHHHHHHH
Q 039516           96 LLVYEFMPNKSLDSSF-------------------------------------------------------SGTFKDLLC  120 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l-------------------------------------------------------~~~~~~l~~  120 (345)
                      ++||||+++|+|.+++                                                       .+++.+|.|
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  183 (345)
T 3hko_A          104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY  183 (345)
T ss_dssp             EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence            9999999999997654                                                       256677777


Q ss_pred             HHhcCCCceEEeccCCCCeeeCCCC--CEEEEccccceeecCCCCCC--cccceeecCCccccchhcc--CCcCcccchh
Q 039516          121 LHKYSRLRVIHRDLKASNILLDDQL--NTKISDFGMARIFGVNESGA--NTNRIVGTYGYMSLEYTMS--GTVSIKTDVF  194 (345)
Q Consensus       121 lh~~~~~~ivHrdlk~~Nill~~~~--~~kl~Dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~  194 (345)
                      ||..   +|+||||||+||+++.++  .+||+|||++..........  ......||+.|+|||++.+  ..++.++|||
T Consensus       184 LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw  260 (345)
T 3hko_A          184 LHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW  260 (345)
T ss_dssp             HHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred             HHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence            7776   899999999999998766  89999999998764322211  2334578999999999875  6789999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          195 GFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       195 SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      |||+++|+|++|+.||.....      ...............  .+.. ..++++.   .+++..||+.||.+|||+.
T Consensus       261 slG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~--~~~~-~~~~~~~---~~li~~~l~~~p~~Rps~~  326 (345)
T 3hko_A          261 SAGVLLHLLLMGAVPFPGVND------ADTISQVLNKKLCFE--NPNY-NVLSPLA---RDLLSNLLNRNVDERFDAM  326 (345)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCTT--SGGG-GGSCHHH---HHHHHHHSCSCTTTSCCHH
T ss_pred             HHHHHHHHHHHCCCCCCCCCh------HHHHHHHHhcccccC--Cccc-ccCCHHH---HHHHHHHcCCChhHCCCHH
Confidence            999999999999999976432      122222222211110  0100 0012211   5899999999999999954

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.4e-42  Score=307.90  Aligned_cols=236  Identities=14%  Similarity=0.230  Sum_probs=183.9

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--EERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv   98 (345)
                      ..+|.+.+.||+|+||.||+|... ++.||||+++...  ....+.|.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            457999999999999999999885 8999999997652  33456799999999999999999999999876  778999


Q ss_pred             EecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCc--eEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           99 YEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLR--VIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        99 ~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~--ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      |||+++|+|.+++.                 +++.+|.|||.   .+  ++||||||+||+++.++.++|+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            99999999988775                 45556666665   46  9999999999999999999999998875431


Q ss_pred             CCCCCCcccceeecCCccccchhccCCcCc---ccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTMSGTVSI---KTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                             .....||+.|+|||++.+..++.   ++||||||+++|+|++|+.||.....      ..........+.   
T Consensus       165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~---  228 (271)
T 3kmu_A          165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGL---  228 (271)
T ss_dssp             -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCC---
T ss_pred             -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCC---
Confidence                   12346899999999998766554   79999999999999999999975432      111222222221   


Q ss_pred             cccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          237 LIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       237 ~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                        .+.+...++.+.   .+++..||+.||.+|||+.++...|..+.+
T Consensus       229 --~~~~~~~~~~~~---~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          229 --RPTIPPGISPHV---SKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             --CCCCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             --CCCCCCCCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence              111222233222   589999999999999998887777776543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.5e-40  Score=299.65  Aligned_cols=232  Identities=18%  Similarity=0.161  Sum_probs=181.7

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +...|.+.+.||+|+||.||++.. .++..||+|++..........+.+|++++++++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            455699999999999999999975 4578999999977656678889999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeee---CCCCCEEEEccccceeecCCC
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILL---DDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      |+++++|.+++.               +++.+|.+||..   ||+||||||+||++   +.++.+||+|||++.......
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            999999977654               566777788765   89999999999999   788899999999998764322


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                         ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||......      ....... .+....  ....
T Consensus       164 ---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~--~~~~  230 (277)
T 3f3z_A          164 ---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIR-EGTFTF--PEKD  230 (277)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HCCCCC--CHHH
T ss_pred             ---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-hCCCCC--Cchh
Confidence               22345789999999988654 899999999999999999999999764321      1111111 111110  0000


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ...+++..   .+++..||+.||.+|||+.
T Consensus       231 ~~~~~~~~---~~li~~~l~~dp~~R~s~~  257 (277)
T 3f3z_A          231 WLNVSPQA---ESLIRRLLTKSPKQRITSL  257 (277)
T ss_dssp             HTTSCHHH---HHHHHHHTCSSTTTSCCHH
T ss_pred             hhcCCHHH---HHHHHHHccCChhhCcCHH
Confidence            00122111   5899999999999999953

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-42  Score=316.92  Aligned_cols=244  Identities=21%  Similarity=0.290  Sum_probs=183.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCC-----CcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPN-----EQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~-----~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ...|.+.+.||+|+||.||+|....     +..||||.++... ......+.+|+.++++++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            4678999999999999999997532     2469999997553 334567899999999999999999999999989999


Q ss_pred             EEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           97 LVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      +||||+++++|.+++.                +++.+|.+||..   ||+||||||+||+++.++.+||+|||++.....
T Consensus       123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            9999999999988764                456677777765   899999999999999999999999999987643


Q ss_pred             CCCC-CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          161 NESG-ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                      .... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....      ... ......+...   
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~-~~~~~~~~~~---  269 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEV-MKAINDGFRL---  269 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHH-HHHHHTTCCC---
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------HHH-HHHHHCCCcC---
Confidence            2211 11222345778999999999999999999999999999999 9999975432      111 1112122110   


Q ss_pred             cccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccccc
Q 039516          239 DLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGL  285 (345)
Q Consensus       239 d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~  285 (345)
                        .....++    .. .+++..||+.||.+|||+.++...|..++...
T Consensus       270 --~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          270 --PTPMDCP----SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             --CCCTTCB----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             --CCcccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence              0111122    23 58999999999999999999888888877643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=308.87  Aligned_cols=242  Identities=21%  Similarity=0.277  Sum_probs=188.0

Q ss_pred             CCeeeEE-EeeccCCeEEEEEEcC---CCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           24 LDWHMYI-QQEQTRDRVILVGKFP---NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        24 ~~~~~~~-~lG~G~~g~vy~~~~~---~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      .+|.+.. .||+|+||.||+|...   ++..||||.++.. .....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4577776 8999999999999753   5788999999765 334567799999999999999999999999 56679999


Q ss_pred             EecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           99 YEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        99 ~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      |||+++++|.+++.                +++.+|.+||..   ||+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            99999999988763                566777777765   89999999999999999999999999998764322


Q ss_pred             CC-CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          163 SG-ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      .. .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+   .    ......+..     +
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~----~~~i~~~~~-----~  232 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V----MAFIEQGKR-----M  232 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---H----HHHHHTTCC-----C
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---H----HHHHhcCCc-----C
Confidence            21 11222356889999999998899999999999999999998 999997654211   1    111112211     1


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      .....++++-   .+++..||+.||.+|||+.++...|..++..
T Consensus       233 ~~~~~~~~~l---~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          233 ECPPECPPEL---YALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             CCCTTCCHHH---HHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            1111223222   5899999999999999998888888877653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=314.22  Aligned_cols=185  Identities=21%  Similarity=0.331  Sum_probs=147.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCcc-CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQ-GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      .+|.+.++||+|+||.||++... +++.||+|++...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            35999999999999999999764 7899999999654322 122456799999999999999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      +++ +|.+++.                +++.+|.|||..   ||+||||||+||+++.++.+||+|||++.......  .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~  155 (324)
T 3mtl_A           82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K  155 (324)
T ss_dssp             CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence            985 6655543                566777777765   89999999999999999999999999998653222  1


Q ss_pred             cccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  205 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST  205 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2233578999999999876 568999999999999999999999997644

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.7e-41  Score=302.01  Aligned_cols=230  Identities=20%  Similarity=0.247  Sum_probs=160.9

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      .-.+|.+.+.||+|+||.||++.. .+|+.||||.+...   .......+.+|+.++++++||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            345699999999999999999975 57999999999643   22345779999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           98 VYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        98 v~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      ||||+++++|.+++.                +++.+|.+||..   |++||||||+||+++.++.+||+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            999999999987754                566677777765   8999999999999999999999999999876432


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      ..  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..........          ....   .+..
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------~~~~---~~~~  230 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----------KVVL---ADYE  230 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCS---SCCC
T ss_pred             CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH----------HHhh---cccC
Confidence            21  1223578999999999998889999999999999999999999997643221100          0000   0111


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +...++.+.   .+++..||+.||.+|||+.
T Consensus       231 ~~~~~~~~~---~~li~~~l~~dp~~Rps~~  258 (278)
T 3cok_A          231 MPSFLSIEA---KDLIHQLLRRNPADRLSLS  258 (278)
T ss_dssp             CCTTSCHHH---HHHHHHHSCSSGGGSCCHH
T ss_pred             CccccCHHH---HHHHHHHcccCHhhCCCHH
Confidence            111122211   5999999999999999953

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.7e-41  Score=311.13  Aligned_cols=253  Identities=19%  Similarity=0.218  Sum_probs=182.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHH--HhcCCCCeeeEEEEEEE-----CCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLI--AKLQYTNLVKLLGCSIH-----GEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l--~~l~H~niv~~~~~~~~-----~~~~   95 (345)
                      -.+|.+.++||+|+||.||+|.. +++.||||++...   ....+..|.+++  ..++||||+++++++..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46799999999999999999977 5899999999643   244555565554  45899999999986653     2357


Q ss_pred             EEEEecCCCCChHHHHH--------------hHHHHHHHHHhcC------CCceEEeccCCCCeeeCCCCCEEEEccccc
Q 039516           96 LLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYS------RLRVIHRDLKASNILLDDQLNTKISDFGMA  155 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~------~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~  155 (345)
                      ++||||+++|+|.+++.              +++.+|.|||...      ..||+||||||+|||++.++.+||+|||++
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a  167 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS  167 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence            89999999999988765              5677777888762      238999999999999999999999999999


Q ss_pred             eeecCCCC------CCcccceeecCCccccchhcc-------CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccH-
Q 039516          156 RIFGVNES------GANTNRIVGTYGYMSLEYTMS-------GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNL-  221 (345)
Q Consensus       156 ~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~-  221 (345)
                      +.......      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||........... 
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  247 (336)
T 3g2f_A          168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA  247 (336)
T ss_dssp             EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred             eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence            87643221      111223468999999999886       4567889999999999999999877654332211110 


Q ss_pred             ----------HHHHHHHHhcCCccccccccCCCCCC--hhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          222 ----------VGIAWQLWNEGKDLELIDLTLDGSCP--PNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       222 ----------~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                                .............    .+.+.....  ...... .+++..||+.||++|||+.++...|.+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          248 FQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence                      0011111111111    111111111  123334 799999999999999999998888888776

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.4e-42  Score=311.15  Aligned_cols=242  Identities=22%  Similarity=0.268  Sum_probs=191.9

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ..+|.+.+.||+|+||.||++... ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            456999999999999999999764 58899999997543 3467899999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          102 MPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       102 ~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      +++++|.+++.                 +++.+|.+||..   ||+||||||+||+++.++.+||+|||++....... .
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~  166 (288)
T 3kfa_A           91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-Y  166 (288)
T ss_dssp             CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-S
T ss_pred             CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc-c
Confidence            99999988764                 556677777765   89999999999999999999999999998654322 1


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                      .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......   ...    ......     .....
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~----~~~~~~-----~~~~~  234 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEKDY-----RMERP  234 (288)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHTTC-----CCCCC
T ss_pred             ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhccC-----CCCCC
Confidence            22333567889999999999999999999999999999999 999997654221   111    111110     11111


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      ..++...   .+++..||+.||.+|||+.++...|..++..
T Consensus       235 ~~~~~~l---~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          235 EGCPEKV---YELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             TTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHH---HHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            1122221   5999999999999999999888888887764

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.8e-42  Score=318.60  Aligned_cols=255  Identities=24%  Similarity=0.272  Sum_probs=189.9

Q ss_pred             eecccccccccCCCCeeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCee
Q 039516           11 TWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLV   83 (345)
Q Consensus        11 s~~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv   83 (345)
                      +.+.+....+-...+|.+.+.||+|+||.||+|..      .+++.||||.+... .......+.+|+.++++++||||+
T Consensus        17 ~sss~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   96 (327)
T 2yfx_A           17 KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV   96 (327)
T ss_dssp             EEECGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CccchhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCC
Confidence            34445555555667899999999999999999974      35789999999644 334456799999999999999999


Q ss_pred             eEEEEEEECCeeEEEEecCCCCChHHHHH----------------------hHHHHHHHHHhcCCCceEEeccCCCCeee
Q 039516           84 KLLGCSIHGEERLLVYEFMPNKSLDSSFS----------------------GTFKDLLCLHKYSRLRVIHRDLKASNILL  141 (345)
Q Consensus        84 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~----------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill  141 (345)
                      ++++++......++||||+++++|.+++.                      +++.+|.+||..   ||+||||||+||++
T Consensus        97 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli  173 (327)
T 2yfx_A           97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLL  173 (327)
T ss_dssp             CEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             eEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEE
Confidence            99999999999999999999999987764                      455667777765   89999999999999


Q ss_pred             CC---CCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q 039516          142 DD---QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTER  217 (345)
Q Consensus       142 ~~---~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~  217 (345)
                      +.   +..+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||...... 
T Consensus       174 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-  252 (327)
T 2yfx_A          174 TCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-  252 (327)
T ss_dssp             SCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             ecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-
Confidence            84   44699999999976543332223334567889999999999999999999999999999998 99998754311 


Q ss_pred             cccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          218 PLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                           ... .....+...     .....++...   .+++..||+.||.+|||+.++...+..+..
T Consensus       253 -----~~~-~~~~~~~~~-----~~~~~~~~~l---~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          253 -----EVL-EFVTSGGRM-----DPPKNCPGPV---YRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             -----HHH-HHHHTTCCC-----CCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----HHH-HHHhcCCCC-----CCCCCCCHHH---HHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence                 111 111122111     1111222221   589999999999999998887777776654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.2e-41  Score=319.17  Aligned_cols=255  Identities=19%  Similarity=0.210  Sum_probs=193.6

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--eeEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE--ERLL   97 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--~~~l   97 (345)
                      +...|.+.+.||+|+||.||+|.. .+|+.||||+++... ......+.+|++++++++||||+++++++....  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            456799999999999999999975 468999999997542 345677889999999999999999999998755  7899


Q ss_pred             EEecCCCCChHHHHH------------------hHHHHHHHHHhcCCCceEEeccCCCCeee----CCCCCEEEEccccc
Q 039516           98 VYEFMPNKSLDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILL----DDQLNTKISDFGMA  155 (345)
Q Consensus        98 v~e~~~~gsL~~~l~------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill----~~~~~~kl~Dfgl~  155 (345)
                      ||||+++|+|.+++.                  +++.+|.|||..   ||+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            999999999977654                  566677777765   89999999999999    77788999999999


Q ss_pred             eeecCCCCCCcccceeecCCccccchhcc--------CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 039516          156 RIFGVNESGANTNRIVGTYGYMSLEYTMS--------GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQ  227 (345)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  227 (345)
                      +......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||.........  ......
T Consensus       164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~  238 (396)
T 4eut_A          164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYK  238 (396)
T ss_dssp             EECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHH
T ss_pred             eEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHH
Confidence            8764322   2233578999999998875        56788999999999999999999999765432221  222222


Q ss_pred             HHhcCCcccc--c----------cccC--CCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          228 LWNEGKDLEL--I----------DLTL--DGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       228 ~~~~~~~~~~--~----------d~~l--~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      .........+  +          ...+  ....+...... ..++..||+.||++|||+.++...+.+++..
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            2222211000  0          0011  11122333444 7999999999999999998888888887764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2e-40  Score=305.57  Aligned_cols=232  Identities=16%  Similarity=0.146  Sum_probs=182.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc------cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG------QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      ...|.+.+.||+|+||.||++.. .+|+.||+|.++....      .....+.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            45599999999999999999975 4689999999965422      2467899999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC----CEEEEccccce
Q 039516           96 LLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL----NTKISDFGMAR  156 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfgl~~  156 (345)
                      ++||||+++++|.+++.               +++.+|.+||..   ||+||||||+||+++.++    .+||+|||++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            99999999999988765               567777777765   899999999999999887    79999999998


Q ss_pred             eecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          157 IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                      ......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||......      ...... .....  
T Consensus       168 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i-~~~~~--  235 (321)
T 2a2a_A          168 EIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANI-TSVSY--  235 (321)
T ss_dssp             ECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHH-HTTCC--
T ss_pred             ecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH-Hhccc--
Confidence            764322   223357899999999999999999999999999999999999999754311      111111 11111  


Q ss_pred             cccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          237 LIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       237 ~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      -.++......+...   .+++..||+.||.+|||+.
T Consensus       236 ~~~~~~~~~~~~~~---~~li~~~l~~dp~~Rps~~  268 (321)
T 2a2a_A          236 DFDEEFFSHTSELA---KDFIRKLLVKETRKRLTIQ  268 (321)
T ss_dssp             CCCHHHHTTCCHHH---HHHHHTTSCSSTTTSCCHH
T ss_pred             ccChhhhcccCHHH---HHHHHHHcCCChhhCcCHH
Confidence            01111111122211   5899999999999999954

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-42  Score=322.33  Aligned_cols=244  Identities=22%  Similarity=0.294  Sum_probs=178.3

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcC--C--CcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCee
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFP--N--EQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH-GEER   95 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~--~--~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~   95 (345)
                      ....|.+.+.||+|+||.||+|...  +  +..||+|.++.. .......|.+|+.++++++||||+++++++.. .+..
T Consensus        87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            3456888999999999999999753  2  246899998654 33456789999999999999999999998764 4578


Q ss_pred             EEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           96 LLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      ++||||+++|+|.+++.                +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++...
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence            99999999999988764                566777777765   89999999999999999999999999998653


Q ss_pred             CCCCC--CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          160 VNESG--ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       160 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                      .....  .......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+   ....    ...+..  
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~----~~~~~~--  314 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LLQGRR--  314 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH----HHTTCC--
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH----HHcCCC--
Confidence            32211  11223456788999999999999999999999999999999 677776544322   1111    111111  


Q ss_pred             cccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          237 LIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       237 ~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ...   ...++..-   .+++..||+.||.+|||+.++...|.+++.
T Consensus       315 ~~~---p~~~~~~l---~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          315 LLQ---PEYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             CCC---CTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCC---CCCCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            011   11122211   589999999999999999988888888765

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.1e-42  Score=339.13  Aligned_cols=239  Identities=23%  Similarity=0.351  Sum_probs=187.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ..+|.+.++||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            45689999999999999999998878899999997653 346789999999999999999999999865 6789999999


Q ss_pred             CCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          103 PNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       103 ~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ++|+|.+++.                 +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++....... .
T Consensus       344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~  419 (535)
T 2h8h_A          344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  419 (535)
T ss_dssp             TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-H
T ss_pred             cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-e
Confidence            9999988764                 556677777765   899999999999999999999999999976532110 0


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ......++..|+|||++.+..++.++|||||||++|||++ |+.||......      +.. .....+...     ....
T Consensus       420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~~~-~~i~~~~~~-----~~~~  487 (535)
T 2h8h_A          420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVL-DQVERGYRM-----PCPP  487 (535)
T ss_dssp             TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------HHH-HHHHTTCCC-----CCCT
T ss_pred             cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHH-HHHHcCCCC-----CCCC
Confidence            1112346778999999999999999999999999999999 99999764321      111 111122110     0111


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .++    .. .+++..||+.||++|||+.++...|..++.
T Consensus       488 ~~~----~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          488 ECP----ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             CCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            122    23 589999999999999998888877777654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9.7e-41  Score=311.53  Aligned_cols=232  Identities=18%  Similarity=0.206  Sum_probs=166.2

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +...|.+.+.||+|+||.||++... +++.||||+++...  ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3456999999999999999999764 68899999997543  34568899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC---CCCEEEEccccceeecCCC
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD---QLNTKISDFGMARIFGVNE  162 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgl~~~~~~~~  162 (345)
                      |+++++|.+++.               +++.+|.|||..   ||+||||||+|||++.   ++.+||+|||+++..... 
T Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-  204 (349)
T 2w4o_A          129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-  204 (349)
T ss_dssp             CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence            999999977654               567777788765   8999999999999975   889999999999865322 


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||......      ............. ...+ .
T Consensus       205 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~i~~~~~~-~~~~-~  274 (349)
T 2w4o_A          205 --VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------QFMFRRILNCEYY-FISP-W  274 (349)
T ss_dssp             ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------HHHHHHHHTTCCC-CCTT-T
T ss_pred             --cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------HHHHHHHHhCCCc-cCCc-h
Confidence              1223457899999999999999999999999999999999999999754321      1111111121111 0111 1


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ....+.+.   .+++..||+.||++|||+.
T Consensus       275 ~~~~~~~~---~~li~~~L~~dP~~Rpt~~  301 (349)
T 2w4o_A          275 WDEVSLNA---KDLVRKLIVLDPKKRLTTF  301 (349)
T ss_dssp             TTTSCHHH---HHHHHTTSCSSGGGSCCHH
T ss_pred             hhhCCHHH---HHHHHHHccCChhhCcCHH
Confidence            11122222   5899999999999999953

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.1e-41  Score=305.70  Aligned_cols=235  Identities=19%  Similarity=0.264  Sum_probs=186.8

Q ss_pred             ccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee
Q 039516           18 FVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        18 ~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      ........|.+.+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+.++++++||||+++++++......
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           16 LKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             CEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            3344556699999999999999999964 578999999997553 34577899999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           96 LLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      ++||||+++++|.+++.              +++.+|.+||..   ||+||||||+||+++.++.+||+|||++......
T Consensus        96 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             EEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             EEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            99999999999987664              566777777765   8999999999999999999999999999876433


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      ..  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......      ....... .+.     .+.
T Consensus       173 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~-----~~~  238 (303)
T 3a7i_A          173 QI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLFLIP-KNN-----PPT  238 (303)
T ss_dssp             BC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-HSC-----CCC
T ss_pred             cc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHHHhh-cCC-----CCC
Confidence            21  223457899999999999999999999999999999999999999754321      1111111 111     112


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +...++...   ..++..||+.||.+|||+.
T Consensus       239 ~~~~~~~~l---~~li~~~l~~dp~~Rps~~  266 (303)
T 3a7i_A          239 LEGNYSKPL---KEFVEACLNKEPSFRPTAK  266 (303)
T ss_dssp             CCSSCCHHH---HHHHHHHCCSSGGGSCCHH
T ss_pred             CccccCHHH---HHHHHHHcCCChhhCcCHH
Confidence            222233222   5899999999999999954

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.8e-41  Score=310.02  Aligned_cols=244  Identities=18%  Similarity=0.139  Sum_probs=178.8

Q ss_pred             ccCCCCeeeE-EEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeE
Q 039516           20 ENSSLDWHMY-IQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        20 ~~~~~~~~~~-~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~   96 (345)
                      ..|...|.+. +.||+|+||.||++.. .+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..+
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            4456678885 6799999999999975 47899999999876666778899999999985 7999999999999999999


Q ss_pred             EEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC---EEEEccccceee
Q 039516           97 LVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN---TKISDFGMARIF  158 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfgl~~~~  158 (345)
                      +||||+++++|.+++.               +++.+|.|||..   ||+||||||+||+++.++.   +||+|||++...
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            9999999999988764               566777777776   8999999999999988766   999999998765


Q ss_pred             cCCCC-----CCcccceeecCCccccchhcc-----CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccH-------
Q 039516          159 GVNES-----GANTNRIVGTYGYMSLEYTMS-----GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNL-------  221 (345)
Q Consensus       159 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~-------  221 (345)
                      .....     ........||+.|+|||++.+     ..++.++|||||||++|+|++|+.||...........       
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            32211     111223468999999999875     5688999999999999999999999987543321110       


Q ss_pred             -HHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          222 -VGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       222 -~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                       ..........+... ..... ....+    .. .+++.+||+.||.+|||+.
T Consensus       245 ~~~~~~~~i~~~~~~-~~~~~-~~~~~----~~~~~li~~~L~~dP~~Rps~~  291 (316)
T 2ac3_A          245 CQNMLFESIQEGKYE-FPDKD-WAHIS----CAAKDLISKLLVRDAKQRLSAA  291 (316)
T ss_dssp             HHHHHHHHHHHCCCC-CCHHH-HTTSC----HHHHHHHHHHSCSSTTTSCCHH
T ss_pred             HHHHHHHHHhccCcc-cCchh-cccCC----HHHHHHHHHHhhCChhhCCCHH
Confidence             01111111111110 00000 00112    22 5999999999999999953

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=314.57  Aligned_cols=256  Identities=16%  Similarity=0.144  Sum_probs=181.1

Q ss_pred             cccccccCCCCeeeEEEeeccCCeEEEEEEcC----CCcEEEEEEeccCCcc-----------CHHHHHHHHHHHHhcCC
Q 039516           15 GAKFVENSSLDWHMYIQQEQTRDRVILVGKFP----NEQEVAIKRLAWTSGQ-----------GRVEFQNEAKLIAKLQY   79 (345)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~~----~~~~VaiK~~~~~~~~-----------~~~~~~~E~~~l~~l~H   79 (345)
                      .....+....+|.+.+.||+|+||.||+|...    ++..||||.+......           ....+.+|+..++.++|
T Consensus        28 g~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h  107 (345)
T 2v62_A           28 GKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDY  107 (345)
T ss_dssp             TCEEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSC
T ss_pred             CCeeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccc
Confidence            33444455678999999999999999999764    5789999998755321           12246678889999999


Q ss_pred             CCeeeEEEEEEE----CCeeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCee
Q 039516           80 TNLVKLLGCSIH----GEERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNIL  140 (345)
Q Consensus        80 ~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nil  140 (345)
                      |||+++++++..    ....++||||+ +++|.+++.               +++.+|.|||..   ||+||||||+|||
T Consensus       108 ~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  183 (345)
T 2v62_A          108 LGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLL  183 (345)
T ss_dssp             CCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             cCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEE
Confidence            999999999988    77899999999 999977653               667778888876   8999999999999


Q ss_pred             eCCCC--CEEEEccccceeecCCCCC-----CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          141 LDDQL--NTKISDFGMARIFGVNESG-----ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       141 l~~~~--~~kl~Dfgl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                      ++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  263 (345)
T 2v62_A          184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN  263 (345)
T ss_dssp             EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred             EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            98877  9999999999876432211     1123457899999999999999999999999999999999999999643


Q ss_pred             CCCCcccHHHHHHHHHhcCCccccccccC-CCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          214 HTERPLNLVGIAWQLWNEGKDLELIDLTL-DGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                      ....  ............. ....+.... ...++.+.   .+++..||+.||++|||+.++...|..
T Consensus       264 ~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l---~~li~~~l~~dp~~Rps~~~l~~~L~~  325 (345)
T 2v62_A          264 LKDP--VAVQTAKTNLLDE-LPQSVLKWAPSGSSCCEI---AQFLVCAHSLAYDEKPNYQALKKILNP  325 (345)
T ss_dssp             TTCH--HHHHHHHHHHHHT-TTHHHHHHSCTTSCCHHH---HHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred             cccc--HHHHHHHHhhccc-ccHHHHhhccccccHHHH---HHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            2111  1111111111111 111111111 11222222   589999999999999997766555554

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-41  Score=319.86  Aligned_cols=188  Identities=22%  Similarity=0.315  Sum_probs=146.4

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECC--eeE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGE--ERL   96 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~--~~~   96 (345)
                      ..+|.+.+.||+|+||.||++.. .+|+.||||++...  .......+.+|+.+++++. ||||+++++++...+  ..|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            45699999999999999999964 57999999998543  3344567889999999997 999999999998544  689


Q ss_pred             EEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           97 LVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      +||||++ ++|.+++.              +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++......
T Consensus        88 lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             EEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            9999998 47766554              566777777765   89999999999999999999999999998753211


Q ss_pred             -------------------CCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          163 -------------------SGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       163 -------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                                         .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                               0112234579999999999886 678999999999999999999999997654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=7.1e-41  Score=302.16  Aligned_cols=226  Identities=18%  Similarity=0.211  Sum_probs=175.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|.+.+.||+|+||.||++.. .+++.||+|.+...   .......+.+|+.++++++||||+++++++.+....++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            4699999999999999999965 56789999998543   2234567899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||+++++|.+++.               +++.+|.+||..   ||+||||||+||+++.++.+||+|||++......   
T Consensus        89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---  162 (279)
T 3fdn_A           89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---  162 (279)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc---
Confidence            9999999977654               556667777754   8999999999999999999999999998654321   


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                       ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....      ...... .....      .....
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~------~~~~~  228 (279)
T 3fdn_A          163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKR-ISRVE------FTFPD  228 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHH-HHHTC------CCCCT
T ss_pred             -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------HHHHHH-HHhCC------CCCCC
Confidence             22335789999999999999999999999999999999999999975431      111111 11111      11111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..+...   .+++..||+.||.+|||+.
T Consensus       229 ~~~~~~---~~li~~~l~~~p~~Rps~~  253 (279)
T 3fdn_A          229 FVTEGA---RDLISRLLKHNPSQRPMLR  253 (279)
T ss_dssp             TSCHHH---HHHHHHHCCSSGGGSCCHH
T ss_pred             cCCHHH---HHHHHHHhccChhhCCCHH
Confidence            122211   5899999999999999953

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.3e-41  Score=302.05  Aligned_cols=235  Identities=21%  Similarity=0.272  Sum_probs=181.5

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      +..+|++.+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            345699999999999999999975 478999999996543 334567899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||+++++|.+++.               +++.+|.+||..   |++|+||||+||+++.++.+||+|||++.........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            9999998866543               567777777765   8999999999999999999999999999876433222


Q ss_pred             CcccceeecCCccccchhccCCc-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                      .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........ ..     ..+......  ..+  .
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-----~~~~~~~~~--~~~--~  231 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY-----SDWKEKKTY--LNP--W  231 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HH-----HHHHTTCTT--STT--G
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HH-----HHhhhcccc--cCc--h
Confidence            22334578999999999987665 7889999999999999999999976543221 11     111111110  000  0


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..++...   .+++..||+.||.+|||+.
T Consensus       232 ~~~~~~~---~~li~~~l~~~p~~Rps~~  257 (276)
T 2yex_A          232 KKIDSAP---LALLHKILVENPSARITIP  257 (276)
T ss_dssp             GGSCHHH---HHHHHHHSCSSTTTSCCHH
T ss_pred             hhcCHHH---HHHHHHHCCCCchhCCCHH
Confidence            0122211   5899999999999999953

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.6e-41  Score=308.36  Aligned_cols=243  Identities=21%  Similarity=0.239  Sum_probs=185.7

Q ss_pred             CCCeeeEE-EeeccCCeEEEEEEc---CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           23 SLDWHMYI-QQEQTRDRVILVGKF---PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        23 ~~~~~~~~-~lG~G~~g~vy~~~~---~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ...|.+.+ .||+|+||.||+|..   .+++.||||.++...  ....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35688888 899999999999953   347899999997553  22356799999999999999999999998 677889


Q ss_pred             EEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           97 LVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      +||||+++++|.+++.               +++.+|.+||..   ||+||||||+||+++.++.+||+|||++......
T Consensus        94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            9999999999988764               566777777765   8999999999999999999999999999876432


Q ss_pred             CCCC-cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          162 ESGA-NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       162 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      .... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......       ........+...    
T Consensus       171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~----  239 (291)
T 1xbb_A          171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERM----  239 (291)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCC----
T ss_pred             CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCC----
Confidence            2211 1122345788999999998899999999999999999999 99999764321       111222222111    


Q ss_pred             ccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          240 LTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       240 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                       .....++..-   .+++..||+.||.+|||+.++...|.+++..
T Consensus       240 -~~~~~~~~~l---~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          240 -GCPAGCPREM---YDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             -CCCTTCCHHH---HHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence             1111222222   5999999999999999998888888877653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=339.71  Aligned_cols=239  Identities=21%  Similarity=0.274  Sum_probs=182.4

Q ss_pred             CeeeEE-EeeccCCeEEEEEEcC---CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           25 DWHMYI-QQEQTRDRVILVGKFP---NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        25 ~~~~~~-~lG~G~~g~vy~~~~~---~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ++.+.+ +||+|+||.||+|.+.   ++..||||+++... ....+.|.+|+++|++++|||||+++++|.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            445555 7999999999999653   46789999997653 3467889999999999999999999999865 5689999


Q ss_pred             ecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          100 EFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       100 e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      ||+++|+|.+++.                +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            9999999988763                567777888875   899999999999999999999999999986543221


Q ss_pred             C-CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          164 G-ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      . .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+       .......+...     .
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~-----~  559 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM-----E  559 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCCC-----C
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCC-----C
Confidence            1 11122345689999999999999999999999999999998 999998654321       11122222111     1


Q ss_pred             CCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          242 LDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       242 l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                          .+...... .+++..||+.||++|||+.++...|..++.
T Consensus       560 ----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          560 ----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             ----CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                11222233 599999999999999999888887777654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.2e-40  Score=310.22  Aligned_cols=240  Identities=18%  Similarity=0.139  Sum_probs=178.6

Q ss_pred             cccccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC
Q 039516           15 GAKFVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHG   92 (345)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~   92 (345)
                      +......+..+|++.+.||+|+||.||++.. .+|+.||||.++.....    +.+|++++.++ +||||+++++++.+.
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~   88 (342)
T 2qr7_A           13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDG   88 (342)
T ss_dssp             ------CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             hcccccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence            3334445677899999999999999999965 47899999999765432    45788888888 799999999999999


Q ss_pred             CeeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC----CCEEEEccc
Q 039516           93 EERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ----LNTKISDFG  153 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~----~~~kl~Dfg  153 (345)
                      ...|+||||+++|+|.+.+.               +++.+|.|||..   ||+||||||+|||+..+    +.+||+|||
T Consensus        89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg  165 (342)
T 2qr7_A           89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFG  165 (342)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence            99999999999999987654               566777777765   89999999999998543    349999999


Q ss_pred             cceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 039516          154 MARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGK  233 (345)
Q Consensus       154 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (345)
                      +++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........   .. .......+.
T Consensus       166 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~-~~~~i~~~~  239 (342)
T 2qr7_A          166 FAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP---EE-ILARIGSGK  239 (342)
T ss_dssp             TCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH---HH-HHHHHHHCC
T ss_pred             CcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH---HH-HHHHHccCC
Confidence            9987643322  23345789999999999888899999999999999999999999975432221   11 112222222


Q ss_pred             ccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          234 DLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       234 ~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..  +........+.+.   .+++..||+.||.+|||+.
T Consensus       240 ~~--~~~~~~~~~s~~~---~~li~~~L~~dP~~R~t~~  273 (342)
T 2qr7_A          240 FS--LSGGYWNSVSDTA---KDLVSKMLHVDPHQRLTAA  273 (342)
T ss_dssp             CC--CCSTTTTTSCHHH---HHHHHHHTCSSTTTSCCHH
T ss_pred             cc--cCccccccCCHHH---HHHHHHHCCCChhHCcCHH
Confidence            11  0111111122222   5899999999999999953

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2e-40  Score=301.11  Aligned_cols=249  Identities=18%  Similarity=0.179  Sum_probs=187.4

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEE-EECCeeEEEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCS-IHGEERLLVY   99 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~-~~~~~~~lv~   99 (345)
                      +...|.+.+.||+|+||.||++.. .+++.||||.+.....  ...+.+|+.+++.++|+|++..+..+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            456799999999999999999974 6789999998754432  23578999999999988877766655 6778889999


Q ss_pred             ecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeee---CCCCCEEEEccccceeecC
Q 039516          100 EFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILL---DDQLNTKISDFGMARIFGV  160 (345)
Q Consensus       100 e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfgl~~~~~~  160 (345)
                      ||+ +++|.+++.                +++.+|.|||..   ||+||||||+|||+   +.++.+||+|||++.....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 999988765                566777777765   89999999999999   7889999999999987654


Q ss_pred             CCCC-----CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 039516          161 NESG-----ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDL  235 (345)
Q Consensus       161 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (345)
                      ....     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........................ 
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-  239 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-  239 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-
Confidence            3221     1223457899999999999999999999999999999999999999876554433333222211111100 


Q ss_pred             ccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          236 ELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       236 ~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                          +.+...++.+-   .+++..||+.||++|||+.++...+.++++.
T Consensus       240 ----~~~~~~~~~~l---~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          240 ----EVLCKGYPSEF---ATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             ----HHHTTTSCHHH---HHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ----hhhhccCCHHH---HHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence                00111122221   5999999999999999999888888887764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=315.08  Aligned_cols=242  Identities=18%  Similarity=0.154  Sum_probs=168.3

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEE------
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIH------   91 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~------   91 (345)
                      +.....|.+.++||+|+||.||++.. .+|+.||||++..........+.+|+.++.++. ||||+++++++..      
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            33455799999999999999999975 578999999997666566778999999999996 9999999999853      


Q ss_pred             --CCeeEEEEecCCCCChHHHHH------------------hHHHHHHHHHhcCCCc--eEEeccCCCCeeeCCCCCEEE
Q 039516           92 --GEERLLVYEFMPNKSLDSSFS------------------GTFKDLLCLHKYSRLR--VIHRDLKASNILLDDQLNTKI  149 (345)
Q Consensus        92 --~~~~~lv~e~~~~gsL~~~l~------------------~~~~~l~~lh~~~~~~--ivHrdlk~~Nill~~~~~~kl  149 (345)
                        ....++||||+. |+|.+++.                  +++.+|.|||..   +  |+||||||+|||++.++.+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence              335799999996 67766543                  556666677664   6  999999999999999999999


Q ss_pred             EccccceeecCCCCCC----------cccceeecCCccccchh---ccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 039516          150 SDFGMARIFGVNESGA----------NTNRIVGTYGYMSLEYT---MSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTE  216 (345)
Q Consensus       150 ~Dfgl~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~  216 (345)
                      +|||++..........          ......||+.|+|||++   .+..++.++||||||+++|+|++|+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9999998764322111          11134689999999988   5667899999999999999999999999753321


Q ss_pred             CcccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          217 RPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ..          . .+.    .........+..-   ..++..||+.||.+|||+.++...|..+.+
T Consensus       260 ~~----------~-~~~----~~~~~~~~~~~~~---~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          260 RI----------V-NGK----YSIPPHDTQYTVF---HSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             ---------------------CCCCTTCCSSGGG---HHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Hh----------h-cCc----ccCCcccccchHH---HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            10          0 000    0000111112111   489999999999999998888877777665

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9e-41  Score=306.02  Aligned_cols=246  Identities=17%  Similarity=0.233  Sum_probs=180.5

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      ...+|.+.+.||+|+||.||++.. .+|+.||||++...   .......+.+|+.++++++||||+++++++...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            345799999999999999999975 57999999999753   23345678999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           98 VYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        98 v~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      ||||+++++|.+++.                   +++.+|.+||..   |++||||||+||+++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            999999999987663                   556677777765   8999999999999999999999999998865


Q ss_pred             cCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                      .....  ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.....    ......... .......  
T Consensus       187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-~~~~~~~--  257 (310)
T 2wqm_A          187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKI-EQCDYPP--  257 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHH-HTTCSCC--
T ss_pred             cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHh-hcccCCC--
Confidence            43221  22335789999999999999999999999999999999999999975321    122222211 1221111  


Q ss_pred             cccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          239 DLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       239 d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                        .....++.+.   .+++..||+.||.+|||+.++...+..+.+.
T Consensus       258 --~~~~~~~~~l---~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          258 --LPSDHYSEEL---RQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             --CCTTTSCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CcccccCHHH---HHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence              1111122222   5899999999999999998888888877663

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-40  Score=302.00  Aligned_cols=234  Identities=18%  Similarity=0.176  Sum_probs=176.6

Q ss_pred             cccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           19 VENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        19 ~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ...+...|.+.++||+|+||.||++.. .++..||+|.+... .......+.+|++++++++||||+++++++.+....+
T Consensus        17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   96 (285)
T 3is5_A           17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY   96 (285)
T ss_dssp             SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence            334556799999999999999999965 56899999999755 3445788999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeee---CCCCCEEEEcccc
Q 039516           97 LVYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILL---DDQLNTKISDFGM  154 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfgl  154 (345)
                      +||||+++++|.+.+.                   +++.+|.+||..   ||+||||||+||++   +.++.+||+|||+
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~  173 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGL  173 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred             EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence            9999999999977653                   556677777765   89999999999999   4567899999999


Q ss_pred             ceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 039516          155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKD  234 (345)
Q Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (345)
                      +.......   ......||+.|+|||++. +.++.++||||||+++|+|++|+.||.....      .............
T Consensus       174 a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~~  243 (285)
T 3is5_A          174 AELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------EEVQQKATYKEPN  243 (285)
T ss_dssp             CCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC
T ss_pred             ceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH------HHHHhhhccCCcc
Confidence            97654322   223457899999999875 5689999999999999999999999976431      1111111111110


Q ss_pred             cccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          235 LELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       235 ~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ...    .....+++.   .+++..||+.||.+|||+.
T Consensus       244 ~~~----~~~~~~~~~---~~li~~~L~~dP~~Rps~~  274 (285)
T 3is5_A          244 YAV----ECRPLTPQA---VDLLKQMLTKDPERRPSAA  274 (285)
T ss_dssp             CCC------CCCCHHH---HHHHHHHTCSCTTTSCCHH
T ss_pred             ccc----ccCcCCHHH---HHHHHHHccCChhhCcCHH
Confidence            000    000122222   5899999999999999954

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.1e-40  Score=301.63  Aligned_cols=186  Identities=23%  Similarity=0.256  Sum_probs=153.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc--cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG--QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      .+|.+.++||+|+||.||++.. .+|+.||||++.....  .....+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            4699999999999999999976 4689999999865432  235668899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          101 FMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       101 ~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |+++++|.+++.               +++.+|.+||..   ||+||||||+||+++.++.+||+|||++........  
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--  157 (311)
T ss_dssp             CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--
Confidence            999998876644               566777777765   899999999999999999999999999987643221  


Q ss_pred             cccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  207 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS  207 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            2234578999999999876 678999999999999999999999997654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.9e-40  Score=307.60  Aligned_cols=252  Identities=19%  Similarity=0.210  Sum_probs=190.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHh--cCCCCeeeEEEEEEECC----eeE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAK--LQYTNLVKLLGCSIHGE----ERL   96 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~~~~~~~~~~----~~~   96 (345)
                      ..+|.+.+.||+|+||.||++.. +|+.||||.++..   ....+.+|++++..  ++||||+++++++....    ..+
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~  116 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW  116 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred             cccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence            45799999999999999999987 4899999999643   35678899999987  79999999999998776    789


Q ss_pred             EEEecCCCCChHHHHH--------------hHHHHHHHHHhc-----CCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516           97 LVYEFMPNKSLDSSFS--------------GTFKDLLCLHKY-----SRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~-----~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      +||||+++|+|.+++.              +++.+|.+||..     ++.+|+||||||+||+++.++.+||+|||++..
T Consensus       117 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~  196 (342)
T 1b6c_B          117 LVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  196 (342)
T ss_dssp             EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCcee
Confidence            9999999999988765              567778888832     145899999999999999999999999999987


Q ss_pred             ecCCCCCC--cccceeecCCccccchhccC------CcCcccchhhHHHHHHHHHhC----------CCCCCCCCCCCcc
Q 039516          158 FGVNESGA--NTNRIVGTYGYMSLEYTMSG------TVSIKTDVFGFGVLVLKIVCG----------KKNNKSYHTERPL  219 (345)
Q Consensus       158 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~SlG~il~el~tg----------~~p~~~~~~~~~~  219 (345)
                      ........  ......||+.|+|||++.+.      .++.++||||||+++|||++|          +.||........ 
T Consensus       197 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~-  275 (342)
T 1b6c_B          197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP-  275 (342)
T ss_dssp             EETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-
T ss_pred             ccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc-
Confidence            65432211  12335789999999998865      344789999999999999999          678765433221 


Q ss_pred             cHHHHHHHHHhcCCccccccccCCCCC-ChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          220 NLVGIAWQLWNEGKDLELIDLTLDGSC-PPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      ....+. .......    ..+.+...+ ....... .+++..||+.||++|||+.++...|..+.+.
T Consensus       276 ~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          276 SVEEMR-KVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CHHHHH-HHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cHHHHH-HHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            111211 1111111    112221111 1233344 7999999999999999999888888887654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.8e-40  Score=299.38  Aligned_cols=248  Identities=18%  Similarity=0.181  Sum_probs=189.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEE-EECCeeEEEEe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCS-IHGEERLLVYE  100 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~-~~~~~~~lv~e  100 (345)
                      ..+|.+.+.||+|+||.||+|.. .+|+.||||++.....  ...+.+|+.+++.++|++++..+..+ ......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46799999999999999999974 6799999999865432  24688999999999988866666654 56788899999


Q ss_pred             cCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC---CCCCEEEEccccceeecCC
Q 039516          101 FMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD---DQLNTKISDFGMARIFGVN  161 (345)
Q Consensus       101 ~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfgl~~~~~~~  161 (345)
                      |+ +++|.+++.                +++.+|.|||..   ||+||||||+||+++   .++.+||+|||++......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 899988765                566677777765   899999999999994   7889999999999876543


Q ss_pred             CCCC-----cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          162 ESGA-----NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       162 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                      ....     ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........................  
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  239 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI--  239 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH--
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch--
Confidence            3211     123457999999999999999999999999999999999999999876544333322222111101000  


Q ss_pred             cccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          237 LIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       237 ~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                         +.+...++.+-   .+++..||+.||.+|||+.++...|..++..
T Consensus       240 ---~~~~~~~~~~l---~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          240 ---EVLCKGYPSEF---ATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             ---HHHTTTSCHHH---HHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHhhCCHHH---HHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence               01111123222   5899999999999999999888888887764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.1e-41  Score=314.79  Aligned_cols=225  Identities=23%  Similarity=0.323  Sum_probs=176.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc---cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG---QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ..|.+.+.||+|+||.||+|.. .+|+.||||++.....   .....+.+|++++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4589999999999999999974 6799999999975432   23457899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          100 EFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       100 e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      ||+. |+|.+.+.                +++.+|.|||..   ||+||||||+|||++.++.+||+|||++.....   
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence            9997 46655442                566777777776   899999999999999999999999999976532   


Q ss_pred             CCcccceeecCCccccchhc---cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          164 GANTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                         .....||+.|+|||++.   .+.++.++|||||||++|||++|+.||.....      ............. ..   
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~~~-~~---  273 (348)
T 1u5q_A          207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESP-AL---  273 (348)
T ss_dssp             ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCC-CC---
T ss_pred             ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCC-CC---
Confidence               22357899999999884   56789999999999999999999999975431      1222222222111 00   


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                       ....++...   .+++..||+.||++|||+.
T Consensus       274 -~~~~~~~~l---~~li~~~l~~dP~~Rps~~  301 (348)
T 1u5q_A          274 -QSGHWSEYF---RNFVDSCLQKIPQDRPTSE  301 (348)
T ss_dssp             -CCTTSCHHH---HHHHHHHTCSSGGGSCCHH
T ss_pred             -CCCCCCHHH---HHHHHHHcccChhhCcCHH
Confidence             111122221   5899999999999999954

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1e-40  Score=308.38  Aligned_cols=234  Identities=19%  Similarity=0.171  Sum_probs=177.5

Q ss_pred             ccCCCCeeeE-EEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCe
Q 039516           20 ENSSLDWHMY-IQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEE   94 (345)
Q Consensus        20 ~~~~~~~~~~-~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~   94 (345)
                      +.|...|.+. +.||+|+||.||++.. .+|+.||+|++...  .......+.+|+.++.++ +||||+++++++.+.+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3445568887 7899999999999965 46999999999654  344577899999999999 56999999999999999


Q ss_pred             eEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC---CCCEEEEcccc
Q 039516           95 RLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD---QLNTKISDFGM  154 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgl  154 (345)
                      .++||||+++|+|.+++.                 +++.+|.+||..   ||+||||||+||+++.   ++.+||+|||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            999999999998876642                 566777777765   8999999999999988   78999999999


Q ss_pred             ceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 039516          155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKD  234 (345)
Q Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (345)
                      +.......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+      ...... ....
T Consensus       181 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~-~~~~  250 (327)
T 3lm5_A          181 SRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLNIS-QVNV  250 (327)
T ss_dssp             CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HTCC
T ss_pred             ccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHHH-hccc
Confidence            98764322   2233578999999999999999999999999999999999999997643211      111111 1100


Q ss_pred             cccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCC
Q 039516          235 LELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCP  271 (345)
Q Consensus       235 ~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  271 (345)
                      .  ........++...   .+++..||+.||.+|||+
T Consensus       251 ~--~~~~~~~~~~~~~---~~li~~~L~~dP~~Rpt~  282 (327)
T 3lm5_A          251 D--YSEETFSSVSQLA---TDFIQSLLVKNPEKRPTA  282 (327)
T ss_dssp             C--CCTTTTTTSCHHH---HHHHHHHSCSSGGGSCCH
T ss_pred             c--cCchhhcccCHHH---HHHHHHHcCCChhhCcCH
Confidence            0  0001111122211   589999999999999994

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.4e-41  Score=305.07  Aligned_cols=235  Identities=21%  Similarity=0.301  Sum_probs=178.4

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-CeeEEEEec
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG-EERLLVYEF  101 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-~~~~lv~e~  101 (345)
                      ..+|++.+.||+|+||.||++... |+.||||.++..  ...+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            357999999999999999999874 899999999754  3467899999999999999999999997654 478999999


Q ss_pred             CCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          102 MPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       102 ~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      +++++|.+++.                 +++.+|.+||..   |++||||||+||+++.++.+||+|||++......   
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  170 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence            99999987764                 455666677765   8999999999999999999999999998765322   


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                        .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.......   ..    .....+.     .....
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~----~~~~~~~-----~~~~~  236 (278)
T 1byg_A          171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGY-----KMDAP  236 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----HHHTTTC-----CCCCC
T ss_pred             --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHhcCC-----CCCCc
Confidence              122367889999999999999999999999999999998 999997643211   11    1111111     11111


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ..+++.-   .+++..||+.||.+|||+.++...|..+..
T Consensus       237 ~~~~~~l---~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          237 DGCPPAV---YEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             TTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccCCHHH---HHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            2233222   589999999999999998888887777654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.5e-41  Score=314.02  Aligned_cols=188  Identities=22%  Similarity=0.311  Sum_probs=161.4

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      -...+|.+.+.||+|+||.||++.. .+++.||+|.+... .......+.+|+.++++++||||+++++++..++..++|
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            3456799999999999999999976 47899999999765 334456799999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |||+++++|.+++.               +++.+|.|||..+  ||+||||||+||+++.++.+||+|||++......  
T Consensus       110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            99999999988765               5677788888754  7999999999999999999999999998754321  


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                        ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence              1223578999999999999999999999999999999999999997543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.9e-41  Score=306.17  Aligned_cols=241  Identities=21%  Similarity=0.288  Sum_probs=183.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCC----CcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPN----EQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~----~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      ..+|.+.+.||+|+||.||+|...+    +..||+|.+... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-EEPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-SSSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCCEE
Confidence            4569999999999999999997532    346999999765 3345678999999999999999999999975 456799


Q ss_pred             EEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           98 VYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        98 v~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      ||||+++++|.+++.                +++.+|.+||..   ||+||||||+||+++.++.+||+|||++......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            999999999988764                556667777765   8999999999999999999999999999865432


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.......   ....    ...+...     
T Consensus       167 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~----~~~~~~~-----  233 (281)
T 3cc6_A          167 DYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGV----LEKGDRL-----  233 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHH----HHHTCCC-----
T ss_pred             ccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHH----HhcCCCC-----
Confidence            211 1223456788999999998999999999999999999998 999997544322   1111    1111110     


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .....+++.-   .+++..||+.||.+|||+.++...|..++.
T Consensus       234 ~~~~~~~~~l---~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          234 PKPDLCPPVL---YTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             CCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHH---HHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence            0111122221   589999999999999999888888877654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-41  Score=316.43  Aligned_cols=230  Identities=18%  Similarity=0.204  Sum_probs=178.1

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc----CCCcEEEEEEeccCC----ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCe
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF----PNEQEVAIKRLAWTS----GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEE   94 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~----~~~~~VaiK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~   94 (345)
                      .+|.+.+.||+|+||.||++..    .+|+.||||+++...    ......+.+|+.+++++ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5799999999999999999976    368999999986432    23445678899999999 79999999999999999


Q ss_pred             eEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           95 RLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      .++||||+++++|.+++.               +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++...
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            999999999999988765               566777777765   89999999999999999999999999998764


Q ss_pred             CCCCCCcccceeecCCccccchhcc--CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTMS--GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLEL  237 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
                      .... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||........  ............     
T Consensus       211 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~-----  282 (355)
T 1vzo_A          211 ADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE-----  282 (355)
T ss_dssp             GGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCC-----
T ss_pred             cCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccC-----
Confidence            3221 12234579999999999885  3478999999999999999999999976443222  222222222111     


Q ss_pred             ccccCCCCCChhHHHH-HHHHhhccCCCCCcCCC
Q 039516          238 IDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQC  270 (345)
Q Consensus       238 ~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs  270 (345)
                        +.....++    .. .+++.+||+.||.+||+
T Consensus       283 --~~~~~~~~----~~~~~li~~~L~~dP~~R~~  310 (355)
T 1vzo_A          283 --PPYPQEMS----ALAKDLIQRLLMKDPKKRLG  310 (355)
T ss_dssp             --CCCCTTSC----HHHHHHHHHHTCSSGGGSTT
T ss_pred             --CCCCcccC----HHHHHHHHHHhhhCHHHhcC
Confidence              11111122    23 58999999999999995

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-40  Score=322.89  Aligned_cols=230  Identities=18%  Similarity=0.212  Sum_probs=181.9

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      -.+|.+.+.||+|+||.||+|.. .+|+.||||+++..   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            35699999999999999999975 47999999999643   223456789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      |||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||++......  
T Consensus        95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--  169 (476)
T 2y94_A           95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--  169 (476)
T ss_dssp             EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc--
Confidence            99999999977653               566677777765   8999999999999999999999999999876432  


Q ss_pred             CCcccceeecCCccccchhccCCc-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                       .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......      ..... ...+...      .
T Consensus       170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~~-i~~~~~~------~  235 (476)
T 2y94_A          170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFKK-ICDGIFY------T  235 (476)
T ss_dssp             -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHHH-HHTTCCC------C
T ss_pred             -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHHH-HhcCCcC------C
Confidence             22334579999999999988766 68999999999999999999999754321      11111 1122110      1


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCCCCCcc
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~  274 (345)
                      ....+++.   .+++..||+.||.+|||+.++
T Consensus       236 p~~~s~~~---~~Li~~~L~~dP~~Rpt~~ei  264 (476)
T 2y94_A          236 PQYLNPSV---ISLLKHMLQVDPMKRATIKDI  264 (476)
T ss_dssp             CTTCCHHH---HHHHHHHTCSSTTTSCCHHHH
T ss_pred             CccCCHHH---HHHHHHHcCCCchhCcCHHHH
Confidence            11122222   589999999999999996543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-41  Score=305.73  Aligned_cols=245  Identities=21%  Similarity=0.266  Sum_probs=185.1

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcC-C---CcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee-
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFP-N---EQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER-   95 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~-~---~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~-   95 (345)
                      ....|.+.++||+|+||.||+|... +   +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. 
T Consensus        19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            3455777899999999999999742 2   3379999997543 34467899999999999999999999999876655 


Q ss_pred             EEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           96 LLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      ++||||+.+++|.+++.                +++.+|.+||..   ||+||||||+||+++.++.+||+|||+++...
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            99999999999988765                566677777765   89999999999999999999999999997653


Q ss_pred             CCC--CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 039516          160 VNE--SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLEL  237 (345)
Q Consensus       160 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
                      ...  .........+|+.|+|||.+.+..++.++||||||+++|+|++|..|+.....  .......    ...+..   
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~----~~~~~~---  246 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHF----LAQGRR---  246 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHH----HHTTCC---
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHH----hhcCCC---
Confidence            221  11222334678899999999999999999999999999999996655433221  1111111    111110   


Q ss_pred             ccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          238 IDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       238 ~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                        ......++    .. .+++..||+.||.+|||+.++...|.++++.
T Consensus       247 --~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          247 --LPQPEYCP----DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             --CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCccch----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence              00111122    23 5999999999999999999888888887763

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.1e-40  Score=303.84  Aligned_cols=245  Identities=17%  Similarity=0.115  Sum_probs=179.6

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc---cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG---QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      ...+|.+.+.||+|+||.||++.. .+++.||+|.+.....   .....+.+|+.++++++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            356799999999999999999975 4789999999975432   234678999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           98 VYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        98 v~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      ||||+++++|.+++.               +++.+|.+||..   ||+||||||+||+++.++.+||+|||++.......
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            999999999988764               566677777765   89999999999999999999999999997654322


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                      . .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.....       .............   ....
T Consensus       189 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~---~~~~  257 (309)
T 2h34_A          189 L-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIPR---PSTV  257 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCCC---GGGT
T ss_pred             c-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCCC---cccc
Confidence            1 122345789999999999999999999999999999999999999975321       1111222111110   0111


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCC-CCCcchhhhhcccc
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQ-CPMLFPCLLMNLLP  283 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~~~~~~l~~ll~  283 (345)
                      ...++..-   .+++..||+.||.+|| |+.++...+..++.
T Consensus       258 ~~~~~~~l---~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          258 RPGIPVAF---DAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             STTCCTHH---HHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             CCCCCHHH---HHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence            12233222   4899999999999999 77777777776655

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.4e-41  Score=308.71  Aligned_cols=250  Identities=20%  Similarity=0.272  Sum_probs=188.4

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-----CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--e
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-----PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE--E   94 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-----~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--~   94 (345)
                      ...+|++.+.||+|+||.||++..     .+|+.||||++..........+.+|+.++++++||||+++++++...+  .
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            356699999999999999999973     468999999998766666778999999999999999999999986543  6


Q ss_pred             eEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           95 RLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      .++||||+++++|.+++.                +++.+|.+||..   ||+||||||+||+++.++.+||+|||++...
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            899999999999988764                556677777765   8999999999999999999999999999876


Q ss_pred             cCCCCCC-cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCC---------CCcccHHHHHHHH
Q 039516          159 GVNESGA-NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHT---------ERPLNLVGIAWQL  228 (345)
Q Consensus       159 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~---------~~~~~~~~~~~~~  228 (345)
                      ....... ......++..|+|||++.+..++.++||||||+++|+|++|..|+.....         .............
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence            4332211 11223567789999999998999999999999999999999998763210         0000001111111


Q ss_pred             HhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          229 WNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       229 ~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ...+...     .....++    .. .+++..||+.||++|||+.++...|..+.+
T Consensus       276 ~~~~~~~-----~~~~~~~----~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          276 LKNNGRL-----PRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHTTCCC-----CCCTTCC----HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhcCCCC-----CCCCccc----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1111110     0111122    23 589999999999999999888877776654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.2e-40  Score=312.12  Aligned_cols=231  Identities=16%  Similarity=0.128  Sum_probs=170.1

Q ss_pred             CCCCeeeE-EEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHh-cCCCCeeeEEEEEEE----CCe
Q 039516           22 SSLDWHMY-IQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAK-LQYTNLVKLLGCSIH----GEE   94 (345)
Q Consensus        22 ~~~~~~~~-~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~~~~~~~~----~~~   94 (345)
                      ...+|.+. +.||+|+||.||++.. .+|+.||||+++.     ...+.+|+.++.+ .+||||+++++++..    ...
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            44668877 6899999999999965 5789999999963     2467789988754 589999999999876    567


Q ss_pred             eEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC---CCCEEEEcccc
Q 039516           95 RLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD---QLNTKISDFGM  154 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgl  154 (345)
                      +|+||||+++|+|.+++.                 +++.+|.|||..   ||+||||||+|||++.   ++.+||+|||+
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence            899999999999987764                 566777788765   8999999999999987   78899999999


Q ss_pred             ceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCccc-HHHHHHHHHhcCC
Q 039516          155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLN-LVGIAWQLWNEGK  233 (345)
Q Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~  233 (345)
                      ++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ...    ....+.
T Consensus       211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~i~~~~  283 (400)
T 1nxk_A          211 AKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQ  283 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH----HHHHTC
T ss_pred             ccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH----HHHcCc
Confidence            9875422   22334678999999999999999999999999999999999999997654332111 111    111111


Q ss_pred             ccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          234 DLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       234 ~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .. ...+. ...++.+.   .+++..||+.||.+|||+.
T Consensus       284 ~~-~~~~~-~~~~s~~~---~~li~~~L~~dP~~Rpt~~  317 (400)
T 1nxk_A          284 YE-FPNPE-WSEVSEEV---KMLIRNLLKTEPTQRMTIT  317 (400)
T ss_dssp             CC-CCTTT-TTTSCHHH---HHHHHTTSCSSGGGSCCHH
T ss_pred             cc-CCCcc-cccCCHHH---HHHHHHHCCCChhHCcCHH
Confidence            10 00000 01122222   5999999999999999954

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.8e-40  Score=302.03  Aligned_cols=233  Identities=18%  Similarity=0.213  Sum_probs=179.9

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+...|.+.+.||+|+||.||++.. .+|+.||+|.++.........+.+|+.++++++||||+++++++.+....++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            4456799999999999999999975 479999999998665445567899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeee---CCCCCEEEEccccceeecCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILL---DDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      ||+++++|.+++.               +++.+|.+||..   ||+||||||+||++   +.++.+||+|||++..... 
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-  161 (304)
T 2jam_A           86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-  161 (304)
T ss_dssp             CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred             EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence            9999999987654               566777777765   89999999999999   7788999999999875422 


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                         .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......      .. ......+...  +...
T Consensus       162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~-~~~i~~~~~~--~~~~  229 (304)
T 2jam_A          162 ---GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------KL-FEKIKEGYYE--FESP  229 (304)
T ss_dssp             ---BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------HH-HHHHHHCCCC--CCTT
T ss_pred             ---CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HH-HHHHHcCCCC--CCcc
Confidence               1223457899999999999999999999999999999999999999754311      11 1111122110  0111


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .....+.+.   .+++..||+.||.+|||+.
T Consensus       230 ~~~~~~~~~---~~li~~~l~~dp~~Rps~~  257 (304)
T 2jam_A          230 FWDDISESA---KDFICHLLEKDPNERYTCE  257 (304)
T ss_dssp             TTTTSCHHH---HHHHHHHHCSSTTTSCCHH
T ss_pred             ccccCCHHH---HHHHHHHcCCChhHCcCHH
Confidence            111122222   5999999999999999953

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.2e-41  Score=306.14  Aligned_cols=241  Identities=18%  Similarity=0.216  Sum_probs=174.8

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-----ccCHHHHHHHHHHHHhcC---CCCeeeEEEEEEEC
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-----GQGRVEFQNEAKLIAKLQ---YTNLVKLLGCSIHG   92 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~   92 (345)
                      +..+|++.++||+|+||.||++.. .+|+.||||++....     ......+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            345799999999999999999975 578999999986432     122456778888877774   99999999999876


Q ss_pred             C-----eeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEE
Q 039516           93 E-----ERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKIS  150 (345)
Q Consensus        93 ~-----~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~  150 (345)
                      .     ..++||||+.+ +|.+++.                 +++.+|.|||..   ||+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence            5     57999999974 8776553                 566777777765   79999999999999999999999


Q ss_pred             ccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh
Q 039516          151 DFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWN  230 (345)
Q Consensus       151 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  230 (345)
                      |||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ..........
T Consensus       163 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~  236 (308)
T 3g33_A          163 DFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIG  236 (308)
T ss_dssp             SCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred             eCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhC
Confidence            99999765322   22344678999999999999999999999999999999999999997643221   1111112111


Q ss_pred             cCCcccc------ccccCCCC--C-----ChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          231 EGKDLEL------IDLTLDGS--C-----PPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       231 ~~~~~~~------~d~~l~~~--~-----~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .......      ........  .     .+..... .+++..||+.||.+|||+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  292 (308)
T 3g33_A          237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF  292 (308)
T ss_dssp             CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHH
Confidence            1110000      00000000  0     0111123 6899999999999999953

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1e-40  Score=301.34  Aligned_cols=226  Identities=17%  Similarity=0.162  Sum_probs=176.4

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC--CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCee
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~   95 (345)
                      ..+..+|++.++||+|+||.||++... +++.||||.++..  .......+.+|+..+.++ +||||+++++++.+.+..
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A            7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            345567999999999999999999764 7999999999754  233456788999999999 999999999999999999


Q ss_pred             EEEEecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC------------
Q 039516           96 LLVYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ------------  144 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~------------  144 (345)
                      ++||||+++++|.+++.                   +++.+|.|||..   ||+||||||+||+++.+            
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccc
Confidence            99999999999988764                   556677777765   89999999999999844            


Q ss_pred             -------CCEEEEccccceeecCCCCCCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 039516          145 -------LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTE  216 (345)
Q Consensus       145 -------~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~~~  216 (345)
                             ..+||+|||++.......      ...||+.|+|||++.+. .++.++||||||+++|+|++|..++....  
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--  235 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--  235 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--
T ss_pred             ccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--
Confidence                   479999999998764321      23589999999998865 56789999999999999999988764321  


Q ss_pred             CcccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          217 RPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                              .+.....+..     +.+...++.+.   .+++..||+.||++|||+.
T Consensus       236 --------~~~~~~~~~~-----~~~~~~~~~~~---~~li~~~l~~dp~~Rps~~  275 (289)
T 1x8b_A          236 --------QWHEIRQGRL-----PRIPQVLSQEF---TELLKVMIHPDPERRPSAM  275 (289)
T ss_dssp             --------HHHHHHTTCC-----CCCSSCCCHHH---HHHHHHHTCSSGGGSCCHH
T ss_pred             --------HHHHHHcCCC-----CCCCcccCHHH---HHHHHHHhCCCcccCCCHH
Confidence                    1111222222     11122233222   5899999999999999953

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.6e-41  Score=311.13  Aligned_cols=246  Identities=20%  Similarity=0.189  Sum_probs=177.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ..+|.+.+.||+|+||.||++.. .+|+.||||++....  ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            46799999999999999999976 468999999986543  223456889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||+++++|.++..               +++.+|.+||..   ||+||||||+||+++.++.+||+|||++........ 
T Consensus       104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  179 (331)
T 4aaa_A          104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  179 (331)
T ss_dssp             ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence            9999988876542               667777777776   899999999999999999999999999986543221 


Q ss_pred             CcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHH--------HHHHHHhcCC-c
Q 039516          165 ANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVG--------IAWQLWNEGK-D  234 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~-~  234 (345)
                       ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||......+....+.        .....+.... .
T Consensus       180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence             22335789999999998875 78999999999999999999999997654221111000        0011111111 0


Q ss_pred             cccccccCCCCCCh-----hHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          235 LELIDLTLDGSCPP-----NEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       235 ~~~~d~~l~~~~~~-----~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .....+.+....+.     ..... .+++..||+.||.+|||+.+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e  303 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE  303 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHH
Confidence            11111111111111     11223 69999999999999999653

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.3e-41  Score=302.61  Aligned_cols=234  Identities=21%  Similarity=0.241  Sum_probs=184.4

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE-------
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH-------   91 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-------   91 (345)
                      +.+..+|.+.+.||+|+||.||++... +|+.||+|.++...    ..+.+|++++++++||||+++++++..       
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            345567999999999999999999764 79999999997543    357789999999999999999998864       


Q ss_pred             ---------CCeeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC
Q 039516           92 ---------GEERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL  145 (345)
Q Consensus        92 ---------~~~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~  145 (345)
                               ....++||||+++++|.+++.                 +++.+|.+||..   ||+||||||+||+++.++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence                     345799999999999988764                 556677777765   899999999999999999


Q ss_pred             CEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 039516          146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIA  225 (345)
Q Consensus       146 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~  225 (345)
                      .+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..|+...         ...
T Consensus       160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~  227 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKF  227 (284)
T ss_dssp             EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHH
T ss_pred             CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHH
Confidence            999999999987643321   22346899999999999999999999999999999999999886421         111


Q ss_pred             HHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          226 WQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       226 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ......+.        +...++...   .+++..||+.||.+|||+.++...+..+..
T Consensus       228 ~~~~~~~~--------~~~~~~~~~---~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          228 FTDLRDGI--------ISDIFDKKE---KTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             HHHHHTTC--------CCTTSCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             HHHhhccc--------ccccCCHHH---HHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            11122221        112233222   489999999999999998877766665543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.2e-41  Score=317.92  Aligned_cols=221  Identities=14%  Similarity=0.135  Sum_probs=168.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHH---HHHHhcCCCCeeeEE-------EE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEA---KLIAKLQYTNLVKLL-------GC   88 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~~~-------~~   88 (345)
                      ..+|.+.+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|+   +++++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46799999999999999999986 56999999999743   334467899999   555566899999998       76


Q ss_pred             EEECC-----------------eeEEEEecCCCCChHHHHH----------------------hHHHHHHHHHhcCCCce
Q 039516           89 SIHGE-----------------ERLLVYEFMPNKSLDSSFS----------------------GTFKDLLCLHKYSRLRV  129 (345)
Q Consensus        89 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~----------------------~~~~~l~~lh~~~~~~i  129 (345)
                      +...+                 ..++||||+ +|+|.+++.                      +++.+|.|||..   ||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            66543                 278999999 679876553                      455666677765   89


Q ss_pred             EEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccC-----------CcCcccchhhHHH
Q 039516          130 IHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG-----------TVSIKTDVFGFGV  198 (345)
Q Consensus       130 vHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Di~SlG~  198 (345)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986421     2334567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          199 LVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       199 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      ++|||++|+.||.........               ..+... . ..++.+.   .+++..||+.||.+|||+.+
T Consensus       302 il~elltg~~Pf~~~~~~~~~---------------~~~~~~-~-~~~~~~~---~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGS---------------EWIFRS-C-KNIPQPV---RALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             HHHHHHHSSCCC------CCS---------------GGGGSS-C-CCCCHHH---HHHHHHHTCSSGGGCCCHHH
T ss_pred             HHHHHHHCCCCCcccccccch---------------hhhhhh-c-cCCCHHH---HHHHHHHcCCCchhCCCHHH
Confidence            999999999999764322211               111110 0 1233222   58999999999999999653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.3e-39  Score=301.98  Aligned_cols=232  Identities=18%  Similarity=0.168  Sum_probs=183.8

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ....+|.+.+.||+|+||.||++.. .+++.||+|.+...   .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            3456799999999999999999975 46889999998654   2334567899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           97 LVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      +||||+++++|.+++.               +++.+|.|||..   ||+||||||+||+++.++.+||+|||++......
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            9999999999987654               566777777765   8999999999999999999999999999876432


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      ..  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....      ........ .+..      .
T Consensus       195 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~-~~~~------~  259 (335)
T 2owb_A          195 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIK-KNEY------S  259 (335)
T ss_dssp             TC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH-HTCC------C
T ss_pred             cc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHh-cCCC------C
Confidence            22  22345789999999999998999999999999999999999999975431      11111111 1111      1


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      +...++...   .+++..||+.||.+|||+.+
T Consensus       260 ~~~~~~~~~---~~li~~~l~~dp~~Rps~~e  288 (335)
T 2owb_A          260 IPKHINPVA---ASLIQKMLQTDPTARPTINE  288 (335)
T ss_dssp             CCTTSCHHH---HHHHHHHTCSSGGGSCCGGG
T ss_pred             CCccCCHHH---HHHHHHHccCChhHCcCHHH
Confidence            111122221   58999999999999999653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.1e-39  Score=294.76  Aligned_cols=232  Identities=18%  Similarity=0.164  Sum_probs=183.6

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ....+|.+.+.||+|+||.||++... +++.||+|.+...   .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            34567999999999999999999764 6889999998654   2334567899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           97 LVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      +||||+++++|.+++.               +++.+|.+||..   ||+||||||+||+++.++.+||+|||++......
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            9999999999987654               566777777765   8999999999999999999999999999876432


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      ..  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....      ..... ....+..      .
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~-~~~~~~~------~  233 (294)
T 2rku_A          169 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYL-RIKKNEY------S  233 (294)
T ss_dssp             TC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHH-HHHTTCC------C
T ss_pred             cc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHH-HHhhccC------C
Confidence            22  22335789999999999998899999999999999999999999975431      11111 1111111      1


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      +....+...   .+++..||+.||++|||+.+
T Consensus       234 ~~~~~~~~~---~~li~~~l~~~p~~Rps~~~  262 (294)
T 2rku_A          234 IPKHINPVA---ASLIQKMLQTDPTARPTINE  262 (294)
T ss_dssp             CCTTSCHHH---HHHHHHHTCSSGGGSCCGGG
T ss_pred             CccccCHHH---HHHHHHHcccChhhCcCHHH
Confidence            111122211   58999999999999999653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.5e-40  Score=329.51  Aligned_cols=249  Identities=17%  Similarity=0.167  Sum_probs=192.9

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~l   97 (345)
                      -.+|++.+.||+|+||.||++.. .+++.||||+++..   .......+..|..++..+ +||||+++++++.+.+.+|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            35799999999999999999975 46899999999653   234456788999999988 79999999999999999999


Q ss_pred             EEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           98 VYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        98 v~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      ||||+++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++......
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            999999999987765               566677777765   89999999999999999999999999998643222


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      .+...... .+..      .+
T Consensus       497 --~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~-~~~~------~~  561 (674)
T 3pfq_A          497 --VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIM-EHNV------AY  561 (674)
T ss_dssp             --CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-SSCC------CC
T ss_pred             --cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHH-hCCC------CC
Confidence              234456899999999999999999999999999999999999999976432      11112222 1111      11


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccceeeEE
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLHFLL  294 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~~~~  294 (345)
                      ....+.+.   .+++..||+.||.+||++..  ....+++.+..+...++..
T Consensus       562 p~~~s~~~---~~li~~lL~~dP~~R~~~~~--~~~~ei~~h~ff~~i~w~~  608 (674)
T 3pfq_A          562 PKSMSKEA---VAICKGLMTKHPGKRLGCGP--EGERDIKEHAFFRYIDWEK  608 (674)
T ss_dssp             CTTSCHHH---HHHHHHHSCSSSTTCTTCST--THHHHHHSSGGGSSCCHHH
T ss_pred             CccCCHHH---HHHHHHHccCCHHHCCCCCC--CcHHHHhcCccccCCCHHH
Confidence            11122222   59999999999999999632  2334566666665554443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.8e-40  Score=295.63  Aligned_cols=231  Identities=17%  Similarity=0.180  Sum_probs=178.2

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCC------ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTS------GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ..|.+.+.||+|+||.||++... +|+.||+|.++...      ....+.+.+|+.++++++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            45999999999999999999764 68999999986542      124678999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC----CEEEEcccccee
Q 039516           97 LVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL----NTKISDFGMARI  157 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfgl~~~  157 (345)
                      +||||+++++|.+++.               +++.+|.+||..   |++||||||+||+++.++    .+||+|||++..
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            9999999999988764               566777777765   899999999999998877    799999999987


Q ss_pred             ecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 039516          158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLEL  237 (345)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
                      .....   ......||+.|+|||++.+..++.++||||||+++|+|++|..||......      .. ..........  
T Consensus       162 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~-~~~~~~~~~~--  229 (283)
T 3bhy_A          162 IEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ET-LTNISAVNYD--  229 (283)
T ss_dssp             CC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HH-HHHHHTTCCC--
T ss_pred             ccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HH-HHHhHhcccC--
Confidence            64322   223356899999999999999999999999999999999999999764311      11 1111111110  


Q ss_pred             ccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          238 IDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       238 ~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .++......+...   .+++..||+.||.+|||+.
T Consensus       230 ~~~~~~~~~~~~~---~~li~~~l~~dp~~Rps~~  261 (283)
T 3bhy_A          230 FDEEYFSNTSELA---KDFIRRLLVKDPKRRMTIA  261 (283)
T ss_dssp             CCHHHHTTCCHHH---HHHHHTTSCSSGGGSCCHH
T ss_pred             CcchhcccCCHHH---HHHHHHHccCCHhHCcCHH
Confidence            0010001122111   5899999999999999954

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.3e-41  Score=310.09  Aligned_cols=240  Identities=22%  Similarity=0.274  Sum_probs=184.0

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcE--EEEEEeccC-CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQE--VAIKRLAWT-SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~--VaiK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~l   97 (345)
                      ..+|.+.+.||+|+||.||++.. .+|..  ||+|.++.. .......+.+|+++++++ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            36799999999999999999975 35664  499998653 334456799999999999 99999999999999999999


Q ss_pred             EEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC
Q 039516           98 VYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN  146 (345)
Q Consensus        98 v~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~  146 (345)
                      ||||+++++|.+++.                               +++.+|.+||..   ||+||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence            999999999987753                               455667777765   8999999999999999999


Q ss_pred             EEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHH
Q 039516          147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIA  225 (345)
Q Consensus       147 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~  225 (345)
                      +||+|||+++......   ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.....      ... 
T Consensus       181 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~-  250 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AEL-  250 (327)
T ss_dssp             EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHH-
T ss_pred             EEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------HHH-
Confidence            9999999987432211   1222456889999999998899999999999999999998 9999976431      111 


Q ss_pred             HHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          226 WQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       226 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      ......+.     .......++    .. .+++..||+.||.+|||+.++...|..+++.
T Consensus       251 ~~~~~~~~-----~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          251 YEKLPQGY-----RLEKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             HHHGGGTC-----CCCCCTTBC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHhhcCC-----CCCCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            11111111     011111122    23 5899999999999999999888888887764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.5e-40  Score=296.63  Aligned_cols=226  Identities=18%  Similarity=0.178  Sum_probs=179.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|.+.+.||+|+||.||++.. .+++.||+|.+...   .......+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            5699999999999999999975 46889999998543   2234567899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||+++++|.+++.               +++.+|.+||..   ||+||||||+||+++.++.+||+|||++......   
T Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---  167 (284)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---
T ss_pred             EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc---
Confidence            9999999987654               556666677654   8999999999999999999999999999765322   


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                       ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.....      ........ ...      ..+..
T Consensus       168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~-~~~------~~~~~  233 (284)
T 2vgo_A          168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIV-NVD------LKFPP  233 (284)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH-TTC------CCCCT
T ss_pred             -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHh-ccc------cCCCC
Confidence             22335789999999999999999999999999999999999999975431      11111111 111      11111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..+.+.   .+++..||+.||.+|||+.
T Consensus       234 ~~~~~~---~~li~~~l~~~p~~Rps~~  258 (284)
T 2vgo_A          234 FLSDGS---KDLISKLLRYHPPQRLPLK  258 (284)
T ss_dssp             TSCHHH---HHHHHHHSCSSGGGSCCHH
T ss_pred             cCCHHH---HHHHHHHhhcCHhhCCCHH
Confidence            122211   5899999999999999953

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.1e-41  Score=307.51  Aligned_cols=244  Identities=17%  Similarity=0.180  Sum_probs=181.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE----CCeeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH----GEERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~l   97 (345)
                      ..+|.+.+.||+|+||.||++.. .+|+.||||++..........+.+|+.++++++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            45699999999999999999975 6799999999977666667789999999999999999999999873    347899


Q ss_pred             EEecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           98 VYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        98 v~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      ||||+++++|.+++.                   +++.+|.+||..   ||+||||||+||+++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            999999999977654                   556677777765   8999999999999999999999999998764


Q ss_pred             cCCCCCC-------cccceeecCCccccchhccCC---cCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 039516          159 GVNESGA-------NTNRIVGTYGYMSLEYTMSGT---VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQL  228 (345)
Q Consensus       159 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  228 (345)
                      .......       ......||+.|+|||++.+..   ++.++||||||+++|+|++|+.||........ ....    .
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~  259 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----A  259 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH----H
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH----H
Confidence            3211110       011235689999999987544   68899999999999999999999864211110 0100    0


Q ss_pred             HhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          229 WNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       229 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                      .... .    .......++...   .+++..||+.||.+|||+.++...|..+.
T Consensus       260 ~~~~-~----~~~~~~~~~~~l---~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          260 VQNQ-L----SIPQSPRHSSAL---WQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HHCC-------CCCCTTSCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hhcc-C----CCCccccCCHHH---HHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            1110 0    000011122211   59999999999999999877776666543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-41  Score=312.93  Aligned_cols=252  Identities=16%  Similarity=0.187  Sum_probs=188.7

Q ss_pred             ccccCCCCeeeEEEeeccCCeEEEEEEcC---------CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeee----
Q 039516           18 FVENSSLDWHMYIQQEQTRDRVILVGKFP---------NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVK----   84 (345)
Q Consensus        18 ~~~~~~~~~~~~~~lG~G~~g~vy~~~~~---------~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~----   84 (345)
                      ..+....+|.+.+.||+|+||.||++...         +++.||||.+...     ..+.+|++++++++||||++    
T Consensus        36 i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~  110 (352)
T 2jii_A           36 LTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKK  110 (352)
T ss_dssp             EECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             eecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhh
Confidence            33444578999999999999999999765         3789999999644     36889999999999999987    


Q ss_pred             -----------EEEEEEE-CCeeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccC
Q 039516           85 -----------LLGCSIH-GEERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLK  135 (345)
Q Consensus        85 -----------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk  135 (345)
                                 +++++.. +...++||||+ +++|.+++.                 +++.+|.|||..   ||+|||||
T Consensus       111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dik  186 (352)
T 2jii_A          111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVT  186 (352)
T ss_dssp             HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCC
T ss_pred             hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCC
Confidence                       6788776 77899999999 999988764                 566677777765   89999999


Q ss_pred             CCCeeeCCCC--CEEEEccccceeecCCCCC-----CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCC
Q 039516          136 ASNILLDDQL--NTKISDFGMARIFGVNESG-----ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK  208 (345)
Q Consensus       136 ~~Nill~~~~--~~kl~Dfgl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~  208 (345)
                      |+||+++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++||||||+++|+|++|+.
T Consensus       187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  266 (352)
T 2jii_A          187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL  266 (352)
T ss_dssp             GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999988  8999999999876432211     11233478999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccHHHHHHHHHhcCCccccccccCC-CCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          209 NNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD-GSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      ||....... ...... ...+.. ....+.+.... ..++.+.   .+++..||+.||.+|||+.++...|.++++.
T Consensus       267 pf~~~~~~~-~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~l---~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          267 PWTNCLPNT-EDIMKQ-KQKFVD-KPGPFVGPCGHWIRPSETL---QKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             TTGGGTTCH-HHHHHH-HHHHHH-SCCCEECTTSCEECCCHHH---HHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CcccCCcCH-HHHHHH-HHhccC-ChhhhhhhccccCCCcHHH---HHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            998643211 111111 111111 11122221111 1122222   5899999999999999999888888887764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.7e-41  Score=338.31  Aligned_cols=235  Identities=21%  Similarity=0.261  Sum_probs=178.7

Q ss_pred             EEeeccCCeEEEEEEc---CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCC
Q 039516           30 IQQEQTRDRVILVGKF---PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN  104 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~---~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  104 (345)
                      ++||+|+||.||+|.+   .+++.||||+++..  .....+.|.+|+++|++++|||||++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            4799999999999954   34689999999754  3344678999999999999999999999985 5568999999999


Q ss_pred             CChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC-Cccc
Q 039516          105 KSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG-ANTN  168 (345)
Q Consensus       105 gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~  168 (345)
                      |+|.+++.               +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++........ ....
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  530 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  530 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence            99988765               567777788765   8999999999999999999999999999876432211 1222


Q ss_pred             ceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCC
Q 039516          169 RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCP  247 (345)
Q Consensus       169 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  247 (345)
                      ...+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+       .......+...     .....++
T Consensus       531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~-----~~p~~~~  598 (635)
T 4fl3_A          531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERM-----GCPAGCP  598 (635)
T ss_dssp             ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCC-----CCCTTCC
T ss_pred             CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC-----CCCCCCC
Confidence            3456788999999999999999999999999999998 999997654211       12222222111     1111233


Q ss_pred             hhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          248 PNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       248 ~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .+.   .+++..||+.||++|||+.++...|.++..
T Consensus       599 ~~l---~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          599 REM---YDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             HHH---HHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHH---HHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            222   599999999999999998888777776543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.9e-40  Score=308.10  Aligned_cols=188  Identities=20%  Similarity=0.301  Sum_probs=154.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE--------
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH--------   91 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--------   91 (345)
                      -.+|.+.++||+|+||.||++.. .+|+.||||++....  ......+.+|+.++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46799999999999999999976 579999999986542  2335678899999999999999999999987        


Q ss_pred             CCeeEEEEecCCCCChHHHH----------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccc
Q 039516           92 GEERLLVYEFMPNKSLDSSF----------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMA  155 (345)
Q Consensus        92 ~~~~~lv~e~~~~gsL~~~l----------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~  155 (345)
                      .+..++||||+++ +|.+.+                .+++.+|.|||..   ||+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            4468999999986 443332                2667777778765   8999999999999999999999999999


Q ss_pred             eeecCCCC--CCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          156 RIFGVNES--GANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       156 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ........  ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  233 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT  233 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            87643221  122234578999999998876 558999999999999999999999998644

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8e-41  Score=326.11  Aligned_cols=233  Identities=20%  Similarity=0.206  Sum_probs=176.4

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      .+...|.+.++||+|+||.||++.. .++..||+|++....  ......+.+|+.+++.++||||++++++|.+....++
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3455799999999999999999975 478999999997542  3346679999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC---CCEEEEccccceeec
Q 039516           98 VYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ---LNTKISDFGMARIFG  159 (345)
Q Consensus        98 v~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfgl~~~~~  159 (345)
                      |||||++|+|.+.+.               +++.+|.|||..   ||+||||||+|||++..   +.+||+|||++....
T Consensus       114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            999999999976543               567777777765   89999999999999764   559999999998764


Q ss_pred             CCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccc
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID  239 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  239 (345)
                      ...   ......||+.|+|||++. +.++.++||||+||++|+|++|..||......      ...... ..+.... ..
T Consensus       191 ~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i-~~~~~~~-~~  258 (494)
T 3lij_A          191 NQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRKV-EKGKYTF-DS  258 (494)
T ss_dssp             TTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH-HHTCCCC-CS
T ss_pred             CCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH-HhCCCCC-Cc
Confidence            322   233457999999999876 56899999999999999999999999764321      111111 1121110 01


Q ss_pred             ccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          240 LTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       240 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +.. ...++..   .+++..||+.||.+|||+.
T Consensus       259 ~~~-~~~s~~~---~~li~~~L~~dp~~R~s~~  287 (494)
T 3lij_A          259 PEW-KNVSEGA---KDLIKQMLQFDSQRRISAQ  287 (494)
T ss_dssp             GGG-TTSCHHH---HHHHHHHTCSSTTTSCCHH
T ss_pred             hhc-ccCCHHH---HHHHHHHCCCChhhCccHH
Confidence            111 1122222   5899999999999999954

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.4e-40  Score=297.52  Aligned_cols=230  Identities=21%  Similarity=0.265  Sum_probs=174.8

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE----CCeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH----GEERL   96 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~   96 (345)
                      ..|.+...||+|+||.||+|.. .++..||+|.+...  .......+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            4478888999999999999965 56889999998654  33456679999999999999999999999875    35689


Q ss_pred             EEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC-CCCCEEEEccccceeecC
Q 039516           97 LVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD-DQLNTKISDFGMARIFGV  160 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgl~~~~~~  160 (345)
                      +||||+++++|.+++.               +++.+|.|||... .+|+||||||+||+++ .++.+||+|||++.....
T Consensus       106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence            9999999999988765               5566677777651 1399999999999997 788999999999965422


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                          .......||+.|+|||++. +.++.++||||||+++|+|++|+.||......     .. .......+.....++ 
T Consensus       185 ----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~-~~~~~~~~~~~~~~~-  252 (290)
T 1t4h_A          185 ----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQ-IYRRVTSGVKPASFD-  252 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HH-HHHHHTTTCCCGGGG-
T ss_pred             ----cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HH-HHHHHhccCCccccC-
Confidence                2233457899999999876 45899999999999999999999999754321     11 111222221111111 


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                         ...+++.   .+++..||+.||.+|||+.
T Consensus       253 ---~~~~~~l---~~li~~~l~~dp~~Rps~~  278 (290)
T 1t4h_A          253 ---KVAIPEV---KEIIEGCIRQNKDERYSIK  278 (290)
T ss_dssp             ---GCCCHHH---HHHHHHHSCSSGGGSCCHH
T ss_pred             ---CCCCHHH---HHHHHHHccCChhhCCCHH
Confidence               1122211   5899999999999999954

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=297.24  Aligned_cols=234  Identities=21%  Similarity=0.243  Sum_probs=176.5

Q ss_pred             ccccCCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           18 FVENSSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        18 ~~~~~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      ..+.....|++.+.||+|+||.||+|... +|+.||+|.+....  ....+.+|+.++++++||||+++++++...+..+
T Consensus        23 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           23 LTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             -------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            34455678999999999999999999764 68999999997543  3567899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           97 LVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      +||||+++++|.+++.                +++.+|.+||..   |++|+||||+||+++.++.+||+|||++.....
T Consensus       101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            9999999999988764                566677777765   899999999999999999999999999987643


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ...  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......      .......... .....  
T Consensus       178 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~~~--  246 (314)
T 3com_A          178 TMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIPTNP-PPTFR--  246 (314)
T ss_dssp             TBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC-CCCCS--
T ss_pred             hcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCC-CcccC--
Confidence            222  223357899999999999999999999999999999999999999754321      1111111111 10000  


Q ss_pred             cCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          241 TLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       241 ~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                           .+...... .+++..||+.||.+|||+.
T Consensus       247 -----~~~~~~~~l~~li~~~l~~dp~~Rpt~~  274 (314)
T 3com_A          247 -----KPELWSDNFTDFVKQCLVKSPEQRATAT  274 (314)
T ss_dssp             -----SGGGSCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             -----CcccCCHHHHHHHHHHccCChhhCcCHH
Confidence                 01111123 5899999999999999954

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-39  Score=301.22  Aligned_cols=183  Identities=17%  Similarity=0.311  Sum_probs=156.6

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEE--CCeeEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIH--GEERLL   97 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~--~~~~~l   97 (345)
                      ...+|.+.++||+|+||.||++. ..+++.||||+++..   ....+.+|+.++++++ ||||+++++++.+  ....++
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            35779999999999999999996 467999999999643   3578999999999997 9999999999987  667899


Q ss_pred             EEecCCCCChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC-CEEEEccccceeecCCCCC
Q 039516           98 VYEFMPNKSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL-NTKISDFGMARIFGVNESG  164 (345)
Q Consensus        98 v~e~~~~gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||||+++++|.+++.            +++.+|.|||..   ||+||||||+|||++.++ .+||+|||+++......  
T Consensus       111 v~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--  185 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--  185 (330)
T ss_dssp             EEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--
T ss_pred             EEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--
Confidence            999999999977643            667777888865   899999999999999776 79999999998764322  


Q ss_pred             CcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSY  213 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~  213 (345)
                       ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus       186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~  234 (330)
T 3nsz_A          186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  234 (330)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence             2233578999999999877 67899999999999999999999999643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.5e-41  Score=302.11  Aligned_cols=234  Identities=20%  Similarity=0.223  Sum_probs=178.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCeeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH--GEERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~l   97 (345)
                      ..+|++.+.||+|+||.||++.. .+|+.||+|.+...  .......+.+|+.++++++||||+++++++..  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            35699999999999999999975 47899999999754  23345679999999999999999999998865  568899


Q ss_pred             EEecCCCCChHHHHH-------------------hHHHHHHHHHhcC--CCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516           98 VYEFMPNKSLDSSFS-------------------GTFKDLLCLHKYS--RLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus        98 v~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~--~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                      ||||+++++|.+++.                   +++.+|.+||...  ..+|+||||||+||+++.++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999987754                   5667788888763  1239999999999999999999999999997


Q ss_pred             eecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          157 IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                      ......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....      ... ......+... 
T Consensus       165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~-~~~i~~~~~~-  234 (279)
T 2w5a_A          165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KEL-AGKIREGKFR-  234 (279)
T ss_dssp             HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HHHHHHTCCC-
T ss_pred             eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH------HHH-HHHHhhcccc-
Confidence            653211  112335789999999999998999999999999999999999999976431      111 1112222211 


Q ss_pred             cccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          237 LIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       237 ~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                          .+...++.+.   .+++..||+.||.+|||+.+
T Consensus       235 ----~~~~~~~~~l---~~li~~~l~~~p~~Rps~~~  264 (279)
T 2w5a_A          235 ----RIPYRYSDEL---NEIITRMLNLKDYHRPSVEE  264 (279)
T ss_dssp             ----CCCTTSCHHH---HHHHHHHTCSSGGGSCCHHH
T ss_pred             ----cCCcccCHHH---HHHHHHHcCCCcccCCCHHH
Confidence                1111223222   58999999999999999653

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.8e-40  Score=319.71  Aligned_cols=236  Identities=19%  Similarity=0.180  Sum_probs=183.4

Q ss_pred             ccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Q 039516           18 FVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE   93 (345)
Q Consensus        18 ~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~   93 (345)
                      .+..+...|.+.+.||+|+||.||++.. .+|+.||||++....   ......+.+|+.++++++||||+++++++.+.+
T Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   99 (484)
T 3nyv_A           20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG   99 (484)
T ss_dssp             CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            3455667799999999999999999975 479999999996542   345778999999999999999999999999999


Q ss_pred             eeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeee---CCCCCEEEEccccc
Q 039516           94 ERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILL---DDQLNTKISDFGMA  155 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfgl~  155 (345)
                      ..++||||+.+++|.+.+.               +++.+|.|||..   ||+||||||+|||+   +.++.+||+|||++
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            9999999999999977653               666777777775   89999999999999   56788999999999


Q ss_pred             eeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 039516          156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDL  235 (345)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (345)
                      ......   .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......      ...... ..+...
T Consensus       177 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i-~~~~~~  245 (484)
T 3nyv_A          177 THFEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY------DILKKV-EKGKYT  245 (484)
T ss_dssp             HHBCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH-HHCCCC
T ss_pred             EEcccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH-HcCCCC
Confidence            866322   22344579999999998875 6899999999999999999999999764321      111111 122111


Q ss_pred             ccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          236 ELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       236 ~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ... +.. ..++++.   .+++..||+.||.+|||+.
T Consensus       246 ~~~-~~~-~~~s~~~---~~li~~~L~~dp~~R~s~~  277 (484)
T 3nyv_A          246 FEL-PQW-KKVSESA---KDLIRKMLTYVPSMRISAR  277 (484)
T ss_dssp             CCS-GGG-GGSCHHH---HHHHHHHTCSSGGGSCCHH
T ss_pred             CCC-ccc-ccCCHHH---HHHHHHHCCCChhHCcCHH
Confidence            000 000 0122211   5999999999999999953

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.6e-40  Score=307.39  Aligned_cols=188  Identities=22%  Similarity=0.274  Sum_probs=148.1

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      ..-.+|.+.++||+|+||.||++. ..+|+.||||+++...  ......+.+|+.++++++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            344679999999999999999996 4579999999997553  2234568899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC-----CCCCEEEEcccccee
Q 039516           98 VYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD-----DQLNTKISDFGMARI  157 (345)
Q Consensus        98 v~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~-----~~~~~kl~Dfgl~~~  157 (345)
                      ||||+++ +|.+++.               +++.+|.|||..   ||+||||||+|||++     ..+.+||+|||++..
T Consensus       111 v~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            9999985 7776654               566777777775   899999999999994     455699999999986


Q ss_pred             ecCCCCCCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          158 FGVNESGANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      .....  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus       187 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  242 (329)
T 3gbz_A          187 FGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS  242 (329)
T ss_dssp             HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence            54222  122335789999999998874 48999999999999999999999997643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.7e-40  Score=302.78  Aligned_cols=233  Identities=18%  Similarity=0.255  Sum_probs=177.0

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .....|++.+.||+|+||.||++... +|+.||+|.+..........+.+|+.++++++||||+++++++...+..++||
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            34567999999999999999999764 68999999998776677889999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          100 EFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       100 e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      ||+++++|.+++.                +++.+|.+||..   |++||||||+||+++.++.+||+|||++....... 
T Consensus        96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            9999999987653                566777788775   89999999999999999999999999875432111 


Q ss_pred             CCcccceeecCCccccchhc-----cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          164 GANTNRIVGTYGYMSLEYTM-----SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                       .......||+.|+|||++.     +..++.++||||||+++|+|++|+.||.....      ............. ...
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~-~~~  243 (302)
T 2j7t_A          172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDPP-TLL  243 (302)
T ss_dssp             -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCC-CCS
T ss_pred             -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCCc-ccC
Confidence             1112347899999999883     66788999999999999999999999976432      1111222211111 110


Q ss_pred             cccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          239 DLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       239 d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .   ...++    .. ..++..||+.||.+|||+.
T Consensus       244 ~---~~~~~----~~l~~li~~~l~~dp~~Rps~~  271 (302)
T 2j7t_A          244 T---PSKWS----VEFRDFLKIALDKNPETRPSAA  271 (302)
T ss_dssp             S---GGGSC----HHHHHHHHHHSCSCTTTSCCHH
T ss_pred             C---ccccC----HHHHHHHHHHcccChhhCCCHH
Confidence            0   01112    22 5899999999999999953

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.6e-41  Score=323.28  Aligned_cols=187  Identities=22%  Similarity=0.231  Sum_probs=151.7

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC------
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG------   92 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------   92 (345)
                      ...+|++.++||+|+||.||++. ..+|+.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            34679999999999999999996 457999999999654  334466789999999999999999999998654      


Q ss_pred             CeeEEEEecCCCCChHH------------HHHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           93 EERLLVYEFMPNKSLDS------------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~------------~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      ...|+||||++++.+..            ++.+++.+|.|||..   ||+||||||+|||++.++.+||+|||+++....
T Consensus       140 ~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          140 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             CEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             CeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            35799999998753321            233677777788776   899999999999999999999999999987643


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       217 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~  267 (464)
T 3ttj_A          217 S---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  267 (464)
T ss_dssp             C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             C---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2   22344689999999999999999999999999999999999999997654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.3e-39  Score=316.50  Aligned_cols=235  Identities=22%  Similarity=0.237  Sum_probs=179.0

Q ss_pred             cccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc-------------cCHHHHHHHHHHHHhcCCCCeee
Q 039516           19 VENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG-------------QGRVEFQNEAKLIAKLQYTNLVK   84 (345)
Q Consensus        19 ~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~   84 (345)
                      ...+...|.+.++||+|+||.||++.. .+++.||||++.....             .....+.+|+.++++++||||++
T Consensus        31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  110 (504)
T 3q5i_A           31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK  110 (504)
T ss_dssp             CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            344567899999999999999999975 4689999999965421             34567899999999999999999


Q ss_pred             EEEEEEECCeeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC---C
Q 039516           85 LLGCSIHGEERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL---N  146 (345)
Q Consensus        85 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~---~  146 (345)
                      +++++.+....++|||||++|+|.+.+.               +++.+|.|||..   ||+||||||+|||++.++   .
T Consensus       111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999999977653               566777777765   899999999999998776   6


Q ss_pred             EEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 039516          147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAW  226 (345)
Q Consensus       147 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~  226 (345)
                      +||+|||++.......   ......||+.|+|||++. +.++.++||||+||++|+|++|..||......      ....
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~  257 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------DIIK  257 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHH
Confidence            9999999998764322   233457999999999876 56899999999999999999999999764321      1111


Q ss_pred             HHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          227 QLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       227 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .. ..+....  +.......+.+.   .+++..||+.||.+|||+.
T Consensus       258 ~i-~~~~~~~--~~~~~~~~s~~~---~~li~~~L~~dp~~R~t~~  297 (504)
T 3q5i_A          258 KV-EKGKYYF--DFNDWKNISDEA---KELIKLMLTYDYNKRCTAE  297 (504)
T ss_dssp             HH-HHCCCCC--CHHHHTTSCHHH---HHHHHHHTCSSTTTSCCHH
T ss_pred             HH-HcCCCCC--CccccCCCCHHH---HHHHHHHcCCChhHCCCHH
Confidence            11 1221110  000001122221   5899999999999999954

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.5e-39  Score=311.95  Aligned_cols=186  Identities=19%  Similarity=0.269  Sum_probs=150.3

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----C
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG-----E   93 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~   93 (345)
                      ...+|.+.+.||+|+||.||++.. .+|+.||||+++..  .....+.+.+|+.+|++++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            356799999999999999999965 56899999999654  333456789999999999999999999998765     5


Q ss_pred             eeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           94 ERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      ..|+||||+.+ +|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          104 ELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             CEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            78999999874 7776654               567777777766   8999999999999999999999999999876


Q ss_pred             cCCCCC--------------------CcccceeecCCccccchh-ccCCcCcccchhhHHHHHHHHHhCCCCCC
Q 039516          159 GVNESG--------------------ANTNRIVGTYGYMSLEYT-MSGTVSIKTDVFGFGVLVLKIVCGKKNNK  211 (345)
Q Consensus       159 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~SlG~il~el~tg~~p~~  211 (345)
                      ......                    .......||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            432211                    122456889999999986 56679999999999999999998655554

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8e-40  Score=318.41  Aligned_cols=238  Identities=21%  Similarity=0.224  Sum_probs=181.6

Q ss_pred             ccccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC
Q 039516           16 AKFVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG   92 (345)
Q Consensus        16 ~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~   92 (345)
                      ......+...|.+.++||+|+||+||++.. .+|+.||||++...  .......+.+|+.++++++||||+++++++.+.
T Consensus        14 ~~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   93 (486)
T 3mwu_A           14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS   93 (486)
T ss_dssp             CTTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence            334455678899999999999999999975 47999999998643  234567899999999999999999999999999


Q ss_pred             CeeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC---CCCCEEEEcccc
Q 039516           93 EERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD---DQLNTKISDFGM  154 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfgl  154 (345)
                      ...++||||+++++|.+.+.               +++.+|.|||..   ||+||||||+|||++   .++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            99999999999999976653               566777777765   899999999999995   456799999999


Q ss_pred             ceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 039516          155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKD  234 (345)
Q Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (345)
                      ++.....   .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.....      ....... ..+..
T Consensus       171 a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i-~~~~~  239 (486)
T 3mwu_A          171 STCFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRV-ETGKY  239 (486)
T ss_dssp             TTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-HHTCC
T ss_pred             CeECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH-HhCCC
Confidence            9765322   12233578999999998875 589999999999999999999999976432      1111111 11211


Q ss_pred             cccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          235 LELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       235 ~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .... +.. ...+.+.   .+++..||+.||.+|||+.
T Consensus       240 ~~~~-~~~-~~~s~~~---~~li~~~L~~dp~~R~t~~  272 (486)
T 3mwu_A          240 AFDL-PQW-RTISDDA---KDLIRKMLTFHPSLRITAT  272 (486)
T ss_dssp             CSCS-GGG-GGSCHHH---HHHHHHHTCSSTTTSCCHH
T ss_pred             CCCC-ccc-CCCCHHH---HHHHHHHcCCChhhCcCHH
Confidence            1000 000 0112211   5999999999999999953

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-40  Score=308.10  Aligned_cols=192  Identities=23%  Similarity=0.265  Sum_probs=154.5

Q ss_pred             ccccccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 039516           14 EGAKFVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSI   90 (345)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~   90 (345)
                      ++....-.....|.+.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+.++++++||||+++++++.
T Consensus        15 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   94 (367)
T 1cm8_A           15 EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT   94 (367)
T ss_dssp             ECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred             EecCceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence            44444445567899999999999999999975 57999999999543  2334567899999999999999999999987


Q ss_pred             ECC------eeEEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEE
Q 039516           91 HGE------ERLLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKIS  150 (345)
Q Consensus        91 ~~~------~~~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~  150 (345)
                      ...      ..|+||||+ +++|.+++.              +++.+|.|||..   ||+||||||+||+++.++.+||+
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~  170 (367)
T 1cm8_A           95 PDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKIL  170 (367)
T ss_dssp             SCSSTTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             cCCccccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEE
Confidence            653      469999999 788877654              566777777765   89999999999999999999999


Q ss_pred             ccccceeecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          151 DFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       151 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      |||+++.....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus       171 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  230 (367)
T 1cm8_A          171 DFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD  230 (367)
T ss_dssp             CCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999875322     233578999999999887 679999999999999999999999998654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.9e-40  Score=306.43  Aligned_cols=252  Identities=17%  Similarity=0.177  Sum_probs=187.4

Q ss_pred             cceeecccccccccCCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccC-----------------HHHHHHH
Q 039516            8 GCQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQG-----------------RVEFQNE   70 (345)
Q Consensus         8 ~~~s~~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~-----------------~~~~~~E   70 (345)
                      .........+..+.+..+|.+.+.||+|+||.||++.. +|+.||||.+.......                 ...+.+|
T Consensus        15 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E   93 (348)
T 2pml_X           15 NLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE   93 (348)
T ss_dssp             TEEECCEEESSSCEEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHH
T ss_pred             hhHHHHHHhhhcccccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHH
Confidence            33344444444455567899999999999999999988 89999999986442111                 1789999


Q ss_pred             HHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCChHHH------H-----------------HhHHHHHHHHHhcCCC
Q 039516           71 AKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSS------F-----------------SGTFKDLLCLHKYSRL  127 (345)
Q Consensus        71 ~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~------l-----------------~~~~~~l~~lh~~~~~  127 (345)
                      +.++++++||||+++++++.+.+..++||||+++++|.++      +                 .+++.+|.+||..  .
T Consensus        94 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~  171 (348)
T 2pml_X           94 LQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--K  171 (348)
T ss_dssp             HHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT--S
T ss_pred             HHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhcc--C
Confidence            9999999999999999999999999999999999988765      2                 2667778888871  3


Q ss_pred             ceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccC-CcCc-ccchhhHHHHHHHHHh
Q 039516          128 RVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG-TVSI-KTDVFGFGVLVLKIVC  205 (345)
Q Consensus       128 ~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Di~SlG~il~el~t  205 (345)
                      ||+||||||+||+++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++||||||+++|+|++
T Consensus       172 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~  247 (348)
T 2pml_X          172 NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY  247 (348)
T ss_dssp             CEECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHH
T ss_pred             CEeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHh
Confidence            8999999999999999999999999999876432    23345789999999999877 6666 9999999999999999


Q ss_pred             CCCCCCCCCCCCcccHHHHHHHHHhcCCccccc------cccCC---CCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          206 GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI------DLTLD---GSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       206 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------d~~l~---~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      |+.||......     ... ......+......      .+...   .......... .+++..||+.||.+|||+.
T Consensus       248 g~~pf~~~~~~-----~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~  318 (348)
T 2pml_X          248 NVVPFSLKISL-----VEL-FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE  318 (348)
T ss_dssp             SSCSSCCSSCS-----HHH-HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             CCCCCCCCCcH-----HHH-HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHH
Confidence            99999865431     111 1112222111000      00000   0000111123 6999999999999999954

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.7e-39  Score=302.64  Aligned_cols=233  Identities=18%  Similarity=0.226  Sum_probs=179.6

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCcc--------CHHHHHHHHHHHHhc-CCCCeeeEEEEEEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQ--------GRVEFQNEAKLIAKL-QYTNLVKLLGCSIH   91 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~--------~~~~~~~E~~~l~~l-~H~niv~~~~~~~~   91 (345)
                      +..+|.+.+.||+|+||.||++... +|+.||||++......        ....+.+|+.+++++ +||||+++++++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            3467999999999999999999764 7999999998654311        145688999999999 89999999999999


Q ss_pred             CCeeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516           92 GEERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus        92 ~~~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                      ....++||||+++++|.+++.               +++.+|.|||..   ||+||||||+||+++.++.+||+|||++.
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSC  248 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCccc
Confidence            999999999999999987754               567777788765   89999999999999999999999999998


Q ss_pred             eecCCCCCCcccceeecCCccccchhcc------CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh
Q 039516          157 IFGVNESGANTNRIVGTYGYMSLEYTMS------GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWN  230 (345)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  230 (345)
                      ......   ......||+.|+|||++.+      ..++.++|||||||++|+|++|+.||.....      .... ....
T Consensus       249 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~~~-~~i~  318 (365)
T 2y7j_A          249 HLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------ILML-RMIM  318 (365)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHH
T ss_pred             ccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH------HHHH-HHHH
Confidence            764322   2334679999999998863      3588999999999999999999999975321      1111 1111


Q ss_pred             cCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          231 EGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       231 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .+.... ..+.. ...+...   .+++..||+.||.+|||+.
T Consensus       319 ~~~~~~-~~~~~-~~~~~~~---~~li~~~L~~dP~~Rps~~  355 (365)
T 2y7j_A          319 EGQYQF-SSPEW-DDRSSTV---KDLISRLLQVDPEARLTAE  355 (365)
T ss_dssp             HTCCCC-CHHHH-SSSCHHH---HHHHHHHSCSSTTTSCCHH
T ss_pred             hCCCCC-CCccc-ccCCHHH---HHHHHHHcCCChhHCcCHH
Confidence            111110 00000 0112111   5899999999999999954

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.3e-40  Score=297.81  Aligned_cols=227  Identities=20%  Similarity=0.287  Sum_probs=172.6

Q ss_pred             eEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCCCC
Q 039516           28 MYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS  106 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gs  106 (345)
                      ....||+|+||.||+|.. .+++.||||.+..........+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus        26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  105 (295)
T 2clq_A           26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS  105 (295)
T ss_dssp             SBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred             CcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence            334799999999999974 5789999999987666667789999999999999999999999999999999999999999


Q ss_pred             hHHHHH------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC-CCCEEEEccccceeecCCCCCCcc
Q 039516          107 LDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD-QLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       107 L~~~l~------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      |.+++.                  +++.+|.+||..   ||+|+||||+||+++. ++.+||+|||++........  ..
T Consensus       106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~  180 (295)
T 2clq_A          106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CT  180 (295)
T ss_dssp             HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------
T ss_pred             HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cc
Confidence            987654                  456667777765   8999999999999987 89999999999987643211  12


Q ss_pred             cceeecCCccccchhccCC--cCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          168 NRIVGTYGYMSLEYTMSGT--VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~--~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      ....||+.|+|||++.+..  ++.++||||||+++|+|++|+.||.......   ...+.....       ...+.+...
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~-------~~~~~~~~~  250 (295)
T 2clq_A          181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVGMF-------KVHPEIPES  250 (295)
T ss_dssp             CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---HHHHHHHHH-------CCCCCCCTT
T ss_pred             cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---HHHHhhccc-------ccccccccc
Confidence            3357899999999987654  7899999999999999999999996432111   000000010       011122222


Q ss_pred             CChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          246 CPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       246 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ++.+.   .+++..||+.||.+|||+.
T Consensus       251 ~~~~~---~~li~~~l~~dp~~Rps~~  274 (295)
T 2clq_A          251 MSAEA---KAFILKCFEPDPDKRACAN  274 (295)
T ss_dssp             SCHHH---HHHHHHTTCSSTTTSCCHH
T ss_pred             CCHHH---HHHHHHHccCChhhCCCHH
Confidence            33222   5899999999999999953

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.1e-39  Score=293.49  Aligned_cols=227  Identities=18%  Similarity=0.219  Sum_probs=172.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|.+.+.||+|+||.||++... +|+.||||.+...   .......+.+|+.++++++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            56999999999999999999764 7999999999643   2334668899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||+++++|.+++.               +++.+|.+||..   |++|+||||+||+++.++.+||+|||++.......  
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--  165 (276)
T 2h6d_A           91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--  165 (276)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred             eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence            9999999987764               567777888876   89999999999999999999999999998654321  


Q ss_pred             CcccceeecCCccccchhccCCc-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                       ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.....      .. .......+..      .+.
T Consensus       166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~-~~~~~~~~~~------~~~  231 (276)
T 2h6d_A          166 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PT-LFKKIRGGVF------YIP  231 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHCCC------CCC
T ss_pred             -ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HH-HHHHhhcCcc------cCc
Confidence             1233578999999999887765 6899999999999999999999975321      11 1111111111      011


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..++...   ..++..||+.||.+|||+.
T Consensus       232 ~~~~~~l---~~li~~~l~~~p~~Rps~~  257 (276)
T 2h6d_A          232 EYLNRSV---ATLLMHMLQVDPLKRATIK  257 (276)
T ss_dssp             TTSCHHH---HHHHHHHTCSSGGGSCCHH
T ss_pred             hhcCHHH---HHHHHHHccCChhhCCCHH
Confidence            1122211   5899999999999999954

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.6e-39  Score=292.71  Aligned_cols=237  Identities=19%  Similarity=0.216  Sum_probs=180.5

Q ss_pred             cccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc---------cCHHHHHHHHHHHHhcC-CCCeeeE
Q 039516           17 KFVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG---------QGRVEFQNEAKLIAKLQ-YTNLVKL   85 (345)
Q Consensus        17 ~~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~~   85 (345)
                      .....+..+|.+.+.||+|+||.||++.. .+|+.||||.++....         ...+.+.+|+.+++++. ||||+++
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (298)
T 1phk_A           10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL   89 (298)
T ss_dssp             -----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             cCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            34566788899999999999999999975 4689999999965431         22456889999999995 9999999


Q ss_pred             EEEEEECCeeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEE
Q 039516           86 LGCSIHGEERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKIS  150 (345)
Q Consensus        86 ~~~~~~~~~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~  150 (345)
                      ++++......++||||+++++|.+++.               +++.+|.+||..   |++|+||||+||+++.++.+||+
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           90 KDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             eeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEe
Confidence            999999999999999999999988765               566777777765   89999999999999999999999


Q ss_pred             ccccceeecCCCCCCcccceeecCCccccchhc------cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHH
Q 039516          151 DFGMARIFGVNESGANTNRIVGTYGYMSLEYTM------SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGI  224 (345)
Q Consensus       151 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~  224 (345)
                      |||++.......   ......|++.|+|||++.      ...++.++||||||+++|+|++|+.||.....      ...
T Consensus       167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~  237 (298)
T 1phk_A          167 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLM  237 (298)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH
T ss_pred             cccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHH
Confidence            999998764322   223357899999999885      45688999999999999999999999975431      111


Q ss_pred             HHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          225 AWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       225 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..... .+.... ..+.     ....... .+++..||+.||.+|||+.
T Consensus       238 ~~~~~-~~~~~~-~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~  279 (298)
T 1phk_A          238 LRMIM-SGNYQF-GSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAE  279 (298)
T ss_dssp             HHHHH-HTCCCC-CTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             HHHHh-cCCccc-Cccc-----ccccCHHHHHHHHHHccCCcccCCCHH
Confidence            11111 111110 0000     0111223 6999999999999999953

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.5e-40  Score=309.32  Aligned_cols=233  Identities=10%  Similarity=0.047  Sum_probs=159.9

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc---cCHHHHHHHHHHHHhc--CCCCeeeEE-------EEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG---QGRVEFQNEAKLIAKL--QYTNLVKLL-------GCS   89 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l--~H~niv~~~-------~~~   89 (345)
                      ..+|.+.+.||+|+||.||+|.. .+|+.||||++.....   .....+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            34599999999999999999975 5799999999976532   3345677886555555  699988765       454


Q ss_pred             EEC-----------------CeeEEEEecCCCCChHHHHH----------------------hHHHHHHHHHhcCCCceE
Q 039516           90 IHG-----------------EERLLVYEFMPNKSLDSSFS----------------------GTFKDLLCLHKYSRLRVI  130 (345)
Q Consensus        90 ~~~-----------------~~~~lv~e~~~~gsL~~~l~----------------------~~~~~l~~lh~~~~~~iv  130 (345)
                      ...                 ...|+||||++ ++|.+++.                      +++.+|.|||..   ||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence            433                 33799999999 89877654                      445566666654   899


Q ss_pred             EeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhcc--CCcCcccchhhHHHHHHHHHhCCC
Q 039516          131 HRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS--GTVSIKTDVFGFGVLVLKIVCGKK  208 (345)
Q Consensus       131 Hrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~el~tg~~  208 (345)
                      ||||||+|||++.++.+||+|||+++....     ......+|+.|+|||++.+  ..++.++|||||||++|||++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999987532     1113456799999999987  679999999999999999999999


Q ss_pred             CCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          209 NNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ||..........        +............+........... .+++..||+.||++|||+.
T Consensus       292 Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  348 (371)
T 3q60_A          292 PFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL  348 (371)
T ss_dssp             STTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHH
T ss_pred             CCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence            998654321100        0000000000111110010111223 5899999999999999954

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.9e-40  Score=316.95  Aligned_cols=234  Identities=19%  Similarity=0.217  Sum_probs=169.1

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--------ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--------GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH   91 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~   91 (345)
                      .+..+|.+.++||+|+||.||+|.. .+++.||||++....        ......+.+|+.+|++++||||+++++++ +
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-D  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE-E
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE-e
Confidence            3457799999999999999999965 568999999986431        11223588999999999999999999997 4


Q ss_pred             CCeeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC---CCEEEEccc
Q 039516           92 GEERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ---LNTKISDFG  153 (345)
Q Consensus        92 ~~~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfg  153 (345)
                      .+..++||||+++|+|.+++.               +++.+|.|||..   +|+||||||+|||++.+   +.+||+|||
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecc
Confidence            567899999999999976542               677788888865   79999999999999754   459999999


Q ss_pred             cceeecCCCCCCcccceeecCCccccchhc---cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh
Q 039516          154 MARIFGVNESGANTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWN  230 (345)
Q Consensus       154 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  230 (345)
                      +++.....   .......||+.|+|||++.   ...++.++|||||||++|+|++|+.||........  +..    ...
T Consensus       288 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~----~i~  358 (419)
T 3i6u_A          288 HSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD----QIT  358 (419)
T ss_dssp             TTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH----HHH
T ss_pred             cceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH----HHh
Confidence            99876422   2233467999999999885   36788999999999999999999999976443221  111    111


Q ss_pred             cCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          231 EGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       231 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .+.....  +......+...   .+++..||+.||.+|||+.
T Consensus       359 ~~~~~~~--~~~~~~~~~~~---~~li~~~L~~dP~~Rps~~  395 (419)
T 3i6u_A          359 SGKYNFI--PEVWAEVSEKA---LDLVKKLLVVDPKARFTTE  395 (419)
T ss_dssp             TTCCCCC--HHHHTTSCHHH---HHHHHHHSCSSTTTSCCHH
T ss_pred             cCCCCCC--chhhcccCHHH---HHHHHHHccCChhHCcCHH
Confidence            1211100  00001112111   5899999999999999954

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.5e-40  Score=318.00  Aligned_cols=248  Identities=18%  Similarity=0.196  Sum_probs=190.1

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCC-CCeeeEEEEEEECCeeEEEEe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY-TNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ..+|.+.++||+|+||.||+|.. .+++.||||+++....  ...+..|+++++.++| +++..+..++......++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            45699999999999999999974 6799999999865432  2357899999999977 566666777778889999999


Q ss_pred             cCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeee---CCCCCEEEEccccceeecCC
Q 039516          101 FMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILL---DDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus       101 ~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      |+ +++|.+++.                +++.+|.|||..   ||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 999988765                566777778775   89999999999999   57899999999999887543


Q ss_pred             CCC-----CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          162 ESG-----ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       162 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                      ...     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........................
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA  239 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence            321     122346799999999999999999999999999999999999999987654333222222111111111110


Q ss_pred             cccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          237 LIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       237 ~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                           +...++.+.   .+++..||+.+|.+||++.++...|..++..
T Consensus       240 -----l~~~~p~~l---~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          240 -----LCRGYPTEF---ASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             -----HHTTSCHHH---HHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -----HhcCCcHHH---HHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence                 001123222   5999999999999999999888888887663

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=303.47  Aligned_cols=188  Identities=23%  Similarity=0.306  Sum_probs=150.0

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCcc-----CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCe
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQ-----GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE   94 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~   94 (345)
                      .....|.+.+.||+|+||.||++... +|+.||||.+......     ....+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34567999999999999999999764 6899999999654221     12468899999999999999999999999999


Q ss_pred             eEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           95 RLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      .++||||+++ +|.+.+.                +++.+|.|||..   ||+||||||+||+++.++.+||+|||+++..
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999986 6655443                567777788776   7999999999999999999999999999865


Q ss_pred             cCCCCCCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ....  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus       163 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~  217 (346)
T 1ua2_A          163 GSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS  217 (346)
T ss_dssp             TSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence            4322  222335789999999998764 58899999999999999999999987643

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.1e-40  Score=300.76  Aligned_cols=238  Identities=20%  Similarity=0.293  Sum_probs=162.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ..+|.+.+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            46799999999999999999975 468999999986542 3345678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH-----------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          101 FMPNKSLDSSFS-----------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       101 ~~~~gsL~~~l~-----------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      |+++++|.+++.                       +++.+|.+||..   |++||||||+||+++.++.+||+|||++..
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            999999987753                       456677777765   899999999999999999999999999876


Q ss_pred             ecCCCC---CCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCC
Q 039516          158 FGVNES---GANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGK  233 (345)
Q Consensus       158 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (345)
                      ......   ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......   ..   ........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~~~~~~~  244 (303)
T 2vwi_A          171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VL---MLTLQNDP  244 (303)
T ss_dssp             CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHHTSSC
T ss_pred             eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HH---HHHhccCC
Confidence            532211   111233578999999998875 568999999999999999999999997654321   11   11111111


Q ss_pred             ---ccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          234 ---DLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       234 ---~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                         .....++.+...++.+.   .+++..||+.||.+|||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~---~~li~~~l~~dp~~Rps~~  283 (303)
T 2vwi_A          245 PSLETGVQDKEMLKKYGKSF---RKMISLCLQKDPEKRPTAA  283 (303)
T ss_dssp             CCTTC-----CCCCCCCHHH---HHHHHHHCCSSGGGSCCHH
T ss_pred             CccccccccchhhhhhhHHH---HHHHHHHccCChhhCcCHH
Confidence               01111222222233222   5899999999999999954

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.1e-39  Score=309.38  Aligned_cols=183  Identities=21%  Similarity=0.291  Sum_probs=149.6

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCe------e
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE------R   95 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~------~   95 (345)
                      ....|.+.+.||+|+||+||++....+..||+|++.....    ...+|+++++.++||||+++++++.....      .
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            3457999999999999999999887777799999854422    12379999999999999999999865433      7


Q ss_pred             EEEEecCCCCChHHH------------------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeC-CCCCEEEEccccce
Q 039516           96 LLVYEFMPNKSLDSS------------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLD-DQLNTKISDFGMAR  156 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~------------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgl~~  156 (345)
                      ++||||++++.+...                  +.+++.+|.|||..   ||+||||||+|||++ .++.+||+|||+++
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            899999987644322                  22667778888875   899999999999998 78999999999998


Q ss_pred             eecCCCCCCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          157 IFGVNESGANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      .......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..
T Consensus       191 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  246 (394)
T 4e7w_A          191 ILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES  246 (394)
T ss_dssp             ECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            7643322   2235789999999998764 58999999999999999999999998654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.1e-40  Score=302.20  Aligned_cols=243  Identities=23%  Similarity=0.300  Sum_probs=176.4

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC--CCc--EEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP--NEQ--EVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~--~~~--~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      ..+|++.+.||+|+||.||+|...  +++  .||||.++..   .....+.+.+|+.++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            467999999999999999999742  333  6999998654   2334678999999999999999999999987654 8


Q ss_pred             EEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           96 LLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      ++||||+++++|.+++.                +++.+|.+||..   |++||||||+||+++.++.+||+|||++....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            99999999999987754                556677777765   89999999999999999999999999998764


Q ss_pred             CCCCCC-cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 039516          160 VNESGA-NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLEL  237 (345)
Q Consensus       160 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
                      ...... ......+|..|+|||++.+..++.++||||||+++|+|++ |+.||.....      ..........+...  
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~~--  244 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERL--  244 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCC--
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccCCCC--
Confidence            322211 1223456788999999998899999999999999999999 9999976432      11112222111110  


Q ss_pred             ccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          238 IDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       238 ~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                         .....++.+.   .+++..||+.||.+|||+.++...|.++.+
T Consensus       245 ---~~~~~~~~~l---~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          245 ---PRPEDCPQDI---YNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             ---CCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ---CCCcCcCHHH---HHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence               1111122221   599999999999999998887777776654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.8e-39  Score=305.41  Aligned_cols=191  Identities=20%  Similarity=0.216  Sum_probs=155.3

Q ss_pred             cccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC--------CCCeeeEEEEE
Q 039516           19 VENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ--------YTNLVKLLGCS   89 (345)
Q Consensus        19 ~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~~~~~~   89 (345)
                      .+.+..+|.+.++||+|+||.||++.. .+++.||||+++.. ......+.+|+.++++++        |+||+++++++
T Consensus        32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            344567899999999999999999964 57899999999643 334567899999999995        78899999998


Q ss_pred             E----ECCeeEEEEecCCCCChHHHH----------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC----
Q 039516           90 I----HGEERLLVYEFMPNKSLDSSF----------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL----  145 (345)
Q Consensus        90 ~----~~~~~~lv~e~~~~gsL~~~l----------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~----  145 (345)
                      .    .....++||||+.++.+..+.                .+++.+|.|||..+  ||+||||||+|||++.++    
T Consensus       111 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          111 KISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             EEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred             eecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence            7    455789999999544333222                25667777777643  799999999999998775    


Q ss_pred             ---------------------------------------------CEEEEccccceeecCCCCCCcccceeecCCccccc
Q 039516          146 ---------------------------------------------NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE  180 (345)
Q Consensus       146 ---------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE  180 (345)
                                                                   .+||+|||++......     .....||+.|+|||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE  263 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence                                                         7999999999876422     22347899999999


Q ss_pred             hhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 039516          181 YTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTER  217 (345)
Q Consensus       181 ~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~  217 (345)
                      ++.+..++.++|||||||++|||++|+.||.......
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  300 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE  300 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSS
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccc
Confidence            9999999999999999999999999999998765443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2e-39  Score=304.08  Aligned_cols=189  Identities=20%  Similarity=0.257  Sum_probs=155.9

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----Cee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG-----EER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~~   95 (345)
                      ...|.+.+.||+|+||.||++.. .+++.||||++.... ......+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            45799999999999999999964 478999999997543 33456789999999999999999999998754     368


Q ss_pred             EEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           96 LLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      ++||||+.+ +|.+++.              +++.+|.|||..   ||+||||||+|||++.++.+||+|||++......
T Consensus       106 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             EEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence            999999985 7766544              566777777765   8999999999999999999999999999876433


Q ss_pred             CCC-CcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 039516          162 ESG-ANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHT  215 (345)
Q Consensus       162 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~~  215 (345)
                      ... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  237 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY  237 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred             CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence            221 11234578999999998654 5589999999999999999999999976543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.3e-39  Score=298.83  Aligned_cols=192  Identities=24%  Similarity=0.332  Sum_probs=155.9

Q ss_pred             cccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC----
Q 039516           19 VENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG----   92 (345)
Q Consensus        19 ~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~----   92 (345)
                      ...+..+|.+.+.||+|+||.||+|.. .+|+.||||.+.... ......+.+|+.++++++||||+++++++...    
T Consensus         6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   85 (353)
T 2b9h_A            6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN   85 (353)
T ss_dssp             CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred             ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence            345667899999999999999999975 478999999996542 33456788999999999999999999988654    


Q ss_pred             -CeeEEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516           93 -EERLLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus        93 -~~~~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                       ...++||||+. ++|.+++.              +++.+|.+||..   ||+||||||+||+++.++.+||+|||++..
T Consensus        86 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           86 FNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             CCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence             67899999997 47766543              566777777765   899999999999999999999999999987


Q ss_pred             ecCCCCCC--------cccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          158 FGVNESGA--------NTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       158 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  227 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD  227 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            64321111        1123478999999998764 778999999999999999999999997653

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.7e-40  Score=301.74  Aligned_cols=231  Identities=20%  Similarity=0.246  Sum_probs=171.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcC--CCCeeeEEEEEEECCeeEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQ--YTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~~~~~lv   98 (345)
                      ..+|.+.+.||+|+||.||++...+++.||||.+...  .......+.+|+.++++++  |+||+++++++...+..++|
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            4569999999999999999998888999999999654  3334567899999999997  59999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      || +.+++|.+++.               +++.+|.+||..   ||+||||||+||++++ +.+||+|||++........
T Consensus       107 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~  181 (313)
T 3cek_A          107 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT  181 (313)
T ss_dssp             EC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred             Ee-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence            99 66788877654               566677777765   8999999999999964 8899999999987643333


Q ss_pred             CCcccceeecCCccccchhcc-----------CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC
Q 039516          164 GANTNRIVGTYGYMSLEYTMS-----------GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEG  232 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (345)
                      ........||+.|+|||++.+           ..++.++||||||+++|+|++|+.||.....     ..........  
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~--  254 (313)
T 3cek_A          182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIID--  254 (313)
T ss_dssp             --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHC--
T ss_pred             cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHHHh--
Confidence            222334578999999999875           4688899999999999999999999975431     1111111111  


Q ss_pred             CccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          233 KDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       233 ~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                             +......+...... .+++..||+.||.+|||+.
T Consensus       255 -------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  288 (313)
T 3cek_A          255 -------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP  288 (313)
T ss_dssp             -------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             -------cccccCCcccchHHHHHHHHHHccCCcccCcCHH
Confidence                   11111111111223 5899999999999999954

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9.4e-40  Score=307.25  Aligned_cols=187  Identities=22%  Similarity=0.241  Sum_probs=148.6

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC----
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE----   93 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----   93 (345)
                      ....+|.+.+.||+|+||.||++.. .+|+.||||++...  .......+.+|+.+++.++||||+++++++....    
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            3456799999999999999999964 57899999999653  2334567889999999999999999999997654    


Q ss_pred             --eeEEEEecCCCCChHHHHH-------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           94 --ERLLVYEFMPNKSLDSSFS-------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        94 --~~~lv~e~~~~gsL~~~l~-------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                        ..++||||+++ +|.+.+.             +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++..
T Consensus       102 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          102 FQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             CCEEEEEEECCSE-EHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             ccceEEEEEcCCC-CHHHHHhhccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence              78999999986 5554432             667777788765   8999999999999999999999999999865


Q ss_pred             cCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ...   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus       178 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  230 (371)
T 2xrw_A          178 GTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  230 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            322   12234578999999999999999999999999999999999999997643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=299.02  Aligned_cols=231  Identities=20%  Similarity=0.276  Sum_probs=172.0

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEE------CC
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIH------GE   93 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~------~~   93 (345)
                      ....|.+.+.||+|+||.||+|.. .+|+.||||.+.... .....+.+|+.+++++ +||||+++++++..      ..
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            455699999999999999999976 578999999997543 3456789999999999 89999999999987      46


Q ss_pred             eeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccce
Q 039516           94 ERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMAR  156 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~  156 (345)
                      ..++||||+++++|.+++.                 +++.+|.+||..   ||+|+||||+||+++.++.+||+|||++.
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence            7899999999999987764                 456667777765   89999999999999999999999999988


Q ss_pred             eecCCCCCCcccceeecCCccccchhc-----cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc
Q 039516          157 IFGVNESGANTNRIVGTYGYMSLEYTM-----SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNE  231 (345)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  231 (345)
                      ......  .......||+.|+|||++.     +..++.++||||||+++|+|++|+.||......      .........
T Consensus       178 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~  249 (326)
T 2x7f_A          178 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIPRN  249 (326)
T ss_dssp             ---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS
T ss_pred             ecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhcC
Confidence            653221  1223357899999999987     567889999999999999999999999754321      111111111


Q ss_pred             CCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          232 GKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       232 ~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                       .....    ....++...   ..++..||+.||.+|||+.
T Consensus       250 -~~~~~----~~~~~~~~l---~~li~~~l~~dp~~Rps~~  282 (326)
T 2x7f_A          250 -PAPRL----KSKKWSKKF---QSFIESCLVKNHSQRPATE  282 (326)
T ss_dssp             -CCCCC----SCSCSCHHH---HHHHHHHCCSSGGGSCCHH
T ss_pred             -ccccC----CccccCHHH---HHHHHHHhccChhhCCCHH
Confidence             11111    111122221   5899999999999999953

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.3e-40  Score=317.94  Aligned_cols=180  Identities=21%  Similarity=0.272  Sum_probs=136.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----Ce
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG-----EE   94 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~   94 (345)
                      ..+|.+.+.||+|+||+||++.. .+|+.||||++...  .....+.+.+|+.+|++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            46799999999999999999964 47899999999653  333456789999999999999999999998543     56


Q ss_pred             eEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           95 RLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      .|+||||+. ++|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++...
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            899999985 56766543               566777777765   89999999999999999999999999998764


Q ss_pred             CCCCC-------------------------CcccceeecCCccccchh-ccCCcCcccchhhHHHHHHHHHhC
Q 039516          160 VNESG-------------------------ANTNRIVGTYGYMSLEYT-MSGTVSIKTDVFGFGVLVLKIVCG  206 (345)
Q Consensus       160 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~SlG~il~el~tg  206 (345)
                      .....                         .......||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            22111                         122345789999999976 466799999999999999999993

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.4e-40  Score=309.65  Aligned_cols=182  Identities=18%  Similarity=0.252  Sum_probs=147.2

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--------
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG--------   92 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--------   92 (345)
                      ...+|.+.+.||+|+||.||++.. .+|+.||||++.....    ...+|+.+++.++||||+++++++...        
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~   80 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP   80 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence            456799999999999999999964 6799999999865432    234799999999999999999998543        


Q ss_pred             ------------------------------CeeEEEEecCCCCChHHHHH-------------------hHHHHHHHHHh
Q 039516           93 ------------------------------EERLLVYEFMPNKSLDSSFS-------------------GTFKDLLCLHK  123 (345)
Q Consensus        93 ------------------------------~~~~lv~e~~~~gsL~~~l~-------------------~~~~~l~~lh~  123 (345)
                                                    ...++||||+++ +|.+.+.                   +++.+|.|||.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  159 (383)
T 3eb0_A           81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS  159 (383)
T ss_dssp             -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                                          348899999985 6554432                   55666777775


Q ss_pred             cCCCceEEeccCCCCeeeC-CCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccC-CcCcccchhhHHHHHH
Q 039516          124 YSRLRVIHRDLKASNILLD-DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVL  201 (345)
Q Consensus       124 ~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~  201 (345)
                      .   ||+||||||+|||++ .++.+||+|||+++.......   .....||+.|+|||++.+. .++.++||||+||++|
T Consensus       160 ~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          160 L---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             T---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             C---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            4   899999999999997 688999999999987643322   2335789999999988765 4899999999999999


Q ss_pred             HHHhCCCCCCCCC
Q 039516          202 KIVCGKKNNKSYH  214 (345)
Q Consensus       202 el~tg~~p~~~~~  214 (345)
                      ||++|+.||....
T Consensus       234 ell~g~~pf~~~~  246 (383)
T 3eb0_A          234 ELILGKPLFSGET  246 (383)
T ss_dssp             HHHHSSCSSCCSS
T ss_pred             HHHhCCCCCCCCC
Confidence            9999999998644

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=296.34  Aligned_cols=230  Identities=17%  Similarity=0.167  Sum_probs=173.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC----ccCHHHHHHHHHHHHhcCCCCeeeEEEEEE--ECCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS----GQGRVEFQNEAKLIAKLQYTNLVKLLGCSI--HGEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~--~~~~~   95 (345)
                      ..+|.+.+.||+|+||.||++.. .+++.||+|.++...    ......+.+|+.++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            35699999999999999999976 468999999996532    234567999999999999999999999984  45578


Q ss_pred             EEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           96 LLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      ++||||++++ |.+++.                 +++.+|.+||..   ||+||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999877 433332                 567777777765   8999999999999999999999999999876


Q ss_pred             cCCCCCCcccceeecCCccccchhccCC--cCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          159 GVNESGANTNRIVGTYGYMSLEYTMSGT--VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                      .............||+.|+|||++.+..  ++.++||||||+++|+|++|+.||.....      .... .....+..  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~-~~i~~~~~--  230 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLF-ENIGKGSY--  230 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHH-HHHHHCCC--
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHH-HHHhcCCC--
Confidence            4332233333456899999999987644  47899999999999999999999975321      1111 11112211  


Q ss_pred             cccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          237 LIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       237 ~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                          .+...++...   .+++.+||+.||.+|||+.
T Consensus       231 ----~~~~~~~~~l---~~li~~~l~~dp~~Rps~~  259 (305)
T 2wtk_C          231 ----AIPGDCGPPL---SDLLKGMLEYEPAKRFSIR  259 (305)
T ss_dssp             ----CCCSSSCHHH---HHHHHHHTCSSTTTSCCHH
T ss_pred             ----CCCCccCHHH---HHHHHHHccCChhhCCCHH
Confidence                1112233222   5899999999999999954

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.4e-40  Score=297.54  Aligned_cols=231  Identities=21%  Similarity=0.241  Sum_probs=161.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccC-HHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQG-RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~-~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ..+|++.+.||+|+||.||++.. .+|+.||+|+++... ... ...+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            45699999999999999999975 579999999997542 222 223444555678889999999999999999999999


Q ss_pred             ecCCCCChHHHHH-------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516          100 EFMPNKSLDSSFS-------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus       100 e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      ||+++ +|.+++.                   +++.+|.|||...  ||+||||||+||+++.++.+||+|||++.....
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            99985 6655432                   5667777777642  799999999999999999999999999987643


Q ss_pred             CCCCCcccceeecCCccccchh----ccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYT----MSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                      ..   ......||+.|+|||++    .+..++.++||||||+++|+|++|+.||......     .............. 
T Consensus       163 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~-  233 (290)
T 3fme_A          163 DV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPSPQ-  233 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCCCC-
T ss_pred             cc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCCCC-
Confidence            22   22234689999999996    4667899999999999999999999999753211     11111222121110 


Q ss_pred             cccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          237 LIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       237 ~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .    ....++.+.   .+++..||+.||.+|||+.
T Consensus       234 ~----~~~~~~~~~---~~li~~~l~~~p~~Rpt~~  262 (290)
T 3fme_A          234 L----PADKFSAEF---VDFTSQCLKKNSKERPTYP  262 (290)
T ss_dssp             C----CTTTSCHHH---HHHHHHHTCSSGGGSCCHH
T ss_pred             c----ccccCCHHH---HHHHHHHhhcChhhCcCHH
Confidence            0    011122221   5899999999999999954

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2e-39  Score=310.89  Aligned_cols=183  Identities=19%  Similarity=0.231  Sum_probs=155.0

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhc------CCCCeeeEEEEEEECCe
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL------QYTNLVKLLGCSIHGEE   94 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~~~~~~~~~~~   94 (345)
                      ....|++.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+.+++.+      .|+||+++++++.....
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            345699999999999999999965 56899999999653 23345678899988887      57799999999999999


Q ss_pred             eEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC--EEEEccccc
Q 039516           95 RLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN--TKISDFGMA  155 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~--~kl~Dfgl~  155 (345)
                      .++||||+. ++|.+++.                 +++.+|.|||..   +|+||||||+|||++.++.  +||+|||++
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999996 47765543                 667778888876   8999999999999999887  999999999


Q ss_pred             eeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      .....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       250 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          250 CYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             EETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            76432     1223578999999999999999999999999999999999999997654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1e-38  Score=301.25  Aligned_cols=187  Identities=21%  Similarity=0.217  Sum_probs=155.2

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-CC-----CeeeEEEEEEEC
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YT-----NLVKLLGCSIHG   92 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~~~~~~~~~   92 (345)
                      +.+..+|.+.+.||+|+||.||+|.. .+++.||||+++.. ......+..|+.+++.++ |+     +|+++++++...
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            33456799999999999999999965 46899999999643 233566788999998885 55     499999999999


Q ss_pred             CeeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC--CCCCEEEEccc
Q 039516           93 EERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD--DQLNTKISDFG  153 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~--~~~~~kl~Dfg  153 (345)
                      +..++||||+++ +|.+++.                 +++.+|.|||. |..||+||||||+|||++  .++.+||+|||
T Consensus       129 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          129 NHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             TEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            999999999965 8776653                 56677778874 245899999999999995  47789999999


Q ss_pred             cceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          154 MARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       154 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      +++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          207 SSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             TCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             Cceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99876322     223578999999999999999999999999999999999999998654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=8.3e-40  Score=306.11  Aligned_cols=189  Identities=23%  Similarity=0.245  Sum_probs=148.6

Q ss_pred             cccCCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCcc-----------CHHHHHHHHHHHHhcCCCCeeeEEE
Q 039516           19 VENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQ-----------GRVEFQNEAKLIAKLQYTNLVKLLG   87 (345)
Q Consensus        19 ~~~~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~~~~   87 (345)
                      ...+..+|.+.+.||+|+||.||++...+|+.||||++......           ..+.+.+|+.++++++||||+++++
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   96 (362)
T 3pg1_A           17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD   96 (362)
T ss_dssp             HHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             HHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence            34456679999999999999999998888999999998543211           1367999999999999999999999


Q ss_pred             EEEEC-----CeeEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC
Q 039516           88 CSIHG-----EERLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN  146 (345)
Q Consensus        88 ~~~~~-----~~~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~  146 (345)
                      ++...     ...++||||+. |+|.+.+.                +++.+|.|||..   ||+||||||+||+++.++.
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~  172 (362)
T 3pg1_A           97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNND  172 (362)
T ss_dssp             EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred             eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCC
Confidence            98653     36799999998 46655442                566777777776   8999999999999999999


Q ss_pred             EEEEccccceeecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       147 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      +||+|||++.......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       173 ~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          173 ITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             EEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             EEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            9999999997543221   2233578999999998876 678999999999999999999999997643

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.8e-39  Score=299.12  Aligned_cols=234  Identities=19%  Similarity=0.195  Sum_probs=173.2

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--------ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--------GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG   92 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~   92 (345)
                      +..+|.+.+.||+|+||.||++.. .+++.||||.+....        ......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            345699999999999999999965 568999999986432        12234588999999999999999999998655


Q ss_pred             CeeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC---EEEEcccc
Q 039516           93 EERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN---TKISDFGM  154 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfgl  154 (345)
                       ..++||||+++++|.+++.               +++.+|.+||..   ||+||||||+||+++.++.   +||+|||+
T Consensus        88 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           88 -DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             -SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             -ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence             4899999999999977653               566777777765   8999999999999987654   99999999


Q ss_pred             ceeecCCCCCCcccceeecCCccccchhc---cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc
Q 039516          155 ARIFGVNESGANTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNE  231 (345)
Q Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  231 (345)
                      +......   .......||+.|+|||++.   ...++.++||||||+++|+|++|..||........  +....    ..
T Consensus       164 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~----~~  234 (322)
T 2ycf_A          164 SKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI----TS  234 (322)
T ss_dssp             CEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH----HH
T ss_pred             ceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH----Hh
Confidence            9876321   1223457899999999874   56788999999999999999999999976543221  11111    11


Q ss_pred             CCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          232 GKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       232 ~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      +....  .+.....++...   .+++..||+.||.+|||+.+
T Consensus       235 ~~~~~--~~~~~~~~~~~~---~~li~~~l~~dP~~Rps~~~  271 (322)
T 2ycf_A          235 GKYNF--IPEVWAEVSEKA---LDLVKKLLVVDPKARFTTEE  271 (322)
T ss_dssp             TCCCC--CHHHHTTSCHHH---HHHHHHHSCSSTTTSCCHHH
T ss_pred             Ccccc--CchhhhhcCHHH---HHHHHHHcccCHhhCCCHHH
Confidence            11110  000101122211   59999999999999999643

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.7e-40  Score=330.41  Aligned_cols=242  Identities=20%  Similarity=0.237  Sum_probs=185.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC----CCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP----NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~----~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      ..+|.+.+.||+|+||.||+|...    .+..||||.++.. .....+.|.+|+.++++++||||+++++++ ..+..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-ecCceEE
Confidence            456899999999999999999763    2568999998754 333456799999999999999999999998 4567899


Q ss_pred             EEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           98 VYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        98 v~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      ||||+++|+|.+++.                +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.....
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            999999999988764                566777777765   8999999999999999999999999999876432


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      .. .......+|+.|+|||++.+..++.++||||||+++|||++ |..||......      ....... .+...     
T Consensus       545 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------~~~~~i~-~~~~~-----  611 (656)
T 2j0j_A          545 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIE-NGERL-----  611 (656)
T ss_dssp             ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHH-HTCCC-----
T ss_pred             cc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHH-cCCCC-----
Confidence            21 12223456789999999999999999999999999999997 99999764321      1111111 11111     


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      .+...+++..   .+++..||+.||.+|||+.++...|..+++.
T Consensus       612 ~~~~~~~~~l---~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          612 PMPPNCPPTL---YSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             CCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCccccHHH---HHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            1111233222   5899999999999999999888888887754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.3e-40  Score=308.60  Aligned_cols=195  Identities=21%  Similarity=0.249  Sum_probs=147.0

Q ss_pred             eecccccccccCCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEE
Q 039516           11 TWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLG   87 (345)
Q Consensus        11 s~~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~   87 (345)
                      ...++.+.+-.....|.+.+.||+|+||.||+|. ..+|+.||||++...  .......+.+|+.+++.++||||+++++
T Consensus        16 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~   95 (367)
T 2fst_X           16 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD   95 (367)
T ss_dssp             EEEEETTEEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             ceEeecCcccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            3345555555666889999999999999999996 457999999999653  2334567889999999999999999999


Q ss_pred             EEEEC------CeeEEEEecCCCCChHHHH--------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCE
Q 039516           88 CSIHG------EERLLVYEFMPNKSLDSSF--------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNT  147 (345)
Q Consensus        88 ~~~~~------~~~~lv~e~~~~gsL~~~l--------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~  147 (345)
                      ++...      ...++||||+ +++|.+++              .+++.+|.|||..   ||+||||||+|||++.++.+
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~  171 (367)
T 2fst_X           96 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL  171 (367)
T ss_dssp             EECSCSSGGGCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             EEecCCccccCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCE
Confidence            98654      5679999999 56665543              2677778888865   89999999999999999999


Q ss_pred             EEEccccceeecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       148 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ||+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus       172 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  234 (367)
T 2fst_X          172 KILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD  234 (367)
T ss_dssp             EECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             EEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999865321     234578999999999886 678999999999999999999999997654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3e-39  Score=310.01  Aligned_cols=232  Identities=19%  Similarity=0.156  Sum_probs=168.1

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEEec
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ..-|.+.+.||+|+||+||.+...+|+.||||++...   ....+.+|+.+++++ +||||+++++++.+.+..++||||
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            3346777889999999997665567999999998643   345678999999886 899999999999999999999999


Q ss_pred             CCCCChHHHHH----------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC-------------CC
Q 039516          102 MPNKSLDSSFS----------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ-------------LN  146 (345)
Q Consensus       102 ~~~gsL~~~l~----------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~-------------~~  146 (345)
                      |. |+|.+++.                      +++.+|.|||..   ||+||||||+|||++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceE
Confidence            96 58866543                      556677777765   89999999999999654             47


Q ss_pred             EEEEccccceeecCCCCCC--cccceeecCCccccchhcc-------CCcCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 039516          147 TKISDFGMARIFGVNESGA--NTNRIVGTYGYMSLEYTMS-------GTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTE  216 (345)
Q Consensus       147 ~kl~Dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~  216 (345)
                      +||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            9999999998865432211  1234579999999999875       668999999999999999999 99999653211


Q ss_pred             CcccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          217 RPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      .    .    .........    +.+........... .+++..||+.||.+|||+.+
T Consensus       247 ~----~----~i~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  292 (434)
T 2rio_A          247 E----S----NIIRGIFSL----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK  292 (434)
T ss_dssp             H----H----HHHHTCCCC----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             H----H----HHhcCCCCc----ccccccccccchHHHHHHHHHHhhCChhhCCCHHH
Confidence            1    1    111111000    00111112222334 79999999999999999653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.8e-39  Score=304.03  Aligned_cols=197  Identities=23%  Similarity=0.229  Sum_probs=158.8

Q ss_pred             ceeecccccccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeE
Q 039516            9 CQTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKL   85 (345)
Q Consensus         9 ~~s~~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~   85 (345)
                      .|...++.+..-.+...|.+.+.||+|+||.||++.. .+|+.||||++...  .......+.+|+.+++.++||||+++
T Consensus        27 g~~~~~~~~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~  106 (371)
T 4exu_A           27 GFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGL  106 (371)
T ss_dssp             TEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             cceeeeeccceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhh
Confidence            3344455555555677899999999999999999964 57999999999754  22335678899999999999999999


Q ss_pred             EEEEEECCee------EEEEecCCCCChHHHH-------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC
Q 039516           86 LGCSIHGEER------LLVYEFMPNKSLDSSF-------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN  146 (345)
Q Consensus        86 ~~~~~~~~~~------~lv~e~~~~gsL~~~l-------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~  146 (345)
                      ++++...+..      ++||||+. ++|.+.+             .+++.+|.|||..   ||+||||||+|||++.++.
T Consensus       107 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~  182 (371)
T 4exu_A          107 LDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCE  182 (371)
T ss_dssp             SEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred             hhheeccCCcccceeEEEEEcccc-ccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCC
Confidence            9999876654      99999998 4665433             3677777788776   8999999999999999999


Q ss_pred             EEEEccccceeecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       147 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      +||+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       183 ~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  246 (371)
T 4exu_A          183 LKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  246 (371)
T ss_dssp             EEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             EEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999865322     223578999999999887 678999999999999999999999997643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.1e-40  Score=302.06  Aligned_cols=190  Identities=24%  Similarity=0.317  Sum_probs=150.3

Q ss_pred             cCCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEE---------
Q 039516           21 NSSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSI---------   90 (345)
Q Consensus        21 ~~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~---------   90 (345)
                      .+...|.+.+.||+|+||.||++... +|+.||+|++........+.+.+|+.++++++||||+++++++.         
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A            8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            34567999999999999999999764 58999999998766666778999999999999999999999873         


Q ss_pred             -----ECCeeEEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC-CCCCEEEE
Q 039516           91 -----HGEERLLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD-DQLNTKIS  150 (345)
Q Consensus        91 -----~~~~~~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~-~~~~~kl~  150 (345)
                           +....++||||++ |+|.+++.              +++.+|.+||..   ||+||||||+||+++ .++.+||+
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence                 3467899999998 58876654              667777777765   899999999999997 56789999


Q ss_pred             ccccceeecCCCC-CCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          151 DFGMARIFGVNES-GANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       151 Dfgl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      |||++........ ........+|..|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  229 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH  229 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence            9999986532211 112233467899999998765 678999999999999999999999998654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.8e-39  Score=297.76  Aligned_cols=186  Identities=20%  Similarity=0.198  Sum_probs=156.5

Q ss_pred             cccCCCCeeeEEEeeccCCeEEEEEEc--CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCC------CeeeEEEEEE
Q 039516           19 VENSSLDWHMYIQQEQTRDRVILVGKF--PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYT------NLVKLLGCSI   90 (345)
Q Consensus        19 ~~~~~~~~~~~~~lG~G~~g~vy~~~~--~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~------niv~~~~~~~   90 (345)
                      .+.+..+|++.+.||+|+||.||++..  .+|+.||||+++.. ......+.+|+.+++.++|+      +++++++++.
T Consensus         9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A            9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            344567899999999999999999975  46899999999643 23456788999999998765      4999999999


Q ss_pred             ECCeeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC----------
Q 039516           91 HGEERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD----------  143 (345)
Q Consensus        91 ~~~~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~----------  143 (345)
                      ..+..++||||+ +++|.+++.                 +++.+|.|||..   ||+||||||+|||++.          
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence            999999999999 788876654                 566677777765   8999999999999987          


Q ss_pred             ---------CCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          144 ---------QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       144 ---------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                               ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             cccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                     668999999999864321     223578999999999999999999999999999999999999997654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.2e-39  Score=297.47  Aligned_cols=185  Identities=22%  Similarity=0.322  Sum_probs=152.4

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc--CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhc---CCCCeeeEEEEEE-----
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF--PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKL---QYTNLVKLLGCSI-----   90 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~--~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~-----   90 (345)
                      ..+|.+.+.||+|+||.||++..  .+|+.||+|++....  ......+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            45699999999999999999976  468999999986432  22234567788877766   8999999999987     


Q ss_pred             ECCeeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccc
Q 039516           91 HGEERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFG  153 (345)
Q Consensus        91 ~~~~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg  153 (345)
                      .....++||||++ |+|.+++.                 +++.+|.+||..   ||+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCc
Confidence            4567899999998 58877654                 556677777765   89999999999999999999999999


Q ss_pred             cceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          154 MARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       154 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus       166 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  223 (326)
T 1blx_A          166 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  223 (326)
T ss_dssp             SCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            997653221   2233578999999999999999999999999999999999999997643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.1e-39  Score=299.72  Aligned_cols=186  Identities=20%  Similarity=0.276  Sum_probs=139.4

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCe-------e
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE-------R   95 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~-------~   95 (345)
                      .+|.+.+.||+|+||.||++.. .+|+.||||++.... .....+.+|++.++.++||||+++++++.....       .
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            5699999999999999999975 578999999986543 233467788888999999999999999876433       7


Q ss_pred             EEEEecCCCCChHHH------------------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCC-CCCEEEEccccce
Q 039516           96 LLVYEFMPNKSLDSS------------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDD-QLNTKISDFGMAR  156 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~------------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgl~~  156 (345)
                      ++||||++++.+...                  +.+++.++.|||. |+.||+||||||+|||++. ++.+||+|||++.
T Consensus       102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~  180 (360)
T 3e3p_A          102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK  180 (360)
T ss_dssp             EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred             EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence            899999987533211                  2255666777772 2669999999999999996 8999999999998


Q ss_pred             eecCCCCCCcccceeecCCccccchhccCC-cCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          157 IFGVNESGANTNRIVGTYGYMSLEYTMSGT-VSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      .......   .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....
T Consensus       181 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  236 (360)
T 3e3p_A          181 KLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN  236 (360)
T ss_dssp             CCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence            7643222   22346899999999987654 8999999999999999999999998643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.2e-38  Score=304.59  Aligned_cols=236  Identities=19%  Similarity=0.234  Sum_probs=168.5

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC----C--ee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG----E--ER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~----~--~~   95 (345)
                      ...|.+.+.||+|+||.||+|.. .+|+.||||++.....    .+.+|+++|++++|||||+++++|...    +  .+
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            44699999999999999999976 4699999999965422    234799999999999999999988642    1  36


Q ss_pred             EEEEecCCCCChHHH-------------------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCC-CCEEEEccccc
Q 039516           96 LLVYEFMPNKSLDSS-------------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ-LNTKISDFGMA  155 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~-------------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgl~  155 (345)
                      ++||||++++ |.+.                   +.+++.+|.|||..   ||+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhccccc-HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence            7999999863 3322                   22566777777764   89999999999999965 56899999999


Q ss_pred             eeecCCCCCCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHh----
Q 039516          156 RIFGVNESGANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWN----  230 (345)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----  230 (345)
                      +.......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.  +.... ....    
T Consensus       205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~-~~lg~p~~  278 (420)
T 1j1b_A          205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEII-KVLGTPTR  278 (420)
T ss_dssp             EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH-HHHCSCCH
T ss_pred             hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCCH
Confidence            87643222   2235789999999998764 789999999999999999999999986432211  11111 1110    


Q ss_pred             ------cCCccccccccCCCC-----CChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          231 ------EGKDLELIDLTLDGS-----CPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       231 ------~~~~~~~~d~~l~~~-----~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                            .....+..-+.+...     +.+..... .+++.+||+.||.+|||+.
T Consensus       279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~  332 (420)
T 1j1b_A          279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL  332 (420)
T ss_dssp             HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHH
Confidence                  011111111111100     11111223 6999999999999999954

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.4e-39  Score=297.82  Aligned_cols=234  Identities=20%  Similarity=0.237  Sum_probs=154.8

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHH-HHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAK-LIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ..+|.+.+.||+|+||.||++.. .+|+.||||+++... ......+..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            46799999999999999999976 479999999997653 233445666666 677789999999999999999999999


Q ss_pred             ecCCCCChHHHHH--------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516          100 EFMPNKSLDSSFS--------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus       100 e~~~~gsL~~~l~--------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      ||+++ +|.+++.                    +++.+|.+||...  ||+||||||+||+++.++.+||+|||++....
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            99986 5554432                    5566777777642  79999999999999999999999999997654


Q ss_pred             CCCCCCcccceeecCCccccchh----ccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 039516          160 VNESGANTNRIVGTYGYMSLEYT----MSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDL  235 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (345)
                      ...   ......||+.|+|||++    .+..++.++||||||+++|+|++|+.||........         ..  ....
T Consensus       178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~~--~~~~  243 (327)
T 3aln_A          178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------QL--TQVV  243 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCC
T ss_pred             ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------HH--HHHh
Confidence            321   12234789999999998    456789999999999999999999999975431100         00  0000


Q ss_pred             ccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          236 ELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       236 ~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      ....+.+........... .+++..||+.||.+|||+.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  282 (327)
T 3aln_A          244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE  282 (327)
T ss_dssp             CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHH
Confidence            000111111111111223 59999999999999999654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1e-38  Score=290.33  Aligned_cols=231  Identities=19%  Similarity=0.232  Sum_probs=168.5

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE----------
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH----------   91 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----------   91 (345)
                      ..+|++.+.||+|+||.||++.. .+|+.||||.+... ......+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            45699999999999999999975 57999999999643 2345678999999999999999999999865          


Q ss_pred             ---CCeeEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcc
Q 039516           92 ---GEERLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF  152 (345)
Q Consensus        92 ---~~~~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Df  152 (345)
                         ....++||||+++++|.+++.                +++.+|.+||..   ||+||||||+||+++.++.+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeC
Confidence               346799999999999988764                556677777765   8999999999999999999999999


Q ss_pred             ccceeecCCCC------------CCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 039516          153 GMARIFGVNES------------GANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPL  219 (345)
Q Consensus       153 gl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~  219 (345)
                      |++........            ........||+.|+|||++.+. .++.++||||||+++|+|++   ||....     
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-----  232 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-----  232 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-----
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-----
Confidence            99976532110            1122345789999999998864 68999999999999999998   443211     


Q ss_pred             cHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          220 NLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ...... .......      ..+...++...... .+++..||+.||.+|||+.
T Consensus       233 ~~~~~~-~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  279 (303)
T 1zy4_A          233 ERVNIL-KKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGAR  279 (303)
T ss_dssp             HHHHHH-HHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hHHHHH-Hhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHH
Confidence            111111 1111111      11111122222233 6899999999999999954

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.3e-38  Score=285.22  Aligned_cols=237  Identities=21%  Similarity=0.216  Sum_probs=181.7

Q ss_pred             cccccCCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Q 039516           17 KFVENSSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE   93 (345)
Q Consensus        17 ~~~~~~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~   93 (345)
                      .....+..+|.+.+.||+|+||.||++... +++.||+|++...  .......+.+|++++++++||||+++++++....
T Consensus        15 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (287)
T 2wei_A           15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS   94 (287)
T ss_dssp             HHTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hHHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC
Confidence            334555678999999999999999999764 7899999998654  3345778999999999999999999999999999


Q ss_pred             eeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC---CCEEEEccccc
Q 039516           94 ERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ---LNTKISDFGMA  155 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfgl~  155 (345)
                      ..++||||+++++|.+.+.               +++.+|.+||..   |++||||||+||+++.+   +.+||+|||++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             eEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            9999999999999976653               567777788765   89999999999999754   46999999999


Q ss_pred             eeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 039516          156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDL  235 (345)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (345)
                      .......   ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.....      .... .....+...
T Consensus       172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~-~~~~~~~~~  240 (287)
T 2wei_A          172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDIL-KRVETGKYA  240 (287)
T ss_dssp             GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHHHCCCC
T ss_pred             eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH------HHHH-HHHHcCCCC
Confidence            7653322   1223468999999998875 489999999999999999999999976431      1111 112122111


Q ss_pred             ccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          236 ELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       236 ~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ... + ....++.+.   .+++..||+.||.+|||+.
T Consensus       241 ~~~-~-~~~~~~~~~---~~li~~~l~~dp~~Rps~~  272 (287)
T 2wei_A          241 FDL-P-QWRTISDDA---KDLIRKMLTFHPSLRITAT  272 (287)
T ss_dssp             CCS-G-GGTTSCHHH---HHHHHHHTCSSGGGSCCHH
T ss_pred             CCc-h-hhhhcCHHH---HHHHHHHcccChhhCcCHH
Confidence            000 0 001122222   5899999999999999954

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.5e-40  Score=300.42  Aligned_cols=242  Identities=19%  Similarity=0.204  Sum_probs=179.5

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ...+|.+.+.||+|+||.||+|...  ..||+|.++..  .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            3567999999999999999999875  35999998654  2333456889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC-
Q 039516          100 EFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE-  162 (345)
Q Consensus       100 e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-  162 (345)
                      ||+++++|.+++.                +++.+|.+||..   ||+||||||+||+++ ++.+||+|||++....... 
T Consensus       109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            9999999987654                567777788875   899999999999998 6799999999987643211 


Q ss_pred             --CCCcccceeecCCccccchhcc---------CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhc
Q 039516          163 --SGANTNRIVGTYGYMSLEYTMS---------GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNE  231 (345)
Q Consensus       163 --~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  231 (345)
                        .........||+.|+|||++.+         ..++.++||||||+++|+|++|+.||.....      ....+... .
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~-~  257 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------EAIIWQMG-T  257 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------HHHHHHHH-T
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHhc-c
Confidence              1122233468999999998874         4578899999999999999999999975432      11112221 2


Q ss_pred             CCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          232 GKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       232 ~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      +.......    ..++.+-   .+++..||+.||.+|||+.++...|..+.+
T Consensus       258 ~~~~~~~~----~~~~~~l---~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          258 GMKPNLSQ----IGMGKEI---SDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             TCCCCCCC----SSCCTTH---HHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             CCCCCCCc----CCCCHHH---HHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            21111111    1122222   489999999999999998887777777665

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=301.42  Aligned_cols=185  Identities=19%  Similarity=0.284  Sum_probs=138.5

Q ss_pred             CCeee-EEEeeccCCeEEEEEEcC---CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCeeEE
Q 039516           24 LDWHM-YIQQEQTRDRVILVGKFP---NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH--GEERLL   97 (345)
Q Consensus        24 ~~~~~-~~~lG~G~~g~vy~~~~~---~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~l   97 (345)
                      ..|++ .++||+|+||.||++...   +++.||||++....  ....+.+|+.+|++++||||+++++++..  ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            33665 346999999999999854   57899999996542  23578899999999999999999999965  678999


Q ss_pred             EEecCCCCChHHHH------------------------HhHHHHHHHHHhcCCCceEEeccCCCCeee----CCCCCEEE
Q 039516           98 VYEFMPNKSLDSSF------------------------SGTFKDLLCLHKYSRLRVIHRDLKASNILL----DDQLNTKI  149 (345)
Q Consensus        98 v~e~~~~gsL~~~l------------------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill----~~~~~~kl  149 (345)
                      ||||+.+ +|.+++                        .+++.+|.|||..   ||+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999975 554432                        2566777777765   89999999999999    67789999


Q ss_pred             EccccceeecCCCC-CCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          150 SDFGMARIFGVNES-GANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       150 ~Dfgl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      +|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            99999987643211 122334678999999999887 458999999999999999999999997654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.3e-39  Score=296.67  Aligned_cols=225  Identities=18%  Similarity=0.214  Sum_probs=176.7

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCcc------CHHHHHHHHHHHHhcC--CCCeeeEEEEEE
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSGQ------GRVEFQNEAKLIAKLQ--YTNLVKLLGCSI   90 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~~~~~~~   90 (345)
                      +.+..+|.+.+.||+|+||.||+|. ..+++.||||.+......      ....+.+|+.++++++  |+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            4567789999999999999999996 457899999999654211      2245778999999996  599999999999


Q ss_pred             ECCeeEEEEecCCC-CChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC-CCCCEEEEccc
Q 039516           91 HGEERLLVYEFMPN-KSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD-DQLNTKISDFG  153 (345)
Q Consensus        91 ~~~~~~lv~e~~~~-gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfg  153 (345)
                      ..+..++||||+.+ ++|.+++.               +++.+|.|||..   ||+||||||+|||++ +++.+||+|||
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            99999999999986 78877654               567777788765   899999999999998 78899999999


Q ss_pred             cceeecCCCCCCcccceeecCCccccchhccCCc-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC
Q 039516          154 MARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEG  232 (345)
Q Consensus       154 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (345)
                      ++......    ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....            ..... 
T Consensus       196 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~~~-  258 (320)
T 3a99_A          196 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRG-  258 (320)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHC-
T ss_pred             cccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhhcc-
Confidence            99876432    2233578999999999887666 688999999999999999999996421            01111 


Q ss_pred             CccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCc
Q 039516          233 KDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       233 ~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  273 (345)
                      ..      .....++.+.   .+++.+||+.||.+|||+.+
T Consensus       259 ~~------~~~~~~~~~~---~~li~~~l~~dp~~Rps~~~  290 (320)
T 3a99_A          259 QV------FFRQRVSSEC---QHLIRWCLALRPSDRPTFEE  290 (320)
T ss_dssp             CC------CCSSCCCHHH---HHHHHHHTCSSGGGSCCHHH
T ss_pred             cc------cccccCCHHH---HHHHHHHccCChhhCcCHHH
Confidence            10      1112233222   58999999999999999643

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.8e-38  Score=295.59  Aligned_cols=183  Identities=19%  Similarity=0.274  Sum_probs=150.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-----------CCCeeeEEEEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-----------YTNLVKLLGCSI   90 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~~~~~~~   90 (345)
                      ..+|.+.+.||+|+||.||++.. .+++.||||++... ......+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            45799999999999999999975 57899999999643 234567889999999886           899999999987


Q ss_pred             ECC----eeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC------C
Q 039516           91 HGE----ERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD------D  143 (345)
Q Consensus        91 ~~~----~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~------~  143 (345)
                      ..+    ..++||||+ +++|.+++.                 +++.+|.|||..+  ||+||||||+|||++      .
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence            654    789999999 888877654                 5566777777642  799999999999994      4


Q ss_pred             CCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       144 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      .+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       174 ~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             cceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            457999999999876432     223478999999999999999999999999999999999999998654

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=303.98  Aligned_cols=229  Identities=18%  Similarity=0.237  Sum_probs=165.4

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEEec
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ..+|.+.+.||+|+||.|+.....+|+.||||++......   .+.+|+.+|+++ +|||||++++++.+....|+||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            4569999999999999855444457999999999654322   356899999999 899999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC-----CCCEEEEccccceeecC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD-----QLNTKISDFGMARIFGV  160 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~-----~~~~kl~Dfgl~~~~~~  160 (345)
                      |. |+|.+++.                +++.+|.|||..   ||+||||||+|||++.     ...+||+|||+++....
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            97 47776654                667777888775   8999999999999953     34588999999987643


Q ss_pred             CCC-CCcccceeecCCccccchhc---cCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 039516          161 NES-GANTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDL  235 (345)
Q Consensus       161 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (345)
                      ... ........||+.|+|||++.   ...++.++|||||||++|||++ |..||......       .......... .
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~-~  247 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILLGACS-L  247 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHTTCCC-C
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHhccCC-c
Confidence            221 12233457999999999987   4567889999999999999999 99998643211       1111111111 1


Q ss_pred             ccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          236 ELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       236 ~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ....      ........ .+++..||+.||.+|||+.
T Consensus       248 ~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~  279 (432)
T 3p23_A          248 DCLH------PEKHEDVIARELIEKMIAMDPQKRPSAK  279 (432)
T ss_dssp             TTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             cccC------ccccccHHHHHHHHHHHhCCHhhCCCHH
Confidence            1010      01112223 6899999999999999954

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=300.14  Aligned_cols=186  Identities=23%  Similarity=0.246  Sum_probs=152.2

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCe--
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE--   94 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~--   94 (345)
                      -.+..+|.+.+.||+|+||.||+|.. .+|+.||||.+....  ......+.+|+.++++++||||+++++++.....  
T Consensus        20 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   99 (353)
T 3coi_A           20 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR   99 (353)
T ss_dssp             EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             cccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence            33456799999999999999999975 579999999996542  2335678999999999999999999999987654  


Q ss_pred             ----eEEEEecCCCCChHHH-------------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516           95 ----RLLVYEFMPNKSLDSS-------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus        95 ----~~lv~e~~~~gsL~~~-------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                          .++||||+. ++|.++             +.+++.+|.|||..   ||+||||||+||+++.++.+||+|||++..
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          100 NFYDFYLVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             GCCCCEEEEECCS-EEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             cceeEEEEecccc-CCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence                499999997 466543             33677778888875   899999999999999999999999999976


Q ss_pred             ecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          158 FGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ....     .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  228 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  228 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            4321     233578999999999886 678999999999999999999999997643

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.6e-38  Score=291.84  Aligned_cols=232  Identities=16%  Similarity=0.094  Sum_probs=148.9

Q ss_pred             CCCCeeeEE-EeeccCCeEEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE----CCee
Q 039516           22 SSLDWHMYI-QQEQTRDRVILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH----GEER   95 (345)
Q Consensus        22 ~~~~~~~~~-~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~   95 (345)
                      +..+|.+.+ .||+|+||.||++... +|+.||||++...    .....+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            456799866 5999999999999754 7999999999643    2222233344667799999999999876    4458


Q ss_pred             EEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC---CCCEEEEccccc
Q 039516           96 LLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD---QLNTKISDFGMA  155 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgl~  155 (345)
                      ++||||+++|+|.+++.                 +++.+|.|||..   ||+||||||+||+++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999987764                 566777778776   8999999999999976   455999999999


Q ss_pred             eeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 039516          156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDL  235 (345)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (345)
                      ......    ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........   .......+.. 
T Consensus       179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~-  250 (336)
T 3fhr_A          179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLGQY-  250 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhcccc-
Confidence            875322    22345789999999999888999999999999999999999999976442211000   0000000000 


Q ss_pred             ccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          236 ELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       236 ~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      . +.......++.+.   .+++..||+.||.+|||+.
T Consensus       251 ~-~~~~~~~~~~~~~---~~li~~~L~~dP~~Rpt~~  283 (336)
T 3fhr_A          251 G-FPNPEWSEVSEDA---KQLIRLLLKTDPTERLTIT  283 (336)
T ss_dssp             C-CCTTTSTTCCHHH---HHHHHHHSCSSGGGSCCHH
T ss_pred             c-cCchhhccCCHHH---HHHHHHHCCCChhHCcCHH
Confidence            0 0000001122222   5899999999999999954

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-39  Score=293.38  Aligned_cols=226  Identities=20%  Similarity=0.259  Sum_probs=168.0

Q ss_pred             ccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCcc------CHHHHHHHHHHHHhc----CCCCeeeEE
Q 039516           18 FVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQ------GRVEFQNEAKLIAKL----QYTNLVKLL   86 (345)
Q Consensus        18 ~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~~~   86 (345)
                      ..+.+..+|.+.+.||+|+||.||++.. .+++.||||.+......      ....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3455677899999999999999999975 57899999999654321      223466799999999    899999999


Q ss_pred             EEEEECCeeEEEEec-CCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC-CCCCEEE
Q 039516           87 GCSIHGEERLLVYEF-MPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD-DQLNTKI  149 (345)
Q Consensus        87 ~~~~~~~~~~lv~e~-~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~-~~~~~kl  149 (345)
                      +++...+..++|||| +.+++|.+++.               +++.+|.+||..   ||+||||||+||+++ .++.+||
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence            999999999999999 78999987764               567778888876   899999999999998 7899999


Q ss_pred             EccccceeecCCCCCCcccceeecCCccccchhccCCc-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 039516          150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQL  228 (345)
Q Consensus       150 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  228 (345)
                      +|||++......    ......||..|+|||++.+..+ +.++||||||+++|+|++|+.||....            ..
T Consensus       182 ~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~  245 (312)
T 2iwi_A          182 IDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------EI  245 (312)
T ss_dssp             CCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HH
T ss_pred             EEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------HH
Confidence            999999876432    2234568999999999887666 458999999999999999999996421            00


Q ss_pred             HhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          229 WNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       229 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      . ....      .+...++...   .+++..||+.||++|||+.
T Consensus       246 ~-~~~~------~~~~~~~~~~---~~li~~~l~~~p~~Rps~~  279 (312)
T 2iwi_A          246 L-EAEL------HFPAHVSPDC---CALIRRCLAPKPSSRPSLE  279 (312)
T ss_dssp             H-HTCC------CCCTTSCHHH---HHHHHHHTCSSTTTSCCHH
T ss_pred             h-hhcc------CCcccCCHHH---HHHHHHHccCChhhCcCHH
Confidence            0 0000      1111122222   5899999999999999954

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=289.41  Aligned_cols=232  Identities=19%  Similarity=0.242  Sum_probs=157.4

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc-cCH-HHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG-QGR-VEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~-~~~-~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      -.+|.+.+.||+|+||.||++.. .+|+.||||.+..... ... ..+.++..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            35699999999999999999976 4799999999975532 222 23444556788889999999999999999999999


Q ss_pred             ecCCCCChHHHH----------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516          100 EFMPNKSLDSSF----------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       100 e~~~~gsL~~~l----------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      ||+ ++.+..+.                .+++.+|.+||..+  ||+||||||+||+++.++.+||+|||++....... 
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence            999 44443332                26777888888743  79999999999999999999999999997654322 


Q ss_pred             CCcccceeecCCccccchhc-----cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          164 GANTNRIVGTYGYMSLEYTM-----SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                        ......||+.|+|||++.     ...++.++||||||+++|+|++|+.||......     ............. ...
T Consensus       180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~-~~~  251 (318)
T 2dyl_A          180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEPP-LLP  251 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCCC-CCC
T ss_pred             --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCCC-CCC
Confidence              122357899999999984     456889999999999999999999999753321     1111222221111 000


Q ss_pred             cccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          239 DLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       239 d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .   ...++.+.   .+++..||+.||.+|||+.
T Consensus       252 ~---~~~~~~~l---~~li~~~l~~dp~~Rps~~  279 (318)
T 2dyl_A          252 G---HMGFSGDF---QSFVKDCLTKDHRKRPKYN  279 (318)
T ss_dssp             S---SSCCCHHH---HHHHHHHTCSCTTTSCCHH
T ss_pred             c---cCCCCHHH---HHHHHHHccCChhHCcCHH
Confidence            0   01122222   5899999999999999954

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.1e-38  Score=290.87  Aligned_cols=185  Identities=18%  Similarity=0.178  Sum_probs=152.0

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEEcC-CC-cEEEEEEeccCCccCHHHHHHHHHHHHhcCCCC------eeeEEEEEEE
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGKFP-NE-QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTN------LVKLLGCSIH   91 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~~~-~~-~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~~~~~~~~   91 (345)
                      +.+..+|.+.+.||+|+||.||++... ++ +.||+|+++.. ......+.+|+.++++++|+|      ++.+++++..
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            334667999999999999999999753 44 78999999643 234567889999999997765      9999999999


Q ss_pred             CCeeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeee-------------
Q 039516           92 GEERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILL-------------  141 (345)
Q Consensus        92 ~~~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill-------------  141 (345)
                      .+..++||||+. ++|.+.+.                 +++.+|.|||..   ||+||||||+|||+             
T Consensus        94 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           94 HGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             CCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence            999999999994 45544332                 556666677654   89999999999999             


Q ss_pred             ------CCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          142 ------DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       142 ------~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                            +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                  56788999999999864321     233578999999999999999999999999999999999999998644

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.9e-38  Score=315.45  Aligned_cols=216  Identities=16%  Similarity=0.193  Sum_probs=170.3

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcC--CCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCe----
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFP--NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE----   94 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~--~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~----   94 (345)
                      +...|.+.+.||+|+||.||++...  +|+.||||.+... .......+.+|+.++++++||||+++++++...+.    
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            3467999999999999999999764  6899999998654 33445678999999999999999999999987655    


Q ss_pred             -eEEEEecCCCCChHHHHH-------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           95 -RLLVYEFMPNKSLDSSFS-------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        95 -~~lv~e~~~~gsL~~~l~-------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                       .|+||||+++++|.+++.             +++.+|.|||..   ||+||||||+|||++.+ .+||+|||+++....
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS  233 (681)
T ss_dssp             EEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred             eeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence             799999999999876543             667777788765   89999999999999885 899999999987632


Q ss_pred             CCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      .      ....||+.|+|||++.++. +.++|||||||++|+|++|..||........                      
T Consensus       234 ~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------------  284 (681)
T 2pzi_A          234 F------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------------  284 (681)
T ss_dssp             C------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------------
T ss_pred             C------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------------
Confidence            2      3357999999999987654 8999999999999999999988764211100                      


Q ss_pred             cCCCCCCh-hHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          241 TLDGSCPP-NEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       241 ~l~~~~~~-~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                        ....+. ..... ..++.+||+.||.+||+..
T Consensus       285 --~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~  316 (681)
T 2pzi_A          285 --PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTA  316 (681)
T ss_dssp             --CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred             --cccccccccCHHHHHHHhhhccCChhhCCCHH
Confidence              000011 11123 6899999999999999753

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.9e-37  Score=279.40  Aligned_cols=218  Identities=11%  Similarity=0.034  Sum_probs=166.7

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCc---cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSG---QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      +...|.+.+.||+|+||.||++... +|+.||||.+.....   .....+.+|+.++++++||||+++++++.+.+..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            3467999999999999999999764 589999999976532   234679999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH-------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516           98 VYEFMPNKSLDSSFS-------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus        98 v~e~~~~gsL~~~l~-------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||||+++++|.+++.             +++.+|.|||..   ||+||||||+|||++.++.+||+++|           
T Consensus       109 v~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             EEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            999999999988764             566677777765   89999999999999999999987443           


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc-ccc-ccC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE-LID-LTL  242 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~d-~~l  242 (345)
                                 |++       .++.++|||||||++|||++|+.||............        ...... ... ..+
T Consensus       175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~  228 (286)
T 3uqc_A          175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ERDTAGQPIEPADI  228 (286)
T ss_dssp             -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CBCTTSCBCCHHHH
T ss_pred             -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HHHhccCCCChhhc
Confidence                       333       3688999999999999999999999875432211000        000000 000 001


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      ...++.+-   ..++.+||+.||.+| |+.++...|..+..
T Consensus       229 ~~~~~~~l---~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          229 DRDIPFQI---SAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             CTTSCHHH---HHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             ccCCCHHH---HHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            11122221   589999999999999 98887777776654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.6e-37  Score=307.46  Aligned_cols=239  Identities=21%  Similarity=0.207  Sum_probs=175.9

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE------CCee
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH------GEER   95 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~------~~~~   95 (345)
                      .+|.+.+.||+|+||.||++.. .+|+.||||+++.. .......+.+|+.++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            5699999999999999999975 56899999998754 34446679999999999999999999998755      6678


Q ss_pred             EEEEecCCCCChHHHHH------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC---EEEEcccc
Q 039516           96 LLVYEFMPNKSLDSSFS------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN---TKISDFGM  154 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfgl  154 (345)
                      ++||||+++|+|.+++.                  +++.+|.|||..   ||+||||||+||+++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999988764                  566777778775   8999999999999987665   99999999


Q ss_pred             ceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 039516          155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKD  234 (345)
Q Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (345)
                      +.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||......     ..|..........
T Consensus       171 a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~  242 (676)
T 3qa8_A          171 AKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNE  242 (676)
T ss_dssp             CCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC-----
T ss_pred             cccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccch
Confidence            98764322   223457899999999999999999999999999999999999999753210     1110000000000


Q ss_pred             ----cccc------cccC--CCCCChhHHHH-HHHHhhccCCCCCcCCCCCc
Q 039516          235 ----LELI------DLTL--DGSCPPNEDAF-LLVSCVCKSKQQIDVQCPML  273 (345)
Q Consensus       235 ----~~~~------d~~l--~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~  273 (345)
                          ....      ...+  ........... .+++..||+.||.+|||+.+
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence                0000      0000  11123333444 79999999999999999865

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.5e-36  Score=286.96  Aligned_cols=221  Identities=15%  Similarity=0.148  Sum_probs=159.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCC-CCe---------e------
Q 039516           24 LDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQY-TNL---------V------   83 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H-~ni---------v------   83 (345)
                      ..|...+.||+|+||+||+|. ..+|+.||||+++...   ....+.|.+|+.+++.++| +|.         +      
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            458888999999999999997 5679999999997442   2336789999999999987 221         1      


Q ss_pred             ------eEEEEEEE-----CCeeEEEEecCCCCChHHHH----------------------HhHHHHHHHHHhcCCCceE
Q 039516           84 ------KLLGCSIH-----GEERLLVYEFMPNKSLDSSF----------------------SGTFKDLLCLHKYSRLRVI  130 (345)
Q Consensus        84 ------~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l----------------------~~~~~~l~~lh~~~~~~iv  130 (345)
                            .++.++..     ....+++|+++ +++|.+++                      .+++.+|.|||..   ||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence                  11111111     22356777765 56777665                      2566777777765   899


Q ss_pred             EeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchh----------ccCCcCcccchhhHHHHH
Q 039516          131 HRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYT----------MSGTVSIKTDVFGFGVLV  200 (345)
Q Consensus       131 Hrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Di~SlG~il  200 (345)
                      ||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999998875322     333567 999999998          555688999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcc
Q 039516          201 LKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       201 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~  274 (345)
                      |||++|+.||........               ...++...  ..++.+.   .+++..||+.||.+|||+.++
T Consensus       308 ~elltg~~Pf~~~~~~~~---------------~~~~~~~~--~~~~~~~---~~li~~~l~~dP~~Rpt~~~~  361 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGG---------------SEWIFRSC--KNIPQPV---RALLEGFLRYPKEDRLLPLQA  361 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSC---------------SGGGGSSC--CCCCHHH---HHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHCCCCCCCcchhhh---------------HHHHHhhc--ccCCHHH---HHHHHHHccCChhhCcCHHHH
Confidence            999999999976432221               11111111  1233221   589999999999999996443

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3e-35  Score=268.22  Aligned_cols=208  Identities=17%  Similarity=0.171  Sum_probs=155.5

Q ss_pred             ccCCCCeeeE-EEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHH-HhcCCCCeeeEEEEEEE----C
Q 039516           20 ENSSLDWHMY-IQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLI-AKLQYTNLVKLLGCSIH----G   92 (345)
Q Consensus        20 ~~~~~~~~~~-~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~~~~~~~~----~   92 (345)
                      +.+..+|.+. +.||+|+||.||++.. .+++.||+|.++.     ...+.+|+.++ +.++||||+++++++..    .
T Consensus        13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   87 (299)
T 3m2w_A           13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGR   87 (299)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence            3455678888 6799999999999965 5789999999953     24677899888 55699999999999887    6


Q ss_pred             CeeEEEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC---CCCEEEEcc
Q 039516           93 EERLLVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD---QLNTKISDF  152 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~---~~~~kl~Df  152 (345)
                      ...++||||+++++|.+++.                 +++.+|.|||..   ||+||||||+||+++.   ++.+||+||
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            67899999999999987764                 556677777765   8999999999999998   788999999


Q ss_pred             ccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcC
Q 039516          153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEG  232 (345)
Q Consensus       153 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (345)
                      |++....                        +..++.++|||||||++|+|++|+.||.........           ..
T Consensus       165 g~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~  209 (299)
T 3m2w_A          165 GFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PG  209 (299)
T ss_dssp             TTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CC
T ss_pred             ccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HH
Confidence            9987541                        244678999999999999999999999764321100           00


Q ss_pred             CccccccccCCCCCCh----hHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          233 KDLELIDLTLDGSCPP----NEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       233 ~~~~~~d~~l~~~~~~----~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ....+......  .+.    ..... .+++..||+.||.+|||+.
T Consensus       210 ~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~  252 (299)
T 3m2w_A          210 MKTRIRMGQYE--FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT  252 (299)
T ss_dssp             SCCSSCTTCCS--SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHhhcccc--CCchhcccCCHHHHHHHHHHcccChhhCCCHH
Confidence            00001000000  111    11122 6899999999999999954

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2e-34  Score=267.10  Aligned_cols=177  Identities=15%  Similarity=0.077  Sum_probs=146.4

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCC--------ccCHHHHHHHHHHHHhcC---------CCCeeeE
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTS--------GQGRVEFQNEAKLIAKLQ---------YTNLVKL   85 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~~   85 (345)
                      ..+|.+.++||+|+||.||+|.. +|+.||||++....        ......+.+|+.+++.++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35689999999999999999987 68999999997542        234578999999999886         8888888


Q ss_pred             EEEEE------------------------------ECCeeEEEEecCCCCChHHHH--------------HhHHHHHHHH
Q 039516           86 LGCSI------------------------------HGEERLLVYEFMPNKSLDSSF--------------SGTFKDLLCL  121 (345)
Q Consensus        86 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l--------------~~~~~~l~~l  121 (345)
                      .+++.                              ..+..|+||||+++|++.+.+              .+++.+|.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence            88754                              267899999999998653322              2777888888


Q ss_pred             H-hcCCCceEEeccCCCCeeeCCCC--------------------CEEEEccccceeecCCCCCCcccceeecCCccccc
Q 039516          122 H-KYSRLRVIHRDLKASNILLDDQL--------------------NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE  180 (345)
Q Consensus       122 h-~~~~~~ivHrdlk~~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE  180 (345)
                      | ..   ||+||||||+|||++.++                    .+||+|||+++....       ....||+.|+|||
T Consensus       178 H~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE  247 (336)
T 2vuw_A          178 EASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED  247 (336)
T ss_dssp             HHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred             HHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence            8 55   799999999999999887                    899999999987642       2358999999999


Q ss_pred             hhccCCcCcccchhhHHHH-HHHHHhCCCCCC
Q 039516          181 YTMSGTVSIKTDVFGFGVL-VLKIVCGKKNNK  211 (345)
Q Consensus       181 ~~~~~~~~~~~Di~SlG~i-l~el~tg~~p~~  211 (345)
                      ++.+.. +.++||||+|++ .+++++|..||.
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence            998766 899999998776 777888988874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=2.3e-31  Score=262.95  Aligned_cols=172  Identities=15%  Similarity=0.152  Sum_probs=118.0

Q ss_pred             eeccCCeEEEEE-EcCCCcEEEEEEeccCC----------ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEEE
Q 039516           32 QEQTRDRVILVG-KFPNEQEVAIKRLAWTS----------GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        32 lG~G~~g~vy~~-~~~~~~~VaiK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+.|++|.+..+ +.-.|+.||+|.+....          ....+.|.+|+++|+++ .|+||++++++++++...||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            566666655543 23358999999996542          22345799999999999 7999999999999999999999


Q ss_pred             ecCCCCChHHHHH------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          100 EFMPNKSLDSSFS------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       100 e~~~~gsL~~~l~------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      ||++|++|.+.+.            +++.+|.|+|..   |||||||||+|||++.+|.+||+|||+++......  ...
T Consensus       322 Eyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~  396 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWP  396 (569)
T ss_dssp             ECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCS
T ss_pred             ecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccc
Confidence            9999999988876            566677777765   89999999999999999999999999998764332  234


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKN  209 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p  209 (345)
                      ...+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus       397 ~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             cCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            45689999999998875 467789999999998877655433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.1e-27  Score=235.43  Aligned_cols=177  Identities=18%  Similarity=0.139  Sum_probs=137.5

Q ss_pred             EEEeeccCCeEEEEEEcCCCcEEEEEEeccCCcc--------CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           29 YIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQ--------GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      .+.||+|+||.||++.. .++.+++|+.......        ..+.+.+|++++++++||||+++..++...+..|+|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            45799999999999965 4789999987443211        13458999999999999999966666667888899999


Q ss_pred             cCCCCChHHHHH-------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC-----ccc
Q 039516          101 FMPNKSLDSSFS-------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA-----NTN  168 (345)
Q Consensus       101 ~~~~gsL~~~l~-------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-----~~~  168 (345)
                      |+++++|.+++.       +++.+|.|||..   +|+||||||+|||++.  .+||+|||+++.........     ...
T Consensus       420 ~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~  494 (540)
T 3en9_A          420 YINGKLAKDVIEDNLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKK  494 (540)
T ss_dssp             CCCSEEHHHHSTTCTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhh
Confidence            999999987653       677788888865   8999999999999999  99999999999864321111     123


Q ss_pred             ceeecCCccccchhcc--CCcCcccchhhHHHHHHHHHhCCCCCC
Q 039516          169 RIVGTYGYMSLEYTMS--GTVSIKTDVFGFGVLVLKIVCGKKNNK  211 (345)
Q Consensus       169 ~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~el~tg~~p~~  211 (345)
                      ...||+.|+|||++..  ..|+..+|+||..+-..+.+.++.+|.
T Consensus       495 ~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          495 AVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             hhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            5689999999999986  668888999999999998888877763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=2e-24  Score=195.23  Aligned_cols=147  Identities=15%  Similarity=0.075  Sum_probs=114.3

Q ss_pred             eeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCc------------------cCHHHHHHHHHHHHhcCCCCeeeEEE
Q 039516           26 WHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSG------------------QGRVEFQNEAKLIAKLQYTNLVKLLG   87 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~~~~   87 (345)
                      |.+.+.||+|+||.||+|...+|+.||||.++....                  .....+.+|+.++++++  | +++++
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~  168 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK  168 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred             EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence            445599999999999999887799999999964321                  12456899999999999  4 55556


Q ss_pred             EEEECCeeEEEEecCCCCChHH--------HHHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           88 CSIHGEERLLVYEFMPNKSLDS--------SFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        88 ~~~~~~~~~lv~e~~~~gsL~~--------~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      ++.. +..++||||+++++|.+        ++.+++.++.+||..   ||+||||||+|||++ ++.+||+|||++..  
T Consensus       169 ~~~~-~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG~a~~--  241 (282)
T 1zar_A          169 VYAW-EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE--  241 (282)
T ss_dssp             EEEE-ETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCTTCEE--
T ss_pred             EEec-cceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECCCCeE--
Confidence            5433 55699999999999875        234777888888865   899999999999999 99999999999864  


Q ss_pred             CCCCCCcccceeecCCccccchhcc----------CCcCcccchhh
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTMS----------GTVSIKTDVFG  195 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Di~S  195 (345)
                                   +..+.|||++..          ..++..+|+|.
T Consensus       242 -------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          242 -------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             -------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence                         334688998754          33455566664

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=2e-19  Score=160.26  Aligned_cols=125  Identities=15%  Similarity=0.173  Sum_probs=94.6

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcE--EEEEEeccCCccC------------------------HHHHHHHHHHHHhcC
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQE--VAIKRLAWTSGQG------------------------RVEFQNEAKLIAKLQ   78 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~--VaiK~~~~~~~~~------------------------~~~~~~E~~~l~~l~   78 (345)
                      |.+...||+|+||.||+|.. .+|+.  ||||+++......                        ...+.+|+.+|.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999987 67889  9999975432110                        136789999999998


Q ss_pred             CCCe--eeEEEEEEECCeeEEEEecCCC-C----ChHHH------------HHhHHHHHHHHHhcCCCceEEeccCCCCe
Q 039516           79 YTNL--VKLLGCSIHGEERLLVYEFMPN-K----SLDSS------------FSGTFKDLLCLHKYSRLRVIHRDLKASNI  139 (345)
Q Consensus        79 H~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Ni  139 (345)
                      |+|+  +.++++    ...++||||+.+ |    +|.+.            +.+++.++.+||.  +.||+||||||+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp~NI  202 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQ--EAELVHADLSEYNI  202 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCSTTSE
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHE
Confidence            8754  444443    356899999942 3    55443            2356667777772  33899999999999


Q ss_pred             eeCCCCCEEEEccccceee
Q 039516          140 LLDDQLNTKISDFGMARIF  158 (345)
Q Consensus       140 ll~~~~~~kl~Dfgl~~~~  158 (345)
                      |++.  .++|+|||++...
T Consensus       203 Ll~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          203 MYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EESS--SEEECCCTTCEET
T ss_pred             EEcC--cEEEEECcccccC
Confidence            9998  8999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.69  E-value=7.6e-18  Score=157.10  Aligned_cols=126  Identities=13%  Similarity=0.116  Sum_probs=91.9

Q ss_pred             CeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCc--------------cCHH--------HHHHHHHHHHhcCCCCe
Q 039516           25 DWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSG--------------QGRV--------EFQNEAKLIAKLQYTNL   82 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~H~ni   82 (345)
                      -|.+..+||+|++|.||+|...+|+.||||+++....              ....        ...+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3889999999999999999988999999998754210              0111        12356777777755444


Q ss_pred             e--eEEEEEEECCeeEEEEecCCCCChHHH---------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC------
Q 039516           83 V--KLLGCSIHGEERLLVYEFMPNKSLDSS---------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL------  145 (345)
Q Consensus        83 v--~~~~~~~~~~~~~lv~e~~~~gsL~~~---------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~------  145 (345)
                      .  ..+++  .  ..+|||||++|++|.++         +.+++.++.+||..   |||||||||.|||+++++      
T Consensus       176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d~~  248 (397)
T 4gyi_A          176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAEDPS  248 (397)
T ss_dssp             SCCCEEEE--E--TTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSCTT
T ss_pred             CCCeeeec--c--CceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCccccc
Confidence            2  33322  2  23799999998877543         34667777777764   899999999999998776      


Q ss_pred             ----CEEEEcccccee
Q 039516          146 ----NTKISDFGMARI  157 (345)
Q Consensus       146 ----~~kl~Dfgl~~~  157 (345)
                          .+.|+||+-+..
T Consensus       249 ~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          249 SITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SEEEEEEECCCTTCEE
T ss_pred             ccccceEEEEeCCccc
Confidence                389999997764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.42  E-value=1.1e-12  Score=116.30  Aligned_cols=132  Identities=14%  Similarity=0.075  Sum_probs=106.0

Q ss_pred             CeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEEEecCC
Q 039516           25 DWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      +|.+...+|.|+++.||+.... ++.+++|............+.+|+.+++.+. +.++.++++++...+..|+||||++
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~   93 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD   93 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred             cceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence            4778888899999999999764 7899999986532122346889999999984 6788899999999899999999999


Q ss_pred             CCChHHH----------HHhHHHHHHHHHhcC------------------------------------------------
Q 039516          104 NKSLDSS----------FSGTFKDLLCLHKYS------------------------------------------------  125 (345)
Q Consensus       104 ~gsL~~~----------l~~~~~~l~~lh~~~------------------------------------------------  125 (345)
                      |.+|.+.          ...+++.+..||...                                                
T Consensus        94 G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  173 (263)
T 3tm0_A           94 GVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF  173 (263)
T ss_dssp             SEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHH
T ss_pred             CeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHH
Confidence            9988663          346777888888821                                                


Q ss_pred             --------CCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          126 --------RLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       126 --------~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                              ...++|+|+++.||++++...+.|+||+.+..
T Consensus       174 l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                    14699999999999998766667999987754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.42  E-value=6e-13  Score=117.49  Aligned_cols=135  Identities=18%  Similarity=0.140  Sum_probs=102.3

Q ss_pred             ccCCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCC--eeeEEEEEEECCeeEE
Q 039516           20 ENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTN--LVKLLGCSIHGEERLL   97 (345)
Q Consensus        20 ~~~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~~~~~~~~~~~~~l   97 (345)
                      .....++.+....++|..+.||+....+|..+++|.....   ....+..|+.+++.+.+.+  +.+++++...++..++
T Consensus        16 ~~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~   92 (264)
T 1nd4_A           16 VERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   92 (264)
T ss_dssp             TTTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             HHhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence            3334456665444566679999998777888999997543   2245788999999985444  5678998887778999


Q ss_pred             EEecCCCCChH-------HHHHhHHHHHHHHHhcC---------------------------------------------
Q 039516           98 VYEFMPNKSLD-------SSFSGTFKDLLCLHKYS---------------------------------------------  125 (345)
Q Consensus        98 v~e~~~~gsL~-------~~l~~~~~~l~~lh~~~---------------------------------------------  125 (345)
                      ||||++|.+|.       .....++..+..||...                                             
T Consensus        93 v~e~i~G~~l~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A           93 LLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             EEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             EEEecCCcccCcCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence            99999998885       44556777777777643                                             


Q ss_pred             ----------CCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          126 ----------RLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       126 ----------~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                                ..+++|+|++|.||++++++.+.|+|||.+..
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                      12399999999999998776678999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.09  E-value=4e-10  Score=104.55  Aligned_cols=130  Identities=11%  Similarity=0.166  Sum_probs=96.6

Q ss_pred             eeEEEeeccCCeEEEEEEcCCCcEEEEEEec--cCC-ccCHHHHHHHHHHHHhcC--CCCeeeEEEEEEEC---CeeEEE
Q 039516           27 HMYIQQEQTRDRVILVGKFPNEQEVAIKRLA--WTS-GQGRVEFQNEAKLIAKLQ--YTNLVKLLGCSIHG---EERLLV   98 (345)
Q Consensus        27 ~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~---~~~~lv   98 (345)
                      ....+|+.|.++.||+.... +..+++|+..  ... ......+.+|+.+++.+.  +..+++++.++.+.   +..|+|
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            35677999999999999875 4678888875  332 122346888999999996  45688999988766   347999


Q ss_pred             EecCCCCChH-------------HHHHhHHHHHHHHHhcC----------------------------------------
Q 039516           99 YEFMPNKSLD-------------SSFSGTFKDLLCLHKYS----------------------------------------  125 (345)
Q Consensus        99 ~e~~~~gsL~-------------~~l~~~~~~l~~lh~~~----------------------------------------  125 (345)
                      |||++|.++.             .....+...|..||...                                        
T Consensus       120 me~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (359)
T 3dxp_A          120 MEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS  199 (359)
T ss_dssp             EECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred             EEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence            9999998773             12456777888888731                                        


Q ss_pred             ---------------CCceEEeccCCCCeeeCCCCC--EEEEcccccee
Q 039516          126 ---------------RLRVIHRDLKASNILLDDQLN--TKISDFGMARI  157 (345)
Q Consensus       126 ---------------~~~ivHrdlk~~Nill~~~~~--~kl~Dfgl~~~  157 (345)
                                     ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                           257999999999999987753  68999998875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.85  E-value=2.2e-09  Score=97.19  Aligned_cols=174  Identities=16%  Similarity=0.175  Sum_probs=108.2

Q ss_pred             EEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCC--eeeEEEEEEECC---eeEEEEecC
Q 039516           29 YIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTN--LVKLLGCSIHGE---ERLLVYEFM  102 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~n--iv~~~~~~~~~~---~~~lv~e~~  102 (345)
                      ...++.|.+..||+..    ..+++|.....  .....+.+|+.+|+.+ .+..  +.+++......+   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3458999999999853    56889986422  3356788999999888 3333  455555543333   348999999


Q ss_pred             CCCChHHH-------------HHhHHHHHHHHHhc---------------------------------------------
Q 039516          103 PNKSLDSS-------------FSGTFKDLLCLHKY---------------------------------------------  124 (345)
Q Consensus       103 ~~gsL~~~-------------l~~~~~~l~~lh~~---------------------------------------------  124 (345)
                      +|.+|.+.             ..+++..+..||..                                             
T Consensus        99 ~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  178 (304)
T 3sg8_A           99 KGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR  178 (304)
T ss_dssp             CCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred             CCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence            99887542             23455555555541                                             


Q ss_pred             ----------CCCceEEeccCCCCeeeCC--CCCEEEEccccceeecCCCC----CCc---c-----cceeecCCccc-c
Q 039516          125 ----------SRLRVIHRDLKASNILLDD--QLNTKISDFGMARIFGVNES----GAN---T-----NRIVGTYGYMS-L  179 (345)
Q Consensus       125 ----------~~~~ivHrdlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~----~~~---~-----~~~~gt~~y~a-P  179 (345)
                                ....++|+|+++.||+++.  ...+.|+||+.+..-.....    ...   .     ..+....+... |
T Consensus       179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~  258 (304)
T 3sg8_A          179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIP  258 (304)
T ss_dssp             HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHH
T ss_pred             HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcH
Confidence                      1135899999999999988  45678999998875321000    000   0     00000001111 2


Q ss_pred             chhccCCcCcccchhhHHHHHHHHHhCCCCC
Q 039516          180 EYTMSGTVSIKTDVFGFGVLVLKIVCGKKNN  210 (345)
Q Consensus       180 E~~~~~~~~~~~Di~SlG~il~el~tg~~p~  210 (345)
                      +....  .....+.|++|.++|.+.+|..+|
T Consensus       259 ~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          259 TVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            22111  122358999999999999998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.51  E-value=8.4e-07  Score=80.34  Aligned_cols=124  Identities=20%  Similarity=0.167  Sum_probs=87.5

Q ss_pred             EEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCC---CeeeEEEEEE-ECCeeEEEEecCCC
Q 039516           29 YIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYT---NLVKLLGCSI-HGEERLLVYEFMPN  104 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~~~~~~~-~~~~~~lv~e~~~~  104 (345)
                      ...++.|....||+.    |..+++|...  .......+..|+++|+.+.+.   .+.+++.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            455889999999987    5678888853  223356789999999999652   3667777764 34557899999999


Q ss_pred             CChHHH-------------HHhHHHHHHHHHhc-----------------------------------------------
Q 039516          105 KSLDSS-------------FSGTFKDLLCLHKY-----------------------------------------------  124 (345)
Q Consensus       105 gsL~~~-------------l~~~~~~l~~lh~~-----------------------------------------------  124 (345)
                      .++.+.             ..++...|..||..                                               
T Consensus        98 ~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  177 (306)
T 3tdw_A           98 QILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ  177 (306)
T ss_dssp             EECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred             eECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence            887642             12233333333322                                               


Q ss_pred             ----------CCCceEEeccCCCCeeeCC---CCC-EEEEccccceee
Q 039516          125 ----------SRLRVIHRDLKASNILLDD---QLN-TKISDFGMARIF  158 (345)
Q Consensus       125 ----------~~~~ivHrdlk~~Nill~~---~~~-~kl~Dfgl~~~~  158 (345)
                                ....++|+|+++.||+++.   ++. +.|+||+.+..-
T Consensus       178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                      2335799999999999987   455 589999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.46  E-value=2.7e-06  Score=75.19  Aligned_cols=123  Identities=17%  Similarity=0.116  Sum_probs=87.8

Q ss_pred             eeccCCe-EEEEEEcC-CCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEEEecCCCCChH
Q 039516           32 QEQTRDR-VILVGKFP-NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLVYEFMPNKSLD  108 (345)
Q Consensus        32 lG~G~~g-~vy~~~~~-~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~gsL~  108 (345)
                      +..|..| .||+.... ++..+.+|.-...   ....+..|...|+.+. +--+.++++++.+.+..++|||+++|.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            4555554 68887654 4678999987533   2456888999998884 334778899999999999999999998775


Q ss_pred             HHHH-----------hHHHHHHHHHhc-----------------------------------------------------
Q 039516          109 SSFS-----------GTFKDLLCLHKY-----------------------------------------------------  124 (345)
Q Consensus       109 ~~l~-----------~~~~~l~~lh~~-----------------------------------------------------  124 (345)
                      +...           .+...+..||..                                                     
T Consensus       109 ~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  188 (272)
T 4gkh_A          109 QVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLP  188 (272)
T ss_dssp             HHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCC
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhccc
Confidence            4321           223333333321                                                     


Q ss_pred             --CCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          125 --SRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       125 --~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                        ....++|+|+.+.|||++..+.+-|+||+.+..
T Consensus       189 ~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          189 FSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence              111379999999999999877778999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.36  E-value=2.1e-06  Score=80.45  Aligned_cols=76  Identities=8%  Similarity=-0.054  Sum_probs=51.7

Q ss_pred             eEEEeeccCCeEEEEEEcC-CCcEEEEEEeccCCc-------cCHHHHHHHHHHHHhcCC--C-CeeeEEEEEEECCeeE
Q 039516           28 MYIQQEQTRDRVILVGKFP-NEQEVAIKRLAWTSG-------QGRVEFQNEAKLIAKLQY--T-NLVKLLGCSIHGEERL   96 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~-~~~~VaiK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~-niv~~~~~~~~~~~~~   96 (345)
                      ....||.|..+.||++... +++.|+||.......       .....+..|.++++.+..  + .+.+++.+  +.+..+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            3567999999999999754 468999998643211       123456789999988742  3 45566654  455678


Q ss_pred             EEEecCCCC
Q 039516           97 LVYEFMPNK  105 (345)
Q Consensus        97 lv~e~~~~g  105 (345)
                      +||||+++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.34  E-value=5.5e-07  Score=83.12  Aligned_cols=81  Identities=4%  Similarity=-0.002  Sum_probs=56.3

Q ss_pred             eEEEe-eccCCeEEEEEEcC-------CCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcC-C--CCeeeEEEEEEEC-
Q 039516           28 MYIQQ-EQTRDRVILVGKFP-------NEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQ-Y--TNLVKLLGCSIHG-   92 (345)
Q Consensus        28 ~~~~l-G~G~~g~vy~~~~~-------~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~~~~~~~~~-   92 (345)
                      ....| +.|....+|+....       ++..+++|......   ......+.+|+.+++.+. +  -.+.+++.++.+. 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            34567 88888999987654       26788999865432   101245778999988884 2  3577888887654 


Q ss_pred             --CeeEEEEecCCCCChH
Q 039516           93 --EERLLVYEFMPNKSLD  108 (345)
Q Consensus        93 --~~~~lv~e~~~~gsL~  108 (345)
                        +..++||||++|.++.
T Consensus       104 ~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTSSCEEEEECCCCBCCC
T ss_pred             ccCCceEEEEecCCCChh
Confidence              3568999999986643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.28  E-value=5.5e-06  Score=75.54  Aligned_cols=75  Identities=15%  Similarity=0.125  Sum_probs=44.5

Q ss_pred             eEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC--CCCeeeEEE------EEEECCeeEEEE
Q 039516           28 MYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ--YTNLVKLLG------CSIHGEERLLVY   99 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~~~~------~~~~~~~~~lv~   99 (345)
                      ....|+.|..+.||+....+| .+++|.....    ...+..|..++..|.  .-.+.+++.      +....+..+++|
T Consensus        36 ~~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~  110 (346)
T 2q83_A           36 KIDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY  110 (346)
T ss_dssp             EEEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred             EeeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence            455677778899999877544 5899998642    234445666665553  112333332      123467789999


Q ss_pred             ecCCCCCh
Q 039516          100 EFMPNKSL  107 (345)
Q Consensus       100 e~~~~gsL  107 (345)
                      +|++|.++
T Consensus       111 ~~i~G~~~  118 (346)
T 2q83_A          111 DWIEGRPF  118 (346)
T ss_dssp             ECCCCBCC
T ss_pred             EeecCccC
Confidence            99998643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.24  E-value=1.5e-05  Score=72.24  Aligned_cols=77  Identities=18%  Similarity=0.072  Sum_probs=62.1

Q ss_pred             eeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC---CCCeeeEEEEEEECCeeEEEEecCC
Q 039516           27 HMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ---YTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        27 ~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      .....|+.|....+|+... ++..+++|.....   ....+..|+..|+.|.   ...++++++++...+..++||||++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3456799999999999886 4778899987532   3567889999998883   3678899999888888999999999


Q ss_pred             CCCh
Q 039516          104 NKSL  107 (345)
Q Consensus       104 ~gsL  107 (345)
                      +..+
T Consensus       115 G~~~  118 (312)
T 3jr1_A          115 KSKN  118 (312)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            8764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.24  E-value=4.1e-06  Score=74.91  Aligned_cols=78  Identities=13%  Similarity=0.118  Sum_probs=58.6

Q ss_pred             eeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCC---CCeeeEEEEEEECCeeEEEEecC
Q 039516           26 WHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY---TNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ..-...+|.|..+.||+.+..+|+.|.+|+...........|..|+..|+.|.-   --+++++++.    ..++||||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l   92 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence            455677999999999999999999999998765544444568899999998842   2355666542    237899999


Q ss_pred             CCCCh
Q 039516          103 PNKSL  107 (345)
Q Consensus       103 ~~gsL  107 (345)
                      +++..
T Consensus        93 ~~~~~   97 (288)
T 3f7w_A           93 DERPP   97 (288)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            87654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=98.02  E-value=2.2e-05  Score=71.15  Aligned_cols=145  Identities=14%  Similarity=0.048  Sum_probs=85.0

Q ss_pred             eeecccccccccCCC-CeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCC--eeeEE
Q 039516           10 QTWSEGAKFVENSSL-DWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTN--LVKLL   86 (345)
Q Consensus        10 ~s~~~~~~~~~~~~~-~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~~~   86 (345)
                      ++.+++..+...+.. .......|+.|....+|+....+| .+++|......  ....+..|+.++..|...+  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            455566666655433 233456688898899999877655 68899886521  1234556777777763212  33333


Q ss_pred             EE------EEECCeeEEEEecCCCCChH----HHHHhHHHH---------------------------------------
Q 039516           87 GC------SIHGEERLLVYEFMPNKSLD----SSFSGTFKD---------------------------------------  117 (345)
Q Consensus        87 ~~------~~~~~~~~lv~e~~~~gsL~----~~l~~~~~~---------------------------------------  117 (345)
                      ..      ....+..+++|+|++|..+.    .....+.+.                                       
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      12346679999999986542    111111111                                       


Q ss_pred             ----------HHHHHhc----CCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          118 ----------LLCLHKY----SRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       118 ----------l~~lh~~----~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                                +..+...    ...+++|+|+.+.|||+++++.+.|+||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                      1122211    134699999999999998876668999987753

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.01  E-value=4e-05  Score=72.38  Aligned_cols=74  Identities=9%  Similarity=0.076  Sum_probs=47.6

Q ss_pred             eEEEeeccCCeEEEEEEcCCCcEEEEEEeccC-----C--c--cCHHHHHHHHHHHH-hcCCCCeeeEEEEEEECCeeEE
Q 039516           28 MYIQQEQTRDRVILVGKFPNEQEVAIKRLAWT-----S--G--QGRVEFQNEAKLIA-KLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~-----~--~--~~~~~~~~E~~~l~-~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      ....||.|..+.||+... +++.++||.....     .  .  .....+..|+..+. ......+.+++.+.  .+..++
T Consensus        38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            456699999999999865 4788999943221     1  1  12334444443332 22335677777765  567799


Q ss_pred             EEecC-CC
Q 039516           98 VYEFM-PN  104 (345)
Q Consensus        98 v~e~~-~~  104 (345)
                      ||||+ ++
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 76

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.87  E-value=5.3e-05  Score=68.73  Aligned_cols=125  Identities=11%  Similarity=0.081  Sum_probs=79.4

Q ss_pred             EEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCC--CeeeEEEE-----EEECCeeEEEEec
Q 039516           29 YIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYT--NLVKLLGC-----SIHGEERLLVYEF  101 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~~~~~-----~~~~~~~~lv~e~  101 (345)
                      ...++ |....||+....+|+.+++|...... .....+..|..++..+...  .+++++..     ....+..+++|+|
T Consensus        31 ~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             CEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             EEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            34567 78888998877677789999986432 2355677888888877421  23444432     2235567899999


Q ss_pred             CCCCChH----HHHHhHHHH-----------------------------------------------------HHHHHhc
Q 039516          102 MPNKSLD----SSFSGTFKD-----------------------------------------------------LLCLHKY  124 (345)
Q Consensus       102 ~~~gsL~----~~l~~~~~~-----------------------------------------------------l~~lh~~  124 (345)
                      ++|.++.    +.+..+...                                                     +..+...
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9885432    111100000                                                     1111111


Q ss_pred             ----CCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          125 ----SRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       125 ----~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                          ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                234689999999999999 4 899999987754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.69  E-value=9.8e-05  Score=69.94  Aligned_cols=74  Identities=12%  Similarity=0.164  Sum_probs=51.7

Q ss_pred             eEEEeeccCCeEEEEEEcCC--------CcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCC-eeeEEEEEEECCeeEEE
Q 039516           28 MYIQQEQTRDRVILVGKFPN--------EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTN-LVKLLGCSIHGEERLLV   98 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~~--------~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~~~~lv   98 (345)
                      ....|++|....+|+....+        +..+++|+....  .....+..|..+++.|...+ ..++++.+.  +  .+|
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v  150 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL  150 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEE
Confidence            45668899999999998653        578999998431  12256678999998884333 367777653  2  389


Q ss_pred             EecCCCCCh
Q 039516           99 YEFMPNKSL  107 (345)
Q Consensus        99 ~e~~~~gsL  107 (345)
                      |||++|.+|
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999986443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.67  E-value=0.00011  Score=68.50  Aligned_cols=124  Identities=18%  Similarity=0.197  Sum_probs=77.6

Q ss_pred             EEEeeccCCeEEEEEEcC--------CCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEEE
Q 039516           29 YIQQEQTRDRVILVGKFP--------NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~--------~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~   99 (345)
                      +.+|..|-...+|+....        +++.+.+|+.... ......+.+|..+++.|. +.-..++++++.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            355888888899998874        2578999986332 234567789999998884 3334667766532    3999


Q ss_pred             ecCCCCChHH-------HHHhHHHHHHHHHh-------------------------------------------------
Q 039516          100 EFMPNKSLDS-------SFSGTFKDLLCLHK-------------------------------------------------  123 (345)
Q Consensus       100 e~~~~gsL~~-------~l~~~~~~l~~lh~-------------------------------------------------  123 (345)
                      ||++|.+|..       ....+++.|..||.                                                 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            9998865421       11111121111111                                                 


Q ss_pred             -------cCCCceEEeccCCCCeeeCCC----CCEEEEcccccee
Q 039516          124 -------YSRLRVIHRDLKASNILLDDQ----LNTKISDFGMARI  157 (345)
Q Consensus       124 -------~~~~~ivHrdlk~~Nill~~~----~~~kl~Dfgl~~~  157 (345)
                             .....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                   112358999999999999876    6899999998865

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.65  E-value=0.00046  Score=65.81  Aligned_cols=75  Identities=15%  Similarity=0.099  Sum_probs=49.6

Q ss_pred             eEEEeeccCCeEEEEEEcCC-CcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCe-eeEEEEEEECCeeEEEEecCCCC
Q 039516           28 MYIQQEQTRDRVILVGKFPN-EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNL-VKLLGCSIHGEERLLVYEFMPNK  105 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~~-~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~g  105 (345)
                      .+..|+.|-...+|+....+ +..+++|+....... ......|..+++.|...++ .++++++.  +  .+||||++|.
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            45668999999999998764 478999987543221 1123589999998865444 57777762  2  3599999875


Q ss_pred             Ch
Q 039516          106 SL  107 (345)
Q Consensus       106 sL  107 (345)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            43

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.60  E-value=0.00011  Score=66.05  Aligned_cols=120  Identities=13%  Similarity=0.152  Sum_probs=79.4

Q ss_pred             EEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCe-eeEEEEEEECCeeEEEEecC-CCCC
Q 039516           29 YIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNL-VKLLGCSIHGEERLLVYEFM-PNKS  106 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~-~~gs  106 (345)
                      ...|++|....+|+.     ..+++|+....... .....+|+.+++.+...++ .+++++  ..+.-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            667999999999998     56888987543211 1123568888877742222 466654  344457999999 6665


Q ss_pred             hHH--------HHHhHHHHHHHHHhcC--------------------------------------------------CCc
Q 039516          107 LDS--------SFSGTFKDLLCLHKYS--------------------------------------------------RLR  128 (345)
Q Consensus       107 L~~--------~l~~~~~~l~~lh~~~--------------------------------------------------~~~  128 (345)
                      +..        ....+++.|.-||...                                                  ...
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            532        2344555555555431                                                  124


Q ss_pred             eEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          129 VIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       129 ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      ++|+|+.+.||+ ..++.+.++||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5566789999988765

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.56  E-value=0.00054  Score=62.25  Aligned_cols=124  Identities=16%  Similarity=0.151  Sum_probs=70.6

Q ss_pred             EEeeccCCeE-EEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCC--CCeeeEEEEEEECCeeEEEEecCCCCC
Q 039516           30 IQQEQTRDRV-ILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY--TNLVKLLGCSIHGEERLLVYEFMPNKS  106 (345)
Q Consensus        30 ~~lG~G~~g~-vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~~~~~~~~~~~~~lv~e~~~~gs  106 (345)
                      ..|++|+... +|+....+|..+++|.......   ..+..|+.++..+..  -.+.+++.+....  -+++||++.+.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence            3466665554 7777654477788887543321   233456777766632  3456777764333  378999997765


Q ss_pred             hHHHH-----------HhHHHHHHHHHh----------------------------------------------------
Q 039516          107 LDSSF-----------SGTFKDLLCLHK----------------------------------------------------  123 (345)
Q Consensus       107 L~~~l-----------~~~~~~l~~lh~----------------------------------------------------  123 (345)
                      +.+.+           ..+...|..||.                                                    
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            53221           111111111111                                                    


Q ss_pred             -cCCCceEEeccCCCCeeeCCC----CCEEEEccccceee
Q 039516          124 -YSRLRVIHRDLKASNILLDDQ----LNTKISDFGMARIF  158 (345)
Q Consensus       124 -~~~~~ivHrdlk~~Nill~~~----~~~kl~Dfgl~~~~  158 (345)
                       .....++|+|+.+.||+++.+    +.+.|+||+.+..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence             123479999999999999874    67999999988653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.52  E-value=0.0002  Score=66.20  Aligned_cols=75  Identities=9%  Similarity=-0.007  Sum_probs=46.4

Q ss_pred             eEEEeeccCCeEEEEEEcCC---------CcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCC-eeeEEEEEEECCeeEE
Q 039516           28 MYIQQEQTRDRVILVGKFPN---------EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTN-LVKLLGCSIHGEERLL   97 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~~---------~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~~~~l   97 (345)
                      ....|+.|....+|+....+         +..+++|+....... ......|..+++.+...+ +.++++..  .  -++
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~  111 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR  111 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence            35568889889999987653         268899987543221 112467888888874333 45677654  2  378


Q ss_pred             EEecCCCCCh
Q 039516           98 VYEFMPNKSL  107 (345)
Q Consensus        98 v~e~~~~gsL  107 (345)
                      ||||++|.++
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999988543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.38  E-value=0.00092  Score=61.08  Aligned_cols=72  Identities=8%  Similarity=0.019  Sum_probs=45.7

Q ss_pred             EEEeec--cCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC---CCCeeeEEEE------EEECCeeEE
Q 039516           29 YIQQEQ--TRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ---YTNLVKLLGC------SIHGEERLL   97 (345)
Q Consensus        29 ~~~lG~--G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~------~~~~~~~~l   97 (345)
                      ...+..  |....||+....+| .+++|+......      ..|+.++..|.   -|++++++..      ....+..++
T Consensus        26 ~~~l~~G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~   98 (339)
T 3i1a_A           26 AQFIQGGADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKII   98 (339)
T ss_dssp             EEEETTTSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEE
T ss_pred             eEEeeccCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEE
Confidence            444533  33678999987767 899998765431      35666666652   1224455432      233567899


Q ss_pred             EEecCCCCCh
Q 039516           98 VYEFMPNKSL  107 (345)
Q Consensus        98 v~e~~~~gsL  107 (345)
                      +|+|++|..+
T Consensus        99 l~~~i~G~~~  108 (339)
T 3i1a_A           99 AYPFIHAPNG  108 (339)
T ss_dssp             EEECCCCCBT
T ss_pred             EEeccCCCcC
Confidence            9999998755

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.79  E-value=0.0024  Score=60.17  Aligned_cols=75  Identities=12%  Similarity=0.040  Sum_probs=50.2

Q ss_pred             eEEEeeccCCeEEEEEEcCC--------CcEEEEEEeccCCccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEE
Q 039516           28 MYIQQEQTRDRVILVGKFPN--------EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~~--------~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv   98 (345)
                      .+.++..|-...+|+....+        +..+++|+...... ......+|..+++.+. +.-..++++.+  .  -++|
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I  148 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRI  148 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence            45668888889999987653        58899999754322 1223457888888884 33345666543  2  2789


Q ss_pred             EecCCCCCh
Q 039516           99 YEFMPNKSL  107 (345)
Q Consensus        99 ~e~~~~gsL  107 (345)
                      |||++|.+|
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999988653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.96  E-value=0.19  Score=46.73  Aligned_cols=30  Identities=27%  Similarity=0.416  Sum_probs=25.5

Q ss_pred             ceEEeccCCCCeee------CCCCCEEEEcccccee
Q 039516          128 RVIHRDLKASNILL------DDQLNTKISDFGMARI  157 (345)
Q Consensus       128 ~ivHrdlk~~Nill------~~~~~~kl~Dfgl~~~  157 (345)
                      .++|+|+.+.|||+      +++..+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567799999998875

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=88.59  E-value=0.025  Score=53.81  Aligned_cols=59  Identities=12%  Similarity=-0.008  Sum_probs=17.1

Q ss_pred             EEeeccCCeEEEEEEcCC-CcEEEE------EEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE
Q 039516           30 IQQEQTRDRVILVGKFPN-EQEVAI------KRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH   91 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~~-~~~Vai------K~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~   91 (345)
                      ++||   ||.||+|.+.. ..+||+      |..+..  ..+....|.+|..++..++|||+++.+++-..
T Consensus       148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            3466   99999998853 468899      766542  23344578899999999999999999887653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	345
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-36
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-36
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-34
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-32
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-32
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-31
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-31
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-31
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-31
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-31
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-31
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-30
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-30
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-30
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-29
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-29
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-29
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-29
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-29
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-28
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-28
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-28
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-28
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-27
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-27
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-27
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-27
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-27
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-26
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-26
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-26
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-25
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-25
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-24
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-24
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-23
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-23
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-23
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-23
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-23
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-23
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-22
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-22
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-22
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-21
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-20
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-20
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-20
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-20
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-20
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-19
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-18
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-18
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-17
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-16
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-16
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-15
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-15
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-15
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-15
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-13
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-11
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-11

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 5e-36
 Identities = 46/239 (19%), Positives = 96/239 (40%), Gaps = 25/239 (10%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           GK+  +  V +  +   + Q    F+NE  ++ K ++ N++  +G S   +   +V ++ 
Sbjct: 27  GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWC 85

Query: 103 PNKSLDS---SFSGTFKD----------LLCLHKYSRLRVIHRDLKASNILLDDQLNTKI 149
              SL          F+              +       +IHRDLK++NI L + L  KI
Sbjct: 86  EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI 145

Query: 150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM---SGTVSIKTDVFGFGVLVLKIVCG 206
            DFG+A +           ++ G+  +M+ E          S ++DV+ FG+++ +++ G
Sbjct: 146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205

Query: 207 KKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQ 265
           +    +      +N       +   G     +   +  +CP      +   C+ K + +
Sbjct: 206 QLPYSN------INNRDQIIFMVGRGYLSPDLS-KVRSNCPKAMKRLMA-ECLKKKRDE 256

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 8e-36
 Identities = 42/186 (22%), Positives = 75/186 (40%), Gaps = 22/186 (11%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQG-RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
            V  V   P+   +A K +        R +   E +++ +     +V   G      E  
Sbjct: 21  VVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80

Query: 97  LVYEFMPNKSLDSS---------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILL 141
           +  E M   SLD                      K L  L    + +++HRD+K SNIL+
Sbjct: 81  ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILV 138

Query: 142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVL 201
           + +   K+ DFG++         +  N  VGT  YMS E       S+++D++  G+ ++
Sbjct: 139 NSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 194

Query: 202 KIVCGK 207
           ++  G+
Sbjct: 195 EMAVGR 200

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 6e-34
 Identities = 50/213 (23%), Positives = 86/213 (40%), Gaps = 17/213 (7%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G + N+ +VAIK +         +F  EA+++ KL +  LV+L G  +      LV+EFM
Sbjct: 24  GYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82

Query: 103 PNKSLDSSFSGTFKD-------------LLCLHKYSRLRVIHRDLKASNILLDDQLNTKI 149
            +  L                          +       VIHRDL A N L+ +    K+
Sbjct: 83  EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKV 142

Query: 150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKK 208
           SDFGM R    ++   ++        + S E       S K+DV+ FGVL+ ++   GK 
Sbjct: 143 SDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201

Query: 209 NNKSYHTERPLNLVGIAWQLWN-EGKDLELIDL 240
             ++      +  +   ++L+        +  +
Sbjct: 202 PYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 234

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 2e-32
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 23/183 (12%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G +    +VA+K L   S      F  EA L+ +LQ+  LV+L       E   ++ E+M
Sbjct: 32  GYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89

Query: 103 PNKSLDSS-----------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL 145
            N SL                     +   + +  + +      IHRDL+A+NIL+ D L
Sbjct: 90  ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTL 146

Query: 146 NTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC 205
           + KI+DFG+AR+   NE  A          + + E    GT +IK+DV+ FG+L+ +IV 
Sbjct: 147 SCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

Query: 206 GKK 208
             +
Sbjct: 206 HGR 208

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 7e-32
 Identities = 49/245 (20%), Positives = 93/245 (37%), Gaps = 29/245 (11%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEER- 95
              L+     +   A+K L   +  G V  F  E  ++    + N++ LLG  +  E   
Sbjct: 45  HGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 104

Query: 96  LLVYEFMPNKSLDSSFSGTFKDLLC-------------LHKYSRLRVIHRDLKASNILLD 142
           L+V  +M +  L +       +                +   +  + +HRDL A N +LD
Sbjct: 105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 164

Query: 143 DQLNTKISDFGMARIFGVNESGANTNR--IVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           ++   K++DFG+AR     E  +  N+        +M+LE   +   + K+DV+ FGVL+
Sbjct: 165 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 224

Query: 201 LKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVC 260
            +++              +N   I   L    +        L     P+    +++ C  
Sbjct: 225 WELMTRGA-----PPYPDVNTFDITVYLLQGRR-------LLQPEYCPDPLYEVMLKCWH 272

Query: 261 KSKQQ 265
              + 
Sbjct: 273 PKAEM 277

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 1e-31
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 17/180 (9%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           G +     VAIK L          F  EA+++ KL++  LV+L    +  E   +V E+M
Sbjct: 36  GTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYM 93

Query: 103 PNKSLDSSFSGTFKD--------------LLCLHKYSRLRVIHRDLKASNILLDDQLNTK 148
              SL     G                     +    R+  +HRDL+A+NIL+ + L  K
Sbjct: 94  SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCK 153

Query: 149 ISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++DFG+AR+   NE  A          + + E  + G  +IK+DV+ FG+L+ ++    +
Sbjct: 154 VADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 212

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-31
 Identities = 47/187 (25%), Positives = 78/187 (41%), Gaps = 20/187 (10%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
            V L      E+ VA+K +         E  + E  +   L + N+VK  G    G  + 
Sbjct: 20  EVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79

Query: 97  LVYEFMPNKSLDSS---------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILL 141
           L  E+     L                  F      ++ LH    + + HRD+K  N+LL
Sbjct: 80  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLL 136

Query: 142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLV 200
           D++ N KISDFG+A +F  N      N++ GT  Y++ E        +   DV+  G+++
Sbjct: 137 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 196

Query: 201 LKIVCGK 207
             ++ G+
Sbjct: 197 TAMLAGE 203

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 5e-31
 Identities = 48/196 (24%), Positives = 86/196 (43%), Gaps = 13/196 (6%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL 97
            V         QEVAI+++       +    NE  ++ + +  N+V  L   + G+E  +
Sbjct: 35  TVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94

Query: 98  VYEFMPNKSLDSSFSGTFKD-----------LLCLHKYSRLRVIHRDLKASNILLDDQLN 146
           V E++   SL    + T  D           L  L      +VIHRD+K+ NILL    +
Sbjct: 95  VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS 154

Query: 147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG 206
            K++DFG        +S    + +VGT  +M+ E         K D++  G++ ++++ G
Sbjct: 155 VKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Query: 207 KKNNKSYHTERPLNLV 222
           +    + +  R L L+
Sbjct: 213 EPPYLNENPLRALYLI 228

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 6e-31
 Identities = 45/185 (24%), Positives = 76/185 (41%), Gaps = 15/185 (8%)

Query: 38  RVILVGKFPNEQEVAIKRL---AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE 94
            V+L  +    +E AIK L                E  ++++L +   VKL       E+
Sbjct: 23  TVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 82

Query: 95  RLLVYEFMPNKSLDS--SFSGTFKD----------LLCLHKYSRLRVIHRDLKASNILLD 142
                 +  N  L       G+F +          +  L       +IHRDLK  NILL+
Sbjct: 83  LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN 142

Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
           + ++ +I+DFG A++       A  N  VGT  Y+S E     +    +D++  G ++ +
Sbjct: 143 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 202

Query: 203 IVCGK 207
           +V G 
Sbjct: 203 LVAGL 207

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 6e-31
 Identities = 40/188 (21%), Positives = 76/188 (40%), Gaps = 20/188 (10%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL 97
           +V            A K +   S +   ++  E  ++A   + N+VKLL    +     +
Sbjct: 27  KVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86

Query: 98  VYEFMPNKSLDSSFSGTFKDL-------------LCLHKYSRLRVIHRDLKASNILLDDQ 144
           + EF    ++D+      + L               L+     ++IHRDLKA NIL    
Sbjct: 87  LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD 146

Query: 145 LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGT-----VSIKTDVFGFGVL 199
            + K++DFG++       +    +  +GT  +M+ E  M  T        K DV+  G+ 
Sbjct: 147 GDIKLADFGVSAKN--TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGIT 204

Query: 200 VLKIVCGK 207
           ++++   +
Sbjct: 205 LIEMAEIE 212

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 7e-31
 Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 17/213 (7%)

Query: 43  GKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM 102
           GK+  + +VAIK +   S     EF  EAK++  L +  LV+L G         ++ E+M
Sbjct: 23  GKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81

Query: 103 PNKSLDSSFSGTFKDL-------------LCLHKYSRLRVIHRDLKASNILLDDQLNTKI 149
            N  L +                        +      + +HRDL A N L++DQ   K+
Sbjct: 82  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 141

Query: 150 SDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIV-CGKK 208
           SDFG++R   +++   ++        +   E  M    S K+D++ FGVL+ +I   GK 
Sbjct: 142 SDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 200

Query: 209 NNKSYHTERPLNLVGIAWQLW-NEGKDLELIDL 240
             + +        +    +L+       ++  +
Sbjct: 201 PYERFTNSETAEHIAQGLRLYRPHLASEKVYTI 233

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  115 bits (290), Expect = 2e-30
 Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 30/191 (15%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQG---RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE 94
            V       N + VAIK+++++  Q      +   E + + KL++ N ++  GC +    
Sbjct: 30  AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89

Query: 95  RLLVYEFMPNKSLDSS---------------FSGTFKDLLCLHKYSRLRVIHRDLKASNI 139
             LV E+    + D                   G  + L  LH      +IHRD+KA NI
Sbjct: 90  AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNI 146

Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS---GTVSIKTDVFGF 196
           LL +    K+ DFG A I       A  N  VGT  +M+ E  ++   G    K DV+  
Sbjct: 147 LLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200

Query: 197 GVLVLKIVCGK 207
           G+  +++   K
Sbjct: 201 GITCIELAERK 211

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 2e-30
 Identities = 40/183 (21%), Positives = 73/183 (39%), Gaps = 26/183 (14%)

Query: 47  NEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER----LLVYE 100
              EVA   L     +   R  F+ EA+++  LQ+ N+V+         +     +LV E
Sbjct: 33  TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 92

Query: 101 FMPNKSLDSSFSGT-----------FKDLLCLHKY---SRLRVIHRDLKASNILLDDQLN 146
            M + +L +                 + +L   ++       +IHRDLK  NI +     
Sbjct: 93  LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG 152

Query: 147 T-KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC 205
           + KI D G+A +       +    ++GT  +M+ E           DV+ FG+ +L++  
Sbjct: 153 SVKIGDLGLATLK----RASFAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMAT 207

Query: 206 GKK 208
            + 
Sbjct: 208 SEY 210

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 8e-30
 Identities = 41/188 (21%), Positives = 73/188 (38%), Gaps = 25/188 (13%)

Query: 38  RVILVGKFPNEQEVAIKRL---AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE 94
            V L  +  ++  +A+K L            + + E ++ + L++ N+++L G       
Sbjct: 21  NVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 80

Query: 95  RLLVYEFMPNKSLDSS---------------FSGTFKDLLCLHKYSRLRVIHRDLKASNI 139
             L+ E+ P  ++                   +     L   H     RVIHRD+K  N+
Sbjct: 81  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENL 137

Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
           LL      KI+DFG +     +   +    + GT  Y+  E         K D++  GVL
Sbjct: 138 LLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 193

Query: 200 VLKIVCGK 207
             + + GK
Sbjct: 194 CYEFLVGK 201

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 1e-29
 Identities = 48/195 (24%), Positives = 81/195 (41%), Gaps = 27/195 (13%)

Query: 38  RVILVGKFPNEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER 95
           R   + +  + + +  K L     +   +    +E  L+ +L++ N+V+     I     
Sbjct: 19  RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78

Query: 96  LL--VYEFMPNKSLDSSFSGTFKD-------------------LLCLHKYSR--LRVIHR 132
            L  V E+     L S  +   K+                   L   H+ S     V+HR
Sbjct: 79  TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 138

Query: 133 DLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTD 192
           DLK +N+ LD + N K+ DFG+ARI   + S A     VGT  YMS E     + + K+D
Sbjct: 139 DLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRMSYNEKSD 196

Query: 193 VFGFGVLVLKIVCGK 207
           ++  G L+ ++    
Sbjct: 197 IWSLGCLLYELCALM 211

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (281), Expect = 2e-29
 Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 17/179 (9%)

Query: 47  NEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK 105
            E  VAIK L +  + + R +F +EA ++ +  + N++ L G        +++ EFM N 
Sbjct: 53  REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENG 112

Query: 106 SLDSSFSGTFKD-------------LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF 152
           SLDS                        +   + +  +HRDL A NIL++  L  K+SDF
Sbjct: 113 SLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDF 172

Query: 153 GMARIFGVNESGANTNRIVG---TYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           G++R    + S       +G      + + E       +  +DV+ +G+++ +++   +
Sbjct: 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 5e-29
 Identities = 40/177 (22%), Positives = 77/177 (43%), Gaps = 16/177 (9%)

Query: 47  NEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNK 105
            + +VAIK L   + +   E    EA+++ +L    +V+L+G     E  +LV E     
Sbjct: 35  KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGG 93

Query: 106 SLDSSFSGTFKDL-------------LCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF 152
            L     G  +++             + +        +HRDL A N+LL ++   KISDF
Sbjct: 94  PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 153

Query: 153 GMARIFGVNES-GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           G+++  G ++S     +       + + E       S ++DV+ +GV + + +   +
Sbjct: 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  111 bits (278), Expect = 6e-29
 Identities = 44/208 (21%), Positives = 77/208 (37%), Gaps = 37/208 (17%)

Query: 38  RVILVGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           R   +  +     VA+K L    S   + +FQ EA L+A+    N+VKLLG    G+   
Sbjct: 33  RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92

Query: 97  LVYEFMPNKSLDSSFSGTFKDLLC------------------------------------ 120
           L++E+M    L+          +C                                    
Sbjct: 93  LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 152

Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           +   S  + +HRDL   N L+ + +  KI+DFG++R     +             +M  E
Sbjct: 153 MAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 212

Query: 181 YTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
                  + ++DV+ +GV++ +I     
Sbjct: 213 SIFYNRYTTESDVWAYGVVLWEIFSYGL 240

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 6e-29
 Identities = 41/176 (23%), Positives = 82/176 (46%), Gaps = 15/176 (8%)

Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           E  VAIK L A  + + RV+F  EA ++ +  + N+++L G     +  +++ E+M N +
Sbjct: 36  EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA 95

Query: 107 LDSSFSGTFKDL-------------LCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFG 153
           LD        +                +   + +  +HRDL A NIL++  L  K+SDFG
Sbjct: 96  LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 155

Query: 154 MARIFGVNESGANT-NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++R+   +     T +       + + E       +  +DV+ FG+++ +++   +
Sbjct: 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE 211

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 2e-28
 Identities = 39/248 (15%), Positives = 80/248 (32%), Gaps = 36/248 (14%)

Query: 49  QEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE----ERLLVYEFMPN 104
           +EVA+K  + +  +     + E      L++ N++  +           +  LV ++  +
Sbjct: 27  EEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85

Query: 105 KSLDS--------------SFSGTFKDLLCLHK-----YSRLRVIHRDLKASNILLDDQL 145
            SL                    T   L  LH        +  + HRDLK+ NIL+    
Sbjct: 86  GSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145

Query: 146 NTKISDFGMARIF--GVNESGANTNRIVGTYGYMSLEY------TMSGTVSIKTDVFGFG 197
              I+D G+A       +      N  VGT  YM+ E               + D++  G
Sbjct: 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205

Query: 198 VLVLKIVCGKKNNKSYHTERP----LNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF 253
           ++  +I         +   +     L     + +   +    + +   +       E   
Sbjct: 206 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR 265

Query: 254 LLVSCVCK 261
           ++   + +
Sbjct: 266 VMAKIMRE 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 2e-28
 Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 13/171 (7%)

Query: 51  VAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKSLDS 109
           VAIK L   TS +   E  +EA ++A +   ++ +LLG  +    +L+         LD 
Sbjct: 41  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDY 100

Query: 110 SFSGTFKD------------LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARI 157
                                  ++     R++HRDL A N+L+    + KI+DFG+A++
Sbjct: 101 VREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160

Query: 158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
            G  E   +         +M+LE  +    + ++DV+ +GV V +++    
Sbjct: 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 211

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 4e-28
 Identities = 42/175 (24%), Positives = 71/175 (40%), Gaps = 16/175 (9%)

Query: 49  QEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
           + VA+K L         + E   EA ++ +L    +V+++G     E  +LV E      
Sbjct: 35  KTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGP 93

Query: 107 LDSSF--SGTFKD----------LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGM 154
           L+     +   KD           + +        +HRDL A N+LL  Q   KISDFG+
Sbjct: 94  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153

Query: 155 ARIFGVNESGANTN-RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           ++    +E+             + + E       S K+DV+ FGVL+ +     +
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 208

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 8e-28
 Identities = 48/230 (20%), Positives = 91/230 (39%), Gaps = 34/230 (14%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERL-LVYEFMPNK 105
              +VA+K +   +      F  EA ++ +L+++NLV+LLG  +  +  L +V E+M   
Sbjct: 29  RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86

Query: 106 SLDSSFSGTFKDLL--------------CLHKYSRLRVIHRDLKASNILLDDQLNTKISD 151
           SL        + +L               +        +HRDL A N+L+ +    K+SD
Sbjct: 87  SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 146

Query: 152 FGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNK 211
           FG+ +     E+ +  +       + + E       S K+DV+ FG+L+ +I    +   
Sbjct: 147 FGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 201

Query: 212 SYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCK 261
                + +           +G  ++  D      CPP     +  +C   
Sbjct: 202 PRIPLKDV------VPRVEKGYKMDAPD-----GCPPAVYEVMK-NCWHL 239

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (269), Expect = 1e-27
 Identities = 39/186 (20%), Positives = 78/186 (41%), Gaps = 20/186 (10%)

Query: 38  RVILVGKFPNEQEVAIKRL---AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE 94
           RV L+    N +  A+K L        +      +E  +++ + +  ++++ G     ++
Sbjct: 19  RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ 78

Query: 95  RLLVYEFMPNKSLDSSFSGTFKD------------LLCLHKYSRLRVIHRDLKASNILLD 142
             ++ +++    L S    + +              L L       +I+RDLK  NILLD
Sbjct: 79  IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD 138

Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
              + KI+DFG A+          T  + GT  Y++ E   +   +   D + FG+L+ +
Sbjct: 139 KNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 193

Query: 203 IVCGKK 208
           ++ G  
Sbjct: 194 MLAGYT 199

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 3e-27
 Identities = 51/245 (20%), Positives = 85/245 (34%), Gaps = 29/245 (11%)

Query: 38  RVILVGKFPNEQEVAIKRL---AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE 94
           R            VA+K L     +  +   +F  E   +  L + NL++L G  +    
Sbjct: 26  RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM 85

Query: 95  RLLVYEFMPNKSLDSSFSGTFKDLL-------------CLHKYSRLRVIHRDLKASNILL 141
           ++ V E  P  SL           L              +      R IHRDL A N+LL
Sbjct: 86  KM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 144

Query: 142 DDQLNTKISDFGMARIFGVNES-GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
             +   KI DFG+ R    N+            + + + E   + T S  +D + FGV +
Sbjct: 145 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204

Query: 201 LKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVC 260
            ++    +          LN   I  ++  EG+ L   +      CP +    ++  C  
Sbjct: 205 WEMFTYGQ-----EPWIGLNGSQILHKIDKEGERLPRPE-----DCPQDIYNVMV-QCWA 253

Query: 261 KSKQQ 265
              + 
Sbjct: 254 HKPED 258

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  105 bits (263), Expect = 6e-27
 Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 16/176 (9%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPNKS 106
               VA+K L   + +   EF  EA ++ ++++ NLV+LLG         ++ EFM   +
Sbjct: 41  YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99

Query: 107 LDSSFSGTFKD--------------LLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDF 152
           L        +                  +    +   IHRDL A N L+ +    K++DF
Sbjct: 100 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF 159

Query: 153 GMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
           G++R+   +   A+         + + E       SIK+DV+ FGVL+ +I     
Sbjct: 160 GLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  106 bits (266), Expect = 7e-27
 Identities = 36/185 (19%), Positives = 64/185 (34%), Gaps = 18/185 (9%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL 97
            V  V +       A K +       +   + E + ++ L++  LV L        E ++
Sbjct: 41  VVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100

Query: 98  VYEFMPNKSLDSSFSGTFKDL-------------LCLHKYSRLRVIHRDLKASNILLDDQ 144
           +YEFM    L    +     +               L        +H DLK  NI+   +
Sbjct: 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK 160

Query: 145 LNT--KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
            +   K+ DFG+       +   +     GT  + + E      V   TD++  GVL   
Sbjct: 161 RSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 217

Query: 203 IVCGK 207
           ++ G 
Sbjct: 218 LLSGL 222

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 8e-27
 Identities = 44/191 (23%), Positives = 75/191 (39%), Gaps = 33/191 (17%)

Query: 48  EQEVAIKRL-AWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLVYEFMPNK 105
             + AIKR+  + S     +F  E +++ KL  + N++ LLG   H     L  E+ P+ 
Sbjct: 37  RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 96

Query: 106 SLDSSFSGTFKD----------------------------LLCLHKYSRLRVIHRDLKAS 137
           +L      +                                  +   S+ + IHRDL A 
Sbjct: 97  NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 156

Query: 138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFG 197
           NIL+ +    KI+DFG++R     E             +M++E       +  +DV+ +G
Sbjct: 157 NILVGENYVAKIADFGLSRGQ---EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 213

Query: 198 VLVLKIVCGKK 208
           VL+ +IV    
Sbjct: 214 VLLWEIVSLGG 224

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 5e-26
 Identities = 45/234 (19%), Positives = 81/234 (34%), Gaps = 43/234 (18%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQG-RVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEER 95
               + K      VA+K L  ++    R    +E K+++ L  + N+V LLG    G   
Sbjct: 43  TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102

Query: 96  LLVYEFMPNKSLDSS---------------------------------FSGTFKDLLCLH 122
           L++ E+     L +                                       K +  L 
Sbjct: 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 162

Query: 123 KYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYT 182
                  IHRDL A NILL     TKI DFG+AR    + +            +M+ E  
Sbjct: 163 S---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI 219

Query: 183 MSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE 236
            +   + ++DV+ +G+ + ++     +           +    +++  EG  + 
Sbjct: 220 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-----PVDSKFYKMIKEGFRML 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 6e-26
 Identities = 39/185 (21%), Positives = 69/185 (37%), Gaps = 16/185 (8%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
           + I +        VAIK     +     E F  EA  + +  + ++VKL+G  I      
Sbjct: 25  QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVW 83

Query: 97  LVYEFMPNKSLDSSFSGTFKDL-------------LCLHKYSRLRVIHRDLKASNILLDD 143
           ++ E      L S        L               L      R +HRD+ A N+L+  
Sbjct: 84  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 143

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
               K+ DFG++R    + +    ++      +M+ E       +  +DV+ FGV + +I
Sbjct: 144 NDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 202

Query: 204 VCGKK 208
           +    
Sbjct: 203 LMHGV 207

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  103 bits (259), Expect = 7e-26
 Identities = 44/240 (18%), Positives = 77/240 (32%), Gaps = 37/240 (15%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL 97
            V    +    +    K +       +   +NE  ++ +L +  L+ L        E +L
Sbjct: 44  VVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103

Query: 98  VYEFMPNKSLDSSFSGTFKDL-------------LCLHKYSRLRVIHRDLKASNILLDDQ 144
           + EF+    L    +     +               L       ++H D+K  NI+ + +
Sbjct: 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK 163

Query: 145 LNT--KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
             +  KI DFG+A     +E          T  + + E      V   TD++  GVL   
Sbjct: 164 KASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYV 220

Query: 203 IVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKS 262
           ++ G                      +    DLE +          +EDAF  VS   K 
Sbjct: 221 LLSGL-------------------SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 1e-25
 Identities = 47/190 (24%), Positives = 77/190 (40%), Gaps = 23/190 (12%)

Query: 42  VGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
           V K   E  VAIK +    S + R+EF NEA ++ +    ++V+LLG    G+  L++ E
Sbjct: 44  VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103

Query: 101 FMPNKSLDSSFSGTFKD----------------------LLCLHKYSRLRVIHRDLKASN 138
            M    L S                                 +   +  + +HRDL A N
Sbjct: 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 163

Query: 139 ILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGV 198
            ++ +    KI DFGM R     +      + +    +MS E    G  +  +DV+ FGV
Sbjct: 164 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 223

Query: 199 LVLKIVCGKK 208
           ++ +I    +
Sbjct: 224 VLWEIATLAE 233

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 3e-25
 Identities = 47/208 (22%), Positives = 78/208 (37%), Gaps = 37/208 (17%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQG-RVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEER 95
               + K     +VA+K L   +    R    +E K++ +L  + N+V LLG        
Sbjct: 57  TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116

Query: 96  LLVYEFMPNKSLDSSFSG---------------------------TFKDLLC-------- 120
            L++E+     L +                               TF+DLLC        
Sbjct: 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 176

Query: 121 LHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLE 180
           +        +HRDL A N+L+      KI DFG+AR    + +            +M+ E
Sbjct: 177 MEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 236

Query: 181 YTMSGTVSIKTDVFGFGVLVLKIVCGKK 208
               G  +IK+DV+ +G+L+ +I     
Sbjct: 237 SLFEGIYTIKSDVWSYGILLWEIFSLGV 264

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 99.0 bits (246), Expect = 1e-24
 Identities = 48/244 (19%), Positives = 92/244 (37%), Gaps = 30/244 (12%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQG---RVEFQNEAKLIAKLQYTNLVKLLGCSIH--- 91
            V L       ++VA+K L     +     + F+ EA+  A L +  +V +         
Sbjct: 22  EVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81

Query: 92  -GEERLLVYEFMPNKSLDS--SFSGTFKD----------LLCLHKYSRLRVIHRDLKASN 138
            G    +V E++   +L       G                 L+   +  +IHRD+K +N
Sbjct: 82  AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPAN 141

Query: 139 ILLDDQLNTKISDFGMARIFGVN-ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFG 197
           I++      K+ DFG+AR    +  S   T  ++GT  Y+S E     +V  ++DV+  G
Sbjct: 142 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 201

Query: 198 VLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVS 257
            ++ +++ G+          P          +   ++  +           + DA +L  
Sbjct: 202 CVLYEVLTGE---------PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVL-K 251

Query: 258 CVCK 261
            + K
Sbjct: 252 ALAK 255

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 8e-24
 Identities = 36/188 (19%), Positives = 72/188 (38%), Gaps = 18/188 (9%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
            V       N+  VAIK+++    Q   +    E K++ + ++ N++ +           
Sbjct: 23  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82

Query: 97  LVYEFMPNKSLDSSFSGTFKD---------------LLCLHKYSRLRVIHRDLKASNILL 141
           +   ++    + +      K                L  L       V+HRDLK SN+LL
Sbjct: 83  MKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 142

Query: 142 DDQLNTKISDFGMARIFGVNESGANT-NRIVGTYGYMSLEYTMSGTVSI-KTDVFGFGVL 199
           +   + KI DFG+AR+   +          V T  Y + E  ++        D++  G +
Sbjct: 143 NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 202

Query: 200 VLKIVCGK 207
           + +++  +
Sbjct: 203 LAEMLSNR 210

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.6 bits (237), Expect = 3e-23
 Identities = 39/207 (18%), Positives = 79/207 (38%), Gaps = 25/207 (12%)

Query: 38  RVILVGKFPNEQEVAIKRL------AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH 91
            V    +     + A K +      +   G  R + + E  ++ ++Q+ N++ L     +
Sbjct: 25  VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84

Query: 92  GEERLLVYEFMPNKSLDSSFSG------------TFKDLLCLHKYSRLRVIHRDLKASNI 139
             + +L+ E +    L    +               + L  ++    L++ H DLK  NI
Sbjct: 85  KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 144

Query: 140 LLDDQ----LNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFG 195
           +L D+       KI DFG+A      + G     I GT  +++ E      + ++ D++ 
Sbjct: 145 MLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 201

Query: 196 FGVLVLKIVCGKKNNKSYHTERPLNLV 222
            GV+   ++ G         +  L  V
Sbjct: 202 IGVITYILLSGASPFLGDTKQETLANV 228

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 95.9 bits (238), Expect = 3e-23
 Identities = 46/186 (24%), Positives = 82/186 (44%), Gaps = 19/186 (10%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVE-FQNEAKLIAKLQYTNLVKLLGCSIHGEERL 96
            VIL      ++ VAIK +A  + +G+    +NE  ++ K+++ N+V L      G    
Sbjct: 24  EVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83

Query: 97  LVYEFMPNKSLDS--SFSGTFKD----------LLCLHKYSRLRVIHRDLKASNILL--- 141
           L+ + +    L       G + +          L  +     L ++HRDLK  N+L    
Sbjct: 84  LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL 143

Query: 142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVL 201
           D+     ISDFG++++    + G+  +   GT GY++ E       S   D +  GV+  
Sbjct: 144 DEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAY 200

Query: 202 KIVCGK 207
            ++CG 
Sbjct: 201 ILLCGY 206

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.0 bits (238), Expect = 4e-23
 Identities = 44/218 (20%), Positives = 80/218 (36%), Gaps = 17/218 (7%)

Query: 38  RVILVGKFPNEQEVAIKRL---AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE 94
           +VILV +    +  A+K L      +         E++++   ++  L  L       + 
Sbjct: 20  KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79

Query: 95  RLLVYEFMPNKSLDSSFSGTFKD------------LLCLHKYSRLRVIHRDLKASNILLD 142
              V E+     L    S                 +  L       V++RD+K  N++LD
Sbjct: 80  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139

Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
              + KI+DFG+ +       GA      GT  Y++ E           D +G GV++ +
Sbjct: 140 KDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 197

Query: 203 IVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL 240
           ++CG+    +   ER   L+ +    +      E   L
Sbjct: 198 MMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.9 bits (235), Expect = 6e-23
 Identities = 41/234 (17%), Positives = 83/234 (35%), Gaps = 36/234 (15%)

Query: 36  RDRVILVGKFPNEQEVAIKRL-AWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGE 93
               +   K     +VA+K L +  + +   +  +E +++  + ++ N++ LLG      
Sbjct: 33  EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92

Query: 94  ERLLVYEFMPNKSLDSSFSGTFKD----------------------------LLCLHKYS 125
              ++ E+    +L                                         +   +
Sbjct: 93  PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 152

Query: 126 RLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSG 185
             + IHRDL A N+L+ +    KI+DFG+AR     +    T        +M+ E     
Sbjct: 153 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212

Query: 186 TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELID 239
             + ++DV+ FGVL+ +I     +         L      ++L  EG  ++   
Sbjct: 213 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL------FKLLKEGHRMDKPS 260

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.1 bits (236), Expect = 8e-23
 Identities = 34/185 (18%), Positives = 73/185 (39%), Gaps = 19/185 (10%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL 97
            V    +  +++    K +    G  +V  + E  ++   ++ N++ L       EE ++
Sbjct: 20  IVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78

Query: 98  VYEFMPNKSL-----DSSFSGTFKDLLCLHKY--------SRLRVIHRDLKASNILLDDQ 144
           ++EF+    +      S+F    ++++                 + H D++  NI+   +
Sbjct: 79  IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR 138

Query: 145 LNT--KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
            ++  KI +FG AR     +   N   +     Y + E      VS  TD++  G LV  
Sbjct: 139 RSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYV 195

Query: 203 IVCGK 207
           ++ G 
Sbjct: 196 LLSGI 200

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.2 bits (233), Expect = 9e-23
 Identities = 42/188 (22%), Positives = 73/188 (38%), Gaps = 20/188 (10%)

Query: 38  RVILVGKFPNEQEVAIKRL-----AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG 92
            V         Q VAIK++     +            E KL+ +L + N++ LL    H 
Sbjct: 13  TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 72

Query: 93  EERLLVYEFMPNKSLDSSFSGTFKD------------LLCLHKYSRLRVIHRDLKASNIL 140
               LV++FM           +               L  L    +  ++HRDLK +N+L
Sbjct: 73  SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL 132

Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVL 199
           LD+    K++DFG+A+ FG           V T  Y + E      +  +  D++  G +
Sbjct: 133 LDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCI 190

Query: 200 VLKIVCGK 207
           + +++   
Sbjct: 191 LAELLLRV 198

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 94.4 bits (234), Expect = 2e-22
 Identities = 49/225 (21%), Positives = 83/225 (36%), Gaps = 26/225 (11%)

Query: 38  RVILVGKFPNEQEVAIKRL---AWTSGQGRVEFQNEAKLIAKLQYT---NLVKLLGCSIH 91
            V    K    +  A+K L        QG     NE  +++ +       +V +      
Sbjct: 19  EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 78

Query: 92  GEERLLVYEFMPNKSLDSSFSGTFKD------------LLCLHKYSRLRVIHRDLKASNI 139
            ++   + + M    L    S                 +L L       V++RDLK +NI
Sbjct: 79  PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 138

Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGT-VSIKTDVFGFGV 198
           LLD+  + +ISD G+A  F    S    +  VGT+GYM+ E    G       D F  G 
Sbjct: 139 LLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 194

Query: 199 LVLKIVCGKKNNKSYHTERPLNLVGIAWQL---WNEGKDLELIDL 240
           ++ K++ G    + + T+    +  +   +     +    EL  L
Sbjct: 195 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 239

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.3 bits (231), Expect = 3e-22
 Identities = 47/219 (21%), Positives = 82/219 (37%), Gaps = 18/219 (8%)

Query: 38  RVILVGKFPNEQEVAIKRL---AWTSGQGRVEFQNEAKLIAK-LQYTNLVKLLGCSIHGE 93
           +V L       Q  AIK L                E ++++   ++  L  +       E
Sbjct: 17  KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76

Query: 94  ERLLVYEFMPNKSLDSSFSGTFKD------------LLCLHKYSRLRVIHRDLKASNILL 141
               V E++    L        K             +L L       +++RDLK  NILL
Sbjct: 77  NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 136

Query: 142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVL 201
           D   + KI+DFGM +   + ++   TN   GT  Y++ E  +    +   D + FGVL+ 
Sbjct: 137 DKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 194

Query: 202 KIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL 240
           +++ G+        E   + + +    +    + E  DL
Sbjct: 195 EMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 233

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.7 bits (229), Expect = 5e-22
 Identities = 39/195 (20%), Positives = 77/195 (39%), Gaps = 25/195 (12%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQG--RVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER 95
            V         Q+VA+K++   + +    +    E K++  L++ N+V L+         
Sbjct: 25  EVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 84

Query: 96  --------LLVYEFMPNKSLDSSFSGTFKD------------LLCLHKYSRLRVIHRDLK 135
                    LV++F  +       +   K             L  L+   R +++HRD+K
Sbjct: 85  YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 144

Query: 136 ASNILLDDQLNTKISDFGMARIFGVNESGANTNR--IVGTYGYMSLEYTMSGT-VSIKTD 192
           A+N+L+      K++DFG+AR F + ++         V T  Y   E  +         D
Sbjct: 145 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPID 204

Query: 193 VFGFGVLVLKIVCGK 207
           ++G G ++ ++    
Sbjct: 205 LWGAGCIMAEMWTRS 219

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.7 bits (224), Expect = 2e-21
 Identities = 55/259 (21%), Positives = 89/259 (34%), Gaps = 42/259 (16%)

Query: 38  RVILVGKFPNEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH-GEE 94
               + K    + VA+K L    T  + R        LI    + N+V LLG     G  
Sbjct: 33  DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92

Query: 95  RLLVYEFMPNKSLDSSFSG--------------------TFKDLLC--------LHKYSR 126
            +++ EF    +L +                        T + L+C        +   + 
Sbjct: 93  LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 152

Query: 127 LRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGT 186
            + IHRDL A NILL ++   KI DFG+AR    +              +M+ E      
Sbjct: 153 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 212

Query: 187 VSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC 246
            +I++DV+ FGVL+ +I               + +     +   EG  +   D T     
Sbjct: 213 YTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEEFCRRLKEGTRMRAPDYT----- 262

Query: 247 PPNEDAFLLVSCVCKSKQQ 265
              E    ++ C      Q
Sbjct: 263 -TPEMYQTMLDCWHGEPSQ 280

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 88.2 bits (218), Expect = 1e-20
 Identities = 44/201 (21%), Positives = 77/201 (38%), Gaps = 37/201 (18%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSG---------QGRVEFQNEAKLIAKLQ-YTNLVKLLG 87
            V      P  +E A+K +  T G         + R     E  ++ K+  + N+++L  
Sbjct: 18  VVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 77

Query: 88  CSIHGEERLLVYEFMPNKSLDSS---------------FSGTFKDLLCLHKYSRLRVIHR 132
                    LV++ M    L                       + +  LH   +L ++HR
Sbjct: 78  TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHR 134

Query: 133 DLKASNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV----- 187
           DLK  NILLDD +N K++DFG +      + G     + GT  Y++ E            
Sbjct: 135 DLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAPEIIECSMNDNHPG 191

Query: 188 -SIKTDVFGFGVLVLKIVCGK 207
              + D++  GV++  ++ G 
Sbjct: 192 YGKEVDMWSTGVIMYTLLAGS 212

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.2 bits (218), Expect = 1e-20
 Identities = 39/193 (20%), Positives = 67/193 (34%), Gaps = 27/193 (13%)

Query: 38  RVILVGKFPNEQEVAIKRL------AWTSGQGRVEFQNEAKLIAKLQ--YTNLVKLLGCS 89
            V    +  +   VAIK +       W           E  L+ K+   ++ +++LL   
Sbjct: 19  SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78

Query: 90  IHGEERLLVYEFMPNKSLDSSF---SGTFKD----------LLCLHKYSRLRVIHRDLKA 136
              +  +L+ E          F    G  ++          L  +       V+HRD+K 
Sbjct: 79  ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKD 138

Query: 137 SNILLD-DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV-SIKTDVF 194
            NIL+D ++   K+ DFG   +              GT  Y   E+            V+
Sbjct: 139 ENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 194

Query: 195 GFGVLVLKIVCGK 207
             G+L+  +VCG 
Sbjct: 195 SLGILLYDMVCGD 207

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.4 bits (218), Expect = 1e-20
 Identities = 45/185 (24%), Positives = 74/185 (40%), Gaps = 16/185 (8%)

Query: 38  RVILVGKFPNEQEVAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER 95
            V         + VA+K  RL   +         E  L+ +L + N+VKLL       + 
Sbjct: 17  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 76

Query: 96  LLVYEFMPNKSLDSSFSG-------------TFKDLLCLHKYSRLRVIHRDLKASNILLD 142
            LV+EF+         +               F+ L  L      RV+HRDLK  N+L++
Sbjct: 77  YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN 136

Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
            +   K++DFG+AR FGV      T+ +V  +             S   D++  G +  +
Sbjct: 137 TEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 195

Query: 203 IVCGK 207
           +V  +
Sbjct: 196 MVTRR 200

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.3 bits (215), Expect = 3e-20
 Identities = 39/185 (21%), Positives = 70/185 (37%), Gaps = 15/185 (8%)

Query: 38  RVILVGKFPNEQEVAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER 95
            V         + VA+K  RL             E  L+ +L++ N+V+L       ++ 
Sbjct: 17  TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL 76

Query: 96  LLVYEFMPNKSLDSSF------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDD 143
            LV+EF                      S  F+ L  L       V+HRDLK  N+L++ 
Sbjct: 77  TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR 136

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
               K+++FG+AR FG+      +  +V  +         +   S   D++  G +  ++
Sbjct: 137 NGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

Query: 204 VCGKK 208
               +
Sbjct: 196 ANAGR 200

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 86.4 bits (213), Expect = 7e-20
 Identities = 38/239 (15%), Positives = 72/239 (30%), Gaps = 28/239 (11%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLG-CSIHGEERL 96
            + L       +EVAIK           +   E+K+   +Q    +  +  C   G+  +
Sbjct: 22  DIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79

Query: 97  LVYEFMPNKSLDSSFSGTFKD------------LLCLHKYSRLRVIHRDLKASNILLDDQ 144
           +V E +     D     + K             +  +        IHRD+K  N L+   
Sbjct: 80  MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG 139

Query: 145 LNTKI---SDFGMARIFGVNESGAN-----TNRIVGTYGYMSLEYTMSGTVSIKTDVFGF 196
               +    DFG+A+ +    +  +        + GT  Y S+   +    S + D+   
Sbjct: 140 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL 199

Query: 197 GVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLL 255
           G +++    G    +                     K +      L    P     +L 
Sbjct: 200 GYVLMYFNLGSLPWQGLKAATKRQKY-----ERISEKKMSTPIEVLCKGYPSEFATYLN 253

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 85.3 bits (210), Expect = 1e-19
 Identities = 42/180 (23%), Positives = 73/180 (40%), Gaps = 17/180 (9%)

Query: 43  GKFPNEQEVAIK--RLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE 100
            +    +  A+K  RL             E  ++ +L+++N+VKL       +  +LV+E
Sbjct: 21  AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80

Query: 101 FMPNKSLDS--SFSGTFKD----------LLCLHKYSRLRVIHRDLKASNILLDDQLNTK 148
            +            G  +           L  +      RV+HRDLK  N+L++ +   K
Sbjct: 81  HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELK 140

Query: 149 ISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTM-SGTVSIKTDVFGFGVLVLKIVCGK 207
           I+DFG+AR FG           + T  Y + +  M S   S   D++  G +  ++V G 
Sbjct: 141 IADFGLARAFG--IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.8 bits (201), Expect = 3e-18
 Identities = 36/184 (19%), Positives = 69/184 (37%), Gaps = 26/184 (14%)

Query: 47  NEQEVAIKRLAWTSGQGRVEFQ-----NEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF 101
             + VA+KR+   +G+  +           + +   ++ N+V+L                
Sbjct: 32  GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91

Query: 102 M------------------PNKSLDSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDD 143
           +                  P    ++     F+ L  L      RV+HRDLK  NIL+  
Sbjct: 92  LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 151

Query: 144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKI 203
               K++DFG+ARI+    +      +V T  Y + E  +  + +   D++  G +  ++
Sbjct: 152 SGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 208

Query: 204 VCGK 207
              K
Sbjct: 209 FRRK 212

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 81.4 bits (200), Expect = 3e-18
 Identities = 34/208 (16%), Positives = 66/208 (31%), Gaps = 25/208 (12%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERL 96
            +       N Q+VAIK     S     + ++E +    L   T +  +      G   +
Sbjct: 20  VIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77

Query: 97  LVYEFMPNKSLDSSFSGTFKD------------LLCLHKYSRLRVIHRDLKASNILLDDQ 144
           LV + +     D       K             L  +       +++RD+K  N L+   
Sbjct: 78  LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRP 137

Query: 145 LNT-----KISDFGMARIFGVNESGAN-----TNRIVGTYGYMSLEYTMSGTVSIKTDVF 194
            +       + DFGM + +    +  +        + GT  YMS+   +    S + D+ 
Sbjct: 138 NSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLE 197

Query: 195 GFGVLVLKIVCGKKNNKSYHTERPLNLV 222
             G + +  + G    +           
Sbjct: 198 ALGHVFMYFLRGSLPWQGLKAATNKQKY 225

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.7 bits (193), Expect = 5e-17
 Identities = 39/192 (20%), Positives = 71/192 (36%), Gaps = 28/192 (14%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER-- 95
            V       + + VAIK++     Q +     E +++ KL + N+V+L        E+  
Sbjct: 35  VVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90

Query: 96  ----LLVYEFMPNKSLDSSFSGTFKD---------------LLCLHKYSRLRVIHRDLKA 136
                LV +++P      +   +                     L       + HRD+K 
Sbjct: 91  EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKP 150

Query: 137 SNILLD-DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFG 195
            N+LLD D    K+ DFG A+     E   N + I   Y         +   +   DV+ 
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWS 208

Query: 196 FGVLVLKIVCGK 207
            G ++ +++ G+
Sbjct: 209 AGCVLAELLLGQ 220

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 77.5 bits (190), Expect = 1e-16
 Identities = 43/185 (23%), Positives = 75/185 (40%), Gaps = 20/185 (10%)

Query: 38  RVILVGKFPNEQEVAIKRL---AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE 94
           RV+LV    +    A+K L        +      NE +++  + +  LVKL         
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115

Query: 95  RLLVYEFMPNKSLDSSF--SGTFKD----------LLCLHKYSRLRVIHRDLKASNILLD 142
             +V E++    + S     G F +          +L       L +I+RDLK  N+L+D
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175

Query: 143 DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLK 202
            Q   +++DFG A+          T  + GT   ++ E  +S   +   D +  GVL+ +
Sbjct: 176 QQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230

Query: 203 IVCGK 207
           +  G 
Sbjct: 231 MAAGY 235

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.7 bits (188), Expect = 2e-16
 Identities = 36/192 (18%), Positives = 74/192 (38%), Gaps = 30/192 (15%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGC----SIHG 92
           +V+ +     +++ A+K L     Q   + + E +L  +  Q  ++V+++          
Sbjct: 27  KVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81

Query: 93  EERLLVYEFMPNKSLDSSFSGT-------------FKDLLCLHKY-SRLRVIHRDLKASN 138
           +  L+V E +    L S                   K +    +Y   + + HRD+K  N
Sbjct: 82  KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 141

Query: 139 ILLDDQLNT---KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFG 195
           +L   +      K++DFG A+    + S         T  Y++ E           D++ 
Sbjct: 142 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWS 198

Query: 196 FGVLVLKIVCGK 207
            GV++  ++CG 
Sbjct: 199 LGVIMYILLCGY 210

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.6 bits (182), Expect = 1e-15
 Identities = 41/187 (21%), Positives = 68/187 (36%), Gaps = 20/187 (10%)

Query: 38  RVILVGKFPNEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH---- 91
            V        ++ VAIK+L   + +         E  L+  + + N++ LL         
Sbjct: 32  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91

Query: 92  --GEERLLVYEFMPNKSLDSSFSGTFKD---------LLCLHKYSRLRVIHRDLKASNIL 140
              ++  LV E M              +         L  +       +IHRDLK SNI+
Sbjct: 92  EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151

Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLV 200
           +      KI DFG+AR  G +         V T  Y + E  +        D++  G ++
Sbjct: 152 VKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 208

Query: 201 LKIVCGK 207
            ++V  K
Sbjct: 209 GEMVRHK 215

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.1 bits (181), Expect = 2e-15
 Identities = 41/189 (21%), Positives = 73/189 (38%), Gaps = 24/189 (12%)

Query: 38  RVILVGKFPNEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE-- 93
            V          +VAIK+L   + S         E +L+  +++ N++ LL      E  
Sbjct: 33  AVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92

Query: 94  ----ERLLVYEFMPNKSLDSSFSGTFKD----------LLCLHKYSRLRVIHRDLKASNI 139
               +  LV  FM              +          L  L       +IHRDLK  N+
Sbjct: 93  DDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL 152

Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGT-VSIKTDVFGFGV 198
            +++    KI DFG+AR     ++ +     V T  Y + E  ++    +   D++  G 
Sbjct: 153 AVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 207

Query: 199 LVLKIVCGK 207
           ++ +++ GK
Sbjct: 208 IMAEMITGK 216

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.3 bits (179), Expect = 3e-15
 Identities = 38/189 (20%), Positives = 76/189 (40%), Gaps = 20/189 (10%)

Query: 38  RVILVGKFPNEQEVAIKRL----AWTSGQGRVEFQNEAKLIAKLQYT-NLVKLLGCSIHG 92
            V  +      +  A+K L         +     + E +++  ++ +  LV L       
Sbjct: 42  LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101

Query: 93  EERLLVYEFMPNKSLDSSFSGTFKD------------LLCLHKYSRLRVIHRDLKASNIL 140
            +  L+ +++    L +  S   +             +L L    +L +I+RD+K  NIL
Sbjct: 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 161

Query: 141 LDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSI--KTDVFGFGV 198
           LD   +  ++DFG+++ F  +E+        GT  YM+ +    G        D +  GV
Sbjct: 162 LDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 220

Query: 199 LVLKIVCGK 207
           L+ +++ G 
Sbjct: 221 LMYELLTGA 229

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 72.2 bits (176), Expect = 7e-15
 Identities = 35/185 (18%), Positives = 70/185 (37%), Gaps = 22/185 (11%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY-TNLVKLLGCSIHGEERL 96
            V       N ++V +K L       + + + E K++  L+   N++ L         R 
Sbjct: 50  EVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106

Query: 97  --LVYEFMPNKSLDSSFSGTFKD----------LLCLHKYSRLRVIHRDLKASNILLDDQ 144
             LV+E + N         T  D          L  L     + ++HRD+K  N+++D +
Sbjct: 107 PALVFEHVNNTDFKQ-LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 165

Query: 145 LNT-KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLK 202
               ++ D+G+A  +     G   N  V +  +   E  +         D++  G ++  
Sbjct: 166 HRKLRLIDWGLAEFY---HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 222

Query: 203 IVCGK 207
           ++  K
Sbjct: 223 MIFRK 227

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.8 bits (167), Expect = 1e-13
 Identities = 36/188 (19%), Positives = 64/188 (34%), Gaps = 22/188 (11%)

Query: 38  RVILVGKFPNEQEVAIKRL--AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER 95
            V           VA+K+L   + S         E +L+  +++ N++ LL         
Sbjct: 33  SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92

Query: 96  ------LLVYEFMPNKSLDSSFSGTFKD----------LLCLHKYSRLRVIHRDLKASNI 139
                  LV   M     +        D          L  L       +IHRDLK SN+
Sbjct: 93  EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL 152

Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVL 199
            +++    KI DFG+AR          T  +   +             +   D++  G +
Sbjct: 153 AVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 208

Query: 200 VLKIVCGK 207
           + +++ G+
Sbjct: 209 MAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 60.8 bits (146), Expect = 4e-11
 Identities = 33/200 (16%), Positives = 62/200 (31%), Gaps = 31/200 (15%)

Query: 38  RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL 97
            V L     N   VA+K +           ++E KL+ ++   +  K      +   +LL
Sbjct: 28  TVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86

Query: 98  VY---------------EFMPNKSLDSSFSGT------------FKDLLCLHKY--SRLR 128
            +               E +    L                    K LL    Y   R  
Sbjct: 87  DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG 146

Query: 129 VIHRDLKASNILLD-DQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTV 187
           +IH D+K  N+L++       +    +A +        +    + T  Y S E  +    
Sbjct: 147 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPW 206

Query: 188 SIKTDVFGFGVLVLKIVCGK 207
               D++    L+ +++ G 
Sbjct: 207 GCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 58.6 bits (141), Expect = 6e-11
 Identities = 27/152 (17%), Positives = 49/152 (32%), Gaps = 20/152 (13%)

Query: 39  VILVGKFPNEQEVAIKRL----------AWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGC 88
            +         E  +K                  G + F   A   A+ ++  L KL G 
Sbjct: 15  AVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL 74

Query: 89  SIHG----EERLLVYEFMPNKSLDSSFSGTFKDLL-----CLHKYSRLRVIHRDLKASNI 139
           ++      E   ++ E +  K L         ++L      + K+    ++H DL   N+
Sbjct: 75  AVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNV 134

Query: 140 LLDDQLNTKISDFGMARIFGVNESGANTNRIV 171
           L+ ++    I DF  +   G         R V
Sbjct: 135 LVSEE-GIWIIDFPQSVEVGEEGWREILERDV 165

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	345
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.58
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.36
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.72
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.47
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.4
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.31

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=379.53  Aligned_cols=240  Identities=23%  Similarity=0.271  Sum_probs=182.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      .+|++.++||+|+||.||+|.+.+++.||||+++... ...+.|.+|++++++++|||||+++|+|..++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            4689999999999999999998888999999997543 456789999999999999999999999999999999999999


Q ss_pred             CCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          104 NKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       104 ~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      +|+|.+++.                +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~  159 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SS  159 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce-ee
Confidence            999988764                677788888875   7999999999999999999999999999876433222 22


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHhC-CCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCG-KKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      ....||+.|+|||++.+..++.++|||||||++|||+|+ .+||....      ......... .+.  ....|   ..+
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~~~~~i~-~~~--~~~~p---~~~  227 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDIS-TGF--RLYKP---RLA  227 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHHHHHHHH-HTC--CCCCC---TTS
T ss_pred             cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC------HHHHHHHHH-hcC--CCCCc---ccc
Confidence            335789999999999999999999999999999999995 44444322      111111111 111  11111   112


Q ss_pred             ChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          247 PPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       247 ~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      +++-   .+++..||+.||++||||.+++..|.++++
T Consensus       228 ~~~l---~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         228 STHV---YQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHH---HHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            2211   599999999999999999988888887764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-53  Score=377.73  Aligned_cols=235  Identities=21%  Similarity=0.251  Sum_probs=182.1

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      |-.+|++.++||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            445799999999999999999965 579999999997653 234567899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++........
T Consensus        83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            9999999976653               677778888765   8999999999999999999999999999986543333


Q ss_pred             CcccceeecCCccccchhccCCc-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                      .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... .     .............    
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~-----~~~~~~~~~~~~~----  229 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y-----SDWKEKKTYLNPW----  229 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-H-----HHHHTTCTTSTTG----
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-H-----HHHhcCCCCCCcc----
Confidence            33445689999999999988776 57899999999999999999999764432211 0     1111111110000    


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ...+++.   .+++.+||+.||++|||+.
T Consensus       230 ~~~s~~~---~~li~~~L~~dP~~R~t~~  255 (271)
T d1nvra_         230 KKIDSAP---LALLHKILVENPSARITIP  255 (271)
T ss_dssp             GGSCHHH---HHHHHHHSCSSTTTSCCHH
T ss_pred             ccCCHHH---HHHHHHHcCCChhHCcCHH
Confidence            0112211   5899999999999999953

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-53  Score=387.72  Aligned_cols=257  Identities=20%  Similarity=0.236  Sum_probs=191.7

Q ss_pred             cceeecccccccccCC-----CCeeeEEEeeccCCeEEEEEEcC-CC---cEEEEEEeccC-CccCHHHHHHHHHHHHhc
Q 039516            8 GCQTWSEGAKFVENSS-----LDWHMYIQQEQTRDRVILVGKFP-NE---QEVAIKRLAWT-SGQGRVEFQNEAKLIAKL   77 (345)
Q Consensus         8 ~~~s~~~~~~~~~~~~-----~~~~~~~~lG~G~~g~vy~~~~~-~~---~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l   77 (345)
                      ..+|++++.+++..|.     .+|++.+.||+|+||.||+|... +|   ..||||.+... .....+.|.+|+++|+++
T Consensus         5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l   84 (299)
T d1jpaa_           5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF   84 (299)
T ss_dssp             CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred             CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence            4567778777776653     56889999999999999999764 33   36899998654 344566899999999999


Q ss_pred             CCCCeeeEEEEEEECCeeEEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeee
Q 039516           78 QYTNLVKLLGCSIHGEERLLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILL  141 (345)
Q Consensus        78 ~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill  141 (345)
                      +|||||+++|+|.+++..++|||||++|+|.+++.                +++.+|.|||..   +|+||||||+|||+
T Consensus        85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl  161 (299)
T d1jpaa_          85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV  161 (299)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence            99999999999999999999999999999987654                677888888875   89999999999999


Q ss_pred             CCCCCEEEEccccceeecCCCCCC---cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q 039516          142 DDQLNTKISDFGMARIFGVNESGA---NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTER  217 (345)
Q Consensus       142 ~~~~~~kl~Dfgl~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~  217 (345)
                      +.++.+||+|||+++.........   ......||+.|+|||++.++.++.++|||||||++|||+| |+.||...... 
T Consensus       162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-  240 (299)
T d1jpaa_         162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-  240 (299)
T ss_dssp             CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred             CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-
Confidence            999999999999998764332221   1222457899999999999999999999999999999998 89999765421 


Q ss_pred             cccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          218 PLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                           +...... .+..     +.    .+...... .+++.+||+.||++||||.+++..|.++++
T Consensus       241 -----~~~~~i~-~~~~-----~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         241 -----DVINAIE-QDYR-----LP----PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             -----HHHHHHH-TTCC-----CC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----HHHHHHH-cCCC-----CC----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                 1111111 1111     01    11222233 589999999999999999998888888765

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-52  Score=374.74  Aligned_cols=232  Identities=20%  Similarity=0.217  Sum_probs=182.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|++.+.||+|+||.||+|.. .+|+.||||+++..   .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            4699999999999999999975 57999999999643   2345678999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.+......
T Consensus        88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            9999999987765               556666666665   8999999999999999999999999999987544333


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.      ........ .+..      .+..
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~-~~~~------~~p~  231 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIFQKII-KLEY------DFPE  231 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-TTCC------CCCT
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHHHHHH-cCCC------CCCc
Confidence            344456899999999999999999999999999999999999999976431      11111111 2211      1112


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCcc
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPMLF  274 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~  274 (345)
                      .++++.   .+++.+||+.||++|||+.++
T Consensus       232 ~~s~~~---~~li~~~L~~dP~~R~t~~e~  258 (288)
T d1uu3a_         232 KFFPKA---RDLVEKLLVLDATKRLGCEEM  258 (288)
T ss_dssp             TCCHHH---HHHHHTTSCSSGGGSTTSGGG
T ss_pred             cCCHHH---HHHHHHHccCCHhHCcCHHHH
Confidence            233322   589999999999999997653

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-52  Score=374.82  Aligned_cols=233  Identities=19%  Similarity=0.264  Sum_probs=188.4

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ....|++.++||+|+||+||+|.. .+|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus        18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            356799999999999999999975 5799999999987666667889999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          101 FMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       101 ~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      ||++|+|.+++.              +++.||.|||..   ||+||||||+|||++.++.+||+|||+++.+....  ..
T Consensus        98 y~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~  172 (293)
T d1yhwa1          98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK  172 (293)
T ss_dssp             CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CC
T ss_pred             ecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc--cc
Confidence            999999987654              667777888865   89999999999999999999999999999764332  22


Q ss_pred             ccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....      ..........+.......    ..+
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~~~~~~~----~~~  242 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTPELQNP----EKL  242 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSCCCSSG----GGS
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCCCCCCc----ccC
Confidence            3446899999999999999999999999999999999999999975432      122222222221111000    112


Q ss_pred             ChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          247 PPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       247 ~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      +.+.   .+++.+||+.||.+|||+.
T Consensus       243 s~~~---~~li~~~L~~dP~~R~s~~  265 (293)
T d1yhwa1         243 SAIF---RDFLNRCLDMDVEKRGSAK  265 (293)
T ss_dssp             CHHH---HHHHHHHTCSSTTTSCCHH
T ss_pred             CHHH---HHHHHHHccCChhHCcCHH
Confidence            2211   5899999999999999953

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-52  Score=374.80  Aligned_cols=245  Identities=21%  Similarity=0.289  Sum_probs=185.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ..+|.+.++||+|+||.||+|++.  ..||||+++..  .....+.|.+|+.+|++++|||||++++++. .+.+++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence            356888899999999999999874  46999999654  3445678999999999999999999999874 567899999


Q ss_pred             cCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          101 FMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       101 ~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||++|+|.+++.                +++.+|.|||..   +||||||||+|||++.++.+||+|||+++........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            999999988774                677888888875   8999999999999999999999999999876543333


Q ss_pred             CcccceeecCCccccchhcc---CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          165 ANTNRIVGTYGYMSLEYTMS---GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      .......||+.|+|||++.+   +.++.++|||||||++|||+||+.||.......      ........+.....+ +.
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~~p~~-~~  233 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSPDL-SK  233 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSCCCCG-GG
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCCcc-hh
Confidence            34455689999999999864   458999999999999999999999998654221      112222222111111 11


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      +...++.+.   .+++.+||+.||++|||+.++...|..+.+
T Consensus       234 ~~~~~~~~l---~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         234 VRSNCPKAM---KRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             SCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccchHHH---HHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            222233222   589999999999999999888877776554

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=366.78  Aligned_cols=226  Identities=18%  Similarity=0.213  Sum_probs=183.1

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|++.+.||+|+||.||++.. .+|+.||+|++...   .......+.+|++++++++|||||++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            3699999999999999999975 57899999998643   2345678999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++....    
T Consensus        86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~----  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----  158 (263)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----
T ss_pred             eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC----
Confidence            9999999987765               667777777765   899999999999999999999999999986532    


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ... ......+..      .+..
T Consensus       159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~-~~~i~~~~~------~~p~  225 (263)
T d2j4za1         159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QET-YKRISRVEF------TFPD  225 (263)
T ss_dssp             CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHH-HHHHHTTCC------CCCT
T ss_pred             CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHH-HHHHHcCCC------CCCc
Confidence            223346799999999999999999999999999999999999999975431      111 111112211      1111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .++++.   .+++.+||+.||++|||+.
T Consensus       226 ~~s~~~---~~li~~~L~~dp~~R~t~~  250 (263)
T d2j4za1         226 FVTEGA---RDLISRLLKHNPSQRPMLR  250 (263)
T ss_dssp             TSCHHH---HHHHHHHTCSSGGGSCCHH
T ss_pred             cCCHHH---HHHHHHHccCCHhHCcCHH
Confidence            223222   5899999999999999954

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-52  Score=372.39  Aligned_cols=240  Identities=25%  Similarity=0.329  Sum_probs=187.2

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ..+|++.++||+|+||.||+|.+++++.||||+++... ...+.|.+|++++++++|||||+++|++. ++..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeC
Confidence            35789999999999999999999888999999997543 45678999999999999999999999875 56789999999


Q ss_pred             CCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          103 PNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       103 ~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ++|+|.+++.                 +++.+|.|||..   +|+||||||+|||+++++.+||+|||+++....... .
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc-c
Confidence            9999976543                 677788888875   799999999999999999999999999998653322 1


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      ......||+.|+|||++.++.++.++|||||||++|||+||..|+.....     ... .......+.     .+.....
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-----~~~-~~~~i~~~~-----~~~~p~~  234 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NPE-VIQNLERGY-----RMVRPDN  234 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHH-HHHHHHTTC-----CCCCCTT
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-----HHH-HHHHHHhcC-----CCCCccc
Confidence            22345789999999999999999999999999999999997665543221     111 111122221     1111122


Q ss_pred             CChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          246 CPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       246 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                      ++.+.   .+++.+||+.||++||||.+++..|.++.
T Consensus       235 ~~~~l---~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         235 CPEEL---YQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             CCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ChHHH---HHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            33222   58999999999999999888777666543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-52  Score=369.35  Aligned_cols=236  Identities=24%  Similarity=0.297  Sum_probs=191.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMP  103 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  103 (345)
                      ++|++.++||+|+||+||+|+.++++.||||+++... ...+.|++|+.++++++||||++++|+|.+++.+++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            4688889999999999999998888999999997653 356789999999999999999999999999999999999999


Q ss_pred             CCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          104 NKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       104 ~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      +|+|.+++.                ++++||.|||..   ||+||||||+||+++.++.+||+|||+++........ ..
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~  158 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SS  158 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce-ee
Confidence            999877644                778888899875   8999999999999999999999999999876543222 23


Q ss_pred             cceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCC
Q 039516          168 NRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSC  246 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  246 (345)
                      ....||+.|+|||++.+..++.++|||||||++|||+| |+.||......      +.... ...+..  ...|   ..+
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~~~~~-i~~~~~--~~~p---~~~  226 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEH-IAQGLR--LYRP---HLA  226 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHH-HHTTCC--CCCC---TTC
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH------HHHHH-HHhCCC--CCCc---ccc
Confidence            34578999999999999999999999999999999998 89999765422      11122 222211  1111   112


Q ss_pred             ChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          247 PPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       247 ~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                      +    .. .+++..||+.||++|||+.++++.|.+
T Consensus       227 ~----~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         227 S----EKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             C----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             c----HHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            2    23 599999999999999998777666643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-52  Score=377.49  Aligned_cols=243  Identities=22%  Similarity=0.257  Sum_probs=192.5

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ..+|++.++||+|+||.||+|.. .+|+.||||+++... ...++|.+|+++|++++|||||+++++|.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            35689999999999999999976 468999999997543 4577899999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          102 MPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       102 ~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |++|+|.+++.                 +++.||.|||..   ||+||||||+|||++.++.+||+|||+++....... 
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-  170 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-  170 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc-
Confidence            99999987764                 667788888875   799999999999999999999999999987643222 


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      .......||+.|+|||++.++.++.++|||||||++|||++|..|+.....     . .........+..     +....
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~-~~~~~~i~~~~~-----~~~~~  239 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----L-SQVYELLEKDYR-----MERPE  239 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----H-HHHHHHHHTTCC-----CCCCT
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----H-HHHHHHHhcCCC-----CCCCc
Confidence            223345689999999999999999999999999999999997776643221     1 111222222211     11111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      .++++.   .+++..||+.||++|||+.+++..|..+++.
T Consensus       240 ~~~~~l---~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         240 GCPEKV---YELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             TCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             cchHHH---HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            233222   5999999999999999998888877777653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-52  Score=371.85  Aligned_cols=232  Identities=21%  Similarity=0.233  Sum_probs=172.8

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH--GEERLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv   98 (345)
                      .+|++.+.||+|+||.||+|.. .+|+.||||.++...  ....+.+.+|+++|++++|||||++++++.+  .+.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            4699999999999999999964 679999999997653  3345678999999999999999999999864  4568999


Q ss_pred             EecCCCCChHHHHH-------------------hHHHHHHHHHhcC--CCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516           99 YEFMPNKSLDSSFS-------------------GTFKDLLCLHKYS--RLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus        99 ~e~~~~gsL~~~l~-------------------~~~~~l~~lh~~~--~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      ||||++|+|.+++.                   +++.+|.|||...  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999987653                   6778888888763  23599999999999999999999999999987


Q ss_pred             ecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 039516          158 FGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLEL  237 (345)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||+||+.||......      +. ......+.... 
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~-~~~i~~~~~~~-  233 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------EL-AGKIREGKFRR-  233 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HH-HHHHHHTCCCC-
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HH-HHHHHcCCCCC-
Confidence            64322  2234468999999999999999999999999999999999999999764321      11 11222222211 


Q ss_pred             ccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          238 IDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       238 ~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                          +...++++.   .+++.+||+.||.+|||+.
T Consensus       234 ----~~~~~s~~l---~~li~~~L~~dp~~Rps~~  261 (269)
T d2java1         234 ----IPYRYSDEL---NEIITRMLNLKDYHRPSVE  261 (269)
T ss_dssp             ----CCTTSCHHH---HHHHHHHTCSSGGGSCCHH
T ss_pred             ----CCcccCHHH---HHHHHHHcCCChhHCcCHH
Confidence                112233322   5899999999999999954

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-51  Score=368.61  Aligned_cols=231  Identities=20%  Similarity=0.219  Sum_probs=183.1

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ..|++.++||+|+||.||+|.. .+|+.||||+++.......+.|.+|+++|++++|||||++++++.+.+..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            3599999999999999999975 579999999998776667788999999999999999999999999999999999999


Q ss_pred             CCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          103 PNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       103 ~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      ++|+|.+++.                +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++......  ..
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence            9999987753                667777777765   89999999999999999999999999998653211  11


Q ss_pred             ccceeecCCccccchhc-----cCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          167 TNRIVGTYGYMSLEYTM-----SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      .....||+.|+|||++.     +..|+.++|||||||++|||++|+.||......+.      ........ ...+..+ 
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~~~~-~~~~~~~-  238 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKSE-PPTLAQP-  238 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHHSC-CCCCSSG-
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHHHHcCC-CCCCCcc-
Confidence            23467999999999884     45688999999999999999999999976543221      11111111 1111100 


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                        ..++++.   .+++.+||+.||++|||+.
T Consensus       239 --~~~s~~~---~~li~~~L~~dp~~R~t~~  264 (288)
T d2jfla1         239 --SRWSSNF---KDFLKKCLEKNVDARWTTS  264 (288)
T ss_dssp             --GGSCHHH---HHHHHHHSCSSTTTSCCHH
T ss_pred             --ccCCHHH---HHHHHHHccCChhHCcCHH
Confidence              0122211   5899999999999999953

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-51  Score=376.89  Aligned_cols=239  Identities=20%  Similarity=0.216  Sum_probs=187.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CC-----cEEEEEEeccC-CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCee
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NE-----QEVAIKRLAWT-SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~-----~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~   95 (345)
                      .+|++.++||+|+||+||+|... .+     ..||+|.+... .......|.+|+.+|.++ +|||||+++++|.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            57999999999999999999753 22     37999998654 334456799999999998 899999999999999999


Q ss_pred             EEEEecCCCCChHHHHH--------------------------------------hHHHHHHHHHhcCCCceEEeccCCC
Q 039516           96 LLVYEFMPNKSLDSSFS--------------------------------------GTFKDLLCLHKYSRLRVIHRDLKAS  137 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~--------------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~  137 (345)
                      ++|||||++|+|.+++.                                      +++.+|.|||..   +||||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence            99999999999988762                                      567778888865   8999999999


Q ss_pred             CeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 039516          138 NILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTE  216 (345)
Q Consensus       138 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~  216 (345)
                      |||++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987655444334445678999999999999999999999999999999998 89999765432


Q ss_pred             CcccHHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhc
Q 039516          217 RPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMN  280 (345)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~  280 (345)
                      ..      .......+.     .+.....++    .. .+++..||+.||++|||+.+++..|.+
T Consensus       274 ~~------~~~~~~~~~-----~~~~p~~~~----~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         274 AN------FYKLIQNGF-----KMDQPFYAT----EEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             HH------HHHHHHTTC-----CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH------HHHHHhcCC-----CCCCCCcCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            21      112222221     111111222    23 599999999999999998877666543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=369.55  Aligned_cols=240  Identities=21%  Similarity=0.278  Sum_probs=187.0

Q ss_pred             CCeeeEE-EeeccCCeEEEEEEcC---CCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           24 LDWHMYI-QQEQTRDRVILVGKFP---NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        24 ~~~~~~~-~lG~G~~g~vy~~~~~---~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      .+|.+.+ +||+|+||.||+|...   ++..||||+++.. .....+.|.+|+++|++++|||||+++|+|. .+.+|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec-cCeEEEE
Confidence            3477777 4999999999999653   3568999999755 3345678999999999999999999999986 4568999


Q ss_pred             EecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           99 YEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        99 ~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      ||||++|+|.+++.                +++.||.|||..   +|+||||||+|||++.++.+||+|||+++......
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            99999999988754                677888888875   89999999999999999999999999999875432


Q ss_pred             CC-CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          163 SG-ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      .. .......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+   +    ......+...     
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~----~~~i~~~~~~-----  231 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V----MAFIEQGKRM-----  231 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---H----HHHHHTTCCC-----
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCCC-----
Confidence            21 12233468999999999999999999999999999999998 999998654221   1    1222222211     


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                      .....++++-   .+++..||+.||++||||.++...|....
T Consensus       232 ~~p~~~~~~l---~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         232 ECPPECPPEL---YALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             CCCTTCCHHH---HHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCcCCHHH---HHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            1112233222   59999999999999999887776665543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=378.05  Aligned_cols=187  Identities=22%  Similarity=0.314  Sum_probs=163.2

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ...+|++.++||+|+||+||+|.. .+|+.||+|+++... ......+.+|+.+|++++|||||+++++|.+.++.|+||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            356799999999999999999975 579999999997653 334567999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||++|+|.+++.               +++.+|.|||..+  ||+||||||+|||++.++.+||+|||+|+.....   
T Consensus        84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---  158 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  158 (322)
T ss_dssp             ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence            9999999988765               6778888888643  7999999999999999999999999999875322   


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                       ......||+.|+|||++.+..|+.++||||+||++|||++|+.||....
T Consensus       159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence             2234689999999999999999999999999999999999999997644

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=369.26  Aligned_cols=242  Identities=20%  Similarity=0.240  Sum_probs=181.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCC-C----cEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPN-E----QEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~-~----~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      ..|.+.+.||+|+||.||+|.+.+ +    ..||||+++.. .......|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            468999999999999999997643 2    47999999755 33345679999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           98 VYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        98 v~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      |||||.++++.+.+.                +++.++.|||..   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            999999998876543                677778888875   7999999999999999999999999999876433


Q ss_pred             CCC-CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          162 ESG-ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ... .......||+.|+|||++.++.++.++|||||||++|||++|..|+......     .. .......+.       
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~~-~~~~i~~~~-------  230 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HE-VMKAINDGF-------  230 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HH-HHHHHHTTC-------
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----HH-HHHHHhccC-------
Confidence            222 1223356899999999999999999999999999999999976665432211     11 112222221       


Q ss_pred             cCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          241 TLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       241 ~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                        +...+...... .+++.+||+.||++||||.++...|.++++
T Consensus       231 --~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         231 --RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             --CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence              11112222233 699999999999999999988888877765

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-51  Score=367.21  Aligned_cols=233  Identities=21%  Similarity=0.267  Sum_probs=178.5

Q ss_pred             EEeeccCCeEEEEEEcC---CCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecCCC
Q 039516           30 IQQEQTRDRVILVGKFP---NEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFMPN  104 (345)
Q Consensus        30 ~~lG~G~~g~vy~~~~~---~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  104 (345)
                      ++||+|+||.||+|.+.   +++.||||+++..  +....+.|.+|+++|++++|||||+++|+|. .+..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence            46999999999999753   3578999999654  2334567999999999999999999999985 4567999999999


Q ss_pred             CChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC-Cccc
Q 039516          105 KSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG-ANTN  168 (345)
Q Consensus       105 gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~  168 (345)
                      |+|.+++.               +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++........ ....
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            99988765               677888888875   7999999999999999999999999999876433222 1223


Q ss_pred             ceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCCCC
Q 039516          169 RIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGSCP  247 (345)
Q Consensus       169 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  247 (345)
                      ...||+.|+|||++.+..++.++|||||||++|||+| |+.||......      + .......+...     .....++
T Consensus       169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~------~-~~~~i~~~~~~-----~~p~~~~  236 (277)
T d1xbba_         169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------E-VTAMLEKGERM-----GCPAGCP  236 (277)
T ss_dssp             --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCCC-----CCCTTCC
T ss_pred             ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH------H-HHHHHHcCCCC-----CCCcccC
Confidence            3568999999999999999999999999999999998 89999864321      1 11222222211     1112233


Q ss_pred             hhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcc
Q 039516          248 PNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNL  281 (345)
Q Consensus       248 ~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~l  281 (345)
                      .+.   .+++.+||+.||++|||+.++...|...
T Consensus       237 ~~~---~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         237 REM---YDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             HHH---HHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHH---HHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            222   5899999999999999987776666543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-50  Score=358.42  Aligned_cols=228  Identities=21%  Similarity=0.285  Sum_probs=174.6

Q ss_pred             eeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE----CCeeEEE
Q 039516           26 WHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH----GEERLLV   98 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~lv   98 (345)
                      |+..++||+|+||+||+|.. .+++.||+|.+...  .....+.|.+|+++|++++|||||++++++.+    +..+|+|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            35667899999999999975 57899999998654  33446679999999999999999999999875    3468999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC-CCCCEEEEccccceeecCCC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD-DQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      ||||++|+|.+++.               +++.+|.|||... .+|+||||||+|||++ .++.+||+|||+++...   
T Consensus        91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~---  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---  166 (270)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred             EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc---
Confidence            99999999988765               6677777777651 2399999999999996 57899999999997542   


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                       ........||+.|+|||++.+ .++.++|||||||++|||++|+.||......      .........+....    .+
T Consensus       167 -~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~----~~  234 (270)
T d1t4ha_         167 -ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPA----SF  234 (270)
T ss_dssp             -TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCG----GG
T ss_pred             -CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCc----cc
Confidence             223345689999999998865 6999999999999999999999999754321      11122222221111    11


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ....+++.   .+++.+||+.||++|||+.
T Consensus       235 ~~~~~~~~---~~li~~~l~~dp~~R~s~~  261 (270)
T d1t4ha_         235 DKVAIPEV---KEIIEGCIRQNKDERYSIK  261 (270)
T ss_dssp             GGCCCHHH---HHHHHHHSCSSGGGSCCHH
T ss_pred             CccCCHHH---HHHHHHHccCCHhHCcCHH
Confidence            11122222   5899999999999999953

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.3e-51  Score=370.36  Aligned_cols=243  Identities=21%  Similarity=0.295  Sum_probs=191.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      ..+|++.++||+|+||+||+|+..      +++.||||+++... ....+.|.+|+++|++++||||++++++|...+..
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            456999999999999999999753      45799999997653 33456799999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHH---------------------------------------hHHHHHHHHHhcCCCceEEeccCC
Q 039516           96 LLVYEFMPNKSLDSSFS---------------------------------------GTFKDLLCLHKYSRLRVIHRDLKA  136 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~---------------------------------------~~~~~l~~lh~~~~~~ivHrdlk~  136 (345)
                      ++||||+++|+|.+++.                                       +++.+|.|||..   +||||||||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp  168 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT  168 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcc
Confidence            99999999999988763                                       456667777765   899999999


Q ss_pred             CCeeeCCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCC-CCCCCCCC
Q 039516          137 SNILLDDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK-KNNKSYHT  215 (345)
Q Consensus       137 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~-~p~~~~~~  215 (345)
                      +|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|. +||.....
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            99999999999999999998664443333444567899999999999999999999999999999999986 56665432


Q ss_pred             CCcccHHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          216 ERPLNLVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .      +.... ...+....     ....++++-   .+++..||+.||++||||.+++..|.++++
T Consensus       249 ~------e~~~~-v~~~~~~~-----~p~~~~~~~---~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         249 E------EVIYY-VRDGNILA-----CPENCPLEL---YNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             H------HHHHH-HHTTCCCC-----CCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             H------HHHHH-HHcCCCCC-----CCccchHHH---HHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            1      22222 22332211     112233222   599999999999999999999888887764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.9e-50  Score=364.04  Aligned_cols=233  Identities=18%  Similarity=0.185  Sum_probs=167.9

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ....|++.+.||+|+||+||+|.. .+|+.||||++.... ......+.+|+.+|++++|||||++++++.+++..|+||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            345599999999999999999965 579999999997553 233456889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC---CCCCEEEEccccceeecCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD---DQLNTKISDFGMARIFGVN  161 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfgl~~~~~~~  161 (345)
                      |||++|+|.+++.               +++.+|.|||..   ||+||||||+|||+.   .++.+||+|||+++.....
T Consensus        87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            9999999988765               667777777765   899999999999995   5788999999999865432


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                         .......||+.|+|||++.+..++.++|||||||++|||++|+.||......      ....... .+...  ++..
T Consensus       164 ---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~-~~~~~--~~~~  231 (307)
T d1a06a_         164 ---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQIL-KAEYE--FDSP  231 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHH-TTCCC--CCTT
T ss_pred             ---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHh-ccCCC--CCCc
Confidence               2233468999999999999999999999999999999999999999754311      1111111 11111  1111


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      .....+++.   .+++.+||+.||++|||+.
T Consensus       232 ~~~~~s~~~---~~li~~~L~~dP~~R~s~~  259 (307)
T d1a06a_         232 YWDDISDSA---KDFIRHLMEKDPEKRFTCE  259 (307)
T ss_dssp             TTTTSCHHH---HHHHHHHSCSSGGGSCCHH
T ss_pred             cccCCCHHH---HHHHHHHccCCHhHCcCHH
Confidence            111233222   5999999999999999953

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-50  Score=361.82  Aligned_cols=239  Identities=23%  Similarity=0.321  Sum_probs=182.0

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      ..+|++.++||+|+||.||+|...+++.||||+++... ...+.|.+|+.++++++|||||+++|+|. .+..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence            35799999999999999999998888899999996543 45678999999999999999999999984 56689999999


Q ss_pred             CCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          103 PNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       103 ~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ++|+|..++.                 +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence            9999876643                 677888888876   7999999999999999999999999999876433222 


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDGS  245 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  245 (345)
                      ......||+.|+|||++.++.++.++|||||||++|||++|..|+.....     ..+.. .....+.     .+.....
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-----~~~~~-~~i~~~~-----~~~~~~~  238 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVL-DQVERGY-----RMPCPPE  238 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHH-HHHHTTC-----CCCCCTT
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-----HHHHH-HHHHhcC-----CCCCCcc
Confidence            22335789999999999999999999999999999999997666544221     11111 1111221     1111122


Q ss_pred             CChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          246 CPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       246 ~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                      ++    .. .+++.+||+.||++||||.+++..|.+..
T Consensus       239 ~~----~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         239 CP----ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             SC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             cC----HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            23    23 59999999999999999887766666544

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-50  Score=368.80  Aligned_cols=226  Identities=23%  Similarity=0.319  Sum_probs=179.1

Q ss_pred             CCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCCc---cCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTSG---QGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      ..|+.+++||+|+||+||+|. ..+|+.||||+++....   ...+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            349999999999999999996 46799999999975532   33457899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||++|+|..++.               +++.||.|||..   ||+||||||+|||++.++.+||+|||+++....    
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence            9999998865433               677788888875   899999999999999999999999999986532    


Q ss_pred             CcccceeecCCccccchhcc---CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          165 ANTNRIVGTYGYMSLEYTMS---GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                        .....||+.|+|||++.+   +.|+.++|||||||++|||++|+.||.....      ........... .....   
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~~~-~~~~~---  235 (309)
T d1u5ra_         168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE-SPALQ---  235 (309)
T ss_dssp             --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-CCCCS---
T ss_pred             --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCC-CCCCC---
Confidence              233579999999999864   4689999999999999999999999975432      11122222221 11111   


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                       ...++++.   .+++.+||+.||.+|||+.
T Consensus       236 -~~~~s~~~---~~li~~~L~~dP~~Rpt~~  262 (309)
T d1u5ra_         236 -SGHWSEYF---RNFVDSCLQKIPQDRPTSE  262 (309)
T ss_dssp             -CTTSCHHH---HHHHHHHTCSSGGGSCCHH
T ss_pred             -CCCCCHHH---HHHHHHHCcCChhHCcCHH
Confidence             11223222   5899999999999999954

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-49  Score=361.48  Aligned_cols=243  Identities=17%  Similarity=0.167  Sum_probs=190.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|++++.||+|+||.||++.. .+|+.||||++++.   .......+.+|+.+|++++|||||++++++.+.+.+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            3699999999999999999964 67999999999653   3345678999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.+|.+||+|||+++.....  .
T Consensus        85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~--~  159 (337)
T d1o6la_          85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--G  159 (337)
T ss_dssp             ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--T
T ss_pred             eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC--C
Confidence            9999999987765               455566666655   8999999999999999999999999999865332  2


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..      .... ....+.+      .+..
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~-~i~~~~~------~~p~  226 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFE-LILMEEI------RFPR  226 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH-HHHHCCC------CCCT
T ss_pred             cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHHH-HHhcCCC------CCCc
Confidence            2334578999999999999999999999999999999999999999864421      1111 1112211      1112


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccc
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKN  289 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~  289 (345)
                      .++++.   .+++..||+.||.+||+...  ..+.+++++..+.+
T Consensus       227 ~~s~~~---~dli~~~L~~dP~~R~~~~~--~~~~eil~Hp~f~~  266 (337)
T d1o6la_         227 TLSPEA---KSLLAGLLKKDPKQRLGGGP--SDAKEVMEHRFFLS  266 (337)
T ss_dssp             TSCHHH---HHHHHHHTCSSTTTSTTCST--TTHHHHHTSGGGTT
T ss_pred             cCCHHH---HHHHHhhccCCchhhccccc--ccHHHHHcCccccc
Confidence            233332   58999999999999998432  12344555554444

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.5e-49  Score=366.13  Aligned_cols=233  Identities=16%  Similarity=0.129  Sum_probs=185.9

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      ...+|++.++||+|+||.||+|.. .+|+.||||+++.........+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            345699999999999999999964 5799999999987655556788999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeC--CCCCEEEEccccceeecCCC
Q 039516          101 FMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLD--DQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus       101 ~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~--~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      ||++|+|.+.+.                +++.+|.|||..   ||+||||||+|||++  .++.+||+|||+++..... 
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-  182 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-  182 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence            999999976543                667777777765   899999999999997  5789999999999987432 


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                        .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+....      ........ +...  +....
T Consensus       183 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~-~~~~--~~~~~  251 (352)
T d1koba_         183 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKR-CDWE--FDEDA  251 (352)
T ss_dssp             --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHH-CCCC--CCSST
T ss_pred             --CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCCC--CCccc
Confidence              2334568999999999999999999999999999999999999999764321      11111111 1110  11111


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ....+++.   .+++.+||+.||.+|||+.
T Consensus       252 ~~~~s~~~---~~li~~~L~~dp~~R~s~~  278 (352)
T d1koba_         252 FSSVSPEA---KDFIKNLLQKEPRKRLTVH  278 (352)
T ss_dssp             TTTSCHHH---HHHHHTTSCSSGGGSCCHH
T ss_pred             ccCCCHHH---HHHHHHHccCChhHCcCHH
Confidence            11233222   5999999999999999954

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.3e-49  Score=367.02  Aligned_cols=231  Identities=16%  Similarity=0.137  Sum_probs=184.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      .+|++.++||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|+|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            4699999999999999999965 579999999998766666778999999999999999999999999999999999999


Q ss_pred             CCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC--CCCEEEEccccceeecCCCCC
Q 039516          103 PNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD--QLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       103 ~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ++|+|.+++.                +++.+|.|||..   |||||||||+|||++.  ++.+||+|||+++.....   
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~---  179 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---  179 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT---
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc---
Confidence            9999988763                667777777765   8999999999999964  578999999999876432   


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.      .+...... .+...  ++.....
T Consensus       180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~-~~~~~--~~~~~~~  250 (350)
T d1koaa2         180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVK-SCDWN--MDDSAFS  250 (350)
T ss_dssp             SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HTCCC--SCCGGGG
T ss_pred             cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCCC--CCccccc
Confidence            233456899999999999999999999999999999999999999975432      11111111 11110  0111101


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..+.+.   .+++.+||+.||++|||+.
T Consensus       251 ~~s~~~---~~li~~~L~~dP~~R~t~~  275 (350)
T d1koaa2         251 GISEDG---KDFIRKLLLADPNTRMTIH  275 (350)
T ss_dssp             GCCHHH---HHHHHHHCCSSGGGSCCHH
T ss_pred             CCCHHH---HHHHHHHccCChhHCcCHH
Confidence            122211   5899999999999999943

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=353.32  Aligned_cols=233  Identities=16%  Similarity=0.168  Sum_probs=183.2

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC------ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCe
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS------GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEE   94 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~   94 (345)
                      +...|++.++||+|+||+||+|.. .+|+.||||+++...      ....+.|.+|+.+|++++|||||++++++.+.+.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            345699999999999999999975 579999999986431      2346789999999999999999999999999999


Q ss_pred             eEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC----CEEEEccccc
Q 039516           95 RLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL----NTKISDFGMA  155 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfgl~  155 (345)
                      .|+|||||++|+|.+++.               +++.+|.|||..   +|+||||||+|||++.++    .+||+|||++
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999999988765               567777777765   799999999999998776    4999999999


Q ss_pred             eeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 039516          156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDL  235 (345)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (345)
                      .......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....      +..... ..+...
T Consensus       165 ~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i-~~~~~~  234 (293)
T d1jksa_         165 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANV-SAVNYE  234 (293)
T ss_dssp             EECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH-HTTCCC
T ss_pred             hhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HHHHHH-HhcCCC
Confidence            8764322   233457899999999999999999999999999999999999999764321      111111 111110


Q ss_pred             ccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          236 ELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       236 ~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                        +.+......+.+.   .+++.+||+.||++|||+.
T Consensus       235 --~~~~~~~~~s~~~---~~li~~~L~~dP~~R~s~~  266 (293)
T d1jksa_         235 --FEDEYFSNTSALA---KDFIRRLLVKDPKKRMTIQ  266 (293)
T ss_dssp             --CCHHHHTTSCHHH---HHHHHTTSCSSGGGSCCHH
T ss_pred             --CCchhcCCCCHHH---HHHHHHHccCChhHCcCHH
Confidence              0000001122211   5899999999999999953

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-50  Score=365.75  Aligned_cols=240  Identities=22%  Similarity=0.314  Sum_probs=183.2

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCc----EEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQ----EVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~----~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l   97 (345)
                      .+|++.++||+|+||.||+|.. .+|+    +||+|+++.. .....+.|.+|+.++++++|||||+++|+|.+ +..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence            4699999999999999999975 3444    6899998654 44567889999999999999999999999976 45788


Q ss_pred             EEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           98 VYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        98 v~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      +|||+.+|+|.+.+.                +++.||.|||..   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            899999999876544                677788888875   8999999999999999999999999999876544


Q ss_pred             CCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      ..........||+.|+|||++.++.++.++|||||||++|||+| |..||......+   +..    ....+..     +
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~----~i~~~~~-----~  232 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGER-----L  232 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH----HHHHTCC-----C
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCC-----C
Confidence            44434444578999999999999999999999999999999998 788887654322   111    1111111     0


Q ss_pred             cCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          241 TLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       241 ~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                          ..++..... .+++.+||+.||.+|||+.+++..+..+..
T Consensus       233 ----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         233 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                112222233 589999999999999999888877776654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-48  Score=355.48  Aligned_cols=240  Identities=17%  Similarity=0.185  Sum_probs=186.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|++.++||+|+||+||++.. .+|+.||||+++..   .....+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4699999999999999999975 57999999999643   3345678999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||+||+|...+.               +++.+|.|||.   .||+||||||+|||++.++.+||+|||+++.....   
T Consensus        84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             eecCCccccccccccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence            9999999877654               55556666665   48999999999999999999999999999876432   


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.      ......... +..      ....
T Consensus       158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~-~~~------~~p~  222 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILN-AEL------RFPP  222 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH-CCC------CCCT
T ss_pred             --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHc-CCC------CCCC
Confidence              2346899999999999999999999999999999999999999976432      111122221 111      1111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccccccccc
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKN  289 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~  289 (345)
                      ..+++.   .+++.+||+.||.+||+..  .....+++.+..+.+
T Consensus       223 ~~s~~~---~~li~~~L~~dp~~R~~~~--r~t~~~il~Hp~f~~  262 (316)
T d1fota_         223 FFNEDV---KDLLSRLITRDLSQRLGNL--QNGTEDVKNHPWFKE  262 (316)
T ss_dssp             TSCHHH---HHHHHHHTCSCTTTCTTSS--TTTTHHHHTSGGGSS
T ss_pred             CCCHHH---HHHHHHHhhhCHHhccccc--hhhHHHHHcCccccc
Confidence            122222   5899999999999997421  112344555554444

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=356.65  Aligned_cols=241  Identities=21%  Similarity=0.253  Sum_probs=179.1

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCC----CcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPN----EQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~----~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      .+|++.+.||+|+||.||+|....    +..||||.++.. .....+.|.+|+.+|++++|||||++++++. .+..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            469999999999999999997532    457999998654 3334567999999999999999999999985 5778999


Q ss_pred             EecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           99 YEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        99 ~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      |||+++|+|.+++.                +++.+|.|||..   +|+||||||+||+++.++.+||+|||+++......
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            99999999977643                667777777775   89999999999999999999999999998764322


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccccccc
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLT  241 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  241 (345)
                      . .......||+.|+|||++.+..++.++|||||||++|||++ |..||......+   +..    ....+...     .
T Consensus       163 ~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~----~i~~~~~~-----~  229 (273)
T d1mp8a_         163 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG----RIENGERL-----P  229 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCC-----C
T ss_pred             c-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcCCCC-----C
Confidence            2 22334578999999999999999999999999999999998 899997654322   111    11122211     1


Q ss_pred             CCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccc
Q 039516          242 LDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPG  284 (345)
Q Consensus       242 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~  284 (345)
                      ....++.+.   .+++..||+.||++|||+.++...|.++++.
T Consensus       230 ~~~~~~~~~---~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         230 MPPNCPPTL---YSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             CCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHH---HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            112233222   5999999999999999999988888877763

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=352.53  Aligned_cols=232  Identities=21%  Similarity=0.293  Sum_probs=177.8

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCeeEEEEecC
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH-GEERLLVYEFM  102 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~  102 (345)
                      .+|++.++||+|+||.||+|.+. |+.||||+++..  ...+.|.+|++++++++||||++++|+|.+ .+.+++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            46899999999999999999984 889999999654  345789999999999999999999999865 45689999999


Q ss_pred             CCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          103 PNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       103 ~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      ++|+|.+++.                 +++.+|.|||..   +|+||||||+|||++.++.+||+|||+++.....    
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----  156 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  156 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----
Confidence            9999988764                 667778888865   7999999999999999999999999999865321    


Q ss_pred             cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                       .....+|..|+|||++.++.++.++|||||||++|||+| |+.||......+   +...    ...+.     .+....
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~----i~~~~-----~~~~~~  223 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGY-----KMDAPD  223 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH----HTTTC-----CCCCCT
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCC-----CCCCCc
Confidence             223467899999999999999999999999999999998 677776543221   2211    11221     111111


Q ss_pred             CCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          245 SCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       245 ~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                      .++    .. .+++.+||+.||.+||||.++...|..+.
T Consensus       224 ~~~----~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         224 GCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCC----HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            222    33 59999999999999999988777776554

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5e-48  Score=360.01  Aligned_cols=246  Identities=20%  Similarity=0.178  Sum_probs=184.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHH---HHHHHhcCCCCeeeEEEEEEECCeeE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNE---AKLIAKLQYTNLVKLLGCSIHGEERL   96 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E---~~~l~~l~H~niv~~~~~~~~~~~~~   96 (345)
                      .+|++.+.||+|+||.||+|.. .+|+.||||++...   .......+.+|   +.+++.++|||||++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            4699999999999999999975 57999999998543   12233344444   66777778999999999999999999


Q ss_pred             EEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCC
Q 039516           97 LVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVN  161 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~  161 (345)
                      +|||||++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            9999999999988765               566667777765   8999999999999999999999999999976433


Q ss_pred             CCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccc
Q 039516          162 ESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDL  240 (345)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  240 (345)
                      .    .....||+.|+|||++.. ..++.++|||||||++|||+||+.||.........   ....... ..      ..
T Consensus       161 ~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~~~~~~-~~------~~  226 (364)
T d1omwa3         161 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTL-TM------AV  226 (364)
T ss_dssp             C----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---HHHHHSS-SC------CC
T ss_pred             c----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhcc-cC------CC
Confidence            2    334579999999999875 56899999999999999999999999865433221   1111100 00      11


Q ss_pred             cCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccccccccee
Q 039516          241 TLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLH  291 (345)
Q Consensus       241 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~  291 (345)
                      .....++++.   .+++.+||+.||++|||+..  ....+++++..+.+.+
T Consensus       227 ~~~~~~s~~~---~~li~~~L~~dP~~R~t~~~--~~a~eil~Hp~f~~i~  272 (364)
T d1omwa3         227 ELPDSFSPEL---RSLLEGLLQRDVNRRLGCLG--RGAQEVKESPFFRSLD  272 (364)
T ss_dssp             CCCSSSCHHH---HHHHHHHTCSSTTTSTTTSS--STHHHHHTSGGGTTCC
T ss_pred             CCCCCCCHHH---HHHHHHHcccCHHHhCCCcc--cCHHHHHcCccccCCC
Confidence            1111233322   59999999999999999532  1234555565555433

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=353.61  Aligned_cols=252  Identities=18%  Similarity=0.161  Sum_probs=186.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHH--HHHHHhcCCCCeeeEEEEEEECC----eeEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNE--AKLIAKLQYTNLVKLLGCSIHGE----ERLL   97 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E--~~~l~~l~H~niv~~~~~~~~~~----~~~l   97 (345)
                      .+|.+.++||+|+||.||+|++ +|+.||||+++...   ...+..|  +..+.+++|||||+++++|.+.+    .+|+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            4688889999999999999987 58999999996432   3344444  44556789999999999998654    6799


Q ss_pred             EEecCCCCChHHHHH--------------hHHHHHHHHHhc-----CCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           98 VYEFMPNKSLDSSFS--------------GTFKDLLCLHKY-----SRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        98 v~e~~~~gsL~~~l~--------------~~~~~l~~lh~~-----~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      |||||++|+|.++++              +++.++.|+|..     +.+||+||||||+|||++.++.+||+|||+++..
T Consensus        79 v~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             EEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            999999999988876              678889999974     5679999999999999999999999999999987


Q ss_pred             cCCCCC--CcccceeecCCccccchhccC------CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcc--------cHH
Q 039516          159 GVNESG--ANTNRIVGTYGYMSLEYTMSG------TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPL--------NLV  222 (345)
Q Consensus       159 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~--------~~~  222 (345)
                      ......  .......||+.|+|||++.+.      .++.++|||||||++|||+||..||.........        ...
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            543221  123346799999999998754      3678899999999999999999887543322110        111


Q ss_pred             HHHHHHHhcCCccccccccCCCCCCh-hHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          223 GIAWQLWNEGKDLELIDLTLDGSCPP-NEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       223 ~~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .........+    .++|.+...... +.... .+++.+||+.||++||||.++...|.++.+
T Consensus       239 ~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         239 EEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            1122222111    122322222222 23334 789999999999999999988888877654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.1e-48  Score=346.91  Aligned_cols=244  Identities=20%  Similarity=0.225  Sum_probs=179.9

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCC---ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC----
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTS---GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE----   93 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----   93 (345)
                      ...+|++.+.||+|+||.||+|. ..+|+.||||+++...   ......|.+|++++++++|||||++++++...+    
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            35569999999999999999996 4679999999997653   233557999999999999999999999988654    


Q ss_pred             eeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceee
Q 039516           94 ERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIF  158 (345)
Q Consensus        94 ~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~  158 (345)
                      ..|+||||+++++|.+++.               +++.+|.|||..   ||+||||||+|||++.++..+|+|||.+...
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence            3799999999999987654               667777777765   8999999999999999999999999998765


Q ss_pred             cCCC-CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 039516          159 GVNE-SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLEL  237 (345)
Q Consensus       159 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
                      .... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.....      .+........+...  
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~--  233 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP--  233 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC--
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCC--
Confidence            4322 12233446899999999999999999999999999999999999999975431      22233333332221  


Q ss_pred             ccccCCCCCChhHHHHHHHHhhccCCCCCcCC-CCCcchhhhhc
Q 039516          238 IDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQ-CPMLFPCLLMN  280 (345)
Q Consensus       238 ~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~~~~~~l~~  280 (345)
                       ........+++.   .+++.+||+.||++|| |+.++...|..
T Consensus       234 -~~~~~~~~s~~l---~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         234 -PSARHEGLSADL---DAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             -GGGTSSSCCHHH---HHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -CchhccCCCHHH---HHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence             111112233222   4899999999999999 55544444433

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=358.54  Aligned_cols=243  Identities=21%  Similarity=0.215  Sum_probs=181.9

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccC-CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC-Ce
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHG-EE   94 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~-~~   94 (345)
                      .+|++.++||+|+||.||+|...      +++.||||+++.. .....+.+.+|...+.++ +|+|||.+++++... ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            56999999999999999999742      3578999999754 333456788888888877 689999999998764 46


Q ss_pred             eEEEEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC
Q 039516           95 RLLVYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD  143 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~  143 (345)
                      .++|||||++|+|.+++.                               +++.||.|||..   +|+||||||+|||++.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence            899999999999988763                               566777777765   8999999999999999


Q ss_pred             CCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCC-CCCCCCCCCCcccHH
Q 039516          144 QLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK-KNNKSYHTERPLNLV  222 (345)
Q Consensus       144 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~-~p~~~~~~~~~~~~~  222 (345)
                      ++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+||. .||.......     
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-----  244 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----  244 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-----
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-----
Confidence            9999999999998765444444445568999999999999999999999999999999999975 5676543221     


Q ss_pred             HHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          223 GIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       223 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                       ........+...     .....++++.   .+++.+||+.||++|||+.++...|.++++
T Consensus       245 -~~~~~~~~~~~~-----~~~~~~~~~l---~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         245 -EFCRRLKEGTRM-----RAPDYTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             -HHHHHHHHTCCC-----CCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHhcCCCC-----CCCccCCHHH---HHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence             112222222211     1111223222   599999999999999999998888888775

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-47  Score=353.58  Aligned_cols=243  Identities=17%  Similarity=0.153  Sum_probs=189.7

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVY   99 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~   99 (345)
                      .+|+++++||+|+||.||++.. .+|+.||||+++..   .....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4699999999999999999965 57999999998643   2345678999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC
Q 039516          100 EFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG  164 (345)
Q Consensus       100 e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~  164 (345)
                      ||+.+|+|.+++.               +++.+|.|||..   +||||||||+|||++.++.+||+|||+++....    
T Consensus       121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~----  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred             ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc----
Confidence            9999999977654               566777777765   899999999999999999999999999997642    


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                       ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....      ........ .+..      ....
T Consensus       194 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~-~~~~------~~p~  259 (350)
T d1rdqe_         194 -RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIV-SGKV------RFPS  259 (350)
T ss_dssp             -CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCCC------CCCT
T ss_pred             -ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHh-cCCC------CCCc
Confidence             22346899999999999999999999999999999999999999975431      11111121 1111      1111


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCC-CCCcchhhhhcccccccccceeeE
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQ-CPMLFPCLLMNLLPGLYLKNLHFL  293 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~~~~~~l~~ll~~~~~~~~~~~  293 (345)
                      .++++.   .+++..||+.||.+|+ ++..   .+.+++.+..+...++.
T Consensus       260 ~~s~~~---~~li~~~L~~dP~kR~~~~r~---t~~ell~Hp~f~~~~~~  303 (350)
T d1rdqe_         260 HFSSDL---KDLLRNLLQVDLTKRFGNLKN---GVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             TCCHHH---HHHHHHHSCSCTTTCTTSSTT---TTHHHHTSGGGTTCCHH
T ss_pred             cCCHHH---HHHHHHHhhhCHHhccccccc---cHHHHHcCccccCCCHH
Confidence            233322   4999999999999995 2221   23445556555554443

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-49  Score=359.13  Aligned_cols=242  Identities=23%  Similarity=0.308  Sum_probs=192.8

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC------CCcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP------NEQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~------~~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      ..+|++.++||+|+||.||+|.+.      +++.||||+++.. .......|.+|+.++++++|||||+++++|...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            467999999999999999999763      3578999999754 333445799999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHH-------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEE
Q 039516           96 LLVYEFMPNKSLDSSFS-------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKIS  150 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~-------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~  150 (345)
                      ++||||+++|+|.+++.                         ++++||.|||..   +|+||||||+|||++.++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence            99999999999987643                         566777777765   79999999999999999999999


Q ss_pred             ccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCC-CCCCCCCCCCcccHHHHHHHHH
Q 039516          151 DFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGK-KNNKSYHTERPLNLVGIAWQLW  229 (345)
Q Consensus       151 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~~  229 (345)
                      |||+++...............||+.|+|||.+.++.++.++||||||+++|||+||. .||.....      ........
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~~~i~  249 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFVM  249 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHHHHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHHHHHH
Confidence            999998765444434445567899999999999999999999999999999999985 66654332      22222222


Q ss_pred             hcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          230 NEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       230 ~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                       .+.....     ...++    .. .+++.+||+.||++||||.+++..|.+.++
T Consensus       250 -~~~~~~~-----p~~~~----~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         250 -EGGLLDK-----PDNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             -TTCCCCC-----CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -hCCCCCC-----cccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence             2221111     11122    23 699999999999999999988888877665

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-49  Score=358.95  Aligned_cols=243  Identities=20%  Similarity=0.223  Sum_probs=191.6

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc------CCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCe
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF------PNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEE   94 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~------~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~   94 (345)
                      ..+|++.++||+|+||.||+|++      .+++.||||+++... ......|.+|+.+++++ +|||||+++++|.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            36799999999999999999974      346799999997653 33455799999999999 69999999999999999


Q ss_pred             eEEEEecCCCCChHHHHH---------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeee
Q 039516           95 RLLVYEFMPNKSLDSSFS---------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILL  141 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~---------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill  141 (345)
                      .++|||||++|+|.+++.                                 +++.++.|||..   +++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence            999999999999877652                                 667777788876   79999999999999


Q ss_pred             CCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCccc
Q 039516          142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLN  220 (345)
Q Consensus       142 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~  220 (345)
                      +.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |.+||......+   
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~---  255 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---  255 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999987754444444455689999999999999999999999999999999999 555554433221   


Q ss_pred             HHHHHHHHHhcCCccccccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          221 LVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                         ........+.         ....+...... .+++.+||+.||.+||||.+++..|.+.+.
T Consensus       256 ---~~~~~i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         256 ---KFYKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             ---HHHHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHhcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence               1112222221         11111112233 599999999999999999888877776554

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.8e-47  Score=340.10  Aligned_cols=233  Identities=20%  Similarity=0.217  Sum_probs=182.7

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCcc---------CHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQ---------GRVEFQNEAKLIAKLQ-YTNLVKLLGCSI   90 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~---------~~~~~~~E~~~l~~l~-H~niv~~~~~~~   90 (345)
                      |..+|++.+.||+|+||+||++.. .+|+.||||+++.....         ..+.+.+|+.++++++ |||||++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            567899999999999999999965 67999999999654211         2346889999999997 999999999999


Q ss_pred             ECCeeEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccc
Q 039516           91 HGEERLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMA  155 (345)
Q Consensus        91 ~~~~~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~  155 (345)
                      +++..|+|||||++|+|.+++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence            9999999999999999988875               667777777765   7999999999999999999999999999


Q ss_pred             eeecCCCCCCcccceeecCCccccchhcc------CCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHH
Q 039516          156 RIFGVNESGANTNRIVGTYGYMSLEYTMS------GTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLW  229 (345)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  229 (345)
                      +......   ......||+.|+|||++.+      ..++.++||||+||++|||++|+.||......      . .....
T Consensus       158 ~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~-~~~~i  227 (277)
T d1phka_         158 CQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------L-MLRMI  227 (277)
T ss_dssp             EECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHH
T ss_pred             eEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------H-HHHHH
Confidence            9874322   2334679999999998863      34688999999999999999999999864321      1 11212


Q ss_pred             hcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          230 NEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       230 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..+... ...+ ....++++.   .+++.+||+.||.+|||+.
T Consensus       228 ~~~~~~-~~~~-~~~~~s~~~---~~li~~~L~~~p~~R~s~~  265 (277)
T d1phka_         228 MSGNYQ-FGSP-EWDDYSDTV---KDLVSRFLVVQPQKRYTAE  265 (277)
T ss_dssp             HHTCCC-CCTT-TGGGSCHHH---HHHHHHHCCSSGGGSCCHH
T ss_pred             HhCCCC-CCCc-ccccCCHHH---HHHHHHHccCChhHCcCHH
Confidence            222211 0000 111123222   5999999999999999953

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-49  Score=353.53  Aligned_cols=239  Identities=23%  Similarity=0.293  Sum_probs=175.8

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC--CC--cEEEEEEeccC---CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP--NE--QEVAIKRLAWT---SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~--~~--~~VaiK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~   95 (345)
                      ..+|++.++||+|+||.||+|...  ++  ..||||+++..   .....+.|.+|+.+|++++|||||+++|+|.+ +..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            367999999999999999999752  23  47899998654   33345689999999999999999999999964 577


Q ss_pred             EEEEecCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           96 LLVYEFMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      ++||||+++|++.+.+.                +++.||.|||..   +|+||||||+||+++.++.+||+|||+++...
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            99999999999876643                677888888875   89999999999999999999999999999864


Q ss_pred             CCCCCC-cccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 039516          160 VNESGA-NTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLNLVGIAWQLWNEGKDLEL  237 (345)
Q Consensus       160 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
                      ...... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.....      .+........+...+ 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------~~~~~~i~~~~~~~~-  235 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERLP-  235 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCCC-
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------HHHHHHHHhCCCCCC-
Confidence            432221 2223457889999999999999999999999999999998 8999975432      222233333321111 


Q ss_pred             ccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhh
Q 039516          238 IDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLM  279 (345)
Q Consensus       238 ~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~  279 (345)
                          ....++.+-   .+++..||+.||++|||+.++...|.
T Consensus       236 ----~~~~~~~~l---~~li~~cl~~dp~~RPt~~ei~~~L~  270 (273)
T d1u46a_         236 ----RPEDCPQDI---YNVMVQCWAHKPEDRPTFVALRDFLL  270 (273)
T ss_dssp             ----CCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----CcccccHHH---HHHHHHHcCCChhHCcCHHHHHHHHH
Confidence                111233222   59999999999999999876654443

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-49  Score=357.05  Aligned_cols=243  Identities=18%  Similarity=0.233  Sum_probs=189.1

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEcC--------CCcEEEEEEeccCC-ccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKFP--------NEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHG   92 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~~--------~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~   92 (345)
                      ..+|++.++||+|+||.||+|+..        ++..||||+++... ......+.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            467999999999999999999642        23579999997653 34457789999999888 799999999999999


Q ss_pred             CeeEEEEecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeee
Q 039516           93 EERLLVYEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILL  141 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill  141 (345)
                      +..++|||||++|+|.+++.                               +++.+|.|||..   +||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence            99999999999999988763                               566677777765   79999999999999


Q ss_pred             CCCCCEEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHh-CCCCCCCCCCCCccc
Q 039516          142 DDQLNTKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVC-GKKNNKSYHTERPLN  220 (345)
Q Consensus       142 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~t-g~~p~~~~~~~~~~~  220 (345)
                      +.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |..||.....     
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-----  243 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  243 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-----
Confidence            9999999999999998765554444555688999999999999999999999999999999998 6888865432     


Q ss_pred             HHHHHHHHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          221 LVGIAWQLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                        ......+..+....     ....++++-   .+++.+||+.||++|||+.++.+.|.+++.
T Consensus       244 --~~~~~~i~~~~~~~-----~p~~~~~~l---~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         244 --EELFKLLKEGHRMD-----KPSNCTNEL---YMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             --HHHHHHHHTTCCCC-----CCSSCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHHHcCCCCC-----CCccchHHH---HHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence              12223333332111     111122221   599999999999999999988888877653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=356.14  Aligned_cols=239  Identities=22%  Similarity=0.264  Sum_probs=183.5

Q ss_pred             CCeeeEEEeeccCCeEEEEEEcC-CCc--EEEEEEeccC-CccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKFP-NEQ--EVAIKRLAWT-SGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~~-~~~--~VaiK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv   98 (345)
                      .+|++.++||+|+||.||+|.+. +|.  .||||+++.. .....+.|.+|+++|+++ +|||||+++++|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            56889999999999999999764 443  5888988644 344566899999999999 799999999999999999999


Q ss_pred             EecCCCCChHHHHH-------------------------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCE
Q 039516           99 YEFMPNKSLDSSFS-------------------------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNT  147 (345)
Q Consensus        99 ~e~~~~gsL~~~l~-------------------------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~  147 (345)
                      |||+++|+|.+++.                               +++.|+.|||..   +|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            99999999988763                               566777777765   89999999999999999999


Q ss_pred             EEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCC-CCCCCCCCCcccHHHHHH
Q 039516          148 KISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKK-NNKSYHTERPLNLVGIAW  226 (345)
Q Consensus       148 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~-p~~~~~~~~~~~~~~~~~  226 (345)
                      ||+|||+++......   ......||..|+|||.+.++.++.++|||||||++|||++|.. ||....      ......
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~~~  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYE  237 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHH
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHHHH
Confidence            999999998653222   1233568999999999999999999999999999999999764 665432      111112


Q ss_pred             HHHhcCCccccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          227 QLWNEGKDLELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       227 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .. ..+.     .+.....++++.   .+++.+||+.||++||||.++...|.++++
T Consensus       238 ~i-~~~~-----~~~~~~~~~~~~---~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         238 KL-PQGY-----RLEKPLNCDDEV---YDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HG-GGTC-----CCCCCTTBCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH-HhcC-----CCCCCccCCHHH---HHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11 1221     111111122221   599999999999999999999988888776

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-48  Score=352.56  Aligned_cols=238  Identities=21%  Similarity=0.277  Sum_probs=183.7

Q ss_pred             EEEeeccCCeEEEEEEcCC----CcEEEEEEeccC-CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCeeEEEEecC
Q 039516           29 YIQQEQTRDRVILVGKFPN----EQEVAIKRLAWT-SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH-GEERLLVYEFM  102 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~~----~~~VaiK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~  102 (345)
                      .++||+|+||+||+|.+.+    ...||||+++.. +....++|.+|+++|++++|||||+++|++.. +...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            5679999999999998643    236999999754 44456789999999999999999999999876 46899999999


Q ss_pred             CCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCC--
Q 039516          103 PNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESG--  164 (345)
Q Consensus       103 ~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~--  164 (345)
                      ++|+|.+++.                +++.+|.|+|..   +|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            9999987665                566777777765   7999999999999999999999999999876433222  


Q ss_pred             CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLDG  244 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  244 (345)
                      .......||+.|+|||.+.++.++.++||||||+++|||+||..||.......     ....... .+..  ...|   .
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-----~~~~~i~-~g~~--~~~p---~  257 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLL-QGRR--LLQP---E  257 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHH-TTCC--CCCC---T
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-----HHHHHHH-cCCC--CCCc---c
Confidence            12233578999999999999999999999999999999999888876432211     1111112 2211  1111   1


Q ss_pred             CCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          245 SCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       245 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                      .++.+-   .+++..||+.||++||||.+++..|.+++.
T Consensus       258 ~~~~~l---~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         258 YCPDPL---YEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             TCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCcHHH---HHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            122211   599999999999999999999999888875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-47  Score=348.82  Aligned_cols=228  Identities=20%  Similarity=0.209  Sum_probs=182.3

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC---CccCHHHHHHHHHHHH-hcCCCCeeeEEEEEEECCeeEEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT---SGQGRVEFQNEAKLIA-KLQYTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~~~~~~~~~~~~~lv   98 (345)
                      .+|++.+.||+|+||+||+|.. .+|+.||||++++.   .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            3699999999999999999965 57999999999643   2345667788887765 68999999999999999999999


Q ss_pred             EecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           99 YEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        99 ~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      ||||++|+|.+++.               +++.||.|||..   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-  157 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence            99999999988775               566777777765   79999999999999999999999999998654322 


Q ss_pred             CCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccCC
Q 039516          164 GANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTLD  243 (345)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  243 (345)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....       .......+..      ...
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~------~~p  223 (320)
T d1xjda_         158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNP------FYP  223 (320)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC------CCC
T ss_pred             -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC------CCC
Confidence             22334689999999999999999999999999999999999999997643211       1111112211      111


Q ss_pred             CCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          244 GSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       244 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ..++++.   .+++.+||+.||++|||+.
T Consensus       224 ~~~s~~~---~dli~~~L~~dP~~R~s~~  249 (320)
T d1xjda_         224 RWLEKEA---KDLLVKLFVREPEKRLGVR  249 (320)
T ss_dssp             TTSCHHH---HHHHHHHSCSSGGGSBTTB
T ss_pred             ccCCHHH---HHHHHHhcccCCCCCcCHH
Confidence            1233322   5999999999999999964

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-48  Score=350.28  Aligned_cols=183  Identities=23%  Similarity=0.268  Sum_probs=150.2

Q ss_pred             eeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCcc-----CHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           27 HMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQ-----GRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        27 ~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +.++.||+|+||+||+|.. .+|+.||||+++.....     ....+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            3567899999999999975 56999999999654221     13468899999999999999999999999999999999


Q ss_pred             cCCCCChHHHH---------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          101 FMPNKSLDSSF---------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       101 ~~~~gsL~~~l---------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      |+.++++....               .+++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--  155 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--  155 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence            99987665433               2677777777765   899999999999999999999999999986543222  


Q ss_pred             cccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~  205 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS  205 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC
Confidence            22335799999999988754 57999999999999999999999997644

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-47  Score=348.36  Aligned_cols=232  Identities=16%  Similarity=0.163  Sum_probs=182.7

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEe
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYE  100 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  100 (345)
                      +..+|.+.++||+|+||+||+|.. .+|+.||||.++... .....+.+|+++|++++|||||++++++.+++.+|+|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            456799999999999999999965 578999999997654 234568899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCC--CCEEEEccccceeecCCC
Q 039516          101 FMPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQ--LNTKISDFGMARIFGVNE  162 (345)
Q Consensus       101 ~~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~--~~~kl~Dfgl~~~~~~~~  162 (345)
                      ||+||+|.+++.                +++.+|.|||..   ||+||||||+|||++.+  ..+||+|||+++....  
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--  156 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--  156 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc--
Confidence            999999987764                667778888865   89999999999999854  5799999999987632  


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccccccC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELIDLTL  242 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  242 (345)
                       ........||+.|+|||.+.+..++.++||||+||++|+|++|+.||......      ........ +...  ++...
T Consensus       157 -~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~-~~~~--~~~~~  226 (321)
T d1tkia_         157 -GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMN-AEYT--FDEEA  226 (321)
T ss_dssp             -TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH-TCCC--CCHHH
T ss_pred             -CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCCC--CChhh
Confidence             22334467899999999999999999999999999999999999999764321      11111111 1110  01000


Q ss_pred             CCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          243 DGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       243 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                      ...++++.   .+++..||+.||.+|||+.
T Consensus       227 ~~~~s~~~---~~li~~~L~~dp~~R~s~~  253 (321)
T d1tkia_         227 FKEISIEA---MDFVDRLLVKERKSRMTAS  253 (321)
T ss_dssp             HTTSCHHH---HHHHHTTSCSSGGGSCCHH
T ss_pred             ccCCCHHH---HHHHHHHccCChhHCcCHH
Confidence            01122222   5899999999999999954

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=347.07  Aligned_cols=229  Identities=17%  Similarity=0.130  Sum_probs=173.2

Q ss_pred             CCeeeEEE-eeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhc-CCCCeeeEEEEEEE----CCeeE
Q 039516           24 LDWHMYIQ-QEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKL-QYTNLVKLLGCSIH----GEERL   96 (345)
Q Consensus        24 ~~~~~~~~-lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~----~~~~~   96 (345)
                      .+|++..+ ||+|+||+||+|.. .+|+.||||+++.     ...+.+|+.++.++ +|||||+++++|.+    +..+|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            46998865 99999999999964 6799999999953     35678899987655 89999999999875    45689


Q ss_pred             EEEecCCCCChHHHHH-----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC---CCCEEEEccccce
Q 039516           97 LVYEFMPNKSLDSSFS-----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD---QLNTKISDFGMAR  156 (345)
Q Consensus        97 lv~e~~~~gsL~~~l~-----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgl~~  156 (345)
                      +|||||+||+|.+++.                 +++.+|.|||..   ||+||||||+|||++.   .+.+||+|||+++
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceee
Confidence            9999999999988775                 667778888865   8999999999999975   5679999999998


Q ss_pred             eecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccc
Q 039516          157 IFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLE  236 (345)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
                      ......   ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.........   .......+..  
T Consensus       163 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i~~~~~--  234 (335)
T d2ozaa1         163 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQY--  234 (335)
T ss_dssp             ECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS--
T ss_pred             eccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHHhcCCC--
Confidence            764332   23345899999999999999999999999999999999999999976543221110   0000000000  


Q ss_pred             cccccCCCCCChhHHHH-HHHHhhccCCCCCcCCCCC
Q 039516          237 LIDLTLDGSCPPNEDAF-LLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       237 ~~d~~l~~~~~~~~~~~-~~l~~~Cl~~~P~~RPs~~  272 (345)
                          .+........... .+++.+||+.||++|||+.
T Consensus       235 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~  267 (335)
T d2ozaa1         235 ----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT  267 (335)
T ss_dssp             ----SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             ----CCCCcccccCCHHHHHHHHHHccCChhHCcCHH
Confidence                0000000011123 6899999999999999954

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-47  Score=339.23  Aligned_cols=222  Identities=18%  Similarity=0.209  Sum_probs=173.6

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCc------cCHHHHHHHHHHHHhcC--CCCeeeEEEEEEEC
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSG------QGRVEFQNEAKLIAKLQ--YTNLVKLLGCSIHG   92 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~   92 (345)
                      +..+|++.+.||+|+||+||+|.. .+|+.||||+++....      .....+.+|+.+|++++  |||||++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            456799999999999999999964 5799999999864311      12234678999999996  89999999999999


Q ss_pred             CeeEEEEecCCC-CChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC-CCCEEEEccccc
Q 039516           93 EERLLVYEFMPN-KSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD-QLNTKISDFGMA  155 (345)
Q Consensus        93 ~~~~lv~e~~~~-gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgl~  155 (345)
                      +..++||||+.+ +++.+++.               +++.+|.|||..   ||+||||||+|||++. ++.+||+|||++
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence            999999999976 56655443               667777777765   8999999999999985 478999999999


Q ss_pred             eeecCCCCCCcccceeecCCccccchhccCCc-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCc
Q 039516          156 RIFGVNESGANTNRIVGTYGYMSLEYTMSGTV-SIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKD  234 (345)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (345)
                      +.....    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....            ..... . 
T Consensus       159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~-~-  220 (273)
T d1xwsa_         159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRG-Q-  220 (273)
T ss_dssp             EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHC-C-
T ss_pred             eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhc-c-
Confidence            875322    2334689999999999987765 577999999999999999999996421            11111 1 


Q ss_pred             cccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCC
Q 039516          235 LELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPM  272 (345)
Q Consensus       235 ~~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  272 (345)
                           ..+...++++.   .+++.+||+.||++|||+.
T Consensus       221 -----~~~~~~~s~~~---~~li~~~L~~dp~~R~s~~  250 (273)
T d1xwsa_         221 -----VFFRQRVSSEC---QHLIRWCLALRPSDRPTFE  250 (273)
T ss_dssp             -----CCCSSCCCHHH---HHHHHHHTCSSGGGSCCHH
T ss_pred             -----cCCCCCCCHHH---HHHHHHHccCCHhHCcCHH
Confidence                 11222234332   4899999999999999954

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-46  Score=337.85  Aligned_cols=185  Identities=24%  Similarity=0.319  Sum_probs=154.0

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +|+++++||+|+||.||+|.. .+|+.||||+++...  ......+.+|+++|++++|||||++++++.+++..|+||||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~   82 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   82 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence            699999999999999999964 679999999996542  23467899999999999999999999999999999999999


Q ss_pred             CCCCChHHH----------------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCC
Q 039516          102 MPNKSLDSS----------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGA  165 (345)
Q Consensus       102 ~~~gsL~~~----------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  165 (345)
                      +.++.+...                +.+++.+|.|||..   |||||||||+|||++.++.+||+|||+++......  .
T Consensus        83 ~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~  157 (298)
T d1gz8a_          83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--R  157 (298)
T ss_dssp             CSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--B
T ss_pred             cCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc--c
Confidence            987544322                22677777788765   89999999999999999999999999998764322  2


Q ss_pred             cccceeecCCccccchhccCC-cCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          166 NTNRIVGTYGYMSLEYTMSGT-VSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ......||+.|+|||++.... ++.++||||+||++|+|++|+.||...+
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~  207 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS  207 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence            233457999999999877665 4789999999999999999999997643

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1e-45  Score=333.78  Aligned_cols=185  Identities=22%  Similarity=0.299  Sum_probs=155.5

Q ss_pred             CeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEecC
Q 039516           25 DWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  102 (345)
                      +|+++++||+|+||+||+|...+|+.||||+++..  .....+.+.+|+.+|++++|||||++++++...+..+++|||+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~   82 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence            69999999999999999998888999999999654  2334678999999999999999999999999999999999999


Q ss_pred             CCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCcc
Q 039516          103 PNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGANT  167 (345)
Q Consensus       103 ~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  167 (345)
                      .++.+..+..               +++.+|.|||..   +|+||||||+|||++.++.+||+|||++........  ..
T Consensus        83 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~  157 (286)
T d1ob3a_          83 DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KY  157 (286)
T ss_dssp             SEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             hhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc--cc
Confidence            8876654433               677888888865   899999999999999999999999999987643222  22


Q ss_pred             cceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          168 NRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       168 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~  205 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS  205 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC
Confidence            33568999999998875 456899999999999999999999997654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=333.99  Aligned_cols=186  Identities=22%  Similarity=0.295  Sum_probs=152.0

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CC-CcEEEEEEeccC--CccCHHHHHHHHHHHHhc---CCCCeeeEEEEEEE----
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PN-EQEVAIKRLAWT--SGQGRVEFQNEAKLIAKL---QYTNLVKLLGCSIH----   91 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~-~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~~----   91 (345)
                      ..+|+++++||+|+||+||+|.. .+ ++.||||+++..  .......+.+|+.+|+.|   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            45799999999999999999975 34 678999998643  222334567788877766   79999999999863    


Q ss_pred             -CCeeEEEEecCCCCChHHH----------------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccc
Q 039516           92 -GEERLLVYEFMPNKSLDSS----------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGM  154 (345)
Q Consensus        92 -~~~~~lv~e~~~~gsL~~~----------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl  154 (345)
                       ....+++|||+.++++...                +.+++.+|.|||..   +|+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhh
Confidence             2467999999998866432                23677777888765   899999999999999999999999999


Q ss_pred             ceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          155 ARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ++.....   .......||+.|+|||++.+..|+.++||||+||++|||++|+.||....
T Consensus       163 ~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~  219 (305)
T d1blxa_         163 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  219 (305)
T ss_dssp             CCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence            8765322   22344689999999999999999999999999999999999999997654

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-45  Score=333.91  Aligned_cols=250  Identities=16%  Similarity=0.175  Sum_probs=187.2

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc----CCCcEEEEEEeccC----CccCHHHHHHHHHHHHhcCC-CCeeeEEEEEEECCe
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF----PNEQEVAIKRLAWT----SGQGRVEFQNEAKLIAKLQY-TNLVKLLGCSIHGEE   94 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~----~~~~~VaiK~~~~~----~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~   94 (345)
                      .+|++++.||+|+||+||+|..    .+|+.||||.++..    .....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999964    25899999998643    22345678899999999966 899999999999999


Q ss_pred             eEEEEecCCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           95 RLLVYEFMPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      .+++|||+.+|+|.+++.               +++.++.|+|..   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            999999999999987765               566777777765   89999999999999999999999999998764


Q ss_pred             CCCCCCcccceeecCCccccchhccC--CcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcccc
Q 039516          160 VNESGANTNRIVGTYGYMSLEYTMSG--TVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLEL  237 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
                      ..... ......|++.|+|||.+.+.  .++.++|||||||++|+|++|+.||...........+  ........     
T Consensus       181 ~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~~~~-----  252 (322)
T d1vzoa_         181 ADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSE-----  252 (322)
T ss_dssp             GGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHCC-----
T ss_pred             ccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcccCC-----
Confidence            33222 23345789999999998764  4678999999999999999999999876544332221  11111111     


Q ss_pred             ccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccccccccccee
Q 039516          238 IDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLPGLYLKNLH  291 (345)
Q Consensus       238 ~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~~~~~~~~~  291 (345)
                        +.....++++.   .+++.+||+.||.+|||+..  ....+++++..+...+
T Consensus       253 --~~~~~~~s~~~---~~li~~~l~~dP~~R~s~~~--~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         253 --PPYPQEMSALA---KDLIQRLLMKDPKKRLGCGP--RDADEIKEHLFFQKIN  299 (322)
T ss_dssp             --CCCCTTSCHHH---HHHHHHHTCSSGGGSTTSST--TTHHHHHTSGGGTTCC
T ss_pred             --CCCcccCCHHH---HHHHHHHcccCHHHcCCCCc--ccHHHHHcCHhhcCCC
Confidence              11111123222   58999999999999998531  1234445555444433

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=333.23  Aligned_cols=196  Identities=23%  Similarity=0.249  Sum_probs=156.0

Q ss_pred             eeecccccccccCCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEE
Q 039516           10 QTWSEGAKFVENSSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLL   86 (345)
Q Consensus        10 ~s~~~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~   86 (345)
                      |...++.+..-.+...|+++++||+|+||+||+|.. .+|+.||||+++..  +....+.+.+|+++|++++|||||+++
T Consensus         4 ~~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~   83 (346)
T d1cm8a_           4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL   83 (346)
T ss_dssp             BCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCS
T ss_pred             cEEEeccCceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEE
Confidence            334456555555778899999999999999999974 57999999999754  333456789999999999999999999


Q ss_pred             EEEEECC------eeEEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC
Q 039516           87 GCSIHGE------ERLLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN  146 (345)
Q Consensus        87 ~~~~~~~------~~~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~  146 (345)
                      ++|...+      .+|+||||+ +.+|....+              +++.+|.|||..   ||+||||||+|||++.++.
T Consensus        84 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~  159 (346)
T d1cm8a_          84 DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCE  159 (346)
T ss_dssp             EEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred             EEeccCccccccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccc
Confidence            9997654      569999999 555654433              677788888865   8999999999999999999


Q ss_pred             EEEEccccceeecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       147 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      +||+|||+++.....     .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....
T Consensus       160 ~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~  223 (346)
T d1cm8a_         160 LKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD  223 (346)
T ss_dssp             EEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence            999999999876432     234578999999998876 456899999999999999999999997653

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=329.46  Aligned_cols=188  Identities=20%  Similarity=0.284  Sum_probs=151.6

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE--------C
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH--------G   92 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--------~   92 (345)
                      .+|+++++||+|+||+||+|.. .+|+.||||++...  ......++.+|+.+|++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            5699999999999999999975 57999999998644  33456789999999999999999999998855        3


Q ss_pred             CeeEEEEecCCCCChHHH---------------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516           93 EERLLVYEFMPNKSLDSS---------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~---------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      +..|+||||+.++.+...               +.+++.+|.|||..   ||+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeee
Confidence            467999999987765432               22566677777755   899999999999999999999999999987


Q ss_pred             ecCCCC--CCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          158 FGVNES--GANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       158 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      +.....  ........||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~  226 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT  226 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence            653221  1222335799999999998764 68999999999999999999999997643

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.7e-43  Score=320.31  Aligned_cols=246  Identities=17%  Similarity=0.173  Sum_probs=184.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCC-CCeeeEEEEEEECCeeEEEEec
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY-TNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      ..|++.++||+|+||+||+|.. .+|+.||||+++....  ...+.+|++.++.++| +|++.+++++..+...++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            4699999999999999999974 5799999999865432  2357789999999965 8999999999999999999999


Q ss_pred             CCCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC-----CCCEEEEccccceeecC
Q 039516          102 MPNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD-----QLNTKISDFGMARIFGV  160 (345)
Q Consensus       102 ~~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~-----~~~~kl~Dfgl~~~~~~  160 (345)
                      + +++|.+++.                +++.+|.+||   +.||+||||||+|||++.     ++.+||+|||+++....
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9 678877654                3444455555   558999999999999964     57799999999998654


Q ss_pred             CCCC-----CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCcc
Q 039516          161 NESG-----ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDL  235 (345)
Q Consensus       161 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (345)
                      ....     .......||+.|+|||++.+..++.++|||||||++|||+||+.||.........................
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  238 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence            3221     12334679999999999999999999999999999999999999998655443322222111111111111


Q ss_pred             ccccccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhcccc
Q 039516          236 ELIDLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLLP  283 (345)
Q Consensus       236 ~~~d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll~  283 (345)
                           .+...++++-   ..++..|++.+|++||+...+...+.++++
T Consensus       239 -----~l~~~~p~~l---~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         239 -----ELCAGFPEEF---YKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             -----HHTTTSCHHH---HHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             -----HhcCCCCHHH---HHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence                 1112233222   488889999999999997666666666554

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=329.63  Aligned_cols=182  Identities=21%  Similarity=0.275  Sum_probs=148.3

Q ss_pred             CCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC------Cee
Q 039516           23 SLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG------EER   95 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------~~~   95 (345)
                      ..+|...++||+|+||+||+|.. .+|+.||||+++....    .+.+|+++|++++||||++++++|...      ..+
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            34699999999999999999975 5799999999975532    234799999999999999999998643      357


Q ss_pred             EEEEecCCCCChHHH------------------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC-CEEEEccccce
Q 039516           96 LLVYEFMPNKSLDSS------------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL-NTKISDFGMAR  156 (345)
Q Consensus        96 ~lv~e~~~~gsL~~~------------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgl~~  156 (345)
                      |+|||||+++.+..+                  +.+++.||.|||..   ||+||||||+|||++.++ .+||+|||+++
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence            899999987643322                  22666777777754   899999999999999775 89999999998


Q ss_pred             eecCCCCCCcccceeecCCccccchhcc-CCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          157 IFGVNESGANTNRIVGTYGYMSLEYTMS-GTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ......   ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus       172 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~  227 (350)
T d1q5ka_         172 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS  227 (350)
T ss_dssp             ECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred             hccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence            764332   2234579999999998775 568999999999999999999999997644

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-43  Score=320.15  Aligned_cols=244  Identities=19%  Similarity=0.188  Sum_probs=175.4

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCe-eeEEEEEEECCeeEEEEecC
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNL-VKLLGCSIHGEERLLVYEFM  102 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~  102 (345)
                      .|++.++||+|+||.||+|.. .+|+.||||.+......  ..+..|+++++.++|+|+ +.+.+++.+.+..++||||+
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~   85 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   85 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence            599999999999999999964 57999999998755322  357899999999987664 55556667888999999999


Q ss_pred             CCCChHHHHH----------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCC---CCCEEEEccccceeecCCCC
Q 039516          103 PNKSLDSSFS----------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDD---QLNTKISDFGMARIFGVNES  163 (345)
Q Consensus       103 ~~gsL~~~l~----------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      .+ +|...+.                +++.+|.|||..   ||+||||||+|||++.   +..+||+|||+++.+.....
T Consensus        86 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          86 GP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             CC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             CC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            55 4443332                566677777765   8999999999999864   45799999999998754332


Q ss_pred             C-----CcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHHhcCCccccc
Q 039516          164 G-----ANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYHTERPLNLVGIAWQLWNEGKDLELI  238 (345)
Q Consensus       164 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
                      .     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................     
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-----  236 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-----  236 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-----
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-----
Confidence            2     123446799999999999999999999999999999999999999987654333222211111100000     


Q ss_pred             cccCCCCCChhHHHHHHHHhhccCCCCCcCCCCCcchhhhhccc
Q 039516          239 DLTLDGSCPPNEDAFLLVSCVCKSKQQIDVQCPMLFPCLLMNLL  282 (345)
Q Consensus       239 d~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~~~~~l~~ll  282 (345)
                      .+.+...++++-   .+++..||+.+|++||++.++...|..++
T Consensus       237 ~~~~~~~~p~~~---~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         237 IEVLCKGYPSEF---ATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             HHHHTTTSCHHH---HHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             hhHhccCCCHHH---HHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            111112233322   48999999999999999766555555443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-43  Score=327.93  Aligned_cols=188  Identities=19%  Similarity=0.246  Sum_probs=152.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCC-ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECC----eeEE
Q 039516           24 LDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTS-GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGE----ERLL   97 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----~~~l   97 (345)
                      ..|+++++||+|+||+||+|. ..+|+.||||+++... ....+.+.+|+.+|++++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            459999999999999999996 4689999999997543 334567899999999999999999999987543    2355


Q ss_pred             EEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCC
Q 039516           98 VYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNES  163 (345)
Q Consensus        98 v~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~  163 (345)
                      +++|+.+|+|.+++.              +++.+|.|||..   |||||||||+|||++.++.+||+|||+++.......
T Consensus        88 l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            566777999988765              667777777765   899999999999999999999999999987643322


Q ss_pred             -CCcccceeecCCccccchhc-cCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          164 -GANTNRIVGTYGYMSLEYTM-SGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       164 -~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                       ........||+.|+|||++. +..++.++||||+||++|+|++|+.||....
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~  217 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  217 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence             12234467999999999885 4567899999999999999999999997643

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-43  Score=317.30  Aligned_cols=183  Identities=22%  Similarity=0.264  Sum_probs=156.3

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEECCeeEEEEec
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHGEERLLVYEF  101 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  101 (345)
                      +|+++++||+|+||+||+|+. .+|+.||||+++...  ......+.+|+.+|++++||||+++++++.+....++||++
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~   82 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence            699999999999999999975 678999999996543  23467899999999999999999999999999999999999


Q ss_pred             CCCCChHHHHH---------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCCCCCc
Q 039516          102 MPNKSLDSSFS---------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNESGAN  166 (345)
Q Consensus       102 ~~~gsL~~~l~---------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  166 (345)
                      +.+++|..++.               +++.+|.|||..   ||+||||||+|||++.++.+||+|||.++.......  .
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~  157 (292)
T d1unla_          83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--C  157 (292)
T ss_dssp             CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--C
T ss_pred             ccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc--c
Confidence            99988765543               667777777775   899999999999999999999999999988654322  2


Q ss_pred             ccceeecCCccccchhccCC-cCcccchhhHHHHHHHHHhCCCCCCC
Q 039516          167 TNRIVGTYGYMSLEYTMSGT-VSIKTDVFGFGVLVLKIVCGKKNNKS  212 (345)
Q Consensus       167 ~~~~~gt~~y~aPE~~~~~~-~~~~~Di~SlG~il~el~tg~~p~~~  212 (345)
                      .....+++.|+|||++.+.. ++.++||||+||++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  204 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence            22345788899999887665 68999999999999999999999754

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.9e-43  Score=320.12  Aligned_cols=184  Identities=18%  Similarity=0.300  Sum_probs=155.1

Q ss_pred             CCCCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEEC--CeeEE
Q 039516           22 SSLDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHG--EERLL   97 (345)
Q Consensus        22 ~~~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~--~~~~l   97 (345)
                      ...+|+++++||+|+||+||+|.. .+|+.||||+++..   ..+.+.+|+++|++++ ||||+++++++...  ...++
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            346799999999999999999965 67999999999643   3568899999999995 99999999999753  56899


Q ss_pred             EEecCCCCChHHHH------------HhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCC-CEEEEccccceeecCCCCC
Q 039516           98 VYEFMPNKSLDSSF------------SGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQL-NTKISDFGMARIFGVNESG  164 (345)
Q Consensus        98 v~e~~~~gsL~~~l------------~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~~  164 (345)
                      |||||.+++|....            .+++.||.|||..   ||+||||||+|||++.++ .+||+|||+++......  
T Consensus       110 v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--  184 (328)
T d3bqca1         110 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--  184 (328)
T ss_dssp             EEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--
T ss_pred             EEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC--
Confidence            99999999986543            3777888888876   899999999999998665 58999999998764332  


Q ss_pred             CcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          165 ANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                       ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus       185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~  234 (328)
T d3bqca1         185 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  234 (328)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             -cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence             23345789999999998765 47999999999999999999999997654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-42  Score=320.91  Aligned_cols=185  Identities=22%  Similarity=0.228  Sum_probs=146.0

Q ss_pred             CCeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccC--CccCHHHHHHHHHHHHhcCCCCeeeEEEEEEE------CCe
Q 039516           24 LDWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWT--SGQGRVEFQNEAKLIAKLQYTNLVKLLGCSIH------GEE   94 (345)
Q Consensus        24 ~~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~------~~~   94 (345)
                      .+|+++++||+|+||+||+|.. .+|+.||||+++..  +......+.+|+.++++++|||||+++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5699999999999999999975 57999999999754  33345578999999999999999999999864      368


Q ss_pred             eEEEEecCCCCChHHH------------HHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecCCC
Q 039516           95 RLLVYEFMPNKSLDSS------------FSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGVNE  162 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~------------l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~~~  162 (345)
                      +|+|||||.++.+...            +.+++.+|.|||..   ||+||||||+|||++.++.+|++|||+++..... 
T Consensus        97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~-  172 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-  172 (355)
T ss_dssp             EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccccc-
Confidence            8999999987655432            22667777777766   8999999999999999999999999998876432 


Q ss_pred             CCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          163 SGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                        .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+
T Consensus       173 --~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~  222 (355)
T d2b1pa1         173 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             --cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence              22344578999999999999999999999999999999999999997543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-42  Score=317.88  Aligned_cols=184  Identities=18%  Similarity=0.239  Sum_probs=150.7

Q ss_pred             CCCeeeEEEeeccCCeEEEEEE-cCCCcEEEEEEeccCC--ccCHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----Ce
Q 039516           23 SLDWHMYIQQEQTRDRVILVGK-FPNEQEVAIKRLAWTS--GQGRVEFQNEAKLIAKLQYTNLVKLLGCSIHG-----EE   94 (345)
Q Consensus        23 ~~~~~~~~~lG~G~~g~vy~~~-~~~~~~VaiK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~   94 (345)
                      ...|+++++||+|+||+||+|. ..+|+.||||+++...  ....+.+.+|+++|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            4569999999999999999996 4679999999997553  23455788999999999999999999998643     34


Q ss_pred             eEEEEecCCCCChHHHHH--------------hHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeecC
Q 039516           95 RLLVYEFMPNKSLDSSFS--------------GTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFGV  160 (345)
Q Consensus        95 ~~lv~e~~~~gsL~~~l~--------------~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~~  160 (345)
                      .+++|+|+.+|+|.+++.              +++.+|.|||..   ||+||||||+|||++.++.+|++|||++.....
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc
Confidence            477788888999987764              667777788765   899999999999999999999999999976432


Q ss_pred             CCCCCcccceeecCCccccchhccC-CcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          161 NESGANTNRIVGTYGYMSLEYTMSG-TVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                           ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+
T Consensus       174 -----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~  223 (348)
T d2gfsa1         174 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD  223 (348)
T ss_dssp             -----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             -----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence                 23345789999999987765 46899999999999999999999997643

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7e-37  Score=284.31  Aligned_cols=182  Identities=19%  Similarity=0.204  Sum_probs=144.6

Q ss_pred             CeeeEEEeeccCCeEEEEEEc-CCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-----------CCCeeeEEEEEEE-
Q 039516           25 DWHMYIQQEQTRDRVILVGKF-PNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-----------YTNLVKLLGCSIH-   91 (345)
Q Consensus        25 ~~~~~~~lG~G~~g~vy~~~~-~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~~~~~~~~-   91 (345)
                      .|+++++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+++.++           |+||+++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            499999999999999999975 679999999997542 23467889999998875           5789999998764 


Q ss_pred             -CCeeEEEEecCCCCCh------------------HHHHHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCC------
Q 039516           92 -GEERLLVYEFMPNKSL------------------DSSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLN------  146 (345)
Q Consensus        92 -~~~~~lv~e~~~~gsL------------------~~~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~------  146 (345)
                       ....+++|+++..+..                  ..++.+++.++.|||..+  ||+||||||+|||++.++.      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccce
Confidence             4566777777655432                  223347788888888743  8999999999999976543      


Q ss_pred             EEEEccccceeecCCCCCCcccceeecCCccccchhccCCcCcccchhhHHHHHHHHHhCCCCCCCCC
Q 039516          147 TKISDFGMARIFGVNESGANTNRIVGTYGYMSLEYTMSGTVSIKTDVFGFGVLVLKIVCGKKNNKSYH  214 (345)
Q Consensus       147 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~el~tg~~p~~~~~  214 (345)
                      ++++|||.+.....     ......||+.|+|||++.+..++.++||||+||++++|++|+.||....
T Consensus       171 ~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         171 IKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             EEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             eeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence            89999999986532     2233579999999999999999999999999999999999999997654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=1.2e-23  Score=177.17  Aligned_cols=155  Identities=16%  Similarity=0.131  Sum_probs=112.7

Q ss_pred             eeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCcc------------------CHHHHHHHHHHHHhcCCCCeeeEEE
Q 039516           26 WHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQ------------------GRVEFQNEAKLIAKLQYTNLVKLLG   87 (345)
Q Consensus        26 ~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~------------------~~~~~~~E~~~l~~l~H~niv~~~~   87 (345)
                      +.+.++||+|+||+||+|...+|+.||||+++.....                  ....+..|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            3578899999999999998888999999987532110                  1123457889999999999999887


Q ss_pred             EEEECCeeEEEEecCCCCChH--------HHHHhHHHHHHHHHhcCCCceEEeccCCCCeeeCCCCCEEEEccccceeec
Q 039516           88 CSIHGEERLLVYEFMPNKSLD--------SSFSGTFKDLLCLHKYSRLRVIHRDLKASNILLDDQLNTKISDFGMARIFG  159 (345)
Q Consensus        88 ~~~~~~~~~lv~e~~~~gsL~--------~~l~~~~~~l~~lh~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~~~  159 (345)
                      +.  .  .+++|||++++.+.        .++.+++.++.+||..   ||+||||||+|||+++++ ++|+|||++....
T Consensus        82 ~~--~--~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~liDFG~a~~~~  153 (191)
T d1zara2          82 WE--G--NAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVG  153 (191)
T ss_dssp             EE--T--TEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EEECCCTTCEETT
T ss_pred             ec--C--CEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EEEEECCCcccCC
Confidence            63  2  37999999886553        3455778888888875   899999999999998654 8999999997642


Q ss_pred             CCCCCCcccceeecCCccc------cchhccCCcCcccchhhHHHH
Q 039516          160 VNESGANTNRIVGTYGYMS------LEYTMSGTVSIKTDVFGFGVL  199 (345)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~Di~SlG~i  199 (345)
                      .+.    ..      .|..      .+.+ ...|+.++|+||..--
T Consensus       154 ~~~----~~------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         154 EEG----WR------EILERDVRNIITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             STT----HH------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred             CCC----cH------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence            111    10      1111      1111 3567889999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.58  E-value=9.2e-08  Score=82.16  Aligned_cols=139  Identities=16%  Similarity=0.101  Sum_probs=95.0

Q ss_pred             ccccccccCCCCeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEEC
Q 039516           14 EGAKFVENSSLDWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHG   92 (345)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~   92 (345)
                      ++.+..+.    |...+..++++.+.||+... +++.+.+|+...........+.+|...+..+. +--+.+++.++..+
T Consensus         8 ~l~~~~~~----~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~   82 (263)
T d1j7la_           8 ELKKLIEK----YRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHHHHTT----SEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHHHhhhc----eEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence            44444444    55555555566678998875 46677889886554344446778998888774 43467888888888


Q ss_pred             CeeEEEEecCCCCChHHH----------HHhHHHHHHHHHhc--------------------------------------
Q 039516           93 EERLLVYEFMPNKSLDSS----------FSGTFKDLLCLHKY--------------------------------------  124 (345)
Q Consensus        93 ~~~~lv~e~~~~gsL~~~----------l~~~~~~l~~lh~~--------------------------------------  124 (345)
                      +..++||++++|.++.+.          ...+++.+..||..                                      
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred             CceEEEEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence            999999999998776432          11223333333321                                      


Q ss_pred             ------------------CCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          125 ------------------SRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       125 ------------------~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                                        ....++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                              112379999999999999877678999987764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.36  E-value=2.4e-06  Score=72.62  Aligned_cols=123  Identities=19%  Similarity=0.124  Sum_probs=85.0

Q ss_pred             eeccCC-eEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcC--CCCeeeEEEEEEECCeeEEEEecCCCCChH
Q 039516           32 QEQTRD-RVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ--YTNLVKLLGCSIHGEERLLVYEFMPNKSLD  108 (345)
Q Consensus        32 lG~G~~-g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~gsL~  108 (345)
                      +..|.. +.||+....++..+.+|.......   ..+..|...++.+.  .-.+.+++.+..+++..++||+|++|.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            455554 689999887788889998754432   24667888887773  334677888888888899999999887653


Q ss_pred             H-------HHHhHHHHHHHHHh---------------------------------------------------c----CC
Q 039516          109 S-------SFSGTFKDLLCLHK---------------------------------------------------Y----SR  126 (345)
Q Consensus       109 ~-------~l~~~~~~l~~lh~---------------------------------------------------~----~~  126 (345)
                      +       ....+.+.+..||.                                                   .    ..
T Consensus        95 ~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  174 (255)
T d1nd4a_          95 SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED  174 (255)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred             cccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCC
Confidence            2       22222222222221                                                   1    11


Q ss_pred             CceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          127 LRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       127 ~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                      ..++|+|+.|.|||++.+..+-|+||+.+..
T Consensus       175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         175 LVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            2479999999999999876678999987754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.72  E-value=0.00013  Score=66.10  Aligned_cols=76  Identities=8%  Similarity=-0.061  Sum_probs=50.5

Q ss_pred             EEEeeccCCeEEEEEEcCC-CcEEEEEEeccC-------CccCHHHHHHHHHHHHhc-CC--CCeeeEEEEEEECCeeEE
Q 039516           29 YIQQEQTRDRVILVGKFPN-EQEVAIKRLAWT-------SGQGRVEFQNEAKLIAKL-QY--TNLVKLLGCSIHGEERLL   97 (345)
Q Consensus        29 ~~~lG~G~~g~vy~~~~~~-~~~VaiK~~~~~-------~~~~~~~~~~E~~~l~~l-~H--~niv~~~~~~~~~~~~~l   97 (345)
                      .+.||.|....||+....+ ++.|+||.-...       -+....+...|.+.|+.+ .+  ..+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4569999999999997654 678999975321       112234456788888766 23  456677665  4566789


Q ss_pred             EEecCCCCC
Q 039516           98 VYEFMPNKS  106 (345)
Q Consensus        98 v~e~~~~gs  106 (345)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.47  E-value=0.00013  Score=64.11  Aligned_cols=70  Identities=7%  Similarity=-0.008  Sum_probs=48.3

Q ss_pred             CCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCCCCe--eeEE-----EEEEECCeeEEEEecCCCCC
Q 039516           36 RDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQYTNL--VKLL-----GCSIHGEERLLVYEFMPNKS  106 (345)
Q Consensus        36 ~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~~~-----~~~~~~~~~~lv~e~~~~gs  106 (345)
                      .--.||+....+|+.|++|...... ...+++..|...+..|...++  +...     ..+...+..+.++++++|..
T Consensus        34 ~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          34 YENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ccceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            3458999999899999999986542 345678889998888743222  1111     12345667889999998754

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.40  E-value=0.00028  Score=61.41  Aligned_cols=145  Identities=13%  Similarity=0.058  Sum_probs=82.5

Q ss_pred             eeecccccccccCCC-CeeeEEEeeccCCeEEEEEEcCCCcEEEEEEeccCCccCHHHHHHHHHHHHhcCC-----CCee
Q 039516           10 QTWSEGAKFVENSSL-DWHMYIQQEQTRDRVILVGKFPNEQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQY-----TNLV   83 (345)
Q Consensus        10 ~s~~~~~~~~~~~~~-~~~~~~~lG~G~~g~vy~~~~~~~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~H-----~niv   83 (345)
                      .|.+|++.+.+.+.. ...-...|..|.--+.|+.+..+| .+++|++.....  ......|++++..|..     |..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence            456677777777654 344455577787788898877655 589999864322  2234456666666632     2221


Q ss_pred             eEE-E--EEEECCeeEEEEecCCCCChHHH----HH--------------------------------------------
Q 039516           84 KLL-G--CSIHGEERLLVYEFMPNKSLDSS----FS--------------------------------------------  112 (345)
Q Consensus        84 ~~~-~--~~~~~~~~~lv~e~~~~gsL~~~----l~--------------------------------------------  112 (345)
                      ... |  +.........++.+..+......    ..                                            
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            111 0  12234566777777766433110    00                                            


Q ss_pred             -----hHHHHHHHHHh----cCCCceEEeccCCCCeeeCCCCCEEEEcccccee
Q 039516          113 -----GTFKDLLCLHK----YSRLRVIHRDLKASNILLDDQLNTKISDFGMARI  157 (345)
Q Consensus       113 -----~~~~~l~~lh~----~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl~~~  157 (345)
                           .+......+..    ....|+||+|+.++||+++++...-|+||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence                 01111111111    1244899999999999999988778999998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.31  E-value=0.00048  Score=62.11  Aligned_cols=74  Identities=12%  Similarity=0.156  Sum_probs=52.1

Q ss_pred             eEEEeeccCCeEEEEEEcCC--------CcEEEEEEeccCCccCHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCeeEEE
Q 039516           28 MYIQQEQTRDRVILVGKFPN--------EQEVAIKRLAWTSGQGRVEFQNEAKLIAKLQ-YTNLVKLLGCSIHGEERLLV   98 (345)
Q Consensus        28 ~~~~lG~G~~g~vy~~~~~~--------~~~VaiK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv   98 (345)
                      .+++|+.|-.-.+|+....+        ...|.+++.- . ........+|..+++.+. +.-..++++++.+    .+|
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            34679999999999987653        3567777764 2 233456678999998884 4334578887642    689


Q ss_pred             EecCCCCCh
Q 039516           99 YEFMPNKSL  107 (345)
Q Consensus        99 ~e~~~~gsL  107 (345)
                      |||++|.++
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987544